<SEC-DOCUMENT>0001628280-21-016106.txt : 20210806
<SEC-HEADER>0001628280-21-016106.hdr.sgml : 20210806
<ACCEPTANCE-DATETIME>20210806170121
ACCESSION NUMBER:		0001628280-21-016106
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		136
CONFORMED PERIOD OF REPORT:	20210630
FILED AS OF DATE:		20210806
DATE AS OF CHANGE:		20210806

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUTERA INC
		CENTRAL INDEX KEY:			0001162461
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				770492262
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50644
		FILM NUMBER:		211153657

	BUSINESS ADDRESS:	
		STREET 1:		3240 BAYSHORE BOULEVARD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		94005

	MAIL ADDRESS:	
		STREET 1:		3240 BAYSHORE BOULEVARD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALTUS MEDICAL INC
		DATE OF NAME CHANGE:	20011119
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>cutr-20210630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:c7947e62-414c-45c3-9059-a14473012559,g:b6549df2-51ec-4e04-8ce7-629c1e713d47,d:b4896268598045f0bc55c9d056377420--><html xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:cutr="http://cutera.com/20210331/20210630" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cutr-20210630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80L2ZyYWc6OGZmMGM1MDBjOGMyNGU3ODlkZjM1YTRiODJiZDg0ZDIvdGFibGU6NjUwZWIxYmQ1NjQ5NDliNzhmNzFhM2VjYWE2ZTFhOTUvdGFibGVyYW5nZTo2NTBlYjFiZDU2NDk0OWI3OGY3MWEzZWNhYTZlMWE5NV8yLTEtMS0xLTA_51935e3e-a23d-453b-9b79-4d1943d47ed4">0001162461</ix:nonNumeric><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80L2ZyYWc6OGZmMGM1MDBjOGMyNGU3ODlkZjM1YTRiODJiZDg0ZDIvdGFibGU6NjUwZWIxYmQ1NjQ5NDliNzhmNzFhM2VjYWE2ZTFhOTUvdGFibGVyYW5nZTo2NTBlYjFiZDU2NDk0OWI3OGY3MWEzZWNhYTZlMWE5NV8zLTEtMS0xLTA_ade6a893-1ee1-4e13-933c-f6ac1d887efa">false</ix:nonNumeric><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80L2ZyYWc6OGZmMGM1MDBjOGMyNGU3ODlkZjM1YTRiODJiZDg0ZDIvdGFibGU6NjUwZWIxYmQ1NjQ5NDliNzhmNzFhM2VjYWE2ZTFhOTUvdGFibGVyYW5nZTo2NTBlYjFiZDU2NDk0OWI3OGY3MWEzZWNhYTZlMWE5NV80LTEtMS0xLTA_e0c4e1e6-200e-478b-81d2-cd625a28cb73">December 31</ix:nonNumeric><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80L2ZyYWc6OGZmMGM1MDBjOGMyNGU3ODlkZjM1YTRiODJiZDg0ZDIvdGFibGU6NjUwZWIxYmQ1NjQ5NDliNzhmNzFhM2VjYWE2ZTFhOTUvdGFibGVyYW5nZTo2NTBlYjFiZDU2NDk0OWI3OGY3MWEzZWNhYTZlMWE5NV81LTEtMS0xLTA_d43283c9-363d-4762-8ab2-bae01cf0972d">Q2</ix:nonNumeric><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80L2ZyYWc6OGZmMGM1MDBjOGMyNGU3ODlkZjM1YTRiODJiZDg0ZDIvdGFibGU6NjUwZWIxYmQ1NjQ5NDliNzhmNzFhM2VjYWE2ZTFhOTUvdGFibGVyYW5nZTo2NTBlYjFiZDU2NDk0OWI3OGY3MWEzZWNhYTZlMWE5NV82LTEtMS0xLTA_7cb39057-a0b4-4c69-bd9a-3e49352791af">2021</ix:nonNumeric><ix:nonNumeric contextRef="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630" name="cutr:ExtendedServiceContractOptionOneTerm" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfMzg0ODI5MDY5ODIyNg_e653e8fe-f332-4582-857d-3372b1518b74">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630" name="cutr:ExtendedServiceContractOptionTwoTerm" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfMzg0ODI5MDY5ODIzOA_506311e3-b01b-41cc-9bc7-3004836d0ad0">P2Y</ix:nonNumeric><ix:nonNumeric contextRef="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630" name="cutr:ExtendedServiceContractOptionOneTerm" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODg3OA_37d5a87f-934a-4984-8ce6-ca3dbd45b43b">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630" name="cutr:ExtendedServiceContractOptionTwoTerm" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODg5MA_759bd265-f34f-4f56-92c1-11dc5f2a0f73">P2Y</ix:nonNumeric><ix:nonNumeric contextRef="i274a6e322a504ca69c72bdb069af291a_I20210630" name="us-gaap:CapitalizedContractCostAmortizationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcxMDQxMA_6ae4c934-3ce2-494d-a9ef-e60aa0c8aad9">P2Y</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="ie7a69c86013f47fd84b88ded0e2796dd_D20210101-20210630" decimals="4" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83Ni9mcmFnOjI5NzM2Yjc3MDVhMzRkMDI4MTc5ODQ1MjcyYjNjMTJlL3RhYmxlOjNiNzc1YjM2ZTE1ZDQwNTI4Y2M3NjUwMDBhMGFlNWZhL3RhYmxlcmFuZ2U6M2I3NzViMzZlMTVkNDA1MjhjYzc2NTAwMGEwYWU1ZmFfMi0xLTEtMS0w_04968a77-b6fb-4e41-bcb5-e9307174b6c2">2.78</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i8d63e931f0e34f97838b48f7c9d93f52_D20210101-20210630" decimals="4" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83Ni9mcmFnOjI5NzM2Yjc3MDVhMzRkMDI4MTc5ODQ1MjcyYjNjMTJlL3RhYmxlOjNiNzc1YjM2ZTE1ZDQwNTI4Y2M3NjUwMDBhMGFlNWZhL3RhYmxlcmFuZ2U6M2I3NzViMzZlMTVkNDA1MjhjYzc2NTAwMGEwYWU1ZmFfMi0xLTEtMS0w_8e23faa9-da2c-490c-8f82-d1f6d830180b">2.78</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i8d63e931f0e34f97838b48f7c9d93f52_D20210101-20210630" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83Ni9mcmFnOjI5NzM2Yjc3MDVhMzRkMDI4MTc5ODQ1MjcyYjNjMTJlL3RhYmxlOjNiNzc1YjM2ZTE1ZDQwNTI4Y2M3NjUwMDBhMGFlNWZhL3RhYmxlcmFuZ2U6M2I3NzViMzZlMTVkNDA1MjhjYzc2NTAwMGEwYWU1ZmFfMy0xLTEtMS0w_739a98a0-2332-4f0a-aa44-1b71811a467d">25</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ie7a69c86013f47fd84b88ded0e2796dd_D20210101-20210630" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83Ni9mcmFnOjI5NzM2Yjc3MDVhMzRkMDI4MTc5ODQ1MjcyYjNjMTJlL3RhYmxlOjNiNzc1YjM2ZTE1ZDQwNTI4Y2M3NjUwMDBhMGFlNWZhL3RhYmxlcmFuZ2U6M2I3NzViMzZlMTVkNDA1MjhjYzc2NTAwMGEwYWU1ZmFfMy0xLTEtMS0w_fb71f808-fcda-41b6-972d-ddba9b4f9d6a">25</ix:nonFraction><ix:nonNumeric contextRef="i274a6e322a504ca69c72bdb069af291a_I20210630" name="us-gaap:LesseeFinanceLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDkwNw_973afb6b-4acd-4a55-af58-d468b11c7d99">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i274a6e322a504ca69c72bdb069af291a_I20210630" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDkwNw_c98812fc-de92-4bc9-ae63-a2ea2dcf1178">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i85fff53fbac547228677e769db10e805_I20210630" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_191ff28f-24ee-4553-9783-0b42ebb65ac6">us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_919b7924-791c-4466-b8a7-24aa8118f77b">us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="i85fff53fbac547228677e769db10e805_I20210630" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_b5e783e0-1851-4646-b5d7-45c5c8303178">us-gaap:AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_f32d24a1-2fa6-47cd-9e48-aa722ac2d210">us-gaap:AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_10ea67d4-7eb5-4177-82e5-7c042f1357e2">us-gaap:OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i85fff53fbac547228677e769db10e805_I20210630" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_88c2e4ea-2944-4622-bbd8-af1b7cb70fc0">us-gaap:OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i0d2437002d5848e6ba1f2e904bcedb15_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDAvZnJhZzo2M2IwM2M2NDc3Mjk0NzZhYWQ0ZmM0MTQ0YjMxODA0NS90YWJsZTo5OGI3Y2Y3MjU5Y2Q0ZTIyODQ2NzIzM2Y0NDExY2JjYy90YWJsZXJhbmdlOjk4YjdjZjcyNTljZDRlMjI4NDY3MjMzZjQ0MTFjYmNjXzEtMy0xLTEtMzAwMw_0ee4a481-56e1-4dd3-a996-8ce260a87a0e">0.0301</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cutr-20210630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i0f37c4df46fd44559fdc74b178f893a0_I20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i85fff53fbac547228677e769db10e805_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic827721b28ff49aca3277a242cc858a0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i2fcfd7b210f74dc5976983de27855478_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcb365aaec5f4975a3f836175dc8e2ce_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfb65299d11046adb017318fb542b3be_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb26dda9fd88462aabb4723bea6e2287_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8b6fed2a51f45858d2dcecd28277fef_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73f49a322eb84c7383e92e7174381a6c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd94bfca54cb406f8ffb1fc2d03add57_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a0c97ff1a1844bfaafd62ddbe64c6ed_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf7ddfb11c484a379285f7f24ccbb30f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7d9d29deb264e90befea8186ad2923a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic54b608c69b7450ab0118143a7142782_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbee004c85ae406b9b109bd61037d4b4_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71ba6bea3ea04bdf840846d3dc75fca6_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73640a3ad3ca43178734929432dc6628_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf4c9f98bfbf40d2a4bbf237cf1e1846_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaee018047a74b78859eeb591b6c591f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i485b22c217834e23b0364e76e06a2371_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3010403a70d436483ab771b941a207d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8367f0895fb4ca3b02c812b17b329e3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia490656dd3ce42e2bf315a7086535095_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i484a97403f27472ea9481c015d1527fb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie07d79b96d4d4295b68c970c1206cf32_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44e8ae2855f24ec191abeac87edead4a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e00e169b2114d2997dc62ba88fc41f2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1e3e98112d445a2b78ea2ada37f81ed_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5bc0220b3cd4bbd82245f12526ec90e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f3e187f8cdd4a27a16464c1e2230fec_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i244e0262c30f4bc59029986047588df0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i570d20ed67764205924e7fee40c9295a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b3d4dae27cb4fb68ccfb9a3a1a93823_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33947892bb224113abf96b09e46ffa54_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85bdd8375cea4bfcbeb0257fbde7b2b9_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i170f952087874acbaa3da79723af4837_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3b47574caca46b99fb6499883087ed3_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba9e052e19bc4d9cb3949ba436e89381_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5cfedb49abf43a58191f2993ef3e540_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7cb0aefbadc4fae96b37599c7955716_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i341bd948a0694080b463b58e446e0e46_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03250011c65e4e58a12c712ed93a235f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb9afea6585c438abf605e46f4b90bf5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c44dc3e39a944f386ee804f3d8d2f1d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaca8eee5ccbc423ea5d21f84cdc0c483_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc6ab3c5a57d4419a7741a81e73e8cba_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff1d956612db4dee81869096bfed413a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06df2fa92c07439982ab4b6fddb466f1_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia11ce6b42e50441a8bfd1cd6564d5f99_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7fdc7a0b6b84196a94bd8e81d4ff9ca_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic074f4f3008d47a7a3965891ed645a3b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8358e3138b90489dafac816f75a0e5f8_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="country"><xbrli:measure>cutr:country</xbrli:measure></xbrli:unit><xbrli:context id="i2456eaded80b44f784a0a4a1f81e0150_D20210305-20210305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-05</xbrli:startDate><xbrli:endDate>2021-03-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i65e02799f7d2458f8b8251dfac3c7b7b_I20210305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie60ebd26bc7440ba9911c6237d5ce6df_D20210305-20210305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-05</xbrli:startDate><xbrli:endDate>2021-03-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd2a463e83364d2bbb2747aea222f7be_D20181001-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cutr:ProductRemediationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95ac0510552241b18a45a3559b512564_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cutr:ProductRemediationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa7cefa41ffa4fcca09040bf29e8bd08_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cutr:ProductRemediationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie45277ed62d346cdb9916dbb3ad17292_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cutr:ProductRemediationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2c95c40b3a643028669a714bdf84fcc_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cutr:ProductRemediationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3522b04102fc4ee69538b27d4416746f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cutr:ProductRemediationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic95c28211b0e434aad49ee7875023aa1_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cutr:ProductRemediationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc4ad6178c2c49418650716374160150_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2407102de7bf456bba0a70df24f73953_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-07-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i881844cc567943b08e58b8c62bf2cdb7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebd0fb6eb91a42ec917f088a099d13af_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5f9a379644248b4bb314bae98be198c_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc6d773f0c1a4f6b95a87d9eb4d6ac20_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i470d10cc776b41649b8a03cf1ec2f3fc_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3f410467d4d4330ad372e3a956470ad_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:CustomerMarketingSupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36aa596dff8748588786668800832709_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:LoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f22dd0f34be4388a01961e660f5caf8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:LoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i274a6e322a504ca69c72bdb069af291a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c7a53758f744376b8ee593f5591f92b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35c2ccc976154aaa943236bfb9c494ca_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3cba542e3a741d4a477c46679b67946_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6676b6bef6f2454fbbc76aea9a2cc1da_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea529016b4144eb5becac8fb1c31a306_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39a83be3b8224826a825113043c0f630_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56e825e587f849159fe52471c86de3c9_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i043c44727e4748838f975923cbe8de27_D20190601-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8051166907c44cc3b4d720878ae84444_I20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:AmendedAndRestated2004EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc771595ca97435b917e76c6379187af_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c1cc14f1d17439ab6dc582f75bd1a5b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cutr:NonEmployeeDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia86610d6c30943a98b2884869af2e9a8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cutr:ExecutiveOfficersSeniorManagementAndCertainEmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9988de6b19146808f537a79f2f4003b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cutr:ExecutiveOfficersSeniorManagementAndCertainEmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13634336729642d784da25921efe552a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cutr:NonEmployeeDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if82f30c5243c44b4ad80cd7520748ea9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cutr:ExecutiveOfficersAndSeniorManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8283a2c2e73d47759779e4f3016de4be_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cutr:ExecutiveOfficersAndSeniorManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5eb930ee997642608de2ef098dda5547_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:NonqualifiedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cutr:ExecutiveOfficersAndSeniorManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b76898f620849e68db8504b5c340666_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:NonqualifiedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cutr:ExecutiveOfficersAndSeniorManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7a69c86013f47fd84b88ded0e2796dd_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d63e931f0e34f97838b48f7c9d93f52_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:NonqualifiedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2f388401ace46cab8547a66f8274e5c_D20190930-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-30</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0086c16aff3843a88d06e0b9a23ab663_D20190930-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-30</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i260072c69a4b43b297a42091f34d2d34_D20190930-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-30</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c46e2208d6a4e10972c5f842c7fcf68_D20190930-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-30</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3774f37aef574876bfd257a704d58d18_D20190930-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">cutr:ShareBasedPaymentArrangementTrancheFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-30</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida744089b3ac429ba5d244a28072197f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i686fa2a5de5542978b650edda0bb93db_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20bf571b99a94909a5b0526d60ddfc07_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i244333557f0f4c1f9b9e1e26967d871c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if91020effb684eec96e7ae9b7579c211_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04a939a51cb44bbfab0551c699f24582_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38c5dcae21c84726b4ba51da80b02ac4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie58ba076e2704369a7e7ca1be3068f0a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e5db1d27c0d467fa8a06f3edfd4046b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c3011eb06b8441e960fb49156c2b7bb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6d4ff6c6be04324bd9520f1387d71dc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41584b05a4664ba3af97fb224bccbdae_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19202ea6769b485981af1a269c354a3e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe19bb61d2c04cc187ecedbd6e6de449_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if15f1055aa4c497db7227c965f673e0b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1d2e0e7bf114927b546768a3c34a81d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb17262b381746f787063be8b5d55b71_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e15052c9d0d44619f2e3d20485ef206_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9707b7e07a2a420e93afba7c1ea09419_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idee8ae2735f8498b9407c4ced951bf09_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic21ba9ca8ecf493ba645bdbe2ad6c2a1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26b8cbc3a16e449f9a39f3289247bef9_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28760ad245b749f6b1743389a6736740_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaac0feab41147a8a2bc8fd8f7ba33f3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3e1bb0168eb49be9bc31f592a1a35d1_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99969d197ffd450f94deac6fd22dac12_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fcff246ef044996b2ff3e18abe4904e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2385bd8fa768474f8fd3a114312d5e7d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4ecd89ae62344f7917567fbab93bd54_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24a4aae559244b6da9a355eef4892d50_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if55087856ea4480f878b84dad9aa0b2f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c67032870244a09929098911256c828_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2e0ff6f1deb4186b8284936187d5163_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d1b842b5a004755b84c230f3296b806_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i134de9f1f57f47888632a9ceef35480a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic53569eddd914356abdacfc8f46a8065_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia12fb8b4c6934135894efcee0133760d_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib073b66268e747c7beb7c3e8cb6725cd_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1c39d3cd4704eb18a973e3632ebf4c9_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i927cb99cf11849a28b18cccb13b34952_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i248c328a529348aa9cc98c13d080a639_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fcb4b561a904836a0f0d23aa399f03b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic24aac68960d4d5abac630ee5fc03264_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i422e7e2d5153428685677e8df3cd31cf_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icea00b8fe11140daa1cb985e030d37f8_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1aafabe8c64f4228aed37026513d86ff_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieedfa579e0344b4d82de2102e49f38e2_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b551207fffb4cf09782a3a505b3bc0e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i401936e680d64b628acd735705146547_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbf8f9287eb3474aaf029523648da76e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5163e2df3c5d4005869929c9e18ad6d6_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4ce9a67e28441f483cb009b64dade32_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0774db4163af4fd1a5b476fc7f6ec2c8_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2ec6fabd2ce464c93e692843370b13e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iceba727bc88e4acfafb969683a5040c0_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7cbfd7fb2004b41977955079c24d470_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dfc2cdcabad463db38b6603f1116204_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie02f2877a5a94ba1af32fcc4842c447f_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35e40b62c61640d6ac4a638987ded61b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2704d4d253f94eceac8a62deac8a8b8a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0078d122644a4dddab29d2f40360b3c0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i895c5dc933e94035967c4ca15bcf095a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3039819417a84fd7b2aa536ffb2ed8d4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41feb9a60cd54b25be885f1459623391_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0624b58f9374ca4b58497be819f0521_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7035befba854bb787b41b7a326649e7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="day"><xbrli:measure>cutr:day</xbrli:measure></xbrli:unit><xbrli:context id="iaea3ce259c6d4b31887911f5a24f9386_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026FirstConversionTriggerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07f11bb2c2e748f7a93f2cf71e0ba828_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026SecondConversionTriggerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ddc6ffd69484d648267e3fa81be0a45_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i489cafda5c3f4762af77cae7f75a401e_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1290f60e05c943b9995db59a6927e23a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia674f145a1a94467899389e49f535d8f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerItem"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>cutr:item</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ic40cdb4b583b4d60bd81237f32311633_I20210304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0131d61368a466d8a6ca8117c109ad7_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1ba13fde0c14860bd56f281fcae9480_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dceabdb8060472888bc8746205213da_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0afd02d742a4c50bfc5ec134cc472c9_I20180530"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:WellsFargoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f5872525ec8417bb65b72a9ac49e61b_D20200709-20200709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:SiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-09</xbrli:startDate><xbrli:endDate>2020-07-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73dd1591ec4d4f828e27088ad0d09aeb_I20200709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:SiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84e5687763244213b65265c035c8bdcd_D20200709-20200709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:SiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-09</xbrli:startDate><xbrli:endDate>2020-07-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id99d22627e1c49f080008eaaceb8a64e_D20200422-20200422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-22</xbrli:startDate><xbrli:endDate>2020-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22ce661a87cf458ba03c056354564a8e_I20200422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id84ea3c345a84c8c820c9be723af5e27_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54330428060a4653bc4b61cd17bfbb1e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d2437002d5848e6ba1f2e904bcedb15_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>cutr:segment</xbrli:measure></xbrli:unit><xbrli:context id="i5cd8c122a6db4b479f4cb170d5340e5f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc32166982764821b862930f62f92b51_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0916cb6cfef149efba3569c230352115_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc041928fcd442d691a2b8f145bf69f3_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60cc413c28af471da2fd3a5cb7567dfe_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i001f2e7ffc384283a6262f680531b654_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45c4fddf3ca04af29dc98fd3b2a1c1b3_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaee1d9be4d174579b2a79cbe1837cf25_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i605c06860c2a4b9ba038414773646e05_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b993bcbab604605a3f9186a75679bc5_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icac68fb392c34970af1e7c3bbd64b047_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5628efd5ddc746118fb44e8463069210_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec6fc50f8e8e41c4b1b36ce9c699fe36_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1e77ae11263421aacb8d6bb8940ff5b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b6561e7c0bc4c82b78cc302b59ada69_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedce34eaadb2414ca33df76ede46361d_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72c021f9acb64626b780975f2f7b37bd_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieae31fb3cfae4ce588f0407780016251_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74194697532c48e689caa0d810cf7dee_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic61b8af9d2a44ba89d29a042679de961_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i257d2e51a1bc4c85b8cffc47eabccc0b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ProductsExcludingConsumablesAndSkincareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id006d6e7ce234b7486129ec2b87c40c0_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ProductsExcludingConsumablesAndSkincareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe8306ccc3f44558b1235fa08edef7ed_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ProductsExcludingConsumablesAndSkincareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id97644f373e8442c982dab972c23de51_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ProductsExcludingConsumablesAndSkincareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief96e147f922486883c4d8cc587f8f60_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd1e322af3b8489a8e9d1c2f562b5e8b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3afbc47a9fd48df8033033413b4338e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c347ebd3f934ddaaec736c2f53a0eeb_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i612e38fd3e404dcb98febb98ac966dcd_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i532d55314af64158ac48f5d2f1d43acc_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70f692ff4e534504a06fd1b76829e106_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a21f86e33ca4228a03854c5f5b0821c_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ib4896268598045f0bc55c9d056377420_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDcx_57222b5b-97e1-45c9-8ebb-fb2bafac115c">10-Q</ix:nonNumeric></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Mark One)</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6ODEyYWQzZmIyNTEzNGYxZWIxN2RkMWJhMjEzNWY4YmMvdGFibGVyYW5nZTo4MTJhZDNmYjI1MTM0ZjFlYjE3ZGQxYmEyMTM1ZjhiY18wLTAtMS0xLTA_dbd93ee4-5d57-48c9-badb-a09621df70cd">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMTk5MDIzMjU3NjM4_40d9a4ee-66e6-4c50-9be6-6d90f9111b42">June&#160;30, 2021</ix:nonNumeric> </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6Y2RmZDY4ZGVmZTIwNDg3YzgyZTVhNWQzNTQxZjAyY2IvdGFibGVyYW5nZTpjZGZkNjhkZWZlMjA0ODdjODJlNWE1ZDM1NDFmMDJjYl8wLTAtMS0xLTA_58e051d2-41e0-4552-b821-27dedb7f0e77">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from&#160;_____ to_____.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDcy_7c8669f2-fbac-4629-bacb-8fad7f115d1e">000-50644</ix:nonNumeric></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDcz_6a3fb106-e28c-41ac-8c9c-3a080fc54c33">Cutera, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6YWY4YWI2OTI1YTBkNGZkMWFmNTIyOTk3N2ZjZmZkYTQvdGFibGVyYW5nZTphZjhhYjY5MjVhMGQ0ZmQxYWY1MjI5OTc3ZmNmZmRhNF8wLTAtMS0xLTIyNQ_3c4141f4-f48f-46e7-980b-013262cae3d3">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6YWY4YWI2OTI1YTBkNGZkMWFmNTIyOTk3N2ZjZmZkYTQvdGFibGVyYW5nZTphZjhhYjY5MjVhMGQ0ZmQxYWY1MjI5OTc3ZmNmZmRhNF8wLTEtMS0xLTA_3fdbd20e-6bf1-48f9-a8da-75d127ce2298">77-0492262</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or<br/>organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDc4_e230b3ec-be09-4d50-a253-ee2aa4102cc0">3240 Bayshore Blvd.</ix:nonNumeric>, <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDc5_dfea992f-cb46-4c2e-b1ad-ba996ff3dd9b">Brisbane</ix:nonNumeric>, <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8zODQ4MjkwNjk5Mjk3_754f122d-57d6-4d12-90d1-43f0f31f259e">California</ix:nonNumeric> <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDgw_e7ed0f0c-8698-4c6b-a28d-5b799724c286">94005</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Address of principal executive offices)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDc0_07198069-5d07-43c5-bb12-b5153be9ab91">415</ix:nonNumeric>) <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDc1_35f174ed-cf5f-405f-b329-fd6bb318e7fb">657-5500</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Registrant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">s telephone number, including area code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6NGE5YWE5OWMyZWFiNDJlODg2ZjhjZGJjYzVjY2MwM2EvdGFibGVyYW5nZTo0YTlhYTk5YzJlYWI0MmU4ODZmOGNkYmNjNWNjYzAzYV8xLTAtMS0xLTA_e950e56e-ae31-4d4d-8727-7a34e554825d">Common Stock ($0.001 par value)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6NGE5YWE5OWMyZWFiNDJlODg2ZjhjZGJjYzVjY2MwM2EvdGFibGVyYW5nZTo0YTlhYTk5YzJlYWI0MmU4ODZmOGNkYmNjNWNjYzAzYV8xLTEtMS0xLTA_06c570b9-3072-4d14-8f56-52bfd4cf9dc0"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6NGE5YWE5OWMyZWFiNDJlODg2ZjhjZGJjYzVjY2MwM2EvdGFibGVyYW5nZTo0YTlhYTk5YzJlYWI0MmU4ODZmOGNkYmNjNWNjYzAzYV8xLTEtMS0xLTA_482fd247-4b8b-41ea-9ae5-ee73ce565429">CUTR</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6NGE5YWE5OWMyZWFiNDJlODg2ZjhjZGJjYzVjY2MwM2EvdGFibGVyYW5nZTo0YTlhYTk5YzJlYWI0MmU4ODZmOGNkYmNjNWNjYzAzYV8xLTItMS0xLTIxNQ_56497388-3a83-4e27-800e-6d9756c66521">The NASDAQ Stock Market, LLC</ix:nonNumeric></span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDc2_3405accc-6fb7-4c90-bebe-b267fb6591a9">Yes</ix:nonNumeric>&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDY5_f88fbc6e-16fe-4c4b-b141-ed9e0e05b78b">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;No&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act (check one):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.290%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6ZDEwOGRkZjcwODQ2NGMzZDhjOGNmZmY0YzM4NmIwZTUvdGFibGVyYW5nZTpkMTA4ZGRmNzA4NDY0YzNkOGM4Y2ZmZjRjMzg2YjBlNV8wLTItMS0xLTA_696b959e-2a49-4eab-a3f5-63f4e8bb7384">Accelerated filer</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6ZDEwOGRkZjcwODQ2NGMzZDhjOGNmZmY0YzM4NmIwZTUvdGFibGVyYW5nZTpkMTA4ZGRmNzA4NDY0YzNkOGM4Y2ZmZjRjMzg2YjBlNV8wLTctMS0xLTA_36235b8c-17ab-45f0-9586-08d320bf3e36">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6ZDEwOGRkZjcwODQ2NGMzZDhjOGNmZmY0YzM4NmIwZTUvdGFibGVyYW5nZTpkMTA4ZGRmNzA4NDY0YzNkOGM4Y2ZmZjRjMzg2YjBlNV8wLTktMS0xLTA_73dc4b92-dd9e-428a-9f1c-07ad6f174eac">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.):&#160;&#160;&#160;&#160;Yes&#160;&#160;&#160;&#160;&#9744;&#160;&#160;&#160;&#160;No&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" format="ixt:booleanfalse" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8zODQ4MjkwNjk5Mjk4_39f71386-b0cc-44c4-bb5f-56f9b1eb1b2b">x</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of Registrant&#8217;s common stock issued and outstanding as of July&#160;30, 2021, was <ix:nonFraction unitRef="shares" contextRef="i0f37c4df46fd44559fdc74b178f893a0_I20210730" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8zODQ4MjkwNjk5MzI3_e982dee0-7127-4a66-bc46-12288e4d489f">17,942,446</ix:nonFraction>.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib4896268598045f0bc55c9d056377420_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.749%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ib4896268598045f0bc55c9d056377420_13">PART I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_13">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ib4896268598045f0bc55c9d056377420_16">Item 1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_16">Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_19">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_25">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_25">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_28">Condensed Consolidated Statements of Comprehensive</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_28"> Income (</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_28">Loss</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_28">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_31">Condensed Consolidated Statements of Changes in Stockholders&#8217;&#160;Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_31">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_34">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_34">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_37">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_37">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ib4896268598045f0bc55c9d056377420_106">Item 2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_106">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_106">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ib4896268598045f0bc55c9d056377420_127">Item 3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_127">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_127">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ib4896268598045f0bc55c9d056377420_130">Item 4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_130">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_130">39</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ib4896268598045f0bc55c9d056377420_133">PART II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_133">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ib4896268598045f0bc55c9d056377420_136">Item 1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_136">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_136">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ib4896268598045f0bc55c9d056377420_139">Item 1A</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_139">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_139">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ib4896268598045f0bc55c9d056377420_142">Item 2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_142">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_142">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ib4896268598045f0bc55c9d056377420_145">Item 3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_145">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_145">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ib4896268598045f0bc55c9d056377420_148">Item 4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_148">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_148">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ib4896268598045f0bc55c9d056377420_151">Item 5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_151">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_151">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ib4896268598045f0bc55c9d056377420_154">Item 6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_154">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_154">41</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_157">Signature</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_157">42</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib4896268598045f0bc55c9d056377420_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Quarterly Report on Form 10-Q, &#8220;Cutera,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;its&#8221; refer to Cutera, Inc. and its consolidated subsidiaries.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report may contain references to its proprietary intellectual property, including among others, trademarks for its systems and ancillary products, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cutera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AccuTip</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, CoolGlide</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, CoolGlide excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, enlighten</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, excel HR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, excel V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, excel V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, LimeLight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, MyQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, PicoGenesis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,ProWave</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Solera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">flex, Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These trademarks and trade names are the property of Cutera or the property of its consolidated subsidiaries and are protected under applicable intellectual property laws. Solely for convenience, its trademarks and tradenames referred to in this Quarterly Report on Form 10-Q may appear without the &#174; or symbols, but such references are not intended to indicate in any way that&#160;the Company&#160;will not assert, to the fullest extent under applicable law, its rights to these trademarks and tradenames.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ib4896268598045f0bc55c9d056377420_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div id="ib4896268598045f0bc55c9d056377420_16"></div><div style="margin-top:10pt;padding-left:49.5pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS (UNAUDITED)</span></div><div id="ib4896268598045f0bc55c9d056377420_19"></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMy0xLTEtMS0w_a7cc4688-d327-4b5f-9ad9-5581af57d63f">169,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMy0zLTEtMS0w_e5c69269-817c-444a-b892-f31001432933">47,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable, net of allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNC0wLTEtMS0wL3RleHRyZWdpb246ZGQyMzc3ZjVkOTc1NGEwNmEwM2E1MThlMjU4YTY5YzJfMjE5OTAyMzI1NTY1Nw_37f4a90a-8761-44b0-a8cc-dab0fd2587b3">1,639</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNC0wLTEtMS0wL3RleHRyZWdpb246ZGQyMzc3ZjVkOTc1NGEwNmEwM2E1MThlMjU4YTY5YzJfNzA_8b8f6949-00ea-4a37-a702-34d131047791">1,598</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNC0xLTEtMS0w_36385ac0-18b5-41b4-b03b-43406aeb1e55">25,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNC0zLTEtMS0w_b678bb3e-3d04-447e-89bf-929aa247d7f1">21,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNS0xLTEtMS0w_ff02c849-d89c-4807-ba67-492f6d4a92c0">34,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNS0zLTEtMS0w_60233852-9933-4814-8daa-9ade22126561">28,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other current assets and prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNi0xLTEtMS0w_7947d5ec-1104-48f4-a82b-52cc7697fbb4">8,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNi0zLTEtMS0w_782d922e-2546-4ab3-8ea0-e0861cbe6e24">8,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNy0xLTEtMS0w_3df37dc4-fd79-4dae-b817-5c1973e69e30">238,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNy0zLTEtMS0w_c9235d9f-6718-4507-b9e2-3f40501d2be4">106,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfOS0xLTEtMS0w_735c30f0-63e8-433c-af0b-e24b8a8dbebc">2,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfOS0zLTEtMS0w_0d287565-9f5a-4e19-8705-d9af98ed10e9">2,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTAtMS0xLTEtMA_38b1a870-6cf6-4334-b492-91adc4905d9c">592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTAtMy0xLTEtMA_b2ce9e9f-b286-41b2-83f0-f8d40feac659">643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTEtMS0xLTEtMA_955c224a-b7c1-47ad-85f7-97b8e9c7f6aa">15,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTEtMy0xLTEtMA_ad310d73-4e42-4238-a5a3-54a19fe65368">17,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTItMS0xLTEtMA_6ccebe36-823e-4d94-a271-6363876ede33">1,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTItMy0xLTEtMA_6c100840-d248-4aee-89a8-33e80ff8cdef">1,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTMtMS0xLTEtMA_c2f5c335-4be4-412a-93f7-c92dc1119e4d">5,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTMtMy0xLTEtMA_cbda10c1-d769-48f9-9c10-2e05f738dca6">5,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTQtMS0xLTEtMA_71754b1a-fafe-40cc-ad8b-6438321b7dc4">264,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTQtMy0xLTEtMA_2d2d1aa0-461f-4c1d-91c7-f3815d916182">132,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Liabilities and Stockholders' Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTgtMS0xLTEtMA_63ad8576-9852-43f0-b136-7f4a39f28d30">6,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTgtMy0xLTEtMA_8347e233-3fbc-4ce8-8007-5c4c1d29fdaa">6,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTktMS0xLTEtMA_606da794-3b0b-44fd-9768-96e35cb82979">41,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTktMy0xLTEtMA_2ef18032-323c-4e28-82d5-b264984f776c">31,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjAtMS0xLTEtMA_4a71dfd6-5e08-4c54-9401-fc91702a8f2d">2,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjAtMy0xLTEtMA_32357f57-3ee0-41c5-a259-c6d849e6cc63">2,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PPP loan payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:UnsecuredDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjEtMS0xLTEtMA_4a6c3272-f256-4634-a937-feecbce100e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnsecuredDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjEtMy0xLTEtMA_a1dabc87-b94f-4ac6-9752-29a5adfd0fa5">3,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Extended warranty liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" name="us-gaap:ExtendedProductWarrantyAccrualCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjItMS0xLTEtMA_4d7c9c6d-6a02-4b3c-91eb-4484a2bf471a">649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ExtendedProductWarrantyAccrualCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjItMy0xLTEtMA_87d57a67-4ede-486e-8183-9a20fd87f119">1,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredRevenueCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjMtMS0xLTEtMA_92adb23c-0c93-4716-9aa4-0c56170d9699">9,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredRevenueCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjMtMy0xLTEtMA_a94bb240-92c6-4d43-9e3f-fd76e5efae6a">9,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjQtMS0xLTEtMA_bf845964-9ea1-4c09-87bf-121851d0c0ad">60,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjQtMy0xLTEtMA_ff57ebbc-16c9-4128-83ac-ecf35a0ec560">54,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred revenue, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredRevenueNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjYtMS0xLTEtMA_f8fdc722-97c7-4b64-92fd-1687a19492f0">1,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredRevenueNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjYtMy0xLTEtMA_92423149-33be-49e8-bf5f-4156253651b8">1,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjctMS0xLTEtMA_464359b4-730b-481b-9b6a-2b87cd915a7c">14,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjctMy0xLTEtMA_6dd5a79e-185a-4a3a-988a-7bcd1ce40bb1">15,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PPP loan payable, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:UnsecuredLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjgtMS0xLTEtMA_aad363ae-aed8-4c28-bc9d-3d928644cbdd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnsecuredLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjgtMy0xLTEtMA_956f6732-de25-45f0-ad60-46be46d89bf1">3,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Convertible notes, net of unamortized debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmVmZjJkMGEwMDZjMTRiODNhZDliZWY2OTQyYjQxZTc0XzY1_2f9e0923-c2c5-44ee-9bcc-8aba7e15d421">4,450</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjktMS0xLTEtMA_48e7b645-dce6-4f86-803c-bad5a3022cd8">133,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjktMy0xLTEtMA_690fd541-5e90-4bac-a817-4ccc7b03e641">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzAtMS0xLTEtMA_4ef78c48-2fd5-4b7e-994c-e513cc8a505f">288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzAtMy0xLTEtMA_f9282331-5409-4133-a93b-0baf5856fa36">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzEtMS0xLTEtMA_8c992cae-129f-4f7f-99f6-d0d7920b3f37">210,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzEtMy0xLTEtMA_b79e8690-eb57-4717-953e-8ad58088fba8">75,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commitments and Contingencies (Notes 12)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzMtMS0xLTEtMA_06301e36-648d-4cb2-ab22-712d7bb8dfdb"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzMtMy0xLTEtMA_c011a998-2745-431d-847f-30f452085df0"></ix:nonFraction></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4Mjk0YzcxZGY3MjRiYmQ5ZmUzZGExZTdmZDdjMzdkXzE4_1fc8c1c2-345e-4b28-a56c-9efd1b78cc9e"><ix:nonFraction unitRef="usdPerShare" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4Mjk0YzcxZGY3MjRiYmQ5ZmUzZGExZTdmZDdjMzdkXzE4_467b2080-6518-47da-ab8f-691801cf4525">0.001</ix:nonFraction></ix:nonFraction> par value; authorized: <ix:nonFraction unitRef="shares" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4Mjk0YzcxZGY3MjRiYmQ5ZmUzZGExZTdmZDdjMzdkXzQ0_9a096e3f-d389-4073-bea3-22f2199f3d85"><ix:nonFraction unitRef="shares" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4Mjk0YzcxZGY3MjRiYmQ5ZmUzZGExZTdmZDdjMzdkXzQ0_c3ec2ed5-5957-4267-ab06-0df4deb53f37">50,000,000</ix:nonFraction></ix:nonFraction> shares; issued and outstanding: <ix:nonFraction unitRef="shares" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4Mjk0YzcxZGY3MjRiYmQ5ZmUzZGExZTdmZDdjMzdkXzc5_1674434d-8339-4aa4-b84f-dd4bced2ad3d"><ix:nonFraction unitRef="shares" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4Mjk0YzcxZGY3MjRiYmQ5ZmUzZGExZTdmZDdjMzdkXzc5_297cf9b3-0dd1-409b-9663-b7e90ba91e22">17,933,020</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4Mjk0YzcxZGY3MjRiYmQ5ZmUzZGExZTdmZDdjMzdkXzg2_961b71bb-1564-4dfc-9cd8-9f3a0cc285bd"><ix:nonFraction unitRef="shares" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4Mjk0YzcxZGY3MjRiYmQ5ZmUzZGExZTdmZDdjMzdkXzg2_c623987f-6942-4b06-97d8-3275d17769a6">17,679,232</ix:nonFraction></ix:nonFraction> shares at June&#160;30, 2021 and December&#160;31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMS0xLTEtMA_3fc906dd-43f8-419b-8bc2-dc34220b4590">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMy0xLTEtMA_946db9bf-80ac-42f6-82ff-d61547d52ce2">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzctMS0xLTEtMA_5fbabb29-e839-43f2-82a6-65bb78718ec5">106,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzctMy0xLTEtMA_9377087d-a49a-4516-96af-679c1bf65e3c">117,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzgtMS0xLTEtMA_152e6887-4a66-4f68-aea0-176208380395">52,848</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzgtMy0xLTEtMA_8d0f14b4-50bc-4d72-9cb7-c154acbf1129">60,235</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzktMS0xLTEtMA_72633838-4a65-4c93-8d24-b525850cced8">53,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzktMy0xLTEtMA_40ca6b01-9fef-445a-b0d3-ea51beb15336">56,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNDAtMS0xLTEtMA_61adb58f-6d78-4146-adca-6e2a07706109">264,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNDAtMy0xLTEtMA_4e4001fe-51ba-4693-a3e6-6f4536e13204">132,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ib4896268598045f0bc55c9d056377420_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.429%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2fcfd7b210f74dc5976983de27855478_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMy0xLTEtMS0w_22e7cc09-801f-45a1-9a19-eb3ca68d0a39">51,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibcb365aaec5f4975a3f836175dc8e2ce_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMy0zLTEtMS0w_4b693800-6083-4e67-bcff-e6d5f1880f6e">21,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfb65299d11046adb017318fb542b3be_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMy01LTEtMS01Mzc_ef3b29b6-f929-4dde-b6a6-10f2cfb3d2ea">95,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb26dda9fd88462aabb4723bea6e2287_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMy03LTEtMS01Mzk_14d83606-1eba-40d1-8a24-83426fb6aa82">48,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia8b6fed2a51f45858d2dcecd28277fef_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNC0xLTEtMS0w_68d0bcf0-1bb5-4afa-90a0-fa35a0de1949">6,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73f49a322eb84c7383e92e7174381a6c_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNC0zLTEtMS0w_e93a7b9d-1568-4c19-ace2-bed8743a5104">4,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNC01LTEtMS01Mzc_0707e399-3f94-4bbd-999e-df63e03a4b02">12,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd94bfca54cb406f8ffb1fc2d03add57_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNC03LTEtMS01Mzk_ec2e8367-d0fa-45d2-bb7b-92ae8e5ba128">10,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNS0xLTEtMS0w_703c591f-e03b-4142-a2d7-a977d67fff2b">58,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNS0zLTEtMS0w_a40ad88a-0298-4062-bf49-0ca9ff56c62d">26,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNS01LTEtMS01Mzc_2a874e82-3811-45dc-b2ce-d1f18e7a488c">108,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNS03LTEtMS01Mzk_b5724f04-1a12-439a-aef3-8042e84c9a4e">58,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2fcfd7b210f74dc5976983de27855478_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNy0xLTEtMS0w_688b1c6a-1982-41be-b37f-c1f8ac9b4ec4">20,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibcb365aaec5f4975a3f836175dc8e2ce_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNy0zLTEtMS0w_093510aa-7992-4646-a2fd-0b33be7f4e45">12,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfb65299d11046adb017318fb542b3be_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNy01LTEtMS01NDE_7d4ac69e-2dfa-46f5-82fc-004877357623">39,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb26dda9fd88462aabb4723bea6e2287_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNy03LTEtMS01NDQ_fdac71a3-92f9-4d8e-8ffd-38db7a936467">26,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia8b6fed2a51f45858d2dcecd28277fef_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfOC0xLTEtMS0w_c91232b4-812a-42c6-9493-47956cc7cba1">3,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73f49a322eb84c7383e92e7174381a6c_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfOC0zLTEtMS0w_077235d3-5187-400f-9b84-7f136e30a501">2,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfOC01LTEtMS01NDE_6a6d3787-f463-4191-b8d9-6939545d65f4">7,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd94bfca54cb406f8ffb1fc2d03add57_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfOC03LTEtMS01NDQ_98acbd40-0088-410b-a710-3f28c54b25c4">6,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfOS0xLTEtMS0w_e6b35956-0dbc-41f2-abd5-fb3954940cac">24,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfOS0zLTEtMS0w_8b367cc2-7c20-4470-8251-f2fe240600f4">14,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfOS01LTEtMS01NDE_b4a4c495-e6fa-47ae-ae71-6df952da8584">46,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfOS03LTEtMS01NDQ_28e8d58b-65f3-4878-bd5b-40bde536948a">32,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTAtMS0xLTEtMA_664fd142-0b7d-4bfc-a4a6-20315401d800">33,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTAtMy0xLTEtMA_b7a2d63e-9e73-45f1-818e-2a7cdc8e2b8b">11,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTAtNS0xLTEtNTQx_e7349397-7f7b-42f1-98a7-0b67064127c9">61,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTAtNy0xLTEtNTQ0_352e08d2-9be6-4dbe-b06e-97e20a5a0cdc">25,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTMtMS0xLTEtMA_0599b273-1789-4a75-a730-5661a0e5b4ee">18,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTMtMy0xLTEtMA_d91e6387-284d-4f7e-af0b-a5f192f2b8ef">11,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTMtNS0xLTEtNTQ4_666173d6-25b7-488a-ab36-7315dabd9388">33,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTMtNy0xLTEtNTUy_cac279a7-2ac0-4514-b2de-461dc1c446e6">25,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTQtMS0xLTEtMA_1ec330fb-f6dd-4ac7-900a-19b32d791855">4,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTQtMy0xLTEtMA_9a8fc69a-76e9-4af5-818c-4d7ede9e3987">2,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTQtNS0xLTEtNTQ4_63ad1141-fb6b-44fb-bb6e-6a70d5a501c2">8,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTQtNy0xLTEtNTUy_136987a5-48ab-4ee4-8cb0-2e65408393f7">6,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTUtMS0xLTEtMA_5339b111-1ff3-4af4-aae5-6f2ffa00b278">8,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTUtMy0xLTEtMA_9f3e95be-09ea-4444-b5ce-d55be7d7466c">8,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTUtNS0xLTEtNTQ4_2caceae0-9423-4250-9f62-6d96f669fcb8">15,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTUtNy0xLTEtNTUy_8aae286c-a165-474e-904a-bb4848aa9a1a">16,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTYtMS0xLTEtMA_9ee31c37-a67b-414a-bf39-eaa87e199943">31,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTYtMy0xLTEtMA_17288473-afd2-4e1c-9016-5006b63e696c">22,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTYtNS0xLTEtNTQ4_d1b23965-e318-4dc6-a1a7-43d90b711764">58,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTYtNy0xLTEtNTUy_6ead5b8c-ac5d-4ab3-95a5-784e1c10b0c8">49,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTctMS0xLTEtMA_80c978ee-13d4-44c3-938d-1de3fc0c5934">2,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTctMy0xLTEtMA_43aaac16-b7c8-48ff-ae32-3162a603309d">10,931</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTctNS0xLTEtNTQ4_a1cf1eb2-e85b-400b-9992-00ade9cf0043">3,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTctNy0xLTEtNTUy_acc75a90-c4a8-4730-a760-12c640395af3">23,061</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other income (expense), net:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTktMS0xLTEtMA_352a9a44-05ff-40e7-aeda-ea9eccc4fd61">215</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTktMy0xLTEtMA_2d12a209-a354-4189-b3dc-618ffae06c91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTktNS0xLTEtNTU2_aacb433e-0efd-45ad-ba5d-274f29543858">267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTktNy0xLTEtNTYw_9bfe96bb-c6e7-4cd8-a583-4844675d9d39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjAtMS0xLTEtMA_5df877f8-87f4-444a-8ff6-00af1f1d9cfd">778</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjAtMy0xLTEtMA_926b4616-637e-4b11-970f-c8e3aa28811a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjAtNS0xLTEtNTU2_619f2dd0-a4fc-4eed-9ca3-9a234bc1d327">969</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjAtNy0xLTEtNTYw_8023aecf-8f8b-4b63-97ad-48c914979d85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on extinguishment of PPP loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjEtMS0xLTEtNTIwNg_40731346-01c6-4379-ae33-44ce61e66a8f">7,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjEtMy0xLTEtNTIwNg_3c853585-d326-4ee7-8a62-54a0e19827f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjEtNS0xLTEtNTIwNg_2eb68186-9298-47ef-bc21-fc5e636af4ac">7,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjEtNy0xLTEtNTIwNg_a2eafb7b-a32f-4bb5-88ca-74b9d3787d27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjEtMS0xLTEtMA_e1c648e7-9535-4c11-95ab-bd897512d214">392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjEtMy0xLTEtMA_edb151d8-3940-432a-bff8-11adddfdae78">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjEtNS0xLTEtNTU2_5949fe66-ad3d-46f8-8adc-b25cd2e8382c">1,415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjEtNy0xLTEtNTYw_d71ca608-7a5e-494f-99eb-a6d063c0d681">204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total interest and other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjItMS0xLTEtMA_42456d98-32f5-44b8-b2fd-90c4a469955b">5,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjItMy0xLTEtMA_202dfe93-4a44-48aa-b1d7-b29ae43445dd">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjItNS0xLTEtNTU2_fd1b5403-e0f8-4469-a433-0165385baf28">4,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjItNy0xLTEtNTYw_6eef2f4e-1f56-4d1c-9685-03f020863813">204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjMtMS0xLTEtMA_fa3ba32a-9341-4c4d-8b9c-d402d3ee1595">7,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjMtMy0xLTEtMA_6cd2f247-09c1-485e-b34f-3d35e4205274">10,928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjMtNS0xLTEtNTU2_05bb2961-e899-4b4f-8158-53a8e63d6d70">7,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjMtNy0xLTEtNTYw_f07ebc7a-b40c-44f9-9ee7-3f352dfb2755">23,265</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjQtMS0xLTEtMA_f6ef73ac-7da8-4daa-8b5b-202c6e64122a">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjQtMy0xLTEtMA_75268d70-cb28-445f-bcc0-70a0eafe2c12">466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjQtNS0xLTEtNTU2_2d5c630e-9d14-4293-b4f0-8ebed9f983a6">380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjQtNy0xLTEtNTYw_1311b2ae-71ec-4cc4-97e8-bf8f92ed7a2c">543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjUtMS0xLTEtMA_b2d37b1d-406c-4c40-a663-7c23db0b0f84">7,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjUtMy0xLTEtMA_e0169dd0-cb63-4daf-b842-9f2c7abc801a">11,394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjUtNS0xLTEtNTU2_ae12db4c-f232-44b2-8714-2da9eeabbd16">7,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjUtNy0xLTEtNTYw_905040ef-91f3-4884-b155-9ba55bb70aea">23,808</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjgtMS0xLTEtMA_1889d49a-b88b-4ef5-92eb-c1c0475e7495">0.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjgtMy0xLTEtMA_48910880-2165-4776-b508-54286f887c39">0.67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjgtNS0xLTEtNTYy_2f557795-803f-4951-afe3-fa0b88551794">0.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjgtNy0xLTEtNTY2_4997c172-0bec-4d0b-bed1-0236d01eaeb9">1.51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjktMS0xLTEtMzE1NA_8712644e-fd13-4ef4-8d03-0659cf19222c"><ix:nonFraction unitRef="usdPerShare" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjktMS0xLTEtMzE1NA_f0e42c5b-c208-4f14-8d88-dc20fb4105f2">0.39</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjktMy0xLTEtMzE1NA_1b06ef4b-5639-43cb-8d96-a0a0bb3af37f"><ix:nonFraction unitRef="usdPerShare" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjktMy0xLTEtMzE1NA_71afcbb9-141a-4def-bad0-94fb929a3e80">0.67</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjktNS0xLTEtMzE1NA_4917a147-3b4c-4f90-a89e-d24ad41050c1"><ix:nonFraction unitRef="usdPerShare" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjktNS0xLTEtMzE1NA_a5bebe1f-0c02-47c3-a905-9c8de2cb8c58">0.40</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjktNy0xLTEtMzE1NA_01d0ea8f-0301-4e37-b1eb-8cdc02029734"><ix:nonFraction unitRef="usdPerShare" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjktNy0xLTEtMzE1NA_ee9c25a4-a03a-41e5-b9d5-d29a851d3be0">1.51</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average number of shares used in per share calculations:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMzEtMS0xLTEtMA_e9e8b725-0e48-4318-a2ab-4552617a2efa">17,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMzEtMy0xLTEtMA_518bad1c-f035-4b6e-90bf-0d13b796acf3">17,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMzEtNS0xLTEtNTY5_a5910721-5646-4753-a5f9-ab7a5fe5e94c">17,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMzEtNy0xLTEtNTcy_ab556825-7e0c-46c6-b53d-1aa0db716bc8">15,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMzItMS0xLTEtMzE1MA_b4c2a25f-538f-48dc-9bb0-2254cad36e85">22,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMzItMy0xLTEtMzE1MA_774534ce-8852-486a-8568-db9c32b741f7">17,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMzItNS0xLTEtMzE1MA_2d1d444e-1db0-4af4-847b-d3d30bfbaeee">20,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMzItNy0xLTEtMzE1MA_9dd5012f-e034-4511-9441-2cc344f6359d">15,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ib4896268598045f0bc55c9d056377420_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.429%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfMi0xLTEtMS0w_d4e83669-2b7a-48ea-9ce4-c576c6f5175f">7,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfMi0zLTEtMS0w_981874bf-06c1-4052-ad3d-b654eec1708a">11,394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfMi01LTEtMS01OTc_1229d83e-689a-4b2a-9e62-60235eea0738">7,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfMi03LTEtMS01OTk_93af3c59-8335-4638-b2ff-84cd4baecd2b">23,808</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive gain:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassification adjustment for losses on investments recognized during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNS0xLTEtMS0w_80b1f28b-5fb7-4ef4-a985-f96fed2d26cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNS0zLTEtMS0w_70eabf33-7d71-4db0-a859-af0fa62dd549">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNS01LTEtMS02MDE_55df9bf8-a197-4570-b347-4a94e0d53a68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNS03LTEtMS02MDM_1db58fdd-9caa-4a3f-825c-801815605539">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net change in unrealized gain on available-for-sale investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNi0xLTEtMS0w_228faf04-5497-421c-9f57-5a6575f77c3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNi0zLTEtMS0w_e50307f9-8b03-4f0a-a72e-a41ea287080b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNi01LTEtMS02MDE_d0077d1d-34a9-4185-8c61-276b402dc5f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNi03LTEtMS02MDM_a88dfb31-3dbd-4556-a64d-d8b3549860e4">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive gain, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNy0xLTEtMS0w_d37c139f-129e-4509-bb99-fe43b326a88c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNy0zLTEtMS0w_427db695-6b5e-4d5d-bcfc-b814f623add6">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNy01LTEtMS02MDE_22fd9079-a80b-463e-ba79-9e1497c59c94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNy03LTEtMS02MDM_d59620e5-1c47-4a24-8aea-6bc1a6be80e7">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfOC0xLTEtMS0w_dba1091b-ec9e-488d-84ed-741d19eba074">7,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfOC0zLTEtMS0w_2778ae97-3ec8-4fc3-b055-133305f16f11">11,392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfOC01LTEtMS02MDE_9ae023a6-8646-478f-a2b7-6853fcd59581">7,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfOC03LTEtMS02MDM_31bacd0e-4769-495c-aaed-30f657af0d42">23,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ib4896268598045f0bc55c9d056377420_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share amounts)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three and Six Months Ended June 30, 2021</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:24.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.286%"></td><td style="width:0.1%"></td></tr><tr style="height:35pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retained<br/>Earnings<br/>(Accumulated<br/>Deficit)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8a0c97ff1a1844bfaafd62ddbe64c6ed_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMi0xLTEtMS0w_bacb4912-9aea-4ed9-a4fb-615a6269a0da">17,679,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a0c97ff1a1844bfaafd62ddbe64c6ed_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMi0zLTEtMS0w_adb49cdc-57aa-4f43-b744-19e9ca760a93">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf7ddfb11c484a379285f7f24ccbb30f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMi01LTEtMS0w_656f1964-7e09-4f21-87ac-d29f5e804f86">117,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7d9d29deb264e90befea8186ad2923a_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMi03LTEtMS0w_7826ce2a-85fd-4738-8816-6e298282f358">60,235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic54b608c69b7450ab0118143a7142782_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMi05LTEtMS0w_800677b5-e73b-485d-974a-e95dc8a42957">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMi0xMS0xLTEtMA_500e502d-0226-4118-9864-689bb00e5ac7">56,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Issuance of common stock for employee purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idbee004c85ae406b9b109bd61037d4b4_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMy0xLTEtMS0zNDAz_894d556b-954c-442c-b544-06ea28a849b3">38,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71ba6bea3ea04bdf840846d3dc75fca6_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMy01LTEtMS0zNDAz_14990733-37c1-4384-bfca-e83f0082f435">645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMy0xMS0xLTEtMzQwMw_d93e288f-ef33-4fb3-96bb-1410dc6d97cb">645</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idbee004c85ae406b9b109bd61037d4b4_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMy0xLTEtMS0w_6893b5a6-f716-4717-9025-0326c19bc48f">53,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71ba6bea3ea04bdf840846d3dc75fca6_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMy01LTEtMS0w_bea1f6ef-20aa-4aa3-b2e3-d730a953201f">1,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMy0xMS0xLTEtMA_42f493cf-69e3-4be1-9d5e-8a23d7db11a2">1,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchase of capped call</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71ba6bea3ea04bdf840846d3dc75fca6_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cutr:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfNC01LTEtMS0w_cac112e2-4332-4652-b480-9f1664e3cc84">16,134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cutr:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfNC0xMS0xLTEtMA_deb13a3d-2f08-4998-ad9b-c4176203d3d9">16,134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idbee004c85ae406b9b109bd61037d4b4_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfNS0xLTEtMS0w_b67225ac-4ee5-4017-b75a-f6d2f6f7df87">161,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71ba6bea3ea04bdf840846d3dc75fca6_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfNS01LTEtMS0w_26a99b92-fb0d-44ec-9746-7f2515e7bdb4">1,452</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfNS0xMS0xLTEtMA_8fa6b762-570a-47f4-92ba-ebc0ee599469">1,452</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71ba6bea3ea04bdf840846d3dc75fca6_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfNi01LTEtMS0w_e91bb92c-153e-4446-8893-284b3d0eae1a">4,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfNi0xMS0xLTEtMA_532774fa-a279-407a-b7d4-f81c72dfca20">4,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73640a3ad3ca43178734929432dc6628_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfNy03LTEtMS0w_bfc4900c-1603-467b-8838-33005a2b7a4a">7,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfNy0xMS0xLTEtMA_ada277d9-48de-4633-923c-104f67893fbd">7,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf4c9f98bfbf40d2a4bbf237cf1e1846_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfOC0xLTEtMS0w_2daa1eb0-7173-421f-a022-da2906e33771">17,933,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf4c9f98bfbf40d2a4bbf237cf1e1846_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfOC0zLTEtMS0w_849d8f41-40e0-49fe-b237-08b371036f5f">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaee018047a74b78859eeb591b6c591f_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfOC01LTEtMS0w_8cde7dcd-1470-42f1-a2fd-5e590532f1d0">106,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i485b22c217834e23b0364e76e06a2371_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfOC03LTEtMS0w_27857a2d-69d5-4508-a486-460bf1eadab7">52,848</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3010403a70d436483ab771b941a207d_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfOC05LTEtMS0w_fce47f74-77c9-4a25-a6c2-9968c198aae3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfOC0xMS0xLTEtMA_48e117bd-c779-4059-b6b3-a06ca8cda86f">53,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:24.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.286%"></td><td style="width:0.1%"></td></tr><tr style="height:35pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retained<br/>Earnings<br/>(Accumulated<br/>Deficit)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie8367f0895fb4ca3b02c812b17b329e3_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMi0xLTEtMS02MTQ_e0caa191-0c5b-42bb-9870-0d2827232e2a">17,801,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8367f0895fb4ca3b02c812b17b329e3_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMi0zLTEtMS02MTg_ed0139a7-9d4e-447e-8c79-e08017756518">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia490656dd3ce42e2bf315a7086535095_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMi01LTEtMS02MTY_32a73477-f351-4995-97ec-aec4f98d0de8">102,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i484a97403f27472ea9481c015d1527fb_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMi03LTEtMS02MjI_c6147844-82b0-4bf9-857c-6c53600aebf6">60,594</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie07d79b96d4d4295b68c970c1206cf32_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMi05LTEtMS02MjQ_6f9961cc-fa3b-4c28-8146-d049a9aa4082">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44e8ae2855f24ec191abeac87edead4a_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMi0xMS0xLTEtNjI2_a57c2ff0-978f-4dfa-9778-1e4a31fd66ed">41,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Issuance of common stock for employee purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9e00e169b2114d2997dc62ba88fc41f2_D20210401-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMy0xLTEtMS0zNDA5_77446f21-d708-4ab6-b6f5-fc8990f00f29">38,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1e3e98112d445a2b78ea2ada37f81ed_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMy01LTEtMS0zNDA5_577d45ca-4450-44cf-85dc-5a0ba18787d7">645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMy0xMS0xLTEtMzQwOQ_a5b51a44-0c8a-4c35-9334-ef89fe9dc326">645</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9e00e169b2114d2997dc62ba88fc41f2_D20210401-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMy0xLTEtMS02MTQ_ce03bcdd-0f33-4911-891b-bda78ba7dc46">29,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1e3e98112d445a2b78ea2ada37f81ed_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMy01LTEtMS02MTY_bf2e2cdc-218d-424c-a39b-9a45597d55f5">856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMy0xMS0xLTEtNjI2_9e4075be-7994-417e-bf1c-2d048d4d2425">856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9e00e169b2114d2997dc62ba88fc41f2_D20210401-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfNS0xLTEtMS02MjA_13b80465-a839-4707-ac2f-0ff4b850eef2">62,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1e3e98112d445a2b78ea2ada37f81ed_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfNS01LTEtMS02MTY_f69f1f90-0db6-4d9c-a6fc-1fe841c0da91">453</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfNS0xMS0xLTEtNjI2_60b00cac-2798-445d-808a-d12983209e84">453</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1e3e98112d445a2b78ea2ada37f81ed_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfNi01LTEtMS02MTY_b8039c6f-7f2f-41a8-af5b-af88328e5211">2,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfNi0xMS0xLTEtNjI2_920d529a-1641-4aea-8daf-a170f4480ca0">2,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5bc0220b3cd4bbd82245f12526ec90e_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfNy03LTEtMS02Mjg_ff29e06e-68c1-4c94-81e5-5e4ce8265c7b">7,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfNy0xMS0xLTEtNjI2_b5f86096-bccf-43b8-8553-6bc003a9709e">7,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf4c9f98bfbf40d2a4bbf237cf1e1846_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfOC0xLTEtMS02MzA_f6a43328-c689-494a-a730-0e43be976dd1">17,933,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf4c9f98bfbf40d2a4bbf237cf1e1846_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfOC0zLTEtMS02MzA_001669ae-b8b6-40be-ac6b-32fc149b8618">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaee018047a74b78859eeb591b6c591f_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfOC01LTEtMS02MzA_6378a274-3787-4d1f-a84e-4f49af2b5aa7">106,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i485b22c217834e23b0364e76e06a2371_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfOC03LTEtMS02MzA_4ca56fb8-f782-42fc-876d-2937c1062abb">52,848</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3010403a70d436483ab771b941a207d_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfOC05LTEtMS02MzA_3d81771e-b528-416c-9784-8cc15499073d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfOC0xMS0xLTEtNjI2_5933378d-580f-4494-a873-360fd6185606">53,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three and Six Months Ended June 30, 2020</span></div><div style="margin-top:5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:24.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.286%"></td><td style="width:0.1%"></td></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retained<br/>Earnings<br/>(Accumulated<br/>Deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f3e187f8cdd4a27a16464c1e2230fec_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMi0xLTEtMS0w_277913e7-c28e-469c-87d1-4bdf61023eea">14,315,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3e187f8cdd4a27a16464c1e2230fec_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMi0zLTEtMS0w_e3b2e0a7-feef-4fc2-acd8-494c3bbf2c9d">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i244e0262c30f4bc59029986047588df0_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMi01LTEtMS0w_61e7a9b0-dda1-42e8-9759-62f8645f8e5c">82,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i570d20ed67764205924e7fee40c9295a_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMi03LTEtMS0w_d125c845-597f-4951-b675-5516bb628d62">36,358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b3d4dae27cb4fb68ccfb9a3a1a93823_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMi05LTEtMS0w_a040c595-9f6a-49fa-b5b4-4ccb47ecc9a6">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33947892bb224113abf96b09e46ffa54_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMi0xMS0xLTEtMA_05bdb042-bd45-4740-bd03-509f1a3be1c5">45,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Issuance of common stock for employee purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85bdd8375cea4bfcbeb0257fbde7b2b9_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMy0xLTEtMS0zMTY5_65a3d2ef-b03f-434b-9ff1-64cac811ca38">39,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i170f952087874acbaa3da79723af4837_D20200101-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMy01LTEtMS0zMTY5_c1449616-b0ac-4404-896e-4bc7250e9f31">437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMy0xMS0xLTEtMzE2OQ_afafa3fc-1807-4213-b020-0d3d6a66a617">437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85bdd8375cea4bfcbeb0257fbde7b2b9_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMy0xLTEtMS0w_7cf9595a-cbc5-4b1c-86a6-5bf190ea4d1d">46,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i170f952087874acbaa3da79723af4837_D20200101-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMy01LTEtMS0w_a7ff3e11-06de-4863-a162-5b423dedd713">411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMy0xMS0xLTEtMA_99071cbf-cd4a-452e-9192-e1b92a5ebac5">411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85bdd8375cea4bfcbeb0257fbde7b2b9_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNC0xLTEtMS0w_00e1232e-e547-4403-8711-089d7d533f3f">423,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85bdd8375cea4bfcbeb0257fbde7b2b9_D20200101-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNC0zLTEtMS0w_be38f55f-6b52-4882-b1c8-97e87a13e351">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i170f952087874acbaa3da79723af4837_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNC01LTEtMS0w_b927335d-8df1-4597-ada1-131a1afd4f1d">3,118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNC0xMS0xLTEtMA_54dddea1-de37-4096-bf04-813ce3e5fbb7">3,117</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock in connection with public offering, net of offering cost of $<ix:nonFraction unitRef="usd" contextRef="i85bdd8375cea4bfcbeb0257fbde7b2b9_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNi0wLTEtMS0zNTU2L3RleHRyZWdpb246NDk1OGYyNzZhZTQ1NDk2Y2E3ZTM3YjRjNzQ0YTgyNTFfMjE5OTAyMzI1NTY1Ng_871b7bc8-236d-4f34-8cf1-882787fa3b66">2,303</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85bdd8375cea4bfcbeb0257fbde7b2b9_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNS0xLTEtMS03OTc_60bb4076-005a-43e4-86a2-c18b0d22d94e">2,742,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85bdd8375cea4bfcbeb0257fbde7b2b9_D20200101-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNS0zLTEtMS03OTc_ddd22227-9865-4961-abe0-0f8142346c78">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i170f952087874acbaa3da79723af4837_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNS01LTEtMS03OTc_06c52987-977d-4b6e-8a5a-e8509bbc6716">26,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNS0xMS0xLTEtNzk3_e6866f49-1c3c-4495-b7e7-05bd931f4818">26,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i170f952087874acbaa3da79723af4837_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNS01LTEtMS0w_816948d9-3664-48f2-b4a6-f1d2c8e00773">6,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNS0xMS0xLTEtMA_095b6c4a-695d-4561-a08a-d73650f072b9">6,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3b47574caca46b99fb6499883087ed3_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNi03LTEtMS0w_b8d2c095-eedb-4cec-bffe-0d11f3c1bbda">23,808</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNi0xMS0xLTEtMA_04abf387-67a5-4155-9544-30cf2f729b34">23,808</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net change in unrealized loss on available-for-sale investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba9e052e19bc4d9cb3949ba436e89381_D20200101-20200630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNy05LTEtMS0w_3fd46548-063f-44f8-9bcd-2e5f964e25df">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNy0xMS0xLTEtMA_45f46a42-b63c-4acf-8b65-27d9a4a5bbe3">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5cfedb49abf43a58191f2993ef3e540_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfOC0xLTEtMS0w_f489d79e-57d4-4de7-9ce6-74d83e712382">17,567,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5cfedb49abf43a58191f2993ef3e540_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfOC0zLTEtMS0w_c8641a07-b4e5-4c07-ba10-8a4dd6393db5">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7cb0aefbadc4fae96b37599c7955716_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfOC01LTEtMS0w_8e0517d8-7d4d-47f9-8501-d02bb4f3eb1b">112,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i341bd948a0694080b463b58e446e0e46_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfOC03LTEtMS0w_4dc43aa5-e1f6-4e64-87fe-735f0ee7342b">60,166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03250011c65e4e58a12c712ed93a235f_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfOC05LTEtMS0w_354dabc5-8365-47a6-88a7-85a0d52c0783">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfOC0xMS0xLTEtMA_555cacb1-e767-42d3-8dcb-a975afa442a4">52,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:24.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.286%"></td><td style="width:0.1%"></td></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retained<br/>Earnings<br/>(Accumulated<br/>Deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c44dc3e39a944f386ee804f3d8d2f1d_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMi0xLTEtMS02NDU_d3c2e67a-c549-4049-9050-2172dbae53d4">14,578,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c44dc3e39a944f386ee804f3d8d2f1d_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMi0zLTEtMS02NDk_27980ed3-0789-4f0d-8056-510b6fadf212">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaca8eee5ccbc423ea5d21f84cdc0c483_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMi01LTEtMS02NDc_eed6b9b4-bdd4-45c3-b968-6ce4931def81">82,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc6ab3c5a57d4419a7741a81e73e8cba_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMi03LTEtMS02NTM_dbe58c88-7438-4a83-b8f4-d20255c5a8cc">48,772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff1d956612db4dee81869096bfed413a_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMi05LTEtMS02NTM_b7e07c8c-79ae-451b-a818-e42db4794075">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06df2fa92c07439982ab4b6fddb466f1_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMi0xMS0xLTEtNjUz_295d4ca3-8b6a-4714-a77e-c1f300274957">33,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Issuance of common stock for employee purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia11ce6b42e50441a8bfd1cd6564d5f99_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMy0xLTEtMS0zMTc4_ce476a31-3449-4650-9fad-63ae3334b8c4">39,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7fdc7a0b6b84196a94bd8e81d4ff9ca_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMy01LTEtMS0zMTc4_a651ea63-c97f-4b96-9324-dc22b2a6f746">437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMy0xMS0xLTEtMzE3OA_39f5ea75-68ca-4f78-a9af-cdb310f2f526">437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia11ce6b42e50441a8bfd1cd6564d5f99_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMy0xLTEtMS02NDU_790effe7-973f-455a-aa2b-397801cfe76a">23,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7fdc7a0b6b84196a94bd8e81d4ff9ca_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMy01LTEtMS02NDc_7313e7a4-b5a8-4541-8ef0-962fa821188e">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMy0xMS0xLTEtNjU1_d2ed7893-c5f8-4dd5-b276-1494a84c477d">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia11ce6b42e50441a8bfd1cd6564d5f99_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNC0xLTEtMS02NDU_b7fce47e-55c5-4735-a986-47f10d3edbf6">183,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11ce6b42e50441a8bfd1cd6564d5f99_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNC0zLTEtMS02NTE_7669e5e6-1629-44ff-b207-abd52c7dec0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7fdc7a0b6b84196a94bd8e81d4ff9ca_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNC01LTEtMS02NDc_1b61f0a9-b869-4fee-909c-465a249a9776">883</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNC0xMS0xLTEtNjU1_648f074d-2880-4494-ab01-7e17e02b3023">883</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock in connection with public offering, net of offering cost of $<ix:nonFraction unitRef="usd" contextRef="ia11ce6b42e50441a8bfd1cd6564d5f99_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNS0wLTEtMS04NjkvdGV4dHJlZ2lvbjpiN2NlODVkMjVkOGE0OGE2YWM1NDVjMWI2NzZkNjA4NV8zODQ4MjkwNjk3MzIx_94c42847-6119-4818-830d-55134efda329">2,303</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia11ce6b42e50441a8bfd1cd6564d5f99_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNS0xLTEtMS04MDE_3aa22234-247e-44ad-b5af-cf6d1158ad8b">2,742,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11ce6b42e50441a8bfd1cd6564d5f99_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNS0zLTEtMS04MDE_65d93168-3a49-4156-9673-b5a40b56637a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7fdc7a0b6b84196a94bd8e81d4ff9ca_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNS01LTEtMS04MDE_228f0c18-a279-4e40-b910-4a2c964668d9">26,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNS0xMS0xLTEtODAx_a2352d7b-0c46-4640-9dad-0033aaf71a3f">26,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7fdc7a0b6b84196a94bd8e81d4ff9ca_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNS01LTEtMS02NDc_de3eb743-7514-42eb-9d51-b44ff2872a4d">4,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNS0xMS0xLTEtNjU1_81efdded-76ee-44fd-a595-4ef13c266349">4,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic074f4f3008d47a7a3965891ed645a3b_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNi03LTEtMS02NTc_538229eb-69a2-4872-ab63-3ae2d7f9bd3b">11,394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNi0xMS0xLTEtNjU1_2c6b8a56-7b4f-4524-bd3e-8a8b6c68255a">11,394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net change in unrealized loss on available-for-sale investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8358e3138b90489dafac816f75a0e5f8_D20200401-20200630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNy05LTEtMS02NTk_99ad1a1f-a7e4-4b11-ac9b-2e4b10ffff5b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNy0xMS0xLTEtNjU1_c26d75b6-d41f-4a87-8fef-4f28bfc6ee03">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5cfedb49abf43a58191f2993ef3e540_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfOC0xLTEtMS02NjE_0cf92b71-481f-482c-b1d4-1c25eca276ab">17,567,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5cfedb49abf43a58191f2993ef3e540_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfOC0zLTEtMS02NjE_175b2976-15ac-4e79-bb56-8da252f40e9d">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7cb0aefbadc4fae96b37599c7955716_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfOC01LTEtMS02NjE_42f79b66-eabe-4ba5-9aa4-58fc093e9a41">112,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i341bd948a0694080b463b58e446e0e46_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfOC03LTEtMS02NjE_ebff27ef-d55d-46bd-85d7-95b2c2a5ad9a">60,166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03250011c65e4e58a12c712ed93a235f_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfOC05LTEtMS02NjE_84e6fa09-dee9-4bc3-aecc-dc6f14337296">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfOC0xMS0xLTEtNjU1_f7badb17-7027-45e7-9b62-e948ca06fa1c">52,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="ib4896268598045f0bc55c9d056377420_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMy0xLTEtMS0w_bd2da935-5aef-49f6-bb77-1cfd33127fa5">7,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMy0zLTEtMS0w_eaba8e35-32b7-4152-9c43-3cabb25ed7b4">23,808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNS0xLTEtMS0w_a42afaea-4889-4908-bcdf-dc57c3a9d702">4,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNS0zLTEtMS0w_6fbbe678-cf0d-44a7-a38c-1720f9c20da3">6,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNi0xLTEtMS0w_3ab1ba81-1ab5-44dd-9a0d-530b29123f96">707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" name="cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNi0zLTEtMS0w_1a2fea45-472b-4356-acbb-eaf9d61a849f">715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of contract acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfAcquisitionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNy0xLTEtMS0w_7567400e-2cd9-4451-91c3-bd95cdb73363">1,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfAcquisitionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNy0zLTEtMS0w_4f32a61e-1a66-4ba5-8cbc-c443d9cf2ce5">1,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfOC0xLTEtMS0w_40633e82-9801-4c1c-9bc9-0463f46734e1">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfOC0zLTEtMS0w_beb2275d-0857-40e9-9d13-2b4854cd9fcf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairment of capitalized cloud computing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:CapitalizedComputerSoftwareImpairments1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfOS0xLTEtMS0w_17a6776e-57a6-4abd-bd84-ff1e8c685b6c">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" name="us-gaap:CapitalizedComputerSoftwareImpairments1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfOS0zLTEtMS0w_be753438-b9eb-496d-847b-ddc0cb3f5458">805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in deferred tax asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTAtMS0xLTEtMA_1dd9249d-b5c6-47ed-adfb-4a4a82eabffa">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTAtMy0xLTEtMA_0f8312f1-d916-4698-8c8c-8cb84fcc839a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTEtMS0xLTEtMA_2d1dd376-81da-42c8-a308-53cd08a7dce7">492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTEtMy0xLTEtMA_be26249d-0169-40ed-8290-d04f650c0a6b">1,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on sale of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTItMS0xLTEtMA_afb2a8c5-3aae-4e79-adc6-6898dadd18c6">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTItMy0xLTEtMA_7675f008-5a69-4b97-b1b3-a927159a5ebe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on extinguishment of PPP loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTMtMS0xLTEtNDEyMA_995369cf-5205-4e27-889e-b3faf6995255">7,185</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTMtMy0xLTEtNDI0Mw_cf17192a-04ad-4b00-a894-3c8be779ac24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="cutr:ChangeInRightofuseAssetAndLiabilityDueToModification" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTMtMS0xLTEtMA_74170465-700f-467a-b6d0-05932b64ddba">604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="cutr:ChangeInRightofuseAssetAndLiabilityDueToModification" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTMtMy0xLTEtMA_fcf4440b-56d4-422e-a784-c8e6efc784da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTQtMS0xLTEtMA_158f8ed5-670c-471e-bd8f-f38f3c06e835">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTQtMy0xLTEtMA_299783f2-0035-40f7-98e0-0c8157a01248">198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTYtMS0xLTEtMA_dac8feeb-a645-4689-871a-0be762b671e3">4,433</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTYtMy0xLTEtMA_cca400fb-3286-409d-b14a-d956c9b262b5">6,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTctMS0xLTEtMA_54ef359b-b7d6-45d3-856e-6aec26666cd0">5,958</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTctMy0xLTEtMA_f924b786-e68b-47f0-98ac-6768b6207be1">2,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets and prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTgtMS0xLTEtMA_f6124a4f-31ea-4a41-8335-5f5f8f685d51">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTgtMy0xLTEtMA_efaa183d-b537-4863-81c5-17495019252f">316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTktMS0xLTEtMA_0ab3227f-e92c-4c19-8406-076b489420fe">1,720</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTktMy0xLTEtMA_1333e7f3-6827-4b7a-8bf5-d75df2e0c5fc">519</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjAtMS0xLTEtMA_9fd47db4-3f5e-4901-aa3f-fb4bf9afd33a">474</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjAtMy0xLTEtMA_70a8a483-de82-442a-8696-71fb126362d2">1,004</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjEtMS0xLTEtMA_55f4b6a7-615a-4133-a76b-628cbf3355b5">10,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjEtMy0xLTEtMA_e6478d99-1c55-4be6-884d-37a60a245c00">9,754</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Extended warranty liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" sign="-" name="cutr:IncreaseDecreaseInExtendedProductWarrantyAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjItMS0xLTEtMA_ad676e27-f674-47c8-8006-28a6b285d7e8">567</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" name="cutr:IncreaseDecreaseInExtendedProductWarrantyAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjItMy0xLTEtMA_a08175fd-6b2d-4e85-9409-7eaa3cc24177">339</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" sign="-" name="cutr:IncreaseDecreaseInOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjMtMS0xLTEtMA_d57c30a3-45e6-471d-af45-30a600585ffd">530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="cutr:IncreaseDecreaseInOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjMtMy0xLTEtMA_33c9b777-e294-483e-ac06-14896bbe55c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjQtMS0xLTEtMA_f81793a7-b248-4003-b402-4d37e3428a33">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjQtMy0xLTEtMA_92ff0d9b-9ec9-4761-919e-a2f8811db957">2,443</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjUtMS0xLTEtMA_e011d786-8fa0-4ad9-9bd0-f0b83d8b027f">4,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjUtMy0xLTEtMA_277fc7be-9b79-4554-a7e8-8724cdd00a9a">17,951</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of property, equipment, and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjgtMS0xLTEtMA_a12969a1-6767-4ca5-8257-2bcbd8a31878">370</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjgtMy0xLTEtMA_9d6c3875-3637-4fc9-a3c1-ccdf1b7db196">435</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from disposal of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjktMS0xLTEtMA_a6b5002d-a333-46bf-91b8-63007810317b">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjktMy0xLTEtMA_0008c75f-110b-4c0e-8387-ebab60f5caa8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from maturities of marketable investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzAtMS0xLTEtMA_26f1abdc-cb2a-4752-a697-d3e4ed89473f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzAtMy0xLTEtMA_3d9638f2-2449-422f-ac39-fbb0b4e049ee">10,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of marketable investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzEtMS0xLTEtMA_8ac15573-d863-4f71-bb23-896dc7a6cb56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzEtMy0xLTEtMA_27f48825-b8ad-4e8b-ae91-0c25ef8fef1a">16,167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzItMS0xLTEtMA_dc5ff073-7412-4f33-bacc-a3aaae45d7da">299</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzItMy0xLTEtMA_db35746b-71d8-4bc0-b544-642227c338e4">5,702</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options and employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzUtMS0xLTEtMA_2f686908-af55-46a2-a827-02fb38d61471">1,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzUtMy0xLTEtMA_03fe5a18-e333-4b53-b7eb-4009031f1427">848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase&#160;of capped call</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForDerivativeInstrumentFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzYtMS0xLTEtMA_f9f21475-516a-4277-96da-f48ad299817c">16,134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsForDerivativeInstrumentFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzYtMy0xLTEtMA_c4a43a5c-c9c2-4a56-8227-cd9cde91a1f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of Convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzctMS0xLTEtMA_bb03e941-0055-4d46-be2c-2722b89736bc">138,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzctMy0xLTEtMA_dccf3319-f971-414d-bef4-73d85341799f">7,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of issuance costs of Convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzgtMS0xLTEtMA_ad53ac72-5cd1-4423-b3b5-c6331ac0e133">4,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzgtMy0xLTEtMA_a43192d5-0953-4675-8f02-572519bced69">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from equity offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDAtMS0xLTEtMzIwNQ_e8def00e-7e99-4ac9-87e8-00cb5cb16d49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDAtMy0xLTEtMzIwNQ_52bce4e4-1063-40ef-8d55-4d7af83e5a7e">28,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of equity offering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDEtMS0xLTEtMzIwNQ_e13219b1-433d-4dd4-a62b-0d0740cfb169">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDEtMy0xLTEtMzIwNQ_68bb43ab-2c6e-4ae5-ac36-8a73abeafd35">2,303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzktMS0xLTEtMA_52a9c581-0371-42ba-b1fd-4c82718f67e2">1,451</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzktMy0xLTEtMA_e2a7cd69-7bbf-4ed8-bfc1-6813124c99e2">3,117</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on finance lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDAtMS0xLTEtMA_0b079170-26f5-4248-9833-e54350805e66">211</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDAtMy0xLTEtMA_774de236-7e91-4da7-9077-a357d82b8a85">380</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDEtMS0xLTEtMA_57d552b8-87d1-4287-8eed-e386625efc28">117,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDEtMy0xLTEtMA_cec6114a-c8b1-4b57-bf45-ccb1998fd6ce">30,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDMtMS0xLTEtMA_f5c042e8-d051-4289-97b5-35cf5ff5799c">122,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDMtMy0xLTEtMA_a3ceb9fd-2066-432b-84d9-670e5fe8bfa3">7,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDQtMS0xLTEtMA_abd7062b-1306-452b-87c4-ca4712d45882">47,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33947892bb224113abf96b09e46ffa54_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDQtMy0xLTEtMA_2cab3ab7-3fca-4ab8-8645-2f1c53cb33a7">26,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDUtMS0xLTEtMA_74c8ac67-8382-48cb-9371-20247b6dee6b">169,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDUtMy0xLTEtMA_39676202-970f-4e2a-a324-8602cc9b1c37">33,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental disclosure of non-cash items:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets acquired under finance lease</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDgtMS0xLTEtMA_68de1562-fa6c-448b-b570-a83f37044c33">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDgtMy0xLTEtMA_efd0f558-2c2c-4959-8ee4-4452e8b46f32">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets acquired under operating lease</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDktMS0xLTEtMA_65c35e40-1e49-4d15-9ea0-358cd8739601">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDktMy0xLTEtMA_39bc1753-9d26-47d0-a5e3-11271b122d69">1,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on extinguishment of PPP loan</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesReduction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDktMS0xLTEtNDI0NQ_477a7e47-c50c-489b-918e-5f21db171e6c">7,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:NotesReduction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDktMy0xLTEtNDI0NQ_564a9b60-0eaf-452d-ad5f-0dafecd13cb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt issuance costs accrued</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNTAtMS0xLTEtMA_5f577ad0-954b-4fee-9f34-a52c03fffe20">452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNTAtMy0xLTEtMA_774b62fc-c9cb-49a0-add4-b6ed54d33dbb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax paid</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNTItMS0xLTEtMA_54385efe-e4e5-43a1-827b-ff540dcc8711">458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNTItMy0xLTEtMA_907416d3-bdb4-47fb-9873-eb42c78a941b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="ib4896268598045f0bc55c9d056377420_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div id="ib4896268598045f0bc55c9d056377420_40"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1. <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMTQ0NDI_f8663c87-214e-4980-9bbb-384272caeaed" continuedAt="i9e5170bdf0a94e56b75fcb1b60a7fe2f" escape="true">Summary of Significant Accounting Policies&#160;</ix:nonNumeric></span></div><ix:continuation id="i9e5170bdf0a94e56b75fcb1b60a7fe2f" continuedAt="i0a69054280ae48e299aed7ad75daab35"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMTQ0NDM_93742ea2-85a3-41ae-b7f2-66529c348871" continuedAt="i0f5f32d106084501bd09ee64e0d2895a" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Operations and Principles of Consolidation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cutera, Inc. (&#8220;Cutera&#8221; or the &#8220;Company&#8221;) provides energy-based aesthetic systems for practitioners worldwide. The Company develops, manufactures, distributes, and markets energy-based product platforms for use by physicians and other qualified practitioners, enabling them to offer safe and effective aesthetic treatments to their customers. The Company currently markets the following system platforms: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten, excel, Secret PRO, Juliet, Secret RF,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Several of the Company&#8217;s systems offer multiple hand pieces and applications, providing customers the flexibility to upgrade their systems. The sales of (i) systems, system upgrades, and hand pieces (collectively &#8220;Systems&#8221; revenue); (ii) replacement hand pieces, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan, truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">D,truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cycle refills, as well as single use disposable tips applicable to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO, Juliet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;Consumables&#8221; revenue); (iii) the distribution of third party manufactured skincare products (&#8220;Skincare&#8221; revenue); and (iv) the leasing of equipment through a membership program; are collectively classified as &#8220;Products&#8221; revenue. In addition to Products revenue, the Company generates revenue from the sale of post-warranty service contracts, parts, detachable hand piece replacements (except for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan, truSculpt 3D, truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and service labor for the repair and maintenance of products that are out of warranty, all of which are collectively classified as &#8220;Service&#8221; revenue.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0f5f32d106084501bd09ee64e0d2895a">The Company&#8217;s corporate headquarters and U.S. operations are located in Brisbane, California, where the Company conducts manufacturing, warehousing, research and development, regulatory, sales and marketing, service, and administrative activities. The Company also maintains regional distribution centers (&#8220;RDCs&#8221;) in select locations across the U.S. These RDCs serve as forward warehousing for systems and service parts in various geographies. The Company markets, sells and services its products through its sales and service employees in North America (including Canada), Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, Spain, Switzerland, and the United Kingdom. Sales and services outside of these direct markets are made through a worldwide distributor network in over <ix:nonFraction unitRef="country" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="INF" name="cutr:NumberOfCountriesInWhichEntityUtilizesADistributorNetwork" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMjQwOA_11fe282a-b906-45ed-b194-975c9972e50a">42</ix:nonFraction> countries. The condensed consolidated financial statements include the accounts of the Company and its subsidiaries.</ix:continuation> </span></div><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="cutr:BasisOfPresentationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMzg0ODI5MDcxNjYyNg_7e7e6def-bcfd-4fec-9b89-092b975b2bc4" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements included in this report reflect all adjustments necessary for a fair statement of its condensed consolidated statements of financial position as of June&#160;30, 2021 and December&#160;31, 2020, and its condensed consolidated statements of results of operations, comprehensive income (loss), changes in equity, and cash flows for the three and six months ended June&#160;30, 2021, and 2020. The December&#160;31, 2020 condensed consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;). The results for interim periods are not necessarily indicative of results for the entire year or any other interim period.&#160;Presentation of certain prior year balances have been updated to conform with current year presentation. All significant intercompany accounts and transactions have been eliminated upon consolidation. The accompanying condensed consolidated financial statements should be read in conjunction with the Company&#8217;s previously filed audited financial statements and the related notes thereto included in the Company&#8217;s annual report on Form 10-K for the year ended December&#160;31, 2020 filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 23, 2021.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="cutr:RisksAndUncertaintiesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMTQ0NDQ_a3659068-0030-4937-99a0-82fc02292100" continuedAt="id586357cd16d483aa359bec90a7ff63e" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's future results of operations involve a number of risks and uncertainties. Factors that could affect the Company's future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company's products, stability of global financial markets, cybersecurity breaches and other disruptions that could compromise the Company&#8217;s information or results, business disruptions that are caused by natural disasters or pandemic events, management of international activities, competition from substitute products and larger companies, ability to obtain and maintain regulatory approvals, government regulations and oversight, patent and other types of litigation, ability to protect proprietary technology from counterfeit versions of the Company's products, strategic relationships and dependence on key individuals.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020,&#160;the World Health Organization declared the COVID-19&#160;outbreak a pandemic. The COVID-19&#160;outbreak has negatively affected the United States and global economies. Though the economy is gradually recovering as of the second quarter of 2021, the timing and extent of a full global economic recovery is still uncertain. The spread of the coronavirus and the Delta variant in particular, has impacted the global economy broadly in 2020, including restrictions on travel, shifting work </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><ix:continuation id="i0a69054280ae48e299aed7ad75daab35" continuedAt="i9dfd97c5389648b19f6779d973df5b41"><ix:continuation id="id586357cd16d483aa359bec90a7ff63e"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">forces to work remotely and quarantine policies put into place by businesses and governments, had a material economic effect on the Company&#8217;s business during the year ended December&#160;31, 2020 and in the six months ended June&#160;30, 2021. Healthcare facilities in many countries effectively banned elective procedures and this had a significant impact on the Company. Many of the Company&#8217;s products are used in aesthetic elective procedures and as such, the bans on elective procedures substantially reduced the Company&#8217;s sales and marketing efforts in the early months of the pandemic and led the Company to implement cost control measures. Although the Company&#8217;s revenues and profits have&#160;improved compared to the first half of fiscal 2020 and the overall economic outlook has also improved in 2021, the&#160;COVID-19&#160;outbreak continues to be fluid especially in light of the Delta variant, and the long-term impact on the Company's business due to COVID-19 is still uncertain. The Company&#160;cannot presently predict the scope and severity of any impacts in future periods from business shutdowns or disruptions due to the&#160;COVID-19&#160;pandemic, but the impact on economic activity including the possibility of recession or financial market instability could have a material adverse effect on the Company&#8217;s business, revenue, operating results, cash flows and financial condition. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to assess whether any impairment of its goodwill or its long-lived assets has occurred and has determined that no&#160;charges, other than an impairment loss of $<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfNTUxOA_6b41ad95-c220-404e-a9c5-2186c869dd5b">0.2</ix:nonFraction> million on capitalized implementation costs of&#160;cloud-based customer relationship management (&#8220;CRM&#8221;) software occurred were necessary during the six months&#160;ended June&#160;30, 2021.&#160;The Company will continue to monitor future conditions important to its assessment of potential impairment of its long-lived assets and goodwill, including the impacts of the&#160;COVID&#8211;19&#160;pandemic and other ongoing impacts which are subject to uncertainty.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has experienced a significant increase in sales of skincare products under the exclusive distribution agreement with ZO Skin Health, Inc. (&#8220;ZO&#8221;), which allows&#160;the Company to sell ZO&#8217;s skincare products in Japan. The reason for the increase in skincare products sales may have been the&#160;result of changes in customers&#8217; spending habits as customers purchased more aesthetic treatments that were able to be applied at home, due to limitations on&#160;in-person&#160;aesthetic procedures, social distancing and mask wearing requirements due to the&#160;COVID-19&#160;pandemic. Future growth in sales of skincare products depends on customers&#8217; spending habits, which may revert to original spending habits after the&#160;COVID-19&#160;pandemic. Such changes may have a material adverse effect on the Company&#8217;s revenue, operating results, and cash flows.</span></div></ix:continuation><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMTQ0NDY_93fea48b-a6b1-4085-8fbb-ea4c94da4d7d" continuedAt="i79f2c561a4694c189cb73b11e9d345c6" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Policies</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements are prepared in accordance with the rules and regulations of the SEC applicable to interim financial statements. While these statements reflect all normal recurring adjustments that are, in the opinion of management, necessary for fair presentation of the results of the interim period, they do not include all of the information and footnotes required by GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the financial statement disclosures in its annual report on Form 10-K for the year ended December&#160;31, 2020 filed with the SEC on March 23, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the same accounting policies in preparing quarterly and annual financial statements. Unless otherwise noted, amounts presented within the notes to condensed consolidated financial statements refer to the Company&#8217;s continuing operations. Note 13 provides information about the Company&#8217;s adoption of the new accounting standard for debt with conversion and other options, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued $<ix:nonFraction unitRef="usd" contextRef="i2456eaded80b44f784a0a4a1f81e0150_D20210305-20210305" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfOTQ2Mw_74be82f1-9cc8-4d06-a2c3-2114d2d07f87">138.3</ix:nonFraction> million of convertible senior notes ("Notes" or "Convertible notes") in a private placement offering on March&#160;5, 2021. The Convertible notes bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="i65e02799f7d2458f8b8251dfac3c7b7b_I20210305" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfOTYxNQ_3cea609e-279e-450a-86ad-38cc075d581a">2.25</ix:nonFraction>% per year. In accordance with Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020-6,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contracts in Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">s Own Equity (Subtopic 815-40),</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company recorded the Convertible&#160;notes as long-term debt with no separation between the Convertible notes and the conversion option. Each reporting period, the Company will determine whether any criteria is met for the note holders to have the option to redeem the Convertible notes early, which will result in a change in the classification of the Convertible notes to current liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The circumstances described in the paragraph above were met during the second quarter of 2021 as the Company's stock traded at a price in excess of the conversion price, and as a result, the Notes are convertible at the option of the holder from July 1, 2021 until September 30, 2021. Upon any conversion of the Convertible notes, the Company would be required to pay or deliver, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#8217;s election. To the extent there are any conversions during the period from July 1, 2021 until September 30, 2021, the Company intends to settle such conversions by issuing shares of common stock; therefore, as of June&#160;30, 2021, the Convertible notes have been included as long term liability on the condensed consolidated balance sheet.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><ix:continuation id="i9dfd97c5389648b19f6779d973df5b41"><ix:continuation id="i79f2c561a4694c189cb73b11e9d345c6"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs associated with issuance of the Convertible notes, including underwriters&#8217; fees, are presented in the condensed consolidated balance sheet as a direct deduction from the carrying amount of the Convertible notes. The debt issuance costs are being amortized over the life of the Convertible notes as additional non-cash interest expense.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with issuance of the Convertible notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally designated to reduce the potential dilution of the Company's&#160;common stock upon any conversion of the Notes. The capped calls were purchased for $<ix:nonFraction unitRef="usd" contextRef="ie60ebd26bc7440ba9911c6237d5ce6df_D20210305-20210305" decimals="-5" format="ixt:numdotdecimal" name="cutr:CappedCallTransactionsCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMTA4NjM_eec9d98e-3f4d-44a1-b974-1c64de7b9b43">16.1</ix:nonFraction> million and recorded as a reduction to additional paid in capital in the condensed consolidated balance sheet as of June&#160;30, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalized cloud computing systems implementation costs of $<ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CapitalizedComputerSoftwareAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMjE5OTAyMzI3NDk0OA_3405dae1-31c9-4389-a8c3-0919fce9c6a2">0.6</ix:nonFraction>&#160;million during the three months ending June 30, 2021. These costs relate to an on-going implementation of a new Enterprise Resource Planning system and are included in Other long-term assets and Other current assets and prepaid expenses on the condensed consolidated balance sheet.</span></div></ix:continuation><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMTQ0NDc_6b930124-3682-42ea-8d9e-696b0fa70fcf" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commission, allowance for credit losses, sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, implicit and incremental borrowing rates related to the Company&#8217;s leases, variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, assumptions used in operating and sales-type lease classification, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, residual value of leased equipment, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMTQ0NDg_434805a0-7ebc-4f9f-b41a-42129f1e79ca" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">No.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)-Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to remove certain exceptions and improve consistency of application, including, among other things, requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. The Company adopted this guidance in the three and six months&#160;ended June&#160;30, 2021. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated financial position and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the&#160;FASB&#160;issued ASU No. 2020-6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt &#8211; Debt with Conversion and Other Options (Topic 470) and Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Topic 815), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to simplify the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the amendment, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#8217;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the computation of diluted earnings per share. The Company early adopted the guidance on a prospective basis effective January 1, 2021. See Note 13 &#8211; Debt.</span></div></ix:nonNumeric></ix:continuation><div id="ib4896268598045f0bc55c9d056377420_46"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2. <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80Ni9mcmFnOmJmN2ZlNmM2NDRiMjQ2OGQ5ZjIwNzZjMGUzZDMzN2I4L3RleHRyZWdpb246YmY3ZmU2YzY0NGIyNDY4ZDlmMjA3NmMwZTNkMzM3YjhfMTgx_7e1389f4-97d1-4251-b532-cadd3f1c4484" continuedAt="i7273c0a80765423f9169f9cd1a7f26c5" escape="true">Cash, Cash Equivalents</ix:nonNumeric></span></div><ix:continuation id="i7273c0a80765423f9169f9cd1a7f26c5"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80Ni9mcmFnOmJmN2ZlNmM2NDRiMjQ2OGQ5ZjIwNzZjMGUzZDMzN2I4L3RleHRyZWdpb246YmY3ZmU2YzY0NGIyNDY4ZDlmMjA3NmMwZTNkMzM3YjhfMTgy_fd451db5-af42-416c-bf5c-bfb70c3a0014" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's cash and&#160;cash equivalents (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80Ni9mcmFnOmJmN2ZlNmM2NDRiMjQ2OGQ5ZjIwNzZjMGUzZDMzN2I4L3RhYmxlOjZhYzU0ZmFkMGVjODRhZGJhNTY4ZTczYTlhN2M2YTU1L3RhYmxlcmFuZ2U6NmFjNTRmYWQwZWM4NGFkYmE1NjhlNzNhOWE3YzZhNTVfMS0xLTEtMS0w_7d9106ae-3d7c-44d5-b7a3-87f81ad749bd">169,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80Ni9mcmFnOmJmN2ZlNmM2NDRiMjQ2OGQ5ZjIwNzZjMGUzZDMzN2I4L3RhYmxlOjZhYzU0ZmFkMGVjODRhZGJhNTY4ZTczYTlhN2M2YTU1L3RhYmxlcmFuZ2U6NmFjNTRmYWQwZWM4NGFkYmE1NjhlNzNhOWE3YzZhNTVfMS0zLTEtMS0w_31a2eb66-d6e2-469b-95f7-c0fdb38073ab">47,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had <ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80Ni9mcmFnOmJmN2ZlNmM2NDRiMjQ2OGQ5ZjIwNzZjMGUzZDMzN2I4L3RleHRyZWdpb246YmY3ZmU2YzY0NGIyNDY4ZDlmMjA3NmMwZTNkMzM3YjhfMTQx_c8cae86b-990e-41af-971d-a439852672af"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80Ni9mcmFnOmJmN2ZlNmM2NDRiMjQ2OGQ5ZjIwNzZjMGUzZDMzN2I4L3RleHRyZWdpb246YmY3ZmU2YzY0NGIyNDY4ZDlmMjA3NmMwZTNkMzM3YjhfMTQx_f7df959e-0331-4d3d-a6f6-98a186cbe744">no</ix:nonFraction></ix:nonFraction> marketable securities as of June&#160;30, 2021 and December&#160;31, 2020.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="ib4896268598045f0bc55c9d056377420_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3. <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81Mi9mcmFnOjZlN2UyNjc3ZWY3YjQ3YjJiMGNjODA4ZmJlZjA2NDI4L3RleHRyZWdpb246NmU3ZTI2NzdlZjdiNDdiMmIwY2M4MDhmYmVmMDY0MjhfMjA2Mw_56326039-f169-4530-82a1-48e06ad80538" continuedAt="id492d430edfd4ad99f6aa8f205f89eb7" escape="true">Fair Value of Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="id492d430edfd4ad99f6aa8f205f89eb7"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain financial assets at fair value, including cash and cash equivalents. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy contains the following three levels of inputs that may be used to measure fair value, in accordance with ASC 820:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level 1: inputs, which include quoted prices in active markets for identical assets or liabilities;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level 2: inputs, which include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. When sufficient quoted pricing for identical securities is not available, the Company uses market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level 3: inputs, which include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques, as well as significant management judgment or estimation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considering counterparty credit risk in its assessment of fair value.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 13 - Debt for the carrying amount and estimated fair value of the Company&#8217;s Convertible notes due 2026.</span></div></ix:continuation><div id="ib4896268598045f0bc55c9d056377420_55"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4. <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMTQzNQ_c200fcec-fe32-4b17-aa7f-ace5cea7ef71" continuedAt="i46514d7bd21245629e1fad2b89009d52" escape="true">Balance Sheet Details</ix:nonNumeric></span></div><ix:continuation id="i46514d7bd21245629e1fad2b89009d52" continuedAt="i7c77905e59dd4b4996e48cc79d29c065"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMTQzNg_897d845c-c77b-40ae-8d2a-f0d56ba138a9" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021 and December&#160;31, 2020, inventories consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjllY2M0MGZlMTY0NzRhZGVhMTkwZmVjNmE3YmY2MzAyL3RhYmxlcmFuZ2U6OWVjYzQwZmUxNjQ3NGFkZWExOTBmZWM2YTdiZjYzMDJfMS0xLTEtMS0w_2ebb7aa6-f5b0-447e-b235-39fe4f8f34a8">15,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjllY2M0MGZlMTY0NzRhZGVhMTkwZmVjNmE3YmY2MzAyL3RhYmxlcmFuZ2U6OWVjYzQwZmUxNjQ3NGFkZWExOTBmZWM2YTdiZjYzMDJfMS0zLTEtMS0w_a59fc019-092e-4f83-9039-3ef2ae2e067e">14,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjllY2M0MGZlMTY0NzRhZGVhMTkwZmVjNmE3YmY2MzAyL3RhYmxlcmFuZ2U6OWVjYzQwZmUxNjQ3NGFkZWExOTBmZWM2YTdiZjYzMDJfMi0xLTEtMS0w_1c32ed88-2935-4c6b-92c2-e99a8833860e">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjllY2M0MGZlMTY0NzRhZGVhMTkwZmVjNmE3YmY2MzAyL3RhYmxlcmFuZ2U6OWVjYzQwZmUxNjQ3NGFkZWExOTBmZWM2YTdiZjYzMDJfMi0zLTEtMS0w_d32a1284-4f7f-428d-ae08-be0c2c23ce71">1,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjllY2M0MGZlMTY0NzRhZGVhMTkwZmVjNmE3YmY2MzAyL3RhYmxlcmFuZ2U6OWVjYzQwZmUxNjQ3NGFkZWExOTBmZWM2YTdiZjYzMDJfMy0xLTEtMS0w_5fbad377-e03d-4d84-a670-c7d312dc8c88">17,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjllY2M0MGZlMTY0NzRhZGVhMTkwZmVjNmE3YmY2MzAyL3RhYmxlcmFuZ2U6OWVjYzQwZmUxNjQ3NGFkZWExOTBmZWM2YTdiZjYzMDJfMy0zLTEtMS0w_378f3ebf-6237-46aa-8ada-36e7dbf512b6">12,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjllY2M0MGZlMTY0NzRhZGVhMTkwZmVjNmE3YmY2MzAyL3RhYmxlcmFuZ2U6OWVjYzQwZmUxNjQ3NGFkZWExOTBmZWM2YTdiZjYzMDJfNC0xLTEtMS0w_c748925b-1c84-49bb-b3b8-6f4877ec476d">34,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjllY2M0MGZlMTY0NzRhZGVhMTkwZmVjNmE3YmY2MzAyL3RhYmxlcmFuZ2U6OWVjYzQwZmUxNjQ3NGFkZWExOTBmZWM2YTdiZjYzMDJfNC0zLTEtMS0w_ab72c7a9-1997-416f-949d-f6809852cf6d">28,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Liabilities</span></div><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMTQzNw_8fff466d-f125-4ade-88ea-5cfeb3f3140a" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021 and December&#160;31, 2020, accrued liabilities consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued payroll and related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedSalariesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfMS0xLTEtMS0w_3b0dae36-8db0-4519-adac-a99560c59e51">16,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedSalariesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfMS0zLTEtMS0w_a592d494-c768-451a-b1c5-9d3f5db8f230">12,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cutr:SalesAndMarketingAccrualsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfMi0xLTEtMS0w_032b0006-b48b-4fac-a2c0-e01c4ca5f5db">3,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cutr:SalesAndMarketingAccrualsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfMi0zLTEtMS0w_488033b7-d4d4-41f3-a079-9ff93339ff70">2,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued inventory in transit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cutr:AccruedInventoryInTransitCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfMy0xLTEtMS0w_59513754-c699-4ff6-9cbb-88b1654b8cf4">4,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cutr:AccruedInventoryInTransitCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfMy0zLTEtMS0w_28b73a2e-9a36-4595-9c46-115daf78df67">2,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfNC0xLTEtMS0w_0a00002a-0d36-4b3b-9f7c-ac95038a7006">3,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfNC0zLTEtMS0w_e23a8a11-8854-407d-873a-7ee693d2922a">2,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued sales tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SalesAndExciseTaxPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfNS0xLTEtMS0w_874b61bc-20c2-41e7-95e1-641afe9d07ec">5,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SalesAndExciseTaxPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfNS0zLTEtMS0w_51f9a833-c764-4da3-a8b0-a1ccdb0b7504">5,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfNi0xLTEtMS0w_48ef0dbd-e681-46a5-a493-b1be2b452a22">8,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfNi0zLTEtMS0w_a6663149-9935-4162-b09e-1ab0ece05937">5,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfNy0xLTEtMS0w_2a75a6c4-b56b-43a7-8d8b-d7c998f0445f">41,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfNy0zLTEtMS0w_246dd1d6-c42b-4af2-a487-6747098f4a06">31,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Remediation Liability</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2018, the Company recognized a liability for a product remediation plan related to one of its legacy systems. This was related to a voluntary action initiated by the Company to replace a component in one of the Company&#8217;s </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><ix:continuation id="i7c77905e59dd4b4996e48cc79d29c065"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">legacy products. The remediation plan consists primarily of replacement of a component in the system. The accrued liability consisted of the estimated cost of materials and labor to replace the component in all units that were under the Company's standard warranty or were covered under the existing extended warranty contracts. The Company recorded a&#160;liability of approximately $<ix:nonFraction unitRef="usd" contextRef="ibd2a463e83364d2bbb2747aea222f7be_D20181001-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfODc2_0fdccb82-b736-4fc4-ab56-9641c94a8210">5.0</ix:nonFraction> million in 2018.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021 and December&#160;31, 2020, approximately $<ix:nonFraction unitRef="usd" contextRef="i95ac0510552241b18a45a3559b512564_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfOTE3_90841af2-b905-43b0-a68e-eb25507dca50"><ix:nonFraction unitRef="usd" contextRef="ifa7cefa41ffa4fcca09040bf29e8bd08_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfOTE3_c36cfa15-6c6f-47a6-ac10-3d0a8f9c3774">0.3</ix:nonFraction></ix:nonFraction> million of the total product remediation liability balance was recorded as a component of the Company&#8217;s product warranty and included in accrued liabilities,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="ifa7cefa41ffa4fcca09040bf29e8bd08_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtendedProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMTA3NA_14cf27fe-0481-4d22-8f1a-d257851e0e63">0.7</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="i95ac0510552241b18a45a3559b512564_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtendedProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMTA4MQ_05bd9dab-7b88-41ed-91af-2a6fd7e9be18">1.2</ix:nonFraction> million, respectively, was separately recorded as extended warranty liability. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2021, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="cutr:StandardAndExtendedProductWarrantyAccrualExcessReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMzg0ODI5MDY5OTA3NQ_84ac138e-3c47-4e69-b8cf-a3d7d246c97a">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="cutr:StandardAndExtendedProductWarrantyAccrualExcessReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMzg0ODI5MDY5OTA4OQ_bcaa544b-db67-4e55-b0a5-b1cd11c569e5">0.2</ix:nonFraction>&#160;million, respectively, of excess reserve related to extended warranty and product warranty. Total costs incurred (including excess reversals) related to product warranty and extended warranty liability during the three and six months&#160;ended June&#160;30, 2021 were $<ix:nonFraction unitRef="usd" contextRef="ie45277ed62d346cdb9916dbb3ad17292_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMTI3MQ_2c8d139e-0fc5-44b0-a464-ff4272d951b2">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia2c95c40b3a643028669a714bdf84fcc_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMTI3OA_7bf18b5e-9586-4a00-80cd-3cf7c25c3f22">0.5</ix:nonFraction> million, respectively. Total costs incurred related to product warranty and extended warranty liability during the three and six months ended June&#160;30, 2020 were <ix:nonFraction unitRef="usd" contextRef="i3522b04102fc4ee69538b27d4416746f_D20200401-20200630" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:ProductWarrantyAccrualPayments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMzg0ODI5MDY5OTExNA_ecd1312b-2901-473b-8244-6155183eeced">Nil</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic95c28211b0e434aad49ee7875023aa1_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMjE5OTAyMzI1NzQ1Nw_ed36e10b-f8be-418b-8ce0-aba6b2823959">0.3</ix:nonFraction> million, respectively.</span></div></ix:continuation><div id="ib4896268598045f0bc55c9d056377420_61"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5. <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:ProductWarrantyDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMTY2Mg_699fe324-e412-4898-a390-4f4b6cbc5032" continuedAt="i5170754215544ce1bb221e854d61abe2" escape="true">Warranty and Extended Service Contract</ix:nonNumeric></span></div><ix:continuation id="i5170754215544ce1bb221e854d61abe2"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a direct field service organization in North America (including Canada). Internationally, the Company provides direct service support in Australia, Belgium, France, Germany, Hong Kong, Japan, Spain, Switzerland, and the United Kingdom. In several other countries, where the Company does not have a direct presence, the Company provides service through a network of distributors and third-party service providers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis. The Company provides for the estimated cost to repair or replace products under standard warranty at the time of sale. Costs incurred in connection with extended service contracts are recognized at the time when costs are incurred, except for a one-time extended service contracts charge of $<ix:nonFraction unitRef="usd" contextRef="ifc4ad6178c2c49418650716374160150_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtendedProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfOTY5_bb1e8055-2e3d-4e88-b3dc-8683d34344aa">3.2</ix:nonFraction> million recorded in the year ended December&#160;31, 2018 related to the cost to replace a component in one of the Company's legacy products.</span></div><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMTY2Mw_984a32a5-b0f5-4817-abdd-a8d1242c81f5" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the changes in the product&#160;warranty accrual for the three and six months ended June&#160;30, 2021 and 2020 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020&#160;(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020&#160;(1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i44e8ae2855f24ec191abeac87edead4a_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfMi0xLTEtMS0w_de76bc4d-d547-4716-8853-0d3873635466">3,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i06df2fa92c07439982ab4b6fddb466f1_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfMi0zLTEtMS0w_a437cef0-d622-4b47-81cc-c9e564bd22fc">3,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfMi01LTEtMS05ODA_8845feee-37f5-4a7d-ae23-b1265c797879">2,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33947892bb224113abf96b09e46ffa54_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfMi03LTEtMS05ODI_0b182626-77a3-4449-9a4f-46df2dcf6e66">4,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Add: Accruals for warranties issued during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfMy0xLTEtMS0w_b1547fa6-5267-4bbf-ae89-5abce02e9d08">2,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfMy0zLTEtMS0w_90a94f08-3d61-4345-b253-7832bdfbc469">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfMy01LTEtMS05ODA_088f75ee-924f-4baa-90cf-6df30c7b1059">3,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfMy03LTEtMS05ODI_21a89c0a-89e6-436c-9594-455205580c27">1,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrualPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfNC0xLTEtMS0w_6b3bb415-1c42-4718-bef6-075f517e8808">1,772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrualPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfNC0zLTEtMS0w_90558d7f-3c82-47cf-aba3-cf5285ae69f1">1,343</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrualPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfNC01LTEtMS05ODA_7a505bad-389b-4147-b6a8-8a1c897ade5c">2,854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrualPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfNC03LTEtMS05ODI_daa150d2-4540-4f66-b0e0-337685a1bf10">3,206</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfNS0xLTEtMS0w_0112afa5-a96a-42d5-9f56-94e0509b5781">3,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfNS0zLTEtMS0w_326d14c5-c5f1-4dcb-b7df-a62e7d675c6e">3,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfNS01LTEtMS05ODA_e4b19ed4-e7e7-4caf-9572-62df92581c3a">3,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfNS03LTEtMS05ODI_e535e73f-0828-4991-a58e-e7ba1f4624e9">3,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">The ending product warranty accrual balance excludes <ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtendedProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMzg0ODI5MDcwMDQyNg_2c480703-18e4-479e-828b-c350c473cb18">0.6</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="usd" contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtendedProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMzg0ODI5MDcwMDQzOQ_a902d077-5a85-4462-921d-2b5ab521eec2">1.7</ix:nonFraction>&#160;million as of June&#160;30, 2021 and 2020, respectively, related to one-time extended service contracts costs to replace components in one of the Company&#8217;s legacy products.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $<ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMTQyNg_91e75474-c452-457b-a664-acecf08a9440">1.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMjE5OTAyMzI1NzI0NA_9559314f-a7c3-44c2-8f0e-a5de33a5adda">2.9</ix:nonFraction> million&#160;of settlements made in the three and six months ended June&#160;30, 2021, and $<ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMjE5OTAyMzI1NzI0OA_6e1f25eb-9672-4723-b38e-c9f2c26d94aa">1.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StandardProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMjE5OTAyMzI1NzI1Ng_d358c77b-95b7-4de9-9638-dc0e4c8efe7e">3.2</ix:nonFraction> million made in the three and six months ended June&#160;30, 2020, respectively, exclude costs&#160;related to extended service contract cost of $<ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtendedProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMjE5OTAyMzI1NzYxNg_36b66210-c644-4e8d-bb19-505cab0e1956"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtendedProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMjE5OTAyMzI1NzYxNg_85de7252-164d-45d2-87a9-1f1e8778cfa3">0.1</ix:nonFraction></ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtendedProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMjE5OTAyMzI1NzY0Mw_778dd540-817f-4357-8b86-0551295acaa6"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtendedProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMjE5OTAyMzI1NzY0Mw_dd58b85d-1076-49ed-8052-fbf1a783d24b">0.3</ix:nonFraction></ix:nonFraction> million in the respective periods, incurred to replace a component in one of the Company's legacy products.</span></div></ix:continuation><div id="ib4896268598045f0bc55c9d056377420_64"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6. <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="cutr:ContractWithCustomerLiabilityTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfNzcz_587f6586-7c19-4c08-85ee-b398393b8cdf" continuedAt="ic2cd6ce0b73f4b8499a7da91c9b30780" escape="true">Deferred Revenue</ix:nonNumeric></span></div><ix:continuation id="ic2cd6ce0b73f4b8499a7da91c9b30780" continuedAt="i4a85e73b8d984ce69667eeb60526801b"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records deferred revenue when revenue is to be recognized subsequent to invoicing. For extended service contracts, the Company generally invoices customers at the beginning of the extended service contract term. The Company&#8217;s extended service contracts typically have <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfMzg0ODI5MDY5ODIyNg_e653e8fe-f332-4582-857d-3372b1518b74">one</span>, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfMzg0ODI5MDY5ODIzOA_506311e3-b01b-41cc-9bc7-3004836d0ad0">two</span> or <ix:nonNumeric contextRef="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630" format="ixt-sec:durwordsen" name="cutr:ExtendedServiceContractOptionThreeTerm" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfMzg0ODI5MDY5ODI1Nw_bc2486a7-e722-4302-bcc6-93bd4e1dca68">three year</ix:nonNumeric> terms. Deferred revenue also includes payments for training and extended marketing support service. Approximately <ix:nonFraction unitRef="number" contextRef="i2407102de7bf456bba0a70df24f73953_I20210630" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfNDQ5_1c3099ba-b31c-4ad6-a3d4-2b5c070a7470">84</ix:nonFraction>% of the Company&#8217;s deferred revenue balance of $<ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfNDk3_1e4178ed-899e-4c00-88dd-a760a7575ca9">11.4</ix:nonFraction> million as of June&#160;30, 2021 will be recognized over the next <ix:nonNumeric contextRef="i2407102de7bf456bba0a70df24f73953_I20210630" format="ixt-sec:durmonth" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfNzc0_3c24afab-d75f-4788-9a62-54264d910ae7">12</ix:nonNumeric> months.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfNzc1_f2c305d0-0499-4600-aca8-46e1a140979d" continuedAt="i70e6b5299f1d4188903939adc6114a01" escape="true">The following table provides changes in the deferred revenue balance for the three and six months ended June&#160;30, 2021 and 2020 (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><ix:continuation id="i4a85e73b8d984ce69667eeb60526801b"><div><ix:continuation id="i70e6b5299f1d4188903939adc6114a01"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i44e8ae2855f24ec191abeac87edead4a_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfMi0xLTEtMS0w_61935443-b3a8-48ba-8841-e578a66c8481">11,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i06df2fa92c07439982ab4b6fddb466f1_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfMi0zLTEtMS0w_cbb48c7e-34d2-4de9-95f0-49d82f93f0df">12,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfMi01LTEtMS05Nzg_09ec0044-9760-4069-8694-9dbd7084506b">11,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33947892bb224113abf96b09e46ffa54_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfMi03LTEtMS05NzQ_c8650e8d-563c-4043-8a92-37a14d0b11ee">14,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Add: Payments received</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfMy0xLTEtMS0w_b33e7c35-188b-4f45-9735-a821cc196e62">4,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfMy0zLTEtMS0w_8fdaad67-cef0-492a-b909-3ea6fa5e036c">2,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfMy01LTEtMS05Nzg_ea0fc918-c7c0-4b35-930d-02725048b804">9,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfMy03LTEtMS05NzQ_665632ed-4ee3-4815-8136-96729f4395c0">6,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="cutr:ContractWithCustomerLiabilityPeriodDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNC0xLTEtMS0w_d2d41bdc-cfa1-461c-862c-2bb302aa5d68">1,834</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="cutr:ContractWithCustomerLiabilityPeriodDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNC0zLTEtMS0w_752701ae-8303-41e9-9915-6ee2c7d4f6f7">1,107</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="cutr:ContractWithCustomerLiabilityPeriodDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNC01LTEtMS05Nzg_93505dd7-810c-4618-9ff5-3d944aaa9dfd">2,279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="cutr:ContractWithCustomerLiabilityPeriodDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNC03LTEtMS05NzQ_e715cd65-48b3-486d-b3cb-1bda9d4d7fd9">1,699</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Revenue included in the beginning balance and recognized as revenue in the current quarter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNS0xLTEtMS0w_146a0202-25d8-4efe-b784-5e1330f68a10">2,923</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNS0zLTEtMS0w_e13e1df3-a66f-4817-8138-afbd0eafe735">2,637</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNS01LTEtMS05Nzg_2649c095-7b5f-47fa-9467-94f69af6b5ef">6,907</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNS03LTEtMS0xMDQ1_eb56b055-ae82-47da-a813-be88ebcc1551">6,869</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNi0xLTEtMS0w_44e9ed91-3068-457c-ba6b-fc038f62bd22">11,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNi0zLTEtMS0w_29fd6c3b-46fe-4a1c-82bc-33c55b0db8a5">11,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNi01LTEtMS05Nzg_6e225301-164b-41a0-8d25-6aa0e9f98b0e">11,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNi03LTEtMS05NzQ_378f8039-37c8-4797-a2ef-9770b388a168">11,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs for extended service contracts were $<ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="cutr:CostsForExtendedServiceContracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfNzE2_6b9a14bd-5a0b-4439-8947-de7ac434f8ef">2.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="cutr:CostsForExtendedServiceContracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfNzIz_f623b7f5-2ca5-4040-93a2-8afa47b817e6">4.2</ix:nonFraction> million for the three and six months ended June&#160;30, 2021, respectively, and were $<ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-5" name="cutr:CostsForExtendedServiceContracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfMjE5OTAyMzI1NjM0NA_2e897398-0ef9-4c8b-a2cf-7a95b3cfe835">2.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-5" name="cutr:CostsForExtendedServiceContracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfMjE5OTAyMzI1NjM1Ng_e1f5ac4f-d740-4b3c-b700-153dcd17b477">3.5</ix:nonFraction> million for the three and six months ended June&#160;30, 2020, respectively.</span></div></ix:continuation><div id="ib4896268598045f0bc55c9d056377420_67"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7. <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMTE1ODM_b3f29a13-3c6b-4316-a783-6d1837369186" continuedAt="i181e71536e70401aa2a2522d9b369b15" escape="true">Revenue</ix:nonNumeric></span></div><ix:continuation id="i181e71536e70401aa2a2522d9b369b15" continuedAt="ic34d03319ddc416083633dde2c30e048"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company&#8217;s performance obligations are satisfied either over time or at a point in time. Revenue from performance obligations that are transferred to customers over time accounted for approximately <ix:nonFraction unitRef="number" contextRef="i881844cc567943b08e58b8c62bf2cdb7_D20200401-20200630" decimals="2" name="cutr:RevenuePerformanceObligationSatisfiedOverTimePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMjE5OTAyMzI2ODM4Mg_0202dce0-997e-4441-82cd-d24ae690fefb"><ix:nonFraction unitRef="number" contextRef="iebd0fb6eb91a42ec917f088a099d13af_D20210401-20210630" decimals="2" name="cutr:RevenuePerformanceObligationSatisfiedOverTimePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMjE5OTAyMzI2ODM4Mg_8c5c4a5e-5eaf-43eb-bd07-738cd468588f">12</ix:nonFraction></ix:nonFraction>% of the Company's total revenue for the three months ended June&#160;30, 2021 and 2020, and <ix:nonFraction unitRef="number" contextRef="id5f9a379644248b4bb314bae98be198c_D20200101-20200630" decimals="2" name="cutr:RevenuePerformanceObligationSatisfiedOverTimePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMjE5OTAyMzI2ODc5NQ_2514ac6e-1ea5-4493-9f8f-0fa45f94cb2f"><ix:nonFraction unitRef="number" contextRef="ifc6d773f0c1a4f6b95a87d9eb4d6ac20_D20210101-20210630" decimals="2" name="cutr:RevenuePerformanceObligationSatisfiedOverTimePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMjE5OTAyMzI2ODc5NQ_cc042dcd-61c8-4eb0-976d-42491b97212f">18</ix:nonFraction></ix:nonFraction>% of the Company's total revenue for the six months ended June&#160;30, 2021 and 2020. &#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain system sale arrangements that contain multiple products and services. For these bundled sale arrangements, the Company accounts for individual products and services as separate performance obligations if they are distinct. The Company&#8217;s products and services are distinct if a customer can benefit from the product or service on its own or with other resources that are readily available to the customer, and if the Company&#8217;s promise to transfer the products or service to the customer is separately identifiable from other promises in the sale arrangements. The Company&#8217;s system sale arrangements can include all or a combination of the following performance obligations: the system and software license (considered as one performance obligation), system accessories (hand pieces), training, other accessories, extended service contracts, marketing services, and time and materials services.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s system sale arrangements that include an extended service contract, the period of service commences at the expiration of the Company&#8217;s standard warranty offered at the time of the system sale. The Company considers the extended service contracts terms in the arrangements that are legally enforceable to be performance obligations. Other than extended service contracts and marketing services, which are satisfied over time, the Company generally satisfies all performance obligations at a point in time. Systems, system accessories (hand pieces), service contracts, training, and time and materials services are also sold on a stand-alone basis, and these performance obligations are satisfied at a point in time. For contracts with multiple performance obligations, the Company allocates the transaction price of the contract to each performance obligation on a relative standalone selling price basis. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Judgments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of whether two or more contracts entered into at or near the same time with the same customer should be combined and accounted for as one contract may require the use of significant judgment. In making this determination, the Company considers whether the contracts are negotiated as a package with a single commercial objective, have price interdependencies, or promise goods or services that represent a single performance obligation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company&#8217;s purchase agreements do not provide customers with a contractual right of return, the Company maintains a sales allowance to account for potential returns or refunds as a reduction in transaction price at the time of sale. The Company estimates sales returns and other variable consideration based on historical experience.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the standalone selling price ("SSP") for each performance obligation as follows:</span></div><div style="margin-top:10pt;padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Systems: The SSPs for systems are based on directly observable sales in similar circumstances to similar customers.</span></div><div style="margin-top:10pt;padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Extended warranty/Service contracts: SSP is based on observable price when sold on a standalone basis (by customer type).</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><ix:continuation id="ic34d03319ddc416083633dde2c30e048" continuedAt="if554653866c44296afec0dacf7655607"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Products and Services</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Systems</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systems revenue is generated from the sale of systems and from the sale of upgrades to existing systems. A system consists of a console that incorporates a universal graphic user interface, a laser or other energy-based module, control system software and high voltage electronics, as well as one or more hand pieces. In certain applications, the laser or other energy-based module is contained in the hand piece, such as with the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl Fractional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> applications, rather than within the console.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers customers the ability to select the system that best fits their practice at the time of purchase and then to cost-effectively add applications to their system as their practice grows. This provides customers the flexibility to upgrade their systems whenever they choose and provides the Company with a source of additional Systems revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The system or upgrade and the right to use the embedded software represent a single performance obligation as the software license is integral to the functionality of the system or upgrade.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For systems sold directly to end-customers that are credit approved, revenue is recognized when the Company transfers control to the end-customer, which occurs when the product is shipped to the customer or when the customer receives the product, depending on the nature of the arrangement. When collectability is not established in advance of receipt of payment from the customer, revenue is recognized upon the later of the receipt of payment or the satisfaction of the performance obligation. For systems sold through credit approved distributors, revenue is recognized upon shipment to the distributor.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company typically receives payment for its system consoles and other accessories within <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" format="ixt-sec:durday" name="cutr:RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcxMDY0OA_b4cd1e53-0831-46b0-a912-e9884fec4425">30</ix:nonNumeric> days of shipment. Certain international distributor arrangements allow for longer payment terms.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skincare products</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells&#160;third-party manufactured skincare products in Japan. The skincare products are purchased from a&#160;third-party manufacturer and sold to medical offices and licensed physicians. The Company warrants that the skincare products are free of significant defects in workmanship and materials for&#160;<ix:nonNumeric contextRef="i470d10cc776b41649b8a03cf1ec2f3fc_D20210101-20210630" format="ixt-sec:durday" name="cutr:SaleOfThirdPartyProductWarrantyPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcxMDYzMQ_42e24d4f-2c4c-4ce7-a8d9-3546108bd26a">90</ix:nonNumeric> days from shipment. These are typically sold in a separate contract as the only performance obligations. The Company acts as the principal in this arrangement, as the Company determines the price to charge customers for the skincare products and controls the products before they are transferred to the customer. The Company recognizes revenue for skincare products upon shipment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consumables and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accessories</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its customers' purchases of replacement cycles for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as well as replacement hand pieces, Titan and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt 3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces, and single use disposable tips applicable to&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO, Juliet,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as Consumable revenue, which provides the Company with a source of recurring revenue from existing customers. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Juliet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products'&#160;single use disposable tips&#160;must be replaced after every treatment. Sales of these consumable tips further enhance the Company&#8217;s recurring revenue. The Company&#8217;s systems offer multiple hand pieces and applications, which allow customers to upgrade their systems.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equipment leasing</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases equipment to customers through membership programs and receives a fixed monthly fee over the term of the arrangement. The Company classifies its lease income as product revenue. The Company recognizes lease income over the term of the lease if the lease is classified as an operating lease. For agreements that grant customers the right to purchase the leased system, the Company typically classifies the lease as a sales-type lease as the Company has determined it is reasonably certain that the customer will exercise the purchase option. On the commencement of sales-type leases, the Company recognizes revenue upfront in product revenue and the corresponding receivables recorded in other current assets and prepaid expenses on the condensed consolidated balance sheets (See Note&#160;11 - Leases). There was <ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:SalesTypeLeaseRevenue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODg1OQ_b6a3b92c-7974-41fe-a073-6046ed61ed73"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:SalesTypeLeaseRevenue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODg1OQ_b9cb6754-c1c3-43f8-a1cd-fb977f51dafd"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:SalesTypeLeaseRevenue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODg1OQ_d96e2322-5997-4ca3-b904-159911ef2868"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:SalesTypeLeaseRevenue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODg1OQ_f5dff5fe-88ac-40a1-83ec-c8c8ba53405a">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> revenue recognized for sales-type leases for the three and six months ended June&#160;30, 2021 or 2020. Revenue from equipment leases, which was accounted for as operating leases, was&#160;not&#160;material for&#160;the three and six months&#160;ended&#160; June&#160;30, 2021 or 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Extended contract services</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers post-warranty services to its customers through extended service contracts that cover parts and labor for terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODg3OA_37d5a87f-934a-4984-8ce6-ca3dbd45b43b">one</span>, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODg5MA_759bd265-f34f-4f56-92c1-11dc5f2a0f73">two</span>, or <ix:nonNumeric contextRef="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630" format="ixt-sec:durwordsen" name="cutr:ExtendedServiceContractOptionThreeTerm" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODkwNA_3f83d961-35e6-4ee7-a8e1-1428e2121547">three years</ix:nonNumeric>. Service contract revenue is recognized over time, using a time-based measure of progress, as customers benefit from the service throughout the service period. The Company also offers services on a time-and-materials </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><ix:continuation id="if554653866c44296afec0dacf7655607"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">basis for systems and detachable hand piece replacements. Revenue related to services performed on a time-and-materials basis is recognized when performed. These post-warranty services serve as additional sources of recurring revenue from the Company&#8217;s installed product base.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Training</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of systems to customers include training on the use of the system to be provided within <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" format="ixt-sec:durday" name="cutr:ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcxMDM5MQ_da012253-9f25-48d5-a858-84e68daaf49f">180</ix:nonNumeric> days of purchase. The Company considers training a separate performance obligation as customers can immediately benefit from the training together with the customer&#8217;s system. Training is also sold separately from systems. The Company recognizes revenue for training when the training is provided. Training is not required for customers to use the systems.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer Marketing Support</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In North America, the Company offers marketing and consulting phone support to its customers across all system platforms. These customer marketing support services include a practice development model and marketing training, performed remotely with ongoing phone consultations for <ix:nonNumeric contextRef="if3f410467d4d4330ad372e3a956470ad_D20210101-20210630" format="ixt-sec:durwordsen" name="cutr:RevenueFromContractWithCustomerTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcxMDY3OQ_273c9698-4c48-4db2-9366-0e935adbe0ae">six months</ix:nonNumeric> from date of purchase. The Company considers customer marketing support a separate performance obligation, and recognizes revenue over the <ix:nonNumeric contextRef="if3f410467d4d4330ad372e3a956470ad_D20210101-20210630" format="ixt-sec:durwordsen" name="cutr:RevenueFromContractWithCustomerTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcxMDY0Mg_630746c7-1cf9-41ab-a092-9f68d67e4fd3">six-month</ix:nonNumeric> term of the contracts.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loyalty Program</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has&#160;a customer loyalty program for qualified customers located in the U.S. and Canada. Under the loyalty program, based on their purchasing levels, customers accumulate points that can be redeemed for such rewards as the right to attend the Company&#8217;s advanced training event for&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or a ticket for the Company&#8217;s annual forum. A customer&#8217;s account must be in good standing to receive the benefits of the rewards program. Rewards are earned on a quarterly basis and must be used in the following quarter.&#160;All unused rewards are forfeited. The fair value of the reward earned by loyalty program members is included in accrued liabilities and recorded as a reduction of net revenue at the time the reward is earned. As of June&#160;30, 2021 and December&#160;31, 2020,&#160;the liability for the loyalty program included in accrued liabilities was $<ix:nonFraction unitRef="usd" contextRef="i36aa596dff8748588786668800832709_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMTA2MTg_303af04b-acfb-427e-b189-f0d68b8db277">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6f22dd0f34be4388a01961e660f5caf8_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMTA2MjU_b1c5c459-2814-41a9-af58-8b70cce588e5">0.3</ix:nonFraction> million, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Sales Commissions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract, which consist primarily of commissions and related payroll taxes, are capitalized and amortized on a straight-line basis over the expected period of benefit, except for costs that are recognized when product is sold. The Company uses the portfolio method to recognize the amortization expense related to these capitalized costs related to initial contracts and such expense is recognized over a period associated with the revenue of the related portfolio, which is generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcxMDQxMA_6ae4c934-3ce2-494d-a9ef-e60aa0c8aad9">two</span> to <ix:nonNumeric contextRef="i3c7a53758f744376b8ee593f5591f92b_I20210630" format="ixt-sec:durwordsen" name="us-gaap:CapitalizedContractCostAmortizationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcxMDQyNA_5ba48e76-33a6-4c21-b197-5f4210bf5bfa">three years</ix:nonNumeric>.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total capitalized costs as of June&#160;30, 2021 and December&#160;31, 2020 were $<ix:nonFraction unitRef="usd" contextRef="i35c2ccc976154aaa943236bfb9c494ca_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CapitalizedContractCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMTEyNTM_eb2df5d3-8dc2-4d04-a42b-ab2149d20aad">3.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia3cba542e3a741d4a477c46679b67946_I20201231" decimals="-5" name="us-gaap:CapitalizedContractCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMjE5OTAyMzI2NzE4NA_b685c3b2-1a68-48bd-8288-a435e61713ff">3.4</ix:nonFraction> million, respectively, and are included in Other long-term assets in the Company&#8217;s condensed consolidated balance sheet. Amortization expense for these assets was $<ix:nonFraction unitRef="usd" contextRef="i6676b6bef6f2454fbbc76aea9a2cc1da_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMTE0MTE_e16b783f-33bd-4c9f-becc-5c97cf29e8a3">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iea529016b4144eb5becac8fb1c31a306_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMjE5OTAyMzI2NzYyMg_ac6aebfd-7a36-4a15-b50d-3f4628e0fe2e">1.0</ix:nonFraction> million during the three and six months ended June&#160;30, 2021, respectively, and was $<ix:nonFraction unitRef="usd" contextRef="i39a83be3b8224826a825113043c0f630_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMjE5OTAyMzI2NzYxOA_61476853-c80d-4d35-86bb-bbded0aee07d">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i56e825e587f849159fe52471c86de3c9_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMjE5OTAyMzI2NzY2NQ_96f67ee6-2d17-4ff9-a00b-610b700a6e31">1.4</ix:nonFraction> million during the three and six months ended June&#160;30, 2020, respectively. The amortization related to these capitalized costs is included in sales and marketing expense in the Company&#8217;s condensed consolidated&#160;statement of operations.</span></div></ix:continuation><div id="ib4896268598045f0bc55c9d056377420_73"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8. <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfNDUyMA_899279fc-bf53-4928-a0f4-21fc2bf83afb" continuedAt="iff3f1bd68e8a45a596a048c64a6342f4" escape="true">Stockholders</ix:nonNumeric></span><ix:continuation id="iff3f1bd68e8a45a596a048c64a6342f4" continuedAt="ia2c0874a10b94134affc0382262f087b"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity and Stock-based Compensation Expense</span></ix:continuation></div><ix:continuation id="ia2c0874a10b94134affc0382262f087b" continuedAt="ia373c9327d194fdc9599f6134cbb595f"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s equity incentive plans are broad-based, long-term programs intended to attract and retain talented employees and align stockholder and employee interests. In June 2019, stockholders approved an amendment and restatement of the Amended and Restated 2004 Equity Incentive Plan as the 2019 Equity Incentive Plan (the &#8220;2019 Plan&#8221;) and approved an additional <ix:nonFraction unitRef="shares" contextRef="i043c44727e4748838f975923cbe8de27_D20190601-20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfNDI4_f2657cbc-c08d-4112-84f9-7517c58fe635">700,000</ix:nonFraction> shares, available for future grants (in addition to the <ix:nonFraction unitRef="shares" contextRef="i8051166907c44cc3b4d720878ae84444_I20190531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfNDg3_dcffde80-4e02-44c3-ad1f-0ad7a850c880">9,701,192</ix:nonFraction> shares provided under the Prior Plan). In June 2021, stockholders approved an additional <ix:nonFraction unitRef="shares" contextRef="ibc771595ca97435b917e76c6379187af_D20210601-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMjE5OTAyMzI2MDEwMA_5e5a3b61-8e61-4e86-bf0e-17bf7615e6ea">450,000</ix:nonFraction> shares for future grants. The 2019 Plan provides for the grant of incentive stock options, non-statutory stock options, RSAs restricted stock units (&#8220;RSUs&#8221;), stock appreciation rights, performance stock units, performance shares, and other stock or cash awards.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company issued <ix:nonFraction unitRef="shares" contextRef="i1c1cc14f1d17439ab6dc582f75bd1a5b_D20210401-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwNTA1MA_49293f09-425b-4dd0-9053-f98a34d61242">4,085</ix:nonFraction> PSUs to a non-employee director during the three months ended June 30, 2021. The Company&#8217;s Board of Directors granted its executive officers, senior management and certain employees <ix:nonFraction unitRef="shares" contextRef="ia86610d6c30943a98b2884869af2e9a8_D20210401-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcxMDA5OA_bc01aad1-fb97-4021-90d3-0dcaa8f77124">82,549</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ie9988de6b19146808f537a79f2f4003b_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcxMDEwNg_1058c175-c646-43af-bfec-3b7be92cb7fd">171,137</ix:nonFraction> performance stock units (&#8220;PSUs&#8221;) during the three and six months&#160;ended June&#160;30, 2021. The PSUs granted in the three and six months ended June&#160;30, 2021 vest subject to continued service and the Company&#8217;s achievement of certain operational goals for the 2021 fiscal year related to product milestones, sales and commercial milestones and certain cost reduction targets.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company issued <ix:nonFraction unitRef="shares" contextRef="i13634336729642d784da25921efe552a_D20210401-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMjE5OTAyMzI2MTQyMA_2506971d-5e31-4f69-835d-90f22003fef0">29,361</ix:nonFraction> RSUs to its non-employee directors during the three months ended June 30, 2021.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company&#8217;s Board of Directors also granted its executive officers and senior management <ix:nonFraction unitRef="shares" contextRef="if82f30c5243c44b4ad80cd7520748ea9_D20210401-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMTM3NQ_830327cd-1a8f-4221-bda1-847bcb4edffc">73,186</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i8283a2c2e73d47759779e4f3016de4be_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwMzM0OA_1a4848a3-a53d-4da0-bfc0-a43a23a528c0">129,783</ix:nonFraction> RSUs and <ix:nonFraction unitRef="shares" contextRef="i5eb930ee997642608de2ef098dda5547_D20210401-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMTM4Nw_5901d18a-118d-4ff7-93a2-b533ea27d2e9">103,466</ix:nonFraction> and </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><ix:continuation id="ia373c9327d194fdc9599f6134cbb595f" continuedAt="ie9a5bb8efce647bb95317bce1cc04d17"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"><ix:nonFraction unitRef="shares" contextRef="i8b76898f620849e68db8504b5c340666_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwMzM1Nw_0b8ae150-91b6-4a56-9b7d-c5246b4aff3e">172,139</ix:nonFraction> non-qualified stock options (&#8220;NQs&#8221;) during the three and six months&#160;ended June&#160;30, 2021, respectively. The RSUs and NQs vest over <ix:nonNumeric contextRef="ie7a69c86013f47fd84b88ded0e2796dd_D20210101-20210630" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMTQ4NA_0e0e3f89-d033-4717-a792-1aaf0866dc19"><ix:nonNumeric contextRef="i8d63e931f0e34f97838b48f7c9d93f52_D20210101-20210630" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMTQ4NA_81d6a57b-1545-4796-ae81-397ceb66dd49">four years</ix:nonNumeric></ix:nonNumeric> with one-fourth&#160;vesting&#160;on the first anniversary of the vesting commencement date of January 1, 2021 and 1/36th of the underlying shares vesting each month thereafter.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On September 30, 2019, the Company's Board awarded its new CEO, David H. Mowry, <ix:nonFraction unitRef="shares" contextRef="ib2f388401ace46cab8547a66f8274e5c_D20190930-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODczNA_32c70c15-df19-4caa-a04d-dafc900c66cd">67,897</ix:nonFraction> shares, which were scheduled to vest over <ix:nonNumeric contextRef="ib2f388401ace46cab8547a66f8274e5c_D20190930-20190930" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODc0OQ_3ad8a6b4-84ac-42f3-b129-79ce2693a0f4">four years</ix:nonNumeric> from 2019 through 2022 (the 2019 tranche is <ix:nonFraction unitRef="number" contextRef="i0086c16aff3843a88d06e0b9a23ab663_D20190930-20190930" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODc2MQ_7a8aa193-263d-4234-94d4-7134f41e75b8">15</ix:nonFraction>% of the award, or <ix:nonFraction unitRef="shares" contextRef="i0086c16aff3843a88d06e0b9a23ab663_D20190930-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODc2Ng_35e46dcf-177f-4dca-8b1c-e7fa059b46ac">10,185</ix:nonFraction> PSUs; the 2020 tranche is <ix:nonFraction unitRef="number" contextRef="i260072c69a4b43b297a42091f34d2d34_D20190930-20190930" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODc3NA_e6eb62c0-38ee-4d24-918c-34104be8adc4">25</ix:nonFraction>% of the award, or <ix:nonFraction unitRef="shares" contextRef="i260072c69a4b43b297a42091f34d2d34_D20190930-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODc3OQ_8d2926d9-55b2-4a21-8b95-1f3e09b00eb1">16,974</ix:nonFraction> PSUs; the 2021 tranche is <ix:nonFraction unitRef="number" contextRef="i1c46e2208d6a4e10972c5f842c7fcf68_D20190930-20190930" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODc4Nw_0949bef9-b9ac-4f87-ad9c-639f01aac094">30</ix:nonFraction>% of the award, or <ix:nonFraction unitRef="shares" contextRef="i1c46e2208d6a4e10972c5f842c7fcf68_D20190930-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODc5Mg_29bab53b-6f77-44b8-9ced-6f18614cd547">20,369</ix:nonFraction> PSUs; the 2022 tranche is <ix:nonFraction unitRef="number" contextRef="i3774f37aef574876bfd257a704d58d18_D20190930-20190930" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODgwMA_6dac46be-75c7-40c6-9f04-97bd3b5a1462">30</ix:nonFraction>% of the award, or <ix:nonFraction unitRef="shares" contextRef="i3774f37aef574876bfd257a704d58d18_D20190930-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODgwNQ_06ed2250-4a79-43c1-8bfd-57df360a7a85">20,369</ix:nonFraction> PSUs). These PSUs are subject to certain performance-based vesting criteria related to the achievement of financial metrics included in the Board approved annual budgets for the years 2019 through 2022. As of June 30, 2021, the 2019, 2020 and 2021 tranches met the criteria for measurement and recognition.  <ix:nonFraction unitRef="shares" contextRef="ida744089b3ac429ba5d244a28072197f_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODgxMw_3dfa864c-32ea-4f99-8b38-0147c15c0ac4">8,657</ix:nonFraction> shares of the 2019 tranche vested during the three months ended March 31, 2020.  The 2020 tranche did not vest in accordance with the initial terms, however, during the quarter ending June 30, 2021, the Company&#8217;s Board of Directors approved the vesting of Mr. Mowry&#8217;s 2020 PSU tranche. Upon this modification to the vesting terms of the 2020 PSU tranche, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i686fa2a5de5542978b650edda0bb93db_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODgyMA_95c08867-84a5-4a90-8f42-350f96faeb57">0.5</ix:nonFraction>&#160;million of stock-based compensation expense in the quarter ending June 30, 2021.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2019 Plan, the Company issued <ix:nonFraction unitRef="shares" contextRef="i20bf571b99a94909a5b0526d60ddfc07_D20210401-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzQ4MQ_06794af1-380f-4737-84a9-dbf6348cc042">92,103</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i244333557f0f4c1f9b9e1e26967d871c_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwMzM3Nw_290c22d8-8855-4466-96ba-a1ce0eebab27">214,797</ix:nonFraction> shares of common stock during the three and six months ended June&#160;30, 2021, in conjunction with stock options exercised and the vesting of RSUs and PSUs, net of shares withheld for employee taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021,&#160;the unrecognized compensation cost, net of expected forfeitures, was $<ix:nonFraction unitRef="usd" contextRef="if91020effb684eec96e7ae9b7579c211_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzczOA_16167aba-c92c-4b0b-b1f0-3a34eb4fdc1e">2.0</ix:nonFraction> million for stock options, which will be recognized over an estimated weighted-average remaining amortization period of&#160;<ix:nonNumeric contextRef="i04a939a51cb44bbfab0551c699f24582_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg1Mw_9c756810-da09-4622-b2f8-b88d802e036f">3.6</ix:nonNumeric> years. The unrecognized compensation cost, net of expected forfeitures, for stock awards, including performance-based awards, was $<ix:nonFraction unitRef="usd" contextRef="i38c5dcae21c84726b4ba51da80b02ac4_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzk4MA_f455324f-5fc2-47ea-9909-2bd78fc5da8e">16.1</ix:nonFraction> million, which will be recognized over an estimated weighted-average remaining amortization period of&#160;<ix:nonNumeric contextRef="ie58ba076e2704369a7e7ca1be3068f0a_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfNDA3Nw_d7458c73-9297-43b5-b6e8-0e42aa5986d2">2.0</ix:nonNumeric> years. The actual expense recorded in the future may vary based on a number of factors, including, actual forfeitures experienced and the degree of achievement of the performance goals related to the PSUs granted.</span></div><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfNDUyMQ_dd2c454f-9523-40e8-889a-d08241e8ba1e" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the 2019 Plans is summarized as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Options Outstanding</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shares<br/>Available<br/>for Grant</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of<br/>Stock Options<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average Remaining Term<br/>&#160;(in Years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aggregate Intrinsic Value <br/>(in Millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfMi0xLTEtMS0w_985d2f64-c635-43c5-a465-61c4873c03f2">1,085,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfMi0zLTEtMS0w_9e7cb308-e727-4ad7-ac70-88ff8f45c1b8">217,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfMi01LTEtMS0w_f6bcbab4-546b-48e6-9dfa-d4791a828b7c">22.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6e5db1d27c0d467fa8a06f3edfd4046b_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfMi03LTEtMS01NTE1_160ace5a-937b-4d13-8b8e-938cb1b4c6b3">3.75</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfMi05LTEtMS01NTE1_c96e6963-17be-4998-ae1f-e98d8216dc8e">1.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional shares reserved</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfMy0xLTEtMS0zMzYx_f3285075-f6e3-4324-9a23-93b4a4d3ac19">450,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNC0xLTEtMS02MDU0_bb4a3d8a-5199-477a-993b-2ce521d90346">354,735</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfMy0xLTEtMS0w_5839fcd3-273f-473f-9436-e92e2e649555">172,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfMy0zLTEtMS0w_ce7dd43b-5dc9-49fd-973b-783295de72fe">172,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfMy01LTEtMS0w_67c5aa2d-6fae-4705-a3fa-a6b9e75adb05">30.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="INF" format="ixt:zerodash" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNC0xLTEtMS0w_e3ae217b-bcf7-454b-9ae1-d9df47e39de4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNC0zLTEtMS0w_7f47b635-a3a5-4bae-abca-82fbb87441bc">53,598</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNC01LTEtMS0w_4133251d-e2b8-4569-99a5-023b519cc007">23.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock awards canceled / forfeited / expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNS0xLTEtMS0w_acd9f5a1-15ee-40cb-bf46-d2a0a6df28a8">212,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options canceled / forfeited / expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNi0xLTEtMS0w_e88447de-3521-4d3a-9a2a-0fe2396f323a">16,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNi0zLTEtMS0w_14c3045d-2acb-4d09-9192-e05d7702c3e1">16,224</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNi01LTEtMS0w_a678b5d7-8f6b-4e60-939f-5ad3dce152df">33.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance, June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNy0xLTEtMS0w_9c55093d-da5b-4e13-bcd1-6f01a22df6ff">1,237,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNy0zLTEtMS0w_fc1c22a2-3d1f-4ade-bfa5-8bdb7e34847a">319,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNy01LTEtMS0w_9f51d49f-93e2-4c8b-9449-3ca59f5f6261">26.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfOC03LTEtMS01NTE1_5f9db3f9-4f27-4c4b-98e8-935da06be411">5.13</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfOC05LTEtMS01NTE1_6fcb5f20-7253-4e5f-adf1-2303fbe85061">7.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Awards Outstanding</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Awards Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value per Share</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value <br/>(in Millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4c3011eb06b8441e960fb49156c2b7bb_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfMS0xLTEtMS01NTI4_bdd77153-e239-4990-946f-f024fbb83770">779,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4c3011eb06b8441e960fb49156c2b7bb_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfMS0zLTEtMS01NTI4_597f256b-1ab5-4a7d-9fa7-12b6a67f68b3">23.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c3011eb06b8441e960fb49156c2b7bb_I20201231" decimals="-4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfMS01LTEtMS01NTI4_0673f32c-f206-436f-ac20-50ef1d39919a">18.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie58ba076e2704369a7e7ca1be3068f0a_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfMy0xLTEtMS01NTI4_a4b4bfda-17f5-45c2-b9d8-6de4447939c7">354,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie58ba076e2704369a7e7ca1be3068f0a_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfMy0zLTEtMS01NTI4_5be5aa4a-cbfb-4a4a-aed9-ee1775641603">31.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awards released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie58ba076e2704369a7e7ca1be3068f0a_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfNC0xLTEtMS01NTI4_a8eeb500-0e78-4a6e-aa51-af654c9f7814">161,199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie58ba076e2704369a7e7ca1be3068f0a_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfNC0zLTEtMS01NTI4_3ebfdbbe-7750-4eda-9c0a-c8cbccc25f7d">22.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards canceled / forfeited / expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie58ba076e2704369a7e7ca1be3068f0a_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfNS0xLTEtMS01NTI4_41034763-350e-48ed-855d-d52f53da2820">212,571</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie58ba076e2704369a7e7ca1be3068f0a_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfNS0zLTEtMS01NTI4_17ff1622-bac3-4587-bbdd-a65d70812fcf">28.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i38c5dcae21c84726b4ba51da80b02ac4_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfNi0xLTEtMS01NTI4_d4c03690-abb7-4213-84ec-e832bc8efd5f">760,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i38c5dcae21c84726b4ba51da80b02ac4_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfNi0zLTEtMS01NTI4_3ed8e88a-5bd8-487d-906d-beb643d50eed">26.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38c5dcae21c84726b4ba51da80b02ac4_I20210630" decimals="-4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfNi01LTEtMS01NTI4_07104ec7-30aa-4974-9323-effce4102d0e">7.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><ix:continuation id="ie9a5bb8efce647bb95317bce1cc04d17"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation Expense</span></div><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfNDUyMg_7c95f463-a3c7-42a6-ad76-bc2c5f44d108" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense&#160;by department recognized during the three and six months ended June&#160;30, 2021 and 2020 was as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6d4ff6c6be04324bd9520f1387d71dc_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfMi0xLTEtMS0w_b7f818ef-763d-45ca-908c-019a4010cddb">434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41584b05a4664ba3af97fb224bccbdae_D20200401-20200630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfMi0zLTEtMS0w_24b4ffca-6745-49c1-b8f8-79c3f0920069">743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19202ea6769b485981af1a269c354a3e_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfMi01LTEtMS0xMDQy_51d56dc5-b82d-434c-84ce-8bcd4739eda9">578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe19bb61d2c04cc187ecedbd6e6de449_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfMi03LTEtMS0xMDQy_05520c31-4232-45fb-90cf-cd1e8c7e1214">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6676b6bef6f2454fbbc76aea9a2cc1da_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfMy0xLTEtMS0w_5a2f6c91-8681-4649-a8b8-f23247fcf738">522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39a83be3b8224826a825113043c0f630_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfMy0zLTEtMS0w_1b4e12ba-00da-40b0-918e-f3f5d17e0c55">1,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea529016b4144eb5becac8fb1c31a306_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfMy01LTEtMS0xMDQy_374e3ad6-b68c-4a01-9384-0e50829da05f">1,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56e825e587f849159fe52471c86de3c9_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfMy03LTEtMS0xMDQy_30c7fd78-5904-4856-ba55-08f9c31d2fd4">1,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if15f1055aa4c497db7227c965f673e0b_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNC0xLTEtMS0w_f465e3d7-d550-4786-8dc1-9d941fd05bb0">307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d2e0e7bf114927b546768a3c34a81d_D20200401-20200630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNC0zLTEtMS0w_8e96b762-07d3-4fe0-bba7-fc9c6593be52">769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb17262b381746f787063be8b5d55b71_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNC01LTEtMS0xMDQy_68c0a8f1-0778-4ec4-8b09-0247f5531ae4">608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e15052c9d0d44619f2e3d20485ef206_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNC03LTEtMS0xMDQy_13c19051-fc89-419d-aae5-a75a9793fc8b">1,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9707b7e07a2a420e93afba7c1ea09419_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNS0xLTEtMS0w_bd998126-686d-4d5c-baeb-0d7d293582f6">1,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee8ae2735f8498b9407c4ced951bf09_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNS0zLTEtMS0w_6237daab-aecd-410d-b03e-32f7a22f6ccb">1,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic21ba9ca8ecf493ba645bdbe2ad6c2a1_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNS01LTEtMS0xMDQy_1e0944d5-a4d9-45e9-a6fb-a5913c168994">2,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26b8cbc3a16e449f9a39f3289247bef9_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNS03LTEtMS0xMDQy_69458553-ba37-4279-b3b6-6f961a42f9f8">1,982</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNi0xLTEtMS0w_45799224-dd70-4609-9a7a-991e2c9da784">2,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNi0zLTEtMS0w_420b2ee3-a6bd-425a-94e3-ff7a728fb018">4,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNi01LTEtMS0xMDQy_bf00bc0d-ea75-4976-b931-54aed0aff27a">4,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNi03LTEtMS0xMDQy_4d931fb8-46c5-4aa1-8cc0-fc9b8564dcde">6,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ib4896268598045f0bc55c9d056377420_79"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9. <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RleHRyZWdpb246YjA3MWY4NjNhNWQwNDY2NDhiNDhmYjQ2ZGFhZDg1YzlfMTg5OQ_8af6cb4b-1909-490c-9916-03e8b6188215" continuedAt="ia71d32ea06d147c1a98018e0161cf190" escape="true">Net Income (Loss) Per Share</ix:nonNumeric></span></div><ix:continuation id="ia71d32ea06d147c1a98018e0161cf190" continuedAt="i8145d8f9afb74fe5a7e8a0381da65605"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021, the Company adopted the accounting standard update to simplify the accounting for convertible debt instruments. The Company now uses the if converted method for its Convertible notes in calculating the diluted net income per share, and includes the effect of potential share settlement for the Convertible notes, if the effect is dilutive. </span></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share (&#8220;EPS&#8221;) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method or the if-converted method. Dilutive potential common shares include outstanding stock options, stock awards, performance stock awards, and conversion shares under the Convertible notes. The diluted EPS is computed with the assumption that the Company will settle the convertible debt in shares, rather than cash.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of June&#160;30, 2021, the Company&#8217;s Convertible notes were potentially convertible into <ix:nonFraction unitRef="shares" contextRef="i28760ad245b749f6b1743389a6736740_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RleHRyZWdpb246YjA3MWY4NjNhNWQwNDY2NDhiNDhmYjQ2ZGFhZDg1YzlfNjMw_9caaa72b-6c97-4e5f-9cbe-54aad6246c16">4,167,232</ix:nonFraction> shares of common stock. The Company used the if converted stock method to calculate the potential dilutive effect of the conversion spread on diluted net income per share, for the three and six  months ended June&#160;30, 2021. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The denominator for diluted net income per share does not include any effect from the capped call transactions the Company entered into concurrently with the issuance of the Convertible notes, as this effect would be anti-dilutive. In the event of conversion of a Convertible note, shares delivered to the Company under the capped call will offset the dilutive effect of the shares that the Company would issue under the Convertible notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the three and six months ended June&#160;30, 2020, basic loss per common share and diluted loss per common share are the same as inclusion of any potentially issuable&#160;shares would be&#160;anti-dilutive.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RleHRyZWdpb246YjA3MWY4NjNhNWQwNDY2NDhiNDhmYjQ2ZGFhZDg1YzlfMTkwMA_84c70a24-ffd6-4e61-a706-6104e64c0937" continuedAt="i8821ea06871d4611a37497018c5ebd3f" escape="true">The following table sets forth the computation of basic and diluted net income (loss) and the weighted average number of </ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><ix:continuation id="i8145d8f9afb74fe5a7e8a0381da65605"><ix:continuation id="i8821ea06871d4611a37497018c5ebd3f"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares used in computing basic and diluted net income (loss) per share (in thousands, except per share data):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) used in calculating net income (loss) per share,  basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMi0xLTEtMS0w_6ddd1b22-b32e-4899-a8d5-7e3c5b1ef204">7,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMi0zLTEtMS0w_7620cfb6-61d9-4bce-949a-2a1c08fb2d3f">11,394</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNC01LTEtMS0xMDcw_b8a6c30c-bbae-41bc-af04-882788dc1adc">7,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNC03LTEtMS0xMDcw_374cd371-b50e-449d-b04b-f3e2b382a9b2">23,808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense on Convertible notes, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNC0xLTEtMS01MTUx_4a9ae025-0e9e-4105-b5ca-cb4d02e11275">758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNC0zLTEtMS01NDE0_de2a5c20-b6fb-4b7e-bf66-37fbbff49f01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNC01LTEtMS01MTU4_a218fbfb-ab27-440c-b733-cb1ecab23230">740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNC03LTEtMS01NDE4_73860b33-721b-4c82-baf1-fb8819dccdc4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of debt issuance cost, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" name="cutr:AmortizationOfDebtIssuanceCostsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNS0xLTEtMS01MTUx_4025416f-a0eb-4613-887e-2523e627f71a">209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="cutr:AmortizationOfDebtIssuanceCostsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNS0zLTEtMS01NDE0_dac5c019-970b-42f1-b29d-957779eb2f47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="cutr:AmortizationOfDebtIssuanceCostsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNS01LTEtMS01MTU4_1a939b9f-881a-4f6d-8f87-e4a40b353339">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="cutr:AmortizationOfDebtIssuanceCostsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNS03LTEtMS01NDE4_423b7311-1a97-43a6-a50e-4216db10916b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income used in calculating net income per share, diluted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNi0xLTEtMS01NDEy_a48a6a38-66b9-4bd3-bea9-7cb06ae89ffd">8,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNi0zLTEtMS01NDE0_d333efad-64d2-46b2-961f-685be4325f5b">11,394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNi01LTEtMS01NDE2_97a32ca2-8568-4148-9fda-31a656691dcc">8,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNi03LTEtMS01NDE4_0490f0f2-4e6d-43ef-9e3f-9381067cb47b">23,808</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNC0xLTEtMS0w_a93bc612-f136-4b1b-b225-3557cdbe0d02">17,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNC0zLTEtMS0w_257c0123-6e9d-4768-8a42-e8f769b3488a">17,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNi01LTEtMS0xMDcy_1898a42e-89e8-43c1-a1f8-ef4543cd2adc">17,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNi03LTEtMS0xMDc0_a180a7cd-6766-42bc-be1a-063886428409">15,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dilutive effect of incremental shares and share equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTAtMS0xLTEtNTE4NQ_3f7ec208-ff66-41b2-9cd1-88098b6f6ce5">4,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTAtMy0xLTEtNTQyMA_17fe8027-9da0-49ab-abbf-682b390625c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTAtNS0xLTEtNTE5OQ_e3ef9574-0526-4110-896c-b4e957eeed60">2,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTAtNy0xLTEtNTQyMg_886cd43d-1d77-49d5-a43b-525110d14b55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaaac0feab41147a8a2bc8fd8f7ba33f3_D20210401-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtMS0xLTEtNTE4NQ_1b99f2cd-a538-46c0-aa69-213449937a44">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ie3e1bb0168eb49be9bc31f592a1a35d1_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtMy0xLTEtNTQyMA_c408ac42-5739-45aa-895d-e538e1dc2d6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04a939a51cb44bbfab0551c699f24582_D20210101-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtNS0xLTEtNTE5OQ_a050b785-fb95-4dab-b621-f46434ff1e4c">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99969d197ffd450f94deac6fd22dac12_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtNy0xLTEtNTQyMg_310094eb-482c-4178-9ecf-9310300234db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8fcff246ef044996b2ff3e18abe4904e_D20210401-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTItMS0xLTEtNTE4NQ_bbfe1e30-1ce1-4d37-a5ed-0201e3fd27a8">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i2385bd8fa768474f8fd3a114312d5e7d_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTItMy0xLTEtNTQyMA_ae7d6fa9-e2f8-4fe1-8c10-1fc77471543e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7a69c86013f47fd84b88ded0e2796dd_D20210101-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTItNS0xLTEtNTE5OQ_2e6a4d2a-b132-421b-bd7a-0713bf64f3ac">270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia4ecd89ae62344f7917567fbab93bd54_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTItNy0xLTEtNTQyMg_4c2d0cf5-5a8d-4bf6-be79-b7e7a1a39efe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i24a4aae559244b6da9a355eef4892d50_D20210401-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTMtMS0xLTEtNTE4NQ_9d864302-d677-4bde-a038-2f9a9dbe7ea9">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="if55087856ea4480f878b84dad9aa0b2f_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTMtMy0xLTEtNTQyMA_f88d08a4-b7eb-4bbf-8371-1728fd02dc9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1c67032870244a09929098911256c828_D20210101-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTMtNS0xLTEtNTE5OQ_61dcbe30-b869-4180-9bf6-b4d0683ba380">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic2e0ff6f1deb4186b8284936187d5163_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTMtNy0xLTEtNTQyMg_e944bec1-271d-4ff5-85dd-99adb4938b61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d1b842b5a004755b84c230f3296b806_D20210401-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTQtMS0xLTEtNTE4NQ_9cb0b3aa-e57a-4a10-9f31-682c301c8a2f">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i134de9f1f57f47888632a9ceef35480a_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTQtMy0xLTEtNTQyMA_b4a71b4e-6b4e-4a25-a700-d30ba1503668">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic53569eddd914356abdacfc8f46a8065_D20210101-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTQtNS0xLTEtNTE5OQ_f1510aa2-8fd6-4c98-b85e-b41f52e304ee">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia12fb8b4c6934135894efcee0133760d_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTQtNy0xLTEtNTQyMg_2cb67cd3-b952-48d3-bdd9-fce80cd3e2fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares of common stock outstanding used in computing net income (loss) per share, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNi0xLTEtMS0w_87f40309-70b1-44e3-a70e-0521ba74a7ed">22,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNi0zLTEtMS0w_c9760113-dc6d-4a4b-a227-2ffb2b660c66">17,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfOC01LTEtMS0xMDcy_a69fd038-c197-48ed-a0c9-be0a92af3b11">20,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfOC03LTEtMS0xMDc0_41a1c6c7-cbbc-4bf5-8493-b5232ae582d1">15,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss) per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) per share, basic </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfOC0xLTEtMS0w_7147bebf-cf2d-445e-9d48-0b19da67805b">0.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfOC0zLTEtMS0w_99ee072f-12bf-4c3c-81be-e83e07d7a591">0.67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTAtNS0xLTEtMTA3Ng_bc54f285-412f-48be-bb6c-5ac540c2e2a5">0.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTAtNy0xLTEtMTA3Ng_ab38921f-e736-4c56-9eb1-6c2de846b4e0">1.51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtMS0xLTEtNDE3NA_8712644e-fd13-4ef4-8d03-0659cf19222c"><ix:nonFraction unitRef="usdPerShare" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtMS0xLTEtNDE3NA_f0e42c5b-c208-4f14-8d88-dc20fb4105f2">0.39</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtMy0xLTEtNDE3NA_1b06ef4b-5639-43cb-8d96-a0a0bb3af37f"><ix:nonFraction unitRef="usdPerShare" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtMy0xLTEtNDE3NA_71afcbb9-141a-4def-bad0-94fb929a3e80">0.67</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtNS0xLTEtNDE3NA_4917a147-3b4c-4f90-a89e-d24ad41050c1"><ix:nonFraction unitRef="usdPerShare" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtNS0xLTEtNDE3NA_a5bebe1f-0c02-47c3-a905-9c8de2cb8c58">0.40</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtNy0xLTEtNDE3NA_01d0ea8f-0301-4e37-b1eb-8cdc02029734"><ix:nonFraction unitRef="usdPerShare" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtNy0xLTEtNDE3NA_ee9c25a4-a03a-41e5-b9d5-d29a851d3be0">1.51</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RleHRyZWdpb246YjA3MWY4NjNhNWQwNDY2NDhiNDhmYjQ2ZGFhZDg1YzlfMTkwMQ_af1ec447-9c6f-49f2-a5f4-c85e7b35c0d7" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following numbers of shares outstanding, prior to the application of the if converted stock method, were excluded from the computation of diluted net income (loss) per common share for the periods presented because including them would have had an anti-dilutive effect (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capped call (1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib073b66268e747c7beb7c3e8cb6725cd_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfMi0xLTEtMS0w_27b59669-2b91-4932-8ac4-0293db9f11f5">4,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id1c39d3cd4704eb18a973e3632ebf4c9_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfMi0zLTEtMS0w_0a3e04ab-8884-4468-91a2-c194ac889408">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i927cb99cf11849a28b18cccb13b34952_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfMi01LTEtMS0xMDY1_e765cce6-bd4c-4d8d-a755-64f85fce4536">4,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i248c328a529348aa9cc98c13d080a639_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfMi03LTEtMS0xMDY3_8e3c768f-5671-4980-b4b7-4ce3daa10503">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5fcb4b561a904836a0f0d23aa399f03b_D20210401-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfMy0xLTEtMS0w_933afc4c-7033-435e-bc0c-e0873346fb60">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic24aac68960d4d5abac630ee5fc03264_D20200401-20200630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfMy0zLTEtMS0w_de39bca8-e7cb-488c-9721-85f462d97b61">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i422e7e2d5153428685677e8df3cd31cf_D20210101-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfMy01LTEtMS0xMDY1_f81bdd4c-57bc-4e4f-96e3-d7c48600b196">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icea00b8fe11140daa1cb985e030d37f8_D20200101-20200630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfMy03LTEtMS0xMDY3_3199d92f-7cd5-4b08-b5fb-470db723d216">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1aafabe8c64f4228aed37026513d86ff_D20210401-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNC0xLTEtMS0w_bfc968f8-2c62-45f0-8d20-0145ed567616">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieedfa579e0344b4d82de2102e49f38e2_D20200401-20200630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNC0zLTEtMS0w_91ac837c-8d16-44e6-a36d-8b9510698721">803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4b551207fffb4cf09782a3a505b3bc0e_D20210101-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNC01LTEtMS0xMDY1_bb8ab66f-ad47-4f68-ab7b-3f18716dd903">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i401936e680d64b628acd735705146547_D20200101-20200630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNC03LTEtMS0xMDY3_d604f4a5-f702-4c4d-b065-12257b5c419f">736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idbf8f9287eb3474aaf029523648da76e_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNS0xLTEtMS0w_d1591f4b-c21c-40be-ad87-153481eb08fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5163e2df3c5d4005869929c9e18ad6d6_D20200401-20200630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNS0zLTEtMS0w_2d71cb44-0675-492c-bfbd-144d7a10a493">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4ce9a67e28441f483cb009b64dade32_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNS01LTEtMS0xMDY1_d0b9af3c-260b-4289-bf03-c4840f1daf63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0774db4163af4fd1a5b476fc7f6ec2c8_D20200101-20200630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNS03LTEtMS0xMDY3_6c8e79aa-b42f-4e53-a1ed-5c3f5be740e0">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2ec6fabd2ce464c93e692843370b13e_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNi0xLTEtMS0w_6e862d6d-4b80-45ed-9e80-ebb0265ad74a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iceba727bc88e4acfafb969683a5040c0_D20200401-20200630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNi0zLTEtMS0w_4bfbb452-c241-4c94-b979-ba005018724f">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7cbfd7fb2004b41977955079c24d470_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNi01LTEtMS0xMDY1_1016df81-d80f-4f4c-a6fa-f7cd88ec53c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5dfc2cdcabad463db38b6603f1116204_D20200101-20200630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNi03LTEtMS0xMDY3_40c82395-547f-423c-b5d9-39ff5a7fed5a">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNy0xLTEtMS0w_7e276a4e-cf8d-4974-a26c-11ab4ce48aec">4,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNy0zLTEtMS0w_671699d6-7ed8-41ca-9066-36392f36ffaa">1,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNy01LTEtMS0xMDY1_e1e330bc-84dd-4001-b0f2-1a7b4ffbf9ee">4,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNy03LTEtMS0xMDY3_704eb85d-d654-4412-ad5f-e8e221d3a183">1,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">The Company entered into capped call transactions with certain financial institutions, which are generally designated to reduce common stock dilution upon conversion of the Convertible notes. The capped call transactions are excluded from the computation of diluted net income (loss) per common share as their effect would be anti-dilutive.</span></div></ix:nonNumeric></ix:continuation><div id="ib4896268598045f0bc55c9d056377420_85"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10. <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84NS9mcmFnOjUwNDI4ZjdkYjNhODRlYTM5YmJhNGY5NGFlNmU0NDI1L3RleHRyZWdpb246NTA0MjhmN2RiM2E4NGVhMzliYmE0Zjk0YWU2ZTQ0MjVfMzY5_e51da327-1021-4e67-8409-4603b3976d08" continuedAt="ie1ea5daed29d4da582a35013044a5067" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="ie1ea5daed29d4da582a35013044a5067" continuedAt="i463e6d375069419db96d4703f11681ee"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended June&#160;30, 2021, the Company's income tax expense was $<ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84NS9mcmFnOjUwNDI4ZjdkYjNhODRlYTM5YmJhNGY5NGFlNmU0NDI1L3RleHRyZWdpb246NTA0MjhmN2RiM2E4NGVhMzliYmE0Zjk0YWU2ZTQ0MjVfMjE5OTAyMzI1NzQ3Mg_aebae755-07bb-4dcd-bdfe-a4af8d12c20d">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84NS9mcmFnOjUwNDI4ZjdkYjNhODRlYTM5YmJhNGY5NGFlNmU0NDI1L3RleHRyZWdpb246NTA0MjhmN2RiM2E4NGVhMzliYmE0Zjk0YWU2ZTQ0MjVfMjE5OTAyMzI1NzQ3Ng_14765f00-f6b3-40f7-bbb0-82149cb84981">0.4</ix:nonFraction> million, respectively, compared to $<ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84NS9mcmFnOjUwNDI4ZjdkYjNhODRlYTM5YmJhNGY5NGFlNmU0NDI1L3RleHRyZWdpb246NTA0MjhmN2RiM2E4NGVhMzliYmE0Zjk0YWU2ZTQ0MjVfMjE5OTAyMzI1NzQwMw_05f4105b-3f46-40aa-bde1-d47a0c86e089"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84NS9mcmFnOjUwNDI4ZjdkYjNhODRlYTM5YmJhNGY5NGFlNmU0NDI1L3RleHRyZWdpb246NTA0MjhmN2RiM2E4NGVhMzliYmE0Zjk0YWU2ZTQ0MjVfMjE5OTAyMzI1NzQwMw_c76d3a98-5923-47f4-8ca1-ab4360e19e2f">0.5</ix:nonFraction></ix:nonFraction> million for both three and six months ended June&#160;30, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's income tax expense for the three and six months ended June&#160;30, 2021 is due primarily to income taxes in foreign jurisdictions. The PPP loan forgiveness recognized during the three months ended June&#160;30, 2021 is excluded from taxable income under Section 1106(i) of the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;). The Company continues to maintain a full valuation allowance on its U.S. deferred tax assets.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the U.S. federal government enacted the CARES Act, which changed several of the existing U.S. corporate income tax laws by, among other things, increasing the amount of deductible interest, allowing companies to carry back certain </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i463e6d375069419db96d4703f11681ee">Net Operating Losses (&#8220;NOLs&#8221;) and increasing the amount of NOLs that corporations can use to offset income. The CARES Act did not have a material impact on the Company's income tax provision, deferred tax assets and liabilities, and related taxes payable. The Company is currently assessing the future implications of these provisions within the CARES Act on the Company's consolidated financial statements, but does not expect the impact to be material.</ix:continuation></span></div><div id="ib4896268598045f0bc55c9d056377420_88"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11. <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDYyMw_9b195d6f-cf4e-4117-a120-0cfb4ef6a9f3" continuedAt="i9b2b5fc11b27495e9b799a8685ac38e8" escape="true"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:OperatingLeasesOfLessorDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDYyMw_a3ae4b1b-19b3-4ced-85b1-191d4faf32fb" continuedAt="idd3770bb772b4af4bd4d597c062b9194" escape="true"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDYyMw_caf38611-c7c6-41d4-8b30-31821b96bd37" continuedAt="i9629f63b8a234f6d9ac1ca463148463c" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i9b2b5fc11b27495e9b799a8685ac38e8" continuedAt="id53cef8ad7cb49cbbd6cd94b19a87992"><ix:continuation id="idd3770bb772b4af4bd4d597c062b9194" continuedAt="i654a3ecbdc97416a8bb3bfc9541e9bd4"><ix:continuation id="i9629f63b8a234f6d9ac1ca463148463c" continuedAt="ia224e54e2a044d8daa4857c92c9081c8"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to certain operating and finance leases for vehicles, office space and storage facilities. The Company&#8217;s operating leases consist of office space, as well as storage facilities and finance leases consist of automobiles. The Company&#8217;s leases generally have remaining terms of&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDkwNw_973afb6b-4acd-4a55-af58-d468b11c7d99"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDkwNw_c98812fc-de92-4bc9-ae63-a2ea2dcf1178">one</span></span>&#160;to&#160;<ix:nonNumeric contextRef="i3c7a53758f744376b8ee593f5591f92b_I20210630" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MjQxMw_c8d93c23-286a-471e-a012-1ac2cafa4fb7">ten years</ix:nonNumeric>, some of which include options to renew the leases for up to&#160;<ix:nonNumeric contextRef="i85fff53fbac547228677e769db10e805_I20210630" format="ixt-sec:durwordsen" name="us-gaap:LesseeFinanceLeaseRenewalTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMzkw_a96d02be-91e1-40da-80fa-cbec43ded549"><ix:nonNumeric contextRef="i85fff53fbac547228677e769db10e805_I20210630" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDk0NzgwMjMzMDI2OQ_620ae3db-4817-4cd5-836c-fa4dca8dc307">five years</ix:nonNumeric></ix:nonNumeric>. The Company leases space for operations in the United States, Japan, Belgium, France and Spain. In addition to the above facility leases, the Company also routinely leases automobiles for certain sales and field service employees under finance leases.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract contains a lease at inception. Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments&#160;not&#160;yet paid. Operating lease assets represent the right to use an underlying asset and are based upon the operating lease liabilities adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments&#160;not&#160;yet paid, the Company estimates the incremental secured borrowing rates corresponding to the maturities of the leases. The Company based the rate estimates on prevailing financial market conditions, credit analysis, and management judgment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce the Company&#8217;s right-of-use (&#8220;ROU&#8221;) asset related to the lease. These are amortized through the ROU asset as reductions of expense over the lease term.</span></div><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="cutr:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDYyNA_549e3cfa-87c1-4316-a201-9f12b3be56ea" continuedAt="i8903544c9aa04a8996c72b73a4a172a6" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMi0zLTEtMS0w_283d556f-3d80-4d9b-aa1e-61de005885fa">15,919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMi01LTEtMS0w_cc4e1b29-dfc7-429f-a442-7cff036efd0c">17,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_191ff28f-24ee-4553-9783-0b42ebb65ac6"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_919b7924-791c-4466-b8a7-24aa8118f77b">Property and equipment, net (1)</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0zLTEtMS0w_d0578781-717c-4e53-a75a-ec98307f8b25">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy01LTEtMS0w_7028980e-d7e3-4996-b426-f3097c59a660">467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total leased assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cutr:LeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfNC0zLTEtMS0w_e770cb7a-896d-4c99-a5c2-4bfcd6c2a541">16,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cutr:LeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfNC01LTEtMS0w_39680be7-e057-4fa1-a67f-4a9d57e87213">17,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1) Finance lease assets included in Property and equipment, net, in the condensed consolidated balance sheets.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfMi0zLTEtMS0w_64b95c1b-ca95-41e1-9249-a21900f0ee2e">2,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfMi01LTEtMS0w_7cff7fdc-c2f0-4d46-8803-16309bcd776d">2,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfMy0zLTEtMS0w_3fc53bb5-0a8d-40e4-9b05-669e70c88dc8">14,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfMy01LTEtMS0w_61fa0207-0e51-4971-9b1d-ee2b0fd5ee09">15,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNC0zLTEtMS0w_f59f5921-e247-4ec1-be18-bc7864589a74">17,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNC01LTEtMS0w_24994e4d-d647-4341-83a4-388369df8539">18,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_b5e783e0-1851-4646-b5d7-45c5c8303178"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_f32d24a1-2fa6-47cd-9e48-aa722ac2d210">Accrued liabilities (1)</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0zLTEtMS0w_43aa5267-b069-4739-b946-1757d008b2be">429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy01LTEtMS0w_3d19d6a0-ffdc-42ae-80d0-35cd045bcfa7">370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_10ea67d4-7eb5-4177-82e5-7c042f1357e2"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_88c2e4ea-2944-4622-bbd8-af1b7cb70fc0">Other long-term&#160;liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0zLTEtMS0w_7d982463-240e-47e6-a7c5-6f3dca55d0d9">288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC01LTEtMS0w_b6b0f822-a4ef-4267-868e-e3a7e84c6cab">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOS0zLTEtMS0w_faa5c507-99b9-4d2c-8d49-1c1407cba7ef">717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOS01LTEtMS0w_12e22ec0-82a6-4cb1-b2aa-ad8dccffca9a">611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1) Finance lease liabilities included in Accrued liabilities in the condensed consolidated balance sheets.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDk0NzgwMjMzMDI2NA_203d3c69-0073-48a6-b1f6-08d874b4d73a" continuedAt="i5b3dfa5b657249a39289ebaafc3c7248" escape="true">Lease costs during the&#160;three and six&#160;months ended&#160; June&#160;30, 2021&#160;and&#160;2020 (in thousands):</ix:nonNumeric></span></div></ix:continuation></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><ix:continuation id="id53cef8ad7cb49cbbd6cd94b19a87992" continuedAt="i4f7395ffb65f4b92a094a4b327a282f2"><ix:continuation id="i654a3ecbdc97416a8bb3bfc9541e9bd4" continuedAt="i04ad02519ed9440a970581478f4db30f"><ix:continuation id="ia224e54e2a044d8daa4857c92c9081c8" continuedAt="i78b5807e9e44465685d673611b4f8ce8"><ix:continuation id="i5b3dfa5b657249a39289ebaafc3c7248"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfMi0zLTEtMS0w_8b3175c8-cece-4391-be07-2c4ad75abe50">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfMi01LTEtMS0w_59f8edb4-7364-4f7f-a196-2192e264df63">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfMi03LTEtMS0xMDU1_6a31d04c-0315-4d4a-9a46-81e20c9bc8b1">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfMi05LTEtMS0xMDU3_f259d62a-c773-4362-93ec-43e269952fde">425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest for finance lease</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfMy0zLTEtMS0w_5f740c98-484b-456b-909b-5bc49c3e0dc0">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfMy01LTEtMS0w_f2d2fa14-6f7c-494d-bf4f-6839cebd7b75">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfMy03LTEtMS0xMDU1_b69da498-2c0c-45c9-8189-4f4214467ece">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfMy05LTEtMS0xMDU3_5ba162ca-389d-4625-b1d9-82f5650537cd">35</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfNC0zLTEtMS0w_33d3483e-8f11-4f26-9f80-258a91ede249">881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfNC01LTEtMS0w_b9b5795c-ada9-4c41-b762-2f5f8fde66a6">728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfNC03LTEtMS0xMDU1_fa2b2099-9f18-4e6f-8680-d9fa9044b43b">1,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfNC05LTEtMS0xMDU3_ae5735aa-6874-4cb1-9d37-bb78cf61aaeb">1,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities during the&#160;six&#160;months ended June&#160;30, 2021 and 2020&#160;was as follows&#160;(in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUzN2EyOGJjYTUyNDQ2Y2M5YzY3MDg1YTM2MmQ3MTdjL3RhYmxlcmFuZ2U6ZTM3YTI4YmNhNTI0NDZjYzljNjcwODVhMzYyZDcxN2NfMi0zLTEtMS0w_14ddc269-66ca-49f8-a141-902e83e77c0e">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUzN2EyOGJjYTUyNDQ2Y2M5YzY3MDg1YTM2MmQ3MTdjL3RhYmxlcmFuZ2U6ZTM3YTI4YmNhNTI0NDZjYzljNjcwODVhMzYyZDcxN2NfMi01LTEtMS0w_b65f26a7-61b3-4338-8b25-8c9825675146">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUzN2EyOGJjYTUyNDQ2Y2M5YzY3MDg1YTM2MmQ3MTdjL3RhYmxlcmFuZ2U6ZTM3YTI4YmNhNTI0NDZjYzljNjcwODVhMzYyZDcxN2NfMy0zLTEtMS0w_39528ea8-65b6-4995-bac9-36405604a896">211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUzN2EyOGJjYTUyNDQ2Y2M5YzY3MDg1YTM2MmQ3MTdjL3RhYmxlcmFuZ2U6ZTM3YTI4YmNhNTI0NDZjYzljNjcwODVhMzYyZDcxN2NfMy01LTEtMS0w_a45d099a-b346-4689-9024-e1721db576bb">380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUzN2EyOGJjYTUyNDQ2Y2M5YzY3MDg1YTM2MmQ3MTdjL3RhYmxlcmFuZ2U6ZTM3YTI4YmNhNTI0NDZjYzljNjcwODVhMzYyZDcxN2NfNC0zLTEtMS0w_b8c7be86-424f-47b7-b12d-1052ce970e9f">1,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUzN2EyOGJjYTUyNDQ2Y2M5YzY3MDg1YTM2MmQ3MTdjL3RhYmxlcmFuZ2U6ZTM3YTI4YmNhNTI0NDZjYzljNjcwODVhMzYyZDcxN2NfNC01LTEtMS0w_2a7c1c32-5406-4884-8afa-b186d8a3b7ca">1,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">leases</span></div><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDYyNQ_cae37273-5abb-4411-8c54-88a913177316" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of facility leases were as follows as of June&#160;30, 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmM4MTAxOTkzNDJiMDQ2NDRhMDM5YjY4NzJiYWY2MDQ2L3RhYmxlcmFuZ2U6YzgxMDE5OTM0MmIwNDY0NGEwMzliNjg3MmJhZjYwNDZfMS0xLTEtMS0w_bc82bb02-7c7e-4443-a050-d4f9656ae076">1,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmM4MTAxOTkzNDJiMDQ2NDRhMDM5YjY4NzJiYWY2MDQ2L3RhYmxlcmFuZ2U6YzgxMDE5OTM0MmIwNDY0NGEwMzliNjg3MmJhZjYwNDZfMi0xLTEtMS0w_ee863c98-14f1-49d4-ab0c-28027e913796">3,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmM4MTAxOTkzNDJiMDQ2NDRhMDM5YjY4NzJiYWY2MDQ2L3RhYmxlcmFuZ2U6YzgxMDE5OTM0MmIwNDY0NGEwMzliNjg3MmJhZjYwNDZfMy0xLTEtMS0w_5dbe47a8-4715-4329-899e-8c3aac953ce3">3,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmM4MTAxOTkzNDJiMDQ2NDRhMDM5YjY4NzJiYWY2MDQ2L3RhYmxlcmFuZ2U6YzgxMDE5OTM0MmIwNDY0NGEwMzliNjg3MmJhZjYwNDZfNC0xLTEtMS0w_4e60fe32-ddf6-42aa-a148-f8eecdeb68e6">2,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmM4MTAxOTkzNDJiMDQ2NDRhMDM5YjY4NzJiYWY2MDQ2L3RhYmxlcmFuZ2U6YzgxMDE5OTM0MmIwNDY0NGEwMzliNjg3MmJhZjYwNDZfNS0xLTEtMS0w_86630c0c-90dc-42e2-8a63-121144ee7ea9">2,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026&#160;and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cutr:LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmM4MTAxOTkzNDJiMDQ2NDRhMDM5YjY4NzJiYWY2MDQ2L3RhYmxlcmFuZ2U6YzgxMDE5OTM0MmIwNDY0NGEwMzliNjg3MmJhZjYwNDZfNi0xLTEtMS0w_05e7e32d-187a-496b-8f5d-1fa55314f786">6,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmM4MTAxOTkzNDJiMDQ2NDRhMDM5YjY4NzJiYWY2MDQ2L3RhYmxlcmFuZ2U6YzgxMDE5OTM0MmIwNDY0NGEwMzliNjg3MmJhZjYwNDZfNy0xLTEtMS0w_ca8a2c30-508c-4dc3-8a9f-7066f3896b6e">19,953</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmM4MTAxOTkzNDJiMDQ2NDRhMDM5YjY4NzJiYWY2MDQ2L3RhYmxlcmFuZ2U6YzgxMDE5OTM0MmIwNDY0NGEwMzliNjg3MmJhZjYwNDZfOC0xLTEtMS0w_4a2ca481-5728-4387-b89f-5791a892980d">2,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmM4MTAxOTkzNDJiMDQ2NDRhMDM5YjY4NzJiYWY2MDQ2L3RhYmxlcmFuZ2U6YzgxMDE5OTM0MmIwNDY0NGEwMzliNjg3MmJhZjYwNDZfOS0xLTEtMS0w_04ebc51f-fdaa-4735-9122-9b0f06b88f22">17,127</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vehicle Leases</span></div><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDYyMA_7b902f9a-a746-4579-ad0b-362e1aa9f308" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable&#160;finance leases as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUwNjczMDc5YTRkNzQzYWFhZmRlMTJmMzkxN2MyOWZhL3RhYmxlcmFuZ2U6ZTA2NzMwNzlhNGQ3NDNhYWFmZGUxMmYzOTE3YzI5ZmFfMS0xLTEtMS0w_b7c87880-9528-454c-91b9-1ade221464b2">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUwNjczMDc5YTRkNzQzYWFhZmRlMTJmMzkxN2MyOWZhL3RhYmxlcmFuZ2U6ZTA2NzMwNzlhNGQ3NDNhYWFmZGUxMmYzOTE3YzI5ZmFfMi0xLTEtMS0w_48be64e5-5a3b-4eea-93e6-bebddbff319f">379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUwNjczMDc5YTRkNzQzYWFhZmRlMTJmMzkxN2MyOWZhL3RhYmxlcmFuZ2U6ZTA2NzMwNzlhNGQ3NDNhYWFmZGUxMmYzOTE3YzI5ZmFfMy0xLTEtMS0w_1831166b-cfdc-4036-a09b-25b024ee1234">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUwNjczMDc5YTRkNzQzYWFhZmRlMTJmMzkxN2MyOWZhL3RhYmxlcmFuZ2U6ZTA2NzMwNzlhNGQ3NDNhYWFmZGUxMmYzOTE3YzI5ZmFfNC0xLTEtMS0yMTU1_95ede536-aa9c-4d41-bd78-b66d0dc48462">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUwNjczMDc5YTRkNzQzYWFhZmRlMTJmMzkxN2MyOWZhL3RhYmxlcmFuZ2U6ZTA2NzMwNzlhNGQ3NDNhYWFmZGUxMmYzOTE3YzI5ZmFfNC0xLTEtMS0w_98067f5b-18b3-4c9f-aad3-ab3dc5b9066b">773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUwNjczMDc5YTRkNzQzYWFhZmRlMTJmMzkxN2MyOWZhL3RhYmxlcmFuZ2U6ZTA2NzMwNzlhNGQ3NDNhYWFmZGUxMmYzOTE3YzI5ZmFfNS0xLTEtMS0w_ef8c97d2-fbeb-4b3b-9e01-550f43ed6edb">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="-3" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUwNjczMDc5YTRkNzQzYWFhZmRlMTJmMzkxN2MyOWZhL3RhYmxlcmFuZ2U6ZTA2NzMwNzlhNGQ3NDNhYWFmZGUxMmYzOTE3YzI5ZmFfNi0xLTEtMS0w_48c3b854-cec4-44ca-afb0-c6d33e11a08b">717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8903544c9aa04a8996c72b73a4a172a6" continuedAt="i5b82a403a84e40658deddbc444ff6e35">Weighted-average remaining lease term and discount rate,&#160;as of June&#160;30, 2021, were as follows:</ix:continuation></span></div></ix:continuation></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><ix:continuation id="i4f7395ffb65f4b92a094a4b327a282f2"><ix:continuation id="i04ad02519ed9440a970581478f4db30f"><ix:continuation id="i78b5807e9e44465685d673611b4f8ce8"><div style="margin-top:5pt"><ix:continuation id="i5b82a403a84e40658deddbc444ff6e35"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Term and Discount Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i85fff53fbac547228677e769db10e805_I20210630" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmOTZjOTdiMGFkZDRkNjQ5MTAwNGNjMWQyY2QwYjBhL3RhYmxlcmFuZ2U6OWY5NmM5N2IwYWRkNGQ2NDkxMDA0Y2MxZDJjZDBiMGFfMi0xLTEtMS0w_c214f37b-a0d7-4185-b220-cf8f6286f764">6.3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i85fff53fbac547228677e769db10e805_I20210630" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmOTZjOTdiMGFkZDRkNjQ5MTAwNGNjMWQyY2QwYjBhL3RhYmxlcmFuZ2U6OWY5NmM5N2IwYWRkNGQ2NDkxMDA0Y2MxZDJjZDBiMGFfMy0xLTEtMS0w_ea7c9c41-b4ec-4330-b896-c13d93cf7745">1.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average discount rate</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmOTZjOTdiMGFkZDRkNjQ5MTAwNGNjMWQyY2QwYjBhL3RhYmxlcmFuZ2U6OWY5NmM5N2IwYWRkNGQ2NDkxMDA0Y2MxZDJjZDBiMGFfNS0xLTEtMS0w_3ec06f61-8569-41fe-840d-b9c8a95e7470">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i85fff53fbac547228677e769db10e805_I20210630" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmOTZjOTdiMGFkZDRkNjQ5MTAwNGNjMWQyY2QwYjBhL3RhYmxlcmFuZ2U6OWY5NmM5N2IwYWRkNGQ2NDkxMDA0Y2MxZDJjZDBiMGFfNi0xLTEtMS0w_c30020d4-b786-4ae6-87af-c11935cf6db9">6.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessor Information related to the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s system leasing</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year ended December&#160;31, 2020, the Company entered into leasing transactions, in which the Company is the lessor, offered through the Company's membership program. The Company's leases for equipment rentals were all accounted for as operating leases during the second and third quarters of 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter ended December&#160;31, 2020, certain&#160;of the membership program agreements were amended, granting the customers the exclusive right and option to purchase the leased system from the Company, at any time during the period of <ix:nonNumeric contextRef="ie02f2877a5a94ba1af32fcc4842c447f_D20201001-20201231" format="ixt-sec:durmonth" name="cutr:LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDk0NzgwMjMzMDI3NA_d1a8ad53-b0f2-4589-8750-25ca77d09658">12</ix:nonNumeric> months from signing the amended agreement. For contracts signed under the amended membership agreement,&#160;the Company classified and accounted for the arrangements as sales-type leases as of December&#160;31, 2020, as the Company determined it is reasonably certain that the customer will exercise the purchase option.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the sales-type leases, the net investment of the Company&#8217;s lease receivable is measured at the commencement date and is included in the condensed consolidated balance sheets as a component of other current assets and prepaid expenses. As of December&#160;31, 2020, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i6e5db1d27c0d467fa8a06f3edfd4046b_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SalesTypeLeaseRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMzgwOA_525c8f35-44d7-4dac-ba92-65070858d394"><ix:nonFraction unitRef="usd" contextRef="i35e40b62c61640d6ac4a638987ded61b_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMzgwOA_f8ce1588-193f-4e2d-b079-8eb2de5a25c2">0.7</ix:nonFraction></ix:nonFraction> million of revenue for the sales-type leases in the condensed consolidated statement of operations and the related lease receivable in other current assets of the condensed consolidated balance sheet. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was <ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:SalesTypeLeaseRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDAxNA_82adf6cd-7b01-43fd-be3f-c31adc17c6d4"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:SalesTypeLeaseRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDAxNA_8cbf2b62-8513-4edd-8d10-0ad6a0a8f357"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:SalesTypeLeaseRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDAxNA_b2fbfcf2-6257-4246-84eb-6e972d5b1a49"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:SalesTypeLeaseRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDAxNA_de0c27e5-c1f4-42b4-8a0f-a7b66ab75684">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> revenue recognized from the sales-type lease arrangement for the three and six months ended June&#160;30, 2021 and 2020, respectively. During the three and six months&#160;ended June&#160;30, 2021, the Company received a full payment of $<ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="cutr:ProceedsFromExerciseOfPurchaseOptionSalesTypeLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDE3OQ_a6160d01-d0d4-4008-84e6-69ed26bf1a9f">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-5" name="cutr:ProceedsFromExerciseOfPurchaseOptionSalesTypeLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDMxNg_c9c209c3-94ad-4cef-8df1-bf23259d6201">0.2</ix:nonFraction> million from a customer who exercised its purchase option. As of June&#160;30, 2021, the lease receivable balance included in other current assets of the condensed consolidated balance sheet was $<ix:nonFraction unitRef="usd" contextRef="i2704d4d253f94eceac8a62deac8a8b8a_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDM1Mw_4ecb2774-0c04-47b8-a379-86710b127fe9">0.5</ix:nonFraction> million </span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment lease revenue for operating lease agreements is recognized over the life of the lease. The amount of operating lease income included in Product revenue in the accompanying condensed consolidated statements of operations for the three and six months&#160;ended June&#160;30, 2021 was <ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OperatingLeaseLeaseIncome" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMzg0ODI5MDcwMjUzMA_94111c95-559b-44ad-b218-998ec8ccd7fd">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMzg0ODI5MDcwMjU0NA_2cad66dd-08aa-4a6d-869d-e4563e4d6011">0.1</ix:nonFraction>&#160;million, respectively.</span></div></ix:continuation></ix:continuation></ix:continuation><div id="ib4896268598045f0bc55c9d056377420_94"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12. <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85NC9mcmFnOmI5MDlmYmJlZDY2YzRkMzhhYzk2OGY4NzI4M2U0ZjVmL3RleHRyZWdpb246YjkwOWZiYmVkNjZjNGQzOGFjOTY4Zjg3MjgzZTRmNWZfMjA5NQ_9e894d81-a177-4d6b-a5fa-2fec694367da" continuedAt="iebafbc7fed79432b87bf4b3a12e9a356" escape="true">Contingencies</ix:nonNumeric></span></div><ix:continuation id="iebafbc7fed79432b87bf4b3a12e9a356"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named from time to time as a party to other legal proceedings, product liability, commercial disputes, employee disputes, and contractual lawsuits in the normal course of business. A liability and related charge are recorded to earnings in the Company&#8217;s consolidated financial statements for legal contingencies when the loss is considered probable and the amount can be reasonably estimated. The assessment is re-evaluated each accounting period and is based on all available information, including discussion with outside legal counsel. If a reasonable estimate of a known or probable loss cannot be made, but a range of probable losses can be estimated, the low-end of the range of losses is recognized if no amount within the range is a better estimate than any other. If a material loss is reasonably possible, but not probable and can be reasonably estimated, the estimated loss or range of loss is disclosed in the notes to the consolidated financial statements. The Company expenses legal fees as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">InMode Ltd. filed a complaint with the United States International Trade Commission alleging that Ilooda, Co., Ltd&#8217;s Secret RF fractional radiofrequency microneedling system, distributed in the United States by the Company, infringes U.S. Patent&#160;No.&#160;10,799,285&#160;("285&#160;patent"). The Company&#160;intends to vigorously defend against this lawsuit and, based on a preliminary investigation, believes that the Company has a&#160;strong defense and that the&#160;patent claim at issue is likely invalid in view of prior art. Based on the current information available to the Company, it&#160;believes that any possible loss will&#160;not&#160;be material.&#160;If, following a successful&#160;third-party action for infringement, the Company cannot obtain a license for the Company&#8217;s products, it&#160; may&#160;have to stop selling the applicable products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021 and&#160;December&#160;31, 2020, the Company had accrued $<ix:nonFraction unitRef="usd" contextRef="i0078d122644a4dddab29d2f40360b3c0_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85NC9mcmFnOmI5MDlmYmJlZDY2YzRkMzhhYzk2OGY4NzI4M2U0ZjVmL3RleHRyZWdpb246YjkwOWZiYmVkNjZjNGQzOGFjOTY4Zjg3MjgzZTRmNWZfMTkwMA_a74c58dc-1603-4b01-a4d2-0964dda65fd2">0.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i895c5dc933e94035967c4ca15bcf095a_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85NC9mcmFnOmI5MDlmYmJlZDY2YzRkMzhhYzk2OGY4NzI4M2U0ZjVmL3RleHRyZWdpb246YjkwOWZiYmVkNjZjNGQzOGFjOTY4Zjg3MjgzZTRmNWZfMTkwNw_4796a40a-0174-4ba8-b206-a69c48ca33c3">0.4</ix:nonFraction> million, respectively, related to various pending commercial and product liability lawsuits. The Company does not believe that a material loss in excess of accrued amounts is reasonably likely.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="ib4896268598045f0bc55c9d056377420_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13. <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTQ0Mjk_04a50855-a65b-4333-a02b-22f83efc43ac" continuedAt="i3df3969388464eb3be40123bf0ffda7b" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="i3df3969388464eb3be40123bf0ffda7b" continuedAt="ia1f26c5d951f4257b34ab0bbf4ac0cd2"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible notes, net of unamortized debt issuance costs</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i3039819417a84fd7b2aa536ffb2ed8d4_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTAz_7946a4df-aae5-46a8-9ed2-5679a8aae3f6">138.3</ix:nonFraction> million aggregate principal amount of convertible senior notes&#160;due on March 15, 2026 in a private placement offering. The Convertible notes bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="i3039819417a84fd7b2aa536ffb2ed8d4_I20210331" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjM4_105adc65-1f31-4e42-8d37-2ac51675c033">2.25</ix:nonFraction>% per year payable semiannually in arrears on March 15 and September 15 of each year, beginning on September 15, 2021. Upon conversion, the Convertible notes will be convertible into cash, shares of the Company&#8217;s common stock or a combination thereof, at the Company&#8217;s election. The Convertible notes are presented as Convertible notes, net of unamortized debt issuance costs, on the condensed consolidated balance sheet.&#160;Proceeds from the offering were $<ix:nonFraction unitRef="usd" contextRef="i41feb9a60cd54b25be885f1459623391_D20210301-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNjkz_bf2007ad-e8fe-4afb-a8d5-73e019c3b205">133.6</ix:nonFraction> million, net of issuance costs, including initial purchasers fees.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Initially, each $1,000 principal amount of Notes was convertible into 30.1427 shares of the Company&#8217;s common stock at a conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic0624b58f9374ca4b58497be819f0521_I20210331" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfODgx_2dc2d31c-57d4-4613-b254-4d353abf9d54">33.18</ix:nonFraction> per share. The conversion rate for the Convertible notes is subject to adjustment for certain events as set forth in the Indenture governing the Convertible notes. The Convertible notes will mature on March 15, 2026, unless earlier converted, redeemed, or repurchased in accordance with the terms of the Convertible notes. No sinking fund is provided for the Notes. As of June&#160;30, 2021, the net carrying amount of the Company&#8217;s Convertible notes was <ix:nonFraction unitRef="usd" contextRef="ib7035befba854bb787b41b7a326649e7_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMzg0ODI5MDcyNzE4OQ_142908a6-795f-4b75-b75c-9f672b30f54a">133.9</ix:nonFraction>&#160;million and the unamortized debt issuance costs were&#160;$<ix:nonFraction unitRef="usd" contextRef="ib7035befba854bb787b41b7a326649e7_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTQxMA_0e07b2d7-fa1a-4135-ba91-3bf4826fcb23">4.4</ix:nonFraction> million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their Notes at their option prior to the close of business on the business day immediately preceding December 15, 2025, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-top:10pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During any fiscal quarter commencing after the fiscal quarter ending on June 30, 2021 (and only during such fiscal quarter), if the last reported sale price of the common stock for at least <ix:nonFraction unitRef="day" contextRef="iaea3ce259c6d4b31887911f5a24f9386_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTgyMg_ac199006-3770-4801-a8f4-26311d9eb481">20</ix:nonFraction> trading days (whether or not consecutive) during a period of <ix:nonFraction unitRef="day" contextRef="iaea3ce259c6d4b31887911f5a24f9386_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTg4Ng_23f78162-de1f-459f-8a4a-45d9300fcf20">30</ix:nonFraction> consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to <ix:nonFraction unitRef="number" contextRef="iaea3ce259c6d4b31887911f5a24f9386_D20210301-20210331" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjAzMg_c94eb09f-5a89-438b-a2f3-fee4a2d74a8f">130</ix:nonFraction>% of the conversion price for the Convertible notes on each applicable trading day;</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the <ix:nonFraction unitRef="day" contextRef="i07f11bb2c2e748f7a93f2cf71e0ba828_D20210301-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjEyOA_a57c0933-4f96-4713-855d-3e3f76f384f0">five</ix:nonFraction>-business day period after any <ix:nonFraction unitRef="day" contextRef="i07f11bb2c2e748f7a93f2cf71e0ba828_D20210301-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjE2MQ_df5c5f18-e1c5-4fa4-824c-e685573534b7">five</ix:nonFraction> consecutive trading day period (the &#8220;measurement period&#8221;) in which the &#8220;trading price&#8221;&#160;per $1,000 principal amount of Convertible notes for each trading day of the measurement period was less than <ix:nonFraction unitRef="number" contextRef="i07f11bb2c2e748f7a93f2cf71e0ba828_D20210301-20210331" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjM1Nw_74e08e96-0b6d-4df0-989b-370ff71d9591">98</ix:nonFraction>% of the product of the last reported sale price of the Company's&#160;common stock and the conversion rate on each such trading day;</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company calls such Convertible notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Upon the occurrence of specified corporate events.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after December 15, 2025, and until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The circumstances described in the first bullet of the paragraph above were met during the second quarter of 2021 as the Company's stock traded at a price in excess of the conversion price, and as a result, the Notes are convertible at the option of the holder from July 1, 2021 until September 30, 2021.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Upon any conversion of the Convertible notes, the Company would be required to pay or deliver, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#8217;s election with respect to such conversion. To the extent there are any conversions during the period from July 1, 2021 until September 30, 2021, the Company intends to settle such conversions in shares of common stock, therefore, as of June&#160;30, 2021, the Convertible notes have been included as Long-term debt on its condensed consolidated balance sheet.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may not redeem the Convertible notes prior to March 20, 2024. On or after March 20, 2024, the Company may redeem for cash all or any portion of the Notes, at the Company&#8217;s option, if the last reported sale price of the Company&#8217;s common stock has been at least <ix:nonFraction unitRef="number" contextRef="i41feb9a60cd54b25be885f1459623391_D20210301-20210331" decimals="2" name="cutr:DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMzM5Mw_d56990d2-0358-4323-af10-02b44f887da5">130</ix:nonFraction>% of the conversion price then in effect for at least <ix:nonFraction unitRef="day" contextRef="i41feb9a60cd54b25be885f1459623391_D20210301-20210331" decimals="INF" name="cutr:DebtInstrumentRedeemableThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMzQ0OA_df058f3d-1062-4743-b4fa-0af0a5467285">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="day" contextRef="i41feb9a60cd54b25be885f1459623391_D20210301-20210331" decimals="INF" name="cutr:DebtInstrumentRedeemableThresholdConsecutiveTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMzUwMg_4213b52f-34c1-48a4-8a0c-c7f41760d81f">30</ix:nonFraction> consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="i41feb9a60cd54b25be885f1459623391_D20210301-20210331" decimals="2" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMzczOQ_d00e297f-7001-438d-aad2-a248f552c909">100</ix:nonFraction>% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem fewer than all of the outstanding Notes, at least $<ix:nonFraction unitRef="usd" contextRef="i3039819417a84fd7b2aa536ffb2ed8d4_I20210331" decimals="-5" format="ixt:numdotdecimal" name="cutr:DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMzk1MA_8590d5c1-980f-47f4-99bb-7fea961a12a6">50.0</ix:nonFraction> million aggregate principal amount of Notes must be outstanding and not subject to redemption as of the relevant redemption notice date.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a fundamental change occurs, note holders have the option to require the Company to repurchase any portion or all of their Convertible notes in $<ix:nonFraction unitRef="usd" contextRef="i5ddc6ffd69484d648267e3fa81be0a45_I20210331" decimals="INF" format="ixt:numdotdecimal" name="cutr:DebtInstrumentRedemptionIncrementalRepurchaseAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNDIyOQ_ef902ad6-e123-418e-acca-a0d7e89d29c0">1,000</ix:nonFraction> principal increments for cash. The price for such repurchase is calculated as <ix:nonFraction unitRef="number" contextRef="i489cafda5c3f4762af77cae7f75a401e_D20210301-20210331" decimals="2" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNDMxMA_51aa7cea-e02d-44fc-b631-add483fac40a">100</ix:nonFraction>% of the principal amounts of Notes, plus accrued and unpaid interest to the day immediately preceding the Fundamental Change repurchase date. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><ix:continuation id="ia1f26c5d951f4257b34ab0bbf4ac0cd2" continuedAt="i863c90c216aa4ffc9cb01917a4c5f4df"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, holders of the Notes who convert in connection with a fundamental change are, under certain circumstances, entitled to an increase in conversion rate.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Convertible notes are general senior unsecured obligations that rank senior to any of the Company&#8217;s indebtedness that is explicitly subordinated to the Notes. The Notes have equal rank in right of payment with all existing and future unsecured indebtedness that is not subordinated to the Notes. The Notes will be junior to any of the Company&#8217;s secured indebtedness to the extent of the value of the assets securing such indebtedness. The Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Convertible notes was approximately $<ix:nonFraction unitRef="usd" contextRef="i1290f60e05c943b9995db59a6927e23a_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNTMzMg_256fb694-83f7-45eb-86aa-57fddb424ad0">226.4</ix:nonFraction> million as of June&#160;30, 2021, which the Company&#160;determined through consideration of market prices. The fair value measurement is classified as Level 2, as defined in Note 3.</span></div><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:ConvertibleDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTQ0MzA_ae9bc4ec-b7e5-40d6-be22-ede670362ecf" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents outstanding principal amount and carrying value of the Convertible notes (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding principal amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib7035befba854bb787b41b7a326649e7_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RhYmxlOmM4OWEwNmY5MmVlYzRmOWI5YWQ2MTVmZTE3NWU4OTgwL3RhYmxlcmFuZ2U6Yzg5YTA2ZjkyZWVjNGY5YjlhZDYxNWZlMTc1ZTg5ODBfMS0xLTEtMS0w_a4c285b1-4970-4edd-a7ac-ddd338482374">138,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia674f145a1a94467899389e49f535d8f_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RhYmxlOmM4OWEwNmY5MmVlYzRmOWI5YWQ2MTVmZTE3NWU4OTgwL3RhYmxlcmFuZ2U6Yzg5YTA2ZjkyZWVjNGY5YjlhZDYxNWZlMTc1ZTg5ODBfMS0zLTEtMS0w_0cf9daae-8985-4480-b4d4-7d1562313ed2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib7035befba854bb787b41b7a326649e7_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RhYmxlOmM4OWEwNmY5MmVlYzRmOWI5YWQ2MTVmZTE3NWU4OTgwL3RhYmxlcmFuZ2U6Yzg5YTA2ZjkyZWVjNGY5YjlhZDYxNWZlMTc1ZTg5ODBfMi0xLTEtMS0w_3d0da55c-ddd8-42aa-9766-f1924d475aae">4,450</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia674f145a1a94467899389e49f535d8f_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RhYmxlOmM4OWEwNmY5MmVlYzRmOWI5YWQ2MTVmZTE3NWU4OTgwL3RhYmxlcmFuZ2U6Yzg5YTA2ZjkyZWVjNGY5YjlhZDYxNWZlMTc1ZTg5ODBfMi0zLTEtMS0w_4444ddfb-714f-4bd4-aa85-1ec54690ab7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Carrying Value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib7035befba854bb787b41b7a326649e7_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RhYmxlOmM4OWEwNmY5MmVlYzRmOWI5YWQ2MTVmZTE3NWU4OTgwL3RhYmxlcmFuZ2U6Yzg5YTA2ZjkyZWVjNGY5YjlhZDYxNWZlMTc1ZTg5ODBfMy0xLTEtMS0w_dda80b8f-7b7e-490c-9905-c0cf083d289a">133,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia674f145a1a94467899389e49f535d8f_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RhYmxlOmM4OWEwNmY5MmVlYzRmOWI5YWQ2MTVmZTE3NWU4OTgwL3RhYmxlcmFuZ2U6Yzg5YTA2ZjkyZWVjNGY5YjlhZDYxNWZlMTc1ZTg5ODBfMy0zLTEtMS0w_7b9c53ae-6650-444b-bd4b-fda5f7e98e1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with issuance of the Convertible notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally intended to reduce the potential dilution of the Company's&#160;common stock upon any conversion or settlement of the Notes or to offset any cash payment the Company is required to make in excess of the principal amount upon conversion of the Notes, as the case may be, with such reduction or offset subject to a cap based on the cap price. If the market price per share of the Company&#8217;s common stock exceeds the cap price of the capped calls transaction, then the Company&#8217;s stock would experience some dilution and/or the capped call would not fully offset the potential cash payments, in each case to the extent the then-market price per share of its common stock exceeds the cap price. Under the capped call transactions, the Company purchased from the option counterparties capped call options that in the aggregate relate to the total number of shares of the Company's common stock underlying the Convertible notes, with a strike price equal to the conversion price of the Convertible notes and with an initial cap price equal to $<ix:nonFraction unitRef="usdPerItem" contextRef="i44e8ae2855f24ec191abeac87edead4a_I20210331" decimals="INF" name="us-gaap:DerivativeCapPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNjgxMg_d33f0650-b9b7-4033-96fa-a7e8d09d78bc">45.5350</ix:nonFraction>, which represents a <ix:nonFraction unitRef="number" contextRef="i44e8ae2855f24ec191abeac87edead4a_I20210331" decimals="2" name="cutr:DerivativeCapPricePremiumOverStockPricePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNjgzNQ_ff6be12d-1bf8-4d49-be91-b1449abc7eaa">75</ix:nonFraction>% premium over the last reported sale price of the Company's common stock of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic40cdb4b583b4d60bd81237f32311633_I20210304" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNjkxMw_b58346f2-7f00-407c-bdfe-33e290e8eecb">26.02</ix:nonFraction> per share on March&#160;4, 2021, with certain adjustments to the settlement terms that reflect standard anti-dilution provisions. The capped call transactions expire over <ix:nonFraction unitRef="day" contextRef="ib0131d61368a466d8a6ca8117c109ad7_D20210301-20210331" decimals="INF" name="cutr:DerivativeCappedCallTransactionTermConsecutiveTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNzA3MA_426198ac-064c-44a7-94b6-b3f2b7193ab6">40</ix:nonFraction> consecutive scheduled trading days ended on March 12, 2026. The capped calls were purchased for $<ix:nonFraction unitRef="usd" contextRef="ib0131d61368a466d8a6ca8117c109ad7_D20210301-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsForDerivativeInstrumentFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNzE2OQ_49180bee-cbbd-4131-988b-d135fcf7383b">16.1</ix:nonFraction> million. The Company evaluated the capped call transaction under authoritative accounting guidance and determined that it should be accounted for as a separate transaction and classified as a net reduction to Additional paid-in capital within stockholders&#8217; equity with no recurring fair value measurement recorded.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company early adopted ASU 2020-6, Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40). In accordance with Subtopic 470-20 and 815-40, as revised by ASU 2020-6, the Company records the Convertible notes in long-term debt with no separation between the Notes and the conversion option. Each reporting period, the Company will determine whether any criteria is met for the note holders to have the option to redeem the Notes early, which could&#160;result in a change in the classification of the Notes to current liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Debt Issuance Cost</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance costs related to the Convertible notes are presented in the condensed consolidated balance sheet as a direct deduction from the carrying amount of the Convertible notes. During the six months ended June&#160;30, 2021, the Company incurred direct costs associated with the issuance of Convertible notes of $<ix:nonFraction unitRef="usd" contextRef="ib7035befba854bb787b41b7a326649e7_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfODQ2Nw_b28750bd-98ed-4d6c-91b4-682e525aa13d">4.7</ix:nonFraction> million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance costs are&#160;amortized using&#160;an effective interest method basis over the term of the Convertible notes and accordingly the Company recorded approximately&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ia1ba13fde0c14860bd56f281fcae9480_D20210401-20210630" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfODY1Mw_89669b80-7e54-48f7-873f-e6f019e64cfd">0.2</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="i2dceabdb8060472888bc8746205213da_D20210101-20210630" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjE5OTAyMzI3OTkwOA_b7f26144-71f2-4300-90e7-a4a5250c1d6b">0.3</ix:nonFraction> million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of amortization of debt issuance costs during the three and six months ended June&#160;30, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective interest rate on the Convertible notes is <ix:nonFraction unitRef="number" contextRef="ia1ba13fde0c14860bd56f281fcae9480_D20210401-20210630" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfODc4Mg_2dc62a7e-8bd6-477d-997d-3fa07dcc73bf"><ix:nonFraction unitRef="number" contextRef="i2dceabdb8060472888bc8746205213da_D20210101-20210630" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfODc4Mg_6e8ccc40-1a00-49c9-b027-7ad09153a848">2.97</ix:nonFraction></ix:nonFraction>%. Interest expense for the three and six months ended June&#160;30, 2021 totaled approximately $<ix:nonFraction unitRef="usd" contextRef="ia1ba13fde0c14860bd56f281fcae9480_D20210401-20210630" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjE5OTAyMzI3MjcwMQ_d10f237c-de91-4451-8c5e-254ccb85cc49">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2dceabdb8060472888bc8746205213da_D20210101-20210630" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjE5OTAyMzI3MjcwOQ_86e419ce-f2d2-4a72-bd4c-718fcb3ad917">1.2</ix:nonFraction> million, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="ia1ba13fde0c14860bd56f281fcae9480_D20210401-20210630" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjE5OTAyMzI3MjcyMA_57281046-498e-42b9-b556-67f2f8f1c204">0.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2dceabdb8060472888bc8746205213da_D20210101-20210630" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjE5OTAyMzI3MjcyOA_06bbf92a-f713-4705-bf1b-76e24bdd0d0a">1.0</ix:nonFraction> million, respectively, relate to accruing the semiannual interest payment with the remaining balance relating to the&#160;amortization of debt issuance costs.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><ix:continuation id="i863c90c216aa4ffc9cb01917a4c5f4df"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loan and Security Agreement</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;30, 2018, the Company and Wells Fargo Bank, N.A. (&#8220;Wells Fargo&#8221;) entered into a Loan and Security Agreement (the &#8220;Wells Fargo Revolving Line of Credit&#8221;) in the original principal amount of $<ix:nonFraction unitRef="usd" contextRef="ic0afd02d742a4c50bfc5ec134cc472c9_I20180530" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfOTMxMA_18317e1a-26ed-4d3a-9268-431459533e0e">25.0</ix:nonFraction> million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;9, 2020, the Company terminated its undrawn revolving line of credit with Wells Fargo and subsequently entered into a Loan and Security Agreement with Silicon Valley Bank for a <ix:nonNumeric contextRef="i6f5872525ec8417bb65b72a9ac49e61b_D20200709-20200709" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNDk0NzgwMjM0MjQ3OA_934e6744-4444-45a2-b53d-7e22c614ef22">four-year</ix:nonNumeric> secured revolving loan facility (&#8220;SVB Revolving Line of Credit&#8221;) in an aggregate principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="i73dd1591ec4d4f828e27088ad0d09aeb_I20200709" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfOTYwNA_40b07c2c-70f8-4915-a549-a9ace19dd43a">30.0</ix:nonFraction> million. The SVB Revolving Line of Credit matures on July 9, 2024.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to draw on the full amount of the SVB Revolving Line of Credit, the Company must satisfy certain liquidity ratios. If the Company is unable to meet these liquidity ratios, then availability under the revolving line is calculated as <ix:nonFraction unitRef="number" contextRef="i73dd1591ec4d4f828e27088ad0d09aeb_I20200709" decimals="2" name="cutr:DebtInstrumentPercentageOfQualifyingAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfOTkwNw_915705ab-2c8b-45f2-9034-bc81b62d0602">80</ix:nonFraction>% of the Company&#8217;s qualifying accounts receivable. The proceeds of the revolving loans may be used for general corporate purposes. The Company&#8217;s obligations under the Loan and Security Agreement with Silicon Valley Bank are secured by substantially all of the assets of the Company. Interest on principal amount outstanding under the revolving line shall accrue at a floating per annum rate equal to the greater of either <ix:nonFraction unitRef="number" contextRef="i84e5687763244213b65265c035c8bdcd_D20200709-20200709" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTAzMzA_96c7c955-b320-486a-b148-95e5d810e38c">1.75</ix:nonFraction>% above the Prime Rate or five percent (<ix:nonFraction unitRef="number" contextRef="i73dd1591ec4d4f828e27088ad0d09aeb_I20200709" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTAzNzE_c915842c-7ef5-4dce-b7e9-fd572794606c">5.0</ix:nonFraction>%). The Company paid a non-refundable revolving line commitment fee of $<ix:nonFraction unitRef="usd" contextRef="i6f5872525ec8417bb65b72a9ac49e61b_D20200709-20200709" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTA0NDM_41df178b-a0fe-4a1e-83be-bc7e35353491">0.3</ix:nonFraction> million, on the effective date of the Loan and Security Agreement with Silicon Valley Bank of July&#160;9, 2020, and the Company is required to pay an anniversary fee of $<ix:nonFraction unitRef="usd" contextRef="i73dd1591ec4d4f828e27088ad0d09aeb_I20200709" decimals="-5" format="ixt:numdotdecimal" name="cutr:DebtInstrumentAnniversaryFeeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTA1OTM_f7fa54a6-5195-4180-9511-ffdf09458596">0.3</ix:nonFraction> million on each twelve-month anniversary of the effective date of the Loan and Security Agreement.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan and Security Agreement with Silicon Valley Bank contains customary affirmative covenants, such as financial statement reporting requirements and delivery of borrowing base certificates, as well as customary covenants that restrict the Company&#8217;s ability to, among other things, incur additional indebtedness, sell certain assets, guarantee obligations of third parties, declare dividends, or make certain distributions, and undergo a merger or consolidation or certain other transactions. The Loan and Security Agreement also contains certain financial covenants, including maintaining a quarterly minimum revenue of $<ix:nonFraction unitRef="usd" contextRef="i6f5872525ec8417bb65b72a9ac49e61b_D20200709-20200709" decimals="-5" format="ixt:numdotdecimal" name="cutr:DebtCovenantQuarterlyMinimumRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjE5OTAyMzI4NjAwMg_ceb3d2b4-b294-4ca2-a058-9b3b0809ecf7">90.0</ix:nonFraction>&#160;million, determined in accordance with GAAP on a trailing twelve-month basis. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;4, 2021, the Loan and Security Agreement dated July&#160;9, 2020 was amended to (i)&#160;permit the Company to issue the Convertible notes and perform its obligations in connection therewith, and (ii)&#160;permit the Capped Call transactions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company had not drawn on the SVB Revolving Line of Credit and the Company is in compliance with all financial covenants of the SVB Revolving Line of Credit.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Paycheck Protection Program (PPP) Loan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;22, 2020, the Company received loan proceeds of $<ix:nonFraction unitRef="usd" contextRef="id99d22627e1c49f080008eaaceb8a64e_D20200422-20200422" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTE5NjQ_438a8213-5139-45f6-b66d-2341dd6c7ebc">7.1</ix:nonFraction> million pursuant to the Paycheck Protection Program (the &#8220;PPP&#8221;) under the CARES Act. The loan, which is in the form of a promissory note dated April 21, 2020, between the Company and Silicon Valley Bank as the lender, matures on April 21, 2022 and bears interest at a fixed rate of <ix:nonFraction unitRef="number" contextRef="i22ce661a87cf458ba03c056354564a8e_I20200422" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTIzMDA_4ee300d5-a097-4e46-bdbb-1acd901a44bc">1.00</ix:nonFraction>% per annum, payable monthly commencing September 2021. There is no prepayment penalty. Under the terms of the PPP, all or a portion of the principal may be forgiven if the loan proceeds are used for qualifying expenses as described in the CARES Act, such as payroll costs, benefits, rent, and utilities. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PPP loan and related accrued interest were forgiven under the provisions of the CARES Act, and the $<ix:nonFraction unitRef="usd" contextRef="id84ea3c345a84c8c820c9be723af5e27_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjE5OTAyMzI4NTQ1Mw_34881f31-c087-49d0-ad38-c4caa5f973e4"><ix:nonFraction unitRef="usd" contextRef="i54330428060a4653bc4b61cd17bfbb1e_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjE5OTAyMzI4NTQ1Mw_aedf76dc-fb8e-426a-9103-026258795cf4">7.2</ix:nonFraction></ix:nonFraction>&#160;million gain on forgiveness of PPP loan was recorded as Gain on extinguishment of PPP loan in the condensed consolidated statement of operations for the three and six months ended June&#160;30, 2021.</span></div></ix:continuation><div id="ib4896268598045f0bc55c9d056377420_103"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14. <ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90ZXh0cmVnaW9uOjZhZGVlMTYwODAzODQ2NmJhMmRjNzJhYzVmYWY3YTBiXzEzNTg_f17c8369-7b78-40ca-8143-4dad0ba4e13d" continuedAt="ief7ae49f2aba4bcb9231729b27ccdcef" escape="true">Segment reporting</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ief7ae49f2aba4bcb9231729b27ccdcef" continuedAt="ia372b7a87f4c424e920e4cb4766b29eb">Segment reporting is based on the &#8220;management approach,&#8221; following the method that management organizes the Company&#8217;s reportable segments for which separate financial information is made available to, and evaluated regularly by, the chief operating decision maker in allocating resources and in assessing performance. The Company&#8217;s chief operating decision makers ("CODM") are its Chief Executive Officer ("CEO") and Chief Financial Officer (&#8220;CFO&#8221;), who make decisions on allocating resources and in assessing performance. The CEO and CFO review the Company's consolidated results as&#160;<ix:nonFraction unitRef="segment" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90ZXh0cmVnaW9uOjZhZGVlMTYwODAzODQ2NmJhMmRjNzJhYzVmYWY3YTBiXzYxNg_b6991588-1d0d-44bf-976f-24e8fd67682a">one</ix:nonFraction>&#160;operating segment. In making operating decisions, the CODM primarily considers consolidated financial information, accompanied by disaggregated information about revenues by geography and product. All of the Company&#8217;s principal operations and decision-making functions are located in the U.S. The Company&#8217;s CODM view its operations, manages its business, and uses&#160;one&#160;measurement of profitability for the&#160;one&#160;operating segment - which sells aesthetic medical equipment and services, and distributes skincare products, to qualified medical practitioners. Substantially all of the Company&#8217;s long-lived assets are located in the U.S.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><ix:continuation id="ia372b7a87f4c424e920e4cb4766b29eb"><ix:nonNumeric contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" name="us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90ZXh0cmVnaW9uOjZhZGVlMTYwODAzODQ2NmJhMmRjNzJhYzVmYWY3YTBiXzEzNTk_02a918e9-b27d-4d3b-a299-2e77158c1283" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of revenue by geography for the three and six months June&#160;30, 2021 and 2020 (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue mix by geography:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5cd8c122a6db4b479f4cb170d5340e5f_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzMtMS0xLTEtMA_b8973b14-b671-4eb4-922f-0ddf62688fa0">22,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifc32166982764821b862930f62f92b51_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzMtMy0xLTEtMA_cc92308b-a87e-4b45-a6ad-a064bfcd4b32">10,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0916cb6cfef149efba3569c230352115_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzMtNS0xLTEtMTA4Mw_c3238c4f-6fae-4235-82e9-1427a872c44f">41,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc041928fcd442d691a2b8f145bf69f3_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzMtNy0xLTEtMTA4NQ_6fcc80fa-ffac-41c6-afb9-2c8902812af5">24,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i60cc413c28af471da2fd3a5cb7567dfe_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzQtMS0xLTEtMA_89ba583a-e1c7-480f-9122-3a586f37a857">17,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i001f2e7ffc384283a6262f680531b654_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzQtMy0xLTEtMA_62e008ef-33a4-43fb-b8ee-5cc2c3f1d8e0">8,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45c4fddf3ca04af29dc98fd3b2a1c1b3_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzQtNS0xLTEtMTA4Mw_adb7b51d-b85a-4e6e-be27-d2b4563cb8f2">33,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee1d9be4d174579b2a79cbe1837cf25_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzQtNy0xLTEtMTA4NQ_cab9e2bf-8fd2-4fba-8c1c-f8809d1c8232">15,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asia, excluding Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i605c06860c2a4b9ba038414773646e05_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzUtMS0xLTEtNTIzOQ_7fdbd75e-115e-470a-b3e0-79e43fee1492">3,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b993bcbab604605a3f9186a75679bc5_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzUtMy0xLTEtNTIzOQ_6eb4b40f-7825-47ca-85f6-92c36a80a6ee">1,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icac68fb392c34970af1e7c3bbd64b047_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzUtNS0xLTEtNTIzOQ_9ba3d2a5-ffc0-4711-87a8-ab77ce04612b">6,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5628efd5ddc746118fb44e8463069210_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzUtNy0xLTEtNTIzOQ_da2598f5-8ea5-4c25-8bf7-319c729bc07d">5,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6fc50f8e8e41c4b1b36ce9c699fe36_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzYtMS0xLTEtNTIzOQ_a258dbf0-3abc-4546-87fc-17096f19191b">4,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e77ae11263421aacb8d6bb8940ff5b_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzYtMy0xLTEtNTIzOQ_c81a5302-a9c5-4504-867b-3e998917426d">1,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b6561e7c0bc4c82b78cc302b59ada69_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzYtNS0xLTEtNTIzOQ_90310cc5-2d0c-4765-8f5d-b67e440e6e06">9,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedce34eaadb2414ca33df76ede46361d_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzYtNy0xLTEtNTIzOQ_4449fb52-5902-45fc-bc2f-7259987d4a50">4,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rest of the  World, other than United States, Asia and Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i72c021f9acb64626b780975f2f7b37bd_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzctMS0xLTEtMA_6b45488e-819b-46f7-9d71-c879ce19ef4d">9,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieae31fb3cfae4ce588f0407780016251_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzctMy0xLTEtMA_7d416f04-007d-46b4-9bcd-10d15360771c">3,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74194697532c48e689caa0d810cf7dee_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzctNS0xLTEtMTA4Mw_b4f225db-8b4e-4203-ad05-c24dee9e91ec">17,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic61b8af9d2a44ba89d29a042679de961_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzctNy0xLTEtMTA4NQ_ea0256e4-e90d-4ba4-80a8-e2af1a0362ad">9,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total consolidated revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzgtMS0xLTEtMA_0e645ffd-4435-42ab-b438-02cac756b040">58,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzgtMy0xLTEtMA_53e5acf2-8cd4-4188-a20c-cbea80301645">26,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzgtNS0xLTEtMTA4Mw_c4e6cd78-1995-41f7-bea4-1aa077f65841">108,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzgtNy0xLTEtMTA4NQ_7fc9033d-dd4a-4fb4-b837-5b5838b65262">58,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue mix by product category:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i257d2e51a1bc4c85b8cffc47eabccc0b_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEwLTEtMS0xLTA_08980c74-c838-4f66-a188-444e30633f23">35,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id006d6e7ce234b7486129ec2b87c40c0_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEwLTMtMS0xLTA_351bea16-b4df-40dd-b8c7-d81a317b97d0">15,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8306ccc3f44558b1235fa08edef7ed_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEwLTUtMS0xLTEwODc_e0965439-c0bc-4f7f-8d7c-a1a9bafff219">63,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97644f373e8442c982dab972c23de51_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEwLTctMS0xLTEwODk_1e88aa5c-6c96-4ad3-8937-71bcab26bb1b">36,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ief96e147f922486883c4d8cc587f8f60_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzExLTEtMS0xLTA_9c9d0e51-852f-4318-966d-7da65f428271">4,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibd1e322af3b8489a8e9d1c2f562b5e8b_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzExLTMtMS0xLTA_e4eb7ad6-2f6b-4116-890e-b4ca0abfc8a5">1,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3afbc47a9fd48df8033033413b4338e_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzExLTUtMS0xLTEwODc_14591a7c-2a70-44d8-ae87-1a9d4243b6b3">7,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c347ebd3f934ddaaec736c2f53a0eeb_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzExLTctMS0xLTEwODk_12f6f47d-90ec-4cde-8883-0447564cd652">3,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skincare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i612e38fd3e404dcb98febb98ac966dcd_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEyLTEtMS0xLTA_a1bdfb1b-ae08-44a8-bff1-e1fcbdd83fed">11,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i532d55314af64158ac48f5d2f1d43acc_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEyLTMtMS0xLTA_a2429402-0a53-4de3-8746-8be24ce8a714">4,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70f692ff4e534504a06fd1b76829e106_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEyLTUtMS0xLTEwODc_1ebe2374-0641-4235-97f6-3d30f38871b8">24,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a21f86e33ca4228a03854c5f5b0821c_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEyLTctMS0xLTEwODk_4ba13e77-61b7-4445-a805-160d08c8d830">7,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total product revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2fcfd7b210f74dc5976983de27855478_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEzLTEtMS0xLTA_e4f05bf2-0af6-4165-9bdc-075a6945db67">51,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibcb365aaec5f4975a3f836175dc8e2ce_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEzLTMtMS0xLTA_46cfac36-48cc-470d-a5b7-91b3fd6db688">21,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfb65299d11046adb017318fb542b3be_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEzLTUtMS0xLTEwODc_72c87d86-60f4-43b2-99f7-6cb5dfa596b4">95,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb26dda9fd88462aabb4723bea6e2287_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEzLTctMS0xLTEwODk_0811da9c-0044-4b4f-b976-80f5d4890c93">48,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia8b6fed2a51f45858d2dcecd28277fef_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzE0LTEtMS0xLTA_1c4828d3-1281-4292-914e-2c933927bcf7">6,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73f49a322eb84c7383e92e7174381a6c_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzE0LTMtMS0xLTA_a09d2961-d414-4d0d-88c0-a527c318e4d5">4,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzE0LTUtMS0xLTEwODc_6cffc70e-3fdb-4e09-b8cb-b51fe5d7c849">12,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd94bfca54cb406f8ffb1fc2d03add57_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzE0LTctMS0xLTEwODk_4129b02d-843b-41cb-9b6c-d3e2fd94b10d">10,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total consolidated revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzE1LTEtMS0xLTA_95741eaa-c52d-41bf-a5ba-b9eef86c07b3">58,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzE1LTMtMS0xLTA_84151908-6c4d-47f4-8568-0f9f96ae82de">26,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzE1LTUtMS0xLTEwODc_98aaafe8-4f23-4178-8b5e-bf3eac125936">108,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzE1LTctMS0xLTEwODk_a903bc89-1f56-4fb2-8d3d-0edaf2c2e3f6">58,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="ib4896268598045f0bc55c9d056377420_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;padding-left:49.5pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">s Discussion and Analysis should be read in conjunction with the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">s financial condition and results of operations in conjunction with the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">s unaudited condensed consolidated financial statements and notes thereto included in Part I, Item 1 of this Quarterly Report on Form 10-Q and the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">s audited financial statements and notes thereto for the year ended December 31, 2020, included in its annual report on Form 10-K filed with the U.S. Securities and Exchange Commission (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SEC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">) on March 23, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless otherwise indicated, all results presented are prepared in a manner that complies, in all material respects, with accounting principles generally accepted in the United States of America (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GAAP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">). Additionally, unless otherwise indicated, all changes identified for the current-period results represent comparisons to results for the prior corresponding fiscal period.</span></div><div id="ib4896268598045f0bc55c9d056377420_109"></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special note regarding forward-looking statements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report contains forward-looking statements that involve risks and uncertainties. The Company&#8217;s actual results could differ materially from those discussed in the forward-looking statements. The statements contained in this report that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, ("the Exchange Act"). Forward-looking statements are often identified by the use of words such as, but not limited to, &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;can,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;strategy,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and similar expressions or variations intended to identify forward- looking statements. These statements are based on the beliefs and assumptions of the Company&#8217;s management based on information currently available to management. Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed in the section titled &#8220;Risk Factors&#8221; included under Part II, Item 1A below.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, such forward-looking statements speak only as of the date of this report. Except as required by law, the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.</span></div><div id="ib4896268598045f0bc55c9d056377420_112"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Introduction</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Management&#8217;s Discussion and Analysis, or MD&amp;A, is organized as follows:</span></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Executive Summary. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This section provides a general description and history of the Company&#8217;s business, a brief discussion of the its product lines and the opportunities, trends, challenges and risks the Company focuses on in the operation of its business.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Critical Accounting Policies and Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;This section describes the key accounting policies that are affected by critical accounting estimates.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Results of Operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;This section provides the Company&#8217;s analysis and outlook for the significant line items on its condensed consolidated statements of operations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Liquidity and Capital Resources.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This section provides an analysis of the Company&#8217;s liquidity and cash flows, as well as a discussion of its Commitments that existed as of June 30, 2021.</span></div><div id="ib4896268598045f0bc55c9d056377420_115"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company Description</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a leading medical device company specializing in the research, development, manufacture, marketing and servicing of light and other energy-based aesthetics systems for practitioners worldwide. In addition to internal development of products, the Company distributes third party sourced products under the Company&#8217;s own brand names. The Company offers easy-to-use products which enable practitioners to perform safe and effective aesthetic procedures, including treatment for body contouring, skin resurfacing and revitalization, tattoo removal, removal of benign pigmented lesions, vascular conditions, hair removal, toenail fungus and women's intimate health. The Company&#8217;s platforms are designed to be easily upgraded to add additional applications and hand pieces, which provide flexibility for the Company&#8217;s customers as they expand their practices. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to systems and upgrade revenue, the Company generates revenue from the sale of post warranty service contracts, providing services for products that are out of warranty, hand piece refills and other per procedure related revenue on select systems and distribution of third-party manufactured skincare products. The Company also expands its revenues from&#160;sales of third-party skincare products by utilizing its network and relationships with physicians and practitioners.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s ongoing research and development activities primarily focus on developing new products, as well as improving and enhancing the Company&#8217;s portfolio of existing products. The Company also explores ways to expand the Company&#8217;s product offerings through alternative arrangements with other companies, such as distribution arrangements. The Company introduced&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Julie</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t, a product for women&#8217;s intimate health, in December 2017,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a fractional RF microneedling device for skin revitalization, in January 2018,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in April 2018,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in July 2018,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in February 2019&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in June 2019, Secret PRO in July 2020 and excel V+III during the fourth quarter of 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s corporate headquarters and U.S. operations are located in Brisbane, California, where the Company conducts manufacturing, warehousing, research and development, regulatory, sales and marketing, service, and administrative activities. The Company markets sells and services the Company&#8217;s products through direct sales and service employees in North America (including Canada), Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, Spain, Switzerland and the United Kingdom. Sales and Services outside of these direct markets are made through a worldwide distributor network in over 42 countries.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Products and Services</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company derives revenue from the sale of Products and Services. Product revenue includes revenue from the sale of systems, hand pieces and upgrade of systems (collectively &#8220;Systems&#8221; revenue), replacement hand pieces,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;cycle refills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;cycle refills, as well as single use disposable tips applicable to&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Juliet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(&#8220;Consumables&#8221; revenue), the sale of third party manufactured skincare products (&#8220;Skincare&#8221; revenue); and the leasing of equipment through a membership program. A system consists of a console that incorporates a universal graphic user interface, a laser and or other energy-based module, control system software and high voltage electronics, as well as one or more hand pieces. However, depending on the application, the laser or other energy-based module is sometimes contained in the hand piece such as with the Company&#8217;s&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fractional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;applications instead of within the console.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers customers the ability to select the system that best fits their practice at the time of purchase and then to cost-effectively add applications to their system as their practice grows. This provides customers the flexibility to upgrade their systems whenever they choose and provides the Company with a source of additional Systems revenue. The Company&#8217;s primary system platforms include&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Juliet,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RF,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skincare revenue relates to the distribution of ZO&#8217;s skincare products in Japan. The skincare products are purchased from a third-party manufacturer and sold to medical offices and licensed physicians. The Company acts as the principal in this arrangement, as the Company determines the price to charge customers for the skincare products and controls the products before they are transferred to the customer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenue includes prepaid service contracts,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;installation, customer marketing support and labor on out-of-warranty products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Business Trends</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that its ability to grow revenue will be primarily dependent on the following:</span></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continuing to expand the Company&#8217;s product offerings, both through internal development and sourcing from other vendors;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ongoing investment in the Company&#8217;s global sales and marketing infrastructure;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">use of clinical results to support new aesthetic products and applications;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enhanced luminary development and reference selling efforts (to develop a location where Company&#8217;s products can be displayed and used to assist in selling efforts);</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">customer demand for the Company&#8217;s products;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">consumer demand for the application of the Company&#8217;s products;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">marketing to physicians in the core dermatology and plastic surgeon specialties, as well as outside those specialties; and</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">generating recurring revenue from the Company&#8217;s growing installed base of customers through the sale of system upgrades, services, hand piece refills,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;cycles, skincare products and replacement tips for&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Juliet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret&#160;RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;products.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a detailed discussion of the significant business trends impacting its business, please see the section titled &#8220;Results of Operations&#8221; below.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Factors that May Impact Future Performance</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s industry is impacted by numerous competitive, regulatory and other significant factors. The Company&#8217;s industry is highly competitive and the Company&#8217;s future performance depends on the Company&#8217;s ability to compete successfully. Additionally, the Company&#8217;s future performance is dependent upon the ability to continue to expand the Company&#8217;s product offerings with innovative technologies, obtain regulatory clearances for the Company&#8217;s products, protect the proprietary technology of the products and manufacturing processes, manufacture the products cost-effectively, and successfully market and distribute the products in a profitable manner. If the Company fails to execute on the aforementioned initiatives, the Company&#8217;s business would be adversely affected.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company supports any reasonable action that helps ensure patient safety going forward. The Company has a robust, multi-functional process that reviews its promotional claims and materials to ensure they are truthful, not misleading, fair and balanced, and supported by sound scientific evidence.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A detailed discussion of these and other factors that could impact the Company&#8217;s future performance are provided in (1) the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020- Part I, Item 1A &#8220;Risk Factors,&#8221; and (2) other announcements the Company makes from time to time.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of COVID-19 on Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s business and operations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;the World Health Organization declared the COVID-19&#160;outbreak a pandemic. The COVID-19&#160;outbreak, and lately the Delta variant, has negatively affected the United States and global economies. The spread of the coronavirus, which caused a broad impact in 2020 globally, including restrictions on travel, shifting work force to work remotely and quarantine policies put into place by businesses and governments, had a material economic effect on the Company&#8217;s business during the year ended December 31, 2020. Notably, healthcare facilities in many countries effectively banned elective procedures. Many of the Company&#8217;s products are used in aesthetic elective procedures and as such, the bans on elective procedures substantially reduced the Company&#8217;s sales and marketing efforts in the early months of the pandemic and led the Company to implement cost control measures. Although the Company&#8217;s operation and results of operations have significantly improved as the economic outlook due to the&#160;COVID-19&#160;pandemic improves in 2021, the&#160;COVID-19&#160;outbreak continues to be fluid and the aftermath of the business and economic disruptions due to the&#160;COVID-19 is still uncertain, making it difficult to forecast the final impact it could have on&#160;the Company&#8217;s&#160;future operations, including disruptions in the Company's supply chain and contract manufacturing operations. The Company&#160;cannot presently predict the scope and severity of any impacts in future periods from the business shutdowns or disruptions due to the&#160;COVID-19&#160;pandemic, but the impact on economic activity including the possibility of recession or financial market instability could have a material adverse effect on the Company&#8217;s business, revenue, operating results, cash flows and financial condition. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to assess whether any impairment of its goodwill or its long-lived assets has occurred, and has determined that no&#160;charges other than an impairment loss of $0.2&#160;million on capitalized implementation costs of&#160;cloud-based CRM software during the six months ended June 30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company&#8217;s assumptions about future conditions important to its assessment of potential impairment of its long-lived assets, and goodwill, including the impacts of the&#160;COVID&#8211;19&#160;pandemic and other ongoing impacts to its business, are subject to uncertainty, and the Company will continue to monitor these conditions in future periods as new information becomes available, and will update its analyses accordingly.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has experienced a significant increase in sales of skincare products under the exclusive distribution agreement with ZO Skin Health, Inc., which allows&#160;the Company to sell ZO&#8217;s skincare products in Japan. The reason for the increase in skincare products sales may have been the&#160;result of changes in customers&#8217; spending habits as customers purchased more aesthetic treatments that were able to be applied at home, due to limitations on&#160;in-person&#160;aesthetic procedures, social distancing and mask wearing requirements due to the&#160;COVID-19&#160;pandemic. Future growth in sales of skincare products depends on customers&#8217; spending habits, which may revert to original spending habits after the&#160;COVID-19&#160;pandemic. Such changes may have a material adverse effect on the Company&#8217;s revenue, operating results and cash flows.</span></div><div id="ib4896268598045f0bc55c9d056377420_118"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical accounting policies, significant judgments and use of estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s consolidated financial statements and related notes requires the Company to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The Company has based its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. The Company periodically reviews its </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimates and makes adjustments when facts and circumstances dictate. To the extent that there are material differences between these estimates and actual results, its financial condition or results of operations will be affected.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An accounting policy is considered to be critical if it requires an accounting estimate to be made based on assumptions about matters that are highly uncertain at the time the estimate is made, and if different estimates that reasonably could have been used, or changes in the accounting estimates that are reasonably likely to occur periodically, could materially impact the consolidated financial statements. The Company believes that its critical accounting policies reflect the more significant estimates and assumptions used in the preparation of its audited consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies and estimates that the Company considers to be critical, subjective, and requiring judgment in their application are summarized in &#8220;Item 7-Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in its Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on March 23, 2021. Except the new policies explained below, there have been no new or material changes to the significant accounting policies discussed in the Company&#8217;s Annual Report on Form 10-K that are of significance, or potential significance, to the Company.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company established new accounting policies to account for the Convertible notes and related transactions during the first quarter of 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued $138.3 million of convertible senior notes in a private placement offering on March 5, 2021. The notes bear interest at a rate of 2.25% per year. In accordance with ASU 2020-06, the Company recorded the Notes in long-term debt with no separation between the notes and the conversion option. Each reporting period, the Company will determine whether any criteria are met for the note holders to have the option to redeem the notes early, which will result in a change in the classification of the notes to current liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance costs related to the Convertible notes are presented in the balance sheet as a direct deduction from the carrying amount of the Convertible notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with issuance of the notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally designated to reduce the potential dilution of the Company's&#160;common stock upon any conversion of the notes.&#160;The capped calls were purchased for $16.1 million and recorded as a reduction to stockholders&#8217; equity</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic income (loss) per share of common stock is calculated by dividing net income available to common stockholders by the weighted average number of common shares outstanding for the respective period in accordance with ASC 260. Diluted loss per common share reflects the potential dilution that would occur if contracts to issue common stock were exercised or converted into common stock. See&#160;Note 9 the unaudited condensed consolidated financial statements included in Item I, Part 1 of this Quarterly Report on Form 10-Q.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="ib4896268598045f0bc55c9d056377420_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth selected consolidated financial data for the periods indicated, expressed as a percentage of total net revenue. Percentages in this table and throughout its discussion and analysis of financial condition and results of operations may reflect rounding adjustments.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on Convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on extinguishment of PPP loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of the Company&#8217;s revenue is significantly affected by the mix of system products, installation, training, consumables and extended contract services. The revenue generated in any given period is also impacted by whether the revenue is recognized over time or upon completion of delivery. For an additional description on revenue, see Note 1 in the notes to consolidated financial statements on the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and Note 7 to the unaudited condensed consolidated financial statements included in Item I, Part 1 of this Quarterly Report on Form 10-Q.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company&#8217;s performance obligations are satisfied either over time or at a point in time. Revenue from performance obligations that are transferred to customers over time accounted for approximately 12% and 18% of the Company&#8217;s total revenue for the six months ended June 30, 2021 and 2020, respectively. Revenue recognized over time relates to revenue from the Company&#8217;s extended service contracts and marketing services. Revenue recognized upon delivery is primarily generated by the sales of systems, consumables and skincare.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Net Revenue</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue mix by geography:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,786&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">130&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,622&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,084&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,995&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,382&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">131&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,230&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,197&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,934&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">North America as a percentage of total revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Japan as a percentage of total revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rest of World as a percentage of total revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue mix by product category:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems - North America</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,888&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,673&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,596&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems &#8211; Rest of World (including Japan)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total Systems</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,568&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">129&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,542&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,888&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">75&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,500&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skincare</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,812&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">147&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,778&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,678&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total Products</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,363&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,777&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,624&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,894&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,472&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total Net Revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,589&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,369&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,257&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,608&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s total net revenue increased by 122% and 85% in the three and six months periods ended June 30, 2021, respectively, compared to the same periods in 2020, as a result of recovery in the demand of the Company&#8217;s products and services as the economic&#160;outlook due to the&#160;COVID-19&#160;pandemic improves.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by Geography</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s North America revenue increased by $15.2 million or 130%, and $22.1 million or 82%  in the three and six months ended June 30, 2021, respectively, compared to the same periods in 2020. The increase was due primarily to significant recovery in sales in the North America market as the U.S. economic outlook improved in the first half of 2021 and continuous growth in Japan skincare revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue in Japan increased by $8.9 million or 105%, and $18.3 million or 117% in the three and six month periods ended June 30, 2021, respectively, compared to the same periods in 2020, due to a significant increase in sales of Skincare products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Rest of World revenue increased by $8.2 million or 131%, and $9.3 million or 58% in the three and six month periods ended June 30, 2021, respectively, compared to the same periods in 2020. The increase was mostly due to growth in the Company&#8217;s direct business in Australia and Europe.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by Product Type</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Systems Revenue</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systems revenue in North America increased by $11.7 million or 142%, and $18.1 million or 97% in the three and six month periods ended June 30, 2021, respectively, compared to the same periods in 2020, mainly due to the recovery from the business disruptions caused by the COVID-19 pandemic.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Rest of the World (including Japan) systems revenue increased by $8.4 million or 114%, and  $9.3 million or 52% in the three and six month periods ended June 30, 2021, respectively, compared to the same periods in 2020, primarily due to increased sales in the Company&#8217;s direct business in Australia and Europe, partially offset by decreased sales from distributors in Middle East and Asian regions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Consumables Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consumables revenue increased by $3.0 million or 211%, and $3.4 million or 86% in the three and six month periods ended June 30, 2021, respectively, compared to the same periods in 2020. The increase in consumables revenue was primarily due to the increasing installed base of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt 3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> each of which have a consumable element.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Skincare Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue from Skincare products in Japan increased by $7.0 million or 147%, and $16.4 million or 214% in the three and six month periods ended June 30, 2021, respectively, compared to the same periods in 2020. The increase was due primarily to increased marketing and promotional activities and&#160;the changes in the customer&#8217;s spending habits, as customers purchased more aesthetic treatments that could be applied at home, as a result of limitations on in-person aesthetic procedures.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Service Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Service revenue increased $2.2 million or 47%, and $2.4 million or 23%, in the three and six month periods ended June 30, 2021, respectively, compared to the same periods in 2020. This increase was due primarily to increased sales of service contracts, and support and maintenance services provided on a time and materials basis.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,789&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,624&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,960&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a percentage of total net revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cost of revenue consists primarily of material, personnel expenses, product warranty costs, and manufacturing overhead expenses.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit as a percentage of revenue for the three and six month periods ended June 30, 2021 increased 14% and 13%, respectively, compared to the same periods in 2020. The increase in gross profit as a percentage of revenue was primarily driven by an increase in selling prices and volumes as a result of the economic recovery. The increase in sales volume improved the Company's leveraging of fixed costs, which improved the Company's gross margin.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales and Marketing</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales and marketing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,035&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,309&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a percentage of total net revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expenses consist primarily of personnel expenses, expenses associated with customer-attended workshops and trade shows, post-marketing studies, advertising, and training.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expenses for the three months ended June 30, 2021 increased $7.4 million or 67%, compared to the same period in 2020 due primarily to:</span></div><div style="margin-top:10pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$3.5 million increase in personnel related expenses, including $3.0 million increase in commission costs;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$1.0 million increase in travel; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.9 million increase in services due to paid marketing services to launch new business;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.6 million increase in tradeshows and costs related to promotions and public relations; and</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.4 million increase in freight and shipping.</span></div><div><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expenses for the six months ended June 30, 2021 increased  $7.7 million or 27% , respectively, compared to the same period in 2020 due primarily to:</span></div><div style="margin-top:10pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$4.2 million increase in personnel related expenses, including $4.4 million increase in commission costs;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.9 million increase in services due to paid marketing services to launch new business;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.6 million increase in freight and shipping; </span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.1 million increase in travel; and</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.1 million increase in tradeshows and costs related to promotions and public relations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">R&amp;D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.702%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,991&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,962&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,862&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a percentage of total net revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses consist primarily of personnel expenses, clinical research, regulatory and material costs. R&amp;D expenses increased by $1.9 million or 62%, and $2.1 million or 31% in the three and six month periods ended June 30, 2021, respectively, compared to the same period in 2020. The increase was due primarily to higher personnel expenses driven primarily by an increase in headcount.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">G&amp;A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.556%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General and administrative</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a percentage of total net revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">G&amp;A expenses consist primarily of personnel expenses, legal, accounting, audit and tax consulting fees, as well as other general and administrative expenses. G&amp;A expenses decreased by $0.1 million or 1%, for the three months ended June 30, 2021, compared to the same period in 2020. G&amp;A expenses represented 14% of total net revenue in the three months ended June 30, 2021 compared to 32% of total net revenue in the same period in 2020. G&amp;A expenses decreased by $0.5 million or 3%, and represented 15% of total net revenue in the six months ended June 30, 2021 compared to 28% of total net revenue in the same period in 2020. These decreases was mainly due to $1.1 million and $1.8 million decreases in inside and outside services fees, $0.9 million and $1.2 million decreases in credit losses,&#160;and $0.6 million and $0.4 million decreases in legal fees; partially offset by $1.7 million and $1.7 million increases in personnel related costs.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest and Other income (expense), Net</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other income (expense), net, consists of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.556%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest and other income (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">expense), net</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,233&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,323)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a percentage of total net revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other&#160;income (expense), net, increased $5.8 million and $4.7 million  in the three and six month periods ended June 30, 2021, respectively, compared to the same periods in 2020. These increases were due primarily to a $7.2&#160;million gain resulting from the forgiveness of PPP Loan and accrued interest. This gain was partially offset by $0.8 million and $1.0 million in interest expense for the three and six month periods ended June 30, 2021, respectively, related to Convertible notes issued in March 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.556%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18,796</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,928)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,767&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$31,032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,265)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's income tax expenses were $0.1 million and $0.4 million for the three and six months ended June 30, 2021, respectively, compared to $0.5 million for both the periods in 2020. </span></div><div id="ib4896268598045f0bc55c9d056377420_124"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s principal source of liquidity was cash generated from net proceeds from the issuance of the Convertible notes and from the issuance of common stock through exercise of stock options and the Company&#8217;s employee stock purchasing program, as well as cash generated from operating activities. The Company actively manages its cash usage to ensure the maintenance of sufficient funds to meet its daily needs. The majority of the Company&#8217;s cash and cash equivalent are held in U.S. banks and its foreign subsidiaries maintain a limited amount of cash in their local banks to cover their short-term operating expenses.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2021 and December 31, 2020, the Company had $178.2 million and $51.9 million of working capital, respectively. Cash and cash equivalents increased by $122.2 million to $169.2 million as of June 30, 2021 from $47.0 million as of December 31, 2020, primarily due to net proceeds from the issuance of the Convertible notes, partially offset by $16.1 million in premiums paid at the same time for separate capped call transactions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes its cash, cash equivalents and marketable investments:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash flow provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,818&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,951)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(299)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,702)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,634&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,996&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,153&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,343&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Operating Activities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities in the six months ended June 30, 2021 was approximately $4.8 million, which was due primarily to:</span></div><div style="margin-top:10pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$7.4 million net income as adjusted for non-cash related items, consisting primarily of PPP loan forgiveness of $7.2 million, $4.8 million of stock-based compensation expense, $1.7 million of depreciation and amortization expenses, $0.5 million of provision for credit losses and $0.6 million related to increase in right-of-use assets;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$10.2 million cash generated as a result of an increase in accrued liabilities;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.2 million cash generated due to an increase in deferred revenue; partially offset by</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$6.0 million cash used as a result of an increase in inventory;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$4.4 million cash used as a result of an increased accounts receivable;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.5 million  cash used due to a decrease in accounts payable;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.5 million cash used as a result of a decrease in operating lease liabilities; and</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$1.7 million cash used as a result of an increase in other long-term assets.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities in the six months ended June 30, 2020 was approximately $18.0 million, which was primarily due to:</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$23.8 million net loss as adjusted for non-cash related items, consisting primarily of stock-based compensation expense of $6.1 million, $2.1 million of depreciation and amortization expenses, 1.7 million of provision for credit losses and $0.8 million related to impairment of software development costs;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$10.8 million cash used to settle accounts payable and accrued liabilities;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$6.0 million from a decrease in accounts receivables:</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$2.7 million from a decrease in inventories;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$2.4 million from a decreased in deferred revenue;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.5 million from a decrease in other long term assets; and</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.3 million used to settle extended warranty liabilities.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Investing Activities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $0.3 million in the six months ended June 30, 2021, which was attributable to  purchases of property, equipment and software.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $5.7 million in the six months ended June 30, 2020, which was primarily due to:</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$16.2 million of cash used to purchase marketable investments;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.4 million of cash used in the acquisition of property, equipment, and software;  partially offset by </span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$10.9 million in net proceeds from the maturities of marketable investments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Financing Activities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities was $117.6 million&#160;in the six months ended June 30, 2021, which was primarily due to:</span></div><div style="margin-top:10pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$133.5 million proceeds from the issuance of Convertible notes net of debt issuance costs;</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$1.9 million net proceeds from the issuance of common stock due to employee stock option exercises; partially offset by</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$16.1 million of cash used for the capped call transaction in connection with the issuance of Convertible notes;</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$1.5 million million of cash used for taxes paid related to net share settlement of equity awards; and</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.2 million of cash used to pay finance lease obligations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities was $31.0 million in the six months ended June 30, 2020, which was primarily due to:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$26.5 net proceeds from the issuance of common stock in April 2020;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$7.1 million received for the PPP loan;</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.8 million net proceeds from the issuance of common stock due to employee stock option exercises and purchases of stock through the Employee Stock Purchase Plan (&#8220;ESPP&#8221;) program; offset by</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$3.1 million of cash used for taxes related to net share settlement of equity awards; and</span></div><div style="padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$0.4 million of cash used to pay finance lease obligations.</span></div><div><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adequacy of Cash Resources to Meet Future Needs</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had cash, cash equivalents of $169.2 million as of June 30, 2021. In the first half of 2021, the Company&#8217;s principal source of liquidity was $133.5 million of net proceeds from the issuance of the Company&#8217;s notes, partially offset by $16.1 million in premiums paid concurrently for separate capped call transaction. In addition, cash was generated from the issuance of common stock through the exercise of stock options and the Company&#8217;s employee stock purchasing program. The Company intends to use the cash generated in first half of 2021 to fund growth initiatives and market development activities  and to provide for general corporate purposes, which may include working capital, capital expenditures, clinical trials, other corporate expenses and acquisitions of complementary products, technologies, or businesses.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that the existing cash and cash equivalents and the cash available under the revolving credit facility will be sufficient to meet the Company&#8217;s anticipated cash needs for at least the next 12 months.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Company issued $138.3 million aggregate principal amount of convertible notes due on March 15, 2026 in a private placement offering. The Convertible notes bear interest at a rate of 2.25% per year payable semiannually in arrears on March 15 and September 15 of each year, beginning on September 15, 2021. The Convertible notes are presented as long-term debt, net of debt discount. Proceeds from the offering were $133.5 million, net of issuance costs, including underwriters&#8217; fees, which were recorded in the condensed consolidated balance sheet.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 9, 2020, the Company terminated its undrawn revolving line of credit with Wells Fargo and subsequently entered into a Loan and Security Agreement with Silicon Valley Bank. The agreement provides for a four-year secured revolving loan facility (&#8220;SVB Revolving Line of Credit&#8221;) in an aggregate principal amount of up to $30.0 million. See Note 13&#160;&#8211; Debt in the accompanying notes to consolidated financial statements&#160;for more information.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of Convertible notes, the Company entered into Amendment No. 1 to Loan and Security Agreement on March 4, 2021, which amended the Company&#8217;s Loan and Security Agreement, dated as of July 9, 2020 between the Company, as borrower, and Silicon Valley Bank. The Amendment amends the Loan and Security Agreement to (i) permit the Company to issue the Convertible notes and perform its obligations in connection therewith, and (ii) permit the Capped Call transactions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan and Security Agreement with Silicon Valley Bank contains customary affirmative covenants, such as financial statement reporting requirements and delivery of borrowing base certificates, as well as customary covenants that restrict the Company&#8217;s ability to, among other things, incur additional indebtedness, sell certain assets, guarantee obligations of third parties, declare dividends, or make certain distributions, and undergo a merger or consolidation or certain other transactions. The Loan and Security Agreement also contains certain financial condition covenants. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 4, 2021, the Loan and Security Agreement dated July 9, 2020 was amended to (i)&#160;permit the Company to issue the Convertible notes and perform its obligations in connection therewith, and (ii)&#160;permit the Capped Call transactions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or about May 28, 2021, the Loan and Security Agreement was amended. The amendment removed the quarterly minimum revenue requirement but kept the in place the other financial covenants.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2021, the Company had not drawn on the SVB Revolving Line of Credit and the Company is in compliance with all financial covenants of the SVB Revolving Line of Credit.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commitments and Contingencies</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this report, there were no material changes to the Company&#8217;s&#160;contractual&#160;obligations&#160;and commitments outside the ordinary course of business since March 23, 2021, as reported in the Company&#8217;s Annual Report on 2020 Form 10-K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="ib4896268598045f0bc55c9d056377420_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;padding-left:49.5pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the key market risks facing the Company is disclosed below. For a detailed discussion, please see the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 23, 2021 and other announcements the Company makes from time to time.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The conditional conversion feature of the convertible notes, if triggered, may adversely affect our financial condition and operating results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During any fiscal quarter commencing after the fiscal quarter ending on June 30, 2021 (and only during such fiscal quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price for the Convertible notes on each applicable trading day. This condition was met for the convertible notes during the fiscal quarter ended June 30, 2021, as the Company's stock traded at a price in excess of the conversion price, which means that the holders of the convertible notes may elect to convert such notes at their option at any time during the fiscal quarter ending September 30, 2021. If one or more holders elect to convert their convertible notes, unless the Company elects to satisfy its conversion obligation by delivering solely shares of its common stock, the Company would be required to settle a portion or all of its conversion obligation through the payment of cash, which could adversely affect the Company&#8217;s liquidity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate and Market Risk</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2021, the Company had not drawn on the Original Revolving Line of Credit, as amended. Overall interest rate sensitivity is primarily influenced by any amount borrowed on the line of credit and the prevailing interest rate on the line of credit facility. T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he effective interest rate on the line of credit facility is based on a floating per annum rate equal to the Prime rate. The Prime rate was 3.25% as of June 30, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021, and accordingly the Company may incur additional expenses if the Company has an outstanding balance on the line of credit and the Prime rate increases in future periods.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inflation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not believe that inflation has had a material effect on the Company&#8217;s business, financial condition, or results of operations. If the Company&#8217;s costs were to become subject to significant inflationary pressures, the Company may not be able to fully offset such higher costs through price increases. The Company&#8217;s inability or failure to do so could harm the Company&#8217;s business, financial condition, and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Exchange Fluctuations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates revenue in Japanese Yen, Euros, Australian Dollars, Canadian Dollars, British Pounds, and Swiss Francs. Additionally, a portion of the Company&#8217;s operating expenses, and assets and liabilities are denominated in each of these currencies. Therefore, fluctuations in these currencies against the U.S. dollar could materially and adversely affect the Company&#8217;s results of operations upon translation of the Company&#8217;s revenue denominated in these currencies, as well as the re-measurement of the Company&#8217;s international subsidiaries&#8217; financial statements into U.S. dollars. The Company has historically not engaged in hedging activities relating to the Company&#8217;s foreign currency denominated transactions.</span></div><div id="ib4896268598045f0bc55c9d056377420_130"></div><div style="margin-top:10pt;padding-left:49.5pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation as of June 30, 2021 was carried out under the supervision and with the participation of the Company&#8217;s management, including the Company&#8217;s Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), of the effectiveness of the Company&#8217;s &#8220;disclosure controls and procedures.&#8221; Rule 13a-15(e) under the Exchange Act defines &#8220;disclosure controls and procedures&#8221; as controls and other procedures of a company that are designed to ensure that the information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to the company&#8217;s management, including its CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. Based upon that evaluation, the Company&#8217;s CEO and CFO concluded that the Company&#8217;s disclosure controls and procedures were effective at June 30, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attached as exhibits to this Quarterly Report are certifications of the Company&#8217;s CEO and CFO, which are required in accordance with Rule 13a-14 of the Exchange Act. This Controls and Procedures section includes the information concerning </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the controls evaluation referred to in the certifications, and it should be read in conjunction with the certifications for a more complete understanding of the topics presented.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company implemented certain controls related to the Convertible notes issued on March 5, 2021. These controls were designed and implemented to ensure the completeness and accuracy over financial reporting. With the exception of these additional controls, there were no changes in the Company&#8217;s internal control over financial reporting during the six months ended June 30, 2021 that have materially affected, or are reasonably likely to materially affect,&#160;the Company's&#160;internal control over financial reporting.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Limitations on the Effectiveness of Controls</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within a company have been detected. Accordingly, the Company&#8217;s disclosure controls and procedures are designed to provide reasonable, not absolute, assurance that the objectives of the Company&#8217;s disclosure control system are met. As set forth above, the Company&#8217;s Chief Executive Officer and Chief Financial Officer have concluded, based on their evaluation as of the end of the period covered by this report, that the Company&#8217;s disclosure controls and procedures were effective to provide reasonable assurance that the objectives of the Company&#8217;s disclosure control system were met.</span></div><div id="ib4896268598045f0bc55c9d056377420_133"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. OTHER INFORMATION</span></div><div id="ib4896268598045f0bc55c9d056377420_136"></div><div style="margin-top:10pt;padding-left:49.5pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may be involved in legal and administrative proceedings and claims of various types. For a description of the Company&#8217;s material pending legal and regulatory proceedings and settlements, see&#160;Note 12 to the Company&#8217;s consolidated financial statements entitled &#8220;Commitments and Contingencies,&#8221; in the Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 23, 2021.</span></div><div id="ib4896268598045f0bc55c9d056377420_139"></div><div style="margin-top:10pt;padding-left:49.5pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There&#160;are no material changes from the Risk Factors previously disclosed in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, filed with the SEC on March 23, 2021.</span></div><div id="ib4896268598045f0bc55c9d056377420_142"></div><div style="margin-top:10pt;padding-left:49.5pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued $138.3 million aggregate principal amount of Convertible notes in a private placement offering on March 5, 2021. The notes bear interest at a rate of 2.25% per year.&#160;In connection with issuance of the notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally expected to reduce the potential dilution of the Company's&#160;common stock upon any conversion of the Notes.&#160;The capped calls were purchased for $16.1 million.</span></div><div id="ib4896268598045f0bc55c9d056377420_145"></div><div style="margin-top:10pt;padding-left:49.5pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;DEFAULTS UPON SENIOR SECURITIES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ib4896268598045f0bc55c9d056377420_148"></div><div style="margin-top:10pt;padding-left:49.5pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ib4896268598045f0bc55c9d056377420_151"></div><div style="margin-top:10pt;padding-left:49.5pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="ib4896268598045f0bc55c9d056377420_154"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:10pt;padding-left:49.5pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.&#160;&#160;&#160;&#160;EXHIBITS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit<br/>No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description</span></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774917018538/ex_99509.htm">Amended and Restated Certificate of Incorporation of the Registrant (filed as Exhibit 3.5 to its Quarterly Report on Form 10-Q filed on November 7, 2017 and incorporated herein by reference).</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774915000466/ex3-4.htm">Bylaws of the Registrant&#160;(filed as Exhibit 3.4 to its Current Report on Form 8-K filed on January 8, 2015 and incorporated herein by reference).</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312505061000/dex41.htm">Specimen Common Stock certificate of the Registrant (filed as Exhibit 4.1 to its Annual Report on Form 10-K filed on March 25, 2005 and incorporated herein by reference).</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a1zomedicalandcuteraagreem.htm">ZO Medical and Cutera Agreement 5 Aug 2013</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a2zoskinhealthamendment21a.htm">ZO Skin Health Amendment 21  Aug 2013</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a3zoskinhealthamendment25j.htm">ZO Skin Health A</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a3zoskinhealthamendment25j.htm">mendment </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a3zoskinhealthamendment25j.htm">25 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a3zoskinhealthamendment25j.htm">Jan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a3zoskinhealthamendment25j.htm"> 2021</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a4zoskinhealthamendment14j.htm">ZO Skin Health Amendment 14 Jun 2021</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="cutr-20210630x10qexx311.htm">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="cutr-20210630x10qexx312.htm">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="cutr-20210630x10qexx321.htm">Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.ins</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instance Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.sch</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.cal</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.def</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.lab</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.pre</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="ib4896268598045f0bc55c9d056377420_157"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib4896268598045f0bc55c9d056377420_7">Contents</a></span></div></div><div style="margin-top:10pt;text-align:center;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of The Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Brisbane, State of California, on the 6th day of August, 2021.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CUTERA, INC.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Rohan Seth</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rohan Seth</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer<br/>(Principal Financial and Accounting Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a1zomedicalandcuteraagreem.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iae447f9396414b31bf99c2f192d0e09a_1"></div><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:99.82pt;padding-right:99.82pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS NOT MATERIAL AND (I) WOULD BE COMPETITIVELY HARMFUL TO THE REGISTRANT IF PUBLICLY DISCLOSED OR (II) IS INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. SUCH INFORMATION HAS BEEN MARKED WITH &#8220;&#91;***&#93;&#8221; TO INDICATE WHERE OMISSIONS HAVE BEEN MADE.</font></div><div style="padding-left:27.17pt;padding-right:27.17pt;text-align:center"><font><br></font></div><div style="padding-left:27.17pt;padding-right:27.17pt;text-align:center"><font><br></font></div><div style="margin-top:0.04pt;padding-left:27.17pt;padding-right:27.17pt;text-align:center"><font style="color:#262626;font-family:'Arial',sans-serif;font-size:28.5pt;font-weight:700;line-height:120%">Distribution Agreement between</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:26.72pt;padding-right:26.72pt;text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:25.5pt;font-style:italic;font-weight:700;line-height:120%">ZO&#174; SKIN HEALTH, INC.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:28.65pt;padding-right:28.65pt;text-align:center"><font style="color:#262626;font-family:'Arial',sans-serif;font-size:23pt;font-weight:400;line-height:120%">&#38;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:30.07pt;padding-right:30.07pt;text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:25.5pt;font-style:italic;font-weight:700;line-height:120%">CUTERA, INC</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:29.4pt;padding-right:29.4pt;text-align:center"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:120%">August 5</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:120%">, </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:120%">2013</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_4"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;padding-left:25.82pt;padding-right:25.82pt;text-align:center"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">DISTRIBUTION </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AGREEMENT</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:14.35pt;padding-right:66.75pt;text-align:justify;text-indent:0.1pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">THIS </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">DISTRIBUTIO</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">N </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">AGREEMENT </font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">i</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">s made on August 5, 2013, and shall </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">become </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">effective on October </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">l </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">2013 (the </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">&#34;Effective </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Date&#34;) </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">and between ZO SKIN </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">HEALTH</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">INC., a company established and existing under the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">laws </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">of the State of California, having its principal place of </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">business </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">at </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">1 </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Technology </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Drive, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Suite </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">B-123</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Irvine</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">CA </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">92618, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">USA</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">, (&#34;ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">SKIN HEALTH&#34;) and CUTERA, INC., a corporation organized and validly existing </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">under </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">laws of </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Delaware</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">having  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">its  principal  place of  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">business  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">at  3240 </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Bay</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">shore  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Blvd.,  Brisbane, CA   94005,  </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">USA </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">&#34; </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor'</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">'). </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">ZO SKIN HEALTH and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">th</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">e </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Di</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">str</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">ibutor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">are sometimes referred to </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">herein </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">collectively as the </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">&#34;</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Partie</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">s'' </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">and individually as </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">&#34;Party.&#34;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:27.75pt;padding-right:27.75pt;text-align:center"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RECITALS</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:13.65pt;padding-right:69.05pt;text-align:justify;text-indent:1.45pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">WHEREAS, ZO SKIN HEALTH develops and markets a </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">line </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">of products </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">known </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">as </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">&#34; Z</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">O </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Medic</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">al,</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">&#34; </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">as </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">described </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:117%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Section </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">1.8 </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">below and Exhibit A attached </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">hereto </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">incorporated </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">herein </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">this reference, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">but contracts </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">to </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">have the Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">manufactured for it by unaffiliated </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">manufacturing businesses&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:13.65pt;padding-right:69.15pt;text-align:justify;text-indent:0.95pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">WHEREAS, ZO SKIN HEAL</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">TH </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">de</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">s</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">ire</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">s </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">have </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">distribute </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Products and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Related Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(defined in Section 3 hereof) in the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Territory </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">identified </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">below</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">&#59; </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:13.65pt;padding-right:67.7pt;text-align:justify"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">WHEREAS</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO SKIN BEALTH and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor deem </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">it </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to be in their </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">mutual </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">bes</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">t </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">interests to enter into an agreement </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">whereby Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall be appointed as an exclusive distributor of the Products and Related </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products </font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">i</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">n </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Territory </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and under the terms and conditions set for </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">below.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:13.25pt;padding-right:68.2pt;text-align:justify;text-indent:0.2pt"><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">NOW </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">THEREFORE, in consideration of </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">t</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">h</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">e recitals </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">set </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">forth above and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the terms</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">, condi</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">tion</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">mutual </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">covenants set </font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:118%">forth </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">below, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Parties agree as follows&#58;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:30.55pt;text-indent:-16.55pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">DEFINITIONS</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:13.15pt;text-align:justify"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">purpose</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of this Agreement, the following words shall </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">have </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the following </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">meanings&#58;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:12pt;padding-right:68.9pt;text-align:justify;text-indent:36.1pt"><font style="color:#424242;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:122%">1.1&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%">&#8220;Affil</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%">i</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%">ate&#8221; </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">means</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">with respect to any specific entity, any </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">o</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ther </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">entity that, directly or </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">indirectly, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">through one or </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">more </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">intermediaries, controls, is controlled </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">is under </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">common control with </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">such </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">specified entity, or </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">has </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">a contractual </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">relationship </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">with such specified </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">entity.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:12pt;padding-right:69.65pt;text-align:justify;text-indent:36.25pt"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:124%">1.2&#160;&#160;&#160;&#160;</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:124%">&#8220;</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:124%">Agreement&#8221; </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">means this</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:124%"> </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">Distribution </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">Agreement and all exhibits, schedules and annexes which </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">are </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">attached </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">to this Agreement </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">from time </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">time and form a </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">part </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">hereof.</font></div><div><font><br></font></div><div style="padding-left:11pt;padding-right:69.15pt;text-align:justify;text-indent:35.75pt"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%">1.3&#160;&#160;&#160;&#160;&#8220;Channels of Distrib</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%">u</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%">tion&#8221; </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">means distribution </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">through </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">physicians</font><font style="color:#797979;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">' </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">offices and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">medical </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">spas </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">where a </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">physi</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">c</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ian  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">is on-site and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">respon</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">s</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ib</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">e for adm</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">i</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">nistering </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products&#59; </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">but, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:122%">it </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">excludes </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">all </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">other channels of </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">distribution </font><font style="color:#c3c3c3;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">.</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">including </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">resort spas, mass merchants, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">warehouse </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">clubs, traditional food </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and drug </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">stores, web sites and e-tailers (e.g., </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">drug</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">sto</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">re.com, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">etc.). </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">The </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products sold </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">under </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Agreement </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">may be reso</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">d over </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">internet through </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">&#8217;s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">website for the sole </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">purpos</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">e </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">fulfilling orders of existing Customers</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">. </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">No </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">other </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">internet </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">sa</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">les </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">are authorized </font><font style="color:#313131;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">this Agreement. </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor agrees </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">establish and maintain </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">appropriate measures to ensure that the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products are</font></div><div style="height:55pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:38.204%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution Agree</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">m</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ent ZO Medical&#8212;Int&#8217;l</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Form v</font><font style="color:#797979;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">. </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4</font><font style="color:#8e8e8e;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">.</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">0 </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">- Cutera</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:1.127%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_7"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.2pt"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:47px"></div><div style="margin-top:4.6pt;padding-left:14.45pt"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">only </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">distribu</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">ted </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">within </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">t</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">he </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Territory and sold pursuant </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">to </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">the </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">terms </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">of this Agreement.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:67pt;text-indent:-15.9pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.4&#160;&#160;&#160;&#160;&#8220;Confidential </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Information&#8221; </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">is </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">defined </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">in Section 13.l hereof.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:13.3pt;padding-right:67.1pt;text-align:justify;text-indent:37.35pt"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">1.5&#160;&#160;&#160;&#160;</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;Customer&#8221; </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">means </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">any </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">entity or </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">business described </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:120%">in </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Section 1.3 who used or  uses the </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Product</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">s  </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">and  </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Related </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Products </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">in </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">servicing its  clients,  who purchases the  Products and Related </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Produ</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">cts </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">from </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">the Distributor or an approved sub-distributor in the </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">T</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">erritory </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">for resale or for use solely within the Channels of Distribution </font><font style="color:#3d3d3d;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">in </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">the Territory.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:13.15pt;padding-right:66.55pt;text-align:justify;text-indent:36.95pt"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%">1.6&#160;&#160;&#160;&#160;</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:118%">&#8220;Distributor </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:118%">Purchase </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%">Prices&#8221; </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">mean</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">s </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">the prices </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">pa</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">yab</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">l</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">e </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">by Distributor </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">to </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">ZO SKIN </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">HEALTH </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">as consideration for </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">th</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">e </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">purchase by </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">Di</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">stributor </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">of </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">the </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">Products and Related Products, </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">as set </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">forth in Exhibit A, as </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%">may </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">be unilaterally amended from time to time by ZO </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">SKIN </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">HEAL</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">TH </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">after </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">60</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">days' advance written notice to Distributor.</font></div><div><font><br></font></div><div style="padding-left:13.25pt;padding-right:67.1pt;text-align:justify;text-indent:36.9pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:124%">1.7&#160;&#160;&#160;&#160;</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:124%">&#8220;ZO SKIN HEAL</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:124%">TH </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:124%">Marks&#8221; </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">means the trademarks, trade </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">names </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">a</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">nd </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">service </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">marks, domain </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">name</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">s, </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">and </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">logo</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">s </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">of ZO SKIN HEALTH and other commercial symbols</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%"> identifying </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">Z</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">O </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">SKIN HEALTH or the Products and Related </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">Product</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">s </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">and&#47;or other products and services of ZO SKIN HEAL</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">TH</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">, </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">including those set forth in Exhibit C, and those developed  </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">in </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">the future, as </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">the </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">same may be modified, deleted or </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">supplemented </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">at any time upon written notice from </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">ZO </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">SKIN HEALTH.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:13.15pt;padding-right:66.55pt;text-align:justify;text-indent:36.95pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%">1.8&#160;&#160;&#160;&#160;</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%">&#8220;</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%">Products&#8221; </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">means the </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">&#34;ZO Medical&#34; </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">lin</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">e of skin ca</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">re </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">products produced by or for ZO </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">SKIN </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">HEALTH as </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">de</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">sc</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">ribed </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">in Exhibit A, which exhibit may be unilaterally amended by ZO </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">SKIN </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">HEALTH after </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">60 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">days' advance </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">wr</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">itten notice </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">to </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">Di</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">stri</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">butor</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">, </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">thereby adding and deleting Products available for distribution from time to time.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:65.4pt;text-indent:-16.4pt"><font style="color:#3d3d3d;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.9&#160;&#160;&#160;&#160;</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> &#8220;Proprietary </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Information&#8221; </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">is </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">defined </font><font style="color:#3d3d3d;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">in </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Section 13.1.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:13pt;padding-right:68.25pt;text-align:justify;text-indent:35.75pt"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:124%">1.10&#8220;SKU&#8221; or </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:124%">a </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:124%">&#34;Stock Keeping Unit&#34; </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">is </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">an ide</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">ntifier </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">to permit </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">the </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">tracking of Products or Related </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">Products </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">by unit, type of Product </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">or </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">Related </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">Product </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">or one </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">or </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">more particular </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">Produc</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">t </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">or Related </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">P</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">roduct.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:14.25pt;padding-right:68.05pt;text-align:justify;text-indent:36.85pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:124%">1.11 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:124%">&#8220;Territory&#8221; </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">means the </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">country(ies) set </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">forth in Exhibit A, </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">in</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">cludi</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">n</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">g, </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">without limitation, their territories and possessions and any other </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">geograph</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">ic </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">area </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">agreed </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">upon in writing by </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">t</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">he </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">Parties for the </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">exe</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">rcise </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">of </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">Distribut</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">or's </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">rights and obligations </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">in </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">this Agreement.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:50.05pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.12 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;Trade </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Secrets&#8221; </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">is defined in </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Sectio</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">n 13.1.</font></div><div style="margin-top:9.45pt;padding-left:30.1pt;text-indent:-18.05pt"><font style="color:#2a2a2a;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">APPOINTMEN</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">T</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:12.75pt;padding-right:68.55pt;text-align:justify;text-indent:35.45pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:128%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:128%;text-decoration:underline">Grant </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:128%;text-decoration:underline">of </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:128%;text-decoration:underline">Rights</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:128%">. </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">ZO </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">SKIN HEALTH hereby grants to Distributor, and Distributor hereby accepts, </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">upon the </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">terms  and conditions  set  forth  in  </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">thi</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">s  </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">Agreement,  the  exclusive right to promote, </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">market</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">, sell, </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">distribut</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">e </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">through itself and approved sub-distributors, if any, the Products and </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">Related P</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">ro</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">ducts </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">to Customers located  within the Territory for sale or use within </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">the </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">Territory and only within the Channels of </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">Di</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">strib</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">uti</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">o</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">n.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:11.85pt;padding-right:69.5pt;text-indent:34.9pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:128%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:128%;text-decoration:underline">Technical and Sales </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:128%;text-decoration:underline">Literature </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:128%;text-decoration:underline">License</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:128%">. </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">During the term of this </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">Agreement, </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">and </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">sub</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">ject </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">to its </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">terms </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">and conditions, ZO SKIN HEALTH grants to </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">Distribut</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">or </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">a nonexclusive,</font></div><div style="height:56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.781%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution A</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">greement ZO Medical &#8211; </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Int&#8217;l</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> Form </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%">v</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4.</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">0 </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">- </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Cutera final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:1.127%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">3</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_10"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:12.8pt;padding-right:67.3pt;text-align:justify;text-indent:0.45pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">nontransferable, royalty free </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">license, to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">use those ZO SKIN HEALTH Marks which are </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">related to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Products and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products and the ZO SKIN HEALTH sales and technical </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">literatur</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">materials to exc</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">lu</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ively </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">promote, market</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sell and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">distribute </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Product</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related Products in the Territory.</font></div><div style="margin-top:10.45pt;padding-left:11.85pt;padding-right:67.85pt;text-align:justify;text-indent:36.35pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.3&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Sales Outside the Territory, Channels of Distribution&#59; Internet Sales</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Unless specifically authorized in writing by ZO SKIN HEALTH, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall not&#58; (a) through itsel</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">f, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or any sub-di</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">tributor o</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">r </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Customer</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">distribute, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sell or otherwise </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">provide </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">he </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">outside the Territory or outside the Channe</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">l</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distribution</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; (</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b) advertise, promote or solicit Customers for the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or Related </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">outside the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Territory </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or outside the Channels of Distribution&#59; (c) sell or distribute the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products to any sub-distributor or Customer who </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">it </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">knows sells </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products outside the Territory or outside the Channels of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distribution&#59; </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d) </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">promote </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or sell </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products or Related Products to the general public </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">u</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sing </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Internet&#59; (e) sell or distribute the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or Related </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to any sub-distributor or Customer who it knows sel1s the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or Related </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">on its website&#59; and (f) sell or distribute the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or Related </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to any sub distributor or Customer who </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">it </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">knows promotes or sells </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">genera</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">l </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">public using the Internet. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and ZO SKIN HEALTH shall monitor </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor's </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">if </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">applicable, its sub-distributors' </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">distribution </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and sale of the Products and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">insure </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related Products are </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">not, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">directly </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or indirectly, being re</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">istributed or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">resold </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">outside the Territory or outside the Channels of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distribution. Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall be responsible for any violation of this section by it or </font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">person or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">entity </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">who receives the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or Related </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products, directly </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or indirectly, from Distributor. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall immediately  terminate </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sub</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">agreement or Customer agreement and immediately stop selling </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a sub-distributor or Customer </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">if </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">it </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">learns </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that the sub</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">distributor or Customer, directly or indirectly</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">distributed </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">outside the Territory or outside the Channels of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distribution&#59; by doing </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">so, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">not </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">be in breach of this Agreement as a result of such activity by </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sub</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">distributor or Customer. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Except </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as otherwise specifically </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">provided herein, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any violation of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Section 2.3 shall be deemed an </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">immediate</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">incurable breach of this Agreement which constitutes grounds for termination of this Agreement by ZO SKIN HEALTH</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in addition to any other remedies </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">available </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">under this Agreement</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">at law or in equity. Notwithstanding the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">immediately preceding </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sentence</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">if </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">there is  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">not a  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">pattern </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of violations of this Section 2.3</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as determined by ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in its discretion</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">then </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall have a period of 30 </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">days </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to cure the breach after </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">receipt </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of  written  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">notice </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of such </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">violation </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">from ZO SKIN HEALTH.   Waiver by ZO SK.IN HEALTH of any violat</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">on of this section by </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor's </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sub distributors or their Customers shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">not </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">constitute a waiver of any other violations under </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">section. For </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">purposes </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of this Section 2.3</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">term</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#8220;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">indirectly&#8221; refers to actions by&#58; (a) a subdistributor</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b) </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Customer</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c) any Affiliate of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or a sub-distributor or Customer</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or</font></div><div style="margin-top:0.9pt;padding-left:11.5pt;padding-right:69.95pt;text-align:justify;text-indent:0.4pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">(d) any person or business specifica11y directed by </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">Distributor</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">or a sub-distributor or Customer, or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">an </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">Affiliate of any of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">them</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">to circumvent </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">provisions set </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:106%">forth </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">above.</font></div><div style="margin-top:12.35pt;padding-left:10.55pt;padding-right:70.3pt;text-align:justify;text-indent:36.2pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%">2.4&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%;text-decoration:underline">Reserved </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%;text-decoration:underline">Rights</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%">.</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%"> </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Except </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">as otherwise se</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">t </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">forth </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Agreement, no express or implied right is granted </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">regarding </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or Related Products</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the ZO SKIN HEALTH </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">technical </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and sales </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">literature </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">o</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">r </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the ZO SKIN HEALTH Marks. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">acknowledges that all copyright</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">patent, trade secret and other intellectual property rights in and to the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and that ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">HEAL</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">TH may </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ha</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">v</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">e in the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Related Products</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO</font></div><div style="height:55pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.781%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution A</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">greement ZO Medical &#8211; </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Int&#8217;l</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> Form </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%">v</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4.</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">0 </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">- </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Cutera final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:1.127%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">3</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_13"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9.5pt;padding-left:13.75pt;padding-right:67.35pt;text-align:justify;text-indent:0.3pt"><img alt="image_1a.jpg" src="image_1a.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:43px"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">SKIN HEALTH technical and sales literature and the ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">HEALTH  Marks </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">are the sole property of ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">HEAL</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">TH. ZO SKIN HEAL</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">TH reserves </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">all </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">rights </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">not expressly granted </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">h</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ere</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">in</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:13.15pt;padding-right:66pt;text-align:justify;text-indent:36.55pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.5&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Sub</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">-D</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">istrib</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">utors</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of the Effective </font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">D</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ate, the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Parties do </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">not </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">intend for </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">have the right to use sub-distributors. Consistent therewith, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall not, without the prior written consent of ZO SKIN HEALTH</font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">which consent may be withheld by ZO SKIN HEALTH in </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">its </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sole and absolute discretion, appoint </font><font style="color:#b5b5b5;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any third party as a sub-distributor of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(&#8220;sub distributor&#8221;), which includes </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">without limitati</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">o</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">n </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor selling or consigning Products or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products to any </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">per</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">son </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or entity that </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">is </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">not a Customer, to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">promote</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">market, distribute and&#47;or sell the Products and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">within </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Territory. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall submit </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for written approval </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">prior </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">engaging </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sub</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">distributor </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to promote</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">market </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">distribute </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and&#47;or sell the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related Products, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dis</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ributor&#8217;s written agreement with the sub-distributor, which shall contain at </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">least </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the contractual obligations and rights set forth </font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit E attached </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">hereto. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">rights </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">granted to a sub-distributor </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">hall </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">not, in any event, be greater than the rights of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor under the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">terms of this Agreement&#59; and, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">remain </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">primarily responsible for any and al</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">l </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">actions taken by sub</font><font style="color:#0c0c0c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">distributor.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.05pt;padding-left:13.3pt;padding-right:67.35pt;text-align:justify;text-indent:34.9pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.6&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Pricing</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following provisions of this Section 2.6 shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">be </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">effective to the extent that they do not violate the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">laws </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Japan. </font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">f, at any time, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">it </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">is </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">determined that the following provisions violate </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Japanese law</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">then </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">extent </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">prohibited by </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">law</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">they shall not be followed by the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Parties. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">will </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">pro</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">vi</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">de Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">from time to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">time </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">writ</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ing </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">with a suggested price at which </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Products and Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products should be sold to Customers. </font><font style="color:#2f2f2f;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">In </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the event </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">its </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sub-distribu</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or shall sell </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">its </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Customers at a</font></div><div style="padding-left:12.9pt;text-align:justify"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:129%">price below the suggested </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:129%">price </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:129%">to Customers (such factual circumstances </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:129%">are </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:129%">hereafter </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:129%">referred </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:129%">to</font></div><div style="padding-left:13.25pt;padding-right:67.6pt;text-align:justify;text-indent:0.2pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">as the </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">&#8220;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">Pricing Default&#8221;</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">), </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">may on thirty </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">(30) days&#8217;</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">advance written </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">notice </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">to the  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">Distributor  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">or  sub-distributor terminate  the  Distribution  Agreement  or  sub</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">-d</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">istributor</font></div><div style="padding-left:9.2pt;text-align:justify"><font style="color:#858585;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">agreement. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">hereby appoints  ZO SKIN HEALTH as  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">its </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">attorney in fact, which</font></div><div style="padding-left:13pt;padding-right:65.55pt;text-align:justify;text-indent:0.45pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">appointment is coupled with an interest, for the sole purpose of terminating a sub</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-d</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">istributor </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">pursuant </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to the foregoing sentence. If a </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pricing Default </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">arises from </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">conduct of a sub </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">distributor, rather </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">than </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">then </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">hall </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">immediately stop selling the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Produ</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">cts</font></div><div style="margin-top:0.15pt;padding-left:12.7pt;padding-right:67.9pt;text-align:justify;text-indent:0.75pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">and Related </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">to that entity upon </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">learning </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">of that conduct by written notice from ZO SKIN HEAL</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">TH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">or otherwise&#59; by doing </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">so, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Di</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">s</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">tributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">not be </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">in </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">breach </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Agreement as a </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">result </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">of such activity </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">the sub</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">-di</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">stributor. Failure of ZO SKIN HEALTH to terminate the</font></div><div style="margin-top:0.35pt;padding-left:13.15pt;padding-right:66.8pt;text-align:justify"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor or a </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">su</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">b </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">distr</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ibutor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">within ninety (90) days from a </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Pricing </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Default shall constitute a waiver of its termination rights for that particular </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">occurrence, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">but </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">not for any other </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Pricing </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Defaults.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:32.05pt;text-indent:-17.5pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ADDITIONAL </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PRODUCTS</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:13.15pt;padding-right:68.15pt;text-align:justify;text-indent:35.65pt"><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.1&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Prod</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">u</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">cts</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ZO </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ma</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">y </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">from time </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">time offer </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">produc</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ts </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for sale related </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to the &#8220;</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Z</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">O </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Medical&#8221; line of products which are not </font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">li</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sted in Exhibit A (&#8220;Related Products&#8221;). Such </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related Products, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">new or not, may be unilaterally added to Exhibit A by ZO SKIN HEALTH at any time and </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sha</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ll  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">thereafter become subject to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Agreement.   If ZO </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">its sole discretion</font><font style="color:#6d6d6d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">choo</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ses </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to distribute </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">such </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related Products in the Territory during the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">term </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">his </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Agreement, ZO SKIN HEALTH shall offer </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor the </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">exc</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">lu</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sive </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">right to promote, market, sell and distribute such </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">in </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Territory</font></div><div style="height:57pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.781%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution A</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">greement ZO Medical &#8211; </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Int&#8217;l</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> Form </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%">v</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4.</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">0 </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">- </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Cutera final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:1.127%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">3</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_16"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.25pt"><img alt="image_2a.jpg" src="image_2a.jpg" style="height:29px;margin-bottom:5pt;vertical-align:text-bottom;width:43px"></div><div style="margin-top:4.55pt;padding-left:15.3pt;padding-right:66.75pt;text-align:justify;text-indent:0.35pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">within the  Channels of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distribution</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,  su</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">bject </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to the terms of  this Agreement, which offer shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">be </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">open for acceptance for a period no </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">longer </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">than thirty (30) days. In the event Distributor chooses not to accept ZO SKIN HEAL</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">TH&#8217;s offer </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to include any such Related Products as a part of  its </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Minimum. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Product  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Purchases  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">under  Section  4.l(a) </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">hereof</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> , </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ZO  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SKIN  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH may </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">enter into distributor agreements with other </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">distributors in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Territory for the distribution of such </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to Customers without further </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ob</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">liga</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">tion </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Di</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">tributor.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:14.85pt;padding-right:66.8pt;text-align:justify;text-indent:35.35pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%">3.2&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%;text-decoration:underline">Excluded Products.</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%"> </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Not included </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">in </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">the products </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">w</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">hich </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">are subject to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Agreement </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">are </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">products sold </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">under the label </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">&#8220;ZO </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Ski</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">n </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Health.&#8221; Absent a separate written agreement executed by</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:119%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">both </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">and  ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:119%">SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">HEALTH  for  that </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">label, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">has </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">no  right to  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">distribute </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">such products.   </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">In  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">the event </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">and ZO SKIN HEALTH enter into an agreement for distribution of the </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">&#8220;Z</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">O </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Skin Health&#8221; </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">line </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">of  products, a  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">breach </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">that </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">agreement </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">sha</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ll be deemed  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">a  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">breach </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">of  this  Agreement&#59; if  that agreement is </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">terminated </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">as a result of the breach, this Agreement shall also be </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">terminated as </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">a result of such breach.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:14.2pt;padding-right:67.5pt;text-align:justify;text-indent:35.55pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%">3.3&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%;text-decoration:underline">Cooperation </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%;text-decoration:underline">with Distributor of ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%;text-decoration:underline">Ski</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%;text-decoration:underline">n </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%;text-decoration:underline">Healt</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%;text-decoration:underline">h </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%;text-decoration:underline">Products</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%">. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">If </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor is </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">not also selling </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">the </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">&#8220;Z</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">O </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Skin </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Health</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">&#8221; </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">line of products, then </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">reasonably </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">cooperate wi</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">th </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">entity engaged </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ZO SKIN HEAL</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">TH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">to sell the </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">&#8220;ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Skin Health&#8221; </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">line </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">in the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Territory </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">so as to enhance the mutual success of that entity and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">in their </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">respective </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">s</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">pheres.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:30.7pt;text-indent:-17.2pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">GENERAL OBLIGATIONS OF DISTRIBUTOR</font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:65.15pt;text-indent:-17pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">4.1&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Min</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">imum </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Purchase </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Requirement</font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:47.8pt;padding-right:67.7pt;text-indent:34.9pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%;text-decoration:underline">Minimum Product </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%;text-decoration:underline">Purcha</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%;text-decoration:underline">ses</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Subject to Section 3 above, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Dist</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">r</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ibutor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">must purchase all Products and Related Products offe</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">r</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ed from time </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">to time by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ZO SKIN HEALTH to the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:47.85pt;padding-right:68.35pt;text-indent:35.35pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">M</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">in</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">imum </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Pu</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">rchase </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Requirement</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">During </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">term </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of this Agreement, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Di</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">stri</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">butor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">make </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">at </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">least the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">minimum </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">purchases  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">from </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">ZO</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as required by Exhibit A</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. P</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">urchases counted toward the Minimum </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Purchase </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Requirement for any </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">period </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">provided for </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">here</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall be based upon ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8217;s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">net invoice </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">price</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for the Products and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Prod</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">u</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">cts </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">which are </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">paid by Distributor prior </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">expiration of the applicable calendar year.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:47.15pt;padding-right:68pt;text-indent:35.05pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of  </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">D</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">istributor Rights</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">event that the Distributor fa</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ls </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to achieve the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Minimum </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Purchase </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Requirement set forth above </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any calendar year, then </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sha</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ll </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">arrange to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">meet with ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">during the first </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">quarter </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">following the end of the year </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in question </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to discuss </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">developing </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">an </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">improvement </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">plan and&#47;or changing </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Minimum Purchase </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Requirement for future </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">periods. Both </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ZO SKIN HEALTH and Distributor have </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">obligation to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">negotiate in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">good faith&#59; however, ZO SKIN HEALTH shall not </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">be required </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to accept </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">lower Minimum Purchase Requ</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ir</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ement. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">they fai</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">l </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to develop an improvement plan or agree to a revised Minimum </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Purcha</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">se </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Requir</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ement </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for future </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">periods</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">then </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the failure s</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">h</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">all constitute grounds,</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">at ZO SKIN HEALTH's so</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">l</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e discretion, to terminate this Agreement, which </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">it </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">may </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">do </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">at any time </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">during </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the second quarter following the end of</font></div><div style="height:57pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.781%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution A</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">greement ZO Medical &#8211; </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Int&#8217;l</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> Form </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%">v</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4.</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">0 </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">- </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Cutera final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:1.127%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">3</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_19"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9.05pt;padding-left:49.75pt;padding-right:65.75pt;text-align:justify;text-indent:0.05pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the year in </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">question. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Waiver </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:122%">SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">HEALTH  of  any failure  to meet the Minimum </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Purchase </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Requirement shall not constitute a waiver  of  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">any </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">rights </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">that </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO SKIN </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">HEALTH may </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">have with </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">respect </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to any other failure </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">meet </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Minimum Purchase Requirement.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:49.1pt;padding-right:66.2pt;text-indent:35.05pt"><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Notwithstanding subsections  (a) through </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">c) above, if  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">also has a contract with ZO SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:117%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">for distribution of </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">its </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">&#8220;ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Skin </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Health</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">&#8221; </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">line </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">of products, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">then Di</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">stributo</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">r may </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">fail to reach </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Minimum </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Purchase Requiremen</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">t </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">under </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Agreement </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">by ten </font><font style="background-color:#000000;color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">xxxxxxxxx)</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> or less without violating this Agreement if the cumulative </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">total purchases </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">under </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">both </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">this Agreement and the agreement for the </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">&#8220;ZO</font></div><div style="margin-top:0.9pt;padding-left:48.8pt;padding-right:67.25pt;text-align:justify;text-indent:0.45pt"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Skin Health&#8221;</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">line of products equals or exceeds the sum of the Minimum Purchase Requirements </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">under </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">both agreements.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:12.9pt;padding-right:66.95pt;text-align:justify;text-indent:36.25pt"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%">4.2&#160;&#160;&#160;&#160;</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%;text-decoration:underline">Promotion and </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%;text-decoration:underline">Marketing</font><font style="color:#0a0a0a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%">.  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">use </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">commercially reasonable efforts to further the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">promotion</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">marketing, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">sale and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">distribution of </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Pr</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">oducts </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Territory</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">. </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">including </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">but </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">not limi</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">te</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">d </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to, building brand </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">awareness </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and value.  During the term of this Agreement, the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distribu</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">r </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">s</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">hall </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">expend on a calendar year basis, for </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">advertising of the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Related Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Territory </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">through media advertisements,  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">public   </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">relations, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">promotions</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">me</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">rch</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">andising</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">tradeshows, workshops, and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">displays </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">(in each case as previously approved  by ZO  SKIN HEAL</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">TH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in writing), </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">not </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">less than an amount equal </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to </font><font style="background-color:#000000;color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">xxx</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%"> of net sales of the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Product </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Related Product</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">made </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">during </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">such calendar  year, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">at  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the           </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">discretion </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the Distributor. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Notwithstanding </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">anything </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">he</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">r</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ein to the contrary, no payroll costs of any kind (including, without limitation, salaries and&#47;or commissions </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">payable to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">beauty consultants) shall be applied </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">toward </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">minimum </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">advertising expenditures </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">req</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">uired pursuant </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">this section. </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">The </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">cost of general media (including agency </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">fees, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">production fees and cooperative advertising)&#59; gift-with-purchase&#59; promotion </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">displa</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ys </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and their installation costs&#59; </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">public </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">re1ations activities&#59; samples and testers&#59; and Collateral Materials may be applied </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">toward the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">minimum advertising expenditure required above</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">. </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall upon written request provide ZO SKJN HEALTH with documentation of all such </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">expenditures </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">as well as photographs, ad copy, and all other </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">relevant documents </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">relating to its </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">public </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">relations efforts. ZO SKIN HEALTH </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">may</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in its reasonable </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">discretion</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">,  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">prepare  promotional  programs  for  the Products  and  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Related  Product</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in  the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Territory </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and   </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distribut</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">agrees  to  </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">coop</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">erate  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">with ZO  SKIN  HEALTH  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">sales  or  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">promo</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">tional </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">programs prepared </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO SKIN HEALTH.  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall not make, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">nor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">permit  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">its </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">sub-distr</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">i</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">butors to make, any materially misleading or </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">untrue </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">statements concerning </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Related Products. </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:122%">In </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">addition&#58;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:47.5pt;padding-right:68.25pt;text-indent:34.25pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">s</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">hall </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">maintain </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">an </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">office and well-trained staff to promote the sale of the Products and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Related Products, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">and to solicit orders for them.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:47.15pt;padding-right:70.15pt;text-indent:34.6pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">sha</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">ll </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">provide full and accurate advice and assistance to Customers when soliciting orders for Products and Related Products.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46.9pt;padding-right:68.65pt;text-indent:34.35pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">handle </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">promptly, efficiently, courteous</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">y </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">properly all </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">inqu</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">irie</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">s, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">quotations, correspondence</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">orders and complaints </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">connection with the Products and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Related Products.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:116.2pt;text-indent:-35pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">hall </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">promptly inform ZO SKIN HEAL</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">TH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of any complaints</font></div><div style="height:56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.781%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution A</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">greement ZO Medical &#8211; </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Int&#8217;l</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> Form </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%">v</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4.</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">0 </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">- </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Cutera final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:1.127%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">3</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_22"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8.55pt;padding-left:49.85pt"><img alt="image_3a.jpg" src="image_3a.jpg" style="height:38px;margin-bottom:5pt;vertical-align:text-bottom;width:42px"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">it </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">receives that are of either a material or a recurring nature.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:49.55pt;padding-right:66.35pt;text-indent:35.05pt"><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor shall use its best commercial effort </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">to </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">ensure that </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">location and display of the Products and Related </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Pr</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">oducts </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">in </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">each location in which the </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Products </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">and Related Products are sold in </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the Territory </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">w</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">ill </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">be </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">at least </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">as </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">favorable as the </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">location </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">of </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">any </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">similar </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">or </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">compet</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">itive </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">products.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:49.25pt;padding-right:66.25pt;text-indent:34.85pt"><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">If </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">sha</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ll be </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">affiliated </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">wi</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">th </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">any customer of the Products and Related Products, Distributor </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">s</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">hall </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">not </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">favor </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">such Affiliate </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">over any other </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">customer.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:118.6pt;text-indent:-34.5pt"><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distr</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ibutor </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall make  </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">no </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">representation, guarantee or  warranty,  either</font></div><div style="margin-top:0.85pt;padding-left:48.4pt;padding-right:65.8pt;text-align:justify;text-indent:0.6pt"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">express  or  implied, </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">with  </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">respect to any </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Product </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or Related Product, beyond those contained in </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">SKIN HEALTH approved package </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">label</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">s </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and products instructions, without the express written consent of ZO SKIN HEALTH or as otherwise required by </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">laws of the jurisdiction in which the </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Produc</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ts </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and Related </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">P</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">roducts </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">are offered </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">for sale </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the Territory. </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Di</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">stribu</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">tor </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall not </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ha</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ve t</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">h</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">e </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">right, power or authority to make any representation, guarantee </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">warranty on behalf of </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">SKIN HEALTH. Distributor shall not make </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">cause to </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">be </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">made or authorize any modifications or additions </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the Products or </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">R</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">e</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">lated </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">without </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the express prior written </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">conse</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">nt </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of ZO </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">SKIN </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">HEALTH.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:47.85pt;padding-right:66.55pt;text-indent:35.8pt"><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distribut</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or shal</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">at all times keep </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">maintain at its office set forth above </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">accurate </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">accounts and records </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">all transactions </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">pertainin</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">g </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to the Products and Related Products and to this Agreement. All such accounts and </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">records </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">be retained </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">by Distribut</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">during the term of this Agreement and for a </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">period </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of three </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">(3) </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">years after the date of  any termination of this Agreement and, upon mutual consent of the Parties, </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">be  </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">subject  to </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">exami</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">nati</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">on </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and audit by ZO SKIN HEALTH or its authorized </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">repre</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">sentative,  </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">during  normal  business hours.  </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor  </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall at all times promptly make available </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO SKIN HEALTH </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">such </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of its records as are necessary for ZO SKIN HEALTH to fulfill any recall or </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">other obligation </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:122%">it </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">deems necessary </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">unde</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">r </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">any applicable </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">aw, rule or </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">r</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">egulation and </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">such  obligations </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">survive  and  continue </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">after </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">termination of th</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">i</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">s Agreement.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:12.75pt;padding-right:67.2pt;text-align:justify;text-indent:35.9pt"><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%">4.3&#160;&#160;&#160;&#160;</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">Competing </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">Products</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%">.    </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">During the </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">term </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of this Agreement, Distributor </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">sha</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ll  </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">not </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">sell,  </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">distribute</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">,  </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">market,  advertise  or </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">so</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">icit  purchase  </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">orders for </font><font style="color:#3d3d3d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:122%">any  </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">product  that  is </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">competit</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ively </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">positioned  in  the </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Ter</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">r</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">i</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">tory with  ZO  </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">SKIN  HEALTH's  products,  including  without  </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">limita</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">tion, </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and Related </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products.  </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">However, notwithstanding the  immediately preceding </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">sentence, </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the Distributor </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">have the right </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">distribute the inventory </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of competitively </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">positioned products that it </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">purcha</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">sed </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">prior to </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Effective Date </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">this </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Agreement </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">until  the end </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">business on March 31, 2014&#59; except </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">that, </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">those products listed </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">on Exhibit F </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">attached  hereto  and incorporated herein by this reference may be purchased and sold by </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">until the end of business on September </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">30, </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">2015. The term </font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">&#34;</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">competitively positioned&#34; </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">refers to </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">medica</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">cosmeceutical </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">skin care products marketed and sold through the Channels </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distribution </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">. </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Except as </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">provided above, Distributor shall promptly terminate any sub-distributor who </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">wit</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">h</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">out </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">w</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ritten </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">consent of </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Parties sells, distributes, markets, advertises or </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">so</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">li</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">cits </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">purchase orders </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">for </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">any product </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">that </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">is </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">com</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">p</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">eti</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">t</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ively </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">positioned with </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Z</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">O </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">SKIN </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">HEALTH's </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">products </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the Territory.  Distributor </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">s</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">hall </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">advise ZO SKIN HEALTH in </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">writing </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of </font><font style="color:#4d4d4d;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:122%">(i) </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">any known or suspected duplication of the </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Produ</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">cts </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or Re</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ated </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">(ii) </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">competitors </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the</font></div><div style="height:57pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.781%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution A</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">greement ZO Medical &#8211; </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Int&#8217;l</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> Form </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%">v</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4.</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">0 </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">- </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Cutera final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:1.127%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">3</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_25"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;padding-left:14.6pt;padding-right:65.85pt;text-align:justify;text-indent:0.8pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Territory competing with the Products and </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Related </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Products, and </font><font style="color:#414141;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:119%">(</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:119%">iii</font><font style="color:#5e5e5e;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:119%">) </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">any change in regulations and</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">&#47;</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">or </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">practices </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">within the </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Territory </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">affecting the use of the Products and Related </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Products. Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">and its sub-distributors</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:119%">if </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">applicable</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">shall at all times </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">make </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ZO SKIN HEALTH</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">&#8217;s </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Products and </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Related </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Products the </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">primary </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">focus of their marketing and sales efforts.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:14.35pt;padding-right:65.8pt;text-align:justify;text-indent:35.75pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%">4.4&#160;&#160;&#160;&#160;</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">Business </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">P</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">l</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">an and </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">Reporting</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%">. </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">By </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">1</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:6.82pt;font-weight:400;line-height:122%;position:relative;top:-3.67pt;vertical-align:baseline">s</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:6.82pt;font-weight:400;line-height:122%;position:relative;top:-3.67pt;vertical-align:baseline">t</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%"> </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">business </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">day of November</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">2013, </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall create a business plan (&#8220;Business </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Plan</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">'&#8221;</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">) for the marketing, distribution and sale of  Products  and  Related Products in the Territory and by October l</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:122%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%"> of each year prepare the same for the following calendar year. The Business Plan shall include a description of the </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor's   </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">sales   organization  (including   that  of  any  sub-distributors)</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">,  </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">a  competitive  market analysis, </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">methods </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of distribution, a marketing plan</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">projected quarterly sales by </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and Related </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and such other information ZO SKIN HEALTH may reasonably request from  time to time</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">.  </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Following  the </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">end  </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of each calendar year during the term of this Agreement, but no </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">later </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">than March 15</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:122%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">  of the following  year, </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall send to ZO SKIN HEALTH a report containing the number of accounts, the nature of the accounts, a market review, etc.</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">i</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">n </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">form and substance mutually agreed </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">by ZO SKIN HEALTH and Distributer.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:13.3pt;padding-right:66.45pt;text-align:justify;text-indent:35.85pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:123%">4.5&#160;&#160;&#160;&#160;</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:123%;text-decoration:underline">Governmental </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:123%;text-decoration:underline">Req</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:123%;text-decoration:underline">u</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:123%;text-decoration:underline">irements</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:123%">. </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Subject to the terms of </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">this </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Agreement, </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">shall,  and shall require its sub-distributors </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">to </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">(i</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">) </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">comply with all applicable </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">laws </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">and regulations of the United States </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">and </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">the Territory, including </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">but </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">not </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">limited </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">to, export </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">laws </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">and restrictions and regu</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">l</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">ations of </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">the </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">United States Department of Commerce or other United States or foreign agency or authority</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">and shall not export, or participate </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">in </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">any transaction which may involve </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">the </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">export or </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">re-export </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">of any </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Products </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">or Related Products </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">in </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">violation of any such restrictions, laws or regulations&#59; </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">(ii) </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">assist ZO SKIN HEALTH in obtaining any required  registrations, licenses  and </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">permits  </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">for  the  </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Products  </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">and  Related  Products  and </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">the </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">marketing</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">sale and distribution of the Products and </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Related Products </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">in the </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Territory </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">by supplying such documentation or information as may be reasonably requested by ZO SKIN </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">HEALTH</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">&#59; </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">and (jii) obtain and </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">maintain </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">during the term of this Agreement all governmental approvals and licenses necessary to import the </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Products </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">and Related Products into </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">the </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Territory</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">. </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">If any governmental registration,</font><font style="color:#c6c6c6;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%"> </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">license or approval for the market</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">i</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">ng, sale and distribution of the Products and Related Products is required, Distributor shall obtain ZO SKIN HEALTH&#8217;s written approval prior to commencing any registration or approval process. </font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">U</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">nless otherwise  required  by applicable law, all registrations, licenses  and  approvals for the Products and Related Products and the distribution of </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">the Products </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">and Related </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Products in </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">the Territory shall be in </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">the name </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">of and shall be solely owned by ZO SKIN HEALTH.  ZO SKIN HEALTH</font></div><div style="padding-left:13.75pt;text-align:justify"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:99%">will </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:99%">reimburse </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:99%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:99%">for any pre-approved and reasonable fees for assistance in</font></div><div style="margin-top:0.5pt;padding-left:12.3pt;padding-right:67.5pt;text-align:justify;text-indent:1.15pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">obtaining such registrations</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">licenses and approvals that are in ZO SKIN HEALTH's name or that are transferred to ZO SKIN HEAL</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">TH </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">on termination of this Agreement. </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">shall provide ZO SKIN HEALTH with a copy of all registrations</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">, </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">licenses </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">and approvals obtained or received for the Products </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">and Related </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Products and for the distribution of the Products and Related  Products  </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">in </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">the </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Territory </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">within five (5) </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">business days </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">of </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Distributor</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">'</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">s receipt of each such  registration</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">, </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">license </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">and approval.  Should </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Distributor, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">either prior to this Agreement or at any time after execution of this Agreement, obtain a registration</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">, </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">license </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">or approval for the Products and Related Products or for the distribution of the Products and Related </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Products </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">in the Territory, </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">agrees to </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">immediatel</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">y </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">take the appropriate action to transfer such registration, </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">license </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">or approval to ZO SKIN </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">HEALTH </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">as required </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">above </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">and as is </font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">c</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">onsistent</font></div><div style="height:57pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.781%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution A</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">greement ZO Medical &#8211; </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Int&#8217;l</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> Form </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%">v</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4.</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">0 </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">- </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Cutera final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:1.127%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">3</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_28"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:7.6pt;padding-left:12.3pt;padding-right:67.7pt;text-align:justify;text-indent:0.95pt"><img alt="image_4a.jpg" src="image_4a.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:43px"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">with  the  spirit  and  intent  of this Section 4.5. </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">In </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">furtherance of, but without  </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">limiting  </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the foregoing, </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor represents </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">that it </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">has </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">read, understood and will comply and cause </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">its </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">sub </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">distributors </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">to comply with the anti-bribery provisions of the </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%">U.S. </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Foreign </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Corrupt </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Practices </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Act. </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">covenants and agrees that it shall promptly notify ZO </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">SKIN </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">HEAL</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">TH </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">of any disciplinary  action  or change  </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">in  </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">status with regard to any </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">license,  </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">permit or  authorization required  by </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">l</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">aw</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">.  </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">For its pact, ZO SKIN HEALTH recognizes the need for the </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">to comply with all </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">l</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">ocal legal requirements and that from time to time such </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">legislation </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">may p</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">r</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">event the </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">from fully complying </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">with </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">one or other terms of this Agreement. </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">In </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">such cases, providing sufficient evidence </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">is </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">provided, ZO </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%">SKIN HEALTH </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">will not deem a failure to comply with </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">that term </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">or condition a breach of this Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:65.2pt;text-indent:-18pt"><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">4.6&#160;&#160;&#160;&#160;</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Expenses</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">. </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Except as provided </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Section 4.5, </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">assumes full</font></div><div style="margin-top:0.2pt;padding-left:12pt;padding-right:69.35pt;text-align:justify;text-indent:0.3pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">responsibility </font><font style="color:#414141;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:122%">for </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">all </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">its </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">own costs and expenses </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">incurred </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in carrying out its obligations under </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">this </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Agreement, including but not </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">limited </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to all r</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">e</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">nts</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">salaries</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">commissions, advertising, translations of </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">documents </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and materials</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">demonstration</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">travel and accommodation for the employees</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">agents</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">representatives or other personnel of Distributor.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:11.55pt;padding-right:69.05pt;text-align:justify;text-indent:35.2pt"><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">4.7&#160;&#160;&#160;&#160;</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Marketing </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Materials</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">. </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">marketing materials created </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">by </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or for </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">for </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any sub-distributor relating to the </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and Related Pro</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">du</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">cts shall be approved in writing within 7 days of submission by ZO SKIN HEALTH prio</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">r </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to use by </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or any su</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> distributor.  Such  marketing  materials shall contain copyright, trademark  and  accreditation </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">notices </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as prepared by </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">ZO</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SKIN HEALTH. </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">An </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">approved  sub-distributor shall not be permitted to  create  any marketing materials with respect to Products or </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related Products.   </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Further</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the name &#8220;</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Obagi&#8221; may only be used to sell, market, or advertise products or services if &#8220;Obagi&#8221; </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">is</font></div><div style="margin-top:0.3pt;padding-left:11.45pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">part of  the phrase &#8220; </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">y  Zein  Obagi</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,  </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">M.D.</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;  </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and  so  </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">long </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as  the phrase </font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">by Zein Obagi</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, M.D.&#8221;</font></div><div style="margin-top:0.35pt;padding-left:10.7pt;padding-right:69.65pt;text-align:justify;text-indent:0.8pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">appears in a font size not </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">materially </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">d</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">i</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">fferent than </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:123%">the </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">proportional </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">relationship </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">to the font size of &#8220;ZO</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%"> &#174;  </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">MEDICAL&#8221; that is shown </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">in </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Exhibit C.&#160;&#160;&#160;&#160;</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">Any </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">violation of the requirements set forth in the immediately preceding sentence shall be considered a materia</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">l </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">breach of this Agreement.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:9.3pt;padding-right:70.1pt;text-align:justify;text-indent:36.45pt"><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">4.8&#160;&#160;&#160;&#160;</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Quarterly </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Fore</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">c</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">ast</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">. </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall provide ZO </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SKIN </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH with reports of </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">its </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">activities</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">competitor activities</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and other information regarding the Products and Related Products </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the markets for </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">them </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">the </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Territory in such detail and with such frequency as ZO </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SKIN </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH shall reasonab</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">l</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">y require </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">from </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">time </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">time</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">order to help ZO </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SKIN HEALTH </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">provide inventory on a timely and consistent basi</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to Distrib</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">u</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">r</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor agrees to provide </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ZO SKIN HEALTH</font><font style="color:#1a1a1a;font-family:'Arial',sans-serif;font-size:11.5pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">on a quarterly basis </font><font style="color:#414141;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">a </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">twe</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">l</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ve (12) month rolling forecast of </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8217;</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">projected </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">purchase orders (including that of sub-distr</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ibutors) </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">on the form attached hereto as Exhibit </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">B.  </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor</font><font style="color:#757575;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">'</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s provision of the above-mentioned forecast shall not be interpreted as a commitment from </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">buy </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any Products or Related </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">P</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">roducts </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">in </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">x</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">cess of Distributor's Minimum Purchase Requirement, </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">unless </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">otherwise agree</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in writing by the Parties.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:9.3pt;padding-right:70.15pt;text-align:justify;text-indent:35.5pt"><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%">4.9&#160;&#160;&#160;&#160;</font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">Development </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">of Faculty</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%">. </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO SKIN HEALTH</font><font style="color:#414141;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:122%"> </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">anticipates that Dr. Zein </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Obagi </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">will, from time to time</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">conduct seminars and make other pub</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ic appearances to promote ZO SKJN HEALTH products within </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Territory, for the mutua</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">benefit of ZO SKIN HEALTH and </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor. </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Dr. Obagi</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">&#8217;</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">s standard personal appearance fee will be </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">b</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">orne by </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and a separate personal appearance </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">contract </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:122%">will </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">be </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">executed </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">by </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">an</font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">d </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">between </font><font style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Dr. </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Obagi and Distributor</font></div><div style="height:58pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.781%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution A</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">greement ZO Medical &#8211; </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Int&#8217;l</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> Form </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%">v</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4.</font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">0 </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">- </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Cutera final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:1.127%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">3</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_31"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8.55pt;padding-left:12.65pt;padding-right:67.15pt;text-align:justify;text-indent:1.2pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">prior to any such appearance. ZO SKIN HEALTH and Dr. Obagi intend to associate with other qualified physicians to form a faculty of </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">professionals </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">who are trained and </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">qualified </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">to conduct seminars and other public appearances either </font><font style="color:#3f3f3f;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">'in </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">conjunction with </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Dr. Obagi </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">or on his behalf. Distributor  agrees  to </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">use </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">its best efforts to help locate suitable physicians who are willing</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">able</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">and qualified to</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">become part of that faculty</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">and to make introductions or otherwise facilita</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">t</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">e a relationship between those physicians and ZO SKIN HEALTH.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:12.95pt;padding-right:68.6pt;text-align:justify;text-indent:35.25pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">4.10&#160;&#160;&#160;&#160;</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;text-decoration:underline">Free Goods</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">.   </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">ZO SKIN HEALTH will provide </font><font style="background-color:#000000;color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">xxx</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> of Net Sales as Free Goods and Related Products and collaterals in the first year of this Agreement&#59; for each year thereafter, the abo</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">v</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">e percentage shall be </font><font style="background-color:#000000;color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">xx</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="padding-left:14.25pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">5. GENERAL </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">OBLIGATIONS </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">OF ZO </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">SKIN HEAL</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">TH</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.85pt;padding-left:12.45pt;padding-right:68.7pt;text-indent:35.65pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:112%">5.1&#160;&#160;&#160;&#160;</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:112%;text-decoration:underline">General</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:112%">.  </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">ZO SKIN HEALTH shall u</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">s</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">e commercially reasonable efforts to maintain and  enhance  the  reputation</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">,  </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">usefulness</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">,  </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">and  acceptance of its  </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">Products  </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">and  Related </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">Products </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">and to assist </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">Distributor </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">in all reasonable ways to promote the sale of the </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">Products </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">and Related Products in </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">the Territory.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:11.95pt;padding-right:68.55pt;text-indent:36.15pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">5.2&#160;&#160;&#160;&#160;</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Distributor Training</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">. </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">ZO SKIN </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">HEALTH </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">shall </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">provide </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">initial training on the Products and Rela</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">t</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">ed </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Products </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">and subsequent training upon the release of new </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Products </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">or new Related </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Products </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">that are subject to this Agreement. The </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">date, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">duration, content and location of </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">the </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">initial training and training relating to any new Products or </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Related </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Products shall be  as  ZO SKIN HEALTH determines fr</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">m time to time to be reasonable and appropriate after communicating with and considering the interests of Distributor. Notwithstanding the foregoing, </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">and ZO SKIN HEALTH shall each </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">bear </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">their own costs of travel and living  expenses  for their  own  personnel to participate in training</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">whether for initial or subsequent training for the release of </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">new </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Products or Related </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Products. </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">training is provided at Distributor's </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">location</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">shall provide reasonable training facilities without expense to ZO SKIN HEALTH.   Distributor shall be solely responsible for any other training of its sales staff.</font></div><div style="margin-top:11.65pt;padding-left:11.8pt;padding-right:68.7pt;text-indent:35.85pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%">5.3&#160;&#160;&#160;&#160;</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%;text-decoration:underline">Marketing Support</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%">. </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">ZO SKIN HEALTH shall provide </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Distributor </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">with an electronic and one hard copy of ZO SKIN HEALTH&#8217;s </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">marketing </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">materials in English. </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Distributor  </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">shall  provide language translations of such materials that </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">D</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">i</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">stributor plans to use within the Territory to ZO SKIN HEALTH at Distributor&#8217;s sole expense. </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Distributor </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">shall not change the </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">literal </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">meaning of the ZO SKIN </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">HEALTH </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">technical information or sales literature or materials provided to </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">it </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">without </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Distributor </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">providing ZO SKIN HEAL</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">TH </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">with an accurate interpretation of any changes and securing ZO SKIN HEALTH&#8217;s express written permission for the changes. Such translated </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">material </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">shall be in conformity with the requirements of Section 4.7 </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">hereof </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">and shall be </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">produced </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">at Distributor&#8217;s sole expense.</font></div><div><font><br></font></div><div style="padding-left:30.4pt;text-indent:-17pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">PURCHASE </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">OF </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">PRODUCTS, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">RELATED </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">PRODUCTS </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">AND SERVICES</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:11.25pt;padding-right:69.5pt;text-align:justify;text-indent:35.85pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%">6.1&#160;&#160;&#160;&#160;</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%;text-decoration:underline">Purchase </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%;text-decoration:underline">Orders and Delivery</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%">. </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">Distributor shall order Products and Related Products only from ZO SKIN HEALTH. All purchases of Products and Related Products by </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">Distributor </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">from ZO SKIN HEALTH hereunder shall be </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">purchased </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">and paid for at the </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">Distributor Purchase </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">Prices. Products and Related </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">Products </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">ordered by </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">Distributor </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">from ZO</font></div><div style="height:57pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:1.691%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.65pt;padding-left:1pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.372%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">D</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">i</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">stri</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">bu</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">tio</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">n </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Ag</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">re</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">e</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ment </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Z</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">O </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Medical</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#183; Int&#8217;l </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Fo</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">rm </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">v. 4</font><font style="color:#8c8c8c;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">.</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">0 </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#183; </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">C</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ut</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">e</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ra fina</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">-</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">l2</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_34"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.25pt"><img alt="image_5a.jpg" src="image_5a.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:46px"></div><div style="margin-top:4.55pt;padding-left:12.8pt;padding-right:68pt;text-align:justify;text-indent:0.3pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">SKIN  HEALTH  will  be  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">deli</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">vered  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">by  ZO SKIN HEALTH directly to the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor&#8217;</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">designated freight forwarding agent. ZO SKIN HEAL</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">TH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">shall use commercially </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">reasonable </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">efforts to deliver </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ordered Products and Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Products  within thirty (30) days of  the date of  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">receipt </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">of a purchase order from </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">All </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">and Related Products with </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">a </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">stated  shelf  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">life </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">of more than two years shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">have </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">a minimum of 24 </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">months </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">of remaining shelf life at the time of shipment from ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">and all </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">and  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Related  Products  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">with  a stated shelf </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:119%">life </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">of two years shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">have </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">a minimum of </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:119%">18 </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">months  of remaining </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">shelf </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">life </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">at the time of shipment from ZO SKIN HEALTH to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:12.2pt;padding-right:68.25pt;text-align:justify;text-indent:35.9pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%">6.2&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%;text-decoration:underline">Modification of Orders</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">All order(s) of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Di</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">s</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">tributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">are </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">non-cancelable, non refundable </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">and non-exchangeable</font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">except as otherwise agreed to in writing by the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Parties. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">All order(s)  placed  with ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">HEALTH  by </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Distributor  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">for  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Products shall be </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">made </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">through the submission of a </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">pur</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">c</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">ha</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">se </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">order </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">the form required by ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">HEAL</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">TH from </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">time </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">to time.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:12.2pt;padding-right:68.45pt;text-align:justify;text-indent:35.35pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%">6.3&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%;text-decoration:underline">Delivery </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%;text-decoration:underline">Terms</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%">.  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">All </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">deliveries </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Products and Related Products shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">be FOB </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">ZO  SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%"> </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">HEALTH&#8217;s  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">manufacturing  or  warehouse  facility.  ZO  SKIN  HEALTH  shal</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">l  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">consign  each  shipment  to the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">freight </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">forwarding agent and customs </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">broker </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">specified by </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">in </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">purchase order.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:11.95pt;padding-right:69pt;text-align:justify;text-indent:35.65pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">6.4&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">T</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">i</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">tle</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to each of the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall transfer upon consignment and de</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">l</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ivery by ZO SKIN HEALTH at ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH&#8217;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s facility to the freight forwarding agent specified in Distributor&#8217;s </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">purchase </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">order. ZO SKIN HEALTH may, but </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">is not </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">required  to,  purchase </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">insurance </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">loss, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">damage or theft of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and&#47;or Related Products while they are </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">transit and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">it </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">may charge </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for any such </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">insuran</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ce </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">purchased</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:11.25pt;padding-right:69.25pt;text-align:justify;text-indent:35.85pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%">6.5&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%;text-decoration:underline">Acce</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%;text-decoration:underline">p</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%;text-decoration:underline">tance </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:119%;text-decoration:underline">of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%;text-decoration:underline">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%;text-decoration:underline">and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%;text-decoration:underline">Related Products</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%">. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:119%">ln </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">the event of any shortage</font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">damage or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">discrepancy </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">in or to a shipment of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Products, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distribu</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">to</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">r </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">shall</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">promptly report </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">same </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ZO SKIN HEALTH and furnish such written </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">evide</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">nce </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">or other documentation as ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">may deem appropriate. ZO SKIN HEALTII shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">not </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">be </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">liable  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">for  any  such  shortage, damage or discrepancy </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">unless </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ZO SKIN  HEALTH  has received  sufficient  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">notice  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">and evidence  thereof  from </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">within thirty </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(30) </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">days from ZO </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">SKIN HEAL</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">TH&#8217;s delivery of  the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Product</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">or Related Products to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">&#8217;s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">freight  forwarding  agent. If </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">s</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">uch </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ev</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">idence  demonstrates </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">to  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ZO SKIN HEALTH's satisfaction that ZO SKIN HEALTH </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">is </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">responsible for </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">such </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">shortage</font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">damage or discrepanc</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">y, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ZO SKIN HEALTH  </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">s</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">hall  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">at  its  sole  obligation </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">promptly </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">deliver additional or </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">s</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ubstitute Produc</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ts </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">or Related Products to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributo</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">r </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">therefor.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:11.05pt;padding-right:69.85pt;text-align:justify;text-indent:35.1pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:122%">6.6&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">Ret</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">u</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">rn of  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">Defective </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">P</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">r</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">oducts or </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">Related </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">Products</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%">. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO SKIN HEALTH shall use reasonable commercial efforts to supply </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">with Products </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and Related Products manufactured </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in accordance with applicable good </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">manufacturing </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">practices. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">In </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the event </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Related Produc</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ts </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">which are delivered to Distributor are not commercially acceptable in the ordinary </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">course </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of business </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Territory and the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or Related </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">were delivered </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO SKIN HEALTH to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">within one </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">hundred </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">twenty</font></div><div style="margin-top:0.05pt;padding-left:10.8pt;padding-right:70.05pt;text-align:justify;text-indent:0.15pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">(120)  days  from  ZO SKIN HEALTH&#8217;s receipt </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">of </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">written  notice  of  defect  from  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">Distributor</font><font style="color:#808080;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">SKIN  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">HEAL</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">TH  shall  reasonably </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">replace  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">the Products  or Related </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">(the</font></div><div style="height:56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:1.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.372%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution Agreement </font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Medica</font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">l </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8226; </font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Int&#8217;l Form v 4.0-Cutera final</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">-</font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_37"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8.55pt;padding-left:13.7pt;padding-right:56.15pt;text-indent:-0.65pt"><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">&#34;Defective </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">Product&#34;) </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">or credit </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">Distributor </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">for the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">purchase price reflected </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">on the invoice for </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">the Defective Product, provided Distributor&#58; </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">(a) </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">has </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">obtained ZO SKIN </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">HEALTH&#8217;s prior</font></div><div style="padding-left:13.75pt"><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">written  consent  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">to return  or  destroy </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">the  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Defective Product,  that </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">will  not  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">be  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">withheld</font></div><div style="margin-top:0.8pt;padding-left:12.95pt;padding-right:67.8pt;text-align:justify;text-indent:0.85pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">unreasonably&#59; </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">and </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(b) Distributor returns </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">or </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">destroys with ZO </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">SKIN </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">HEALTH&#8217;s </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">prior </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">approval the Defective Product </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">within ninety (90) </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">days </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">from </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">the date of receipt </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">of </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">th</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">e written </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">consent to </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">return  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">or destroy from </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">ZO </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">SKIN </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">HEAL</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">TH to  Distributor  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">accompanied  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">by a</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> compl</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">eted  Product  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Complaint  Form</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:117%">, </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">in </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">the form </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">attached hereto as </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Exhibit </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">D. All </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">costs associated with </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">the </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">return or </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">destruction </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">of </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">the Defective </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">P</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">rod</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">u</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">ct </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">will </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">be borne by </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">ZO </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">SKIN </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">HEALTH.  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">The  provisions  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">of this Section </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">6.6 </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">shall </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">constitute  Distributor's  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">sole  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">and </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">exclusive remedy with respect to </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Defective Products. Distributor </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">shall </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">provide all reasonably requested </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">assistance with </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">respect to </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">a</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">n</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">y </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Pr</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">oducts</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> or Related Products recalls initiated by </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">ZO SKIN HEALTH or by </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">any </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">governmental </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">agency </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">or authority.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:12.5pt;padding-right:68.65pt;text-align:justify;text-indent:35.5pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">6.7&#160;&#160;&#160;&#160;</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%;text-decoration:underline">Price Changes </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%;text-decoration:underline">Not</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%;text-decoration:underline">ification</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%">. </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor Purchase Prices </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">offered </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">to Distributor </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">are and s</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">hall </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">remain </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">based </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">on </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">standard </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">distributor discounts from current </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">US </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">pricing. </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">ZO SKIN </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">HEALTH </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">shall </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">give written notice to Distributor </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">of </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">any amendment to </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor Purchase Prices </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">of </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Products </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">or </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Related </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Products at </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">least </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">sixty (60) </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">days </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">in </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">advance of </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">th</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">e </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">change.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:11.85pt;padding-right:68.85pt;text-align:justify;text-indent:36.2pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%">6.8&#160;&#160;&#160;&#160;</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">Price Increase Protection</font><font style="color:#030303;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:122%">.</font><font style="color:#030303;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%"> </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Any </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">orders </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">from Distributor </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">for </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products or Related Products </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">which </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">are </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">received by </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO SKIN </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">HEALTH </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">prior to </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the effe</font><font style="color:#030303;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">c</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">tive </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">date </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of a price </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">c</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">r</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ease shall be invoiced at </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the previous price.  Price </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">protection will be </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">extended </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Di</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">stributor </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">by </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO SKIN </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">HEALTH </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">for </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">purpose of satisfying </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">legally </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">bindi</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">n</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">g Customer </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">purchase  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">agreements  and  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">quotations </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">for </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products  or  Related Products </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">with  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor which  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">are  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">force on the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">effective date </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">price increase. In </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">order to obtain price </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">protection, Distributor </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">must </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">provide </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">SKIN HEAL</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">TH </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">with </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">satisfactory documentation of s</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">u</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ch purchase agreement or </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">binding quotation</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">prior </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to the </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">effective </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">date of </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the price </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">increase.</font></div><div style="margin-top:10.55pt;padding-left:11.1pt;padding-right:69.55pt;text-align:justify;text-indent:35.75pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.9&#160;&#160;&#160;&#160;</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Price </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Decrease </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Protection</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">. </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">event </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ZO SKIN </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH decreases the price of </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any  Products   </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or Related  Products, Distributor </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">m</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ay apply for </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a  credit for  </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">P</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">roducts  or </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related  Products  purchased  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">by  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">with</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sixty  (60)  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">days  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">announced price  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">decrease  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(the &#8220;Qualifying  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Product</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.   </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The credit  shall  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">be  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">given  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">product  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall be equal to </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the difference </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">between </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the price paid by Distributor </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Qualifying Product, </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(less  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">any  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">prior </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">credits granted </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">by </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ZO </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SKIN HEALTH) and the announced decreased </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">price for </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Products </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related Products. </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Issuance of the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">price </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">protection credit </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">by </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ZO SKIN </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH is </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">contingent </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">upon Distributor&#8217;s </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">submission to ZO SKIN </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">not later </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">than </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">thirty </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(30) </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">days </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">after </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">effective </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">date </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of such price </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">decrease</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">an accurate </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">report of the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Qualifying Product.  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">verification  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">inventory  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">report by ZO </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SKIN HEAL</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">TH, </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a cred</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">it </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">product </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">will </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">be </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">given </font><font style="color:#363636;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">to </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor no later than </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sixty (60) </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">days after receipt </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">by ZO SKJN HEALTH of such </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">report.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:11.05pt;padding-right:70.6pt;text-align:justify;text-indent:34.65pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:122%">6.10&#160;&#160;&#160;&#160;</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">Product Changes</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%">. </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO SKIN </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">HEALTH </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">may at any time </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">up</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">on sixty (60) </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">days&#8217; </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">advance written notice </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">t</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">o </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">without </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">liability </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor&#58;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:114.85pt;text-indent:-35.05pt"><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Alter the </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">specifications for </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any Products </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">o</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">r </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related Products</font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:44.6pt;padding-right:70.45pt;text-indent:35.2pt"><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Discontinue </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">development </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of any </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">new </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products, whether or </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">not </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">such new </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">P</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">roducts </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">have been </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">announced publicly&#59;</font></div><div style="height:57pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.575%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution </font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Agreement </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ZO Medical - Int'! Form </font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">v. </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4.0 &#8226; </font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Cutera</font><font style="color:#b6b6b6;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">, </font><font style="color:#5e5e5e;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">final-2&#160;&#160;&#160;&#160;</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">l </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">3</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_40"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9.05pt;padding-left:117.15pt;text-indent:-34.5pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Discontinue the sale of any </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products&#59; </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:47.85pt;padding-right:68.65pt;text-indent:34.85pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(d)&#160;&#160;&#160;&#160;Commence the development and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">distribution </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">of new Products and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Products which may make </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">any </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">current Products or Related </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">obsolete.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:31.85pt;text-align:right;text-indent:-17.05pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">PRICES AND PAYMENT TERMS</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:12.75pt;padding-right:68.05pt;text-align:justify;text-indent:35.8pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:117%">7.1&#160;&#160;&#160;&#160; </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:117%;text-decoration:underline">Products and Related Products Prices</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:117%">. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Subjec</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">t </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">to Sections 6.7 through 6.9 above</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">SKIN HEALTH may, in its sole </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">discretion, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">change the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Purchase </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Prices </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">for </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">and  Related </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Products  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">listed  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">in  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Exhibit A at any </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">time. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Subject </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">the provision</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">of Section 2.6</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">SKIN HEALTH may</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">its sole discretion</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">adjust </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">suggested price at which the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">and Related </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">should be sold </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Custome</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">r</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">s and the suggested retail price at which </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">the Products and Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Products are </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">to be </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">sold to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">the public </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(i.e.</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">end-user) from time to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">time. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">All </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Purchase Prices shall be measured in U.S. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">dollars.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:12.2pt;padding-right:68.95pt;text-align:justify;text-indent:35.9pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">7.2&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Payment Terms</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">.  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The first order shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">be </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">prepaid. Thereafter</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as long as </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">is n</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">o</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t in breach of this Agreement</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor&#8217;s </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">v</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">oices shall be due net thirt</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">y </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(30) </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">days</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">pay </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SKIN HEALTH by international bank wire transfer </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">an account specified </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SKIN HEALTH in ZO SKIN HEALTH</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8217;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s invoice to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or by a </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">confirmed letter </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of cr</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">dit or an approved c</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">r</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">edit card. All payment</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall be </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">made in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">U.S. dollars.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:11.85pt;padding-right:68.95pt;text-align:justify;text-indent:35.75pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">7.3&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:117%;text-decoration:underline">Delinquent Accounts</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:117%">.  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">All </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">amounts </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">due and owing to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">SKIN HEALTH </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">h</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">e</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">reunder</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">but  not  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">paid  by </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">in accordance  with  the permitted net  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">paymen</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">t </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">terms</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">shall  become  immediately due and owing (the &#8220;Delinquent Accounts</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">&#8221;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">).  The  Delinquent Accounts shall, for  the  first thirty (30) da</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">y</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">s of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">delinquency, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">bear interest </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:400;line-height:117%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">U.S. dollars at the rate of the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">lesser </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">of&#58; </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">i) four percent (4%) per annum above </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">then applicable prime </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">interes</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">t</font></div><div style="margin-top:0.45pt;padding-left:11.95pt;padding-right:69.15pt;text-align:justify;text-indent:0.35pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">rate  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">announced  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">by  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the  Wall  Street Journal for  90-day  </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">U.</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">S.  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">dollar  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">loans  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">prime </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">c</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ommercial  customers  in  the  United States&#59; or (ii) the maximum lawful </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">interest </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">rate permitted under California law.  Any  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">De</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">inquent  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Accounts not  paid  within the first thirty</font></div><div style="padding-left:11.25pt;padding-right:69.8pt;text-align:justify;text-indent:0.65pt"><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">30) days of  becoming delinquent shall bear </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">interest </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">at </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">the lesser </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">of (x) eighteen percent (18%) per  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">annum </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">or (y) the highest rate permitted by California </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">law</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">until </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">paid.  Such  interest shall at  all   times </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">accrue </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">monthly  on  the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">balance </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">the Delinquent </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Accounts. Timely payment is a material term of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Agreement. Failure by Distributor </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">pay an invoice within 60 days of invoicing shall excuse </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">SKIN HEALTH from its obligation to ship any further Product or Related </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Product </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">and entitle </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">it </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">to terminate </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Distributor</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">&#8217;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">s rights under this Agreement, without an opportunity to cure. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">This </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">right to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">terminate </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">shall continue for 90 days after the invoice is </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">paid </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">and is </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">not </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">waived by acceptance of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">payment.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:11pt;padding-right:70.1pt;text-align:justify;text-indent:35.6pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">7.4&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Taxes</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall be responsible for all taxes </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">payable in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Territory. Distributor</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">way of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">illustration </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">not </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">by way of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">limitation </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">be responsible </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for all excise</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sales</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">us</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">GST  and value add</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">taxes  relating  to  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products sold </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Territory</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">including any goods and services taxes pa</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">y</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">able in the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Territory.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:29.8pt;text-align:right;text-indent:-17.4pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">TERMS </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">AND </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">TERMINATION</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:10.55pt;padding-right:70.05pt;text-align:justify;text-indent:35.6pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%">8.1&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%;text-decoration:underline">Term</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%">. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">This </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Agreement shall commence on the Effecti</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">v</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">e </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Date </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">and shall continue </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">effect for a period of five (5) years</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">unless otherwise terminated pursuant to the provisions</font></div><div style="height:58pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.537%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">14</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.513%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">D</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">istribu</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">tion Agree</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">m</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">en</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">t </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ZO M</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">edi</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">c</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">a</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">l &#8226; l</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">n </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">t&#8217;l</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> Fo</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">rm v. 4</font><font style="color:#9c9c9c;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">,</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">0 </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">- </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">C</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">u1era fina</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">l</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">-</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_43"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9.05pt;padding-left:13.25pt;padding-right:67.25pt;text-align:justify;text-indent:0.15pt"><img alt="image_6a.jpg" src="image_6a.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:42px"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of this Agreement. </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">F</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">urther</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">if Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">has not, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">at </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">any </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">time</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">breached </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">any </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">material </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">term of this Agreement, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">then </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">at the </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">election </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">which shall be communicated to </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">SKIN HEAL</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">TH in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">writing at least 180 days </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">prior </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to the end of the then-current term</font><font style="color:#727272;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the term </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Agreement shall continue for a subsequent 2-year period.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:47.95pt;padding-right:67.6pt;text-indent:36.2pt"><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">' s  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">right </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">to continue </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Agreement for subsequent 2-year periods </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">s</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">hall continue </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">as </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">long </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">as </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">has </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">not breached a material </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">term of </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Agreement  and  Distributor </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">provides </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">timely notice of its election </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ZO SKIN HEALTH, as </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">provided above.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:47.6pt;padding-right:67.85pt;text-indent:36.05pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:118%">If </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">so elects to </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">extend </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the term for a subsequent 2-year </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">period,</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">prior to </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the end </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">of the then-current term, Distributor and ZO SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:118%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">shall </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">negotiate  to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">reach an </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">agreement </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">on </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Di</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">stributo</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">r</font><font style="color:#727272;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">' </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">s </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Minimum Purchase Requirements </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">for </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">each </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">year of the next </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">2</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">-ye</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">ar </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">period.  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">If they </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">are unable </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">to reach </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">an agreement on </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor&#8217;</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">s </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Minimum Purchase Requirements prior </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">to the end of the </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">then-current </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">term, the Minimum </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Purchase Requirement for </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">each year of the subsequent 2-year </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">period </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">shall</font></div><div style="margin-top:0.35pt;padding-left:48.05pt"><img alt="image_7a.jpg" src="image_7a.jpg" style="height:16px;margin-bottom:5pt;vertical-align:text-bottom;width:40px"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">be </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">set  at&#160;&#160;&#160;&#160;of  the  Minimum  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Purchase  Requirement </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">year  immediately</font></div><div style="margin-top:0.35pt;padding-left:48.05pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">preceding that particular year.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:47pt;padding-right:68.6pt;text-indent:36.2pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:122%">If </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">during any </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">subsequent 2</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">-</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">year period, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">its </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">owners desire to sell  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">either  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">a  controlling  interest </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:122%">in </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ownership of </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">substantially </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">all of the assets  of  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor must </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">provide wr</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">i</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">tten </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">notice </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the transaction </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to ZO SKIN  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">HEAL</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">TH  within 30 </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">days </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of date of that transaction </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">obtain ZO SK</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">I</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">N HEALTH&#8217;s consent </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to continue </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">with </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">this Agreement.  If Distributor fails </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to get ZO SKIN </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">HEALTH&#8217;s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">consent, ZO SKIN HEALTH shall be entitled to </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">terminate this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Agreement.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:11.95pt;padding-right:69.8pt;text-indent:36.1pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:114%">8.2&#160;&#160;&#160;&#160;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:114%;text-decoration:underline">Termination</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:114%">.&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Either </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Party </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">may </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">specifically </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">terminate this Agreement </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">the following circumstances&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:47.15pt;padding-right:69.1pt;text-indent:35.55pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">If  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">either  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Party  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">gives </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">other Party wr</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">i</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">tten notice to </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">correct </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">one or more breaches of the terms of </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Agreement and </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">other Party fails </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">correct such </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">breach  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">within  thirty  (30) </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">days </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">after receipt of written </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">notice </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">same,  the aggrieved Party </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">may </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">immediately term</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ate this Agreement. </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Notwithstan</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ding the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">foregoing,  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">SKIN HEALTH </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">may </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">terminate </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Agreement without any advanced </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">notice  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and without providing </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">an </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">opportunity to cure for&#58; (i) failure </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">by Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to pay an invoice within 60 days of </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">invoicing </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">(as </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">discussed </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in section 7</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">.</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">3)&#59; (ii) violation </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">section 2.3</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%"> </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%;text-decoration:underline">(&#8220;Sales </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%;text-decoration:underline">Outside </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%;text-decoration:underline">the Territory. Channels of </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%;text-decoration:underline">Distribution&#59;</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%"> </font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%;text-decoration:underline">I</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%;text-decoration:underline">nternet Sales,</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">&#8221; if </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">SKIN HEALTH determines </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">that </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">there </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">is </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">a </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">pattern </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of violating that section&#59; (iii) failure by </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor to meet </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">its minimum </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">purchase requirements </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">(as </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">discussed in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">section 4.1)&#59; or  (iv) violation of the restrictions for </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">use </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the name &#34;Obagi&#34; </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">as provided </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">section 4.7.  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Waiver  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">by  ZO  SKIN  HEALTH  or  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of  a breach </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the  other </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Party </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall not constitute a waiver of any </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">continuing breach </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or of any </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">future breach by the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">other </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Party.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46.65pt;padding-right:70.1pt;text-indent:35.1pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">(b)&#160;&#160;&#160;&#160;Eit</font><font style="color:#1c1c1c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">h</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">er </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Party may </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">immediately </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">terminate thi</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Agreement for cause upon giving  written  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">notice  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">such termination </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to the other </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Party </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">as </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">a result </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of the occurrence of any of the following events&#58;</font></div><div style="height:57pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.537%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">15</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.090%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Distribution Agreement </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">ZO Medical-</font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Int'l </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Form v. 4,0 </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">&#8226; </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Cutera </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">final-2</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_46"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8.05pt;padding-left:84.3pt;padding-right:89.9pt;text-indent:35pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">i</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">f</font><font style="color:#5b5b5b;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:117%"> </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">the other Party </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">makes a  voluntary </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">petition </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">in </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">bankruptcy, insolvency </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">or similar </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">petition&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:84.15pt;padding-right:89.5pt;text-indent:35.1pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">an involuntary petition in bankruptcy</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">insolvency </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">or similar petition </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">is made against </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">the other Party&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:83.7pt;padding-right:67.15pt;text-indent:34.6pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(iii)&#160;&#160;&#160;&#160;if </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">other Party </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">becomes </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">insolvent or </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">makes a </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">general assignment for </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">benefit of creditors, suffers or </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">permits </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">an appointment of a </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">receiver </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">for </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">its business </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">assets or is </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">liquidated</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#59; </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or</font></div><div style="margin-top:12.2pt;padding-left:83.25pt;padding-right:67.7pt;text-indent:35.05pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">(iv)&#160;&#160;&#160;&#160;the  enactment  or adoption of any change </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:122%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">laws, rules, regu</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ations or governmental policies or other cha</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">n</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ge in circumstances that makes it illegal, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">impossible </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">impracticable to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">export, import, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">market</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">sell </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and distribute </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to or </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Territory as contemplated </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">this Agreement.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:49.05pt;text-align:justify"><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">8.3</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%"> </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Rights </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Upo</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">n </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Termination</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">.  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon termination  or  expiratio</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">n </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of this Agreement&#58;</font></div><div style="margin-top:0.2pt;padding-left:12.5pt;padding-right:67.85pt;text-align:justify;text-indent:0.85pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">(a) all of </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distribu</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">r's rights </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">granted </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">hereunder </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">immediately </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">cease&#59; (b) </font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Di</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">stributor shall </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">deliver </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to ZO SKIN </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">HEALTH</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">,  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or at ZO SKIN HEALTH&#8217;s </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">direction  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">destroy </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">any and all  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">language  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">translations of ZO SKIN HEALTH&#8217;s sales </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">technical  l</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">i</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">terature  and </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">materials </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in Distributor's  possess</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">i</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">on  or  co</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">n</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">trol, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">costs of which shall </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">be </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">borne  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">by the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Party w</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">h</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ose breach of </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Agreement caused the term</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ation, if app</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">li</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ca</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ble</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">otherwise, such costs  shall  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">be </font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">b</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">orne by ZO SKIN </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">HEALTH&#59; </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">(c) </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall return to ZO SKIN HEAL</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">TH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">any </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Related Products in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">its </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">possession </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">which were purchased from ZO SKIN HEALTH  within  one </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">hundred </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">twenty (120) </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">days </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of the </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">date </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of termination or </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">expiration  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Agreement, except for </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">required to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">fulfill </font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">egally binding Customer </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">purchase </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">agreements and quotations for a </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">period </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of no </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">longer </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">than one </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">hundred </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">twenty </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">(120) days </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">from the </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">date </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of termination or expiration&#59; (d) </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">immediately return </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to ZO SKIN </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">all other ZO SKIN HEALTH property, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">including</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">but no</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">t </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">limited to, all original </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">documents and </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">copies wh</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">i</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ch contain ZO SKIN HEALTH </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Proprietary Information&#59; </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">(e) </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">deliver to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO SKIN </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">such </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">documents </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">instruments </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">as ZO SKIN HEALTH may </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">reasonably </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">request </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:122%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">connection with the termination or expiration of this Agreement, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">but </font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">no case shall th</font><font style="color:#0a0a0a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">i</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">s </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">excee</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">d </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the requi</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">re</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ments of </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Section </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">4.2(h) </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">above</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">&#59; </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and (f) </font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Di</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">stributor shall remove from all of its facilities all signs, billboards and other similar </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">item</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">bearing any of the ZO SKIN HEALTH </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Ma</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">r</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ks </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or identifying </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">as an authorized distributor of ZO SKIN </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or the Products </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Products and, within a </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">rea</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">sona</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ble </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">period of </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">time </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">following such termination, withdraw or cancel </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">any registrations </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or</font></div><div style="margin-top:0.2pt;padding-left:11.95pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">filings  with  governmental  authorities  relating  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to  Distributor</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8217;   </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">use  of  any  of  the  ZO  SKIN</font></div><div style="margin-top:0.35pt;padding-left:11.7pt;padding-right:68.95pt;text-align:justify;text-indent:0.45pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Marks. </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">It  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">is  agreed </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that  Products </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">held </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">by </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that were </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">purchased  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">from ZO SKIN </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH  more </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">than one </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">hundred  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">twenty (120) days prior  to  the  date of  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">termination  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">be deemed </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;she</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">l</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">f worn&#8221; and of  no value.  ZO SKIN HEAL</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">TH  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall  promptly refund to Distributor </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">price Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">paid for  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Produ</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">cts </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and  Related Products  returned  which  were purchased  within one </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">hundred  twenty </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">20) </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">days </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of term</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ation. Except as </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">required </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor's </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">performance </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">obligations under this Section 8.3 or Section 8.4, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">upon </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ex</font><font style="color:#c6c6c6;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">p</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">iration  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or earlier </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">termination </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Agreement, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distribu</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">r </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sha</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ll </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">immediately cease and </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">desist </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">from any further </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">use </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of Proprietary Information of ZO SKIN </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH. </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Surviving </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Te</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">rms</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">.  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The prov</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sions of Sections 2.4, 7, 8.2, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.3</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11, 12, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">14</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15 </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">16  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and  each other  provision  of  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Agreement,  which  </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">by  its  nature </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">survives</font></div><div style="height:57pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.218%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution Agreement ZOMedical </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8211; Int&#8217;l</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Form</font><font style="color:#939393;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">v 4.0</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8226; </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Cutera final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.255%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">16</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_49"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9.5pt;padding-left:13.85pt;padding-right:68.9pt;text-align:justify;text-indent:-0.45pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">expiration or termination, shall survive the expiration or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">termination of this Agreement by either </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Party </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">for any </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">reason.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:25.75pt;text-align:right;text-indent:-12.3pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ZO SKIN HEALTH'S WARRANTY </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AND </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">INDEMNITY</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:12.45pt;padding-right:69.9pt;text-align:justify;text-indent:36.15pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%">9.1&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:119%;text-decoration:underline">Limited </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%;text-decoration:underline">Warranties.</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Subject </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Section </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:119%">9</font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:119%">.</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:119%">2, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:119%">SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">HEALTH </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">represen</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ts </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">and warrants to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">that (a) ZO SKIN HEALTH has been duly incorporated and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">i</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">s valid</font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">l</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">y existing and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">good standing under the laws of its jurisdiction of incorporation&#59; </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:119%">(b) </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ZO SKIN HEALTH </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">its </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">authorized signatory) has the necessary corporate power, authority and legal capacity to enter into and to observe and perform </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">its </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">covenants and obligations </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">under </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">this Agreement  and has  taken  all  necessary corporate </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">action in re</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">spect   </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">thereof&#59; (c) this Agreement has been duly executed and delivered by ZO SKIN HEALTH and constitutes ZO SKIN HEALTH's lega</font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">l</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, enforceable and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">bindin</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">g </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">obligation&#59; (d) ZO SKIN HEALTH&#8217;s execution and performance of this Agreement w</font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ill </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">not conflict with the terms or conditions of any other agreement or contract </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">which it is a</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:119%"> </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">party </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">or is </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">otherwise </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">bound&#59; (e) no approval, action or authorization </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">any governmental authority or agency </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">i</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">required for ZO SKIN HEALTH's execution and performance hereof (except for governmental certifications, registrations,</font></div><div style="padding-left:13pt;text-align:justify"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">licenses </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">and approvals for </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">the export </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">of the Products and Related </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">Products </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">to</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:13.5pt;font-style:italic;font-weight:400;line-height:105%"> </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">the Territ</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">ory)</font></div><div style="padding-left:12.3pt;padding-right:71.5pt;text-align:justify;text-indent:1pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">which </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">has not </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">already </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">been obtained&#59; </font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">f</font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">) </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ubject </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to any other provision in this Agreement to the contrary, ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SKIN HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">owns all </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SKIN HEALTH Marks and any patents, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">inventions</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">discoveries, know-how, confidential information, proprietary information and trade secrets, trademarks, service </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">marks</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">internet </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">domain </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">names, copyrights and other copyrightable works, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">including, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">databases and </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">softwa</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">re </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and all registrations and app1ications for </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">regi</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">stration </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of any of the  foregoing  (the </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Inte</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">llectual Property&#8221;</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">related with the Products and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products or used or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">needed </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for the operation of </font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">business of ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">holds </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">adequate</font></div><div style="padding-left:12.55pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:108%">licenses </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:108%">or otherwise possesses sufficient rights to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:108%">use </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:108%">such Intellectual </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:108%">Property </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:108%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:108%">the United</font></div><div style="margin-top:0.2pt;padding-left:12.2pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">States of America and the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Territor</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">y&#59; </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">and, (g)</font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">all </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Related </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#58;Products shall be of ZO</font></div><div style="padding-left:12.1pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">HEALTH standard </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">quality</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">..</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:12.55pt;padding-right:70.1pt;text-align:justify;text-indent:35.1pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">9.2&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%;text-decoration:underline">Disclaimer of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Warranties</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">EXCEPT AS PROVIDED </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">IN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">SECTION </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">9.1 </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">ABOVE, ZO </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">HEALTH MAKES </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">NO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">WARRANTIES, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">EITHER </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">EXPRESS </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">OR </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">IMPLIED,  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">WITH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">REGARD TO </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">THE PRODUCTS</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">,  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">THE </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">RELATED PRODUCTS </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">OR </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">THE ZO SKIN HEALTH MARKS, INCLUDING WITHOUT </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">LIMITA</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">TION ANY IMPLIED</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">WARRANTIES </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">OF </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE AND </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">NON</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">-INFRINGEMENT.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:65.65pt;text-align:right;text-indent:-17.55pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.3&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">ZO SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">BEALTH's </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Indemnification</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46.4pt;padding-right:69.9pt;text-indent:36.3pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(a)&#160;&#160;&#160;&#160;ZO SKIN HEALTH shall defend, indemnify and hold </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">harmless from and against any claim of a third </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">party </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">that is</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-style:italic;font-weight:400;line-height:118%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">either </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">reduced </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">to final</font><font style="color:#7c7c7c;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">non-appealable judgment  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">or  settled  with  ZO  SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">HEALTH'</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">s co</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">n</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">se</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">nt</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">not to be  unreasonably withheld,  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the extent arising </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">from </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the gross negligence or willful </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">misconduct </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">SKIN HEALTH, its </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">emplo</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">yees </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">or agents </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(other </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">than </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor or sub-distributors of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor) in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the performance of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">its </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">obligations </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">under this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Agreement. ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">HEALTH  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">will  pay  resulting  court  costs,  damages  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">and  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">legal  fees </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">finally  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">awarded,</font></div><div style="padding-left:46.2pt;padding-right:71.15pt;text-align:justify;text-indent:0.9pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">provided Distributor promptly notifies ZO SKIN HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">writing of any such claim,  ZO  SKIN  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">HEAL</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">TH   </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">has  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">sole  control  of  the  defense  and  all  related</font></div><div style="height:57pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.936%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Distribution </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Agreement </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">ZO Medical &#8211; Int&#8217;l Form v</font><font style="color:#7c7c7c;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">. </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">4</font><font style="color:#7c7c7c;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">.</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">0 &#8226; Cutera final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.678%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">17</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_52"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.75pt;padding-left:49.55pt;padding-right:66.7pt;text-align:justify;text-indent:0.3pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">settlement negotiations, and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Distributor provides </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">ZO SKIN HEALTH with such assistance and all related information for such defense as ZO SKIN HEALTH may </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">reasonably  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">request.  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">In</font><font style="color:#2f2f2f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:114%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">the event ZO SIGN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">HEAL</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">TH assumes control of the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">defense </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">of a </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">matter</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">,  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:114%">it </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">shall consult with </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">on a </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">regular basis </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">keep </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Distributor apprised of the status of the action.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:49.4pt;padding-right:67.25pt;text-indent:35.7pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;ZO SKIN HEALTH shall defend, indemnify and hold </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">harmless from  and  against any  claim </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that the Products</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ZO SKIN HEALTH technical and sales  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">lit</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ra</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ture  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ZO SKIN HEAL</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">TH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Marks </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">infringe  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the Territory  on a patent,  trademark  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">copyright  of  a third party </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Cla</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">im</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">pay </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">resulting court costs, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">direct </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">damages and legal fees incurred </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">connection with such Claim, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">provided</font></div><div style="padding-left:63.7pt;text-align:justify;text-indent:-14.25pt"><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:113%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:113%">Distributor promptly </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:113%">notifies ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:113%">HEALTH </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:113%">writing of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:113%">any </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:113%">such Claim </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:113%">and</font></div><div style="margin-top:0.15pt;padding-left:47.75pt;padding-right:67.4pt;text-align:justify;text-indent:1.7pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;gives  ZO  SKIN  HEALTH sole control of the defense of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the same </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and  all negotiations  for  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">its  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">settlement  or  compromise.  Should  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any  Product</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or  Related </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">become,  or in ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH&#8217;s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">opinion </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">be </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">likely  to  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">become</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the  subject of  a  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">claim  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">infringement,  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">permit  ZO  SKIN  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH,  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">at  ZO SKIN  HEALTH&#8217;s  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">option  and </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">expense, to (x) </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">procure </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor  the  righ</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to continue  using the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or Related Products, </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(y) </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">replace or modify the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or Related  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products  to  become non-infringing</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or  (z) if neither procurement  nor replacement is commercially reasonable, terminate the sale of the Products or Related </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">terminate  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">this  Agreement by giving  written  notice  thereof  to  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Distributor</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">with </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">no </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">further obligation or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">liability to Distr</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ibutor. Notwithstanding </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">foregoing,  ZO SKIN HEALTH  shall have no </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">liability </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for any claim of  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">infringement  to the  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">extent  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">based upon  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any modification of  the Products, ZO SKIN HEALTH </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">technical </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and  sales  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">literature  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or  of  the ZO SKIN HEALTH </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Marks </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">not made  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">by  </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Z</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">O </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SKIN HEALTH or  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">its </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">authorized </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">representatives </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">with ZO SKIN HEAL</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">TH</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8217;s </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">prior </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">express written consent and, in no </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">event </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall ZO SKIN HEALTH have </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">liability </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for any </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">infringement until </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">such time </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ZO SKIN HEAL</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">TH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">receives actual notice of alleged </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">infringement  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">then  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the  liability shall only be for claims thereafter and only  in the event  ZO  SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">authorizes  in  writing </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">continuing  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">use </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of  the  same.   In the event  ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">does </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">not </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">authorize </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">w</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">riting </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the continuing </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">use </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of the </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">same,  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any  affected  Products shall be considered </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Defective </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">under  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">this Agreement. THE FOREGOING PROVISIONS OF </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THIS SECTION </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">STATE </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THE E</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">N</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">TIRE  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LIABILITY  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">OF  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ZO SKIN  HEAL</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">TH  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WITH  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">RESPECT  TO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">INFRINGEMENT  IN  THE  TERRITORY OF  ANY  PROPERTY  RIGHT  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">OF  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A THIRD </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PAR</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">TY </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BY </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THE </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PRODUCTS OR </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THE RELATED PRODUCTS, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ZO</font></div><div style="margin-top:1pt;padding-left:48.3pt;padding-right:68.7pt;text-align:justify"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">SKIN HEALTH </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">TECHNICAL </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">AND SALES </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">LITERATURE </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">AND </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">THE </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:104%">SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">MARKS.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:31.5pt;text-align:right;text-indent:-17.5pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;DISTRIBUTOR WARRANTY AND INDEMNITY</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:12.2pt;padding-right:70.95pt;text-align:justify;text-indent:36pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">10.1&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Limited</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%"> </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Warranties</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">.  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distribut</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">o</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">r  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">represents  and warrants  to ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that (a) </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">has been </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">duly incorporated </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">validly existing and in good standing under the laws of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">its </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">jurisdiction of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">incorporation</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b) </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(and its authorized signatory) </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">has the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">necessary corporate </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">power</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">authority </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">legal </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">capacity to enter into and to observe and perform its covenants and obligations </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">under this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Agreement </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and has </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">taken all necessary corporate </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">action </font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">respect thereof&#59; </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c) </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">D</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">stributor has all required </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">lice</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">nsing, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">is</font></div><div style="height:57pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.654%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Distribution Agreement ZO Medical &#8211; Int&#8217;l Form v</font><font style="color:#898989;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">. </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">4,0 </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">- </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cutera final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.537%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.65pt;padding-left:1pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">18</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_55"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9.5pt;padding-left:14.4pt;padding-right:68.05pt;text-align:justify;text-indent:0.45pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">authorized, </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">sell </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">pharmaceutical </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">products in the Territory&#59; (</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">d) </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">this Agreement </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">has </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">been duly executed and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">delivered by Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">and constitutes </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor&#8217;s legal, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">enforceable and binding obligations&#59; (e) </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor&#8217;s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">execution </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">and </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">performance of </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Agreement </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%">will </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">not conflict with the terms or conditions of any other </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">agreement </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">or contract to which </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">is a party or is otherwise </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">bound&#59; </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">and (f) no approval, action or authorization by any governmental </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">authority </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">or agency is required for </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor&#8217;s execution </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">and performance hereof (except for governmental certifications</font><font style="color:#6b6b6b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">registrations, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">licenses </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">and approvals </font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">for </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the marketing, sale </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">and </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">distribution of </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Products and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Related Products in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Territory) </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">which has </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">not </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">already </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">been </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">obtained.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:15.2pt;padding-right:68.45pt;text-align:justify;text-indent:36.4pt"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">10.2&#160;&#160;&#160;&#160;</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Distributor</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">'</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">s Indemnification</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Distributor shall defend, indemnify and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">hold </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">ZO SKIN </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">HEAL</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">TH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">harmless </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">from </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">against </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">any claim </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">of </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">a third party that is e</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">i</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">ther reduced to</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-style:italic;font-weight:400;line-height:115%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">final, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">non-appealable </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">judgment or settled with </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Distributor's </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">consent, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">no</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">t </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">to be </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">unreasonably </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">withheld, to </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">extent arising out of or resulting from&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:48.8pt;padding-right:67.2pt;text-indent:36.25pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor&#8217;</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">s   </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">and   sub-distributors</font><font style="color:#6b6b6b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">&#8217;   </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">negligent    acts    or  omissions  or  willful </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">misconduct in the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">use, import, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">marketing</font><font style="color:#6b6b6b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">promotion, advertising, distribution and  sale  of  the  Products or </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Related Products</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">,  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">including but not </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">l</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">imited to Distributor&#8217;s and sub-distributors&#8217; promotional or advertising materials for the Products or </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Related Products&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:48.6pt;padding-right:68.15pt;text-indent:35.55pt"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Any statements, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">claims</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">representations or warranties made </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">by Di</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">st</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">or any sub-distributor relating to the Products or Related Products, other than as authorized or </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">made </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">by ZO SKIN </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">HEALTH in</font><font style="color:#313131;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">writing, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">including </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">but not </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">limited </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">to </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">those made </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">in the ZO </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">HEAL</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:119%">TH </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">technical </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">and sales </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">literature </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">and materials&#59;</font></div><div style="margin-top:10.2pt;padding-left:48.95pt;padding-right:68.7pt;text-indent:34.7pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(c)&#160;&#160;&#160;&#160;Any</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">breach  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">by Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">and&#47;or any sub-distributor of their obligations </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">under this Agreement </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">or a sub-distribution agreement&#59; and</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:47.35pt;padding-right:68.15pt;text-indent:36.3pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Any </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">infringement or claim thereof of any </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">patent</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">copyright, trademark, service mark, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">trade </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">name</font><font style="color:#6b6b6b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">trade </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">secret or any other property right of a third </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">party </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">arising from the use by </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">or any sub-distributors of (i) </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">any </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">symbol, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">insignia, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">name </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">o</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">r </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">identifying characteristic other than the </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">SKIN HEALTH&#8217;s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Marks, (ii) any combination of any </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">HEAL</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">TH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Mark with </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">any materials not provided </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">or approved </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">ZO SKIN HEALTH, (iii) </font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">any modification </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">to</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-style:italic;font-weight:400;line-height:115%"> </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">or </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Related Products not made </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">by ZO SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">HEAL</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">TH, or (iv) any use of the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">or Related </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Products not </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">authorized or certified </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">ZO SKIN HEALTH or </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">HEALTH technical </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">and </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">sales </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">literature </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">and materials.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:30.45pt;text-align:right;text-indent:-17.4pt"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;LIMITATION OF </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">LIABILITY.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:11.2pt;padding-right:69.2pt;text-align:justify;text-indent:36.55pt"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:118%">11.1&#160;&#160;&#160;&#160;</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">DISTRIBUTOR  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">AGREES  THAT ZO SKIN  HEALTH'S  TOTAL AGGREGATE </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">LIABILITY </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">UNDER </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">TIDS </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">AGREEMENT SHALL NOT EXCEED THE</font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:118%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">AGGREGATE AMOUNTS </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">PAID BY DISTRIBUTOR </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">TO ZO SKIN HEALTH FOR PRODUCTS UNDER THIS AGREEMENT </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">DURING </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">THE IMMEDIATELY </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">PRECEDING </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">TWELVE </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%">(</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">12</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%">) </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">MONTHS OR, IN </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">THE </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">EVENT </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">THIS </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">AGREEMENT HAS </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">BEE</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">N </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">IN EFFECT LESS </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">THAN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">TWELVE (12) MONTHS, TWELVE </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(12) </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">ANNUALIZED </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">MONTHS </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">FROM </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">THE </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">EFFECTIVE </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">DATE.</font></div><div style="height:57pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:38.063%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Distribution </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Agreement ZO Medical &#8211; </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Int&#8217;l</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Form </font><font style="color:#6b6b6b;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">v. </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">4</font><font style="color:#9c9c9c;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">.</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">0 </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">- </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cutera final-2</font><font style="color:#b3b3b3;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">.</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.537%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.65pt;padding-left:1pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">19</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_58"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9.05pt;padding-left:14.4pt;padding-right:66.85pt;text-align:justify;text-indent:36.75pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.2&#160;&#160;&#160;&#160;</font><img alt="image_8a.jpg" src="image_8a.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:43px"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN  NO EVENT WILL ZO SKIN HEALTH BE LIABLE TO DISTRIBUTOR FOR CONSEQUENTIAL, EXEMPLA</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">R</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Y, INCIDENTAL OR IN</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">DI</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">RECT OR PUN</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IT</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IVE DAMAGES OR LOSS OF GOO</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">D</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WILL, BUSINESS OPPO</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">R</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">TUNITY OR PROFIT, IN CONNECTION  W</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IT</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">H THE  SU</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">P </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PLY,  USE OR PERFORMANCE  </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">OF</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> THE  PRODUCTS</font></div><div style="padding-left:14.7pt;text-align:justify"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AND RELATED  PRODUCTS PROVIDED  </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">H</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EREUNDER, OR IN CONNECTION  WITH</font></div><div style="padding-left:14.35pt;text-align:justify"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ANY   C</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">L</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AI M  ARISING  FROM   OR  RELATED  TO THIS AGREEMENT,   EVEN  IF</font></div><div style="margin-top:0.25pt;padding-left:13.5pt;padding-right:67.25pt;text-align:justify;text-indent:0.1pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">D</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ISTRIBUTOR  HAS BEEN ADVISED OF THE POSSIBILITY OF  SUCH DAMAGES  OR  IF THE EXCLUSIVE REME</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">D</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IES STATED HEREIN FAIL OF THEIR ESSENTIAL PURPOSE.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:13.65pt;padding-right:67.2pt;text-align:justify;text-indent:36.5pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:117%">11.3&#160;&#160;&#160;&#160;</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">D</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">ISTRIBU</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">TO</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">R FURTHER AGREES </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">T</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">HAT THE BENEFITS OF THIS SECTION 11 SHALL EQUALLY APPLY TO PERSONS OR ENTITIES RELATED TO ZO SKIN </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:117%">HEALTH, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">INCLU</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">D</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">ING ITS </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:117%">PAST</font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:117%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">CURRENT AND FUTURE EMPLOYEES</font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">ATTORNEYS AND </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">DI</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">STRIBU</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">T</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">ORS</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">.</font></div><div><font><br></font></div><div style="padding-left:13.4pt;padding-right:67.95pt;text-align:justify;text-indent:36.75pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.4&#160;&#160;&#160;&#160;</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithsta</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">n</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">g  </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">he  foregoi</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">n</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">g  provisions of this Section 1</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,  </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">th</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s  Agreement shall  not limit the liab</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">lity of </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ZO </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SKIN HEALTH for perso</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">n</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">al injury, including deat</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">h</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">arising from the gross negligence or wi</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ll</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ful misconduc</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of ZO SKIN HEALTH or its employees acting with</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in  </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">h</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e  </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">scope  </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of their employment, or  for  strict  product  </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Li</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ability  to the extent the Parties are prohibited by applicable law from limiting ZO SKIN HEALTH&#8217;s respons</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ib</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ility therefor</font><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:10.2pt;padding-left:31.35pt;text-indent:-17.4pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;PR</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">OP</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RIETARY RIGHTS</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:13.15pt;padding-right:68.5pt;text-align:justify;text-indent:-0.05pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Except as otherwise provided herein, ZO SKIN HEALTH expressly reta</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ns tit e and ownership to al</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">l  </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">worldwide  Inte</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ll</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ectual  </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">P</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">roperty rights, including w</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">thout </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">li</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">mitation, des</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">gn,  know-how, patent  rights,  trademarks,  and copyrights in and to the Products or used in connection with Related Products, ZO SKIN HEALTH trademarks</font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">service marks </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">n</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">logos, and any modifications</font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">adaptations, derivative works</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and enhancements made t</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">h</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ereto.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:31.2pt;text-align:right;text-indent:-16.7pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">C</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">O</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NFIDENTIALITY</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:11.15pt;padding-right:69.65pt;text-align:justify;text-indent:36.55pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">13.1&#160;&#160;&#160;&#160;</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">D</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">e</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">fini</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">t</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">i</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">ons</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">p</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">urposes of this Agreement, &#8220;Trade Secrets&#8221; means information which&#58;  </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">derives economic value, actual or potential</font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">from not be</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ng generally known to, and not bei</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">n</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">g readily ascertainable by proper means by, other persons who can obtain economic value from its disclosure or use&#59; a</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">n</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d (b) is the subject of efforts tha</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">are reasonable </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">u</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">nder the circumstances to maintain </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ts </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">secrecy. </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Confidential </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Information&#8221; means information, other than Trade Secrets</font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">h</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">at is of value to </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ts owner and is treated as confidential</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Proprietary </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Information&#8221; </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">m</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">eans Trade Secrets and Confidentia</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">l </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Information.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:10.3pt;padding-right:69.7pt;text-align:justify;text-indent:37.45pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%">13.2&#160;&#160;&#160;&#160;</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%;text-decoration:underline">Nondis</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%;text-decoration:underline">cl</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%;text-decoration:underline">o</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%;text-decoration:underline">sur</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%;text-decoration:underline">e </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%;text-decoration:underline">R</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%;text-decoration:underline">e</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%;text-decoration:underline">qu</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%;text-decoration:underline">ire</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%;text-decoration:underline">men</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%;text-decoration:underline">ts</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%">. </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Each Party agrees </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">t</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">o ho</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">d Proprietary Info</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">rm</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ation of  the  other Party in  s</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">tr</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ictest confi</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">d</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ence and not to copy, reproduce, distrib</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">u</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">te</font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">,  </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">manufacture, duplicate, reveal</font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">report, pub</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ish, disc</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ose, cause to be disclosed, or otherw</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">i</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">se transfer the Proprietary  Information  of  the other Party to any </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">t</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">hir</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">d </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">party, or util</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">iz</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">e such Proprieta</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">r</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">y </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">I</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">nformation for any  purpose  whatsoeve</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">r </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">other  </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">t</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">han as expressly contemp</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ated  by this Agreement or  as  othe</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">r</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">wise  agreed  to in w</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">r</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">iting  by the  Parties. Each Party may on</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">y d</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">i</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">sc</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ose the other Party&#8217;s Prop</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">r</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ietary Information to employees</font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">re</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">p</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">resentatives </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">consulta</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">n</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ts of such Party who are under a written obligation to comply with the nond</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">i</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">sclosure obl</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">i</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">gations set forth herein. Each Party agrees to notify the </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">other </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Party in wr</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">i</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ting of any suspec</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">t</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ed or known breach of the</font></div><div style="height:56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.654%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Agreement ZO Medical </font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#126;Int&#8217;l</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Form v.</font><font style="color:#878787;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4</font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">.0 </font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8211; </font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Cutera final</font><font style="color:#565656;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.678%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">20</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_61"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9.05pt;padding-left:13.4pt;padding-right:66.75pt;text-align:justify;text-indent:1pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">obligations or </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">restrictions </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">set forth in this Section 13. The obligations of this Section 13.2 shall continue for so </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">long </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">as such information constitutes a </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Trade Secret </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">under </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">applicable law </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and for </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Confidential Information, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">for the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">term </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of this Agreement and for a period </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">three (3) years following termination or expiration of this Agreement. Notwithstanding </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">foregoing, any </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">previously </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">executed nondisclosure agreement between the Parties shall continue </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">full force </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">effect, provided </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">that </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to the extent of any </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">inconsistency </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or ambiguity </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">between </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">such non-disclosure</font></div><div style="margin-top:1.1pt;padding-left:13.95pt;padding-right:67.4pt;text-align:justify"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">agreement and this Agreement, this Agreement shal</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">l </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">take </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">precedence </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">and control </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">and </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">govern </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">all respects.&#160;&#160;&#160;&#160;</font><font style="color:#8a8a8a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">&#183;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:13.15pt;padding-right:67.3pt;text-align:justify;text-indent:36.45pt"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%">13.3&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%;text-decoration:underline">Exceptions</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%">. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">The foregoing obligations of this Section 13 shall not apply </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">if </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">and to the extent that&#58; (i) the information communicated was </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">already </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">known to a </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Party </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">without obligation to keep such </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">information </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">confidential at </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the time </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">of a </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Party's </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">receipt from the other </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Party&#59; </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(ii) the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">information </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">communicated was </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">recei</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">v</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">ed by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">a Party </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">good </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%">faith </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">from a </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">third </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">party </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">lawfully in possession </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">thereof and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">having no </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">obligation to keep such </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">informa</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">tio</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">n </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">confidential, or</font></div><div style="padding-left:13.3pt;padding-right:67.85pt;text-align:justify;text-indent:0.05pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">(iii)&#160;&#160;&#160;&#160;a  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Party </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">establishes that the information communicated was publicly known at the time of such </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Party&#8217;s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">receipt from the other Party </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">or has </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">become publicly </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">known </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">other than by a </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">breach </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">of </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Agreement. </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">If </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">either </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Party is required </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">to disclose all or </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">part </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">of </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Proprietary Information of </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">the  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">other  Party  pursuant  to  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">any </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">legal requirement of </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">any </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">country which </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">may </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">have jurisdiction over that </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Party</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">such </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Party </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">shall </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">immediat</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">e</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">ly </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">upon </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">becoming </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">aware that such disclosure is required, give the other </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Party notice </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">of </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">circumstances in which the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">disclosure is </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">required </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">and</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">subject to applicable </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">law</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">agree </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">with  the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">other </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Party </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">on the extent and timing of such </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">disclosure.</font></div><div style="margin-top:9.7pt;padding-left:36.05pt;text-align:right;text-indent:-16.75pt"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">TRADEMARKS</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:16.05pt;padding-right:68.6pt;text-align:justify;text-indent:36.5pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%">14.1&#160;&#160;&#160;&#160;</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">Use of </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">ZO SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">HEALTH </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">Marks</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%">.  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO SKIN  HEALTH  hereby grants    to </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and Distributor hereby </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">accepts </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">from ZO SKIN HEALIB, a </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">nonexclusive</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">nontransferable </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">r</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">oya</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">lty-free </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">license </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">use the ZO SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:122%">HEALTH </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Marks </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">set </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">forth on Exhibit C  hereto,  solely </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">connection with the marketing,  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">distribution,  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">promotion,  advertising  and sale  of  the  Products  and Related Products  in the  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Territory </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">accordance with </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">any </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO SKIN </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">standards and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">instructions</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and for no other purpose. ZO SKIN HEALTH may </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">inspect </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and monitor </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor's use </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO SKIN </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">HEALTH Marks. D</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">istributo</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">r </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">not </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">adopt,  use  or   </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">register  any  </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">words, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">phrases or symbols which are identical to or confusingly similar </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">any of  the ZO SKIN HEALTH Marks or oppose any such registration by ZO SKIN HEALTH. </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor is </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">not granted any </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">right, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">title or interest </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the ZO </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">HEALTH Marks other </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">than </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">foregoing limited license, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Di</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">stributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">not </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">use </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ZO SKIN HEALTH Marks as part of </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor's </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">business entity or trade name or </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">permit </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">any third party </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">do so.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:15.35pt;padding-right:68.6pt;text-align:justify;text-indent:36.2pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%">14.2&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%;text-decoration:underline">Markings</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:119%">.   </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Dist</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ributor  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">shall  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">not  remove </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">or  alter  any ZO  SKIN  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">trade  names,</font><font style="color:#c6c6c6;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">trademarks, copyright notices, serial </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">numbers</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">labels</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">tags or other </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">identifying </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">marks, symbols or legends affixed </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">to </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">any Products or </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Related Product</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">s, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">documentation </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">or containers  or  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">packages.  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:119%">In  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">the  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">event re-labeling, insertion </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">of </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">legends  and&#47;or  any  other regulatory modifications or </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">insertions to labeling, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">tags or </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">legends </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">are required by </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Territory&#8217;</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">competent regulatory autbori6es, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">shall </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">provide </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">advance written </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">notice </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">of such requirements to ZO SKIN HEALTH and the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Parties </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">shall work together to satisfy those requirements.</font></div><div style="height:57pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.500%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Distribution Agreement ZO Medical&#8226; Int&#8217;l Form v</font><font style="color:#afafaf;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">. </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">4,0 -Cutera </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">flnal-</font><font style="color:#727272;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.678%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.65pt;padding-left:1pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">21</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_64"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9.15pt;padding-left:18.1pt;padding-right:66pt;text-align:justify;text-indent:36.85pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">14.3&#160;&#160;&#160;&#160;</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%;text-decoration:underline">Infringements</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">.  </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Distributor shall provide prompt notice to ZO  SKIN </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">HEALTH </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">of any infringement or potential infringement of the ZO SKIN HEALTH Marks by a  third  </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">party </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">and of any challenge </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">to </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">its use of the ZO SKIN HEAL</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">TH </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Marks by a third party. ZO  SKIN  HEALTH  </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">reserves  </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">the right  in  its  sole  discretion  to  </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">institute</font><font style="color:#bdbdbd;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">. </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">any  proceedings against third party </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">infringers </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">of the ZO SKIN HEALTH </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Marks</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">and </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">shall refrain from  </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">doing </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">so.  Distributor shall cooperate fully with ZO SKIN HEALTH in any legal action taken  by  ZO SKIN HEALTH against </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">such third parties, provided that ZO SIG</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">N </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">HEALTH shall </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">pay </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">all expenses of such action and all damage</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">s</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%"> </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">which may be awarded or agreed </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">upon </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">in settlement of such action shall accrue to ZO SKIN HEALTH.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:18.25pt;padding-right:66.6pt;text-align:justify;text-indent:36.7pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">14.4&#160;&#160;&#160;&#160;</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Termination of </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Use</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">. </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Except as o</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">t</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">herwise provided </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">in </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Section 8.3(c) hereof</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">upon termination of this Agreement, </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">shall immediately cease any use of the ZO SKIN HEALTH Marks in any manner. </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">addit</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">i</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">on</font><font style="color:#6d6d6d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">hereby appoints ZO SKIN HEALTH its attorney </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">in </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">fact</font><font style="color:#6d6d6d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">which appointment is coupled with an interest</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">to allow ZO SKIN  HEALTH to cancel, revoke or withdra</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">w </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">any governmental registration or authorization permitting </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Distributor to use the </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">ZO SKIN HEALTH Marks in the Territory. To effectuate the purposes of this </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">provision</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Distribut</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">r shall sign and </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">deliver </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">any </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">documents </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">and perform any </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">further </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">acts as ma</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">y </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">be </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">reasonably requested by ZO SKIN HEALTH.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:17.5pt;padding-right:66.9pt;text-align:justify;text-indent:36.95pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:110%">14.5&#160;&#160;&#160;&#160;</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:110%;text-decoration:underline">Distributor</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:110%">  </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:110%;text-decoration:underline">Web Sites</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:110%">.   </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">Notwithstanding anything  herein to </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">the </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">contrary</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:110%">1 </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">Distributor shall </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">not </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">operate an Internet site that </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">references </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">any of the </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">P</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">r</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">oducts or Related </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">Products  </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">or  the  ZO SKIN HEALTH Marks (</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">&#34;</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">Distributor Web Site&#34; </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">) </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">without the prior written consent of ZO SKIN HEALTH, not to be unreasonably withheld</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">. </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">In </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:110%">consideration of</font></div><div style="margin-top:0.65pt;padding-left:17pt;padding-right:66.85pt;text-align:justify;text-indent:1pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">ZO SKIN HEALTH allowing Distributor to reference the Products and Related </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Products </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">or use the ZO SKIN HEALTH Marks in </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">the Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Web Site</font><font style="color:#6d6d6d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">, </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">ZO </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">SKIN HEALTH </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">may </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">provide and Distributor shall </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">post upon </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">mutual agreement on </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">the Distributor Web </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Site within the </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Territory, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">mandatory content</font><font style="color:#6d6d6d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">, </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">including </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">but not limited </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">to </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">privacy policies</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">terms of use</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">copyright and </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">trademark </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">notices</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">and graphic</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">s </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">and </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">trademark policies. </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Subject to ZO SKIN HEALTH&#8217;s prior written consent and upon mutual agreement</font><font style="color:#6d6d6d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">, </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">shall prominently provide on </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">the home page </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">of </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">the </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Distributor Web Site within the </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Territory a link to ZO SKIN HEALTH&#8217;s </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Internet </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">site in location, style, size and </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">manner </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">specified by ZO SKIN HEALTH</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:11.15pt;padding-left:17.05pt;padding-right:70.65pt;text-align:justify;text-indent:36.95pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:114%">14.6&#160;&#160;&#160;&#160;</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:114%;text-decoration:underline">Internet Search Strategies</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:114%">. </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">Distributor may not use any ZO SKIN HEALTH Mark or any of the Products and Related </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">Products </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">in connection with any domain name</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">directory</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">address</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">, </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">locator, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">linking</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">co-branding</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">metatag, or with </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:114%">any </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">other Internet search strategy.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:34.3pt;text-align:right;text-indent:-20.8pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;INSURANCE</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:17.6pt;padding-right:67.8pt;text-align:justify;text-indent:34.45pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:114%">15.1&#160;&#160;&#160;&#160;</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:114%;text-decoration:underline">Distributor Insurance.</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:114%"> </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">shall</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">at it</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">s </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">own </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">co</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">s</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">t and </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">e</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">x</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">pense, obtain and maintain </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">in full force</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%"> and effect the following insurance </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">during </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">the term of this Agreement&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:48.1pt;padding-right:67.7pt;text-indent:35.05pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Commercial and Umbrella </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#47; </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Excess General Liability </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">insurance </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">with per occurrence and general aggregate </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">limits</font><font style="color:#6d6d6d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">combined</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">of </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">not less </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">than </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$1</font><font style="color:#6d6d6d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">000,000 </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">per occurrence and in the </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">aggregate&#59;</font></div><div style="height:58pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.781%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Di</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">s</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">tribu</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ti</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">on </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">A</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">gr</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ee</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ment </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Z</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">O </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Med</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">i</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ca</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">l &#8226; Int&#8217;l F</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">o</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">rm </font><font style="color:#6d6d6d;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">v</font><font style="color:#979797;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">. </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4.0</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#183; </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">C</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ut</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">era final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.678%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">22</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_67"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9.5pt;padding-left:50pt;padding-right:66.45pt;text-indent:34.6pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">Products </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">and Completed Operations Liability Insurance with $1</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">,</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">000,000 each claim and general aggregate </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">limits </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">of not </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">less </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">than $5</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">,</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">000</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">,</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">000&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:50pt;padding-right:66.9pt;text-indent:34.6pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">(c)&#160;&#160;&#160;&#160;Workers' Compensation Insurance with statutory </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">limits </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">for Workers' Compensation to the extent required </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor&#8217;s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">jurisdiction&#59;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:49.75pt;padding-right:66.45pt;text-indent:34.85pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(d)&#160;&#160;&#160;&#160;Distributor shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">obta</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">i</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">n </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">a waiver from any insurance carrier with whom </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">carries Workers&#8217; Compensation insurance releasing its subrogation rights against ZO SIGN HEAL</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:115%">TH.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:49.55pt;padding-right:67.05pt;text-indent:34.6pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Distributor </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">shall furnish certificates of insurance for all of the above noted policies  as soon as practicable </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">after </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the Effective Date and upon </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">renewal </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or replacement of any such policies.  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Each insurance policy </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">that is required </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">under this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Section 15.1 shall be obtained from an </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">insurance </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">carrier with an A</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">.</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">M. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Best rating </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of at </font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">l</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">east</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">A-.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:14.25pt;padding-right:67.7pt;text-align:justify;text-indent:34.9pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%">15.2&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%;text-decoration:underline">ZO SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%;text-decoration:underline">BEALTH </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%;text-decoration:underline">Insurance.</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">ZO SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">shall, at its own cost and expense</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:118%">1 </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">obtain and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">maintain in full </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">force and effect the following </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">insurance </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">or program of self-insurance (provided ZO SKIN </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">HEAL</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">TH</font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:118%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">maintains a </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">financial </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">condition </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">reasonably </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">sufficient to cover such commitments) during </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">term of this Agreement&#58;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:54pt;padding-right:66.65pt;text-indent:34.6pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(a)&#160;&#160;&#160;&#160;Commercial and Umbrella &#47; Excess General Liability </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">insurance </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">with per occurrence and general aggregate </font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">l</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">imits</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">combined</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">of not less than $5</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">,</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">000,000 per occurrence and </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">aggregate</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">&#59;</font></div><div style="margin-top:0.4pt;padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;padding-right:66.65pt;text-indent:34.5pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Products and Completed Operations Liability Insurance with per occurrence and general aggregate </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">limits </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of not less than $5</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">000,000&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:48.85pt;padding-right:67.35pt;text-indent:34.8pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Distributor shall be named as additional </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">insured </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">under the Commercial General Liability and Products and Comp</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">l</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">eted Operations </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Liability </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">insurance </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">policies </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as respects  the  products and  completed operations  outlined  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">this Agreement, subject to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the limitations </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of those </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">insurance </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">policies.</font></div><div><font><br></font></div><div style="padding-left:48.55pt;padding-right:75.85pt;text-indent:0.25pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ZO SKIN </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:119%">HEALTH </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">furnish </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Distributor certificates of insurance for any policies obtained and which reflect that Distributor </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">is </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">an additional insured as soon as practicable after the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Effective </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Date and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">upon </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">renewal or replacement of any such policies. Any insurance policy that </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">is </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">obtained in</font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">satisfaction of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">this </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Section 15.2 shall be obtained from an insurance carrier with an A.M. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Best </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">rating of at least A-</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:40.1pt;text-align:right;text-indent:-21.75pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">MISCELLANEOUS.</font></div><div style="margin-top:11.3pt;padding-left:13.5pt;padding-right:67.95pt;text-align:justify;text-indent:40.5pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:123%">16.1&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:123%;text-decoration:underline">Independent Contractors</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:123%">. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Notwithstanding anything set forth herein to the contrary</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">relationship </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">of the Parties </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">is </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">that of independent contractors, and nothing herein shall be construed to create a partnership, joint venture</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">franchise, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">employment or agency relationship  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">between the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Parties. Neither Party shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">have </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">authority to enter </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">into </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">agreements of any kind on behalf of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">other </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Party </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">and shall not have the power or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">authority </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">to bind or obligate </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">other </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Party </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">in any manner to any third </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">party.</font></div><div style="height:56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.372%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.65pt;padding-left:1pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Di</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">s</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">tri</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">b</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">uti</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">o</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">n A</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">gree</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">m</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">e</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">nt </font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">ZO M</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">edical </font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">&#8211; </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Int&#8217;l Form</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">v</font><font style="color:#959595;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">4 </font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">,0 </font><font style="color:#7e7e7e;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">- </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cutera final-</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.678%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">23</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_70"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:14.9pt;padding-right:66.9pt;text-align:justify;text-indent:35.25pt"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">16.2&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%;text-decoration:underline">Assignment</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">. </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Neither </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Party shall assign or otherwise </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">transfer </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">i</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">ncluding by operation of </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">law </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">its rights or obligations </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">under </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">this Agreement without the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">prior </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">written consent of the other </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Party.</font></div><div><font><br></font></div><div style="padding-left:14.4pt;padding-right:66.25pt;text-align:justify;text-indent:34.75pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%">16.3&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%;text-decoration:underline">Force </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%;text-decoration:underline">Majeure</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%">. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Except for </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor</font><font style="color:#676767;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">'</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">s obl</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">i</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">gation to </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">pay </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">under Section 7, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">neither  Party  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">shall </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">be liable </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">fo</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">r </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">any failure to </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">perform </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">or delay in performance of </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">its </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">obligations  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">hereunder  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">caused  by  circumstances  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">beyond </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">its </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">reasonable </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">control</font><font style="color:#676767;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">includ</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">i</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">ng, but not limited </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">to</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">,  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">fire, storm, flood,  ea</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">rthquake</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">,  explosion,  accident,  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">acts </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">of a public  enemy or  rebe</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">lli</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">on</font><font style="color:#676767;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">insurrection, riot, civil commotion, strikes or other labor disputes, sabotage, epidemic, quarantine </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">or </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">any agency thereof, judicial action, raw product shortages, and any other such external circumstances (a </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">&#8220; </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Force </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Majeure&#8221;).</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:14.25pt;padding-right:67.6pt;text-align:justify;text-indent:34.9pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%">16.4&#160;&#160;&#160;&#160;</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%;text-decoration:underline">No</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%;text-decoration:underline">tic</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%;text-decoration:underline">e</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%;text-decoration:underline">s</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%">. </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">No</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">tices </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">p</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">ermitted or required to be given </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">hereunder </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">shall </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">be deemed </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">sufficient </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">if </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">given by (a) registered or cert</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">i</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">fied  mail, postage prepaid</font><font style="color:#676767;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">,  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">return receipt requested,</font></div><div style="padding-left:14.4pt;padding-right:67.15pt;text-align:justify;text-indent:-0.15pt"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:115%">(b) </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">reliab</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">l</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">e private courier service, such as Federal Express, or (c) </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">facsimile </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">sent to the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">respective </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">addresses  or  facsim</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">il</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">e  </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">numbers  </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">and  to the attention of the representatives of </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">the </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Parties </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">set forth</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">below or at  such other addresses or facsimile </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">numbers </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">or </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">representative </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">as the respective</font></div><div style="margin-top:0.1pt;padding-left:14.3pt;padding-right:67.1pt;text-align:justify;text-indent:-0.65pt"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Parties may </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">designate by </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">lik</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">e </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">notice </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">from </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">time </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">to time. </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Notices </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">so given shall be effective upon receipt </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">by </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">the Party to which </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">notice </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">i</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">s </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">given.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:86.6pt"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">To ZO SKIN HEALTH&#58;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:121.05pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ZO </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Skin Health, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Inc.</font></div><div style="margin-top:0.15pt;padding-left:121.1pt"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attn&#58; James </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">R. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Headley, </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pre</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ident </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#38; </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CEO</font></div><div style="margin-top:0.6pt;padding-left:117.55pt;padding-right:232pt;text-indent:0.35pt"><font style="color:#313131;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:123%">1 </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Technology </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Drive, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">Suite B-123 Irvine, CA</font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:123%"> </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:123%">92618</font></div><div style="padding-left:117.65pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Fax&#58; (949) 988-7544</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:86.9pt"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">With </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">a </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">cop</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">y </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">to&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:117.9pt;padding-right:308.9pt;text-indent:1.2pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">William P</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Cates </font><font style="color:#676767;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Esq. Cates </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Peterson </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">LLP</font></div><div style="margin-top:0.4pt;padding-left:117.5pt;padding-right:268.85pt;text-indent:0.6pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">4100 Newport </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Place</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Suite </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">230 </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Newport </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">B</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">each, CA 92660 Fax&#58; </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">(949) </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">724</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">-</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">1190</font></div><div style="margin-top:10.65pt;padding-left:85.65pt"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">To Distributor&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:119.35pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CUTERA</font><font style="color:#676767;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">INC.</font></div><div style="margin-top:0.85pt;padding-left:116.45pt;padding-right:126.4pt;text-indent:-0.15pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Attn&#58; </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Rajesh </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Madan, Vice </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">President </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">of </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Fin</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">ance </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">and Legal </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">3240 </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Brisbane Blvd.</font><font style="color:#777777;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">,</font></div><div style="margin-top:0.4pt;padding-left:116.2pt"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Brisbane, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CA 94005</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:116.2pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Fax&#58; (415) 715-3529</font></div><div style="height:57pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.654%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Agreement </font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ZO </font><font style="color:#676767;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Medica</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">l</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">- </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Int&#8217;l Form</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> v</font><font style="color:#777777;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">. </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4.0</font><font style="color:#575757;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">- Cutera</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> fina</font><font style="color:#676767;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">1</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">-</font><font style="color:#676767;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.678%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">24</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_73"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9.05pt;padding-left:86.9pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:114%">With </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:114%">a </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:114%">copy to&#58;</font></div><div style="padding-left:116.45pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:119%">CUTERA</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:119%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">K.K</font><font style="color:#3f3f3f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:119%">.</font></div><div style="margin-top:0.15pt;padding-left:116.6pt;padding-right:174.1pt;text-indent:-0.35pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">Attn&#58; Chris West, Vice President Pacific Rim, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">Japan </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">12-10 </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">Sakuragaoka-cho</font></div><div style="padding-left:116.65pt;padding-right:309.25pt;text-indent:0.35pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Infoss Annex Bldg. 3F Shibuya-ku, Tokyo Japan </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">150-0031</font></div><div style="padding-left:116.15pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Email&#58; cwest&#64;cutera.com</font></div><div style="margin-top:11.6pt;padding-left:10.85pt;padding-right:68.45pt;text-align:justify;text-indent:36.4pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">16.5&#160;&#160;&#160;&#160;</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Arbitratio</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">n</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">any dispute arises between </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">and ZO SKIN HEALTH relating to the subject matter of this Agreement, Distributor and ZO SKIN HEAL</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">TH </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">shall each make a good faith effort </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">neg</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">otiate </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">an amicable settlement of such matter</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">The </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Parties agree that, except as otherwise provided </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">below, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">any </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">disput</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e,</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> claim or controversy arising out of or relating </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in any </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">way </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Parties&#8217;</font><font style="color:#757575;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"> </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">relat</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">i</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">onship and&#47;or to this Agreement </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">or </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">the breach, termination, enforcement, interpretation or validity thereof, including the determination of the </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">scope </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">or applicability of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">this </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Agreement to arbitrate</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">be </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">determined </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">by </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">arbitration in </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Orange </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">County</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">California</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">United States, before one arbitrator. The arbitration shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">be </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">administered </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">by </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Judicial Arbitration and Mediation Services (&#8220;JAMS&#8221;</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">) </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">pursuant to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">its </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Comprehensive Arbitration </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Rules </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Procedures. Judgmen</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">t </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">on the award may </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">be </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">entered </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in a</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">ny court having jurisdiction. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">To </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">the maximum </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">extent </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">possible, the existence</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">s</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">ubject, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">evidence</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">proceedings, and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">ru</font><font style="color:#0a0a0a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">l</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">ing resulting from the arbitration proceedings shall </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">be</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> deemed confidential information, and sha</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">ll </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">not be disclosed by either </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Party</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">their representatives, or the arbitrator, except&#58; (a) </font><font style="color:#3f3f3f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">the </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">professiona</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">l </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">advisers of ZO SKIN HEALTH and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Distributor&#59; </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b) in </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">connection with a public offering of securities </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">by </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">ZO </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">SKIN </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">HEALTH or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Distributor</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(c) as o</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">rd</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">ered by </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any c</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">ourt of competent </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">jurisdiction&#59; </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">or (d) as required to comp</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">l</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">y with any applicable governmental </font><font style="color:#3f3f3f;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">statute </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">or </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">regulati</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">n The arbitrator sha</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">ll </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">be </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">required to prepare written findings of fact. </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Notwithstanding </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">the foregoing, either </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Party </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">may apply </font><font style="color:#3f3f3f;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">a court of competent jurisdiction for a temporary restraining order, preliminary </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">injunction or </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">other equitable relief</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">as </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">necessary </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">in order to supplement  the  claims presented in the arbitration</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">without </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">breach </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">of this arbitration agreement and without abridgement of  the powers of  the  arb</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">i</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">trato</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">r</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:11.35pt;padding-left:9.9pt;padding-right:69.95pt;text-align:justify;text-indent:35.45pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:114%">16.6&#160;&#160;&#160;&#160;</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:114%;text-decoration:underline">A</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:114%;text-decoration:underline">ttorney</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:114%;text-decoration:underline">s' Fees</font><font style="color:#757575;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:114%">. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">If </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">any </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">Party </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">brings an action or proceeding to enforce this Agreement or its rights under this Agreement, the P</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">r</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">evailing </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">Party </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">(as hereafter defined) </font><font style="color:#2f2f2f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:114%">in </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">any </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">s</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">uch </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">proceeding </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">or </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">action, or appeal </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">thereon</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">shall be entitled </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:114%">to </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">reasonab</font><font style="color:#0a0a0a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">l</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">e attorneys</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">' </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">fees and costs.  S</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">u</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">ch fees and costs may </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">be </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">awarded in</font><font style="color:#2f2f2f;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:114%"> </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">the same action or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">proceeding </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">recovered </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">in</font><font style="color:#3f3f3f;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%"> </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">a separate action or </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">proceeding</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">whether or not such action or proceeding </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">is </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">pursued </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:114%">to </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">decision or judgment.  The term, </font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">&#8220;</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">Prevailing </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">Party&#8221;</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%"> </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">inc</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">lude,</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%"> without </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">limitation, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">a Party </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">who </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">substantially obtains </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">or </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">defeats the relief sought, as the case may </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">be, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">whether by </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">compromise, settleme</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">nt, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">judgment., or the abandonment </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">b</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">y </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">the other </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">Party </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">of its </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">claim </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">or defense.</font></div><div><font><br></font></div><div style="padding-left:8.6pt;padding-right:70.35pt;text-align:justify;text-indent:36.3pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:114%">16.7&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:114%;text-decoration:underline">Governing </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:114%;text-decoration:underline">Law</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:114%">. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">This Agreemen</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">t </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">has </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">been made</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">executed </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">and </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">delivered </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">in </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">California, in which state the offices of </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">ZO </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">SKIN HEALTH</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:700;line-height:114%"> </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">are </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">l</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">ocated</font><font style="color:#757575;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">. </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">Accordingly, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">the Parties  </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">invoke the laws o</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">f </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">C</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">alifornia regarding </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">the protection of their rights and enforcement of their obl</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">i</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">gations hereunder and they mutually </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">sti</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">pulate </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">and agree that this Agreement is </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">in </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">all respects </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">(</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">including</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">but not limited to</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">all matters of interpretation</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">validity, performance and the </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">co</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">n</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">sequences  </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">of  breach) to be exclusive</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">l</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">y construed, </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">governe</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">d </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">and enforced in accordance with the </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">in</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">ternal </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">laws (excluding all conflict of laws ru</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">l</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">es) </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">of </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">Ca</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">l</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">ifornia and any a</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">p</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">plicable federal laws of the U</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">ni</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">ted States of America</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">as from time to time amended and in effect. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">The </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">Parties agree that the United Nations Convention on Contracts for the International Sale of</font></div><div style="height:57pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.372%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Distribution </font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Agreement ZO Me</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">d</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">ica</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">l -Int&#8217;l </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Form </font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">v. </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">4</font><font style="color:#8c8c8c;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">.</font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">0 </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">&#8226; Cutera </font><font style="color:#606060;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">final</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">-</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.678%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">25</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_76"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:12.5pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Goods shall not apply in any respect to this Agreement or the Parties.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:12.95pt;padding-right:69.15pt;text-align:justify;text-indent:34.3pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">16.8&#160;&#160;&#160;&#160;</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">No Solicitation of </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Related Personnel</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">. </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">During the term of this Agreement</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and for a period of twenty four (24) months after termination of this Agreement, </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">neither </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ZO SKIN HEALTH,  </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">nor  Distributor </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">nor  any subsidiary or parent thereof,  shall</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,  </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">directly  or indirectly</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)  solicit for  employment or  consulting engagement</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,  </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii) offer employment to</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or  </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">iii)  engage  the r elated  business services of any p</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">rson who </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">is </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or was an  officer</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">employee or consultant of the other Party.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:12.9pt;padding-right:68.65pt;text-indent:34.35pt"><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">16.9&#160;&#160;&#160;&#160;</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Entire </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Agreement&#59; Amendments&#59; </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Severability</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Agreement constitutes the entire agreement between the Parties concerning the subject matter hereof</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">upersedes and replaces all prior or contemporaneous understandings or agreements, written or ora</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">l</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">regarding such subject matter. No amendment to or modification of this Agreement</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or an</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">y </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">waiver of any term or condition of this Agreement will be binding </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">unless </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in writing and signed by a duly authorized representative of both Parties. The section and subsection headings in this Agreement are inserted solely as a matter of convenience and for reference</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and shall not be considered in the construction or interpretation of any </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">provision </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">hereof. </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">provision </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">hereof </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">is </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">declared invalid by a court or arbitral </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">tribunal </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of competent </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">jurisdiction</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">such </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">provision </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall be ineffective only to the extent of such invalidity</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">so that the remainder of that provision and </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">all </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">remaining provisions of this Agreement will continue in full force and effect.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:12.5pt;padding-right:69.2pt;text-align:justify;text-indent:34.75pt"><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%">16.10&#160;&#160;&#160;&#160;</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%;text-decoration:underline">Language</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%">. </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">The official </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">language </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">of this Agreement is English. All </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">c</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">ontract interpretations</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">notices </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">and </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">dispute </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">resolutions shall be in English. Any amendments to this Agreement shall </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">be in </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">English. Translations of any of these documents shall no</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">t </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">be construed as official or original versions of the documents</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">or otherwise referred to </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">in </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the interpretation or construction of the intentions o</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">f </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">the </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Parties hereto.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:11.95pt;padding-right:68.4pt;text-align:justify;text-indent:35.25pt"><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:118%">16.11&#160;&#160;&#160;&#160;</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:118%;text-decoration:underline">Interpretation</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:118%">. </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">This </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Agreement </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">has </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">been negotiated between </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">unrelated </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Parties who  are  sophisticated and knowledgeable in  the  matters  contained in this Agreement and who have acted </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">in </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">their own self-interest. In addition</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">each Party has </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">been represented </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">by experienced and knowledgeable legal counsel. Accordingly</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">any rule of law, including Section 1654 of the California Civil Code, as well as any other statute, law, ordinance</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">or common law principle</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">or other authority of any jurisdicti</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">o</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">n of similar effect</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">or </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">legal </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">dec</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">i</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">sion </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">that </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">would require </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">interpretation </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">of any ambiguities </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">in </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">this Agreement against the Party who has drafted </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">it </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">is not applicable and is hereby waived</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">. </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">The </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">provisions of this Agreement shall not be interpreted or construed  against  </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">any </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Party  </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">to this Agreement because that </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Party </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">or any attorney or representative for that  </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Party </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">drafted this Agreement or participated </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">in </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">the drafting of this Agreement.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:11.35pt;padding-right:69.9pt;text-align:justify;text-indent:35.4pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">16.12&#160;&#160;&#160;&#160;</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Third </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Party </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Beneficiaries</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Nothing herein express or implied is intended to or will </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">be </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">construed to confer </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">upon </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or give an</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">y </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">person or entity</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">other than the </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Parties</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any rights or remedies under or by reason of this Agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:12pt;padding-right:69.65pt;text-align:justify;text-indent:34.75pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">16.13&#160;&#160;&#160;&#160;</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Public </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;text-decoration:underline">Announcements</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">. </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Neither </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Party </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">will make </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:120%">any </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">press release or other public disclosure </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">regarding </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">this Agreement or </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">he transactions contemplated hereby without the other  Party</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8217;</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s  express prior written consent</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">except as required under applicable </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">law  </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or regulations, including SEC </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">regulations, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">if applicable</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or by any governmental agency</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in which case the </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Party </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">required to make the press </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">release </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or public di</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">closure shall </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">use </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">commercially reasonable efforts to obtain the written approval of the other </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Party </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as to the form</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">nature and</font></div><div style="height:55pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:38.345%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Di</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">s</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">tri</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">b</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">u</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">tio</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">n Agreement </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ZO Me</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">di</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ca</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">l &#8211; Int&#8217;l Form </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">v</font><font style="color:#a7a7a7;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">, </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4</font><font style="color:#a7a7a7;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">.</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">0 </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8211; </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">C</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">utera fina</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">l</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.678%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">26</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_79"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:22.05pt;padding-right:75.85pt;text-indent:-0.5pt"><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">extent of the press release or </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">public disclosure prior </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">to </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">issuing </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">the press </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">release </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">or making the public disclosure.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.85pt;padding-left:21.6pt;padding-right:85.5pt;text-align:justify;text-indent:32.9pt"><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">16.14&#160;&#160;&#160;&#160;</font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Execution</font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">.  </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">This  </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Agreement may be executed </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">in </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">any numbe</font><font style="color:#151515;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">r </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of counterparts, each of which shall be deemed </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">an </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">original </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">hereunder. </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Each Party agrees </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">to be </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">bo</font><font style="color:#151515;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">und </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">by </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:112%">its </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">own facsimile or </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">telecopy </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">PDF </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">signature, and accepts </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">facsimile or </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">te</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">lecopy </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or PDF signature </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:112%">of </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the other Party hereto.</font></div><div style="margin-top:10.7pt;padding-left:21.95pt"><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accepted </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">agreed on behalf of&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:20.9pt"><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">ZO SKIN HEALTH, </font><font style="color:#bdbdbd;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">INC.&#160;&#160;&#160;&#160;CUTERA, INC.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:250.92pt;padding-right:250.92pt;text-align:center"><img alt="image_9a.jpg" src="image_9a.jpg" style="height:123px;margin-bottom:5pt;vertical-align:text-bottom;width:247px"><img alt="image_10a.jpg" src="image_10a.jpg" style="height:80px;margin-bottom:5pt;vertical-align:text-bottom;width:271px"><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Name&#58; Title&#58;</font></div><div style="height:68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.808%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution Agreement </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ZO Medical&#8226; Int&#8217;l Form v. 4</font><font style="color:#8e8e8e;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">.</font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">0 </font><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8226; </font><font style="color:#505050;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Cutera final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.537%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">27</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_82"></div><hr style="page-break-after:always"><div style="min-height:69pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.1pt;padding-left:32.2pt;padding-right:32.2pt;text-align:center"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:120%">EXHIBIT A</font></div><div style="margin-top:8.35pt;padding-left:33pt;padding-right:33pt;text-align:center"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:102%">TO THE DISTRIBUTION</font></div><div style="padding-left:31.92pt;padding-right:31.92pt;text-align:center"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:115%">AGREEMENT     BETWEEN</font></div><div style="margin-top:6.4pt;padding-left:32.37pt;padding-right:32.37pt;text-align:center"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:104%">ZO SKIN HEALTH, INC.</font></div><div style="padding-left:32.02pt;padding-right:32.02pt;text-align:center"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:87%">AND</font></div><div style="padding-left:30.65pt;padding-right:30.65pt;text-align:center"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:101%">CUTERA, INC</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:101%">.</font></div><div style="margin-top:0.1pt"><img alt="image_11a.jpg" src="image_11a.jpg" style="height:0px;margin-bottom:5pt;vertical-align:text-bottom;width:82px"></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43.9pt;text-align:right;text-indent:-34.45pt"><font style="color:#444444;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">PRODUCTS.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:44.3pt;padding-right:56.15pt;text-indent:0.15pt"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">ZO SKIN HEALTH skin care </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">products </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">currently subject to this </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Distribution </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Agreement include&#58;</font></div><div style="margin-top:4.55pt;padding-left:167.2pt;padding-right:167.2pt;text-align:center"><font style="color:#2f2f2f;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">SUGGESTED</font></div><div style="margin-top:3.4pt;padding-left:179.6pt;padding-right:179.6pt;text-align:center"><font style="color:#2f2f2f;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:154%">DISTRIBUTOR&#160;&#160;&#160;&#160;PRICE&#160;&#160;&#160;&#160;SUGGESTED PURCHASE&#160;&#160;&#160;&#160;TO&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;RETAIL</font></div><div style="padding-left:53.5pt;padding-right:53.5pt;text-align:center"><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:130%">ITEM#&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:130%">PRODUCT DESCRIPTION&#160;&#160;&#160;&#160;SIZE&#160;&#160;&#160;&#160;PRICE&#160;&#160;&#160;&#160;</font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:130%">CUSTOMERS&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:130%">PRICE</font></div><div style="margin-top:3.75pt;padding-left:11.1pt"><img alt="image_12a.jpg" src="image_12a.jpg" style="height:245px;margin-bottom:5pt;vertical-align:text-bottom;width:53px"><img alt="image_13a.jpg" src="image_13a.jpg" style="height:109px;margin-bottom:5pt;vertical-align:text-bottom;width:37px"><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">050000&#160;&#160;&#160;&#160;Oilacleanse</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">TM&#160;&#160;&#160;&#160;</font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">240ml&#47;8oz.</font></div><div style="margin-top:2.45pt;padding-left:11.1pt"><img alt="image_14a.jpg" src="image_14a.jpg" style="height:311px;margin-bottom:5pt;vertical-align:text-bottom;width:53px"><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">050100&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Normacleanse</font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8482;&#160;&#160;&#160;&#160;</font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">240ml&#47;8oz</font><font style="color:#777777;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:3.35pt;padding-left:11.1pt"><font style="color:#595959;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">050200&#160;&#160;&#160;&#160;</font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Balatone&#8482;&#160;&#160;&#160;&#160;180ml&#47;6oz.</font></div><div style="height:56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.077%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">D</font><font style="color:#777777;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">istribu</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">tion Agreement  ZO </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Medical </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">&#8211; Int&#8217;l Form </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">v</font><font style="color:#919191;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">. </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">4</font><font style="color:#919191;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">.</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">0 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">&#8226; </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cutera final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.255%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">28</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:69pt;width:100%"><div><font><br></font></div></div><div style="margin-top:2.9pt;padding-left:11.1pt"><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">051200     Glycogent&#8482;&#160;&#160;&#160;&#160;75ml&#47;2.5oz.</font></div><div style="margin-top:2.4pt;padding-left:11.1pt"><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">050300     Cebatrol&#8482; </font><font style="color:#595959;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(60 </font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">pads)&#160;&#160;&#160;&#160;</font><font style="color:#595959;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">75ml&#47;2.5oz.</font></div><div style="margin-top:2.9pt;padding-left:11.1pt"><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">050400&#160;&#160;&#160;&#160;RetamaxThl&#160;&#160;&#160;&#160;75ml&#47;2 </font><font style="color:#777777;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">.</font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5oz.</font></div><div style="margin-top:2.9pt;padding-left:11.1pt;padding-right:292.55pt"><img alt="image_15a.jpg" src="image_15a.jpg" style="height:18px;margin-bottom:5pt;vertical-align:text-bottom;width:34px"><img alt="image_16a.jpg" src="image_16a.jpg" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:20px"><img alt="image_17a.jpg" src="image_17a.jpg" style="height:126px;margin-bottom:5pt;vertical-align:text-bottom;width:35px"><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:148%">050500&#160;&#160;&#160;&#160;Brightenex'&#34;'&#160;&#160;&#160;&#160;75ml&#47;2.5oz</font><font style="color:#919191;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:148%">. </font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:148%">051</font><font style="color:#acacac;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:148%">.</font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:148%">600&#160;&#160;&#160;&#160;ZO&#174; Controlled Depth Pee&#8482;</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:148%">'&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#2f2f2f;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:148%">NIA </font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:148%">080000&#160;&#160;&#160;&#160;04rx Melamin</font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:148%">&#8482; </font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:148%">(Rx only)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;80g&#47;2</font><font style="color:#777777;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:148%">,</font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:148%">8oz.</font></div><div style="padding-left:11.1pt"><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:128%">080100&#160;&#160;&#160;&#160;08rx </font><font style="color:#2f2f2f;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:128%">Melamix&#8482;    </font><font style="color:#595959;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:128%">(Rx </font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:128%">only)&#160;&#160;&#160;&#160;80g&#47;2</font><font style="color:#777777;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:128%">.</font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:128%">8oz</font><font style="color:#919191;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:128%">,</font></div><div style="margin-top:2.35pt;padding-left:10.65pt"><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">080200&#160;&#160;&#160;&#160;Tretinoin </font><font style="color:#2f2f2f;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">0</font><font style="color:#595959;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">.1%   (</font><font style="color:#2f2f2f;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Rx </font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">only)&#160;&#160;&#160;&#160;2091.7oz.</font></div><div style="margin-top:2.4pt;padding-left:10.65pt"><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">080300&#160;&#160;&#160;&#160;Tretinoin0.05%  </font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Rx </font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">only)&#160;&#160;&#160;&#160;</font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">20gl.7oz</font></div><div style="margin-top:2.9pt;padding-left:10.65pt"><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">051000     Vitascrub&#8482; &#160;&#160;&#160;&#160;16291502</font><font style="color:#777777;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:2.9pt;padding-left:10.65pt"><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">051800&#160;&#160;&#160;&#160;lnvisapeel</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8482;</font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;50ml&#47;1 </font><font style="color:#777777;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">.</font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7oz.</font></div><div style="margin-top:2.35pt;padding-left:10.65pt"><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">511000&#160;&#160;&#160;&#160;Hydrafirm&#8482;&#160;&#160;&#160;&#160;1591.5oz.</font></div><div style="margin-top:2.4pt;padding-left:10.65pt"><img alt="image_18a.jpg" src="image_18a.jpg" style="height:75px;margin-bottom:5pt;vertical-align:text-bottom;width:38px"><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">051400&#160;&#160;&#160;&#160;Aknetrol&#8482;&#160;&#160;&#160;&#160;60mll2oz.</font></div><div style="margin-top:2.4pt;padding-left:9.65pt"><img alt="image_19a.jpg" src="image_19a.jpg" style="height:6px;margin-bottom:5pt;vertical-align:text-bottom;width:35px"><img alt="image_20a.jpg" src="image_20a.jpg" style="height:11px;margin-bottom:5pt;vertical-align:text-bottom;width:21px"><font style="color:#595959;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">520000&#160;&#160;&#160;&#160;ZO&#174;3</font><font style="color:#2f2f2f;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">-Step </font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Stimulation Peel&#8482; Kit&#160;&#160;&#160;&#160;6 Peels</font></div><div style="margin-top:2.45pt;padding-left:17.1pt"><img alt="image_21a.jpg" src="image_21a.jpg" style="height:31px;margin-bottom:5pt;vertical-align:text-bottom;width:29px"><img alt="image_22a.jpg" src="image_22a.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:38px"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">N&#47;A&#160;&#160;&#160;&#160;</font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Oclipse&#174; C SPF 50&#160;&#160;&#160;&#160;120ml&#47;4oz </font><font style="color:#777777;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:2.45pt;padding-left:17.3pt"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">N&#47;A&#160;&#160;&#160;&#160;</font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">LipRebuild&#8482;&#160;&#160;&#160;&#160;15gl</font><font style="color:#777777;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">.</font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5oz.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:18.25pt;text-indent:-5.35pt"><font style="color:#595959;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Conversion </font><font style="color:#2f2f2f;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">between </font><font style="color:#444444;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">milliliters and ounces is approximate.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:42.8pt;text-align:right;text-indent:-34.45pt"><font style="color:#2f2f2f;font-family:'Courier New',monospace;font-size:13pt;font-weight:700;line-height:120%">B.&#160;&#160;&#160;&#160;</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TERRITORY.</font></div><div style="margin-top:5.55pt;padding-left:43pt;padding-right:78.45pt;text-align:justify;text-indent:-0.15pt"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">The </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">Territory </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">Distributor </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">shall </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">be Japan</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">, </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">and </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">a</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">ny </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">other geographic area designated by ZO </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">SKIN HEALTII </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">in writing and agreed to by </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">Distributor </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">for the exercise of Distributor's rights and obligations in the </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">Distribution </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:124%">Agreement.</font></div><div style="height:56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.077%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">D</font><font style="color:#777777;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">istribu</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">tion Agreement  ZO </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Medical </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">&#8211; Int&#8217;l Form </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">v</font><font style="color:#919191;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">. </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">4</font><font style="color:#919191;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">.</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">0 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">&#8226; </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cutera final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.255%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">28</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_85"></div><hr style="page-break-after:always"><div style="min-height:69pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:5.4pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit A, </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Page 2</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:40.15pt;text-align:right;text-indent:-34.55pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">C.&#160;&#160;&#160;&#160;DISTRIBUTOR</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">'</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">S </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">MINIMUM PURCHASE </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">REQUIREMENT</font></div><div style="margin-top:6.5pt;padding-left:7.52pt;padding-right:7.52pt;text-align:center"><img alt="image_23a.jpg" src="image_23a.jpg" style="height:16px;margin-bottom:5pt;vertical-align:text-bottom;width:81px"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor's Minimum Purchase  Requirements  </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of  Products  and  </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related</font></div><div style="height:56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.218%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">D</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">i</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">strib</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">u</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">tion Agr</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">e</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">em</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">en</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">t ZO Me</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">di</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ca</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">l</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">- I</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">n</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">t&#8217;l </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">F</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">o</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">rm </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">v</font><font style="color:#999999;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">. </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4.</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">0 </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8226; C</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ut</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">era final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.678%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">29</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_88"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:33.088%"><div style="margin-top:0.85pt;padding-left:40.55pt;text-indent:0.05pt"><img alt="image_24a.jpg" src="image_24a.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:81px"><img alt="image_25a.jpg" src="image_25a.jpg" style="height:16px;margin-bottom:5pt;vertical-align:text-bottom;width:86px"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Products </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">combined shall be 2015</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">to </font><font style="background-color:#000000;color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">xxxxxx</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> .in 20</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">1</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">6</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">to</font></div><div style="margin-top:0.85pt;padding-left:61.5pt;padding-right:-0.45pt;text-indent:-21.2pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.366%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:33.088%"><div style="padding-left:61.5pt;padding-right:-0.45pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">in 2014</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">and shall _increase to in 2017, and to </font><font style="background-color:#000000;color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">xxxxx</font></div><div style="margin-top:0.85pt;padding-left:15.4pt;padding-right:88.65pt;text-indent:47.65pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.366%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:33.092%"><div style="padding-left:15.4pt;padding-right:88.65pt"><font style="background-color:#000000;color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">in</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">in </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">2018 (pro</font></div></div></div><div style="padding-left:40.2pt;padding-right:89.65pt;text-align:justify;text-indent:0.5pt"><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">rated </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">for the short year). ZO SKIN </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">HEAL</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">T</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">H&#8217;</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">S </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">remedies on </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Distributor</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">&#8217;</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">s failure to </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">m</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">e</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">et the Minimum </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Purchase Requirements </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">of </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Products </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">and Related </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Products </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">a</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">r</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">e set forth </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">i</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">n Sections </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">4.1 </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">and 8.1 of th.is Agreement. The above </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">dollar </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">amounts </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">refer </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">to Uni</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">t</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">ed States currency.</font></div><div style="height:46.9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.218%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">D</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">i</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">strib</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">u</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">tion Agr</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">e</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">em</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">en</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">t ZO Me</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">di</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ca</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">l</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">- I</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">n</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">t&#8217;l </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">F</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">o</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">rm </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">v</font><font style="color:#999999;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">. </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4.</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">0 </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8226; C</font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ut</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">era final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.678%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">29</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_91"></div><hr style="page-break-after:always"><div style="min-height:57pt;width:100%"><div><font><br></font></div></div><div style="margin-top:4.55pt;padding-left:161.32pt;padding-right:161.32pt;text-align:center"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:120%">EXHIBITB</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.45pt;padding-left:173.95pt;padding-right:173.95pt;text-align:center"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:120%;text-decoration:underline">PURCHASE ORDER AND </font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:120%;text-decoration:underline">ROLLING </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:120%;text-decoration:underline">FORECAST </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:120%;text-decoration:underline">FORM</font></div><div style="margin-top:11pt;padding-left:257.3pt;padding-right:257.3pt;text-align:center"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">R</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">o</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">llin</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">g </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">4-Q </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">F</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">ore</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">cast </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">by </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">U</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">nit</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">s an</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">d </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">Actual </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">P.O Rolling </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">3</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">-Q </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">Foreca</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">st </font><font style="color:#3a3a3a;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">by </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">Units</font></div><div style="margin-top:9.45pt;padding-left:204.35pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Distributo</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">r'</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">s Name&#58; </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">_ _ _ _ </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">_ _ _ _ _ </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">_ _ _  _  </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">_</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:170.2pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Distributor's </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">S</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">i</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">g</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">n</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">atu</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">r</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">e</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#58; </font><font style="color:#777777;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">_ </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">_ _ _ _ </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">_ _ _ _ </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">_&#160;&#160;&#160;&#160;Date&#58; </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">_ _ _ _ _ _ </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">_ _ _ </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">_</font></div><div><font><br></font></div><div style="margin-bottom:0.05pt;margin-top:0.25pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:6.35pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.186%"><tr><td style="width:1.0%"></td><td style="width:6.277%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.945%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.466%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:53.05pt;padding-right:53.05pt;text-align:center"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:114%">QUARTER </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">1</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:52pt;padding-right:52pt;text-align:center"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:105%">QUARTER2</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:54.7pt;padding-right:54.7pt;text-align:center"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:99%">QUA</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:99%">RTER </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:99%">3</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:60.4pt;padding-right:60.4pt;text-align:center"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:86%">QUARTER4</font></div></td></tr><tr><td colspan="12" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:6.85pt"><font style="color:#777777;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">' </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">This Qua</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">rt</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">er represents a Purchase Order</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6.65pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:105%">UNIT</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6.5pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:105%">This Qua</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:105%">r</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:105%">ter is a Forecast Q2</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:7.25pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:104%">UNIT</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6.65pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%">This Quarter is a Forecast Q3</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:6.35pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:93%">UNlT</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6.3pt"><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:93%">T</font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:93%">h</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:93%">is </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:93%">Quarter </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:93%">is </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:93%">a </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:93%">F</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:93%">orecast</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:93%">Q4</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6.15pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:87%">UNIT</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">PROD</font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">UCTS</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:8.6pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Oct. </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:6.85pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Nov</font><font style="color:#777777;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">. </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:7.1pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Dec</font><font style="color:#8c8c8c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6.95pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Qtr</font><font style="color:#777777;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">. </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Tota</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">l</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:1.7pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Jan</font><font style="color:#777777;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">. </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:7.15pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Feb</font><font style="color:#777777;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">. </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:7.15pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:111%">Ma</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:111%">r</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:111%">. </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:111%">13</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:7.05pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:111%">Qtr. Total</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6.8pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:111%">Apr. </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:111%">13</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:7.25pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:105%">Ma</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:105%">y. </font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:105%">1</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:105%">3</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.8pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:111%">Jun</font><font style="color:#a5a5a5;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:111%">_ </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:111%">1</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:111%">3</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6.7pt"><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:105%">Q </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:105%">tr</font><font style="color:#777777;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:105%">. </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:105%">Total</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6.35pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%">Jul. 13</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6.5pt"><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%">Aug</font><font style="color:#a5a5a5;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%">. </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%">1</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%">3</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6.1pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%">Sep </font><font style="color:#8c8c8c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%">. </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%">13</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5.9pt"><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%">Qtr</font><font style="color:#777777;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%">. </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%">To</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%">tal</font></div></td></tr><tr style="height:30pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:30pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:30pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:31pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:30pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:32pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:0.25pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:7.25pt;padding-left:12.2pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Note</font><font style="color:#8c8c8c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#58; </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">This is </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">j</font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">u</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">st </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">a sample spreadsheet </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">in </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">the </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">format in which </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">to </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">l</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">ayout your spreadsheet. </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Not </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">all products are available </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">in </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">all countries. P</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">l</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">ease use o</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">n</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">ly those products that are appropriate for your </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">market.</font><font style="color:#777777;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">)</font></div><div style="margin-top:2.35pt;padding-left:12.95pt;padding-right:239.25pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:152%">*The Quarter not shaded, </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:152%">s</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:152%">ignifies an actual Purchase Order and cons</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:152%">titu</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:152%">tes a binding order. The following three shaded quarters are v</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:152%">i</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:152%">ewed as forecasts Your signat</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:152%">u</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:152%">re above approves a shipment of product noted in Quarter one. Unit orders must be plac</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:152%">ed </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:152%">in </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:152%">master </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:152%">shipper quantities</font><font style="color:#8c8c8c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:152%">.</font></div><div style="padding-left:12.3pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:109%">This order is subject to a</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:109%">l</font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:109%">l </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:109%">the </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:109%">terms </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:109%">and conditions contained </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:109%">i</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:109%">n your International </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:109%">Product Di</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:109%">strib</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:109%">u</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:109%">tion Agreement.</font></div><div style="margin-top:2.85pt;padding-left:11.8pt"><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">This </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Form (Purc</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">h</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">ase order and </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">R</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">olli</font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">n</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">g </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</font><font style="color:#161616;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">-</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Q </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">F</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">orecast </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">by units) </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">mu</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">st </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">be provided </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">t</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o ZO </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">SKIN HEALTH by </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Febru</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">ary </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</font><font style="color:#777777;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, </font><font style="color:#4b4b4b;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">by </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">May 1, by August 1</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, and </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">by</font><font style="color:#4b4b4b;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">ovember 1</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">of </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">each year</font><font style="color:#8c8c8c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</font></div><div style="height:56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.829%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Distribution   Agreement ZO Medical</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">&#8226; </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Int'l Form, </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">v</font><font style="color:#8c8c8c;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">. </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">4</font><font style="color:#777777;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">.</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">0 </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">&#8226; </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cutera </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">final</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8226;2.</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.235%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:1pt;padding-left:1pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">30</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_94"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.45pt;padding-left:91.32pt;padding-right:91.32pt;text-align:center"><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:120%">EXHIBITC</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.45pt;padding-left:90.9pt;padding-right:90.9pt;text-align:center"><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:120%;text-decoration:underline">ZO SKIN HEALTH MARKS</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:7.9pt;padding-right:36pt;text-indent:-0.05pt"><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%">ZO Skin Health </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%">has registered </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%">several trademarks with the United States Patent and Trademark </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%">Office </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%">with </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%">respect </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%">to </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%">its </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%">brand and products. They include&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:42pt;text-indent:-17.75pt"><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;ZO&#8221;</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">'</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">registration no. 3443712</font></div><div style="margin-top:3.45pt;padding-left:41.5pt;text-indent:-17.25pt"><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;</font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offects</font><font style="color:#777777;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;, registration no. 3</font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">818858</font></div><div style="margin-top:3.4pt;padding-left:42pt;text-indent:-17.3pt"><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ossential</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">registration </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">no. </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3593734</font></div><div style="margin-top:3.4pt;padding-left:41.5pt;text-indent:-16.8pt"><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;</font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Omme</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">se&#8221;&#174;, registration no. 3544801</font></div><div style="margin-top:2.95pt;padding-left:41.5pt;text-indent:-17.25pt"><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;</font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Oclipse&#34;&#174;</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">registration </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">no. </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3774720</font></div><div style="margin-top:3.4pt;padding-left:41.5pt;text-indent:-16.8pt"><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;</font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Olluminate</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">registration </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">no. </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3534953</font></div><div style="margin-top:3.45pt;padding-left:41.5pt;text-indent:-17.25pt"><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Oraser&#34;</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;, </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">registration </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">no. 3534951</font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:7.15pt;padding-right:36pt;text-indent:-0.3pt"><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">ZO Skin Health also </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">has </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">several other trademarks tha</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">t </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">it regularly </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">uses in commerce. </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">ZO </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">Skin Health has </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">trademark applications </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">pending </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">with </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">the </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">United States </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">Patent </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">and Trademark </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">Office </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">for the follow</font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">in</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">g </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">trademarks&#58;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:41.5pt;text-indent:-17.25pt"><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Balatone,</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">application no</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85505883</font></div><div style="margin-top:3.9pt;padding-left:41.05pt;text-indent:-17.3pt"><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#777777;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Brightenex</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#34; </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">application no</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85505893</font></div><div style="margin-top:2.95pt;padding-left:41.05pt;text-indent:-17.3pt"><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Cebatrol,</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">application no</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85505978</font></div><div style="margin-top:2.9pt;padding-left:41.05pt;text-indent:-17.3pt"><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Glycogent</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">'</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">' </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">application </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">no. </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85505981</font></div><div style="margin-top:3.45pt;padding-left:41.05pt;text-indent:-17.3pt"><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; Melamin,</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">application no</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85505963</font></div><div style="margin-top:3.4pt;padding-left:41.05pt;text-indent:-17.3pt"><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; Melamix,</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">application no. 85505965</font></div><div style="margin-top:3.4pt;padding-left:40.55pt;text-indent:-16.8pt"><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Normacleanse</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,'' </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applicatio</font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">no. 85</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">05878</font></div><div style="margin-top:3.45pt;padding-left:41.05pt;text-indent:-17.3pt"><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;Oila</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">leanse</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#34; </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">application no</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85505870</font></div><div style="margin-top:2.9pt;padding-left:40.55pt;text-indent:-16.8pt"><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retamax</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#34; </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">application no. </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85505957&#59;</font></div><div style="margin-top:3.45pt;padding-left:40.55pt;text-indent:-17.3pt"><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ZO Medical</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,'' </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">application </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">no. 85518544</font></div><div style="margin-top:3.4pt;padding-left:40.55pt;text-indent:-17.3pt"><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;ZO Controlled </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depth </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pee</font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; application no. 85505983</font></div><div><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:36pt"><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">All of </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">the above marks </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">are </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">collectively </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">referred to as the </font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">&#8220;</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">ZO trademarks.</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">&#8221; </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">ZO Skin Health actively </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">uses </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">and  </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">markets </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">all of the ZO Trademarks in commerce</font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">.</font></div><div style="height:53pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.235%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Dis</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">tribution Agreement </font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">ZO  Medical</font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%"> </font><font style="color:#777777;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">&#8211; Int&#8217;l</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%"> </font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Form v. 4</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">.</font><font style="color:#626262;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">0 </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">- Cutera final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.528%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">31</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_97"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:7.3pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit C, Page 2</font></div><div><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:7.15pt;padding-right:36pt;text-indent:-0.35pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">For purposes of Section 4.7, the phrase &#8220;by Zein </font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Obagi</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">, </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">M</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">.</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">D</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">.&#8221;</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%"> </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">may only be used in a font size not materially different than the proportional relationship to the font size of &#8220;ZO&#174; MEDICAL&#8221; </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">set </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">forth below&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                        </font><img alt="image_26a.jpg" src="image_26a.jpg" style="height:682px;margin-bottom:5pt;vertical-align:text-bottom;width:310px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">       </font></div><div style="height:53pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution Agreement </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ZO Medical</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> - </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Int'l Form v</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">. </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4.0- Cutera </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.528%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">32</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="height:53pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution Agreement </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ZO Medical</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> - </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Int'l Form v</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">. </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4.0- Cutera </font><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.528%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">32</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_100"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:13.1pt;padding-left:91.72pt;padding-right:91.72pt;text-align:center"><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">EXHIBIT D</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.4pt;padding-left:90.77pt;padding-right:90.77pt;text-align:center"><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:120%;text-decoration:underline">Defective </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:120%;text-decoration:underline">Product Complaint</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:7.9pt;padding-right:31.15pt;text-align:justify;text-indent:0.85pt"><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Below </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">is </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">the written procedure for reporting, processing and handling complaints regarding cosmet</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">i</font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">c products manufactured  by  or  </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">fo</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">r ZO </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">SKIN HEALTH, Inc. </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(&#8220;Z</font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">O </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">SKIN HEALTH&#8221;).  ZO  SKIN HEALTH may modify</font><font style="color:#797979;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">, </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">remove</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">, </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">or </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">replace </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">these </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">procedures at any time and from time to time </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">by </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">prior written notice to Distributor.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:7.5pt;padding-right:30.55pt;text-align:justify;text-indent:0.9pt"><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Upon receipt of a </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">compla</font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">int </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">by </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Distributor </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">or a sub-distributor, the attached Product Complaint Form must be completed and </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">fully </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">identify the complaint and </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">product(s</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">) </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">involved. The complaint </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">mu</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">st </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">be submitted to ZO SKIN HEAL</font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">TH's International </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Sales and Market</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">in</font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">g </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Department</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">, w</font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">h</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">ic</font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">h receives </font><font style="color:#484848;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:118%">all </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">drug complaints</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">. </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Whenever </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">possible send the </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">product </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">associated w</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">i</font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">th the complaint w</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">ith </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">the &#8220;Product Comp</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">l</font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">aint </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Form.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:7.7pt;text-align:justify"><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nature of the complaint must </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">class</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fied as described </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">belo</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">w</font><font style="color:#797979;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:8.8pt;text-align:justify"><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Quality Defe</font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">ct&#58;</font></div><div style="margin-top:1.7pt;padding-left:7.65pt;padding-right:31.65pt;text-align:justify;text-indent:0.25pt"><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">A  </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">product  complaint expressing dissatisfaction w</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">i</font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">th the quality of a </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">product, </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">e.g</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">. </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">a complaint expressing </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">dis</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">satisfactio</font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">n </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">with the attributes of </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">the </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">product, such as</font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:114%"> </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">missing lot numbers or exp</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">ir</font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">ation dates, discoloration of product, </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">l</font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">eaking caps, </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">etc</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6.9pt;text-align:justify"><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Medical Defect </font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">(</font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Adve</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">rs</font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">e </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Experience)&#58;</font></div><div style="margin-top:2pt;padding-left:6.65pt;padding-right:32.05pt;text-align:justify;text-indent:0.3pt"><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">A </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">product </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">complaint reporting an Adverse Experience associated </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">with </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">the use </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">of </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">the product with </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%;text-decoration:underline">humans</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">. </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">An Adverse   </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">Experien</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">ce </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">is  </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">an </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">event </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">associated with the product, </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">e.g. </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">use of t</font><font style="color:#282828;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">h</font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">e product, </font><font style="color:#484848;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:124%">any </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">significant performance failure or </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">unexpected </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">pharmacological activity&#59; such as </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">rashes</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">, </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">hypo-pigmentation, acne, etc.</font></div><div style="height:53pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.640%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Distribution </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Agreement ZO</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Medical- Int&#8217;l</font><font style="color:#5b5b5b;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%"> </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Form </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">v. 4</font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">.</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">0 </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">&#8211; </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cutera </font><font style="color:#484848;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">final-2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.808%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:1pt;padding-left:1pt"><font style="color:#5b5b5b;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:120%">33</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_103"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:5.05pt;padding-left:162pt;padding-right:178.5pt;text-indent:62.25pt"><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:154%">COSMETIC PRODUCT      </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:154%">COMPLAINT </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:154%">FORM</font></div><div style="margin-top:0.2pt"><img alt="image_27a.jpg" src="image_27a.jpg" style="height:114px;margin-bottom:5pt;vertical-align:text-bottom;width:618px"><img alt="image_28a.jpg" src="image_28a.jpg" style="height:144px;margin-bottom:5pt;vertical-align:text-bottom;width:617px"></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.2pt"><img alt="image_29a.jpg" src="image_29a.jpg" style="height:246px;margin-bottom:5pt;vertical-align:text-bottom;width:615px"></div><div><font><br></font></div><div style="margin-top:0.2pt"><img alt="image_30a.jpg" src="image_30a.jpg" style="height:156px;margin-bottom:5pt;vertical-align:text-bottom;width:620px"></div><div style="height:53pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.955%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Distribution </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Agreement </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">ZO </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Medical - </font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Int</font><font style="color:#878787;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">'l</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%"> </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Form v</font><font style="color:#878787;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">. </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4.0- </font><font style="color:#6e6e6e;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cu</font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">tera </font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">fina</font><font style="color:#313131;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">l-</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.528%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">34</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_106"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.4pt;padding-left:104.5pt;padding-right:104.5pt;text-align:center"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:15.5pt;font-weight:700;line-height:120%">EXHIBIT E</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.4pt;padding-left:104.32pt;padding-right:104.32pt;text-align:center"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:120%;text-decoration:underline">Sub-Distributor Agreement Requirements</font></div><div style="margin-top:4pt;padding-left:43.05pt;text-indent:-19.3pt"><font style="color:#464646;font-family:'Arial',sans-serif;font-size:21pt;font-weight:400;line-height:118%">&#9658;&#160;&#160;&#160;&#160;</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">All&#160;&#160;&#160;&#160;terms </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">defined in </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">the Agreement shall </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">be </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">given the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">same meaning.</font></div><div style="padding-left:43.3pt;text-indent:-19.7pt"><font style="color:#464646;font-family:'Arial',sans-serif;font-size:22pt;font-weight:400;line-height:117%">&#9658;&#160;&#160;&#160;&#160;</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:117%">The&#160;&#160;&#160;&#160;sub-distributor </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:117%">must be </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:117%">restricted  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:117%">from directly </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:117%">or </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:117%">indirectly </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:117%">promoting, marketing, selling and</font></div><div style="padding-left:43.75pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:108%">distributing </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:108%">the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:108%">Products and Related Products </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:108%">through </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:108%">itself </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:108%">to Customers </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:108%">located </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:108%">in the Territory </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:108%">and</font></div><div style="margin-top:1.4pt;padding-left:43.05pt"><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">within the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Channels of Distribution. This does not prevent Distributor </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">from further restricting the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">rights</font></div><div style="margin-top:0.9pt;padding-left:43.25pt"><img alt="image_31.jpg" src="image_31.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:14px"><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">of sub-distributor with respect to </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">the Products and Related </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Products.</font></div><div style="margin-top:0.7pt;padding-left:43.65pt;padding-right:20.45pt;text-indent:-0.15pt"><img alt="image_32a.jpg" src="image_32a.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:15px"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:114%">Appoint </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:114%">ZO </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:114%">SKIN </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">HEAL</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:114%">TH a </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:114%">power </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:114%">of attorney, which appoint shall </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:114%">be coupled </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:114%">with an interest, for </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:114%">purposes </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:114%">of terminating the sub-distribution agreement </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:114%">as </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:114%">set </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">forth </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:114%">below </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:114%">and </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:114%">in the </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:114%">Agreement.</font></div><div style="margin-top:0.25pt;padding-left:42.95pt;padding-right:5.7pt;text-indent:-0.05pt"><img alt="image_34.jpg" src="image_34.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:15px"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Restrict </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">sub-distributor&#8217;s </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">use </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">of  ZO </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">SKIN HEAL</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">TH  sales </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">and  technical  literature  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">and  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">materials </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">to  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">the use </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">required and approved </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">by </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">ZO </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">SKIN HEALTH </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">to </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">exclusively </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">promote</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">market, </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">sell and </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">distribute the Products </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">and </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Related </font><font style="color:#c3c3c3;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Products in </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Territory </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">and within </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">the </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Channels of Trade</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:42.25pt;padding-right:5.7pt;text-indent:0.2pt"><img alt="image_34.jpg" src="image_34.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:15px"><img alt="image_31.jpg" src="image_31.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:14px"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">Reservation </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">of </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">all </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">other </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">rights related to the Products </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:128%">and </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">Related Products to </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">ZO </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">SKIN </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:128%">HEALTH</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:128%">. </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">Subject </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">to </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">laws </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">of </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">Japan, restrict </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">sub-distributor </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">from selling Products and Related Products to </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">Customers at </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">a </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">price </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">below the </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">suggested </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">price </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">to </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">Customers set forth in </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">the Agreement </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">or allowing the sale of </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">Products </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">or </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">Related Products </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">to </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">Customers </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">who sell Products or </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">Related </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">Products to </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">the public </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">(i.e., </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">end-user) at </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">a </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">price </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">which </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">is </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">less than the retail </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">price </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">set forth </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">in the Agreement. </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">ZO SKIN </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">HEALTH as </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">attorney </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">in fact </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">shall </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">have the r</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">i</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">ght to </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">terminate the </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">sub-distribution agreement </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">for </font><font style="color:#464646;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">any </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">breach of </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">these restrictions.</font></div><div style="padding-left:42.3pt;text-indent:0.15pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">Require </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">s</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">ub-distributor</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%"> to </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">use </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">commercially </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">reasonable efforts to further </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">promotion</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">, </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">marketing, </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">sale </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">and distribution </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">of the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">Products </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">and </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">Related Products in </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">Territory </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">and within </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">the </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:130%">Channels of</font></div><div style="padding-left:41.5pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">Distribution,</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:128%"> </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">including </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">but </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">not </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">limited to </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">building brand </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">awareness </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">and </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">participating </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:128%">in </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">any ZO SKIN</font></div><div style="padding-left:41.45pt"><img alt="image_40a.jpg" src="image_40a.jpg" style="height:35px;margin-bottom:5pt;vertical-align:text-bottom;width:15px"><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:119%">HEAL</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:119%">TH </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">sales or </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">promotiona</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">l </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">programs.</font></div><div style="margin-top:1.15pt;padding-left:42.3pt;padding-right:20.45pt;text-indent:0.15pt"><img alt="image_40a.jpg" src="image_40a.jpg" style="height:35px;margin-bottom:5pt;vertical-align:text-bottom;width:15px"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Require</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> sub-distributor </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">not </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">to </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">make </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">any </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">materially </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">misleading or </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">untrue </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">statements concerning </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Products </font></div><div style="margin-top:1.15pt;padding-left:42.3pt;padding-right:20.45pt;text-indent:0.15pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> and Related </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Products</font><font style="color:#757575;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:1.35pt;padding-left:41.8pt;padding-right:5.7pt;text-indent:-0.3pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">Restrict  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">sub-distributor  from selling, </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">distributing</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">, </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">marketing</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">, </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">advertising or soliciting </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">purchase </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">orders for  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">any product </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">that is </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">competitively positioned </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">to </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:119%">the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">Products </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">or </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">Related Products</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">. </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">Distributor </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">shall </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">hav</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">e </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">right </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">to immediately </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">terminate </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">sub-distributor </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:119%">for </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">any </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">breach of these </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">restrictions. ZO </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">SKIN </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:119%">HEAL</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:119%">TH </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">as  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">attorney </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">in </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">fact shall have the </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">right to </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">terminate  </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:119%">the </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">sub-distribution agreement for  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">any breach </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">of </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">these restrictions. </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">Notw</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">ithstanding the </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">foregoing, </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">if there is not a pattern </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">of violations of this </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">restrict</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">i</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">on,  </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">as determined by </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">ZO SKIN HEALTH, in </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">its </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">discretion</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">, </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">then Distributor </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">shall </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">have </font><font style="color:#464646;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">a </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">period of 30 </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">days </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">to cure sub-distributor&#8217;s breach </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">after receipt </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">of written </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">notice </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">of such violation </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">from </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:119%">ZO</font></div><div style="padding-left:39.75pt"><img alt="image_31.jpg" src="image_31.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:14px"><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">SKIN </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:106%">HEALTH.</font></div><div style="height:51pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution Agreement ZO Medical&#183; </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">I</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">nt'l </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Form </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">v</font><font style="color:#979797;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">4</font><font style="color:#757575;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">.</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">0 </font><font style="color:#757575;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">&#8226; </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Cutera final-</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.808%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:1pt;padding-left:1pt"><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">35</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:2.25pt;padding-left:41pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Require </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">sub-distributor to comply with all applicable </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Governmental Requirements </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">and assist ZO SKIN </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">HEALTH </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">in </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">obtaining </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">any licenses</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">registrations or </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">permits </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">of </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">any kind</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">and </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">otherwise, </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">to </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">allow ZO</font></div><div style="margin-top:0.2pt;padding-left:41.5pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">SKIN </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">HEAL</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">TH to </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">be in </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">compliance with </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">all Governmental Requirements in the </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Territory.</font></div><div style="margin-top:1pt;padding-left:41.3pt;padding-right:7.2pt;text-indent:-19.1pt"><font style="color:#5b5b5b;font-family:'Arial',sans-serif;font-size:18.5pt;font-weight:400;line-height:105%">&#9658;&#160;&#160;&#160;&#160;</font><img alt="image_39a.jpg" src="image_39a.jpg" style="height:31px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:105%">Restrict sub-di</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:105%">stributor from </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:105%">using any marketing </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:105%">materials </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:105%">until </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:105%">receiving ZO </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:105%">SKJN </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:105%">HEALTH </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:105%">' s </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:105%">written </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:105%">approval.</font></div><div style="margin-top:3.05pt;padding-left:41pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:111%">Require any return </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:111%">of Products </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:111%">or </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:111%">Related </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:111%">Products to </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:111%">be </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:111%">made through Distributor </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:111%">and </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:111%">not directly to</font></div><div style="padding-left:41.05pt"><img alt="image_40a.jpg" src="image_40a.jpg" style="height:35px;margin-bottom:5pt;vertical-align:text-bottom;width:15px"><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:111%">ZO SKIN </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:111%">HEALTH.</font></div><div style="margin-top:1.45pt;padding-left:41pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Require that the </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">s</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">ub-distribution agreement be </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">co-terminus </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">with the Agreement.</font></div><div style="height:51pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.797%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution Agreement ZO Medical&#183; </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">I</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">nt'l </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Form </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">v</font><font style="color:#979797;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">4</font><font style="color:#757575;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">.</font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">0 </font><font style="color:#757575;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">&#8226; </font><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Cutera final-</font><font style="color:#5b5b5b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.808%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:1pt;padding-left:1pt"><font style="color:#464646;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">35</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_109"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:25.4pt;padding-right:5.65pt;text-indent:1.6pt"><img alt="image_41a.jpg" src="image_41a.jpg" style="height:19px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Require that </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">upon </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">termination or expiration of the sub-distribution agreement&#58; (a</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">all of sub-distributor's </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">rights </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">granted thereunder shall  immediately cea</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e&#59;  (b) sub-distributor shall deliver to  </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any and all language translations of ZO SKIN REALTH&#8217;</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sales and technical literature and materials </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sub distributor&#8217;s possession or control</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c) sub-distributor </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">hall immediately return to </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">all other ZO SKIN HEALTH property</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">including</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">but </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">no</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">limited to</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">all original </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">documents </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and copies which contain ZO SKIN HEALTH Proprietary Information</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e) sub-distributor shall remove from </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">its </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">fac</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">litie</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and other premises all signs</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">billboards and other similar items bearing any of the ZO SKIN HEALTH Marks or </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">identifying </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sub-distributor as an authori</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">z</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ed sub-distributor or distributor of ZO SKIN HEALTH or the </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Related Products </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and, within a reasonable period of time following such termination, withdraw or cancel any registrations or filings with governmental</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">authorities relating to sub-distributor's use of any of the ZO </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SKIN </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HEALTH Marks.  Except as required for sub-distr</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">butor&#8217;s performance of obligations under these requirements</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">upon expiration or earlier termination of the sub-distribution</font></div><div style="margin-top:2.4pt;padding-left:25.5pt;padding-right:36pt;text-indent:-0.15pt"><img alt="image_42a.jpg" src="image_42a.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:4px"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:96%">agreement, sub-distributor shall immediately cease and desist from any further use of Proprietary Information of ZO SKIN</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:13.5pt;font-weight:400;line-height:96%"> </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:96%">HEALTH.</font></div><div style="margin-top:1.85pt;padding-left:42.95pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Restrict sub distributor's use and disclosure of ZO SKIN HEALTH'&#8217;s Proprietary Information to at least</font></div><div style="margin-top:0.35pt;padding-left:42.55pt"><img alt="image_43a.jpg" src="image_43a.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:15px"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the same extent as </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Distributor </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">is restricted by the Agreement.</font></div><div style="margin-top:0.35pt;padding-left:42pt;padding-right:14.95pt;text-indent:0.45pt"><img alt="image_44a.jpg" src="image_44a.jpg" style="height:35px;margin-bottom:5pt;vertical-align:text-bottom;width:15px"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Restrict sub-distributor from operating </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">an </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Internet side that </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">references </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:119%">any </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">of the Products or Related </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Products </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">or the ZO SKIN HEALTH Marks without the prior written consent of ZO SKIN HEAL</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">TH, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">which shall also require sub-distributor to pose any information requested by ZO SKIN HEAL</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">TH </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">with respect to the </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">Products</font><font style="color:#7b7b7b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">s</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">,  Related Products </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:119%">or the ZO SKIN HEALTH Marks.</font></div><div style="margin-top:0.15pt;padding-left:41.8pt;text-indent:0.65pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Restrict </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">sub-distributor from </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">using </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:120%">an</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:120%">y </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ZO SKIN HEALTH Mark or any Products or Related </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Products in</font></div><div style="padding-left:41.8pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">connection with any domain name, directory</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">address</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">locator</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">linking</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">co-branding</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">metatag</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">, </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">or with any othe</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">r </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:109%">Internet search strategy.</font></div><div style="padding-left:42.5pt;text-indent:-19.7pt"><font style="color:#414141;font-family:'Arial',sans-serif;font-size:21pt;font-weight:400;line-height:102%">&#9658;&#160;&#160;&#160;&#160;</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:102%">Make ZO SKIN HEALTH an </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:102%">express </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:102%">and intended third party beneficiary under </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:102%">the </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:102%">sub-distribution</font></div><div style="padding-left:41.8pt"><img alt="image_45a.jpg" src="image_45a.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:15px"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:103%">agreement.</font></div><div style="margin-top:1.75pt;padding-left:42.1pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any and all other requirements placed upon sub-distributors under </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Agreement.</font></div><div style="height:52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.674%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Distribution Agreement ZO Med</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">ica</font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">l </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">&#8211; Int&#8217;l F</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">orm </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">v. </font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">4</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">.</font><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">0. Cutera final</font><font style="color:#7b7b7b;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">-</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">2</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.528%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#414141;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">36</font></div></td></tr></table></div></div></div><div id="iae447f9396414b31bf99c2f192d0e09a_112"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:12.65pt;padding-left:104.32pt;padding-right:104.32pt;text-align:center"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:16.5pt;font-weight:700;line-height:120%">EXHIBIT F</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.4pt;padding-left:104.92pt;padding-right:104.92pt;text-align:center"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:120%;text-decoration:underline">Competing Products Subject to </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:120%;text-decoration:underline">2 </font><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:120%;text-decoration:underline">Year Exception</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:43.4pt;text-indent:-34.35pt"><font style="color:#343434;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Elastilash </font><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(OMP product)</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:43.4pt;text-indent:-34.75pt"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Elastiderm </font><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(OMP product)</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5.6pt"><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Distribution Agreement ZO Medical&#8226;</font><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">lnt'l Form v. 4</font><font style="color:#666666;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">.</font><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">0 </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">- </font><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Cutera </font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">flnal-2</font><font style="color:#4b4b4b;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">37</font></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>a2zoskinhealthamendment21a.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i14dadf27842943a1ba816383e6e67673_1"></div><div style="min-height:59pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.45pt;padding-left:114.2pt;padding-right:114.2pt;text-align:center"><font><br></font></div><div style="padding-left:0.07pt;padding-right:0.07pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS NOT MATERIAL AND (I) WOULD BE COMPETITIVELY HARMFUL TO THE REGISTRANT IF PUBLICLY DISCLOSED OR (II) IS INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. SUCH INFORMATION HAS BEEN MARKED WITH &#8220;&#91;***&#93;&#8221; TO INDICATE WHERE OMISSIONS HAVE BEEN MADE.</font></div><div style="padding-left:52.07pt;padding-right:52.07pt;text-align:center"><font><br></font></div><div style="padding-left:52.07pt;padding-right:52.07pt;text-align:center"><font><br></font></div><div style="padding-left:52.15pt;padding-right:52.15pt;text-align:center"><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">AMENDMENT </font><font style="color:#33383a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">TO SECTION </font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">A OF EXHIBIT A </font><font style="color:#33383a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">OF </font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">THE DISTRIBUTION AGREEMENT</font></div><div style="margin-top:0.7pt;padding-left:70.1pt;padding-right:70.1pt;text-align:center"><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">FOR </font><font style="color:#33383a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">THE </font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">&#91;ZO MEDICAL </font><font style="color:#626667;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">I </font><font style="color:#33383a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">ZO </font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">SKIN HEALTH&#93; PRODUCT LINE</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:14.65pt;padding-right:6pt;text-indent:37.25pt"><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">1.&#160;&#160;&#160;&#160;</font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%;text-decoration:underline">Preamble.</font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">  A  Distribution Agreement </font><font style="color:#626667;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">(&#8220;A</font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">greement&#8221;</font><font style="color:#626667;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">) </font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">for the &#91;ZO Medica</font><font style="color:#626667;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">l </font><font style="color:#7b7c7c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">&#47; </font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">ZO S</font><font style="color:#626667;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">k</font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">in     Health&#93; line of products was entered into by and between </font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:160%">ZO </font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">SKIN HEALTH, INC. </font><font style="color:#626667;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:160%">(&#8220;</font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">ZO SKIN HEALTH&#8221;) and Cutera, Inc. </font><font style="color:#626667;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">(</font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">&#8220;Distributor&#8221;)&#160;&#160;&#160;&#160;effective as of August </font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:160%">5</font><font style="color:#626667;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:160%;position:relative;top:-3.85pt;vertical-align:baseline">t</font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:160%;position:relative;top:-3.85pt;vertical-align:baseline">h</font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:160%">, 2013, </font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">which is currently  i</font><font style="color:#626667;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">n </font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">full force and effect. Under Sections 1.6, 1.8, 3.1 and 7</font><font style="color:#33383a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">.1 </font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">of the Agreement, ZO SKIN HEA</font><font style="color:#626667;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">L</font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%">TH</font></div><div style="margin-top:1.8pt;padding-left:14.85pt;padding-right:6pt;text-indent:0.1pt"><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:178%">reserved the right to amend Exhibit A from time to time to reflect changes to the Products and Related Products and the prices of the Products and Related Products.  Specifically</font><font style="color:#626667;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:178%">, </font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:178%">the Products</font><font style="color:#626667;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:178%">,</font></div><div style="padding-left:13.85pt;padding-right:6pt;text-indent:0.95pt"><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:157%">Related Products, if any, and corresponding prices are identified in </font><font style="color:#33383a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:157%">Section </font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:157%">A of Exhibit A of the Agreement. </font><font style="color:#33383a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:157%">ZO </font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:157%">SKIN HEALTH now wishes to amend Section A of that exhibit.</font></div><div style="margin-top:4.85pt;padding-left:12.95pt;padding-right:5.25pt;text-indent:35.75pt"><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:166%">2.&#160;&#160;&#160;&#160;</font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:166%;text-decoration:underline">Amendment to Section A of Exhibit A</font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:166%">. </font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:166%">ZO </font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:166%">SKIN HEALTH hereby amends Section A of Exhibit A to reflect the Products</font><font style="color:#626667;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:166%">, </font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:166%">Related Products, if any, and prices set forth on the Revised Schedule of Products attached hereto and incorporated herein by </font><font style="color:#626667;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:166%">t</font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:166%">his reference.</font></div><div style="margin-top:4.4pt;padding-left:12.1pt;padding-right:11.55pt;text-indent:35.6pt"><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:157%">3.&#160;&#160;&#160;&#160;</font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%;text-decoration:underline">Effective </font><font style="color:#33383a;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%;text-decoration:underline">Date </font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%;text-decoration:underline">of Revised </font><font style="color:#212423;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%;text-decoration:underline">S</font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%;text-decoration:underline">chedule of Products</font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%">. The revised Products, Re</font><font style="color:#626667;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%">l</font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%">ated Products, if any, and prices set forth in the Revised Sched u</font><font style="color:#626667;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%">l</font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%">e of Products </font><font style="color:#626667;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%">&#91;</font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%">sha</font><font style="color:#626667;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%">ll </font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%">lake effect on </font><font style="color:#7b7c7c;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%">&#47; </font><font style="color:#626667;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%">w</font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%">as </font><font style="color:#33383a;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%">effective </font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%">as of&#93;</font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:157%"> </font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:157%">August </font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:157%">21</font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:157%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:157%">,</font><font style="color:#626667;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:157%"> </font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:157%">2013.</font></div><div style="margin-top:8.9pt;padding-left:11.75pt;padding-right:12.75pt;text-indent:35.15pt"><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:170%">4.&#160;&#160;&#160;&#160;</font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:170%;text-decoration:underline">Waiver of Notice and Consent</font><font style="color:#212423;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:170%">. </font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:170%">Distributor hereby waives notice of t</font><font style="color:#626667;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:170%">h</font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:170%">e change and consents to the Revised Schedule of Products as of the date set forth in paragrap</font><font style="color:#626667;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:170%">h </font><font style="color:#464b4d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:170%">3 above.</font></div><div style="margin-top:7.3pt;padding-left:244pt"><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">ZO </font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SKIN HEAL</font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">TH, </font><font style="color:#464b4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INC.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:59pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8.8pt"><img alt="capture2.jpg" src="capture2.jpg" style="height:312px;margin-bottom:5pt;vertical-align:text-bottom;width:700px"></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i14dadf27842943a1ba816383e6e67673_4"></div><hr style="page-break-after:always"><div style="min-height:78pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.419%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Amendment to Section A of Exhibit A of the </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Distribution </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Agreement</font></div></td></tr></table></div></div><div><font><br></font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:132.5pt;padding-right:132.5pt;text-align:center"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">REVISED SCHEDULE OF PRODUCTS</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:47.3pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Section A of Exhibit A </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">is </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">hereby </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">restated </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">as follows&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:15.95pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;PRODUCTS.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:51.25pt;padding-right:5.65pt;text-indent:0.15pt"><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">ZO </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">SKIN </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">HEALTH skin care products current</font><font style="color:#666666;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">ly </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">subject </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">to this </font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">Distribution </font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">Agreement </font><font style="color:#666666;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">inclu</font><font style="color:#3f3f3f;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:118%">de&#58;</font></div><div style="padding-right:5.65pt"><font><br></font></div><div style="padding-right:5.65pt"><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.75pt;text-align:center;text-indent:-0.01pt"><img alt="capture3.jpg" src="capture3.jpg" style="height:362px;margin-bottom:5pt;vertical-align:text-bottom;width:596px"></div><div style="height:55pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.542%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;padding-left:2.8pt"><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div></td></tr></table></div></div></div><div id="i14dadf27842943a1ba816383e6e67673_7"></div><hr style="page-break-after:always"><div style="min-height:78pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.419%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Amendment to Section A of Exhibit A of the </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Distribution </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Agreement</font></div></td></tr></table></div></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:132.65pt;padding-right:132.65pt;text-align:center"><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">REVISED </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">SCHEDULE OF </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">PRODUCTS</font></div><div><font><br></font></div><div style="padding-left:48.5pt"><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Section </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">A of Exhibit A is hereby restated as follows&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:16.95pt"><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;PRODUCTS.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:52.45pt;text-indent:-0.05pt"><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">ZO SKIN </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">HEALTH </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">skin </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">care products currently </font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">subject </font><font style="color:#646464;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">t</font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">o th</font><font style="color:#646464;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">i</font><font style="color:#383838;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">s </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">Distribution Agreeme</font><font style="color:#646464;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">nt </font><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:114%">include&#58;</font></div><div><font><br></font></div><div><img alt="capture1.jpg" src="capture1.jpg" style="height:426px;margin-bottom:5pt;vertical-align:text-bottom;width:629px"></div><div style="margin-top:3.7pt"><font><br></font></div><div style="height:55pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.542%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;padding-left:2.8pt"><font style="color:#494949;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>a3zoskinhealthamendment25j.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i946fd1b3783741c3bac995c809be1fee_1"></div><div style="min-height:67pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.235%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">DocuSign Envelope ID&#58; 2DE9D554-9FD1-494E-9FC8-C15A9CD7ABE9</font></div></td></tr></table></div></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:99.82pt;padding-right:99.82pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS NOT MATERIAL AND (I) WOULD BE COMPETITIVELY HARMFUL TO THE REGISTRANT IF PUBLICLY DISCLOSED OR (II) IS INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. SUCH INFORMATION HAS BEEN MARKED WITH &#8220;&#91;***&#93;&#8221; TO INDICATE WHERE OMISSIONS HAVE BEEN MADE.</font></div><div style="padding-left:50.15pt;padding-right:50.15pt;text-align:center"><font><br></font></div><div style="margin-top:0.04pt;padding-left:50.57pt;padding-right:50.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AMENDMENT TO THE DISTRIBUTION AGREEMENT</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:16.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Omnibus Amendment to the two Distribution Agreements (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#34;), is made by and between ZO Skin Health, Inc., a California corporation, having its principal place of business at 9685 Research Drive, Irvine, CA 92618 (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ZO SKIN HEALTH</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#34;), and Cutera, Inc., a Delaware corporation, having its principal place of business at 3240 Bayshore Blvd., Brisbane, CA 94005 (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Distributor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,&#34; and together with ZO SKIN HEALTH, the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Parties,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#34; and each, a &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#34;), effective as of January 25, 2021 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-top:6.05pt;padding-left:5pt;padding-right:20.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Parties have entered into two Distribution Agreements, each dated August 5, 2013 (as such agreements have been amended, collectively, the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Existing Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#34;)&#59; and</font></div><div style="margin-top:6pt;padding-left:5pt;padding-right:19.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Parties hereto desire to amend the Existing Agreement on the terms and subject to the conditions set forth herein.</font></div><div style="margin-top:5.95pt;padding-left:5pt;padding-right:19.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:48.85pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.8pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Capitalized terms used and not defined in this Amendment have the respective meanings assigned to them in the Existing Agreement.</font></div><div><font><br></font></div><div style="margin-top:10.25pt;padding-left:5pt;padding-right:36.1pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.8pt;text-decoration:underline">Amendments to the Existing Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. As of the Amendment Effective Date, the Existing Agreement is hereby amended or modified as follows&#58;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:122pt;padding-right:8.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.8pt">Section 4.10 of the Existing Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:122pt;padding-right:5.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Notwithstanding any agreement between the Parties to the contrary, in exchange for Distributor&#8217;s binding commitment to purchase from ZO SKIN HEALTH a minimum of </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">xxxxxx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> US total of Products and Related Products between January 1, 2021 and June 15, 2021 and commitment to provided monthly rolling 12 month forecasts, ZO SKIN HEALTH will provide to Distributor </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">xx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of Net Sales as Free Goods and Related Products and collaterals and a </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">xx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> discount on the prices of Products and Related Products on all Products and Related Products so shipped by ZO SKIN HEALTH during said period. For clarity, for any shipments already made during this period predating the execution of this Agreement, a true up of the discount will be made on the next order. In the event that Distributor fails to meet its commitments, any discount already provided shall be invoiced by ZO SKIN HEALTH and paid back by Distributor.&#8221;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.235%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">DocuSign Envelope ID&#58; 2DE9D554-9FD1-494E-9FC8-C15A9CD7ABE9</font></div></td></tr></table></div></div><div style="margin-top:0.05pt;padding-left:122pt;padding-right:14.55pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.18pt">Section 8.1 of the Existing Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:122pt;padding-right:15.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;This Agreement shall commence on the Effective Date and shall continue in effect until June 30, 2021, unless otherwise terminated pursuant to the provisions of this Agreement.&#8221;</font></div><div id="i946fd1b3783741c3bac995c809be1fee_4"></div><div style="margin-top:4.05pt;padding-left:122pt;padding-right:7.9pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.8pt">Notwithstanding any agreement between the parties to the contrary, absent new agreement of the parties, ZO SKIN HEALTH shall not modify the price of any Product or Related Product prior to June 30, 2021, provided, that ZO SKIN HEALTH shall set the price of any Product or Related Product, new or otherwise, not currently being offered in market by Distributor.</font></div><div><font><br></font></div><div style="margin-top:10.15pt;padding-left:5pt;padding-right:10.3pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.8pt;text-decoration:underline">Date of Effectiveness&#59; Limited Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Amendment will become effective as of the date first written above (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#34;). Except as expressly provided in this Amendment, all of the terms and provisions of the Existing Agreement are and will remain in full force and effect and are hereby ratified and confirmed by the Parties. Without limiting the generality of the foregoing, the amendments contained herein will not be construed as an amendment to or waiver of any other provision of the Existing Agreement or as a waiver of or consent to any further or future action on the part of either Party that would require the waiver or consent of the other Party. On and after the Effective Date, each reference in the Existing Agreement to &#34;this Agreement,&#34; &#34;the Agreement,&#34; &#34;hereunder,&#34; &#34;hereof,&#34; &#34;herein,&#34; or words of like import, and each reference to the Existing Agreement in any other agreements, documents, or instruments executed and delivered pursuant to, or in connection with, the Existing Agreement, will mean and be a reference to the Existing Agreement as amended by this Amendment.</font></div><div><font><br></font></div><div style="margin-top:10.3pt;padding-left:77pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.8pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;padding-right:16.15pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">This Amendment is governed by and construed in accordance with, the laws of the State of California, without regard to the conflict of laws provisions of such State.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:113pt;padding-right:17.1pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">This Amendment shall inure to the benefit of and be binding upon each of the Parties and each of their respective permitted successors and permitted assigns.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:113pt;padding-right:28.8pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The headings in this Amendment are for reference only and do not affect the interpretation of this Amendment.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:113pt;padding-right:14.9pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">This Amendment may be executed in counterparts, each of which is deemed an original, but all of which constitute one and the same agreement. Delivery of an executed counterpart of this Amendment electronically or by facsimile shall be effective as delivery of an original executed counterpart of this Amendment.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:113pt;padding-right:15.9pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">This Amendment constitutes the sole and entire agreement between the Parties with respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings, agreements, representations, and warranties, both written and oral, with respect to such subject matter.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.235%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">DocuSign Envelope ID&#58; 2DE9D554-9FD1-494E-9FC8-C15A9CD7ABE9</font></div></td></tr></table></div></div><div style="margin-top:7.5pt;padding-left:85.72pt;padding-right:85.72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;REMAINDER OF THIS SECTION SHALL REMAIN BLANK&#93;</font></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.818%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></td></tr></table></div></div></div><div id="i946fd1b3783741c3bac995c809be1fee_7"></div><hr style="page-break-after:always"><div style="min-height:67pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.235%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">DocuSign Envelope ID&#58; 2DE9D554-9FD1-494E-9FC8-C15A9CD7ABE9</font></div></td></tr></table></div></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Parties have executed this Amendment on the date first written above.</font></div><div><font><br></font></div><div><font><br></font></div><div><img alt="capture.jpg" src="capture.jpg" style="height:376px;margin-bottom:5pt;vertical-align:text-bottom;width:290px"></div><div style="height:69pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.818%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>a4zoskinhealthamendment14j.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i81337923e0464e669eb54b3db8319b38_1"></div><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:4.55pt;padding-left:99.82pt;padding-right:99.82pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS NOT MATERIAL AND (I) WOULD BE COMPETITIVELY HARMFUL TO THE REGISTRANT IF PUBLICLY DISCLOSED OR (II) IS INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. SUCH INFORMATION HAS BEEN MARKED WITH &#8220;&#91;***&#93;&#8221; TO INDICATE WHERE OMISSIONS HAVE BEEN MADE.</font></div><div style="padding-left:42.67pt;padding-right:42.67pt;text-align:center"><font><br></font></div><div style="padding-left:42.67pt;padding-right:42.67pt;text-align:center"><font><br></font></div><div style="padding-left:43.11pt;padding-right:43.11pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">AMENDMENT TO THE DISTRIBUTION AGREEMENT</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:9.45pt;padding-right:5.05pt;text-align:justify;text-indent:0.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">This Amendment (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:123%">&#8220;Amendment&#8221;) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">to the Existing Agreement (as hereinafter defined), is made by and between ZO Skin Health, Inc., a California corporation, having its principal place of business at 9685 Research Drive, Irvine, CA 92618  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:123%">(''ZO SKIN HEALTH&#34;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">and Cutera, Inc., a Delaware corporation, having its principal place of business at 3240 Bayshore Blvd., Brisbane, CA 94005 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:123%">(&#34;Distributor,&#34; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">and together with ZO SKIN HEALTH, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:123%">&#8220;Parties,&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">and each, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:123%">&#8220;Party&#8221;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">effective as of June 14, 2021 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:123%">(&#8220;Amendment Effective Date&#8221;).</font></div><div style="margin-top:5.8pt;padding-left:9.15pt;padding-right:5.45pt;text-align:justify;text-indent:0.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">WHEREAS, the Parties have entered into a Distribution Agreement, dated August 5, 2013, which was amended by an amendment effective August 21, 2013 (&#8220;August 2013 Amendment&#8221;) and an amendment effective January 25, 2021 (&#8220;January 2021 Amendment&#8221;) (collectively, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:122%">&#8220;Existing Agreement&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">and</font></div><div style="margin-top:5.95pt;padding-left:9.15pt;padding-right:5.1pt;text-align:justify;text-indent:0.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">WHEREAS, the Parties hereto de sire to amend the Existing Agreement on the terms and subject to the conditions set forth herein.</font></div><div style="margin-top:5.3pt;padding-left:9.45pt;padding-right:5.05pt;text-align:justify;text-indent:-0.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">NOW, THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:9.1pt;padding-right:5.5pt;text-indent:18.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">I.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%;text-decoration:underline">Definitions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;Capitalized terms used and not defined in this Amendment have the respective meanings assigned to them in the Existing Agreement.</font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:9.1pt;padding-right:6.05pt;text-indent:17.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%;text-decoration:underline">Amendments to the Existing Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%"> As of the Amendment Effective Date, the Existing Agreement is hereby amended or modified as follows&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:26.45pt;padding-right:5.45pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:129%">(a)&#160;&#160;&#160;&#160;Section 1.3. of the Existing Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:25.8pt;padding-right:5.35pt;text-align:justify;text-indent:18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:131%">&#8220;1.3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:131%">&#8220;Channels of Distribution&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:131%">means distribution through physicians&#8217; offices and medical spas where a physician is on-site and responsible for administering of the Products&#59; but, it excludes all other channels of distribution including non-physician owned medical spas (including salons), resort spas, mass merchants, warehouse clubs, traditional food and drug stores, web sites and e-tailers (e.g., drugstore.com, etc.). The Products and Related Products sold to Distributor under this Agreement may be resold over the internet through Distributor's website for the sole purpose of fulfilling orders of existing Customers. No other internet sales are authorized by this Agreement. Distributor agrees to establish and maintain appropriate measures to ensure that the Products and Related Products are only distributed within the Territory and sold pursuant to the terms of this Agreement.&#34;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:25.75pt;padding-right:6.95pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">(b)&#160;&#160;&#160;&#160;Section 1.5. of the Existing Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:25.65pt;padding-right:5.4pt;text-align:justify;text-indent:17.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">&#8220;1.5. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:123%">&#8220;Customer&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">means a physician office or a medical spa owned, at least in part, by a physician and, in either case, where a physician is regularly on-site and responsible for prescribing and administering the Products to patients&#59; provided that said Customer also meets all of the following requirements&#58; (i) uses the Products in servicing its patients&#59; (ii) purchases the Products solely from the Distributor or an approved sub-distributor in the Territory&#59; (iii) holds the Products for resale or for use by or on its patients&#59; and sells the Products, solely within the Channels of Distribution and solely within the Territory.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i81337923e0464e669eb54b3db8319b38_4"></div><hr style="page-break-after:always"><div style="min-height:74pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.8pt;padding-left:27.55pt;padding-right:6.15pt;text-indent:17.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">(c)&#160;&#160;&#160;&#160;Section 1.6. of the Existing Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:27.2pt;padding-right:6.45pt;text-align:justify;text-indent:17.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:132%">&#8220;1.6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:132%">&#8220;Distributor Purchase Prices&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:132%">means the prices payable by Distributor to ZO SKIN HEALTH as consideration for the purchase by Distributor of the Products and Related Products, as set forth in Exhibit A, as may be adjusted only in accordance with Section 6.7.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:26.8pt;padding-right:6.15pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:129%">(d)&#160;&#160;&#160;&#160;Section 2.6. of the Existing Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:26.5pt;padding-right:6.3pt;text-align:justify;text-indent:36.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">&#8220;2.6.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%;text-decoration:underline">Pricing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">. ZO SKIN HEALTH will provide Distributor from time-to-time in writing with a suggested price for the resale of the Products and Related Products to end-users </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:122%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-style:italic;font-weight:400;line-height:122%">i.e.,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:122%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">patients or other end-customers of Customers)  (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%">&#8220;MSRP&#8221;).  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">The MSRP  is not binding, and neither Distributor, its sub-distributors or its Customers shall be obligated to sell any Products nor Related Products to end users at or above such MSRP.  ZO SKIN HEALTH may increase the MSRP in its sole and absolute discretion, provided, that, unless otherwise agreed by the Parties&#58;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:80.45pt;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;such increases occur no more frequently than </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">xxxx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> per calendar year&#59; and</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:44.7pt;padding-right:26.7pt;text-indent:17.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">(b)&#160;&#160;&#160;&#160;the amount of such increase shall not exceed, in the aggregate across all Products and Related Products, the greater of&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:43.8pt;padding-right:6.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">(i)&#160;&#160;&#160;&#160;the percentage rate of increase for the immediately preceding 12-month period in the Consumer Price Index, All Urban Consumers, United States, All Items (1982 - 1984 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%">&#61; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:118%">100), as published by the Bureau of Labor Statistics of the United States Department of Labor or, if such index is not available, such other index as the parties may agree most closely resembles such index&#59; and</font></div><div><font><br></font></div><div style="margin-top:0.15pt"><img alt="image_01.jpg" src="image_01.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:140px"></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:25.95pt;padding-right:6.35pt"><img alt="image_110.jpg" src="image_110.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:117px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:132%">Prior to increasing the MSRP, ZO SKIN HEALTH will engage in good faith discussions with Distributor to understand any potential negative impact on sales of Products in the Territory that may result from such increase in the MSRP.&#8221;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:25.75pt;padding-right:6.15pt;text-indent:17.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">(e)&#160;&#160;&#160;&#160;Section 3.1. of the Existing Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:25.05pt;padding-right:6.45pt;text-align:justify;text-indent:18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">&#8220;3.1.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%;text-decoration:underline">Related Products.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">   ZO SKIN HEALTH may from time to time offer products for sale related to the &#8220;ZO Medical&#8221; or &#8220;ZO Skin Health&#8221; product lines which are not listed in Exhibit A (&#8220;Related Products&#8221;). Such Related Products, new or not, may be unilaterally added to Exhibit A by ZO SKIN HEALTH at any time and shall thereafter become subject to this Agreement. If ZO SKIN HEALTH, in its sole discretion, chooses to offer such Related Products in the Territory during the Term of this Agreement, Distributor shall have the exclusive right, including with respect to ZO SKIN HEALTH, to promote, market, sell, and distribute such Related Products in the Territory within the Channels of Distribution. For purposes of clarification, ZO SKIN HEALTH shall not, directly or indirectly through any agents, representatives or distributors, except through Distributor hereunder, market, advertise, promote, sell or distribute the Products or Related Products in the Territory.&#8221;</font></div><div style="height:71pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.742%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">2</font></div></td></tr></table></div></div></div><div id="i81337923e0464e669eb54b3db8319b38_7"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.2pt;padding-left:27.55pt;padding-right:5.85pt;text-indent:17.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">(f)&#160;&#160;&#160;&#160;Section 4.1 (b) of the Existing Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:26.8pt;padding-right:6.05pt;text-align:justify;text-indent:18.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">&#8220;(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%;text-decoration:underline">Minimum Purchase Requirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">.   During the term of this Agreement, Distributor shall make at least the minimum purchases of Products and Related Products from ZO SKIN HEALTH as required by Exhibit A. Purchases counted toward the Minimum Purchase Requirement for any period provided for herein shall be based upon ZO SKIN HEALTH's net invoice prices for the Products and Related Products which are ordered by Distributor prior to the expiration of the applicable calendar year. For calendar years subsequent to those listed in Exhibit A, the Minimum Purchase Requirement for each such subsequent year of the Term shall be set at </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">xxx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%"> of the Minimum Purchase Requirement for the year immediately preceding that particular year.&#8221;</font></div><div><font><br></font></div><div style="margin-top:6.4pt;padding-left:26.8pt;padding-right:6.15pt;text-indent:17.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:129%">(g)&#160;&#160;&#160;&#160;Section 4.2. of the Existing Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:25.75pt;padding-right:6.4pt;text-align:justify;text-indent:18.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">&#8220;4.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%;text-decoration:underline">Promotion and Marketing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">. Distributor shall use commercially reasonable efforts to further the promotion, marketing, sale and distribution of the Products and Related Products in the Territory, including but not limited to, building brand awareness and value. During the term of this Agreement, the Distributor shall expend on  a calendar  year basis, for  the advertising  of the Products and Related Products in the Territory through media advertisements, public relations, promotions, merchandising, tradeshows, workshops, and displays (in each case as previously approved by ZO SKIN HEALTH in writing), not less than an amount equal to </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">xxx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%"> of net sales of the Product and Related Products made during such calendar year by Distributor and its sub-distributors, at the discretion of the Distributor. The cost of general  media (including  agency  fees,  production  fees and cooperative advertising)&#59; over-labeling  logistics costs, gift-with-purchase&#59; promotion displays and their installation costs&#59; public relations activities&#59; samples and testers&#59; incentive programs intended to drive revenue and Collateral Materials may  be  applied  toward  the  minimum advertising expenditure required above. Distributor shall upon written request provide ZO SKIN HEALTH with photographs, ad copy, and all other relevant documents relating to its public relations efforts. ZO SKIN HEALTH may, in its reasonable discretion, prepare promotional programs for the Products and Related Products in the Territory and Distributor agrees to cooperate with ZO SKIN HEALTH in sales or promotional programs prepared by ZO SKIN HEALTH. Distributor shall not make, nor permit its sub-distributors to make, any materially misleading or untrue statements concerning the Products or Related Products. In addition&#58;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:43.65pt;padding-right:6.5pt;text-align:justify;text-indent:17.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">(a)&#160;&#160;&#160;&#160;Distributor shall maintain an office and well-trained staff to promote the sale of the Products and Related Products, and to solicit orders for them, and to timely train Customers on the Products and Related Products and ZO SKIN HEALTH protocols, within the Territory.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:43.3pt;padding-right:7.3pt;text-align:justify;text-indent:17.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">(b)&#160;&#160;&#160;&#160;Distributor shall provide full and accurate advice and assistance to Customers when soliciting orders for Products and Related Products, consistent with the ZO sales and technical literature.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:43.1pt;padding-right:7.15pt;text-align:justify;text-indent:17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">(c)&#160;&#160;&#160;&#160;Distributor shall handle promptly, efficiently, courteously and properly all inquiries, quotations, correspondence, orders and complaints in connection with the Products and Related Products.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.742%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">3</font></div></td></tr></table></div></div></div><div id="i81337923e0464e669eb54b3db8319b38_10"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.9pt;padding-left:44.9pt;padding-right:6.35pt;text-align:justify;text-indent:18.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">(d)&#160;&#160;&#160;&#160;Distributor shall promptly inform ZO SKIN HEALTH of any complaints that it receives that are of either a material or a recurring nature and shall promptly inform ZO SKIN HEALTH of all adverse event complaints that it receives regarding the Products and Related Products.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:44.75pt;padding-right:6.35pt;text-align:justify;text-indent:18.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">(e)&#160;&#160;&#160;&#160;Distributor shall use its best commercial effort to ensure that the location and display of the Products and Related Products in each location in which the Products and Related Products are sold in the Territory will be at least as favorable as the location of any similar or competitive products.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:44.15pt;padding-right:6.4pt;text-align:justify;text-indent:18.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">(t) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">Distributor shall ensure that the Products and Related Products will not be displayed or promoted in any manner or environment which misleadingly suggests that they are related to the Obagi&#174; brand of products or the products of any other company or that Dr. Zein Obagi promotes or is related to Obagi Medical Products, Inc. or its products, or any other company or its products.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:44.35pt;padding-right:7.2pt;text-align:justify;text-indent:17.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">(g)&#160;&#160;&#160;&#160;If Distributor shall be affiliated with any Customer of the Products and Related Products, Distributor shall not favor such Affiliate over any other Customer.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:43.65pt;padding-right:6.75pt;text-align:justify;text-indent:18.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">(h)&#160;&#160;&#160;&#160;Distributor shall make no representation, guarantee or warranty, either express or implied, with respect to any Product or Related Product, beyond those contained in ZO SKIN HEALTH approved package labels and products instructions, without the express written consent of ZO SKIN HEALTH or as otherwise required by the laws of the jurisdiction in which the Products and Related Products are offered for sale in the Territory. Distributor shall not have the right, power or authority to make any representation, guarantee or warranty on behalf of ZO SKIN HEALTH. Distributor shall not make or cause to be made or authorize any modifications or additions to the Products or Related Products without the express prior written consent of ZO SKIN HEALTH.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:43pt;padding-right:6.8pt;text-align:justify;text-indent:18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">(i)&#160;&#160;&#160;&#160;Distributor shall at all times keep and maintain at its office set forth above accurate accounts and records of all transactions pe1taining to the Products and Related Products and to this Agreement. All such accounts and records shall be retained by Distributor during the term of this Agreement and for a period of three (3) years after the date of any termination of this Agreement and, upon mutual consent of the Parties, shall be subject to examination and audit by ZO SKIN HEALTH or its authorized representative, upon ten </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(10) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">business days&#8217; notice during normal business hours and no more than once per calendar quarter. Distributor shall at all times promptly make available to ZO SKIN HEALTH such of its records as are necessary for ZO SKIN HEALTH to fulfill any recall or other obligation it deems necessary under any applicable law, rule or regulation and such obligations shall survive and continue after termination of this Agreement.&#8221;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:24.65pt;padding-right:7.2pt;text-indent:17.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">(h)&#160;&#160;&#160;&#160;Section 4.3. of the Existing Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:24.4pt;padding-right:7.2pt;text-align:justify;text-indent:17.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">&#34;4.3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%;text-decoration:underline">Competing Products</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">. During the term of this Agreement, Distributor shall not sell, distribute, market, advertise or solicit purchase orders for any product that is competitively positioned in the Territory with ZO SKIN HEALTH's products, including without limitation, the Products and Related</font></div><div style="margin-top:0.55pt"><img alt="image_210.jpg" src="image_210.jpg" style="height:0px;margin-bottom:5pt;vertical-align:text-bottom;width:192px"></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:6.85pt;padding-right:25.6pt;text-indent:0.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:130%">1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:130%">The Obagi&#174; trademark is a trademark of Obagi Medical Products, Inc. and is not affiliated with ZO SKIN HEALTH in any way. ZO SKIN HEALTH claims no ownership to the Obagi&#174; trademark.</font></div><div style="height:71pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.742%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">4</font></div></td></tr></table></div></div></div><div id="i81337923e0464e669eb54b3db8319b38_13"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:4.25pt;padding-left:26.35pt;padding-right:6pt;text-align:justify;text-indent:0.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">Products. The term &#8220;competitively positioned&#8221; refers to medical and cosmeceutical skin care products marketed and sold through the Channels of Distribution, a list of currently known competitively positioned products is attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%"> to this Amendment and shall be modified by ZO SKIN HEALTH from time to time. Except as provided above, Distributor shall promptly terminate any sub distributor who without the written consent of the Parties sells, distributes, markets, advertises or solicits purchase orders for any product that is competitively positioned with ZO&#8217;s Products in the Territory. Distributor shall advise ZO in writing of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">i</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">any known or suspected duplication of the Products, (ii) competitors in the Territory competing with the Products, and (iii) any change in regulations and&#47;or practices within the Territory affecting the use of the Products. Distributor and its sub-distributors, if applicable, shall at all times make ZO&#8217;s Products the primary focus of their marketing and sales efforts.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:26.1pt;padding-right:6.55pt;text-indent:17.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">(i)&#160;&#160;&#160;&#160;Section 4.5. of the Existing Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:24.3pt;padding-right:6.9pt;text-align:justify;text-indent:19.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8220;4.5. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Governmental Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Subject  to  the terms of this Agreement, Distributor shall, and shall require its sub-distributors to&#58; (i) comply with all applicable laws and regulations of the United States and the Territory, including but not limited to, export laws and restrictions and regulations of the United  States Department of Commerce or other United States or foreign agency or authority, and shall not  export, or participate in any transaction which may involve the export or re-export of any Products or Related Products in violation of any such restrictions, laws or regulations&#59; (ii) assist ZO SKIN HEALTH in obtaining any required registrations, licenses and permits for the Products and Related Products and the marketing, sale and distribution of the Products and Related Products in the Territory by supplying such documentation or information as may be reasonably requested by ZO </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SKIN</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">HEALTH&#59;  and (iii) obtain and maintain during the term of this Agreement all governmental approvals and licenses necessary to import the Products and Related Products into the Territory. If any governmental registration, license, or approval for the marketing, sale and distribution of the Products is required, Distributor shall obtain ZO SKIN HEALTH&#8217;s written approval prior to commencing any registration or approval process.  Unless otherwise required by applicable law, all registrations, licenses and approvals for the Products and Related Products and the distribution of the Products and Related Products in the Territory shall be in the name of and shall be solely owned by ZO SKIN HEALTH. ZO SKIN HEALTH will reimburse Distributor for any pre-approved and reasonable fees for assistance in obtaining such registrations, licenses and approvals that are in ZO SKIN HEALTH&#8217;s name or that are transferred to ZO SKIN HEALTH on termination of this Agreement. Distributor shall provide ZO SKIN HEALTH with a copy of all registrations, licenses and approvals obtained or received for the Products and Related Products and for the distribution of the Products and Related Products in the Territory within thirty (30) calendar days of Distributor&#8217;s receipt of each such registration, license and approval. Should Distributor, either prior to this Agreement or at any time after execution of this Agreement, obtain a registration, license or approval for the Products and Related Products or for the distribution of the Products and Related Products in the Territory, Distributor agrees to immediately take the appropriate action to transfer such registration, license or approval to ZO SKIN HEALTH as required above and as is consistent with the spirit and intent of this section 4.5. In furtherance of, but without limiting the foregoing, Distributor represents that it has read, understood and will comply and cause its sub-distributors to comply with the anti-bribery provisions of the U.S. Foreign Corrupt Practices Act. Distributor covenants and agrees that it shall promptly notify ZO SKIN HEALTH of any disciplinary action or change in status with regard to any license, permit or authorization required by law. For its part, ZO SKIN HEALTH recognizes the need for the Distributor to comply with all local legal requirements and that from time to time such legislation may prevent the Distributor from fully complying with one or other terms of this Agreement. In such cases, providing sufficient evidence is</font></div><div style="height:71pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.742%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">5</font></div></td></tr></table></div></div></div><div id="i81337923e0464e669eb54b3db8319b38_16"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.2pt;padding-left:24.65pt;padding-right:8.65pt;text-align:justify;text-indent:0.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">provided, ZO SKIN HEALTH will not deem a failure to comply with that term or condition a breach of this Agreement. In the event any of the Products or Related Products are not able to receive a governmental registration as a result of Product ingredients or labeling, ZO SKIN HEALTH and Distributor shall cooperate to explore options for alternate ingredients and&#47;or labeling, taking into consideration the costs incurred by ZO SKIN HEALTH to formulate and manufacture an additional Product, the number of SKUs and the expected volume of sales of said Products in the Territory and elsewhere. Ultimately, ZO SKIN HEALTH has the unilateral discretion to decide whether to re formulate the Products for sale in the Territory or to remove the Products from distribution within the Territory. Distributor&#8217;s obligation to diligently pursue all necessary governmental registrations shall be a material term of this Agreement and, if breached, as determined solely in ZO SKIN HEALTH&#8217;s reasonable discretion, ZO SKIN HEALTH shall have the right, but not the obligation, to terminate this Agreement.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:24.3pt;padding-right:5.5pt;text-indent:17.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:129%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:129%">j</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:129%">)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:129%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:129%">Section 4.7. of the Existing Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:23.3pt;padding-right:8.7pt;text-align:justify;text-indent:18.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">&#8220;4.7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%;text-decoration:underline">Marketing Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">. Distributor shall ensure that all of its marketing materials at all times comply with the latest ZO SKIN HEALTH sales and technical literature. All marketing materials created by a Party shall be reviewed and responded to in writing within 15 business days by the other Party. The Parties agree to consult in good faith to resolve any issues relating to such materials, however ZO SKIN HEALTH has the sole right to reject, in its discretion, any Distributor marketing materials solely related to ZO SKIN HEALTH. If Distributor's marketing materials contain promotional materials related to both Parties' products, ZO SKIN HEALTH shall have the right to approve all marketing materials, however, such approval shall not be unreasonably withheld. Such marketing materials shall contain copyright, trademark and accreditation notices as prepared by ZO SKIN HEALTH in accordance with applicable laws. An approved sub-distributor shall not be permitted to create any marketing materials with respect to Products or Related Products. Further, the name &#8220; Obagi&#8221; may only be used to sell, market, or advertise products or services if &#8220;Obagi&#8221; is part of the phrase &#8220;by Zein Obagi, M.D.&#8221; and so long as the phrase &#8220;by Zein Obagi, M.D.&#8221; appears in a font size not materially different than the proportional relationship to the font size of &#8220;ZO SKIN HEALTH&#8221; that is shown in Exhibit C, which may be modified by ZO SKIN HEALTH from time to time. Notwithstanding the foregoing, ZO SKIN HEALTH may terminate Distributor&#8217;s right to use the name &#8220;Obagi&#8221; at any time upon written notice to Distributor. Under no circumstances shall the name &#8220;Obagi&#8221; be used as part of any domain name or other designation or branding of Distributor or its business. Any violation of the requirements set forth in the foregoing clauses of this Section 4.7 shall be considered a material breach of this Agreement. Notwithstanding the foregoing, any marketing materials that consistent, in all material respects, with marketing materials previously reviewed by the other Party, need not be submitted for review absent any material changes.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:41.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">In addition to the foregoing, Distributor shall&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:24pt;padding-right:9.65pt;text-indent:17.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">(a)&#160;&#160;&#160;&#160;Ensure that at least one(!) marketing person on Distributor's staff attends brand training at least one ( l) time per year&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:24pt;padding-right:9.05pt;text-indent:17.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">(b)&#160;&#160;&#160;&#160;Ensure that every marketing, sales and management person participates in ZO SKIN HEALTH brand and marketing webinars&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.742%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">6</font></div></td></tr></table></div></div></div><div id="i81337923e0464e669eb54b3db8319b38_19"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.2pt;padding-left:26.35pt;padding-right:8.45pt;text-align:justify;text-indent:18.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">(c)&#160;&#160;&#160;&#160;Maintain up-to-date software as required by ZO SKIN HEALTH to utilize ZO SKIN HEALTH sales and technical literature, including without limitation marketing collateral&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:26pt;padding-right:7.65pt;text-align:justify;text-indent:18.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">(d)&#160;&#160;&#160;&#160;Distributor shall actively participate in social media to advertise, market and promote Products consistent with the ZO SKIN HEALTH sales and technical literature to the extent available in the Territory. This includes using ZO SKIN HEALTH provided social media materials and translating them for use in the Territory (not all materials must be used). Further, Distributor shall respond to all social media direct messaging in a timely fashion. In the event other, non-social-media, digital or electronic marketing opportunities are utilized by ZO SKIN HEALTH, then Distributor shall likewise participate in such digital or electronic marketing opportunities to the extent they exist in the Territory&#59;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:25.75pt;padding-right:7.75pt;text-align:justify;text-indent:17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">(e)&#160;&#160;&#160;&#160;Provide  ZO SKIN HEALTH with marketing collateral forecasts from time to time as requested by ZO SKIN HEALTH.  Distributor&#8217;s provision of the above-mentioned forecast shall not be interpreted as a commitment from Distributor to buy or take any of the marketing collateral, unless otherwise agreed to in writing by the Parties&#59; provided, that, ZO SKIN HEALTH may refuse to ship marketing collateral to Distributor, in ZO's sole discretion, in the event they exceed any forecast in order to ensure availability of marketing collateral to other territories, including the United States&#59; and</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:25.5pt;padding-right:7.5pt;text-align:justify;text-indent:17.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">Ensure participation in such other mandatory brand and marketing training as offered by ZO SKIN HEALTH.&#8221;</font></div><div><font><br></font></div><div style="padding-left:25.35pt;padding-right:7.95pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">(k)&#160;&#160;&#160;&#160;Section 4.10. of the Existing Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:25.05pt;padding-right:8pt;text-align:justify;text-indent:17.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">&#8220;4.10. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%;text-decoration:underline">Free Goods and Discounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">. During the term of this Agreement, ZO SKIN HEALTH will provide to Distributor&#58; (a) </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">xx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%"> of Net Sales worth as Free Goods and Related Products and collaterals, and (b) a </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">xx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%"> discount on the Distributor Purchase Prices of Products and Related Products set forth in Exhibit A. Free Goods allowances and discounts will be calculated on each order and shall not roll over from one order to the next, or from one year to the next.&#34;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:25pt;padding-right:8pt;text-align:justify;text-indent:17.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">(I)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">Section 6.7. of the Existing Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:24.9pt;padding-right:7.6pt;text-align:justify;text-indent:17.5pt"><img alt="image_310.jpg" src="image_310.jpg" style="height:17px;margin-bottom:5pt;vertical-align:text-bottom;width:192px"><img alt="image_46.jpg" src="image_46.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:329px"><img alt="image_51.jpg" src="image_51.jpg" style="height:15px;margin-bottom:5pt;vertical-align:text-bottom;width:184px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">&#8220;6. 7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%;text-decoration:underline">Price Changes&#58; Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">. Distributor Purchase Prices offered to Distributor are and shall remain based on standard distributor discounts from current US pricing through the end of calendar year 2021. The parties agree that ZO SKIN HEALTH may thereafter, in its sole discretion, increase the Distributor Purchase Price&#59; provided, that the Distributor Purchase Price of a Product or Related Product will not exceed an amount equal to</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:24.65pt;padding-right:7.6pt;text-indent:17.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">(m)&#160;&#160;&#160;&#160;Section 6.10. of the Existing Agreement is hereby deleted and replaced in its entirety with the following&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:25pt;padding-right:5.5pt;text-indent:17.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">&#8220;6.10. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%;text-decoration:underline">Product Changes.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%"> ZO SKIN HEALTH, with no less than sixty (60) days&#8217; prior written notice to Distributor, may&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.742%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">7</font></div></td></tr></table></div></div></div><div id="i81337923e0464e669eb54b3db8319b38_22"></div><hr style="page-break-after:always"><div style="min-height:74pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.8pt;padding-left:44.45pt;padding-right:7.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">(a)&#160;&#160;&#160;&#160;alter the specifications for any Products or Related Products, subject to Distributor&#8217;s prior written confirmation that Distributor has obtained the required regulatory approval from the governmental authorities of the applicable territories&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:44.55pt;padding-right:7.25pt;text-align:justify;text-indent:17.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:129%">(b)&#160;&#160;&#160;&#160;discontinue the development of any new Products, whether or not such new Products have been announced publicly&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:43.8pt;padding-right:7.25pt;text-align:justify;text-indent:18.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">(c)&#160;&#160;&#160;&#160;discontinue the sale of any Products, provided that, upon any such discontinuance of a Product that accounts for at least ten ( 10)% of Distributor's aggregate sales of Products for the proceeding three (3) month period, ZO SKIN HEALTH shall reduce Distributor's Minimum Purchase Requirements by a prorated amount based upon the proportion of Distributor's sales attributable to such Product&#59; and</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:43.65pt;padding-right:7.05pt;text-align:justify;text-indent:18.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">(d)&#160;&#160;&#160;&#160;commence  the  development and distribution of new Products and Related Products which may make any current Products or Related Products obsolete, provided that, in the event that any such  development or distribution results in a Product that accounts for at least ten (10)% of Distributor's sales for the proceeding three (3) month period becoming obsolete, ZO SKIN HEALTH shall reduce Distributor&#8217;s Minimum Purchase Requirements by a prorated amount based upon the proportion of Distributor's sales attributable to such Product.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:25.75pt;padding-right:6.85pt;text-indent:17.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:129%">(n)&#160;&#160;&#160;&#160;Section 7.l. of the Existing Agreement is hereby deleted and replaced in its entirety with the following&#58;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:25.4pt;padding-right:7pt;text-align:justify;text-indent:17.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">&#8220;7. l.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%;text-decoration:underline">Products and Related Products Prices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">.    Subject  to  the provisions of Sections 6.8 and 6.9 above, ZO SKIN HEALTH may adjust the Distributor Purchase Price only as expressly permitted in Section 6.7.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:25.35pt;padding-right:6.85pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:129%">(o)&#160;&#160;&#160;&#160;Section 7.3. of the Existing Agreement is hereby deleted and replaced in its entirety with the following&#58;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:25.35pt;padding-right:6.85pt;text-align:justify;text-indent:17.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:132%">&#8220;7.3. Delinquent Accounts. All amounts due and owing to ZO hereunder, but not paid by Distributor when due (the &#8220;Delinquent Amount&#8221;), shall become immediately due and owing. ZO will hold all shipments until the Delinquent Amount is paid in full. The Delinquent Accounts shall, for the first thirty (30) days of delinquency (the &#8220;Initial Delinquency&#8221;), bear interest at the rate of the lesser of&#58;</font></div><div style="padding-left:24.9pt;padding-right:6.65pt;text-align:justify;text-indent:0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:131%">(i)&#160;&#160;&#160;&#160;four points (e.g., if the prime rate is 2.5%, then the interest will be 6.5%) per annum above the then applicable prime interest rate announced by the Wall Street Journal for 90-day U.S. dollar loans to prime commercial customers in the United States (or a similar prime rate selected by ZO if said rate  is no longer quoted)&#59;  or (ii) the maximum lawful interest rate permitted under California law to Distributor. Any Delinquent Accounts not paid following the Initial Delinquency shall bear interest at the lesser of (x) eighteen percent (18%) per annum or (y) the highest rate permitted by California law to Distributor, until paid. Such interest shall compound on the first day of each calendar month. Timely payment  is a material  term of this Agreement.  Failure by Distributor to pay any amount due when due shall excuse ZO from its obligation to ship any further Products and shall subject Distributor to immediate termination of this Agreement at ZO's option.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.742%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">8</font></div></td></tr></table></div></div></div><div id="i81337923e0464e669eb54b3db8319b38_25"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:4.25pt;padding-left:26.8pt;padding-right:7.15pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:129%">(p)&#160;&#160;&#160;&#160;Section 8.1. of the Existing Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:26.15pt;padding-right:7.05pt;text-align:justify;text-indent:18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">&#8220;8.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%;text-decoration:underline">Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">. This Agreement shall continue in effect until three (3) years from the Amendment Effective Date (the &#8220;Amended Term&#8221;), unless otherwise terminated pursuant to the provisions of this Agreement. Upon expiration of the Amended Term, this Agreement shall automatically renew for two additional successive one </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:122%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">year terms unless either Party provides written notice of nonrenewal at least ninety (90) days prior to the end of the then-current term (each a &#8220;Renewal Term&#8221; and together with the Amended Term, the &#8220;Final Renewal Term&#8221;, unless sooner terminated as provided in Section 8.2, collectively define the &#8220;Term&#8221;). </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">If </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">the Term is renewed for any Renewal Terms pursuant to this Section, the terms and conditions of this Agreement during each such Renewal Term shall be the same  as the terms and conditions in effect immediately prior to such renewal. If either Party provides timely notice of its intent not to renew this Agreement, then, unless otherwise sooner terminated in accordance with its terms, this Agreement shall terminate on the expiration of the then-current Term.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:44.1pt;padding-right:7.25pt;text-align:justify;text-indent:17.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Any reference to &#8220;the term of this Agreement&#8221; or &#8220;the term of the Agreement&#8221; contained in the Existing Agreement will mean and refer to the &#8220;Term&#8221; as defined in Section </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">of this Amendment.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:43.8pt;padding-right:7.25pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">the Parties continue to have a business relationship pursuant to this Agreement after the expiration of the Final Renewal Term, either Party may thereafter terminate the relationship, without cause, by giving the other Party thirty (30) days&#8217; advance written notice of the termination.&#8221;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:61.55pt;text-indent:-18.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(q)&#160;&#160;&#160;&#160;Section 8.3. is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:24.7pt;padding-right:6.75pt;text-align:justify;text-indent:18.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">&#8220;8.3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%;text-decoration:underline">Rights Upon Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">. Upon termination or expiration of this Agreement, subject to Distributor's sell-off rights as set forth herein&#58; (a) all of Distributor's rights granted hereunder shall immediately cease&#59; (b) Distributor shall deliver to ZO SKIN HEALTH, or at ZO SKIN HEALTH&#8217;s direction shall destroy any and all language translations of ZO SKIN HEALTH's sales and technical literature and materials in Distributor&#8217;s possession or control, the costs of which shall be borne by the Party whose breach of the Agreement caused the termination, if applicable,  otherwise such costs shall be borne by ZO SKIN HEALTH&#59;  (c) ZO SKIN HEALTH may, at its option, repurchase the remainder of  Distributor&#8217;s existing inventory of Products and Related Products at the prices Distributor offers such Products and Related Products to its Customers, provided that, if ZO SKIN HEALTH does not exercise such option, Distributor shall have the right to, in accordance with the applicable terms and conditions of this Agreement, sell off its existing inventory of Products and Related Products (and to retain and use related sales and technical literature and materials and other documents and ZO SKIN Health Proprietary Information as reasonably required in support of such sell-off)&#59; (d) Distributor shall immediately return to ZO SKIN HEALTH all other ZO SKIN HEALTH property, including, but not limited to, all original documents and copies which contain ZO SKIN HEALTH Proprietary Information&#59; (e) Distributor shall deliver to ZO SKIN HEALTH such documents and instruments as ZO SKIN HEALTH may reasonably request in connection with termination or expiration of this Agreement, including, but only  if the Parties agree to terminate the Agreement or Distributor terminates the Agreement without cause, the list of Customers that the Products and Related Products were sold to within the Territory, but in no case shall this exceed the requirements of Section 4.2(i)&#59; (f) Distributor shall take all action necessary to transfer, assign and convey to ZO SKIN HEALTH all governmental registrations relating to the Products and Related Products, import of the Products and Related Products, and the marketing, sale and distribution of the Products and Related Products in exchange for</font></div><div style="height:71pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.742%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">9</font></div></td></tr></table></div></div></div><div id="i81337923e0464e669eb54b3db8319b38_28"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.55pt;padding-left:26.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">reimbursement of such expenses as necessary to facilitate this transfer, assignment or conveyance&#59; and</font></div><div style="margin-top:0.55pt;padding-left:26.15pt;padding-right:6.8pt;text-align:justify;text-indent:0.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">(g) except for those items necessary for the purpose of selling any remaining inventory, Distributor shall remove from all of its facilities all signs, billboards and other similar items bearing any of the ZO SKIN HEALTH Marks or identifying Distributor as an authorized distributor of ZO SKIN HEALTH or the Products and Related Products and, within a reasonable period of time following such termination, withdraw or cancel any registrations or filings with governmental authorities relating to Distributor&#8217;s use of any of the ZO SKIN HEALTH Marks. Except as required for Distributor&#8217;s performance of obligations under this Section 8.3 and exercise of its right to sell any remaining inventory, upon expiration or earlier termination of this Agreement, Distributor shall immediately cease and desist from any further use of Proprietary Information of ZO SKIN HEALTH.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:43.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(r) Section 10.1. is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:25.75pt;padding-right:6.65pt;text-align:justify;text-indent:17.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:132%">&#34;10.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:132%;text-decoration:underline">Limited Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:132%">. Distributor represents and warrants to ZO SKIN HEALTH that (a) Distributor has been duly incorporated and is validly existing and in good standing under the laws of its jurisdiction of incorporation&#59; (b) Distributor (and its authorized signatory) has the necessary corporate power, authority and legal capacity to enter into and to observe and perform its covenants and obligations under this Agreement and has taken all necessary corporate action in respect thereof&#59;</font></div><div style="padding-left:25.05pt;padding-right:6.75pt;text-align:justify;text-indent:0.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:131%">(c)&#160;&#160;&#160;&#160;Distributor has all required licensing, and is authorized, to sell pharmaceutical products in the Territory&#59; (d) this Agreement has been duly executed and delivered by Distributor and constitutes Distributor's legal, enforceable and binding obligations&#59; (e) Distributor's execution  and performance of this Agreement will not conflict with the terms or conditions of any other agreement or contract to which Distributor is a party or is otherwise bound&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:131%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:131%">f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:131%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:131%">no approval, action or authorization by any governmental authority or agency is required for Distributor&#8217;s execution and performance hereof (except for governmental certifications, registrations, licenses and approvals for the marketing, sale and distribution  of the Products and Related Products in the Territory) which has not already been obtained&#59; and (g) Distributor shall comply with all laws and regulations, including all governmental certifications, governmental regulations, licenses and approvals, with respect to the marketing, sale and distribution of the Products and Related Products.&#8221;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:61.2pt;text-indent:-18.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(s)&#160;&#160;&#160;&#160;Section 14.1. is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:24.6pt;padding-right:6.7pt;text-align:justify;text-indent:18.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">&#8220;14.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%;text-decoration:underline">Use of the ZO SKIN HEALTH Marks</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">. ZO SKIN HEALTH hereby grants to Distributor, and Distributor hereby accepts from ZO SKIN HEALTH, a nonexclusive, nontransferable, royalty-free license to use the ZO SKIN HEALTH Marks set forth on Exhibit C hereto, solely in connection with the marketing, distribution, promotion, advertising and sale of the Products and Related Products in the Territory and in accordance with any ZO SKIN HEALTH standards and instructions, and for no other purpose. ZO SKIN HEALTH may inspect and monitor Distributor&#8217;s use of the ZO SKIN HEALTH Marks. Distributor shall not adopt, use or register any words, phrases or symbols which are identical to  or confusingly similar to any of the ZO SKIN HEALTH Marks or oppose any such registration by ZO SKIN HEALTH. Distributor is not granted any right, title or interest in the ZO SKIN HEALTH Marks other than the foregoing limited license, and Distributor shall not use the ZO SKIN HEALTH Marks as part of Distributor's business entity or trade name or permit any third party to do so. Distributor agrees to safeguard and maintain the reputation and prestige of the ZO Marks and will not do anything that would tarnish the image of or adversely impact the value, reputation or goodwill associated with the ZO SKIN HEALTH Marks.  Distributor will never attempt to dilute, directly or indirectly, the value of the goodwill attached to the ZO SKIN HEALTH Marks nor to counsel, procure, or assist anyone else to do the same. If,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:122%">ZO </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">SKIN HEALTH's reasonable determination, the use of a ZO SKIN</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.742%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">10</font></div></td></tr></table></div></div></div><div id="i81337923e0464e669eb54b3db8319b38_31"></div><hr style="page-break-after:always"><div style="min-height:74pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.45pt;padding-left:25.6pt;padding-right:7.55pt;text-align:justify;text-indent:0.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">HEALTH  Mark in connection with the Products will infringe or potentially infringe upon the rights of  any third  party or weakens  or  impairs ZO SKIN HEALTH&#8217;s rights  in the ZO SKIN HEALTH Marks, then upon notice from ZO SKIN HEALTH, Distributor will immediately terminate  or modify such use in accordance with ZO SKIN HEALTH&#8217;s instructions, and Distributor will have no rights of damages, offset, or right to terminate this Agreement as a result thereof. Distributor shall strictly comply with all intellectual property use guidelines  and  policies of ZO SKIN HEALTH provided to Distributor from </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">time to time.&#8221;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:61.55pt;text-indent:-18.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(t)&#160;&#160;&#160;&#160;Section 14.5. is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:25.05pt;padding-right:7.05pt;text-align:justify;text-indent:18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">&#8220;14.5. Distributor Web Sites. Notwithstanding anything herein to the contrary, Distributor shall not operate an Internet site that references any of the Products or Related Products or the ZO SKIN HEALTH Marks (&#8220;Distributor Web Site&#8221;) without the prior written consent of ZO SKIN HEALTH, not to be unreasonably withheld. In consideration of ZO SKIN HEALTH allowing Distributor to reference the Products and Related Products or use the ZO SKIN HEALTH Marks in the Distributor Web Site, ZO SKIN HEALTH may provide, and Distributor shall post upon mutual agreement on the Distributor Web Site within the Territory, mandatory content, including but not limited to privacy policies, terms of use, copyright and trademark notices, and graphics and trademark policies. Subject to ZO SKIN HEALTH&#8217;s prior written consent, Distributor shall prominently provide on the home page of the Distributor Web Site within the Territory a link to ZO SKIN HEALTH&#8217;s Internet site in location, style, size and manner specified by ZO SKIN HEALTH.  Notwithstanding anything in this Agreement to the contrary, Distributor shall not register, nor knowingly authorize any other person or entity to register, any domain name, digital media account or social media name, account name, nickname or similar that includes, in part or whole,  any of the ZO SKIN HEALTH Marks or the name or description of any Products, without the prior written consent of ZO SKIN HEALTH, which may be refused in ZO SKIN HEALTH's sole discretion and, if granted, Distributor shall comply with all stipulations required by ZO SKIN HEALTH.&#8221;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:60.85pt;text-indent:-17.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(u)&#160;&#160;&#160;&#160;Section 16.2. is hereby deleted in its entirety and replaced with the following&#58;</font></div><div><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:25.05pt;padding-right:7.15pt;text-align:justify;text-indent:-0.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">&#8220;16.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%;text-decoration:underline">Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">. Neither Party shall assign or otherwise transfer, including by operation of law, its rights or obligations under this Agreement without the prior written consent of the other Party, except that a Party may assign this Agreement and all of its rights and obligations hereunder without such prior written consent to the acquirer or successor in connection with a change of operating control of such Party or the sale of substantially all of the business assets of such Party, or the acquisition of a controlling interest in the stock of a Party by a third party (each, a &#8220;Change of Control&#8221;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">, that if Distributor enters into a Change of Control transaction with a competitor of ZO SKIN HEALTH, Distributor shall be required to obtain the written consent of ZO SKIN HEALTH in connection therewith, or ZO SKIN HEALTH shall have the right in its sole discretion to terminate this Agreement at any time subsequent to such Change of Control.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(v) Exhibit F is hereby deleted in its entirety and replaced with Exhibit F attached to this Amendment.</font></div><div><font><br></font></div><div style="margin-top:8.45pt;padding-left:7pt;padding-right:7.2pt;text-align:justify;text-indent:17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%;text-decoration:underline">Date of Effectiveness&#58; Limited Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">. This Amendment will become effective as of the date first written above (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%">Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%">).  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%">Except as expressly provided  in this Amendment, all of the terms and provisions of the Existing Agreement are and will remain in full force and effect and are hereby ratified and confirmed by the Parties. Without limiting the generality of the foregoing, the</font></div><div style="height:73pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.742%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">11</font></div></td></tr></table></div></div></div><div id="i81337923e0464e669eb54b3db8319b38_34"></div><hr style="page-break-after:always"><div style="min-height:74pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.45pt;padding-left:7.4pt;padding-right:7.6pt;text-align:justify;text-indent:0.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">amendments contained herein will not be construed as an amendment to or waiver of any other provision of the Existing Agreement or as a waiver of or consent to any further or future action on the part of either Party that would require the waiver or consent of the other Party. On and after the Amendment Effective Date, each reference in the Existing Agreement to &#8220;this Agreement,&#8221; &#8220;the Agreement,&#8221; &#8220;hereunder,&#8221; &#8220;hereof,&#8221; &#8220;herein,&#8221; or words of like import, and each reference to the Existing Agreement in any other agreements, documents, or instruments executed and delivered pursuant to, or in connection with, the Existing Agreement, will mean and be a reference to the Existing Agreement as amended by this Amendment.</font></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:43.65pt;text-indent:-18.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:25.4pt;padding-right:7.45pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">(a)&#160;&#160;&#160;&#160;This Amendment is governed by and construed in accordance with, the laws of the State of California, without regard to the conflict of laws provisions of such State.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:25.4pt;padding-right:7.85pt;text-align:justify;text-indent:17.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">(b)&#160;&#160;&#160;&#160;This Amendment shall inure to the benefit of and be binding upon each of the Parties and each of their respective permitted successors and permitted assigns.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:25.3pt;padding-right:7.45pt;text-align:justify;text-indent:17.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:129%">(c)&#160;&#160;&#160;&#160;The headings in this Amendment are for reference only and do not affect the interpretation of this Amendment.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:25.05pt;padding-right:7.5pt;text-align:justify;text-indent:17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%">(d)&#160;&#160;&#160;&#160;This Amendment may be executed in counterparts, each of which is deemed an original, but all of which constitute one and the same agreement. Delivery of an executed counterpart of this Amendment electronically or by facsimile shall be effective as delivery of an original executed counterpart of this Amendment.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:24.95pt;padding-right:7.1pt;text-align:justify;text-indent:17.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">(e)&#160;&#160;&#160;&#160;This Amendment constitutes the sole and entire agreement between the Parties with respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings, agreements, representations, and warranties, both written and oral, with respect to such subject matter.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:88.5pt;padding-right:88.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">&#91;REMAINDER OF THIS SECTION SHALL REMAIN BLANK!</font></div><div style="height:73pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.742%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">12</font></div></td></tr></table></div></div></div><div id="i81337923e0464e669eb54b3db8319b38_37"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:22.45pt"><font style="color:#383a3a;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">IN</font><font style="color:#383a3a;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> </font><font style="color:#383a3a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WITNESS WHEREOF, the Part</font><font style="color:#1f2121;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</font><font style="color:#383a3a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">es have executed this Amendment on the date first written above.</font></div><div><font><br></font></div><div style="margin-top:0.15pt"><img alt="image_61.jpg" src="image_61.jpg" style="height:104px;margin-bottom:5pt;vertical-align:text-bottom;width:171px"></div><div style="margin-top:7.4pt;padding-left:248.85pt"><font style="color:#383a3a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title</font><font style="color:#1f2121;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; </font><font style="color:#383a3a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President &#38; CEO</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:249.15pt"><font style="color:#383a3a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CUTERA</font><font style="color:#696969;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#383a3a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INC.</font></div><div><img alt="image_71.jpg" src="image_71.jpg" style="height:97px;margin-bottom:5pt;vertical-align:text-bottom;width:170px"></div><div style="height:82pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.742%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">13</font></div></td></tr></table></div></div></div><div id="i81337923e0464e669eb54b3db8319b38_40"></div><hr style="page-break-after:always"><div style="min-height:74pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.45pt;padding-left:87.2pt;padding-right:87.2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">EXHIBIT F</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:87.42pt;padding-right:87.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Competing Products</font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:44.95pt;text-indent:-36.05pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx</font></div><div style="margin-top:0.05pt;padding-left:44.95pt;text-indent:-36.05pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx</font></div><div style="margin-top:1.65pt;padding-left:44.9pt;text-indent:-36pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxxxxxxxxxxxxxxxxxxxxx</font></div><div style="margin-top:1.65pt;padding-left:44.7pt;text-indent:-35.8pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx)</font></div><div style="margin-top:1.6pt;padding-left:45.05pt;text-indent:-36.15pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx</font></div><div style="margin-top:1.65pt;padding-left:45.1pt;text-indent:-36.2pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxxxx</font></div><div style="margin-top:1.6pt;padding-left:44.6pt;text-indent:-36.05pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxxxx</font></div><div style="margin-top:1.65pt;padding-left:44.8pt;text-indent:-36.25pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxx</font></div><div style="margin-top:1.65pt;padding-left:44.7pt;text-indent:-36.15pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxxx</font></div><div style="margin-top:1.6pt;padding-left:44.65pt;text-indent:-36.1pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxxx</font></div><div style="margin-top:1.65pt;padding-left:44.35pt;text-indent:-36.15pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxxx</font></div><div style="margin-top:1.6pt;padding-left:44.25pt;text-indent:-36.05pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxx</font></div><div style="margin-top:1.65pt;padding-left:44.3pt;text-indent:-36.1pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxx</font></div><div style="margin-top:1.65pt;padding-left:44.15pt;text-indent:-35.95pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxx</font></div><div style="margin-top:1.15pt;padding-left:44.35pt;text-indent:-36.2pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxx</font></div><div style="margin-top:1.5pt;padding-left:44.4pt;text-indent:-36.2pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxx</font></div><div style="margin-top:1.65pt;padding-left:44.35pt;text-indent:-36.15pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxxx</font></div><div style="margin-top:1.65pt;padding-left:44.1pt;padding-right:389.05pt;text-indent:-35.9pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:129%">&#8226;&#160;&#160;&#160;&#160;xxxx xxxx</font></div><div style="margin-top:0.7pt;padding-left:44.1pt;text-indent:-36.25pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxx</font></div><div style="margin-top:1.75pt;padding-left:44.1pt;text-indent:-36.3pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxx</font></div><div style="margin-top:1.15pt;padding-left:43.95pt;text-indent:-36.15pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxx</font></div><div style="margin-top:1.05pt;padding-left:43.4pt;text-indent:-35.6pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxx</font></div><div style="margin-top:1.15pt;padding-left:44pt;text-indent:-36.55pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxx</font></div><div style="margin-top:1.65pt;padding-left:44pt;text-indent:-36.55pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxx</font></div><div style="margin-top:1.65pt;padding-left:43.55pt;text-indent:-36.05pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxxx</font></div><div style="margin-top:1.6pt;padding-left:43.65pt;text-indent:-36.2pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxxx</font></div><div style="margin-top:1.65pt;padding-left:43.55pt;text-indent:-36.05pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxx</font></div><div style="margin-top:1.25pt;padding-left:43.65pt;padding-right:375.75pt;text-indent:-36.15pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:132%">&#8226;&#160;&#160;&#160;&#160;xxxx xxxxxxx</font></div><div style="padding-left:43.3pt;text-indent:-35.85pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:113%">&#8226;&#160;&#160;&#160;&#160;xxxxx</font></div><div style="margin-top:1.3pt;padding-left:43.25pt;text-indent:-35.8pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxxxxxxx</font></div><div style="margin-top:1.95pt;padding-left:43.65pt;text-indent:-36.2pt"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;xxxxxx</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:7.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">* </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">This list is non-exhaustive and may be updated by ZO from time to time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.494%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.65pt;padding-left:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>cutr-20210630x10qexx311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i64f5a4de02e1468d91f8ccd95e032cd8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 31.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, David H. Mowry, certify that&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Cutera, Inc.&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:76.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under its supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:76.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under its supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:76.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report its conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:76.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s first fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on its most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:76.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:76.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August 6, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; David H. Mowry</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">David H. Mowry<br>Chief Executive Officer<br>(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>cutr-20210630x10qexx312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="if50ecfa30357479ab244352a48cfaaa8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 31.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Financial Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Rohan Seth, certify that&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Cutera, Inc.&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:76.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under its supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared&#59;</font></div><div style="padding-left:76.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under its supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:76.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report its conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:76.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s first fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on its most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditor and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:76.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:76.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.01pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August 6, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Rohan Seth</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rohan Seth<br>Chief Financial Officer<br>(Principal Financial and Accounting Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>cutr-20210630x10qexx321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i93bbcf7b3d974682a59052700e040143_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 32.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, David H. Mowry, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">the accompanying Quarterly Report on Form 10-Q of the Company for the quarterly period ended June 30, 2021 (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:43.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.805%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August 6, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; David H. Mowry</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">David H. Mowry<br>Chief Executive Officer<br>(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Rohan Seth, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">the accompanying Quarterly Report on Form 10-Q of the Company for the quarterly period ended June 30, 2021 (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:43.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.805%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August 6, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Rohan Seth</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rohan Seth<br>Chief Financial Officer<br>(Principal Financial and Accounting Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>cutr-20210630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c7947e62-414c-45c3-9059-a14473012559,g:b6549df2-51ec-4e04-8ce7-629c1e713d47-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cutr="http://cutera.com/20210331/20210630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://cutera.com/20210331/20210630">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cutr-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cutr-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cutr-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cutr-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://cutera.com/20210331/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://cutera.com/20210331/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofChangesInStockholdersEquityUnaudited" roleURI="http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited">
        <link:definition>1005006 - Statement - Consolidated Statements of Changes In Stockholders' Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofChangesInStockholdersEquityUnauditedParenthetical" roleURI="http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnauditedParenthetical">
        <link:definition>1406401 - Statement - Consolidated Statements of Changes In Stockholders' Equity (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1007007 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://cutera.com/20210331/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2403402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalents" roleURI="http://cutera.com/20210331/role/CashCashEquivalents">
        <link:definition>2104102 - Disclosure - Cash, Cash Equivalents</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsTables" roleURI="http://cutera.com/20210331/role/CashCashEquivalentsTables">
        <link:definition>2305301 - Disclosure - Cash, Cash Equivalents (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsSummaryofCashandCashEquivalentsDetails" roleURI="http://cutera.com/20210331/role/CashCashEquivalentsSummaryofCashandCashEquivalentsDetails">
        <link:definition>2406403 - Disclosure - Cash, Cash Equivalents - Summary of Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsNarrativeDetails" roleURI="http://cutera.com/20210331/role/CashCashEquivalentsNarrativeDetails">
        <link:definition>2407404 - Disclosure - Cash, Cash Equivalents - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstruments" roleURI="http://cutera.com/20210331/role/FairValueofFinancialInstruments">
        <link:definition>2108103 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetails" roleURI="http://cutera.com/20210331/role/BalanceSheetDetails">
        <link:definition>2109104 - Disclosure - Balance Sheet Details</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsTables" roleURI="http://cutera.com/20210331/role/BalanceSheetDetailsTables">
        <link:definition>2310302 - Disclosure - Balance Sheet Details (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsInventoriesDetails" roleURI="http://cutera.com/20210331/role/BalanceSheetDetailsInventoriesDetails">
        <link:definition>2411405 - Disclosure - Balance Sheet Details - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsAccruedLiabilitiesDetails" roleURI="http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails">
        <link:definition>2412406 - Disclosure - Balance Sheet Details - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsNarrativeDetails" roleURI="http://cutera.com/20210331/role/BalanceSheetDetailsNarrativeDetails">
        <link:definition>2413407 - Disclosure - Balance Sheet Details - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantyandExtendedServiceContract" roleURI="http://cutera.com/20210331/role/WarrantyandExtendedServiceContract">
        <link:definition>2114105 - Disclosure - Warranty and Extended Service Contract</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantyandExtendedServiceContractTables" roleURI="http://cutera.com/20210331/role/WarrantyandExtendedServiceContractTables">
        <link:definition>2315303 - Disclosure - Warranty and Extended Service Contract (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantyandExtendedServiceContractNarrativeDetails" roleURI="http://cutera.com/20210331/role/WarrantyandExtendedServiceContractNarrativeDetails">
        <link:definition>2416408 - Disclosure - Warranty and Extended Service Contract - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantyandExtendedServiceContractSummaryofWarrantiesDetails" roleURI="http://cutera.com/20210331/role/WarrantyandExtendedServiceContractSummaryofWarrantiesDetails">
        <link:definition>2417409 - Disclosure - Warranty and Extended Service Contract - Summary of Warranties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredRevenue" roleURI="http://cutera.com/20210331/role/DeferredRevenue">
        <link:definition>2118106 - Disclosure - Deferred Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredRevenueTables" roleURI="http://cutera.com/20210331/role/DeferredRevenueTables">
        <link:definition>2319304 - Disclosure - Deferred Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredRevenueNarrativeDetails" roleURI="http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails">
        <link:definition>2420410 - Disclosure - Deferred Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredRevenueNarrativeDetails_1" roleURI="http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails_1">
        <link:definition>2420410 - Disclosure - Deferred Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredRevenueSummaryofDeferredServiceContractRevenueDetails" roleURI="http://cutera.com/20210331/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails">
        <link:definition>2421411 - Disclosure - Deferred Revenue - Summary of Deferred Service Contract Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://cutera.com/20210331/role/Revenue">
        <link:definition>2122107 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNarrativeDetails" roleURI="http://cutera.com/20210331/role/RevenueNarrativeDetails">
        <link:definition>2423412 - Disclosure - Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockbasedCompensationExpense" roleURI="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpense">
        <link:definition>2124108 - Disclosure - Stockholders' Equity and Stock-based Compensation Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockbasedCompensationExpenseTables" roleURI="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseTables">
        <link:definition>2325305 - Disclosure - Stockholders' Equity and Stock-based Compensation Expense (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails" roleURI="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails">
        <link:definition>2426413 - Disclosure - Stockholders' Equity and Stock-based Compensation Expense - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails" roleURI="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails">
        <link:definition>2427414 - Disclosure - Stockholders' Equity and Stock-based Compensation Expense - Activity Of Options Outstanding Under the 2019 Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails" roleURI="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails">
        <link:definition>2428415 - Disclosure - Stockholders' Equity and Stock-based Compensation Expense - Activity of Stock Awards Outstanding Under the 2019 Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails" roleURI="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails">
        <link:definition>2429416 - Disclosure - Stockholders' Equity and Stock-based Compensation Expense - Stock-based Compensation Expense By Department (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShare" roleURI="http://cutera.com/20210331/role/NetIncomeLossPerShare">
        <link:definition>2130109 - Disclosure - Net Income (Loss) Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareTables" roleURI="http://cutera.com/20210331/role/NetIncomeLossPerShareTables">
        <link:definition>2331306 - Disclosure - Net Income (Loss) Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareNarrativeDetails" roleURI="http://cutera.com/20210331/role/NetIncomeLossPerShareNarrativeDetails">
        <link:definition>2432417 - Disclosure - Net Income (Loss) Per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareNetIncomeLossPerShareDetails" roleURI="http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails">
        <link:definition>2433418 - Disclosure - Net Income (Loss) Per Share - Net Income (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails" roleURI="http://cutera.com/20210331/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails">
        <link:definition>2434419 - Disclosure - Net Income (Loss) Per Share - Antidilutive Securities Excluded From Computation of Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://cutera.com/20210331/role/IncomeTaxes">
        <link:definition>2135110 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://cutera.com/20210331/role/IncomeTaxesNarrativeDetails">
        <link:definition>2436420 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://cutera.com/20210331/role/Leases">
        <link:definition>2137111 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://cutera.com/20210331/role/LeasesTables">
        <link:definition>2338307 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://cutera.com/20210331/role/LeasesNarrativeDetails">
        <link:definition>2439421 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>2440422 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCostsDetails" roleURI="http://cutera.com/20210331/role/LeasesLeaseCostsDetails">
        <link:definition>2441423 - Disclosure - Leases - Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCashPaidforAmountsIncludedintheMeasurementofLeaseLiabilitiesDetails" roleURI="http://cutera.com/20210331/role/LeasesCashPaidforAmountsIncludedintheMeasurementofLeaseLiabilitiesDetails">
        <link:definition>2442424 - Disclosure - Leases - Cash Paid for Amounts Included in the Measurement of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" roleURI="http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails">
        <link:definition>2443425 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" roleURI="http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1">
        <link:definition>2443425 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofFinanceLeasesLiabilitiesDetails" roleURI="http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails">
        <link:definition>2444426 - Disclosure - Leases - Maturities of Finance Leases Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofFinanceLeasesLiabilitiesDetails_1" roleURI="http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails_1">
        <link:definition>2444426 - Disclosure - Leases - Maturities of Finance Leases Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseInformationDetails" roleURI="http://cutera.com/20210331/role/LeasesLeaseInformationDetails">
        <link:definition>2445427 - Disclosure - Leases - Lease Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://cutera.com/20210331/role/Contingencies">
        <link:definition>2146112 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesNarrativeDetails" roleURI="http://cutera.com/20210331/role/ContingenciesNarrativeDetails">
        <link:definition>2447428 - Disclosure - Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://cutera.com/20210331/role/Debt">
        <link:definition>2148113 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://cutera.com/20210331/role/DebtTables">
        <link:definition>2349308 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://cutera.com/20210331/role/DebtNarrativeDetails">
        <link:definition>2450429 - Disclosure - Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtOutstandingDebtandCarryingValueDetails" roleURI="http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails">
        <link:definition>2451430 - Disclosure - Debt - Outstanding Debt and Carrying Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://cutera.com/20210331/role/SegmentReporting">
        <link:definition>2152114 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://cutera.com/20210331/role/SegmentReportingTables">
        <link:definition>2353309 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingNarrativeDetails" roleURI="http://cutera.com/20210331/role/SegmentReportingNarrativeDetails">
        <link:definition>2454431 - Disclosure - Segment Reporting - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSummaryofRevenueDetails" roleURI="http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails">
        <link:definition>2455432 - Disclosure - Segment Reporting - Summary of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cutr_ContractWithCustomerLiabilityPeriodDecrease" abstract="false" name="ContractWithCustomerLiabilityPeriodDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" abstract="false" name="DerivativeCappedCallTransactionTermConsecutiveTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cutr_AccruedInventoryInTransitCurrent" abstract="false" name="AccruedInventoryInTransitCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_OperatingLeaseLiabilitiesLesseeAbstract" abstract="true" name="OperatingLeaseLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual" abstract="false" name="IncreaseDecreaseInExtendedProductWarrantyAccrual" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease" abstract="false" name="ProceedsFromExerciseOfPurchaseOptionSalesTypeLease" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_AmortizationOfDebtIssuanceCostsNetOfTax" abstract="false" name="AmortizationOfDebtIssuanceCostsNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_TwoThousandNineteenEquityIncentivePlanMember" abstract="true" name="TwoThousandNineteenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_AmendedAndRestated2004EquityIncentivePlanMember" abstract="true" name="AmendedAndRestated2004EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_CappedCallTransactionsCosts" abstract="false" name="CappedCallTransactionsCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_AsiaExcludingJapanMember" abstract="true" name="AsiaExcludingJapanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_ChangeInContractWithCustomerLiabilityRollForward" abstract="true" name="ChangeInContractWithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cutr_SaleOfThirdPartyProductWarrantyPeriod" abstract="false" name="SaleOfThirdPartyProductWarrantyPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays" abstract="false" name="DebtInstrumentRedeemableThresholdConsecutiveTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cutr_LoanAndSecurityAgreementMember" abstract="true" name="LoanAndSecurityAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_SiliconValleyBankMember" abstract="true" name="SiliconValleyBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_FinanceLeaseLiabilitiesLesseeAbstract" abstract="true" name="FinanceLeaseLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" abstract="false" name="DebtInstrumentPercentageOfQualifyingAccountsReceivable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm" abstract="false" name="LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" abstract="true" name="ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_WeightedAverageRemainingLeaseTermAbstract" abstract="true" name="WeightedAverageRemainingLeaseTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" abstract="false" name="DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_CostsForExtendedServiceContracts" abstract="false" name="CostsForExtendedServiceContracts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember" abstract="true" name="ExecutiveOfficersSeniorManagementAndCertainEmployeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_DerivativeCapPricePremiumOverStockPricePercent" abstract="false" name="DerivativeCapPricePremiumOverStockPricePercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cutr_DebtInstrumentAnniversaryFeeAmount" abstract="false" name="DebtInstrumentAnniversaryFeeAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ExecutiveOfficersAndSeniorManagementMember" abstract="true" name="ExecutiveOfficersAndSeniorManagementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_RevenueFromContractWithCustomerTermOfContract" abstract="false" name="RevenueFromContractWithCustomerTermOfContract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_ProductRemediationLiabilityMember" abstract="true" name="ProductRemediationLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_ProductsExcludingConsumablesAndSkincareMember" abstract="true" name="ProductsExcludingConsumablesAndSkincareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_NonEmployeeDirectorsMember" abstract="true" name="NonEmployeeDirectorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_LeaseRightOfUseAsset" abstract="false" name="LeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ConsumablesMember" abstract="true" name="ConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_SkincareMember" abstract="true" name="SkincareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_BasisOfPresentationPolicyTextBlock" abstract="false" name="BasisOfPresentationPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cutr_ExtendedServiceContractOptionTwoTerm" abstract="false" name="ExtendedServiceContractOptionTwoTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" abstract="false" name="DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" abstract="false" name="ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" abstract="true" name="ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" abstract="false" name="ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_ExtendedServiceContractOptionOneTerm" abstract="false" name="ExtendedServiceContractOptionOneTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_CustomerMarketingSupportMember" abstract="true" name="CustomerMarketingSupportMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" abstract="false" name="DepreciationAndAmortizationExcludingContractAcquisitionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_IncreaseDecreaseInOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ShareBasedPaymentArrangementTrancheFourMember" abstract="true" name="ShareBasedPaymentArrangementTrancheFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_LoyaltyMember" abstract="true" name="LoyaltyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_PaycheckProtectionProgramCARESActMember" abstract="true" name="PaycheckProtectionProgramCARESActMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_NonqualifiedStockOptionsMember" abstract="true" name="NonqualifiedStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_DebtInstrumentRedeemableThresholdTradingDays" abstract="false" name="DebtInstrumentRedeemableThresholdTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cutr_WellsFargoMember" abstract="true" name="WellsFargoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment" abstract="false" name="RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves" abstract="false" name="StandardAndExtendedProductWarrantyAccrualExcessReserves" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_RestOfWorldMember" abstract="true" name="RestOfWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" abstract="true" name="RestrictedStockUnitsAndPerformanceShareUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork" abstract="false" name="NumberOfCountriesInWhichEntityUtilizesADistributorNetwork" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cutr_RevenuePerformanceObligationSatisfiedOverTimePercent" abstract="false" name="RevenuePerformanceObligationSatisfiedOverTimePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cutr_SalesAndMarketingAccrualsCurrent" abstract="false" name="SalesAndMarketingAccrualsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_DebtCovenantQuarterlyMinimumRevenue" abstract="false" name="DebtCovenantQuarterlyMinimumRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" abstract="false" name="RisksAndUncertaintiesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" abstract="false" name="ChangeInRightofuseAssetAndLiabilityDueToModification" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cutr_ExtendedServiceContractOptionThreeTerm" abstract="false" name="ExtendedServiceContractOptionThreeTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cutr_LeasesWeightedAverageDiscountRateAbstract" abstract="true" name="LeasesWeightedAverageDiscountRateAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cutr_ConvertibleSeniorNotesDue2026Member" abstract="true" name="ConvertibleSeniorNotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cutr_ContractWithCustomerLiabilityTextBlock" abstract="false" name="ContractWithCustomerLiabilityTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" abstract="false" name="DebtInstrumentRedemptionIncrementalRepurchaseAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>cutr-20210630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c7947e62-414c-45c3-9059-a14473012559,g:b6549df2-51ec-4e04-8ce7-629c1e713d47-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cutr-20210630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8c786794-5beb-4672-85b3-bf859f690daf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_dbbc65e5-8fda-4de9-b367-311f2fe0579e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8c786794-5beb-4672-85b3-bf859f690daf" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_dbbc65e5-8fda-4de9-b367-311f2fe0579e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_9fedd30f-102e-4302-bce9-af871624796e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8c786794-5beb-4672-85b3-bf859f690daf" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_9fedd30f-102e-4302-bce9-af871624796e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_53a37554-321a-4968-8a2a-aae6215a2920" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8c786794-5beb-4672-85b3-bf859f690daf" xlink:to="loc_us-gaap_InventoryNet_53a37554-321a-4968-8a2a-aae6215a2920" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4693fc86-998c-4a54-855b-6445f2486a38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8c786794-5beb-4672-85b3-bf859f690daf" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4693fc86-998c-4a54-855b-6445f2486a38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_aaaa016a-d0b8-45cf-a742-ba686c7df444" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_312bee45-ba36-4dc8-b2c0-ec5535b0f059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_aaaa016a-d0b8-45cf-a742-ba686c7df444" xlink:to="loc_us-gaap_CommonStockValue_312bee45-ba36-4dc8-b2c0-ec5535b0f059" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_a68d1dc0-e3f3-48f8-a8a4-35b4cd1ee79e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_aaaa016a-d0b8-45cf-a742-ba686c7df444" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_a68d1dc0-e3f3-48f8-a8a4-35b4cd1ee79e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5022df98-c0f5-4f08-9965-206f17a4ce7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_aaaa016a-d0b8-45cf-a742-ba686c7df444" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5022df98-c0f5-4f08-9965-206f17a4ce7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7cf515ba-2290-4c0d-9091-53bac05bf0bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6f5abb4b-20ca-4e4a-b262-a21a7123e141" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7cf515ba-2290-4c0d-9091-53bac05bf0bf" xlink:to="loc_us-gaap_Liabilities_6f5abb4b-20ca-4e4a-b262-a21a7123e141" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b388f301-d8c9-4eae-af42-85c1280c3b26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7cf515ba-2290-4c0d-9091-53bac05bf0bf" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b388f301-d8c9-4eae-af42-85c1280c3b26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_16b16947-f894-4780-8b75-ceab718546be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7cf515ba-2290-4c0d-9091-53bac05bf0bf" xlink:to="loc_us-gaap_StockholdersEquity_16b16947-f894-4780-8b75-ceab718546be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9590ec45-e787-432b-becd-cb1151997557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cdc8194a-f2be-49f1-ba74-f098652b2ae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9590ec45-e787-432b-becd-cb1151997557" xlink:to="loc_us-gaap_AssetsCurrent_cdc8194a-f2be-49f1-ba74-f098652b2ae7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_11ed990f-35ae-4ae1-a64e-962b44ef1155" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9590ec45-e787-432b-becd-cb1151997557" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_11ed990f-35ae-4ae1-a64e-962b44ef1155" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_5550b83e-087b-40e1-a8b3-84fa7b7a6e81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9590ec45-e787-432b-becd-cb1151997557" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_5550b83e-087b-40e1-a8b3-84fa7b7a6e81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2dce7df9-7c63-42f6-9bb6-3ae334cd76f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9590ec45-e787-432b-becd-cb1151997557" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2dce7df9-7c63-42f6-9bb6-3ae334cd76f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b86a8cd7-33b5-4970-b502-b290ccf082fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9590ec45-e787-432b-becd-cb1151997557" xlink:to="loc_us-gaap_Goodwill_b86a8cd7-33b5-4970-b502-b290ccf082fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c33a6069-046a-4d06-9e8b-868ed361e552" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9590ec45-e787-432b-becd-cb1151997557" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c33a6069-046a-4d06-9e8b-868ed361e552" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8469f179-1987-4348-9afd-4d7d1215f618" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_54e6231a-b5db-4805-ae18-7fcf030e4563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8469f179-1987-4348-9afd-4d7d1215f618" xlink:to="loc_us-gaap_LiabilitiesCurrent_54e6231a-b5db-4805-ae18-7fcf030e4563" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_566a1640-f33c-4e17-8fb5-4129cc12a3f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8469f179-1987-4348-9afd-4d7d1215f618" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_566a1640-f33c-4e17-8fb5-4129cc12a3f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d5394401-907b-46c1-b913-5249075e0095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8469f179-1987-4348-9afd-4d7d1215f618" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d5394401-907b-46c1-b913-5249075e0095" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredLongTermDebt_27b9c2bd-b3a0-453b-9504-8f23c875fa2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredLongTermDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8469f179-1987-4348-9afd-4d7d1215f618" xlink:to="loc_us-gaap_UnsecuredLongTermDebt_27b9c2bd-b3a0-453b-9504-8f23c875fa2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_739b298b-60e6-4795-a479-103b1691e610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8469f179-1987-4348-9afd-4d7d1215f618" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_739b298b-60e6-4795-a479-103b1691e610" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c99c330c-a413-44d8-8c46-35c55a8aeb70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8469f179-1987-4348-9afd-4d7d1215f618" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c99c330c-a413-44d8-8c46-35c55a8aeb70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1724c6e0-2328-4b67-988a-af5ad5a333d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_c58f7a16-c3a1-4fa7-81b5-d2004c6d0c2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1724c6e0-2328-4b67-988a-af5ad5a333d0" xlink:to="loc_us-gaap_AccountsPayableCurrent_c58f7a16-c3a1-4fa7-81b5-d2004c6d0c2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_e9205707-8ef7-4c5d-ac47-f98a1f7f625f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1724c6e0-2328-4b67-988a-af5ad5a333d0" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_e9205707-8ef7-4c5d-ac47-f98a1f7f625f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_4da4b575-5d11-4781-a6ae-469415251269" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1724c6e0-2328-4b67-988a-af5ad5a333d0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_4da4b575-5d11-4781-a6ae-469415251269" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtCurrent_5f88a5f7-20e3-4a46-869e-d7a60e8f3990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1724c6e0-2328-4b67-988a-af5ad5a333d0" xlink:to="loc_us-gaap_UnsecuredDebtCurrent_5f88a5f7-20e3-4a46-869e-d7a60e8f3990" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyAccrualCurrent_aa4fbcb3-3c8e-4e7f-9bb3-a6f0da304902" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtendedProductWarrantyAccrualCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1724c6e0-2328-4b67-988a-af5ad5a333d0" xlink:to="loc_us-gaap_ExtendedProductWarrantyAccrualCurrent_aa4fbcb3-3c8e-4e7f-9bb3-a6f0da304902" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_75849db8-7d02-44a6-84d7-cc02e8a85b12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1724c6e0-2328-4b67-988a-af5ad5a333d0" xlink:to="loc_us-gaap_DeferredRevenueCurrent_75849db8-7d02-44a6-84d7-cc02e8a85b12" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cutr-20210630.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_4d45ca8b-718c-4861-9c8f-53127dcfe7d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_5350d7da-406e-43c8-bbd4-64d715d0b447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_4d45ca8b-718c-4861-9c8f-53127dcfe7d8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_5350d7da-406e-43c8-bbd4-64d715d0b447" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_7cd58a2c-7247-4bba-93a0-70080bb0d6b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_4d45ca8b-718c-4861-9c8f-53127dcfe7d8" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_7cd58a2c-7247-4bba-93a0-70080bb0d6b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8d6a64a6-1e59-43cd-965f-4cfa946e1fee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_547ee953-2e8b-4712-8019-6b0308c5b543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8d6a64a6-1e59-43cd-965f-4cfa946e1fee" xlink:to="loc_us-gaap_OperatingIncomeLoss_547ee953-2e8b-4712-8019-6b0308c5b543" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_cbaf447f-2b28-412e-919f-9d656e7af5e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8d6a64a6-1e59-43cd-965f-4cfa946e1fee" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_cbaf447f-2b28-412e-919f-9d656e7af5e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_2d19deaa-e7d4-425e-aac2-fea6afbd707b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_c7428fcc-a94f-4fe6-a9b1-a33f0e4ab3e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2d19deaa-e7d4-425e-aac2-fea6afbd707b" xlink:to="loc_us-gaap_SellingAndMarketingExpense_c7428fcc-a94f-4fe6-a9b1-a33f0e4ab3e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_51311f6e-93c5-469b-ab28-ef97a0a60da8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2d19deaa-e7d4-425e-aac2-fea6afbd707b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_51311f6e-93c5-469b-ab28-ef97a0a60da8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_d49db2eb-a319-45b8-aef0-e2a05011e6ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2d19deaa-e7d4-425e-aac2-fea6afbd707b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_d49db2eb-a319-45b8-aef0-e2a05011e6ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_71de34b4-4944-4c8b-8115-acafc93bcfb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_860ef926-93ca-49cb-8d62-48e6079de5e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_71de34b4-4944-4c8b-8115-acafc93bcfb7" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_860ef926-93ca-49cb-8d62-48e6079de5e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_21fe1cc6-76d2-4e37-98d5-4c65582e3e6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_71de34b4-4944-4c8b-8115-acafc93bcfb7" xlink:to="loc_us-gaap_InterestExpenseDebt_21fe1cc6-76d2-4e37-98d5-4c65582e3e6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5b6a529c-faa4-44b8-9df7-f98c7439da3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_71de34b4-4944-4c8b-8115-acafc93bcfb7" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5b6a529c-faa4-44b8-9df7-f98c7439da3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b2d342c0-9579-47b8-87ab-bfe5ac80362c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_71de34b4-4944-4c8b-8115-acafc93bcfb7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b2d342c0-9579-47b8-87ab-bfe5ac80362c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6c4854cc-8e01-43a5-9698-84c43ad0c975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_df89b326-b601-40bd-92b8-320e627c157a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6c4854cc-8e01-43a5-9698-84c43ad0c975" xlink:to="loc_us-gaap_GrossProfit_df89b326-b601-40bd-92b8-320e627c157a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_196b0a4a-9d04-43cd-9330-976a5b525430" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6c4854cc-8e01-43a5-9698-84c43ad0c975" xlink:to="loc_us-gaap_OperatingExpenses_196b0a4a-9d04-43cd-9330-976a5b525430" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1a4ed10c-c5ef-4787-8b92-4ae71d85494a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5694b52e-9547-42ee-8c59-2f6c1127fae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1a4ed10c-c5ef-4787-8b92-4ae71d85494a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5694b52e-9547-42ee-8c59-2f6c1127fae7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_18b5e748-0b6f-4c7a-88bc-3102b157cb86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1a4ed10c-c5ef-4787-8b92-4ae71d85494a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_18b5e748-0b6f-4c7a-88bc-3102b157cb86" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cutr-20210630.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://cutera.com/20210331/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_2c4c698c-44dc-4172-89da-043e32d2f638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3c9cd0c7-fae2-4e99-a5e6-9a88829ad659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_2c4c698c-44dc-4172-89da-043e32d2f638" xlink:to="loc_us-gaap_NetIncomeLoss_3c9cd0c7-fae2-4e99-a5e6-9a88829ad659" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ade56bb0-4b4c-44bc-acd4-ec1571a59732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_2c4c698c-44dc-4172-89da-043e32d2f638" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ade56bb0-4b4c-44bc-acd4-ec1571a59732" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_42f42ef8-fb0f-4c17-8bb8-db2a56124228" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_921c5f52-4be6-4d32-a16c-876b4c7a85ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_42f42ef8-fb0f-4c17-8bb8-db2a56124228" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_921c5f52-4be6-4d32-a16c-876b4c7a85ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_16631384-7844-4c2d-8f0f-b8a5fafeb3ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_5d68bf14-c6c5-40bc-9ee8-f5d34392f9c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_16631384-7844-4c2d-8f0f-b8a5fafeb3ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_5d68bf14-c6c5-40bc-9ee8-f5d34392f9c6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cutr-20210630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cfb526d9-ad41-4076-9d68-22f58b36b69b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bd4ded00-c67e-4abf-a991-9f5bc108836f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cfb526d9-ad41-4076-9d68-22f58b36b69b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bd4ded00-c67e-4abf-a991-9f5bc108836f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_38ba0e52-cfaf-4c40-b3a0-0abe12853b65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cfb526d9-ad41-4076-9d68-22f58b36b69b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_38ba0e52-cfaf-4c40-b3a0-0abe12853b65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_14faeaaa-730f-4174-90a8-ee1299739709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cfb526d9-ad41-4076-9d68-22f58b36b69b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_14faeaaa-730f-4174-90a8-ee1299739709" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_159a0b08-e7f6-4eab-8554-ecb62a8a1ce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1dd2fb9b-0fd5-45db-8566-01803c87fd6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_159a0b08-e7f6-4eab-8554-ecb62a8a1ce7" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1dd2fb9b-0fd5-45db-8566-01803c87fd6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_bd449ab6-f690-45d0-b2ea-c2df2c0b40b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_159a0b08-e7f6-4eab-8554-ecb62a8a1ce7" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_bd449ab6-f690-45d0-b2ea-c2df2c0b40b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_cb60aa7d-9893-4400-9df0-1070bd5f286f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_159a0b08-e7f6-4eab-8554-ecb62a8a1ce7" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_cb60aa7d-9893-4400-9df0-1070bd5f286f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_733ecc81-9b54-47fe-9c4e-1b4c539a7b8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_159a0b08-e7f6-4eab-8554-ecb62a8a1ce7" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_733ecc81-9b54-47fe-9c4e-1b4c539a7b8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_54be591b-1fa3-4ea3-9a5c-7ca9fafcff02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_159a0b08-e7f6-4eab-8554-ecb62a8a1ce7" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_54be591b-1fa3-4ea3-9a5c-7ca9fafcff02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_8e3742ef-92a5-4fc3-8a54-3d02db7d9b00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_159a0b08-e7f6-4eab-8554-ecb62a8a1ce7" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_8e3742ef-92a5-4fc3-8a54-3d02db7d9b00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_94b8ea5c-d856-40a2-a708-c7012d649e30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_159a0b08-e7f6-4eab-8554-ecb62a8a1ce7" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_94b8ea5c-d856-40a2-a708-c7012d649e30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_ba76a351-412c-4448-bed1-dd8a59e4b0da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_159a0b08-e7f6-4eab-8554-ecb62a8a1ce7" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_ba76a351-412c-4448-bed1-dd8a59e4b0da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_eaf5755c-bb8c-4894-a05d-c28ed927217f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_us-gaap_NetIncomeLoss_eaf5755c-bb8c-4894-a05d-c28ed927217f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_33f85a27-c455-4727-be1e-1ccdd406b226" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_us-gaap_ShareBasedCompensation_33f85a27-c455-4727-be1e-1ccdd406b226" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_61aded05-c6f9-4049-a89c-ab036383e47e" xlink:href="cutr-20210630.xsd#cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_61aded05-c6f9-4049-a89c-ab036383e47e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfAcquisitionCosts_98811da3-31dc-473d-a71c-1007afb271e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfAcquisitionCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_us-gaap_AmortizationOfAcquisitionCosts_98811da3-31dc-473d-a71c-1007afb271e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_bc8201e4-1c8c-44fd-986a-a649119c8779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_bc8201e4-1c8c-44fd-986a-a649119c8779" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareImpairments1_d2b8529b-1614-4da4-a7c5-4f87b3044da3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareImpairments1"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareImpairments1_d2b8529b-1614-4da4-a7c5-4f87b3044da3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0fa912d1-305d-4c22-9fc7-aef72a4cecac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0fa912d1-305d-4c22-9fc7-aef72a4cecac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_6ad19381-2e64-4432-9d72-94a5f88d1d78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_6ad19381-2e64-4432-9d72-94a5f88d1d78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_5a0a8f0a-6a97-46c6-82f4-fafca93f0837" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_5a0a8f0a-6a97-46c6-82f4-fafca93f0837" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_14aca5be-ba23-4f51-ace5-ad502cf886bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_14aca5be-ba23-4f51-ace5-ad502cf886bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_4a5f5971-7e4b-4ec8-bc7d-3247ca253373" xlink:href="cutr-20210630.xsd#cutr_ChangeInRightofuseAssetAndLiabilityDueToModification"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_4a5f5971-7e4b-4ec8-bc7d-3247ca253373" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_c75bdccf-7843-4d77-b93f-48a63409c7bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_c75bdccf-7843-4d77-b93f-48a63409c7bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6bff1d13-b432-4d8a-8e33-ede713994a50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6bff1d13-b432-4d8a-8e33-ede713994a50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_22d04560-1b06-448b-a37a-9967966051a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_22d04560-1b06-448b-a37a-9967966051a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0c1d1877-6312-4a43-8abb-59ea7f9617a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0c1d1877-6312-4a43-8abb-59ea7f9617a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_e6b416f0-5992-4701-a383-b88d6f7ca781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_e6b416f0-5992-4701-a383-b88d6f7ca781" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_3b0685f3-c5bd-416f-ae5d-6a58e73859de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_3b0685f3-c5bd-416f-ae5d-6a58e73859de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_182aa7eb-a1e6-48aa-b15f-1b0859f273f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_182aa7eb-a1e6-48aa-b15f-1b0859f273f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual_b2e3757e-ce45-494d-9b94-5a7827d1a31e" xlink:href="cutr-20210630.xsd#cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual_b2e3757e-ce45-494d-9b94-5a7827d1a31e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_90a71e71-87a8-423d-a0dc-66448abf29c9" xlink:href="cutr-20210630.xsd#cutr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_90a71e71-87a8-423d-a0dc-66448abf29c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_cc633ca1-c473-49c2-acf2-8ffff5011d78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1959a9fb-7f6b-4c83-8d6e-15a955513a99" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_cc633ca1-c473-49c2-acf2-8ffff5011d78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_337fc00d-daf0-4fff-af35-1a46a5410708" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e3088b39-a101-42e3-9f06-196cae1b7d42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_337fc00d-daf0-4fff-af35-1a46a5410708" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e3088b39-a101-42e3-9f06-196cae1b7d42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_4b0cf9c2-ff0b-4467-ab7d-24c4113613ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_337fc00d-daf0-4fff-af35-1a46a5410708" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_4b0cf9c2-ff0b-4467-ab7d-24c4113613ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_34107d05-d793-4783-afc3-20555f21130b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_337fc00d-daf0-4fff-af35-1a46a5410708" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_34107d05-d793-4783-afc3-20555f21130b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_ef6c6e8d-d14a-4192-b80c-b72d64cfeeee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_337fc00d-daf0-4fff-af35-1a46a5410708" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_ef6c6e8d-d14a-4192-b80c-b72d64cfeeee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/BalanceSheetDetailsInventoriesDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#BalanceSheetDetailsInventoriesDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/20210331/role/BalanceSheetDetailsInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e740106d-47df-419e-9ec3-f4622b556c39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_1f5a38b3-185d-4725-9f9e-295bc6c1a805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e740106d-47df-419e-9ec3-f4622b556c39" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_1f5a38b3-185d-4725-9f9e-295bc6c1a805" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_77def61a-80d9-4776-828f-21a9968b5cb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e740106d-47df-419e-9ec3-f4622b556c39" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_77def61a-80d9-4776-828f-21a9968b5cb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d95e87dc-0b79-4e94-870c-826da9a923c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e740106d-47df-419e-9ec3-f4622b556c39" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d95e87dc-0b79-4e94-870c-826da9a923c4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#BalanceSheetDetailsAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_7f0fe8fa-a1cb-4d9d-8b62-6752d4d90a45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_e760c41f-9f0f-4750-bd19-51c199650cc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_7f0fe8fa-a1cb-4d9d-8b62-6752d4d90a45" xlink:to="loc_us-gaap_AccruedSalariesCurrent_e760c41f-9f0f-4750-bd19-51c199650cc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SalesAndMarketingAccrualsCurrent_300b1d9b-d683-4a1f-ac40-a06b22c05648" xlink:href="cutr-20210630.xsd#cutr_SalesAndMarketingAccrualsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_7f0fe8fa-a1cb-4d9d-8b62-6752d4d90a45" xlink:to="loc_cutr_SalesAndMarketingAccrualsCurrent_300b1d9b-d683-4a1f-ac40-a06b22c05648" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AccruedInventoryInTransitCurrent_eaef1cc9-3260-4729-8d45-e4325ab91ecf" xlink:href="cutr-20210630.xsd#cutr_AccruedInventoryInTransitCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_7f0fe8fa-a1cb-4d9d-8b62-6752d4d90a45" xlink:to="loc_cutr_AccruedInventoryInTransitCurrent_eaef1cc9-3260-4729-8d45-e4325ab91ecf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_1b91a7ab-830d-4c23-b6bb-dd0aa929c0d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_7f0fe8fa-a1cb-4d9d-8b62-6752d4d90a45" xlink:to="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_1b91a7ab-830d-4c23-b6bb-dd0aa929c0d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent_f5733be7-34ba-464d-944c-f82e3157ff6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_7f0fe8fa-a1cb-4d9d-8b62-6752d4d90a45" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrent_f5733be7-34ba-464d-944c-f82e3157ff6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_8558c8c2-161d-4a59-81fb-ab03bd8031f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_7f0fe8fa-a1cb-4d9d-8b62-6752d4d90a45" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_8558c8c2-161d-4a59-81fb-ab03bd8031f2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#NetIncomeLossPerShareNetIncomeLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2f8f2153-cabf-4728-bd3e-7ecbe6c71b7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_837d87d9-52fc-4015-af03-c17a78217d19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2f8f2153-cabf-4728-bd3e-7ecbe6c71b7e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_837d87d9-52fc-4015-af03-c17a78217d19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_16171f05-45af-4dbe-a2af-1ad061fdde72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2f8f2153-cabf-4728-bd3e-7ecbe6c71b7e" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_16171f05-45af-4dbe-a2af-1ad061fdde72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7819e98c-f1da-4903-9e6a-2b2f21efd7ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2f8f2153-cabf-4728-bd3e-7ecbe6c71b7e" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7819e98c-f1da-4903-9e6a-2b2f21efd7ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_33b034fa-4609-4923-a206-669031b53446" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4bfc3782-e509-4bdd-a45e-3bc56968cb2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_33b034fa-4609-4923-a206-669031b53446" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4bfc3782-e509-4bdd-a45e-3bc56968cb2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_025c7ccd-c772-4271-ab90-c17e6127ba18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_33b034fa-4609-4923-a206-669031b53446" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_025c7ccd-c772-4271-ab90-c17e6127ba18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AmortizationOfDebtIssuanceCostsNetOfTax_ea17ab7b-b6eb-4e3f-8f96-632ab290ccc5" xlink:href="cutr-20210630.xsd#cutr_AmortizationOfDebtIssuanceCostsNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_33b034fa-4609-4923-a206-669031b53446" xlink:to="loc_cutr_AmortizationOfDebtIssuanceCostsNetOfTax_ea17ab7b-b6eb-4e3f-8f96-632ab290ccc5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_410c071a-1587-4d95-8547-0e01a428ee0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_59868fd2-0f9a-4d2a-baad-2050c077a08c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_410c071a-1587-4d95-8547-0e01a428ee0e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_59868fd2-0f9a-4d2a-baad-2050c077a08c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_d4d80f55-e1ca-4353-86f3-76333c8574e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_410c071a-1587-4d95-8547-0e01a428ee0e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_d4d80f55-e1ca-4353-86f3-76333c8574e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeaseRightOfUseAsset_85de1a8b-99cf-4cec-8b62-618a05b49541" xlink:href="cutr-20210630.xsd#cutr_LeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_2e522824-9a06-47da-a84f-17cebdd10f3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cutr_LeaseRightOfUseAsset_85de1a8b-99cf-4cec-8b62-618a05b49541" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_2e522824-9a06-47da-a84f-17cebdd10f3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_969f973a-2656-4e35-9bd0-12dc254c4cb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cutr_LeaseRightOfUseAsset_85de1a8b-99cf-4cec-8b62-618a05b49541" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_969f973a-2656-4e35-9bd0-12dc254c4cb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ef6d74f9-5a6d-462b-8520-dec0fc905d12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8b9c404c-554e-48f3-b961-d4ce944a87a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_ef6d74f9-5a6d-462b-8520-dec0fc905d12" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8b9c404c-554e-48f3-b961-d4ce944a87a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6aef6c0a-bfe6-48dd-a0f0-b45f857f6ba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_ef6d74f9-5a6d-462b-8520-dec0fc905d12" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6aef6c0a-bfe6-48dd-a0f0-b45f857f6ba5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e831c224-3abe-437d-ab87-3dc80c3b53e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_6a0fbafd-a034-4db0-a207-adea3039e176" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e831c224-3abe-437d-ab87-3dc80c3b53e0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_6a0fbafd-a034-4db0-a207-adea3039e176" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bbac95d7-9251-435f-9d99-b23da0018f84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e831c224-3abe-437d-ab87-3dc80c3b53e0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bbac95d7-9251-435f-9d99-b23da0018f84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_893b8084-1c43-45a1-8f5a-79be36b6ec53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e831c224-3abe-437d-ab87-3dc80c3b53e0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_893b8084-1c43-45a1-8f5a-79be36b6ec53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b8e44eb3-1b81-4dc3-a90a-1c4347b34cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e831c224-3abe-437d-ab87-3dc80c3b53e0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b8e44eb3-1b81-4dc3-a90a-1c4347b34cbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_47a6ef3b-afa4-49be-b524-b6a3739da476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e831c224-3abe-437d-ab87-3dc80c3b53e0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_47a6ef3b-afa4-49be-b524-b6a3739da476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_23f1e947-7f22-4275-8966-7971796ffd7a" xlink:href="cutr-20210630.xsd#cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e831c224-3abe-437d-ab87-3dc80c3b53e0" xlink:to="loc_cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_23f1e947-7f22-4275-8966-7971796ffd7a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="cutr-20210630.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_302dfe25-81e5-4189-8cb3-35de683651e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f15c3b07-8ee0-47e0-af89-dd4c75158bce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_302dfe25-81e5-4189-8cb3-35de683651e3" xlink:to="loc_us-gaap_OperatingLeaseLiability_f15c3b07-8ee0-47e0-af89-dd4c75158bce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b366fd00-4cd8-4a88-827e-006d86c37e1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_302dfe25-81e5-4189-8cb3-35de683651e3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b366fd00-4cd8-4a88-827e-006d86c37e1c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#LeasesMaturitiesofFinanceLeasesLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_fa00df19-24b1-407d-b408-dcec420f3733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_286c9698-8212-4ac6-8e82-a6da961fb5e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_fa00df19-24b1-407d-b408-dcec420f3733" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_286c9698-8212-4ac6-8e82-a6da961fb5e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_1f7d4f78-e3d1-490f-a6bf-32553568639e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_fa00df19-24b1-407d-b408-dcec420f3733" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_1f7d4f78-e3d1-490f-a6bf-32553568639e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_8bef9a7d-2bd2-44ca-a4e2-0e70e3ba373a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_fa00df19-24b1-407d-b408-dcec420f3733" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_8bef9a7d-2bd2-44ca-a4e2-0e70e3ba373a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_4f7efe14-53c9-4d9e-80f4-5aac9857d252" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_fa00df19-24b1-407d-b408-dcec420f3733" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_4f7efe14-53c9-4d9e-80f4-5aac9857d252" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails_1" xlink:type="simple" xlink:href="cutr-20210630.xsd#LeasesMaturitiesofFinanceLeasesLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6fb28257-94ee-467f-a2d8-e69dd8087d0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_9cbdfcfd-38ae-409b-8a51-2649105e6611" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6fb28257-94ee-467f-a2d8-e69dd8087d0e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_9cbdfcfd-38ae-409b-8a51-2649105e6611" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_1030e012-9212-4bc7-b59a-c1f011b8d2aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6fb28257-94ee-467f-a2d8-e69dd8087d0e" xlink:to="loc_us-gaap_FinanceLeaseLiability_1030e012-9212-4bc7-b59a-c1f011b8d2aa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#DebtOutstandingDebtandCarryingValueDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_792025a8-97be-4682-9f93-e0c43b037ca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_bbcf8eec-9c18-4ae1-bb10-de1fe497247b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_792025a8-97be-4682-9f93-e0c43b037ca6" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_bbcf8eec-9c18-4ae1-bb10-de1fe497247b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_8fc49b3c-d407-4592-a6be-f81b4f092a57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_792025a8-97be-4682-9f93-e0c43b037ca6" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_8fc49b3c-d407-4592-a6be-f81b4f092a57" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>cutr-20210630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c7947e62-414c-45c3-9059-a14473012559,g:b6549df2-51ec-4e04-8ce7-629c1e713d47-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cutr-20210630.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended" id="i677f0227c15248d783cff4c200a8f3f7_CondensedConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_37e6455c-131f-4a8b-b43d-dbcdcfb4cf9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_RevenuesAbstract_37e6455c-131f-4a8b-b43d-dbcdcfb4cf9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_acedc04e-712c-4d60-a19f-01480d82855d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_37e6455c-131f-4a8b-b43d-dbcdcfb4cf9b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_acedc04e-712c-4d60-a19f-01480d82855d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_34c5e51b-9f71-49ec-a3ce-1a79ad69c03e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_CostOfRevenueAbstract_34c5e51b-9f71-49ec-a3ce-1a79ad69c03e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_71c10a52-1c26-43a4-9b64-7d34a204732c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_34c5e51b-9f71-49ec-a3ce-1a79ad69c03e" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_71c10a52-1c26-43a4-9b64-7d34a204732c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_553de7a1-3d54-4e41-a217-e8b43855b5cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_GrossProfit_553de7a1-3d54-4e41-a217-e8b43855b5cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_3232be64-22f1-45ef-80d1-b430aed9abdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_OperatingExpensesAbstract_3232be64-22f1-45ef-80d1-b430aed9abdf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_d50d4e0a-a073-4cbe-9d80-da03d929c415" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3232be64-22f1-45ef-80d1-b430aed9abdf" xlink:to="loc_us-gaap_SellingAndMarketingExpense_d50d4e0a-a073-4cbe-9d80-da03d929c415" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_500406c7-4401-4b8a-8240-d8b35e8e78ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3232be64-22f1-45ef-80d1-b430aed9abdf" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_500406c7-4401-4b8a-8240-d8b35e8e78ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_f279fe71-23d1-41e0-9d1e-8a3b64dad827" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3232be64-22f1-45ef-80d1-b430aed9abdf" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_f279fe71-23d1-41e0-9d1e-8a3b64dad827" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_9b2789da-24b5-4eb8-8c33-efd485cb739c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_OperatingExpenses_9b2789da-24b5-4eb8-8c33-efd485cb739c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_78f069ce-7d75-4200-b2d5-c9b82ee1d377" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_OperatingIncomeLoss_78f069ce-7d75-4200-b2d5-c9b82ee1d377" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseAbstract_a4fd6597-e16c-49e8-abf3-1a0268f90789" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_InterestExpenseAbstract_a4fd6597-e16c-49e8-abf3-1a0268f90789" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_8e69736a-ed5d-4148-ba7d-f48bb7fe1598" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestExpenseAbstract_a4fd6597-e16c-49e8-abf3-1a0268f90789" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_8e69736a-ed5d-4148-ba7d-f48bb7fe1598" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_3ae8595a-fd8e-48b3-b661-f6a250b387e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestExpenseAbstract_a4fd6597-e16c-49e8-abf3-1a0268f90789" xlink:to="loc_us-gaap_InterestExpenseDebt_3ae8595a-fd8e-48b3-b661-f6a250b387e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2d9521ef-3a93-4a66-b4d7-ef0dd695f44b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestExpenseAbstract_a4fd6597-e16c-49e8-abf3-1a0268f90789" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2d9521ef-3a93-4a66-b4d7-ef0dd695f44b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_eba53b5d-900d-4922-a1aa-9833f90758a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestExpenseAbstract_a4fd6597-e16c-49e8-abf3-1a0268f90789" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_eba53b5d-900d-4922-a1aa-9833f90758a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_490ac311-1104-4b10-8444-db77f9719a9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestExpenseAbstract_a4fd6597-e16c-49e8-abf3-1a0268f90789" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_490ac311-1104-4b10-8444-db77f9719a9f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7b1f84bb-e107-47e0-b7e3-b97df1f30bd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7b1f84bb-e107-47e0-b7e3-b97df1f30bd1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_428a2735-64ac-4e36-b52e-2e7498a3055c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_428a2735-64ac-4e36-b52e-2e7498a3055c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_06d88e56-96c8-459f-99a4-7afc95873858" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_NetIncomeLoss_06d88e56-96c8-459f-99a4-7afc95873858" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0d64049d-353e-4f76-b0cf-01b008dc2088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_EarningsPerShareAbstract_0d64049d-353e-4f76-b0cf-01b008dc2088" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c3bf6765-1807-4973-9fae-0006f11b8f28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0d64049d-353e-4f76-b0cf-01b008dc2088" xlink:to="loc_us-gaap_EarningsPerShareBasic_c3bf6765-1807-4973-9fae-0006f11b8f28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_17cb63f6-1cfa-42c3-b1e6-82245725df62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0d64049d-353e-4f76-b0cf-01b008dc2088" xlink:to="loc_us-gaap_EarningsPerShareDiluted_17cb63f6-1cfa-42c3-b1e6-82245725df62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_54d3723c-c953-4bce-80e3-bb967f4119ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_54d3723c-c953-4bce-80e3-bb967f4119ff" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_384ce74a-793b-47c3-ac9e-d96ca320784c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_54d3723c-c953-4bce-80e3-bb967f4119ff" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_384ce74a-793b-47c3-ac9e-d96ca320784c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_baa9e26c-3edc-4114-9802-87c9e3d75dfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_54d3723c-c953-4bce-80e3-bb967f4119ff" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_baa9e26c-3edc-4114-9802-87c9e3d75dfd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_56d96c08-cdbb-4779-b55e-73252527bc72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_StatementTable_56d96c08-cdbb-4779-b55e-73252527bc72" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f8a7e4a4-9899-43b1-a610-8cc08f7be62b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_56d96c08-cdbb-4779-b55e-73252527bc72" xlink:to="loc_srt_ProductOrServiceAxis_f8a7e4a4-9899-43b1-a610-8cc08f7be62b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f8a7e4a4-9899-43b1-a610-8cc08f7be62b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f8a7e4a4-9899-43b1-a610-8cc08f7be62b" xlink:to="loc_srt_ProductsAndServicesDomain_f8a7e4a4-9899-43b1-a610-8cc08f7be62b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_781ba4aa-2560-453c-89ac-780c016747b7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f8a7e4a4-9899-43b1-a610-8cc08f7be62b" xlink:to="loc_srt_ProductsAndServicesDomain_781ba4aa-2560-453c-89ac-780c016747b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_95b74f11-a6a8-483f-898d-db78748c4f5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_781ba4aa-2560-453c-89ac-780c016747b7" xlink:to="loc_us-gaap_ProductMember_95b74f11-a6a8-483f-898d-db78748c4f5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_9dcc9136-c27b-4daf-9c9c-5bb8c9cc44f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_781ba4aa-2560-453c-89ac-780c016747b7" xlink:to="loc_us-gaap_ServiceMember_9dcc9136-c27b-4daf-9c9c-5bb8c9cc44f3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited" xlink:type="simple" xlink:href="cutr-20210630.xsd#ConsolidatedStatementsofChangesInStockholdersEquityUnaudited"/>
  <link:definitionLink xlink:role="http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited" xlink:type="extended" id="i8e0a526bb4ec4721942b86a2c6a33cf7_ConsolidatedStatementsofChangesInStockholdersEquityUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7022e597-cea0-4413-9e60-4a95f6b0106d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7022e597-cea0-4413-9e60-4a95f6b0106d" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_49f4920a-9fbc-4a01-a78e-8d3d1520cfb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_49f4920a-9fbc-4a01-a78e-8d3d1520cfb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_81fa678d-00d1-4093-a315-1a22345c74b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_StockholdersEquity_81fa678d-00d1-4093-a315-1a22345c74b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_d8bc596a-314c-48d6-a8e6-bc029f3578cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_d8bc596a-314c-48d6-a8e6-bc029f3578cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1c5c35de-03d8-47fe-9596-8865ef4a6c2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1c5c35de-03d8-47fe-9596-8865ef4a6c2e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_32a75515-c578-4dd8-adf8-bee1afb4e37d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_32a75515-c578-4dd8-adf8-bee1afb4e37d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_dad8fb37-3159-4db1-8a5c-092337dd728a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_dad8fb37-3159-4db1-8a5c-092337dd728a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall_21af3f22-4711-421f-8d5e-88c44180963e" xlink:href="cutr-20210630.xsd#cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall_21af3f22-4711-421f-8d5e-88c44180963e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_96241723-1af5-4345-8fb2-4a7296a903b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_96241723-1af5-4345-8fb2-4a7296a903b1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_d29b5bf4-ceeb-4f00-9664-16c61f1644f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_d29b5bf4-ceeb-4f00-9664-16c61f1644f1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_abdaee31-b47c-4246-b1b8-cdf557d92b89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_abdaee31-b47c-4246-b1b8-cdf557d92b89" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_efe28ac6-5867-460c-a0eb-06d757280840" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_efe28ac6-5867-460c-a0eb-06d757280840" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1f17b961-478c-46ad-8447-2b3d977833dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1f17b961-478c-46ad-8447-2b3d977833dc" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d33ad258-5d69-4922-97b4-fb1f247bc2e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_NetIncomeLoss_d33ad258-5d69-4922-97b4-fb1f247bc2e8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_46bf80ec-ab4f-4b1e-b5a3-dc9f4d72a087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_46bf80ec-ab4f-4b1e-b5a3-dc9f4d72a087" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d4c34eff-6eac-47c9-8417-bb0b21723390" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8c981cb1-de6f-4fda-bb21-2e966db2beff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e2779894-f9ae-41ff-a6b5-1c2fa73deb63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_7022e597-cea0-4413-9e60-4a95f6b0106d" xlink:to="loc_us-gaap_StatementTable_e2779894-f9ae-41ff-a6b5-1c2fa73deb63" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8b07ef5b-36e2-4f3e-8e04-b73d2145f0d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e2779894-f9ae-41ff-a6b5-1c2fa73deb63" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8b07ef5b-36e2-4f3e-8e04-b73d2145f0d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8b07ef5b-36e2-4f3e-8e04-b73d2145f0d6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8b07ef5b-36e2-4f3e-8e04-b73d2145f0d6" xlink:to="loc_us-gaap_EquityComponentDomain_8b07ef5b-36e2-4f3e-8e04-b73d2145f0d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a1c713cb-b4ce-4cbe-99f4-607c52fa0414" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8b07ef5b-36e2-4f3e-8e04-b73d2145f0d6" xlink:to="loc_us-gaap_EquityComponentDomain_a1c713cb-b4ce-4cbe-99f4-607c52fa0414" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5a55c339-b0d7-44be-a605-0628b3a0eff3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a1c713cb-b4ce-4cbe-99f4-607c52fa0414" xlink:to="loc_us-gaap_CommonStockMember_5a55c339-b0d7-44be-a605-0628b3a0eff3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_11333756-e40d-44e5-ac7e-5d4a46826bdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a1c713cb-b4ce-4cbe-99f4-607c52fa0414" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_11333756-e40d-44e5-ac7e-5d4a46826bdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_fa4c22aa-9b05-4104-9400-b9e1e14b6317" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a1c713cb-b4ce-4cbe-99f4-607c52fa0414" xlink:to="loc_us-gaap_RetainedEarningsMember_fa4c22aa-9b05-4104-9400-b9e1e14b6317" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b0e603f2-6950-4d66-8a98-b7edd77ccfcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a1c713cb-b4ce-4cbe-99f4-607c52fa0414" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b0e603f2-6950-4d66-8a98-b7edd77ccfcd" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnauditedParenthetical" xlink:type="simple" xlink:href="cutr-20210630.xsd#ConsolidatedStatementsofChangesInStockholdersEquityUnauditedParenthetical"/>
  <link:definitionLink xlink:role="http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnauditedParenthetical" xlink:type="extended" id="i9c8d8c8087bd4e61af9237530bc8accf_ConsolidatedStatementsofChangesInStockholdersEquityUnauditedParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_efd9b36f-4e31-41aa-8c4a-e32f0a6dfe53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_48160f6b-72cf-46cc-8d93-b80edb18aa45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_efd9b36f-4e31-41aa-8c4a-e32f0a6dfe53" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_48160f6b-72cf-46cc-8d93-b80edb18aa45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d8e2e1fa-f2df-4108-b759-f77732b73834" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_efd9b36f-4e31-41aa-8c4a-e32f0a6dfe53" xlink:to="loc_us-gaap_StatementTable_d8e2e1fa-f2df-4108-b759-f77732b73834" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b3cb0eb5-ebaf-4534-9023-3b9c5ba2aa14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d8e2e1fa-f2df-4108-b759-f77732b73834" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b3cb0eb5-ebaf-4534-9023-3b9c5ba2aa14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b3cb0eb5-ebaf-4534-9023-3b9c5ba2aa14_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b3cb0eb5-ebaf-4534-9023-3b9c5ba2aa14" xlink:to="loc_us-gaap_EquityComponentDomain_b3cb0eb5-ebaf-4534-9023-3b9c5ba2aa14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9f3cd754-c9e6-4dc0-9a08-c3bf4c5f8f11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b3cb0eb5-ebaf-4534-9023-3b9c5ba2aa14" xlink:to="loc_us-gaap_EquityComponentDomain_9f3cd754-c9e6-4dc0-9a08-c3bf4c5f8f11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_06979bf1-3f07-4b92-bb05-a88b992cd6ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9f3cd754-c9e6-4dc0-9a08-c3bf4c5f8f11" xlink:to="loc_us-gaap_CommonStockMember_06979bf1-3f07-4b92-bb05-a88b992cd6ac" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i37402d0566744666a456f0d9cddde26a_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_d976d439-2ab7-468d-b93d-4cb78d3a7b2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork_ef339e3c-10af-48fc-b4e2-4f29e4a66d8f" xlink:href="cutr-20210630.xsd#cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_d976d439-2ab7-468d-b93d-4cb78d3a7b2b" xlink:to="loc_cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork_ef339e3c-10af-48fc-b4e2-4f29e4a66d8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_3c5aeb6e-4a6a-43c9-8917-304e2966858b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_d976d439-2ab7-468d-b93d-4cb78d3a7b2b" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_3c5aeb6e-4a6a-43c9-8917-304e2966858b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_e381d91e-1c65-4532-85da-bcc3a2e19736" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_d976d439-2ab7-468d-b93d-4cb78d3a7b2b" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_e381d91e-1c65-4532-85da-bcc3a2e19736" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b8f7a79f-fdf0-41fa-aa5a-3384221c99ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_d976d439-2ab7-468d-b93d-4cb78d3a7b2b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b8f7a79f-fdf0-41fa-aa5a-3384221c99ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CappedCallTransactionsCosts_3f9525aa-7a1b-4b4e-bab7-dc9e8c461718" xlink:href="cutr-20210630.xsd#cutr_CappedCallTransactionsCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_d976d439-2ab7-468d-b93d-4cb78d3a7b2b" xlink:to="loc_cutr_CappedCallTransactionsCosts_3f9525aa-7a1b-4b4e-bab7-dc9e8c461718" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAdditions_7a4f4247-28d7-4b68-a15f-a387cbdf8a0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_d976d439-2ab7-468d-b93d-4cb78d3a7b2b" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAdditions_7a4f4247-28d7-4b68-a15f-a387cbdf8a0a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_0aa0cd1d-2e4a-4fef-b2b3-a517e67940cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_d976d439-2ab7-468d-b93d-4cb78d3a7b2b" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_0aa0cd1d-2e4a-4fef-b2b3-a517e67940cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b337085b-6b98-45c4-8300-830d8b8afb36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_0aa0cd1d-2e4a-4fef-b2b3-a517e67940cf" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b337085b-6b98-45c4-8300-830d8b8afb36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b337085b-6b98-45c4-8300-830d8b8afb36_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b337085b-6b98-45c4-8300-830d8b8afb36" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b337085b-6b98-45c4-8300-830d8b8afb36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2037de14-cfa6-480d-8c0f-3bd46468984e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b337085b-6b98-45c4-8300-830d8b8afb36" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2037de14-cfa6-480d-8c0f-3bd46468984e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_6370cf47-f5ec-4fa4-8378-3e5d92e8e266" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2037de14-cfa6-480d-8c0f-3bd46468984e" xlink:to="loc_us-gaap_ConvertibleDebtMember_6370cf47-f5ec-4fa4-8378-3e5d92e8e266" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4a417f8a-87b9-4ea8-a32a-eeaaa39fb49e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_0aa0cd1d-2e4a-4fef-b2b3-a517e67940cf" xlink:to="loc_us-gaap_DebtInstrumentAxis_4a417f8a-87b9-4ea8-a32a-eeaaa39fb49e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4a417f8a-87b9-4ea8-a32a-eeaaa39fb49e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_4a417f8a-87b9-4ea8-a32a-eeaaa39fb49e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4a417f8a-87b9-4ea8-a32a-eeaaa39fb49e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_61d3b31a-71e6-489d-9c8b-982c96b4d556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_4a417f8a-87b9-4ea8-a32a-eeaaa39fb49e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_61d3b31a-71e6-489d-9c8b-982c96b4d556" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_26ff1864-f30e-4082-9c68-28a8632d68f4" xlink:href="cutr-20210630.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_61d3b31a-71e6-489d-9c8b-982c96b4d556" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_26ff1864-f30e-4082-9c68-28a8632d68f4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/BalanceSheetDetailsNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#BalanceSheetDetailsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/20210331/role/BalanceSheetDetailsNarrativeDetails" xlink:type="extended" id="i81e330790e9a4c9dafd8244de7bb0c46_BalanceSheetDetailsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyLiabilityLineItems_444b34a9-ff86-4ecf-b271-0eba74692e8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyLiabilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_0bba4f9c-1b85-4cde-841a-c06500348c16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems_444b34a9-ff86-4ecf-b271-0eba74692e8b" xlink:to="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_0bba4f9c-1b85-4cde-841a-c06500348c16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_20851060-5ef5-4fc9-a851-f78145358ac7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems_444b34a9-ff86-4ecf-b271-0eba74692e8b" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_20851060-5ef5-4fc9-a851-f78145358ac7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyAccrual_cec6b5fb-5aba-490f-bd1a-3758d4264b31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtendedProductWarrantyAccrual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems_444b34a9-ff86-4ecf-b271-0eba74692e8b" xlink:to="loc_us-gaap_ExtendedProductWarrantyAccrual_cec6b5fb-5aba-490f-bd1a-3758d4264b31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves_cf487317-9f11-401e-ad49-8d39adf994d8" xlink:href="cutr-20210630.xsd#cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems_444b34a9-ff86-4ecf-b271-0eba74692e8b" xlink:to="loc_cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves_cf487317-9f11-401e-ad49-8d39adf994d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_7ee357cd-ce03-4813-b7a2-7999c5282b19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems_444b34a9-ff86-4ecf-b271-0eba74692e8b" xlink:to="loc_us-gaap_ProductWarrantyAccrualPayments_7ee357cd-ce03-4813-b7a2-7999c5282b19" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyLiabilityTable_fb30f8f0-a2bc-4c83-909f-8300ab5715a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyLiabilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems_444b34a9-ff86-4ecf-b271-0eba74692e8b" xlink:to="loc_us-gaap_ProductWarrantyLiabilityTable_fb30f8f0-a2bc-4c83-909f-8300ab5715a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_d61f0a6f-5d00-4298-86e9-2b7da78bf959" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ProductWarrantyLiabilityTable_fb30f8f0-a2bc-4c83-909f-8300ab5715a5" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_d61f0a6f-5d00-4298-86e9-2b7da78bf959" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d61f0a6f-5d00-4298-86e9-2b7da78bf959_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_d61f0a6f-5d00-4298-86e9-2b7da78bf959" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d61f0a6f-5d00-4298-86e9-2b7da78bf959_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2c6b8583-b2d4-4764-a83d-92855542b489" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_d61f0a6f-5d00-4298-86e9-2b7da78bf959" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2c6b8583-b2d4-4764-a83d-92855542b489" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ProductRemediationLiabilityMember_9fee0cd8-2cc5-4672-a8a6-5b1658bf6eb5" xlink:href="cutr-20210630.xsd#cutr_ProductRemediationLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2c6b8583-b2d4-4764-a83d-92855542b489" xlink:to="loc_cutr_ProductRemediationLiabilityMember_9fee0cd8-2cc5-4672-a8a6-5b1658bf6eb5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#DeferredRevenueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails" xlink:type="extended" id="i1533d2a214634240aac775a62e595574_DeferredRevenueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionOneTerm_66fc33c0-e778-41db-bf36-1926bbc5f8de" xlink:href="cutr-20210630.xsd#cutr_ExtendedServiceContractOptionOneTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_cutr_ExtendedServiceContractOptionOneTerm_66fc33c0-e778-41db-bf36-1926bbc5f8de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionTwoTerm_71f5abce-71f2-4a4b-b31e-bd902f83853e" xlink:href="cutr-20210630.xsd#cutr_ExtendedServiceContractOptionTwoTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_cutr_ExtendedServiceContractOptionTwoTerm_71f5abce-71f2-4a4b-b31e-bd902f83853e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionThreeTerm_205543c8-9dcc-4021-b9d6-bda40a623234" xlink:href="cutr-20210630.xsd#cutr_ExtendedServiceContractOptionThreeTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_cutr_ExtendedServiceContractOptionThreeTerm_205543c8-9dcc-4021-b9d6-bda40a623234" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_242ba892-0b61-4255-9a0b-bf9efb1d8d2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_242ba892-0b61-4255-9a0b-bf9efb1d8d2d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_eb52b485-6cc5-405d-971a-9e0c7aa57682" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_eb52b485-6cc5-405d-971a-9e0c7aa57682" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_6d89ef09-90bc-4600-a98e-33b6e9131a13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_6d89ef09-90bc-4600-a98e-33b6e9131a13" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CostsForExtendedServiceContracts_c49ab239-d0b6-4b64-bf19-5c2ab1515423" xlink:href="cutr-20210630.xsd#cutr_CostsForExtendedServiceContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_cutr_CostsForExtendedServiceContracts_c49ab239-d0b6-4b64-bf19-5c2ab1515423" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6731286f-3f4c-45b5-8852-7e74dec251e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6731286f-3f4c-45b5-8852-7e74dec251e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_37faec58-fa48-49b0-add4-02c6d15731be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6731286f-3f4c-45b5-8852-7e74dec251e7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_37faec58-fa48-49b0-add4-02c6d15731be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_104857de-7782-41c3-b7ed-06e459e24f0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6731286f-3f4c-45b5-8852-7e74dec251e7" xlink:to="loc_srt_ProductOrServiceAxis_104857de-7782-41c3-b7ed-06e459e24f0c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_104857de-7782-41c3-b7ed-06e459e24f0c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_104857de-7782-41c3-b7ed-06e459e24f0c" xlink:to="loc_srt_ProductsAndServicesDomain_104857de-7782-41c3-b7ed-06e459e24f0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_297ab6ed-5692-41e6-a9b9-2a9dd7a2d124" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_104857de-7782-41c3-b7ed-06e459e24f0c" xlink:to="loc_srt_ProductsAndServicesDomain_297ab6ed-5692-41e6-a9b9-2a9dd7a2d124" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_fb1c457d-5557-4db9-82b0-8e6750606718" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_297ab6ed-5692-41e6-a9b9-2a9dd7a2d124" xlink:to="loc_us-gaap_ServiceMember_fb1c457d-5557-4db9-82b0-8e6750606718" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails_1" xlink:type="simple" xlink:href="cutr-20210630.xsd#DeferredRevenueNarrativeDetails_1"/>
  <link:definitionLink xlink:role="http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails_1" xlink:type="extended" id="ia55f7c7da222412e93f4373b293550b9_DeferredRevenueNarrativeDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionOneTerm_66fc33c0-e778-41db-bf36-1926bbc5f8de" xlink:href="cutr-20210630.xsd#cutr_ExtendedServiceContractOptionOneTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_cutr_ExtendedServiceContractOptionOneTerm_66fc33c0-e778-41db-bf36-1926bbc5f8de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionTwoTerm_71f5abce-71f2-4a4b-b31e-bd902f83853e" xlink:href="cutr-20210630.xsd#cutr_ExtendedServiceContractOptionTwoTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_cutr_ExtendedServiceContractOptionTwoTerm_71f5abce-71f2-4a4b-b31e-bd902f83853e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionThreeTerm_205543c8-9dcc-4021-b9d6-bda40a623234" xlink:href="cutr-20210630.xsd#cutr_ExtendedServiceContractOptionThreeTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_cutr_ExtendedServiceContractOptionThreeTerm_205543c8-9dcc-4021-b9d6-bda40a623234" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_242ba892-0b61-4255-9a0b-bf9efb1d8d2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_242ba892-0b61-4255-9a0b-bf9efb1d8d2d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_eb52b485-6cc5-405d-971a-9e0c7aa57682" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_eb52b485-6cc5-405d-971a-9e0c7aa57682" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_6d89ef09-90bc-4600-a98e-33b6e9131a13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_6d89ef09-90bc-4600-a98e-33b6e9131a13" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CostsForExtendedServiceContracts_c49ab239-d0b6-4b64-bf19-5c2ab1515423" xlink:href="cutr-20210630.xsd#cutr_CostsForExtendedServiceContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_cutr_CostsForExtendedServiceContracts_c49ab239-d0b6-4b64-bf19-5c2ab1515423" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6731286f-3f4c-45b5-8852-7e74dec251e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6731286f-3f4c-45b5-8852-7e74dec251e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_104857de-7782-41c3-b7ed-06e459e24f0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6731286f-3f4c-45b5-8852-7e74dec251e7" xlink:to="loc_srt_ProductOrServiceAxis_104857de-7782-41c3-b7ed-06e459e24f0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_104857de-7782-41c3-b7ed-06e459e24f0c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_104857de-7782-41c3-b7ed-06e459e24f0c" xlink:to="loc_srt_ProductsAndServicesDomain_104857de-7782-41c3-b7ed-06e459e24f0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_297ab6ed-5692-41e6-a9b9-2a9dd7a2d124" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_104857de-7782-41c3-b7ed-06e459e24f0c" xlink:to="loc_srt_ProductsAndServicesDomain_297ab6ed-5692-41e6-a9b9-2a9dd7a2d124" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_fb1c457d-5557-4db9-82b0-8e6750606718" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_297ab6ed-5692-41e6-a9b9-2a9dd7a2d124" xlink:to="loc_us-gaap_ServiceMember_fb1c457d-5557-4db9-82b0-8e6750606718" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#RevenueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/20210331/role/RevenueNarrativeDetails" xlink:type="extended" id="i66673a70b93143f7a688e6cb523d8357_RevenueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RevenuePerformanceObligationSatisfiedOverTimePercent_1caa8d2c-2f8d-4435-bd68-0ff8ff3d97f7" xlink:href="cutr-20210630.xsd#cutr_RevenuePerformanceObligationSatisfiedOverTimePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_cutr_RevenuePerformanceObligationSatisfiedOverTimePercent_1caa8d2c-2f8d-4435-bd68-0ff8ff3d97f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment_1da7fd79-556d-409c-a94c-efed5986ad33" xlink:href="cutr-20210630.xsd#cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment_1da7fd79-556d-409c-a94c-efed5986ad33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SaleOfThirdPartyProductWarrantyPeriod_fcb3b75b-4a92-4120-a683-3774e138c7dc" xlink:href="cutr-20210630.xsd#cutr_SaleOfThirdPartyProductWarrantyPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_cutr_SaleOfThirdPartyProductWarrantyPeriod_fcb3b75b-4a92-4120-a683-3774e138c7dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseRevenue_825dd34f-b29b-46b4-9f6f-bcfc42deee65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesTypeLeaseRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_us-gaap_SalesTypeLeaseRevenue_825dd34f-b29b-46b4-9f6f-bcfc42deee65" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionOneTerm_8f8a20b8-9d4a-4532-8eb3-b8b364aed963" xlink:href="cutr-20210630.xsd#cutr_ExtendedServiceContractOptionOneTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_cutr_ExtendedServiceContractOptionOneTerm_8f8a20b8-9d4a-4532-8eb3-b8b364aed963" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionTwoTerm_09271fc0-11ed-4c9c-8eee-03772edd673c" xlink:href="cutr-20210630.xsd#cutr_ExtendedServiceContractOptionTwoTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_cutr_ExtendedServiceContractOptionTwoTerm_09271fc0-11ed-4c9c-8eee-03772edd673c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionThreeTerm_3c0b4067-9696-4c99-b74c-7c51bc561b06" xlink:href="cutr-20210630.xsd#cutr_ExtendedServiceContractOptionThreeTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_cutr_ExtendedServiceContractOptionThreeTerm_3c0b4067-9696-4c99-b74c-7c51bc561b06" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_af403fa8-c69f-4ac6-8aaf-6270a9db59a9" xlink:href="cutr-20210630.xsd#cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_af403fa8-c69f-4ac6-8aaf-6270a9db59a9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RevenueFromContractWithCustomerTermOfContract_24888dda-3470-49b8-8918-356eb9129417" xlink:href="cutr-20210630.xsd#cutr_RevenueFromContractWithCustomerTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_cutr_RevenueFromContractWithCustomerTermOfContract_24888dda-3470-49b8-8918-356eb9129417" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_20b16a8c-b4d0-4be4-b4dd-459aa3caeb37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_us-gaap_ContractWithCustomerLiability_20b16a8c-b4d0-4be4-b4dd-459aa3caeb37" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_9837d00b-2aa4-499b-a876-e2ac52cf2200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_9837d00b-2aa4-499b-a876-e2ac52cf2200" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_0f326c6f-fe10-4d7b-a942-fa33cc82f78a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_us-gaap_CapitalizedContractCostNet_0f326c6f-fe10-4d7b-a942-fa33cc82f78a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_b70958da-c0a3-4f28-9439-3526caee8bf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_b70958da-c0a3-4f28-9439-3526caee8bf1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_2533cae4-8151-4cf7-b3b6-9914922f8550" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_2533cae4-8151-4cf7-b3b6-9914922f8550" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_4a90e909-2e4d-4851-9628-444fe7f09dcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2533cae4-8151-4cf7-b3b6-9914922f8550" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_4a90e909-2e4d-4851-9628-444fe7f09dcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_4a90e909-2e4d-4851-9628-444fe7f09dcd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_4a90e909-2e4d-4851-9628-444fe7f09dcd" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_4a90e909-2e4d-4851-9628-444fe7f09dcd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_987e4537-f1da-44e2-a7b9-ef45a55da7b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_4a90e909-2e4d-4851-9628-444fe7f09dcd" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_987e4537-f1da-44e2-a7b9-ef45a55da7b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_f99b2708-0466-41f3-8475-52fa808bb2dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_987e4537-f1da-44e2-a7b9-ef45a55da7b4" xlink:to="loc_us-gaap_TransferredOverTimeMember_f99b2708-0466-41f3-8475-52fa808bb2dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3ed215bb-4a1f-4807-ae5c-dac5251600f1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2533cae4-8151-4cf7-b3b6-9914922f8550" xlink:to="loc_srt_ProductOrServiceAxis_3ed215bb-4a1f-4807-ae5c-dac5251600f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3ed215bb-4a1f-4807-ae5c-dac5251600f1_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_3ed215bb-4a1f-4807-ae5c-dac5251600f1" xlink:to="loc_srt_ProductsAndServicesDomain_3ed215bb-4a1f-4807-ae5c-dac5251600f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_137f9c03-750e-40f9-9c90-3eb2cf7cc265" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_3ed215bb-4a1f-4807-ae5c-dac5251600f1" xlink:to="loc_srt_ProductsAndServicesDomain_137f9c03-750e-40f9-9c90-3eb2cf7cc265" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_067d7686-df6f-4d0a-9e9b-4aa2cdd8ec0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_137f9c03-750e-40f9-9c90-3eb2cf7cc265" xlink:to="loc_us-gaap_ServiceMember_067d7686-df6f-4d0a-9e9b-4aa2cdd8ec0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CustomerMarketingSupportMember_70827ead-251f-47c0-ab04-9f6f557506ba" xlink:href="cutr-20210630.xsd#cutr_CustomerMarketingSupportMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ServiceMember_067d7686-df6f-4d0a-9e9b-4aa2cdd8ec0a" xlink:to="loc_cutr_CustomerMarketingSupportMember_70827ead-251f-47c0-ab04-9f6f557506ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LoyaltyMember_57d43bbe-a02e-4441-bb89-de1d9e0c61cf" xlink:href="cutr-20210630.xsd#cutr_LoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ServiceMember_067d7686-df6f-4d0a-9e9b-4aa2cdd8ec0a" xlink:to="loc_cutr_LoyaltyMember_57d43bbe-a02e-4441-bb89-de1d9e0c61cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SkincareMember_ca3b5e17-c7c3-4b07-a6a1-094c49fa0352" xlink:href="cutr-20210630.xsd#cutr_SkincareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_137f9c03-750e-40f9-9c90-3eb2cf7cc265" xlink:to="loc_cutr_SkincareMember_ca3b5e17-c7c3-4b07-a6a1-094c49fa0352" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_528adbbe-2a83-4881-a132-66df31901256" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2533cae4-8151-4cf7-b3b6-9914922f8550" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_528adbbe-2a83-4881-a132-66df31901256" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_528adbbe-2a83-4881-a132-66df31901256_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_528adbbe-2a83-4881-a132-66df31901256" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_528adbbe-2a83-4881-a132-66df31901256_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b1b84cfc-0976-4173-91a2-3e1435c1c7c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_528adbbe-2a83-4881-a132-66df31901256" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b1b84cfc-0976-4173-91a2-3e1435c1c7c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_a0176888-9551-4752-b52d-74a542f48e23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b1b84cfc-0976-4173-91a2-3e1435c1c7c5" xlink:to="loc_us-gaap_OtherAssetsMember_a0176888-9551-4752-b52d-74a542f48e23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d7d04554-3832-437e-9ff2-5fc4e9bfc87d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2533cae4-8151-4cf7-b3b6-9914922f8550" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d7d04554-3832-437e-9ff2-5fc4e9bfc87d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d7d04554-3832-437e-9ff2-5fc4e9bfc87d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d7d04554-3832-437e-9ff2-5fc4e9bfc87d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d7d04554-3832-437e-9ff2-5fc4e9bfc87d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4a8480da-47bb-4c4c-a0a3-51229c1ac050" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d7d04554-3832-437e-9ff2-5fc4e9bfc87d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4a8480da-47bb-4c4c-a0a3-51229c1ac050" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_d3735964-4103-4a39-a7f1-669f681669f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4a8480da-47bb-4c4c-a0a3-51229c1ac050" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_d3735964-4103-4a39-a7f1-669f681669f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_237f1179-eeae-4765-8645-11bc6e20d432" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2533cae4-8151-4cf7-b3b6-9914922f8550" xlink:to="loc_srt_StatementGeographicalAxis_237f1179-eeae-4765-8645-11bc6e20d432" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_237f1179-eeae-4765-8645-11bc6e20d432_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_237f1179-eeae-4765-8645-11bc6e20d432" xlink:to="loc_srt_SegmentGeographicalDomain_237f1179-eeae-4765-8645-11bc6e20d432_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7c23de90-570c-48f3-beaa-ff1b5614a5c2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_237f1179-eeae-4765-8645-11bc6e20d432" xlink:to="loc_srt_SegmentGeographicalDomain_7c23de90-570c-48f3-beaa-ff1b5614a5c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_8a9d41f5-cf0a-498b-94be-0b5511dce6cc" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_JP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7c23de90-570c-48f3-beaa-ff1b5614a5c2" xlink:to="loc_country_JP_8a9d41f5-cf0a-498b-94be-0b5511dce6cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cc32c1a3-6bc0-496d-8f93-a5fc85284878" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2533cae4-8151-4cf7-b3b6-9914922f8550" xlink:to="loc_srt_RangeAxis_cc32c1a3-6bc0-496d-8f93-a5fc85284878" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cc32c1a3-6bc0-496d-8f93-a5fc85284878_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cc32c1a3-6bc0-496d-8f93-a5fc85284878" xlink:to="loc_srt_RangeMember_cc32c1a3-6bc0-496d-8f93-a5fc85284878_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_37a8e4aa-4658-40d7-a2da-fd89520da162" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cc32c1a3-6bc0-496d-8f93-a5fc85284878" xlink:to="loc_srt_RangeMember_37a8e4aa-4658-40d7-a2da-fd89520da162" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_645c4693-9e9c-4703-af76-4a456d7d876a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_37a8e4aa-4658-40d7-a2da-fd89520da162" xlink:to="loc_srt_MinimumMember_645c4693-9e9c-4703-af76-4a456d7d876a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c603dba4-f27b-4cd4-9f60-b7e6236ea3bb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_37a8e4aa-4658-40d7-a2da-fd89520da162" xlink:to="loc_srt_MaximumMember_c603dba4-f27b-4cd4-9f60-b7e6236ea3bb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails" xlink:type="extended" id="i669fd47ccc974eb8aaea62e1d4650576_StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_d79202b0-1f09-4054-ba87-4956277b6da2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_d79202b0-1f09-4054-ba87-4956277b6da2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_6576c95c-a030-4b12-b972-50975a13d853" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_6576c95c-a030-4b12-b972-50975a13d853" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cdc8af67-16f2-4b8d-b12e-9afaf5a37cda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cdc8af67-16f2-4b8d-b12e-9afaf5a37cda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_81816d86-a18c-4371-a1c4-32b303595c2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_81816d86-a18c-4371-a1c4-32b303595c2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1416405b-e7d7-4a50-8402-eedbbfd7b338" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1416405b-e7d7-4a50-8402-eedbbfd7b338" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_e96d93ec-4e4d-4286-882c-04d7eb9d84dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_e96d93ec-4e4d-4286-882c-04d7eb9d84dc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear_3bf09cdc-7419-4b90-90a4-1a8ca1c76ef9" xlink:href="cutr-20210630.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear_3bf09cdc-7419-4b90-90a4-1a8ca1c76ef9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_36183805-641f-445d-81ed-8b394e361938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_36183805-641f-445d-81ed-8b394e361938" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_bc582c0c-96ff-4a5e-b137-935bcb05f879" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_bc582c0c-96ff-4a5e-b137-935bcb05f879" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6e717624-2d02-4844-8e48-e49a5e3486de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6e717624-2d02-4844-8e48-e49a5e3486de" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_49e5fb47-eac7-401f-8ef0-f8b4ad3aa8a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_49e5fb47-eac7-401f-8ef0-f8b4ad3aa8a9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_57296d1c-6347-44db-8757-4b1683481143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_57296d1c-6347-44db-8757-4b1683481143" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3364c779-b6fa-429d-90fe-6ea6d9ed692d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3364c779-b6fa-429d-90fe-6ea6d9ed692d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_a1f5e088-c80e-4746-bf33-3432410939de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3364c779-b6fa-429d-90fe-6ea6d9ed692d" xlink:to="loc_us-gaap_PlanNameAxis_a1f5e088-c80e-4746-bf33-3432410939de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a1f5e088-c80e-4746-bf33-3432410939de_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_a1f5e088-c80e-4746-bf33-3432410939de" xlink:to="loc_us-gaap_PlanNameDomain_a1f5e088-c80e-4746-bf33-3432410939de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_89432980-b317-4630-b643-4f4552223c00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_a1f5e088-c80e-4746-bf33-3432410939de" xlink:to="loc_us-gaap_PlanNameDomain_89432980-b317-4630-b643-4f4552223c00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TwoThousandNineteenEquityIncentivePlanMember_69a462d8-4565-44e5-8e62-b9864f2b6818" xlink:href="cutr-20210630.xsd#cutr_TwoThousandNineteenEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_89432980-b317-4630-b643-4f4552223c00" xlink:to="loc_cutr_TwoThousandNineteenEquityIncentivePlanMember_69a462d8-4565-44e5-8e62-b9864f2b6818" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AmendedAndRestated2004EquityIncentivePlanMember_9eefd410-dba9-4579-8f3d-5a1d5a0e7aef" xlink:href="cutr-20210630.xsd#cutr_AmendedAndRestated2004EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_89432980-b317-4630-b643-4f4552223c00" xlink:to="loc_cutr_AmendedAndRestated2004EquityIncentivePlanMember_9eefd410-dba9-4579-8f3d-5a1d5a0e7aef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1cdb7bcb-20f6-44ae-a5f2-bb0231f61dd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3364c779-b6fa-429d-90fe-6ea6d9ed692d" xlink:to="loc_us-gaap_AwardTypeAxis_1cdb7bcb-20f6-44ae-a5f2-bb0231f61dd8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1cdb7bcb-20f6-44ae-a5f2-bb0231f61dd8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1cdb7bcb-20f6-44ae-a5f2-bb0231f61dd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1cdb7bcb-20f6-44ae-a5f2-bb0231f61dd8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22a7b99d-358a-4a7e-95db-30026ab74c6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1cdb7bcb-20f6-44ae-a5f2-bb0231f61dd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22a7b99d-358a-4a7e-95db-30026ab74c6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_6d590fbe-ea2c-494d-82b5-1ba17f24c64e" xlink:href="cutr-20210630.xsd#cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22a7b99d-358a-4a7e-95db-30026ab74c6d" xlink:to="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_6d590fbe-ea2c-494d-82b5-1ba17f24c64e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_1390c3a2-2a38-4318-a64a-e76ba2e9a9d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_6d590fbe-ea2c-494d-82b5-1ba17f24c64e" xlink:to="loc_us-gaap_PerformanceSharesMember_1390c3a2-2a38-4318-a64a-e76ba2e9a9d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a4e93c81-33ae-46bb-a1cd-7613a47fea67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_6d590fbe-ea2c-494d-82b5-1ba17f24c64e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a4e93c81-33ae-46bb-a1cd-7613a47fea67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NonqualifiedStockOptionsMember_731a2158-9260-4415-bacc-847e28ced6da" xlink:href="cutr-20210630.xsd#cutr_NonqualifiedStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22a7b99d-358a-4a7e-95db-30026ab74c6d" xlink:to="loc_cutr_NonqualifiedStockOptionsMember_731a2158-9260-4415-bacc-847e28ced6da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_7a9a3585-9e0f-469b-8402-349ef79accd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22a7b99d-358a-4a7e-95db-30026ab74c6d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_7a9a3585-9e0f-469b-8402-349ef79accd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_659ffdcd-faaa-4729-9703-cb7ddf2a5d50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3364c779-b6fa-429d-90fe-6ea6d9ed692d" xlink:to="loc_us-gaap_VestingAxis_659ffdcd-faaa-4729-9703-cb7ddf2a5d50" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_659ffdcd-faaa-4729-9703-cb7ddf2a5d50_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_659ffdcd-faaa-4729-9703-cb7ddf2a5d50" xlink:to="loc_us-gaap_VestingDomain_659ffdcd-faaa-4729-9703-cb7ddf2a5d50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_91182074-b573-49b4-8661-96f899c3cd60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_659ffdcd-faaa-4729-9703-cb7ddf2a5d50" xlink:to="loc_us-gaap_VestingDomain_91182074-b573-49b4-8661-96f899c3cd60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_76e2d036-21f8-4951-8dd6-4b342e7fe526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_91182074-b573-49b4-8661-96f899c3cd60" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_76e2d036-21f8-4951-8dd6-4b342e7fe526" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_c52857da-e6c2-4fce-9c9d-d10b2567474f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_91182074-b573-49b4-8661-96f899c3cd60" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_c52857da-e6c2-4fce-9c9d-d10b2567474f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_cf048986-58d6-4227-88c0-f80df9ae9788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_91182074-b573-49b4-8661-96f899c3cd60" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_cf048986-58d6-4227-88c0-f80df9ae9788" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedPaymentArrangementTrancheFourMember_f281ab94-ad05-4b1a-9553-048767934af6" xlink:href="cutr-20210630.xsd#cutr_ShareBasedPaymentArrangementTrancheFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_91182074-b573-49b4-8661-96f899c3cd60" xlink:to="loc_cutr_ShareBasedPaymentArrangementTrancheFourMember_f281ab94-ad05-4b1a-9553-048767934af6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_d7c05f33-7a2e-4376-a8eb-68691a929398" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3364c779-b6fa-429d-90fe-6ea6d9ed692d" xlink:to="loc_srt_TitleOfIndividualAxis_d7c05f33-7a2e-4376-a8eb-68691a929398" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_d7c05f33-7a2e-4376-a8eb-68691a929398_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_d7c05f33-7a2e-4376-a8eb-68691a929398" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_d7c05f33-7a2e-4376-a8eb-68691a929398_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7368aa7e-b663-499f-ac84-8d2f96499950" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_d7c05f33-7a2e-4376-a8eb-68691a929398" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7368aa7e-b663-499f-ac84-8d2f96499950" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NonEmployeeDirectorsMember_dd2ac16a-9a83-4d85-a91e-ac9d32823c92" xlink:href="cutr-20210630.xsd#cutr_NonEmployeeDirectorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7368aa7e-b663-499f-ac84-8d2f96499950" xlink:to="loc_cutr_NonEmployeeDirectorsMember_dd2ac16a-9a83-4d85-a91e-ac9d32823c92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember_e3b9b73e-f327-4f21-a308-2258818414df" xlink:href="cutr-20210630.xsd#cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7368aa7e-b663-499f-ac84-8d2f96499950" xlink:to="loc_cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember_e3b9b73e-f327-4f21-a308-2258818414df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExecutiveOfficersAndSeniorManagementMember_5a996b18-56d8-4b17-bec1-bf8c58e7f98d" xlink:href="cutr-20210630.xsd#cutr_ExecutiveOfficersAndSeniorManagementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7368aa7e-b663-499f-ac84-8d2f96499950" xlink:to="loc_cutr_ExecutiveOfficersAndSeniorManagementMember_5a996b18-56d8-4b17-bec1-bf8c58e7f98d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_a65ed61c-a3e7-4c80-90d0-d858af5ef6c0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7368aa7e-b663-499f-ac84-8d2f96499950" xlink:to="loc_srt_ChiefExecutiveOfficerMember_a65ed61c-a3e7-4c80-90d0-d858af5ef6c0" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails" xlink:type="extended" id="i7313039b186d4c1b9cb5a5766fa7b905_StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e33d876-df31-431a-ba7d-dd1a3af4e1dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_be1d8f1f-354d-4fdf-ab33-3618ecb6b2ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e33d876-df31-431a-ba7d-dd1a3af4e1dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_be1d8f1f-354d-4fdf-ab33-3618ecb6b2ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb0f636b-953f-4bd4-af04-8fc75cc80bad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_be1d8f1f-354d-4fdf-ab33-3618ecb6b2ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb0f636b-953f-4bd4-af04-8fc75cc80bad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_38476de8-2db0-44b8-b928-2fe924602cca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_be1d8f1f-354d-4fdf-ab33-3618ecb6b2ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_38476de8-2db0-44b8-b928-2fe924602cca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d09f0108-b170-486f-a9fd-bf8bde9eb4d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_be1d8f1f-354d-4fdf-ab33-3618ecb6b2ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d09f0108-b170-486f-a9fd-bf8bde9eb4d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9c4b3607-d050-4b50-8a07-554b860960ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_be1d8f1f-354d-4fdf-ab33-3618ecb6b2ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9c4b3607-d050-4b50-8a07-554b860960ae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4462a6fb-cd84-478d-9975-d2c603b9c44d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_505a0815-4ea0-47d3-a1ab-d5c15131f1c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e33d876-df31-431a-ba7d-dd1a3af4e1dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_505a0815-4ea0-47d3-a1ab-d5c15131f1c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_009daa8e-036f-4c39-8d8c-2e7d63ab63ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_505a0815-4ea0-47d3-a1ab-d5c15131f1c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_009daa8e-036f-4c39-8d8c-2e7d63ab63ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ca4e73d3-bcc0-489a-82ab-4cc2e9a6e0cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_505a0815-4ea0-47d3-a1ab-d5c15131f1c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ca4e73d3-bcc0-489a-82ab-4cc2e9a6e0cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e0ab3be3-a66d-4cb6-a32b-cb5be104833d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_505a0815-4ea0-47d3-a1ab-d5c15131f1c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e0ab3be3-a66d-4cb6-a32b-cb5be104833d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9ca3109c-bee6-4eab-8572-dcf4932e3c13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_505a0815-4ea0-47d3-a1ab-d5c15131f1c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9ca3109c-bee6-4eab-8572-dcf4932e3c13" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a8b4517e-7b9f-4572-9896-7ab195f09622" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_d536551a-8b3b-4963-84a7-907c4e9a106c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e33d876-df31-431a-ba7d-dd1a3af4e1dd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_d536551a-8b3b-4963-84a7-907c4e9a106c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_27ca45e9-58ad-4ad0-82e3-978a7f769ad4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_d536551a-8b3b-4963-84a7-907c4e9a106c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_27ca45e9-58ad-4ad0-82e3-978a7f769ad4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_1f364fd0-8950-4878-a118-66486abbe3ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d0b55af3-bff0-4e1d-ad2a-ab0f80269597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e33d876-df31-431a-ba7d-dd1a3af4e1dd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d0b55af3-bff0-4e1d-ad2a-ab0f80269597" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0fddcd0e-6eeb-4f12-9c8e-8a06ee772068" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d0b55af3-bff0-4e1d-ad2a-ab0f80269597" xlink:to="loc_us-gaap_AwardTypeAxis_0fddcd0e-6eeb-4f12-9c8e-8a06ee772068" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0fddcd0e-6eeb-4f12-9c8e-8a06ee772068_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_0fddcd0e-6eeb-4f12-9c8e-8a06ee772068" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0fddcd0e-6eeb-4f12-9c8e-8a06ee772068_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_50286df4-a7a8-43df-8c92-1c6b7e9e8805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_0fddcd0e-6eeb-4f12-9c8e-8a06ee772068" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_50286df4-a7a8-43df-8c92-1c6b7e9e8805" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_272a2ccd-f9c5-493b-9956-52c4d9ae1017" xlink:href="cutr-20210630.xsd#cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_50286df4-a7a8-43df-8c92-1c6b7e9e8805" xlink:to="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_272a2ccd-f9c5-493b-9956-52c4d9ae1017" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails" xlink:type="extended" id="i7cc938f85fee42478ef8fc0e85dd0c41_StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c032951-4633-4b08-b4df-898fb2c4e7b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_45d9a617-d066-4d16-98af-b6fdec897fd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c032951-4633-4b08-b4df-898fb2c4e7b3" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_45d9a617-d066-4d16-98af-b6fdec897fd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c53ddbf-fecd-484f-8d40-27bc3136d9ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c032951-4633-4b08-b4df-898fb2c4e7b3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c53ddbf-fecd-484f-8d40-27bc3136d9ef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1b920b5b-5e9d-442a-b164-f09a81020b83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c53ddbf-fecd-484f-8d40-27bc3136d9ef" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1b920b5b-5e9d-442a-b164-f09a81020b83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1b920b5b-5e9d-442a-b164-f09a81020b83_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1b920b5b-5e9d-442a-b164-f09a81020b83" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1b920b5b-5e9d-442a-b164-f09a81020b83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b84cbff5-f201-43b2-89bd-f1a62b3079a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1b920b5b-5e9d-442a-b164-f09a81020b83" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b84cbff5-f201-43b2-89bd-f1a62b3079a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0fbcd202-2c68-4cfa-82c1-b4a8d2232514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b84cbff5-f201-43b2-89bd-f1a62b3079a0" xlink:to="loc_us-gaap_CostOfSalesMember_0fbcd202-2c68-4cfa-82c1-b4a8d2232514" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_9f50cf40-8c38-42cd-9a5a-91be14b48120" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b84cbff5-f201-43b2-89bd-f1a62b3079a0" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_9f50cf40-8c38-42cd-9a5a-91be14b48120" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e220e07d-502e-4027-92e5-c124aed379be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b84cbff5-f201-43b2-89bd-f1a62b3079a0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e220e07d-502e-4027-92e5-c124aed379be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_7acbe236-d057-41b6-b109-6f71685cdf91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b84cbff5-f201-43b2-89bd-f1a62b3079a0" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_7acbe236-d057-41b6-b109-6f71685cdf91" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/NetIncomeLossPerShareNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#NetIncomeLossPerShareNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/20210331/role/NetIncomeLossPerShareNarrativeDetails" xlink:type="extended" id="ic9f66d9335f744549ceae648399d8833_NetIncomeLossPerShareNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e3f76c13-bf5c-4732-88af-9a60fea0b7ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_d2ae627e-ef40-4729-8429-d58f94352d48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e3f76c13-bf5c-4732-88af-9a60fea0b7ea" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_d2ae627e-ef40-4729-8429-d58f94352d48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_59857ecb-6e23-4405-8443-c160480e3f54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e3f76c13-bf5c-4732-88af-9a60fea0b7ea" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_59857ecb-6e23-4405-8443-c160480e3f54" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_58e5d5f7-e8e7-4c3b-9166-8bef692c2b0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_59857ecb-6e23-4405-8443-c160480e3f54" xlink:to="loc_us-gaap_DebtInstrumentAxis_58e5d5f7-e8e7-4c3b-9166-8bef692c2b0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_58e5d5f7-e8e7-4c3b-9166-8bef692c2b0b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_58e5d5f7-e8e7-4c3b-9166-8bef692c2b0b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_58e5d5f7-e8e7-4c3b-9166-8bef692c2b0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_08860e1b-c6fe-444a-bba4-5967dd2caea6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_58e5d5f7-e8e7-4c3b-9166-8bef692c2b0b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_08860e1b-c6fe-444a-bba4-5967dd2caea6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_b531f17d-6b6e-40e2-9b3f-ae1f5fdea3c5" xlink:href="cutr-20210630.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_08860e1b-c6fe-444a-bba4-5967dd2caea6" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_b531f17d-6b6e-40e2-9b3f-ae1f5fdea3c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5ba4e828-17e6-4011-817a-79d95f4afe5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_59857ecb-6e23-4405-8443-c160480e3f54" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5ba4e828-17e6-4011-817a-79d95f4afe5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5ba4e828-17e6-4011-817a-79d95f4afe5d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5ba4e828-17e6-4011-817a-79d95f4afe5d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5ba4e828-17e6-4011-817a-79d95f4afe5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2f685c61-46b0-4d30-9d36-56e68d39f54a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5ba4e828-17e6-4011-817a-79d95f4afe5d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2f685c61-46b0-4d30-9d36-56e68d39f54a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_a6b040a5-f85c-46ae-b8e7-56e65b73ee80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2f685c61-46b0-4d30-9d36-56e68d39f54a" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_a6b040a5-f85c-46ae-b8e7-56e65b73ee80" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#NetIncomeLossPerShareNetIncomeLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails" xlink:type="extended" id="i61a8307066ad4871bba0ece4d1846fd4_NetIncomeLossPerShareNetIncomeLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_536d0938-2b6b-4437-9c15-f5353d66965d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_6ccbaf86-d67b-4746-a093-e485fd847992" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_536d0938-2b6b-4437-9c15-f5353d66965d" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_6ccbaf86-d67b-4746-a093-e485fd847992" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_09697b31-dd0f-4e70-a5e8-5ba142eda71b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_6ccbaf86-d67b-4746-a093-e485fd847992" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_09697b31-dd0f-4e70-a5e8-5ba142eda71b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_8c91bb3e-c914-4dfa-a341-ba2a16dd2455" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_6ccbaf86-d67b-4746-a093-e485fd847992" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_8c91bb3e-c914-4dfa-a341-ba2a16dd2455" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AmortizationOfDebtIssuanceCostsNetOfTax_56d43e3e-f328-4b18-8cca-a99de4bdf2da" xlink:href="cutr-20210630.xsd#cutr_AmortizationOfDebtIssuanceCostsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_6ccbaf86-d67b-4746-a093-e485fd847992" xlink:to="loc_cutr_AmortizationOfDebtIssuanceCostsNetOfTax_56d43e3e-f328-4b18-8cca-a99de4bdf2da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_b13a18fd-1466-4c76-bfe0-36970a77ef60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_6ccbaf86-d67b-4746-a093-e485fd847992" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_b13a18fd-1466-4c76-bfe0-36970a77ef60" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_c627eba1-9899-4baf-89ce-d58a7429805a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_536d0938-2b6b-4437-9c15-f5353d66965d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_c627eba1-9899-4baf-89ce-d58a7429805a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0b6eba4b-2434-4dcc-9a79-32921344c564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_c627eba1-9899-4baf-89ce-d58a7429805a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0b6eba4b-2434-4dcc-9a79-32921344c564" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_b23ae29c-cffa-46c5-abd5-87c87904d719" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_536d0938-2b6b-4437-9c15-f5353d66965d" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_b23ae29c-cffa-46c5-abd5-87c87904d719" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_38a28b9a-0ae1-4a66-8214-c920a400f86c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_b23ae29c-cffa-46c5-abd5-87c87904d719" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_38a28b9a-0ae1-4a66-8214-c920a400f86c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8fa4a85c-13a2-41e5-b8e7-e7ebe9ae01a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_b23ae29c-cffa-46c5-abd5-87c87904d719" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8fa4a85c-13a2-41e5-b8e7-e7ebe9ae01a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_af0c563b-ecc2-40ae-8701-86b8170bd3ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_b23ae29c-cffa-46c5-abd5-87c87904d719" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_af0c563b-ecc2-40ae-8701-86b8170bd3ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1b6af651-9568-4691-9347-32c7e5666f83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_536d0938-2b6b-4437-9c15-f5353d66965d" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1b6af651-9568-4691-9347-32c7e5666f83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4b0ebc94-b968-4837-a504-f4d3823b314e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1b6af651-9568-4691-9347-32c7e5666f83" xlink:to="loc_us-gaap_EarningsPerShareBasic_4b0ebc94-b968-4837-a504-f4d3823b314e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a45cd368-3300-44d4-9da2-4d54660887bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1b6af651-9568-4691-9347-32c7e5666f83" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a45cd368-3300-44d4-9da2-4d54660887bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_8d149a74-499b-4297-84b3-b862ef20294d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_536d0938-2b6b-4437-9c15-f5353d66965d" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_8d149a74-499b-4297-84b3-b862ef20294d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c0e25e91-a814-4424-ae81-2ad38f9848a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_8d149a74-499b-4297-84b3-b862ef20294d" xlink:to="loc_us-gaap_AwardTypeAxis_c0e25e91-a814-4424-ae81-2ad38f9848a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c0e25e91-a814-4424-ae81-2ad38f9848a8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c0e25e91-a814-4424-ae81-2ad38f9848a8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c0e25e91-a814-4424-ae81-2ad38f9848a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f123134d-0525-4bee-bb3a-b6cb599f43b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c0e25e91-a814-4424-ae81-2ad38f9848a8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f123134d-0525-4bee-bb3a-b6cb599f43b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_081fd5a4-4757-4efc-9174-d7c9c8c3e4b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f123134d-0525-4bee-bb3a-b6cb599f43b4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_081fd5a4-4757-4efc-9174-d7c9c8c3e4b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2ed91be3-b6e3-4e24-9343-243f6c54df03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f123134d-0525-4bee-bb3a-b6cb599f43b4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2ed91be3-b6e3-4e24-9343-243f6c54df03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_afb4614e-c5fe-4ee3-b53f-d09cf82123b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f123134d-0525-4bee-bb3a-b6cb599f43b4" xlink:to="loc_us-gaap_PerformanceSharesMember_afb4614e-c5fe-4ee3-b53f-d09cf82123b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_efe75e69-ff9c-4aa0-a106-8a0ca8e6a126" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f123134d-0525-4bee-bb3a-b6cb599f43b4" xlink:to="loc_us-gaap_EmployeeStockMember_efe75e69-ff9c-4aa0-a106-8a0ca8e6a126" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/20210331/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails" xlink:type="extended" id="i99225e4d141a4c5291160e6c1d8f27d6_NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9147cf50-396c-4716-a603-2f1cb71be8a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e05fa5f0-1062-4a4b-b225-7049736ddd8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9147cf50-396c-4716-a603-2f1cb71be8a4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e05fa5f0-1062-4a4b-b225-7049736ddd8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_272fba3e-5a1d-46d8-9529-c6cfc7425b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9147cf50-396c-4716-a603-2f1cb71be8a4" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_272fba3e-5a1d-46d8-9529-c6cfc7425b58" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1e1c56f3-d5e2-4b76-879e-0f60964f413b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_272fba3e-5a1d-46d8-9529-c6cfc7425b58" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1e1c56f3-d5e2-4b76-879e-0f60964f413b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1e1c56f3-d5e2-4b76-879e-0f60964f413b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1e1c56f3-d5e2-4b76-879e-0f60964f413b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1e1c56f3-d5e2-4b76-879e-0f60964f413b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_30f04408-0b01-4993-9645-4babded5bfb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1e1c56f3-d5e2-4b76-879e-0f60964f413b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_30f04408-0b01-4993-9645-4babded5bfb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_6340ce6e-fb25-410c-a059-f698b7c936d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_30f04408-0b01-4993-9645-4babded5bfb4" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_6340ce6e-fb25-410c-a059-f698b7c936d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a67027e4-365b-468e-86cb-00eaa2b0ad7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_30f04408-0b01-4993-9645-4babded5bfb4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a67027e4-365b-468e-86cb-00eaa2b0ad7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_30b068fc-6e60-4929-bc4c-69fc748f152c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_30f04408-0b01-4993-9645-4babded5bfb4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_30b068fc-6e60-4929-bc4c-69fc748f152c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_88b27711-acf3-41ff-a267-e9d6b5dcbe58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_30f04408-0b01-4993-9645-4babded5bfb4" xlink:to="loc_us-gaap_PerformanceSharesMember_88b27711-acf3-41ff-a267-e9d6b5dcbe58" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_e75105fd-efee-4414-aaa8-57d882e42b69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_30f04408-0b01-4993-9645-4babded5bfb4" xlink:to="loc_us-gaap_EmployeeStockMember_e75105fd-efee-4414-aaa8-57d882e42b69" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/20210331/role/LeasesNarrativeDetails" xlink:type="extended" id="i55c5c213af984874962cf9d01f9b9b85_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_04b27f1c-d031-4233-ba5d-228342c3a517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_fb6bc706-8fc6-4435-9f46-ef3cd5806b37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_04b27f1c-d031-4233-ba5d-228342c3a517" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_fb6bc706-8fc6-4435-9f46-ef3cd5806b37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_153386cf-1b3e-42cd-a8a3-edda951cd6eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_04b27f1c-d031-4233-ba5d-228342c3a517" xlink:to="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_153386cf-1b3e-42cd-a8a3-edda951cd6eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_a42486a1-f070-4762-aa62-efb17f4eb374" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_04b27f1c-d031-4233-ba5d-228342c3a517" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_a42486a1-f070-4762-aa62-efb17f4eb374" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_59f9a4c0-b895-4c03-934a-ba8a8d3d5897" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_04b27f1c-d031-4233-ba5d-228342c3a517" xlink:to="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_59f9a4c0-b895-4c03-934a-ba8a8d3d5897" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_4b5de3bb-1720-4a08-a1f7-d1cda34f93bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_04b27f1c-d031-4233-ba5d-228342c3a517" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_4b5de3bb-1720-4a08-a1f7-d1cda34f93bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4cf40010-60b2-4ce5-9d7d-48981cf9b7a2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4b5de3bb-1720-4a08-a1f7-d1cda34f93bb" xlink:to="loc_srt_RangeAxis_4cf40010-60b2-4ce5-9d7d-48981cf9b7a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4cf40010-60b2-4ce5-9d7d-48981cf9b7a2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4cf40010-60b2-4ce5-9d7d-48981cf9b7a2" xlink:to="loc_srt_RangeMember_4cf40010-60b2-4ce5-9d7d-48981cf9b7a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_796d79b2-b65d-4218-86a9-e2ed810d986c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4cf40010-60b2-4ce5-9d7d-48981cf9b7a2" xlink:to="loc_srt_RangeMember_796d79b2-b65d-4218-86a9-e2ed810d986c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6dcfd141-7927-44d9-934b-1d90579fbf92" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_796d79b2-b65d-4218-86a9-e2ed810d986c" xlink:to="loc_srt_MinimumMember_6dcfd141-7927-44d9-934b-1d90579fbf92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_fbf66d88-f775-4a30-a4b2-73ac13d97943" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_796d79b2-b65d-4218-86a9-e2ed810d986c" xlink:to="loc_srt_MaximumMember_fbf66d88-f775-4a30-a4b2-73ac13d97943" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionLineItems_ce8c1861-1f57-49bc-ba97-00094fd78d44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm_36ed9466-9b03-4ad9-968c-a8e8b9f12a0c" xlink:href="cutr-20210630.xsd#cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_ce8c1861-1f57-49bc-ba97-00094fd78d44" xlink:to="loc_cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm_36ed9466-9b03-4ad9-968c-a8e8b9f12a0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_7dea5804-6029-4539-9873-82e1630e1377" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_ce8c1861-1f57-49bc-ba97-00094fd78d44" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_7dea5804-6029-4539-9873-82e1630e1377" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseRevenue_2a959bb5-6d29-40ae-bd63-9415cf86c661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesTypeLeaseRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_ce8c1861-1f57-49bc-ba97-00094fd78d44" xlink:to="loc_us-gaap_SalesTypeLeaseRevenue_2a959bb5-6d29-40ae-bd63-9415cf86c661" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease_2fc147d7-2023-4635-84dd-982920b3a129" xlink:href="cutr-20210630.xsd#cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_ce8c1861-1f57-49bc-ba97-00094fd78d44" xlink:to="loc_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease_2fc147d7-2023-4635-84dd-982920b3a129" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_f953b1e7-40f2-4f11-9011-393e5fa7f252" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_ce8c1861-1f57-49bc-ba97-00094fd78d44" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_f953b1e7-40f2-4f11-9011-393e5fa7f252" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionTable_1dafdfa4-1dbf-4ac7-aea7-2b3734a0c337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_ce8c1861-1f57-49bc-ba97-00094fd78d44" xlink:to="loc_us-gaap_LessorLeaseDescriptionTable_1dafdfa4-1dbf-4ac7-aea7-2b3734a0c337" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_13862cc9-c372-4912-a993-40d5f63d19ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_1dafdfa4-1dbf-4ac7-aea7-2b3734a0c337" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_13862cc9-c372-4912-a993-40d5f63d19ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_13862cc9-c372-4912-a993-40d5f63d19ac_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_13862cc9-c372-4912-a993-40d5f63d19ac" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_13862cc9-c372-4912-a993-40d5f63d19ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_008d2515-d9a3-4886-a6dd-1e6d5829490f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_13862cc9-c372-4912-a993-40d5f63d19ac" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_008d2515-d9a3-4886-a6dd-1e6d5829490f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_e6895148-a39a-4ea9-9e84-da2e45962751" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_008d2515-d9a3-4886-a6dd-1e6d5829490f" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_e6895148-a39a-4ea9-9e84-da2e45962751" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/ContingenciesNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#ContingenciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/20210331/role/ContingenciesNarrativeDetails" xlink:type="extended" id="i92a91e45c74b4c3aafc82b87158a78e0_ContingenciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_1ddf5d84-adb6-4863-a206-2a1078b5cdd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_e1cc19f9-26e3-450e-b939-cb8da2f3d4e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_1ddf5d84-adb6-4863-a206-2a1078b5cdd2" xlink:to="loc_us-gaap_LitigationReserve_e1cc19f9-26e3-450e-b939-cb8da2f3d4e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_65f19d5b-9034-4121-ad77-ad236f36e730" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_1ddf5d84-adb6-4863-a206-2a1078b5cdd2" xlink:to="loc_us-gaap_LossContingenciesTable_65f19d5b-9034-4121-ad77-ad236f36e730" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_c02e0cda-5d29-419e-aeef-ba8c4f02cdbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_65f19d5b-9034-4121-ad77-ad236f36e730" xlink:to="loc_us-gaap_LitigationStatusAxis_c02e0cda-5d29-419e-aeef-ba8c4f02cdbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_c02e0cda-5d29-419e-aeef-ba8c4f02cdbe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_c02e0cda-5d29-419e-aeef-ba8c4f02cdbe" xlink:to="loc_us-gaap_LitigationStatusDomain_c02e0cda-5d29-419e-aeef-ba8c4f02cdbe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_5b4e038e-ec07-4149-a214-8e990f747462" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_c02e0cda-5d29-419e-aeef-ba8c4f02cdbe" xlink:to="loc_us-gaap_LitigationStatusDomain_5b4e038e-ec07-4149-a214-8e990f747462" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_b525ad04-3370-456f-becd-8676ff842c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_5b4e038e-ec07-4149-a214-8e990f747462" xlink:to="loc_us-gaap_PendingLitigationMember_b525ad04-3370-456f-becd-8676ff842c2a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/20210331/role/DebtNarrativeDetails" xlink:type="extended" id="i7bfaa901c7044860ad107e854761f386_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f7138f89-5a0d-4b7a-890c-8438a2d54448" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f7138f89-5a0d-4b7a-890c-8438a2d54448" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_961d48cf-c603-4668-905b-94f7723df68e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_961d48cf-c603-4668-905b-94f7723df68e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_27dcc6e4-f65b-4486-a5f2-411b7bd42133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_27dcc6e4-f65b-4486-a5f2-411b7bd42133" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_ca22d3b8-79fe-4ccb-81d8-cd49d4507478" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_ca22d3b8-79fe-4ccb-81d8-cd49d4507478" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_9ad5600a-3e3b-4a7d-a757-983b056b763d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_9ad5600a-3e3b-4a7d-a757-983b056b763d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_f07c84b2-3723-4e32-b4a1-c7c7f4799733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_ConvertibleDebt_f07c84b2-3723-4e32-b4a1-c7c7f4799733" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_d01bd248-7fd5-4cd3-806d-82954d760600" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_d01bd248-7fd5-4cd3-806d-82954d760600" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_5885c61a-d351-4206-b387-1f3146f3f9f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_5885c61a-d351-4206-b387-1f3146f3f9f8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_4f429cfc-ab8a-4daf-9e6d-f9063f874454" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_4f429cfc-ab8a-4daf-9e6d-f9063f874454" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6bd0b645-8cd3-4d2c-ade4-4c525bb264ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6bd0b645-8cd3-4d2c-ade4-4c525bb264ac" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger_748331e6-2a38-4774-a3e2-6ca457360650" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger_748331e6-2a38-4774-a3e2-6ca457360650" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedeemableThresholdTradingDays_5b8dfc8e-1723-4f51-914f-aeb18b9a924c" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentRedeemableThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DebtInstrumentRedeemableThresholdTradingDays_5b8dfc8e-1723-4f51-914f-aeb18b9a924c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays_85f27ba6-0f30-4bbf-8875-45d5eed0a4ad" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays_85f27ba6-0f30-4bbf-8875-45d5eed0a4ad" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_98abe148-5040-4111-ac24-2fdbbead7f90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_98abe148-5040-4111-ac24-2fdbbead7f90" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_e8a777dc-cdd9-4a2b-b987-ab4b3a5453b0" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_e8a777dc-cdd9-4a2b-b987-ab4b3a5453b0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_75dc39a2-5d51-413a-877e-78cec65887a6" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_75dc39a2-5d51-413a-877e-78cec65887a6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_3930919c-1a07-416d-88d0-2bfe288fd3f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_3930919c-1a07-416d-88d0-2bfe288fd3f4" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCapPrice_a0978a2c-cb54-43a5-afee-882c1c52f775" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCapPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DerivativeCapPrice_a0978a2c-cb54-43a5-afee-882c1c52f775" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DerivativeCapPricePremiumOverStockPricePercent_b75d887f-e152-478e-90cc-33fcdfcf51e2" xlink:href="cutr-20210630.xsd#cutr_DerivativeCapPricePremiumOverStockPricePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DerivativeCapPricePremiumOverStockPricePercent_b75d887f-e152-478e-90cc-33fcdfcf51e2" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_f8f2bea8-f4ac-4728-ad29-be1ca6505893" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_SharePrice_f8f2bea8-f4ac-4728-ad29-be1ca6505893" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_fcc4b122-891d-48e5-9334-db6bf99a9505" xlink:href="cutr-20210630.xsd#cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_fcc4b122-891d-48e5-9334-db6bf99a9505" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_12ddf240-8aa9-4a97-864b-3cadd4cd5559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_12ddf240-8aa9-4a97-864b-3cadd4cd5559" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_16a097a1-94dc-49fb-803f-ded908afc617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_16a097a1-94dc-49fb-803f-ded908afc617" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_065ff117-0d1c-4fcb-b48a-8bfc3f9d8814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_065ff117-0d1c-4fcb-b48a-8bfc3f9d8814" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_a7db8a1e-dc23-4509-9bf9-be81d39e6a03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_a7db8a1e-dc23-4509-9bf9-be81d39e6a03" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_118338d3-66a3-41f8-bfee-6add3f8e7882" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_InterestExpenseDebt_118338d3-66a3-41f8-bfee-6add3f8e7882" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_3e111a71-8417-4715-bca8-91dbcdf76c7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_3e111a71-8417-4715-bca8-91dbcdf76c7f" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9868271d-5c6e-44da-bbb3-6af738e57441" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9868271d-5c6e-44da-bbb3-6af738e57441" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_e6bc3c5b-f633-4126-ba7d-01cc7991460f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentTerm_e6bc3c5b-f633-4126-ba7d-01cc7991460f" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_05a3a346-7f05-4a65-9538-7bea593e0690" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_05a3a346-7f05-4a65-9538-7bea593e0690" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_12dec6dc-5b57-47be-885c-60de2c31b3fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_12dec6dc-5b57-47be-885c-60de2c31b3fe" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_c5f66ee5-eb61-4d77-873a-9c1904019b03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_c5f66ee5-eb61-4d77-873a-9c1904019b03" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentAnniversaryFeeAmount_8994770c-fef1-45d0-9b99-ec9d5d52a1c4" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentAnniversaryFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DebtInstrumentAnniversaryFeeAmount_8994770c-fef1-45d0-9b99-ec9d5d52a1c4" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtCovenantQuarterlyMinimumRevenue_48b0dd6b-ed56-4678-ae97-2ff4367213bf" xlink:href="cutr-20210630.xsd#cutr_DebtCovenantQuarterlyMinimumRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DebtCovenantQuarterlyMinimumRevenue_48b0dd6b-ed56-4678-ae97-2ff4367213bf" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_dda9bafd-8432-4d27-830c-f47c959b210a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_dda9bafd-8432-4d27-830c-f47c959b210a" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fae9e520-3d5a-4f72-9e9f-f54dba807b6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fae9e520-3d5a-4f72-9e9f-f54dba807b6a" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c68cff82-c1a8-4657-ad2b-649f810014aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c68cff82-c1a8-4657-ad2b-649f810014aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c68cff82-c1a8-4657-ad2b-649f810014aa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c68cff82-c1a8-4657-ad2b-649f810014aa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c68cff82-c1a8-4657-ad2b-649f810014aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_eefab421-4450-4eae-b54a-ca292981104a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c68cff82-c1a8-4657-ad2b-649f810014aa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_eefab421-4450-4eae-b54a-ca292981104a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_c2f97dc2-03a8-406d-ab36-cbd37972739d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_eefab421-4450-4eae-b54a-ca292981104a" xlink:to="loc_us-gaap_ConvertibleDebtMember_c2f97dc2-03a8-406d-ab36-cbd37972739d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_55bee1b7-cbd3-4f8c-860a-545f1baf4761" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:to="loc_us-gaap_DebtInstrumentAxis_55bee1b7-cbd3-4f8c-860a-545f1baf4761" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_55bee1b7-cbd3-4f8c-860a-545f1baf4761_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_55bee1b7-cbd3-4f8c-860a-545f1baf4761" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_55bee1b7-cbd3-4f8c-860a-545f1baf4761_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_934e1baa-f4fb-4b85-b944-3e552e801409" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_55bee1b7-cbd3-4f8c-860a-545f1baf4761" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_934e1baa-f4fb-4b85-b944-3e552e801409" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_ef7d2c3f-4397-4dd8-8381-4832f9a0523e" xlink:href="cutr-20210630.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_934e1baa-f4fb-4b85-b944-3e552e801409" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_ef7d2c3f-4397-4dd8-8381-4832f9a0523e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_0c60af09-11c0-44d5-a7d8-7220852b2317" xlink:href="cutr-20210630.xsd#cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_ConvertibleSeniorNotesDue2026Member_ef7d2c3f-4397-4dd8-8381-4832f9a0523e" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_0c60af09-11c0-44d5-a7d8-7220852b2317" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_10cf510a-6317-43dc-ba88-fb0e91d6b777" xlink:href="cutr-20210630.xsd#cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_ConvertibleSeniorNotesDue2026Member_ef7d2c3f-4397-4dd8-8381-4832f9a0523e" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_10cf510a-6317-43dc-ba88-fb0e91d6b777" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LoanAndSecurityAgreementMember_2403281b-0dff-4fde-bcc3-48359ac40299" xlink:href="cutr-20210630.xsd#cutr_LoanAndSecurityAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_934e1baa-f4fb-4b85-b944-3e552e801409" xlink:to="loc_cutr_LoanAndSecurityAgreementMember_2403281b-0dff-4fde-bcc3-48359ac40299" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PaycheckProtectionProgramCARESActMember_1a90e15b-1217-4f57-b842-e6c361cd0136" xlink:href="cutr-20210630.xsd#cutr_PaycheckProtectionProgramCARESActMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_934e1baa-f4fb-4b85-b944-3e552e801409" xlink:to="loc_cutr_PaycheckProtectionProgramCARESActMember_1a90e15b-1217-4f57-b842-e6c361cd0136" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_280bd921-da06-42b7-9fd5-fcc99537ea34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_280bd921-da06-42b7-9fd5-fcc99537ea34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_280bd921-da06-42b7-9fd5-fcc99537ea34_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_280bd921-da06-42b7-9fd5-fcc99537ea34" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_280bd921-da06-42b7-9fd5-fcc99537ea34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2a187ba9-06ed-4aa9-b95e-bde05331ed63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_280bd921-da06-42b7-9fd5-fcc99537ea34" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2a187ba9-06ed-4aa9-b95e-bde05331ed63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_879b3c61-a283-4574-8b56-a4dfe4d69a70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2a187ba9-06ed-4aa9-b95e-bde05331ed63" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_879b3c61-a283-4574-8b56-a4dfe4d69a70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_5809f43a-37aa-4a0b-bbcb-03b5af4d922b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_5809f43a-37aa-4a0b-bbcb-03b5af4d922b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_5809f43a-37aa-4a0b-bbcb-03b5af4d922b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_5809f43a-37aa-4a0b-bbcb-03b5af4d922b" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_5809f43a-37aa-4a0b-bbcb-03b5af4d922b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_b1651883-83f3-4a8b-939b-e2ba8f46933b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_5809f43a-37aa-4a0b-bbcb-03b5af4d922b" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_b1651883-83f3-4a8b-939b-e2ba8f46933b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_WellsFargoMember_7a9716c4-0623-4a13-8c75-06d6c249a489" xlink:href="cutr-20210630.xsd#cutr_WellsFargoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_b1651883-83f3-4a8b-939b-e2ba8f46933b" xlink:to="loc_cutr_WellsFargoMember_7a9716c4-0623-4a13-8c75-06d6c249a489" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SiliconValleyBankMember_ae941066-082f-46a0-a857-763fe993e001" xlink:href="cutr-20210630.xsd#cutr_SiliconValleyBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_b1651883-83f3-4a8b-939b-e2ba8f46933b" xlink:to="loc_cutr_SiliconValleyBankMember_ae941066-082f-46a0-a857-763fe993e001" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5cd2d02f-6cab-4835-9cb9-2e39ecb489eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:to="loc_us-gaap_CreditFacilityAxis_5cd2d02f-6cab-4835-9cb9-2e39ecb489eb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5cd2d02f-6cab-4835-9cb9-2e39ecb489eb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_5cd2d02f-6cab-4835-9cb9-2e39ecb489eb" xlink:to="loc_us-gaap_CreditFacilityDomain_5cd2d02f-6cab-4835-9cb9-2e39ecb489eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_122c59fc-ce4c-40bc-afa9-c04e686d4cf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_5cd2d02f-6cab-4835-9cb9-2e39ecb489eb" xlink:to="loc_us-gaap_CreditFacilityDomain_122c59fc-ce4c-40bc-afa9-c04e686d4cf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_43815b0c-4e0c-4750-b8a7-66ba79442eb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_122c59fc-ce4c-40bc-afa9-c04e686d4cf2" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_43815b0c-4e0c-4750-b8a7-66ba79442eb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_759ae4fa-4e35-437a-b66f-d5d3d8dabb63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:to="loc_us-gaap_VariableRateAxis_759ae4fa-4e35-437a-b66f-d5d3d8dabb63" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_759ae4fa-4e35-437a-b66f-d5d3d8dabb63_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_759ae4fa-4e35-437a-b66f-d5d3d8dabb63" xlink:to="loc_us-gaap_VariableRateDomain_759ae4fa-4e35-437a-b66f-d5d3d8dabb63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_35fe4f9d-9531-4569-99a2-46fb27c380e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_759ae4fa-4e35-437a-b66f-d5d3d8dabb63" xlink:to="loc_us-gaap_VariableRateDomain_35fe4f9d-9531-4569-99a2-46fb27c380e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_acf4a5b4-c1aa-4695-80e5-71170abedbec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_35fe4f9d-9531-4569-99a2-46fb27c380e1" xlink:to="loc_us-gaap_PrimeRateMember_acf4a5b4-c1aa-4695-80e5-71170abedbec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_93105596-a1ef-423f-9763-24cab3a19be0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:to="loc_us-gaap_StatementClassOfStockAxis_93105596-a1ef-423f-9763-24cab3a19be0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_93105596-a1ef-423f-9763-24cab3a19be0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_93105596-a1ef-423f-9763-24cab3a19be0" xlink:to="loc_us-gaap_ClassOfStockDomain_93105596-a1ef-423f-9763-24cab3a19be0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f4809568-0d04-4edf-bff0-b9e8d1a76b96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_93105596-a1ef-423f-9763-24cab3a19be0" xlink:to="loc_us-gaap_ClassOfStockDomain_f4809568-0d04-4edf-bff0-b9e8d1a76b96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4a02f7f2-7a84-43df-87c4-9e56aa4e4e45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f4809568-0d04-4edf-bff0-b9e8d1a76b96" xlink:to="loc_us-gaap_CommonStockMember_4a02f7f2-7a84-43df-87c4-9e56aa4e4e45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3947cb3a-1b5e-480d-aef3-241845f802e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3947cb3a-1b5e-480d-aef3-241845f802e3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_3947cb3a-1b5e-480d-aef3-241845f802e3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3947cb3a-1b5e-480d-aef3-241845f802e3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_3947cb3a-1b5e-480d-aef3-241845f802e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_dd94f461-c5bf-421e-87d5-5c3db9618306" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3947cb3a-1b5e-480d-aef3-241845f802e3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_dd94f461-c5bf-421e-87d5-5c3db9618306" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_03f397a8-04aa-4461-bd4f-98d3b616582b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_dd94f461-c5bf-421e-87d5-5c3db9618306" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_03f397a8-04aa-4461-bd4f-98d3b616582b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#DebtOutstandingDebtandCarryingValueDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails" xlink:type="extended" id="i010670e4866b419d8deeae6e77cbcf92_DebtOutstandingDebtandCarryingValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b03f658a-779d-4679-8ab2-9d331044cdb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_4c25f343-d55f-4606-b9c0-b287928c4004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b03f658a-779d-4679-8ab2-9d331044cdb3" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_4c25f343-d55f-4606-b9c0-b287928c4004" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_ee91759c-28b7-49b5-a3f7-cb23d6b75d50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b03f658a-779d-4679-8ab2-9d331044cdb3" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_ee91759c-28b7-49b5-a3f7-cb23d6b75d50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f49b3c0a-7c4b-46df-8734-a865e8c65693" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b03f658a-779d-4679-8ab2-9d331044cdb3" xlink:to="loc_us-gaap_LongTermDebt_f49b3c0a-7c4b-46df-8734-a865e8c65693" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a55a85d3-1777-490f-b1ff-326941de319b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b03f658a-779d-4679-8ab2-9d331044cdb3" xlink:to="loc_us-gaap_DebtInstrumentTable_a55a85d3-1777-490f-b1ff-326941de319b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_87fad07a-38fd-4d31-a169-00621adea9d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a55a85d3-1777-490f-b1ff-326941de319b" xlink:to="loc_us-gaap_DebtInstrumentAxis_87fad07a-38fd-4d31-a169-00621adea9d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_87fad07a-38fd-4d31-a169-00621adea9d2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_87fad07a-38fd-4d31-a169-00621adea9d2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_87fad07a-38fd-4d31-a169-00621adea9d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c78dd0fc-0b1d-4a5e-afe7-2ab25afa5542" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_87fad07a-38fd-4d31-a169-00621adea9d2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c78dd0fc-0b1d-4a5e-afe7-2ab25afa5542" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_349a040a-f7d6-4fa4-b06d-4ade31ecfe8a" xlink:href="cutr-20210630.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c78dd0fc-0b1d-4a5e-afe7-2ab25afa5542" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_349a040a-f7d6-4fa4-b06d-4ade31ecfe8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_694092d0-f9b1-4a86-a4dc-f2cabc8feb2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a55a85d3-1777-490f-b1ff-326941de319b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_694092d0-f9b1-4a86-a4dc-f2cabc8feb2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_694092d0-f9b1-4a86-a4dc-f2cabc8feb2b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_694092d0-f9b1-4a86-a4dc-f2cabc8feb2b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_694092d0-f9b1-4a86-a4dc-f2cabc8feb2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a15c6815-0e3d-4166-a6e1-865459802346" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_694092d0-f9b1-4a86-a4dc-f2cabc8feb2b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a15c6815-0e3d-4166-a6e1-865459802346" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_0e4f6b0d-25eb-49b6-8950-09d63fd76c64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a15c6815-0e3d-4166-a6e1-865459802346" xlink:to="loc_us-gaap_ConvertibleDebtMember_0e4f6b0d-25eb-49b6-8950-09d63fd76c64" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#SegmentReportingSummaryofRevenueDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails" xlink:type="extended" id="ib96fd03554c94e3bbc7615fff8af5067_SegmentReportingSummaryofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e0f564a1-7806-4461-be5c-44b6d416d40c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_f9066c5e-56d1-492a-ae86-0fc8ad93dc27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e0f564a1-7806-4461-be5c-44b6d416d40c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_f9066c5e-56d1-492a-ae86-0fc8ad93dc27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_30ef530a-8d59-438d-80a7-6ffe88055b18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e0f564a1-7806-4461-be5c-44b6d416d40c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_30ef530a-8d59-438d-80a7-6ffe88055b18" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_864d38c8-a3fd-4ecf-ae7f-ba6f1412ce1f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_30ef530a-8d59-438d-80a7-6ffe88055b18" xlink:to="loc_srt_StatementGeographicalAxis_864d38c8-a3fd-4ecf-ae7f-ba6f1412ce1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_864d38c8-a3fd-4ecf-ae7f-ba6f1412ce1f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_864d38c8-a3fd-4ecf-ae7f-ba6f1412ce1f" xlink:to="loc_srt_SegmentGeographicalDomain_864d38c8-a3fd-4ecf-ae7f-ba6f1412ce1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_14b8bec0-9e35-413d-aa63-c36355eaa147" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_864d38c8-a3fd-4ecf-ae7f-ba6f1412ce1f" xlink:to="loc_srt_SegmentGeographicalDomain_14b8bec0-9e35-413d-aa63-c36355eaa147" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cd74e9d0-643e-4f6a-877e-ad1fd6d17b4c" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_14b8bec0-9e35-413d-aa63-c36355eaa147" xlink:to="loc_country_US_cd74e9d0-643e-4f6a-877e-ad1fd6d17b4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_60b4647e-258e-419c-b0de-42135f6f3f7d" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_JP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_14b8bec0-9e35-413d-aa63-c36355eaa147" xlink:to="loc_country_JP_60b4647e-258e-419c-b0de-42135f6f3f7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AsiaExcludingJapanMember_f8561910-b267-41a4-9597-3602b1319580" xlink:href="cutr-20210630.xsd#cutr_AsiaExcludingJapanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_14b8bec0-9e35-413d-aa63-c36355eaa147" xlink:to="loc_cutr_AsiaExcludingJapanMember_f8561910-b267-41a4-9597-3602b1319580" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_13ecf976-83ff-48a6-9793-fc210dd9c888" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_14b8bec0-9e35-413d-aa63-c36355eaa147" xlink:to="loc_srt_EuropeMember_13ecf976-83ff-48a6-9793-fc210dd9c888" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestOfWorldMember_3d180904-a013-49d8-967c-2811c1774c38" xlink:href="cutr-20210630.xsd#cutr_RestOfWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_14b8bec0-9e35-413d-aa63-c36355eaa147" xlink:to="loc_cutr_RestOfWorldMember_3d180904-a013-49d8-967c-2811c1774c38" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6765b116-e287-4552-8e77-263f7a82e7de" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_30ef530a-8d59-438d-80a7-6ffe88055b18" xlink:to="loc_srt_ProductOrServiceAxis_6765b116-e287-4552-8e77-263f7a82e7de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6765b116-e287-4552-8e77-263f7a82e7de_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_6765b116-e287-4552-8e77-263f7a82e7de" xlink:to="loc_srt_ProductsAndServicesDomain_6765b116-e287-4552-8e77-263f7a82e7de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0dc58782-7bbf-459e-a4ba-75c39e8df558" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_6765b116-e287-4552-8e77-263f7a82e7de" xlink:to="loc_srt_ProductsAndServicesDomain_0dc58782-7bbf-459e-a4ba-75c39e8df558" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_bed4acfc-40ab-4f4b-a9d3-0d98acb2ee10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0dc58782-7bbf-459e-a4ba-75c39e8df558" xlink:to="loc_us-gaap_ProductMember_bed4acfc-40ab-4f4b-a9d3-0d98acb2ee10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ProductsExcludingConsumablesAndSkincareMember_0c4ac1d2-80c1-45b1-8357-2684551d372e" xlink:href="cutr-20210630.xsd#cutr_ProductsExcludingConsumablesAndSkincareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductMember_bed4acfc-40ab-4f4b-a9d3-0d98acb2ee10" xlink:to="loc_cutr_ProductsExcludingConsumablesAndSkincareMember_0c4ac1d2-80c1-45b1-8357-2684551d372e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConsumablesMember_f67a9485-c94d-4eb9-939b-8532c2237986" xlink:href="cutr-20210630.xsd#cutr_ConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductMember_bed4acfc-40ab-4f4b-a9d3-0d98acb2ee10" xlink:to="loc_cutr_ConsumablesMember_f67a9485-c94d-4eb9-939b-8532c2237986" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SkincareMember_0c6d2624-8fc4-4a82-9823-c3395ca26711" xlink:href="cutr-20210630.xsd#cutr_SkincareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductMember_bed4acfc-40ab-4f4b-a9d3-0d98acb2ee10" xlink:to="loc_cutr_SkincareMember_0c6d2624-8fc4-4a82-9823-c3395ca26711" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_3ff7fee0-bc3c-43f8-b945-ce0b036791c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0dc58782-7bbf-459e-a4ba-75c39e8df558" xlink:to="loc_us-gaap_ServiceMember_3ff7fee0-bc3c-43f8-b945-ce0b036791c9" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>cutr-20210630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c7947e62-414c-45c3-9059-a14473012559,g:b6549df2-51ec-4e04-8ce7-629c1e713d47-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_44d8611b-c0d8-4bca-8778-3a91c92d7d9a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8edaf8fb-a98d-4fad-8e03-c759588eb528_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4cd45d64-41dc-4cc8-8994-4aba6151dd72_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_fbfecb99-9e4b-49ed-a2f1-24596242368a_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3f3b30ac-881c-4370-9b55-315e82e75bff_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, beginning balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_742273b0-38fc-46dd-a476-19ff454a0cf5_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, ending balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_de4eb439-d4f6-4c41-8adb-94ac6c26692e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_52f63e88-3732-43b1-9453-0f22f2ba432a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Liability Accrual</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_53e750f3-b39c-4f0b-8b3d-5ffb8fc33dec_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ca213a7d-e517-434f-9b6a-598772f85a7c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ea3fefe4-615a-4fd5-ac49-202154ab3723_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b92825d1-4758-4b9b-81ec-71d84b8b2657_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_17c07e78-4228-46ac-b3a1-4c52b4b8089f_terseLabel_en-US" xlink:label="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capped-call transaction term, consecutive trading days</link:label>
    <link:label id="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_label_en-US" xlink:label="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Capped Call Transaction Term, Consecutive Trading Days</link:label>
    <link:label id="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_documentation_en-US" xlink:label="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Capped Call Transaction Term, Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" xlink:href="cutr-20210630.xsd#cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" xlink:to="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductInformationLineItems_d6feadca-1910-485e-bf2b-1b6fc0d8c71f_terseLabel_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductInformationLineItems_label_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_07697d12-04d9-4ea1-927f-2cdb76103721_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_8f441d00-267b-49e1-8bc2-dd8dc3aab3cb_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_26fef17f-33f4-49e3-b27f-48a310051461_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_91a45241-13ad-4fa7-9145-cc3648ad23ea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards released (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_823cc1ce-9e5b-476a-820a-9eb54647ee1c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_0733c26c-4e32-40bb-b136-702eeb315b53_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_1333e6b7-8ac6-43f4-ac6d-f0d577ee029c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_4fd4f751-0409-49ed-9913-e63693020862_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty and Extended Service Contract</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:to="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_SalesAndMarketingAccrualsCurrent_aa36027c-6203-4010-8d91-75e034e4d433_terseLabel_en-US" xlink:label="lab_cutr_SalesAndMarketingAccrualsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing accruals</link:label>
    <link:label id="lab_cutr_SalesAndMarketingAccrualsCurrent_label_en-US" xlink:label="lab_cutr_SalesAndMarketingAccrualsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales And Marketing Accruals, Current</link:label>
    <link:label id="lab_cutr_SalesAndMarketingAccrualsCurrent_documentation_en-US" xlink:label="lab_cutr_SalesAndMarketingAccrualsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of the obligations incurred through that date and payable for sales and marketing costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SalesAndMarketingAccrualsCurrent" xlink:href="cutr-20210630.xsd#cutr_SalesAndMarketingAccrualsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_SalesAndMarketingAccrualsCurrent" xlink:to="lab_cutr_SalesAndMarketingAccrualsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_e6875b58-760f-4268-a618-be15b0f814c3_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7a94514f-b357-481e-8b45-ab7ccb4fa86d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LeasesWeightedAverageDiscountRateAbstract_75ea5bda-5cd8-4c7f-a003-7202ded6718c_terseLabel_en-US" xlink:label="lab_cutr_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate</link:label>
    <link:label id="lab_cutr_LeasesWeightedAverageDiscountRateAbstract_label_en-US" xlink:label="lab_cutr_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Weighted Average Discount Rate [Abstract]</link:label>
    <link:label id="lab_cutr_LeasesWeightedAverageDiscountRateAbstract_documentation_en-US" xlink:label="lab_cutr_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Weighted Average Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeasesWeightedAverageDiscountRateAbstract" xlink:href="cutr-20210630.xsd#cutr_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LeasesWeightedAverageDiscountRateAbstract" xlink:to="lab_cutr_LeasesWeightedAverageDiscountRateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a00b88cb-37ba-4dc6-9fb4-e5c05b49ac72_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAdditions_c77e579b-b7f6-4609-a93d-61e05ac6ba1f_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized cloud computing systems implementation costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAdditions_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_42809440-7037-4588-a5fb-cf6840aad973_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost, Amortization expense</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_5952f88d-2981-45f9-a45c-7c419cf688f6_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product warranty</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:to="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AssetsAndLiabilitiesLesseeTableTextBlock_bfb0561b-ac03-4f51-ab9d-03c123fc7237_terseLabel_en-US" xlink:label="lab_cutr_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_cutr_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_cutr_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_cutr_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_cutr_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="cutr-20210630.xsd#cutr_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_cutr_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_2402c470-a442-4cf3-9fed-2746c8f49528_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_b43c1647-5e10-44fe-853b-e21ce9ea8260_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of Convertible notes</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_2920d810-4a75-4104-ab45-c8931a69c911_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan proceeds</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_8cecbbbb-3df4-4dca-a022-a4767eda6d48_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_CappedCallTransactionsCosts_55a54c28-4b1a-4fd4-8666-e886d68d401b_terseLabel_en-US" xlink:label="lab_cutr_CappedCallTransactionsCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capped call transactions costs</link:label>
    <link:label id="lab_cutr_CappedCallTransactionsCosts_label_en-US" xlink:label="lab_cutr_CappedCallTransactionsCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capped Call Transactions Costs</link:label>
    <link:label id="lab_cutr_CappedCallTransactionsCosts_documentation_en-US" xlink:label="lab_cutr_CappedCallTransactionsCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of costs associated with capped call transactions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CappedCallTransactionsCosts" xlink:href="cutr-20210630.xsd#cutr_CappedCallTransactionsCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_CappedCallTransactionsCosts" xlink:to="lab_cutr_CappedCallTransactionsCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_87bfc76a-18f9-4b6c-b8b6-50866e5b8b91_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_087c6e8a-35ce-454a-8723-1bcc47267453_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_8e924742-6776-45e2-a38c-41c40ca39d67_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of issuance costs of Convertible notes</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_587de270-19f0-4e93-8859-b660217df5d0_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_77fc36af-936f-4da3-b053-894968b6a048_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Deferred Service Contract Revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_b2a066fe-a5be-459e-a276-6bf56d6cff26_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSUs</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_7a6e485e-178c-4321-98b3-09a527d8605c_verboseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance stock units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_647d72ec-3951-4535-be85-b81e1e29418e_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time</link:label>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredOverTimeMember" xlink:to="lab_us-gaap_TransferredOverTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_515484fa-e8c7-4846-86f2-48793ad145eb_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets and prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6c122944-cd5f-44ce-aae4-1eed7f470bbb_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f80f99b2-9b84-4ece-a4bd-1f5bb05638d9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_00c163a7-9699-44db-be68-440f39cabb19_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_a39beec3-d3d8-4dab-b96b-7991c783920d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_e4205df1-8c34-4a19-9392-3a2becc6b93e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies (Notes 12)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_5d1cbf24-a984-472a-95ac-bd12ef633991_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_fb7fc908-b779-4dbd-8a95-8f2331e7f9d7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_788c4561-aa6c-4e3c-b112-35391ba27e23_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Tranche</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_7cd15b29-e5a6-4f23-937d-f30a91d99b26_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_465e3b9b-22a6-44fb-bf9e-75d6e38331de_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_29d8dbff-370d-49f4-bada-92bf1f2f38b8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3639dc01-27f1-4275-8e6b-e7cdd31522b6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_90fb5915-08de-4801-a6ab-77d40620bb6d_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards released (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_5b54423b-63cf-41ab-b272-8808380b5454_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flow, Operating lease</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_ce42d8fb-9ebd-405a-b5c0-57b6a8a5da3c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AsiaExcludingJapanMember_281d9df5-9639-4e9e-9f30-b5f1d28efb11_terseLabel_en-US" xlink:label="lab_cutr_AsiaExcludingJapanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia, excluding Japan</link:label>
    <link:label id="lab_cutr_AsiaExcludingJapanMember_label_en-US" xlink:label="lab_cutr_AsiaExcludingJapanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia, Excluding Japan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AsiaExcludingJapanMember" xlink:href="cutr-20210630.xsd#cutr_AsiaExcludingJapanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AsiaExcludingJapanMember" xlink:to="lab_cutr_AsiaExcludingJapanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_dff5fc91-6f2f-4cdd-ba15-558d1722ea5a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_64144ab8-f10d-424c-8dda-b73710bf9fd4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_a33408de-da1c-46a0-86f3-0800755073f7_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_1e206b57-0cb7-4c6a-adce-c1a6261e7051_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_135297c1-fdb5-4b94-bcaa-4cfbcd55963f_verboseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on extinguishment of PPP loan</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_727606c8-de30-4fa0-909b-fd9b5235ca22_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on extinguishment of PPP loan</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_97f91467-078f-4206-b503-9db86e667371_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_da52d648-e1f7-4239-9c56-428e40a2c4c7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_f5669110-8249-4edb-b756-8912ee8299cb_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Convertible Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:to="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_6b609a05-5f29-4e34-9e4d-4e24408ffc13_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_26b9a778-3f40-4bec-8a79-83cbd87be15e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ddf39a5a-1790-4317-8c43-f0bf981672e4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b86fe498-1a5c-4eaf-b8ff-84c5cf62047a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease_9f66564d-f694-4f0b-b493-992a942ed012_terseLabel_en-US" xlink:label="lab_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from customer's exercise of purchase option</link:label>
    <link:label id="lab_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease_label_en-US" xlink:label="lab_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Exercise Of Purchase Option, Sales-Type Lease</link:label>
    <link:label id="lab_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease_documentation_en-US" xlink:label="lab_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of cash inflow from proceeds from the exercise of purchase option sales type lease.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease" xlink:href="cutr-20210630.xsd#cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease" xlink:to="lab_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_15e6bd1a-6516-47e0-9367-86b8d331e7b2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_747faebd-7a00-4f22-b925-eb65f2217fe2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember_e526594e-347d-45ae-bd36-5155b2179025_terseLabel_en-US" xlink:label="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Plan</link:label>
    <link:label id="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember_label_en-US" xlink:label="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Nineteen Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to the 2019 equity incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TwoThousandNineteenEquityIncentivePlanMember" xlink:href="cutr-20210630.xsd#cutr_TwoThousandNineteenEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_TwoThousandNineteenEquityIncentivePlanMember" xlink:to="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_CustomerMarketingSupportMember_d178ba60-3227-4cc8-81e7-cb1cd7bf15c6_terseLabel_en-US" xlink:label="lab_cutr_CustomerMarketingSupportMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Marketing Support</link:label>
    <link:label id="lab_cutr_CustomerMarketingSupportMember_label_en-US" xlink:label="lab_cutr_CustomerMarketingSupportMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Marketing Support [Member]</link:label>
    <link:label id="lab_cutr_CustomerMarketingSupportMember_documentation_en-US" xlink:label="lab_cutr_CustomerMarketingSupportMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Marketing Support</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CustomerMarketingSupportMember" xlink:href="cutr-20210630.xsd#cutr_CustomerMarketingSupportMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_CustomerMarketingSupportMember" xlink:to="lab_cutr_CustomerMarketingSupportMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_3af21022-cb0f-43fb-827d-09745cea2c26_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6296cc92-02d5-4949-8236-4d71e2ba23b1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive gain:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_0ad90bbf-175a-4bef-82b2-b5914e2788d0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_3cf1d470-3d0f-4d27-b5f2-1adc94dfc8da_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual_fc0620bf-7e34-44c0-b5de-a5f56833b715_verboseLabel_en-US" xlink:label="lab_cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended warranty liabilities</link:label>
    <link:label id="lab_cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual_label_en-US" xlink:label="lab_cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual</link:label>
    <link:label id="lab_cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual_documentation_en-US" xlink:label="lab_cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of increase (decrease) in extended product warranty accrual.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual" xlink:href="cutr-20210630.xsd#cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual" xlink:to="lab_cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_2593042e-d378-4ff4-911c-1d413216ab9d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_cfe8246e-6302-40a4-a33f-0b87460d59b9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_508b64d2-8d38-4ff3-9041-c46b213c20c2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options canceled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_d914d588-b54a-496c-826e-0aca8336a137_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_acc9f77d-8cde-4282-b9dc-3e8d53b233d5_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_665cc374-2801-4b0d-a94f-36082ca699fd_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flow, Finance lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtInstrumentAnniversaryFeeAmount_1f67ae8c-7a19-4791-9e0d-23efeae8e4b3_terseLabel_en-US" xlink:label="lab_cutr_DebtInstrumentAnniversaryFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anniversary fee amount</link:label>
    <link:label id="lab_cutr_DebtInstrumentAnniversaryFeeAmount_label_en-US" xlink:label="lab_cutr_DebtInstrumentAnniversaryFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Anniversary Fee Amount</link:label>
    <link:label id="lab_cutr_DebtInstrumentAnniversaryFeeAmount_documentation_en-US" xlink:label="lab_cutr_DebtInstrumentAnniversaryFeeAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents anniversary fee amount for debt instrument.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentAnniversaryFeeAmount" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentAnniversaryFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtInstrumentAnniversaryFeeAmount" xlink:to="lab_cutr_DebtInstrumentAnniversaryFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_SiliconValleyBankMember_c5d4a910-6cf8-4a99-8517-9f65943bdc3b_terseLabel_en-US" xlink:label="lab_cutr_SiliconValleyBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Silicon Valley Bank</link:label>
    <link:label id="lab_cutr_SiliconValleyBankMember_label_en-US" xlink:label="lab_cutr_SiliconValleyBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Silicon Valley Bank [Member]</link:label>
    <link:label id="lab_cutr_SiliconValleyBankMember_documentation_en-US" xlink:label="lab_cutr_SiliconValleyBankMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information related to Silicon Valley Bank.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SiliconValleyBankMember" xlink:href="cutr-20210630.xsd#cutr_SiliconValleyBankMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_SiliconValleyBankMember" xlink:to="lab_cutr_SiliconValleyBankMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_4d504ca0-935b-46ff-abdf-af5254b9921f_terseLabel_en-US" xlink:label="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_label_en-US" xlink:label="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four</link:label>
    <link:label id="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_documentation_en-US" xlink:label="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of lessee's undiscounted obligation for lease payment for operating lease due after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:href="cutr-20210630.xsd#cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:to="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_03c8e283-c28d-425c-ba39-d88161365bb8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_e356d768-2fb8-4d9e-a74f-fa18e2c0c9c3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_53e018dd-d1b2-447c-828c-bdf028bd1e3f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2f9736e5-d26b-4821-a809-c0ea642f2dd4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options canceled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_e763160b-50ca-46cf-beba-ea703fff2e70_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options canceled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_dd40c90e-6812-403d-862a-5a7d4c595a1e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_b566edcb-f0ee-4e7f-bb9c-a30f99ea63d9_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_f11e7a48-b3fa-446e-aa7b-e813dc30bd88_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_a0d53fbe-a6ed-45d6-b41c-93fe4d37aba9_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_bbc563a8-8a4e-4a9b-a44a-2b2198d68a4f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Tranche</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_7ce50da8-24a9-490d-90ad-2c0a9219ae79_terseLabel_en-US" xlink:label="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_label_en-US" xlink:label="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_documentation_en-US" xlink:label="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets, excluding contract acquisition costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" xlink:href="cutr-20210630.xsd#cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" xlink:to="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_OperatingLeaseLiabilitiesLesseeAbstract_72ec7ad7-2061-40f9-aa30-963cd164ed3d_terseLabel_en-US" xlink:label="lab_cutr_OperatingLeaseLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_cutr_OperatingLeaseLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_cutr_OperatingLeaseLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_cutr_OperatingLeaseLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_cutr_OperatingLeaseLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liabilities, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OperatingLeaseLiabilitiesLesseeAbstract" xlink:href="cutr-20210630.xsd#cutr_OperatingLeaseLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_OperatingLeaseLiabilitiesLesseeAbstract" xlink:to="lab_cutr_OperatingLeaseLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_c9503bdd-6a02-4704-9b5c-f8a944e69438_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value (in Millions)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_0268d983-e1f5-43a6-a1c4-c9b355bad3a8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:to="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays_e222cd5a-8bfc-46e9-972b-2c32eaf74d5f_terseLabel_en-US" xlink:label="lab_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption threshold consecutive trading days</link:label>
    <link:label id="lab_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays_label_en-US" xlink:label="lab_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redeemable, Threshold Consecutive Trading Days</link:label>
    <link:label id="lab_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays_documentation_en-US" xlink:label="lab_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redeemable, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays" xlink:to="lab_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_d5f926b3-e2c7-400c-bc69-26bec2291a6e_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortization" xlink:to="lab_us-gaap_CapitalizedContractCostAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_d92b6be5-6215-4236-af5a-b6cd368bd0f8_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_26b894a7-8ce8-4eeb-a90f-e3736feb9347_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt, conversion ratio</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_67ce479e-5397-4609-9816-ac1d0c4c9f48_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_54da7a87-075f-472d-954d-fcb5c72de412_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_88e49a95-8d1d-4460-9d8f-108dba3d8dea_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_26e3cd96-e1a1-4918-b37a-08bd238329e5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_36aad3f5-d7cc-4445-882d-d6e4a0b1bf3a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityPeriodDecrease_b63696b2-53ea-471a-adab-f4e14290c665_negatedLabel_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityPeriodDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Revenue</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityPeriodDecrease_label_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityPeriodDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Period Decrease</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityPeriodDecrease_documentation_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityPeriodDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of decrease in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from revenue deferred.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityPeriodDecrease" xlink:href="cutr-20210630.xsd#cutr_ContractWithCustomerLiabilityPeriodDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ContractWithCustomerLiabilityPeriodDecrease" xlink:to="lab_cutr_ContractWithCustomerLiabilityPeriodDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReduction_2ad25d1c-7c44-448d-b6c7-e90d87a73bce_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReduction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on extinguishment of PPP loan</link:label>
    <link:label id="lab_us-gaap_NotesReduction_label_en-US" xlink:label="lab_us-gaap_NotesReduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReduction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReduction" xlink:to="lab_us-gaap_NotesReduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_1f266adc-b9d0-47d3-9c34-ac177e69d839_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod_dcf357c4-6c8f-4b4f-a37a-ec7f466e4e99_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Exercises In Period</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Exercises In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod" xlink:href="cutr-20210630.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_25022a87-8ff6-4bfe-82bf-c6b34c497460_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_7325b901-f852-4c7f-8ff3-2ec4da3525e3_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_8943bf55-0dd8-434c-9080-4e1f4ed0dcf7_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_40732d46-6daf-46f4-a3a1-8c30c4308b0e_terseLabel_en-US" xlink:label="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required outstanding amount not subject to redemption</link:label>
    <link:label id="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_label_en-US" xlink:label="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible Required, Outstanding Amount Not Subject To Redemption</link:label>
    <link:label id="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_documentation_en-US" xlink:label="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of required outstanding amount not subject to redemption of a convertible debt instrument.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" xlink:to="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_5c576415-60c1-4578-98ec-02efa1d1adb1_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, net of unamortized debt issuance costs of $4,450</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AmortizationOfDebtIssuanceCostsNetOfTax_d5f9f602-2c8d-4563-ac1f-f081a7ae9866_terseLabel_en-US" xlink:label="lab_cutr_AmortizationOfDebtIssuanceCostsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance cost, net of tax</link:label>
    <link:label id="lab_cutr_AmortizationOfDebtIssuanceCostsNetOfTax_label_en-US" xlink:label="lab_cutr_AmortizationOfDebtIssuanceCostsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Debt Issuance Costs, Net Of Tax</link:label>
    <link:label id="lab_cutr_AmortizationOfDebtIssuanceCostsNetOfTax_documentation_en-US" xlink:label="lab_cutr_AmortizationOfDebtIssuanceCostsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Debt Issuance Costs, Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AmortizationOfDebtIssuanceCostsNetOfTax" xlink:href="cutr-20210630.xsd#cutr_AmortizationOfDebtIssuanceCostsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AmortizationOfDebtIssuanceCostsNetOfTax" xlink:to="lab_cutr_AmortizationOfDebtIssuanceCostsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_cd04701c-80b3-4410-8173-e0d4fc63f5c4_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward_1f7fd35c-f0ab-4ea9-93ea-e35097edbfb6_terseLabel_en-US" xlink:label="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward" xlink:href="cutr-20210630.xsd#cutr_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward" xlink:to="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be8bd5cc-b71b-4263-a9fb-dc40ceee164d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_22fff701-396a-4612-b25f-cc477263c05f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_134f50b8-a0f2-4fa9-bdec-3dd7110f750e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_043c260d-b6e9-4102-a77a-18d57fea137a_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization Period</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:to="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_94af05bb-9787-4ef9-a8a4-e3691220832c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from equity offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_1366e80a-2ba6-450f-84f9-c1832fced8c6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Occurrence of Fundamental Change</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_d76f1b52-4e49-4f47-87ed-033428df48a6_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3217cbdf-b890-4c4f-a861-935888c199c5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of Basic and Diluted Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfAcquisitionCosts_0600dc79-c175-418a-b724-f39a469879b5_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of contract acquisition costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfAcquisitionCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Acquisition Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfAcquisitionCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfAcquisitionCosts" xlink:to="lab_us-gaap_AmortizationOfAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_b8833bba-4c19-4f08-b6b2-5f45267be1c5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_62dd8394-73ef-4d91-b73e-343670b64851_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_cdd184f2-e661-4dc4-87b3-f9de1a8cd1df_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_f75f1c6a-c82b-4f71-9b38-29b0143565a5_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_0a6855a8-f193-4216-970c-a6ae78070cf9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyLiabilityLineItems_7deb9d57-cb97-4c51-840f-8243540f3da1_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Liability [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyLiabilityLineItems_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Liability [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyLiabilityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyLiabilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems" xlink:to="lab_us-gaap_ProductWarrantyLiabilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyAccrualPayments_f10316de-23ff-44cd-8b8d-50e86e02d534_terseLabel_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended service contracts charge</link:label>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyAccrualPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtendedProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtendedProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_ExtendedProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_bc77e13d-0887-495b-83f2-5737b3d4a890_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Details</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_edf1beae-bdba-4936-b26c-22d8f1b675a8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_474dddb8-24d3-4a62-a92b-60b4a7f03e9b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_b96573fa-8ebe-44cd-ba35-b34aaa749d70_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026Member_b4b68a85-af8c-4d62-b10d-1dd229dd69c3_terseLabel_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2026</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026Member_label_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2026 [Member]</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026Member_documentation_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to convertible senior notes due 2026.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member" xlink:href="cutr-20210630.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ConvertibleSeniorNotesDue2026Member" xlink:to="lab_cutr_ConvertibleSeniorNotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_51d37d38-34e2-4818-b287-35a10a6be423_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_0d21eaf9-089c-4850-b028-90540d9a3b7d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases renewal terms (up to)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_RestOfWorldMember_965591ae-50a9-42d0-8f18-cf86c4bcceac_terseLabel_en-US" xlink:label="lab_cutr_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of the World, other than United States, Asia and Europe</link:label>
    <link:label id="lab_cutr_RestOfWorldMember_label_en-US" xlink:label="lab_cutr_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestOfWorldMember" xlink:href="cutr-20210630.xsd#cutr_RestOfWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_RestOfWorldMember" xlink:to="lab_cutr_RestOfWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_7622dcfd-bbe8-45ff-94f4-7c7dec39b087_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ConsumablesMember_623bb198-afb7-4bd0-9237-58d39618b4cd_terseLabel_en-US" xlink:label="lab_cutr_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables</link:label>
    <link:label id="lab_cutr_ConsumablesMember_label_en-US" xlink:label="lab_cutr_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:label id="lab_cutr_ConsumablesMember_documentation_en-US" xlink:label="lab_cutr_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to consumables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConsumablesMember" xlink:href="cutr-20210630.xsd#cutr_ConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ConsumablesMember" xlink:to="lab_cutr_ConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_e7afa723-c524-47fa-8658-69dc1adbf18c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_80cec7ce-0d45-4e3b-8303-a532896a9c81_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_c43681ba-3ada-42e3-80e6-99c1350e513a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan shares</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtInstrumentRedeemableThresholdTradingDays_c31d8da5-e8e0-4aa0-94ca-826df4615a8e_terseLabel_en-US" xlink:label="lab_cutr_DebtInstrumentRedeemableThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption threshold trading days</link:label>
    <link:label id="lab_cutr_DebtInstrumentRedeemableThresholdTradingDays_label_en-US" xlink:label="lab_cutr_DebtInstrumentRedeemableThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redeemable, Threshold Trading Days</link:label>
    <link:label id="lab_cutr_DebtInstrumentRedeemableThresholdTradingDays_documentation_en-US" xlink:label="lab_cutr_DebtInstrumentRedeemableThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redeemable, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedeemableThresholdTradingDays" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentRedeemableThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtInstrumentRedeemableThresholdTradingDays" xlink:to="lab_cutr_DebtInstrumentRedeemableThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_de769afd-aa10-429f-ae25-8d778b0e74bf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a2a53795-4c3b-418f-8789-1acb219f618b_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss, current</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_6e7ba29f-2252-4fbf-b8f1-a7c42157daec_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_8dccc9be-4e1c-42f1-9d76-e47e6de8915d_verboseLabel_en-US" xlink:label="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_label_en-US" xlink:label="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">cutr_IncreaseDecreaseInOperatingLeaseLiabilities</link:label>
    <link:label id="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of increase (decrease) in operating lease liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="cutr-20210630.xsd#cutr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_ee9b9b86-081d-4389-bf4a-f790d5e150fc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9f35788f-38c6-47f7-8b27-1a019958a9d2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_072a8ede-d7a5-4713-86ba-b3672e6c0886_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent_09d95b0f-ef06-4aeb-9e15-aeee7415d430_terseLabel_en-US" xlink:label="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium over stock price (percent)</link:label>
    <link:label id="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent_label_en-US" xlink:label="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Cap Price, Premium Over Stock Price, Percent</link:label>
    <link:label id="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent_documentation_en-US" xlink:label="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percent premium over the stock price for derivative caps.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DerivativeCapPricePremiumOverStockPricePercent" xlink:href="cutr-20210630.xsd#cutr_DerivativeCapPricePremiumOverStockPricePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DerivativeCapPricePremiumOverStockPricePercent" xlink:to="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_e84caaa2-6b8e-4690-b4ba-92404ef90513_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Revenue by Geography</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_fb2ee74a-4ae7-45d6-a675-b7167bda11e6_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Lease Costs</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExecutiveOfficersAndSeniorManagementMember_9611ca38-e003-4254-8929-c48c8bfcf68f_terseLabel_en-US" xlink:label="lab_cutr_ExecutiveOfficersAndSeniorManagementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Officers And Senior Management</link:label>
    <link:label id="lab_cutr_ExecutiveOfficersAndSeniorManagementMember_label_en-US" xlink:label="lab_cutr_ExecutiveOfficersAndSeniorManagementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Officers And Senior Management [Member]</link:label>
    <link:label id="lab_cutr_ExecutiveOfficersAndSeniorManagementMember_documentation_en-US" xlink:label="lab_cutr_ExecutiveOfficersAndSeniorManagementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Officers And Senior Management</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExecutiveOfficersAndSeniorManagementMember" xlink:href="cutr-20210630.xsd#cutr_ExecutiveOfficersAndSeniorManagementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExecutiveOfficersAndSeniorManagementMember" xlink:to="lab_cutr_ExecutiveOfficersAndSeniorManagementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_0b9e126c-783a-4407-ba8b-2a5b34362fe7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fc1962bd-7161-4f72-bdb3-64fc463db342_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_fc1a459d-c865-43cb-882f-44709588b33f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_6805e184-d9f3-4c99-9f4d-7798be3b92b1_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_a4df1506-1e4e-4ec2-ac19-4b40b7585af7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion threshold percentage of stock price trigger</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_ccdf5e0d-ce01-4a3e-b766-e24255ef6d79_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_1ddc452f-62b4-449b-bbee-46a3e1e6a2eb_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with public offering, net of offering cost of $2,303</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_d1164e27-2c9a-458c-8818-e9b874764f09_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in settlement of restricted and performance stock unites, net of shares withheld for employee taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_343d8564-85a8-424c-9f49-d2ed309344dc_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flow, Finance lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_91d776cb-b07a-4ddc-b5db-650782293ac8_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_8f9af12f-4ddc-4317-95a5-35a0511c3e28_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on convertible notes</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_25895811-0782-49f7-931f-ca129d63f336_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on Convertible notes</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_975494e9-f874-417c-9c7a-8c3960400158_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_160390fc-d33f-4952-a823-81db79afd41d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_fca82a91-2e05-4338-843f-62ce798bc8fd_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_6333e4cd-aa77-4bd3-876b-6b82d3fd5a87_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_3bcc9055-7324-4686-a0f5-fcd95f3fb995_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_021a89b0-645e-4224-bda1-645c7f6dd532_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorLeaseDescriptionTable_21068df9-31bc-4eee-a775-22b7f0604df1_terseLabel_en-US" xlink:label="lab_us-gaap_LessorLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LessorLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LessorLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable" xlink:to="lab_us-gaap_LessorLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_260383f7-2c41-44b0-9b4c-94eed5da91ea_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesOfLessorDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:to="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_2c45550e-ce07-4c9e-a71d-4b75b5152c58_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_7d52f5d3-185d-41ea-91bc-671e0a6e0c7f_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CEO</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_7ae0a72e-d936-4bf7-b57c-8ae8c1f82f2f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Minimum Finance Lease Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_e5f8a404-3a05-45e6-8d98-bd96e3235c3b_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_2479d6aa-7358-4961-983d-97c7ec4827a9_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_65ee62d6-ec05-4300-9645-f47cc53ed91b_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_434c1b01-0756-4ea1-b68d-45d16a7270f5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated weighted-average remaining amortization period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ebec629f-56e7-4091-a9f3-b6f0304f3d24_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AmendedAndRestated2004EquityIncentivePlanMember_565307f1-a50b-425b-8ddc-eeaeedb20d87_terseLabel_en-US" xlink:label="lab_cutr_AmendedAndRestated2004EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Plan</link:label>
    <link:label id="lab_cutr_AmendedAndRestated2004EquityIncentivePlanMember_label_en-US" xlink:label="lab_cutr_AmendedAndRestated2004EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended And Restated 2004 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_cutr_AmendedAndRestated2004EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_cutr_AmendedAndRestated2004EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended And Restated 2004 Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AmendedAndRestated2004EquityIncentivePlanMember" xlink:href="cutr-20210630.xsd#cutr_AmendedAndRestated2004EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AmendedAndRestated2004EquityIncentivePlanMember" xlink:to="lab_cutr_AmendedAndRestated2004EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtCurrent_1829d4e0-59a9-4026-9a70-6ce95b83ac20_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP loan payable</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtCurrent_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtCurrent" xlink:to="lab_us-gaap_UnsecuredDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a9c6b04b-e3c0-4d05-8960-a64d26876f5b_negatedLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Revenue included in the beginning balance and recognized as revenue in the current quarter</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_39a0cd81-2d87-461d-b46c-5867330a759b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) used in calculating net income (loss) per share, basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_a73c6101-c181-4e02-b29c-51323b3add53_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_80d154a2-af66-4330-83dc-0d9bf83b0973_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_be6c2ae1-d46f-4939-8ecd-5db0ba6638ec_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_53f941fa-4bc1-4cb7-9cec-9333cb658aed_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, net of current portion</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueNoncurrent" xlink:to="lab_us-gaap_DeferredRevenueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_21ca43f2-6acb-412b-8c18-35a327697b36_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_94b18bbd-87de-46ca-a623-e280b67fc9a4_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_dd34c078-b708-4f4d-b130-46a746f22271_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_c73b3c9a-66c5-455b-9437-b2cffcc8749a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_d0655940-b284-44b0-941d-e6f7e24af7cb_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_238505d0-b5d1-4b7d-a084-6d8e7675c0d7_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_b084dcc9-65a6-4763-a90d-3971c6452613_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_5622a537-9d74-4868-acd8-286bfe284e6c_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_country_JP_eac7143f-ff57-4efd-ab12-71e325c418eb_terseLabel_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan</link:label>
    <link:label id="lab_country_JP_label_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JAPAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_JP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_JP" xlink:to="lab_country_JP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_f48aa0b4-490c-4558-b214-198d3f8fb1ad_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_632c2632-706e-4955-8ef3-b208a6025ffb_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_fce447f7-8137-4006-a27a-2edd172be099_terseLabel_en-US" xlink:label="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental repurchase amount</link:label>
    <link:label id="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_label_en-US" xlink:label="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Incremental Repurchase Amount</link:label>
    <link:label id="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_documentation_en-US" xlink:label="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Incremental Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" xlink:to="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_a40bcb90-9696-449b-a528-f0f807d2d6c7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost, Interest for finance lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_c9c7631f-1eb0-4c4c-9275-c2e691c53024_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_f7c57c8a-db31-4f90-ae50-5c3d49feaf91_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_cbfb1081-0186-4dc0-b245-5606f17524c2_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_fc535e12-ae91-49da-ab3d-2aa05f65fea3_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_650d00d4-4de0-4bb0-95e3-7d2fe9d0838a_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt at fair value</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_62560c83-b649-4315-835a-d830264812d7_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_ee90089b-e30f-4784-8db7-aaaeeb418609_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type lease receivable</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_1672b1ab-7680-4324-be76-bb776c3203e6_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_dc7c8411-86d5-4fbf-a695-4eb06f710409_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_51b460f2-7e36-484d-a786-63a65cbc8c9e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_c90ea74c-44c2-491c-8223-860afce36ca6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ff6f404c-7484-4a0d-ab2b-e8768e4a7a00_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of share-based payment arrangements (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_4edf492a-cf73-4c2a-9b5b-8932d2d9fc2e_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard product warranty accrual</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_a7869472-48b7-491e-a283-f38fbcafd162_periodStartLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_46b59648-115e-4df1-a73f-15170f98189e_periodEndLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_76aedfbf-b8ad-4140-851a-0a877b0dbb37_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets Held-for-use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_a1dde0c0-7709-4416-bf5e-606cef3f6d44_terseLabel_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense on Convertible notes, net of tax</link:label>
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_label_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on Convertible Debt, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:to="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_a207643e-5e32-4ca9-bf0d-a86bd1450417_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, excluding amortization</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_7d124017-4b83-4ad7-95f6-4a5f40e97dea_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_67605d9b-ef80-4082-b52a-d69934eaf128_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_c4acf6f5-d1e5-4df7-93f1-9725790b0b51_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_3873f597-d1f5-42f5-818a-4f1a9b423b98_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4dc7736a-c8f0-4df3-a3f0-357f144747f1_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets and prepaid expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_2bf3e9c3-c571-4077-91b3-f403f84613c0_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Accruals for warranties issued during the period</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork_83dc2865-f2f7-424f-b0de-7190a462c098_terseLabel_en-US" xlink:label="lab_cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of countries in which entity utilizes a distributor network</link:label>
    <link:label id="lab_cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork_label_en-US" xlink:label="lab_cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Countries In Which Entity Utilizes A Distributor Network</link:label>
    <link:label id="lab_cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork_documentation_en-US" xlink:label="lab_cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Countries In Which Entity Utilizes A Distributor Network</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork" xlink:href="cutr-20210630.xsd#cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork" xlink:to="lab_cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_CostsForExtendedServiceContracts_72bb3d07-6462-4c61-acba-6494d5dc91c6_terseLabel_en-US" xlink:label="lab_cutr_CostsForExtendedServiceContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs for Extended Service Contracts</link:label>
    <link:label id="lab_cutr_CostsForExtendedServiceContracts_label_en-US" xlink:label="lab_cutr_CostsForExtendedServiceContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs For Extended Service Contracts</link:label>
    <link:label id="lab_cutr_CostsForExtendedServiceContracts_documentation_en-US" xlink:label="lab_cutr_CostsForExtendedServiceContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of costs for extended service contracts during period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CostsForExtendedServiceContracts" xlink:href="cutr-20210630.xsd#cutr_CostsForExtendedServiceContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_CostsForExtendedServiceContracts" xlink:to="lab_cutr_CostsForExtendedServiceContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_9fb76878-0632-4141-916d-67bcd11f79ee_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0203f5ba-1e9e-4a20-a31b-822cc52e7b7d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_406fea5b-81b2-406a-b658-ed5f2c24b89c_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_c79c0f80-56e9-47d4-8b3a-dcbcd162e773_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_bda1aaa9-433d-4567-a784-eaba1b77a8b2_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_bbcb87e1-3e17-4466-bca3-30eaf0d3d636_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_PaycheckProtectionProgramCARESActMember_80ef9355-6a2c-418f-984a-858447683fd3_terseLabel_en-US" xlink:label="lab_cutr_PaycheckProtectionProgramCARESActMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP Loan</link:label>
    <link:label id="lab_cutr_PaycheckProtectionProgramCARESActMember_label_en-US" xlink:label="lab_cutr_PaycheckProtectionProgramCARESActMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program CARES Act [Member]</link:label>
    <link:label id="lab_cutr_PaycheckProtectionProgramCARESActMember_documentation_en-US" xlink:label="lab_cutr_PaycheckProtectionProgramCARESActMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents loan designed to provide funds for small businesses to keep their employees on the payroll.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PaycheckProtectionProgramCARESActMember" xlink:href="cutr-20210630.xsd#cutr_PaycheckProtectionProgramCARESActMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_PaycheckProtectionProgramCARESActMember" xlink:to="lab_cutr_PaycheckProtectionProgramCARESActMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_NonEmployeeDirectorsMember_3aabf7fc-93b0-45af-be37-94dd08dc6dba_terseLabel_en-US" xlink:label="lab_cutr_NonEmployeeDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Employee Directors</link:label>
    <link:label id="lab_cutr_NonEmployeeDirectorsMember_label_en-US" xlink:label="lab_cutr_NonEmployeeDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Employee Directors [Member]</link:label>
    <link:label id="lab_cutr_NonEmployeeDirectorsMember_documentation_en-US" xlink:label="lab_cutr_NonEmployeeDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Employee Directors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NonEmployeeDirectorsMember" xlink:href="cutr-20210630.xsd#cutr_NonEmployeeDirectorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_NonEmployeeDirectorsMember" xlink:to="lab_cutr_NonEmployeeDirectorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_9e918e21-3eb5-4716-b864-1ac7f441d4a2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_ba37513f-3122-4fe1-beea-18bec6ea06d3_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized contract costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostNet" xlink:to="lab_us-gaap_CapitalizedContractCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_36c50097-2192-47a6-97f3-9a5e84a3af03_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of property, equipment, and software</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_7f3b8456-0f6a-436b-99b7-78772dfeec9a_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_2f960bbd-d2cf-48fd-aa44-2f724360c755_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f48588d5-8167-4146-a353-eddbf8763d39_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_e6e25e43-a01d-4907-b314-4a8e5c609aff_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue balance, percentage</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrent_c0bcfd1a-8438-451a-96c3-adeacf4c5a51_terseLabel_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued sales tax</link:label>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrent_label_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and Excise Tax Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b76a09ad-e4e3-41e6-88eb-39ad1eb6c7fb_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_265e4984-2b96-4373-9d66-00938027b9e4_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:to="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_2c8723fc-0273-4995-8eea-10539703b745_terseLabel_en-US" xlink:label="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualifying accounts receivable</link:label>
    <link:label id="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_label_en-US" xlink:label="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Percentage Of Qualifying Accounts Receivable</link:label>
    <link:label id="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_documentation_en-US" xlink:label="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents percentage of qualifying accounts receivable for debt instrument.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" xlink:to="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_3168473f-bc88-4495-8c36-5c2ffa85147b_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LoyaltyMember_9f0e6373-a110-4428-926f-d25a84775307_terseLabel_en-US" xlink:label="lab_cutr_LoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loyalty</link:label>
    <link:label id="lab_cutr_LoyaltyMember_label_en-US" xlink:label="lab_cutr_LoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loyalty [Member]</link:label>
    <link:label id="lab_cutr_LoyaltyMember_documentation_en-US" xlink:label="lab_cutr_LoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information related to loyalty</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LoyaltyMember" xlink:href="cutr-20210630.xsd#cutr_LoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LoyaltyMember" xlink:to="lab_cutr_LoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_6776e619-0729-4796-a445-7fe6a03e824f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantiesDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:to="lab_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyAccrual_72b77507-7b79-4f10-abf6-db618ba76df7_terseLabel_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended product warranty accrual</link:label>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyAccrual" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtendedProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtendedProductWarrantyAccrual" xlink:to="lab_us-gaap_ExtendedProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_aa7cc5e5-088c-4972-9e53-c9c55a0fc871_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_eb46c17c-596e-4e17-9ef9-dbf0f010850e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_dc9aed08-5e3e-4455-9144-bdd4ebed8e7b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LoanAndSecurityAgreementMember_283fc292-2c3e-401b-b773-23241ec506df_terseLabel_en-US" xlink:label="lab_cutr_LoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan and Security Agreement</link:label>
    <link:label id="lab_cutr_LoanAndSecurityAgreementMember_label_en-US" xlink:label="lab_cutr_LoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan and Security Agreement [Member]</link:label>
    <link:label id="lab_cutr_LoanAndSecurityAgreementMember_documentation_en-US" xlink:label="lab_cutr_LoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information pertaining to the Loan and Security Agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LoanAndSecurityAgreementMember" xlink:href="cutr-20210630.xsd#cutr_LoanAndSecurityAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LoanAndSecurityAgreementMember" xlink:to="lab_cutr_LoanAndSecurityAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember_75f14bb9-c1fa-4121-963b-fb37ce262bf3_terseLabel_en-US" xlink:label="lab_cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Officers, Senior Management, and Certain Employees</link:label>
    <link:label id="lab_cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember_label_en-US" xlink:label="lab_cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Officers, Senior Management, And Certain Employees [Member]</link:label>
    <link:label id="lab_cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember_documentation_en-US" xlink:label="lab_cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Officers, Senior Management, And Certain Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember" xlink:href="cutr-20210630.xsd#cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember" xlink:to="lab_cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_3eef527d-b6dc-4759-b784-a4125516ab11_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_4b49dda4-e452-4c90-95df-4de3774e68b0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_063b2e11-cba2-4d57-b589-066d8bec77ea_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_70cf2db5-1777-4763-985d-97023d62d8cb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_9da14671-3726-4e36-a49c-86b5853fb2ac_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt convertible to common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Number of Equity Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:to="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_dcba8704-9f15-4e8c-820a-40578f8c3788_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_01050b9d-619f-436c-93e6-3b781c6760cd_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustment for losses on investments recognized during the period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_08304898-a11b-49e7-aedc-e6896456e27e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_3307dfb6-b188-4071-a95c-2dd9509093c4_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs incurred related to product warranty and extended warranty liability</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_664fdf0e-0195-4e36-80ab-390517ed5f9a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_dde92f06-9286-41fe-b693-2ee7077a002a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_784f2e9b-a079-42d3-972d-d38c4236d4e0_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_6e5a146d-aab3-45f7-a0d5-92fec589db11_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0f15cb56-67f6-45dc-a24f-81c74e6a5c0f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_f2462020-5642-4295-8820-1c4eb65ca18b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_c9690d08-50be-4464-b965-8b59f082f212_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_e366f8b1-4a48-46c6-b931-f20445e10ecd_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2d6fc1f3-3a6c-4d4d-8f63-ef52dba32564_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets acquired under finance lease</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved_2973650e-0999-4995-8509-a33d548f5974_verboseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional shares reserved (in shares)</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment, Shares Available For Grant, Additional Shares Reserved</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment, Shares Available For Grant, Additional Shares Reserved</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved" xlink:href="cutr-20210630.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_43937cb8-3362-4563-a3dc-651e4a999c0a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards canceled / forfeited / expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyAccrualCurrent_ab844b11-8ba4-4a29-932f-99f778fb492d_terseLabel_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended warranty liability</link:label>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyAccrualCurrent_label_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Product Warranty Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyAccrualCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtendedProductWarrantyAccrualCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtendedProductWarrantyAccrualCurrent" xlink:to="lab_us-gaap_ExtendedProductWarrantyAccrualCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_4544e3aa-abd6-4c45-9171-22a526a0adde_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalariesCurrent" xlink:to="lab_us-gaap_AccruedSalariesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_64ae330e-c5ee-40ef-a070-63b027f9d3cb_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_4d2c17f5-3bb1-4331-bf6e-52f4d14190cb_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0de3bbe4-9d2c-4412-89b3-ff38f2810f26_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_cdf6aa9a-3d3e-4684-b759-cd3c76c4f041_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_12bf79d8-3458-4398-9921-3342536723ae_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9de87da1-ff86-4e35-83df-bf64c452118a_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtCovenantQuarterlyMinimumRevenue_87db768f-d5e5-40b2-a3ce-435ff3c6ffc2_terseLabel_en-US" xlink:label="lab_cutr_DebtCovenantQuarterlyMinimumRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly minimum revenue</link:label>
    <link:label id="lab_cutr_DebtCovenantQuarterlyMinimumRevenue_label_en-US" xlink:label="lab_cutr_DebtCovenantQuarterlyMinimumRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Quarterly Minimum Revenue</link:label>
    <link:label id="lab_cutr_DebtCovenantQuarterlyMinimumRevenue_documentation_en-US" xlink:label="lab_cutr_DebtCovenantQuarterlyMinimumRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents quarterly minimum revenue under debt covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtCovenantQuarterlyMinimumRevenue" xlink:href="cutr-20210630.xsd#cutr_DebtCovenantQuarterlyMinimumRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtCovenantQuarterlyMinimumRevenue" xlink:to="lab_cutr_DebtCovenantQuarterlyMinimumRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_84789579-cfe4-4661-8e68-3821b4de4127_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Activity under the 2019 Plan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_58e87f02-30b8-4f95-8a60-8693bc0f2346_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities of marketable investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_f84da9f1-878b-4d81-a68a-e63218272177_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_4f17d2b0-d429-47c8-9d1a-71f9b8f2e406_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1_d3f417ec-f1ba-493f-afdb-b77e59af9cf7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases renewal terms (up to)</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:to="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_521686ef-e6fd-4919-afe2-b95d2ff1764c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_4223c418-0b59-4c13-a009-4554e47f157d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_78e4c032-1712-4358-9f19-c671f2ad53e0_terseLabel_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2026, Second Conversion Trigger</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_label_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2026, Second Conversion Trigger [Member]</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_documentation_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to the second conversion trigger feature of debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" xlink:href="cutr-20210630.xsd#cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" xlink:to="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_4c9adc9a-be03-44ee-ac73-1e3081ee658d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_fba6b3cb-8c6f-48ff-bb18-8e3fc3fe0569_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Awards Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityTextBlock_02d0562c-a60a-40e1-b68d-f325f3001dbf_terseLabel_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityTextBlock_label_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer Liability [Text Block]</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityTextBlock_documentation_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure of contract with customer liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityTextBlock" xlink:href="cutr-20210630.xsd#cutr_ContractWithCustomerLiabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ContractWithCustomerLiabilityTextBlock" xlink:to="lab_cutr_ContractWithCustomerLiabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_61ddc7ec-357b-481e-a43d-b730e75c4535_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_bcfd189c-f100-456b-9bdf-9c8e64293cf7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_ee2f1434-f665-481e-80cf-8279d51f92a6_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product warranty accrual, Increase for warranties issued, total</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_d808c7ba-04ed-4a39-a94e-330eb8094947_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_9293e494-aaed-4d6f-b85d-3d2d72a83935_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_78857966-59e4-441f-8c57-1db9dcccb654_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $1,639 and $1,598, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3548ae3c-7bc5-48e7-9d5f-222925d9f26b_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_68d93616-d4a1-4a7a-b772-caa13a095f17_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_17bfa007-6b11-4c1c-96f0-3bdd021d3359_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from equipment leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_28171a1b-6ecf-4714-8d77-68469060e6b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_222659d2-6d71-420a-90b4-4d242a03c3b6_terseLabel_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2026, First Conversion Trigger</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_label_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2026, First Conversion Trigger [Member]</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_documentation_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to the first conversion trigger of debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" xlink:href="cutr-20210630.xsd#cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" xlink:to="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_7be7b957-e35c-4e37-8750-fc7a350a7ad0_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_18dd8cf5-24dd-4aae-b672-15679a494b17_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_FinanceLeaseLiabilitiesLesseeAbstract_bc8eeb6a-832c-43f5-8806-e28d07056fe8_terseLabel_en-US" xlink:label="lab_cutr_FinanceLeaseLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities</link:label>
    <link:label id="lab_cutr_FinanceLeaseLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_cutr_FinanceLeaseLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_cutr_FinanceLeaseLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_cutr_FinanceLeaseLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liabilities, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_FinanceLeaseLiabilitiesLesseeAbstract" xlink:href="cutr-20210630.xsd#cutr_FinanceLeaseLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_FinanceLeaseLiabilitiesLesseeAbstract" xlink:to="lab_cutr_FinanceLeaseLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_ac401b08-7879-4c6e-bfdb-63ded1b79f9f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease terms of operating leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_eb04bffc-a196-4bb9-b959-21006a35b27b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_30b453b8-2c94-4c22-a889-5cf67a5d412a_terseLabel_en-US" xlink:label="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in right-of-use assets</link:label>
    <link:label id="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_label_en-US" xlink:label="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in right-of-use asset</link:label>
    <link:label id="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_documentation_en-US" xlink:label="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the change in right-of-use asset and liability due to modification during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" xlink:href="cutr-20210630.xsd#cutr_ChangeInRightofuseAssetAndLiabilityDueToModification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" xlink:to="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExtendedServiceContractOptionOneTerm_dfca50f7-e79f-4398-a9b7-d511d1dc33f2_terseLabel_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionOneTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended service contract, option one, term</link:label>
    <link:label id="lab_cutr_ExtendedServiceContractOptionOneTerm_label_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionOneTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Service Contract, Option One, Term</link:label>
    <link:label id="lab_cutr_ExtendedServiceContractOptionOneTerm_documentation_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionOneTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Service Contract, Option One, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionOneTerm" xlink:href="cutr-20210630.xsd#cutr_ExtendedServiceContractOptionOneTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExtendedServiceContractOptionOneTerm" xlink:to="lab_cutr_ExtendedServiceContractOptionOneTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_eec0fd82-4d85-4b70-b9cb-bde2e19ca37c_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedPaymentArrangementTrancheFourMember_98f1ddbd-0cc1-40ff-8856-b0e10d34bb39_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedPaymentArrangementTrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Tranche</link:label>
    <link:label id="lab_cutr_ShareBasedPaymentArrangementTrancheFourMember_label_en-US" xlink:label="lab_cutr_ShareBasedPaymentArrangementTrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Four [Member]</link:label>
    <link:label id="lab_cutr_ShareBasedPaymentArrangementTrancheFourMember_documentation_en-US" xlink:label="lab_cutr_ShareBasedPaymentArrangementTrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedPaymentArrangementTrancheFourMember" xlink:href="cutr-20210630.xsd#cutr_ShareBasedPaymentArrangementTrancheFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedPaymentArrangementTrancheFourMember" xlink:to="lab_cutr_ShareBasedPaymentArrangementTrancheFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0d01a1ca-7e66-49a1-a346-d683e2664b28_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive gain, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_785941d3-4e1e-4484-ac10-6d989147022b_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_627b908a-701d-4906-8bbe-544f8ddc72be_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_1cbbdca8-ee9c-4d48-b9b3-ec5fdf7310a1_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AccruedInventoryInTransitCurrent_72b9daaf-ec8d-4601-b212-8568179b6937_terseLabel_en-US" xlink:label="lab_cutr_AccruedInventoryInTransitCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued inventory in transit</link:label>
    <link:label id="lab_cutr_AccruedInventoryInTransitCurrent_label_en-US" xlink:label="lab_cutr_AccruedInventoryInTransitCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory In Transit, Current</link:label>
    <link:label id="lab_cutr_AccruedInventoryInTransitCurrent_documentation_en-US" xlink:label="lab_cutr_AccruedInventoryInTransitCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents current accrued inventory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AccruedInventoryInTransitCurrent" xlink:href="cutr-20210630.xsd#cutr_AccruedInventoryInTransitCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AccruedInventoryInTransitCurrent" xlink:to="lab_cutr_AccruedInventoryInTransitCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_236a741f-2c94-407e-ad47-a47d6799d891_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_333d25e3-b07a-4b95-9845-744b8da167ca_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes issued</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_ed30be31-4cb2-4646-b261-738996dfed2e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ProductRemediationLiabilityMember_1e6e9a79-a994-4921-8160-526ac789358d_terseLabel_en-US" xlink:label="lab_cutr_ProductRemediationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation Liability</link:label>
    <link:label id="lab_cutr_ProductRemediationLiabilityMember_label_en-US" xlink:label="lab_cutr_ProductRemediationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Remediation Liability [Member]</link:label>
    <link:label id="lab_cutr_ProductRemediationLiabilityMember_documentation_en-US" xlink:label="lab_cutr_ProductRemediationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to product remediation liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ProductRemediationLiabilityMember" xlink:href="cutr-20210630.xsd#cutr_ProductRemediationLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ProductRemediationLiabilityMember" xlink:to="lab_cutr_ProductRemediationLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_92a57d9d-94cb-4b2a-a268-ae1f4db81171_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_3ece459b-cda0-455e-8ce1-53e86dbde352_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_0abc51fe-f39d-4a0f-b277-072207915cf9_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_e7da637a-682e-4231-b900-aee6f6ca9472_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase&#160;of capped call</link:label>
    <link:label id="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_683de75d-a25c-4bad-b8ed-13ff43bb594f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of capped call</link:label>
    <link:label id="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Derivative Instrument, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:to="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_870c2d63-bc31-4ded-b74b-efcbd77890b4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued, offering cost</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2c2da29c-e62e-4666-adf2-452c7663ccfe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock_b5a34fc3-983a-4226-86a3-5460a1f3ef0a_terseLabel_en-US" xlink:label="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties</link:label>
    <link:label id="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for risks and uncertainties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:href="cutr-20210630.xsd#cutr_RisksAndUncertaintiesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:to="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_ccb1b102-78ef-4262-b94e-c2c096973fd5_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of non-cash items:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_6d7360f1-c177-42b9-8b5c-1832b621ec43_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_15add6c9-f8c6-4826-b05a-0a64466908dd_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_b467b9b1-3855-48ac-b851-b2d913562f90_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_35c896fb-dc0b-4da8-9b80-5feb1c606578_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d9fdc09f-c488-4b0b-b65a-740e51578549_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares of common stock outstanding used in computing net income (loss) per share, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_eb5117a5-302b-47c5-bcf7-bc80e63d2634_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_8e30ca92-10ed-4f49-b258-b7307fbfe091_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share, basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_460fafe0-d9cd-4218-b36a-279653ca0399_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c2adb7bc-d11b-45dc-b07f-1c3a2fa2ce2f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_95dbdaae-3b00-422f-874d-476310cd117f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards canceled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_bc67b22b-16be-4959-9a06-866538cc577a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards canceled / forfeited / expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_a7c71e28-5421-4eb9-a899-ae366a36235e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExtendedServiceContractOptionTwoTerm_21a657f3-5cc0-4c01-8a90-84e957c67765_terseLabel_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionTwoTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended service contract, option two, term</link:label>
    <link:label id="lab_cutr_ExtendedServiceContractOptionTwoTerm_label_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionTwoTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Service Contract, Option Two, Term</link:label>
    <link:label id="lab_cutr_ExtendedServiceContractOptionTwoTerm_documentation_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionTwoTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Service Contract, Option Two, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionTwoTerm" xlink:href="cutr-20210630.xsd#cutr_ExtendedServiceContractOptionTwoTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExtendedServiceContractOptionTwoTerm" xlink:to="lab_cutr_ExtendedServiceContractOptionTwoTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_95a9ada6-7678-4586-80e7-b93aa8afbb99_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_4b0ad907-e7fc-47da-b84a-ce46eccdaa46_negatedLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_9b77c362-6f41-4c65-bc76-fc195ebc3fe8_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_888b99fc-7898-4044-ba47-3b1d4f8b45ca_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_312ecccc-2277-4541-b76a-e5edfa503c19_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue balance, amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_06b2bb7c-4cd6-47fe-b1d9-69b628a31ef5_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_2acf78d8-add6-4765-b1fc-aecc5523757f_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_cf6b951c-2660-41c1-bd3d-d424592ec00e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for employee purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_8ff5c910-8ba4-4bad-b94e-057e3bf9edd2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_2361a773-f549-42b4-939a-9f48d9d5e21c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value; authorized: 50,000,000 shares; issued and outstanding: 17,933,020 and 17,679,232 shares at June&#160;30, 2021 and December&#160;31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_806ee381-5344-476c-bfc2-d74c38830840_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_0c0987ba-f220-4223-8cf6-f272ed35b215_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_bd54897f-d178-4b3f-a3b9-bad54f46052b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate during period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExtendedServiceContractOptionThreeTerm_90b78fba-65ea-4e83-bd78-ae75f11fb87c_terseLabel_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionThreeTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended service contract, option three, term</link:label>
    <link:label id="lab_cutr_ExtendedServiceContractOptionThreeTerm_label_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionThreeTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Service Contract, Option Three, Term</link:label>
    <link:label id="lab_cutr_ExtendedServiceContractOptionThreeTerm_documentation_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionThreeTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Service Contract, Option Three, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionThreeTerm" xlink:href="cutr-20210630.xsd#cutr_ExtendedServiceContractOptionThreeTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExtendedServiceContractOptionThreeTerm" xlink:to="lab_cutr_ExtendedServiceContractOptionThreeTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_85996ccc-1dc0-49d8-acb8-ed3c91718a3f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_f2d83047-e323-40c5-98a1-5ea6b6a70be5_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_aaa30508-15f0-44f8-882a-33c88d8451c2_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Available for Grant</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Available For Grant [Roll Forward]</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Available For Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" xlink:href="cutr-20210630.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bad78c17-2379-4353-a5d4-3e5fa46e7c71_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ProductsExcludingConsumablesAndSkincareMember_07cd2835-e436-4462-9326-e3ace95f5d01_terseLabel_en-US" xlink:label="lab_cutr_ProductsExcludingConsumablesAndSkincareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_cutr_ProductsExcludingConsumablesAndSkincareMember_label_en-US" xlink:label="lab_cutr_ProductsExcludingConsumablesAndSkincareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products Excluding Consumables and Skincare [Member]</link:label>
    <link:label id="lab_cutr_ProductsExcludingConsumablesAndSkincareMember_documentation_en-US" xlink:label="lab_cutr_ProductsExcludingConsumablesAndSkincareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information pertaining to products excluding consumables and skincare.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ProductsExcludingConsumablesAndSkincareMember" xlink:href="cutr-20210630.xsd#cutr_ProductsExcludingConsumablesAndSkincareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ProductsExcludingConsumablesAndSkincareMember" xlink:to="lab_cutr_ProductsExcludingConsumablesAndSkincareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_604d8826-d476-4f8e-89d2-3cf884e12940_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting rights (percentage)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_28e0fbab-c8c5-4366-a91d-6dd0f7107697_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_0b992c41-97b7-4daf-afa7-21b6e84e1832_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_e5cce19a-4dd1-4d92-8ccd-58d05521d4c9_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_62aee752-4e0b-4ce4-8085-0f24b55ce323_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_38ec349a-4618-4832-b19b-56b6da9fd6ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_42cfb927-e6bd-41e6-ae1b-e2aba54bb3af_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_9a9d32c3-6212-4f3e-aebd-f57d72d1a187_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_RevenueFromContractWithCustomerTermOfContract_861e433b-f058-4d5e-827e-6d0eedbab22b_terseLabel_en-US" xlink:label="lab_cutr_RevenueFromContractWithCustomerTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of contract</link:label>
    <link:label id="lab_cutr_RevenueFromContractWithCustomerTermOfContract_label_en-US" xlink:label="lab_cutr_RevenueFromContractWithCustomerTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Term Of Contract</link:label>
    <link:label id="lab_cutr_RevenueFromContractWithCustomerTermOfContract_documentation_en-US" xlink:label="lab_cutr_RevenueFromContractWithCustomerTermOfContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Term Of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RevenueFromContractWithCustomerTermOfContract" xlink:href="cutr-20210630.xsd#cutr_RevenueFromContractWithCustomerTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_RevenueFromContractWithCustomerTermOfContract" xlink:to="lab_cutr_RevenueFromContractWithCustomerTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_abef4295-f523-4c43-926d-55f2cad1e554_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Marketable Securities [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_17c92773-f6b6-49c3-8af6-02f75a64b484_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredLongTermDebt_e38b13c2-126f-4897-a74c-d9d88ebee50e_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP loan payable, net of current portion</link:label>
    <link:label id="lab_us-gaap_UnsecuredLongTermDebt_label_en-US" xlink:label="lab_us-gaap_UnsecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Long-term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredLongTermDebt" xlink:to="lab_us-gaap_UnsecuredLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_afee7de9-7772-4a88-a789-68196c1bc668_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_89d14379-8111-4547-9fae-9f41aac45802_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c1fe4fac-62a1-49c7-adce-88064a721fec_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_fbde4b9f-8caf-490f-a774-7a3df591099c_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_761e2181-f989-4a18-8106-52f2505adec3_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_308deeee-4fd6-4045-8ca6-08a03b6be29d_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_8d50521f-f283-4874-8825-77f1581ef395_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of equity offering</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_f64f1b52-1f58-4197-b8fe-27a0b9031fe8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_9f2b9e1b-c244-4e2e-9825-13d2a53efc48_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee amount</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_ce4127b1-eb41-4d16-a64e-b98336a40a2f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_e9735f3e-a440-4335-9ae4-35c7a0340d44_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived_f38c2d48-ede7-47a6-818e-d18672d90cda_terseLabel_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Payments received</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived_label_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase, Advance Payments Received</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived_documentation_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from advance payments received.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" xlink:href="cutr-20210630.xsd#cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" xlink:to="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_392e7d1b-e810-4c2e-9bd1-d7c27170086a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a20d833-c324-428f-b59c-5364a0d8f335_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_375ff92f-46b9-4822-953e-dcbf81a7b704_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_8d86281f-7c15-4f4e-aed2-198c1cb1a06f_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_0f15e193-a9c8-4d3f-ad91-1bb25019c41f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_33deb7e4-8fbc-44e6-b39b-dce76d27084b_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3a028ac3-1141-4092-a1e3-80ecac677a46_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_6f9d472a-3149-49f9-af74-cf51b1a94f8c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_7daf5be3-8b41-4743-adeb-afd43aaa6e12_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_SkincareMember_5813e290-e2ab-4833-8777-2392cd39ec42_terseLabel_en-US" xlink:label="lab_cutr_SkincareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skincare</link:label>
    <link:label id="lab_cutr_SkincareMember_label_en-US" xlink:label="lab_cutr_SkincareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skincare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SkincareMember" xlink:href="cutr-20210630.xsd#cutr_SkincareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_SkincareMember" xlink:to="lab_cutr_SkincareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_f06b1ff2-35c9-46f5-8df7-db500325c216_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total product revenue</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_afa133c9-4544-4cf8-80e7-a133b2471ef8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_a2663ca1-d30e-41fb-add0-4f813f300ac2_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in unrealized gain on available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_7dbc13d0-7d66-499d-a71a-fdc9a9e4eb56_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in unrealized loss on available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_02d0eba3-c9a3-489e-bc95-f505aed6da7c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_7e2b04cc-7a39-4e5d-97bc-9191cf4f7dab_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_9fce4d51-55f4-40cf-b6a9-9a4aad4f6d37_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_0e0801d3-00b0-4c83-a947-6adfcbf1e6e5_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_7dbf9ef2-7124-45c7-9901-36f55700e8c8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1b674b76-16cc-49b8-b445-d47e6f643ed1_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity and Stock-based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_86aeedf7-5862-4ae0-bbe6-c15bf9fa9420_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_2a86ef87-e853-4402-8d79-0b6d3c05c9b3_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_0d0b952d-4404-4ddd-8073-fb4be66318d0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_03c22f3f-f3b4-484b-95de-54ad744ebe17_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_639ea637-d133-4f13-a0c0-115611b1a1c8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_a3727f3c-a2e2-4c6a-be62-deb0cf89a013_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_4b1486ac-ffa4-4b18-a1dd-1d1d1c6a2bbc_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_7b9fc6ef-4ddc-4689-8184-fa09faf2f0e0_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_c4ce54fc-9081-43c0-a00b-d7d84527ae43_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_2e9a1099-3ef1-4a61-8e99-776b09f39dda_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_12f9816e-0df3-45e0-adc6-38fcad9115db_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_b5e4063d-4ccb-47cc-a553-2441d84f7a56_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_ea463928-ee5f-4ff3-83d4-3931f2b0faec_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_8aa17a22-7f60-4ff1-9035-36c3c483bb3f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_NonqualifiedStockOptionsMember_22f1e5bb-369c-4d1f-ade9-973c84899587_terseLabel_en-US" xlink:label="lab_cutr_NonqualifiedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-qualified Stock Options</link:label>
    <link:label id="lab_cutr_NonqualifiedStockOptionsMember_label_en-US" xlink:label="lab_cutr_NonqualifiedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-qualified Stock Options [Member]</link:label>
    <link:label id="lab_cutr_NonqualifiedStockOptionsMember_documentation_en-US" xlink:label="lab_cutr_NonqualifiedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to non-qualified stock options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NonqualifiedStockOptionsMember" xlink:href="cutr-20210630.xsd#cutr_NonqualifiedStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_NonqualifiedStockOptionsMember" xlink:to="lab_cutr_NonqualifiedStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_e2419119-5b52-4b86-8777-954dfa6b0541_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0645151b-4a75-47f6-8c4f-84920fe9f1e1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Stock Options Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_dc97ce98-d293-44ce-bd2b-9a5651d0f1fe_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebt_8b079439-4d6d-4a60-b8f2-b3eab5b92095_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of convertible debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebt" xlink:to="lab_us-gaap_ConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_2d9de606-049c-4c6e-8ae2-f96c862cbb16_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income used in calculating net income per share, diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseRevenue_1e4a2ecd-03e7-4c05-9d78-85ae55d12309_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type lease, revenue</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseRevenue_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesTypeLeaseRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseRevenue" xlink:to="lab_us-gaap_SalesTypeLeaseRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_76ca01e7-2eb7-477b-8534-6dcd1b8ab4ec_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves_0209477a-2bb4-4250-86d4-929626875195_terseLabel_en-US" xlink:label="lab_cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and extended product warranty, excess reserves</link:label>
    <link:label id="lab_cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves_label_en-US" xlink:label="lab_cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard And Extended Product Warranty Accrual, Excess Reserves</link:label>
    <link:label id="lab_cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves_documentation_en-US" xlink:label="lab_cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard And Extended Product Warranty Accrual, Excess Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves" xlink:href="cutr-20210630.xsd#cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves" xlink:to="lab_cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_76a9dc4d-f5e9-4ee3-9653-715d40ffd0b4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price, percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_ea2d9165-5e53-4788-9465-f2f94157df7f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for employee purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_a0dfe834-cdc0-4a13-97e8-9f2df5fc3989_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_7e2611dd-0a71-44ac-ac33-9b231677100b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock-based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_901e10b5-c7f1-4b5b-8dd7-57dcdbf77ef9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_584bed5a-1fd0-4945-b233-df6f3096db60_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareImpairments1_9cddcd3e-6d60-41f1-bf03-6f7a04a33f94_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareImpairments1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of capitalized cloud computing costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareImpairments1_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareImpairments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Impairments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareImpairments1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareImpairments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareImpairments1" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareImpairments1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_5ac665c2-b0a2-4217-b16e-235b79d41404_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Operations and Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_f42c8c6d-a11d-476f-98d0-b29ba870506d_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_1f5e5004-47ce-49fa-9c13-9b7ba4a6ffbd_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_aa45ad13-66b9-4230-bfcc-ce180a216489_terseLabel_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs accrued</link:label>
    <link:label id="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_label_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:to="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_d5374cfb-6054-43c7-9f41-a982d5599cc9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease terms of finance leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm_06b8dff2-2130-412d-8b8b-6ca406881058_terseLabel_en-US" xlink:label="lab_cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customers' right to purchase leased system, term</link:label>
    <link:label id="lab_cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm_label_en-US" xlink:label="lab_cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type Lease, Lessee Option to Purchase Underlying Asset, Term</link:label>
    <link:label id="lab_cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm_documentation_en-US" xlink:label="lab_cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type Lease, Lessee Option to Purchase Underlying Asset, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm" xlink:href="cutr-20210630.xsd#cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm" xlink:to="lab_cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2913bd8b-78e8-4f60-8353-ee272f8a849b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with public offering, net of offering cost of $2,303 (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_252bb162-e4a4-430d-a135-b394bd94d633_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_WellsFargoMember_3f23a33c-bb6d-407f-8bb7-85e97abc0b81_terseLabel_en-US" xlink:label="lab_cutr_WellsFargoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wells Fargo</link:label>
    <link:label id="lab_cutr_WellsFargoMember_label_en-US" xlink:label="lab_cutr_WellsFargoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wells Fargo [Member]</link:label>
    <link:label id="lab_cutr_WellsFargoMember_documentation_en-US" xlink:label="lab_cutr_WellsFargoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to the lender, Wells Fargo.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_WellsFargoMember" xlink:href="cutr-20210630.xsd#cutr_WellsFargoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_WellsFargoMember" xlink:to="lab_cutr_WellsFargoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_51c2243e-3333-41bb-8fd9-9ad1361b093f_terseLabel_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Training provided with sale of system, period</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_label_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Training Provided With Sale Of System, Period</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_documentation_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Training Provided With Sale Of System, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" xlink:href="cutr-20210630.xsd#cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" xlink:to="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorLeaseDescriptionLineItems_62c7904a-2359-4c6f-bd51-b55d1fba4d8b_terseLabel_en-US" xlink:label="lab_us-gaap_LessorLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LessorLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LessorLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LessorLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_a51b62c5-75a1-4db5-a3d1-38c567177b2b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_42071fa6-f3fc-49f8-96be-bba215c83080_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected timing of satisfaction, period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_0f068f53-4ae5-4de5-b88f-88f9dc0de979_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyLiabilityTable_3683a922-64bb-42b9-b07d-92c9850aa9b9_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Liability [Table]</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyLiabilityTable_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Liability [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyLiabilityTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyLiabilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyLiabilityTable" xlink:to="lab_us-gaap_ProductWarrantyLiabilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_ff3dfc05-85ec-48ab-8b84-65f6bdcffe02_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of incremental shares and share equivalents:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_29a8bfc1-5b9e-419c-a589-b7efeafba9a8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9eabcf7b-c39a-48a2-a567-27fb8d028d31_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0ba40e0d-6b6f-4ae7-a634-e2040c91d40d_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_afdef224-b11a-4608-92c9-09f0c80accbd_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total interest and other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_39d05143-5574-405d-ad73-e56355148169_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_2576d11b-fd48-469e-8000-3bed567e4338_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Maturities of Facility Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_WeightedAverageRemainingLeaseTermAbstract_d41a52fa-5562-490e-ad92-9dd590534df3_terseLabel_en-US" xlink:label="lab_cutr_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term (years)</link:label>
    <link:label id="lab_cutr_WeightedAverageRemainingLeaseTermAbstract_label_en-US" xlink:label="lab_cutr_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:label id="lab_cutr_WeightedAverageRemainingLeaseTermAbstract_documentation_en-US" xlink:label="lab_cutr_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_WeightedAverageRemainingLeaseTermAbstract" xlink:href="cutr-20210630.xsd#cutr_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_WeightedAverageRemainingLeaseTermAbstract" xlink:to="lab_cutr_WeightedAverageRemainingLeaseTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_0f7bfb7e-c2e6-47c8-a462-a1e99d88b3b0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_a2e59895-31c4-4a80-ab36-62c1f3103d7f_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options to purchase common stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d6f80a6e-c956-4c47-872d-e8a31e86499e_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_46abe77a-3b5d-408a-90ab-d790d5cea0cb_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_38b4e085-08c6-45f8-8bfa-1d2a3c4afa08_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d322e438-b7e3-4762-a2ab-d2120c468c43_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_938f9535-ba56-4f7d-9b1f-39bddb5a8c2c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_c2ac6666-f23c-4e8a-a27d-af70c0b64926_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_4510a4ca-0691-4812-b8a8-14abf66d29de_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger_10a55f73-29bd-4ebd-b697-66def30830dc_terseLabel_en-US" xlink:label="lab_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption threshold percentage of stock price trigger</link:label>
    <link:label id="lab_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redeemable, Threshold Percentage of Stock Price Trigger</link:label>
    <link:label id="lab_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger_documentation_en-US" xlink:label="lab_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redeemable, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" xlink:to="lab_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_df8c2253-e6a6-45a1-b965-f5fc16f81913_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets acquired under operating lease</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_34a90056-6b0d-4db9-b998-20c2d8ed33c4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_31ca77fe-e5ca-4c5f-8336-e578e62988c9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_b48d859c-02da-4fa7-b3cd-806f24b2604e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_fc82c8fa-110a-4d86-b42e-f175bc703894_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_5ba0ef41-3cc8-4c65-88d5-2fefca1d991f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of marketable investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_5d887964-7411-494a-8c98-338265508045_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall_cbfe1df6-222f-449b-b482-1220172580ae_terseLabel_en-US" xlink:label="lab_cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of capped call</link:label>
    <link:label id="lab_cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall_label_en-US" xlink:label="lab_cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of capped call</link:label>
    <link:label id="lab_cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall_documentation_en-US" xlink:label="lab_cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of adjustments to additional paid in capital purchase of capped call.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall" xlink:href="cutr-20210630.xsd#cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall" xlink:to="lab_cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_0d5b247e-c947-46e8-90c3-9f1b6b5e17e6_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_529109c5-13ea-4579-be90-7521841bca7b_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_fdd9f4c7-6ac8-472d-9d50-8be8aa436db6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_50247d40-4178-4bf4-8f78-6217d1bbd114_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share, diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_f156fce1-4c7c-4f6b-ba33-6a95a5c6980a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_SaleOfThirdPartyProductWarrantyPeriod_3e0c5485-068c-4803-ad63-8d17453ab06f_terseLabel_en-US" xlink:label="lab_cutr_SaleOfThirdPartyProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of third-party product, warranty period</link:label>
    <link:label id="lab_cutr_SaleOfThirdPartyProductWarrantyPeriod_label_en-US" xlink:label="lab_cutr_SaleOfThirdPartyProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Third-Party Product, Warranty Period</link:label>
    <link:label id="lab_cutr_SaleOfThirdPartyProductWarrantyPeriod_documentation_en-US" xlink:label="lab_cutr_SaleOfThirdPartyProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Third-Party Product, Warranty Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SaleOfThirdPartyProductWarrantyPeriod" xlink:href="cutr-20210630.xsd#cutr_SaleOfThirdPartyProductWarrantyPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_SaleOfThirdPartyProductWarrantyPeriod" xlink:to="lab_cutr_SaleOfThirdPartyProductWarrantyPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_cc6991b2-97e7-4a7b-88a8-a0cac14a0d14_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_d1e642af-21d9-42d4-98ff-b77a88d65bad_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Tranche</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_8d81404a-e7aa-492a-a8f7-f7d4ba3bbaa0_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_7858d612-4d27-4b64-aee0-ef0fe5ef690d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_ef568588-fb5e-4508-8e60-c378fbb93391_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrimeRateMember_4d70449b-fc37-4065-8f87-789758f0fb64_terseLabel_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate</link:label>
    <link:label id="lab_us-gaap_PrimeRateMember_label_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrimeRateMember" xlink:to="lab_us-gaap_PrimeRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_8931d14a-dc06-429d-bb4b-3e137c1031c0_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_681cc92c-c6c9-46fc-a12f-aa6a0262adba_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_e0d1823a-c4e7-4ce7-93d2-2860842d8bc6_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_9077bd44-16b2-40f5-8d68-30b6cbd4f931_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_a21852e4-6f2c-42a2-9742-3d7e0e4b7e0e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3d6e2d24-f35d-41bb-a30f-e15fda59bcd8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_6355ba67-3720-4a8f-ab37-75c78c0951cc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold Consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_dfb1b5f1-659b-43f0-9dd3-e18673bc8128_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8bea8fdf-7596-485e-bc1b-2b98296152ae_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_78fe0b77-6195-4b28-8b0b-4be864851d56_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_28993d7a-8ac2-4ceb-bab2-8bff94a90ede_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCapPrice_67a30fec-1d7e-491a-8a8e-c96a6519fb58_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeCapPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cap price (in USD per per share)</link:label>
    <link:label id="lab_us-gaap_DerivativeCapPrice_label_en-US" xlink:label="lab_us-gaap_DerivativeCapPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Cap Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCapPrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCapPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCapPrice" xlink:to="lab_us-gaap_DerivativeCapPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment_5f1d0833-c012-458b-a44a-d3ed2e62ab22_terseLabel_en-US" xlink:label="lab_cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Typical payment receipt, period post shipment</link:label>
    <link:label id="lab_cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment_label_en-US" xlink:label="lab_cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Typical Payment Receipt, Period Post Shipment</link:label>
    <link:label id="lab_cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment_documentation_en-US" xlink:label="lab_cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Typical Payment Receipt, Period Post Shipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment" xlink:href="cutr-20210630.xsd#cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment" xlink:to="lab_cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_ff06b781-884d-49b8-8635-9fc03afd0915_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance cost, net of tax</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_ff0c415c-b202-4f22-865c-606344775433_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_BasisOfPresentationPolicyTextBlock_169f76f0-74ad-4c33-a336-71ece44731eb_terseLabel_en-US" xlink:label="lab_cutr_BasisOfPresentationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_cutr_BasisOfPresentationPolicyTextBlock_label_en-US" xlink:label="lab_cutr_BasisOfPresentationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Policy Text Block]</link:label>
    <link:label id="lab_cutr_BasisOfPresentationPolicyTextBlock_documentation_en-US" xlink:label="lab_cutr_BasisOfPresentationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_BasisOfPresentationPolicyTextBlock" xlink:href="cutr-20210630.xsd#cutr_BasisOfPresentationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_BasisOfPresentationPolicyTextBlock" xlink:to="lab_cutr_BasisOfPresentationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_07a4487c-e103-47b9-8981-c56e86156d0b_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_f4e5a1f9-391a-420f-ac1c-394b2d408edc_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LeaseRightOfUseAsset_99566ff2-b809-41c9-8168-408077e43668_totalLabel_en-US" xlink:label="lab_cutr_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total leased assets</link:label>
    <link:label id="lab_cutr_LeaseRightOfUseAsset_label_en-US" xlink:label="lab_cutr_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Right-Of-Use Asset</link:label>
    <link:label id="lab_cutr_LeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_cutr_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of lessee's right to use underlying asset under finance and operating lease.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeaseRightOfUseAsset" xlink:href="cutr-20210630.xsd#cutr_LeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LeaseRightOfUseAsset" xlink:to="lab_cutr_LeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_a51f167a-0eff-41b7-b108-d5000f84e79e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_494e42ba-abef-4f31-a17f-13f42c70e187_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_975bd324-c299-4a96-a7c7-fad54234abc5_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_d9eaca88-5548-48ad-be13-1331c6b92a34_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Term (in Years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear_6eaa54e0-eaa2-41b2-9ac9-d6dc2dc5c85c_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting rights, monthly after first year (percentage)</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Award Vesting Rights, Monthly Percentage After First Year</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The monthly percentage of award vesting rights after the first year under a share-based compensation arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear" xlink:href="cutr-20210630.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6da92877-3e41-4913-ac32-4e8a37ac515d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20d6a3aa-8ae6-4257-bb04-3ddf41a60c71_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_bdea2f4e-fd51-45ad-82b4-b20d5dc96a83_terseLabel_en-US" xlink:label="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards</link:label>
    <link:label id="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_label_en-US" xlink:label="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance Share Units [Member]</link:label>
    <link:label id="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_documentation_en-US" xlink:label="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents restricted stock units and performance share units.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:href="cutr-20210630.xsd#cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:to="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_bf118581-46cc-48cc-8fe9-d5c62012bf35_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e4b427bd-e137-44b7-8e02-14256297db10_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of shares used in per share calculations:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_50abf683-814e-4e5d-8a9d-92945b6fe577_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_df033216-2532-44e4-804b-3ce45698a7df_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_716e75ac-078a-448f-bc78-46ada48db2a6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options and employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPayments_b34f1637-fbb8-4049-a472-26c311589d97_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPayments_72f5628d-037e-4ec4-80da-540ab00f65b1_negatedLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Settlements made during the period</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_8b26a817-3bdf-4925-aa28-968c935f23aa_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseAbstract_1528fb9b-f2ee-4758-9655-da27e1715d45_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other income (expense), net:</link:label>
    <link:label id="lab_us-gaap_InterestExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_InterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseAbstract" xlink:to="lab_us-gaap_InterestExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_3376c529-8cf2-46f5-8383-3b04aa2ddc25_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_7f84ead8-da72-4508-ae1e-2bde4c5b4a25_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_4d43163f-1711-45f2-81ea-57a0dbd444f4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_e94bdafc-2a80-4854-9c8b-000a7c0ec2ed_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronoucements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_RevenuePerformanceObligationSatisfiedOverTimePercent_1d42b3a3-7469-433e-aa4c-683c7e20686b_terseLabel_en-US" xlink:label="lab_cutr_RevenuePerformanceObligationSatisfiedOverTimePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from performance obligations transferred to customers, percent</link:label>
    <link:label id="lab_cutr_RevenuePerformanceObligationSatisfiedOverTimePercent_label_en-US" xlink:label="lab_cutr_RevenuePerformanceObligationSatisfiedOverTimePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Satisfied Over Time, Percent</link:label>
    <link:label id="lab_cutr_RevenuePerformanceObligationSatisfiedOverTimePercent_documentation_en-US" xlink:label="lab_cutr_RevenuePerformanceObligationSatisfiedOverTimePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenue from performance obligations that are transferred to customers over time.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RevenuePerformanceObligationSatisfiedOverTimePercent" xlink:href="cutr-20210630.xsd#cutr_RevenuePerformanceObligationSatisfiedOverTimePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_RevenuePerformanceObligationSatisfiedOverTimePercent" xlink:to="lab_cutr_RevenuePerformanceObligationSatisfiedOverTimePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_1a04e593-15ff-499e-b052-249c4ab36244_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>cutr-20210630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c7947e62-414c-45c3-9059-a14473012559,g:b6549df2-51ec-4e04-8ce7-629c1e713d47-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cutera.com/20210331/role/Cover" xlink:type="simple" xlink:href="cutr-20210630.xsd#Cover"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_969871e9-5510-4048-886f-b2ca96a9bf12" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_DocumentType_969871e9-5510-4048-886f-b2ca96a9bf12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_15d65373-06f2-44d4-99ae-7872103938cb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_DocumentQuarterlyReport_15d65373-06f2-44d4-99ae-7872103938cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_7b370acb-e5f2-4b6c-918b-13c7ad592026" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_DocumentPeriodEndDate_7b370acb-e5f2-4b6c-918b-13c7ad592026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_09a7c429-f590-4059-90b4-c30ac65627ce" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_DocumentTransitionReport_09a7c429-f590-4059-90b4-c30ac65627ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_fd4db9b4-1af6-4139-9e8a-afdfbc527c5f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_EntityFileNumber_fd4db9b4-1af6-4139-9e8a-afdfbc527c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_46bfbdf4-e17c-4595-995f-20ed2c08bfcf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_EntityRegistrantName_46bfbdf4-e17c-4595-995f-20ed2c08bfcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_1fbec703-5e14-420f-8940-1ccd0773fec1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_1fbec703-5e14-420f-8940-1ccd0773fec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_a2490da5-a245-482b-abe2-4bb88047d70e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_EntityTaxIdentificationNumber_a2490da5-a245-482b-abe2-4bb88047d70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_d60c1eeb-7937-4dbe-bb2c-dbd28039a054" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_EntityAddressAddressLine1_d60c1eeb-7937-4dbe-bb2c-dbd28039a054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_822cbe00-4562-436b-adcc-c9570c125508" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_EntityAddressCityOrTown_822cbe00-4562-436b-adcc-c9570c125508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_98dd6e4d-1518-4285-b1bc-8b697aa8a1f6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_EntityAddressStateOrProvince_98dd6e4d-1518-4285-b1bc-8b697aa8a1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_2d473890-e324-475a-b34d-1961888fecc9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_EntityAddressPostalZipCode_2d473890-e324-475a-b34d-1961888fecc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_be713175-07b1-4017-9171-823430a42088" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_CityAreaCode_be713175-07b1-4017-9171-823430a42088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_4a09d477-df2a-4811-a519-d675d7d71dec" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_LocalPhoneNumber_4a09d477-df2a-4811-a519-d675d7d71dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ed6fb8ed-8082-483b-9604-f7e8cf38fa48" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_Security12bTitle_ed6fb8ed-8082-483b-9604-f7e8cf38fa48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_cda2f979-f425-49a6-bda6-75777bc79c7a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_TradingSymbol_cda2f979-f425-49a6-bda6-75777bc79c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_1300d0bb-c49b-46c8-ac4a-690eaf68952e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_SecurityExchangeName_1300d0bb-c49b-46c8-ac4a-690eaf68952e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_807f4457-5723-4633-ada5-9604be665ef1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_EntityCurrentReportingStatus_807f4457-5723-4633-ada5-9604be665ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_86d21aa0-c90a-4c29-a605-32756b98f902" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_EntityInteractiveDataCurrent_86d21aa0-c90a-4c29-a605-32756b98f902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_28a6cdd0-d970-4aec-b9f2-7791c9fb2ab4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_EntityFilerCategory_28a6cdd0-d970-4aec-b9f2-7791c9fb2ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_a89cc222-c39f-4000-8539-1e26e3fb90c3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_EntitySmallBusiness_a89cc222-c39f-4000-8539-1e26e3fb90c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_c7271cbe-a8ce-4ed7-bbd5-686e8f6c83cf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_EntityEmergingGrowthCompany_c7271cbe-a8ce-4ed7-bbd5-686e8f6c83cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_79537ebc-5061-4202-975a-7c02b4162aa4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_EntityShellCompany_79537ebc-5061-4202-975a-7c02b4162aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_43c2e5a5-7f84-42a9-91f5-8a45e5534e5b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_43c2e5a5-7f84-42a9-91f5-8a45e5534e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_9387c557-e920-4d58-bec7-6ec68203b364" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_EntityCentralIndexKey_9387c557-e920-4d58-bec7-6ec68203b364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a3ae0f27-421d-4fd5-a41a-caea2921626a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_AmendmentFlag_a3ae0f27-421d-4fd5-a41a-caea2921626a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_da4267dc-03f9-46d8-a3e8-bb986229f451" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_CurrentFiscalYearEndDate_da4267dc-03f9-46d8-a3e8-bb986229f451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_3f1c11d4-d643-4e88-8f6d-9e64bd01d5ce" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_DocumentFiscalPeriodFocus_3f1c11d4-d643-4e88-8f6d-9e64bd01d5ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_6980157b-b643-4e20-9a84-58b09dec9411" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_16bb9efa-1238-4c67-b9d4-d572ba17e7a4" xlink:to="loc_dei_DocumentFiscalYearFocus_6980157b-b643-4e20-9a84-58b09dec9411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cutr-20210630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_388a08ad-34c3-420e-8d91-d80c8e02da54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_b86b08c1-56e8-4ff6-ba1a-14e8c1bf25d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_388a08ad-34c3-420e-8d91-d80c8e02da54" xlink:to="loc_us-gaap_AssetsAbstract_b86b08c1-56e8-4ff6-ba1a-14e8c1bf25d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_ae670ab7-526c-4b31-8a79-7235df7ac51f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b86b08c1-56e8-4ff6-ba1a-14e8c1bf25d3" xlink:to="loc_us-gaap_AssetsCurrentAbstract_ae670ab7-526c-4b31-8a79-7235df7ac51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3eda2527-350a-4f47-a598-08abb677ebc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ae670ab7-526c-4b31-8a79-7235df7ac51f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3eda2527-350a-4f47-a598-08abb677ebc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_6eca6447-f2c4-430e-98e6-bd0a80116c69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ae670ab7-526c-4b31-8a79-7235df7ac51f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_6eca6447-f2c4-430e-98e6-bd0a80116c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_7b70d9b9-41cf-44ad-9403-474282d279db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ae670ab7-526c-4b31-8a79-7235df7ac51f" xlink:to="loc_us-gaap_InventoryNet_7b70d9b9-41cf-44ad-9403-474282d279db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_939a2336-841d-4004-a9cf-ec6a1f4ef13f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ae670ab7-526c-4b31-8a79-7235df7ac51f" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_939a2336-841d-4004-a9cf-ec6a1f4ef13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_24b45718-40fd-46c9-a837-4623b02f529e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ae670ab7-526c-4b31-8a79-7235df7ac51f" xlink:to="loc_us-gaap_AssetsCurrent_24b45718-40fd-46c9-a837-4623b02f529e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_2d358b90-d6de-4e09-91bf-db09853b98e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b86b08c1-56e8-4ff6-ba1a-14e8c1bf25d3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_2d358b90-d6de-4e09-91bf-db09853b98e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_2a050dea-29a9-416c-8159-9ba830289e1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b86b08c1-56e8-4ff6-ba1a-14e8c1bf25d3" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_2a050dea-29a9-416c-8159-9ba830289e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_69a3f8bb-bdb7-4021-9403-725d4d9461b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b86b08c1-56e8-4ff6-ba1a-14e8c1bf25d3" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_69a3f8bb-bdb7-4021-9403-725d4d9461b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8d6c82e1-d6d2-4c97-ae18-c716dbb51070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b86b08c1-56e8-4ff6-ba1a-14e8c1bf25d3" xlink:to="loc_us-gaap_Goodwill_8d6c82e1-d6d2-4c97-ae18-c716dbb51070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4b4234d9-502d-4338-9022-2c739009393e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b86b08c1-56e8-4ff6-ba1a-14e8c1bf25d3" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_4b4234d9-502d-4338-9022-2c739009393e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5bebc469-bb4f-4e7d-afb5-e18260ebff4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b86b08c1-56e8-4ff6-ba1a-14e8c1bf25d3" xlink:to="loc_us-gaap_Assets_5bebc469-bb4f-4e7d-afb5-e18260ebff4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_694e100b-8263-42b1-b5ec-0a4144d35f62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_388a08ad-34c3-420e-8d91-d80c8e02da54" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_694e100b-8263-42b1-b5ec-0a4144d35f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_b3b56929-a875-482a-b648-b1c1e0da007f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_694e100b-8263-42b1-b5ec-0a4144d35f62" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_b3b56929-a875-482a-b648-b1c1e0da007f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f4ef9efb-9aee-4c6e-8569-d65d3319a674" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b3b56929-a875-482a-b648-b1c1e0da007f" xlink:to="loc_us-gaap_AccountsPayableCurrent_f4ef9efb-9aee-4c6e-8569-d65d3319a674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a07fc55b-9ae1-47aa-b158-5a29244bea60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b3b56929-a875-482a-b648-b1c1e0da007f" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_a07fc55b-9ae1-47aa-b158-5a29244bea60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c43c8d0b-7154-48e3-a3b3-65da54bafb9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b3b56929-a875-482a-b648-b1c1e0da007f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c43c8d0b-7154-48e3-a3b3-65da54bafb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtCurrent_7a94d176-aa66-46a6-a08c-b04f38bc1c6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b3b56929-a875-482a-b648-b1c1e0da007f" xlink:to="loc_us-gaap_UnsecuredDebtCurrent_7a94d176-aa66-46a6-a08c-b04f38bc1c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyAccrualCurrent_e2e8becc-f052-40a7-8436-8c2c5734eb79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtendedProductWarrantyAccrualCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b3b56929-a875-482a-b648-b1c1e0da007f" xlink:to="loc_us-gaap_ExtendedProductWarrantyAccrualCurrent_e2e8becc-f052-40a7-8436-8c2c5734eb79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_5522fedd-235c-4178-9d37-c201062d3f88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b3b56929-a875-482a-b648-b1c1e0da007f" xlink:to="loc_us-gaap_DeferredRevenueCurrent_5522fedd-235c-4178-9d37-c201062d3f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_cd61cf78-757d-4e85-89cc-fb1ff8b9b93a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b3b56929-a875-482a-b648-b1c1e0da007f" xlink:to="loc_us-gaap_LiabilitiesCurrent_cd61cf78-757d-4e85-89cc-fb1ff8b9b93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_b1c5769a-daa9-43b2-b6bf-af86f0046136" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_694e100b-8263-42b1-b5ec-0a4144d35f62" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_b1c5769a-daa9-43b2-b6bf-af86f0046136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fc2f4e59-8d81-4c28-a684-e875d1df9b1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_694e100b-8263-42b1-b5ec-0a4144d35f62" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fc2f4e59-8d81-4c28-a684-e875d1df9b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredLongTermDebt_294e16ed-6e16-479e-9fde-608a9db74bbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_694e100b-8263-42b1-b5ec-0a4144d35f62" xlink:to="loc_us-gaap_UnsecuredLongTermDebt_294e16ed-6e16-479e-9fde-608a9db74bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_eb83a2be-642b-40ea-9e06-b1405fef409d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_694e100b-8263-42b1-b5ec-0a4144d35f62" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_eb83a2be-642b-40ea-9e06-b1405fef409d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2d27a64c-d818-4fb2-82d7-fbe77acf4299" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_694e100b-8263-42b1-b5ec-0a4144d35f62" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2d27a64c-d818-4fb2-82d7-fbe77acf4299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b52ae19b-b714-4497-b6ff-f1511383db44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_694e100b-8263-42b1-b5ec-0a4144d35f62" xlink:to="loc_us-gaap_Liabilities_b52ae19b-b714-4497-b6ff-f1511383db44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_c4f3dfdd-d8ae-4698-99c5-b7a6de6d69f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_694e100b-8263-42b1-b5ec-0a4144d35f62" xlink:to="loc_us-gaap_CommitmentsAndContingencies_c4f3dfdd-d8ae-4698-99c5-b7a6de6d69f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_d5c68f36-b52a-46f2-a3c5-b68286de7046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_694e100b-8263-42b1-b5ec-0a4144d35f62" xlink:to="loc_us-gaap_StockholdersEquityAbstract_d5c68f36-b52a-46f2-a3c5-b68286de7046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_4f3641a4-9a68-4b21-baa9-40bd6addfcc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d5c68f36-b52a-46f2-a3c5-b68286de7046" xlink:to="loc_us-gaap_CommonStockValue_4f3641a4-9a68-4b21-baa9-40bd6addfcc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4854c8c6-3097-417d-847d-7ea032394185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d5c68f36-b52a-46f2-a3c5-b68286de7046" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4854c8c6-3097-417d-847d-7ea032394185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_90112d75-070c-40ae-b523-e7c623cb7510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d5c68f36-b52a-46f2-a3c5-b68286de7046" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_90112d75-070c-40ae-b523-e7c623cb7510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_57796c23-854e-4b03-bdba-0496a5b50497" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d5c68f36-b52a-46f2-a3c5-b68286de7046" xlink:to="loc_us-gaap_StockholdersEquity_57796c23-854e-4b03-bdba-0496a5b50497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_bd150ffe-2ec5-436f-b394-df03bc6f8fbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_694e100b-8263-42b1-b5ec-0a4144d35f62" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_bd150ffe-2ec5-436f-b394-df03bc6f8fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="cutr-20210630.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_694237e0-025e-4b3b-b2b2-b7aebd799ab7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7bc43589-1700-4d8d-92f7-d0e2e0a80565" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_694237e0-025e-4b3b-b2b2-b7aebd799ab7" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7bc43589-1700-4d8d-92f7-d0e2e0a80565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_65e54556-3d4c-4a2d-ac7e-820a2ca7def0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_694237e0-025e-4b3b-b2b2-b7aebd799ab7" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_65e54556-3d4c-4a2d-ac7e-820a2ca7def0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_15037129-fde4-452e-b74a-4f9cc706f1c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_694237e0-025e-4b3b-b2b2-b7aebd799ab7" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_15037129-fde4-452e-b74a-4f9cc706f1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_9852e223-af46-494b-b387-f94320281450" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_694237e0-025e-4b3b-b2b2-b7aebd799ab7" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_9852e223-af46-494b-b387-f94320281450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_cbc08a1e-3cfd-42e9-b7e2-960d22736f71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_694237e0-025e-4b3b-b2b2-b7aebd799ab7" xlink:to="loc_us-gaap_CommonStockSharesIssued_cbc08a1e-3cfd-42e9-b7e2-960d22736f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_13be141f-7a7b-4656-b3dc-f7ceaf159fc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_694237e0-025e-4b3b-b2b2-b7aebd799ab7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_13be141f-7a7b-4656-b3dc-f7ceaf159fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cutr-20210630.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_f2b8502e-edf2-4d93-b680-d65f20d85d5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_56d96c08-cdbb-4779-b55e-73252527bc72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f2b8502e-edf2-4d93-b680-d65f20d85d5b" xlink:to="loc_us-gaap_StatementTable_56d96c08-cdbb-4779-b55e-73252527bc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f8a7e4a4-9899-43b1-a610-8cc08f7be62b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_56d96c08-cdbb-4779-b55e-73252527bc72" xlink:to="loc_srt_ProductOrServiceAxis_f8a7e4a4-9899-43b1-a610-8cc08f7be62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_781ba4aa-2560-453c-89ac-780c016747b7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f8a7e4a4-9899-43b1-a610-8cc08f7be62b" xlink:to="loc_srt_ProductsAndServicesDomain_781ba4aa-2560-453c-89ac-780c016747b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_95b74f11-a6a8-483f-898d-db78748c4f5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_781ba4aa-2560-453c-89ac-780c016747b7" xlink:to="loc_us-gaap_ProductMember_95b74f11-a6a8-483f-898d-db78748c4f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_9dcc9136-c27b-4daf-9c9c-5bb8c9cc44f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_781ba4aa-2560-453c-89ac-780c016747b7" xlink:to="loc_us-gaap_ServiceMember_9dcc9136-c27b-4daf-9c9c-5bb8c9cc44f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_56d96c08-cdbb-4779-b55e-73252527bc72" xlink:to="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_37e6455c-131f-4a8b-b43d-dbcdcfb4cf9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_RevenuesAbstract_37e6455c-131f-4a8b-b43d-dbcdcfb4cf9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_acedc04e-712c-4d60-a19f-01480d82855d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_37e6455c-131f-4a8b-b43d-dbcdcfb4cf9b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_acedc04e-712c-4d60-a19f-01480d82855d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_34c5e51b-9f71-49ec-a3ce-1a79ad69c03e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_CostOfRevenueAbstract_34c5e51b-9f71-49ec-a3ce-1a79ad69c03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_71c10a52-1c26-43a4-9b64-7d34a204732c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_34c5e51b-9f71-49ec-a3ce-1a79ad69c03e" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_71c10a52-1c26-43a4-9b64-7d34a204732c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_553de7a1-3d54-4e41-a217-e8b43855b5cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_GrossProfit_553de7a1-3d54-4e41-a217-e8b43855b5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_3232be64-22f1-45ef-80d1-b430aed9abdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_OperatingExpensesAbstract_3232be64-22f1-45ef-80d1-b430aed9abdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_d50d4e0a-a073-4cbe-9d80-da03d929c415" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3232be64-22f1-45ef-80d1-b430aed9abdf" xlink:to="loc_us-gaap_SellingAndMarketingExpense_d50d4e0a-a073-4cbe-9d80-da03d929c415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_500406c7-4401-4b8a-8240-d8b35e8e78ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3232be64-22f1-45ef-80d1-b430aed9abdf" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_500406c7-4401-4b8a-8240-d8b35e8e78ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_f279fe71-23d1-41e0-9d1e-8a3b64dad827" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3232be64-22f1-45ef-80d1-b430aed9abdf" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_f279fe71-23d1-41e0-9d1e-8a3b64dad827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_9b2789da-24b5-4eb8-8c33-efd485cb739c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_OperatingExpenses_9b2789da-24b5-4eb8-8c33-efd485cb739c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_78f069ce-7d75-4200-b2d5-c9b82ee1d377" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_OperatingIncomeLoss_78f069ce-7d75-4200-b2d5-c9b82ee1d377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseAbstract_a4fd6597-e16c-49e8-abf3-1a0268f90789" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_InterestExpenseAbstract_a4fd6597-e16c-49e8-abf3-1a0268f90789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_8e69736a-ed5d-4148-ba7d-f48bb7fe1598" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestExpenseAbstract_a4fd6597-e16c-49e8-abf3-1a0268f90789" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_8e69736a-ed5d-4148-ba7d-f48bb7fe1598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_3ae8595a-fd8e-48b3-b661-f6a250b387e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestExpenseAbstract_a4fd6597-e16c-49e8-abf3-1a0268f90789" xlink:to="loc_us-gaap_InterestExpenseDebt_3ae8595a-fd8e-48b3-b661-f6a250b387e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2d9521ef-3a93-4a66-b4d7-ef0dd695f44b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestExpenseAbstract_a4fd6597-e16c-49e8-abf3-1a0268f90789" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2d9521ef-3a93-4a66-b4d7-ef0dd695f44b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_eba53b5d-900d-4922-a1aa-9833f90758a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestExpenseAbstract_a4fd6597-e16c-49e8-abf3-1a0268f90789" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_eba53b5d-900d-4922-a1aa-9833f90758a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_490ac311-1104-4b10-8444-db77f9719a9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestExpenseAbstract_a4fd6597-e16c-49e8-abf3-1a0268f90789" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_490ac311-1104-4b10-8444-db77f9719a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7b1f84bb-e107-47e0-b7e3-b97df1f30bd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7b1f84bb-e107-47e0-b7e3-b97df1f30bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_428a2735-64ac-4e36-b52e-2e7498a3055c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_428a2735-64ac-4e36-b52e-2e7498a3055c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_06d88e56-96c8-459f-99a4-7afc95873858" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_NetIncomeLoss_06d88e56-96c8-459f-99a4-7afc95873858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0d64049d-353e-4f76-b0cf-01b008dc2088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_EarningsPerShareAbstract_0d64049d-353e-4f76-b0cf-01b008dc2088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c3bf6765-1807-4973-9fae-0006f11b8f28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0d64049d-353e-4f76-b0cf-01b008dc2088" xlink:to="loc_us-gaap_EarningsPerShareBasic_c3bf6765-1807-4973-9fae-0006f11b8f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_17cb63f6-1cfa-42c3-b1e6-82245725df62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0d64049d-353e-4f76-b0cf-01b008dc2088" xlink:to="loc_us-gaap_EarningsPerShareDiluted_17cb63f6-1cfa-42c3-b1e6-82245725df62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_54d3723c-c953-4bce-80e3-bb967f4119ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c12d9197-3b51-419c-997f-ad62ff245c63" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_54d3723c-c953-4bce-80e3-bb967f4119ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_384ce74a-793b-47c3-ac9e-d96ca320784c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_54d3723c-c953-4bce-80e3-bb967f4119ff" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_384ce74a-793b-47c3-ac9e-d96ca320784c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_baa9e26c-3edc-4114-9802-87c9e3d75dfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_54d3723c-c953-4bce-80e3-bb967f4119ff" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_baa9e26c-3edc-4114-9802-87c9e3d75dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cutr-20210630.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_022bc47e-7ef9-4f67-900b-a20f7ff996db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e79433e1-a82c-4ddf-a174-af978b9f5d38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_022bc47e-7ef9-4f67-900b-a20f7ff996db" xlink:to="loc_us-gaap_NetIncomeLoss_e79433e1-a82c-4ddf-a174-af978b9f5d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b3137dad-8099-4288-9abb-c9d6ee10cdd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_022bc47e-7ef9-4f67-900b-a20f7ff996db" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b3137dad-8099-4288-9abb-c9d6ee10cdd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_0f07b9cd-4c4c-4880-a6b1-e86df0cb77fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b3137dad-8099-4288-9abb-c9d6ee10cdd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_0f07b9cd-4c4c-4880-a6b1-e86df0cb77fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_6cb1dbb2-612e-4cc6-a49f-5775e2cc671d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_0f07b9cd-4c4c-4880-a6b1-e86df0cb77fe" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_6cb1dbb2-612e-4cc6-a49f-5775e2cc671d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_ecc6f232-7f35-4c3a-b411-8dc1df0cad7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_0f07b9cd-4c4c-4880-a6b1-e86df0cb77fe" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_ecc6f232-7f35-4c3a-b411-8dc1df0cad7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_45381b0d-b898-481f-8211-bcb636ca3f60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b3137dad-8099-4288-9abb-c9d6ee10cdd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_45381b0d-b898-481f-8211-bcb636ca3f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4b4f5a49-91f8-4f1e-bd9f-928f0af7d96b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_022bc47e-7ef9-4f67-900b-a20f7ff996db" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_4b4f5a49-91f8-4f1e-bd9f-928f0af7d96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited" xlink:type="simple" xlink:href="cutr-20210630.xsd#ConsolidatedStatementsofChangesInStockholdersEquityUnaudited"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_370b646f-ce7b-4562-aef8-6b9354c98e07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e2779894-f9ae-41ff-a6b5-1c2fa73deb63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_370b646f-ce7b-4562-aef8-6b9354c98e07" xlink:to="loc_us-gaap_StatementTable_e2779894-f9ae-41ff-a6b5-1c2fa73deb63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8b07ef5b-36e2-4f3e-8e04-b73d2145f0d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e2779894-f9ae-41ff-a6b5-1c2fa73deb63" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8b07ef5b-36e2-4f3e-8e04-b73d2145f0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a1c713cb-b4ce-4cbe-99f4-607c52fa0414" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8b07ef5b-36e2-4f3e-8e04-b73d2145f0d6" xlink:to="loc_us-gaap_EquityComponentDomain_a1c713cb-b4ce-4cbe-99f4-607c52fa0414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5a55c339-b0d7-44be-a605-0628b3a0eff3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a1c713cb-b4ce-4cbe-99f4-607c52fa0414" xlink:to="loc_us-gaap_CommonStockMember_5a55c339-b0d7-44be-a605-0628b3a0eff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_11333756-e40d-44e5-ac7e-5d4a46826bdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a1c713cb-b4ce-4cbe-99f4-607c52fa0414" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_11333756-e40d-44e5-ac7e-5d4a46826bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_fa4c22aa-9b05-4104-9400-b9e1e14b6317" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a1c713cb-b4ce-4cbe-99f4-607c52fa0414" xlink:to="loc_us-gaap_RetainedEarningsMember_fa4c22aa-9b05-4104-9400-b9e1e14b6317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b0e603f2-6950-4d66-8a98-b7edd77ccfcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a1c713cb-b4ce-4cbe-99f4-607c52fa0414" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b0e603f2-6950-4d66-8a98-b7edd77ccfcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7022e597-cea0-4413-9e60-4a95f6b0106d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e2779894-f9ae-41ff-a6b5-1c2fa73deb63" xlink:to="loc_us-gaap_StatementLineItems_7022e597-cea0-4413-9e60-4a95f6b0106d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7022e597-cea0-4413-9e60-4a95f6b0106d" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_49f4920a-9fbc-4a01-a78e-8d3d1520cfb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_49f4920a-9fbc-4a01-a78e-8d3d1520cfb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_81fa678d-00d1-4093-a315-1a22345c74b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_StockholdersEquity_81fa678d-00d1-4093-a315-1a22345c74b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_d8bc596a-314c-48d6-a8e6-bc029f3578cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_d8bc596a-314c-48d6-a8e6-bc029f3578cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1c5c35de-03d8-47fe-9596-8865ef4a6c2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1c5c35de-03d8-47fe-9596-8865ef4a6c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_32a75515-c578-4dd8-adf8-bee1afb4e37d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_32a75515-c578-4dd8-adf8-bee1afb4e37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_dad8fb37-3159-4db1-8a5c-092337dd728a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_dad8fb37-3159-4db1-8a5c-092337dd728a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall_21af3f22-4711-421f-8d5e-88c44180963e" xlink:href="cutr-20210630.xsd#cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall_21af3f22-4711-421f-8d5e-88c44180963e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_96241723-1af5-4345-8fb2-4a7296a903b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_96241723-1af5-4345-8fb2-4a7296a903b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_d29b5bf4-ceeb-4f00-9664-16c61f1644f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_d29b5bf4-ceeb-4f00-9664-16c61f1644f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_abdaee31-b47c-4246-b1b8-cdf557d92b89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_abdaee31-b47c-4246-b1b8-cdf557d92b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_efe28ac6-5867-460c-a0eb-06d757280840" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_efe28ac6-5867-460c-a0eb-06d757280840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1f17b961-478c-46ad-8447-2b3d977833dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1f17b961-478c-46ad-8447-2b3d977833dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d33ad258-5d69-4922-97b4-fb1f247bc2e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_NetIncomeLoss_d33ad258-5d69-4922-97b4-fb1f247bc2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_46bf80ec-ab4f-4b1e-b5a3-dc9f4d72a087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_46bf80ec-ab4f-4b1e-b5a3-dc9f4d72a087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d4c34eff-6eac-47c9-8417-bb0b21723390" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d4c34eff-6eac-47c9-8417-bb0b21723390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8c981cb1-de6f-4fda-bb21-2e966db2beff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_569e8fbc-927d-4079-ad71-67c135724203" xlink:to="loc_us-gaap_StockholdersEquity_8c981cb1-de6f-4fda-bb21-2e966db2beff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnauditedParenthetical" xlink:type="simple" xlink:href="cutr-20210630.xsd#ConsolidatedStatementsofChangesInStockholdersEquityUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_601b784d-90d7-42da-9584-9dd85d5ba88d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d8e2e1fa-f2df-4108-b759-f77732b73834" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_601b784d-90d7-42da-9584-9dd85d5ba88d" xlink:to="loc_us-gaap_StatementTable_d8e2e1fa-f2df-4108-b759-f77732b73834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b3cb0eb5-ebaf-4534-9023-3b9c5ba2aa14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d8e2e1fa-f2df-4108-b759-f77732b73834" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b3cb0eb5-ebaf-4534-9023-3b9c5ba2aa14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9f3cd754-c9e6-4dc0-9a08-c3bf4c5f8f11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b3cb0eb5-ebaf-4534-9023-3b9c5ba2aa14" xlink:to="loc_us-gaap_EquityComponentDomain_9f3cd754-c9e6-4dc0-9a08-c3bf4c5f8f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_06979bf1-3f07-4b92-bb05-a88b992cd6ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9f3cd754-c9e6-4dc0-9a08-c3bf4c5f8f11" xlink:to="loc_us-gaap_CommonStockMember_06979bf1-3f07-4b92-bb05-a88b992cd6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_efd9b36f-4e31-41aa-8c4a-e32f0a6dfe53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d8e2e1fa-f2df-4108-b759-f77732b73834" xlink:to="loc_us-gaap_StatementLineItems_efd9b36f-4e31-41aa-8c4a-e32f0a6dfe53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_48160f6b-72cf-46cc-8d93-b80edb18aa45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_efd9b36f-4e31-41aa-8c4a-e32f0a6dfe53" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_48160f6b-72cf-46cc-8d93-b80edb18aa45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cutr-20210630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_68ada3c1-059c-4a89-a6ac-67f04d2dc09e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f6942c81-92c5-443c-9cd8-f404d38a69e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_68ada3c1-059c-4a89-a6ac-67f04d2dc09e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f6942c81-92c5-443c-9cd8-f404d38a69e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e711f96e-e029-4694-83ce-f5f2826b5c75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f6942c81-92c5-443c-9cd8-f404d38a69e0" xlink:to="loc_us-gaap_NetIncomeLoss_e711f96e-e029-4694-83ce-f5f2826b5c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f4862752-e11a-41c2-b824-ce880966d402" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f6942c81-92c5-443c-9cd8-f404d38a69e0" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f4862752-e11a-41c2-b824-ce880966d402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6900e905-bcb4-4c26-b3b4-e9125588c70c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f4862752-e11a-41c2-b824-ce880966d402" xlink:to="loc_us-gaap_ShareBasedCompensation_6900e905-bcb4-4c26-b3b4-e9125588c70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_3ef6ba2a-f463-4985-a6c7-97978714787e" xlink:href="cutr-20210630.xsd#cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f4862752-e11a-41c2-b824-ce880966d402" xlink:to="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_3ef6ba2a-f463-4985-a6c7-97978714787e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfAcquisitionCosts_357f2531-4fc9-4dd6-a832-5caac24566f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfAcquisitionCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f4862752-e11a-41c2-b824-ce880966d402" xlink:to="loc_us-gaap_AmortizationOfAcquisitionCosts_357f2531-4fc9-4dd6-a832-5caac24566f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_14f969e1-d310-4739-8fc5-d3da6faadcf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f4862752-e11a-41c2-b824-ce880966d402" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_14f969e1-d310-4739-8fc5-d3da6faadcf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareImpairments1_2c712965-6ff1-4d8f-9916-ba26e39c115d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareImpairments1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f4862752-e11a-41c2-b824-ce880966d402" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareImpairments1_2c712965-6ff1-4d8f-9916-ba26e39c115d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1662ee78-2696-4281-a2ca-9af9b79d0c69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f4862752-e11a-41c2-b824-ce880966d402" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1662ee78-2696-4281-a2ca-9af9b79d0c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_2997b16f-fa70-4045-b71a-c6704c5be537" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f4862752-e11a-41c2-b824-ce880966d402" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_2997b16f-fa70-4045-b71a-c6704c5be537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_c8136946-ba34-404f-aa69-524d9b9c1a97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f4862752-e11a-41c2-b824-ce880966d402" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_c8136946-ba34-404f-aa69-524d9b9c1a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3ed1153e-b2dc-48cc-8969-1a800a583893" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f4862752-e11a-41c2-b824-ce880966d402" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3ed1153e-b2dc-48cc-8969-1a800a583893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_bf2827a0-06ac-4cc1-a3ff-9a765dc35f4d" xlink:href="cutr-20210630.xsd#cutr_ChangeInRightofuseAssetAndLiabilityDueToModification"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f4862752-e11a-41c2-b824-ce880966d402" xlink:to="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_bf2827a0-06ac-4cc1-a3ff-9a765dc35f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_94f23c62-6801-46e8-91c7-93f2ac85fc07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f4862752-e11a-41c2-b824-ce880966d402" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_94f23c62-6801-46e8-91c7-93f2ac85fc07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba35ad5e-3f3b-4f3b-a835-4366999f64e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f6942c81-92c5-443c-9cd8-f404d38a69e0" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba35ad5e-3f3b-4f3b-a835-4366999f64e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_29b816c8-b04d-4458-806e-ac8c6d3e65ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba35ad5e-3f3b-4f3b-a835-4366999f64e5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_29b816c8-b04d-4458-806e-ac8c6d3e65ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_6dd31d7b-8fa7-4950-8f69-86c5eafa0821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba35ad5e-3f3b-4f3b-a835-4366999f64e5" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_6dd31d7b-8fa7-4950-8f69-86c5eafa0821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5af9b371-2a16-4e7a-8325-28c063bdfe15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba35ad5e-3f3b-4f3b-a835-4366999f64e5" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5af9b371-2a16-4e7a-8325-28c063bdfe15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_304d5beb-5dd2-48e7-9cfa-17ca0a4b8268" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba35ad5e-3f3b-4f3b-a835-4366999f64e5" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_304d5beb-5dd2-48e7-9cfa-17ca0a4b8268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_ce629262-ca7c-4a37-b123-e104f3a6026e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba35ad5e-3f3b-4f3b-a835-4366999f64e5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_ce629262-ca7c-4a37-b123-e104f3a6026e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_2ed1667a-6521-491e-9d28-067cada4f409" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba35ad5e-3f3b-4f3b-a835-4366999f64e5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_2ed1667a-6521-491e-9d28-067cada4f409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual_204f20e6-f73a-4491-a43c-c98f996c6234" xlink:href="cutr-20210630.xsd#cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba35ad5e-3f3b-4f3b-a835-4366999f64e5" xlink:to="loc_cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual_204f20e6-f73a-4491-a43c-c98f996c6234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_7cdf0645-39d4-4fd9-b985-086769781fcf" xlink:href="cutr-20210630.xsd#cutr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba35ad5e-3f3b-4f3b-a835-4366999f64e5" xlink:to="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_7cdf0645-39d4-4fd9-b985-086769781fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_8c8246c5-9e2c-4332-80eb-b6554358d00f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba35ad5e-3f3b-4f3b-a835-4366999f64e5" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_8c8246c5-9e2c-4332-80eb-b6554358d00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f52fc8be-a0ed-40b3-8d2d-521a3860992a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f6942c81-92c5-443c-9cd8-f404d38a69e0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f52fc8be-a0ed-40b3-8d2d-521a3860992a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6762488b-35e9-4205-95da-06fc5b2a3aae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_68ada3c1-059c-4a89-a6ac-67f04d2dc09e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6762488b-35e9-4205-95da-06fc5b2a3aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_880862c2-b9d5-4799-980b-192ed26347d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6762488b-35e9-4205-95da-06fc5b2a3aae" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_880862c2-b9d5-4799-980b-192ed26347d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_2e7ea932-3c2f-4667-a08a-33e837113f66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6762488b-35e9-4205-95da-06fc5b2a3aae" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_2e7ea932-3c2f-4667-a08a-33e837113f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_d73bde98-4528-4f36-a40d-914e66a50029" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6762488b-35e9-4205-95da-06fc5b2a3aae" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_d73bde98-4528-4f36-a40d-914e66a50029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_a53befb8-fc9f-423f-bfbf-13e082f0b167" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6762488b-35e9-4205-95da-06fc5b2a3aae" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_a53befb8-fc9f-423f-bfbf-13e082f0b167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ebe5c9d0-1ae7-46c8-9a41-7a21803ee672" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6762488b-35e9-4205-95da-06fc5b2a3aae" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ebe5c9d0-1ae7-46c8-9a41-7a21803ee672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_fcbb0730-1e37-43bc-808f-2719b4cb1fc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_68ada3c1-059c-4a89-a6ac-67f04d2dc09e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_fcbb0730-1e37-43bc-808f-2719b4cb1fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e102e509-5f01-4ce7-b9d7-e31ccd724f1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_fcbb0730-1e37-43bc-808f-2719b4cb1fc2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e102e509-5f01-4ce7-b9d7-e31ccd724f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_2fd1a495-60c7-4fd6-a394-7af8b59a08ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_fcbb0730-1e37-43bc-808f-2719b4cb1fc2" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_2fd1a495-60c7-4fd6-a394-7af8b59a08ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_ae6a14a9-0e35-4d8b-8b47-d0853c294851" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_fcbb0730-1e37-43bc-808f-2719b4cb1fc2" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_ae6a14a9-0e35-4d8b-8b47-d0853c294851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_2675b9e3-1a37-4dae-85aa-f1a1b2c974f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_fcbb0730-1e37-43bc-808f-2719b4cb1fc2" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_2675b9e3-1a37-4dae-85aa-f1a1b2c974f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_4caf6100-b84a-4b42-a070-90d8472fd23d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_fcbb0730-1e37-43bc-808f-2719b4cb1fc2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_4caf6100-b84a-4b42-a070-90d8472fd23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_8cbe8ff0-7e8e-486f-9f1d-bafcbb887345" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_fcbb0730-1e37-43bc-808f-2719b4cb1fc2" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_8cbe8ff0-7e8e-486f-9f1d-bafcbb887345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_91163378-7f40-4b8c-9a21-ed770cc1d2de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_fcbb0730-1e37-43bc-808f-2719b4cb1fc2" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_91163378-7f40-4b8c-9a21-ed770cc1d2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_a23c5661-1535-4f23-8d33-83d19fb26161" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_fcbb0730-1e37-43bc-808f-2719b4cb1fc2" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_a23c5661-1535-4f23-8d33-83d19fb26161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d714f298-db2b-4131-a844-624dede0d5f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_fcbb0730-1e37-43bc-808f-2719b4cb1fc2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d714f298-db2b-4131-a844-624dede0d5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_41303749-005c-4de5-a423-348010dfbb31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_68ada3c1-059c-4a89-a6ac-67f04d2dc09e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_41303749-005c-4de5-a423-348010dfbb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_abcd97d4-e791-4620-88da-acb25a8668c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_68ada3c1-059c-4a89-a6ac-67f04d2dc09e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_abcd97d4-e791-4620-88da-acb25a8668c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_48ca9feb-c808-4c71-811c-a0a8fbfcdff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_68ada3c1-059c-4a89-a6ac-67f04d2dc09e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_48ca9feb-c808-4c71-811c-a0a8fbfcdff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_b6e0fe10-7d10-42bc-926c-25e71c0e87d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_68ada3c1-059c-4a89-a6ac-67f04d2dc09e" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_b6e0fe10-7d10-42bc-926c-25e71c0e87d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_148b5fff-dec9-439c-9299-f6b2a0cc3f2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_b6e0fe10-7d10-42bc-926c-25e71c0e87d9" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_148b5fff-dec9-439c-9299-f6b2a0cc3f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_7dbf57b1-8e6b-4512-8767-e7cda76056c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_b6e0fe10-7d10-42bc-926c-25e71c0e87d9" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_7dbf57b1-8e6b-4512-8767-e7cda76056c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReduction_d6c3981a-6d86-42d3-8a72-5a44ae087efa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReduction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_b6e0fe10-7d10-42bc-926c-25e71c0e87d9" xlink:to="loc_us-gaap_NotesReduction_d6c3981a-6d86-42d3-8a72-5a44ae087efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_897a99cc-cd65-4868-85fa-88a21eacc8e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_b6e0fe10-7d10-42bc-926c-25e71c0e87d9" xlink:to="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_897a99cc-cd65-4868-85fa-88a21eacc8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_c614c33a-018f-45f7-b894-80899c4106d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_68ada3c1-059c-4a89-a6ac-67f04d2dc09e" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_c614c33a-018f-45f7-b894-80899c4106d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_a95b0c8e-c5be-41cd-a4cb-da970a197b00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c614c33a-018f-45f7-b894-80899c4106d5" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_a95b0c8e-c5be-41cd-a4cb-da970a197b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="cutr-20210630.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_12f27f07-7b5f-4d3e-b1a8-e01d68d9cb67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_538491e7-a7cf-4f9a-9280-e04987a6b883" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_12f27f07-7b5f-4d3e-b1a8-e01d68d9cb67" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_538491e7-a7cf-4f9a-9280-e04987a6b883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cutr-20210630.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0da5f8a8-8dc8-4c90-bb6a-fc63bfc03575" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_c6dad871-1229-48ca-9547-4890c264f29e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0da5f8a8-8dc8-4c90-bb6a-fc63bfc03575" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_c6dad871-1229-48ca-9547-4890c264f29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_BasisOfPresentationPolicyTextBlock_59cb547f-3edc-4964-8add-96bb25157e08" xlink:href="cutr-20210630.xsd#cutr_BasisOfPresentationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0da5f8a8-8dc8-4c90-bb6a-fc63bfc03575" xlink:to="loc_cutr_BasisOfPresentationPolicyTextBlock_59cb547f-3edc-4964-8add-96bb25157e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock_1a63481f-5f44-4043-b4ec-5addc0d73a25" xlink:href="cutr-20210630.xsd#cutr_RisksAndUncertaintiesPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0da5f8a8-8dc8-4c90-bb6a-fc63bfc03575" xlink:to="loc_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock_1a63481f-5f44-4043-b4ec-5addc0d73a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7f961ff9-0a1d-46f5-8691-7b74a3f46737" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0da5f8a8-8dc8-4c90-bb6a-fc63bfc03575" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7f961ff9-0a1d-46f5-8691-7b74a3f46737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_e7bae6b8-2c9e-4e1f-a056-56fa16f3d604" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0da5f8a8-8dc8-4c90-bb6a-fc63bfc03575" xlink:to="loc_us-gaap_UseOfEstimates_e7bae6b8-2c9e-4e1f-a056-56fa16f3d604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f7e2b877-c54f-46c8-8345-1b019033f982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0da5f8a8-8dc8-4c90-bb6a-fc63bfc03575" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f7e2b877-c54f-46c8-8345-1b019033f982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a6424ea2-d1a9-4166-8b5e-12dab314d968" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_0aa0cd1d-2e4a-4fef-b2b3-a517e67940cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a6424ea2-d1a9-4166-8b5e-12dab314d968" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_0aa0cd1d-2e4a-4fef-b2b3-a517e67940cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b337085b-6b98-45c4-8300-830d8b8afb36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_0aa0cd1d-2e4a-4fef-b2b3-a517e67940cf" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b337085b-6b98-45c4-8300-830d8b8afb36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2037de14-cfa6-480d-8c0f-3bd46468984e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b337085b-6b98-45c4-8300-830d8b8afb36" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2037de14-cfa6-480d-8c0f-3bd46468984e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_6370cf47-f5ec-4fa4-8378-3e5d92e8e266" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2037de14-cfa6-480d-8c0f-3bd46468984e" xlink:to="loc_us-gaap_ConvertibleDebtMember_6370cf47-f5ec-4fa4-8378-3e5d92e8e266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4a417f8a-87b9-4ea8-a32a-eeaaa39fb49e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_0aa0cd1d-2e4a-4fef-b2b3-a517e67940cf" xlink:to="loc_us-gaap_DebtInstrumentAxis_4a417f8a-87b9-4ea8-a32a-eeaaa39fb49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_61d3b31a-71e6-489d-9c8b-982c96b4d556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4a417f8a-87b9-4ea8-a32a-eeaaa39fb49e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_61d3b31a-71e6-489d-9c8b-982c96b4d556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_26ff1864-f30e-4082-9c68-28a8632d68f4" xlink:href="cutr-20210630.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_61d3b31a-71e6-489d-9c8b-982c96b4d556" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_26ff1864-f30e-4082-9c68-28a8632d68f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_d976d439-2ab7-468d-b93d-4cb78d3a7b2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_0aa0cd1d-2e4a-4fef-b2b3-a517e67940cf" xlink:to="loc_us-gaap_ProductInformationLineItems_d976d439-2ab7-468d-b93d-4cb78d3a7b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork_ef339e3c-10af-48fc-b4e2-4f29e4a66d8f" xlink:href="cutr-20210630.xsd#cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_d976d439-2ab7-468d-b93d-4cb78d3a7b2b" xlink:to="loc_cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork_ef339e3c-10af-48fc-b4e2-4f29e4a66d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_3c5aeb6e-4a6a-43c9-8917-304e2966858b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_d976d439-2ab7-468d-b93d-4cb78d3a7b2b" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_3c5aeb6e-4a6a-43c9-8917-304e2966858b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_e381d91e-1c65-4532-85da-bcc3a2e19736" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_d976d439-2ab7-468d-b93d-4cb78d3a7b2b" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_e381d91e-1c65-4532-85da-bcc3a2e19736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b8f7a79f-fdf0-41fa-aa5a-3384221c99ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_d976d439-2ab7-468d-b93d-4cb78d3a7b2b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b8f7a79f-fdf0-41fa-aa5a-3384221c99ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CappedCallTransactionsCosts_3f9525aa-7a1b-4b4e-bab7-dc9e8c461718" xlink:href="cutr-20210630.xsd#cutr_CappedCallTransactionsCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_d976d439-2ab7-468d-b93d-4cb78d3a7b2b" xlink:to="loc_cutr_CappedCallTransactionsCosts_3f9525aa-7a1b-4b4e-bab7-dc9e8c461718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAdditions_7a4f4247-28d7-4b68-a15f-a387cbdf8a0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAdditions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_d976d439-2ab7-468d-b93d-4cb78d3a7b2b" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAdditions_7a4f4247-28d7-4b68-a15f-a387cbdf8a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/CashCashEquivalents" xlink:type="simple" xlink:href="cutr-20210630.xsd#CashCashEquivalents"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/CashCashEquivalents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_5f770199-9aa8-4943-8069-f71ff20c6280" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_0d6ad401-d58b-4744-8baf-d606f7b143e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_5f770199-9aa8-4943-8069-f71ff20c6280" xlink:to="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_0d6ad401-d58b-4744-8baf-d606f7b143e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/CashCashEquivalentsTables" xlink:type="simple" xlink:href="cutr-20210630.xsd#CashCashEquivalentsTables"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/CashCashEquivalentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_c303e406-7f17-4722-a156-294c294a9519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_e7718208-6e09-4e3f-a19c-85ca041b6c60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_c303e406-7f17-4722-a156-294c294a9519" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_e7718208-6e09-4e3f-a19c-85ca041b6c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/CashCashEquivalentsSummaryofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#CashCashEquivalentsSummaryofCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/CashCashEquivalentsSummaryofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_ecbb1a05-d7d0-49de-87d6-946490c96382" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_54b3738e-ce2f-43e8-a890-67dde1147e8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_ecbb1a05-d7d0-49de-87d6-946490c96382" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_54b3738e-ce2f-43e8-a890-67dde1147e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/CashCashEquivalentsNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#CashCashEquivalentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/CashCashEquivalentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_cee6bdbb-7e7f-4208-ac79-c037c26db9e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_9a4df306-f453-4260-9e18-fd6260941b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_cee6bdbb-7e7f-4208-ac79-c037c26db9e1" xlink:to="loc_us-gaap_MarketableSecurities_9a4df306-f453-4260-9e18-fd6260941b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/FairValueofFinancialInstruments" xlink:type="simple" xlink:href="cutr-20210630.xsd#FairValueofFinancialInstruments"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/FairValueofFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b8eda643-629d-4759-aaed-5710a4f0a196" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_66073ccc-b988-4822-86c1-dee22116c782" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b8eda643-629d-4759-aaed-5710a4f0a196" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_66073ccc-b988-4822-86c1-dee22116c782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/BalanceSheetDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#BalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/BalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2ff641e4-d628-470e-858f-ce2e513a54e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_d1b36a9c-b9b2-4627-9bb4-a75abaafedd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2ff641e4-d628-470e-858f-ce2e513a54e2" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_d1b36a9c-b9b2-4627-9bb4-a75abaafedd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/BalanceSheetDetailsTables" xlink:type="simple" xlink:href="cutr-20210630.xsd#BalanceSheetDetailsTables"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/BalanceSheetDetailsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1caf3a6b-c854-448b-9283-1b92ee1ac662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_9a5c2ee1-61e9-40de-8ae7-fd0cdc328e4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1caf3a6b-c854-448b-9283-1b92ee1ac662" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_9a5c2ee1-61e9-40de-8ae7-fd0cdc328e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_72e391d9-afac-4518-8ae7-a9827aab58cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1caf3a6b-c854-448b-9283-1b92ee1ac662" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_72e391d9-afac-4518-8ae7-a9827aab58cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/BalanceSheetDetailsInventoriesDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#BalanceSheetDetailsInventoriesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/BalanceSheetDetailsInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b7f7a698-f563-4db5-b74e-0438eaefd841" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_b2f4ec59-53e4-4056-a231-c1618451be13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b7f7a698-f563-4db5-b74e-0438eaefd841" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_b2f4ec59-53e4-4056-a231-c1618451be13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_35ce9287-7d13-43fc-a69b-ae64a0ccf2a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b7f7a698-f563-4db5-b74e-0438eaefd841" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_35ce9287-7d13-43fc-a69b-ae64a0ccf2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_23cf9ce5-45ea-4b0b-990d-32fed5c85236" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b7f7a698-f563-4db5-b74e-0438eaefd841" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_23cf9ce5-45ea-4b0b-990d-32fed5c85236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ac621ebd-3fdb-4bba-bfaa-09fa47d3b2bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b7f7a698-f563-4db5-b74e-0438eaefd841" xlink:to="loc_us-gaap_InventoryNet_ac621ebd-3fdb-4bba-bfaa-09fa47d3b2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#BalanceSheetDetailsAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_989b6b81-0344-412f-a21c-734dcf419e34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_1dc89857-4879-4e0e-9bb1-dfc4609d0399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_989b6b81-0344-412f-a21c-734dcf419e34" xlink:to="loc_us-gaap_AccruedSalariesCurrent_1dc89857-4879-4e0e-9bb1-dfc4609d0399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SalesAndMarketingAccrualsCurrent_13300285-e30d-43c1-804d-2e447fe65246" xlink:href="cutr-20210630.xsd#cutr_SalesAndMarketingAccrualsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_989b6b81-0344-412f-a21c-734dcf419e34" xlink:to="loc_cutr_SalesAndMarketingAccrualsCurrent_13300285-e30d-43c1-804d-2e447fe65246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AccruedInventoryInTransitCurrent_6eacfb65-de78-43cb-8548-8be4c8510996" xlink:href="cutr-20210630.xsd#cutr_AccruedInventoryInTransitCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_989b6b81-0344-412f-a21c-734dcf419e34" xlink:to="loc_cutr_AccruedInventoryInTransitCurrent_6eacfb65-de78-43cb-8548-8be4c8510996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_0c32a118-9bc8-41e9-8e15-539ba2f2a7ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_989b6b81-0344-412f-a21c-734dcf419e34" xlink:to="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_0c32a118-9bc8-41e9-8e15-539ba2f2a7ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent_00d37336-bf26-4693-b041-bcc89ffcb446" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_989b6b81-0344-412f-a21c-734dcf419e34" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrent_00d37336-bf26-4693-b041-bcc89ffcb446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_129226a4-5957-4937-b7db-a0e22807489c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_989b6b81-0344-412f-a21c-734dcf419e34" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_129226a4-5957-4937-b7db-a0e22807489c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f0bbd1af-b7d9-4d97-a960-fb78bc98e029" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_989b6b81-0344-412f-a21c-734dcf419e34" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f0bbd1af-b7d9-4d97-a960-fb78bc98e029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/BalanceSheetDetailsNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#BalanceSheetDetailsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/BalanceSheetDetailsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1a3b51d3-7795-476c-952f-b53d17089767" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyLiabilityTable_fb30f8f0-a2bc-4c83-909f-8300ab5715a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyLiabilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1a3b51d3-7795-476c-952f-b53d17089767" xlink:to="loc_us-gaap_ProductWarrantyLiabilityTable_fb30f8f0-a2bc-4c83-909f-8300ab5715a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_d61f0a6f-5d00-4298-86e9-2b7da78bf959" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantyLiabilityTable_fb30f8f0-a2bc-4c83-909f-8300ab5715a5" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_d61f0a6f-5d00-4298-86e9-2b7da78bf959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2c6b8583-b2d4-4764-a83d-92855542b489" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_d61f0a6f-5d00-4298-86e9-2b7da78bf959" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2c6b8583-b2d4-4764-a83d-92855542b489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ProductRemediationLiabilityMember_9fee0cd8-2cc5-4672-a8a6-5b1658bf6eb5" xlink:href="cutr-20210630.xsd#cutr_ProductRemediationLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2c6b8583-b2d4-4764-a83d-92855542b489" xlink:to="loc_cutr_ProductRemediationLiabilityMember_9fee0cd8-2cc5-4672-a8a6-5b1658bf6eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyLiabilityLineItems_444b34a9-ff86-4ecf-b271-0eba74692e8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyLiabilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantyLiabilityTable_fb30f8f0-a2bc-4c83-909f-8300ab5715a5" xlink:to="loc_us-gaap_ProductWarrantyLiabilityLineItems_444b34a9-ff86-4ecf-b271-0eba74692e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_0bba4f9c-1b85-4cde-841a-c06500348c16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems_444b34a9-ff86-4ecf-b271-0eba74692e8b" xlink:to="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_0bba4f9c-1b85-4cde-841a-c06500348c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_20851060-5ef5-4fc9-a851-f78145358ac7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems_444b34a9-ff86-4ecf-b271-0eba74692e8b" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_20851060-5ef5-4fc9-a851-f78145358ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyAccrual_cec6b5fb-5aba-490f-bd1a-3758d4264b31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtendedProductWarrantyAccrual"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems_444b34a9-ff86-4ecf-b271-0eba74692e8b" xlink:to="loc_us-gaap_ExtendedProductWarrantyAccrual_cec6b5fb-5aba-490f-bd1a-3758d4264b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves_cf487317-9f11-401e-ad49-8d39adf994d8" xlink:href="cutr-20210630.xsd#cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems_444b34a9-ff86-4ecf-b271-0eba74692e8b" xlink:to="loc_cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves_cf487317-9f11-401e-ad49-8d39adf994d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_7ee357cd-ce03-4813-b7a2-7999c5282b19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems_444b34a9-ff86-4ecf-b271-0eba74692e8b" xlink:to="loc_us-gaap_ProductWarrantyAccrualPayments_7ee357cd-ce03-4813-b7a2-7999c5282b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/WarrantyandExtendedServiceContract" xlink:type="simple" xlink:href="cutr-20210630.xsd#WarrantyandExtendedServiceContract"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/WarrantyandExtendedServiceContract" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_8534b65e-c5fb-4420-b516-28b576494270" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock_1be95f63-7050-47bd-ace0-afb9c85a442a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_8534b65e-c5fb-4420-b516-28b576494270" xlink:to="loc_us-gaap_ProductWarrantyDisclosureTextBlock_1be95f63-7050-47bd-ace0-afb9c85a442a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/WarrantyandExtendedServiceContractTables" xlink:type="simple" xlink:href="cutr-20210630.xsd#WarrantyandExtendedServiceContractTables"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/WarrantyandExtendedServiceContractTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_1ac06416-d770-42bd-aee1-f6dfb05374b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_74bbf0f9-bc9a-403f-a04b-ab4e15912213" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_1ac06416-d770-42bd-aee1-f6dfb05374b5" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_74bbf0f9-bc9a-403f-a04b-ab4e15912213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/WarrantyandExtendedServiceContractNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#WarrantyandExtendedServiceContractNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/WarrantyandExtendedServiceContractNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_540aed27-7fd2-488e-a9ec-4bdef0a0b563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyAccrualPayments_98e77ce9-0190-41db-a957-eb681fcb3376" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtendedProductWarrantyAccrualPayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_540aed27-7fd2-488e-a9ec-4bdef0a0b563" xlink:to="loc_us-gaap_ExtendedProductWarrantyAccrualPayments_98e77ce9-0190-41db-a957-eb681fcb3376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments_a5862c0c-c9c8-4ca0-b467-7e8d31de3b3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_540aed27-7fd2-488e-a9ec-4bdef0a0b563" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualPayments_a5862c0c-c9c8-4ca0-b467-7e8d31de3b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/WarrantyandExtendedServiceContractSummaryofWarrantiesDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#WarrantyandExtendedServiceContractSummaryofWarrantiesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/WarrantyandExtendedServiceContractSummaryofWarrantiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_1948342b-d4a4-404a-931d-38d028a9a08a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_d6a5edba-9eed-47df-aee1-c24aec91216b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_1948342b-d4a4-404a-931d-38d028a9a08a" xlink:to="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_d6a5edba-9eed-47df-aee1-c24aec91216b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_1d1aaddd-cd2d-407d-aa7e-f2cefa72b1f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_d6a5edba-9eed-47df-aee1-c24aec91216b" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_1d1aaddd-cd2d-407d-aa7e-f2cefa72b1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_ed70f9a8-f5b1-42ba-9753-2d042cb5ea15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_d6a5edba-9eed-47df-aee1-c24aec91216b" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_ed70f9a8-f5b1-42ba-9753-2d042cb5ea15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments_2770b19d-0273-4693-90cd-e173bff53838" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_d6a5edba-9eed-47df-aee1-c24aec91216b" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualPayments_2770b19d-0273-4693-90cd-e173bff53838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_f9c7156e-807f-4569-ab05-1c811a7520bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_d6a5edba-9eed-47df-aee1-c24aec91216b" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_f9c7156e-807f-4569-ab05-1c811a7520bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyAccrual_b24fbd07-9bac-494f-9c4a-8a88c76dfb0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtendedProductWarrantyAccrual"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_1948342b-d4a4-404a-931d-38d028a9a08a" xlink:to="loc_us-gaap_ExtendedProductWarrantyAccrual_b24fbd07-9bac-494f-9c4a-8a88c76dfb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/DeferredRevenue" xlink:type="simple" xlink:href="cutr-20210630.xsd#DeferredRevenue"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/DeferredRevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5de22bf6-951e-4359-98f8-8762da7e9840" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityTextBlock_89b8c142-9bc3-41ed-bf57-c03a464f1109" xlink:href="cutr-20210630.xsd#cutr_ContractWithCustomerLiabilityTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5de22bf6-951e-4359-98f8-8762da7e9840" xlink:to="loc_cutr_ContractWithCustomerLiabilityTextBlock_89b8c142-9bc3-41ed-bf57-c03a464f1109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/DeferredRevenueTables" xlink:type="simple" xlink:href="cutr-20210630.xsd#DeferredRevenueTables"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/DeferredRevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_810abeef-200d-4f2e-b1ce-4f52b6cea6fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_b7a05d46-a732-4df1-9160-5ebff44dadcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_810abeef-200d-4f2e-b1ce-4f52b6cea6fa" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_b7a05d46-a732-4df1-9160-5ebff44dadcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#DeferredRevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7894c97e-02c4-4efa-ba03-83d626ee0dca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6731286f-3f4c-45b5-8852-7e74dec251e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7894c97e-02c4-4efa-ba03-83d626ee0dca" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6731286f-3f4c-45b5-8852-7e74dec251e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_37faec58-fa48-49b0-add4-02c6d15731be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6731286f-3f4c-45b5-8852-7e74dec251e7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_37faec58-fa48-49b0-add4-02c6d15731be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_104857de-7782-41c3-b7ed-06e459e24f0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6731286f-3f4c-45b5-8852-7e74dec251e7" xlink:to="loc_srt_ProductOrServiceAxis_104857de-7782-41c3-b7ed-06e459e24f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_297ab6ed-5692-41e6-a9b9-2a9dd7a2d124" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_104857de-7782-41c3-b7ed-06e459e24f0c" xlink:to="loc_srt_ProductsAndServicesDomain_297ab6ed-5692-41e6-a9b9-2a9dd7a2d124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_fb1c457d-5557-4db9-82b0-8e6750606718" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_297ab6ed-5692-41e6-a9b9-2a9dd7a2d124" xlink:to="loc_us-gaap_ServiceMember_fb1c457d-5557-4db9-82b0-8e6750606718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6731286f-3f4c-45b5-8852-7e74dec251e7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionOneTerm_66fc33c0-e778-41db-bf36-1926bbc5f8de" xlink:href="cutr-20210630.xsd#cutr_ExtendedServiceContractOptionOneTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_cutr_ExtendedServiceContractOptionOneTerm_66fc33c0-e778-41db-bf36-1926bbc5f8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionTwoTerm_71f5abce-71f2-4a4b-b31e-bd902f83853e" xlink:href="cutr-20210630.xsd#cutr_ExtendedServiceContractOptionTwoTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_cutr_ExtendedServiceContractOptionTwoTerm_71f5abce-71f2-4a4b-b31e-bd902f83853e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionThreeTerm_205543c8-9dcc-4021-b9d6-bda40a623234" xlink:href="cutr-20210630.xsd#cutr_ExtendedServiceContractOptionThreeTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_cutr_ExtendedServiceContractOptionThreeTerm_205543c8-9dcc-4021-b9d6-bda40a623234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_242ba892-0b61-4255-9a0b-bf9efb1d8d2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_242ba892-0b61-4255-9a0b-bf9efb1d8d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_eb52b485-6cc5-405d-971a-9e0c7aa57682" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_eb52b485-6cc5-405d-971a-9e0c7aa57682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_6d89ef09-90bc-4600-a98e-33b6e9131a13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_6d89ef09-90bc-4600-a98e-33b6e9131a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CostsForExtendedServiceContracts_c49ab239-d0b6-4b64-bf19-5c2ab1515423" xlink:href="cutr-20210630.xsd#cutr_CostsForExtendedServiceContracts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b688d1b0-bf78-4cde-a0b8-e79ae5209a02" xlink:to="loc_cutr_CostsForExtendedServiceContracts_c49ab239-d0b6-4b64-bf19-5c2ab1515423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails_1" xlink:type="simple" xlink:href="cutr-20210630.xsd#DeferredRevenueNarrativeDetails_1"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://cutera.com/20210331/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#DeferredRevenueSummaryofDeferredServiceContractRevenueDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_26380006-7e8b-43e8-ad34-e6ed185c53a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_a16c4abe-819a-4e11-8abf-6e69e2d311f4" xlink:href="cutr-20210630.xsd#cutr_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_26380006-7e8b-43e8-ad34-e6ed185c53a9" xlink:to="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_a16c4abe-819a-4e11-8abf-6e69e2d311f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_b2149ed3-702c-460d-9817-77c5f7de75b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_a16c4abe-819a-4e11-8abf-6e69e2d311f4" xlink:to="loc_us-gaap_ContractWithCustomerLiability_b2149ed3-702c-460d-9817-77c5f7de75b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived_711bbde9-b568-4545-94bd-7c3d164efc1f" xlink:href="cutr-20210630.xsd#cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_a16c4abe-819a-4e11-8abf-6e69e2d311f4" xlink:to="loc_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived_711bbde9-b568-4545-94bd-7c3d164efc1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityPeriodDecrease_168c073c-d45e-47b7-bd3c-24d0e0c6fc39" xlink:href="cutr-20210630.xsd#cutr_ContractWithCustomerLiabilityPeriodDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_a16c4abe-819a-4e11-8abf-6e69e2d311f4" xlink:to="loc_cutr_ContractWithCustomerLiabilityPeriodDecrease_168c073c-d45e-47b7-bd3c-24d0e0c6fc39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_4aa23af8-21e7-45fc-aafb-990d039c1375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_a16c4abe-819a-4e11-8abf-6e69e2d311f4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_4aa23af8-21e7-45fc-aafb-990d039c1375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_42242f5d-4f2a-4d75-bc4a-1fe7a89c14ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_a16c4abe-819a-4e11-8abf-6e69e2d311f4" xlink:to="loc_us-gaap_ContractWithCustomerLiability_42242f5d-4f2a-4d75-bc4a-1fe7a89c14ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/Revenue" xlink:type="simple" xlink:href="cutr-20210630.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bc8acba4-36fa-43f0-a211-489cde1aa424" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_72aa8ac1-66c0-4d5c-865b-6b2f5fffef4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bc8acba4-36fa-43f0-a211-489cde1aa424" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_72aa8ac1-66c0-4d5c-865b-6b2f5fffef4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#RevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9d4e0274-7bbd-43db-8f1f-95b9db51e18e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_2533cae4-8151-4cf7-b3b6-9914922f8550" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9d4e0274-7bbd-43db-8f1f-95b9db51e18e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_2533cae4-8151-4cf7-b3b6-9914922f8550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_4a90e909-2e4d-4851-9628-444fe7f09dcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2533cae4-8151-4cf7-b3b6-9914922f8550" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_4a90e909-2e4d-4851-9628-444fe7f09dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_987e4537-f1da-44e2-a7b9-ef45a55da7b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_4a90e909-2e4d-4851-9628-444fe7f09dcd" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_987e4537-f1da-44e2-a7b9-ef45a55da7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_f99b2708-0466-41f3-8475-52fa808bb2dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_987e4537-f1da-44e2-a7b9-ef45a55da7b4" xlink:to="loc_us-gaap_TransferredOverTimeMember_f99b2708-0466-41f3-8475-52fa808bb2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3ed215bb-4a1f-4807-ae5c-dac5251600f1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2533cae4-8151-4cf7-b3b6-9914922f8550" xlink:to="loc_srt_ProductOrServiceAxis_3ed215bb-4a1f-4807-ae5c-dac5251600f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_137f9c03-750e-40f9-9c90-3eb2cf7cc265" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_3ed215bb-4a1f-4807-ae5c-dac5251600f1" xlink:to="loc_srt_ProductsAndServicesDomain_137f9c03-750e-40f9-9c90-3eb2cf7cc265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_067d7686-df6f-4d0a-9e9b-4aa2cdd8ec0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_137f9c03-750e-40f9-9c90-3eb2cf7cc265" xlink:to="loc_us-gaap_ServiceMember_067d7686-df6f-4d0a-9e9b-4aa2cdd8ec0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CustomerMarketingSupportMember_70827ead-251f-47c0-ab04-9f6f557506ba" xlink:href="cutr-20210630.xsd#cutr_CustomerMarketingSupportMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ServiceMember_067d7686-df6f-4d0a-9e9b-4aa2cdd8ec0a" xlink:to="loc_cutr_CustomerMarketingSupportMember_70827ead-251f-47c0-ab04-9f6f557506ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LoyaltyMember_57d43bbe-a02e-4441-bb89-de1d9e0c61cf" xlink:href="cutr-20210630.xsd#cutr_LoyaltyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ServiceMember_067d7686-df6f-4d0a-9e9b-4aa2cdd8ec0a" xlink:to="loc_cutr_LoyaltyMember_57d43bbe-a02e-4441-bb89-de1d9e0c61cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SkincareMember_ca3b5e17-c7c3-4b07-a6a1-094c49fa0352" xlink:href="cutr-20210630.xsd#cutr_SkincareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_137f9c03-750e-40f9-9c90-3eb2cf7cc265" xlink:to="loc_cutr_SkincareMember_ca3b5e17-c7c3-4b07-a6a1-094c49fa0352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_528adbbe-2a83-4881-a132-66df31901256" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2533cae4-8151-4cf7-b3b6-9914922f8550" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_528adbbe-2a83-4881-a132-66df31901256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b1b84cfc-0976-4173-91a2-3e1435c1c7c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_528adbbe-2a83-4881-a132-66df31901256" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b1b84cfc-0976-4173-91a2-3e1435c1c7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_a0176888-9551-4752-b52d-74a542f48e23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b1b84cfc-0976-4173-91a2-3e1435c1c7c5" xlink:to="loc_us-gaap_OtherAssetsMember_a0176888-9551-4752-b52d-74a542f48e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d7d04554-3832-437e-9ff2-5fc4e9bfc87d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2533cae4-8151-4cf7-b3b6-9914922f8550" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d7d04554-3832-437e-9ff2-5fc4e9bfc87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4a8480da-47bb-4c4c-a0a3-51229c1ac050" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d7d04554-3832-437e-9ff2-5fc4e9bfc87d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4a8480da-47bb-4c4c-a0a3-51229c1ac050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_d3735964-4103-4a39-a7f1-669f681669f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4a8480da-47bb-4c4c-a0a3-51229c1ac050" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_d3735964-4103-4a39-a7f1-669f681669f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_237f1179-eeae-4765-8645-11bc6e20d432" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2533cae4-8151-4cf7-b3b6-9914922f8550" xlink:to="loc_srt_StatementGeographicalAxis_237f1179-eeae-4765-8645-11bc6e20d432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7c23de90-570c-48f3-beaa-ff1b5614a5c2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_237f1179-eeae-4765-8645-11bc6e20d432" xlink:to="loc_srt_SegmentGeographicalDomain_7c23de90-570c-48f3-beaa-ff1b5614a5c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_8a9d41f5-cf0a-498b-94be-0b5511dce6cc" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_JP"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7c23de90-570c-48f3-beaa-ff1b5614a5c2" xlink:to="loc_country_JP_8a9d41f5-cf0a-498b-94be-0b5511dce6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cc32c1a3-6bc0-496d-8f93-a5fc85284878" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2533cae4-8151-4cf7-b3b6-9914922f8550" xlink:to="loc_srt_RangeAxis_cc32c1a3-6bc0-496d-8f93-a5fc85284878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_37a8e4aa-4658-40d7-a2da-fd89520da162" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cc32c1a3-6bc0-496d-8f93-a5fc85284878" xlink:to="loc_srt_RangeMember_37a8e4aa-4658-40d7-a2da-fd89520da162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_645c4693-9e9c-4703-af76-4a456d7d876a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_37a8e4aa-4658-40d7-a2da-fd89520da162" xlink:to="loc_srt_MinimumMember_645c4693-9e9c-4703-af76-4a456d7d876a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c603dba4-f27b-4cd4-9f60-b7e6236ea3bb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_37a8e4aa-4658-40d7-a2da-fd89520da162" xlink:to="loc_srt_MaximumMember_c603dba4-f27b-4cd4-9f60-b7e6236ea3bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2533cae4-8151-4cf7-b3b6-9914922f8550" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RevenuePerformanceObligationSatisfiedOverTimePercent_1caa8d2c-2f8d-4435-bd68-0ff8ff3d97f7" xlink:href="cutr-20210630.xsd#cutr_RevenuePerformanceObligationSatisfiedOverTimePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_cutr_RevenuePerformanceObligationSatisfiedOverTimePercent_1caa8d2c-2f8d-4435-bd68-0ff8ff3d97f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment_1da7fd79-556d-409c-a94c-efed5986ad33" xlink:href="cutr-20210630.xsd#cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment_1da7fd79-556d-409c-a94c-efed5986ad33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SaleOfThirdPartyProductWarrantyPeriod_fcb3b75b-4a92-4120-a683-3774e138c7dc" xlink:href="cutr-20210630.xsd#cutr_SaleOfThirdPartyProductWarrantyPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_cutr_SaleOfThirdPartyProductWarrantyPeriod_fcb3b75b-4a92-4120-a683-3774e138c7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseRevenue_825dd34f-b29b-46b4-9f6f-bcfc42deee65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesTypeLeaseRevenue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_us-gaap_SalesTypeLeaseRevenue_825dd34f-b29b-46b4-9f6f-bcfc42deee65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionOneTerm_8f8a20b8-9d4a-4532-8eb3-b8b364aed963" xlink:href="cutr-20210630.xsd#cutr_ExtendedServiceContractOptionOneTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_cutr_ExtendedServiceContractOptionOneTerm_8f8a20b8-9d4a-4532-8eb3-b8b364aed963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionTwoTerm_09271fc0-11ed-4c9c-8eee-03772edd673c" xlink:href="cutr-20210630.xsd#cutr_ExtendedServiceContractOptionTwoTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_cutr_ExtendedServiceContractOptionTwoTerm_09271fc0-11ed-4c9c-8eee-03772edd673c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionThreeTerm_3c0b4067-9696-4c99-b74c-7c51bc561b06" xlink:href="cutr-20210630.xsd#cutr_ExtendedServiceContractOptionThreeTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_cutr_ExtendedServiceContractOptionThreeTerm_3c0b4067-9696-4c99-b74c-7c51bc561b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_af403fa8-c69f-4ac6-8aaf-6270a9db59a9" xlink:href="cutr-20210630.xsd#cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_af403fa8-c69f-4ac6-8aaf-6270a9db59a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RevenueFromContractWithCustomerTermOfContract_24888dda-3470-49b8-8918-356eb9129417" xlink:href="cutr-20210630.xsd#cutr_RevenueFromContractWithCustomerTermOfContract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_cutr_RevenueFromContractWithCustomerTermOfContract_24888dda-3470-49b8-8918-356eb9129417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_20b16a8c-b4d0-4be4-b4dd-459aa3caeb37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_us-gaap_ContractWithCustomerLiability_20b16a8c-b4d0-4be4-b4dd-459aa3caeb37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_9837d00b-2aa4-499b-a876-e2ac52cf2200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_9837d00b-2aa4-499b-a876-e2ac52cf2200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_0f326c6f-fe10-4d7b-a942-fa33cc82f78a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_us-gaap_CapitalizedContractCostNet_0f326c6f-fe10-4d7b-a942-fa33cc82f78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_b70958da-c0a3-4f28-9439-3526caee8bf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2241207d-8022-4b4d-ab06-565d618a75bb" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_b70958da-c0a3-4f28-9439-3526caee8bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpense" xlink:type="simple" xlink:href="cutr-20210630.xsd#StockholdersEquityandStockbasedCompensationExpense"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpense" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c5ea6611-df03-49fb-92ff-319f30be5b08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0e429836-7b44-4620-8b9c-fe46ad03ae96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c5ea6611-df03-49fb-92ff-319f30be5b08" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0e429836-7b44-4620-8b9c-fe46ad03ae96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseTables" xlink:type="simple" xlink:href="cutr-20210630.xsd#StockholdersEquityandStockbasedCompensationExpenseTables"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7ddc18d7-7113-4af9-80df-ff43b6a0451a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ea7fd5bc-81fe-47f5-b3cd-a1d276e43049" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7ddc18d7-7113-4af9-80df-ff43b6a0451a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ea7fd5bc-81fe-47f5-b3cd-a1d276e43049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2da1d4a2-ce58-492c-a785-3d302c197eef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7ddc18d7-7113-4af9-80df-ff43b6a0451a" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2da1d4a2-ce58-492c-a785-3d302c197eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_85676e9a-b607-406b-8661-5c39c5a4b87e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3364c779-b6fa-429d-90fe-6ea6d9ed692d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_85676e9a-b607-406b-8661-5c39c5a4b87e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3364c779-b6fa-429d-90fe-6ea6d9ed692d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_a1f5e088-c80e-4746-bf33-3432410939de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3364c779-b6fa-429d-90fe-6ea6d9ed692d" xlink:to="loc_us-gaap_PlanNameAxis_a1f5e088-c80e-4746-bf33-3432410939de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_89432980-b317-4630-b643-4f4552223c00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_a1f5e088-c80e-4746-bf33-3432410939de" xlink:to="loc_us-gaap_PlanNameDomain_89432980-b317-4630-b643-4f4552223c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TwoThousandNineteenEquityIncentivePlanMember_69a462d8-4565-44e5-8e62-b9864f2b6818" xlink:href="cutr-20210630.xsd#cutr_TwoThousandNineteenEquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_89432980-b317-4630-b643-4f4552223c00" xlink:to="loc_cutr_TwoThousandNineteenEquityIncentivePlanMember_69a462d8-4565-44e5-8e62-b9864f2b6818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AmendedAndRestated2004EquityIncentivePlanMember_9eefd410-dba9-4579-8f3d-5a1d5a0e7aef" xlink:href="cutr-20210630.xsd#cutr_AmendedAndRestated2004EquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_89432980-b317-4630-b643-4f4552223c00" xlink:to="loc_cutr_AmendedAndRestated2004EquityIncentivePlanMember_9eefd410-dba9-4579-8f3d-5a1d5a0e7aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1cdb7bcb-20f6-44ae-a5f2-bb0231f61dd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3364c779-b6fa-429d-90fe-6ea6d9ed692d" xlink:to="loc_us-gaap_AwardTypeAxis_1cdb7bcb-20f6-44ae-a5f2-bb0231f61dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22a7b99d-358a-4a7e-95db-30026ab74c6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1cdb7bcb-20f6-44ae-a5f2-bb0231f61dd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22a7b99d-358a-4a7e-95db-30026ab74c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_6d590fbe-ea2c-494d-82b5-1ba17f24c64e" xlink:href="cutr-20210630.xsd#cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22a7b99d-358a-4a7e-95db-30026ab74c6d" xlink:to="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_6d590fbe-ea2c-494d-82b5-1ba17f24c64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_1390c3a2-2a38-4318-a64a-e76ba2e9a9d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_6d590fbe-ea2c-494d-82b5-1ba17f24c64e" xlink:to="loc_us-gaap_PerformanceSharesMember_1390c3a2-2a38-4318-a64a-e76ba2e9a9d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a4e93c81-33ae-46bb-a1cd-7613a47fea67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_6d590fbe-ea2c-494d-82b5-1ba17f24c64e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a4e93c81-33ae-46bb-a1cd-7613a47fea67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NonqualifiedStockOptionsMember_731a2158-9260-4415-bacc-847e28ced6da" xlink:href="cutr-20210630.xsd#cutr_NonqualifiedStockOptionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22a7b99d-358a-4a7e-95db-30026ab74c6d" xlink:to="loc_cutr_NonqualifiedStockOptionsMember_731a2158-9260-4415-bacc-847e28ced6da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_7a9a3585-9e0f-469b-8402-349ef79accd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22a7b99d-358a-4a7e-95db-30026ab74c6d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_7a9a3585-9e0f-469b-8402-349ef79accd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_659ffdcd-faaa-4729-9703-cb7ddf2a5d50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3364c779-b6fa-429d-90fe-6ea6d9ed692d" xlink:to="loc_us-gaap_VestingAxis_659ffdcd-faaa-4729-9703-cb7ddf2a5d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_91182074-b573-49b4-8661-96f899c3cd60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_659ffdcd-faaa-4729-9703-cb7ddf2a5d50" xlink:to="loc_us-gaap_VestingDomain_91182074-b573-49b4-8661-96f899c3cd60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_76e2d036-21f8-4951-8dd6-4b342e7fe526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_91182074-b573-49b4-8661-96f899c3cd60" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_76e2d036-21f8-4951-8dd6-4b342e7fe526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_c52857da-e6c2-4fce-9c9d-d10b2567474f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_91182074-b573-49b4-8661-96f899c3cd60" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_c52857da-e6c2-4fce-9c9d-d10b2567474f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_cf048986-58d6-4227-88c0-f80df9ae9788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_91182074-b573-49b4-8661-96f899c3cd60" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_cf048986-58d6-4227-88c0-f80df9ae9788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedPaymentArrangementTrancheFourMember_f281ab94-ad05-4b1a-9553-048767934af6" xlink:href="cutr-20210630.xsd#cutr_ShareBasedPaymentArrangementTrancheFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_91182074-b573-49b4-8661-96f899c3cd60" xlink:to="loc_cutr_ShareBasedPaymentArrangementTrancheFourMember_f281ab94-ad05-4b1a-9553-048767934af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_d7c05f33-7a2e-4376-a8eb-68691a929398" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3364c779-b6fa-429d-90fe-6ea6d9ed692d" xlink:to="loc_srt_TitleOfIndividualAxis_d7c05f33-7a2e-4376-a8eb-68691a929398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7368aa7e-b663-499f-ac84-8d2f96499950" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_d7c05f33-7a2e-4376-a8eb-68691a929398" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7368aa7e-b663-499f-ac84-8d2f96499950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NonEmployeeDirectorsMember_dd2ac16a-9a83-4d85-a91e-ac9d32823c92" xlink:href="cutr-20210630.xsd#cutr_NonEmployeeDirectorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7368aa7e-b663-499f-ac84-8d2f96499950" xlink:to="loc_cutr_NonEmployeeDirectorsMember_dd2ac16a-9a83-4d85-a91e-ac9d32823c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember_e3b9b73e-f327-4f21-a308-2258818414df" xlink:href="cutr-20210630.xsd#cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7368aa7e-b663-499f-ac84-8d2f96499950" xlink:to="loc_cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember_e3b9b73e-f327-4f21-a308-2258818414df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExecutiveOfficersAndSeniorManagementMember_5a996b18-56d8-4b17-bec1-bf8c58e7f98d" xlink:href="cutr-20210630.xsd#cutr_ExecutiveOfficersAndSeniorManagementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7368aa7e-b663-499f-ac84-8d2f96499950" xlink:to="loc_cutr_ExecutiveOfficersAndSeniorManagementMember_5a996b18-56d8-4b17-bec1-bf8c58e7f98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_a65ed61c-a3e7-4c80-90d0-d858af5ef6c0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7368aa7e-b663-499f-ac84-8d2f96499950" xlink:to="loc_srt_ChiefExecutiveOfficerMember_a65ed61c-a3e7-4c80-90d0-d858af5ef6c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3364c779-b6fa-429d-90fe-6ea6d9ed692d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_d79202b0-1f09-4054-ba87-4956277b6da2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_d79202b0-1f09-4054-ba87-4956277b6da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_6576c95c-a030-4b12-b972-50975a13d853" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_6576c95c-a030-4b12-b972-50975a13d853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cdc8af67-16f2-4b8d-b12e-9afaf5a37cda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cdc8af67-16f2-4b8d-b12e-9afaf5a37cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_81816d86-a18c-4371-a1c4-32b303595c2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_81816d86-a18c-4371-a1c4-32b303595c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1416405b-e7d7-4a50-8402-eedbbfd7b338" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1416405b-e7d7-4a50-8402-eedbbfd7b338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_e96d93ec-4e4d-4286-882c-04d7eb9d84dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_e96d93ec-4e4d-4286-882c-04d7eb9d84dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear_3bf09cdc-7419-4b90-90a4-1a8ca1c76ef9" xlink:href="cutr-20210630.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear_3bf09cdc-7419-4b90-90a4-1a8ca1c76ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_36183805-641f-445d-81ed-8b394e361938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_36183805-641f-445d-81ed-8b394e361938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_bc582c0c-96ff-4a5e-b137-935bcb05f879" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_bc582c0c-96ff-4a5e-b137-935bcb05f879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6e717624-2d02-4844-8e48-e49a5e3486de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6e717624-2d02-4844-8e48-e49a5e3486de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_49e5fb47-eac7-401f-8ef0-f8b4ad3aa8a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_49e5fb47-eac7-401f-8ef0-f8b4ad3aa8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_57296d1c-6347-44db-8757-4b1683481143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a3c1d008-a2ce-4a4c-9f2f-d70775f80e96" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_57296d1c-6347-44db-8757-4b1683481143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_015eae49-03e7-4186-b7c8-7be7456ca85d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_8e4520ee-dc90-47cc-86b0-798d052ede47" xlink:href="cutr-20210630.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_015eae49-03e7-4186-b7c8-7be7456ca85d" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_8e4520ee-dc90-47cc-86b0-798d052ede47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_d64477c4-105e-4937-87e2-58c701e41c05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_8e4520ee-dc90-47cc-86b0-798d052ede47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_d64477c4-105e-4937-87e2-58c701e41c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved_a52f2c53-93c7-4e40-a53e-8f90a3565c03" xlink:href="cutr-20210630.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_8e4520ee-dc90-47cc-86b0-798d052ede47" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved_a52f2c53-93c7-4e40-a53e-8f90a3565c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fc28bd3a-5b64-40da-b72e-29448026f932" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_8e4520ee-dc90-47cc-86b0-798d052ede47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fc28bd3a-5b64-40da-b72e-29448026f932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ddad2fdf-dcc7-4def-bb45-fb4a02bc3aca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_8e4520ee-dc90-47cc-86b0-798d052ede47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ddad2fdf-dcc7-4def-bb45-fb4a02bc3aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod_531839bc-603a-4358-a385-2aa13b71da4a" xlink:href="cutr-20210630.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_8e4520ee-dc90-47cc-86b0-798d052ede47" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod_531839bc-603a-4358-a385-2aa13b71da4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_fc3249c5-2a7f-4b8e-89fb-846398962213" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_8e4520ee-dc90-47cc-86b0-798d052ede47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_fc3249c5-2a7f-4b8e-89fb-846398962213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_f8151db6-9875-4975-b626-c8239be1dd59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_8e4520ee-dc90-47cc-86b0-798d052ede47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_f8151db6-9875-4975-b626-c8239be1dd59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_4ffba583-84a5-40e6-a56b-8a05db400036" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_8e4520ee-dc90-47cc-86b0-798d052ede47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_4ffba583-84a5-40e6-a56b-8a05db400036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5a989a1b-5854-43d9-8af0-c4cbb61ff61d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_015eae49-03e7-4186-b7c8-7be7456ca85d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5a989a1b-5854-43d9-8af0-c4cbb61ff61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_11504ec5-2c77-4d39-814b-45dab8660c58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5a989a1b-5854-43d9-8af0-c4cbb61ff61d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_11504ec5-2c77-4d39-814b-45dab8660c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_f1736ade-c970-473a-9ad1-54bde245567c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5a989a1b-5854-43d9-8af0-c4cbb61ff61d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_f1736ade-c970-473a-9ad1-54bde245567c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7dc3a7a1-94fc-4aa1-b007-929ab8f91825" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5a989a1b-5854-43d9-8af0-c4cbb61ff61d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7dc3a7a1-94fc-4aa1-b007-929ab8f91825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_c8b116d0-ed35-47e6-b134-eb3c33bf25b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5a989a1b-5854-43d9-8af0-c4cbb61ff61d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_c8b116d0-ed35-47e6-b134-eb3c33bf25b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_cbf10d68-69c1-4055-8086-8f685b430f5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5a989a1b-5854-43d9-8af0-c4cbb61ff61d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_cbf10d68-69c1-4055-8086-8f685b430f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a73c0404-0f60-405e-8c7e-9eafdcbff138" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_015eae49-03e7-4186-b7c8-7be7456ca85d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a73c0404-0f60-405e-8c7e-9eafdcbff138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_79d671c3-8540-46f4-9b0c-f2dd6739b991" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a73c0404-0f60-405e-8c7e-9eafdcbff138" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_79d671c3-8540-46f4-9b0c-f2dd6739b991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_984f9844-3f8f-437d-ae51-a14137d9a1fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a73c0404-0f60-405e-8c7e-9eafdcbff138" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_984f9844-3f8f-437d-ae51-a14137d9a1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5fa9eb92-4432-4868-a52c-ba2e6ac60582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a73c0404-0f60-405e-8c7e-9eafdcbff138" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5fa9eb92-4432-4868-a52c-ba2e6ac60582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1b60dce3-2ab8-498c-b826-467e52b5fd3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a73c0404-0f60-405e-8c7e-9eafdcbff138" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1b60dce3-2ab8-498c-b826-467e52b5fd3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_10b94796-e9d9-4ce4-925a-754cc683fe53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a73c0404-0f60-405e-8c7e-9eafdcbff138" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_10b94796-e9d9-4ce4-925a-754cc683fe53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ba5efb11-d894-4786-a4e1-6a2bee165226" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_015eae49-03e7-4186-b7c8-7be7456ca85d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ba5efb11-d894-4786-a4e1-6a2bee165226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c405a3cd-49d1-44c1-82e7-04d7ce8483e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ba5efb11-d894-4786-a4e1-6a2bee165226" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c405a3cd-49d1-44c1-82e7-04d7ce8483e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_03a8000b-a0bc-4af7-a34e-8ad64cb5b3d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ba5efb11-d894-4786-a4e1-6a2bee165226" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_03a8000b-a0bc-4af7-a34e-8ad64cb5b3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_bc9b99c4-4e7d-4cfc-9067-b574f52f6e5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ba5efb11-d894-4786-a4e1-6a2bee165226" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_bc9b99c4-4e7d-4cfc-9067-b574f52f6e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6c76e04b-2b9d-45c2-b196-b7a42c90e1a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d0b55af3-bff0-4e1d-ad2a-ab0f80269597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6c76e04b-2b9d-45c2-b196-b7a42c90e1a9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d0b55af3-bff0-4e1d-ad2a-ab0f80269597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0fddcd0e-6eeb-4f12-9c8e-8a06ee772068" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d0b55af3-bff0-4e1d-ad2a-ab0f80269597" xlink:to="loc_us-gaap_AwardTypeAxis_0fddcd0e-6eeb-4f12-9c8e-8a06ee772068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_50286df4-a7a8-43df-8c92-1c6b7e9e8805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_0fddcd0e-6eeb-4f12-9c8e-8a06ee772068" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_50286df4-a7a8-43df-8c92-1c6b7e9e8805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_272a2ccd-f9c5-493b-9956-52c4d9ae1017" xlink:href="cutr-20210630.xsd#cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_50286df4-a7a8-43df-8c92-1c6b7e9e8805" xlink:to="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_272a2ccd-f9c5-493b-9956-52c4d9ae1017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e33d876-df31-431a-ba7d-dd1a3af4e1dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d0b55af3-bff0-4e1d-ad2a-ab0f80269597" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e33d876-df31-431a-ba7d-dd1a3af4e1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_be1d8f1f-354d-4fdf-ab33-3618ecb6b2ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e33d876-df31-431a-ba7d-dd1a3af4e1dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_be1d8f1f-354d-4fdf-ab33-3618ecb6b2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb0f636b-953f-4bd4-af04-8fc75cc80bad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_be1d8f1f-354d-4fdf-ab33-3618ecb6b2ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb0f636b-953f-4bd4-af04-8fc75cc80bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_38476de8-2db0-44b8-b928-2fe924602cca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_be1d8f1f-354d-4fdf-ab33-3618ecb6b2ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_38476de8-2db0-44b8-b928-2fe924602cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d09f0108-b170-486f-a9fd-bf8bde9eb4d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_be1d8f1f-354d-4fdf-ab33-3618ecb6b2ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d09f0108-b170-486f-a9fd-bf8bde9eb4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9c4b3607-d050-4b50-8a07-554b860960ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_be1d8f1f-354d-4fdf-ab33-3618ecb6b2ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9c4b3607-d050-4b50-8a07-554b860960ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4462a6fb-cd84-478d-9975-d2c603b9c44d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_be1d8f1f-354d-4fdf-ab33-3618ecb6b2ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4462a6fb-cd84-478d-9975-d2c603b9c44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_505a0815-4ea0-47d3-a1ab-d5c15131f1c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e33d876-df31-431a-ba7d-dd1a3af4e1dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_505a0815-4ea0-47d3-a1ab-d5c15131f1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_009daa8e-036f-4c39-8d8c-2e7d63ab63ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_505a0815-4ea0-47d3-a1ab-d5c15131f1c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_009daa8e-036f-4c39-8d8c-2e7d63ab63ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ca4e73d3-bcc0-489a-82ab-4cc2e9a6e0cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_505a0815-4ea0-47d3-a1ab-d5c15131f1c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ca4e73d3-bcc0-489a-82ab-4cc2e9a6e0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e0ab3be3-a66d-4cb6-a32b-cb5be104833d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_505a0815-4ea0-47d3-a1ab-d5c15131f1c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e0ab3be3-a66d-4cb6-a32b-cb5be104833d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9ca3109c-bee6-4eab-8572-dcf4932e3c13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_505a0815-4ea0-47d3-a1ab-d5c15131f1c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9ca3109c-bee6-4eab-8572-dcf4932e3c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a8b4517e-7b9f-4572-9896-7ab195f09622" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_505a0815-4ea0-47d3-a1ab-d5c15131f1c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a8b4517e-7b9f-4572-9896-7ab195f09622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_d536551a-8b3b-4963-84a7-907c4e9a106c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e33d876-df31-431a-ba7d-dd1a3af4e1dd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_d536551a-8b3b-4963-84a7-907c4e9a106c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_27ca45e9-58ad-4ad0-82e3-978a7f769ad4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_d536551a-8b3b-4963-84a7-907c4e9a106c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_27ca45e9-58ad-4ad0-82e3-978a7f769ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_1f364fd0-8950-4878-a118-66486abbe3ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_d536551a-8b3b-4963-84a7-907c4e9a106c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_1f364fd0-8950-4878-a118-66486abbe3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6914dd09-1dc9-4c9a-9771-33478959a01c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c53ddbf-fecd-484f-8d40-27bc3136d9ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6914dd09-1dc9-4c9a-9771-33478959a01c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c53ddbf-fecd-484f-8d40-27bc3136d9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1b920b5b-5e9d-442a-b164-f09a81020b83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c53ddbf-fecd-484f-8d40-27bc3136d9ef" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1b920b5b-5e9d-442a-b164-f09a81020b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b84cbff5-f201-43b2-89bd-f1a62b3079a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1b920b5b-5e9d-442a-b164-f09a81020b83" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b84cbff5-f201-43b2-89bd-f1a62b3079a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0fbcd202-2c68-4cfa-82c1-b4a8d2232514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b84cbff5-f201-43b2-89bd-f1a62b3079a0" xlink:to="loc_us-gaap_CostOfSalesMember_0fbcd202-2c68-4cfa-82c1-b4a8d2232514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_9f50cf40-8c38-42cd-9a5a-91be14b48120" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b84cbff5-f201-43b2-89bd-f1a62b3079a0" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_9f50cf40-8c38-42cd-9a5a-91be14b48120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e220e07d-502e-4027-92e5-c124aed379be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b84cbff5-f201-43b2-89bd-f1a62b3079a0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e220e07d-502e-4027-92e5-c124aed379be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_7acbe236-d057-41b6-b109-6f71685cdf91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b84cbff5-f201-43b2-89bd-f1a62b3079a0" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_7acbe236-d057-41b6-b109-6f71685cdf91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c032951-4633-4b08-b4df-898fb2c4e7b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c53ddbf-fecd-484f-8d40-27bc3136d9ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c032951-4633-4b08-b4df-898fb2c4e7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_45d9a617-d066-4d16-98af-b6fdec897fd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4c032951-4633-4b08-b4df-898fb2c4e7b3" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_45d9a617-d066-4d16-98af-b6fdec897fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/NetIncomeLossPerShare" xlink:type="simple" xlink:href="cutr-20210630.xsd#NetIncomeLossPerShare"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/NetIncomeLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_cb6d0269-c2a0-4cde-b2f2-509edcc67e7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_3fccf9c8-7792-4f82-be82-5ff16deb04ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cb6d0269-c2a0-4cde-b2f2-509edcc67e7e" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_3fccf9c8-7792-4f82-be82-5ff16deb04ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/NetIncomeLossPerShareTables" xlink:type="simple" xlink:href="cutr-20210630.xsd#NetIncomeLossPerShareTables"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/NetIncomeLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e03bec60-8098-4265-aaec-2745ef2b73a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c516c8a8-8ec8-4831-9449-79930a3b7beb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e03bec60-8098-4265-aaec-2745ef2b73a3" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c516c8a8-8ec8-4831-9449-79930a3b7beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_de4bf8f9-c22a-4a8d-ba5b-309bbe49dbbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e03bec60-8098-4265-aaec-2745ef2b73a3" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_de4bf8f9-c22a-4a8d-ba5b-309bbe49dbbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/NetIncomeLossPerShareNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#NetIncomeLossPerShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/NetIncomeLossPerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9cc53975-aaf1-4332-a1ed-50a418fcf5fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_59857ecb-6e23-4405-8443-c160480e3f54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9cc53975-aaf1-4332-a1ed-50a418fcf5fb" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_59857ecb-6e23-4405-8443-c160480e3f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_58e5d5f7-e8e7-4c3b-9166-8bef692c2b0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_59857ecb-6e23-4405-8443-c160480e3f54" xlink:to="loc_us-gaap_DebtInstrumentAxis_58e5d5f7-e8e7-4c3b-9166-8bef692c2b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_08860e1b-c6fe-444a-bba4-5967dd2caea6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_58e5d5f7-e8e7-4c3b-9166-8bef692c2b0b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_08860e1b-c6fe-444a-bba4-5967dd2caea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_b531f17d-6b6e-40e2-9b3f-ae1f5fdea3c5" xlink:href="cutr-20210630.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_08860e1b-c6fe-444a-bba4-5967dd2caea6" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_b531f17d-6b6e-40e2-9b3f-ae1f5fdea3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5ba4e828-17e6-4011-817a-79d95f4afe5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_59857ecb-6e23-4405-8443-c160480e3f54" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5ba4e828-17e6-4011-817a-79d95f4afe5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2f685c61-46b0-4d30-9d36-56e68d39f54a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5ba4e828-17e6-4011-817a-79d95f4afe5d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2f685c61-46b0-4d30-9d36-56e68d39f54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_a6b040a5-f85c-46ae-b8e7-56e65b73ee80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2f685c61-46b0-4d30-9d36-56e68d39f54a" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_a6b040a5-f85c-46ae-b8e7-56e65b73ee80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e3f76c13-bf5c-4732-88af-9a60fea0b7ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_59857ecb-6e23-4405-8443-c160480e3f54" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e3f76c13-bf5c-4732-88af-9a60fea0b7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_d2ae627e-ef40-4729-8429-d58f94352d48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e3f76c13-bf5c-4732-88af-9a60fea0b7ea" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_d2ae627e-ef40-4729-8429-d58f94352d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#NetIncomeLossPerShareNetIncomeLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1b2f6432-abbd-424c-b922-4691d69a94b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_8d149a74-499b-4297-84b3-b862ef20294d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1b2f6432-abbd-424c-b922-4691d69a94b0" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_8d149a74-499b-4297-84b3-b862ef20294d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c0e25e91-a814-4424-ae81-2ad38f9848a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_8d149a74-499b-4297-84b3-b862ef20294d" xlink:to="loc_us-gaap_AwardTypeAxis_c0e25e91-a814-4424-ae81-2ad38f9848a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f123134d-0525-4bee-bb3a-b6cb599f43b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c0e25e91-a814-4424-ae81-2ad38f9848a8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f123134d-0525-4bee-bb3a-b6cb599f43b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_081fd5a4-4757-4efc-9174-d7c9c8c3e4b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f123134d-0525-4bee-bb3a-b6cb599f43b4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_081fd5a4-4757-4efc-9174-d7c9c8c3e4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2ed91be3-b6e3-4e24-9343-243f6c54df03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f123134d-0525-4bee-bb3a-b6cb599f43b4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2ed91be3-b6e3-4e24-9343-243f6c54df03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_afb4614e-c5fe-4ee3-b53f-d09cf82123b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f123134d-0525-4bee-bb3a-b6cb599f43b4" xlink:to="loc_us-gaap_PerformanceSharesMember_afb4614e-c5fe-4ee3-b53f-d09cf82123b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_efe75e69-ff9c-4aa0-a106-8a0ca8e6a126" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f123134d-0525-4bee-bb3a-b6cb599f43b4" xlink:to="loc_us-gaap_EmployeeStockMember_efe75e69-ff9c-4aa0-a106-8a0ca8e6a126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_536d0938-2b6b-4437-9c15-f5353d66965d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_8d149a74-499b-4297-84b3-b862ef20294d" xlink:to="loc_us-gaap_EarningsPerShareDilutedLineItems_536d0938-2b6b-4437-9c15-f5353d66965d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_6ccbaf86-d67b-4746-a093-e485fd847992" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_536d0938-2b6b-4437-9c15-f5353d66965d" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_6ccbaf86-d67b-4746-a093-e485fd847992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_09697b31-dd0f-4e70-a5e8-5ba142eda71b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_6ccbaf86-d67b-4746-a093-e485fd847992" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_09697b31-dd0f-4e70-a5e8-5ba142eda71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_8c91bb3e-c914-4dfa-a341-ba2a16dd2455" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_6ccbaf86-d67b-4746-a093-e485fd847992" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_8c91bb3e-c914-4dfa-a341-ba2a16dd2455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AmortizationOfDebtIssuanceCostsNetOfTax_56d43e3e-f328-4b18-8cca-a99de4bdf2da" xlink:href="cutr-20210630.xsd#cutr_AmortizationOfDebtIssuanceCostsNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_6ccbaf86-d67b-4746-a093-e485fd847992" xlink:to="loc_cutr_AmortizationOfDebtIssuanceCostsNetOfTax_56d43e3e-f328-4b18-8cca-a99de4bdf2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_b13a18fd-1466-4c76-bfe0-36970a77ef60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_6ccbaf86-d67b-4746-a093-e485fd847992" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_b13a18fd-1466-4c76-bfe0-36970a77ef60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_c627eba1-9899-4baf-89ce-d58a7429805a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_536d0938-2b6b-4437-9c15-f5353d66965d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_c627eba1-9899-4baf-89ce-d58a7429805a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0b6eba4b-2434-4dcc-9a79-32921344c564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_c627eba1-9899-4baf-89ce-d58a7429805a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0b6eba4b-2434-4dcc-9a79-32921344c564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_b23ae29c-cffa-46c5-abd5-87c87904d719" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_536d0938-2b6b-4437-9c15-f5353d66965d" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_b23ae29c-cffa-46c5-abd5-87c87904d719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_38a28b9a-0ae1-4a66-8214-c920a400f86c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_b23ae29c-cffa-46c5-abd5-87c87904d719" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_38a28b9a-0ae1-4a66-8214-c920a400f86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8fa4a85c-13a2-41e5-b8e7-e7ebe9ae01a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_b23ae29c-cffa-46c5-abd5-87c87904d719" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8fa4a85c-13a2-41e5-b8e7-e7ebe9ae01a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_af0c563b-ecc2-40ae-8701-86b8170bd3ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_b23ae29c-cffa-46c5-abd5-87c87904d719" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_af0c563b-ecc2-40ae-8701-86b8170bd3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1b6af651-9568-4691-9347-32c7e5666f83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_536d0938-2b6b-4437-9c15-f5353d66965d" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1b6af651-9568-4691-9347-32c7e5666f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4b0ebc94-b968-4837-a504-f4d3823b314e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1b6af651-9568-4691-9347-32c7e5666f83" xlink:to="loc_us-gaap_EarningsPerShareBasic_4b0ebc94-b968-4837-a504-f4d3823b314e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a45cd368-3300-44d4-9da2-4d54660887bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1b6af651-9568-4691-9347-32c7e5666f83" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a45cd368-3300-44d4-9da2-4d54660887bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_91d2f52b-b81c-4537-ad2c-e69e00f60321" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_272fba3e-5a1d-46d8-9529-c6cfc7425b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_91d2f52b-b81c-4537-ad2c-e69e00f60321" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_272fba3e-5a1d-46d8-9529-c6cfc7425b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1e1c56f3-d5e2-4b76-879e-0f60964f413b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_272fba3e-5a1d-46d8-9529-c6cfc7425b58" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1e1c56f3-d5e2-4b76-879e-0f60964f413b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_30f04408-0b01-4993-9645-4babded5bfb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1e1c56f3-d5e2-4b76-879e-0f60964f413b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_30f04408-0b01-4993-9645-4babded5bfb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_6340ce6e-fb25-410c-a059-f698b7c936d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_30f04408-0b01-4993-9645-4babded5bfb4" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_6340ce6e-fb25-410c-a059-f698b7c936d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a67027e4-365b-468e-86cb-00eaa2b0ad7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_30f04408-0b01-4993-9645-4babded5bfb4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a67027e4-365b-468e-86cb-00eaa2b0ad7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_30b068fc-6e60-4929-bc4c-69fc748f152c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_30f04408-0b01-4993-9645-4babded5bfb4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_30b068fc-6e60-4929-bc4c-69fc748f152c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_88b27711-acf3-41ff-a267-e9d6b5dcbe58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_30f04408-0b01-4993-9645-4babded5bfb4" xlink:to="loc_us-gaap_PerformanceSharesMember_88b27711-acf3-41ff-a267-e9d6b5dcbe58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_e75105fd-efee-4414-aaa8-57d882e42b69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_30f04408-0b01-4993-9645-4babded5bfb4" xlink:to="loc_us-gaap_EmployeeStockMember_e75105fd-efee-4414-aaa8-57d882e42b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9147cf50-396c-4716-a603-2f1cb71be8a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_272fba3e-5a1d-46d8-9529-c6cfc7425b58" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9147cf50-396c-4716-a603-2f1cb71be8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e05fa5f0-1062-4a4b-b225-7049736ddd8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9147cf50-396c-4716-a603-2f1cb71be8a4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e05fa5f0-1062-4a4b-b225-7049736ddd8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/IncomeTaxes" xlink:type="simple" xlink:href="cutr-20210630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_823fc05f-2803-4a85-8b14-f8017cd768a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_910afc6f-5059-463c-b86b-7ee2617409ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_823fc05f-2803-4a85-8b14-f8017cd768a2" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_910afc6f-5059-463c-b86b-7ee2617409ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4f9a4186-2ac0-44f6-91a3-596b26993064" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8a792f61-e219-40af-88dc-6fd6e6652561" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4f9a4186-2ac0-44f6-91a3-596b26993064" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8a792f61-e219-40af-88dc-6fd6e6652561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/Leases" xlink:type="simple" xlink:href="cutr-20210630.xsd#Leases"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_dbe25820-f0ab-431c-a2a1-2281c4fb7a2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_9711c639-8b34-4c6b-b3a9-0bafe58b5e5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dbe25820-f0ab-431c-a2a1-2281c4fb7a2f" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_9711c639-8b34-4c6b-b3a9-0bafe58b5e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_bbef487b-124b-41b7-b9a5-81c1030ad11c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dbe25820-f0ab-431c-a2a1-2281c4fb7a2f" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_bbef487b-124b-41b7-b9a5-81c1030ad11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_c33d9820-dad6-4fd1-ba0e-81d60d4dc50a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesOfLessorDisclosureTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dbe25820-f0ab-431c-a2a1-2281c4fb7a2f" xlink:to="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_c33d9820-dad6-4fd1-ba0e-81d60d4dc50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/LeasesTables" xlink:type="simple" xlink:href="cutr-20210630.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_14766e0f-9f7c-4fab-b0e0-db0a6ca46bab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AssetsAndLiabilitiesLesseeTableTextBlock_4d6f10ea-1fcd-4172-811d-fec5a08ded0c" xlink:href="cutr-20210630.xsd#cutr_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_14766e0f-9f7c-4fab-b0e0-db0a6ca46bab" xlink:to="loc_cutr_AssetsAndLiabilitiesLesseeTableTextBlock_4d6f10ea-1fcd-4172-811d-fec5a08ded0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_5fbea9e1-c539-4647-85b6-6ed11fe84745" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_14766e0f-9f7c-4fab-b0e0-db0a6ca46bab" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_5fbea9e1-c539-4647-85b6-6ed11fe84745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_9044f6f8-554c-4449-ac57-9a98353322be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_14766e0f-9f7c-4fab-b0e0-db0a6ca46bab" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_9044f6f8-554c-4449-ac57-9a98353322be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_e45c1f74-0fd1-4661-a484-4d8c1e5bb874" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_14766e0f-9f7c-4fab-b0e0-db0a6ca46bab" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_e45c1f74-0fd1-4661-a484-4d8c1e5bb874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_cce15c0d-a2be-4853-b11c-6b4c2b890462" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_4b5de3bb-1720-4a08-a1f7-d1cda34f93bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cce15c0d-a2be-4853-b11c-6b4c2b890462" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_4b5de3bb-1720-4a08-a1f7-d1cda34f93bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4cf40010-60b2-4ce5-9d7d-48981cf9b7a2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4b5de3bb-1720-4a08-a1f7-d1cda34f93bb" xlink:to="loc_srt_RangeAxis_4cf40010-60b2-4ce5-9d7d-48981cf9b7a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_796d79b2-b65d-4218-86a9-e2ed810d986c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4cf40010-60b2-4ce5-9d7d-48981cf9b7a2" xlink:to="loc_srt_RangeMember_796d79b2-b65d-4218-86a9-e2ed810d986c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6dcfd141-7927-44d9-934b-1d90579fbf92" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_796d79b2-b65d-4218-86a9-e2ed810d986c" xlink:to="loc_srt_MinimumMember_6dcfd141-7927-44d9-934b-1d90579fbf92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_fbf66d88-f775-4a30-a4b2-73ac13d97943" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_796d79b2-b65d-4218-86a9-e2ed810d986c" xlink:to="loc_srt_MaximumMember_fbf66d88-f775-4a30-a4b2-73ac13d97943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_04b27f1c-d031-4233-ba5d-228342c3a517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4b5de3bb-1720-4a08-a1f7-d1cda34f93bb" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_04b27f1c-d031-4233-ba5d-228342c3a517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_fb6bc706-8fc6-4435-9f46-ef3cd5806b37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_04b27f1c-d031-4233-ba5d-228342c3a517" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_fb6bc706-8fc6-4435-9f46-ef3cd5806b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_153386cf-1b3e-42cd-a8a3-edda951cd6eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_04b27f1c-d031-4233-ba5d-228342c3a517" xlink:to="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_153386cf-1b3e-42cd-a8a3-edda951cd6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_a42486a1-f070-4762-aa62-efb17f4eb374" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_04b27f1c-d031-4233-ba5d-228342c3a517" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_a42486a1-f070-4762-aa62-efb17f4eb374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_59f9a4c0-b895-4c03-934a-ba8a8d3d5897" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_04b27f1c-d031-4233-ba5d-228342c3a517" xlink:to="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_59f9a4c0-b895-4c03-934a-ba8a8d3d5897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionTable_1dafdfa4-1dbf-4ac7-aea7-2b3734a0c337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorLeaseDescriptionTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cce15c0d-a2be-4853-b11c-6b4c2b890462" xlink:to="loc_us-gaap_LessorLeaseDescriptionTable_1dafdfa4-1dbf-4ac7-aea7-2b3734a0c337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_13862cc9-c372-4912-a993-40d5f63d19ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_1dafdfa4-1dbf-4ac7-aea7-2b3734a0c337" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_13862cc9-c372-4912-a993-40d5f63d19ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_008d2515-d9a3-4886-a6dd-1e6d5829490f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_13862cc9-c372-4912-a993-40d5f63d19ac" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_008d2515-d9a3-4886-a6dd-1e6d5829490f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_e6895148-a39a-4ea9-9e84-da2e45962751" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_008d2515-d9a3-4886-a6dd-1e6d5829490f" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_e6895148-a39a-4ea9-9e84-da2e45962751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionLineItems_ce8c1861-1f57-49bc-ba97-00094fd78d44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_1dafdfa4-1dbf-4ac7-aea7-2b3734a0c337" xlink:to="loc_us-gaap_LessorLeaseDescriptionLineItems_ce8c1861-1f57-49bc-ba97-00094fd78d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm_36ed9466-9b03-4ad9-968c-a8e8b9f12a0c" xlink:href="cutr-20210630.xsd#cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_ce8c1861-1f57-49bc-ba97-00094fd78d44" xlink:to="loc_cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm_36ed9466-9b03-4ad9-968c-a8e8b9f12a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_7dea5804-6029-4539-9873-82e1630e1377" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_ce8c1861-1f57-49bc-ba97-00094fd78d44" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_7dea5804-6029-4539-9873-82e1630e1377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseRevenue_2a959bb5-6d29-40ae-bd63-9415cf86c661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesTypeLeaseRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_ce8c1861-1f57-49bc-ba97-00094fd78d44" xlink:to="loc_us-gaap_SalesTypeLeaseRevenue_2a959bb5-6d29-40ae-bd63-9415cf86c661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease_2fc147d7-2023-4635-84dd-982920b3a129" xlink:href="cutr-20210630.xsd#cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_ce8c1861-1f57-49bc-ba97-00094fd78d44" xlink:to="loc_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease_2fc147d7-2023-4635-84dd-982920b3a129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_f953b1e7-40f2-4f11-9011-393e5fa7f252" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_ce8c1861-1f57-49bc-ba97-00094fd78d44" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_f953b1e7-40f2-4f11-9011-393e5fa7f252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7a4eee80-4161-48f1-971e-98e987b59bf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_9e23a73c-5bfc-42bf-b803-5e0baa1aabec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7a4eee80-4161-48f1-971e-98e987b59bf6" xlink:to="loc_us-gaap_AssetsAbstract_9e23a73c-5bfc-42bf-b803-5e0baa1aabec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_99827ab9-6139-4eaa-af83-2c7ca755522b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9e23a73c-5bfc-42bf-b803-5e0baa1aabec" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_99827ab9-6139-4eaa-af83-2c7ca755522b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_f4d9e59d-fd28-4344-9158-3661735681e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9e23a73c-5bfc-42bf-b803-5e0baa1aabec" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_f4d9e59d-fd28-4344-9158-3661735681e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeaseRightOfUseAsset_dd0487ae-a23d-4aaa-978f-af5d77856216" xlink:href="cutr-20210630.xsd#cutr_LeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9e23a73c-5bfc-42bf-b803-5e0baa1aabec" xlink:to="loc_cutr_LeaseRightOfUseAsset_dd0487ae-a23d-4aaa-978f-af5d77856216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_4400e68e-2143-44f6-a5cc-711ed895bcf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9e23a73c-5bfc-42bf-b803-5e0baa1aabec" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_4400e68e-2143-44f6-a5cc-711ed895bcf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_285f6052-77b2-43b2-9e79-289ba0100d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7a4eee80-4161-48f1-971e-98e987b59bf6" xlink:to="loc_us-gaap_LiabilitiesAbstract_285f6052-77b2-43b2-9e79-289ba0100d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OperatingLeaseLiabilitiesLesseeAbstract_19c5bd32-4182-44d8-8895-689761bfd901" xlink:href="cutr-20210630.xsd#cutr_OperatingLeaseLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_285f6052-77b2-43b2-9e79-289ba0100d74" xlink:to="loc_cutr_OperatingLeaseLiabilitiesLesseeAbstract_19c5bd32-4182-44d8-8895-689761bfd901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7615d75a-24c5-4a62-8d63-cc2cfcb8be16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OperatingLeaseLiabilitiesLesseeAbstract_19c5bd32-4182-44d8-8895-689761bfd901" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7615d75a-24c5-4a62-8d63-cc2cfcb8be16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a83541fc-c3f4-4998-8dc4-16693a06ccd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OperatingLeaseLiabilitiesLesseeAbstract_19c5bd32-4182-44d8-8895-689761bfd901" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a83541fc-c3f4-4998-8dc4-16693a06ccd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c68313cb-8598-486c-9a42-99a24902d0e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OperatingLeaseLiabilitiesLesseeAbstract_19c5bd32-4182-44d8-8895-689761bfd901" xlink:to="loc_us-gaap_OperatingLeaseLiability_c68313cb-8598-486c-9a42-99a24902d0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_FinanceLeaseLiabilitiesLesseeAbstract_f2af5611-ec1a-4391-9885-f54dcff54da6" xlink:href="cutr-20210630.xsd#cutr_FinanceLeaseLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_285f6052-77b2-43b2-9e79-289ba0100d74" xlink:to="loc_cutr_FinanceLeaseLiabilitiesLesseeAbstract_f2af5611-ec1a-4391-9885-f54dcff54da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_3943eefe-7901-46fd-ac0d-31b45b0bee95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_FinanceLeaseLiabilitiesLesseeAbstract_f2af5611-ec1a-4391-9885-f54dcff54da6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_3943eefe-7901-46fd-ac0d-31b45b0bee95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b9393ef8-c8a7-4fb2-8248-a404551e43dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_FinanceLeaseLiabilitiesLesseeAbstract_f2af5611-ec1a-4391-9885-f54dcff54da6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b9393ef8-c8a7-4fb2-8248-a404551e43dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_42b514d5-60db-4db3-9749-1a24450eb08c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_FinanceLeaseLiabilitiesLesseeAbstract_f2af5611-ec1a-4391-9885-f54dcff54da6" xlink:to="loc_us-gaap_FinanceLeaseLiability_42b514d5-60db-4db3-9749-1a24450eb08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_6f6ce5fd-55de-41b7-ac02-582dd972c325" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_FinanceLeaseLiabilitiesLesseeAbstract_f2af5611-ec1a-4391-9885-f54dcff54da6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_6f6ce5fd-55de-41b7-ac02-582dd972c325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_03f62822-495a-4b0b-9527-5ecb4b46bf06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_FinanceLeaseLiabilitiesLesseeAbstract_f2af5611-ec1a-4391-9885-f54dcff54da6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_03f62822-495a-4b0b-9527-5ecb4b46bf06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/LeasesLeaseCostsDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#LeasesLeaseCostsDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/LeasesLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9efc17f9-d52d-4f70-8473-aa7c631119de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_501a241c-d739-4135-acae-0058648fce6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9efc17f9-d52d-4f70-8473-aa7c631119de" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_501a241c-d739-4135-acae-0058648fce6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_b5af3e63-735b-41a2-9372-a4e5cb6afcf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9efc17f9-d52d-4f70-8473-aa7c631119de" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_b5af3e63-735b-41a2-9372-a4e5cb6afcf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_51ca0202-0461-4836-a2e8-c061dbaed68a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9efc17f9-d52d-4f70-8473-aa7c631119de" xlink:to="loc_us-gaap_OperatingLeaseExpense_51ca0202-0461-4836-a2e8-c061dbaed68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/LeasesCashPaidforAmountsIncludedintheMeasurementofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#LeasesCashPaidforAmountsIncludedintheMeasurementofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/LeasesCashPaidforAmountsIncludedintheMeasurementofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a1e16cb7-2532-4d03-9f71-01c48feb4d8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_575189e2-5d87-444e-9630-34bdded734de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a1e16cb7-2532-4d03-9f71-01c48feb4d8b" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_575189e2-5d87-444e-9630-34bdded734de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_21319072-96a8-4010-b1e1-0e67deba269f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a1e16cb7-2532-4d03-9f71-01c48feb4d8b" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_21319072-96a8-4010-b1e1-0e67deba269f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_77675132-7111-4d84-89e5-fe2cafc773a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a1e16cb7-2532-4d03-9f71-01c48feb4d8b" xlink:to="loc_us-gaap_OperatingLeasePayments_77675132-7111-4d84-89e5-fe2cafc773a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5a346605-80b8-46d5-9c33-e023f502e5ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_b70ad415-3349-4220-8c78-611b2b4b7869" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a346605-80b8-46d5-9c33-e023f502e5ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_b70ad415-3349-4220-8c78-611b2b4b7869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0c89e9f1-20ec-4007-9b95-0c0e1a23d316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a346605-80b8-46d5-9c33-e023f502e5ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0c89e9f1-20ec-4007-9b95-0c0e1a23d316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c1542539-8f63-4e97-8af2-bd462406dec3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a346605-80b8-46d5-9c33-e023f502e5ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c1542539-8f63-4e97-8af2-bd462406dec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a4a5e275-0d20-42c2-aa88-fd929bde379c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a346605-80b8-46d5-9c33-e023f502e5ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a4a5e275-0d20-42c2-aa88-fd929bde379c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_415d6cf6-7ad0-4dff-b8ca-99abdb7ff637" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a346605-80b8-46d5-9c33-e023f502e5ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_415d6cf6-7ad0-4dff-b8ca-99abdb7ff637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_36873530-4fd8-443e-ab99-73f49ca54233" xlink:href="cutr-20210630.xsd#cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a346605-80b8-46d5-9c33-e023f502e5ce" xlink:to="loc_cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_36873530-4fd8-443e-ab99-73f49ca54233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_59dcb561-8fd2-4631-95ad-fbc16ff5a0ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a346605-80b8-46d5-9c33-e023f502e5ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_59dcb561-8fd2-4631-95ad-fbc16ff5a0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c12d3df6-b820-4eac-a1c6-77acc3b12055" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a346605-80b8-46d5-9c33-e023f502e5ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c12d3df6-b820-4eac-a1c6-77acc3b12055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_17004f0b-f02d-4cbd-8bf7-50844392f302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a346605-80b8-46d5-9c33-e023f502e5ce" xlink:to="loc_us-gaap_OperatingLeaseLiability_17004f0b-f02d-4cbd-8bf7-50844392f302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="cutr-20210630.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#LeasesMaturitiesofFinanceLeasesLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_eb9882b7-940d-4475-af1e-2a6bb32679f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_ebac1c4f-9e1c-48ee-a03c-540b21d90b83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eb9882b7-940d-4475-af1e-2a6bb32679f9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_ebac1c4f-9e1c-48ee-a03c-540b21d90b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_7b7d6581-acda-41a9-ada9-3a810c0c3d9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eb9882b7-940d-4475-af1e-2a6bb32679f9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_7b7d6581-acda-41a9-ada9-3a810c0c3d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_3d36b2fa-5bc2-49d5-96c0-f6ada04b0f88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eb9882b7-940d-4475-af1e-2a6bb32679f9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_3d36b2fa-5bc2-49d5-96c0-f6ada04b0f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_17648339-89aa-457b-b3fe-45e12a4f0ed9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eb9882b7-940d-4475-af1e-2a6bb32679f9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_17648339-89aa-457b-b3fe-45e12a4f0ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_795cd185-34cb-453b-8e0e-0b56ceb2cc42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eb9882b7-940d-4475-af1e-2a6bb32679f9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_795cd185-34cb-453b-8e0e-0b56ceb2cc42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_0b00150a-1ea3-485a-b9c2-ed8bff96371e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eb9882b7-940d-4475-af1e-2a6bb32679f9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_0b00150a-1ea3-485a-b9c2-ed8bff96371e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_83a2d85b-82ac-4bec-b1f8-1a271e2463e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eb9882b7-940d-4475-af1e-2a6bb32679f9" xlink:to="loc_us-gaap_FinanceLeaseLiability_83a2d85b-82ac-4bec-b1f8-1a271e2463e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails_1" xlink:type="simple" xlink:href="cutr-20210630.xsd#LeasesMaturitiesofFinanceLeasesLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://cutera.com/20210331/role/LeasesLeaseInformationDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#LeasesLeaseInformationDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/LeasesLeaseInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_54b78a2c-9cfb-420e-ada9-a2ac4fe24dc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_WeightedAverageRemainingLeaseTermAbstract_e0bef6c9-7485-43b6-849a-d40d5bd1ebdd" xlink:href="cutr-20210630.xsd#cutr_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_54b78a2c-9cfb-420e-ada9-a2ac4fe24dc0" xlink:to="loc_cutr_WeightedAverageRemainingLeaseTermAbstract_e0bef6c9-7485-43b6-849a-d40d5bd1ebdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ad0ca5b2-1b71-4da2-b9a0-533118ada3a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_WeightedAverageRemainingLeaseTermAbstract_e0bef6c9-7485-43b6-849a-d40d5bd1ebdd" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ad0ca5b2-1b71-4da2-b9a0-533118ada3a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_258e8c58-bace-4819-95df-c8451995dd65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_WeightedAverageRemainingLeaseTermAbstract_e0bef6c9-7485-43b6-849a-d40d5bd1ebdd" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_258e8c58-bace-4819-95df-c8451995dd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeasesWeightedAverageDiscountRateAbstract_5ce4c970-2801-4673-9265-d8ba3592998c" xlink:href="cutr-20210630.xsd#cutr_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_54b78a2c-9cfb-420e-ada9-a2ac4fe24dc0" xlink:to="loc_cutr_LeasesWeightedAverageDiscountRateAbstract_5ce4c970-2801-4673-9265-d8ba3592998c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_71292442-f130-44d4-befd-674c8dfb40e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_LeasesWeightedAverageDiscountRateAbstract_5ce4c970-2801-4673-9265-d8ba3592998c" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_71292442-f130-44d4-befd-674c8dfb40e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_e83381a6-40b2-40f3-880e-67121e2d2c8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_LeasesWeightedAverageDiscountRateAbstract_5ce4c970-2801-4673-9265-d8ba3592998c" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_e83381a6-40b2-40f3-880e-67121e2d2c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/Contingencies" xlink:type="simple" xlink:href="cutr-20210630.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_17fc4f66-5b5f-492a-a65f-58fe2b870970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_62597114-0325-4520-8cd5-51ef06cc612d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_17fc4f66-5b5f-492a-a65f-58fe2b870970" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_62597114-0325-4520-8cd5-51ef06cc612d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/ContingenciesNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#ContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/ContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e59c3002-8492-4ee3-b971-bf0d84120670" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_65f19d5b-9034-4121-ad77-ad236f36e730" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e59c3002-8492-4ee3-b971-bf0d84120670" xlink:to="loc_us-gaap_LossContingenciesTable_65f19d5b-9034-4121-ad77-ad236f36e730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_c02e0cda-5d29-419e-aeef-ba8c4f02cdbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_65f19d5b-9034-4121-ad77-ad236f36e730" xlink:to="loc_us-gaap_LitigationStatusAxis_c02e0cda-5d29-419e-aeef-ba8c4f02cdbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_5b4e038e-ec07-4149-a214-8e990f747462" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_c02e0cda-5d29-419e-aeef-ba8c4f02cdbe" xlink:to="loc_us-gaap_LitigationStatusDomain_5b4e038e-ec07-4149-a214-8e990f747462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_b525ad04-3370-456f-becd-8676ff842c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_5b4e038e-ec07-4149-a214-8e990f747462" xlink:to="loc_us-gaap_PendingLitigationMember_b525ad04-3370-456f-becd-8676ff842c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_1ddf5d84-adb6-4863-a206-2a1078b5cdd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_65f19d5b-9034-4121-ad77-ad236f36e730" xlink:to="loc_us-gaap_LossContingenciesLineItems_1ddf5d84-adb6-4863-a206-2a1078b5cdd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_e1cc19f9-26e3-450e-b939-cb8da2f3d4e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1ddf5d84-adb6-4863-a206-2a1078b5cdd2" xlink:to="loc_us-gaap_LitigationReserve_e1cc19f9-26e3-450e-b939-cb8da2f3d4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/Debt" xlink:type="simple" xlink:href="cutr-20210630.xsd#Debt"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ae190863-edf0-4088-807a-35077a011143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_072d6ddd-c1d9-4901-883e-50658a51ffd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ae190863-edf0-4088-807a-35077a011143" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_072d6ddd-c1d9-4901-883e-50658a51ffd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/DebtTables" xlink:type="simple" xlink:href="cutr-20210630.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_88b40541-e917-4e16-95b4-c5d05abc8c7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock_691c254e-ac13-46d0-9fab-a59fd987e675" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_88b40541-e917-4e16-95b4-c5d05abc8c7f" xlink:to="loc_us-gaap_ConvertibleDebtTableTextBlock_691c254e-ac13-46d0-9fab-a59fd987e675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_172b4dee-8433-4fc6-a6c7-fce02cf384b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_172b4dee-8433-4fc6-a6c7-fce02cf384b7" xlink:to="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c68cff82-c1a8-4657-ad2b-649f810014aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c68cff82-c1a8-4657-ad2b-649f810014aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_eefab421-4450-4eae-b54a-ca292981104a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c68cff82-c1a8-4657-ad2b-649f810014aa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_eefab421-4450-4eae-b54a-ca292981104a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_c2f97dc2-03a8-406d-ab36-cbd37972739d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_eefab421-4450-4eae-b54a-ca292981104a" xlink:to="loc_us-gaap_ConvertibleDebtMember_c2f97dc2-03a8-406d-ab36-cbd37972739d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_55bee1b7-cbd3-4f8c-860a-545f1baf4761" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:to="loc_us-gaap_DebtInstrumentAxis_55bee1b7-cbd3-4f8c-860a-545f1baf4761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_934e1baa-f4fb-4b85-b944-3e552e801409" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_55bee1b7-cbd3-4f8c-860a-545f1baf4761" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_934e1baa-f4fb-4b85-b944-3e552e801409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_ef7d2c3f-4397-4dd8-8381-4832f9a0523e" xlink:href="cutr-20210630.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_934e1baa-f4fb-4b85-b944-3e552e801409" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_ef7d2c3f-4397-4dd8-8381-4832f9a0523e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_0c60af09-11c0-44d5-a7d8-7220852b2317" xlink:href="cutr-20210630.xsd#cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ConvertibleSeniorNotesDue2026Member_ef7d2c3f-4397-4dd8-8381-4832f9a0523e" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_0c60af09-11c0-44d5-a7d8-7220852b2317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_10cf510a-6317-43dc-ba88-fb0e91d6b777" xlink:href="cutr-20210630.xsd#cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ConvertibleSeniorNotesDue2026Member_ef7d2c3f-4397-4dd8-8381-4832f9a0523e" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_10cf510a-6317-43dc-ba88-fb0e91d6b777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LoanAndSecurityAgreementMember_2403281b-0dff-4fde-bcc3-48359ac40299" xlink:href="cutr-20210630.xsd#cutr_LoanAndSecurityAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_934e1baa-f4fb-4b85-b944-3e552e801409" xlink:to="loc_cutr_LoanAndSecurityAgreementMember_2403281b-0dff-4fde-bcc3-48359ac40299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PaycheckProtectionProgramCARESActMember_1a90e15b-1217-4f57-b842-e6c361cd0136" xlink:href="cutr-20210630.xsd#cutr_PaycheckProtectionProgramCARESActMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_934e1baa-f4fb-4b85-b944-3e552e801409" xlink:to="loc_cutr_PaycheckProtectionProgramCARESActMember_1a90e15b-1217-4f57-b842-e6c361cd0136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_280bd921-da06-42b7-9fd5-fcc99537ea34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_280bd921-da06-42b7-9fd5-fcc99537ea34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2a187ba9-06ed-4aa9-b95e-bde05331ed63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_280bd921-da06-42b7-9fd5-fcc99537ea34" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2a187ba9-06ed-4aa9-b95e-bde05331ed63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_879b3c61-a283-4574-8b56-a4dfe4d69a70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2a187ba9-06ed-4aa9-b95e-bde05331ed63" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_879b3c61-a283-4574-8b56-a4dfe4d69a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_5809f43a-37aa-4a0b-bbcb-03b5af4d922b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_5809f43a-37aa-4a0b-bbcb-03b5af4d922b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_b1651883-83f3-4a8b-939b-e2ba8f46933b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_5809f43a-37aa-4a0b-bbcb-03b5af4d922b" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_b1651883-83f3-4a8b-939b-e2ba8f46933b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_WellsFargoMember_7a9716c4-0623-4a13-8c75-06d6c249a489" xlink:href="cutr-20210630.xsd#cutr_WellsFargoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_b1651883-83f3-4a8b-939b-e2ba8f46933b" xlink:to="loc_cutr_WellsFargoMember_7a9716c4-0623-4a13-8c75-06d6c249a489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SiliconValleyBankMember_ae941066-082f-46a0-a857-763fe993e001" xlink:href="cutr-20210630.xsd#cutr_SiliconValleyBankMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_b1651883-83f3-4a8b-939b-e2ba8f46933b" xlink:to="loc_cutr_SiliconValleyBankMember_ae941066-082f-46a0-a857-763fe993e001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5cd2d02f-6cab-4835-9cb9-2e39ecb489eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:to="loc_us-gaap_CreditFacilityAxis_5cd2d02f-6cab-4835-9cb9-2e39ecb489eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_122c59fc-ce4c-40bc-afa9-c04e686d4cf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_5cd2d02f-6cab-4835-9cb9-2e39ecb489eb" xlink:to="loc_us-gaap_CreditFacilityDomain_122c59fc-ce4c-40bc-afa9-c04e686d4cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_43815b0c-4e0c-4750-b8a7-66ba79442eb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_122c59fc-ce4c-40bc-afa9-c04e686d4cf2" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_43815b0c-4e0c-4750-b8a7-66ba79442eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_759ae4fa-4e35-437a-b66f-d5d3d8dabb63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:to="loc_us-gaap_VariableRateAxis_759ae4fa-4e35-437a-b66f-d5d3d8dabb63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_35fe4f9d-9531-4569-99a2-46fb27c380e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_759ae4fa-4e35-437a-b66f-d5d3d8dabb63" xlink:to="loc_us-gaap_VariableRateDomain_35fe4f9d-9531-4569-99a2-46fb27c380e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_acf4a5b4-c1aa-4695-80e5-71170abedbec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_35fe4f9d-9531-4569-99a2-46fb27c380e1" xlink:to="loc_us-gaap_PrimeRateMember_acf4a5b4-c1aa-4695-80e5-71170abedbec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_93105596-a1ef-423f-9763-24cab3a19be0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:to="loc_us-gaap_StatementClassOfStockAxis_93105596-a1ef-423f-9763-24cab3a19be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f4809568-0d04-4edf-bff0-b9e8d1a76b96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_93105596-a1ef-423f-9763-24cab3a19be0" xlink:to="loc_us-gaap_ClassOfStockDomain_f4809568-0d04-4edf-bff0-b9e8d1a76b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4a02f7f2-7a84-43df-87c4-9e56aa4e4e45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f4809568-0d04-4edf-bff0-b9e8d1a76b96" xlink:to="loc_us-gaap_CommonStockMember_4a02f7f2-7a84-43df-87c4-9e56aa4e4e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3947cb3a-1b5e-480d-aef3-241845f802e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3947cb3a-1b5e-480d-aef3-241845f802e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_dd94f461-c5bf-421e-87d5-5c3db9618306" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3947cb3a-1b5e-480d-aef3-241845f802e3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_dd94f461-c5bf-421e-87d5-5c3db9618306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_03f397a8-04aa-4461-bd4f-98d3b616582b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_dd94f461-c5bf-421e-87d5-5c3db9618306" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_03f397a8-04aa-4461-bd4f-98d3b616582b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1cea0ad6-8d40-4757-a5fe-b7fd822f0aff" xlink:to="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f7138f89-5a0d-4b7a-890c-8438a2d54448" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f7138f89-5a0d-4b7a-890c-8438a2d54448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_961d48cf-c603-4668-905b-94f7723df68e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_961d48cf-c603-4668-905b-94f7723df68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_27dcc6e4-f65b-4486-a5f2-411b7bd42133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_27dcc6e4-f65b-4486-a5f2-411b7bd42133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_ca22d3b8-79fe-4ccb-81d8-cd49d4507478" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_ca22d3b8-79fe-4ccb-81d8-cd49d4507478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_9ad5600a-3e3b-4a7d-a757-983b056b763d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_9ad5600a-3e3b-4a7d-a757-983b056b763d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_f07c84b2-3723-4e32-b4a1-c7c7f4799733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_ConvertibleDebt_f07c84b2-3723-4e32-b4a1-c7c7f4799733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_d01bd248-7fd5-4cd3-806d-82954d760600" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_d01bd248-7fd5-4cd3-806d-82954d760600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_5885c61a-d351-4206-b387-1f3146f3f9f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_5885c61a-d351-4206-b387-1f3146f3f9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_4f429cfc-ab8a-4daf-9e6d-f9063f874454" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_4f429cfc-ab8a-4daf-9e6d-f9063f874454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6bd0b645-8cd3-4d2c-ade4-4c525bb264ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6bd0b645-8cd3-4d2c-ade4-4c525bb264ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger_748331e6-2a38-4774-a3e2-6ca457360650" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger_748331e6-2a38-4774-a3e2-6ca457360650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedeemableThresholdTradingDays_5b8dfc8e-1723-4f51-914f-aeb18b9a924c" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentRedeemableThresholdTradingDays"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DebtInstrumentRedeemableThresholdTradingDays_5b8dfc8e-1723-4f51-914f-aeb18b9a924c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays_85f27ba6-0f30-4bbf-8875-45d5eed0a4ad" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays_85f27ba6-0f30-4bbf-8875-45d5eed0a4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_98abe148-5040-4111-ac24-2fdbbead7f90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_98abe148-5040-4111-ac24-2fdbbead7f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_e8a777dc-cdd9-4a2b-b987-ab4b3a5453b0" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_e8a777dc-cdd9-4a2b-b987-ab4b3a5453b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_75dc39a2-5d51-413a-877e-78cec65887a6" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_75dc39a2-5d51-413a-877e-78cec65887a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_3930919c-1a07-416d-88d0-2bfe288fd3f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_3930919c-1a07-416d-88d0-2bfe288fd3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCapPrice_a0978a2c-cb54-43a5-afee-882c1c52f775" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCapPrice"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DerivativeCapPrice_a0978a2c-cb54-43a5-afee-882c1c52f775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DerivativeCapPricePremiumOverStockPricePercent_b75d887f-e152-478e-90cc-33fcdfcf51e2" xlink:href="cutr-20210630.xsd#cutr_DerivativeCapPricePremiumOverStockPricePercent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DerivativeCapPricePremiumOverStockPricePercent_b75d887f-e152-478e-90cc-33fcdfcf51e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_f8f2bea8-f4ac-4728-ad29-be1ca6505893" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_SharePrice_f8f2bea8-f4ac-4728-ad29-be1ca6505893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_fcc4b122-891d-48e5-9334-db6bf99a9505" xlink:href="cutr-20210630.xsd#cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_fcc4b122-891d-48e5-9334-db6bf99a9505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_12ddf240-8aa9-4a97-864b-3cadd4cd5559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_12ddf240-8aa9-4a97-864b-3cadd4cd5559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_16a097a1-94dc-49fb-803f-ded908afc617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_16a097a1-94dc-49fb-803f-ded908afc617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_065ff117-0d1c-4fcb-b48a-8bfc3f9d8814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_065ff117-0d1c-4fcb-b48a-8bfc3f9d8814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_a7db8a1e-dc23-4509-9bf9-be81d39e6a03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_a7db8a1e-dc23-4509-9bf9-be81d39e6a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_118338d3-66a3-41f8-bfee-6add3f8e7882" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_InterestExpenseDebt_118338d3-66a3-41f8-bfee-6add3f8e7882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_3e111a71-8417-4715-bca8-91dbcdf76c7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_3e111a71-8417-4715-bca8-91dbcdf76c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9868271d-5c6e-44da-bbb3-6af738e57441" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9868271d-5c6e-44da-bbb3-6af738e57441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_e6bc3c5b-f633-4126-ba7d-01cc7991460f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentTerm_e6bc3c5b-f633-4126-ba7d-01cc7991460f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_05a3a346-7f05-4a65-9538-7bea593e0690" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_05a3a346-7f05-4a65-9538-7bea593e0690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_12dec6dc-5b57-47be-885c-60de2c31b3fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_12dec6dc-5b57-47be-885c-60de2c31b3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_c5f66ee5-eb61-4d77-873a-9c1904019b03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_c5f66ee5-eb61-4d77-873a-9c1904019b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentAnniversaryFeeAmount_8994770c-fef1-45d0-9b99-ec9d5d52a1c4" xlink:href="cutr-20210630.xsd#cutr_DebtInstrumentAnniversaryFeeAmount"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DebtInstrumentAnniversaryFeeAmount_8994770c-fef1-45d0-9b99-ec9d5d52a1c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtCovenantQuarterlyMinimumRevenue_48b0dd6b-ed56-4678-ae97-2ff4367213bf" xlink:href="cutr-20210630.xsd#cutr_DebtCovenantQuarterlyMinimumRevenue"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_cutr_DebtCovenantQuarterlyMinimumRevenue_48b0dd6b-ed56-4678-ae97-2ff4367213bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_dda9bafd-8432-4d27-830c-f47c959b210a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_dda9bafd-8432-4d27-830c-f47c959b210a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fae9e520-3d5a-4f72-9e9f-f54dba807b6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a5c7be1-3803-4f70-8d0f-873699c2b225" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fae9e520-3d5a-4f72-9e9f-f54dba807b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#DebtOutstandingDebtandCarryingValueDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2ccd6469-101d-42b7-b450-2090cc9ff450" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a55a85d3-1777-490f-b1ff-326941de319b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2ccd6469-101d-42b7-b450-2090cc9ff450" xlink:to="loc_us-gaap_DebtInstrumentTable_a55a85d3-1777-490f-b1ff-326941de319b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_87fad07a-38fd-4d31-a169-00621adea9d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a55a85d3-1777-490f-b1ff-326941de319b" xlink:to="loc_us-gaap_DebtInstrumentAxis_87fad07a-38fd-4d31-a169-00621adea9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c78dd0fc-0b1d-4a5e-afe7-2ab25afa5542" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_87fad07a-38fd-4d31-a169-00621adea9d2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c78dd0fc-0b1d-4a5e-afe7-2ab25afa5542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_349a040a-f7d6-4fa4-b06d-4ade31ecfe8a" xlink:href="cutr-20210630.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c78dd0fc-0b1d-4a5e-afe7-2ab25afa5542" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_349a040a-f7d6-4fa4-b06d-4ade31ecfe8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_694092d0-f9b1-4a86-a4dc-f2cabc8feb2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a55a85d3-1777-490f-b1ff-326941de319b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_694092d0-f9b1-4a86-a4dc-f2cabc8feb2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a15c6815-0e3d-4166-a6e1-865459802346" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_694092d0-f9b1-4a86-a4dc-f2cabc8feb2b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a15c6815-0e3d-4166-a6e1-865459802346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_0e4f6b0d-25eb-49b6-8950-09d63fd76c64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a15c6815-0e3d-4166-a6e1-865459802346" xlink:to="loc_us-gaap_ConvertibleDebtMember_0e4f6b0d-25eb-49b6-8950-09d63fd76c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b03f658a-779d-4679-8ab2-9d331044cdb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a55a85d3-1777-490f-b1ff-326941de319b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_b03f658a-779d-4679-8ab2-9d331044cdb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_4c25f343-d55f-4606-b9c0-b287928c4004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b03f658a-779d-4679-8ab2-9d331044cdb3" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_4c25f343-d55f-4606-b9c0-b287928c4004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_ee91759c-28b7-49b5-a3f7-cb23d6b75d50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b03f658a-779d-4679-8ab2-9d331044cdb3" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_ee91759c-28b7-49b5-a3f7-cb23d6b75d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f49b3c0a-7c4b-46df-8734-a865e8c65693" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b03f658a-779d-4679-8ab2-9d331044cdb3" xlink:to="loc_us-gaap_LongTermDebt_f49b3c0a-7c4b-46df-8734-a865e8c65693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/SegmentReporting" xlink:type="simple" xlink:href="cutr-20210630.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4dda3958-7d44-44ff-b557-b55ad32a7f91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_70b13fe6-06ec-4fcf-b0ad-43f0df1af639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4dda3958-7d44-44ff-b557-b55ad32a7f91" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_70b13fe6-06ec-4fcf-b0ad-43f0df1af639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/SegmentReportingTables" xlink:type="simple" xlink:href="cutr-20210630.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_9d3cebeb-a51b-46aa-8595-14c5be45de6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_33c01e91-213d-401e-b58d-2ad708e45cd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9d3cebeb-a51b-46aa-8595-14c5be45de6b" xlink:to="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_33c01e91-213d-401e-b58d-2ad708e45cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#SegmentReportingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/SegmentReportingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5b5599b1-f766-4ff9-a974-f04558835c9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_758f8a2c-b843-4c58-bfa8-56b6da5ebb6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5b5599b1-f766-4ff9-a974-f04558835c9d" xlink:to="loc_us-gaap_NumberOfOperatingSegments_758f8a2c-b843-4c58-bfa8-56b6da5ebb6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails" xlink:type="simple" xlink:href="cutr-20210630.xsd#SegmentReportingSummaryofRevenueDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7f293b8d-e68d-40ff-8410-90d80ea930c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_30ef530a-8d59-438d-80a7-6ffe88055b18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7f293b8d-e68d-40ff-8410-90d80ea930c4" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_30ef530a-8d59-438d-80a7-6ffe88055b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_864d38c8-a3fd-4ecf-ae7f-ba6f1412ce1f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_30ef530a-8d59-438d-80a7-6ffe88055b18" xlink:to="loc_srt_StatementGeographicalAxis_864d38c8-a3fd-4ecf-ae7f-ba6f1412ce1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_14b8bec0-9e35-413d-aa63-c36355eaa147" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_864d38c8-a3fd-4ecf-ae7f-ba6f1412ce1f" xlink:to="loc_srt_SegmentGeographicalDomain_14b8bec0-9e35-413d-aa63-c36355eaa147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cd74e9d0-643e-4f6a-877e-ad1fd6d17b4c" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_14b8bec0-9e35-413d-aa63-c36355eaa147" xlink:to="loc_country_US_cd74e9d0-643e-4f6a-877e-ad1fd6d17b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_60b4647e-258e-419c-b0de-42135f6f3f7d" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_JP"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_14b8bec0-9e35-413d-aa63-c36355eaa147" xlink:to="loc_country_JP_60b4647e-258e-419c-b0de-42135f6f3f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AsiaExcludingJapanMember_f8561910-b267-41a4-9597-3602b1319580" xlink:href="cutr-20210630.xsd#cutr_AsiaExcludingJapanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_14b8bec0-9e35-413d-aa63-c36355eaa147" xlink:to="loc_cutr_AsiaExcludingJapanMember_f8561910-b267-41a4-9597-3602b1319580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_13ecf976-83ff-48a6-9793-fc210dd9c888" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_14b8bec0-9e35-413d-aa63-c36355eaa147" xlink:to="loc_srt_EuropeMember_13ecf976-83ff-48a6-9793-fc210dd9c888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestOfWorldMember_3d180904-a013-49d8-967c-2811c1774c38" xlink:href="cutr-20210630.xsd#cutr_RestOfWorldMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_14b8bec0-9e35-413d-aa63-c36355eaa147" xlink:to="loc_cutr_RestOfWorldMember_3d180904-a013-49d8-967c-2811c1774c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6765b116-e287-4552-8e77-263f7a82e7de" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_30ef530a-8d59-438d-80a7-6ffe88055b18" xlink:to="loc_srt_ProductOrServiceAxis_6765b116-e287-4552-8e77-263f7a82e7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0dc58782-7bbf-459e-a4ba-75c39e8df558" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6765b116-e287-4552-8e77-263f7a82e7de" xlink:to="loc_srt_ProductsAndServicesDomain_0dc58782-7bbf-459e-a4ba-75c39e8df558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_bed4acfc-40ab-4f4b-a9d3-0d98acb2ee10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0dc58782-7bbf-459e-a4ba-75c39e8df558" xlink:to="loc_us-gaap_ProductMember_bed4acfc-40ab-4f4b-a9d3-0d98acb2ee10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ProductsExcludingConsumablesAndSkincareMember_0c4ac1d2-80c1-45b1-8357-2684551d372e" xlink:href="cutr-20210630.xsd#cutr_ProductsExcludingConsumablesAndSkincareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductMember_bed4acfc-40ab-4f4b-a9d3-0d98acb2ee10" xlink:to="loc_cutr_ProductsExcludingConsumablesAndSkincareMember_0c4ac1d2-80c1-45b1-8357-2684551d372e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConsumablesMember_f67a9485-c94d-4eb9-939b-8532c2237986" xlink:href="cutr-20210630.xsd#cutr_ConsumablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductMember_bed4acfc-40ab-4f4b-a9d3-0d98acb2ee10" xlink:to="loc_cutr_ConsumablesMember_f67a9485-c94d-4eb9-939b-8532c2237986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SkincareMember_0c6d2624-8fc4-4a82-9823-c3395ca26711" xlink:href="cutr-20210630.xsd#cutr_SkincareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductMember_bed4acfc-40ab-4f4b-a9d3-0d98acb2ee10" xlink:to="loc_cutr_SkincareMember_0c6d2624-8fc4-4a82-9823-c3395ca26711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_3ff7fee0-bc3c-43f8-b945-ce0b036791c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0dc58782-7bbf-459e-a4ba-75c39e8df558" xlink:to="loc_us-gaap_ServiceMember_3ff7fee0-bc3c-43f8-b945-ce0b036791c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e0f564a1-7806-4461-be5c-44b6d416d40c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_30ef530a-8d59-438d-80a7-6ffe88055b18" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_e0f564a1-7806-4461-be5c-44b6d416d40c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_f9066c5e-56d1-492a-ae86-0fc8ad93dc27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e0f564a1-7806-4461-be5c-44b6d416d40c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_f9066c5e-56d1-492a-ae86-0fc8ad93dc27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>capture.jpg
<TEXT>
begin 644 capture.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#L17AI9@  34T *@    @ ! $[  (
M   +   (2H=I  0    !   (5IR=  $    6   0SNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $QU8VEL92Y0
M>64    %D ,  @   !0  !"DD 0  @   !0  !"XDI$  @    ,T-P  DI(
M @    ,T-P  ZAP !P  " P   B8     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                    ,C R,3HP.#HP-B P.#HR-CHR-0 R,#(Q.C X.C V
M(# X.C(V.C(U    3 !U &, :0!L &4 +@!0 'D 90   /_A"QUH='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O #P_>'!A8VME="!B96=I;CTG[[N_)R!I
M9#TG5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED)S\^#0H\>#IX;7!M971A('AM
M;&YS.G@](F%D;V)E.FYS.FUE=&$O(CX\<F1F.E)$1B!X;6QN<SIR9&8](FAT
M=' Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/CQR
M9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2)U=6ED.F9A9C5B9&0U+6)A,V0M
M,3%D82UA9#,Q+60S,V0W-3$X,F8Q8B(@>&UL;G,Z9&,](FAT=' Z+R]P=7)L
M+F]R9R]D8R]E;&5M96YT<R\Q+C$O(B\^/')D9CI$97-C<FEP=&EO;B!R9&8Z
M86)O=70](G5U:60Z9F%F-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R
M9C%B(B!X;6QN<SIX;7 ](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B
M/CQX;7 Z0W)E871E1&%T93XR,#(Q+3 X+3 V5# X.C(V.C(U+C0V.3PO>&UP
M.D-R96%T941A=&4^/"]R9&8Z1&5S8W)I<'1I;VX^/')D9CI$97-C<FEP=&EO
M;B!R9&8Z86)O=70](G5U:60Z9F%F-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S
M9#<U,3@R9C%B(B!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE
M;G1S+S$N,2\B/CQD8SIC<F5A=&]R/CQR9&8Z4V5Q('AM;&YS.G)D9CTB:'1T
M<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^/')D
M9CIL:3Y,=6-I;&4N4'EE/"]R9&8Z;&D^/"]R9&8Z4V5Q/@T*"0D)/"]D8SIC
M<F5A=&]R/CPO<F1F.D1E<V-R:7!T:6]N/CPO<F1F.E)$1CX\+W@Z>&UP;65T
M83X-"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/#]X<&%C:V5T(&5N9#TG=R<_
M/O_; $, !P4%!@4$!P8%!@@'!P@*$0L*"0D*%0\0#!$8%1H9&!48%QL>)R$;
M'24=%Q@B+B(E*"DK+"L:("\S+RHR)RHK*O_; $,!!P@("@D*% L+%"H<&!PJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*O_  !$( 7@!(@,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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M:6*-=2MB\RAXU$H)8'."/R/Y4ZWUS2[JUEN;?4+:2&$9DD64%4'J3VKSK6_
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"0R!%#L,%@.3^-.H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>capture1.jpg
<TEXT>
begin 644 capture1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#L17AI9@  34T *@    @ ! $[  (
M   +   (2H=I  0    !   (5IR=  $    6   0SNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $QU8VEL92Y0
M>64    %D ,  @   !0  !"DD 0  @   !0  !"XDI$  @    ,Q,   DI(
M @    ,Q,   ZAP !P  " P   B8     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*O_  !$( IX#W ,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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M '-VR1F4$D#)  )&2*Z*O.KO6=-U?X7VVA:5?6M]JEY8PVL=K;S+)(KE5!+
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MEZ-J>J6]J[1RW-HD6S>O#*H>16<@C'R C/ R>* .@HK%G\5::FF6%Y9F6_\
M[2(%E!:IF2?(R<!L!0!DDL5"]R#Q42>+;=9;J#4=/OM.NK>U>[%O<K&6EB7[
MS(R.R'!P"-P(R,C!S0!OT5@6'B:ZU&"VN(/#&KBWN51TF>2T ", 0Q'GYQ@Y
MZ9]J2Y\6QQSWJV6DZEJ,-@Q2ZN+58MD;@990'=6<@8)VANN.3Q0!T%%<UJ?C
M2#3M+CU2+2=0OM,D2)TO;4P;&$A 7Y7E5^K ?=[U)=>*WLS917'A_5%N[Z=X
M;>TW6Q=ML9<MGSM@& >K9XZ=,@'0T5@7?BEM-T>^U/5M"U*QM[*$RL9&MW,@
M]%"2MS]<#WIT?B?9?VUMJNCZAI0NG\N":Z\EHWD[)F*1]K'G&[ .,9S@$ W:
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOV>.*9'>5BN=H 7&3C)8 =:[6B@ HHHH **** "BBB@ HHHH **** "BBB@
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MXE01RRV=Y-;-,HZ!S$Z[P.<;LXR<=:L6_A_2K0Z?]DLHX!IJ.EHL656(,,,
M!P<X[UHT4 9>I>'-*U>X:;4;7SG:)86/F.H*!PX4@$ C< ?TZ59U/2[/6+$V
M>I0^= 65]NXJ0RD,""""""!T-6Z* ,[5M T[6VMWU"%S-;%C!/!.\$L6X88+
M)&RL 1C(!P<#/2JDG@W0YM)GTZ:UFDAN)4FFD>[F,TDB$%&:8MYA*[5Q\W
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MALC&T=,=*DT[0K32[AIK:;4'=DV$7.HW%PN,@_=D=@#QUQGKZFM*B@ HHHH
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MZEE8WM[-9ZE873"*YNI)W@FB52'1W);!#$%<XR 1WJ*]U"\3X#+J"W<ZWO\
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M!_\ %4 =)17-_P#"Q_!'_0Y>'_\ P:0?_%4?\+'\$?\ 0Y>'_P#P:0?_ !5
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M /P:0?\ Q5'_  L?P1_T.7A__P &D'_Q5 '245S?_"Q_!'_0Y>'_ /P:0?\
MQ5'_  L?P1_T.7A__P &D'_Q5 &GXAU-M%\-:EJ<<?FO9VLDZIV8JI.#[<5B
MP>&KR?2+6]BU[4$UHJDS7+W$CP.QY93;[A'L()& H(&#G/-.NO'W@*]LYK6Z
M\7>'I()XVCD0ZI#AE(P1][T-<O-K'ANZT9-!N_BCX>DT4*(G07,"W4L(&!&T
MWF[>F 2(P2!UR2: .NTJYN)/B%XBMY9I6@BM;)HHF<E4+>=N*CH,[1G'7 ]*
MQ3<:]>6?C2'19YI;V+4TCME,H!2/RX2ZQE_E4[2^.V3FH[SQ3X336SJN@_$#
MPQ8SR6RVT\4]U#-%(B,2AVK*A#+N89SC!QC@8B@UWP9#HMW;I\2=(BU"\NOM
MLM_!J<"'SOEQA-Y'EX15V$G*C!)/- %KP[?Z==:[:0V=]KVE37%O*9M'UO[2
M9)E!P&1Y6.UAU_=L<@\@8X<-"@_X6*VE_;M9^QC2A<>5_;5W_K/-*[L^;GIQ
MC.*K1>*O#%SK-CJ&N_$/PK<MIY=[:.TN(H '="A9BT[D_*2 !CKSGC%L>+?!
M \7'7/\ A.?#_-B+/R?[1@_YZ%]V[?[XQC\: +=M$_B?Q-K$=W>WL5AI4J6D
M-O:W4EOOD,:N\CO&0['YPH&[& 3C)R,37M0U'3?#OBS1UU*[<Z:EM):7AE(G
M2.5L;#(,%B"C?,>2",DGDSW7BGPG%K5QJF@_$+PU93WBJMW%<W<,\4I485]H
ME1E<#Y<AL$8R,@$4KG4? ]WX?U2SN?B'H4NH:LR/=7S7\'5=N%5 XVH N ,D
MC))).20"[X@\2:B?A[-!!<M%K06YM[B:+"LA@1FDD&/N[@HP1T\U<8J&[ODD
M\2:)!JUSK3VLF@B8QZ=)=EFEWH-["W^8\$\GCGZ5#?:AX"O-5UN^'C_04.J6
M+VJQG4(&6W=T"/(/GY+!(LCC[G7GATFO^&(-6L-0TGXC>%89;33O[/9;F>*9
M77<K;AMG3!RH]: +OB2>VLOAS?W.C3ZY IN[9'>YEO%G ,\08)YI\P JQ'R]
M<D=:CM;RUE\7Z=:>$[G76N89=^IP:C)>&-+8J>66YZ,6V[=O/7MFH]2\4>&]
M;T&?3M7^(OA1F>>"5);6:.,*(Y5D(*M.V<[,9R,9[U/K'B;P3?ZWINKV/CSP
M]97]BS(9/M\#B>!OOQ,/,'&0"#G@C.* *^K74MKK6K_\)8/$=K#EY++4]-><
MVEM;J@VEEA/WP=Q/F*0<<G;@5W>D2F?1;.5KZ/4"\",;N) BS\#YPH) SUQF
MN'?Q=HMO<W7]E_%+PVEM<R-*$OKF*Y> MU$;^>N%]%(;'TXK3T?QE\/]#T:T
MTRQ\9:#]GM8A$F_58"Q [GYNI_*@#L:*YO\ X6/X(_Z'+P__ .#2#_XJC_A8
M_@C_ *'+P_\ ^#2#_P"*H Z2BN;_ .%C^"/^AR\/_P#@T@_^*H_X6/X(_P"A
MR\/_ /@T@_\ BJ .DKB_&MTD7B;P[;W<^II93?:O.CTU[@/(512N1!\Y -:'
M_"Q_!'_0Y>'_ /P:0?\ Q59=]XM\$7OB+2M4_P"$Y\/I_9PF'E?VC ?,\Q0O
M7?QC'H<T 9.J7-_9Z!XKN=&FUJWTJ+3 T$NHO<+,MR-VXQ&;]Z%V[<D\9Z=Z
MD:]M&U+2K3PK=>(#KAFBF>"_DOO*-MG$KR+<';LVD@$<[MNWFM/Q'XO\$>(/
M#5_I/_"<^'[?[9 T/F_VC VS(ZXWC/YU5UWQ%X)U:'3Y;/Q[X?LM2TR59+6[
M^WPN%Z!T9?,&59<@C(['M0!)JVOZCI5_XRFM9F=[9+%+5)"62%Y1MW!>F,L"
M?7%;8\+3VLEM<Z?K>HB\BD#3O=7,D\=RO\:F(ML3/8H!M[#'%<[<:S\/KV[U
MYK[QQH,L&M111O$NI0JT7EJ1D-OZY.1P,$=ZKS^(/#NIQVUGKOQ/\-WFG02I
M(T45Q!%+<E"&02OYQ!&0"=JKDCL.* )H[JRN/&'B6+6I_$4OD7D:0)I[WYCC
M0P1DC%O\HY).#SS7=Z6D":7 +3[48=N4^UM*9<'GYO-^?/\ O<BN B\2Z#8:
MWJM]I/Q)\(Q1ZE.L[17+QRE"(U3 9;E,CY<].];]E\1/"4=FBZCXX\,SW(SO
MD@OHHD;GC"F5B.,?Q'^E '5T5S?_  L?P1_T.7A__P &D'_Q5'_"Q_!'_0Y>
M'_\ P:0?_%4 =)17-_\ "Q_!'_0Y>'__  :0?_%4?\+'\$?]#EX?_P#!I!_\
M50!TE%<W_P +'\$?]#EX?_\ !I!_\51_PL?P1_T.7A__ ,&D'_Q5 '245S?_
M  L?P1_T.7A__P &D'_Q5'_"Q_!'_0Y>'_\ P:0?_%4 =)17-_\ "Q_!'_0Y
M>'__  :0?_%4?\+'\$?]#EX?_P#!I!_\50!TE%4]+UC3-<LS=Z+J-IJ-L&*&
M:TG65-PZC<I(SR./>KE !1110 4444 %%%% !1110 4444 <W_PKCP1_T)OA
M_P#\%<'_ ,31_P *X\$?]";X?_\ !7!_\36CJGB+3-&E$=_-(K^49F6*"24I
M&.KML4[5_P!IL#@^AI;_ ,0:=IWV7SY99#> M;K:V\EP9  "2!&K'&"#GWH
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M_P#$T?\ "N/!'_0F^'__  5P?_$UTE% '-_\*X\$?]";X?\ _!7!_P#$T?\
M"N/!'_0F^'__  5P?_$UTE% '-_\*X\$?]";X?\ _!7!_P#$T?\ "N/!'_0F
M^'__  5P?_$UTE% '-_\*X\$?]";X?\ _!7!_P#$T?\ "N/!'_0F^'__  5P
M?_$UTE% '-_\*X\$?]";X?\ _!7!_P#$T?\ "N/!'_0F^'__  5P?_$UTE%
M'-_\*X\$?]";X?\ _!7!_P#$T?\ "N/!'_0F^'__  5P?_$UTE% '-_\*X\$
M?]";X?\ _!7!_P#$T?\ "N/!'_0F^'__  5P?_$UTE% '-_\*X\$?]";X?\
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ML+K)'(H9'0Y# \@@]Q0!SO\ PKCP1_T)OA__ ,%<'_Q-'_"N/!'_ $)OA_\
M\%<'_P 37251BUJPFT\WL4Y:W$WD;A&WW]_E[<8S][B@#)_X5QX(_P"A-\/_
M /@K@_\ B:/^%<>"/^A-\/\ _@K@_P#B:O+XGTAM5_L\73>?YQMPWDOY1E W
M&,2[=A?&?EW9X(QD5K4 <W_PKCP1_P!";X?_ /!7!_\ $T?\*X\$?]";X?\
M_!7!_P#$UTE% '-_\*X\$?\ 0F^'_P#P5P?_ !-'_"N/!'_0F^'_ /P5P?\
MQ-=)10!S?_"N/!'_ $)OA_\ \%<'_P 31_PKCP1_T)OA_P#\%<'_ ,37244
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MT)OA_P#\%<'_ ,37244 <W_PKCP1_P!";X?_ /!7!_\ $T?\*X\$?]";X?\
M_!7!_P#$UTE% '-_\*X\$?\ 0F^'_P#P5P?_ !-'_"N/!'_0F^'_ /P5P?\
MQ-=)10!S?_"N/!'_ $)OA_\ \%<'_P 31_PKCP1_T)OA_P#\%<'_ ,37244
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MT)OA_P#\%<'_ ,37244 <W_PKCP1_P!";X?_ /!7!_\ $T?\*X\$?]";X?\
M_!7!_P#$UTE% '-_\*X\$?\ 0F^'_P#P5P?_ !-'_"N/!'_0F^'_ /P5P?\
MQ-=)7DGQT^*NN?#+^PO[!M=/N/[1^T>;]MC=]OE^7C;M=?[YSG/:@#M_^%<>
M"/\ H3?#_P#X*X/_ (FC_A7'@C_H3?#_ /X*X/\ XFOFW_AJOQO_ - KP_\
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MC?.S9"+M7J3V[]3U.36A10 4444 %%%% !1110 4444 %%%% !1110 4444
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MYPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]G_M&]AM/._M/?Y?F.$W;?*&<9SC(JE0@AO&XB6\OZM;\CW^BBBMSD"BBB@
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MEA%J,HF613'^YMQ(P.8L+G(P">!YAR6QQB*Y^'\5U$NDW0MKG13.;EC/&&N
M[#YPK;<#<_S%@0>2!P1CM:*/9Q#Z[4[+[E\ONZ=CB[KP5=:I86]MJSV%PFF(
MBZ? 8 T+E>"TJ%<#<N%VCA>2.2,6HO#^KVL4$UM/9M.N5^QR _9;4=(S"H'R
MF->. -P)SCC'544>S0?7:CZ+[E]WIU]=2C;:3;0PPB=%NIXRK-<S(ID=U! <
MG'7DXQTS@8%6XH8[>%8H(TBC485$4 #Z 4^BM-CC;<G=A1110(**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@# B\%:-;SSRV
MW]HP-<3-<2B'5;J-7D8Y9BJR 9/TK5O]-M-3CA2^B\U8)X[B,;BNV1&#*W![
M$ XZ5:HH Q]1\*:-JM\UW?6C/*X02A9Y$2<(<J)$5@L@!)X<'KCI4\^@:;<_
MVGYUMN_M6$0WG[QAYJ!2H'7CY6(R,5HT4 95YX8TB_!%W:>8#9/8']ZX_<,0
M63@]]HYZ\=:D&@:6-*N=--FCV=T6::*0EPY;KG))_P ,#%:-% &/:^%-&M1<
MXM6N#=0_9YFO)Y+EFBY_=YE9B%Y/RCCFJX\#Z +*YM7M)I8[J!;:4S7DTC^4
M#D1J[.65<_PJ0#7044 9%IX8T^R#"WFU+#1^7B35;F0*O'0-(=IXZC!%:X&%
M &>/4YHHH **** "BBB@ HHHH *JW/\ K!]*M5%+#YC9W8XQTK#$0E.%HEP:
M3U*E?%GCJVW^./$\XLT:]75+U8DV#]XGGM\^W')&<9[]><5]M_9?]O\ 2O,-
M6_9Z\-:OJU[J4^K:U%<WDSRL\,T2^6'<N47]V2%!/'4XXS7-1IU:;;L;Q]E+
MXW;^MCY1CM\Z&;PV:?:HXRH!08*9'[PKC&1R/U[4+;C^PA>FTC^T^654;!AD
MR/WFW&,C./UKZF?]F_PN\T4IUK7@T?)(GB^<XQS^[].*$_9O\+)<-*-8UTD@
M!5,\6$P,#'[OT)^N3G-=7-4_E_$T]GA-N=_=^._RM\_(^6A:DZ4)19)]O,>W
MRM@R8\X\S9CKV_6OO-'62-7C8,C#*LIR"/6O+O\ AFGPL8BIUO7S(5V^<;B+
MS N<[<^7TKU&PT6#3;=H+1F6$NSK&>1'GDJOH,YX[9]*YJ\*M2VFPG]7C'W)
M._FOP_K?R-&BBBN\X@HHHH **** "BBB@!LG^K;Z&J-7R-RD'N,5%]F3U;\Z
MX\11E4:<32$DEJ?,7[0JC_A95D;T V#:3"A5N<R>?+C ZY]?;->3VEK>F^NE
MUI UNS!CO.4+9^4KST '/MQ7VAXA^&?A3Q5JB:CKVFM=7:0K LGVF5,(&9@,
M*P&078YQGGK6*/@+\.1:FW&@-Y1ZK]NN/7.,^9G&><5<%5C%1L="^JM7ES7^
M7]:]^G9GR-9P7375[_;*AH!("PDR1Y@Z%?8+UQ_#6]\/(;N+XD:')K(S%)K5
MILW'),WG+M*^@Q^@%?3S? KX>.\;MH3[HONG[=<?_%\_C5C3O@QX#TG6(=4L
M-$:.[@E2:-S>3,%9""IVER."!CBK3J]AM8.VCE^']>5OG?H=U1116QQ!1110
M 4444 %%%% !7C_Q[\#>)/&J:)'X6T\7+VZ7*S3>=&GDAS%@?.PSN"MR,XQ[
MU[!12:NBX2Y97M?U/D%O@C\1)&FD'ADQR'AG%_;AYU'3D2X4DCGV_53\%/B(
MNZ=/"BK)<.C2+%?VZLI'4Y\W'7D#\^E?7M%1[/S9U?7/^G<?N_K[MNMKZGR"
M?@?\1D<I;^'$A=W$S7$=Y %+@\ KYI.W&<CU/I0OP1^(:-NM_"_V:.*5I/*6
M^MOW^1@ _O#CN,=,'CFOKZBCV?FP^M_].X_=_P '_@O9W6AS7@"QUC2?!>EZ
M7KMO%#-9V5O$HB8';B-08S@GE""N02" #GK72T45:5E8Y9RYY<UK>@4444R
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MS)Y8#R;MYV[6X)ZGG.!3=*\S5?#T-[K^MW4-GIAN8+GRYFMS,T<I197E1E.
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MUT>$^6_ *^?-ELY[=QCI0![#_P -!_#'_H9O_)"Y_P#C='_#0?PQ_P"AF_\
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MI8JBD,<JH /'' PX^$-&-K% MO/&L,SS0O%=S))"S_>".'#(ISRH(7VK;HH
MSK;0=,LY+![6S2$Z?"\%J(R0(T?;N&,X.=B\G)X]S59_".BM9V=LEM+"MB&6
MW>WNI8I(PWWE$B,'P>XS@X'H*VJ* (+*RMM.L8;.QA2"W@0)'&@P%4=JGHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M" ;]QR1@$#'(R1SAFI^*I9-/;[%%<:?>6VI6UK<P7*1EE#LI_A+*05;J#^5
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MKG/^&@_AC_T,W_DA<_\ QNO/?VF+6*^N?"]M,"#(EX4E'2(CR3D^QZ'/MBO
M(+.UO-4N+$6YMP 0DI8DQE>[ G'/^&*VI3<X*3)DK.Q]@_\ #0?PQ_Z&;_R0
MN?\ XW5G3?CE\.M7U6TTW3_$/G7=Y,D$$?V*X7>[L%49,8 R2.2<5\:VUG:W
MVIW%D+<VX&0DA8DQ[3@[LG'/\\5O_#>&VN/BQH426I@\G5K5T8L24VSIPV3C
MGI]2*U)/NNBBB@ HHHH **** "BBB@ K(U7Q9X<T&Z6UUS7]+TVX=!(L5Y>Q
MPNRDD!@&(.,@C/L:UZ^4OVH;&6\^*%B;?:[QZ+$3$,[B//FY [T ?1/_  L?
MP1_T.7A__P &D'_Q5'_"Q_!'_0Y>'_\ P:0?_%5\'G1[AGE2!XYY8F"O'$22
M,]^1@@'@T+H\\KLMM)%<%)!&_ED_+[G(''7GVH ^\/\ A8_@C_H<O#__ (-(
M/_BJZ"VN8+RUBNK.:.>WF0212Q.&212,AE(X((.017YWQZ1-/@VTD4R>84=T
M)Q'CG+9 XQDY]J^\?AV OPN\+ ,& T:T 89P?W*<\T ='1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '.W^E:S:Z[>:
MEX?:S<W]LL4J7<C((I$SLD7:K;AACE3CH.:;:Z/K/A^TTVTT.:VO;2UM1;RV
MUXYAWN/^6H=4<Y/(*D8KI** ,/2-!ETSPG)IKRQR7,PF>615*H9)69C@<D*"
MV!["J.HZ/XB3P7IFCZ'<6T-Q%#%!>3?:&B;RU3:PB<1L58D<-MR!TYP1U5%
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MPMU4&.07T \LCM]_)R.IQU/M2S?!/QW=6S02^$I%A@/[B,7]OD@=.=_!/?\
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M/;>K+^E3TR82&WD$!42[3L+=-V.,T <&NLZI9Z7XFUD:S=7>G:?#);V?VF*
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MS1N'7(\O/4#O],5IS5/Y1N&%MI-_=]WW=?P/4Z***V.(**** "BBB@ HHHH
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M[2KHSOUZ@YYPW'%6K+Q=HNHW"PVES([2*[0LUM*B7 7[WE,RA9>.?D)XYZ4
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ME-/%LY^;?&C*.!GKTYZ&KUE>0ZA8PWEHS/!.@DC9D*EE(R#@@$?C0!/1110
M4444 %%%% !36D1#AC@_2G55N?\ 6#Z5C6J.G#F145=V&ZCJ]CI6EW6HW\_E
M6MI"\\\FQFV(BEF. "3@ \#FN"_X:#^&/_0S?^2%S_\ &ZV/B"0OPS\3DJ&
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MQ,RNL;Z9G:R]\^;W[],^U-7]F:]$39\:(UP6#"9M*!P<]<&7KR1GTX]*TO\
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M/BCX>>++73M%T[39[.:R2=I;N"5B)"\B[05=1T0''7K7 R?M0^/X03+H>B(
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M0UF:7X=TK17#:7:"W*PB 8=B F]GVX)/\3L?QQT K3H **** "BBB@ HHHH
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M&3)N\U-JNLG08W*X..?K0!N4444 %%%% !1110 4444 %%%% !1110 4444
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M7"R+]M,/#&0 8QZX.<X[\UGAZKDFYLT=&4G[D6SVS_AKG_J2?_*M_P#::/\
MAKG_ *DG_P JW_VFO$]4M[L6J-9J!,\BFZ,/!:3C:>.V<_CS3M0MKQEC33E
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MHHH *\[^('P4\.?$?7X-7UR]U2"XAM5M56SEC5"H9F!(:-CG+GOZ5Z)7SO\
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M3(_!FW&0YSGG>WTSQC JUINDV.D12QZ= ($E<2.H8G+!53/)X^5%''I5RB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *\XL].NE_M77M%C+ZEIVM76
M8D'-W 64R0GW(&5]& ]:]'HH \NT29)?#'@*<?*CZI,_S<8!6<\TY[+6_$NB
MZWJ^FV5HXU*=9["Y>[=)HTMS^Y*H(B,Y4M]X9W]J]/HH S] U:/7?#UCJ<.
MMU"KE1_"V/F7\#D?A6A110 4444 %%%% !1110 4444 %12P^8V=V.,=*EJ&
M:9HW 4#IGFLJW)R^_L5&]]"KJ.C6VJZ7=:=?CS;6[A>":/)7>C*589!!&03R
M.:XMO@3\/WDC=M$):,DJ?MMQU/4G]YR3[UTWB?6[S1_".L:G8Q1RW5E8SW$,
M;J65W2,LH(!!() X!%?-B_M0?$!RP30]$8HP5@+2X.T],'][UK&G"C-7BOS-
M55JT]%*U_P!-CVU?@5\/TF>5=#(=P 3]LN.W3 \S QVQTI@^ GP\%J;<:$?*
M/5?MMQZYQGS,XSSBO%4_:@^($A8)H>B,5;:V+2X.#Z?ZWK0G[4'Q DSY>AZ(
MVUMIVVEP<'T_UO6M?80_IL?UFL]Y/K^._P!_7N>\:;\'?!6DZG!J%CHX2Y@5
MTC9[B:08="C95G(;*DCD&NOBL%AA2*-L(BA5!YP![DUX#\,OCYXO\9_$+3M#
MU72]*ALKEI5FEM[>970K$[@9:0@'*CJ.F:]^^TOZ+^585(T(.TE^8.I6J:RE
M<M4445VG.%%%% !1110 4444 '7K3?+3^XOY4.<1MCT-4_,?^^WYUS5JL:;2
M:N7&+>Q<\M/[B_E1Y:?W%_*ODOXQ^(O&-K\7-8MM#\3ZK:V:/ @M[;4)HT@S
M;QL25!  /)R/?O7"0^,?'URJO;>-=<E0R%&8:K< 1X_B;)X&.<_UXK6*C**=
MB7=.Q]W^6G]Q?RHV(.BK^5?"$/C'Q]<HKV_C;7)(RY1G&JW $>.<MD\#'.?Z
M\5O> /%?C?4/B!X:63Q;K-]9RZO;QSQMJ4[(5\U=RNK'D%<\'@]*KECV"[/M
M.BBBJ$%%%% !1110 4444 %?)/[5?_)4]-_[ L7_ */GKZVKRWXF?!9/B/XG
MMM6FUI;);>U2!8#9>;DJ[MNW>8O!WX*X[=:3;2T1I3C&4K2E;S_X8^+J*^H/
M^&6W*^8?&8-T!M6?^RN0,YZ>=U[9]*4_LM $B/Q:B)(29T&E<29'3_7<#N!V
M-1S3_E_$Z?8X;_G[_P"2O^M.OELV]#Y>K[_^''_)+/"G_8%L_P#T0E>0']EA
M&'ER>+0UNN#'%_9>-I'OYO.>_K[<5[CX=T@:!X9TS2!(LWV&UCMS*L?EB0JH
M!;;D[<D$XR<9IQ<GNK&-6G2BO<GS?)K^O+\;;&E1115F 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '/W'C"SM[R9#:7CVE
MO<K:SWZ(IABE.!M/S;N"P!(4@$\GK3]2\6VNFWEW"UG>W$5@J/?7$"*8[56Y
MRV6#'"_,=@8@<UQ]_=0Q>&?$/AJ27&LW>IS"WMC_ *V82R[TD4=U"G);H-IS
MC%+XDFMO[0\417^I'2IYEC2+3QTU1!& I(^^^X[HR(BAP,$F@#LM2\306%T;
M:VL[O4ITM_M4J601C'%T#'<RYS@X R3@\4L_B>T"V(TV&?5);^(SP0VFS<8@
M!F0EV4*OS*.3G) QUQ@V^L6_A[Q-?7OB(IIJ7VF6LL7F$*NZ(.)(E]6!<84<
MG/%4/#W_ !2USH5SXB8:=!-I#6XDNF")%+YOF>6S'A6*G@'&=A'44 =2?%MB
M^F:?=V<%U=R:BQ2VM8D E9ESO!#E0NW!SD@#'TH'BVQ.D)>B"Z\Q[K[&MF4
MF\_./+P3MSWSNVXYSBN2TN5=,FT/7=1W6>FW%YJ,F^8;%@6XDW1%L_=!"\$X
M^\/6D60*Z>(RS_V3_P )*USYA7Y/)-OY(F_W=_?I@Y]Z .[TC68M76X"P3VM
MQ:R^5/;7 421M@$9VD@@@@@@D'/UK0KF/#,\>I>)/$&JV,@FL)W@AAG0@I*T
M:'>5/< MMSTRIQTKIZ "N8U42:OXXMM%FN;J"QAL&O'2UN)(&ED+A%RZ$-M
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MX&W)'(&<XYQBN7TG2M4\)Z=JVCZ5HR7UB"9=-.^- V_AHY<L"=I_B.25XSG
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MEFCDW9^\>&VX7@_C7V9X;-W)X>M)]0OUU">XC69IHT54^89 3 'RC/!/)[T
M:E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%9$WBC1[?4_L$UTPF$JPLPA<QI(PRJ-(%V*QR."0>1ZTMYXGTBPU!K
M*ZNF25#&)&$+M'"7.$#R!2J$\8#$=1ZB@#6HK)O_ !/I.F7AMKVY9)$"&5EA
M=TA#G"F1U4K&">[$>M6[_5++2Q;_ &^X2#[3.EO"&ZR2.<*H Z\_EU/% %NB
MLO5/$>EZ-,(K^>17\HS,(H))?+C'!=]BG8O^TV!P?0T:CXDTK2Q']JN';S(C
M.HMX))SY8QF0B-6(7D?,>* -2BF0S1W$*302++%(H='1@592,@@CJ#3Z "BB
MLC5-:GMM4M=+TNSCN[ZXC>8K-,88XXEP"S,%8Y+,H  ]>F* ->BN93Q?)=VN
MFKI^F[]0OI)HFMKB?RUMVA)$H=PK'@C PISD'BK5AXKT^721=ZM/;Z5(LTEO
M-%<W"@)+&VUP&. PSSD=B.G2@#<HJ@NNZ2]BUXFJ636JR>49Q<(4#_W=V<9Y
M''O53Q3XA/AK28[T6;7A>XB@$2/M)WMC(R.3[<9]10!M45S_ (D\6VV@>'X=
M4BB-Z+DKY"(^W>"-V[.#@;>>GH.]:=WK.EV%Y%:7VI6EM<S8\J&:=4>3)P,*
M3D\\<4 7:*QXO$5O_:FL6UYY=I!I?E;[F68!6#INR<X"XZ=:LP:]H]U:/=6N
MJV,UO&X1YH[E&16) "E@< DD #W% %^BLD>*O#S0B8:]IAB9_+#B\CVEL9VY
MSUYZ5.VKVT&H2VUW=6,.'BCB!NAYC.^<*4(&"<?* 26YZ8H OT50O-2Q%=QZ
M4;2[O;0*9;:2YV>6",C<55BN1R,KS^M<Y!X]DCDTTZOIT-I!J%DUZ)8KLR"-
M F\!LHO) ;V! Y.: .RHK+\-:R^O^'X-1EM#9R2M(K0%]Y0H[(1G _N^E:E
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M ;H0-RXR.V?3M[]I6D6>B6 LM-B:*W5BRQF1G"DG)QN)P,]AQ7SU_P -<_\
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M!JE1BAO'5Y*S?X+^K=;;7UWU/7Z***V.(**** "BBB@ HHHH *\2^(/[1?\
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M"!=7,,)96<>9(%RJC+'GL!R?2J%MXI\/WEREO::[ID\\AVI%%>1LS'T !R:
M+,&DV5MJD^HV\/EW-Q&L<K*[!7"_=RN=N0.,XSCC.*KZKX<TS69XY[Z&7SXT
M:-9K>XD@DV-U4M&RDJ<="<5J44 9UIH&EV-U;7%G9I!):VIM(?+)"I$65BH7
M..J@YQGBHX/#]AIT4+:99J)K,3M;*\SA0TK;W!//#-WP<=AVK5HH Y[0="NM
M T&^%K%9_P!J7EQ-=NH=A")78D+NV[MH&T=.W09K2T32H]$T6UTZ*1I1 F&D
M88,C$Y9C[EB3^-6X+B&Z@6:UFCFB;[LD;!E/;@BE$\1N# )4\X(',>X;@I)
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MJP;'$8X.,$?E@\U7-4_E!T\+;2;OZ?U\OQL>J4445L<04444 %%%% !1110
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MKFY):)?)R,)@C=\Q(4E 2<DUTNH^%-&U6^:[OK1GE<()0L\B).$.5$B*P60
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MD-RZD<*(_L\NW((ZG]*^O:Y*U=TY62-(PYE<T****ZS,**** "BBB@ HHHH
M1CM0D=AFJWVE_1?RJQ)_JV^AJC7#BJDH-<K-::36IX/\3?CYXO\ !GQ"U+1-
M*TO29K*V:)8I;BWF9F+0HY!*R $Y8]!TQ7+/^U!\0(\>9H>B)EMHW6EP,GT_
MUO6J'Q>4P?&CQ!+*X,<[6RHHP?+9;:,^8<]-HY_&N#TFTDLC/]KNHMLKJL3!
MPXWG[L@_IZ\^E=$*D>1-OH:K"5Y?#!_TK_D>EO\ M0?$"/'F:'HB[FVC=:7
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MN[.,>]<!X>"G5O#UL IL(+[519CMA)"L>![*7 ] *1 !K$5H%1=/7Q<VT X
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MPI/)[5V?GQ_WOT-8SHTK^_+7U1G.O.IT6G9$E%%%=ARA1110 4444 %%%%
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M-> V-A:ZD\J0M)$T9W_.=V8^_0=1^M)96%MJ<LT5LTD3J=Z&0[@4[YP.O?\
M3WH ]_\ ^&N?^I)_\JW_ -IKUSX5?$7_ (6;X5N=9_LO^S/(O6M/)^T>=NVH
MC[MVU?[^,8[5\2V=A;:E=36]HTL;@[H6D.05'7.!UQS^E?5'[+OD#X::J+7>
M8AK4H4N>3^X@YZ4 >T4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2*'21&#*ZD9!!'4$=Z?0!B#PAHOD3Q2VTLXG1(W>XNI97V*VY5#NQ95#<X!
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MB@"C;:/;6D*1Q2WK*DWG RWTTA+8Q@EG)*X_A/RYYQGFKU%% !1110 4444
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M7F_;8T3=YF_&W:[?W#G..U-0L[W9G4Q'M(VY(KT5OZ_+KOJ=M1115G,%%%%
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M3X>ZEIE]H4D]U;20Z1(C1(KM\@:!UGQ\O.Z5E8=.!SSU]#HH **** "BBB@
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M@\<F@#N**\^T?4KGQI<:)#?75W;0-HB7\ZV<[V[2S.VS)="#M&UB%!Q\PSG
MJ/2]2O=<;0-%O;^[V^9?K>30RM#)<?9I!$G[Q,$9W!CM(R1Z=0#T6BN=\'7,
M[VNIV-S<37/]F:C+:1S3L6=HP%==S'EB X&3R<<\UT5 !117$^-+62PT_4=6
MGUK4%O92D.CVUI.\06;'R1B-6VS,SY)W _+D8 6@#MJ*XM;>]\2>(M1L-1O[
MNR_LZQMU06-P\.V>569Y#M(WXVJ &RO7CDUS4WBK5]?T#3IVO)+2-!:17(MH
MIF:XFE5BSXA99-HV@A489).<@8H ]9HK@/#E[JTEK:VUOJ3"+5[6Z:SGG1YC
M;O')M64"1BY1T8/LD9BI^7..!;T*1K#QY)I-M>ZC):)I^9AJ<LK--<"3&^'S
M>6&W=N*?(,IZT =I17-^-VU1-)MI-+@O+BWCN5>_AT]]MS) %8D1G(.=VWA2
M&(R :P[+5TAL=;D\.ZGJ N(-.%P=(UH3":UDVD^9OFW,1@8VC<N1U&: /0**
MX&#Q])I^EZ)9Z@VEIJ5QIL=W-)J&J"WBV'A3O,9+.V"2H7 P>>A-N'Q])J:Z
M&-!TI+R75TN"/-O!&D#0,JON95;*Y8X*@YP.,'( .SHK+\/ZT=;L99);9K2Y
MMIWMKF OO$<B=0&XW#D$' R#T%<UK\MW#XP<:W9Z_<:/+'&ME+HLDP2%L'S3
M,L#"0G.W!PPQTP<T =S17GLFNZDFA>$VT'5X=:MK[4Q ][*QA>:/;(RQL-C'
M(VX9N#E "/F;%VW\83BZCLM+TDW%Q=ZI?6JBXU!MJF%CERS*Q53@D*H.W@ 4
M =K17&V?CF^F%O-=:+%;VK:G_94[B]WND_F&/*KL 9-V!DLIY/R\#-JY\9_9
M_#^N:G]@W?V3>M:>5YV/-P4&[.WY?O\ 3!Z4 =117*IJFH6VM>(_LT+7QAN;
M=(HI;CRXH5,*EF+'.Q1R3@$^Q)K!U7Q_>ZAX2\0MHXL$O-,,*FXLM0%Q"4DQ
M\R/Y8^8<J05&.H- 'I%%<?-XL_L[4-4BFT]VU"-K.!($O6>.:>93M1=P C4'
M.6 &0,D9P*74?&]QHMCK']K:2D>H:;;)=K!!=&2.XB9MH*R% 00P8$%?3&0:
M .OHK"TW7KR;Q"^CZMIL5E.;07<)ANO.#)OVL&^5=K E>!N'/7BL3Q?=1IXX
MT2UOI]56QEL[EWATU[D,[AHMI(M_F.,GGIS0!W%%<!;:^WAFWUS4Y5U)M"0P
M)8KJCR+*\[?*X#7!WK'DIR_ .XCBK5K\2M.QJ(U![%C8VAO&?2K];R-XP=I7
M=M0A\D#! 'S YZX .UHKA;;X@1:GY^GN^G)=3V,LUNVF:HMWL*J2RN0JE&&0
M01N!P>>.;C6EQJ/AOPW<";4&ED6V%P\%W,FY&3+%MC#OU8\^] '745YS>KXE
MC^W6=K_:AA-Z;B.;=(66-9"GEJW7!'EL!GD;SZUZ-0 45YQKGC&YT/Q5KUI'
M)(6?[(L4TRNUM8*RD-*^.%&2..,GKZUT#(?#IT>Q,MYJ=U=W#@W%S?2+F3RR
M22!D;3MP$ VCJ!GJ =/17,_#_4M3U;PE'=ZUY;3O/. Z2ERP$KCD;5 QC  S
MP >,X'34 %%%% !1110 4444 %%%% !117">(+^YO_&UQI0AUFXM;&PCG^SZ
M1<>0[/(S@NTF].%"@!-W)8G:<' !W=%9/A:Z%[X7L)Q?OJ.Z/!N9(O+=R"0=
MR]F&,'W!KSW2[J*]\'33>=XKN-<9KE89+9[]HS()7$>#GR,#"@Y^7@Y[T >L
M45Q6H>.WT>>'2[HZ5_:<-E'->G4-36SC\QA]R/*MO)(8]  ,<\TMU\2=.^RZ
M4]@UFKZE URIU2^6SCBC!V\OA\MNX"J#T8Y  R =I17!Q^+1KFJ>%KRPDE2*
M2XO(KJW@F\Q7>.%^ 5.V1<C*GOD'@\#4\*^+YO$[)+%9V?V5XM[/;:BLTELW
M&U)X]JE&(SP"V"I![$@'44444 %%%% !1110 4444 %12P^8V=V.,=*EHJ90
MC-6D--K8Q]<\,Z?XDT:;2M9C-Q93E3)&':,DJP=?F4@C#*#P>U<G_P *)^'W
MGB;^POG"[1_I=QC'ICS,5Z)167U>FNGYFL:]6&D9-'G2_ ?X?*LH&AM^^)+Y
MO;@DD]3GS.,TA^ WP]:%(CH9V1D%<7MP"".G/F9X[>E>C44_8P_ILKZS6M;F
M9P=C\%_ VG:O#J=GHP2[@!$4AN9F"9!'"ER,\DYQUYZ\UVGV7_;_ $JQ12^K
MTWNOS(E6J3UD[A1116YD%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% '+Q^$]0=[.VU'76O=-LKH744<D!
M-P[*VZ-9)BYW!3@\*"=HR>N8[+POKECKU[JHUK3[BXNWP9+G3)'DBASE84(G
M 51GL.3R<FNLHH Y;4O!]S=SZK'8ZM]DT_62IO[<V^]R=H1S$^X!"Z*%.5;I
MD8J6_P#"UU]NN+C0-333/MEHMK<I);&;(0$(\?SKL=0S#)W _+D<<])10!S4
MGA-[)]-E\-7R:?-I]G]@'VB W"2P<8#*&4[@5!# ]SD'/$:>#&LK#2%TG4C#
M?Z6TK+<W$/FK-YI)EWH&7[S'=P1@@5U-% &7H&C?V)821RW)N[FXG>YN9RFS
MS)'/)"Y.T<  9. !R>M:E%% !7*W/AC69/%DNN0ZQ8NP3R[2*[TYY19H0 P3
M$ZC+8R6QD],X&*ZJB@#G+_PYJ,FI2ZAI&KQV%W>6BVUXS6AE5RN=LD8WC8PW
M-C)8<C(..8_^$+AL8[ Z!.EG-8PQP#[3 +B.94!V%URIWKEB&5E(W'.1Q73T
M4 <W;^$ 1?3WU_)]NO(GA\_3U-JML'.6,*@L59F =F+,2PSTXIUMX:N[G4HK
MSQ-J%OJOV>V>WABCL_)C(D $C2*7;>6"@8X4#=QSQT5% &%/X7M[:WA'A@PZ
M#-#-YP%K;J(9CC:5EB7:'!'N"" 01BHAX8N;RZN[S6]0BN+JXL7L$:UMC D<
M3'+':SN2Q..=V, 8 Y)Z*B@#D[3PEJFG&PN;'6;9+^ULEL)7DL&:&>%"3'F/
MS00PR>0^#D\=,5-6T?7CXJ\+-:ZB\MS:VU[]HU":R#Q%F\KY61"H4'G:-P/R
MCEL'/;T4 9F@:-_8MC)')<-=7-Q.]S<SE=OF2MU(7^$<  9. !R>M5[K2M83
M5I[S1]:2&.Y"^9;7ULUS&C*  8P)$*9 Y&2">>#G.W10!RTG@QETW3XK34 E
MY::F=3>XF@WK-,V_?E RX!\PX /&!UYRMAX,^Q:Q:WWV_?\ 9[^]O=GDXW?:
M,_+G=QMSU[^@KJ** .7_ .$,_P")?]F^W_\ ,<_M?=Y/_3?S?+QN_#=^..U5
M=5\#7M];ZM8VFM1VNGZI<BZEC-GOD1_E) ?>!M)0'&W/)YKLJ* .4UOP0-8D
MOI#=PYN;V"[$5Q:^=#^ZC";)$W#>IZXR,''I5:3P%=75OX@%_K*2S:U% K-'
M9[$@:(G;M7><K@@8)SP?FYX[2B@#D[GP5+>S:A=W.IJM_=-:SPS0V^U;>> '
M:X5F;<I)Y4GH2,YY#;_P3<:Q9ZNVK:K'+J&I6R6BSPVICBMXE;<%6,N226+$
MDMZ8P!7744 9;:+N\71ZYY_W+%K/R-G7=(K[MV?]G&,=^M)<Z)]H\5V&M?:-
MOV.VF@\G9G?YA0YW9XQLZ8YS6K10!FZ_HR:]I#V33R6T@=)8;B/!:&5&#(X!
MX.& X[U1F\/W^KV-]9^)-62YMKN#R!#8VOV=8^<^9EF=B_3'S;>/NFN@HH P
M(='UV6%XM7U^&XB:V:#9;V AWLPQO<EV)(ZX78.3[8U=,LO[-TBSL?,\S[-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%>,C8N[G&. 9_%VO/X<T$WL:Q[FFC@$TY(BM_,8*)),?P*3D],],C.12GO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCW3BW!VN%8,%8XY'(SGC&!4UOXAU>U2*XN[XW%II^NR:9>N\2(987PL<C$
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M,%O;3*T3.#"N!. .,%L@@'YCW?I>MZ\-%T76[S69+C[9J_V*2T-O$(C$TSQ
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M,VUU2[N=<TKQ#+<S&7_A%9+R2!%0([ QED^Z2%+<]<\#! R" >ET5Q/A^_\
M%-Q/I=U/!?W%M=C==_:%M$@C1EW!H?+<R<' PV[()Z&NVH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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+ "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>capture2.jpg
<TEXT>
begin 644 capture2.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#L17AI9@  34T *@    @ ! $[  (
M   +   (2H=I  0    !   (5IR=  $    6   0SNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $QU8VEL92Y0
M>64    %D ,  @   !0  !"DD 0  @   !0  !"XDI$  @    ,X-   DI(
M @    ,X-   ZAP !P  " P   B8     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*O_  !$( >8$0 ,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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MG)H%J+1110,**** "BBFD\'F@!U%4M-U2UU6%I]/N$N(59D+H>C*<$?A5V@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI"
M>* %S29!S@CCK7(^./'-GX0T^/S4:XOKABMK:Q?>D/KD\8!(I_P]M=>M_#GF
M^*;U[J\N9#*%=0# I PG'IU_&F*^IU@.1D44@&% ':EI#"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?=%%(U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **P_%VO7GAK0IM5M=/BOHK==TZ/<F)@,@#;\C ]
M>^/QK-OO%VKZ3H<>M:CH,#:<8UEE>TU R21(V.2C1IGKV)H ZZBHK6YBO+.&
MZMVWPS1K)&V,94C(/Y&I: "BBB@ HHHH **** "BBHVD49RP&!0!)4<DFS.
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M-NA(JA5"CM2T@.1D4A8*.3CZTBQU%(I!'RG-+0 4444 %%%% !1110 4444
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MU&6-4QZ'O]*3L5J]SH1THH'045)84444 %%%% !1110 4444 %%%% !1110
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M@6&I>%=>O(]8^('BK3M0G!WP:6&(M+4\$?(1EV&.K5W<?Q)\$(@1?$=@H'
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MQY8@>54:(#^$KGCVK;/B'21UU6QQT/\ I*?XTBE9&ECVIK-LQP3DXX[5G_\
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M3E3\M[,#\JG_ &0><=Z]32/;@#  & !65X:\,V/A;1(=,TT-Y,7\;@;G/JQ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-M(C?9HHV#$EVP&)*Y]LXI"5S<M?%>L?\)4FD:OHB6*7B2OI\_V@2^84QE7
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDUK2Y&MPFI6;&ZS]G G4^=@X^7GYN?2L_1?%VEZ[JVI6%C=02/8OM^64$R
M;F"]=H8[<\C- &[15.SUC3-1,HT_4;2Z,/\ K!!.K[/K@\50U/7HGTNX/A_4
M])EODC\Q!<3[HPH<*Q(0EL=1Q_%@4 ;=%8>FZEJ\_B*6UOK:V2S^R1S*8BQD
MBD.-R29XY.[&.R\]:W* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSWVEF)/U8CT J;2K:[L]+@M]1OC?W,:XDN3$(S(<]=HX''% RW1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M0: "BH'E58V8L% ZL3P*QHM8DU.[DCTA2\$8(:Z;[I;T7U^O041N]1&_N I:
MY"YT;Q)/?><NO"&'&3$D1^]V .>!ZUK^'M0FOK%OM1S/ YCD/8D=ZIQM&Z87
M-BB@45(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBH99A$K,S *O4D]* )<TA?!Q_6N9/C"*[O)+
M70[>74I4R&>)<1HWHS&F-=>+VNHWBM=.,/&]#(V<>QQ3Y)=17.IW<BG5AG69
M;-HQJT @5V"K-&V]"3Z\?+6TC9SG'X4K,8ZBBB@ HHHH 0G%5KS4+>PM9;BZ
MD$440R[MT%27$@BB+NRJB@EF/:N !N/'^L[G22+P]:R#!W$&Z<<]/[O'7\*J
MG'F=WHEU FB2]\?3$NTEEH,;?(!E9+H^O^[7;6EK':6Z00*J1Q@*J@=!4D42
M1*J1*J*HP !T'I3^E$YWT6P6$;"J2<8 S7.^$@TBZE<D826[;8/8=ZT->OEL
M-#O)Y6PJQ,/S&!_.H/"EJ]GX>M8Y/OLGF-GU8Y_3(%"25-ON+J;8Z4M(*6I&
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M "$XIID .#Q]:9<2B&!Y'8*JC)8]JYK33-XAUM]1F\V/3[8A;:,M@2-W;Z?X
M4U&Z;#K8ZH&EI%Y4'VI:0!112$X% "T56NKV&RA,US(D42_>9CC%%I>I>P+-
M!DQL2 2,=#1TN!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "FDX'-.JAJ.I6^G:?-=WCB.&(?,Q-*S;LNH"ZEJ-MIUG)=7L@BAC7+,?Y5R
MD,-]XV?S=026RT5&!C@Y#W/NWH/I4=A:W7C344U34R\.D1X-M9OP9"/XF'IT
MKN$C 48&!C  Z"MW:DK+XOR$0V=A!81+#:0I%$@P%0  5:P*7%%8:O5C*M]:
M17EG-!<*&212IP.1GO\ 6LCPQ>-Y=UIT[O)-82>5O<Y9UQP36]*,QG'%<WIJ
M[?&FJE,8,*;B.[5<=5)"ZG3@Y%%-3[@^E.J1A3&^Z?I3S6!XIU[^Q=%FF1-U
MP^8X$'.YC_A0HN344!@^([^;Q'JR>&-)D"H"'OI^?D0=5SZGI796%G!8V,5K
M;((X8EVHH'05C>#]#;2-'"W3,]Y<?O;B1CEBQYQGV_J:Z(+UJZC5N2.R'U%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3\P '/S'@8'MGFJ:?#W2D\/QZ0USJ#Q6\HEM96N,26K DCRR  ,9/8Y[YP,
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M -#+I_\ W^JUXE\(:?XFT_[-=QA&4[HIE4;XF]5/].]8-IX-\2)$EK=^)/\
M1XAM5X;4"0K[D]ZTJ2C5]]NS#4ZG1/$^B^(_/&A:G;7_ -GV^;Y$@;9NSC/U
MVG\JU:RM"T*TT.WD6U#M)*0999#EG(SR?S-:M<VG084444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,-L$:Y.Q6R-S$=P0!GBK0U?6M,\57WAZ[OS>*^G-?6=ZT""2/:VTJX4!3['
MJY%\/]-BT.QTTWE^_P#9TIDL;HR(LUMGLK*@!'^\#U^F+R^%H@M[))J-]+?7
MD(@>_<QF5(P<[%&S8HY/1>^>N,(#G=%N_%VJ>"+?7K75$N;J:R8K8FUC4/)N
MP'W<<@9XZ$X^IU?"VIRWFJ7,,NLW-T8X5+V.H6J07,#9.6(5%#*>.1D>YJ:Q
M\&6UAX4/A^/4]1>T#*8I&D02PX8, K*@[COFK>F^'(K#56U*XOKS4+TP?9UF
MNBF4CR&*@(JCD@$D@GCK0!L4444#"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
L0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>capture3.jpg
<TEXT>
begin 644 capture3.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#L17AI9@  34T *@    @ ! $[  (
M   +   (2H=I  0    !   (5IR=  $    6   0SNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $QU8VEL92Y0
M>64    %D ,  @   !0  !"DD 0  @   !0  !"XDI$  @    ,X,P  DI(
M @    ,X,P  ZAP !P  " P   B8     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*O_  !$( I$$.@,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %<CKMG+?W\\'B#P;!XCLU.;">W6W+Q(R@.KB>12K9'W
MD.",< CGKJ* .!L/#>LZ#I_AF[6V.I7&D+<PRVD=P#(L,S JB/(0&,85%^8K
MD*?85:E\.77BF^UR[UBTDTJ#4-+&EPPRNCS*,NS2-L9D'+C #'[O.,XKM**
M//=>TO5/$'AO^R-4\&6U[JRV[6L>IS26YM82PVF9&),J]FVB/.1C/&ZM)-&O
M_#NI/=6>G_VU9WME!:WEM$T:2J\2LH=1(55E8'# L",#&<D#L** /*[SP/>S
MZ/XEGTWPU;:6FI16L-OI$)A5V$4Q9F?:1$"P/0,>!R>U=-HUAI]GJD4FG_#M
MM'F.5%ZMO8KY0([F.8OCZ UUU% 'G&N^'KWQ%IT]OJ?@V!/$+@)'KUH\,<<<
MBG]W,LF_SP%P#MVD\;>1S72^)-*OK^X\--;I]H^PZJEQ<OE5P@AE4M@G^\R\
M#)YKHJ* .'\2Z%]K\=P:E?>%?^$AT]=-, 3;;/Y<OF[L[9G7^'/(]:CU+3)W
MT73UT'P=/IBV.KP7CV,?V2(R*N2S*$EV9Z#D@UWE% '++!J>O^*M+O[S2Y])
MLM)\R55NI8GEGF=#& !$[@*JLQ))R21QQFNIHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KF4\1:S>ZOJUGI&CV4Z:9,L+/<:BT32$QJ_"B
M%@/O8Y-=-7%:9J0T/Q/XG:_L=4(N;Q)8&@TV>995$"#AD0KU!'6@#27QC#+9
M:1<0VCYU#43I\L4KA7M9%$F\,!G)!C(QWSG-0KXJU*\AOKS1M%CO;"RN)('_
M -+*W$IC.'V1",@\YP"ZDX[9%9":1J26NA7%Q9RI/<>)'U">!5WFVC=)L!R,
MC@%03TR<5#JNGZ;/<ZE=G0]9T?Q*ZO"D^DI<;9^<HWFQ@1,&^7/F8QT;&,T
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M?#OCRYBFAO;^VU*'=9ZC/)+</:A>6MW=B=B$_,I.,G()8@8 .SHHHH ****
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MT92,@T^J>D6)TS0[&P9PYM;:.$L/XMJA<_I5R@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX8!'*QMG) R O XJ[H-XUIXBTO3M \62^)M.D287:3S17+VP ++(9D (RV%
M<G(/'W>.]HH \N\(:EIEOX<BCN?'W]E2+/<;K+[19+Y?[]^,21E^>O)[UZ?'
M(DT22PNLD;J&5U.0P/0@]Q3J* "BBB@ HHHH **** "BBB@#E?!R-):^(D1S
M&S:S=@.!]TY'-4_#'B+2O#GA*RTC6KJ*QU+3HA;2V3G$TCKP#&G60-P5*@YS
MCJ"*[:B@#!\$6-SI_@^RAO86@F8R3&%NL8DD9PI]P& Q[5O444 %%%% !111
M0 4444 %%%% !7F\?@R[U+P]KY@GU*PU&35;R6!#>3Q0SKYK%5:,,%V..-P
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M+!(?8G(!Z9<>HKOKO4-*7Q?IVGR6PGU9[>66.1$5FMH1@,S'.55CA1V8CVX
M(+7QOHU[?M96PU-KA'5)$.CW:^46^[O)BP@(YRV!CFMF_OK?3--N;^^D\JVM
M8FFF?:3M102QP.3@ ]*YSP]_R4+Q?_OV?_HBKGCO_DG/B3_L%77_ **:@!UI
MXQT:\NK>W22[@>Z.+<WFGW%LDQQD*K2(JL2.0 <G%)/XRTB#4;JQ']H3W%HX
M2<6NEW,ZQL5# %HXR,X8'KWK%\6O&WPWL+4?->7+V<=D@^^TP=&!7W !8GL
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MNL07Y<]0K[\XZ%O<5ROB5H[R^\17-H5ELFU#2H'=>4>=)@)!GH2%,:GZ8[4
M>BZIK6GZ+I,FIZG=)!9Q@,TIRPP>F ,D_A56Z\4Z7::E/8/]MFN;<*94MM/N
M)]FX97)C0@9'O7FWB>>6[\(ZGX?E+$>&;2;SBP^]G,=MG/K$6;Z@'WKK+2'5
MI?B'XF_LF]LK4!+3>+FS>?=^[;&-LJ8[^M &Y/XKTNVBM7G^W*UXSK!#_9UP
M97*C+?N]F\8'.2*EL/$>F:E//#!-)%-;QB66*ZMY+=U0YP^V15.W@\]*Y[Q!
M%JI\4>$HTO+,7^Z[S.;1C$?W7_//S,]./O\ 7GVJE9N9_$/B'_A-YE6\M-.:
M'R[.!EC>Q<DF5!EG8DC!_NE<#/4@'46OB_1KRX@BAN)E%R^RWFEM)HX9VP2
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M+G_XW4FF^'/"=Q?V-OJ?PZ\.V2:E TUHZ6<$I. &*./+&UMISP6'!YXKH?\
MA7'@C_H3?#__ (*X/_B: .:_X:#^&/\ T,W_ )(7/_QNC_AH/X8_]#-_Y(7/
M_P ;KI?^%<>"/^A-\/\ _@K@_P#B:CG^'_@.UMY)[CPAX>CBB0N[MI<&%4#)
M)^7TH Y[_AH/X8_]#-_Y(7/_ ,;H_P"&@_AC_P!#-_Y(7/\ \;J-= \/R:2=
M9C^%GA]M+V><H^S0"[>+&=XA\K;TYVF0''O\M5M3/PSL=5CMH/"OA"6#["+Z
M2:6&WB)0C*JBF,[G*X8*2O!!H N_\-!_#'_H9O\ R0N?_C='_#0?PQ_Z&;_R
M0N?_ (W3M)TKX;W7ARTU;6/#?@K3DN^8\1VSIT!*[VC7YAT*XXQUK6OO"/PT
MTRVCN-2\/^%+2"4XCEN+*VC5^,\$K@\<T 8__#0?PQ_Z&;_R0N?_ (W45U\>
M/A1>VKVU[K\5Q!(,/%+IMPZL/0@Q8-7UT3X92>*$T./POX9:X>T^U!A8VV"#
MR !C).W+?[N#WXNZ=X2^&>L"0Z1X?\)WPBQYGV6RMI=F>F=H.,X/Y4 9'_#0
M?PQ_Z&;_ ,D+G_XW4,'QV^$]K:_9K;788;?YOW4>F7"I\Q)/ BQR22?7)K0U
MSPIX3T[5-+T_3OA_X9N[C46E"F>TBA1-B[CDB%R<CVJ6'P7X4M8WE\2>"?!F
MF0Y5(Y$CBD#,3C!WP(![<G- &"WQF^#3Z0-*?4K)M.'2S.CSF$<Y^YY6WKST
MZTZW^-7P=M-+?3;75+2"PD5E>UCTB=8F#?>!018(/?CFM+Q1I/PU\,Z;<S2^
M%O"LEW"8P+1[6VC<ESA<_*2!C)S@\*3VJU%X;^&L<5DNI:!X,MKJ\C5XH4@M
MF$H;[IC)12X/8@<T <YI_P 6_@CI-U]ITJZTVQN-I7S;;1)HWP>HRL(.*DU/
MXQ_!C6FC;6=0L=0:($1FZT>:4H#UQNB.*UQX=\$-K>H:?_PA'A>+[%<6T/FW
M%K!&)?.&?E'EGYNP7^(]Q5U_#/PNCU3^S7T3PBM]N"?93:6HEW'D#9C.>?2@
M#&D^._PHELFLY=>B>U>,Q- VF7!1D(P5*^5C&.,=,56TSXT?!S14D31M3L]/
M60@NMKI$\0<CH3MB&:T;#2_AMJLUU%I_A;PF7M;];-Q-;6R%LX^9<(V222%'
M&XJ>16C%X9^%TU\EE#HGA"2ZD)"0):6ID8@D'"XR<%6!^A]* ,:/X\?"F&XF
MGBU^))I\>;(NFW :3 P-Q\K)P.!FEG^/?PKNK:2WNO$*30RH4DBDTZY974C!
M!!BP01QBMBX\,_"ZTO6L[O1/",%TH!:"6TM5<9QC*D9YR/SJW=^ _ -C93W=
MWX1\/106\;2RN=+APJJ,D_<[ 4 <9I_Q;^".DW7VG2KK3;&XVE?-MM$FC?!Z
MC*P@XIE[\5?@;J-Y)=ZA-I=W<R$%YI]#E=WP,#+&')X %:R^'/#PLX-3E^%F
M@C2YBI/EV<,EW'&W1VA$6/0D!R0"3@D8JW9>'OA_/+K7V[P;X:L8-)NA;O/-
M8VX5AL1MQ)0!?OXZF@##?XP?!6328]+DO=/?3XFWQVC:-,84;).0GE8!R2>G
M<U:L/CE\(]*M%M=,UJWLK=22L-OI=Q&@)Y.%$0%;Z>$_AG)I;:E'H'A-[!<[
MKI;*V,0P<<OC'7CK3(/#/PNN;,W=MHGA":V601&:.TM60.<87<!C)R..O- '
M-:=\8?@MH]P\^D7UA832+M>2UT::)F&<X)6(9&:N6WQX^%%E"8K/7HK>,LSE
M(M-N%&YCEC@1=2223W)K:M_"WPPN[":^M="\)3VD&?-N([.V:./ R=S 8'![
MTZ#PG\,[K3I-0M= \)S646?,N8[*V:-,#)RP&!@4 <U;?&?X-V<<*6>IV=NE
MNCQPK%I$ZB-7.75<1<!CR0.IZU:M_CU\*K.VCMK3Q!'!!$H2.*+3;A511T
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MXX].N55% P  (L  =JZ9_ASX($;8\&^'^A_YA<'_ ,35/_A7G@O_ *%#0?\
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MMA S-$(=(G3RRPPQ7$7!(X..M3/\=?A-)?17DFN0O=0J5CG;3+@N@/4!O*R
M:ZI/ASX(,:Y\&^'^@_YA<'_Q-._X5QX(_P"A-\/_ /@K@_\ B:W3NKD'$VOQ
MA^"UC?&]LKZPM[LDDW$6C3)(<]?F$6>:T?\ AH/X8_\ 0S?^2%S_ /&ZZ7_A
M7'@C_H3?#_\ X*X/_B:/^%<>"/\ H3?#_P#X*X/_ (FF!S7_  T'\,?^AF_\
MD+G_ .-T?\-!_#'_ *&;_P D+G_XW72_\*X\$?\ 0F^'_P#P5P?_ !-'_"N/
M!'_0F^'_ /P5P?\ Q- '-?\ #0?PQ_Z&;_R0N?\ XW1_PT'\,?\ H9O_ "0N
M?_C==+_PKCP1_P!";X?_ /!7!_\ $T?\*X\$?]";X?\ _!7!_P#$T 4-+^+/
MA'7+5KG1;G4]1@5S&TMIHE[*H8 $J2L)&<$''N*GG\;>';HQ&YT_6IC#()8C
M)X:OV\MP" PS!P<$\CU-:EGHNE:#";70],L]-MW;S&BL[=849CP6(4 9P ,^
MPJQ7#4Q4H2<;&JIIJYCOX]T.2-DDM-==&!#*WAR_((]#^XJ ^,/##:;_ &<=
M+U<V7E>3]F/AB^\OR\8V;?(QMQQCIBM^OE'QA\8/B1IGCK7+#3M<\JSMK^YC
MMU^R6S!(HY64#<4)X  Y.:JG7G4=DD$HJ.Y]'P>+_#%M)');:5J\+QPBW1H_
M#%\I6(=$!$'"CTZ56&N^"AJW]J#P]?#4-V[[9_PB=YYV<8SO^SYSCCK7S ?C
M?\4ER3XA "H'+?8[7&#TY\O%*?C;\4U=E;Q %*N$.;.U R>@SLYK;][V7XD>
MZ?3FHZSX&U>Z^TZMX:O+Z?:%\VY\)7DC8'09:W)QS5G3O%?A31[8V^D:/JEA
M S%S%:^%[Z)2QP,X6 #/ Y]J^6E^-GQ39PH\089G,8!LK4$L.HYCKTGX$_$?
MQEXO\;W-CXIU3[79C3)+B*,V\,9WK+$N[Y%!Z,PYX_*IE.K"/,TAI1;L>T?\
M)YI!Z6GB#_PG-0_^,4O_  GFD?\ /GX@_P#"<U#_ .,5T4?^K7Z"G5NG=7(.
M;_X3S2/^?/Q!_P"$YJ'_ ,8H_P"$\TC_ )\_$'_A.:A_\8KI**8'-_\ ">:1
M_P ^?B#_ ,)S4/\ XQ1_PGFD?\^?B#_PG-0_^,5TE% '-_\ ">:1_P ^?B#_
M ,)S4/\ XQ1_PGFD?\^?B#_PG-0_^,5TE% '-_\ ">:1_P ^?B#_ ,)S4/\
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MQ->/_5K]!3J0#:H [#%+75%621Q,****8!1110 4444 %%%% !1110 4444
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M<24P0,-DXY_G19VMMJ-W/;BW:V (*,"25 .-IR<9/\Z?)/\ F_!"NNQ]Q?\
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M]*N)+BU29[B5!&T]S<R7$FP$D*'D9B%R2< XR<U?\Q/,\O<N_&[;GG'KBG4
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M]:RY\N>VF61'P2#AE)!P01]15JM*<(P32.6I.527-+<****T,PHHHH ****
M"HYT9XP%&3FI*0D+]X@?6HG%2BTQIV9Q/Q#\!3^//#]OID>H#3O)NA<-+Y E
MW (Z;0-RX/SYSGMTKS:']F>XA*J/%2F&,8A0Z6,Q\8/S>;GGOT]L5[CJFNZ1
MH=JMSK6J66G0,XC66[N$B4L02%!8@9P"<>QK*_X6/X(_Z'+P_P#^#2#_ .*K
M".'A;1LZH8NM35H_E_6GEM?7<\A_X9FO?)&?& -P@*I/_98RJD\X_>]>WL#3
M_P#AFBZ4*L7BQ40AA(HTP?,#U /FY4=2 .F:];_X6/X(_P"AR\/_ /@T@_\
MBJ/^%C^"/^AR\/\ _@T@_P#BJKZO'N_P_P B_P"T,1_-_7_!ZOJM'='DD?[-
M%Q'A/^$K5H$7;$ATP90?[WFY.>_]*WO!'P,E\)ZX-2O?$+ZD?(,#1I:"#S$+
MJX5CO8D!D'''''3.>]_X6/X(_P"AR\/_ /@T@_\ BJNZ7XN\-ZY=-;:+X@TK
M49U0R-%:7L<K!00"Q"DG&2!GW%)X>+6K8?7\0^OX+^M.G;I8UD&(U!Z@4M&<
M]**Z$K*QPA1113 **** "BBB@"">-WD!49&/6HO(D_N_J*MEE7[S ?4TGF)_
M?7\ZY)T*<I-MFBG)(\Z^)?PME^(JZ<AU7^SHK19E<"W$ID$FSH=Z[<;/?.:X
M<?LTW>U]WBR,MM*Q,-*4>6O]W_6Y('^<U[AJFNZ1H=JMSK6J66G0,XC66[N$
MB4L02%!8@9P"<>QK*_X6/X(_Z'+P_P#^#2#_ .*IQP\;:-_@=$,96IKEB_P_
MK;==GJM3R)OV9[LHI'BY?/VJDDITH$R*.Q_>]^_/.*5_V99W4PGQ9_HK($>/
M^SAN;'0[O-S[?3UKUS_A8_@C_H<O#_\ X-(/_BJ/^%C^"/\ H<O#_P#X-(/_
M (JJ^KKN_P /\BO[0Q'?\%\_OZ]^MSR0_LU7C+)YGBU&8C$9&E ;!V'^MR0.
MH]_6NM^'OP?D\#WUQ=7.M/J;SB+<HMQ K-&'"NPWL6(#GJ>N#V&.N_X6/X(_
MZ'+P_P#^#2#_ .*K1TGQ+H6O>;_86M:=J7D;?-^QW:3>7G.-VTG&<'&?0U,L
M/!K5O\ >.Q$E9O\ #^M;:7WMIL:2#$:@]0*6C.>E%=*5E8X0HHHI@%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 <SXO^;4O#$4H'V=]80R9/5EBD:,?]]@'Z@5RGB2.1M<UC3K
M-(C;W6L:;YL,A(B=W7+!P.QV19'?\:]&U+2[/5[(VFHP^;"65P Q5E8'(96!
M!4@C((((JK%X:TF'2+C3!:>9:W3F2<32/(TKG'SL[$L6X&&SD8&,8% '$^*)
M;FTM?$]MJ2VQOIM-@D>^LE>!9;<R%"KQEVPRY?Y@3E3CC;71W,<=M\3-(6R1
M4,FE7*3J@QB)'B\OCT#,P'U-:MCX=TO3XKM(;8R_;1BY>ZE>X>90NT*S2%B5
M R I.!D\<FDTGPYIFB2-)I\,@D:)8?,GN))V6-<[4#2,Q51D_*,"@#(T<2:U
MXGUC6W D&GR/IVG1MT0J!YK^Q9_ESZ)6!IJQQ^ _ ES!C[5]OMR)/XBTH?S^
M?<%\^M>@Z?IUKI=J;>QB\J(R/*1N+99V+L<DD\LQ-4+3PKHUCJ:W]K:,DZ,[
MQ@SR-'$S_?9(RVQ"<G)4 \GU- '%$)_PJV2].W^T!K;3;RWS"X%]M'/KMPO^
M[7IM9!\+:.=6_M$VK>?Y_P!HV^=)Y7F[=OF>5NV;\?Q;<]\YK7H *PO&]Q=V
MO@;6)M/+K<):N5:/[RC')'N!D_A6[10!RVOZ;HD'PSNH(HX(M.MK%I;9DP!&
M0I9)%(Z-G!!'))]ZXO6+74;F?Q//>:G>07!\*1S3Q+'" 3LEW1G,>0N0>F&^
M8\],>@Q>#-"BDC*63>5$_F1VK7$C6T;<G*P%O+&"21A>#R.:MW6@:9>S7TMS
M;;WO[7['<GS&'F0_-\O!X^^W(P>>M '$V^HZ_-<#2=-FU:2/3K" F:SCLB\D
MDJE@9/.*C:H 4!%!.#ELXK3L]0\0:[JXTN\N9- N;738KBY6U2*1GGD9AP7#
MC8-F<#G+8W<<[M[X6TF_DADFAFCDA@^SK);74L#F+^XS1LI9?0-G&3ZFDG\)
MZ-/';HMJUL+:$P1&SGDMF6,\[,QLI*Y&<'C/- '(26NOP^-]>?3[_P"TZLFB
M0&-#'&D4C[I   1D<@D MU;DD=-[PKJL\^J7MA?WFIM<1J'6TU6RCBF0 E2Z
MR1 1R(3C&,D8//-79/!N@2#:=.14^RBS,22.B-$,D*4!"G!)()&0>00:MZ=H
M.GZ5<27%JDSW$J"-I[FYDN)-@)(4/(S$+DDX!QDYH YW7)+^/XH:0=+MK>YF
M_LNYRES<-"N/,BYW*CG/3C'XU=\07^N6?A*\U*62RTJZL#]H"QW'GQ3QKR8W
M+1*1NY'RC.=N#U%:6I^'-.U:^AO+M;A;F"-HXY;:\F@8*Q!(S&RY!('7TJ'_
M (1/26C2.X6\NHTF2<)=ZA/.N],[3AW((!.<=,@'' H X>]NM2\2>'=(U:ZU
M2:U-WK]NL=G D7^A 2[0I+1Y,BD$G/&>,8K1O-<UM-!UWQ##JK(NCW<T,=BT
M,1CF2%MK;SMW[GP3E64#(X]>L;PQI#7,LYM,/-=QWKA97"F=,;9-H. >!G ^
M; SFHKGPCHEWJ#WD]FS222+++&)Y%BE=?NL\0;8Q&!R5)X'I0!SJ:E=6>N,+
M1S$MYXA2"92H)9#;EBO/3E1TYXJ%?$NI"_TFZM;^^O;.\U)+:25[2&*TD5PW
MRQ @3''&'R5.T\GI78OH.FR7 G>VS(MT+P-YC?ZX*4#=?[I(QT]JIQ^"]"BF
MMY%M)";6436ZM=2LD#!MV44MA1GL  >G2@#E-"NK_2IX(8M0FE2\\37=O.)4
MC^91YI)X48)(!./PP.*LZ1K.N?V3X?U:]U9[G^T;X6LUL8(UC",7 ((4,&&T
M'.<>U=3'X8TF.\%RELXD%T;P9GD*K,0P+A=V!G<<@#!S4D?A_3(K&SLX[;%O
M8S">W3S&^1P20<YR?O'@Y'- ')1:SKDNDZ%KG]K.BZIJ,,4MB;>/RTC>3&U3
MMW[@!@DL>IZ<8WO'W_).]?\ ^O";_P! -9*>"[N;5[.6YM[&VBM;XW9DMKJ=
ME<ABPVV[?)$6."Q#$]?6NOU"PMM4TZXL;Z/S;:YC,<J;BNY2,$9&"/PH Y9]
M+UW7['1X+ZVTZQM;:>"Z,\%X\TI\OY@%4Q(%)X!.XX!/!JB-?UG_ (1I/%W]
MHMY37P0Z5Y,?E>29_(V[]OF;_P"+=NQNXVXXKO8XUAB2.,81%"J,] *R!X3T
M4:I_: M&\[[1]JV>?)Y/G8QYGE;O+W]]VW.><YYH Y#1-2U"UUP66GRHJWFM
MZL'2105=D!9,G&0 WI36U;5!I.IV'B*ZU*&]ETB<M:7UE#Y<D@BW,T$T/RE1
MR-K$MTZ8.>T7POHZW F^Q*SB:>?YG9@7F&)"03@AAV/'IBH8/!NAVZ%%MII$
M^SO;(L]W-*(HF&&6/>Q\L$ #Y<< >E &#X>N-4TNZ\+6ESJCWMOJE@Y:%X8U
M6 I&C+L*@-C!(^8MGK7=5171;!9M/E6##Z;&T=J=[?NU*A2.O/  YS5Z@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O-)+;4+F'QO>&+3;BV%
MV\=U!>1NSW$4<2$1AU8>4 I)4X;EB>._I=8^H^%='U6Z>XOK5G>4*)E2>2-)
MPOW1(BL%DQT^8'CCI0!A);ZMJ7B,ZOH&H:7#C288DMKQ'GE0L6<;PKJ4W?+\
MV6SM/%-L?$&H>+[ZQAT^[FT2&;24U!S%''*Y=W9 FYU92J[2>%!.1R.E=!J7
MA?2-6N//O+>02^3Y#-!<20>9'_<?RV&]?9LCD^IK-\1>'+B]NK0Z=I]A)!!;
MM H^VSV,L0.,*)(0=T9 Y0@#(!R>P!GZ%J=]K^@^'8]2N!-<W%Y--/*B!59+
M>5L?*.VX1C_$T7UG9:AJ-EX:\-VX$6G:@E_?7:L2MLX<N5#'),KDD$=@3GL*
MW/"_AF#P[I%E;G9)=6\+1&6-2JX9R[!5S@#<?K@"DLO!>CZ<P^P_VA;J)#+Y
M<>J700L3DDKYF#D]<CF@#G[_ %O6FT?Q%K]MJ9MTT>ZEBAL/)C,4JPD;MY*[
M\OS@JRXRO!YS:UFXU2]UJVT_P_KU];WMTJ3RP^5;O#8P<99MT18ENBKNR22>
M #6W=>$M%O;^2[N+-F>9TDFC$\BQ3,A!5GB#;'(P.6!Z#TIDOA#29=1NKX?;
MX;F[8/.]OJ=S%YA P,A) .  !QP* -L#"@$D\=3WI:BAMTA9F1I"6"@[Y6<<
M# P"3CW(Z]ZEH **** "BBB@ HHHH ;)_JV^AKY4_:0L(]0^)UC&':.9-'B?
M)Y4IYTV>,=1^M?5;\QMCT->+_%3X3>(/'/BRWU+2;BQM[>*UBB8SR.DC,DCM
MM^5&&WYASG.<\=*Y:DN6HI>1O2@JGNW2]3Y9M+"UU"25+=Y8C&=X,AW9C[G@
M=>_Z46=A:Z@TH@:6+RCO.\[LQ]^@^\/UKV]?V=O&B0N\,_A^&Y9@3Y<DP0D'
M@G]UV]/7FE7]G3QA _\ HD^A1+*^^;$TV0>P7]UT!Y[>E5[==C?ZK3_Y^+\?
MZ]>WF>'V=C:W_F^2TL7DG>V_YLQ]^@^][46=A:WZRF)I8A"=[[CNS'[8'WO\
M:]P3]G+Q<DA6*XT.")9%E4PRS!G([-^Z^Z<GCM[TU/V=?&D<):&?P_#/NSB.
M28(Q[$_NNPR,=.<T>W78/JL/^?B_'IO_ ,#OY'J?P *'X-:!Y08)FYVACDX^
MT2UZ?7&?#'PSJ'A#P38:+JB6HFM6E)-FSM'\[L_!8 ]6/&.*[.C#ZJ3\V<U5
M*,K)W"BBBN@R"BBB@ HHHH *AN?]6/K4U17 +1C:">>U95M:;*C\1XG^TNL,
MGPZTM+G>(VUF)=R=5/DS<^_TKY@FL+6TOHK.Y:4R'B1TZ*3TP,<]LU]E_%7P
M3JGCCPS9Z=I'V2.>"^6Y+WA954".1<KM5OF!<$9&.M>21?LY^+EFC,MQH<@@
M $4QFG\P^N?W>/<=<>]<M"IR0LT=<:$:FKFEZ_UL>'R6%M;7\5E<O)YI&)'0
M_*K'[N!C)'3/UI'L+:#4([&=Y/-(VR.I^57/W<#&2!QGUS7M_P#PSIXT*QSM
M<>'_ +;$I6-_-FV@9X/^JZ@9 X]Z=_PSKXP62-DGT(L%*F1I9B\8[!#Y7;G!
M/L*W]NNP_JM/_GXOQ_KU[>9X<UA;0ZA'8S/)YI&UY%/RK(?NX&,D=,^N:]?_
M &;;:.S^*VH6ZEFE31I/-8GY=WG0\#CH/7O6E'^SIXO65-]QH;>2@6*;S9O-
M/&#D^5CZ=<>]=5\-_@WXH\)^*/[4U6^TZ-7M6M93I[2%W3S$< ;D4+]S;GDX
M/KR,ZM92@TD-8:"=_:+\?G_P._X'ND?^K7Z"G4U.(USZ"G5U1^%'"]PHHHJA
M!1110 4444 5;G_6#Z5#4]PK-(-JD\=A47EO_<;\J\BM%NH]#IBURGCW[2<,
M=Q\/-,AF9E$FL1JA4=',,VW/M_C7R]]@MEU%;!VE\XC89 ?E$AZ<8SCM^M?9
M7Q6\$:MXX\,VNG:,]M#-%>"9FNBRA5\MUW*55CN!<8[8S[5Y*G[.?B\2#?<:
M&?+0)'.)9O-/&#D^5W'&>WO710J<D+-&D:$:FKFEZ_UL>'_8+8:B+!FE\[&P
MN#\OF>F,9VYXS^- L+8ZB; -+YV-GF9^7S/3&,[>V?QKVT?LZ>-.;C[1X?\
MMH3RU?S9MN/7_5=0..GXT]_V=/%YE#I-H0>1"DDAFGWJ,8&T^5U []^![UO[
M==A_5:?_ #\7X_UZ]O,\/%A;-J+6"M+YP78)"?E,@[8QG';]:]__ &7H8K>Z
M\6P0EF,?V-79N[#S\X&.!FJ _9S\7F5O,N=#QL"+,LLPE;@ Y/E=P,9[5Z)\
M(?AQXA\"7&KR:^=,D.H+" ]@\C$^7OQN#(O]\\]^*RK5>>#BD#P\(:\Z?W_/
M_@=U]QZU'_JU^@IU-3B-<^@IU=<?A1Q/<****H04444 %%%% !1110 4444
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M+XR #@;>N#GM27/B[Q%'#=7T*:6;6'63I:0-%)O<&7RU<OOPN,KD;3G!.1G
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M7/I]^A>WG7:X#%3UR"".000"#[5GV?A>WANWNM0O+O5KAK<VHDO?+.R(G+*
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M #A<@*?NUZ)K&BPZQ';EYIK6YM91-;W5N5$D+8(.-P((*DJ0000>G2J0\'V
MTMK0SW1G:[-\;[>!/]H_YZ9 VYQ\N-NW;QC'% &7X;MC!-X@TG3[=="OU$<G
MDPL)[6'>I"RQ+M3KM.5('*].><:UEN]#^'GC1[:]N9;FVO[H)=S.#+G:@WD@
M 9&<\ 8Q7<:1H<6DS75P;JYO;N\93/<W3*78*,*N%55 &3P .I/>FV_ARPAL
M]3M)%>XM]4GDFN(YB""9  RC &!@?7WH Y;4K*V\&:W:'PY;+:B?2[L31Q*
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M[[F_G[N['&[O3],\/:SINH7=V-7L;B2]F$D\DNGN9"H^Z@(FP H) X[D\Y-
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+Z?-Z=O7VK)L_&ES:6VEZ;'!;W-[+I\4X-_J'V=KIF) 2(E6\Q\CG)7J.>>
M#O**Y>^\4Q:7>ZGOL;AKB-;2.*$W!/G2S%E2,+DJG/5AG/7G J#4O&]UHEOJ
M2ZOI")>V5NEU'#;W?F1W$3.$)#E%((8X(*^F"<\ '7T5AZ;KMY/K\FD:KI\5
MG<?91=Q&&Y\Y60L5(;*KA@<<#(YZUN4 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 445FZU8'4+>)9-0EL;2*3S;DPR-$TB!3\OF*P*#."2.H&
M.,F@#2HKSZQO+V]T[1--DO+W['J6IW'DW7G.L\UG&KR1_O 0XW;5^;()7ZTM
MK>W5]<6'AV>]O/)75+NWDN$N&2>6*%=R*9%(;/S*"P.3MY/)H ] HKB-,\3Z
MC:VMEI4-K_:EXU_=V"37-SY65@9L,[;6).P $X))&>]7-"\97.K7.FB[TE;.
MWU)9E@<77F.)(OOJ5V@!>'PP))VC(&> #JZ*P-/EU$>,KV'4+A7C-HDL4,6=
MD0,C@=>K87).!UQT%<YJM^\K:?+?7FJ?V=>R7LYBTZ607!V[5AP(SO*!=Q./
ME#,NZ@#T*BLOPQ<75UX5TR?4)HI[J2UC:66)U=7;:,G<ORGZKQGIQ6?X;FU1
MM?UN'6+I9I(S 5CBR(X@R$[5S_/C- '245R]AXQEN[BRFFTSR=*U&X>VM+L7
M&YV<9VEX]ORJVQL$,Q^[D#/$^G:]JMSXIET>\TNSC6" 33W%M?-,(B3A$(,2
M_,PR<9X SW&0#H:*** "BBB@ HHHH ",@@]#4?D1_P!W]33V.U"1V&:\-^,G
MQJ\3_#SQ9:Z=HFG:;/:36*3M+=P2L0[22+C*NHQA!QC/6LI<CDHR6I2O:Z/;
M_(C_ +OZFCR(_P"[^IKY2D_:B\?0J3+HFAH VTEK2<8.,X_UO7'-$G[4/C^(
M$RZ)H: -M.ZTG&#C./\ 6]<4_94_Y4+F?<^K?(C_ +OZFCR(_P"[^IKY2D_:
MA\?Q?ZW1-#3YMOS6DXY]/];UH?\ :A\?Q_ZS1-#3YMOS6DXY]/\ 6]:/94_Y
M4',^Y]7+$BME5P?K3ZX_X8^+-2\9> =,UK6K>"VO+KSO-B@1D5=DKH,!B2.%
M'4UV%%-QU44#OU"BBBM!!1110 4444 %(R*XPPR*6HYI#&@*XZXYJ)N*BW+8
M:O?0/(C_ +OZFCR(_P"[^IKSOXP_$'6O /A&TU/P_9VEU<S7ZV[)<Q.ZA#'(
MQ("LISE!W]:\63]J'Q_(@:/1-#=3G!6TG(..O_+6LX1I35TE]Q3<D[-GU;Y$
M?]W]31Y$?]W]37RDG[4/C^1 \>B:&RG.&6TG(..O_+6A?VH?'[H'31-#92"0
MPM)R#CK_ ,M>U7[*G_*B>9]SZM\B/^[^IH\B/^[^IKY27]J'Q^\8=-$T-D()
M#"TG(('4_P"M[5WWP<^-7B?X@^+KC3==T_3+>U2PDN8Y+6"5&9EDC7&6=@1A
MSVZXJ90IQ5W%?<-.3=KGN8&  .@HI%.Y 3W&:6M5:VA(4444P"BBB@ HHHH
M:T:.<L,GZTWR(_[OZFFS3-&X"@=,\U']I?T7\JY)U**DU):^AHHRMH3>1'_=
M_4T>1'_=_4UY+\:OBKXA^'0T8^'[&PNA>BX,YNX9'V"/R\$;77'WSG.>U>6?
M\-0^/_+\S^Q-#V;=V[[)/C'KGS>E:PC2G'F27W$MR3M<^K?(C_N_J:/(C_N_
MJ:^4O^&H?'_E^9_8FA[-N[=]DGQCUSYO2@_M0^/Q'YAT30]FW=N^R3XQZY\W
MI5>RI_RH7,^Y]6^1'_=_4T>1'_=_4U\I']J'Q^(_,.B:&$VAMWV2?&#T.?-Z
M5ZG\%?BMXA^(O]L_\)#8V%K]A6W:#[+#(F\2>9DG<[9'R#&,=ZF<:4(\S2^X
M:<F[7/7@,  =!12*=R GN,TM:JUM"0HHHI@%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 96MZ-
M)J;V5U970L[^PF,MO,\?F)RI5U=,C<I4D<$$'!!XYS!X-;[&TC:C_P 3=M0.
MHB^$ VB;;L"^62?W>SY-N[./XL\UU%% &/HVBSV%_?ZCJ-ZMY?7WEK(\4/DQ
MHB [552S'^)B26.2:@C\)V[:5K6GWD[RPZM=R7+%%V-%O"X .3RI4$']*WZ*
M .>@\-W=SJ27?B/4HM1\BV>W@CAM?(4"3 D=_G8LQ  XV@<\<\0Z;X2N;6ZT
MO[?JHO+/1@XL(1;['&5V*97W$.50E00JY))/-=/10!REKX,GMWL[1]5$FCV-
MW]KMK06^) P)9%:7=\RJQ) V@\#)..>KHHH *J:KIEMK.E7&GWREH+A-K;3@
MCN"#V(."#ZBK=% '-7'AK5-3M%T[7-;CN],#@RQQV7E37*J<A))-Y4@\;MJ*
M3CL"13[KPD+N/Q*C7TD8UX*"8TPT&(5BZY^;.W/;KCWKHJ* ./M_!5]'JMG?
M'6+:V-E:36L$.GZ:L$<0?!WJK.X#9&3G*G X')*'P"NH7E[=Z]=V\UQ=69M&
MET^S^R,V2I\QSN<NX*)MSP,'@YX[&B@#G)=!UR_TV[LM7U^&:.XLI+4"WT\1
M LZE?,?+L21G.%*#K[8W+"V^Q:=;6N_?Y$2Q[L8W;0!G'X5/10!S@T#6+37]
M5U'2=6L8DU*2.1XKG3WE*%(ECX99DZ[<].]0V_@R32H]-ET/41!?64,D$DUS
M;^:EPDC;WW(&7!W_ # JPQR.0:ZFB@#E(/!<MBUG>Z=J:IJ\+SR7%U/;;X[D
MS$&0-&K*0-RJ5 8;=H'.3G'USPM=67@N[TR.YN-0U;4-2^V6US#:,!%,SJ2S
M8RJ*!NY8@8R*]#HH K:;80Z7I=K86PQ#:PK$@QCA1@?RK"L?#^N:3+?#3-8T
M]8+N\EN]EQIKR,AD;<5W"=0<?05TU% &#_PCL\VK7.HW=]&\]UI:V#B*W**"
M&=MX!<G'S_=SVZU7C\&H+;P_!+>%TT>Q>S;$6//#1+&6Z_+]W..>M=-10!Q]
MKX*OXYM'%YK<<]OH\,D%O&EEY996B,8+MO.6 QR !P>.<B6\\(7\^BQ:4FJ6
M<MDMJL#P7VF+.NY>DB?.N&_WMPX&,=^KHH Y-_ <'V.>WBOYD_<V:6LI4-)!
M);9\N0GHYR1D8'?UX;J'@JZUF'49-7U:.2]O+=+6.2"T,<<$2N'("%V))8<D
MMZ8 QSUU% &8=&SXM&M^?TL3:>3L_P"F@?=NS[8QC\:TZ** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *PO%6@77B*Q@M+>_BM8%F$EQ%-;F5
M+E1T1@'0[<\D9YQCIFMVB@#"N]$U&]LK-IM1M8]2L;GS[:X@LV6(?*4*-&9"
M2"K,#AQV/:JX\)30V-FUIJ*IJMM=R7;7DEON25Y-PD#1AA\I#8 # C:O)QST
MM% '.V7A,6<VCS?;#)+I\MQ/,[1\W,DP;>W7Y?F8D#GC [9ING>$?[/_ +%_
MTWS/[*DN)/\ 58\WS=W'WN,;O?..U=)10!G3:4\FJ7-]%<^5)-9BV7"9V$,Q
M#YSS][I[=:H7/ANXCGT^ZT2_BL[NRM#9;I[8S))$=O!4.I!!0$$'U!![=!10
M!F:-I!T/2[+3[:<26]O&RR&1,O(Q.=V00%Y+$C!ZC&,<R6FF?9=9U&_\[?\
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M#PCH?EDY*?V=%@GUQMI3\//!C%"WA/1"8QA"=/B^7Z?+Q3M5\CHY\)_(_O\
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M%H88:+H]CIP<886ENL6[Z[0*SJ0JSCRZ![3"[QB[^O\ 7K^'F:4?^K7Z"G4
M8  Z"BNF*LK'"%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#!\17UX-3TC1]/N39R:C+)
MYETBJSQQQIN.P,"N2=JY(. 3QG%<Y?>+-1TRWN-'N+\?;TU=;!;XP!G\EXO.
M5Q&HPTNT[0H7YFQA3G%=/K^E7EW=:;J6E-";W3IF9(KABL<R.I1U+ $J<'((
M!Y49'/&/_P (EJ+JVJ236O\ ;1U3^TE0LQA $?E+#NP#CR^-^W.[G;CB@!^E
MWFL:EIVJVVDZU%=S1S1QPSWUL8;FV# ;_,B\M1N R4^4 Y&>!S/I%_J$'BO5
M='EOIM8@M+:*?S9(XTEBE;/[DE B'*@,,@$;N3C%0/H_B=5UK4[*33;76=2$
M$,2B5WBMXX]W.\QY9SO?JF!QP<<Z'A73+S1K,V<^G6=K%DR-/%?O<RW$I/S/
M(6B3+'J6R?3&* ,W0O$6LF;Q/)XCB@A.F!)$M8'W+$AA\S:7P"Q]3C&>G%,L
M-3UFRD\.7VIZD;J'7&\N>V,,:I;2/$94$14!L#:5^8L3D'@UK6WA^0:OXCFN
MW0VVK^6J*A.Y5$(C;.1@'.<=:S].\.ZR;C0X-8ELS9:%N,4D$CL]VPC,4;.A
M4"/"LQ(#-ECQ@=0"A9:]JYTO2/$L^I;[34KY(7L#%&(HH97V1E6"A]P^4DEB
M#D\#BN]KB[/PIJ\4&FZ//+9?V/IMZMU'.CL9Y51R\<93;M7#8RP8Y"]!GCM*
M "LKQ-J[Z%X<NM0AB66:,*D*.<*TCL$3)]-S#/M6K6?KND1:]H=SIL\C1"8
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MJIW?=5FVDKTY(!Q[T 4?&,MUINES:E;:QJ,$@"PV]E:I;D33,VU%'F1,V2Q
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MHHH **** "BBB@ HHHH **Q=>U6[M+O3=-TL0B]U&5E26X0O'"B*7=BH(+'
M  !'+ YXYQ+GQI>V.GW%K=K9)JT.HFP,KEDMP/+\X3L"20@B^8KNZ@C=WH [
M6BN6L=;UN]T>^DL%TS6)DE2.SO+*95MY0V S,N]BOEY)*[LL ,<GAUMKNL6^
ML:GI%W!:ZI>6MFMY;FR4VXDW%E$;!W8*V5SG=C!Z<<@'3T5RUKX@U.PUJ;3O
M$)LYFCTPZBTEE$T?DA6VLC!G;.>=K9&=K<<5'IWB'61<:)/J\=F++7,B*.&-
MUDM',9EC1F+$2956!(5>1Z&@#K:*XRS\5:O+!INL3QV0T?4KT6T<"QN)XE=R
MD<A?<5;) RNT8W=3CGLZ "BBL_7=7CT+0[G498FF\E1MB0X,CDA54>F6(&?>
M@#0HKE;_ %3Q)H.EG6-8_LVXM(</=VMK#(LD$>?F99"Y$A4<XV)N /(Z'1G\
M6:-;7S6LMT^Y)$BDE6WD:&-WQM5Y0I12=R\%A]X>HH V:*QV\5:.NJ?8#<R>
M;YXMMXMY##YI'^K\W;LW=MN[.>.O%$GBS1HM0:S>[8.DPMWE\B3R5E_N&;;Y
M8;D#!;.2!UXH V**PF\::"MY);&\?=%<_997^S2^7%+NV[&DV[5))&,D9R*S
MD\;Q37VL6[M_9ZZ=>PVJS3V<SK)O*CT7!); YXX;E30!UU%8D_C#1+:]:VFN
MI05G%LTPM93 LI(&PS!?+!R0"-W!X/-3Z)J<VI2:FLZQJ+2^>VCV C*JJD$Y
M/7YC0!J45SM[JVJWWB*?1O#WV2 V<4<MW>7D32JI?=MB6-60EL#<6W8 P,$G
MA5UZ[T+2[VZ\:_9K:WLY$5=0ME;RIU=@JGR\LZ$%E4@DCN#C. #H:*P;CQIH
MMI%&\[WJM)&TWD_V;<&9(U."[Q"/>BY_B8 'L:E/BW0OLU[<#48FAL;5+R>1
M0S*(64LKJ0/G!"G[N>1CK0!LT5RWBCQUI_A_1);JWW7ES]E6ZAACBD8-&S!5
M=BJG:,GOC.*;'XZLX=:U.WU$R0VUM'#+$PLYBZH\89FE&TF/!(^\%QR#T- '
M5T5GZSJ#6'AN_P!2M/+D:WM))XMW*L50L.AY''8UF:&WB:^L["_O=3TDP7$4
M<TD$6F2JV&4':'-P0#SUVGZ4 ='16#;^--"NM0@M(;J;=<RM#;RM:3+!,ZYR
MJ3%!&WW3C#'..,U)'XNT2;5!81W;F4SFV$GV>3R&E YC$VWRRW!&T-G((Z\4
M ;5%<]%XNM!KFM6=X&M;?2HHY'N)8W53D'<2Q4 =@!G+<D9[6!XLT86]Y-+<
MR0"R027"7%M+%(B'HVQE#$>X&* -FBJNGZC;ZG:BXM/-\HG ,L#Q%N^0' )'
M/4<&N9N_$]]=>-+WP]IVHZ3I=Q:I&8H]0A::2]+H7)C42Q_*H&"1NYSTQR =
MA16$OB0:?I-C)XEMVL=1NBR?8K9'NG9ESDHL09F7 W9QP",X--F\;Z!#;V4Q
MO9)1?%UMXX+6661V3&]?+52P9<\J0",'(X. #?HK,/B/2QIMS?M<E;:UF\B9
MVB<%'R%VE<9ZL!TJM<>,="M;F>&XO60VTHAN'-O)Y<#$@#?)MVH#D<D@>] &
MY15#3=;L=7DGCLI)#);[3+'-!)"RAL[3M=0<'!P>G!J_0 4444 %%%% !111
M0 4444 %%%% !1574Y[NWTRXETVT^V7:H?)@+A [=@6/ 'K[5SL?B:_TN^U6
MTUXVEV=.T[^T&FL8VC"K\V8V5F;!^4D'/([#% '645RVFZWK4>J:5!KJV)BU
M>!GA%K&Z-;R*N_RV+,0_RY^8!>5Z<U+!\0/#=RD#P7LSI<J6MV%E/B?'58SL
M^=AG!5<L"",<&@#I**YR^\5QM!H\^CLDT5]J@L9O.C=6CX?<-IP5<%,88?A5
MDZW<#^TY(+-[Q+:X6VMXH%^>1]JELDG 4%L9. -IZ\4 ;5%8.D^)(Y?!D.NZ
MTT5HA1FEVY(7YRH4#DDG@ #)). .0*L6_B;3+JUNIH&N7-FRK/!]BF$\>[&W
M]R4\S!SP=N.#Z&@#6HK+TOQ'INLWES:6+7/VBU56FCGLYH"@;.W/F*O7!K4H
M **** "BBB@ HHHH 0C<I![C%8^H>$?#^KW8NM5T:POK@1^4)KFUCD<)DG;E
ME)QDDXZ<FMACM4GT&:\B^*/QW_X5MXGM]'_X1S^TO/LUNO.^W>3MR[KMQY;?
MW,YSWK*2A*24MRXRE'6+.X_X5QX+$1B'A71?+)R4_LZ'!/KC;2GX=>#6*%O"
MVC$QC"$Z=#\OT^7BO$O^&N?^I)_\JW_VFC_AKG_J2?\ RK?_ &FCV4.P_:S[
MGMP^'?@X2-(/"^C!W!#-_9\.6SZG;3?^%<>"Q$8AX5T7RR<E/[.AP3ZXVUXG
M_P -<_\ 4D_^5;_[31_PUS_U)/\ Y5O_ +31[&'8/:U._P#3/H33-%T[1;5+
M;2+*"QMD)*P6T2QH">ORJ *O5R_P^\9_\)WX+T_Q!]@^P?;?-_<>=YNS9(R?
M>VKG.S/0=:ZBG3Y+-0)E=[A1116A(4444 %%%% !39(Q(N&SUSQ3J9+)Y:YQ
MGG%1/EY7S;#5[Z%#4O#^E:S;I!K%A;7\,<@D2.ZA255< @, P(!P2,^YK-'P
M[\'"1I!X7T8.X(9O[/ARV?4[:R/BC\3/^%;>&+?6/[)_M+S[Q;7R?M/D[<H[
M;L[6_N8QCO7E'_#7/_4D_P#E6_\ M-90A2FKQ1I[2I'2Y[9_PKCP6(C$/"NB
M^63DI_9T."?7&VE/PZ\&L4+>%M&)C&$)TZ'Y?I\O%>)?\-<_]23_ .5;_P"T
MT?\ #7/_ %)/_E6_^TU?LH=A>UGW/;A\._!PD:0>%]&#N"&;^SX<MGU.VKFE
M>$M T)Y'T/1['36E $AL[6.$N!TSM S7@O\ PUS_ -23_P"5;_[37:?"[X[_
M /"R?$]QH_\ PCG]F^19M=>=]N\[=AT7;CRU_OYSGM2E3I15VM ]I.74]= V
MJ .PQ2TBG<H/J,TM:JUM#,****8!1110 4444 1R0K(V6)Z8XIOV9/5OSI99
MO+;&W/&>M,^U?['ZUR3EA^9\VYHE.V@[[,GJWYUSY^''@QHUC;PKHI13E5.G
M0X'T&VM[[5_L?K7SK_PUS_U)/_E6_P#M-53C1G\"!RG'KN>W?\*\\'^<)O\
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M"<<':1[U#XBT;6O$B:I=II4EF[:4UE!;S31%YG:17)RK%0!MP,G)R>!7?44
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ML<,*!$11@ "I:VBFHI,XY\O,^78****HD**** "BBB@ HHHH **** "BBB@
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M,;NIQ77UPUIH>KC3=*\.S:=LM=.ODE>^,J&.6*-]Z!5!W[C\H(( &#R:[F@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M '?W7'].U;/CWXW>&_AWKT.DZU9:K//-;+<JUI%&RA2S* 2TBG.4/;TKF/\
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MFPZP'_TR"VTZ47\K8/FQW+>:QQNR2SKMR%(QQ78>,_\ CY\,_P#8<A_]%R4
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M=@10!ZQ17D6JPV,'@CQ#)8:O9WE@;BPW1:/9O!;P,)TW&(AW4N01N"'((4D
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M6CZK9]3R)/V9[I<D^+$+H6,!_LL?N<C&!^]Z?UI5_9IO4CC\OQ>HF0_-(VE
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M[CZ<?XTT?LSW6Z1F\6(6P5BQI8"QKV7'F\@8!'OSZUZ[_P +'\$?]#EX?_\
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M-_..1D@<9.VRN+/Q2INKW6=+GBA:XU.TV/,S=&C4J-C*BA6PJC 9@<FO1Z*
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M9R=R_P!UL@<CGBK&BK9M\0-/N[M+<7MUH$+I*ZKYDLF3N()Y+;.O?'M7>44
M<-)87E_\3-=73]7N=+E73;7#P112!B3+C<)$;('H"OUK",L__"#:G:2/)'K$
M.I1_\)(\H,K-&2-TI5-I,+1@$*NWY P[$GU:B@#R+4X+*#PCXK;1]8TRZMSI
MP,EMHUDT-JDF>'W"1T\PC@@$' 4GH*TH[C1K/4FN_!4+SV<.BSOJ<>GOM+L
M#$'8<B?/F<GY^N:[S6](@U_0[O2KQY$@NXS&[1$!@#Z$@C]*OT >0:'-8)XT
MT5M(.B1)<65VDL6C(2$78&1)9LXE?Y<\JI&"2.0:O^%]+L=4U[P^NI6L5TD/
MAX2QQS('57$V V#QD G![9->H44 <?XFM9;OX@^&8K>^N+%_LU\?.MUC+?\
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MA_9KGW[!XK(MO*\LP_V4.1_W\Q^G^--'[-5SN=F\6#=@K%C2<"-3_#CS>0,
MCWKI^L+L5]6H?\_?P?S_ .!W>Z2U/G62UMET@7XMSN=1&(LG:K9/SYSG''YT
M36MLNDB^6W(:10@CR=J-D_/US@XXSWS7T4?V:KO=YB^+OW[@+*[:3N#J.VWS
M<#/?^E*_[-4SL4/BLBV:/RVA&E#D>H/F8&.W''ZT?6%V_K^OZ0?5Z'_/W\'\
MO^#VZ<Q] 1_ZM?H*=5/2K!=-T](!)),YR\LLARTCGDL?Q[= , <"KE=$+\JN
M<<TE)J+N@HHHJB HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@"CJ>L66D)$;V1PT[[(HH87FDD(
M!)"H@+' !)P. *@/B72!HL.K?; UG<,$B98V9Y')V[%0#<7R"-N,Y!XX-9NK
M,(OB1X=>X91$]I>10Y_YZGRCC/J55L?0UR444MWK]A-;7GV2SF\0W_D7:HK
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MU6G=7$%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0!HW&AZ3=RW$MUI=E-)=($G>2W1C*HQ@,2/F P.#Z"I;'3K+2[;[-IEG;V<
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MLTRQDO9M0U%(;>W6W+(]I+&\'G9"[R>N3VVC;@[O8 UI;"SGFDEGM()))(3
M[O&"6C/)0D]5YZ=*AM]#TFSA6*TTNR@C643!(K=% D'1\ ?>'KUJO;>*-(NH
M+V47+0+8*'NA=P26[0J02&*R*IP0#@XP<&HX?%VBRV]S,UU);K;0B>075M+
MWEG@,%=06!(P" <GCK0!I2:?9R_:/-M('^U*%N-T0/G # #<?,,''--L-,L-
M+A:+3+&VLXV;<R6\*Q@GID@ <UGQ>+M&D2]+3SP&PMOM=Q'<V<T#K#\WSA'0
M,P^5N5!Y&*0>+]&-G#<K+<LEP^R!18SEY_EW9C39N==O.Y05QWH UIK6WN)(
M7N((Y7@??$SH&,;8(W*3T."1D>M2U5T[4K35K,76GS":(DJ3@J58'!5E."K
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MNE"W!,8_? #&&_O#''/:D73[-)HIDM(%EA3RXG$0#1I_=4XX'L*L44 %%%%
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M_@K=V6IY4=-5+J.UEN EPRG*[051^RDY[^O:O8/V:K46?Q2OHFDW3?V+(9%
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MS!(#OWYR=V<G)R>32?\ "+:.=)&G&T/D"?[0&\Y_-\[=N\SS=V_?G^+=GWH
MY35]4OKR]@T76Q;2&UUNR6:6W5DBGC<,Z HQ;!#JN020>#5J:'2AXU\1-JPA
M73K>"QOIVD?:J3J9,,<=>%3@YSA:Z)?"^CKI%SIAM"]M=/YD_F2N\DKY!#-(
MQ+E@0,-G(P,8P*KR^"M"GT][.:UF>.2X6YD=KN8RO(HPK-+OWG&!C)XP/2@"
MIX5@GO=:U;Q)+;/90:DL*6T$@VN\<8.)7'8MNX!Y"J,UU-4-.T>VTMG:VEO7
M,@ /VF^FN ,>@D=L?A5^@ KF_&G_ ![Z+_V&;3_T.NDJGJFDV>L6R0:A&[I'
M(LJ&.5XV5UY#!E(((^M &=XNU6[TK1XO[-1FNKNYCM8V4*60N<;@'(4MCH&(
M&2,Y'!Q+F^\5V.FZA<>5>^19K'=QO>K:F64*?WL)$)*D%!D$!6!R,GBNB_X1
MK36L[BTG6ZNH+E0LB75[-..#D$;W.T@\@C!! .>*EL-!T[3I)I;>%WEG4)++
M<3/.[*.B[I"QV^V<4 <GJ/BO4[A[RXT65GLY;V#3+,Q)&27(+2RKO(!;D* Q
M"Y'(-5M>EUS^QIH=5M[S[&+RR>">^^SB;=YZAD(@8J1T(. >2#GBNQB\,:/#
MX?&B16*+IPSB'<W!W;LAL[@<\@YR.U1CPEHWERK):R3&62.1Y)[F661BA#)\
M[,6P",XSCVY- %?QY_R(>K_]>Y_F*AMHVF\?:Y'',\#-8VP$D84LO,G(W C\
MP:W[^PMM3L)K*^C\VWF7;(FXKN'U'-1OI-F]U<W.QTGNHEBEDCF=&*KG !!&
MW&3R,&@!]_>PZ7I=Q?7CD06L32R,<9VJ,G^5>7Z!J":1K6AZO<Q7T5UK,DD.
MK-/83Q1J\S>9$ [HJG:V$X/1CBO3M2TNSU?37L-1B,UK)MWQEV&[:0PR0<]0
M/KWI-4TJRUK3WL=3A\ZW<JQ7<5.5(8$$$$$$ \&@#AVUO78M+U'7'UB1DLM>
M:S6R%O%Y;P?:A%ACMW[@&X(8?=&03DFM87.H:/>ZK);:E.WVCQ;#:R))'$04
M98MW1 <D$#KT48P<D]R_AS2GTZXL6M<VUS=&[E3S'^:4R"3=G.1\X!P..V,<
M4Q_"VD27TMVUL_FRW,=VX%Q($,R8VR; VT-\HR0.<<YH S]>\8P6/AW4KJQA
MO?M<$>R!)]/GB$DK'8@7>@#G<1PN>*Y;PY?VGA#6_L-G#?/;7FE^8WVFRFMS
M+=VZ$N5,B+DNG)QGE?>O1;[3+34I+5[V+S3:3BXA^<@+( 0&P#@XR>N:;J.D
MVNIFVDN8E::SF$]LY+#RY " >",CDY&<&@#CH=2UZ&7PC>S:VT\>MS@W-K]G
MB$:!H6D"QD+N"CI\S,3@<CG+-%U;7=>U+2+1M9EM(Y])DNYY(((2[NLP08W(
M0.#Z?KS4VE>"+M-<TJ\OK:QLX]->255L[V>9'=E*[8XI %@3YBVU2>BCMFNI
ML?#^F:;<03V5MY4EO;FVC;S&.V,L&*\GGY@#GK0!R>AZ]K'B3^R=/;47L9#9
MSW%U=V\,?F3F.;R0 '5E4'[S?+UP!@5M>!=2U#4_#\LNK72W5S%>W$!E6,(&
M"2LHP![#_P#74&J^%61-/@T2PLWM;0RLJO?W%I/$TC9)2>/<VTDG*$8/R\\
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MCU-+BUWKJJJMX/,8>: NT=#QP,<8K210B*BC"J, >U "T444 %%%% !1110
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MBR)*>KK(&W*3[$=3ZF@#(N[#4(/%WAQ+W5YKIEEN2D@AC1F0)G#@+@DCY20
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M=&E22>8IE>I7]SP3^G;VW_ OP,\8^#O'&GZP-2T62WMGDEE)>621V9&7@&,
M9#;<YZ$GDX%'/+L'U>G_ ,_%^/R_X/;UT/H&BBBM#B"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8"LP560/M)! 0'=M.3G@9X (HM<U">TL;"UU5)YK[4Y+9+P0A)XH41G</&R
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M:>OEO;4R?[&GW>5YD7VCRO-^SY._&,XQC&<<XSFAM%N TD2O&]Q%&)'@4DN
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6Y,2:;I]]?SS-+LA@6,,8XW*&4EW50A88&2">PIX\8V<\5J-.M+R_N[GS/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
C %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_01.jpg
<TEXT>
begin 644 image_01.jpg
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ML-.G3X^ZN[N'?=Z>/7L2"_'%O/ONNR7M&^+\%2M6%)PS8\:,:/?NW27M"@#
MZ%=RZ3YPX$!TVVVW%13..^^\,SIX\. 5G?G::Z\5+<7WWGMO23N'.#^^7>6M
MM]Z*QHT;=\E9U=75 _\#  # V%52Z>[L[!SX-7=P:7WRR2>C_O[^*SYWU:I5
M14OQPH4+2UD[Z/EM;6T#]X@//G/]^O4E[0P P.AUQ:5[__[]T<R9,PO*Y0,/
M/!"=.W>NI*7:V]N+EN*WWWZ[HL___///"W[Q+L=M,0  C$Y75+J/'3L6S9T[
MMZ!4SI\_/^KM[2W+8O&OY4F%N*ZN+CIUZE3%G[]APX:"L^,B_N677Y9\-@
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MAL\^^VS6JP$ $-B02O?RY<L3"^-CCST6>K_<^/[[[Q.O87QO]]&C1[->#P"
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MY;5TISW!9"2^R   D(W4TAV_NKS8?<___?=?T,7R6KJ;FYM3Y[:TM 2;"P!
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M P!@A R[=,>_:"]>O+B@2,9_*/C//_^$V''4BN_9'GR=IDR9$NW=NS?KU0
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@$:FL4'ZN*@  !/8_E0@/RH8)_V$     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
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M(=>821S^H(*FX4&DX9UR-Y3%BBEI"K2K:6[V;$F?4&@.RH+16SUSYL1U#2F
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9J#HU_PO1>&!PTY*0^P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_10a.jpg
<TEXT>
begin 644 image_10a.jpg
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M)\%A]:U!5B-P.#>FM[LN1<=/V3FJGGNXS#%<%0Z7':\>SJ7MZ9W %AOAM]4
MJV4 &\RUPGO4V=93!,<]' :^XM8U!Z_%1@!H<0<#@-]XXXWPRBNOA!=>>"$\
M\\PSX<DGGPS//OML_/VEEU[:^_[.G3O#TT\_'5Y\\<6P9\^>^%U L3F,<0:;
M.]@B*O@;\)GR\<<?QW7RNAX@]E$85?M8NG\&$0ZWPS6L\5:2)$F2)$D:= D.
M#PD<%B#N'PG@=4^"P^I;@ZPR.%PVMG=J'[<+$/LHAUQ>;U4P7 3\TG;*.7I3
M ,C[UF;V.0.[-E$=D-4*+ES<N#91G#F$+1,X%^_ ^X#7SS__/$)<<P:_^NJK
M$? "@)]XXHGP\,,/AP<??##<>^^]X:Z[[@J;-V^./^^YYY[XWMUWWQWNO//.
M<,<==\2R<>/&L&G3IOC>UJU;XW=9!N 8F,PZWGOOO>@Z-A#L"_4!# .K@<EE
M[N%&X+#OPRD<;E?_;.;_K*IPN)6<8<%A29(D29(D:9@D.#Q$<+A90*P+F_:K
MFP!O-.]3P6$=TX.L'!RN.J9W:E\W"XA36%R6VUOEF"B"PND$:AX0&_!-_^:A
M)?) %S ,+ 6<&DC%Z0M,!1#S=XN:L,_:^P!5<Q_;\O@[CEV [7///1<>?_SQ
M"'.W;-D2(>_:M6O#;;?=%FZYY99PXXTWAA4K5H3ERY>'ZZ^_/A;[_9IKK@E7
M7WUUN/SRR\-EEUT6+KKHHC!W[MSX\Y)++@D+%RZ,GV69@.+GGW\^KA,H;2 8
M=S%.85]R<-@B--))_:K"8=^/6X&F[?H_JPH<;M<36AIO)4F2)$F2I&&0X/"0
MP>%F ;'47O4#'!X-^U5P>/3N^V%0/3A<=2SO1+W: 8B+,EVKG)/\^G+0V=S(
M'@(714FD[611$CA]F:@-B$I&+U 7YVWM?R>"XWT<Q7P.& P4!AP#D'G-^SYC
M&= *E"4O&)?P P\\$.'MJE6KPK777ANNNNJJL'3ITK!DR9*P:-&B"'TOO?32
ML&#!@G#QQ1?',G_^_'#AA1>&"RZX(,+@6;-FA:E3IX9CCSTV'''$$>'((X\,
MX\:-"^/'CP]GG'%&7,[JU:LC@":. @<Q=0 $VV1TU-6B)SP<SDU0UTCN<*X?
M-]L_V_E_5CTXW,[X+HVWDB1)DB1)TC!(<+B#I=UP6(!X<-0MB#?:(6&SQY_@
ML-0/\E"M6==P)_9UO6.IV7-6E?.07V<.\GDP[.,JBAS*N7;B?1\% 2 &G@*#
M :N6%6RYOL!5P"I0&(!LD\:1 <R$<:^]]EH$LT\]]538OGU[C(58MVY== ??
M?//-L=QTTTU[7_,^A?=P#UNQSZQ<N3*ZB'$/XQP&&I]WWGD1!L^8,2-,GSX]
M3)LV+<R9,R<L7KPX?I[XB8<>>BB,C(S$3&,B+9CT#M@-^ 9V^X@)VS9 ,?$9
M%I61 \2-].,R0-S-_[.*X' [P;#@L"1)DB1)DC0L$ASN8.D$'.XT(![6,LC]
MK\IZFMV_@ZYFCS_!8:D?9/VT&:=B)_=UE6.IF?-065_-K=.?$U,P;)/<^8GO
MZCE?_;(M"H+O$ZM@[N!T4CE *D"U5JN%#S_\,$)AXAN P8\^^FC,"5ZS9DV$
MN8!:(A_,"8PK&+<P\);/ '#)#>8[9 =3>$VY[[[[HOL7P'O__??'#&)<QWP/
M:(SS&-<Q3F'6@;N8G[B0B9\ +@.D6>8CCSP2F-#NY9=?#C_ZT8\BQ 84$SEA
MD]75_M<=#0BWF QS$)OKVN!Z,_VX:)]7'9>KEJ*QO^K_4_7^KZJZ;DF2)$F2
M)$D:9 D.=[!T"@X+$/<_+.M6W<OZ6C^V2[O5[/$G."SU@WP_K3)^=VM?5SV6
M&NGKC:[7 [XB,&Q9P$!-"N_QV:+UI=N3._]:W 20&#@,0 6J H6)BP ,,[D<
MD1'$19#]>_;99X<33SPQ''KHH>&00PZ)L0\GG'!"=/<"B<D&!@H#?<D'QF%,
M[(25D9&1L&O7KO#**Z^$/7OV1*C+>TQ>MV/'CO@]W,C 8B(D@,W+EBT+5UYY
M9706 XSY"4 &))-K#' &$I-%O'OW[@B)B9P $E/>?__]^!-7,2YBW-.609Q.
M3E=EO^7:,^T'C?3U=L#AJO]3"0Q+DB1)DB1)HUV"PQTLG83# L3]#<NZL0U5
M^EF_M4N[U>SQ)S@L]8-\7QU$.%Q6[V;JEZXS!X=3MS!PV(K!X:+ZI>?.]'-\
M%T"*DQ:W,/$1!H,!NL!60"V0%J<P#F&B'@##9 'OM]]^8?_]]P]CQXX-$R=.
MC'"8[&"<O;???GM8OWY]_"Z@F+)Y\^:P:=.F^!/'+Z[AQQY[+$YB!QC>N7-G
M_(E#&:C,WW$8XRKF>RP/9_&MM]X:)[GC]88-&^+R^!S?>?KIIZ/+&4#,M@"X
MB9P % .(<1&3H\PV XC-06QM2;O4VX>-].%6_E]I! [[_M.I* F-M9(D29(D
M2=*P2'"X@Z73<+@3#IAA+H/8_^KMGZ+^U,C^'F0U>_P)#DO]HD;Z:K?V==6Q
MJ4I=FUUO53CLB^4/V_DPET_L)[&SNMHZ ,SD\)(K#$0%"@-K<>$"=RTZ N#+
M1'&GGGIJA,!,#@<<'C-F3/S)>_R-S_!9G+WD!Q,Q@<.7B>@ RS;Y'(7/ )%O
MN.&&Z/S%*0S<-4C\Y)-/Q@*D]H7W#"(#E:DO,-D ,W_'G0P@QIG\^NNO?R%J
M@FTEBQCW< X0%TWJE^ZW*N>B>O_G- ..ZYT7NW%#79(D29(D29(&78+#'2R]
M@,,"Q/T!RSK=?ZKTIZK[>Y#5CO83')9ZJ4;Z:K?V=:MC5+/U2I==%0[S>SHY
M':_3V(DT?L+68=G#3,Q&S,);;[T5XQBV;=L6W;G777==C(<X\\PSP_'''Q\.
M/_SP<-AAAT483)0$OP.%CS[ZZ!@G86!X[MRY$0Y?=-%%>R>5PTT\:=*D")2/
M.NJH<,011\0R8<*$<,HIIX29,V=&4(P;F.@*P"_YP=3GI9=>BI/?43]S_@)X
M<3CS&J!-+ 40&!C,]X#$+ ,'\<C(2 3> &(^R_<^^NBCN,VXAST@QD%-V]$V
M?K\6[;>B,35]O]5)XIJ%PYT"PQIK)4F2)$F2I&&0X' '2[_!X=$.B >I_[4+
M; H."PY+_:VJ_;7;^[J5L:J5>OGEYN"P >(4#'LHG$XR!_3UQ;)U^0RO?_>[
MW\5\82(6WGCCC>C(O??>>V-4 [F^0-[33CLM MT##C@@?/>[WXT1$N0+$R$!
MV)T\>7*8,6-&./?<<R,09C(Z)HLCDYC7P&&RB:=.G1J..>:8")3Y/LLCB@)
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MP !3X";0%-")&Q9X"O@$C.+ !0KCRB5Z@5QA8.ZR9<NB<Q=HBXN7_&#B'RC
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M."PX/!I4-B:TN\]4$<>.CP*PB(4T.L #/Q]E !PV)ZD?/VP[#<I:7BW?27.
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M<+A%-7(QT@U W"PXZS7(&DVE$W#8+M)YOP@8^'44[7-_ 5\$FMNY?>WHUZW
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M3@+8S+@$',;%BGL8"$T;L5[&"*NSP6$/C8O =FZ[;)O2L=2/1>DXVDDPG'-
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MS2JZ *\2&Y%S 9>5G%.N44=R$5S-08IFH':K<+@(B L.EZO78Z/&V_JR[%Y
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M/_[X_[A' 81,2#9W[MP8(P$89M*Y_?;;+XP9,R;^/G7JU+!DR9*P9<N6^!V
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MX/ 0PHK<15\[P' ]0-SO[5)%*7CP+KL4$!=!8H/#3/)45@P>YTH94/9@V2[
MT\F>6LWQ+.I#[83#99-#%?6S03XNNZU>@]S1,MZV2^UJA_38M6/2;G39I&,
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MSR.[7'QST4TTA"_$2O"^%7[G?28'(DH"B$SA=_Z&.Y!,2)8'(%ZY<F6<8 I
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MYI3C'"::AO>!?CQ5P'BR9\^>F"&+&]BOE]>6IVYPF-@!Q@N*.8=;F92N'>.
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MS1KV=;/OF@L*N,+%*^"S5JOMC5$ # -]B8W@T5DK@% <PX!AX"B?X4*9"V*
M,E#XXX\_CJ"99>*> JSF"I#8)K\#OA@D3L%)T<1-Z45]T?XHZ^_VGCD2_6/?
M!JD]X 'X H[8;MR(P(#;;KLMW'###?%1=-H$.(Q;FC80'!X<]7H<[O78/@AP
MF.,1T,9-)HY%Q@Z.S;0.C"7<F.*&%4\W<'PR:1A ^)ACC@GCQHT+8\>.#<<?
M?WR$PY=<<DET#?-9QC*[B<7X13% [.-HBD"?99M;? UU89RU&V&,(VG\3R.
MN!W'<+?Z7[^H[+BH"H8I[#.;B&[UZM7AFFNN"9===EET#1-7POF1\X/M;XI-
M[,KYI5$XG'M22H!8DB1)DB1)DGJOH83#C4"$3ET$^CKDG,(>#.> , "OK'A(
M7!1=4+8M9>W4JPLOJT_.$5L$O;T3B0M=@ <0!(<<,(4H"?)U;0(GG'2WWWY[
MG,AITZ9-T2W%^\1(X)X%OA ?P??XOL5&X)QBV5P8VP4RO^,6!N@ 6PR^\)K/
M\QGO(DXGU?/MG;NP+^NC]<"QY4G:8]^LVQX!MHMWVHRZDK],I 1PF';!/;9L
MV;+X2#%M(S@\F.KU&-S+?C$H<)ACE'&$&T_FZ@6VIH_;,\9P#!)UPTT;'OTG
M2N+PPP\/AQUV6/QYQ!%'A!-.."&Z/LD:YO@%^C&6L4S&+9;#&)5&X7@X[-O9
M;KK9S23&,X/#*1CV,14I'"X#Q.TXAKO9!_M!9<=$53!,8;\R_C/.+U^^/+K1
MN;' 1(9+ERZ--U-Y:L3VL[_9R7[.W;#UYQ</AW/G]B(X7-9W^G%_2)(D29(D
M2=*@2W"X31> 977(@>'4+9Q"X31W-Y?#6^8@KG+A7>0TLN]U6[DZE8%A9,XV
MVH +5^ 'H 6WKV7J$IM OC 7NH!AG+$X9(&A1$OP-R9=LTGFS"F,"]@@KUT4
MFPO73YYGX 78PN?Y:1 Y=0_G '%1GRW:3[D+[W3?6CZHU=6[O&R9+(>ZXJX&
MBA.I@9N:]F&BJW7KUD5H %A7K,3@J==C<"_[Q:# 88Y1Q@B+>?'1$C;&,+YP
MDXJG'XAZ88(YLH;)&#[DD$,B'#[JJ*/"^/'CPZFGGAHC):Z[[KJP>?/F&*-#
M=(RY?@'1K(-QDO58QK&?D,Z/J=XMG-[L*KM)F7-_%@'B5H_A;O:I?AE7RNK?
M"!QF7^(,YES(#0? ,&7!@@6Q#S'^ X]S-SF+LO2M#KF^4#;AKN"P)$F2)$F2
M)/5.@L,M7)2:RM9=EB^< \-^HI^RD@+BW(5YT78674CV&@ZG;5D%UA@$I2V
M'3CO@)BX?HF3X,(7J$+N)H_(,OLZ!=<P%[Z 81Z[)CX"(,SW :9<#*>3-N4N
M:&T_IEF<YK#SCJO479=&993U97]A[?M,.@F=OT"WQ\&]R\NW,9^ACC@6:2><
MTSR&CGOX^NNOCS]IHY&1$4U(-X#J]1C<RWXQ*'#89PZG-Z/LAA,PEYM6N/LY
M)H%XN(-Q"1]PP $1#A,M<>*))\:)Q!8M6A3'.&Z&<=.G5JOM':,X?NT)",8K
MQH5T>\TM;'7@L]3#QD4#RCF05^_<D@/$K1[#W>P;_3*VE!T35>$P^Y[^P&2K
MG \OOOCBZ!@&#-.'>(*$&X8XUND'_@D4OTQ_'K.ZI>LN^A](<%B2)$F2)$F2
M^D.C&@ZW>E&*JERDY5S#96#88&)1\7"X"!!7R7K,91/V&@[GVK5LG]BD.ESD
M E;,-6QQ$H#?7;MVQ0GH[KSSS@A-;KWUUA@G 3#&,0P8)I.3=J4=;6*W1NIJ
M&8NIXR]]'-><5_Y1[GI]CKK8\CV(IOB\4+_?[#O6QXHR1:D/CYD#GX#HCS[Z
M:'0<DE>*NQHXC/N0M@0BLSWM +?M@H#M.(:'5;T>@WLUK@\2!.08M1M;!F"!
MM^;P95SBI@P3T9&+3M;PO'GSPFFGG1:!\'[[[1<C)<@:YKVY<^?&W%CB<SB6
M^1YCHHT?'.]VT\I'S7A91 ]0F#'5)B/C)]]C3*G7-K:O!@D.%\'L]*9IK\>6
M>L=##@[G_O>@T.\X!_)$S7GGG1=FSYX=G<-,9NAC2?S-!%NO]2D_6:S5+X7#
M14].M9HYW.M](4F2)$F2)$G#HJ&%PZV41E1TD585#/L8"0-^[8+#91=411>5
MS<*1](*P&<#LZ^:=LJDSR?\=6('C[I-//HF0%P<L%[M$(3"QG!4<PL 28"=N
M*( GX!AW,=_%,6RPU;MZJUR<^FU/ 7'J]O9@..<<3MLB7;;!83_1G/4!#YNM
MC=+<YG1=?)_\4:(E<) ! \QAC9OLH8<>"CB*R6$&N@.M_,5]ZH)/+_H;B3GQ
M_;*;Q_"PJM?C:*=*MP!Q-T"QCW\!V@*'&8NX85.KU<(''WRP-Q-\[=JU$=P!
M@2=.G!@GH-M___UCI,24*5/V9@WS.0/#/$$!V+7CT<8F>YK @)[O,P:L+2['
M\M7-T6Q0N1Y(;?:F3C/GGF[UJ7;T@U:WW8/9*MG.O&>Q2^Q' _[T-?H9?8N;
M#M.F38M]B-QAQG\B3'"><W[T-R+]^:7H2:5<GTB=P_6@<-4^4]:VDB1)DB1)
MDB15TY<:N3@>%!C3+8B4N["LZMHIBI+(P6#O/FT4#K?CPKF*#$1:7>JY;XLN
M[#S4-!!J%Z6V/7Y=@!0R-0&; &'<P !@'JG>L6-'A)TC(R/1/0PTYG, Y'3"
M.9N<R6<JYBY@TPM7O_]S@#B7$5V4.5P$+&Q[K?_DG.;T$0]\RB[2/>3@.[3A
M1Q]]% $P$/W>>^^-,]>3/VR9S.0V&VC*Q9_D^J;/IBQSWN6.HVX=P\.L=AS[
MH[&DQ[._,=7L/BC[NP?$C$.XA;D1PXTK "]C%\<DDT0R"=VX<>/BY'/D#1,K
M<>RQQX;ITZ?''&(<_XQ_'*_$Y. ^9FQ(XP3\C:2TKO;$@>4-^ZB<-&K'E]0%
MVLW_';K9/[I9I]PR_?Y)GT(I.J>PS^A;-O$AYST*8SHW *^\\LJ]L22XAGG*
MAIN"W)C@_)B.X_7.,44EC;<HBR6IVBZ]'B\D29(D29(D:1A4"0XW\H_Z:%(*
M$EH!PT4N8;LPS\43%,'A%%XVLUVV;57WL<^II&X^X[9H^>ER4S!L<,+B'@QF
MV+IXGPM=  I0&("R<>/&"#97K5H5XQ',^0H4)CK!)GT"<MHCW.G$<463+56-
M[;"+=[]_BL!PT;&5 BIKDQ0.^\GP[%'Q'" H@EU\GO; '4:N,""=Q]>9C([H
M#0"[Y3+C8L2E;:#(7(56S%W(^WS&SVI?+[+$U[%=#KW1KEY#DT$MZ7'7:,Q,
MT3ZH]QG6Q3$$M./F%6,6QR.1.#SVST1SQQUW7/C!#WX0XR1P#1]XX($Q>QC'
M)UG$1,'PI 3+2.%MV>2>Z;;[;//T205_[DG'N%QDSFA5O3[6C%O=^@EM;N>L
M=(S-?8]]ATN8)T3($*9_\:0-8SY/BI S?/311\>;#\N7+X]/UQ E5*O5XGB>
MJW>Z/>F3/KGM2H^KHANNC?2;HK;MYI@A29(D29(D28,NP>$6Y"]$ZKED<I/0
MV45W+H*@R#E<94*Z5O,1_456/8A@VTD=J)==L!K,3>4?B<W!5KM@-/CK)V4"
M3 )W 9F WK???GMOGC 7N!LV;(A0DZQ$'JT&%N,<YM%8'%!<Z%IN9@ZX-PN&
MT^/!G(!^&8TZNW,7T]XY;,[D(CB<[K<4#AOL8EO+X##.81X[WKU[=X3#N,@\
M&+9\5$H.MIO+,%UOT;$D.-P^]1JR#FI)C[NR?IMK[[)S:)E8%^.3'8LOO/!"
MC(?@.&2"2 #PD4<>&?[B+_XB_/"'/PQCQHR)N<.XAH%[1 /PQ 10F;$2Y8[[
M7#URVYV[D9D^#5$/#H]FU1O;&_V_RY;I<_:]DSL%\GZ?,B8S42M0F"=G +_T
M,?H*-U'I/SC09\V:%2>BV[ES9_PL[G/6X[>GDW"XF?\KR]JV6V.&)$F2)$F2
M) VZ!(=;4-$%29E[N%E 7 5@M@L.^VWSWT\!0FX"-C^K>0X.^#Q+BH]Q\"X]
MMHF_VZ.P.)ZXJ'WQQ1?#DT\^&1W!Q![@E ,&VT1S0$TN=H$DN(F!QUP$$SW!
MX]HVL8YORYP+V[=I52AL)8W8*,N#SNVC(DCE^X_U'=H:$ N4-2B? T!E<)A8
M"1YCIWUQ69,U29O2OCRB#BA@LCJ /' X=0Y[0)R#PW["HJ+^Z+=7<+@]ZC5D
M'>12Y+0O:V?_'3_V5QV3^2Q/-/"H/T]#X-CG6.1&%Z[@&3-FA,,..RS"82(E
M@'FGGGIJG*".R G&/F RXQW+L;K5.Z[\9W(1-CX;/U?2FV &*IMU6P^+ROI6
MU9*#IO[F:=$$I\B?A[CI4*O5XDU2^A:Q(Q1NG/*TS:677AHF39H4YLR9$\^C
MG >X&<@YDW'<MJ?H?\(4^OH;E&6?$QR6)$F2)$F2I/Z0X' +*KO8RT&",D"<
M.K.*LEP;!</MW#_^XHYU&IP$!OJ( >]@3670%WC!!:M-<N0A(NOA<P!&7*W
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MQH^Z$SCWK6]]*Q5I4 U??/'%2=F)Q_#^^^^?5,,77GAAZO?P5Z??HYT"_H"
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M)=_&+O>E"\2?9?NH;8OZO?>*U+%R+[@/P';4V%Q?%,.HM)EJC,(,7V>N.="
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M2W]=+.3A&K*0WX]^]*/D]PPX -+OVK4K+?P'-'CDD4?V*,J PUY1+K DT"3
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M@U$/A;WBR@Y(^\)?[;-IJP6BI7LPQGW.#<9U_/9\4%_C>8IBC*GM7&NFMK,
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M#G>Y_UW;F=VG!UG^?/1_ !/>I4PY_O:WOYVFK ,+KKSRRG2/M% 18 $X3 '
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M=UU:9 DOS8LNNB@IA8$@#$Q1+>%U^."##R8E'6 9>%ORW/5 E6-E\,E[@,H
M8@:V#$IE?:$!M7P_K8>QSJ<+%.Z3[R709 ?:_AYX-;->4PMRI#;C' 7W90MB
ME=EVX]K\]*<_3?<"<'7777<EA1GWS,-A_*!S<-CFU2K#X;;V&7!XXVP>#M?<
M6_FK"M1A!<'T?@I@@#BL)%!L,JL"0(=J^.*++TZS*H##FS9M2I8[-]UTTYXV
MAU<Q?9>WQ+&>KX)Z.66ISL4_VX8"N:9\FW<;7M9HRZVFC;Y(15CY '/??)!S
MLC%!J4Z^H%*G4(LZG5SB.<Q&P8_G,+_C^8O-R>]^][L]B[]*@6[AL+6WL-\5
MFN"PS4FU![U.?L0!AR,B(B(B(B(B(B*6*S8T'/;GV.0Y7 +$7>%P#2 N0>+2
MH+L&='C?0#O(\U8.%A)KFBG[X?V"K@Q$\=%$W0;P8/$D8,<EEUR2@# ;X /(
MB!(.& (489HKMA/?_>YWDRH.@,+^[#7G\_SY6@C)8)G!*(-:U,M2!@,NY8DL
M#T8&J[R.UW@X7/+V':K6SN69A]P>S.<6R;/3P-N M>Z/X+ ?O%OO9>M!S+4!
M#G,_+!S.*8<]',Z=6PEDUUZO95(.UWJ#+VM_N&C NLI;DW+8_MW>;]JI0!U%
M%XIGLMI!-8P/^^VWWY[@'&I.9E8PFX*%.O%C9S&Z3WSB$TGM"4Q&<8Q=3\YG
MV!9_+!RN/:]9%#46U8:[1.Z:S.MS<M>_#0ZKJ*<%WOPQ\SIR@3X>I3I].7TU
MSUCZ<@JRYYQS3K)W8A%8GL?X#M.G\_REL,I[V8<*D5:!W@:'K>>PA\-2&6NV
MSSS@L&^;\]HB(B(B(B(B(B(B5CVJX?#0+]OSCJZ#Y!(@+H%B[]WK06,?/^(V
MK^*<BECG8H\Q!SBMY8!49X %Z\<K(*EIRQX.,T#DM0!9IDMC1;![]^X$$5$D
ML?C<::>=EJ9& ST '4QE9>$YIDGC<0B$?/755Q,TP9("A1T#2'OMFQ345IT'
M^+26"9IR+?#*[W@-G^%M)7* N#10'9J#37#>J[6]C0>OM0L2Y=JA![0"Q)PO
MYVW]F-ETW;B&0'ZF%@.C4),!I@2'L09!Y6UM)1CXER!:D^JZ3YN=592N74V1
MIJU/7*:8)QR9US;+9U3;Y_D"C_H,*79I=[0IVAM6$/_YG__Y)S[LM"4\7Z^Z
MZJKIIS[UJ51  ]RA'-ZV;5OR&P;FL5#=CW_\XSU>P_0'=CJ_7UQ2?40N/TO]
MQ=A@>)'Y5GL\M7DSUC7H\ATC!X=E4:)GL[W'.D[!8?KUR622+"6TN"C/76 P
M><5S&54ZSV3@,)9.@&3Z<VOUX(^G],R2I8GL(@1_[?<)KW#79TD%79J-T>=>
M++)/BHB(B(B(B(B(B%@/T0D.#QV0SROZ@H5:4-P$C-M\BINV$E#.*5SM=;?J
MGASLU&OXNUU$#F@JRP6[&(U5GUHXS. 0\ '4!5XP31H;"11)+#K'@G-''GGD
M=.O6K>G_J(@!QRB+4<[QGE_\XA=)+0Q@9K#(0%/[]]>]=%VEV/;J6F_7H'.5
M<I9SM "Y[\)O77-1YZ1K:^&[%(!2B-F%XP2R_51?'9/=M[]&O$^V&EQKNUD/
M9JPY4( _]]QS:?5ZX##W#'@%1&B#PZ5VU;?=C]U/U("_MG9> X67$1(L$IC,
M:AOC>=3UVMGV:Q?ELL".X/^ ,M3X]'$H[06'+:QC1@4^[,"ZL\XZ:WKZZ:<G
M]3 +T]&?/OWTTTEUK.G^[%>+CJFOT R)MMDG%B3F<F*6>3>/[Q2E\VAJYZ7K
M-+3/+YUW3?_B^Q@5054PU(P77Y"P<!B5.6IS"GT4&"CNX?6/(IWB T7;"RZX
M(/7K%&JQH+#[S1VWS7G_W)*?O<"O%H!5X5%@6X5HZX_==39&EYQ=UOXX(B(B
M(B(B(B(B8IEC%#C<9; WCQ@Z,!T+(->"XJX>QG[JI[43L.#3OHY_I;AE(,ET
M4L @ TH ,8,W/M\/3 5 ^#T#/=Z#CR:J83R&66#N0Q_ZT/2HHXZ:'G300=-]
M]MEG>NBAATY//?74I#[%;@*(_/KKKR>5*I_- %% Q=\W#SP][+9@//=^O<<N
MVF0'JX+#'BR7%GT;FK,>+OG%]:2^DNU#3@DM .6/1?=5Y^RA@;Q/N>[<-]2,
M3#U608#/Y'< !7RC 0J"PTQYS\%A!O]C#.#G$4,A8Q=@M8RQ:) []M;6Y\[J
M7K&_7+\BQ:6\8/D][6HRF235\*]^]:L]BW72MJZ__OKI]NW;$Q ^\\PS$Q1F
MXV>*:4!CVAM>L/23FNF@YP+[%XRC_^#WNL_>VD6;KLN\P_9[7;8QOEOXG/'/
MXYI9.5WS)->OU!:2<^=O%Z3S,TET7PFIU<D[BK:L 8#?,#-ZL"XAMUCHD*(M
M!0B*$O3K3SSQ1,I17T#PSU]K*>$M3<A/ 6*_Z6^^Z&F?9WT*<,O:UT9$1$1$
M1$1$1$2L>JQ;.+PL@#@W,!Q#.>SW+X#@8:JN/?_:16Z ? PH@<0H2?F_!G'R
M\P4<,X!$8<045" ''L/8#^!GR!1I@ 935H'!;$R11JW$]&C\-?&Q99HK0)G/
M FPP0,P!B]S M"\<]JNJ6S6N7_1MGG#8*X?M(%L#Z9QRN D.ZWQM,8"?V0<*
M8:X[0!A #!S60GZHB+F_+&#TY)-/)J" +S2*LRNOO#(M'GC//?=,'WOLL>DK
MK[R2E)#<OU6 I6.#X64_WUPL&N;.$P[/ZE[Y/LD"8JD@K7*8]D&[ M31YS%;
M BL=%@<##F.W QRFSSSQQ!.GIYQR2@)X>,*RB"=MD/:8@\/JN_5[VKB.,0>'
M[<R1>4=?.-P'$"\#'+;GW.6[0>F\5?#UGO36:HAC)Q_HW\DW[($HVJ)2Y_F,
MI1.V)2B' <.HA@'&__S/_SQ]Z:67TK/ GZ^_;DW*8?_L\IN^3VBSQ>: PQ$1
M$1$1$1$1$1'+%>L:#L\+5M0"XUKKB1(8MH/8&B62A:@""!KH656M/ .!Q4!$
M!IK8/[!@#6#WV]_^=EI,B0$GJB/ (=Z%##:!':CAL)9 ;<K@4Q[#^&PR",4'
MD7UJ01H^?U9P. =AK3_G/.%PTT#;^@W[1>(LQ/8*<+]_"Q$T75>_YW<,TJ44
M1T$\F4S2!OAG0]GX\LLO)P",_<<==]R1[C%P']4W4(LIR*@9\4!=!3C<I[T&
M'%[^+=>WSNI>E3[7%I]LX8:@_6EQ,-H8EA(45>@_Y3=,GPD<!M9MV;(E6?&@
M&L9_F+]3>$/]*3A,'V'AL%4LE^!PDZW$O,+V>WVW><#A,:TE2OU,G_,L>?WJ
M&:;G \]L+$RT$!U]-?TX]B0\IRG4DFO\R[.9F2$\EWFV4\0H73N?[Q946]]K
M"W]+4-@^UW)PN&L;CHB(B(B(B(B(B(@8/P(.CP0LVK;:*:9-"]+I.FKP*-CH
M/8A+U]H>LQWT,7!CD D\1$D*S 5J:'HJ"E(\:/'(1.EVS#''3#=OWIS !JHW
M@,>UUUZ;E,+XUN(O#'!D ,K4:B D<-+"CAP<M@/2L>"P!K-^4-WF.3QT,)H;
M9.M\[+'9!>G\%&)[;(+#?B!OIQ]KH1]=!SL5G?N+6AAH!:CG/F,3@;(1C\IO
M?.,;R2:$>_CYSW]^>MUUUZ6?[[___J0J9A%!WL.^EAF6#FVG 8>7=UL$'/;[
MLGVGMW)108;^5 L]HAH&^*+(!_Y25,-;F+[SB"..2( 86$S_>O/--Z<B#1[@
M'@Y;Q;*\X&5GH?:^WN!P+2#.]8N^_\W!X;%]A\?L;^QS++<8H3;R#(4ZSVOZ
MZ:]^]:O3VVZ[+?7?+!*K10]1I=.?8_&D62 4A4OGD'MNV>/PQ^*!L(7"I<43
MV^[O*O6U$1$1$1$1$1$1$:L>ZQ(.$XL"%UT@<8VRN D@>W"8NP;V,RTHL$"!
MP1LJ(A9! @ROK:TE3T+ ("I@!I8,, '#+&P#&&:J*E.C&7SNVK4KJ8H9>/)>
M/&Q1'@,A&;QB6Z'%Y^S@T.>&A=Y>09V#MZ7S]6JG'!BNA<-#\\_#"0N(K2I,
MQ];DA9S+.5F%6#6A_B9P+'L)5.& >A3 *(:Y3T!\E(U !51E@ 549ZB'O_2E
M+R6PA94(GM&_^]WO]L#AMO:PB!BC?08<7M[-]Z&SO%>V[?I^T_=3V@2&:2.T
M,Q3 %,I0WZ/"IX!&?PD,QJ==!;;SSS\_P3R*,[0U%,<6#JLO4'_F%\*S?7D.
M#"\B/WW?MVQPN#339N@U&ZO?L<\+JQK73!_R@^<J?3F%.\ PSVO9 EUUU57I
MN0T@9ET "@_TY?3WP&2LA0"XN7/U;<T7-57$%"3.06O[-UN<M?9' 8<C(B(B
M(B(B(B(BEB=6'@XO<@#1!VST <=VBJD6*;-V R58*D!H%[+C=SIV?2Z#1!8F
MDP(),(QB&* !^-VQ8T=2N[%X$K["\LG\Y"<_F2 B'H9,9^6]4@JC4A449O]:
M%;W)/[D$AKO"X=QT6+N5+"7&4MN58%9.$6T7(6SRE\X-F*4.9O --)#*T/Y=
MT J@ !QF"C+W&7 %* !> 0V8]@X8_N(7OYCN.T4!IB<#_%$6HP+GO0"KFGR?
M=PQM>P&'EW^;Y[U2^RG!80%B"^[HZ^3CCBJ?_O#11Q]-;0LU/M/\ <'65H(^
M%7A'V\,K=FUM+?6A%',\',[YR=MC718P[*]3U^==5WCLS]/G3%OQ=2PPG/O\
M(;FMXU8!D'R0ASQPE_Z8?EDS?,@AP#"60%@\\>\--]R0BGV XQ=>>"'U_11L
MV0_[S#WO_+7S"]/9@J9 <6GS?LGV>TC?-AP1$1$1$1$1$1$1,7ZL-!Q>%5C3
M!W3X0; 4H(*M4HDV#8X%+W*+)]G7 191^6(QP$!3BF%@QB677))6.,<7$ZB!
MM03_O_322Y/=!(-2WH.R%-L!%$V $@^Q-0BWH-O#60M-!4R;E+VE:YT#Q!K8
MUJB&QX##I?M8HPRO5<]I&KL6&.2Z<TXV)_B9<^0> X=1_Z(._][WOI? , L&
M H&9<@Q$  SS,RIB\@!5,;[3O&<RF?R)VFQ9VM\8,#'@\&IL\[A7O@]1&_37
ME=_+UQLHS.P+H!W%,3Q@@7$47O#Q!M(![%AXCGZ4(AOJ8?Z/W03JXN>>>R[U
MP;11#X>;9C;H>+WMSB+SLLO]&D-9G'O^V?M8ZG_'5 UWN2ZU^<WON/? 5?IP
M"JX4<GG6 GKIF\DQGM=X"J,6YMG,<QLU.L"862'//OMLLCDA1^7]ZPO,N7M7
MFO$B2.P7S/.S8'Q1UEJQ!!R.B(B(B(B(B(B(6)Y863B\3'"J)H8 $$$(#0X!
M@4 #^<OZ\]7O^+N@LK4=$$@0I&7 R%1F5CH'%@('F9;*8G/ "X PMA)X"^.-
MN?./B\ZQ2!U  WL"+"DX-L')W.".D!)*@TH+B3T4[@N':P:V7L4\ID=G#DKT
MG3+=M D::-&YTF)_G!NO 0X#%5 -<]^XU_?<<T^:B@SH1P4.' 8,\WM\B)GF
M#D@F/X 2Y%%-#L\KQ@") 8=79ULD'/;OY??TP[0]U)BR; ':::H_T)>^$DL)
M_(8!PVP4V]@ >?2WS+QX[;77DAW/'_[PA]3'TYXM'.;S<L?O^YLQ^K"AT>5^
MC:4>]I^=ZX=+13B?,_.X-C7YS>^X]^0!.<&SFD*N9G^08RC3>28#A,DQ%H?E
MW\]^]K-I5@\S@7[XPQ\FI3'[89^:56)SJW3__'/4/TMK-P^CUUM_&Q$1$1$1
M$1$1$;'*,1<X//87^F6"4UVB+Q!A, 4$E#4 *C4@G?QE_6?HNOL5SZUB%M#,
M]%2 !JI0K -83 ZET=577YW ,,HV[".D%+9*)&#&2R^]E!9/ @QKJJJ=!IVS
M:[ +J%D?0J_NS<'A&F5O#@QX0)R#SF-:2MC/S:G3:@? .6!@@0;'SS74='8
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M\'B5TRS@L 7T0_=M]VF5X/:: VX9Z',-;5& X+6H$5GH"A4P]QTO2NXKWM*
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M&+;'F=MWG_UY,,P]MQ90S-:A/^89S.R=)YYX(H%?GM\\JU&BHQHFW[30(3-
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M')9EC*;\=^V?EBTWN_0'0^!PKB_(M=V^Q^Z+!;G/Z++/7)ZI?Q<<QG*$&1^
M84 O!0B>X2QV2%$/VQ+\K$\[[;0T\X?"!/TXS^\77WPQ%2 H7E#4E76)/U9[
M+$.A]Z+;[B*WB(B(B(B(B(B(B%6./UOT >2B:0!9,WB<I^)P7H,"70O! ZUB
MKE7M9<L '$8EBNH3"P$&B2Q, _P#_N)%>,,--Z3!)9 8!1(;TYR!PH!# *)4
M;4!F]LEGR0/3*MFT"5X*7 )Y[6)YO%>+T0D*YVPEK&JXBV*N[74ZQM)"1F/<
MQU+>]AT\VGU959F%PUK<3X!8JFV@%7 !* !@0#TFU9G@ EZ5\AI&2?R5KWPE
MP0= %V"8/*(@H,4/N:<<1RU@ZP*"2^W:*KW]-A8\#CB\.ML8YUZ3D[*1L(MN
M^K8LNQ:F^^/1C5<WBDW:$VI.5,.'''+(]/WO?__TA!-.F%YXX86I_Z6OQ::'
M-DD;LW#8%@'UN5WSRY[C,N9GT_UH>[XW]0<>XN?@\-!C;"LP=MFW+_K9OEWK
M"_ ,)K]XEC_UU%/3^^^_/Q7VZ+M9?.ZLL\Y*"]&QB"P+'9)[V$ !DGF&4R#F
M&<"S07[T_GKX9^-88+UT+?N\I^_S91[;,K:QB(B(B(B(B(B(B*ZQ='!XR,!Q
MWH"XJV)HK+  P2K,V(""@&'\++&/8"")6@TO819&0M&FJ:? 8!8G PBB9.-G
MP# +UN%AG ,C_E[E!LU^LP-?+;@D2"S5,+_SJN'::ULS^+2#\9RZ;(Q[F,O;
MO@-'#Q#L D+<%P%X>RU1AC'-'1C _0,L 'E1G@%\680093 0&#B,WS2J82Q$
M*"!@*<%KN/] *_9C;4KXS#'A\! PW!42!QQ>']L8YUZ3EP+#=E$X_W[Z7MH9
M=BVH-.EO\1RF" <</O'$$Q,8WG???1,H1JE/GPM$IE #]$.93T''PF%RFO_;
M EGIO'+G;=O6(IY/-='G&=^E+_#G/R1_<D4#N[!I%T"<Z]=55+6%50N'\7XG
MOQYZZ*$TTX=^&S_KDTXZ*6W8E9QZZJGIV8XJG><Y.8E7,<5=WW_[[RT64N>@
M]U  .G8;7C0,#C@<$1$1$1$1$1&Q'F.IX'#3(* +&)[75E+7S!H@\7D6%@JF
M\C-0#_L 0"\#23R$F=)\U%%')5B!THA!)  #Q3#^LBQPPX;:"*@,3 0,"CSG
MU&NZ/W:PK &N'S3;P;V@BU46>]6PO;:U.=,V6//09!: ?\B]+^6^!0@Y.*R-
MZP<<!BB0 T!AB@0___G/_V1*,H !=2-*813D*,KOO//.I"8&6JVMK24;$>X_
MH!G%&>"9_7O_TZ$ K@D.^\+"+ %QP.'5V<8X][;[K+Y4MBTV]^W?@+H N-=>
M>RVI.IEU@54//N[TL0#A0P\]-*F'47E2D.%U]+52=>+G31NC/5M(EYL]8?NP
M4G_'O[8-U?:C\XX^S_FNQ2(/AX<>G^Z-GG.Y9UW;Y]G]Y?IU]>7D!& 7.R>L
MH<@;^FURZY.?_&1ZCF_;MBT]TU$.8RW!+!#Z<0H/>!73AY.C\J_VB[O:\[//
M\:9KV*>O&[L-+QH&!QR.B(B(B(B(B(A8C[$T<+AI ##&@'$6FP?$74#QD &%
MA03V6C  Q/\2]2?>ERPX!J#8;[_]IN]\YSL3I&!Z,Z ". PH!&R@%-4&3&1@
MB0)9:B/YS/IC$"CQD-(/1/V]M&HI"SFE@.ZKPFI2.OG7Y91E0Z/O_2V!" ^&
M/1S6)E !' 8(2"V,IRF*86 4J]:C;*0@@+J1P@$^TRC-4!*S\. SSSR3"@M
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M6J@&+T+@\#GGG#/]]*<_/;WIIIN24A18B'T TYM_\YO?))61U&K6\U>?V[9
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M?6J6@ I!]AAS_?=0.#JOG*@!PV,"XK['FX.$35ONN/UQ:']ZQMM%WP##% <
MPUB,T/<RJ^.66VZ9[MJU*T%A"@O,!J+8P&*&%!Y0H?.LI\A'$9CO"122Z?N!
MO^JKZ6?)*WXGU;)5!WN [?MY>UVL EIV1YQ'P.& PQ$1$1$1$1$1$1LW!L/A
M6C#L%YCRD+@)WBPK'%;HFFC0R$ +U2<#/& #"]( &U ! _* #5NW;IT>>."!
MTT,//32M5(YJF*G+J(CLE&5\B9FR/)E,$MRS \&F>U(: #7!X8T<;=?2Y[$&
MTCE8;+?<(#T7=L .8")W@$[_^J__FG( I3 YQ!3EKWWM:PD\H#3#4H*< F)1
M=$"1SDKWJ(I??/'%]'YR$/@%5.@RF+4#<6^5,A8<7C0@#CB\>G X]SPHY57N
M=<HUVAK]-%80O__][U,1A?;RTDLOI?X7_VX/AP%\6+>P."@0F??0-U/,H=W*
MBU;@+@>'NURW9<N+6C#<!1 //?\2$"X]"TO?-]J^9]@<E)(7N,I]I[! +@"&
MF1U$'\U"L\!?P+#4YQ07* RKF$>.H4('#+_\\LOI64^A@;R4A12;[*E4?""_
M<N#6/J]RLU0X!UL8X3L%YR#8'' XX'!$1$1$1$1$1,3&C%'A<!<PG(/$;8!X
M6>$PP?%Q+O*(!>[]^M>_3@ !I2>*82 > T.L(_ 5WF>??1(<9J5R!HZ77WYY
MFH**PAB5**HT5$3 !U1I6G@F-U#S Z/</<D-\C9Z- T^<P/,IKSVP%@#;:]R
MS'V^ ( 6&\)&@OL/J,(> EA%#MUUUUU)&4R>H&P$5*%D)+< #0!C%18H2J X
M1]&&LHVB19<!NFWK5BW7!0[7#N 7!8AUC'US)>#P?!<>*WUV"5;ZURF7R5O
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M?#? PH2B!$5 GO4<C\]AJ88%A05_-1N%U^F8-.N$S:N*M1^_0**NG3[7@N*
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M0^[?JL/A'"#VGU,#A_V 7??4#O)M+O$:X!2*,: G4Y8!G8\\\D@J(@ @ %$
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M4@WKF4]?HMD'UNK*^\+GK'_8-+M"[]-[<_V3!\0UWP-RSS@/8;L^8[O>TV6
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MERT&IO 2A5XL), ]BGY0QWL[QU'IS:Q;9LKAFCNJE<3>A9[6E/FUO;V:XR;
M8=?<M=.6*4/E]2A# 5_Y.O[QE*#RNO;'+D _I%)__OGG[RT J3"C/0CO'^5P
MM?Y)3J@%H[7V4//^[-YY['F^#!B>J7OWPMKZV6M@N,Z>F=DF'(*5AXY_Z_X:
MFQUM82S4L>AA!2$GW;Y]>YD=9/$Y.4E>EH? 83_-Z% PT%[,<D@^8HECW8*L
M)Y![=+TW;)W'FIO'(F3.73R4DZ-&,#S+56OV5>-B=\<"XJN(FP:'+U-H[NCH
MZ.CHZ.CHZ'BEQ*W11W6V70827V;PL1<0CX-V R<#*M#*WYXK,LCW7 -'ZC(
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M_Q66C/M?(5\\DM<6DIRI\!H.__]QO^!P;$/\C'H?$*0:IA"U )W^!?!1B(+
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MJ!!MYKDY6K,$)NDKX#75?0"V-DS92T7)7UC;IH@'>%E<:/??^[W?>Z\?@-A
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M>"\8/B47-!SNZ.CHZ.CHZ.CH>.7'K9G*<J:ZK(/?+554!<, ,# V+E)5!^6
MTVQ1NA$ 5U_ J'DRQ=A@TL"/*HRB"/PU<+38W+///KM ,=/J*8E-0?[L9S^[
MP#1*RTSYSQ36+5"Z-C7W5'!S["#FJL'P_0#$6X.[O=#K6!B\M6F_8*BV\9_^
MTW]:0 2%&IC*-H(E"1C,CH&O)4#,8@* TNZHUH%5<"-%CWANU^+'>#VU]?2-
ML0^E'V61)^W=U.JT>0LL@2"4PB"8_=#6>0Q3 6O[M4CB;]#8<>D/7J\_F*8/
MR%#NU6).]5/-=/DM.%S;:X5[(^P87Y]^<#_A\$T PUM]_5Q@^"H <?8O8&L&
MAV<Y9@W,>:P6%P)T]0\*4NW6S!"%&0IXOL)_[^_]O44YRD.;Q0"%OZ*.H@?
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M6V X()8B$90 72F';::P:V.>1Y&N;6G+ 0II5R,DJWTEBR#9!VT2H-6V*=Z
M:L6/%U]\\8\MQL0J@K=F%L6CBK3('(ABP3P%$?MM04: FS\QZ.(88QVA'P9*
MVV<@.G XTZ]'_^\1T-;_'6IK:W!X#W2=P<V&PY>#PU<-B(^%PU'PQF[ <^MY
M]+OG:+?Z1Q8JXRDKMRN:Z /Z!,]A11+]DZ(4&-8O]!^%$O<-,++N7[R'<V^*
M3W@4]%O =D^N/!:(70<<KFWCV.M\S#TF$#Y%J<RFR#67AUQ313"S>A1QW;-=
M+SE-_@6 8YD#"@/_\5%7%%  EB/E;N]A=H1\YCIG38&M>W#4S2ENUWW<LD.9
MY<1S >*M?GZ58/@ZX?"IMA@-ASLZ.CHZ.CHZ.CJN-F[-'MP"/3/U<*;-CXO3
M!1!7I6)5\ 8<K"F.O#:+U?S.[_S. @9>>.&%15UD@&B@2$5),1D@8!IQ%J S
M715T\WKOY3VC8!JC'E\=Y(WGI<+K3*NOJLK9(/'8.#1(O"XX?!VPXER#TT/G
M)!ZZP(0B!7@*#(.\5(CO>]_[[GGY K&F,E/DVL GEA**$+RL/?^EEUY:["BT
M[3HU7,S:2/ZN4]JU2P 7V/B-W_B-1;U,+0SR@KV@,#A"+6=_0!+6$3R%%4<H
M[7@1.P8>W!22\11F37'W[MT% @/ 67A+__.XW[,0%P"GL%/A2.WKH_?V5MO:
M"X>W &R>?YU@>.^^/<AP> N*'^-//)LM<0P<KK8#L1RH<#C/\QSW"FU9X<0L
M$""1&IAJ5%_5/RCZ_:2F5SA1P*&@MV"D8B(K"FV\MD.?%UN!^&G+#U$QGP)L
M3P5SUP&&Q^NSMSVL@>P9!*U_>W[]?I %^)QO><>L!O8@KH]\ZGI96,X]G9V/
MZYFMVDB8+:0XYQXO7RH8R)]RNMR>61SV<ZMO!F"/.7JM,#QKW^.]?PWT']O?
M+]..+@.&]_;YJ]H:#G=T='1T='1T='3<OYC"87$($%?U\!H@KC835;48;\?Z
MQ3Z#M;J0#:#%I]A DCJ('RSX:[HP=1$8 )IE81H#1W83%BNB%@,5,ETXTY='
MA5H]WG' ,7M. '8\(^O \AR >.V<7_=@Z3I@18[QJL&PS?7/5&8JQ#MW[BSM
M!)B("ET[HE"K8-AT=7 ", 8O^&%JA]HC13JX-9[;"H<K5/5X71"K*B(MQ$0)
M9U\H(K5M/L*\CJF6+<0$@H$DSSWWW/)<@)IZF1^K?I:"3*PK@%_'"YSH"U3[
MIN<#TEX3.!PP%C_A@+U:!!H!^*&VLP4>]L#(ZU8-OQKA\#D \9CGUN#P""AC
M[> >D041*V3TO"Q"JLW*YWQE>=(J#NJ+%H?,8HR4_@HGX"+?><IBUB^ LON'
M/E'WUZ8OZK_N#_I.U//C\RX+<O=<U^O8:EX:O8_K_6Q<D/78XN?X674&D.LI
M;W[YRU]>"KB*6SS>Y5_74[&7A40*<IDM8690;"3,CG!=07_?#]SCY;#J;7SH
MWCOK3X>N687#]=X_ N)#[[?5U]?VI^%PP^&.CHZ.CHZ.CHZ.JXQ5."S60%X%
M#VOV$EG$:F8SX?]>DR_V&4A&W6F@EU7,*8;!L__P'_[#,C T\ < @#Q P #2
M=%-J,=" /8!!)S51%MSR>156K UH<XQK XQQT#L;0*]-,=T;XV#PE '3.09+
MUP4LK@L.:P/:%-!$L49U1GU&A98V!0)3Z4:Q9EIS5.FL&P GKP%EJ=+!74!I
MO%YUL:VZ0)WGIN@!T )>WLM[>N_L1[R$ 9*WO.4MBV(8G.;#2;E,.0DF>[WW
MT:\"Y@)C4F )(+:O@#!(#!;'4@)$UC\SO;^"X J(9_#C4%N;M>$U0'P=(+CA
M\/D!\2EP.+D^'M@5#M?G>5P.IX2GK.<U3U6O+\:3-JKZ6$I4B$AEK BDS[O_
M5%L448N1VG_ XGALIP+BFY9K<VU2S!TWCV<;@?$6 )T=C^<EYSGWL>^H"]"9
M\6#V RLH.?;O__V_OWBJL_-1&'-=P6*/F]4A1YI9D5E!P+#WE?]F,Q^.N6Y;
MUR:O39_*=YZ9ZOA80'RH;Q_;]QL.-QSNZ.CHZ.CHZ.CH."4VX;!8@WD5 LS4
MPQ40V_SM<?^O'I/>+P-6SP&K#")!+,H@4^6!/-"7)^%[WO.>!9X!P\  U1C%
M$;#VP0]^< $"?%M!,W#,9V?:<@49>XYU"V:NP9?+P.$95#LT>'HUP^%C!L
M!9C =H$7-=]28$*;BG>UM@0*F]:L39G&_-QSSRU00OL#,W[IEWYI@;+L2L!5
M *L"SW$!.NTOQ1&J.>V2I07EL468P&G@@V4%$ *,O.UM;[NGA@3 [)_"![4P
M0)9] ,WTE?AWUS[I\^-OK$^Q9XF]A/W(0GB*-^F3M?V.[?R8Z>9;4*."B%&=
M7!6-M>C2</@T.%S/ZUC(.A<@/A4.!\I&L5OA<([!X]IWE/[ (*]9(!$(3A'%
M?8#27A^*Y8H9 0J*"HN I/X7\!LX[#-R[ZF%D1'TK>6=<T&IM6M[%7 XN<&Y
M';=8/XS > L0K\%ASX\JVS6,?8Z\)?_R"KY]^_:2_^18UU0A3@Y4\*4>!HKE
M/_8A@+^U!JC'75.Y3S[3AL;\E7T<"T^S]GKHNT M^-7O.Z/2>CPWL\\Y=!\\
MM0AQ:IYH.-S1T='1T='1T='1D3@(A\4A.#IZ"U9 '"A<;1VJ>LOO41@!6> 5
M,&P@F<6Y3 \VG=]48@I*@T?P+!NU)?61*<>4F  @9634D/;Q$!@>C_?0 &0<
M-(Z0Y;)P>%19'@.(SS%8NBH8O'8>KQ(,V\!00 %D B:TE1_YD1]9O'VI$"D/
MV4@ $L P)7J%3(H4+!RT2].BM2_@(VK#JJ#7E@.^*->!V:B%3:?FG6VA+.\/
M?&C/3SSQQ,7##S]\\5?^RE^Y>.UK7[M82( E]@_$IA36KDV1]_E =Q9@\GDC
MQ*V0.E8O@=2 <%5+COTR;6@$!R-LG!5$QGZV!BUFP"4Y9 12#8?/!X?/#8B/
M@</9OPJ'M<?8.=1C]#[:)]4[;V^++"K04,X#P_JKO@H.4_PK[NC'%C33KX%'
M1<78"\W@</VL61%DJSULY=I3K_4YX>!LRXR&>#W7S;E.\78$Q>F/>^&PQ[TN
M]W/YBF>TW.O^K(#K6O*$5O12V&4+)>\JS+FF5,-^Y[L.^+.34AQ05-,>[MZ]
MN^2Q64%KEE?&Q>:VO@O,[O$5"E=U]2$XO.<:SOKON:Y_P^&.CHZ.CHZ.CHZ.
MCCUQE*W$"'?6 '$&F!EP!@Q[_OC^'HO_)-"55<PS]9\G(3!L*K'%A@P<*2O!
M,[]35_)H]1QJ4 -0$! ,'*TDCH&T=="T-A )6+@*Y?!LP+9GX'1HL+@WK@($
M;PU<CSG>M7-0_ZYM4]NC7@,H8N-@>KJ" E6N=L5K&!P&)"B&*8HI=14G0&$P
M5ML$9$UUK].9;4 % !48[#F>ZW54QNQ13(T'>8$1L$.[I90#AM_PAC=<O.YU
MK[MXZ*&'%H]A11!@V#Y8;,[K?:;/ *6U[W@%1QD_ JT9)*G 9VVAN;$?U':>
M?K[EN;VEFIOECG'F08#U=2F']\**5SH</@40UVM=VTDM.-2V%-CF&L=6(G!X
MW'__9X&B**(/*))0V>LS<G\@HGL L @B@L>@(U4^ZP)]WGOXG/@)!PZ/Y[N"
MQ6, \=@>3KG.IX"O8W-L[#P"AZOM4PI&F>53H7%@\0B)9X6@M &O-4.!E8W<
MY;XL]RF*L<4Q&\,B='*<0IP90?(PI3#P+P]3@LO/40W+Q:YG["3LSWB\]1J.
M.2_[O@>^CGEOA,)[E<-[KF/#X0;#'1T='1T='1T='?<[-A>D6P.DLT%%77QF
M5!]5]6[>>X0)GF.0:C )!I@Z3_WUOO>];X%U? =! ---H_"D%C.H!/(\UVL,
M'K- 5U44'0M&1]AXS !J-K@[]K/'<WR90=)- <-K ^ Z$$\[6O.X'>'B#(@&
M8 (4 "Y8JV! _<L:@AK8(D@4:SQ*00DP5INRT&%\?2F& 5V>I=X#D !EJTT#
MZ'SW[MT%6%#(4?:"(=HPU2+%HZG08!70:QKU#_[@#RX*1W"8<IA"F$).6P:X
M+*P(<"EV>+TV377L\X%A4#BV$!4.CP/M-5 \*V3,VL@(=&=^FVN>V[,!?]V7
M-=5P713O$*P\Q[:W$'&HKYT[K@H.'Z.FWGO^:G&FMI$U..PUN5=4<%>ON>=I
MVRPAS"#1%Q14]%<>W.X#9HW$;U@_TI^C&M;G?O,W?W/IC[%>&97#X_FN8'%V
M'@X!XE.*!N-YV2JLK+6#K?^/2MI:A &$Y4?Y))N<XC%%J"QRF<WSY=38.%38
M/M[+O8?BF)PH#X+[P+"\9L;$>]_[WN5:NFX@L!P(\,N#9@*YY\N#KF>U"/%^
M"F^!_6..6BN*C<6PM6NX5F"<^0S/\MXI!=O9=;N*>^XA.'R=VY[]NDR1I*.C
MHZ.CHZ.CHZ/CN)C"X0IN#TV5K .,# P#AZM"L2IX1XB1SS'P!,&R^! UL$$B
M3TE V"(U5,/ @)7I_8_ZDZJ(*LF4?3 !M//YH[)I3VSMW\Q"8B\H."8N,Q@\
M1]1K>]GWG;63&0A)>PO F"TLE/=*6QN!4A[3[BC> %33T@,HJ(99E% - [04
M:\ $. Q.*#90)O[;?_MOE_8')E.Q@Q&CV@X<ID@$G7EC:WL@%IC+-D)[]!XO
MO/#"HI)[[KGGEL_CK0E^^$SM%] "2S[\X0\O\(0Z[LZ=.\N"2\"60H=CB%HY
M<+K"8>?K$+0:S_O> D:]?J>J4<=M]!>N"V%5A=^6JO=^*=:N"T:< PZ/^>H<
M*NM#BN+TP:K2S/',"HJCPK,6$O4S?< "9 HK^I!^FON V2/@,+]A?8D255%'
MO],/%6D4;?15_;?FD]GY'N'P7D!\&4B<SZWWVEF?/-0&9NVDPOI1]>I<.[_R
MB/NEC=+7YGQE9D(*47)/BE-9P%)?]=XY!P'^534L?\IG67S.-6(/E=D:5.#@
M/O]HUQ8P5CCS/#F1E8091/$9E@>!ZWB]KX'AK3QU2 U?[_=K1;6]!8,]^>*R
M]_-CX/#] ,&7!>8-@3LZ.CHZ.CHZ.CJN/E;A<!U81FUS"+9Z3CP-ZT!_#02.
MRD6OH=*T8 U/6%82!H^O?_WKE^GV;WK3FRZ>>NJI13D&ZH$%8  /66#.:S-X
MM!_'#B#&@?6:RC$PHRJG7DF#F'/"X;S?#+:/JE6/I?VL>47[696'U?LQT .X
MH%P#50$%MA!4Y;PN%1*J:IA_*5!!,1P5.BL3< G8H#KT?N/^@2G:&^C\R[_\
MRPO  $# #$ 8"*$2IG[CA:H=4SIJNS8+WP%:E''V2T%$8018&6&Z8PS(":0)
M'/;\P.$9]#U7S.#9#+Z,X'?<*@A>V\:<<U-4;-?9OV\B'#X$C<<<N06'Z_GT
MO'@05XL)$!+@I1I58%%< 1*?>.*)BR>??/+BF[_YFQ<XS(K@V6>?78J)"BQ4
MJBD4\KR5"[Q_S3=[VO<:)-XJ,!P+B&NQ:TO97,_A"/K&_%COL<F3H^]_9NJ
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MF%+8(!)T _:H/ U 35TU[11 R-3[434<$#&J$4<EYAYEUSD&6@\2,#[W_LT
MNVO@^H!!P$,@CFLU?J;G>YRJL/I4@S_4PB NL OP4N=2$O(5!F8!)84&OK^
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MDV_Y.+/M<!^6]\R44%B35T%@.?-M;WO;<O\.& :%:[YD_V%ASM_ZK=]:[#\
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M_]M2YEX5'([7N[\K',X^C\<0,%SALO[N'L$J)HN4NA]0[E,,@Y%4_A2K+"?
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M8@"'J=%^IU2D.O8>'_WH1Q<(=>?.G47!3DDWML7 VZIXSA8OS;%O;9WSM*G
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M 3^*89[$!ID\9OD?&K@"")2;WG>$PQ54CPJP.B@^!"R/!<,5[,V\8*M2^9R
M^";#X?%X9]82LWUW/3.UF>K,M3<U&1BFZHU:6!L!=8&C[_N^[UL@K\*"-F31
M*DIARL*WOO6M"\QXRUO>L@ -@ /, )G C!__\1]?BA54R?_EO_R7I8TI9 #
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M! 9W>0PK* !&+"*H"BTR!QZ!%^]XQSN6!9,HW:C>J U9F( 9?$P!*"I%!8P
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M?(QP.-=T+%J,(&,/%&XP/(]3P/ IZN&&PY>+V >D[=>%&NOYEP?T?9ZW;"6
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ML\\;X3 5;!3#P+ "G%D\E-D*:N[# +Q\^I?^TE^Z^)-_\D]>_)D_\V<6. S
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M&:^E]["?9AS=O7MW@>,@K_/@G@,(.YY?^95?62"Q[QM L>\ISI'O*B"Z[R+
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M0+YF%P4K!AP^_[A<Q/G4ZH$YWY/%*<&\5)NH!K 0FF10[8<+8NI)K@V-1>M
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M8A@8!B.R&)*>P@\\\,#9RU_^\JE\' @"B9614Q1K10)N@!<5#/_W?__W!)2
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MWSN,GT2G[Q_^IL<P1;I*F:]^]:M38A)H=G\:JYK4B%\-!(\B.M<P+2:R(&H
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M2O +%BB?U?Y!&P^!,=  "E-1:1L!#%.@90,=  >O 85=.T$VT"\ 3W]&)<O
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M->"NO7FCJ*T+XO2^Y+=?^)>"X5Y@4,>F]^4^I;"]'HQ5Z=G"X4"]%MA5A3"
M#@!0!U/P&FOM.8!7D$ O7Z78U+M9Y(EB&UC0)N+^^^^?E%04:$J4_:L\.=!!
M$ T* [[ +WA/M>>Z4KC9P&'J< I@D-]"=B"&7L44;?;C>DL* $"."Q362Q/$
M!C& $27G*3>O*NX6/+2*T3K^%6Q5Z-.[_KU _;P@9$XEU[9]Z"4Y>CU/EZ!K
M"XA[*N(E +REQ_ <$-X*;R\*(ER5[5:S)< R=\\? H?=2WQRRO+3:L&_^L2"
MP_R42@:)I/0;YCO //W.)9?X#NI0<P-_P6>VS[-CC'HXJN&J&,YQ]7Q%741M
M[MELG^_\/7"Y5K6T^XJZF)_+@G-\=WK :R/!C_+;YDIJ:<FYNOBG_]=-\HW/
M!9)58O"MVCEI)V%^ % #66OU354X5X5UVW[C6+YQ#A)GS&O2+_=FYD^O2>*Y
M@MFJ^#8GFH_,41*A*F.2C#:/F?O,0^8F20AC[+Z31/4^]V55 ;?W4JIY OQK
M2Z?>O7_1</C4MO>\SK,MC<&IX?!<(O16@</9A@T;-FS8L&'#A@T[A7T+'.ZI
M]WPA35]@09S EWI8H"I@%;AJ*:!OHB"-8E6P^^8WOWF" GI.4DL!Q-0_@F7
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M@#5E,$!*':P\&-AP;@" \Q+ ZJF<7KWZ"M]QQQV3*OCI3W_Z!(@IB"F)M8X
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M38N%%C)6%5E*9Q/(U)Z9 F37 X0 O5T/0;<@'%P79 NX'0M(#U0;<V,+: C
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MGM3$7N\X'9_C\AF@LS)KL,&X"(8!"% D*N>L6)]K4>%.%MUIX7""VP3CP -
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M'4%JQVE<E:(;4S#!6.K'# J #6FEL:;<C/4 PI:RVD,"X;IY[18XO%6EV@*
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MFN ,2 /2:M4A>*_]A:,6<OP]*)7C,R9>E_8@8(:@O6Y^!^X[7H#8\8(RU($
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MU_"=$HN>[?29[T&B-?C/G%.@:V^>:A<(6X.BO?NE!X9[8"ZM.^HYM7 X:E[
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M-:^I"M2H9-K6$36XS&)G@B0P!!C6KU-; H&Q'IB"Y2P^!WC<<\\]4YL%:CC
M5% .=@BH00Y )J71 K&ZN%.U5GV3@"];?E?;42P%556!6Q=3JH&TWT>]"UQ3
MA07T@$, ,1!.89B^RC_T0S\T06)*,_\'%?Q="3(8:U$[@!B I5:TW]I&(W"X
M)@[J-?7W]".F> 29@2)PPOXIXD!IXPW,O^QE+YO4S%2)()0R:<=%+><Z>;UC
ML[@56._XM/CXAW_XAPET4$8"Q +ENL!5!<5U89W>?99[:*F_8_O,MK!HKK?C
MEGO]4.OYCR5?L;:0UC&V\P*CI?,\%1SN?<XQ$FOGO>[NQ[0? %D]DY(D$B@
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M8_CPPP]/^P>G? ;HVP)@\ /,HF@#G2CE "YES\KD@7J*-]<%X *E'(=K Z0
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M'>TS6P%Q;9E0H6-5L-;O!ZW/G:LLVGKMC@&'E_QMZV/K_5R3/>Y]]Z[$K<0
M8%M;10"YYKB 8,^;Q('GUCQK'O3\ OR>:]4TGDW5.1(+GG>J<=?8?>!^4/VC
M;8GYVW<!GZ7BQK7W' /&DLN^1V4QNRC[ZUH)M:56SQ_O^5ZZ9<P''!XV;-BP
M8<.&#1MVJ]LN.+QF6\#0TI?S8T 1^TG W^LG/-<OL%WQ? L@;N%9#;BK(DT
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M.[<+8;:)IA[,.H]M </' ,2!PUE\,B#-\\[79?$RZL&H0ZF'/<L2+U'E^W]
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MDW\84 _X!8,!#0=XH:Y]EOI0W8/N "_X89,EZD..IAW2Y5>TA)D"6)Y#3B@
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M '4MXS)UJN" 8(!QUKBKS9W;_1FSNMYF,&45Q$D_[94965$3&)S\T""P("\
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ME9WMX/"CZO[G.'9JPRM0O0+#5VEI=@!QI2A?];>GJH?G.'@%/;X++)[WYCE
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MZ[K.1DSJ()ORJ9>5(^-\^4XO"[Y22CD?>)GER%1JH(%Z ];5(VC!26WU-<#
M$57O( 85-F<?'*4* UPYS X*7 ?PVFE P"G0PKGZH'+C0 ,C%'!@@>\Z1T!5
M;*[K?:I"&R#D^7U.70(AVMU29N>F7 . P5[7 RG8F.NS,Y :;.'@2W-A\QZ
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MV[@W0XLMQH8$ED!:P2A!/\$J2F'W8&P*##1/"IX"B\ZQ&A-Z'E*G/F>,=6\
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M*75[M<.C@'@U?G7P9.:M[10%,_W&2BW=*6UF("M@,\!NE;]]%:#K%1/.H2T
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M[9KJ/4N[]8FD'F S )(V9&N6HK._I&YA(^P5M$F.VJ2% "'U2VU-@0KP@5;
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MNR[BD.8SO:0WRSC=1P"2^YE.3#LK[L/WXJQF1_!.9>'_%$<<='4$_G#X*7S
MI$YY  B#2Y2FG-GDK%5WZHU#SN&EZG(N#A_G'0AVOQ/D:1]./:#+:02QG#O*
MW !+$!JX!ZJI%JF(@:SD!N9H PBNK7V!+N"$(TZEYAG50Q3#@$QV60=HP3&0
MR_4]%S4MIQQ,E?/WPP\_?/G!!Q_<<OMRVGW&9X$0< V$X+C_PS_\PPW.L9_
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MNQ;XROE,;LULO)4EQ2"LGT%,  #8HJ3SK&  QQI4I<@#"=B#]I?^01H&L!1
M3=H%X)1R"RQ5)^X#".?8<O!!.<!7X $$ 9S5 =CAW@087 _$H9 "@@ X]0.8
M4:^Q56"'G64G>?;,KK55J]"RB5%#.X#=];0A]1R0HBT!:DZZ^P7QU"]P PJ"
M.5-5JFT])R!/Q:;NM0,'GZ/ON\[EG$ DM3: Y9K C/XBC8!Z]EP #HCIWF.W
M*^79:B/*74ENUP:XN]0#.T@\E5ZK8Z7(S_?2MZ(>]DR +CCDWVRPUJL@NG]/
M=7/RE"8(U,KC;&J5S9^T/=MAQ^J<'?_ZFTWGM$N6T2=%CG8#9!S:G/WJWR"R
M()E^J_W8IW.R*^.GONOP<W*D:EMMS,;U07U1GS0.L*,.%H%RO03>F"!8! HV
MP%S!JHR/5W!XPIY5CM"=NORI*V+FO+;*-[Q*%Y1E_&Q!&X*%ZE2_T#\ 7;!4
M'S8VZ,/:0MWJ6\8S8XRV3>!+?S.7@</&%=\USZE7_<Q8S^[8VZIN)^!^! Y[
MCCP#^P.CC;_&&.,@FS*6&+O9G7$&B'7?6>GA7ME7CWM@8#:&-5Z#G\85=NSP
M?=>@)C:VL7<!M:SDT4?8D#'3[^:XWFDE,G9EXSX!%>,P6^R5#*WT7\'_V=:I
MPVPN" 8;\_SKW,9LXZ'[=DUMZSF]:^B# BL"..98XZT^E$UQLU&D.3GS&7O1
M!MJZ5TME?%EMHG9O<\8H:I.2*^\:G@?L]@SJVSQD/)H;V+J^SU%'&Q_8,+ ?
M17E2'IE'\FP"6&Q$4#/!9&VHCV@'S[5*K3/;8?;%'42>[UR[H.!N0\NG .(#
MAT\YY9133CGEE%-.>1/E#P(.S^^N%'R[#3P:LD[U;3LS@2F<88X)  BP@9V6
M7((1X!QG$<"C&.(8<A Y)DF! &YP<#G?'%F?][VD0W!.SA$XW$LV=TY!GF,'
MNW+_O3E**U;RG4"P@"C/"CY-.)S\R]DDII77V3P&;%)/O=$<4&.I+R46AU7]
M@.:<54X<.$AM*OV - 043?X/H$9U"*B#&-DMG?-/;9@<H\E#F[R&,Q<M1Y *
MC3,)@G""+;.U[)13"4 #Q!QF (*SS^FDK -2+&.E5 (? #*.9H!*[LO?J;8
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MQ*8SITZE_VILV:4G4/?ZB;ZJG8WS_N_>/*=^IJ\F'W)OEI?<_>[3_:D+\YA
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MR8GHR,8YG#)@F//*0:5@2AH)#@Z'B+-#.0/*<<Y:7=1JG=72\^D@].\ZWV\
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MX3X:T#=XZ&! U/S:5Q\ 7$$D$*@WKP(.!3^D*0'80/=L0)C4.!.J&>L:N@@
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M'<T[AZ T6&RN%\0R)O3[50<!Y_OA5?JN.>Z[Q^0!S]X1#8>O D7WWH]7@/C
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M<Y+ZZ\V) O4:8/12WU7.X5GB]$]5<U0]'$K/ 0ASL#CC'%]@@I--Y>4 *!P
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M<<HIIYQRRBFGG'+**<]17DS5VYLZYM+;IP+BW8MT=KI.3E\.*B<C?\MR5J"
M \<II<JCC*4^ T Y&1PS3A]GT\\<,PYH<A?VYCX<^<YSFF6T'(O=,N()][H>
MYN=6RY:?LLR]ESCF&H'#Z@,L<>]4=EGBR_GBC'-4.5^<7P I!U"5I;X@*745
MYQX<]OV &3D/LXQYY:1VV_=2S58272ENIG(X3ISSN)YVYNA3@0&%X!=PZ-D
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M,)<.[_*[9OGZ5!&S'7U,D %,I6H'DK(!FS:AK/V7?_F7&P0 A$ DP%,0Q]]
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M:Z]L6)J^F_0N47.W<KR#!'.<FVV[>Q_9O;MUH"WGS>><(X'=WALBP>NDO6I
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M8]2] A- 1M1N\N<"1<"G%!%]R#?;RF!C%A@,=NB?@ =E(PBJ'^N+H#@X"7X
MEP&@ "?@V8&-J&:O\HA.6WHT@+!++> \/I.T$E'KJ5,JP4X) [AE&;Y4 NI0
MOPU4 X?_[,_^[+;B0?T!0_HV .\[28&3E0[J24YJYP7L@%IS \"JWO1[4 \<
M!'I!9(#7W[0Q: W^^8[QS_?E.!:84/_&1^.,\QLOV8/K.2A,'5&B"D(VT+)Z
M@3T$;IF;J"+-2<8L8!&(I)#-IHON5=MJ5VT:16;FF4[C,G.G]AR5% 1IAQS)
MS1KUY!R/TMZK5#FKN<NUOOYF0SKU*(#AF4 ^XV\#UP0C!>MB X*6^I)^P![
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M[<U59F[B+E-QVHJ4J51I]?&$J%$T.K([=\Z?:X!DH +@ ?8"&1QQ=>10!PY
MA;,+? #"#5( UQP-AH$*3K;[6"U'S[+1SN>W:^]\/SO+<XA[)WA_<RZ_:[4;
M6_!_;<<>0!3.($C$V0870!@;7'$B*8RH.CTSZ ,X.E><[P:G<0X;BG;[]WU/
M&#Y3C^S:_@KJ[-2=JWZR L(S=VP?<U.MWK"G/]]UL%*>[12G5W!@]J7\KO-H
MY_X"=W($\F1I<'+  CY911!5I,]D&?95/79=MV+8]T%,ZGCPM3=1 [ H X$=
M=@7T $!)?\#>_$Y "L2P4B$;71F+ (X^J"2!CX P@(G*GSH8:-0OV6LVWTN>
M[^2WG0&-F6.S4^*TC:W*(\&'*/\Z:+*JY\#AM)DV3-[XI _)TGYC,9@#ZH"D
MZ@4@IKA6KU]\\<4-$@/$@+IZ5Y= (N ('NGSV@;( ]5!)6IN;0:\24,".&6<
M,U88%UT[P%<;@Y#@K'$1O#1>@(+:!*0$$<TQE*:NH[U<TV%N<0_9X P4%A1@
M"Y[' 6:Q"?8 'B>/LNN!@V 6M2-8EK0@VM.1.NR 7"O\ XS3'E/1F_0+R;F:
MMND4 #-_^$POLYOCTX=]+JDUS"7JE#I8O9B7HWX'68%\?P^@58?J)- T*0/\
M35N9A\Q!QOO,/[GOF=ZGP5\'*MA?Y@O!"==F&]HWF[5J$W X&[;J[^S,_?L,
MNV(7[$1 FGWY/85K-D^C"K9: !"F%)92@OVR!VWO^8!,=FK."AA.CON9,[L5
MN"NE_GQGF:E^=OW^ZMUK%Z3L^6^WRF3>RPP2=HH)-FX>!^TI]7_WN]_= C+L
M0]]3M\G;;BQ5OP)%ZMAX:_S-AK/>]<S]^B)@'P& ]Y:L<LK[V1S;.H@RTW)<
MO<L^6G80_L#A4TXYY9133CGEE%.>J[R2<G@%?%L1.W>V;H=TGF?E0-Y+GS =
ME,Y/VIM!60XL%0"U%^4.!1>0PF'+#M= "P>!@PX* L.<"\X\1XQ#1_%#H0,"
M<4X\TW1\KIXAZI<)AY,3LI?]KARV%1QNI[P=K%:I9KE[=IN?N7!3.,(<34ZP
M9P6X*'(XH6 Z*)*4$>HQ0)B2CJJ.D\;!!\>< YCJG,P<+==NL-?0<06'N]W;
MF?==]ZM]G=N_'+388/YF:2@H (9EJ;K_<Z;!)LX^1Q]DX*A3&64Y.EO@]&M_
M"C3@O%,0K(!K0]YYS[V!579FGSN^K](Y3)@\ >Q4U4Z[F&K!";4GH._-?^8N
M\0EFI*U6T'@%%J<"M]6%JY4$.T"Q LQ7F_]T^[3-]5+R*&:CJ)_*U]WXTPIF
M=@7""B 89X!$=@4* K@@!:4OU:]\HE(@4 ;ZES(0N  PI!( ?T%,@ EP8H-
M)@@%8!B3>@-(<!*P H3U2=>/>A1 \6RK,7H& =H>=XKV>T?:J.N]@6&")ZM@
M1BO^V\[<OWX,?AK'/9MQAR(:**3\-X8;L\%U]6M)/DAL*3X KT]GHSHPCI)8
M_\Y&8A2$Y@#!0.T%ZJEKZD_U#.:!>Z E>.R:5A1H!Y_1)L80;>2[SF'^  J-
M*ZZ1^47[NKZ#>M&AW1,XZ-S1;1/.X_RN+SAG#*:*I82?J7H:I*4>>PY.^U^M
M6DGPHW.^)@#3J0AZ_E[E'N^_]QB7,=&YP'_S!_ /O)N?07603_T"L0*4V@'
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M*<]17NP483LUPPYRKL!P')4&:[U<=:I=IFJOK]/.K-( PKDX#1QF#B''D+-
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M 3[^^..;70@,I.V]CU ?>V9C 1 M(&3S2.\V2<^4/C!3W/0<Z4C.W%VZB*?
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M6#^!_5/J;!>$F@#]7KWOEIROU,YS+NF F^\D=8LQ"9A1SUE:KD^#[C:4 X&
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M*256;3_A<.;:N>_!#"K-%$&/*'^OTCO-X]%\^9UOMU=+]+WO^L$N@-6'ZPG
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MO=HR08*DZ.B-T*[R6;Y*<3\)4FAG,";WP1G7_APQP$8:":HT 04[F7/\0"
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M$)=Z T"A#LB?,O&>L(",@(VDA9P"K,B"##RC3+PG'_*F3,BHW,G$DVEWV'Y
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M><WY*^O4N8OZH[X N:D[?O/<M8ZXMJ]UKKRD[[QNG\]^DWVV6R>Z>14V3]M
M3CF0T;FW4Z01UO4GV;:OIRWRQ(7]VKPR;=*U'UC_M8S=F+!<N28JB^TUXE'?
MW.,Z1XUX*V_[4:[M_%_+4=O7NJ-_TZ?D')/91G4>S7%F7[>?6]?F0]WF6ISS
M3#[G?]LPZ\GRU'6_ZYLY?C+]9/ODI$F3)DV:-&G2I$GGH&LZ8/A*@,,)$),V
M%L%<GI(WQP,2 PX#!I-?]6$,4,Q[+E[!YQI'[SAJR1%:K#"P8&)3P(<XX Y
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ME2>Y_J7RA;BDD^L_3+J\5]G<*5I4,I&7BB,5>*Q+62:_)>HW0L=^3^1WA^U
M>BH!C[!*17BD7*I,6:@GRTSY;%_;A_)497\JC$B#>K0_)%-&^Q/AJ4N4)RAM
MZ%/D21HJ!%-^VY*\Z(/U$L5Z21S*'A5**B%5<*DHM%U5+E6E$O%5'J' (2\O
M0521KS)<I0L\:=*D29,F39HT:=(YZ)J[6X#_)0+0_L]__K,"%8!ULN =;B\
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M)DA>-W+5ZJW;O%9KRBV LP- J[7A2(8$8M.ZK@)D@'$>L^4()Q?6< D,;B4
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=DR9-FO2_1?\/2B>#DM;.,*0     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_110.jpg
<TEXT>
begin 644 image_110.jpg
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M$F,  "%E]5V, 0"D;!LQ!@!P)+TQ5JJ;^)(  '/5'V.N8P  !R/&  ""Q!@
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0Z3XW]0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_11a.jpg
<TEXT>
begin 644 image_11a.jpg
MB5!.1PT*&@H    -24A$4@   ;,    '" 8   ""P:-0    "7!(67,  $SE
M  !,Y0%USO"5    0DE$051XG.W5L0D , P#0>V_=+*!<9<([N$J-^Z4) <
M?C>5U\\!P(8Q Z">,0.@WCAFXU62I(*,F22I/F,F2:KO I>V:A+V-INE
) $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image_12a.jpg
<TEXT>
begin 644 image_12a.jpg
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M1T03PEH2;8J&$*LTG6$/()K_!P:-Y!U$TP-K22 :TH4@FAY82P+1D"X$T?3
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M:DIB.TA#3\ZG0[X=/GW_7?'[KS\BFEY8"Z.I: BQ3%OS[ %$0XA1$$TBUL)
M-,1S$$TBUL) -,1S$$TBUL) -,1S$$TBUL) -,1S$$TBUL) -,1S$$TBUL)
M-,1S$$TBUL(@A" :0D@?X@%$0XCS> #1$.(\'D TA#B/!Q -(<[C 41#B/-X
M -$0XCP>0#2$.(\'$ TASN,!1$.(\W@ T1#B/![(4C36?TQ'B 31)&(M#$1#
M/ ?1)&(M#$1#/ ?1)&(M#$1#/ ?1)&(M#$1#/ ?1)&(M#$1#/ ?1)&(M#$1#
M/ ?1)&(MC#9$L[&Q$7PO\O/S<S$Y.5EY>.J\OYD.>7;XX[>?$$T*UL)H:T5S
M>'@8'(;;V]MB>'@X>:@6%Q>#W^?U];68GY\O/98.^75@19.(M3#:$LW0T%!Q
M?7T='(J3DY.DH1H?'R^>GIZ"WV-K:ZOG\73(KP.B2<1:&&V)1B)+Z=A@;&]O
M]QS,FYN;X+%'1T?)9T ZY-4!T21B+8PV12-96%AX6]:&!D2^%CM.AB=TC R;
M#%WJ<-,AKPZ()A%K8;0M&HF<K4)#(F<W60Y__?G-S<W@Y^7BX<3$1*7!ID->
M'1!-(M;"T!"-Y/CX.#@L\GO[EV>DN;FYZ!EO:6FIUF#3(9\.B"81:V%HB4;N
M+,@=AM# R!T)^<S8V-C;+<K09W9V=AH--AWRZ(!H$K$6AI9H)++,E>5N:'#D
MKL'EY67P:Z>GI\7 P$#CX:9#]SL@FD2LA:$I&HDL=T/#$\O=W5TQ,C+2RF#3
MH?L=$$TBUL+0%HU$EKTI0_7R\E),34VU.MATZ'8'1).(M3#Z(1I9]IZ=G?4<
MK)65%97!ID-W.R":1*R%T0_12&3Y*\O@V%#M[>VI#38=NML!T21B+8Q^B482
MVT]Q?W_?V@5'.N35 =$D8BV,?HEF>GKZ[7?NV!EL=755?;#IT+T.B"81:V'T
M0S2CHZ/%P\-#Z>_CLDEK=G96;;#IT,T.B"81:V%HBT:6P.?GYSTO_$G*GG'2
M)'3H;@=$DXBU,+1%(Q?U4H;J<[[>DMY&Z-#=#H@F$6MA:(I&;D_&EL6R<4LN
M^H6^+G\7T]9@TZ';'1!-(M;"T!*-;+2*7>Q;6UO[\S.Q+>GR^,:F@TV'[G=
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MB.<@FD2LA4$(032$D#[$ XB&$.?Q *(AQ'D\@&@(<1X/(!I"G,<#B(80Y_$
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MU$L9JL_Y>DMZ&Z%#=SL@FD2LA:$I&KD]&5L6R\8MN>@7^KK\74Q;@TV';G=
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M$&*9MN?: XB&D#X'T53$6AR(AG@,HJF(M3@0#?$81%,1:W$@&N(QB*8BUN)
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MB8F)2H--A[PZ()J*6(NC3=%(CH^/@\,BO[=_>4::FYN+GO&6EI9J#38=\NF
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M *B#: ! '40# .H@&@!0!]$ @#J(!@#4030 H ZB 0!U$ T J(-H $ =1 ,
MZB : % 'T0" .H@& -1!- "@#J(! '40#0"H@V@ 0!U$ P#J(!H 4 ?1 ( Z
MB 8 U$$T * .H@$ =1 - *B#: ! '40# .H@&@!0!]$ @#J(!@#4030 H ZB
M 0!U$ T J(-H $ =1 , ZB : % 'T0" .H@& -1!- "@#J(! '40#0"H@V@
M0!U$ P#J(!H 4 ?1 ( ZB 8 U$$T * .H@$ =1 - *B#: ! '40# .H@&@!0
M!]$ @#J(!@#4030 H ZB 0!U$ T J(-H $ =1 , ZB : % 'T0" .H@& -1!
M- "@#J(! '40#0"H@V@ 0!U$ P#J(!H 4 ?1 ( ZB 8 U$$T * .H@$ =1 -
M *B#: ! '40# .H@&@!0!]$ @#J(!@#4030 H ZB 0!U$ T J(-H $ =1 ,
MZB : % 'T0" .H@& -1!- "@#J(! '40#0"H@V@ 0!U$ P#J(!H 4 ?1 ( Z
MB 8 U$$T * .H@$ =1 - *B#: ! '40# .H@&@!0!]$ @#J(!@#4030 H ZB
M 0!U$ T J(-H $ =1 , ZB : % 'T0" .H@& -1!- "@#J(! '40#0"H@V@
M0!U$ P#J(!H 4 ?1 ( ZB 8 U$$T * .H@$ =1 - *B#: ! '40# .H@&@!0
M!]$ @#J(!@#4030 H ZB 0!U$ T J(-H $ =1 , ZB : % 'T0" .H@& -1!
M- "@#J(! '40#0"H@V@ 0!U$ P#J(!H 4 ?1 ( ZB 8 U$$T * .H@$ =1 -
M *B#: ! '40# .H@&@!0!]$ @#J(!@#4030 H ZB 0!U$ T J(-H $ =1 ,
MZB : % 'T0" .H@& -1!- "@#J(! '40#0"H@V@ 0!U$ P#J(!H 4 ?1 ( Z
MB 8 U$$T * .H@$ =1 - *B#: ! '40# .H@&@!0!]$ @#J(!@#4030 H ZB
M 0!U$ T J(-H $ =1 , ZB : % 'T0" .H@& -1!- "@#J(! '40#0"H@V@
M0!U$ P#J(!H 4 ?1 ( ZB 8 U$$T * .H@$ =1 - *B#: ! '40# .H@&@!0
M!]$ @#J(!@#4030 H ZB 0!U$ T J(-H $ =1 , ZB : % 'T0" .H@& -1!
M- "@#J(! '40#0"H@V@ 0!U$ P#J(!H 4 ?1 ( ZB 8 U$$T * .H@$ =1 -
M *B#: ! '40# .H@&@!0!]$ @#J(!@#4030 H ZB 0!U$ T J(-H $ =1 ,
MZB : % 'T0" .H@& -1!- "@#J(! '40#0"H@V@ 0!U$ P#J(!H 4 ?1 ( Z
MB 8 U$$T * .H@$ =1 - *B#: ! '40# .H@&@!0!]$ @#J(!@#4030 H ZB
M 0!U$ T J(-H $ =1 , ZB : % 'T0" .H@& -1!- "@#J(! '40#0"H@V@
M0!U$ P#J(!H 4 ?1 ( ZB 8 U$$T * .H@$ =1 - *B#: ! '40# .H@&@!0
M!]$ @#J(!@#4030 H ZB 0!U$ T J(-H $ =1 , ZB : % 'T0" .H@& -1!
M- "@#J(! '40#0"H@V@ 0!U$ P#J(!H 4 ?1 ( ZB 8 U$$T * .H@$ =1 -
M *B#: ! '40# .H@&@!0!]$ @#J(!@#4030 H ZB 0!U$ T J(-H $ =1 ,
MZB : % 'T0" .H@& -1!- "@#J(! '40#0"H@V@ 0!U$ P#J(!H 4 ?1 ( Z
MB 8 U$$T * .H@$ =1 - *B#: ! '40# .H@&@!0!]$ @#J(!@#4030 H ZB
M 0!U$ T J(-H $ =1 , ZB : % 'T0" .H@& -1!- "@#J(! '40#0"H@V@
M0!U$ P#J(!H 4 ?1 ( ZB 8 U$$T * .H@$ =1 - *B#: ! '40# .H@&@!0
M!]$ @#J(!@#4030 H ZB 0!U$ T J(-H $ =1 , ZB : % 'T0" .H@& -1!
M- "@#J(! '40#0"H@V@ 0!U$ P#J(!H 4 ?1 ( ZB 8 U$$T * .H@$ =1 -
M *B#: ! '40# .H@&@!0!]$ @#J(!@#4030 H ZB 0!U$ T J(-H $ =1 ,
MZB : % 'T0" .H@& -1!- "@#J(! '40#0"H@V@ 0!U$ P#J(!H 4 ?1 ( Z
MB 8 U$$T * .H@$ =1 - *B#: ! '40# .H@&@!0!]$ @#J(!@#4030 H ZB
M 0!U$ T J(-H $ =1 , ZB : % 'T0" .H@& -1!- "@#J(! '40#0"H@V@
M0!U$ P#J(!H 4 ?1 ( ZB 8 U$$T *#._P]6G3'YL8J^.@    !)14Y$KD)@
!@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image_13a.jpg
<TEXT>
begin 644 image_13a.jpg
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M-1 "P$ (  ,A  R$ # 0 L! "  #(0 ,A  P4A("X+5!"  #(0 ,A  P$ +
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MB^V\%N8^U #0H:$=<A9"Q.Y'SV:SO5VXT:&@#CD+<7IZNOJ?,'9$N+R\//@
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M$  &0@ 8" %@( 2 @1  !D( & @!8" $@($0 $920KSZ]U@ $ + 0 @  R$
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M\^R$"M=]L*/OL<1.M:$)LNA09H<DA:@SU6$58D\T0S,UT*',#DD* ?!J( 2
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MZ%!FAR2%J#/5815B3S1#,S70H<P.20H!\&H@!("!$  &0@ 8" %@( 2 @1
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M !@( 6 @!("!$  &0@ 8" %@( 2 @1  !D( & @!8/!=)F@4" %@( 2 @1
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MCO8R '1H?H?LA! ZW579>:U'?')RLM<!H$.S.V0IA$YW]_?W&S^ BXN+@PP
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MPS__\9>TA*@SU6$58D\T0S,UT*'<#G_^TQ^7__G77],1 N U2>Y?)H#7!"$
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MA%@0@A +0A!B00A"+ A!B 4A"+$@!"$6A"#$@A"$6/X/15WF1!.<!I0
(245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>image_14a.jpg
<TEXT>
begin 644 image_14a.jpg
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MRW9][NSL+ X>//B78[KV4\39;<@V>!WFTX%H>E);&&.+YN[=N\4AB3L(\1B
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M#DG<08C' '0=U_5$M3@3QNW0=89;AWET()H!U!;'&**)I6UI..)B7SS0:-E
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M'V]1ECYSY\Z=C09;AWET()H>U)9%IF@BL<R-Y6YI<.*NP?/GSXL_>_+DR>+
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M>E!;%D0CK8=H>E!;%D0CK8=H>E!;%D0CK8=H>E!;%B)"-"*R#VD!HA%I/"U
M-"*-IP6(1J3QM #1B#2>%B :D<;3 D0CTGA:@&A$&D\+$(U(XVD!HA%I/"U
M-"*-IP5F*9K:_T@G$B&:GM06!M%(RR&:GM06!M%(RR&:GM06!M%(RR&:GM06
M!M%(RR&:GM06!M%(RR&:GM06!M%(RR&:GM06QABBN7'C1O&=R._>O5N</'ER
M[>$9\NYF'>;9X=>?OR>:/M06QE@KF@</'A2'X=6K5XO#AP_W'JJ+%R\6?\^'
M#Q\6Y\^?7WJL#O/K8$73D]K"&$LTAPX=6KQX\:(X%(\?/^XU5,>/'U^\??NV
M^#MNW;JU\G@=YM>!:'I26QACB2822^FNP;A]^_;*P7SY\F7QV(</'_8^ ^HP
MKPY$TY/:PAA3-)$+%RY\7-:6!B1^UG5<#$_IF!BV&+J^PZW#O#H034]J"V-L
MT43B;%4:DCB[Q7+XR\_?O'FS^/FX>'CBQ(FU!EN'>74@FI[4%D:&:"*/'CTJ
M#DM\;__C&>G<N7.=9[Q+ERX-&FP=YM.!:'I26QA9HHD["W&'H30P<4<B/G/L
MV+&/MRA+G[ESY\Y&@ZW#/#H034]J"R-+-)%8YL9RMS0X<=?@^?/GQ9\]>?)D
M<># @8V'6X?I=R":GM061J9H(K'<+0U/5UZ_?KTX<N3(*(.MP_0[$$U/:@LC
M6S216/;V&:KW[]\O3ITZ->I@ZS#M#D33D]K"V _1Q+)W>WM[Y6!=N7(E9;!U
MF&X'HNE);6'LAV@BL?R-97#74-V[=R]ML'68;@>BZ4EM8>R7:")=^RG>O'DS
MV@5''>;5@6AZ4EL8^R6:TZ=/?_S.W74&NWKU:OI@ZS"]#D33D]K"V _1'#UZ
M=+&[N[OT^WALTCI[]FS:8.LPS0Y$TY/:PL@632R!GSY]NO+"7V39,TXVB0[3
M[4 T/:DMC&S1Q$6]/D/U6[[<DCY&=)AN!Z+I26UA9(HF;D]V+8MCXU9<]"O]
M//XO9JS!UF':'8BF)[6%D26:V&C5=;'OVK5KOW^F:TMZ/+YQT\'68?H=B*8G
MM861(9K8(]%U=MK:VOK39Y=M2;]\^?+@P=9A'AV(IB>UA3&V:);M^MS9V5D<
M/'CP+\=T[:>(L]N0;? ZS*<#T?2DMC#&%LW=NW>+0Q)W$.(Q %W'=3U1+<Z$
M<3MTG>'683X=B*8GM84QIFAB:5L:CKC8%P\T6C:0<6<ASG"EXY\]>U8\\^F@
M ]'TI+8PQA)-O*^GZT)>O.>GSV#&&6YO;Z_X.^[?O[_R>!WFUX%H>E);&&.(
MIL_3T_KFS)DSG7<GKE^_WGF<#O/L0#0]J2V,3443%_OB/3VE01BZX2O^SZ5K
MR5UZ<9D.\^WPXP_?$DT?:@MC4]$,>65JGW3M("T].5^'^7;XYNNO%K_\]!W1
MK**V,#85C4C-C#7/+4 T(I5"-#VI+0RBD99#-#VI+0RBD99#-#VI+0RBD99#
M-#VI+0RBD99#-#VI+0RBD99#-#VI+0RBD99#-#VI+0RBD99#-#VI+0P1(1H1
MV8>T -&(-)X6(!J1QM,"1"/2>%J :$0:3PL0C4CC:0&B$6D\+4 T(HVG!8A&
MI/&T -&(-)X6F)5H:O]OBTB$:-:DMCB(1EH,T:Q);7$0C;08HEF3VN(@&FDQ
M1+,FM<5!--)BB&9-:HN#:*3%$,V:U!8'T4B+(9HUJ2V.341SX\:-XON0W[U[
MMSAY\N3:PS/DO<TZS+/#KS]_3S3K4%L<FZYH'CQX4!R&5Z]>+0X?/MQ[J"Y>
MO%C\/1\^?%B</W]^Z;$ZS*^#%<V:U!;'IJ(Y=.C0XL6+%\6A>/SX<:^A.G[\
M^.+MV[?%WW'KUJV5Q^LPOPY$LR:UQ;&I:"*QE.X:C-NW;Z\<S)<O7Q:/??CP
M8>\SH [SZD T:U);'&.()G+APH6/R]K2@,3/NHZ+X2D=$\,60]=WN'685P>B
M69/:XAA+-)$X6Y6&),YNL1S^\O,W;]XL?CXN'IXX<6*MP=9A7AV(9DUJBV-,
MT40>/7I4');XWO[',]*Y<^<ZSWB7+ET:--@ZS*<#T:Q);7&,+9JXLQ!W&$H#
M$W<DXC/'CAW[>(NR])D[=^YL--@ZS*,#T:Q);7&,+9I(+'-CN5L:G+AK\/SY
M\^+/GCQYLCAPX,#&PZW#]#L0S9K4%D>&:"*QW"T-3U=>OWZ].'+DR"B#K</T
M.Q#-FM061Y9H(K'L[3-4[]^_7YPZ=6K4P=9AVAV(9DUJBR-3-+'LW=[>7CE8
M5ZY<21EL':;;@6C6I+8X,D43B>5O+(.[ANK>O7MI@ZW#=#L0S9K4%D>V:")=
M^RG>O'DSV@5''>;5@6C6I+8XLD5S^O3IC]^YN\Y@5Z]>31]L':;7@6C6I+8X
M,D5S].C1Q>[N[M+OX[%)Z^S9LVF#K<,T.Q#-FM061Y9H8@G\].G3E1?^(LN>
M<;))=)AN!Z)9D]KBR!)-7-3K,U2_Y<LMZ6-$A^EV()HUJ2V.#-'$[<FN97%L
MW(J+?J6?Q__%C#78.DR[ ]&L26UQC"V:V&C5=;'OVK5KOW^F:TMZ/+YQT\'6
M8?H=B&9-:HMC3-'$'HFNL]/6UM:?/KML2_KERY<'#[8.\^A -&M26QQCB6;9
MKL^=G9W%P8,'_W),UWZ*.+L-V0:OPWPZ$,V:U!;'6**Y>_=N<4CB#D(\!J#K
MN*XGJL69,&Z'KC/<.LRG ]&L26UQC"&:6-J6AB,N]L4#C98-9-Q9B#-<Z?AG
MSYX5SWPZZ$ T:U);')N*)M[7TW4A+][STV<PXPRWM[=7_!WW[]]?>;P.\^M
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MH@&0#M$ 2(=H *1#- #2(1H Z1 -@'2(!D Z1 ,@':(!D [1 $B': "D0S0
MTB$: .D0#8!TB 9 .D0#(!VB 9 .T0!(AV@ I$,T -(A&@#I$ V =(@&0#I$
M R =H@&0#M$ 2(=H *1#- #2(1H Z1 -@'2(!D Z1 ,@':(!D [1 $B': "D
M0S0 TB$: .D0#8!TB 9 .D0#(!VB 9 .T0!(AV@ I$,T -(A&@#I$ V =(@&
M0#I$ R =H@&0#M$ 2(=H *1#- #2(1H Z1 -@'2(!D Z1 ,@':(!D [1 $B'
M: "D0S0 TB$: .D0#8!TB 9 .D0#(!VB 9 .T0!(AV@ I$,T -(A&@#I$ V
M=(@&0#I$ R =H@&0#M$ 2(=H *1#- #2(1H Z1 -@'2(!D Z1 ,@':(!D [1
M $B': "D0S0 TB$: .D0#8!TB 9 .D0#(!VB 9 .T0!(AV@ I$,T -(A&@#I
M$ V =(@&0#I$ R =H@&0#M$ 2(=H *1#- #2(1H Z1 -@'2(!D Z1 ,@':(!
MD [1 $B': "D0S0 TB$: .D0#8!TB 9 .D0#(!VB 9 .T0!(AV@ I$,T -(A
M&@#I$ V =(@&0#I$ R =H@&0#M$ 2(=H *1#- #2(1H Z1 -@'2(!D Z1 ,@
M':(!D [1 $B': "D0S0 TB$: .D0#8!TB 9 .D0#(!VB 9 .T0!(AV@ I$,T
M -(A&@#I$ V =(@&0#I$ R =H@&0#M$ 2(=H *1#- #2(1H Z1 -@'2(!D Z
M1 ,@':(!D [1 $B': "D0S0 TB$: .D0#8!TB 9 .D0#(!VB 9 .T0!(AV@
MI$,T -(A&@#I$ V =(@&0#I$ R =H@&0#M$ 2(=H *1#- #2(1H Z1 -@'2(
M!D Z1 ,@':(!D [1 $B': "D0S0 TB$: .D0#8!TB 9 .D0#(!VB 9 .T0!(
MAV@ I$,T -(A&@#I$ V =(@&0#I$ R =H@&0#M$ 2(=H *1#- #2(1H Z1 -
M@'2(!D Z1 ,@':(!D [1 $B': "D0S0 TB$: .D0#8!TB 9 .D0#(!VB 9 .
MT0!(AV@ I$,T -(A&@#I$ V =(@&0#I$ R =H@&0#M$ 2(=H *1#- #2(1H
MZ1 -@'2(!D Z1 ,@':(!D [1 $B': "D0S0 TB$: .D0#8!TB 9 .D0#(!VB
M 9 .T0!(AV@ I$,T -(A&@#I$ V =(@&0#I$ R =H@&0#M$ 2(=H *1#- #2
M(1H Z1 -@'2(!D Z1 ,@':(!D [1 $B': "D0S0 TB$: .D0#8!TB 9 .D0#
M(!VB 9 .T0!(AV@ I$,T -(A&@#I$ V =(@&0#I$ R =H@&0#M$ 2(=H *1#
M- #2(1H Z1 -@'2(!D Z1 ,@':(!D [1 $B': "D0S0 TB$: .D0#8!TB 9
M.D0#(!VB 9 .T0!(AV@ I$,T -(A&@#I$ V =(@&0#I$ R =H@&0#M$ 2(=H
M *1#- #2(1H Z1 -@'2(!D Z1 ,@':(!D [1 $B': "D0S0 TB$: .D0#8!T
MB 9 .D0#(!VB 9 .T0!(AV@ I$,T -(A&@#I$ V =(@&0#I$ R =H@&0#M$
M2(=H *1#- #2(1H Z1 -@'2(!D Z1 ,@':(!D [1 $B': "D0S0 TB$: .D0
M#8!TB 9 .D0#(!VB 9 .T0!(AV@ I$,T -(A&@#I$ V =(@&0#I$ R =H@&0
M#M$ 2(=H *1#- #2(1H Z1 -@'2(!D Z1 ,@':(!D [1 $B': "D0S0 TB$:
M .D0#8!TB 9 .D0#(!VB 9 .T0!(AV@ I$,T -(A&@#I$ V =(@&0#I$ R =
MH@&0#M$ 2(=H *1#- #2(1H Z1 -@'2(!D Z1 ,@':(!D [1 $B': "D0S0
MTB$: .D0#8!TB 9 .D0#(!VB 9 .T0!(AV@ I$,T -(A&@#I$ V =(@&0#I$
M R =H@&0#M$ 2(=H *1#- #2(1H Z1 -@'2(!D Z1 ,@':(!D [1 $B': "D
M0S0 TB$: .D0#8!TB 9 .D0#(!VB 9 .T0!(AV@ I$,T -(A&@#I$ V =(@&
M0#I$ R =H@&0#M$ 2(=H *1#- #2(1H Z1 -@'2(!D Z1 ,@':(!D [1 $B'
M: "D0S0 TB$: .D0#8!TB 9 .D0#(!VB 9 .T0!(AV@ I$,T -(A&@#I$ V
M=(@&0#I$ R =H@&0#M$ 2(=H *1#- #2(1H Z1 -@'2(!D Z1 ,@':(!D [1
M $B': "D0S0 TB$: .D0#8!TB 9 .D0#(!VB 9 .T0!(AV@ I$,T -(A&@#I
M$ V =(@&0#I$ R =H@&0#M$ 2(=H *1#- #2(1H Z1 -@'2(!D Z1 ,@':(!
MD [1 $B': "D0S0 TB$: .D0#8!TB 9 .D0#(!VB 9 .T0!(AV@ I$,T -(A
M&@#I$ V =(@&0#I$ R =H@&0#M$ 2(=H *1#- #2(1H Z1 -@'2(!D Z1 ,@
M':(!D [1 $B': "D0S0 TB$: .D0#8!TB 9 .D0#(!VB 9 .T0!(AV@ I$,T
M -(A&@#I$ V =(@&0#I$ R =H@&0#M$ 2(=H *1#- #2(1H Z1 -@'2(!D Z
M1 ,@':(!D [1 $B': "D0S0 TB$: .D0#8!TB 9 .D0#(!VB 9 .T0!(AV@
MI$,T -(A&@#I$ V =(@&0#I$ R =H@&0#M$ 2(=H *1#- #2(1H Z1 -@'2(
M!D Z1 ,@':(!D [1 $B': "D0S0 TB$: .D0#8!TB 9 .D0#(!VB 9 .T0!(
MAV@ I$,T -(A&@#I$ V =(@&0#I$ R =H@&0#M$ 2(=H *1#- #2(1H Z1 -
M@'2(!D Z1 ,@':(!D [1 $B': "D0S0 TB$: .D0#8!TB 9 .D0#(!VB 9 .
MT0!(AV@ I$,T -(A&@#I$ V =(@&0#I$ R =H@&0#M$ 2(=H *1#- #2(1H
MZ1 -@'2(!D Z1 ,@':(!D [1 $B': "D0S0 TB$: .D0#8!TB 9 .D0#(!VB
M 9 .T0!(AV@ I$,T -(A&@#I$ V =(@&0#I$ R =H@&0#M$ 2(=H *1#- #2
M(1H Z1 -@'2(!D Z1 ,@':(!D [1 $B': "D0S0 TB$: .D0#8!TB 9 .D0#
M(!VB 9 .T0!(AV@ I$,T -(A&@#I$ V =(@&0#I$ R =H@&0#M$ 2(=H *1#
M- #2(1H Z1 -@'2(!D Z1 ,@':(!D [1 $B': "D0S0 TB$: .D0#8!TB 9
M.D0#(!VB 9 .T0!(AV@ I$,T -(A&@#I$ V =(@&0#I$ R =H@&0#M$ 2(=H
M *1#- #2(1H Z1 -@'2(!D Z1 ,@':(!D [1 $B': "D0S0 TB$: .D0#8!T
MB 9 .D0#(!VB 9 .T0!(AV@ I$,T -(A&@#I$ V =(@&0#I$ R =H@&0#M$
M2(=H *1#- #2(1H Z1 -@'2(!D Z1 ,@':(!D [1 $B': "D0S0 TB$: .D0
M#8!TB 9 .D0#(!VB 9 .T0!(AV@ I$,T -(A&@#I$ V =(@&0#I$ R =H@&0
M#M$ 2(=H *1#- #2(1H Z1 -@'2(!D Z1 ,@':(!D [1 $B': "D0S0 TB$:
M .D0#8!TB 9 .D0#(!VB 9 .T0!(AV@ I$,T -(A&@#I$ V =(@&0#I$ R =
MH@&0#M$ 2(=H *1#- #2(1H Z1 -@'2(!D Z1 ,@':(!D [1 $B': "D0S0
MTB$: .D0#8!TB 9 .D0#(!VB 9 .T0!(AV@ I$,T -(A&@#I$ V =(@&0#I$
E R =H@&0#M$ 2(=H *3S_P.SO??K3/41)P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>image_15a.jpg
<TEXT>
begin 644 image_15a.jpg
MB5!.1PT*&@H    -24A$4@   +(   !A" 8   !R(/OI    "7!(67,  $SE
M  !,Y0%USO"5   $>TE$051XG.W;5T_C2AB'\="+: +11+N@"=$$"$3O7_Q\
MIG-_?/2N%)2P=N(RGO]X_(ST7"P;=I)W?PJV8SJ)@_7?O_\0%<[EZE3]!]3#
MH&;G:@&9Y+E8E2"K!T!Q!&2*)AED]0NGN)) 5K]HBC,@4S1Y@ZQ^H11W0*9H
MJAVR^@52>ZH-LOJ%4;L",D63<\CJ%T3MS"ED]8NA=@=DBJ;*D-4O@,@",D53
M:<CJ)T[TN\*0U4^8*"T@4S3EAJQ^HD2# C)%$9 IFH!,410UY$ZGT\K4<P\2
MLOH) AG(0 X %9"!#&0@5\(,Y(:GGCN0@0QD( ,9R$".*O7<@X.L?F) !G(5
MS$!N>.JY QG(0 8RD($,Y*A2SQW(0 8RD($,Y'[,G1@0 [F] 3F2U'-7!^1(
M4L]='9 C23UW=4".)/7<0PC($:2>>PA%!_GCXR/Y_OXNW.SL[ ^,N;FYW-^W
MO;TMW1?(/9#53P+(0 8RD.5S#Z'H(/<V,3&1/#\_IT(X.SO+=?QY<G+2]WVK
MJZM#O\?WONJYAU!TQ\B_FY^?3SX_/U-1[>WM#<2TN;G9]_B#@X/<)V ^]U7/
M/82BAVQM;&RD@OKZ^DJ6EY=S0;RYN4E&1D8*74WPM:]Z[B'4"LC6T=%1*JJW
MM[=D9F:F[['CX^/)X^/CSV->7EZ2R<G)0HA][JN>N[I6?2!B[VK7U]>IJ.[O
M[Y.QL;&?QUY>7O:]>RXM+95"[&M?]=S5M0JR92=A3T]/J:C.S\__/,:.7WN_
MOKN[6QJQKWW5<U?7.LB67>+*NE1F5Q3LG;#[YXN+B\J(?>RKGKNZ5D*VUM?7
MAUZGM6/5WA_[+JIK7_7<U;7Z-T0.#P\S,=D[I[V#ND1<Y[[JN:MK-60[";NZ
MNDH%M;.S4POBNO95SST$Q*V%;&6=A-W=W26CHZ.U87:]KWKN0!9#MF/1AX>'
MU'?'X^/CVB"[WE<]=R"+(=NEKT$G7G9R5@=DU_NJYPYD(60['AUV!<%.OGKO
M3G-1'?NJYQX<Y*9CSOL?O[BXV'?=UDZ^3D]/4U'9(8"KRW!U[:N>>PB(6P?9
M3K3L'H8N&+O=TKYF:.PCXS14AJTJXCKW5<\=R)XA_[[OP>XR6UA8^/E[^W&>
M]>G;UM96:<1U[ZN>.Y ]0][?WQ^*9&UM+164X;-;+,M KGM?]=R![!'RRLI*
M[A_;6;=>VK5?N]6R"&(?^ZKG#F1/D*>GI__<_]N%\?OVR;1#@=O;VU14=JME
M7L2^]E7/'<@>(-LG9?:)61?$^_M[KDM;4U-3R>OK:RJJ8;^JY'M?]=Q#0/P7
MY"9C[O['9D'(^K'=BR+/'6I9P%3[JN<.9" #&<C4YH!,401D:GQ9"\C4J')#
M!C.%VJ"5"AG,%&) IL8W;&5"!C.%%)"I\>59 R&#F=3E74,A@YF4 9D:7Y&5
M"S*825$MD,%,/BNZ@$S!5685@@QF\A&0J?&5784A@YGJJLHJ!1G,5$= IL97
M=96&#&9RF10RF,E%+A:029JK51FR+?4PJ+FY6DX@LUCJ]3_KTOZW- MDP
*  !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>image_16a.jpg
<TEXT>
begin 644 image_16a.jpg
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!@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>image_17a.jpg
<TEXT>
begin 644 image_17a.jpg
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M0M6W<2RHUBH&X'Y[N.7HW/?IZ6EEF[>UCP&XWQ[N[>WML">ZK);28T.U%C$
M]]O"O;FY.7M^?N[\/U,7&+N[NZ-!M38Q /?;P:UE]N;FINJ48-E^Z\0 W&\*
MMS9(-0G]X-?7TJOP6L4 W&\#MXZTHJ57EQK:0)4^U_,8JX)J[6( [O'AUB5$
MM'$Z.CKZ^)WH6EJO6"T+U5K& -SCPJVSW&@VNKR\_.R[7=?2!P<'@Z%:VQB
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M6]92&C5*TLG#W=U=\;.KJZMYNXQEP;*, ;ASP"UW==$M^?'Q<=ZE=Q506<8
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-Q@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>image_18a.jpg
<TEXT>
begin 644 image_18a.jpg
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M%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0B04BL4 T=S\
M?H58(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8
M(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+
M1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!
M2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0
MB04BL4 D%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0B04B
ML4 D%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0B04BL4 D
M%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$
M I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8
M(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+
M1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!
M2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0
MB04BL4 D%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0B04B
ML4 D%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0B04BL4 D
M%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$
M I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8
M(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+
M1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!2"P0B04BL4 D%HC$ I%8(!(+1&*!
M2"P0B04BL4 D%HAFF5F:6,SBQ&(6)Q:S.+&8Q9V[M;I%&! >@@    !)14Y$
$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>image_19a.jpg
<TEXT>
begin 644 image_19a.jpg
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5;_V48OVA!R-A     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>image_1a.jpg
<TEXT>
begin 644 image_1a.jpg
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M7MLW?6JIT.5'VMKC/@VH66I,'NYP''H7!-9^2 !FG=_3$?(_41/T&=M8O#,
+    245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>image_20a.jpg
<TEXT>
begin 644 image_20a.jpg
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L;FW# DQG,I9_#)\RR:=Q=+C/^1NH(;\ L9^1)9?856      245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>image_210.jpg
<TEXT>
begin 644 image_210.jpg
MB5!.1PT*&@H    -24A$4@   _     &" 8   !D?'67    "7!(67,  $SE
M  !,Y0%USO"5    3TE$051XG.W7H0T , P#0>^_= N+@AM+]]*AD% GR0$
M  !VF,KOQP   (#'@ <  ( "XX ?+Y(D29(D:4T&O"1)DB1)!1GPDB1)DB05
6= 'F-PXP_! S[     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>image_21a.jpg
<TEXT>
begin 644 image_21a.jpg
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-60    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>image_22a.jpg
<TEXT>
begin 644 image_22a.jpg
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3]Y<IL"Y7U@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>image_23a.jpg
<TEXT>
begin 644 image_23a.jpg
MB5!.1PT*&@H    -24A$4@   :P   !8" 8   "IO,,7    "7!(67,  $SE
M  !,Y0%USO"5   &.4E$051XG.W=:6O;"! &X+1)+WHW;6CI36@;TH,>]+Y_
M^OZF_;Y>9L$0J[9B6Y)'LWD*SY<F-B]HF-=V)&OKG[__F@QA:VL+@(:A=N[_
MV?3?EL("V)SLY5^1P@)(D+W\*U)8  FREW]%"@L@0?;RKTAA 23(7OX5*2R
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&3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>image_24a.jpg
<TEXT>
begin 644 image_24a.jpg
MB5!.1PT*&@H    -24A$4@   :P   !>" 8   !_Y2 *    "7!(67,  $SE
M  !,Y0%USO"5   &CDE$051XG.W=V6X321A X0 !(HQ1!#A!1 *1L$0L06PB
MX! G3SO/,2\PM_,@<S\]*J2,(B_I2MSQW]7]63I7Q,515TG'=K7+:__^\V?5
M!&MK:P"  FFJ ]?%V6--L "@WT0'2;   %E$!TFP  !91 =)L   640'2;
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ML   640'2;   %E$!TFP  !91 =)L   640'2;   %E$!TFP  !91 =)L
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!@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>image_25a.jpg
<TEXT>
begin 644 image_25a.jpg
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3ZO[9!.X]&0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>image_26a.jpg
<TEXT>
begin 644 image_26a.jpg
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MAMI/DQ3B"G&%N$)<U0C9HU/05_W1*;%/DQ3B"G&%N$)<U0@=;5V>S8%X[&"
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MKU.(JYY7[1"'(:*#P?N&:6[:M DV"J##<-G')LV:/DD0'TM.1=M!$ ]S?"%
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M>]92DSFN$"]%"G&%N$*\4R ^-#1$B&-#(:[ZO13B"G&%>/,A/A$ME\PY<=C
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M/.IZB*=ZT!5 W$:YPVN'X[$0WV?))WAJ#8<AGLKQ)&37#G%\(PK/&YR*<J<
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MU$M;&%#M$,<!=$AMMDY$B:)\']9I1!OBPO'F0-PV5-LXQ1/W(8XZ5XBK<JE
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M\YK7OO:U;WC#&^!E<_OU1MC U5[UJE?Q=%P0I^ ;\8J2@.;X]#.?^0S, ,:
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MC*>?<<89@/C__,__P !09J'VB%G2?K=9.IDUS-N1L?.S9B2B#+[T(>Y'1=J
MN#?J;SP6K KQG%*(EZ*R(2[CQ+'A0+RGIR<,\7$S;$XA'H;XC%E@@6/&]^_?
MC[>_^<UOUJY=RQRPS(+"_(+,D<(0.4<0DKQTTKF(&C^5A1TXKASB0U$.'A>/
M6PZ@]\T%*+@DVZM?_6H^0>6X0T </P"$..>7LF[1LF@%OF7EHSYE-A-SPO#&
MRX-XF. *\0*E$"]%M4 <)MAC-# P( %QN_M)1$4AGAWB)!WNZ)Y[[EFW;AV#
M)QPA#J<8O :U+[GD$D[8 869DA"O(/[*E2L!8N 8AP''3(\%$,,WY_@3^-&<
M-X1S<1TBF^LOPS''B?@6IKH5CG/:_1N,"/'__N__A@%P3"0?8,( T)1S9G2-
M0)RA(6AOE)V1SV]MCBO$%>*JWZMZB#,9Z78C'^+3T1P\A?A\(8Y7% ;U\^M?
M_WK]^O5\C,G<WXQ?7W[YY1QB"+9B)[C,!%C77W\]C@=DUZQ9<^.--V[8L(%/
M+SEU'HQ>L6+%!S_X09S.&?;8";+S4QQ&3QR' >+X.GR$[\+U<65<G^NTV1#'
MWX6Y:*)F?W^_#?%)LVXDIZ'B,$GLQ3M5B"O$5?-6%DR'3Y>8N.^) ^+HPPRG
M3)@$$3*A@^&446^A9!+<-_VVY?>9) 38[(Z=:I]3L=3>8\W"GTO(NS)C5LEA
M0EI"')XXN R>GFG$E%5 +4?^<:DV8)K^]3777 ,WG&NMT7?F8TF\Q?[ERY?3
M <<! /UUUUT'SYVDQ@;@S@7ON0H$_'=.XX2_SS ZS@+?F107Y]YUUUTP!AD6
MR1_I<3/31^H<MX ;Y/AW'BGQ<8?@0F%!L_V+&_@]GB_$YRNA<U(2B"0CM/=,
M1JD(^)  K^0XKT"(HTXT=XHJ73F-(SO$IZ.1PH3XF'FJ28C;V:_8&1SKSZ]4
MB#L$+XK= 8@37G->$A6'XR@2W3$^Y$3]_.___N\--]P MIY^^NF+%R\^[;33
M&.C@B!$^A 3-05MFIL4VEU3FJI@ +AQG!E* 8^SGA'LNQ0DN<X$(SN?DHIW,
M;@B(@]<,G>-+<37\ ,AE"7&T/N]EUN3/(8^DPH59<U:BF#8>;#I-EA/BJ:ZT
M0^'L$+>+/1&-R!J+1FI-6X]Y^=]%(#YN?OE0)_CQ/GSXL$)<%9)"O D0=_QQ
MQQ,7B.-(5 X@OF'#!O!4(,XE?N!!R]J8<+=!<R[H [)SW"'7.,:1IYYZZI(E
M2Q@!QW7..NLL7 <HYRH3S(["*3^ ^P5&3)^"/1R0CB\%TW$*-G 6-M:N77O'
M'7< .M+0;/I)L^1FH&[M:N&V_2G'*=K/QJ>CR9]R2O,A+J?[$)^U,H4IQ%7M
M2"%>+\3MB$IL<)Q/ @EQ/M@$Q->O7P\7F(M"P./F9$N&JB\TXAC!%2M6,)S"
MX8"<GH,]:]:L66>$MW2E95U-?/KN=[\;/Q) .:B-CYC>EE.$N.8ROHB):IFY
MY;SSSL// #SQ'_S@![ '/K?D0)K9R"NG8N?6^W5N5\5<-'5(?'!_EE##(>X0
M7"&N*E@*\89 /.GQYJQ9F(V/ 2'< B .MQ=.,2 .+QCPO202I\5+1(5,YZ 4
M3L@$IN%EX_0;;[SQ/>]YSQ577,$AAB#^]==?OWKU:D9@L <N.3QN[,=9> 6X
MF0:+BRGCV]_TIC?! 3_QQ!/AC'.AY/_ZK_]"L>EZH]AL=P;!!;CR4$0B#'8;
M.9AFO=F#RNU@RV24TC8,\535"'%6E$)<E4L*\49!W!^@,A=-U^0KBGK//?>
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M?', '=XQX(C*Y_Q/-!"OA@;"=8@&/C5%JS%XC=J&ZPWB]_3T .NC9I5Z!C<
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M# X.,JJS+\IAB8^^^M6O?NUK7WODD4=XFX>-Y!DF#H8)L:JE$7V("XL5XA6
M(HL4XO5((=YPB,O#3SXAQ+<\\, #0#.?*'+6)8>$@^!O><M;X$T#RG#/%R]>
MC TXX-@#4K_][6^_\LHK5ZQ8\;:WO0V..2?IX#K8YEJ=.  7P5M.$>+R;V#W
MZR/ATV7+EC'W+ C.->% <&RC&#?==-//?O8S%'XB2FA%7C-( D>;PVQFS22@
MVV^__<X[[^SKZR.XF7IWQF36YIT"9*S\B>BIN$)<(:Z*ET*\X1"7(^G,0@\^
M^" A#IZ"SO":P5RNDKQ\^7)0&%1=N7(E#H"_+"$7#@W$B1(*9^)#G,@90)(1
M!9>%TXV+_,W?_,U7OO(5 /?FFV]FRG(^S.3ZG( XKH"S\(UPZM>M6_?#'_X0
M%0*"#PT-P0<G-+&!M_P%XO@0V EP?_?==X^;,>#R(%2RJ6 /DZ9!N-JDM:BF
M\VQS.DK/JQ!O@A3B]4@AWG"(RZ=S9J8,-N")<^D&9H5EYA.XR< Q. NG^*_^
MZJ\NO?12H!G>-#!]T447<58.UP "Q"^[[+(++[R0LW7 ZU-//144QD5./OGD
M$TXX 5R^^NJK/_>YS_WB%[_@6,-;;[T5I^!'@AFO\.W777?=%5=<P8>H./VX
MXXY;O7KUCW[T(PXP);:FS<!V1H%@$J Y\(3:@YW\]*<__<YWOO/][W__/__S
M/W_YRU_^[G>_V[AQXR.//+)UZU:.3N$DH DSJ\".J/@03Y5"O#(IQ.N10KSA
M$)<C"7$<?/_]]P/!X"E3PG)6/=@*(G,J/(#^MK>]C:NF >(@.X>=<$D'ICW!
M!O/*,IZ.8ZZ]]EJ0&HC_P <^\-WO?O>QQQY#!7)4"?QQ()NK23 L [\;GC@N
M A?^Q!-/?-G+7@:( \VP =3/A)D-,&V2T#)@,C PT-/3 WN8,Y. ?OO;WP+?
MM]UVVRVWW *:X]?BWGOOO>>>>QY]]-%MV[;U&Q%DX]8*]P[$=UOK12C$FR"%
M>#U2B'<<Q.^[[SZ0])QSSH$/SL>8I#/QS07O.6H0@.;J/_"7B6PP%Z>\]*4O
M?>4K7XDK ,K \3_^XS]^\I.?!%6__>UOWW7777"*474L&X "L'[B$Y^ ]XV#
MX>R#W8 X//VWO.4MRY8M@^>^>/'BXX\_?OWZ]6#QD2-'YLSJFI"$K7$1& ,@
M#F><8 *C<1=WW'''E[[TI1_^\(>_^<UO'G[XX0<??'#SYLV<Y0O+F38QELEH
MW88DB*=R7"%>F13B]4@AWGR(<S\ACF\!\N!HGWGFF:#G*4:@,U=-X[Q-#@$\
M_?3305BFJ/W_V7OOZ*K*?/]_K;O6O7=FKC/741D54) B/802.CJCZ$@1I1-J
M(/0J51 ITA14>A?!@H(TZ;WW7D,)$$:GD$X"SAW+FNO\7O=Y?_?SVYQS<A)(
M3D+9GS_.VF>?W?=S7L][/_M3(#@T+UVZ]".///+88X_ESY^?K\.&#0/<9\Z<
ML5&""&34-#R%I#$Q,>O7KY\T:=*H4:- -AM\^NFG;>0]NY-KBK0_3P-OO/$&
M$.>8N>P:.?G.5'6 2G%Q<=^9&!].A[/@*Z=LW]EJO$6I!90^1:D016JW$D\U
MV5>L>1#W(.[9_UD.0IS'9.5-I2'&&OOFFV_LG]#R--F5:-3=XC/ZVP3'=)Y#
M/"#0LTYSGR7=:57D(7[#*53&M)BN&IL %*U=JU8M.06J6)I2J<BW!+"&A84I
M>SC4+EJT**R/CHY&5BL3%L@&UC>=<$JHC2Z&["-'CGSGG7=0UM"?51#U<F1$
MPB/SY5-(KZ#:;QI;9X^#!@W:L6.'W+T%J;\[Q=4T%*X39$+I=,1E]OZWO_V-
MPT";*USS+W_Y"ZNGFB++WQFO1)^+;^VZ*W6M!6)P=@>T@"TGZRTP^Q"W;N_Q
MID:*,JLDFX#5[TS21P_BG@6SG%7B2H!%D[UHC#^GCY*R_SI+<'<3C_>K[),=
M@N<.Q'UFWB['_1=S<QS3UA01HXR&!P\>[-2I4\N6+:6"%>/3H$$#9#@SFS1I
M F&1YR5*E @/#V>:7^%OLV;-0/.J5:O.GCW+E1$<V1T/3#MW[OSBBR^F3Y_>
MI4L7U>=D4TAX^@#$.P1_T=C++[_<SAC@9J?MV[?G,/BJR*/!@P<#<3IR1>BD
MFBB>FR9K"M.BDLX%B!\Y<F3SYLUKUZ[=LF6+LJ:<.''B_/GS5ZY<H>/_]MMO
M;?6?1),/R^=JVSNBYF3OM;W=[GN7*<23,ZCRDW7+)L1U7FZ(ZW5NFLGLZ$'<
MLTPL9R%NE;@_Q).=$KH>Q&\7XC>=$@H:9X!ZK5NWEOZ5 [@JUD-P5<A$>C]K
M#*F.9A\Z=.C$B1.!YH4+%Q0'+XW/1%Q<W/SY\WOUZM7,F-P664NAF'*  =FJ
MQ0S9V4OSYLU5TK--FS8=.W945646&S!@P+9MVR#.=9,*W$+\I@G>@<L:8/G^
M^^^97K%BQ;OOOHMX?_OMMWDLX-B ^#43I<D)_OG/?Z;QP'0YJ]BA<'^"6XC[
MB''W[;LS)7Y;YD%<YD$\;RQ$$+?#*?&NE)MN[>-!_+:4N)9A@FL"*P&WO -1
MW&7+EE793*@J$8UV!K+*&W[TZ%&-+'-L[MC(F)B8K[[Z:MRX<:^^^BK(AO7H
M]/[]^[,1MB!/Q,C(2+:L!%OL3OZ%-6K40)X_]=13*/WBQ8N7*U>./H,CZ=.G
M#RQ6S$Z2"^(:$@%,7&W:!HV$O>_;MV_1HD4S9\[\Z*./-FW:=/+D2<BNH0.5
M,4IV:@-QM(I3#4CPU%N'4_PA[K^ OWD0SRGS()XWEN,0YV],6X3@ERY=$L1M
MJW4_O=JV?M]#/(N6$<33G(2WVI<@KAPI-8U)-2/#T<7P5)6+>_;L>>[<N;_^
M]:^)3GDS)"T2?N'"A1,F3(#= P<.1&*'A845*5($3'_\\<?[]^__]--/F=^X
M<6/F(+'I&" UT_0-"@>E\T"ML].*%2M6K5J5S\J5*W, ?++'#1LV*-NB#\0U
M88NQ)9J4BH<.'=JQ8\?6K5M7K5JU>O5J)@X?/JP\BXE.!4Z?R^Y/\$Q5MFUR
M'L1SP3R(YXWE+,3Y"L1IILI)K8=H]["X#\1]FK@'<7^(:[]2H^FFEOS.G3O!
M*^B$X_7JU6O5JA5L57%DY@!<Y@P?/IR#IT]E176E2/(Y<^: YBI5JLBYNVC1
MHK_YS6^>?/+)UJU;TS%PR]#F0X8,H3^ URU:M&#C0+Q)DR9L656$,)7N5-)$
M%M"0"QOLUJW;^O7K?2!^PTD%KL#Z[XPOBN#%+5:>6]A-[[)GSQYZD>/'CU^\
M>)'Y:@!J)-==I7ERG. >Q'/0/(CGC>4@Q%4@PKH87KERA7^C=9E*<@8NDYQ*
M8_Y-W(.X/\1336X_O8<4$_?MVR?7%!@*:KMTZ<(G;(6GM6O7ALC1T=%#AP[E
M^@N:=*5<3U@)Q-NW;P]P"Q8L^/CCCX-O/@L5*L1,(,X"TZ=/[]Z]NWS Q>L:
M-6K0);!]05P%*%#Z]!GLB)_H,VK5JA4>,X[[G@  ?_])1$%4'NX#<:[M=\:W
M79=.UT0L9D(#.S_^^*/.5,-$?_K3GWB .W_^/!R/BXO[RU_^DF#*T;EOP6WA
MVT(\VY3.Q#R(RSR(YXWE+,29X)])&X4@_ \MQ!.<.B86X@&;^'T)\1M!+2L0
M3S=!C]>-,\EWQL40I+[\\LL:!]?+1N6B8B8*'9I#=FB(!N<BR#<QV20DH7/=
MM6O7N''C@.^SSSZ+$O_UKW\-FM>L68,6'CUZ-'3F*_ANVK0IFV4Q)C3'0IS.
M0]I<8^7T''0,T'_#A@W0^;I3%^*&R5FHVC0<QE^,Q9NR?+K7*6:47,U&;BT<
M'GW)CAT[.)ASY\ZQ)$>>=FME-1^)G1+(FS!GA7:FYD%<YD$\;RP4$*?]07#Y
M_,KIU8ZHV$;O03R+$$\S!2>53UQ+'CAP )@^__SS,%1)5%YYY155]D$R*S/M
MH$&#N)AGSYX]=NP89)07OUX;LD'XN&7+E@4+%HP<.1(H1T5%Z>WB^/'CV::2
M%ZIH)Z);R560Y!H_D4>C=8]A/DNR0*]>O39OWLS=UVO)9./FS*<\4IA02]!9
MZ(KQ$T?%?GFV.'7J%#(<#<XQ'S]^G)GH .Z@KH"_!G=#,,BO;LAF9-EL8TD>
MQ!WS()XWEOL05XN/=^K&>A /#O$;)II1@^/:!2H5Q:TDL<ADU;I4^A2$.01G
M6DC]X(,/WGSS370W&GG__OTQ,3%<8;V]8!=<7M3ZQQ]_/'?N7# */2=-FM2H
M4:/P\'!$>IDR90 T AQ&P_$__.$/<C1D#AH<[LNSL%JU:FC_B(B(/GWZ;-VZ
ME2USP,E.P7O= O\KIL&3,V?.<%1KC>W>O?OTZ=,J':=6X1Y+":*U4YQ7H!E!
M/#C!/8CGH'D0SP/+?N.P59+=8^*TOS\9LR$;/DI< ^+\Y$$\4X@S1V\%TYRJ
M-SMV[ "I*L'3I$F3R,A(>*H@>Q"L%X\(ZNCH:-A:L&#!(D6* -_.G3N/&3-F
MV;)E@#O)I$91/#>;I;L%H'KSV:-'#[1VQ8H5V1J 9D4VC@:GM^C0H8,&6]@+
MTSP$T)?4KEV;PZA<N3(0W[9M&PW@IE,4(M7$^/SYSW_F+FL0G,]TDUD%W;UJ
MU:IITZ;Q*/#UUU\?.G1(J:]H$FG&LU UWE), BQ_@@>$^'672WC697@.0MQR
M_ X@?MV)V/RKL=N">"Z (HOF03PDEBFFL]\^?C8U[X&X)N".GIW5')5:6B.A
MJ4YHAO[;JOF2<*O%WVK9_(_E",33LF8!(7[#O(H,8G9)-[Y%,?Z]8AES5.+G
M.U-+?LN6+="S5JU:RN4-S37B@78N7;HT\ADI7:Q8,=6\![):0,[=A0H50K!/
MGCQY^_;MY\Z=8[.PE>N@3"F+%BU:L& !VGS6K%E]^_:%YJR5+U\^MFQ5/QMD
MR] <W+=LV5(%-EFL:]>N:'\@KH@DW4W%T],8-+3-3_]K;/'BQ=V[=^>YX8LO
MON#! J9?N'"!A6D5?W4LW@1YVNOO\V[3PCK%A*VG^47A6[9FG]%9-Q^:VR8=
M'.+738A3HBFFH3<'/A /-25RRCR(A\1R >+\)_]I+"#$];<4Q/7'2S(0IZ7Z
M0SS>SQYPB"N?N"#.3$$<5JJLFJ(KE35%60R9CT!F)AQGI@JV@?*PL+#\^?,K
M]=6SSSY;ITX=*(R:AN8HX@,'#AP[=HR)I4N7@G*FX?O!@P?7KET[;]Z\3ITZ
ML1U54D:&UZQ9$]7/CE0A2/D1Z20&#ARX>_=NVH >&I+,\Q:W."XNC@9 5R&/
MPS23!YR'B84+%]);'#]^G+7X*O_",V?.T)W(0>7*E2MR476[&/H/JJ0XN4?<
M$'<C-9M<OEWS(.Y9#EN>0#S)Y+'36(H=%D_R@[A$>A""/\@0%\<#*G$WQ.6R
MK0%Q"(NV[=*E"[2%JI":F7KAJ0) 98T]\\PS"K9$K;,%H(_H'C]^_-BQ8V$Z
M8AQIK,3?G!041K/WZ=.'KD)E@%B%:0C.?B&X=L1G__[]56-3[V!U;=W#*1+C
MW'&PKJCZ2Y<N<8-.GCP)P8\>/0K!A>_8V-C+ER\CX>7=%-S%,-65(^4^@+A[
M."7=Y*W\\<<?0TV)G#(/XB&QO((XC.8?:&5%@I.U+MD$W&OLSXIT'W/_ 1XH
MB(OC%N(VBZ$2M :$."2M5Z^>DH8#<>5. >+\JD*:8#<R,A*.2T>SF!)C84R@
MRG_[V]\^^NBCP!U&MVW;%D$-RN$XMT81\]S3*5.FR!$%2<X&V11[@>.LPGP%
M^_3HT6/CQHV2X0*3I+?N.&<JQQAN.J1F#DNR9<A.\[#=>9(30Q#O"O1-=5*@
MN,T'XN[Y]RC$DTP]4A^(RT$SU)3(*?,@'A++*XAKR%LJS$(\V>4DKB='M=>,
M"/X 0MQRW%JZR4<* 16\S@5Q0QRJ*H&X2F@J#1;J&[SJ#:=^ NBP7G4RJU6K
MQOQ&QL Z'"]<N+ $=94J51#7;.2==]Y9OGSYV;-G;YK$WY]__GET=#0R7^\S
MV;[\Q%D2[C=MVI1UAPX="OII XHPXH(H,_AW)OVL<J=H+$59YCEQ?HHW!9$U
MK0<1.2"FFA3;NHG^X YBR2['\'L(XJE.46GW^P /XI[]G^4:Q/G4-+BAC:I,
M(ARWP3Z)+A?#>,>_T'JG^+3RA+O).R67(6YQ)DLS?N*2X6Z(JQ $:%9B$P@.
M5>4]HN(^RJ/",K5JU9+?(3])I#/1NG5K9#LBG9\@.%M01'Z1(D7*E2N'LF8M
M%I@W;][2I4O'CAW;OGU[H$\/P8KMVK53_D)0#L&9R;Z&#1NV=^]>VH @SJEI
M"$BGH'N=9,9YKYL:]JJG'!<7QZU/=F)VTER>/]?]$A!F=#>37>;/TVPVH=NU
M[$!<3Z@:?DPQT5)<P)]^^BFTC,@Y\R >$LL%B,LUQ0?B>J.E5+1N(MOV?2V0
MN5OY@P;Q@!S_SE7X1H,;7!P+\1=>>$$0AZ0M6K0 ID!<+R&1QE!852,$Y?#P
M\!HU:B@-(<0'RMVZ=4-9*Z<5V^G9LR<386%A9<N6_=WO?O?+7_XR?_[\S%'W
M(-G.!-Q'DK<VQLSZ]>NSP////S]@P(#MV[<K1:)$MU[&<LPI9JQ &I-[JI/B
M7BMON)MHHO]-5SF(E$!)"C."N#],[PF(I_D5A6 905QY'$,,B1PS#^(AL5!#
M_&?'O] -\03C6W;Y\F4^$V\UG]>8/GK<:O:<^N_=6Q"_&2AOK48;;($%?XC;
M80U,@92JK@F.F58$9D1$A.IJ(KJK5:O&6BS9I4N7SIT[LQ8RG.5A.MT T_S*
MND\]]52! @6*%2OV\,,/LR+[8FNO&9/89X(EV1<:G^W3!VS<N%%Y H1CN=,D
MFUQ7''R"<58!W&*3AEETCC><'(TBN"U'EV)>][GOIC_-DP,%UKN;7(XTI*Q;
M]B&NX<<44_;(@[AG(8>XPGSD)/XO%\2O7KUZZ=(E/I-O+<9FF[75XSXA/P\:
MQ 7NFQE;JLF=HF68X!)MVK3)0EPY8SMV[!@5%=6N73NX#)T5E(_Z'C1HT&>?
M?;9\^?+WWW]?60F;-V^.?!9Y6:Q3ITY(<O0[@&:!5UYY!8A'1T?3,73MVG7X
M\.%CQXZ5T+9E/-DU^$;[,U&U:E6ZA"9-FK!!#:?\;,;$Q?$TXVBH>\K!,T=O
ML\5W93;_V;@D"NCN"\Y$@DES:"O\V2;A#_'$C"U'6M%M678@;I]0/8A[]O];
M+D-<_TF:8%Q<G$HF6JV4&*BB9G"(!Q19MV7W"L2#<%Q_<BM7?2 .<R,C(\$H
MTOCEEU]6RBIH"\'+E"DS=>K4TZ=/<WG/G#DS9LP8T*P8>JW(6DAO5I1'>8<.
M'6P'4*-&C3ESYERX<"$F)F;V[-F GF4TPBY)SL)P7%'X=>K4@>9]^_;=MFV;
M:CCHQ@G$FA"P4LVHMYBEDU(BPW03B2K]+G+9O+5)?K(ZZQ#/9N.Y,[L#B.LI
M),5$2.F/D.A4&>4Z\.<*/2=RQCR(A\1"#?&?S7"*7%/^=:L2EZMO@N.7HK]<
MHBOU5:;#*?<BQ-WC))D2W WQC#@N2:M"R1B'M'7K5GA:U1A415F#X%JU:E6I
M4@5]K='PVK5K(\^W;]\N1@#QR9,GLZ0RHJAP!,(<9*O&&W/TTK)^_?KAX>$1
M$1'+EBV3ESI]!MH<Q:V";2H;I-Z"_H,)>H6PL+!NW;JQI$V E>2$W?/YG2F7
MG&+>X%E>:YA(NQ#6=3OT D#C+0H.$AG==S/5%>R3Y!=8GW"KA8+F&?46&1V&
MS\N>I%N[(@_BG@6S4$-<NU &E7^9EYS\ Q.<4#W%:U@W,KWCXE<%-:B]WC=C
MXEF$>Q"(^YN&DCD&>55SG9FY8\<.8%V^?/G2I4M7JE0)50Y>$>;".@2'LZU:
MM0*IG#ZWX^+%BZCI-]]\$W 7+UX<<,-BH,RZ>@6*L04Y+#+!3VSATT\_Y;YP
M(W;NW-FF31LYDK_RRBLL!O05(ZI1<G9:KEPY(+YY\V8.4D- PC3WE(NL 7WK
M#9UD(@;2'*^;&T[U-:NI+9JUI)UI;X=/<*8/-^W3GAV:N"TB!U?T 1F=Z19\
MMN/S,.%!W+-@=M="W(+;@WAPB',6' -7E?^SCQ)'>HO%R.<F39K 4PVS(*X[
M=>IT[-@Q.?/!5E0S,]'7%2M6A-0PMU"A0B5+EM18B@([H3]<EM9F@;???GO/
MGCT*VGKOO?>4 PLM+W W;MQ8[S,K5*C 'MELSYX]V9&R&*8X";#$.+'8CJ6X
M@:48GT3S?,:._O2G/\4Y1N-1-I5X)Q^]M+S=B.6XC_YUAQUX$,]-\R >$LL%
MB/^O8YJV$'?_"7T@?LV5A-:#>!"(:R BW81?:W@AT17L\WMC86%A3*O*#R3E
M$Q"W;-GRR)$CH@-2NH$QD*U\6-+@;=NV1; K21;@5C)"#"@K(>*<.7/$S<\^
M^ZQ'CQYT#"IU+Y<8Y+F*441&1C)GY,B1!PX<L FP$HUVMEI8@T+6\T1#*%HL
MW?5V5T,QM =:SJ5+E\X;LT&_;C&N4[/JWH>M;HYGVI8\B.>4>1 /B>4.Q#,*
M]N&OJ!Q&:JD^$+_/7 Q# 7&-0OB[&+[RRBLP5\,@2'+4-&(<</?MVQ>J F4^
M3YTZQ2KTIHL6+0+Z*EH/K&O6K,F*\+=KUZY145&0O4:-&M6K5T=?/V\,K<TV
M60PQSA7@ABY?OKQ7KUXH<7;' O**Z=RY<\>.'5NW;DVWP?:'#1NV>_=N)4@1
M[/1:,MG)1)CNYT^I=P8WG;PQ-N%7DDG;P)%?OGPY-C96<;_Q3B),GTNJO20%
M\H"R[Q(]B.>.>1 /B>4AQ)527$&;;HCSJSM$\P&'^(W,JG%:APU%/W+,V[9M
M@[S*EZ+<*2"[F;%V[=II< -&HV39_O[]^X<,&0*1!6A^??WUUUD>H0VUX;Y2
MKV#@F"T@JU'<<E 9/'@PM^;''W]<LF0)FAW]CNJO4J4*O[)?]@6^=23AX>%=
MNG19O7HUYRL2<?'U]&"CEM*=($R!6*I<8^*ZR')*T=.&=+>X9H,8W1"W[XTM
MQ#/B>-8AZT$\F^9!/"26.Q"W97V"0#S-*=:>Z#BH>!#/"L133.2>$G]SG9FS
M<^=.R>=JU:J]^.*+D<84L8DTYB=$>H<.'<Z=.X>&W;MW[]BQ8X&O%E;:6)0X
M4AJ(LR3+-S;VTDLOP7=0SM;T_G/:M&GJ"18L6, "0!R-CYQG12"NJIYLD"V7
M+ET:4;]BQ0HNE[C&B:L4LG5-T<B,GBHX'348&>?%DGS"+!:C\= D=-90WOU^
MTF<X)<WQL,Z(X]DGN ?QK)L'\9!8+D!<$9MNB"<Y";!DUTQR#!^(B]<>Q&]D
M9DDFFQTXTT6&B;MV[8*A5:M6C8B(@,)*7?+RRR\CKKMV[0J%FS9MVKMW[].G
M3W."W(BU:]>V:=.&94 P:P%Q ,U:-GV5RA_+B1".@VD%"FW9L@45S$7XY)-/
M%* /WQ'@? K]K,Z669XM*^Q>U-8@B2WEDV1RBZM,LTJR;=RX\:NOOJ)OF#ES
MYN+%B[_^^NOUZ]<?/GR8CN?\^?,<.4MR[S1T[O-VU.V@DNJJ I$<J)1/0A;,
M@WA.F0?QD%B>0QPQ#J,MQ&F:%N*)3CI##^+!(<Y&Y)T"RED%5HJYUD]<J<.5
MY$1*N5^_?L>/'Y>6!XZ=.W<&]TAI5F%A1'1S8SUZ] #B;*1FS9I\-FC00-D-
M^>GCCS^.B8D1I.;-F]>^??L6QJ V]&=?]>K58UV65&)Q(,XC LV !J#]<K0*
MV$DT VBT!#:X;]^^U:M7SYT[E^<##I(#&S%BQ <??#!GSIQ-FS:=.'$"RO,)
MRI7,3RD/DYT,69;@*8Y?2M*MX?AWP'$/XCEE'L1#8J&&^,].[I2,('[UZE7^
MC1E!/.%6=T,/X@$AGNKX]J2;%YO 3N79%'<#0Y5:%H*KTB9([=*ER^;-F[FP
MK (3HZ.C*U>N7*9,&7Y":\O)Y(477D!?(\-KU*B!J)?C(-N!U&^]]1:KZ[TT
MY!TS9@S+TSV\^.*+X%O)"Y][[CD$.)_LE"VSQPT;-J#$-8Z?9@(R-=:A&RTE
M?O+D29XD5JY<.7_^_ \__) MSYX]^[///ENQ8@6]CGI]%?=AUWQ5X0CW7; Y
M_X2\!!.A[@/QC&CK03RDYD$\))8G$*>!JG!/$(BKZ7L0SPK$Y5J79/*0<$G7
MKEVK"'BE.A%)FS5KUJU;-]@*V2M6K BL^_;MB^95C1ZXV;-G3Q5I ],P'1U=
MM&A1.@,EM&*#JL-9I$@1B-RR94LX"W-1\<CDNG7KHN)9D3VR,!!'C*O"IU8L
M7[X\HG[+EBT:\$EQ7 P5TI7L)%SE:MPP[P#<$:H:;V$Q!6IRCH*X5N1KFM^;
MS!3G];BVKUN9$<<]B.>:>1 /B84:XO\*E(HVR:7$5=_'9M>T8BK9R=EV]^=.
ML1:0RYD2/%-,![<45QYM)N@:5ZU:I:H]=>K4@<4(9*5#@> :Z*A0H<(33SQ1
MK%@Q!/6A0X<  7=AX\:-7;MV??SQQY]ZZBDH#W:??OIIED1' VCT>[ERY8H7
M+\XG&WSGG7? -P?/BB-'CD2\JU R?89*^2B+(5_I2\H;&SAPX/[]^VDS2A7
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M=^$FN(T <K,^U;R-5%+ 5.,TO7[]^K"P,!6"@->*VP2O3,M?!>;"5B984KR
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MNH=3U)VS$6['#S_\H)Z><SQZ]"@[FCIUZNG3I[\S.6E940%!DMO))F(HWDG
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M$P)9P/;F;UF!>/"U;*>2:CPRU76EF6KW6?1.N4O,@_@]:;95V93B"(<$XXJ
M^4/<_;>)OS7T+M&5+T4_V>AJ?XAG^L_).L0M3WTX?EL0]P&QSP"W6X.["6X/
M("#$+<<5KYCJ%'U?OWX]REKE+H$O+ :X%N( &G:W;=N6.7KYJ5AY!7FJJ@/0
M9R:K%S.FP1D5>'OAA1?*E"FC1%<-&S9D"^R";2JBARW7,Z9";G7KUF6#2FL^
M8<*$DR=/<IQZ%Z*4($FN:C6*Z)$/Q@U3]YF'-F5K8)HKS"KR,?\?D_8KS905
M5?20CZ#VZ7>3LF<9<3;KEG6(!^QF!'%U8$E.-EK.BS_4O[(6L7F7F ?Q>]*R
M"/%X)PV6^]$UWLEBF!'$+<'O78A;AY,[AKB"%>VK/,YBV[9MJHRL0!N4LJW(
MHW>/H!8*P^*GGWZZ<.'"SSSSS'_^YW_^QW_\1_[\^0$N"T!>ME"A0@5DN,0X
M'"]1H@241W2KX@^2G Z B8H5*RJ\/B(B0G!'AD='1VL!H"^(2XG_C\F;J(Q.
MUTQROG@3^:7A-<5A*BMAHJFE>=,D%4@S3H2Z4':@R5X0?XC[<SR(Z0G&@W@N
MF ?Q>](RA;C^TOX0MS+<ZG3W @E.@L/[&^+!AU/\(<YA< 4V;-@ ;36LH;&1
M[L::-&DB%T.-?3_UU%,0'$87+%BP@+$GGG@B7[Y\?"*NP2[<!^6E2I4J;.S)
M)Y]DK=+&'G[X899\[+''?O&+7] 3%"]>'.+7J5-' ^(JM@G9.0"^<C!L[?WW
MWS]W[AQM0)=:+L^V2U98)OB.BXM3CF+F)!A_#-7Q^;M)@*58(6;>=!59#LYK
M]T!Y0,M4JGL0SRGS('Y/6G"(ZUU6$(B[\]#Z0SS(F/@]!/& @2I!UO6!N)O^
M*2;?].K5JT$J#(7@\!JAC?1NV;*EJO.H4#TT'SERY*Q9LV;.G(E&_N"##YA0
MX6.FITV;MF#!@J7&%BU:Q$^C1X]^ZZVWNG;M2F<P8L2(-]]\<_CPX>^^^^Z'
M'W[8HT</.@;TN)*E, VUH3F[ .7R70'B;/;"A0LT /M&5[?2#HNYG[?4 )3D
M4A!/-^'UJ690F 7^;HJ+\NF^-4$X'L0"#IKGIGD0]^RNMJQ /"-&ZS_L=E^Y
MCR'NXQB>=8B[MW;=>*>L6[=.T3VU:]=FHF3)DFADY?5NV+"A(CG[].ESY,@1
MC64I\%)U%1+-.V<%1JH'5<=P^O3IDR=/KERY<L6*%<>/'S]UZE1,3 S+<.4W
M;][<IDV;2I4J ?%&C1I!;?8+Q!L98U] '&V.$C]__CPM00\?''F*B:4$2>R1
MSP03^'/#.,[+;S+1(-Z^%)%CAJ+STXPW(>>;9,;0,X*X;HW_>\N SB=Y91[$
M/;NK+2L0#S+D#3[\WWS:IN_F^+T+\1NWFOM)/RL0UP+"(C]Q%E 5&0ZR7WGE
M%9"J0$TFD,,H\>>>>ZY^_?K(<$Y?WFG__.<_;>P^5_+JU:M<=ET?^,XE$BZQ
M,\9TD-HCGRP\>/!@U6QC7Z\98X_(?S[9'1"'Z>^]]Q[<9U\Z?O8H6?W--]^H
M^H0ZC)LF>2%F<UH)Z.R%!F.75$M0 _"Y1SYW)\DXYV5GN"/4YD'<L[O:,H5X
M1LXG5H;;3(<^RR2ZQLWO&XC[C]AF!>(WG/)L-TR&R-6K5X>'AR.' 2CT;-*D
MB;Q3E(.P2I4J?'WKK;=84N666)%MQL;&KEV[%KW\YIMO3IX\^<LOOURU:M6"
M!0M0W]NW;]^U:]<77WPQ??KTV;-G+UNV;/'BQ9LV;=J[=R\_??KIIQTZ=%"Y
MB7+ERBF#BLH <0P5*U8$XOPT=NS8$R=.B-TW3470%!-$[G[>2C3N=&GF-:;.
MB-8B;^B_FWH(UQW'E>^-B?7N:^6&N.YIHJG6%L0R=1-,]'-)O%WS("[S('Y/
M6J80M^0-"'&EB?"'>%(@-\1[$>(!P>U>+-TI*!QD3!PYK&)F[)=+"F&+%BT:
M9DS5=C2$HA%JQ<3W[]__P($#7#>57&#%"Q<N;-BP 8A#Y$:-&J'B61+^ F+T
M-5"F/U"ES18M6K! FS9MNAAKV;(E6^8G/H5L]L+,5JU:\310M6I5YM2J50OM
M?_#@0<XEWJ0MY)B3'7=OB65%;*+].9*S9\^>.G4*Z!\_?GSGSIW[]NW3Z(WU
M8-'@CVZ?O3X90=PO>N86RU2G9Y/@'L2M>1"_)RTK$/>GLQOB-EWM@P-Q'VV>
M*<2E3+FP:2:3%"):)=;0Q7!<GH5*18L2;]BPX6NOO=:T:=/!@P=/G3IUX\:-
MJHB&$H>8?)TS9\X[[[S3O7MWED31%RM6S'JG*(9(#BIL'T#;@1H^@3C49E^H
M?G8!Q)G#WM'^-6K4&#9LV.[=NQ-,K$JB29XEB.M>,Y/V<.;,&;J6S9LW+UVZ
M=/[\^1S>Q(D3APP9\L$''ZQ?O_[<N7/ _=BQ8T>.'%'DO>Y@$"6>1<)Z$,\=
M\R!^3YH/Q/7PGF#R+F4$\0376TT?)9[D5&6T_[U0#*?X$-E_O-6?X/X0]^>X
M#Z,S@GB0(7*[EAOB&IX6Q%F RP4!2Y4J9<NSJ<Z],E(]]]QS>MD(@@L4*%"\
M>/'FS9O#RD6+%NW:M>OBQ8N))G\W6V8[.W;LF#!A C0'S<\^^RSJ7MLL4:*$
M4JE4JU8-5=ZL63.HS4^*MD>SRT5=<EX0KUZ]^EMOO<4NKID:V=PFO9-D=Q+@
M<7%Q:.U#APYMV;+EJZ^^XI" ?K=NW=A@9&0DTU]__34$/WGR),N@Z#G4)">3
M>/JM3IG7G0RT5HS[WRRW)64V:!YJB+LY'A#BR4[><\XQT;P*%L1_^NDG^R_S
M(.Y9AO9S4,MT=3?$:7-\\N"OPKA(/^6&MFTWR<\UQ69*BG<E5W%SW&;>\/$9
M#_AO]/^'9/H/S]2"]P&IM_JW^= \*W;SUJ(0/J4AF$XRM0(T9,PQT#M^]MEG
MY<N7AYLU:]:4L[;J:M:N73LB(D)AG("X9,F28)>OR/;\^?.SP+OOOGOBQ GZ
M _I:=0D</WWMAQ]^^/333__B%[^ XVQ6@*97@-W*0%O9F()]HJ*B.G?N#'R5
MA%9[9"W4/4H_W13?<7OU,4>CVXDFHXZ:A JV[=V[=].F37JYRBV&X/OW[S]\
M^# RW+X%56;C>%?Z%'?W>=UD(\@B0.\8XCXMP9_=V61]LI,6)LTI,J[BHGHO
MG>F?-%,+/47^GWD0SQO+08C+$(\TQ(O&Y*/FXR"<%8A;SS#K2^X3?W\W0_RV
M.!X0XFYC:US2'W_\4>XE=(V??/(),CG"F 2R4E I$H<)!#*T;=6JU9MOOMFV
M;5N(7Z%"!5:!M@CS&3-F $HNCG*<0@IX.G'B1+@L;Q.VR<)*CBC?<+;)M.TP
M&C1HT+AQ8R0YK)>S2OWZ]2=-FH243C?.[+H=J:;$3Z)):JC[>]V$:.J\. "Y
M.7)/T>D<P[Y]^Y#AITZ=4AY:+99B/&K<$/<9(K>[NV.[+8@')')V".Y!W+/L
M6LY"7-YL@KB4>*80=\?E^T-<2S[($,?D9")/%33LPH4+RY0I@T8&S<CD%UYX
MX15CREH%<T$J,CDR,K)?OWX(9Q5R \&LA3QGR>'#AW_YY9?;MV_?NG4KQ.32
M<;/6K5LW;=JT 0,&M&C10G(>:<^TJB$#<3;"A% .[NDG7G_]==6$8W=3IDPY
M=^Z<U+WNG5Q-N&6(_:M7KZ:8XG#R?)=_(??QR)$CRY8MFS]_/CT3!W/FS!D-
MQ'%(>A!),$-J>0YQ'QGN0^'L$-R#N&?9M1!!/-:8E5KN094@$$]RI3E,<GF4
M^T?]W/<0=T?M6XBS/("#=V7+E@7?\A617PH8A:IZ]PA\^544UCM)Y+-^_<,?
M_J#!;BB,RF;.S)DS4<$)QGL$AF[;MNVSSSX;,6)$ERY=M  ;"0L+0Y[S5<64
ME91<U>!^[]B$"1. N)P"TTR& %V]>),@^]MOOY6CI'S2N8_,9+\C1XZDLZ&K
M&#)D"!!7XEE!7[Z5;HBSP8 0#X[(Q,Q&5#*EL+L-^! Y*ZMGBGL/XIYERW(<
MXM]__[T&/942V@9D!H%XD!>;M^4]=J]#/&"0)UM3B35%;"*</__\<P!=O7IU
MY:6"JJJTV;)ER[9MV\)$@(X\YR?8BBI_[;77F-:@"MB%YGRBRI5*!:#W[MT;
M=0_-9\V:M7[]>KV6I ,&LALV;%"5Y,J5*ZMRD"(VU57\P1@="0<S;MPX(/[C
MCS^"'@XUU:1 L?<EWN0OA.__:Q+0P^AY\^9QJ.W:M6O?OGW__OWYRJGI30!M
M@P5$;?=C7(KQW["7SCJK9)VA=V8!1U$"-KS@EE''X$'<LVQ9#D+<YA-/<+Q3
ME,70S7%91BZ&[K^*%@LHG3+B^/T!<1_'%3:+@%5R*+8<%Q?WQ1=?(+1KU:JE
M\'=);,"-3&[6K!G(1ILK*!^4P]R7C3%'H^>J= SZ87K)DB41YNCTUJU; WI(
M34_PZ:>?LA<A$K BS*.BHE@&@K-]\*V*/\QA7\Q1;MNI4Z?R[ 5WK!+7]5&(
MIK+,JV@?MW[%BA4??OCA!Q]\L&S9,@3XH4.'Z  T#F[SI^M*ICAUD).=XC[^
M$$\.:MGG>$8$MRWP=K?CTYP\B'N6+<MQB-/R:*\0G/^_J@&X ^MMTP_N)^Y!
MW(TJ"*@*U'Q%HG[YY9?05AD$@;B&4/0R$X[SJ4(0*F>LT'PEJP*U&CU7/0?D
M<[%BQ0H5*E2Z=&EE)P?H3/3JU0NPQIN2\YS4CAT[A@X="O?A-1QG^PK\H1N@
MYT">ZPWGC!DSN.FJ4B\'%5TH^4VFN2IM[M^_?]6J51LW;CQY\B2WGN71[PHK
MU1 *T)>#O-:U]_%ZH#*;N09Q'X+?,<3=;4E-R(.X9]FRG(4X$_PA$TV6)0R(
MTR)]Q+@/Q 5Z]["X_:OX_$,"<OP^@+A_\;9T5UH5YLB-1)A#R2Y>O%@0KVU,
M@]0*U$1'([1??_UU-+)>.8KI:&<^0;G&Q,N6+1L6%L:$TLQ"\\C(R#%CQ@!K
M"/[&&V\L7;I4TIBKNG;M6N:#;V"M87&VJ32V[)3.@ Z#STF3)J'$.500K* 5
M>\NXN1<N7$@ROI(\G*U;MP[<:XA<5X )UA+]TTRB&(TC:1E=_-0,:B4'=.KW
MN8.9CK<$U K6,M+@&0WK^9B[6=J&Y&X_MG_R(.[9G5@H($YC5=IHA2U8K9TI
MQ'V0'>]*;>B&^WT)<7^"VVTJP8C$*1!<LF0)JEDU&?19LV9-/M'%"L91=6,(
M6Z-&C8H5*P+K"A4J(+>+%"E2L&#!QQY[[%>_^E6^?/E8:^S8L=NV;8.PERY=
MXLD)T;UITR8$,ET%[)X]>_:L6;,@N"+U%;TIGW2HS?95/(C^@$Z%/@#N<YPT
M ,EGI9GE<G%V;/_HT:,G3IQ@+URTLV?/'C6V;]^^+5NV[-JUZ_3IT]Q!L5OO
M0N--\4DKZG4I?")=KV=6$2+558?SCB'N5M,^! \2M9 IQ.W]]2#N6;8LU!!7
MN5N+:6O!(9[@!-P_4!#WP9,(Q7DQ!Z&JY;E<RY8M YT:+6G0H 'J6/Z%2C$(
M6U'64+5*E2KERY<O4Z8,6ON11QYY]-%'X3@BNE.G3GWZ]!D]>O2B18O KG4$
MY+IMW;IU_OSY,V;,^/###U'TE2I5HK>@&P#6[(AUY;\HF8_>9[]ZMZE4M'0&
MJK7&8>L6*W0>4\ ]U%91S0T;-DR9,F7@P($(_ZBH*#H)IA<N7$@O(M8CU36>
M;B_XW0!QG[87//0L*Q"WX_X>Q#V[<\L^Q&6VG"LM+\G$<6#?&G./J%B3Z[?&
MQ#-Z^2F7AH 03W"-2 :!>)*?&X"/W1;'0P'Q&ZYJG/Z#*O+&DYC5T K7"HA7
MJU9-.4Q@=ZM6K53K4CFM5-&XBC$%6T9$1(!O%H:8'W_\,=+[R)$C"L%7E4ON
M$7(8IH\8,2(Z.KI%BQ8@FU60[70 A0L79IL:^(;C[ N4 W&6U M2%:.8/GTZ
M<EN=3;(3L<E-23&![^P.K<VG<F !:WH+.I)1HT8-&S;LK;?>8IICV[AQ(]K\
MV+%C@#[%R27B3SWWDTI </O<OKR%N-V"&^+N<TDU+VQ%<Y5 8K-<1@VC99/@
M'L3O?\O^[:>=61G.M *LY8<@[Q1K/M'S0KGFNV/K[;_"!\<^_Z4$OS>? 2$>
MW+(OU;,)<8OR[TS^;N7:5I%[#0TGFJ@93:N"Y9(E2^R@-I@&J0 =F )Q-/A+
MQA2]"7!;MFS9O7OW(4.&?/+))[ ;7FC$@PVRY=C86#3RBA4K>O?NC>A&MLLE
M'/1KQ(8ML ND=[MV[6PLOH)]^O?O3__!?B$^JGSFS)G(9Z4'L,Q-,LG*.>QX
M4Z$MP81Q8G *E$/J:Z8.9X))FZ5\XGH?;@,"F/#I=/U[4']\^[S8#"G$W8E]
M EI&$/=I,-=-03N5Q6 5&Q\@,1[J?W&.F ?QO+&<A;B&;@-"W#\%RFU!/*,_
MTOT-<56!T+L^?7*Y%B]>#+Z5U013.F^-KDB;\],SSSQ3LV9-%"ZZFZMT[MPY
M$,GYP@6VS_2Z=>O&CQ_?MFU;5@D/#W_VV6=5,9DM(^3M>#<T+U*D")V$WF?J
ME:FD=\>.'>DA5/,>CD^;-@VA+6=V-\0U!J)A;EOP/M$X7Z>;M"K?F117N@B<
M-4\&]#%< 5:G/="0?)Z!?"YX;D(\,="8^)U!//76=)B". OHV92UN)(>Q#W+
MDH4.XE>O7E6PCP6T.WK^MB">$<$?!(AK:%@*ER65BE9Z&=I6JU:M0H4*\!J(
M@U<XKJ14H!QI?.#  <Y1U7:X5J=/G_[ZZZ^'#Q_>HD4+%BM?OCS4?O311__K
MO_[KH8<>RI<O'U^E\4L:4X86C8E#:HE].*YWITPH!R'$9^^3)DVBJT@WN5.L
MV$PRKS>5S%*72W<SQ0P0:;@ 5 %N58&PV&)"'$\R,3X^TMM]G34<$5*(!V^!
MF5I&$$_URXC)3SX0UW!*+OR+<\0\B.>-Y3C$E79.V4<1XSX$OUV(^XB@!Q#B
MZ::",'/TGU>P#]I9 9EH9#C+--1^W9CD>514U(4+%[@4K*NL9*!AY\Z=4Z=.
MY2?Y>L-E^%NG3AT^Y:K(ZLV:-6O8L*&HW:Y=NX$#![9OW[Y1HT:*LV<O<C3D
M5U9A/OT!@IWE)TZ<>.;,F>O&F<0-<?IRCH2;FV2&352M32,GY\^?/W;L&&LQ
MP3*QL;&V=)Q.5E .R+LT5_!]2"'NHR0"-L*L0]S=Y-R'K=-)"30FGCO_XAPQ
M#^)Y8Z& . T7?%^Y<L56X_7']^U"/."?QP80W<<05\2CJIUA7-5%BQ8!<85?
M8C:Y(/ %P>'&NG;M>MU454XRP>ZL"#<1YJM6K:(/6+MV[;9MVS9OWOS99Y^M
M6;-FW;IUS%RX<.$GGWSR\<<?(^&1U4SOV+$#O,Z?/[][]^Y 'XCSR2X -Q/L
M!?HW:-"@:M6J 'W\^/&G3IVRWB"Z,HDF8H"-J&J/J+U___[=NW=S)+-GSQXZ
M="@K3IDRA>E//_V4!X7MV[<?.7*$)07T!#.,'N0*YPC$@YO/DK?+<1^(!VQU
M=D3%>J<P;;U3<N%?G"/F03QO+$005YTM/BUM UH6(>[SGW%OX;Z'^'>F(@0S
MA218K-PI0%R!-@K\00O7JU<O.CJZ<>/&R.0>/7IP=BH&!!0X-CFBL#5UJ$GF
ME6.:R52N0!O.Y>+%BT>/'CUX\&!,3 RW0^<"^M]ZZRUX7;%B122_+4#!'I7%
M4(\"X\:-.WGR9(H9,+$7EIO"_56/?OKTZ<.'#T-P=L'$ZM6KWW__?62^AMHY
M\N'#A\^=.Y<.YM"A0QR)!F&2 @VGN"]UCHR)![?DS'*GW"[$D_R2:ETWCIYI
MCHLA%RW5Y6*8"__B'#$/XGEC.0MQ)L#!-5-27;GH LKGVX)X1@1WA_+?QQ!7
M;39F:G>">/GRY:6^574>FJM A/(4PMG^_?L+:M]\\PWT!,1(8,@((&)C8Y',
M9\^>Y2<.E:^*NX'=2.^M6[?NVK4+'"M_&7=P[]Z]0%PEF!4:JI'Q/_[QCVC_
M^O7KTXL(XFXEKFNK:(!KQ@D]P2F:K'O'B8!RG@-6K%@!T!'@'"$'0WM@17M!
M]!AAAVAD&;FFW!G$L])(W)OR?T#,(L0S:IF)3J9UO0$6Q-D=]]V#N&>96XY#
MG+;(7Y2':"A@(9Z1CK9U(3*">$9]@!VBN>\A+B6N*LE 2ED,P\+"JE>O_OSS
MSZ.^.W7JQ*=\PW__^]^CB\'K.^^\PV% U:5+E[[[[KN]>O7JW;OWD"%#QHX=
M.VK4J#???'/HT*%,3YLVC4^F!PT:-&# @,&#!\-K%#&KL]:D29-8@&D-?$-P
M\ VXFS9MJM!09#B[9K_\RO)GSIR1L[,EG6YNHE/?1SE2;'(5+2:O&[W5U +_
M8TS+8\F.U[D/57V8G@L0SXCC68>X?^/4%O3Z&DLPWI88/WD0]RQ+%@J(\[^%
M-:@J4)[H-X;HEM)9@;C/7\)-\ <!XC8+H+9,O[AHT2+YC<!Q!')T=#1L!=_R
M'H'F<';TZ-'GSY^?-V]>RY8MBQ0I\LM?_O+?__W?_^,__N-7QAYZZ*'?_O:W
M^?+E>^RQQ_CUV6>?Y;-HT:*E2I4J7;IT\>+%"Q0H4+!@P6+%BB'Y5>FM8L6*
M[ MJMVG3IF/'CO0<3+1JU>JUUUY3Y-&$"1-B8F)4%"+9*9&L<-QXDSXAW<2=
M<B(LHXA\?F6^4&4KQB6:LIQ"?YJ);TKP"^QRW^5DDU8EI!!/"5J;+5.()[HR
M @4TEN'(%>J5Z-383#2A6![$/<O<<@'B/AR_8XB[5WQP(*Y@&4BGQ;[YYAL@
MKLH^<-R&;@+N=NW:=>O6K7GSYGQE?K-FS1#LA0H5 M J9O_K7__ZW_[MWZ Y
MF%8H$-T C ;<^BHA7[9L6=A=T1@3E2I5JE^_?F1D) )<?BS_'WMG'FU%=>7_
M/WOU;ZWN7JM7VDX;$TV+3#(CH**"8UH31:,H\Z2@!MNH$1.-<8P#X$B<48A#
MVPY)U&B,45%Q5D1009DGY<V/*0HB-OX^?;ZYI\^KNK=NO7>G-^SO'W?5K5M5
MMV[5.9_:=Y]]]A[LI"\%XCPV6)XY<^;2I4L5)RZ(<Z<T5X#&\,8;;[S\\LL+
M%BS@K9P&$)\U?_SC']E&?GFD*A"L6;9LV<=._)^+S/4-+=P:%_]7!H@G<#PE
MQ!,X'H$X!.<J&<1-Y=-N-Y[YE9.2']'K(+B<JEG-\)#"\1#RL)=6YQX4C6P<
MM]1R*1?$0Q9LBBFK[S7K7INS*>1UUH+WX>1[7R7YKZX6I7JXBN8 N/OOOQ_3
M6/#MV[<O_)5_7(G%87J?/GT -]0>.' @6)\]>_833SSQ\,,/WW7779=??ODQ
MQQP#=I5(E@TPPS' 60/!.8[H#+65X5;UV'C+L^&DDTY2I4T17[D,P;K.8<:,
M&3"7!N O3K6;I:D9 [2']]Y[[_WWWY=?GM_+\MRY<^^^^^Y%BQ;5NIA"5BK?
MX<*%"S_\\$,L 'F'??O9V+0N:U50\2=!A7,\^7E0FR_,/*)((_0#FPHGK78^
M<46G<#&%X IRN5DRB+=A82^HI(OF<],$Z:M 7 $&$5-Z8V[%N9Q,\#C-XQQ/
MZ#]UV8)V<X$X3O,(+'*%3^2">)@C);(^K-,F2Y"5BBW!JOWM;W^+)0[!@36&
M<V\G%L"K@L1[]NR)K8T-?L$%%SSYY)/8O\\]]]R\>?->>>65YY]__IY[[CG_
M_/,A,C8UMC:'@L+*A@B15;9MQ(@1F-A*R<(!8?1QQQT'])7%D&7,_!__^,>\
MY7MY!JBRST<??<2#7%RK<]-\!'%-HZ<]Z,\9XH? ]#ONN./>>^_%)*]VCA>>
M3VRC(!;(KM FC[D:-RX:3[93!HCG5;+14)U)=AC^Q?0/AH9,40@?G<*OJW)Q
MXORO_<81_'\"M6:.&\3;L')!7%D@TG.\-4-\<[:,2V6 ^);,?'3-8(2#6.*
M56E2P*[25,'Q PXXH%>O7IC2JMPV;MRXEUYZ"1H"_9$C1TZ>//G22R_%^.4Z
M0_.?__SGV@5!<(@,M4\\\41M><HIIP!NS2'B::%)FYC><!SZ\ZFJ0[ C'V'+
M8]%?>>65&-><I ]!69>1/.- 668UKUR0=]]]=\Z<.7_\XQ_9OL%%-RY>O!@S
MG 6PSC*_5*YA8:XV4S5;SP9/\+J,NZ/M0KS.6>);,ED,!7&6>2**UP9Q4\F5
M#/&\?NW6#/$M07V&K*Z5HD/<?Q362I8$NP<>> !H EG-?5<Y"-@*A57B1P'C
MF-YOO_WV33?=Q$?77W\]VP#EG_SD)YS;CAT[7GSQQ?'CQV.S<RBVA]T_^M&/
M,+VA.>LYCF)=)DR8H'I QV;$QK[._<DGG\Q''$31*:$EKOA"[@MV-U#6A$QY
M"3:ZM,-OO/'&0P\]Q..$CT1Y74/MHID^52Y^R;.X-G! UV3F4M;G4ZD);A#W
M,HBW825 O#9QJDZ;@'@RQXL%\:SN\JVNVJ1ZN/*H@$(@[O->J:P/#,4JA\(L
M8(,?==114Z=.7;!@P5UWW77SS3<__/##SS[[[(,//OC((X\ S0\__)!;\]QS
MSYU__OE[[[TWQCO(QKA6)EL=!]QS?):G3)DR>O1H/E5(^(^<5/6-5U .UF6G
M*Y\X+4'7A)^L2PV.@3L?*;NL2O^@CS_^^$]_^M.;;[[YF:O0IF+06US].2QZ
MN*_L:;PJ_J0A,[3H;YR_=WDAG@S94BL-Q#4DL"DS8Y.^8! WE57)$*]-S?%6
M"_$$CA<1XG&.;W'Y-!I<#(RB]S39!V[*(0ZU-9()T#&0-0,>SIYWWGDOO_PR
M9OB]]]X+N&^YY9;Y\^=S4[!_+[GDDCOOO/.QQQZ;-6N6LEQA<<-H%7*#XQR0
MXRA^\;333ALU:A1&-P0_YIAC0#;;\.3@ZY1*1067.<*,&3.6+ETJ2[S.N3CD
M[EBU:M6B18MDC$-D?2I+G'.[_?;;7WWU59XKV@:R+UZ\F#\0O%5.6II0?;8@
MPL9,6I5V W$U+7J!(.X'-@WBIG(H+\1K4TS;:;40]YR-<WR32[M:(,0C'(_(
MTTK+H.V__NN_P+?*[D#/8<.&L8 MK&@_<#QFS)AITZ8]\\PSO__][__PAS_,
MG3L7K+. V7O##3=T[MQYXL2)F/,8PH 8!+.7,H\/'SZ<!<QPG@W0'$"K$+,J
M^/!X8'OYR@<.''C@@0<J,*9W[]X^=XKWB5>[W+,L\]=AX<*%?/3NN^]"9U[Y
MBP#!Y\R9\Y.?_(1' J=ZU55777;99?QI>.*))_B(C0$ZOU0QYO5-<[?&'Z*%
M^#K*H+P0KW7!.9M=$AA!/(Q.,8B;RJ$$B-<EIO%L*Q#WJ VY7$2(;VU:WCZ4
MMM$R9PO:'GWT4?'TZ*.//NFDDZ9,F8*]S#*V,T@][KCC3CGEE LOO!#+%UR^
M]]Y['WWT$?BN<G/?X2.[/_WTTT\]]13F>:]>O4"P,J)P$ ]QV*H)F4<Z07"^
M3GX;!+LUMPA+G(\...  B(\E#GEW[-BA&\&UU3=J7L_JU:LY#6C.*0GHG,8O
M?O$+SI;#<I!33ST5E/.D80-^(XU!C*O.!*CH"H=7QIOA>2%>4V(5#G$YH/A%
MBN?YS)5G,XB;RJ=DB"=PO/5#/.+<B)ODI8!X>!!]JB-P?(#XN]_]3B8P) 6"
MX\:-&SMV+!3&I@:^*K9YWGGG<?'E/WGVV6>??/))K'+YH#_^^&.0"L2AO^*^
M=2@-6JHJ$ M G(<!"\IOI;Q7FMW#DX-/L=!AMR;^\+W8T1C=7W_]M=BT.5,Z
MLL9-WJ$Q+'4"T+H7G-M++[W$OP1VO....\ WSQMM(X>X;I 2&8IZ(<1EB:?T
MEK0)B.L7A1!7 BR#N*D<R@OQ7!QO$Q"/H[9T$ ]M_-#2ET\<??KII^ 8\H)L
MC.@##SP0>QDS%J3"V1$C1FA\DH5''GE$-OC==]^-80ZR+[[X8E9RG3_XX(/I
MTZ</'#A06<+%<1X,1QUU%+O_\(<_9#W+V-H<"D.;;2 XX);K_,033\1L!^5\
MR@D <?:"Q=ST7;MVZ<)N<O,V-V5J/6N^C^JQ:;263UEF)?\8:"J*.^27*D47
MW!?I='-KW,S,ADQIRDV95..M@> &<2^#>!M6&HC794O''$(\@N.603S"\:R=
M+0'B<03GI6T1(1XQ,R6=>;TK9K;591T!XH,&#>K:M>L^^^S3I4N78YP@[*1)
MDR9/G@QA(7*_?OTPJ)]XXHG77W]]UJQ9PX</![[CQX^_[KKK-,L&4G_K6]_R
MPYB:9'_HH8>RGD.QGB=$MV[=^O?O[\L&\;10(6;XSEN SO>R"Z:ZBD+PS/C\
M\\]U-P4O7A5Y4I4)'*QR=9_]#" V^.*++S:[?+ER!&]V82T*L]/-$L1K,\:X
M?[:E'[0L+<)30#S2.+-"/.Y.,8B;RB'OL].<>T&<'LB?8N7USPOQDBID>E:(
M1T;,(L#=$E2C;S'$$P8M<SG<0XAKOD^=J[[(]>3"/O;88W)&^S0F\!=P@VGY
MM>'LWGOO_?=___=P_(HKKGCAA1>P;0'KBR^^.&W:-(@LTQLBPU_,;7;_?__O
M__W=W_W='GOLL?_^^\OAC@'.IVS#QBSS=>/&C=-D3KX"TUN!ZJA'CQX\!JZY
MYIH//_Q0IZI++<[*Z0'!WW'B3#1K"5310C1ZJ60I_#H?F\AZ%0!2%I$PU"2K
MU[L0U:2>QY#USZ)O5V'##H^6IA%N<2&DFX-\XJS<L6.'KS]N$#>52MY2$,1Y
MS07QB%G4 EN[=!!/B"PLW)V2'N)9W2GZ=%.F7B40?/SQQ[&%X2SXAIX0%KMX
MU*A1L%7SYD78SIT[@U>(#'G/.^^\"R^\\*=.M]UVV^VWWW[GG7?.F3.'YP'6
M^D,//31]^O0)$R:H,!O6][[[[HLESE=P-!7SY)@\(7@ \*C )&?+'_WH1YP&
M'_7ITX=7CL!-YU3K7?:K&N< J7$.<5J"0@R5G5C_S_2@JG+3>5C)1[I!X/[]
M]]]GEQJ7H%4#F\DJ(L2KLP5-%1'B_DNS0IQ7@[BIW HA+O&'FFZI%'0>XKD(
MWGH@GHOC\8'-T$E2=(C'.:[@0F7%XBV7%(C#Z(,..@A+N6_?OMC.8!HS&; "
M="QK.;7YJ$N7+N"8#0#N^/'C+[GDD@<>>$!%EY399I.;72(#_YEGGID[=RX&
M-31GW^[=NT-S%>%4*1_,?P4U_H>3GAELJ;F=-]YX(P\8SE,NH"KG ^$5:QJ"
M\UKGG%=8U@L7+N0$^%$T&WX4P,(,9U_]?$X&@WWQXL7<.ZY#7H(7!>+Q-IF>
MX$6$N"QQS5_E,BI)KT'<5%I%(+YKURX/<2POK+ *$KRY$$^.+]S:TA##ED'<
MJ]:5?=F^?3M&V1=??$$/?^211PX\\$!X#615L1[.RDG2KU\_39%GN5.G3D <
MUF.DWW333<\]]QS@AA3<+TWEYV9M=@G*92,K-2 W[NFGGS[GG',X_O>__WU>
M1XX<R1/BQ!-/E.M<)95Y/>644UC@'#1']-9;;X74G.<F%Y&BB^\38'&IY45A
MF_GSYR]8L("50(IS8 '* W$N@M*F8XPO6K1(%=JJG&<\?N.*J'C+5./)2O"J
M'*,OA4!<P3Q;,PFPO$_<(&XJA^(0UW2/94Z*,:@4P=- W <@)X<8QKTHD>B1
M B&>ZU/U:HUQ<9UY0&+#:MH]>(6>,!J3&4-8P868QC_^\8]5O/A[W_L>&UQ^
M^>58OKK:_':^B^-L<3.\03E(A=JZ4VS#P@<??/#11Q^]]-)+O_C%+PX__/">
M/7L>??31/!@T?(I)/M))9>$X/AMXB'-NHG"]RW-2Y]PI&S9LP/JN<OFP(#6\
M_O###U][[;677WX9BYOU_"B5@X#=G(^&-WGET:(*RQ&#M^A 3^!OUA85M\&+
M"W&-\=K IJE,R@IQ&J+^(&M4*I>E4P:EA'A"E&'<0 X='8TIIMTG0SR78>[A
M7N7".91:A.,#P=FS9\L-#5Y5V$%Y5)0Y5B9YY\Z=__5?_Q4;_/>__[TL7,1O
MAYMWWGGG14Y77WWUZ-&C)TV:]/.?_WS&C!G@GC5SYLQY^^VWH><33SQQX847
M8O)WZ]8-4@\9,N344T_]X0]_.&S8L.'#AW/DTTX[C2]5C2&>(AC[F/,J[*!+
ML3DS!7&5TX=.JJ+YUEMO/?SPP^P"^N?-FP>S5$X$B+,-^-Z0D29MQCD8N8F%
M*!>"(PTUEQ>E<(C7Q0HE;W33[@WBIG(H G'^\M.-:;4J"J%4HI4B>',AGI7C
MR00O+L2W9A.GS<%5]X>?\_[[[]]UUUU '*J><,())Y]\\I%''BF2*H7AH8<>
MRJ==NW;%6K_EEEN6+EVZ<^=.K%T>J,\^^^QEEUV&-<T&O7OWAOY[[[TW6[*@
MO.&P^*RSSGKHH8<6+5KTWGOO/?KHH__YG__9KU^__?;;;^# @5!;HZE\(]^+
M):[IFGW[]CWDD$-FSIS)DYN3U##LYLQ<4RXR7PV7L?$Y&3W7,?9_][O?\=@8
M,V;,^>>??^^]]VK*/C^6C]YXXPV>(K4NOL5GG8V@LU@$KP_B%!,X'B=X<2'>
MF$F M=%RIYC*K!#B*M*FB=<KG(!X+H+'78V5@KB4;(_G(G@1(1Z".\Q#6^^B
M]&258Y8N7+@0B -<  I&@2GF,,8R)-4@)%2%T2Q/FS8-;H)OCL S%31C="OW
M+!NP"]9ZKUZ]E$NK>_?N*N3&T2ZXX((__>E/ !<H/__\\UCK$)\=>4CPJ-!,
M_4&#!FF>)\\,WBHZ!5(#8L'(0UQCIT!94WC\'8?:G-+DR9,5AW[%%5?P=>Q"
MFWGUU5=YA-2[T'@1+7(W_4TLG.#U36L?9^5X@@V>O&]*B-=F<J<8Q$T54 +$
M^6LLB,?MFJSC196%>'ULZJ:('(=X5H(7$>*1HA#JWH(X9BE<GC-G#@S%*%8H
MX3_]TS]UZ=(%O+*R1X\>>^VU%US&@G[[[;>KW=#BBR^^.'7J5,QV< GB(:8L
M:/8"W\JX HO9@(, Z^...^Z11QX!J?PHL'OQQ1>S(\0_\, #V??88X_E2['?
MV5=IL#3:J52T"J'1]=2  ;=83A(5>:AV,X!4R9YMWGSS378</W[\\.'#;[KI
M)LY9Y=EXU1^@5:M6^0)^<8Y''L M4PC39([G K%!7#*(MTEEA3B-=:53FO)L
MK0WB$8ZG<:24%.(Z@HHF<_+0[<$''\3R!:S %'!#;9:5H.KXXX_G%0I??OGE
M_"*.AL$[:]8L+'1L<WB-'<V6RHMRS#''< 157&,OU0E2CO+++KOLM==>DU/[
MFFNNX8#LB+7.OBRS(^P^Z:235-(S##$$XHTNQ%!7OLK%+VHB#W\C:ET!>UGK
MC9FTX^SUS#//W'[[[0\__/#KK[_^[KOOSI\_'TN\R@T&^(J:I8-X?;;:QW&.
M)U.X%!"W?.*F<LBW*D&<MU]^^:6'N*_L4Q,D2\F*\A(Q/2_$DSTJ(933F.&A
M\1ZG<WJ(A]OKF%K#,G]Q'GC@ 86F**T@#%7"$S1BQ BEK[KRRBNY$>P('S'#
M%5L"Q+MUZ\9>0'S"A F3)DT"Q!C7/ ,PJSFF/R#K'WOLL1KGCK_KKKLPDU5+
M"!/^!TY*S\(WJ@P%W%?N%$Z^SDV4YU8*XJM7KY9G1D_T32Y<DNM3[6JML8R]
MR4W!5.=/QL<??\P"'%^T:)&\Y]6N<+"RVM:X"43>!^(?%5D?R?';FHO@$;]*
M72PHMB;F_HXTH?00SW6T!I<[!?G?:Q W_4V["U/>X_M6M<LI#O'D]KW1E;Z5
MM24UE^:Y?)<1 RH!XG&.-S9'<8)[(H>N[>1X\"U-Y_=O#O*LZH1U?#8#XK-G
MS^[:M2OT!)V*_SOAA!,T(?[88X\%TW#\^NNOYR\1W+SMMMLTV1+@8C[W[-D3
MNYN]V/[<<\\%Y1RD=^_>7;IT4<5DECEXOW[]V''5JE5<P">??'+DR)& _HPS
MSL#TYF%PM!/'D7M=5CP0!\&>SMP:75+.07FX5!2BRA4>@]W\'.Y[O7-\:RH3
MVNSBXFDV:]>N5;ATE8M-9 T+=2Z*8W-FCE6-*YTLN"?<XO &Q=E=%Y3HS(7R
M>(-I+L03VF2-2XRCMK?936[BQ_+;.=OTA9(+[,7%DD&\)#*(IX%X(1PO$.+A
M+B'$-P4YGKR9QD=<U7OOO1=2 W$PBFD,2;U9#4R'#!GRRU_^<N'"A8 2V_;J
MJZ^&W7!6R6;91FD.8?&P8<. L@H?*T.ARF:RP$%X#"Q>O)CSF3=OWI@Q8^ [
MV[.CLM1BFRM+K6;V<R8WW723("ZV5CEG2+VKM,DYJWJ]R,XQ:23\9!GFX06O
M=:FO%##.*RR38V%3)FVAWU@73;,<4T(\*\$]Q',1O'"(Q]MJY(0-XJ8D&<13
M0KS%'"\ZQ)5#PQOC(KAVP6+%.K[OOONZ=^\N=S8L!LI0%4!KC!$B8T0KVH_7
MRR^_G(T!+AL<?_SQ?'KBB2>.'CT:2YPUHT:-XA4C??SX\5.<QHT;!\J!,A#G
M2<#)8$1/G3J5IP4H9Z^Q8\?RP% R+ [+>@4=WGCCC8(X5UCWQ?^3X+;R!V*C
MJ_/ K^#$-+N'C[9D\J?K:LB^9GM->*G.5(10$ZIRB5;42&HRR6GK,ZE:DB&>
MB^!U39TP<8(7$>)536,E_=D:Q$U),HBGAW@+.)[5(5XXQ$-C?%.F2C("?]BG
M<^?.Q?Y5B4L0#)>A,!@%IKUZ]6+-Q1=?_,PSS[ ]QB^6>->N73&N6:_9^3#Z
MK+/.@L6\!<?8U[#XM--.PYQ7E(B,]-FS9W,'>6S,GS__/__S/UDYUFGBQ(EL
M"<%/=-)L(RQT07R+RV*HRRYBZE6CFIO<-%'O.6'+K'XD#U]=G*RWLB:3!3/O
M+0[=XG&"QR$>XEO'3$/P%D#<GZI!W)0D@WAR#\_:YT..IU&!$-^4J>#CXU*V
M9O*T-#H_N,"G^3YPV4-<,S:!,F@&Q!C:0X<.Y2.,]$LNN:3!%5BXXXX[6*GX
M$V@+Z $T% ;6K,>XALLJ[P"F55F"S5CY]--/<V)\[Q-//,'V[,BG4%NVO)X9
M' %+7%FQ;KCA!B"^-9/%L-9%7-2[0$.9YW69>8D:H=7%%]85>^,?7;J26S+5
M3743&UVP_!=."MKA"&E\XOY69B5XUO80MMB:V#AD+B4T\C"ZICI(?%B;&=4T
MB)MRRB">!N*1]<WE>+$@[L,*M;VVD1<%<L'3[=NWKUV[%H@KZ[<L:Z"L9%7=
MNW>?,F6*XKZG39O&#^%>+%VZ])9;;E% MVI'0&&YQ56B4W'?@)@%.4S@,B;Y
M?__W?_/ X"+,F3.'YP0'Q\S7W$X>&.S".6@X5)/^%2>NP'9=3T%<ET5DKW,C
MM"QSHWT19%TZ;>"-Z_!VZ*UP[R'.6U:FAWB"PR07P>/ ;3'$U; C$(^<GD'<
ME%T&\;P0S_I1?6H5'>(RNN49UZ$\Q.5.N>^^^S2P*1!C%Y]PP@G*A,5;D ID
MK[WV6GX%!^$*S)LWCVTPE@\^^. #G01?;'D,:E]P64'??9TNN.""/__YSU4N
M]]:,&3-X3O 8P/3FL<%FF/SLR&9]^O3I[^0G^PCBNH;AH&6#F_53Y2),."4>
M#\IL5>]R/WEO>(2;NC6Z'2%G/>YUS+P0CQC@$>PF$#S>A.)*"?&0XS6Q.'>#
MN"FG#.(I(=YBCA<7XI]GY(UQOUZOJU:MNO?>>Z$P1)8W ]-X^/#A<!9S6+,H
M,;3/.^^\5U]]E>NSS665NNFFF\X\\TS,=C; H,9L5\ XNZA"YNC1H_E44_ Y
MU*.//KILV3)V7[AP(=8]E.>+Y$Y!WNO"[N*^<J=HQJ:(7)^9L=F0"2;1S97Y
MO&+%"J4IYJ/01>[1UN F4NJ^Z#IX<][?]PCKFPOQ.(6S$CPOQ..GD0;BD3]\
M!G%33AG$6PSQE!PO$<1#IXKW&O/*5;WGGGLT"1Z& F*E,X3C(T:,4&5Z. Y5
ML:;?>><=X8^]'GKHH9_][&< &NRRF;8!Q"QP$,W@Q]">,&'"[;??SN_:L6,'
M4+[CCCLX/K8V'PUWPNIG8\4R8O*S#/?Y4@QVGSM%[/80Y]=QYMX2YU5Y=3:[
M_"JJSLJ"P%V?<;#(9D<<<_OV[7JPZ>>$8\OU^:)30D,^?M.3(:XV5B#$Y3O*
M!7'OKS>(F[++(-Y<B#>7XT6'N#PG(<3UD0ZX?/GRN^^^NU.G3J*P,JA X6./
M/58Q?ZQ4^/8___,_GWWVV?/FS1,$WW___3__^<\///# &6>< 9$QGSG(O_S+
MO_SKO_[KM[[U+18XU%577?7XXX__Y2]_P4S^Z*./_OC'/UYVV678[%V[=I7!
MC@VN<'(>&#]R@N;Q!%B>W;HX"BO4[9#;1*4U54.9IP4+K.=NJC&H 0"RU4[5
M+M!0 YO;,DFU:EWDHN8!Y85XY([G@GBDE?HV5A2(ZW<9Q$W-5JDA[K?\VHE&
MIMPI/@%6M1N5\O\9:]Q,$-^F??LN$<1K4H]*A9T_@ND$(A0%XHV9J2L18^5!
M%#L  '__241!5%R#>#X(3Y\"2J6B52%C!8T \1_\X = 7-[JH4.'8F)_[WO?
M.^FDDQY\\$&.P*W9XE*3<U->>.$%4#YSYLR++KKHS#//O/CBBR^]]%*6'W[X
MX9=??OFMM]YZXXTW9+ECRRMON&JS'7'$$7"<8T)PUO.]AQ]^.'\(E-00B"MW
MBK>4=7UT(U3N6?$VG,;KK[_^]--//__\\SPM #JWB6<_0-==T!B +'%_%QJ#
M% @Z>$W@6HD\L^/W-"1X!.)Q^!:H2!,-W2F^388M1W]9=(95KK(/'.=RR2K2
MJT&\XZH,$-=K"/'J3"I:#"4:KLPH]3U:,,A6,U7+;B40CYC>/O(D&>)UL2J=
M+8.XWU$^$Q%\NY,V]A#_^../@3AF>/_^_?OUZP<]L865+^644TY1J(D<Y1JQ
MQ+A>O'@QUY/CZ[ <A^N\9,D28/W**Z]\\,$'+"]<N! $O_/..UCK?_C#'YY[
M[KF?__SGRI U<>+$D2-'RM_" 0$Z7Z2X1AX>@YPP_V^^^6:(K!/6[ZIRM80V
MNHQ.+/#5_ HU@+???AN3GP<,]OZ"!0O>>^^]9<N6R807!.M=! L;*Q EC,IO
M:)KPI-;-+:K*-A\R)<2+3NTXQ,,0P]K [^]OO7<*Z>\%EXC;I#[UU5=?&<0[
MM SB;0OBVBMBB8<07[IT*1!7D7L9XXH=//'$$P&K@D98<\())XP=.Q9[?/CP
MX;-FS7KDD4>PLGD \'-4OH/;Q,%UEV6GO_KJJ_?==]^UUUY[R2678)YS0!X2
MO7KU4IIRI0Z7,<ZC0F4V6<D:GA9L<.>==W+7.+(\U_PH93[1'R]:PC:7&WWU
MZM7<>FX-#X\77WR14WKSS3?Y9W#CC3="<S9CS?SY\]]__WWX3CO9FJD3Y"$>
M^9/4UB$>AF#6!CXB_7\RB)L,XFT2XMZI F?]>J$<QMU]]]T:D)05#,HU&_[D
MDT^&L$I+>_SQQX\;-ZYKUZ[?__[W 3TXQG"^\,(+GWCB"2ZR=\'O=H,9_,:W
MWGIKVK1I'$3S/Q7HLN^^^^ZUUUX]>O10GD+EO>(K0#;/"0ZKE2IX/V/&C)4K
M5VI\4L#5O'G5V!2^>0)Q_O*&TTZVN-KV(/O22R_E4/QI^*__^J]''WWTX8<?
M7K1H$4>C&81CF"'$0RZW"8A7Q8(+PTD&.K=ZEVJ&RZ517^5V-G=*1Y=!O/5#
MW(]MAH'A86(_K50LAR .J0_."( "\6'#AD%VI9,=XH1Y#HCWVV\_6 S-6="D
M_"NNN.*IIYY:O'CQJE6KN$<8X/???_]%%UW4OW]_1:UT[]Y]GWWVZ=FSIY*B
M@&D>#Z-'CQXQ8@3&/A8Z1^:IP#'9GA/HTJ4+&X/@)4N6:-Q25T80_\PE0JER
M^;!J77XKI'F8F-X//O@@WX[Y_[.?_>S))Y]\XXTW7G_]]5=>>07BPW=E/6P(
M,EB%!KC'<2N'>-A6XQ"7?%NJ<ED;$4U"^%:W,HAW7!G$VR+$MP5U(>(0O^>>
M>PYU4I@VJ%5:< @.B&$NY%6-GMZ]>\-QQ7'S$73NUJT;&TR9,N622RX!NU=>
M>>4YYYQSVFFGL4OGSIWEGP'ZW_[VM^$XI%:%>_"-D<XK=KJRIO#5'!:"<V0.
MR[=<<\TUG)OB1D*(BY+<;GGY68^)O7;MVH4+%S[^^..< ,^DQQY[[(477I#K
M7!13.Y%C(0+QNJ81)IZA;0OB(<=]&^,WL@V_FNO#>B"^NVEHBD&\(\H@WH8@
M'L^$Y2&N[?D(4,Z>/1N&#ATZ]$@G&=U(5C/,91D<0V%QF;=8T,.'#^=5TS(Q
MHO?88X]__,=_!-9[[KDGFX'CHXXZZKCCCE.6< "]]]Y[?__[W_>1A2KHPP(H
M'S-FC 91><NGFLQYTTTW83O[Z)1ZE_2J*F-':V25\Z]VM9[??//->?/F_?[W
MO[_UUEN?>>89FLJ77WZI0MN0"];K%JBU9(5X32R2K]5"/.N)A8VM+N-+49(9
M>@U7DI5<D&\LQ-!D$&];$ ]WESS$E3T*B-][[[V''WXXR(:J,!?;&8L;C$)5
MD#K 262'X "Z4Z=.8O$))YR $3ULV#"1ND>/'ECK^^^_/]8T]C6(/_#  Y7]
M"NMXUJQ9=]QQ!S;R3W[R$V4J5W0*!SGYY),YB-8HQ) OFCY].G?<CT/*,U";
M*3S&6\Y\V;)EV)B+%BUZ[;776.81Q>7E=>?.G30;\9I?RDH-A&*\U[N9G_Z8
M(<'3L++U0#P\I4A[TQK]=M;PVU>O7LT:@[CI?V40;W,0]]3VFT4@?M]]]REK
MBE*!*Q 0PUP#CWWZ]('OTZ9-^_.?__SHHX^>>^ZYD+J;$^!F^W'CQF&5JRJ;
M KU5G!-!<.@_=>K4UU]_7<720.V%%UZHTIVRUODZ)4U$G ;XYB'!D^"**Z[X
MZ*./Q-D&-UVSQF6C56RX/./5;MH.=Y_#J@(R:S3?AVTP/^5/9X,E2Y9X1TH[
M@'CDE")GI?7\NJTN!Z0@SDJ#N.E_91!O3Q#G51 'TY!4<R995LP?*/<EC&^^
M^6;@R->]\,(+%U]\\<2)$P%N__[]X3@;G^ $FC' H3_K!PT:Q%OL:]:/'CWZ
MJ:>>6KER)=_(';GDDDOX%C\[%.XK@2(;<P[LJ('-JZ^^>NG2I3*Z-V72SWK7
MBK@I8Y-E?L7;;[_]TDLO_>E/?U(CP3R?-V_>_/GS%;$.X@$9WYX5XM5-L[RV
M=8A79]*O*PJ3"Z+">/Q!^<8@;JHXQ*M<NHR&3":-FDS=%@]N@WC$)Q[1IB '
M-V\_^>23.7/F^/3?2EV"40S$X2D(5CZLZ=.G<R.@ %_-Q82,M]UVVVFGG=:Y
M<^?O?.<[??OVA;\C1XX\^^RS.8*2RHX8,0(;G)78XX#[U5=?Y;) TLLOOUP)
MQZ$_X);QS@-#F;!X!F",RR?.QCZP79Z!QDQ:6DY&MU51=*^]]MH33SSQV]_^
M]M>__O6++[[XRBNO//300W???3<G^?CCCV/1\ZLU^SQTB(>6>!SB54T=%UF)
MV7H@'IY5M0L>YS=ZB,L23X!XL_IXB=@2ET&\)"HUQ/\GECM%T^XCN5.\(HT^
M+\0+[%UM!>+A=,UM03)Q/N(K/O_\<_JS+'&L5-@'9S&'59MMP( !JI9Y]-%'
M8T0??/#!K+_JJJODQV OE4/C//_RE[] [6]_^]O_]$__M.>>>P+]BRZZ:,*$
M"3P#8/KIIY\._94>Z]QSSWWYY9>Y+,N6+8.SIYQR"@?_\8]_K!)"2KS% X/M
M62,'SBVWW,(#)IZ'0#?=#])R3S$SERQ9\L$''V!]O_ONNW?<<<>%%U[(HZ+&
MI62@V6"G\[IFS1K5V*QN&ID7&=O<&*3?4<NICCF@DY6W%46XGY+=Z2UQW^24
M.X5?#<<;@]PI&O)57XOT[M V-XBW3Y4?XL5-@-5Q(+XU6V4?@9M+RK75[DN7
M+KW]]MM[].B!-0V%H3D+<HOW[]\?IG?MVA6._^I7O]*WU+J)[W!!\^#GSY]_
MSCGG@&!,<K:$PF>===;DR9-9P :7VX3C\#!X]MEG^470Y-)++\4&9SV\/NJH
MH_@BY2772"D/ -ZR<,\]]X#=\-?)#5+KH@;U Q5"Q^VN<95ZM.4CCSQRY957
M>O\/;8"6P\,#:U337L3E$.*Z*2'$?>,)H9GRUN<UQL,M2P'QAGP)L)(AGI?C
MI8)+3 ;QDL@@WM8ASBNFM.8W8I(#\=MNNZU7KUX:D$3@]?CCCS_\\,,/..
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M2Y>"2Q ,/56VF%=8C($,BP$KKZRY^NJK-44(@_J>>^X9-VZ<"K8I'% );'D
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M)P+E\>/'3YHT"4#+XX&UKK%'P,UZ(*[Q3SZ:/'DR*_D4$&/1\Q%DY[ #!@R
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MU!#/.\ZY+7?A'L_*YD(\UZAI7'D)'H8Y;L\6;I@2Y;EHWBP9Q WBIJ@,XF6
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M<63Z KWFL\\^XWRXU,HHQZOO627MQ<620;PR*@7$L2E4%,(@;A WB"?GZ>2
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MR*X)EEQRBB*(="/2*&HKZD/A>N)\J'5QHCK RC'N5 <)>,W<%IO,]ZVQA0V
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MP(#APX=/GCP9-88^N^>>>VZYY1:.IY#!@P=3_Z%#AXX9,^:..^YXX($'T';
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M6V_EN?/K)Y]\PH  37#TT4>C"6S!CBBI.!-4(Z,0#'S8RIW2VK2)V; RQOG
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MVS37%>*68\?OG@W6^^M94H@WB"0S.J_4Z4+:*+G<Q6[KM2X-MF>+);C9,NH
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MV,6S9\_6P91)@5SN[KOO/NJHHYHU:\:M07-^I<VYY2%#AE#.7GOMA0'.\8"
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M%06Z_T"+A+@QM]S+P1FRNTW\$63H3<YX@[G*()50>9 [I=I%HVH'5-\VRBM
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MO! E$050320E5@CBFH>D>]O238Z7N:WH0^W\((,=X)J31,17I+E8+[SRI#B
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MF3BG3:QAGK<"95[<BUW+!APIQ%-I?#&(\W;2V;[XX@NM]"D$XLG]S9=8X&Y
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M1UMOO?5::ZVUQAIKK+/..AMLL,'&&V\\:-"@S3;;;,,--UQOO?4&#!@P<.#
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MPQ3@SD-(!QMLL('.B4'81TGLVV:;;3;>>&,=&-="MTTVV01!>'80QM_4_[&
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MOOGF,B?>6!G5W?JDP[SJ1;#&5[8;CGF>9*;9<\/_GX3X_P!&C&SJWX"(CP
*  !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>image_27a.jpg
<TEXT>
begin 644 image_27a.jpg
MB5!.1PT*&@H    -24A$4@  #)@   )7" 8   !E^0^N    "7!(67,  $SE
M  !,Y0%USO"5  "+64E$051XG.S="Y<4U;D_X/,=\@7.^0CY"@=$04! 00)B
M1% @ @%%0 7OJ!$D44F,0,)1@]>@"%Y0O(!B5(R*044C<O&&<M$ (B)B_==;
M_X4+L:JGNZNK>V;J>=;:BX S[]ZU^S*9KOW;^[^2#/_U7__U8P,
M     *!WRTR0")@               !4AX )              ! Q0F8
M            5)R "0              0,4)F                %2<@ D
M             $#%"9@               !4G( )              ! Q?W7
MB6$23=,T3=,T3=,T3=,T3=,T3=,T3=,T3=,T3=,T3=,T3=,T3=,TK5I-P$33
M-$W3-$W3-$W3-$W3-$W3-$W3-$W3-$W3-$W3-$W3-$W3-*WB3<!$TS1-TS1-
MTS1-TS1-TS1-TS1-TS1-TS1-TS1-TS1-TS1-TS2MXBT-F"093OXB
M        >B\!$P              @%ZLGIR(@ D              $ O)F "
M              !0<0(F                %2=@ @              4'$"
M)@               !4G8 (              %!Q B8                5
M)V "              !0<0(F                %2=@ @
M4'$")@               !4G8 (              %!Q B8
M   5)V "              !0<0(F                %2=@ @
M    4'$")@               !4G8 (              %!Q B8
M       5)V "              !0<0(F                %2=@ @
M        4'$")@               !4G8 (              %!Q B8
M           5)V "              !0<0(F                %2=@ @
M            4'$")@               !4G8 (              %!Q B8
M               5)V "              !0<0(F                %2=@
M @              4'$")@               !4G8 (              %!Q
M B8                5)V "              !0<0(F
M%2=@ @              4'$")@               !4G8 (
M %!Q B8                5)V "              !0<0(F
M    %2=@ @              4'$")@               !4G8 (
M     %!Q B8                5)V "              !0<0(F
M        %2=@ @              4'$")@               !4G8 (
M         %!Q B8                5)V "              !0<0(F
M            %2=@ @              4'$")@               !4G8 *]
MS/_^[__6W0              ( B80"\C8 (             0*,J$S!I9-%]
M5ZU/GSY)__[]DR%#AB2C1HU*IDR9DEQ[[;7)TJ5+DW7KUB6??OII1ZYQ_?KU
MR?GGGY_TZ]<O&3MV;/IW>IZBCZ. "33G5[_Z54/MHHLN2@X<.-!MQG-B P
M         (!&"9B4U&*![\*%"Y-__O.?R0\__%#Z];WPP@N9XXA_I^<HZW$4
M,(&N-1/DN.FFFTI[CQ<P 0           *"=!$S:T.*4D_OOOS\Y?/AP:=<7
M)UYD]3UNW+C2^J3URGH<!4R@:\V&.5:N7-FMQB-@ @           $ S*A,P
MR5,K&)+GZ-&CR<&#!Y-=NW8EFS9M2AY__/%DP8(%R;GGGENSWK!APY)''GFD
ME-WN^_7KE]EG_'M/5Z5P1%F/8Y7FL!W,9[5T%>88/7IT\NZ[[W9D/
M      #0*@(F301,:MFQ8T=RYYUW)H,'#\ZM.W7JU.233SYIZ77\^M>_SNSK
MO//.:VD_G5"EQ?QE/8Y5FL-V,)_54L^)(9,F34KV[]_?]O$
M0*L(F+0X8'+<H4.'TJ!)WHD4 P<.3#9NW-BBJTB29Y]]-K.?9YYYIF5]=$J5
M%O.7]3A6:0[;P7Q62ST!DVCSYLTKY82J6N,!            @%81,"DI8'+<
MUJU;DS%CQF36[]NW;_+DDT^VI)_PW'//I2==1*@E3L+H#>&24+7%_&4\CE6;
MP[*9SVHY,= Q:M2HFB&3%2M6M'4\             - J B8E!TS"P8,'D\F3
M)V?VT:=/G^3YYY]O65^]D<7\Q9G#UC*?U7)BH..!!QZH&3") ,K;;[_=MO$
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MK);N$C Y/C<QUW$_*>[!Q0:5_?KU2UO\[W@>S)HU*UFZ=&FZ"=S1HT?;.D8
M  "Z)F#2P8!)+!+/ZWOX\.$-UVO%=<0''5DUFMF)_;CWWGNO5P1,HL4''8V*
M\$9W#IC$AU[-B@_+\H(%NW;M:LD8B^BI 9-8H'WFF6=F]G'''7<4JKUHT:+<
M]YQF7^>=?LV4K9E 1SR&<0)-K8!$+/QO),Q09#Q=U7GEE5<*U7KTT4<SKW'[
M]NTM&^/)K9DQ+UZ\N.4U__C'/V;6BA,^&A'/F;RP2I'7?01=LFI&7\V\YN.D
MDEIS&/\=      "HIDX'3-:L69/;?X1 FA7W]#9LV)#<=---R="A0VO>'\UK
ML:'8BA4KDD.'#A6ZQKS[R*UH$8AIQC???),\\, #Z;VB1ON,8,[MM]^>?/[Y
MYX7F!0  @-81,*GQBVS9XI?LO+[CB-9&M>(Z\DXWV+1I4\/C.>[@P8.%YK7=
MCT^MY\3;;[_=<+VOO_ZZH7&7<;VUKNFCCSYJNFY\B)97-W8<:<48BRCKN5/V
M<W+ERI6Y?<3)1T5LW;HUM_:J5:N:JMGIUTS9F@UT[-RY,_V@O-9B_+ONNJMM
MXZE5)TZW*2)"05G7]\033[1LC">? --,."?>LUI=,T[HR:H7-Q@:D7=Z2;1F
M7D?''3ERY,<36DYN<1)5HZ9,F5+S.1W_'0      J*9.!TQB;4+?OGUSQ_#N
MN^\V5&_OWKWI_;P1(T8T')S(:\.&#4LW"&M6=PN8Q/VFV,RP:-^GGGIJ.M?-
MW*\#  "@M01,:OP"6[9CQX[E]AU'IS:J%=<Q8," S!K3IT]/Q]L)[7Y\\OJ+
MTUW:H8SKS:L9"ZJ+B(7+><^9L\XZJZ'G3#NONZBRGY-QLD!6_9$C1[:D_MEG
MGYU9_\(++VRJ7J=?,V4K$NB(#U1K+<:/%D<_MVL\98D3N;*N;>'"A87JYLW9
MG_[TIZ;J1<"JU37C2/.L>O%SLQ$S9\[,K#-APH3"1Z8O6+ @L_;UUU_?<*US
MSCFGYO,Y_CL      %!-G0Z8A*E3I^:.H=%-$B^__/+<6G$_?,F2)<EKK[V6
M!E'BWGF<'K]GSY[DK;?>2I8O7YYN I;UO7WZ]$D6+U[<U/5UEX#)T:-'DUMN
MN26W5MPKB\WH8E.^.+4E6FQ^^>RSSR977GEE;A!HVK1IR7_^\Y^FY@8  (#6
M$#"I\<MSV>(7[KR^^_7KUW"]5EQ'W@<<T>;.G9OLW[^_X7$5U>[')Z^_18L6
ME=9G/?V74;/9#ZU.%,^+O/H??OAAX3$64=9SI\SGY*Y=NW+KSY\_OR5]W'SS
MS;E]-'/T<*=?,V4K&NBXXXX[:B[('S=N7/+%%U^T;3QEB)V$LJYM]NS9A>KF
MS=G33S_=5+V\($R1FG'Z2U:]B1,GUETC'O^\<44XI*B___WON6&0PX</-U3+
M"28      $">[A PN?/..VN&'AJ1%3")<$CT$8&2KL0F8NO7KT_....,S/'<
M>^^]S5[F3UQ[[;69]>/?RQ#7'O<!L_J,:UVW;EV7-;9LV9*,'3LVLT;</Q4R
M 0  Z!P!DPX&3&*'AKR^!PT:U'"]5ES'K;?>6G-.XL. N^^^.UVDVR[=)6"R
M9LV:TOJLI_\R:C[SS#.%Q_NWO_TMM_YCCSU6>(Q%],2 2<Q97OV''GJH)7T\
M\, #N7T\_OCC#=?K]&NF;$4#';%34=[I%,=;?#C]W7??M64\9<FZKHLNNJCE
M-:,U>GSY<1&F:'7-^%F>52\"F_6*]^*\<:U:M:JI<9TH=L[*JQ\[:#4B;G34
M>B[';EP      $ U=8> 2=QWR1M#__[]DV/'CM5=*RM@LG+ERH;'%)N-G7WV
MV3^K%6&5EU]^N>%Z)VMGP"1",U=??75F?P,'#DS^_>]_UUTK-CC-"YE$&"@V
MN0,  *#]!$PZ&##Y\LLO<_L>/GQXP_5:<1W;MV]//\2H-2_1XH25^- @=IZ(
MQ=-EZBX!DT8^""FC_S)J?O#!!X7'&\^!O/J-G+@A8/+_U3I&N!4?+H:77GHI
MMX^%"Q<V7*_3KYFRM2+0\>FGGZ8?CM9:F+]LV;*VC:<,14,6]=:,%D>+-R,^
M\&YUS;S36QIY?.(TJ;P:;[SQ1E/C.M&.'3MRZS_ZZ*,-U8J0SF677999*W:J
M:O1$%       H/?H#@&3N$=9:ZU#A#WJ=7+ Y*JKKFIZ7%NW;DU..>64S'EI
M)/22I9T!D]AL+&]N-VS8T'"]>#P&#!B06>^NN^XJ/-[77W\]F3%C1AI^B8#1
MI$F3DJ>>>JIP70  @-Y,P*3&!PMEB\7]>7W'+[6-:M5UU#HR-JO%+_O777==
M^F%!O3OP=^*ZBO:W>_?NTOJLI_\R:C:[H/I$\4%87OTI4Z84'F,193UWRGQ.
M3ITZ-;?^SIT[6])'+#;/ZV/:M&D-U^OT:Z9LK0IT1+"G5L D6CTAHK(")A&^
M>/_]]]-3;.ZXXX[DBBNN2)^/%UQP07+..>=T.?:B(8LL>36__OKK'E&S7G$S
M(J_&1Q]]U/2XCMN[=V]N_46+%C5<+T(D<9))O,?'<R/^C-.LA$L      *#:
MND/ I-9&G]$V;=I4=ZV3 R9QG[6(O,T&UZY=6ZANNP(FV[9M2S<CS>IKUJQ9
M3=>]YYY[,FN>>NJIZ49^S5JQ8D7N!JO-;+P(  !0%0(F-3Y8*-LKK[R2VW><
M#M*H5EU'[(X1)T_4FIN\-FC0H.1WO_M=\MIKKQ7>9:/5UU6TOT.'#I769SW]
MEU&S%=<4(8*\^HV<7M#.ZRZJS.=D+/C.JQ^+Q%NAUF,V:M2HANMU^C53ME8&
M.I8N75HSC''^^><GGW_^>=O&$^)#]@@+3)X\N>D02;L#)D6.PVYGS7I%0".O
M1BM>1W'26%[]9O[_!@      0);N$#")3=7R0@71GGWVV;IKG1@P:6:3T)/E
MG:XR??KT0G7;%3")$$G>O+[WWGM-UXU[67FGF,3:E69LW[X]Z=NW;\WU+<V<
MN (  % % B8U?IDLVT,//93;=RQ";E2KKR-VL3_CC#-JSE&M=N:99Z:GH11=
M%-_NQR>OO_@@JAW:&;1HQ34=.' @M_Y99YU5>(Q%E/7<*?,Y>?KII^?6+W+"
MPHEJ/69Q-'"C.OV:*5LK QUQRM-EEUU6,Y Q>_;LFJ=!M6H\$:A8M6I5,G;L
MV%*")64&3'I;S;(?@UHM3JD!      !HA>X0, EY885HL0ZB7B<&3)HY%?YD
M<?\T:PU&G-1QY,B1INNV(V 2 9*\.1TW;ESA^O/FS<NL'2>F[-^_O^%ZL>:F
MJS4MUUQS3>%Q P  ]$8")C5^F2Q;G/21UW<S.R64<1VQ$/VNN^Y*A@T;UN4O
MWWDM/@Q9O'AQTQ^(M/OQZ=3SH<S^R[RFHT>/YM8_[;33.CK&LJZ[S/FLM8M*
MD1,63E3K,3OEE%,:KM?IUTS96ADP"7%"27S(6FO1_Y(E2TH=3^P"=..--^;V
M'Z</14#P'__X1[)KUZXTW-158*@[!C=Z2LW1HT=W+& R?OSX0M<.      !P
M7'<)F P=.C1W'"M6K&C;.+),F# A<UQOO/%&TS7;$3!9L&!![IPN7[Z\</T7
M7G@AM_[*E2L;KA?W0KM:RS)Y\N3"XP8  .B-!$QJ_#)9MC%CQN3VO6_?OH;K
ME1TBB(7&L6M$K1,6:K58L!P+E;O3=76'_MK1?]G/C;SZ B:-BX!'7OV8ZU:H
M]9C%#C"-ZO1KIFRM#IB$C1LW=KGP/R]H6'0\$52*W7CR^KWEEEO2<&&CNF-P
MHZ?4[&3 Y)QSSBET[0       ,=UEX!)UBDAQ]O##S_<MG%DF3ES9N:X5J]>
MW73-L@,FQXX=2X8,&9([IV^__7;A/F*3OKSZ,6>-JN<$DZNOOKKPN $  'HC
M 9,:OTR6Z8LOOLCM=^+$B4W5;-=UQ,[WZ]>O3W_9[M^_?Y>_E)_8A@\?GNS=
MN[=;7E>G^FM'_V5>4RQ$K_5X=W*,95UWF?,Y<.# W/H'#QYL21^U'K/HOU&=
M?LV4K8R 2;C[[KMK+OP?.W9L\MEGG[5\/+'#3UZ?M]YZ:Y<GE>3ICL&-GE(S
M'NN\&O&!/0      0$_070(FM=8Q//'$$VT;1Y;++[\\<UQ%3@$I.V#RSCOO
MY,YG;#K9JHT2\T(L\7@VVL>V;=N2/GWZU%R_\N*++[9DW    +V-@$F-7R;+
M]-!##^7VV^P'!YVXCL.'#R?///-,,GOV[)HG+YS89LR8T5 ?[;ZN3B^6;V?0
MHA4?].S>O3NW?IQ:4W2,S3IRY$AICV69SY%1HT;EUM^S9T]+^JCUF,5)"HWJ
M]&NF;&4%3.(DD;ESY]8,F<1N//%<;M5X]N_?GYQ[[KF9?8T?/SY]3V]6=PQN
M])2:4Z9,R:UQZ-"A0F,#      !HE^X0,(G-NVH%"YY[[KFVC"-/7L#DCCON
M:+IFV0&3./4E;SXON.""EO01)DV:E-O/!Q]\T'"]6NMR%BQ8T+)Q P  ]#8"
M)C6"$&6*A;Q9?49((Q9_-Z/3B[SC9))ERY8E0X<.K3FOT=YZZZVZZ[;[NCH]
MCV7TGU<S%IL7%1_DY-6/1=-%QQB+\)OQG__\I[3'LLSGR&]_^]O<^CMW[FQ)
M']NW;\_M8_KTZ0W7Z_1KIFQE!4Q"A(;B0]=:(9,[[[RS9>-Y^NFG<_NY]]Y[
M"UU+=PQN])2:5UUU56Z-??OV%1H;      ! NW2'@$FL6ZBU5F'SYLV%ZA\X
M<"!9MVY=NC8B-I,;-VY<,G+DR.2,,\ZH>U/.K/;[W_^^Z3&5'3!9N'!A[KAC
M#EIEUJQ9N?T\]=133=7<N'%C<LDEER2GGWYZ>MI*A%B>?/+)EHT9  "@-Q(P
MJ?$+?%E>?_WUW#[GS9O7=-WNLL@[=EN/!=&U=@6YY99;ZJ[7[NOJ]#R6T7]>
MS5V[=A4>[_///U_JX_S--]\T-:ZXMK(>RS*?([4^G/O'/_[1DCXV;-B0V\<?
M_O"'ANMU^C53MC(#)N'--]],3ZZI%3)YX8476C*>&V^\,;>/?_WK7X6NHSL&
M-WI*S<6+%^?6^/CCCPN-#0      H%VZ0\#DO??>J[D.)#: :]0//_R0//OL
ML\GLV;.3?OWZU:S?;(O[Q,TJ.V!2*_BQ:-&BEO01XEYF7C_QW (  * ]!$QJ
M_ )?EJE3IV;V%[M9[-BQH^FZW6V1]_KUZW-#)N>??W[===I]79V>QS+ZSZOY
MVFNO%1[OW7??G5O_B2>>J+M.__[],VO$223-J!7D*JK,Y\CCCS^>6__!!Q]L
M21_WWW]_2QZSXSK]FBE;V0&3<-]]]]4,F)QWWGG))Y]\4G@\TZ9-R^WCJZ^^
M*G0-W3&XT5-JKEV[-K?&JZ^^6FAL        [=(= B9KUJS)'4.<8A%AD4;$
M9G$77GAA0V&19EIW#IC$J1]E7W]7;?[\^2VY%@   +HF8%+C%]0RQ.+MO/[^
M^,<_%JK='1=YQS&N66,:/'APW37:?5V=GL<R^L^K^< ##Q0>[^677YY;?]NV
M;777&39L6&:-[=NW-S6N%2M6E/98EOD<^>*++W+KWWSSS2WIXW>_^UUN'[MW
M[VZX7J=?,V5K1\#DV+%CR3777%,S9#)CQHSDVV^_+32>"*KDU?_NN^^:'G]\
M$-\=@QL]I>;GGW^>6^/AAQ\N-#8      (!VZ0X!DUAWD3>&N-_6B+_\Y2\U
MUY2,'#DR_9J77WXYO=]SZ-"A+@,L>??7NW/ )#80K3<(4E:[ZJJK6G(M
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M"IBTL.;NW;O3W;5.KA6AD-@QJQ'Q6,;[ZLFU&@GMG6S*E"DU'^^I4Z<V71L
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M;5@9]XJ*B--+1HP8\;.ZZ]:M:[KFBA4K?G9MQUO<;P,  "";@ D
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M#.W9L^?'N8E39IY[[KGDAAMN2$X]]=2??5^<7!+74E1<<U?S>_755Q?N!P
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M    V01,          "@AL\^^RQY]-%'DQMOO#$-P8P8,2+IW[]_&I(8,&!
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M:44#      " WD# !               H.($3                "I.P 0
M             *#B!$P                J3L $          "@0;_XQ2^Z
M11L_?GRGIZ*P3L]A;YK+$W5Z/GOKO/[RE[_L%FW6K%F=GHK".CV'O6DN3_2K
M7_VJ6[3;;KNMTU/14IV>3_-J7AO1Z?GLK?-:%0(F                %2=@
M @              4'$")@               !4G8 (              %!Q
M B8                5)V "              !0<0(F
M%2=@ @              4'$")@               !4G8 (
M %!Q B8                5)V "              !0<0(F
M    %2=@ @              4'$")@               !4G8 (
M     %!Q B8                5)V "              !0<0(F
M        %2=@ @              4'$")@               !4G8 (
M         %!Q B8                5)V "              !0<0(F
M            %2=@ @              4'$")@               !4G8 (
M             %!Q B8                5)V "              !0<0(F
M                %2=@ @              4'$")@               !4G
M8 (              %!Q B8                5)V "              !0
M<0(F                %2=@ @              4'$")@
M !4G8 (              %!Q B8                5)V "
M  !0<0(F                %2=@ @              4'$")@
M     !4G8 (              %!Q B8                5)V "
M      !0<0(F                %2=@ @              4'$")@
M         !4G8 (              %!Q B8                5)V "
M          !0<0(F                %2=@ @              4'$")@
M             !4G8 (              %!Q B8                5)V "
M_#_V[L1;BNK<&_#_=@4%'% B(!HG4!0%)U#BYP )HBARC6,<",:9*VIP"(J*
M(ZZHB'%"$6<% 451E(L(6-]Z._><',ZIZK&ZN[KK>=:J=:.>WK6KNFIWU5WO
M;V\              $I.P 0              *#D!$P               !*
M3L $              "@Y 1,                2D[ !
MH.0$3                $I.P 0              *#D!$P
M  !*3L $              "@Y 1,                2D[ !
M    H.0$3                $I.P 0              *#D!$P
M      !*3L $              "@Y 1,                2D[ !
M        H.0$3                $I.P 0              *#D!$P
M          !*3L $              "@Y 1,                2D[ !
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M#&CV_ P-F,R;-R_SGA[87GSQQ9R/)MW0:W;RY,G)K[_^*F#21KTT1I /WSD
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MLW4[^%T         H(P$3&KH9,"DVG[JV:+PH9:85;;1=J/89JCXYWH_.[S
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MO)Z5.CW^#O7&&V\D%U]\<26TT<R]'I^+]X>X)S9MVM127\KRNP
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M]\$''U0"",WV*5;0&!JBZ.6 2=Q_L5))WF/(::>=5EE=K9%5!LOVNP
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MZ<S^_?[WOV_I>@WQ[);5?I$")A&VS@J.3Y\^O>5^#OCVVV\/VD^S 9.R_BX
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M#85XVA$P*?I[7CQ;97TNS^?EK/NN* &3&%^SSL,UUUS3<A_S5N;?!0
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M7W755;GUJQ,%#@\__'#F]U"M8+E:04NGMHLNNBBW\]!.G2S^B=EJL_95E-!
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M6P1&PY(E2P;_702FFUEYJ1T!DZ*_YU7K7Y[/RT4/F'3RO:$9?A<
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MU:JF^Q6AC:Q04!YC1,ASG,@*?\7OT1=??-%R7U>O7CVB[5BIJUIXVN\"
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M6DE;;2;O,2+D/4X\_?33F?U]Y957FNYG!(F&MW?222?5#.S[70        "
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MOG1BQNYZ9M", K*L O)ZMIAU=OWZ];GV.XKTLV;U;G2+64^CL+-?O?WVVY6
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MUUR3>G\??_SQR:I5JY)]^_9UNXO04>U\/UJV;-F(>VW"A G)@0,'<ML'
M      !TFH!)'[GDDDL&BYLNO?32CNY;P3) ;S!>0_^* ,FL6;-2[_'8CCKJ
MJ.3**Z],'G_\\63#A@W)CAT[*JN;_/;;;]WN.K1%.]^/AJZ,,G3%(
M    RF=HMF+XUFL$3/I$S,8;L_(.%#>M7[^^H_M7L S0&XS7T-]^^.&'9/KT
MZ9DADZQM_OSYW>XZY*K;[T<          )2'@$F='Z1S;KGEEL'BJ9A-M],4
M+ /T!N,U]+_=NW<GYY]_OH )I=;M]R,          ,I#P*3.#]*<W_WN=X/%
M4*^\\DK-OX\BPB...&+P,RM7KNQ +P^F8!F@-QBOH1SV[]^?W'GGG<GHT:,%
M3.AYO?A^!           O4C I("&%E M7[Z\YM__[6]_&_S[\>/')WOV[.E
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ME;STTDO)M&G3#OJ[-6O6=*1_)Y]\<FIQ<KW;N''C.M)/@+(S7@/0#XK^?@0
M         /U"P*2 AA=0U;/=<LLM'>N?@F6 WF"\!J ?%/W]"
M^H6 20$U4D U=NS89/GRY1WMGX)E@-Y@O :@'Q3]_0@          /J%@$D!
M??_]]\G:M6N3VVZ[+9DS9TYRZJFG5HJJ#CWTT$K!U*1)DY*++KJH4CBU8\>.
M;G<7  "@;;P? 0        ! 9PB8                E)R "0
M    0,D)F                )2<@ D              $#)"9@
M      "4G( )              ! R0F8                E)R "0
M        0,D)F                )2<@ D              $#)"9@
M          "4G( )              ! R0F8                E)R "0
M            0,D)F                )2<@ D              $#)"9@
M              "4G( )              ! R0F8                E)R
M"0              0,D)F                )2<@ D              $#)
M"9@               "4G( )              ! R0F8
ME)R "0              0,D)F                )2<@ D
M $#)"9@               "4G( )              ! R0F8
M    E)R "0              0,D)F                )2<@ D
M     $#)"9@               "4G( )              ! R0F8
M        E)R "0              0,D)F                )2<@ D
M         $#)"9@               "4G( )              ! R0F8
M            E)R "0              0,D)F                )2<@ D
M             $#)"9@               "4G( )              ! R0F8
M                E)R "0              0,D)F                )2<
M@ D              $#)"9@               "4G( )              !
MR0F8                E)R "0              0,D)F
M )2<@ D              $#)"9@               "4G( )
M  ! R0F8                E)R "0              0,D)F
M     )1<7P9,AO;-9K/9;#:;S6:SV6PVFZV=&P        ! /ZBG'D+ Q&:S
MV6PVF\UFL]EL-ILM8P,         Z ?UU$,(F-AL-IO-9K/9;#:;S6:S96P
M         /V@GGJ(G@N8                4#\!$P              @)(3
M, $              "@Y 1,              ("2$S !               H
M.0$3              " DA,P 0              *#D!$P
M@)(3, $              "@Y 1,              ("2$S !
M   H.0$3              " DA,P 0              *#D!$P
M    @)(3, $              "@Y 1,              ("2$S !
M       H.0$3              " DA,P 0              *#D!$P
M        @)(3, $              "@Y 1,              ("2$S !
M           H.0$3              " DA,P 0              *#D!$P
M            @)(3, $              "@Y 1,              ("2$S !
M               H.0$3              " DA,P 0              *#D!
M$P              @)(3, $              "@Y 1,              ("2
M$S !     (#_W[Z=VP 0PT 0Z[_K2YT<_&3VD,!&4@L#        <0(3
M          " .($)              ! G, $               @3F "
M           0)S !              "($Y@               #$"4P
M          #B!"8               !Q A,              ( X@0D
M         $"<P 0              "!.8 (              ! G, $
M         (@3F                ,0)3                .($)@
M         '$"$P              @#B!"0              0)S !
M        ($Y@ @              $"<P 0              B!.8
M        Q E,                X@0F                <0(3
M      " .($)              ! G, $               @3F "
M       0)S !              "($Y@               #$"4P
M      #B!"8               !Q A,              ( X@0D
M     $"<P 0              "!.8 (              ! G, $
M     (@3F                ,0)3                .($)@
M     '$"$P              @#B!"0              0)S !
M    ($Y@ @              $"<P 0              B!.8
M    Q E,                X@0F                <0(3
M  " .($)              ! G, $               @3F "
M   0)S !              "($Y@               #$"4P
M  #B!"8               !Q A,              ( X@0D
M $"<P 0              "!.8 (              ! G, $
M (@3F                ,0)3                .($)@
M '$"$P              @#B!"0              0)S !
M($Y@ @              $"<P 0              B!.8
MQ E,                X@0F                <0(3              "
M.($)              ! G, $               @3F "               0
M)S !              "($Y@               #$"4P               #B
M!"8               !Q A,              ( X@0D              $"<
MP 0              "!.8 (              ! G, $              (@3
MF                ,0)3                .($)@               '$"
M$P              @#B!"0              0)S !               ($Y@
M @              $"<P 0              B!.8                Q E,
M                X@0F                <0(3              " .($)
M              ! G, $               @3F "               0)S !
M              "($Y@               #$"4P               #B!"8
M              !Q A,              ( X@0D              $"<P 0
M             "!.8 (              ! G, $              (@3F
M             ,0)3                .($)@               '$"$P
M            @#B!"0              0)S !               ($Y@ @
M            $"<P 0              B!.8                Q E,
M            X@0F                <0(3              " .($)
M          ! G, $               @3F "               0)S !
M          "($Y@               #$"4P               #B!"8
M          !Q A,              ( X@0D              $"<P 0
M         "!.8 (              ! G, $              (@3F
M         ,0)3                .($)@               '$"$P
M        @#B!"0              0)S !               ($Y@ @
M        $"<P 0              B!.8                Q E,
M        X@0F                <0(3              " .($)
M      ! G, $               @3F "               0)S !
M      "($Y@               #$"4P               #B!"8
M      !Q A,              ( X@0D              $"<P 0
M     "!.8 (              ! G, $              (@3F
M     ,0)3                .($)@               '$"$P
M    @#B!"0              0)S !               ($Y@ @
M    $"<P 0              B!.8                Q E,
M    X@0F                <0(3              " .($)
M  ! G, $               @3F "               0)S !
M  "($Y@               #$"4P               #B!"8
M  !Q A,              ( X@0D              $"<P 0
M "!.8 (              ! G, $              (@3F
M ,0)3                .($)@               '$"$P
M@+CCP 0              ( W"$P               #B!"8
M  !Q A,              ( X@0D              $#<4F R/IF9F9F9F9F9
MF9F9F9F9F9F9F9F9F9F9F=D;$YB8F9F9F9F9F9F9F9F9F9F9F9F9F9F9F9G%
M)S Q,S,S,S,S,S,S,S,S,S,S,S,S,S,S,S.+;RLP^;T               !P
M/8$)              ! G, $               @3F "               0
M)S !              "($Y@               #$"4P               #B
M!"8               !Q A,              ( X@0D              $"<
MP 0              "!.8 (              ! G, $              &#J
5 [%QF2WG2(Z@     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>image_28a.jpg
<TEXT>
begin 644 image_28a.jpg
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MHI@$              "@CR@F 0              Z".*20
M /J(8A(              ( ^HI@$              "@CR@F 0
M    Z".*20               /J(8A(              ( ^\A_%))JF:9JF
M:9JF:9JF:9JF:9JF:9JF:9JF:9JF:9JF:9JF:9JF:=K(;8I)-$W3-$W3-$W3
M-$W3-$W3-$W3-$W3-$W3-$W3-$W3-$W3-$W3^J@I)M$T3=,T3=,T3=,T3=,T
M3=,T3=,T3=,T3=,T3=,T3=,T3=,T3>NCMDLQ"0               /62MS9$
M,0D              $"-*28!              #H(XI)
M^HAB$@              @#ZBF 0              *"/*"8!
M  #H(XI)                ^HAB$@              @#ZBF 0
M     *"/*"8!              #H(XI)                ^HAB$@
M        @#ZBF 0              *"/*"8!              #H(XI)
M            ^HAB$@              @#ZBF 0              *"/*"8!
M              #H(XI)                ^HAB$@              @#ZB
MF 0              *"/*"8!              #H(XI)
M^HAB$@              @#ZBF 0              *"/*"8!
M  #H(XI)                ^HAB$@              @#ZBF 0
M     *"/*"8!              #H(XI)                ^HAB$@
M        @#ZBF 0              *"/*"8!              #H(XI)
M            ^HAB$@              @#ZBF 0              *"/*"8!
M              #H(XI)                ^HAB$@              @#ZB
MF 0              *"/*"8!              #H(XI)
M^HAB$@              @#ZBF 0              *"/*"8!
M  #H(XI)                ^HAB$@              @#ZBF 0
M     *"/*"8!              #H(XI)                ^HAB$@
M        @#ZBF 0              *"/*"8!              #H(XI)
M            ^HAB$@              @#ZBF 0              *"/*"8!
M              #H(XI)                ^HAB$@              @#ZB
MF 0              *"/*"8!              #H(XI)
M^HAB$@              @#ZBF 0              *"/*"8!
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M\O[[[V<>(W:7@EY5M_%,;_KCCS\:NU^FW4OM^IFSF9DS9[J?Z3KS:__P70,
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M9RD       ! +U-,DN+==]]M)/,W*RBY^^Z[.]:?O"(!9.G2I<F?__SG1E)
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M6NUG$8,_7W0'V0%OO?56:K]B[BNCW^;W5OK9#O'W %G'BU;GOR<
MJ()BDIPB6;]9,4FTM6O7=JP_[;)ERY;4<[OJJJM*Q<VZ9D57MHQ$HZIC1O)K
M6KR33SXY5YPSSC@C-<XQQQQ3*FDVQ$JX:;$OO/#"4G&SG'766:G'.^&$$RJ)
M?_SQQZ?&/_OLLPO%&VG%)''/#"2[Q*Y!><5.'%G),X<>>FCI^S%K5>)]]MFG
ML8-'%88FJ]6M3[%S4%I_#CSPP$KZDK4+R[1ITW+'ZF1B6Q6R8N<M !P0.UIE
MC96J^]BKFB7<5=7BWH^5HLL6OX:I4Z>F'F/2I$FEY[=9LV:EQC[UU%,+Q<NZ
M'N>>>VZI?D:A:5;A2^R$,-R\5Z<Y*F1=QX,//KB2_A8Y=IV.UZOS9MRG,6[3
M8D7AV8X=.PKU;\ YYYS3]?DXJ[ N6E7O)YTR4N:-HO?].^^\4WG,-]YXHY*Q
M-%2O/GM:[6>WQ;M*6K]BUXXR^FE^;[6?[="LD#!:_'<       " ?J:8I("%
M"Q<V+2:)I,8OOOBB8_UIAUBU,NW<HJB@C*QK]N233Q:*EU7T4B9F)(NDQ3OV
MV&-;CA'??U:_HA"DK%@A-"WV(8<<DFS?OKUT_,&^_/++S'.)U:.K\->__C7S
M&$56DAU)Q22Q2]! HLNX<>,:JZ?G]<HKKS1-H"FS4T?<'UEQHXBE*G$?M)IH
MU&M]VKQY<V9_+K_\\DKZ<MEEEV4>X_///\\5JY.);57(BEVD\"K$:NII\?;=
M=]_*^]BKFLT795H49<;W$D6;98L\!GSVV6>9Q_OSG_]<.G[L.)>5>/C33S_E
MCI?5UWONN:=T7[,*7Z)]^.&'F9^KVQP5LF+%CE'MUNGQW,DYN=OSYN!WGJ$M
M[N^R8IQU>SYN5DQ2U;S8"2-IWH@=5HK(*C H$S/K';;,.TCHQ6=/GGYV6Q2R
MI?4K"JK*Z*?YO=5^MD,4N&4=+UI=_YX         H"J*20KX^>>?,W>=&&BQ
M\NVOO_[:D?ZT2]IYQ0X25<>,]O;;;Q>*%X435<?\\<<?4^,=<<01+<=8OGQY
M9K^6+EU:J%^#_>M?_\J,_]IKKY6./]B*%2LRC_788X]5<HQ''GDD\Q@K5Z[,
M'6\D%9-<<\TU.Q-=+K[XXD(Q(CDQ"HVR$F@NN>22POU;MFQ99MP[[[RS<-PR
M>JU/CS[Z:&9_[K___DJ.<>^]]V8>(^\X[61B6Q6R8A<MDHHBQ;1X4<Q5=1][
M5;.$N[+MQ!-/3%YXX87*^AK/CZQCW7WWW:7C#]V!:'#+NQ-=R(H5S_6R[KCC
MCLSX,0]EJ=L<%;)B/?[XXY7TM\BQZW2\7ITWFXWG*I[?,6:[/1]/F# ALP^Q
MRT-=C*1YH^A]'S\S5ATSBL:K&$M#]>*S)T\_>T%:OV+WG*ICCM3YO=5^MD,L
M@)%UO&A5+9 !        4%>*20KZ]--/DRE3IC0M*%FT:%''^M,.90LJ6HU9
M=/>)$$GR5<?,VI4ES_=SXXTW9L9X^>67"_5KL/7KUV?&+[KJ:):;;KJIK><2
M7GKII<QCW'SSS;GCC91BDBA(FSAQ8NDDH!!)F%D)-$5W/ E777559MQ(PNZ&
M7NO3E5=>F=F?JI+JGW_^^<QCQ/7(HY.);57(BIUGA[#!FB6'5MW'7M4LX:Z9
M*/#\Y)-/&@5=,V;,:!KGTDLO;13GEA6[?;5S?#7;*>&NN^[*'2\K5JSR7]8S
MSSR3&;_93@%UFZ-"5JSWWGNODOX6.7:=CM>K\V:SG2A6K5I5J&^#-=O)J%,F
M3YZ<V8>B[V+=,)+FC:+W??P<6G7,^#FTDV.^F\^>//WL!6G]ZL6"BEZ=WUOM
M9SO$3G+3IDU+/5[L+A/G"        -#/%).4$ DNS8I)HK623-.N9/=(<'GW
MW7<;*[<N7+@P.??<<QLK@L?_,(]="H;K>SL2\K-BEDF>ZF3,5LV>/3LS1B3:
MEO7UUU]GQK_NNNM*QQ_L_///SSS6IDV;*CE&Q,DZQIPY<W+'&RG%)+$KS$"B
M2XS9&--%Q3VSVVZ[92;N%"U".NFDDS)C?OSQQX7[6T:O]2GFW:S^;-BPH9)C
M1(%9UC%FSIR9*U;=$L:R8F_;MJU0O!T[=E3>WUY.CDR3U=^\?5ZR9$DR:M2H
MS%@GGWQRXWJ7T6Q\??311Z5BAR^__#(S_D47790[7E:L[[[[KG1?/_C@@\SX
M)YQP0N;GZC9'A:Q8\7VU6Z?'<R?GY&[/F\V*T*H8SUNW;NWZ?!P_AV7UH8K$
M_DX92?-&T?N^TS'+Z,5G3YY^5B%^CGKCC3<:.^?,FS<OF3Y]>G+000<E>^^]
M=S)FS)C,8P_7RNBG^;W5?K9+%)3$#B0''GA@,GKTZ,:O\7=D"DD
M%).4CA6[)C0KO#CRR".3SS__O&/]"=]^^VUCM>Q(R"I:,-+I8I)8A;4.,5L5
MB3-9,:I(6(C5W+/B1_%'E9J=2]QK5?CFFV\RCQ'):GF-E&*2TTX[;6=B3>PL
M4M8YYYR3F;AS[+''%HH9US4K9B>2>NO0IV;]B2*?*C1+>(]$N3SJEC"6%;M,
MD4+5_>UTPEQ9529-/O#  TWC%5E=?K!(!LR*7<4J__&\S8I?Y/G4COMU0+-Y
MH-G.<G6;HT)6K$XDA79Z/'=R3N[VO'GXX8=GQBFZX^!@[4J*SF/6K%F9?5BW
M;EW'^E'62)HWVG'?=WLL=:*? XH^>_+TLXRX'V/7T ,.." S?IE61EV^Z[J<
M.P        #%*"8IZ==??TW./OOLIL479YUU5N//M;L_43RQ=.G29,J4*6TI
M(FEG,<E(B]GN[Z!9*Y+<6O1<JDK:C(3?K&-$059>(Z&8)%:G'EC1/W84J2*)
M\KGGGFN:#!4K"^<U?OSXS'AE5F4NH]?ZU*P_522[ASBOK&-,F# A5ZRZ)8S5
MH;]U2YBK.FDR=D9K%O/?__YWX;XV&U_M;E4F,U>AV3PP>?+DS,_5;8X*6;'*
M[.!5]MAU.EZOQMQWWWW;?B]V>SY>L&!!9A_6K%G3L7Z4-9+FC3+Z.>: HL^>
M=O<SBB?NOOONMK\GE"%F]^9B         /Z/8I(*Q,XC4Z=.;9K@?]---[6U
M/[%R]B677))Y_%@5](8;;F@D*462>B3Y#)=PUXM%&G6)>?#!!W>MF.2HHXXJ
M=>YYSJ7,[B^#19RL8QQRR"&YXXV$8I)%BQ;M3*J)@K4J1%)5LT3-:Z^]-G?,
M*'3)BE?%:L=%]%J?FO6GJC'4;+7UT:-'YXI5MX2Q.O2W;@ES52=-?O'%%\FX
M<>,R8\8[5-$B@&;CJ]UMXL2)N?O;SGNAV3RP^^Z[9WZN;G-4Z.:8ZO2QZS#'
M515S[-BQ;;\7NST?KUBQ(K,/L9-379@WQ!Q0]-G3SG[&WXV<>>:9F?'BG>3R
MRR]/GG[ZZ633IDV-@ICAWD/J\KWT<TP         BE%,4I&U:]<.F^2_>O7J
MMO0G$G;FS)F3>=PKK[RRT&K\O5BD49>8W2PF*5)\T4S$:W<Q220A*2;Y/Y',
M=."!!V8FV;2K16)TLUV4TD0R7U:\;A63]%J?.M&?9HE\8\:,R16K;@EC=>AO
MW1+FFLT310TND$MKL7-2$=TL)LD[MD([[X6B";UUFZ-"-\=4IX]=ASFNJIC-
MBDFJNA>[/1]'47]6'^;/G]^Q?I1EWA!S0*\5D\3/IR>==%)FK%FS9B5;MV[-
M%;.JOHG9WI@         %*.8I$*+%R]NFN0_9<J4Y+///JN\/TN6+,D\YM57
M7UUXM>]>+-*H2\SXKK-B_/[[[Z7ZUFG-SN7''W^LY!BQ4T[6,8X\\LC<\>I>
M3!+%:5D)-NUN*U>NS-77"1,F9,;Z_OOOVW2%ZM6G3O0G"@:SCA''SZ-N"6-U
MZ&_=$N::S1%%Q3P?!6M9<:=/GUXH[OCQXS-C]N+S-JNO1=_5!FLV#^RWWWZ9
MGZO;'!6Z.:8Z?>PZS'%5Q9P\>7);[\489[TP'T?1>97S8#>8-T9&S&X^>_+T
M,X\[[[PS,\[<N7,+GW/=O^M^B D       ! ,8I)*A2K8,9*E\T*2LXXXXSD
MEU]^J:P_WWWW77+888>E'NNHHXY*MF_?7OA\>K%(HRXQ3SCAA+878'3*B2>>
MF'DNWWSS327'B#A9QXB59?.J>S%)[#24E6#3[G;:::?EZNM!!QV4&>NKK[YJ
MTQ6J5Y\ZT9\OO_PR\QB1M)I'U<E=\<QK9\)8'1+<ZI8PUVR.*".*;IO%_O>_
M_YT[9K-=G** I==D];6*=X-F\\ 11QR1^;FZS5&AFV.JT\>NPQQ75<RX3]MY
M+\:<T OS\0TWW)#:A]AMX^>??^YH7XHR;XR,F-U\]N3I9ZNV;-F2N<-1%+26
M.=^Z?]?]$!,       " 8A235"R29XX^^NBF!2610%15?YY\\LG,X]QUUUVE
MSJ47BS3J$G/V[-EM+\#HE"ALR#J739LV57*,C1LW9AXC5I#-J\[%)%$@%LF$
M PDUZ]>OK_P8RY8MRTS@&35J5+)Y\^:68\V<.3,S5COZ7L<^14%45G\V;-A0
MR3$^_OCCS&.<?/+)N6)EQ8F"R2*V;MW:UH2Q.B2XU2UA+JN_9?L<JY<W6\T^
M;S%;B(+'K'C=*FAK)JNO7W_]=>G8[[__?F;\*'+-4K<Y*G1S3'7ZV'68XZJ*
M&?=I5IP//_RP5/]"S F],!^_]]Y[F?V(W>GJP+PQ,F)V\]F3IY^MBAU;LV(,
M_3N8O.K^7?=#3         "*44S2!J^\\DICM=9F!27//OML)?VYY))+,H_Q
M^NNOESJ/7BS2J$O,&V^\,3-&%$[4R<TWWYQY+D56D4_STDLO91[CEEMNR1VO
MSL4D#SSPP,YDFADS9K3E&#_]]%,R?OSXS"2>18L6M1QK_OSYF7'6K%G3EO[7
MK4]77755V_NS>O7JS&/$]<@C*T[<-T5$<5([$\;JD.!6MX2YK/Y6T>>__O6O
M3>._\\X[N>)=<<45F;$B$;G79/4UDG'+>OKIIS/C7WGEE9F?J]L<%;HYICI]
M[#K,<57%;#:>5ZU:5:I_H5G2>Z=E%<)=??75'>W'1Q]]E-J/:=.F-?V<>6-D
MQ.SFLR=//UL5N\!FQ8B?-\NH^W?=#S$!        *$8Q29O<???=38M)CCCB
MB)V[.I3I3ZS GW6,+5NVE#J'7BS2J$O,IYYZ*C/&/__YSU)]Z[25*U=FGLNC
MCSY:R3$>>>21S&-$@E)>=2XFF3IUZLYDFL<>>ZQMQ[G\\LLSDW@..." Y(\_
M_F@ISC_^\8_,./?>>V_;^E^G/L7WF-6?^^Z[KY)CW'///9G'B)UH\A@W;EQJ
MG-AAI(@H.FMGPE@=$MSJEC"7U=\J^ARKH(\=.S8S_GGGG9<KWM*E2S-C59%\
M7K6LOBY?OKQT[,6+%Q>:!^HV1X5NCJE.'[L.<UQ5,>.],BO.'7?<4:I_(=[/
M>V4^SBJ4F#AQ8O+KK[]VK!]1 )_6C]CAH1GSQLB(V<UG3YY^MNK00P_-C%%V
M%Y:Z?]?]$!,       " 8A23M,GOO_^>S)DSIVE!R6FGG9;\_///I?H312E9
M\<LD(D4B>2\6:=0EYN>??YX9XZ&''BK5MT[[ZJNO,L\E5IBOPL*%"S./423Q
MIZ[%)+$B_T BS1Y[[)'\^../;3O66V^]E9G$$VWMVK4MQ8G[(RO&99==UK;^
MUZE/7WSQ1=O[<^FEEV8>X\LOO\P5:]*D2:EQBN[R\."##[8U8:P."6YU2YAK
M-C=4H=F*]J-&C4HV;-C0<JQ//_TT,U8DN/::K+[>=---I6.?<\XYF?%C]X$L
M=9NC0C?'5*>/78<YKJJ8'W[X86:<<\\]MU3_0E;A1+?FXU@4(*TO3SSQ1$>.
M_]MOOS4*B(<>?_?==T^V;=O6]+/FC9$1LYO/GCS];%7\_)05XY=??LE[:CO%
MWXW4_;ONAY@         %*.8I(UB9Y!CCCFF:4')@@4+VE9,4B9AXKOOONO)
M(HTZQ3SCC#-28U258/799Y^E%BBU0R0)I9W+\<<?7TG\B),6/XY;1%V+208G
M6'>BZ&'*E"F9B3SGGW]^RW%FS)B1&F/__?>OI)]IR>(Q]]6I3_$L2.M/)'%6
M(<XK+?ZQQQZ;.]8AAQR2&JO5 J.A+KC@@K8FC-4AP:UN"7-9_:VJS_'\VFVW
MW3*/,6_>O%SQ!N_H-+@5?88,M7'CQEUBQ_Q91-8Y3YLVK50?HS@Y:U>A_?;;
M;]C=INHT1X5NCJE.'[L.<UQ5,:,8/^[7M#AQ?Y?YV28<??31/34??_#!!\GH
MT:-WZ<MAAQW6N!;MEK433+R/ML*\4?^8W7[VM-K/5F7U)5KTM:CX>YVZ?]?]
M$!,       " 8A23M-D;;[R1''3004T+2LKTY\033\R,%:OS%Q4K _=JD49=
M8C[VV&.I,2)!;/OV[:7Z%R(!;&CL^^Z[KW3<-$\]]53F-5F_?GVIV/'YK-@K
M5JPH%+..Q221X#1APH2=B30Q=[3;_???GYG(,V;,F&3KUJTMQ?G'/_Z1&>?]
M]]\OW<^''WYXE[BQNGB=^K1TZ=+,_D0R:1EQ/EFQ'WGDD=SQ3CWUU-18L<-(
M7CMV[/B/^[H="6-U2'"+\906KQ/)PD5DG7^527X77GAAYC$BN3I6O6]5UEPV
M=NS82G9XBF?KT-B+%BTJ%*O9M=VT:5/A/JY:M2HS[BVWW#+LY^LT1X5N)J%V
M>CS788ZK,N;--]^<&6OUZM6%^Q?CJQ-S6UYWW'%':G\>>."!MAXW"G,.//#
M78X;S^Q(G&^%>:/^,;O][&FUGZV*OW?)BI'GO6*H=>O6U?Z[[K68=7LW!@
M     !C)%)-T0"3@MJN8)%9\SXKUXHLO%NYS).GT:I%&76+^]--/C160T^(\
M^^RSI?H7J[Q&PO?0N)]\\DFIN%DBX6SZ].FIY[)X\>)2L6^__?;4N,<==USA
M%:CK6$SRQ!-/[$RB.?SPPSMRS$@6S$KDB18)VJV(@H&XOFDQKKONNM+]3-ME
M))*ZZM2G*!;*6FW]^NNO+]67.)^TN'&\(JLPQXY9:?'FS)F3.U84HC5+8*Q"
M'9+F]MY[[]1XPWT_,0<._O-[[KEGX3[DT>[O+$31:K/C7'OMM2W'BH*1B1,G
MIL:)N;6,>-[&KD-#XW[TT4>%XC4[YU9W TB3M4/ J%&CDLV;-P_[^3K-4:'=
M]V<SG1[/=9CCJHP9]VO<MVFQXMVPJ"NOO+(C<UM>,<?$SH)#^[/''GNT[;T^
M7'WUU:G7X9Y[[FDYAGFC_C&[_>QIM9^M.N644S)C1.%+4??>>V_MO^M>B]GI
M9VDLYG'333<U"H[BY]_X-8H7R^Q8 P       #!2*";I@$@2NOCBB]M23!(K
MPF;%*IHP/9#4U*M%&G6*F;4[R<R9,Y/??ONM</^B4&AHS,LOO[QPO%:L7+DR
M]5RB\*'5'2R&BF*&^'Q:W*>??KIP7^M83'+222<52N0KZ_SSS\],$#KRR"-;
MCA/W1UJ,W7??/?GZZZ\+]^_--]_<)68DBM6Q3S$?I/5GW+AQR;???ENH+]]\
M\TWC\VEQERU;5BCFDT\^F1HODO7S[*H4!3W-5H@NFX0VH Y)<X<>>FAJO.'N
MPUA%>_"?/^JHHPKW(8]V?V<#SCGGG,SCQ'W=ZNKX(6MWDKCV<2\6E;;J^KGG
MGELX7K-KN]MNNQ5:S7_Y\N69,>?.G=MRG+K,4:$3]V>63H_G.LQQ5<>,^S8K
M7I'WPQA7,;XZ-;?E]?WWWR=3IT[=I4_QCKQMV[;*CQ?7,.T:Q,\G>>?+?I\W
MZAZS%YX]K?2S57???7=FC(LNNJA0G^+O1J9,F5+[[[K78G;R61H_O\3"&&G'
M._[XXQ64         'U/,4F'?/?==XW_45UU,<EGGWW62-9-BW7PP0<W_GM>
MD3A991\'Z[>8O__^>_+G/_\Y-=:2)4L*]2T2SH;N$A+WP,<??UPH7JLBD2:2
M<-+.)<\*\H/%Y]+B1?%5&74K)MFT:=/.A);1HT<73KXK8NW:M4T3S-Y^^^V6
M8YUWWGF5)I1%0F,D" V-]^JKK]:R3UFKCT>[\,(+"_4G/I<6[_333R\4+T3B
M:M:.-;$R<ZLNN^RRQF<..>20MB2A#:A#TMRL6;-2X[WSSCM-/_?""R]4D@B9
M5[,YH4IIA5F#VRVWW-)RK'C>9B4*WGGGG87Z%V-AZ*K[L=KZ^^^_7RA>R#K7
MR9,G-WZ-YWF>8K=( (X=#-)B[K777HVD[%;598X*G;@_LW1Z/-=ACJLZ9HR!
MN'_3XDV8,"'7SD 1*]X!!X^S;MT[P_4S[7D9NQSF*:P;3A22I#WCXQH5.4Z_
MSQMUC]D+SYY6^MFJC1LW9NYL%$4S17;[&;Q[9)V_ZUZ+V<EG:>Q(TNP[C!U*
M         /J98I(.6K=N72-)J.I"C84+%V;&.^.,,W*M)+]^_?K&RIN*2:J+
M^>677R;3IDW;)58D[<0.(WG$=QF)%T-CY4GP+B.*HDXXX834:Q.[Y.3QR"./
MI,:)^'&<,NI63'+CC3?N3&:)[[>3(@GP@ ,.R$RNN?+**UN.]<,//V2NW+MX
M\>+<_4I+)IP_?WZN.+W6ITC4'$AJ'=KR[D@3XSXM3M&$T,&R$KPB 362N)J)
MU7VONNJJG9]Y[KGGVI*$-J .27-WW'%':KR''WZXZ>=BQZG!?_[QQQ\OW(<\
MVI4TF296PL\Z5B2D_OCCCRW'VKQY<[+//OOL$B<22Y]YYIE<_?KIIY^2&3-F
M[!(K3X%+FJQSC>]VX)]CM>XWWGACV%BK5Z]N[!B4%3-V#,BK+G-4I^[/-)T>
MSW68X]H1\]%''\V,&>/\^>>?'S9&C*/!J]\W2PKO!5%,'#\S#.W;_OOOG[SR
MRBNE8D<Q[&VWW9:::+_OOOOF*M 9JI_GC;K'[)5GSW#]S&/>O'F9<6('H'B^
MMRJ*9L:/'Y\9KT[?=:_%[.2S-&M^&FCQ]S(         _4PQ28=%PGW5A1J1
M>'3LL<=FQCSSS#,;"9;#>>FEEY(CCSRR\9DCCCBBYXLTZA0S5C$?N+:#6Q07
MW7???8T$K^%$DE>L_#LT1JS&&2NR=TKL=C-T9Y2!%JMZ_O+++TT__^NOOR:W
MWGIKZN<C[J>??EJZCW4J)HGO;O#*]VO6K.EX'Q8M6I297!,K@.<I2(OBJ<&)
MFX-;)'>UDAC^U5=?-0KAAG[^F&..&?;^JD.?8E7DH;L=#+0HPHABC&;B>%=?
M?77JYR/NA@T;<O4G3<Q9L8)SUGT1.[M$(F]<EQC3L8-#)-Q%8E@D9 W\N8%5
MR=N1A#:@#DESL?M06@+O<<<=URA22A,%J(-7C]]SSST;.U-U0KN2)M,,MSO2
MW7??G2M>[*84\];0.'$M8ZYKY7G[[KOO-MZ#AL:(9W#9YVW6><9]<,XYY^S\
M][A?8F>S%2M6-.Z?2'Z-%O-'),2?>NJI3:_;)9=<4KB/=9BC.G5_INGT>*[#
M'->NF+%37;/[/,9DC(>X9^-9'F,DOI^5*U<VBB('?T_GGGMNX_OIYKW3BCB'
M>+=/Z^/YYY_?F)_RB#DO=B-)F].B17+]YY]_7KK?_3IOU#UF+SU[JCKWV&$E
M"J2R8L4.@W%NPXGWW('WB:Q=6.KT7?=:S$X^2[-V7!QH\=\!        ^MF(
M+B9I5K0Q7&N7^!_CL9IBU<?]^../F^XH$D4+"Q8L:"1M?O/--XWDWTCJB>2A
M2#"ZX((+=O[9B!/)F&6O5YGK7_>8::(8Y/CCCT^-$;MQ1,)L)(A% DPD?D7B
M3A1NK%JU*KGTTDL;"=I#/Q?W4I'D^K+BOCG]]--3SR420.ZZZZ[DO??>:Q0Z
MQ;G$KY&<'N>8=0TB7I%DMK+?7S>*39HELZ2UDT\^N;)C#UZ!N$QK)N:8N*?3
M/C=ITJ3DVFNO35Y]]=7&]QUST<"]'G-1)*&-'3MVE\_%#@%E$NE[K4]1-!4%
M9FG]B:3)V*WFK;?>VCD?Q*_Q[S?==%-CA?*TST6\*HJQ!MQPPPVE[I$H#ALH
MU*GJWFK'?=O.L3!8)&>F?3Z2.&,E\+CGXKN.[S!69H\$N<%_+@IUJE;%7)#W
M.J1)6XE_N!9)QUGB69JUXU+,]3&.XII'H5E<\[A/(U$VYL>SSSX[-;DQ$M&'
M2X9N1;/K%T59D=A=]KN(A/-6BF::Z:4YJA?NT:':-9[;<8YUB9DFKN'LV;-+
M'R_&58RO9GWO-4\^^63C_22MKT<??71C#$:R>Q19Q"YLO_WV6V..BK$8[]S+
MEBU+KKCBBLP8T:)8)\_N3\,92?-&G6/F.4[HUK.GG><>8R"ML'2@C1X]NE%0
M'KOGQ;M _#P=Q?-1X!!C)W[V&OBSL3-)_(S0B]]U76)FZ=2[<;-=.*/UZJ(3
M         )VBF*0+2>61\!-)S54?-Q(A8^7\,N<="?T;-VYLQ.O%(HVZQ,SR
MW7??)?/GSR]]S,,..RQY\,$'.[HCR5"1L';;;;>E%KGD:?'Y6"V^:))NV6M9
MU?C+(V]23MV*24(D_MQ^^^VI11AY6B1U7W/--94D<?=:GR)I+8I8TA+7\_8G
M$NOS["#3BBA^C-7$B_0I[MF!Q-U0U;W5CONVW6-A0!0T9:W:/ER+I+JL59K+
M*'ON1:Y#FBC:RGN\9L4D8<N6+8W$UK+GM?ONNR>+%R^N['D[W/7;NG5K9N';
M<"WF@DC6KJJOO3)']<(].E2[QG,[SK$N,;/$_1S%!D7OPQ-//+$QKH;K>R^*
M@M4H[&R6%%^D1;'GFV^^V98^CY1YH\XQ\QQG0#>>/>T^]UC(H6R13!0SQ:(=
M>?O;J?.M2\PLG7HW_NM?_]HT5LRS         /U,,4F7DLH_^."#Y-!##ZW\
MN+&B_I(E2S)W?\AJD53TZ*./_L=JHKU8I%&7F,.)57ACMX.\A1B1T!+).K&"
M:J^(XJ/KK[^^4>"2YUSBSU]WW76-(J@RJB@BZ=2X'Y W6::.Q20#OOCBBT92
MX="59(=KL6+PK%FSDG?>>:>R<^_5/D626JP.'DGK>?H313$77711(UFNG6*%
MYN%6]!UHD?!ZYYUW-E9('ZRJ>ZL=]VVGQD*(5=A/.^VT7-_QS3??O,OUK$H5
M<T&1ZS!4) /&.U&>XPU73#(@5A./0MN\B<UQ+\>J_ILW;RYU;D.U<OTB(?>>
M>^Y)]MY[[Y;[&PGS\6[1#MV>HWKA'DW3CO'<CG.L2\SAQ/U]TDDGM7R,&#\Q
MC@8GN,>U3_NSN^VV6Z$^=4H4E=Q___V-G]>*7O.8TV)'PY@3VU&<.%3=YXTZ
MQ\QSG,$Z_>SIQ+G'CB/Q7IJU\TU6BP*'^^Z[[S_^;J07O^NZQ&RF$^_&L0-3
M[.B4%B]VQXL=4         #ZV8@N)NEUD=3=KF3V^)_K+[_\<B-Y(E;FCD2/
M6)DSBA<./_SP9,:,&<G<N7.3O_WM;\EKK[W6MD15FHO5.)]ZZJE&4<599YW5
M2'*(A-I##CFD\<\S9\YL)%3=====R=JU:QL),;TJDC">?_[YY)9;;DEFSYZ=
M''?<<8U[;>">BW^/WX__OGKUZD92!_TC"MW6K%F3+%RX,#GUU%,;]\4>>^S1
M2.",7Z-8X9ACCFDD.D9A6R06]5N?8DRL6+&BL7M1K X=B6SCQHUK),''K_'O
M\?M_^<M?DN7+ES=VN>J4F'M6K5K5V*DDYJ;H2R1S1;\.//# Y,]__G/R\,,/
M_\=N)&1[]]UW&ROMGW+**8W[+))\X[Z+ J>##SZX4;04B<.QNP;5B"+,N$?C
MF1J)@Y$L.V;,F$:+?X[G;B0SQNK4SS[[;"6[(:7)DWP9*_+'KBWSYLUK]'GB
MQ(D[^SQY\N1&H>&MM]Z:O/_^^VWIZU"]/$=UD_'<67&_QWT?]W^,@X$Q$>,C
MQDF,EY4K5Z;N:!'/J+3Q-W[\^"Z<23%1$!OC*W9(BQTE8^[::Z^]=EZ'??;9
MI_%[47@2Q1P///! \OKKKW?M9PCS1F^H\[.G"E$4\L(++S2>\?'W(O'.'W/T
MP'T8<W><UX(%"QH_<_N[D<YK][,TYJ+8H21^;HD% N+7N!\4D@         H
M)@$ @(ZH:B5O(+\H*DL;?Y%4#".99P\         D$4Q"0  =("$7NB>]]Y[
M+W7\Q<X8,))Y]@          6123  ! !TCHA>YY\LDG4\??55==U>VN05MY
M]@          6123  ! !TCHA>ZYX88;4L??LF7+NMTU:"O/'@         @
MBV(2  #H  F]T#W3IDW;9>R-&C4J^?KKK[O=-6@KSQX         ((MB$@
MZ  )O=":P>-C\^;-I>-MW+@Q=>R=>NJI%?06>IMG#P        "013$)  !T
M@(1>:,W@\?'00P^5CO>7O_PE=>RM6;.F@MY";_/L 0        "R*"8! ( .
MD- +K1D\/@X^^.!DQXX=A6.M6[<N&35JU"[C[L033ZRPQ]"[/'L
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MM:,8Q20               !]1#$)              ! 'U%, @
M    T$<4DP               /01Q20               !]1#$)
M      ! 'U%, @              T$<4DP               /01Q20
M          !]1#$)              ! 'U%, @              T$<4DP
M             /01Q20               !]1#$)              ! 'U%,
M @              T$<4DP               /01Q20               !]
M1#$)              ! 'U%, @              T$<4DP
M /01Q20               !]1#$)              ! 'U%, @
M    T$<4DP               /01Q20               !]1#$)
M      ! 'U%, @              T$<4DP               /01Q20 \/^Q
M=^_O5XT)X\?_A^?Y"YX_Y/GA\6D0F6'&/$;G2)2D='PJDPJ5(AHRR2DD&KIR
MEJ2<E1P3*5%$)$*2CO?WNO=,O@U[[=/:>Z^]]GJ]KFM=XS)][G7?:^W]N;;/
M9[V[ 0           *! Q"0                %(B8!               H
M$#$)              ! @8A)                "D1, @
M4"!B$@              @ (1DP               !2(F 0
M *! Q"0                %(B8!               H$#$)
M  ! @8A)                "D1, @              4"!B$@
M    @ (1DP               !2(F 0              *! Q"0
M       %(B8!               H$#$)              ! @8A)
M        "D1, @              4"!B$@              @ (1DP
M         !2(F 0              *! Q"0                %(B8!
M           H$#$)              ! @8A)                "D1, @
M            4"!B$@              @ (1DP               !2(F 0
M             *! Q"0                %(B8!               H$#$)
M              ! @8A)                "D1, @              4"!B
M$@              @ (1DP               !2(F 0              *!
MQ"0                %(B8!               H$#$)              !
M@8A)                "D1, @              4"!B$@
M@ (1DP               !2(F 0              *! Q"0
M   %(B8!               H$#$)              ! @8A)
M    "D1, @              4"!B$H :'3MV++S^^NOA]MMO#V/&C G]^_</
M?_C#'\+O?O>[T*=/GW#>>>>%*ZZX(BQ8L""L6;,F?/?==UE/&0
M  #@-\0D %4</WX\//;88Z5XY)133JGYZ.GI":-'CPZK5Z\.APX=RGH9
M           E71V33)X\.9Q__OEU'5.G3@V'#Q]NZ;SJG=/)QXP9,UHZ-^#?
M_?###V'BQ(EU123ECD<??33KI0              E(A)RARWW79;2^<E)H%\
M^/GGG\/0H4/+QB&C1HT*SS[[;/CJJZ]*NXX<.' @;-FR)=QRRRWAU%-/%9,
M             !U+3))PK%FSIF7S$I- /LR:-:ML2+)HT:**7_?FFV_^)B@1
MDP              G:*K8Y(D#SWT4-5H8\"  6';MFUMG==UUUWWR_D?>^RQ
MMIX;^'=;MVXM&Y(,&S8L'#]^O.K7+UZ\6$P"             '0D,4F%X])+
M+PW???==V^8E)H'.,7/FS+(QR9-//EG3U^_9LT=, @            !T)#%)
ME6/Z].GAZ-&C;9F7F 0Z0WS/GW'&&65CDAB)U.J\\\X3DP
M':?P,4G?OGVK!B5+EBQIR[S$)- 9MFS94C8DZ=.G3UWCC!@Q0DP"
M     '2<PL<D\^;-"Y,G3ZX:E+STTDLMGY>8!#I#?/^5BTF&#AV:]=0
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M#PZK5JVJ&HY4FY^8)%U,,F'"A,QCDOA:;:4++[RP;3')W_[V-S$)
M     $"-Q"1-C$FB'W_\,5Q^^>45'^(?-&A0^.233W[SM<V(25Y__?7$\_;O
MWS]LVK2IX;6)2?ZI&3')U*E3$^_3\N7+4\VO4XP8,2(Q\(@[B313?*TDG6OL
MV+%UCR<F 0            "ZF9BDR3%)M'/GSM(.()6"DE&C1H7]^_?_V]>E
MC4F.'3M6,61YX($'4JU+3/)/S8A)9L^>G7B?[KGGGE3SZQ23)DU*##SFSIW;
MU'--GSX]\5R-W&\Q"0            #0S<0D+8A)HE=>>:5B3!*/:ZZYIA2
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M-V./'S\^];CUB#ONE LS>O7J57I=I;%UZ];$6&7V[-D-CRLF 0
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M^+];MFP)]]Y[;^G^E_NZ7KUZA:5+ES8TIT&#!I4=L]$CWAL
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MRZRG#             "06V(2              "  A&3
M%(B8!               H$#$)                 4B)@$
M "@0,0D              $"!B$D                *1$P"
M  !0(&(2              "  A&3                %(B8!
M    H$#$)                 4B)@$              "@0,0D
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M#UGIAO=.WM>0]_E#EKKA_9/W->1]_I"5;GCOY'T->9\_9*4;0H:\KR'O\P<
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MWN</6>F&]T[>UY#W^4-6NB%DR/L:\CY_ (!VZ(:0(>]KR/O\ 8I 3 (
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M;/=U>NJII[)>-BF(20                I$3 (              % @8A(
M             ( "$9,                4B)@$              "@0,0D
M                !2(F 0              *! Q"0              0(&(
M20                I$3 (              % @8A(              ( "
M$9,                4B)@$              "@0,0D
M!2(F 0              *! Q"0              0(&(20
M  I$3 (              % @8A(              ( "$9,
M   4B)@$              "@0,0D                !2(F 0
M    *! Q"0              0(&(20                I$3 (
M     % @8A(              ( "$9,                4B)@$
M      "@0,0D                !2(F 0              *! Q"0
M        0(&(20                I$3 (              % @8A(
M         ( "$9,                4B)@$              "@0,0D
M            !2(F 0              *! Q"0              0(&(20
M              I$3 (              % @8A(              ( "$9,
M               4B)@$              "@0,0D                !2(F
M 0              *! Q"0              0(&(20                I$
M3 (              % @8A(              ( "$9,                4
MB)@$              "@0,0D                !2(F 0
M*! Q"0              0(&(20                I$3 (
M % @8A(              ( "$9,                4B)@$
M  "@0,0D                !2(F 0              *! Q"0
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M,0D          *FU(B9)<O#@P?#,,\^$@0,'5CWG66>=%5Y\\<74YQ23 #&
M6+!@0>+W@?GSYX=CQXYE/<V.$*_5[;??GGBM9LR848I.  #(CI@$
M (#4VAF3G! ?1([GC;N05-NEY+'''DMU+C$)%-O1HT=+NQTE?0]8N'!AUE/L
M2'%'J:1K-F;,F%(<" ! -L0D          "DED5,<L)33SU54U#R\LLO-WP.
M,0D45]QE8^;,F8GO_TF3)I7^#.5=>^VUB==NW+AQ=B@! ,B(F 0
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M;MRXQ/=\W&7CTT\_S7J*N?+--]^4@KZD:SITZ-!PY,B1K*<) % 88A(
M     %+KA)@D^L,?_E!U'K???GO=XXI)H%C6KEU;\3T_9<J4K*>82_/FS:MX
M71]^^.&LIP@ 4!AB$@          4NN4F&3PX,%5YW'--=?4/:Z8!(KCZ-&C
M8<"  17?\R^__'+6T\RE]]]_O^)U_>,?_Q@.'#B0]30!  I!3 (
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M#^'?G7/..16O<PRZCAT[EO4T 0"ZFI@D0Z^^^FK5_X",?TM#MYP7
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MO56O]8P9,[*>)@! 5^OJF&33IDV)'S3CEI1[]^[->HK_)E;R640=69T7
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M,=%\;]NV+>U2 0"ZK"X7)FGYQ6_[]NV9EI"Y/G#>?//-'7*'BGR$20
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M_?O3+A4 H,OJ,F&2V%6D:?O&IY]^.NLQJU>OSOG!\W>_^UT*E?^/, D
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M76W]:FMK\\[;;;?=%AH:&DIX15W?7__ZU[SS.G7JU+3+[!+BOJY\<QUO9@P
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MCY(X=NQ8&#!@0,YK[-NW;SARY$C)QLS7L2?NN:)P\^?/SSF_]]]_?UD[Z@
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M#)/T[MV[H!H:O?SRRV6]KEFS9C5[3/SB'%NDYONR&4,R,8C2GBXXY3PW
M     '0T89+"CTH,(S05]\VL6K4JTS6@V+IB1XR)$R>&/__YS^&77WXI:9V1
M]<OVS3??9.J,88MBZ^K1HT>8,6-&V+1I4X=UD#A\^'#HV[=OSKH>>."!3$>6
M<HC7FFOL<G5EZ6KV[]^?V8?7UCS&+CD  '2LB@N3//300]<_0-;4U)3LO/E:
M<RY<N+#5Y\6[([1\; P0%.*55U[).E=;H8ZTQFVI99BDV#59O'AQ5BVQ760A
M7GOMM:QSC1T[-NMQ\0MG['Z2Y OQ33?=%)Y\\LG,EYLDRGEN"A?O6/'__M__
M:_68,&%"VN5U:?%W\/_^[_]:/9YXXHFTR\NIDFOO#)YYYIG,'^]:.V+XC]S,
M7WJJ>>Z][Q7'YPT      +JJV$5DZ]:MF1NA/O+((V'$B!'AOOONRX0,NG7K
MEMDLWKU[]\S--6, X'>_^UV8,V=.6+=N76;3_>7+E].^A*H6]P2]^^Z[8<&"
M!6'2I$EAX,"!X<X[[\QTWXAK%]<P[G6):QIO !L[TSS__//AG7?>";MW[P[7
MKEU+I>Y??_TU4T/<1Q3KBS<.CJ^Q^/_3>O/--\.E2Y?*.GZ<@[;V_/3KUZ\L
MP:BN)*Y??*]H:P[CWKUXXUX  #I6185)8MO INGD^,6F5&*'DWRI^M9:,L8-
MAJ4*/\0O-DE#'6F-VU++,$FA@99&N5H9EN*(7]Y:\]UWWV6^!+?G7/$+]:%#
MA_)>4SG/36%L[DQ/)6],KN3:.X-JWI!?"N8O/=4\]][WBN/S!@      0-=1
M7U\?'GWTT3;W^DR=.E48(H>GGGJJS;F+>]YBV 0 @(Y746&2%UYXX?J'R)@L
M+_6="F)7C5P;_->O7Y_UG-:^),1$?B'>>NNMQ*&.M,9MJ6689-2H4075T"BV
M!2UGF*1GSYYMCEU75Q?FS9N7LYUBRR-V$WG]]=?S7E<YSTW[V=R9GDK>F%S)
MM7<&U;PAOQ3,7WJJ>>Z][Q7'YPT      ("NY>K5JYEN/&WM]5F\>'':)79*
MK[WV6IMS%CL77;QX,>T2 0"J5L6$26(KPA@@*6?0(-\1NUJT3) +DU16F"2^
MAO(Y>O1HF#]_?J9]9]+S+EVZ--'UE?/<)&=S9WHJ>6-R)=?>&53SAOQ2,'_I
MJ>:Y][Y7')\WNIY=NW9E?B_R';3-'):7^<UF3HIC_HIC_HKWX8<?)OK;&97'
MVA;/>TQQS%]QS%_YF>/FS$?Q_-L+ *45.Y3$O3]M_9L:?Q8?0\CLLUNY<F6;
M<S5KUBP=20  4E8Q89*-&S=V:'"DK6/GSIW-ZIH[=V[68V+KO4*T)]21UK@M
ME3I,$KMWM*PEMH%,P[ESY\*:-6LRW4R2O#:V;=O6*<Y-?C9WIJ>2-R97<NV=
M035OR"\%\Y>>:IY[[WO%\7FCZ[%YI7CFL+S,;S9S4ASS5QSS5SR;'KLN:UL\
M[S'%,7_%,7_E9XZ;,Q_%\V\O )1'W,O6O7OW5O]=?>BAAZJ^VT;LXO+DDT^V
M.C\WWGAC6+UZ==9-G=,P9LP8A\/A<#@<CK(?G5G%A$D&#1J4>I"D\<-^4XL6
M+<IZS,B1(PNZQG7KUB4.=:0U;DNE#I/$=H^E"LF42OQRLVG3IE!34Y/SM1$W
ME5Z[=JW3G!L  "@=FU>*9P[+R_QF,R?%,7_%,7_%L^FQZ[*VQ?,>4QSS5QSS
M5W[FN#GS43S_]@) ^1PX<" ,'CRXU7];>_?NG773XFJQ>_?N-O="Q7GY^NNO
MTR[QNK0WECH<#H?#X:B.HS.KB##)%U]\T>Q#93D_:!\[=BS<<,,-;?X1+?ZL
MMK;V^N-??/'%K,?$@$4A7GKII<2ACK3&;:G489*77WXYJY9BSUDJ,0W_P0<?
MA/ONNZ_-U\??__[W3G=N  "@>#:O%,\<EI?YS69.BF/^BF/^BF?38]=E;8OG
M/:8XYJ\XYJ_\S'%SYJ-X_NT%@/**-X>--_+]S6]^T^J_L8\]]E@X>_9LVF5V
MB L7+H1GGWVVU;UWW;IU"\N7+P^7+U].N\QFTMY8ZG X' Z'HSJ.SJPBPB0S
M9LRX_L&R;]^^96]Q-VW:M)Q_2'OAA1>N/_:]]][+^GG\<E"(I4N7)@YUI#5N
M2Z4.DVS>O#FKEH$#!Q9USE*+7WQFSIS9ZFLC=HSIK.<&   *9_-*\<QA>9G?
M;.:D..:O..:O>#8]=EW6MGC>8XIC_HIC_LK/'#=G/HKGWUX Z!@__?136+AP
M828TT?+?V?CO<37XZJNOLJ[]QAMO#'/FS DG3IQ(NSP  %K1Z<,D)T^>S'RH
M;/R N7[]^K*/&3N?Y/I#VF]_^]MPZ=*ES&/W[MW;ZF/JZNK:/>[CCS^>.-21
MUK@ME3I,$L<M54BFG.KKZ\.$"1.R:GWPP0<[];D!         (#R.'WZ=%BQ
M8D6X\\X[JSI,TJ-'C\R-<X\?/YYV60  Y-#IPR3+EBV[_B'SUEMOS71N*+?8
M^:1E2*+E\<<__C'SV%]^^:75GW_SS3?M'G?$B!&)0QUIC=M2J<,DL?7CS3??
MG%7/SS__7-1YR^&?__QG5ITU-36=_MP          $#Y_/KKKV'KUJUAVK1I
M8?OV[6F7TR'BOK6)$R>&39LVA8L7+Z9=#@  "73J,$G\4'W''7=<WTR_8,&"
MLH_9Z)UWWLD9)ADX<.#UQ_;KUR_KYZ^]]EJ[QKMZ]6HF+-.>4$=:XS95ZC!)
M-&;,F*QZ8G*]$$V#,K'#3<LP4N/KJ]".-W???7>S.OOV[=LAYP8
M    @$)UZC#)>^^]UVPS_>'#A\L^9J.8CH[M]G(%2G;MVI5Y[)(E2[)^-F7*
ME':-]_777[<Z1JY01UKC-E6.,$D,7[2L9_7JU>T^S^7+ET.W;MVNGV/X\.%9
MCVD,?*Q<N;*@6N/U-JTSAE<ZXMP              %"H3ATF&3ITZ/6-]),F
M32K[>"TM6K0H9YADQHP9F<?%%GTM?Q:[8)P^?;KHL7*%.M(:MZERA$EB_3?<
M<$.S\XX;-Z[=Y]FV;5NS<RQ=NC3K,8V!C\:U;*^FG4_B,77JU XY-P
M        %*K3ADEV[][=;"/])Y]\4M;Q6E-;6YL5:FAZQ)^=.'$BU-?7A_OO
MOS_KYZM6K4HTSKESY\*MM][:[E!'6N,V58XP231MVK2LN3YRY$B[SC%]^O2\
MU]08^(C_>?7JU7;7><\]][0Y]^4\-P          4-ERW>BX,QY+EBQ)>\H
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M%RY<"),G3V[VG$<>>:3-QS<-?#0&:\Z<.9.SKOB:6+Y\>=:<Q;GMJ',#
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M[-Z]>^C9LV<8,6)$6+1H4?CLL\]"0T-#ISDW               D)4P"
M          !0181)                JH@P"0              0!41)@$
M             *@BPB0               !51)@$              "@B@B3
M                5!%A$@              @"HB3 (              %!%
MA$D               "JB# )              ! %1$F 0
MJ"+")                %5$F 0              *"*"),
M  !4$6$2              " *B), @              4$6$20
M     *J(, D              $ 5$28!              "H(L(D
M        5428!               H(H(DP               %0181(
M         ( J(DP"              !0181)                JH@P"0
M            0!41)@$              *@BPB0               !51)@$
M              "@B@B3                5!%A$@              @"HB
M3 (              %!%A$D               "JB# )              !
M%1$F 0              J"+")                %5$F 0
M *"*"),               !4$6$2              " *B), @
M    4$6$20               *J(, D              $ 5$28!
M      "H(L(D                5428!               H(H(DP
M         %0181(              ( J(DP"              !0181)
M            JH@P"0              0!41)@$              *@BPB0
M              !51)@$              "@B@B3                5!%A
M$@              @"HB3 (              %!%A$D               "J
MB# )              ! %1$F 0              J"+")
M %5$F 0              *"*"),               !4$6$2
M  " *B), @              4$6$20               *J(, D
M     $ 5$28!              "H(L(D                5428!
M    @$[AEU]^"1]__'&8/W]^6+-F3=KE=$H3)DS(S,T___G/T-#0D'8Y  !4
M*&$2            4G/MVK7PCW_\(SS[[+.A3Y\^X8$''L@<*U:L2+NT3JEQ
M?N(Q:M2HL';MVG#TZ-&TRP( H,((DP          T$S<P-UTLW*U'-.F34M[
MZJ&JU-75A;???CL,'SZ\U=])89+6M?4>]NBCCV9".;J5  "0A# )
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M.G7J5!@U:E3.]X/X\_/GSZ==:I?VX8<?YGU?7K9L6=IE @"0(F$2
M   *(DP"-'7ITJ4P<>+$O.\'WWSS3=JE5H6Y<^?F78L-&S:D728  "D1)@$
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MGSX=^O;MFW>N:VIJPK5KU](NMRK% %J2WX?GGGLN[5(! .A PB0
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M%LZ>/5OF*_NO%2M6%/0:[*CY[RCQ]9WTVM]___VTR^4_)DZ<F'C-.B*8!0!
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M3&AFZM2IX<477^PTM99#>UZK!PX<2+M<_J.U<%9;QTLOO91VN0  E)DP"0
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M)D^>',Z<.9-VR30Q;-BPQ.NW=^_>M,OE/]H3XHJ_GP  =&W")
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M' H9(ZY35_?[W_\^[SS,GS\_[3*K1NQ*TJ]?OYSK$=]38K<?  "JCS )
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MI79Z#0T-8<N6+6'8L&%MSN7DR9,S(9Y22WO#J</A<#@<CJYUD!YA$@
M     #I,[)+QTDLOA7[]^K4:@NC5JU=8L&!!J*VM3;O43NFCCSX*$R9,:#-$
M,F[<N+!]^_9,X*0<TMYPZG X' Z'HVL=I$>8!           @ X70R6Q4TE;
MW356K%B1=HF=4ELADIDS9X:=.W>6+40" $#7(DP"          ! :JY>O9H)
M0<R;-R_TZ=-'F"2/I@&2D2-'AC5KUH0C1XZD718  !5&F 0          (!.
MX?SY\V'[]NUA_OSYF9 $V29,F!!>??75L&_?OE!?7Y]V.0  5"AA$@
M        @"HB3 (              %!%A$D               "JB# )
M        %>F!!Q[H4L>T:=/2GE( @ Z5]N>O2CJ&#Q]>TKD7)@$
M     *@BPB0               !51)@$              "@B@B3
M        5!%A$@              @"HB3 (              %!%A$D
M          "JB# )              ! %1$F 0              J"+")
M             %5$F 0              *"*"), P/_7OAVD  @#01#\_Z^]
MB0@B"GM(N@KFEL!^H $            @1$P"               0(B8!
M           ($9,               "$B$D               !"Q"0
M           A8A(              ( 0,0D              $"(F 0
M         "!$3 (              ! B)@$               @1DP
M         (2(20               $+$)                "%B$@
M        @! Q"0              0(B8!               ($1, @
M        $"(F 0              "!&3                A(A)
M        0L0D                (6(2              " $#$)
M      ! B)@$               @1$P"               0(B8!
M       ($9,               "$B$D               !"Q"0
M       A8A(              ( 0,0D              $"(F 0
M     "!$3 (              ! B)@$               @1DP
M     (2(20               $+$)                "%B$@
M    @! Q"0              0(B8!               ($1, @
M    $"(F 0              "!&3                A(A)
M    0L0D                (6(2              " $#$)
M  ! B)@$               @1$P"               0(B8!
M   ($9,               "$B$D               !"Q"0
M   A8A(              ( 0,0D              $"(F 0
M "!$3 (              ! B)@$               @1DP
M (2(20               $+$)                "%B$@
M@! Q"0              0(B8!               ($1, @
M$"(F 0              "!&3                A(A)
M0L0D                (6(2              " $#$)              !
MB)@$               @1$P"               0(B8!               (
M$9,               "$B$D               !"Q"0                A
M8A(              ( 0,0D              $"(F 0              "!$
M3 (              ! B)@$               @1DP               (2(
M20               $+$)                "%B$@              @! Q
M"0              0(B8!               ($1, @              $"(F
M 0              "!&3                A(A)                0L0D
M                (6(2              " $#$)              ! B)@$
M               @1$P"               0(B8!               ($9,
M              "$B$D               !"Q"0                A8A(
M             ( 0,0D              $"(F 0              "!$3 (
M             ! B)@$               @1DP               (2(20
M             $+$)                "%B$@              @! Q"0
M            0(B8!               ($1, @              $"(F 0
M            "!&3                A(A)                0L0D
M            (6(2              " $#$)              ! B)@$
M           @1$P"               0(B8!               ($9,
M          "$B$D               !"Q"0                A8A(
M         ( 0,0D              $"(F 0              "!$3 (
M         ! B)@$               @1DP               (2(20
M         $+$)                "%B$@              @! Q"0
M        0,CGF&3X'@                :)20               $+$)
M             "%B$@              @! Q"0              0,BOF.3Z
MR<S,S,S,S,S,S,S,S,S,S,S,S,S,S,S,S/:<F,3,S,S,S,S,S,S,S,S,S,S,
MS,S,S,S,S"PT,8F9F9F9F9F9F9F9F9F9F9F9F9F9F9F9F5EH9TP"
M      # FNZQR.O[X7L                8)"8!               ($9,
M              "$B$D               !"Q"0                A8A(
M             ( 0,0D              $"(F 0              "!$3 (
M             ! B)@$               @1DP               (2(20
A             'AT )G,<SDG1E3S     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>image_29a.jpg
<TEXT>
begin 644 image_29a.jpg
MB5!.1PT*&@H    -24A$4@  #(L   4'" 8   !@20,\    "7!(67,  $SE
M  !,Y0%USO"5  &?ETE$051XG.S=^1?41+[___E79OGASIGYY2*(ZZAW4$0$
M!-E&A0%1D%419+G*-JB R'5'490!D56154$!!5$4<044$41D$11$%,4-\SFO
MS+?YMDU5.DLEG70_'^?449%^ISJ=3B>5][OJ=[_[W>\\&HU&H]%H-!J-1J/1
M:#0:C4:CT6@T&HU&H]%H-!J-1J/1:#0:C4:CT6@T6K%;R>]JW1$:C4:CT6@T
M&HU&H]%H-!J-1J/1:#0:C4:CT6@T&HU&H]%H-!J-1J/1:#1:\G9:L0@
M                  "*A6(1                      " .D*Q"
M                0!VA6 0                      *".4"P"
M              !01R@6 0                      J",4BP
M             -01BD4                       #J",4B
M            =81B$0                      @#I"L0@
M         $ =H5@$                      "@CE L @
M        4$<H%@$                      *@C%(L
M      #4$8I%                        Z@C%(@
M     '6$8A$                      ( Z0K$(
M  ! ':%8!                       H(Y0+ (
M %!'*!8!                      "H(Q2+
MU!&*10                       .H(Q2(                       !U
MA&(1                      " .D*Q"                       0!VA
M6 0                      *".4"P"                      !01R@6
M 0                      J",4BP                       -01BD4
M                      #J",4B                        =81B$0
M                    @#I"L0@                      $ =H5@$
M                  "@CE L @                      4$<H%@$
M                 *@C%(L                       #4$8I%
M                Z@C%(@                       '6$8A$
M             ( Z0K$(                      ! ':%8!
M            H(Y0+ (                      %!'*!8!
M          "H(Q2+                        U!&*10
M         .H(Q2(                       !UA&(1
M      " .D*Q"                       0!VA6 0
M     *".4"P"                      !01R@6 0
M    J",4BP                       -01BD4
M  #J",4B                        =81B$0
M@#I"L0@                      $ =H5@$                      "@
MCE L @                      4$<H%@$                      *@C
M%(L                       #4$8I%                        Z@C%
M(@                       '6$8A$                      ( Z0K$(
M                      ! ':%8!                       H(Y0+ (
M                     %!'*!8!                      "H(Q2+
M                    U!&*10#4K9T[=WISY\[U1HP8X77OWMV[XHHKO(LO
MOMAKTZ:-]X]__,,;-FR8]\@CCWBOO_ZZ]\,//]2ZNV@P__,__Q.Z 0   'G'
M]2T              /E"L0B NK-]^W9O^/#AD9*56K5JY4V<.-%_+9 %DND
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M+S#YXHLOO$\^^<1?I>#?__ZW_]"U9<N6D:X-@5IHI.-1*XJ8WFNO7KUJW34
M     (#8*!9!GN@9I"9GT:1,HT:-\GKW[NU=??75_AB[QLRUXJ_^_:JKKO*N
MN^XZ_YA\\,$'_;R039LV>4>.'*GU6P     R5]AB$9MJA1FZ2?C@@P]JTA\
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M88+QIGO+EBVA7J]!@WHH%A';C!5J&OS0,JK(+Q*L\J=>/I,TBT5$@_^V^ R
MHMS*E2O]1/EFS9KY*VW4:P%%H[Q/V!TY<L1?RK[R]Z-=NW;^@ZNT[-NWSU_B
MOAY^NU ?ZN5:*JRU:]?Z*XE<<LDE_DHCC5(H(HWV60,   ! O?GWO_]MO;?3
M/6XU2M#6[/D:^]+]L(H);.-4:A=??+$W8\:,3";XA'L4B^3;O_[U+^/GHS\O
M HVQ:7S-E.\P<>)$[_///X\5]\LOO_0>?_QQ?[([U\4BMIP5M3%CQL2*"0
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M\JZXX@IC,5F:*W/,F3/'6;$(    D%<-42PBBQ8M"BP6N>JJJ[SWWGLOL_X
M<*>(22EI%XL<.'# &E_%<\BG(A[+]:Y>/I,LBD6^_/)+ZS8T@PX U+NU:]<:
M?S.T"MZWWWZ;>7]4H%+DWR[4AWJYED)U?-8     4&Q9%(OLW;O7NKJ(FB:E
M0C%0+))O12P6>>NMMXQ][MNW;ZK;/7KTJ'?))9=0+ (  ("ZUC#%(IKE=>+$
MB8$%(WWZ]/&^^NJK3/H#P)TB)J6D72SRS3??6.,SP)%?13R6ZUV]?"99%(O\
M^../UFV<>^ZYSK8# 'FEAU:FWXP[[[RS)OW1P_<B_W:A/M3+M12JX[,&
M@&++HEA$;"OSJCW\\,/.MH-T42R2;T4L%ID]>[:QSV/'CDU]VR-'CB27 @
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MFU:$TKFCVF<0ENM]GU;,:DK);F$3,,,T)<YIX%I%HR[>:Y26AZ2W+!*KM7*
M;1M)KX-$!;-:G2A)X8":DH5=7>>5E!+TSSKKK,3]*S4E^VOUA[@)NWG87ZX2
M_)/TOY&*1904'J4PH[SI6'.YLHUBZ;HX:I%2J5UTT47^BH!I[F/7='UE^@W0
M*@Y%EY=KL3C7)-J6'B;&Z:^N\4SWH%K)0BM5Q(FIZYNLWKN*M;2*59Q^ZK/6
M[UK28HJ@OL>AW\3;;[\]]KU'9=-O1)(5C>)\+FG$_/KKKR,5KI<W71_'^9Q=
M[']3R\-U,P     TJJR*1=:O7Q]X;QAF\B_4'L4B^5;$8A'E,)GZ[.(9(P
M -#H&K)81*H5+6CEBR1) U'[$R5.>5/QB(I(-/.IDE94D*&5*50(HJ3-18L6
M^<G(IM<JP45%*"[[8RL649^4A):DB&+.G#F_Z8,2XC3K:9*8FFW>!<V2.V#
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MQ2+WWW]_Z/[I^)TR98HUEHJF=%SK>"^M=*V5QC7^.GKT:.OGK-RRN,^H
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M6=S9*95,Y#KF1Q]]9(RGRO0HA@T;9HRC 9>D2\%J-EM3;"WQFB6M9F*Z*=/
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M%8AHI:\%"Q;XQ6NN!ENUG+EM>YKI*JE''GG$&%NK%WSWW7>!K]5YPM:WI ]
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MXJNH*JF#!P]:X^MZ*LBUUUYK?>W.G3L3]RV./.\O$]=)_U]__;5?&&**&66
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M.+P+88M%9-:L6<;^Z-ECF,E\;"I7'E:+NZJ,5FCZTY_^9"P4*;6U:]?&[BL
M $!142SBF))ZE&3G>KN:]5,SI2=YWUH64,N"2AZ+,(H2TT;);)J9(NDV=:/_
MS#//Y&)%D4I*ME&BMFFVT"A-K]=@DN)%E62[E2T++ON;=I_SVL<\''<V^IXJ
M&3)NWY3L63ZXE>9^UF"*;8"J6E-R77GB>MK'@Q+(9LZ<:2S\B/J9*RD^:4&
M"EAL,ZM7:QK\RVH 59(F9[M*PM8 >=3M59NY7)^#KF62OB\59ZAXRN7OK([9
M1QYYQ%CX$:5I104ENKHX3^5A?]7R&"S1:A6FV"X?+*3Q/HL2TT;'B\Z_IL*C
M,$T%[D>/'JW:]R)2\:*^4T%)[W&:'IQLW;HUE3[GY5HLZ3XJ<LPHVRGY^NNO
MK06X83XK%0)%/?>G_=XU24/2(A@5*ZE ,FI_LWJ_18EID]5ULZZ[@F+I/ L
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M$]'UH7[+2L>AKM/TOJ9.G>K?;S,NDKVTKYMU+E(2A7Y']!!9_]3Q0*$(
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M3\] ]9EH+&___OW>VK5K_><<RDVH?)V^\SIND]"D?M6*133)'@  0*.A6 0
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M()S(A$4         @-X(BP   -"21HT:U2TH\H__^(_9KEV[FKTT:"IA$0
M      "@-\(B    -*QSH"/:P3=J\^;-R:XBT38>3G3"(@        ! ;X1%
M    :%CG0,=]]]W7\'QSY\Y-AD5>?/'% E8+[4U8!         #HC; (
M#>L<Z!@Z=&AVZ-"ANN=Z__WWLQ__^,?=@B+CQHTK<,70OH1%      "@M8T:
M-<HP#,,P#..'T2S"(@   #2L:[!CWKQY=<VS>?/F;-"@0=WF^]=__==LZ]:M
M!:\:VI.P"       M+9F%Z0:AF$8AM%:HUF$10   &A8UW!'C*NNNBK[ZJNO
MJOK\T:-'LZ>>>BKKUZ]?MWE^\I.?9"^]]%(?[P&T#V$1      !H;<TN2#4,
MPS ,H[5&LPB+    T+!46"3&O_W;OV5SYLS)GGWVV>RCCS[*]NS9DQT^?#C[
M[KOOLAT[=F0;-V[,EBY=FHT<.3+Y^7_YEW\1%.&$5BD84NT          $Y,
MPB(    TK%)8I)$Q9LR8[)-//FGVKD%3"8L          /40%@$  *!A$>JX
MZZZ[LO'CQV?_Y__\GX9"(F>??7:V:M6J[.C1H\W>+6@Z81$X_AJ][PS#, S#
M, S#,%II     "<N81$    *=>C0H>R]]][+'GSPP6S!@@79Q1=?G(T:-2H;
M-&A0]N___N_9/_W3/V4__O&/LW_^YW_.^O?OGXT>/3J;-6M6]L ##V3;MFUK
M]O(!.,$UNY#+, S#, S#, RCR $   "<N(1%      #^OV87<AF&81B&81B&
M810Y    @!.7L @              $")"(L               "4B+ (
M          ! B0B+                E(BP"               0(D(BP
M             )2(L @              $")"(L               "4B+ (
M              ! B0B+                E(BP"               0(D(
MBP               )2(L @              $")"(L               "4
MB+ (              ! B0B+                E(BP"
M0(D(BP               )2(L @              $")"(L
M  "4B+ (              ! B0B+                E(BP"
M    0(D(BP               )2(L @              $")"(L
M      "4B+ (              ! B0B+                E(BP"
M        0(D(BP               )2(L @              $")"(L
M          "4B+ (              ! B0B+                E(BP"
M            0(D(BP               )2(L @              $")"(L
M              "4B+ (              ! B0B+                E(BP
M"               0(D(BP               )2(L @              $")
M"(L               "4B+ (              ! B0B+
ME(BP"               0(D(BP               )2(L @
M $")"(L               "4B+ (              ! B0B+
M    E(BP"               0(D(BP               )2(L @
M     $")"(L               "4B+ (              ! B0B+
M        E(BP"               0(D(BP               )2(L @
M         $")"(L               "4B+ (              ! B0B+
M            E(BP"               0(D(BP               )2(L @
M             $")"(L               "4B+ (              ! B0B+
M                E(BP"               0(D(BP               )2(
ML @              $")"(L               "4B+ (              !
MB0B+                E(BP"               0(D(BP
M )2(L @              $")"(L               "4B+ (
M  ! B0B+                E(BP"               0(D(BP
M     )2(L @              $")"(L               "4B+ (
M      ! B0B+                E(BP"         "4U+OOOIO-G#FSV<L
M:"N3)T_._NN__JO7\3__\S_-7BK ">'&&V_,UJU;EQT]>K392P& MB(L @
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M\\TWV:]__>O\?5;M6B+<$F&7(M<!91%!K\[WRY(E2[+#AP\W>UD T/*$10
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MPX</9[_][6^3GWWZZ:<;6A.43?S=.VW:M&/NE;B?&_V[%P#*2E@$
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MA)UJ>;9'AYVU:]=FUUY[;?Z.B.!&S!?=/>+:N/GFF_/M]>5U$,>^Z[T2VP8
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M89$''WPP6?@X=.C0[/KKK\]>??75;/OV[7F1>11C;MFR)5NS9DTV>_;L;,"
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M:W>@6H_#(X\\4M<QZ!@12NP0YR\ZVM4[5P10ZNV^54D\)U/;BNL, $YTPB(
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MYSLZWD0P*MX=/8D.7%.G3DW.MV[=NH;VMZL( Z6VTXQ./ #02H1%
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M];D1O]_QV>B\TDYAD7BVI_Y>B/&?__F?V>>??U[37!$.JQ0^$18I9JUQO@
M81$         :"M__>M?D\6%6[9L*70[K1P6"5$,G5K?Y9=?GNW:M:O7S__E
M+W_)QH\?W^WS P8,J+D@O4.[A$7"K;?>FBQ6O^FFF[(OO_RRU\]'L>MSSSWW
M0R%_QY@S9T[-70C>>>>=8[HBW';;;37OSY___.=DMX:Q8\=FGWSR2:^?C^XB
MG=?0>400)>;OS=Z]>[-%BQ8=LVUAD=JD]C6NAX[N(-$Q(X(6O5UC^_?OSY]A
MJ?,9SXAZ0@%%GX=6N@>ON.**'L,B48C=;'%.4\7Z$="(D$5OG:4.'3J4OS=2
M@8ZX]ZMY;_0F%?;HW[]_]N"##_889(RUQ_60>J?5\\PHVIX]>_)[+W7LHQM+
M'-N>Q+F+$%W'Y^)^+C*(<+S>O1':25T_,>+>>^^]]WJ=X]MOO\WWOW,X55BD
M,7'_I,)'$2P& (1%         *#MS)@QHUM1W-UWWUWW?),G3Z[X#=>UCFJ*
MG(ORT$,/Y86X7=<P9,B0;,&"!=FKK[Z:[=BQ(R\,C^X3GW[Z:;9V[=J\4#-"
M(5T_%\6&\9EJ_.QG/VOH.,7GFRD*EY<M6Y8L5H_B\R@(?>.--[+//OLL+_2-
M8LPH&(Z.*X\\\D@V;=JT;I^+XQJ_TYNXWBIUWJ@T(B355?RLUGEB1-%_RIHU
M:RI^)HK)XYJ*(-'.G3OS8Q(%^=]\\TU>0!SW7^>B_<<??SPOM*UF/1'>:.38
M=(Q++KFDVSZ=<\XY=<^7"@C4.U>,*&3N3:5 1CQ7.G>/B>LO BD??_QQ]O77
M7^?G(O[YT4<?9??>>V\V9<J4Y!JF3Y^>_UYOBCX/*<V\![N*SCH]A47BO[>"
M*+2_X((+DL_4"(M%&"2"7U]]]55^O.*?'WSP01[B2(4=.@*0NW?O+FR-<4Y3
MVXF@RU-//95MW[X]#U<</'@P#WG&N1PS9DPRB!'_K57$NJ.+66K?XOD8QSA"
M=7%_Q;&/8QK/QKA_H_-&Q^].F# A?Q_7&T1H]KLWPCN5YHYS%L&KU:M79]NV
M;<OWL^,ZW+AQ8QZLZ1QJB(Y:U?[]U?5YW,AQ./OLL[OMU\DGGUSW?+$/735R
MCFH-)<??;5WG&#%B1*\!,@ X40B+         $";V;!A0[?"N"CB/'+D2%WS
MM6M8)$17BE2A;:UCZM2I>7%GM9I=L%J4EU]^.9LX<6)#(8 H%(YOQ8_BYVJT
M:E@DO/CBB]TZ-=0RXK/KUZ_/YQ(6*2XL$K[XXHN\*TB]VX^PS]_^]K=>U] 7
MYZ$GS;@'NUJQ8D6/89%6"BU$T"*Z5%3J\%#M&#AP8';''7?4_=[LR?///Y^=
M>NJI#;T?XCW?:B( $N_*>O<K DX1L OM&A8)JU:M2G:RJ'9$H#7"B4%8I/NH
M-2P2[X6N<]QSSSTUS0$ 928L @        !M*+XAOVMQ7!2ZUZ.=PR(AOCUZ
MY<J5=85&H@-!/<>M%0I6BQ+?UA_=&,:/'U]3@7I\DW\$':*[0RU:.2P2(I2P
M9,F2_'JJ=L[H6A %[/'9#L(BQXY&PR(A@@(1;*CE6HV.)-$1IA;',RP2CO<]
MV%4<U[A64D&1G__\YRWY#?UQ_\^9,R?97:JW0OWH\-#Y7NT+T6'CYIMOS@8/
M'ESUVDXYY90\]%-MJ*D9HB/.8X\]EHT<.;+J_3K]]-/S3D"=@SG1@:/K[\6^
M]Z95WKW1\6?NW+EYZ*C:;<>U.F_>O.SSSS__81YAD>ZCEK#(UJU;NP7'SCCC
MC+RK"P#P_PB+         $ ;VKES9[?BOOAV^N^__[[92VNJ#S[X(%N^?'E>
M6!D%D?'MWP,&#,@+.H<-&Y878U]]]=790P\]E'WZZ:?-7FY+B8+Q-]YX([OK
MKKNR:ZZY)CO__//S8QA="Z)@_((++LAFSYZ=%^_'-^?OV;.GV4ON4[%_:]>N
MS;_M/KZY_+SSSLO&CAV;%^C'=31CQHR\&#R^93X*PVE<;V&1#@<.',C^\(<_
M9+_][6_S>WW2I$EYN"?.33P'XV?1->*MM][JD\X1?:69]^#^_?NSQ8L7Y^&&
MG_SD)_D_XWS$L6YET>WBR2>?S OWXSHX[;33\N=]C!$C1N3'+<*5RY8MRS9N
MW'C<]V?OWKW9ZM6KL_GSY^?KB_=0Q_J&#Q^>/U<6+ER8K5NW+C\'[2("1-$5
MYX8;;LCW*SJI1!ABT*!!>3@DKMT;;[PQ#VJEPD;19:1K2* =NT'$L_^))Y[(
MS^^$"1/R$,U))YV4_]T1X9^X_B(H%X'69H1IRR[N^Z[7T1__^,=F+PL 6HJP
M"         "TJ?B&_:Y%<O???W^SEP50EVK#(D![BU!7U[]?(G0!U8I@7==K
M*$([ ,"QA$4         H$T=/7HT_Y;YSH5R\6WP6[9L:?;2 &HF+ (GANBJ
MTK70?_WZ]<U>%FTB.O:,'CWZF.LGNKC$SP& 8PF+         $ ;.W3H4';I
MI9<>4S 7!=:[=^]N]M( :B(L N7W^>>?=PN*].O7+_OZZZ^;O33:0/S=.VW:
MM&.NGS///-/?O0!0@; (         +2Y[[[[+ILR9<HQA7,3)T[,OOSRRV8O
M#:!JPB)0?JM6K>H6%HF_6: W!PX<Z-91;\2($=GV[=N;O30 :%G"(@
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M1(1%                2D18!               H$2$10
M $I$6 0              *!$A$4               !*1%@$
M  "@1(1%                2D18!               H$2$10
M     $I$6 0              *!$A$4               !*1%@$
M      "@1(1%                2D18!               H$2$10
M         $I$6 0              *!$A$4               !*1%@$
M          "@1(1%                2D18!               H$2$10
M             $I$6 0              *!$A$4               !*1%@$
M              "@1(1%                2D18!               H$2$
M10               $I$6 0              *!$A$4               !*
M1%@$              "@1(1%                2D18!
MH$2$10               $I$6 0              *!$A$4
M  !*1%@$              "@1(1%                2D18!
M    H$2$10               $I$6 0              *!$A$4
M      !*1%@$  #XO^S=B9<4U=D_\#_B]Y?$-<:HY%5Q(^*.0>0%4514#"[@
M'C?<4%]%-"HJ$=SB$E'<4,0E[L:XQ7T%00&1*"Z@HO4[3WL&AYFJGNZNZJGN
MFL_GG#J*3C]UZU9U]U!UO_<"          !0(<(B                %2(L
M @              4"'"(@               !4B+ (              % A
MPB(                5(BP"              !0(<(B
M%2(L @              4"'"(@               !4B+ (
M % APB(                5(BP"              !0(<(B
M    %2(L @              4"'"(@               !4B+ (
M     % APB(                5(BP"              !0(<(B
M        %2(L @              4"'"(@               !72=6&1(XXX
M(OF?__F?PK8E2Y:4?4@4I)5K8]*D2<D//_S0UG;EN3ZG3)G2UK8!
M     % ]PB+"(I71ZK5Q\<47M[5=PB(               PF81%AD<K(<VTL
M6+"@;>T2%@$             8#!U75@DR]_^]K?, ??_^[__6W;SNL[99Y^=
MVI?QW[M-O6NC9QL^?'CRYIMO#FJ[3CGEE(W[__O?_SZH^P8
MH+J$14@UU,(BL1UPP ')FC5K!JU=PB(              +2#L BIAF)8)+8_
M__G/R88-&P:E7<(B      !#6Z/WKF.K@FXYWFYI9]'B&<E++[U4=C,
M "B(L BIJAH6V7'''0=\L#-KUJQ!:9>P"     # T#;40@G=<KS=TLZB]1S3
MM&G3DJ5+EY;='       <A(6(555PR*GGWYZ<OCAAP_X<&?1HD5M;Y>P"
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M%]=6$AD^?'CM643>H$@8:J&$;CG>;FEGD>+9PJZ[[MKOF!]XX(&RFP8
M0 .$13K A@T;DD<>>20Y\L@C!USAHN\6@_V/.>:8Y/'''T]^_OGGEO:_[[[[
M-KW?1K?ITZ<7W%O-&R@L$EY\\<5:7]8[EKB.OOWVV\+:U>ZP2-G7%0  P% G
M+$(>[0Z+A+5KUR9CQX[-#(PL7+BPL'UU(F&13<6J(C'@O>_GU6NOO59VTS::
M,V=.ZF?J_/GSRVX:%&JHA1*ZY7B[I9U%B\_>M FV5J]>77;3       8@+!(
MR?[][W_7'L(6$<R8.'%B\L8;;S3=!F&17\3,B0,=S^FGGUY8>**=89%.N*X
M  "&.F$1\AB,L$B(@,#HT:-3][/55ELEK[_^>J'[ZR3"(IN*P$7?SZK)DR=W
MU$0B<6\N[3/U_???+[MI4*BA%DKHEN/MEG86+<*EL5)YW^,^[[SSRFX:
M   #$!8I23QDO>ZZZS)7LY@P84)RRRVW)&^__79M=J8??_PQ^?SSSY,WWWPS
MF3MW;NV8TEZWTTX[)3???'-3;1$6^=599YTUX#'-FS>OD':U(RS22=<5  #
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M/[_V/".^*V.E\SC&V.+\C!LWKO9\8=Z\><F;;[Y9^/ZS//[XXQW]# X
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MEB]?WE0M89%??/OMM[4!"?4>Q$3P(1[B-*N(L$BW75?ANNNN&_#A5@SN 0
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M(-E]]]U3:^ZYYY[)ZM6K"VUGL^*[X:BCCDJM=<899S1=+\Y!6JVXK]_L=\-
MLJZ#V%YXX866:JY;MRZ9/7MVK;WQ61&?Z]=<<TWRW7??%=IV     ("A2%AD
M$%QZZ:69;8L9U8HT=>K4S'U=??75#=<1%DD7,Z[% _ZL/HXM'F;$3&L#R1L6
MZ<;KJK=X<'3\\<?7!C/$K'0Q"UW>01X   "=I.A9\0=CD'0,Q(P9Q[/VU<B
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M%0  P%#2SH!'NP=)__###\E))YV4V?Z8!;JOM6O7UB8VZ/F9F!T[9I0O0M:
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MNN7VQ .(F&%TL'1Z6"2"&3$8(&W_185%>G3R=?7!!Q]DAEEZMJ>>>JJP_0$
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M<$+M/,9W:SN_&\*<.7/Z!3GB>_SSSS\OI'Y\_\0*(_$]&&'1^&<<FZ (
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M.7 >?E7V>7 N?E7V>7 N!I>P"               0(4(BP
M %2(L @              $"%"(L               !4B+ (
M  ! A0B+                5(BP"               0(4(BP
M     %2(L @              $"%"(L               !4B+ (
M      ! A0B+                5(BP"               0(4(BP
M         %2(L @              $"%"(L               !4B+ (
M          ! A0B+                5(BP"               0(4(BP
M             %2(L @              $"%"(L               !4B+ (
M              ! A0B+                5(BP"               0(4(
MBP               %2(L @              $"%"(L               !4
MB+ (              ! A0B+                5(BP"
M0(4(BP               %2(L @              $"%"(L
M  !4B+ (              ! A0B+                5(BP"
M    0(4(BP               %2(L @              $"%"(L
M      !4B+ (              ! A0B+                5(BP"
M        0(4(BP               %2(L @              $"%"(L
M          !4B+ (              ! A0B+                5(BP"
M            0(4(BP               %2(L @              $"%"(L
M              !4B+ (              ! A0B+                5(BP
M"               0(4(BP               %2(L @              $"%
M"(L               !4B+ (              ! A0B+
M5(BP"               0(4(BP               %2(L @
M $"%"(L               !4B+ (              ! A0B+
M    5(BP"               0(4(BP               %2(L @
M     $"%"(L               !4B+ (              ! A0B+
M        5(BP"               0(4(BP               %1(QX=%_O2G
M/Y6^55'9?5K5?FW%;W[SF](W              "J0UADB(8:RN[3JO9K*\H.
MB@B+              !4B[#($ TUE-VG5>W75I0=%!$6 0            "H
MEHX/BP               - X81$              ( *$18!
M  "H$&$1              " "A$6 0              J!!A$0
M    @ H1%@$              *@081$              ( *$18!
M      "H$&$1              " "A$6 0              J!!A$0
M        @ H1%@$              *@081$              ( *$18!
M          "H$&$1              " "A$6 0              J!!A$0
M            @ H1%@$              *@081$              ( *$18!
M              "HD/_/WIUH6U%="P-^B/])[BM<14!!I!.C(B@11<38&XTD
M-L%H5,2HV( :B2@V210$-=)&U(38-Q&%( B*@ 2ED9[ZQZP,O 2J]MFUN]J[
MSO>-4>,(4G.M6M4RF',MQ2(                5HE@$              "@
M0A2+                5(AB$0              @ I1+ (
M % ABD4                J1+$(              ! A2@6 0
M    J!#%(@               !6B6 0              *!"%(L
M      !4B&(1              " "E$L @              4"&*10
M         "I$L0@              $"%*!8!              "H$,4B
M            %:)8!               H$(4BP               %2(8A$
M             ( *42P"              !0(8I%                *D2Q
M"               0(4H%@$              *@0Q2(                5
MHE@$              "@0A2+                5(AB$0
M@ I1+ (              % ABD4                J1+$(
M  ! A2@6 0              J!#%(@               !6B6 0
M     *!"%(L               !4B&(1              " "E$L @
M        4"&*10               "I$L0@              $"%*!8!
M          "H$,4B                %:)8!               H$(4BP
M             %2(8A$              ( *42P"              !0(8I%
M                *D2Q"               0(4H%@$              *@0
MQ2(                5HE@$ "IL_?KUR?SY\Y,[[K@CN?+**Y,++[PP.??<
M<Y,)$R8D4Z9,27[SF]\D<^?.3=Y[[[UD__[]97<7*NU___=_Z]X
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M;6L7^#\2+^$_>J%89-*D29GWZVVWW59*?S9NW.BY0>F\Q_H/YQH
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M9\Y,CR.^C\XXXXQDP( !Z3=DG)>++[XXN?WVVY.77GHI_3ZILC+?4U7]9@$
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MD6+CHZ(@*IYQQ_=IPH0)A5=QJ]7'3GRO=--[JI/?+%$H$JO!9+47SV0%(P
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MK%8_&]'L\_E83SWU5&:_XOND&9W^7NFF]U0GOUD>>>21FN,2*XP
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MQG///=>2/C[SS#.Y;2Q<N+!PO+Q8[[__?D/]B^=%5KS!@P<W%*]=EBQ9DEN
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M5L<\=.A0OWV'U>IG-\CJ5S<63/3*>ZJ3YSI6$)PX<6)F>[$Z3!PC
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MYI[S-]]\L^SNU<W]*^91K7J'M;J?41SQ]--/M_W[LAEB=O>[#P
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META&;G?B:5EBQ9#''W\\&3Y\>,WS$]L''WR0&^?RRR_/W6_]^O4=/*+:RDX
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ML7X\\L@CF?V(%1IJ<?]6(V8WO<-J];->8\>.S8W1["HJO7ZN^T-,
M  " /(I%&A2)@'GM/?#  W7'^>JKKW+C1")BU=QSSSV9QWKZZ:?G[K-MV[;<
M,?KM;W_;P=[75G8"8">3&F?-FM5T?V^XX8;<^#'K?[-];)=FV]NR94O;K^<[
M[K@CMXVM6[<6CM=?$V;CV9-7@/'00P^UI(T''WPPMXVB2=Z]4"P2+K_\\LQS
M_^JKKW:D_4.'#B5CQHPYH?U!@P8E.W?NK+FO^[<:,;OI'5:KG_4Z]=13<V/L
MW[^_Z*']Z,B1(SU_KOM#3           @#R*11JP:=.FM+@AJZV8W7G/GCV%
MXDV8,"$S5B0BML+&C1M/B'W^^>?7M>^Q^Q0]KBRK5Z_./-933CFEYGZ77GII
MYGYGGGEFTWT*644[X\>/+Q2C[ 3 3B8U3IPXL:FX^_;M2P8/'IP9>_3HT6F"
M:K-];)=6M'?111=EQH@$]E:(^R(K_L477]Q0O/Z<,!O/X:P"C,F3)[<D?L3)
MBM_(\[]7BD76KEV;KL!U_+D_[[SSDL.'#[>]_5@5)NO:FSY]>EW[NW][/V8W
MO<-J];->>7V)+?K:J!T[=O3\N>X/,0$          /(H%BDH9AV/0HNL=@8.
M')BL6;.F<,SGGGLN-UXK"C2>??;9$V(__OCC=>U[[#[KUZ]ONB][]^[-3:ZL
MY>677\X]OXV,^?%>?/'%$^(^\L@CA6*4G0#8R:3&V*)HJE$K5JS(C?OHHX\6
MBA6%1EEQVI5TWHIQGC]_?FZ<2*1O1MP/>;$7+%C04,S^G##[VFNOY19A-/M,
MC/WS8B]9LJ1PO%XI%@E//OEDYOE__OGGV]INK+)PUEEGG=#ND"%#TL3X>KA_
M>S]F-[W#:O6S7F>??79NC%@-IU%Y!;Z]=*Z[+6:GOUD          (#^3;%(
M 9%(>N&%%V:V$;.DO_[ZZPW%C8*08<.&9<9]]=57F^ISS&X=*V0<'W?=NG5U
M[7_L/HL6+6JJ+R&.->LX)TV:5'._@P</IDG/6?O>?__]3?<K:^622)(LHMW7
M7QGMU[JOZIV%/TO>S/PGG712LGGSYD*QSCCCC,Q8?<VF'DGCQ_[YH4.'UM5>
M*\8Y^A8%4EEQ'GC@@4*QCA?W0U;<:*_1&>9[)0FW'>(ZB>=35A'&G#ESFHK]
MQ!-/9,:]Y))+TG:+ZJ5BD7@W77WUU2><_U-//37Y\LLOV];NO??>FWG=S9LW
MK^X8[M_>C]E-[[!:_:S7E5=>F1LC"EL:]<PSS_3\N>ZVF)W^9HDB[5FS9J4%
M15&H$C]GSY[=U(HS          ! [U L4J=//_TT<S;RV*)09/'BQ4W%SUM=
M9.S8L6FA1*.R9K_^Q2]^4??^Q^YWW777-=R/HS[[[+/,XXQ$MKXL7;HT<]]!
M@P8EWW[[;<-]^OCCCT^(&8F71;7S^BNK_5KWU<DGG]S0+/IQK^3%O.666PK'
MBWLD*U9?UT3,MG[LG__I3W]:5WNM&N>%"Q=FQAD\>'#R[W__NW"\L'W[]G3_
MK+C-%'OU2A)NN\2S)ZL(8]RX<<EWWWW74,PH/HS]L^(N6[:LH9B]5"P2=NW:
ME4R8,.&$:R#&)5;Q:K48UZQK[O+++R_\GG7_]G;,;GJ'U>IGO9Y^^NG<&-.F
M36NH3U'0E;>27B^=ZVZ+V<EOEB@4B6+'K/8F3YZL8 0          /H!Q2)]
MV+U[=SI3>!2$9,6.%4'>>>>=IOM_^/#AW(2NN7/G-A0SDFV/G_T\9KU>LV9-
MW3&.[\L''WS04%^.FCES9N8QUINP^<M?_K*E"9J1(!P)=\?'>__]]PO':L?U
M5W;[>3%'C1J5_HP9JHL4ZL1YCI4#LF*>?OKI:;)T45.G3LV,%P5>M;SUUEL-
M)=2V:ISS5E:([=>__G7A>"'VRXIWS377-!3OJ%Y)PFV7.%=Q?6058MQWWWT-
MQ8S]LN+==MMM#?>SUXI%0CP_SCWWW!.N@UC%*PIJ6B4*16)6_>/;B?%II!WW
M;V_'[*9W6*U^UFOCQHWI]UU6C"B*:62UGEC9+J]?O72NNRUF)[]9HA"[UCF,
M%48          (!J4RR28]VZ=6EAPY A0W+CQFSD7W_]=<N.8?/FS<GPX<-/
M:"<2 )<O7UXHU@\__)!<>NFE)\1Z]-%'"\4Y?O\SSSPS[6<C_OG/?V8FZQ9)
MK(WBG;R9KN?,F5.H/Y'LFY6<.V/&C**'EFI'4F'9[>?%?.655W[\[Y@E^Z./
M/NHSULJ5*]/BJKR8,5-_(YY\\LG,>"^^^&+-_>Z\\\X3CJD>K1SG2%*/9/6L
M>//FS2L4ZYEGGLF,TV@R_+%Z)0FWG;[__OMDRI0IF<48\^?/+Q1KP8(%F7$B
M?K33J%XL%@FQ$L?$B1,SWS?OO?=>4[&C(/#WO_]]9B+]R)$CTW=]H]R_O1NS
MF]YAM?I9Q.VWWYX;)U;PB>_">D51S&FGG98;KY?.=;?%[.0W2][SZ>@6Q5(
M         $"U]>MBD4@BW;-G3_+--]^D*TE$HM_==]^=)@[6BA<S4D=25Q0;
MM%H45&05J$21Q>.//Y[VN2^???99,G[\^!-BQ"SHL8))$5G''PFV*U:LJ#M&
MC--KK[V6F7@8*Y]\]]UWA?JT=>O6W',4R9)Q3ONR;=NVY-IKKSUA_XLNNBC9
MOW]_H?X<U8ZDPK+;SXL9Y_2&&V[X\=>1B'WCC3<F2Y8L239MVI0FI<86LYG'
M[.177755S7OJ-[_Y3<-]C/:R$L$ON>22W'MT]>K5_U6X-'3HT&37KEU-C4FC
M8HR.7P'HZ#9]^O1DW[Y]-?>/Z_7>>^_-W#_B;MBPH>&^'=4K2;CM%L6!L0)4
M5D%&S-#>U[/CP($#R6.//9:Y?\3]ZJNOFNI?KQ:+A'A>Q$SY6=?$33?=E+[7
MBHAW9:PFDO4NC"V2Y^/=WRSW;V_&[*9W6*N./59(B>^SO%BQBEH<6U_>>..-
M'[]#\U91Z:5SW6TQ._G-DE6@?>P6_Q\          *BVGBL6J97TU.[MG'/.
M26?_[BOYLUF1%#MFS)C,/D3B[ZQ9L])9L*-HXFC!2R0TQBS#UU]_?682VB]^
M\8N&^EUK/,:-&Y<\\<03R:I5J]*^1#^B&"42+./7;[_]=OK_\Y)U8T;C1E=F
MV;Y]>SH+?U;<$2-&)/?==U]: !3)P)&@'7V*MB)Y.)(Z!PX<>,)^L1)+LP4#
M1;=&=:K=6OOOW+DS3;ANMB^1"%Y/$50MD>2;%3N2@>->B?,?;40R?MS#D6AY
M[)^+F;[+'.?HUP477) 9(Q+&'WGDD>233SY)DX'C..)G_#J>!;'Z0M9^$:^1
MXH-V''-9]TD[Q#/EFFNNR2S*B&3?IYYZ*OG\\\_3U3+B7,7/-6O6)$\__70R
M>?+DS/TB7M'"A;S"D$:V;O*7O_PE?89G70<77GAA>B]$,GL44<1*4X<.'4K?
M;7%/Q#@O6K0HN>NNNW)CQ';;;;?55518+_=O=\0LTDXHZQW6SF./>Z#6BG@#
M!@Q(BVI??_WU]#LMBI7V[MV;%C#$O7/%%5?\^&>CP#>^H[KQ7/=*S#SM^F8Y
M7M[?)8YNW?;\!P          6D^Q2!];)%+=<\\]R3OOO-.6E43R[-BQ(TU
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M #K-.PP          (#^3+$(D$NB+0"]RCL,          " _DRQ")!+HBT
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M1+$(              ! A2@6 0              J!#%(@
M !6B6 0              *!"%(L               !4B&(1
M  " "E$L @              4"&*10               "I$L0@
M     $"%*!8!              "H$,4B                %:)8!
M        H$(4BP               %2(8A$              ( *42P"
M          !0(8I%                *D2Q"               0(4H%@$
M             *@0Q2(                5HE@$              "@0A2+
M                5(AB$0              @ I1+ (              % A
MBD4                J1+$(              ! A2@6 0
MJ!#%(@               !6B6 0              *!"%(L
M  !4B&(1              " "E$L @              4"&*10
M     "I$L0@              $"%*!8!              "H$,4B
M        %:)8!               H$(4BP               %2(8A$
M         ( *42P"              !0(8I%                *D2Q"
M            0(4H%@$              *@0Q2(                5HE@$
M              "@0A2+                5(AB$0              @ I1
M+ (              % ABD4                J1+$(              !
MA2@6 0              J!#%(@               !6B6 0
M *!"%(L               !4B&(1              " "E$L @
M    4"&*10               "I$L0@              $"%*!8!
M      "H$,4B                %:)8!               H$(4BP
M         %2(8A$              ( *42P"              !0(8I%
M            *D2Q"               0(4H%@$              *@0Q2(
M               5HE@$              "@0A2+                5(AB
M$0              @ I1+ (              % ABD4                J
M1+$(              ! A71]L<A/?O*3TK=>5_;X56$, 0            "@
M5R@6Z0>%#F6/7Q7&$               >H5BD7Y0Z%#V^%5A# $
M    H%=T?;$(                ]5,L @              4"&*10
M         "I$L0@              $"%*!8!              "H$,4B
M            %:)8!               H$(4BP           /#_V;<#&0
M (!!_M;W^,HC  !@1!8!               8D44               !&9!$
M             ( 1600              &!$%@$              !B110
M             $9D$0              @!%9!               8$06 0
M            &)%%                1F01              " $5D$
M          !@1!8!               8D44               !&9!$
M         ( 1600              &!$%@$              !B110
M         $9D$0              @!%9!               8$06 0
M        &)%%                1F01              " $5D$
M      !@1!8!               8D44               !&9!$
M     ( 1600              &!$%@$              !B110
M     $9D$0              @!%9!               8$06 0
M    &)%%                1F01              " $5D$
M  !@1!8!               8D44               !&9!$
M ( 1600              &!$%@$              !B110
M $9D$0              @!%9!               8$06 0
M&)%%                1F01              " $5D$              !@
M1!8!               8D44               !&9!$              ( 1
M600              &!$%@$              !B110               $9D
M$0              @!%9!               8$06 0              &)%%
M                1F01              " $5D$              !@1!8!
M               8D44               !&9!$              ( 1600
M             &!$%@$              !B110               $9D$0
M            @!%9!               8$06 0              &)%%
M            1F01              " $5D$              !@1!8!
M           8D44               !&9!$              ( 1600
M         &!$%@$              !B110               $9D$0
M        @!%9!               8$06 0              &)%%
M        1F01              " $5D$              !@1!8!
M       8D44               !&9!$              ( 1600
M     &!$%@$              !B110               $9D$0
M    @!%9!               8$06 0              &)%%
M    1F01              " $5D$              !@1!8!
M   8D44               !&9!$              ( 1600
M &!$%@$              !B110               $9D$0
M@!%9!               8$06 0              &)%%
M1F01              " $5D$              !@1!8!               8
MD44               !&9!$              ( 1600              &!$
M%@$              !B110               $9D$0              @!%9
M!               8$06 0              &)%%                1F01
M              " $5D$              !@1!8!               8D44
M              !&9!$              ( 1600              &!$%@$
M             !B110               $9D$0              @!%9!
M            8$06 0              &)%%                1F01
M          " $5D$              !@1!8!               8D44
M          !&9!$              ( 1600              &!$%@$
M         !B110               $9D$0              @!%9!
M        8$06 0              &)%%                1F01
M      " $5D$              !@1!8!               8D44
M      !&9!$              ( 1600              &!$%@$
M     !B110               $9D$0              @!%9!
M    8$06 0              &)%%                1F01
M  " $5D$              !@1!8!               8D44
M  !&9!$              ( 1600              &!$%@$
M !B110               $9D$0              @!%9!
M8$06 0              &)%%                1F01              "
M$5D$              !@1!8!               8D44               !&
M9!$              ( 1600              &!$%@$              !B1
M10               $9D$0              @!%9!               8$06
M 0              &)%%                1F01              " $5D$
M              !@1!8!               8D44               !&9!$
M             ( 1600              &!$%@$              !B110
M             $9D$0              @!%9!               8$06 0
M            &)%%                1F01              " $5D$
M          !@1!8!               8D44               !&9!$
M         ( 1600              &!$%@$              !B110
M         $9D$0              @!%9!               8$06 0
M        &)%%                1F01              " $5D$
M      !@1!8!               8D44               !&9!$
M     ( 1600              &!$%@$              !B110
M     $9D$0              @!%9!               8$06 0
M    &)%%                1F01              " $5D$
M  !@1!8!               8D44               !&9!$
M ( 1600              &!$%@$              !B110
M $9D$0              @!%9!               8$06 0
M&)%%                1F01              " $5D$              !@
M1!8!               8D44               !&9!$              ( 1
M600              &!$%@$              !B110               $9D
M$0              @!%9!               8$06 0              &)%%
M                1F01              " $5D$              !@1!8!
M               8D44               !&9!$              ( 1600
M             &!$%@$              !B110               $9D$0
M            @!%9!               8$06 0              &)%%
M            1F01              " $5D$              !@1!8!
M           8D44               !&9!$              ( 1600
M         &!$%@$              !B110               $9D$0
M        @!%9!               8$06 0              &)%%
M        1F01              " $5D$              !@1!8!
M       8D44               !&9!$              ( 1600
M     &!$%@$              !B110               $9D$0
M    @!%9!               8$06 0              &)%%
M    1F01              " $5D$              !@1!8!
M   8D44               !&9!$              ( 1600
M &!$%@$              !B110               $9D$0
M@!%9!               8$06 0              &)%%
M1F01              " $5D$              !@1!8!               8
MD44               !&9!$              ( 1600              &!$
M%@$              !B110               $9D$0              @!%9
M!               8$06 0              &)%%                1F01
M              " $5D$              !@1!8!               8D44
M              !&9!$              ( 1600              &!$%@$
M             !B110               $9D$0              @!%9!
M            8$06 0              &)%%                1F01
M          " $5D$              !@1!8!               8D44
M          !&9!$              ( 1600              &!$%@$
M         !B110               $9D$0              @!%9!
M        8$06 0              &)%%                1F01
M      " $5D$              !@1!8!               8D44
M      !&9!$              ( 1600     (/;N^TN*,GL<\-_T_6'W#UB2
M(HHD,:$$Q80!Q2PNH!A0$7.6%<6L*Z*N?A9$$!%15A19<3&!!,6 "5 $ZWMN
M[\Z<=J:J9[JK>J:[YGG.J:/ ]*U;Z>V>F7O?%P       *!$-(L
M      "4B&81              " $M$L @              4"*:10
M         $I$LP@              $"):!8!               H$<TB
M            ):)9!               H$0TBP               )2(9A$
M             ( 2T2P"              !0(II%                2D2S
M"               0(EH%@$              "@1S2(                E
MHED$              "@1#2+                E(AF$0
M@!+1+ (              % BFD4               !*1+,(
M  ! B6@6 0              *!'-(@               "6B600
M     *!$-(L               "4B&81              " $M$L @
M        4"*:10               $I$LP@              $"):!8!
M           H$<TB                ):)9!               H$0TBP
M             )2(9A$              ( 2T2P"              !0(II%
M                2D2S"               0(EH%@$              "@1
MS2(                EHED$              "@1#2+
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MP($"LZ>WSCWWW&[7]KGGGFLH5MHSO6'#AF3PX,$U&T8>?/#!H@ZGQWP
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M]N[=F[SZZJO)@@4+DG/..:?RV7CX\.&5U5+BO_'G^/OXK+QBQ8K*UP,
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M'WQ0::BK=;SWW7=?P_NO-Y\\/OWTTV3NW+F9JRK6NI[77'--KO,,
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MF7[RR2=['&]B194B%#G&=-BW;U]EQ<1&&@:KM\&#!R>WWW[[@%_I#
M    !J*V;1:)V?IK%49%\\'6K5O[.\T_R,HUBH*C.#B*MG?MVE4IYHJ9IJ/
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M8VTT+->ZCXX\\LC*M>^+?';MVI69QPTWW%!WO#3SYLW+W$=<*P
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M4O1UW[%C1V65E5KG)58@:48^M>ZQ@P</YCFL3K7&UB%#AA2R#P
MH/5H%NG!GCU[DDF3)F466%U__?4]QHA"KW///3<SQLR9,Y/OO_^^[MR:42PI
M9G.*3Q5 _W<;.G1HO:>NZ:+8_MACC^WS<Q%%P#&;>1'^_O>_9Y[O&,.RQ'U9
M75#\YIMO-K1_8US^F /]''8P5K;N6-DJ:IVW9FC7^R">I35KUB1SY\YM>'64
MB1,G5E;>JD?LLVN<9JR4TXSKOFK5JA[/R;)ERPK/)YHULO87U[$(M<96XPT
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M#84?1[.N>XQCTZ9-JWD^HE$\&G"*RB=67LG:U]=??UW(<=4:6^-S @
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MS-SY9.F+ZQYB=:?1HT?7O.^NN^ZZW/F<=MIIF>_=13CFF&-2XY]^^NF%Q <
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MN6FY            [:&TS2)0K_Z:F1H H)W\_OOOE8:OKI^9HDD%
M  " UJ!9!/Y'LP@ 0,\V;=K4[?-2K!S4BBL< 0          #%2:1>!_-(L
M /3LGGONZ?9YZ9IKKNGOM            *BB603^1[,( $#/3C[YY&Z?EU:N
M7-G?:0$          %!%LPC\CV81              #*0+,(_(]F$0
M        RD"S"/R/9A$              ,I LPC\CV81              #*
M0+,(_(]F$0              RD"S"/R/9A$              ,I LP@#4E9C
M2&\W              !H59I%&) TBP              4%::11B0-(L
M         %!6FD4               !*1+,(              ! B6@6 0
M            *!'-(@               "6B600              *!$-(L
M              "4B&81              " $M$L @              4"*:
M10               $I$LP@              $"):!8!               H
M$<TB                ):)9!               H$0TBP
M )2(9A$              ( 2T2P"              !0(II%
M    2D2S"               0(EH%@$              "@1S2(
M       EHED$              "@1#2+                E(AF$0
M        @!+1+ (              % BFD4               !*1+,(
M          ! B6@6 0              *!'-(@               "6B600
M             *!$-(L               "4B&81              " $M$L
M @              4"*:10               $I$LP@              $")
M:!8!               H$<TB                ):)9!
MH$0TBP               )2(9A$              ( 2T2P"
M  !0(II%                2D2S"               0(EH%@$
M     "@1S2(                EHED$              "@1#2+
M        E(AF$0              @!+1+ (              % BFD4
M          !*1+,(              ! B6@6 0              *!'-(@
M             "6B600              *!$-(L               "4B&81
M              " $M$L @              4"*:10               $I$
MLP@              $"):!8!               H$<TB
M):)9!               H$0TBP               )2(9A$
M ( 2T2P"              !0(II%                2D2S"
M    0(EH%@$              "@1S2(                EHED$
M      "@1#2+                E(AF$0              @!+1+ (
M         % BFD4               !*1+,(              ! B6@6 0
M            *!'-(@               "6B600              *!$-(L
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M?'GR__[?_^NVQ=\#K<7X22MHEZ*S=]YYI[*"2".-(JV0/[02S\W T^C8Z5Z
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MP08 -CPH6<@ XO/YY)OC?W":X](;%WW[]HTV?'2 (R(.<*1EQ&W0ETXH."2
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M*@%'9&0B4*U183O1H6XV&,ZV@"KL@R%3$-67/OC@ ZWKSYX]&QV$5LWC^&[
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L@B (@B (@B (@B (@B (@B (@B#4B/\'B,,8M['N[;D     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>image_2a.jpg
<TEXT>
begin 644 image_2a.jpg
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M_9U9C!D$9V9&%D.1PB-A?+R(A)J.K<D.(X1B2)I!,Q,H<1SR*@C[#N1YR(R
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M:J+F/"T(3.,-J*, Q'WK%QU)8/#3M7E6^NOE#]EL\/R: TEB2^WG'H3@JW:
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2U.7UQCS^     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>image_30a.jpg
<TEXT>
begin 644 image_30a.jpg
MB5!.1PT*&@H    -24A$4@  #)\   ,R" 8   !Y:X&*    "7!(67,  $SE
M  !,Y0%USO"5  "]7DE$051XG.S=";<4Y9D'\'R5^0CS%48$ 5DT(HOBB!@S
M",(Q(F1PU!&58#!NHP@$11$= ^(R&H7H#&* Z,2(1HD+BKC% "HB;BQ2<Y[V
M-'.]]-NWJJNZZ][P^YWSG).(_;Q5;RW-\;S_?G^4Y?"C'_WH> $
M     '#RR)4F$3X!               X.0F?                D"1\ @
M            0)+P"0               $G")P               "0)GP
M             ) D? (              $"2\ D               !)PB<
M              !_Y\ID0X1/                _LX)GP
M )#4\_!)W_^OE%)**:644DHII9122BFEE%)**:644DHII9122BFE_CY+^$0I
MI9122BFEE%)**:644DHII9122BFEE%)**:644DHE2_A$*:644DHII9122BFE
ME%)**:644DHII9122BFEE%)*):OC\ D               !#1YELB/ )
M          # WSGA$P               )*$3P               $@2/@$
M             "!)^ 0              ( DX1,               "2A$\
M              !($CX!               @2?@$              " ).$3
M                DH1/                2!(^ 0              ($GX
M!               @"3A$P               )*$3P               $@2
M/@$              "!)^ 0              ( DX1,               "2
MA$\               !($CX!               @2?@$              "
M).$3                DH1/                2!(^ 0
M($GX!               @"3A$P               )*$3P
M $@2/@$              "!)^ 0              ( DX1,
M  "2A$\               !($CX!               @2?@$
M  " ).$3                DH1/                2!(^ 0
M    ($GX!               @"3A$P               )*$3P
M     $@2/@$              "!)^ 0              ( DX1,
M      "2A$\               !($CX!               @2?@$
M      " ).$3                DH1/                2!(^ 0
M        ($GX!               @"3A$P               )*$3P
M         $@2/@$              "!)^ 0              ( DX1,
M          "2A$\               !($CX!               @2?@$
M          " ).$3                DH1/                2!(^ 0
M            ($GX!               @"3A$P               )*$3P
M             $@2/@$              "!)^ 0              ( DX1,
M              "2A$\               !($CX!               @2?@$
M              " ).$3                DH1/                2!(^
M 0              ($GX!               @"3A$P               )*$
M3P               $@2/@$              "!)^ 0              ( D
MX1,               "2A$\               !($CX!               @
M2?@$              " ).$3                DH1/
M2!(^ 0              ($GX!               @"3A$P
M )*$3P               $@2/@$              "!)^ 0
M ( DX1,               "2A$\               !($CX!
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M2L?JM9-EH7\WKZ'P2;5.EGN2@>7=763BQ(G9IY]^VM-C$SX!
MH!WADYRJ#I_TM7OW[FS^_/G)_E.F3,EV[=I5T9EDV8X=.[+APX>?,,Z2)4LJ
M&Z,N)\M"_VY>0^&3:ITL]R0#RQL^B9HU:U9V^/#AGAV;\ D
M[0B?Y-3-\$G3A@T;LI$C1[8<8_3HT94N5G_EE5<:BYLCP#!APH3L[KOOSHX>
M/5I9_[J<3 O]NW4-A4^J=3+=D[37]_JWV_&J[\Y7O2)\ @           $ [
MPB<Y]2)\$G;NW)F=>>:9+<>)8$H$#DBST+\\X9-JN2=IZGO][[GGGF38L&\]
M\, #/3DVX1,             VA$^R:E7X9.P>_?N;.S8L2W'BG_^T4<?53K>
MWQ,+_<L3/JF6>Y*FOM?_#W_X0[9ITZ8!=T")/]^Z=6O7CTWX!
M (!VA$]RZF7X)/SQCW],+DK^R4]^DATZ=*CR,?\>6.A?GO!)M=R3-/4/GX38
M 66@W4]&CQZ=[=JUJZO')GP"            0#O")SGU.GP2EBY=FAQSU:I5
M71ESJ+/0OSSADVJY)VEJ%3XY=NQ8MG#AP@$#*),G3\[V[]_?M6,3/@$
M      "@'>&3G.H(GWS[[;?9V6>?W7+,$2-&9!]]]%%7QAW*+/0O3_BD6NY)
MFEJ%3T*\ZV?,F#%@ &7V[-G9D2-'NG)LPB<             M"-\DE,=X9/P
MR"./),==LF1)U\8=JBST+T_XI%KN29I2X9/PR2>?9!,F3!@P@-*M][[P"0
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M[Y(I4Z8T G['CATK/3?MO/WVV]DO?O&+7 &I_A7!E)CWP1($!0
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MF5QSS36-W7H^_/##QO6+'8OBW;)Y\^;&LYCZNTO\\Z>??KJRXP0
M  "Z3_@DISK#)V'6K%G)\0=:Q-Q*GMTM\HB%PZT6JU]PP06Y?]F\N4O#::>=
M=D*?=N&35F(Q=JOSRAM***K=/,8BZG'CQAW_9[&@_H8;;LBV;-G26*@;BW3C
M5^ICGAY\\,%L_/CQA1;25W4-B_1]XHDG?O#/XM^-75#>>..-[--//VTL((_S
M?O755QL!C[/..BMYW\9]$\&E3G3C.C_TT$,M>Q8)G_3J6%-B$?^%%U[8<KQX
MAWS\\<<#]HB%_Q,G3FS9(P(197:<"'4^,W4K\MZ.\YPQ8T:NL$'9:Q)Z%3Z9
M-&E2H7=4A!13N^#$?;IGSY[2QQKB'9::XSB7"+KTO3>G3Y^>/?#  ]E;;[W5
MV!DDKD$\?[%K3]R;4Z9,:7O=?O6K7QT?^R]_^<L/ IRQBU@$,^.?1U S>D?(
MZ.VWWVZ\IP;:>26".U7XW>]^UPB8M!HC_D[TSCOO#-@CWCGSY\]/'FN<#P
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MF"C.=_GRY<G>\7Z.0$P9L9M):A>DV;-G-]XW><5<77?==<GC[32$"
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M[R-'CB1[WWSSS;G[Q/NHW;T4]UL1L2M2\[-WW'''#_ZLW34\\\PS"XT#
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MX9.<Z@Z?S)@Q(SE^)V&#;@078A'THX\^FIUWWGFE%IY.GSZ]XT50@R5\4C8
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M\<<?_^!S585/VNV@<=IIIV5[]^XM=7[")R=*]2X2/HF :+M[YN#!@Z6/$P
M         !C:A$]RJBM\\M577R5_17[DR)'9YY]_WE'?NA> 'SER)-NT:5,V
M>_;L 1=*GW_^^8W@2A[")]T+GSSSS#.5'/?2I4N3UWK9LF6Y>J2N\PLOO-#Q
M<=UUUUTM>P[F\,F__=N_)>=RX\:-I?LWQ2+VU#@1VBFB[G=/G?J>;[?")V&@
M72RBID^?GGW]]=?'/U-%^"0"+>UV7KGYYIM+GYOPR8E2O8N$3]:M6]?V?BD;
M&@(           "&/N&3G.H*GZ1V8X@JNN- 7X-I 7B,><XYY[1=^)IWVU7A
MD^Z%3V)KLRHL6+ @>9TW;-B0J\?4J5-;?O[WO_]]Q\?U'__Q'RU[#N;PR<J5
M*Y-SN6K5JM+]F^;.G9L<IVB(8C"]>WJMS+P5<?CPX6S6K%EMWZE1$5YJ!ONJ
M")\\^NBC;<>KXIR%3TZ4ZETD?!+OHW;7;N?.G:6/$P           !C:A$]R
MJB-\\N677V9GG'%&RS%CUY,]>_9TW'NP+0"/'5XNOOCBY!RO7;LV5Q_AD^Z%
M3^ZXXXY*CCL5'(EZ[[WW<O6(71M:??Z___N_.SZNG__\YRU[#N;P281M4G.Y
M<.'"TOV;)DZ<F!PG%M87,=C>/;U4=1"CG<\^^ZSM=6O6BA4K&O]^%>&3=COD
M1%6Q>X;PR8E2O8N$3^+O&\.&#4OVJFKG*P           &#H$C[)J8[PR8TW
MWI@<\_[[[R_5>S N /_XXX^SX<.'EPH^")]T+WSRLY_]K/0Q[]^_/SOEE%-:
M]A\[=NSQ71@&<LDEE[3L\=!##W5\;),G3V[9<S"'3V+!>.J9F39M6NG^S3%2
MU^S""R\LW&\POGMZI9?ADQ"[58P:-6K  ,K33S]=2?CDZJNO;CO.M]]^6_J<
MVNVN(GS2>?@D7'KII<E>RY<O+WV<            P- F?))3K\,GSSWW7'+!
M]XP9,[(C1XZ4ZE_% O#QX\<?_UPL<J["O_[KO[8\KE_]ZE>Y/B]\TKWPR>C1
MHTLO'G_JJ:>2SU&1D,?\^?-;]EBZ=&E'QQ4[,J2>M\$</@FI'5NBJMAI8M.F
M3<G^JU>O+MQ/^*1WX9,0N^.D[NUFC1@Q(EN\>/'Q_]]I^"1VVVDW3A7ADWOO
MO3?97_BD7/BDW:XR$?BK4KS_6HVS8\>.2L<!            JB-\DE,OPR>Q
M"#;U:_7CQHW+]NS94WJ,JL,G6[9L*7U,8=FR92V/ZZZ[[LKU^=CMH9<+VT^F
M\$E4!!'*:!>4*!+&N/GFFUOV6+!@04?'M7[]^N1QE0V?=/N>C&<O=>R//?98
MZ?Z+%BUJV7O8L&'9OGW["O<3/NEM^"3$3EGM0B']J]/P2>Q0U:YO[&Y55M^0
M3/\2/BD7/OGFFV^R,6/&M.P5 :8JKE]3JW?X.>><4UE_            H'K"
M)SGU*GSRVFNO)1=_QLX35?TJ>-7AD^7+EU=R7+%S19G%OS-GSFSY^6W;M@WX
MV5BHV_<S:]>N'? S)UOX9/;LV=FQ8\<ZZMMN<??4J5,+]4W]0O_8L6,+'U_\
M^Q=>>&'RV,J&3[I]3\;Q3Y\^O>48L4M2&5]\\45V^NFGM^R]9,F2CGH*G_0^
M?!)2(:)6U6GXY-%''VW;]^FGGRYU#G&O3Y@P(=E?^*1<^"2T"RK%KC-YQ=]5
MXEK-FC4K.WCPX _^[,"! XV_S_3OW\E.2@           $#O")_DU(OP22S<
M'3%B1,LQ8@'XG__\YTK&"56'3\X]]]SLN^^^*WU<L7-%J^/Z\,,/<WT^M;/&
MQHT;!_SL55==]8//;-Z\><#/G&SADZ@-&S84[AGWQJ677IKL^=O?_K90O]=?
M?SW9:_OV[85ZQ;W1[GS+AD]Z<4_&-4\=?YF0P\J5*Y/OH[U[]W;44_BDGO#)
MX<.'&T& =O=ZLSH-G\2N7.WZ=KHS45/<_^WZ"Y^4#Y\<.G2H$09LU2\"(WEW
M.^H;Z%NQ8L4/_JQ5R/3,,\_,OOKJJ\+'"P           /2.\$E.W0R?O/WV
MVVT7YL="T/?>>Z^B,_E>U>&3J,<??[S4,7WVV6<MPS=%=F^('5A:G=>:-6L&
M_&P$:/I^)L^<GXSADU&C1F6OOOIJH9ZWWWY[LE_<^YWL5C)ITJ26_>;.G9N[
MWZY=NX[O-)1:<%TV?-*K>_+&&V]L.4Y<SR^__++P<;_[[KN-:]VJYQ-//%&X
M7Y/P23WADQ#OV-1ST[<Z#9^$.7/FM.W]\LLO=]0W@@FI9[19PB?EPR<AYF+X
M\.$M>UYQQ14#OE_CW='W,Q,G3CS^9R^^^&)VRBFG5#['            0/<)
MG^14=?@D?EU\Z]:MV?SY\ULNQ&S6#3?<D!T\>+#R\^E&^&3DR)$=[\YR].C1
MEKN>Q-P46:S\[+//MCROV$&BG7?>>><'_WXLT,[C9 J?Q+W:_-^Q\\633SXY
MX"+D6#"^>/'BY/T=]\Q''WW4T7&F=N6(BE_6'V@GGI=>>BF;,&%"X]\_[[SS
ML@<??+!EK[+ADU[=D_%.F3ES9LNQ8O>5>,;R^OSSS[-SSCFG9:\(N90A?%)?
M^"1$V#%VL$@].U%EPB=OO?56V^^TV.&BZ#/_[;??_N#]DRKADVK")^&99YY)
M7L=%BQ:U??=OVK3IA,_$=T'L2M7JWKOFFFL*!Q !          " WA,^R:F3
M\$DLIHQ%L[&0.Q:21]CDOOON:_QR^$"+?W_RDY\T?B&\6[H1/FF&"6(1_Y$C
M1W+WB87(L5M%*D101,QW!"/Z]SGMM-.RO7OWMOQ,'.MEEUWV@W__WGOOS37>
MR10^>?[YYT_8H>>BBRYJ7.^=.W=F^_?O;\SEOGW[LM=>>RU;MFQ98Q%[ZAZ/
MA<VQ2+E3,5ZK>[#O,Q2+QM]___W&PN<(9WS\\<?9YLV;&\&/YL+J^(7_6'C^
MT$,/M>Q3-GS2RWLRWC5QWJW.(X(I>1;]O_+**XV="EKUB$7B19[M5H1/Z@V?
MA"U;MK0-B)0)GX15JU:U_7X;-VY<]MQSS^7J%;MHQ'NF^=EVWYW")]6%3\)3
M3SV5#1LVK&7OV;-G-][[K3SZZ*,G_/NWW79;R]U4+K[XXL8[$@
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MNQJ_9E[5 O.^BWJ;@8!.'#Y\.)LQ8T9'8\?.+3MV[.C*/#9K*(=/0H0;^N^
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M/:KV\LLO%PIWS)T[]X1KW<WP2>C&/3F0SS[[+%NY<F5RYX*!GL?UZ]>7VIE
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M2?@$              " ).$3                DH1/
M2!(^ 0              ($GX!               @"3A$P
M )*$3P               $@2/@$              "!)^ 0
M ( DX1,               "2A$\               !($CX!
M   @2?@$              " ).$3                DH1/
M    2!(^ 0              ($GX!               @"3A$P
M     )*$3P               $@2/@$              "!)^ 0
M     ( DX1,               "2A$\               !($CX!
M       @2?@$              " ).$3                DH1/
M        2!(^ 0              ($GX!               @"3A$P
M         )*$3P               $@2/@$              "!)^ 0
M         ( DX1,               "2A$\               !($CX!
M           @2?@$              " ).$3                DH1/
M            2!(^ 0              ($GX!               @"3A$P
M             )*$3P               $@2/@$              "!)^ 0
M             ( DX1,               "2A$\               !($CX!
M               @2?@$              " ).$3                DH1/
M                2!(^ 0              ($GX!               @"3A
M$P               )*$3P               $@2/@$              "!)
M^ 0              ( DX1,               "2A$\               !(
M$CX!               @2?@$              " ).$3
MDH1/                2!(^ 0              ^#_V[OQKBNK.'_C_-L C
M.\B^2$3 $3R HA@GC#@$Q4%1T!DTPS+Q:'0$26(409U@X!DP)*AG, ;% 5D,
MB+(J\+#(<K_G]O?@05.WZ:6JJ_OA]3KG<PB&_MQ;2_</5?6N2Y+P"0
M         $G")P               "0)GP               ) D? (
M         $"2\ D               !)PB<                D"9\
M          "0)'P"              ! DO )                2<(G
M            ) F?                D"1\ @              0)+P"0
M             $G")P               "0)GP               ) D? (
M             $"2\ D               !)PB<                D"9\
M              "0)'P"              ! DO )                2<(G
M                ) F?                D"1\ @              0)+P
M"0               $G")P               "0)GP               ) D
M? (              $"2\ D               !)PB<                D
M"9\               "0)'P"              ! DO )
M2<(G                ) F?                D"1\ @
M0)+P"0               $G")P               "0)GP
M ) D? (              $"2\ D               !)PB<
M   D"9\               "0)'P"              ! DO )
M    2<(G                ) F?                D"1\ @
M    0)+P"0               $G")P               "0)GP
M     ) D? (              $"2\ D               !)PB<
M       D"9\               "0)'P"              ! DO )
M        2<(G                ) F?                D"1\ @
M        0)+P"0               $G")P               "0)GP
M         )!T4X5/KI^+4DHII9122BFEE%)**:644DHII50M!0   '"S:^9:
MB?")4DHII9122BFEE%)**:644DHII7I] 0   -SLFKE6(GRBE%)**:644DHI
MI9122BFEE%)*J5Y?     #>[9JZ5=%SX!               @/H(GP
M    4).R5Z%12BFEE%)**:4ZH7JC9K9/^ 0         X"92]L,[2BFEE%)*
M*:54)U1OU,SV"9\          -Q$RGYX1RFEE%)**:64ZH3JC9K9/N$3
M          " 7D[X!               @"3A$P               )*$3P
M             $@2/@$              "!)^ 0              ( DX1,
M              "2A$\               !($CX!               @2?@$
M              " ).$3                DH1/                2!(^
M 0              ($GX!               @"3A$P               )*$
M3P               $@2/@$              "!)^ 0              ( D
MX1,               "2A$\               !($CX!               @
M2?@$              " ).$3                DH1/
M2!(^ 0              ($GX!               @"3A$P
M )*$3P               $@2/@$              "!)^ 0
M ( DX1,               "2A$\               !($CX!
M   @2?@$              " ).$3                DH1/
M    2!(^ 0              ($GX!               @"3A$P
M     )*$3P               $@2/@$              "!)^ 0
M     ( DX1,               "2A$\               !($CX!
M       @2?@$              " ).$3                DH1/
M        2!(^ 0              ($GX!               @"3A$P
M         )*$3P               $@2/@$              "!)^ 0
M         ( DX1,               "2A$\               !($CX!
M           @2?@$              " ).$3                DH1/
M            2!(^ 0              ($GX!               @"3A$P
M             )*$3P               $@2/@$              "!)^ 0
M             ( DX1,               "2A$\               !($CX!
M               @2?@$              " ).$3                DH1/
M                2!(^ 0              ($GX!               @"3A
M$P               )*$3P               $@2/@$              "!)
M^ 0              ( DX1.XB?S#/_Q#S04              )'P"=Q$A$\
M             *B7\$FH[X'\&U6?/GW"@ $#PO#AP\.$"1/"K%FSPL*%"\/J
MU:O#EBU;PN'#ATO9QN[N[C!ERI30U=45[KCCCLK?Z3S-'D?A$VX6SFD
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MR;ZS9\\.APX=RG4[;K_]]LRQ)D^>G.LX9;B9'O0OZCC>3/NP%>S/]N 8
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M-)=&E?%[!P       +U17O=J;Z2GIR=,GSX]<YQX;_+33S_-=;QVTHK]"P
MP,U)^*2*5EWTR!)#)JFQCQX]VO"\\]B.7__ZUYF]A@P9$IY^^NFP;=NV<.C0
MH<K%G+AB1OPS_OW==]\-CS[Z:-6'S//:KGHJS_!)7)FFF;FT\CC>:)PHKO8P
M;=JTIO?Q@@4+PJ5+EYJ:3S/;7=2^;/4YF25^M^ZXXX[,/F/&C DK5ZX,?_WK
M7RN_&]]]]UWES_CW^-]'CQZ=^;GX^W/X\.&Z]D6]^^.:/+\S-YI+(\KZO0,
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M[-BQ\,HKKX2[[[[[^Y?OU5.S9LT*V[9M"U>O7FUXN^H=L]9Z[;77&IX3
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MG>P_:M2HIN?8C*+.G2+/R4&#!B7[GSU[-I<QJAVSP8,'U]VO[.],'MKE]PX
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MF^)J$=6.=YES+&J[B]R?<:GG5/\S9\[D,D:U8U;/4M/7E/V=*5*K?^\
M  "@TY7U'$;4T].3''O(D"&%CY^2-9^Q8\?FVJ^WW*,%  "@7,(G591UT6/=
MNG7)<5]^^>6&>I:Q'>?/GP^;-FT*__1/_U1UQ8;K:^[<N76-T>KM*OLB32M#
M&'FLI''TZ-%D_[CZ0[-S;-3%BQ<+.Y9%GB,3)DQ(]C]V[%@N8U0[9A,G3JR[
M7]G?F59IQ>\=        =+HRPR<G3YY,CEW/RQ/SEC6?^/*[//OUQGNT
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MPHYE*\[)N%SSW+ES,\=Y]-%'&YIW_%Q6OP<>>*"A?M>4_9UI5#O^W@$
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M]]WP]--/AUFS9E7V3=PO,1P7_XQ_C_\]KL 4OX]GSY[-;>S>K-U^[P
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MZ*',S\^;-R]\_/''E55:8JCG\.'#E7T5PR;7_[NX>@H   #\F/ )
M  "Y:77@9/SX\6'9LF7APP\_S&VEDY1]^_:%J5.G-C7?*5.FA/W[]]>]KVIU
MXL2),'KTZ(;F%@,J1>]#    .I/P"0          N<DS6-*G3Y_0OW__,&S8
ML#!NW+@P<^;,L&#!@K!Z]>JP>?/FRNH=K197-'GYY9?#F#%CZMJ6& AY]=57
M*ZN.-+*OZG'\^/$P=^[<FGO?<LLME7UZ^?+EO'<7    O83P"0
MU"F&2+9OWQY6K%@19L^>'29,F!"&#!E2"<P,&# @C!T[-LR9,R<\]]QS8<>.
M':4$.S[[[+.P:M6J<-]]]U7F,WCPX-"W;]_*/"=.G!CFSY\?UJU;%TZ=.M7R
MN0$  -!9A$\               !($CX!               @2?@$
M      " ).$3                DH1/                2!(^ 0
M        ($GX!               @"3A$P               )*$3P
M         $@2/@$              "!)^ 0              ( DX1,
M          "2A$\               !($CX!               @2?@$
M          " ).$3                DH1/                2!(^ 0
M            ($GX!               @"3A$P               )*$3P
M             $@2/@$              "!)^ 0              ( DX1,
M              "2A$\               !($CX!               @2?@$
M              " ).$3                DH1/                2!(^
M 0              ($GX!               @"3A$P      X/^Q]Q_>CA37
MPKC]-[W$:\.]X-<DDV$(!DS.F#1$DV$(!@R^8'(.)F=,,&'(:4PP8'(V.6<,
MF&#]OJWWTUD:35=+ZJ36X7G6Z@4S<U2UNSJHI;-W%0       "0I/@$
M         "!)\0D               !)BD\               !(4GP"
M          ! DN(3                DA2?                D*3X!
M            @"3%)P               "0I/@$              "!)\0D
M              !)BD\               !(4GP"              ! DN(3
M                DA2?                D*3X!               @"3%
M)P               "0I/@$              "!)\0D               !)
MBD\               !(4GP"              ! DN(3
MDA2?                D*3X!               @"3%)P
M "0I/@$              "!)\0D               !)BD\
M  !(4GP"              ! DN(3                DA2?
M    D*3X!               @"3%)P               "0I/@$
M     "!)\0D               !)BD\               !(4GP"
M      ! DN(3                DA2?                D*3X!
M        @"3%)P               "0I/@$              "!)\0D
M          !)BD\               !(4GP"              ! DN(3
M            DA2?                D*3X!               @"3%)P
M             "0I/@$              "!)\0D               !)BD\
M              !(4GP"              ! DN(3                DA2?
M                D*3X!               @"3%)P               "0I
M/@$              "!)\0D     -.C__M__._(&P'3Y/__G_XR\ 0
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M>^[I;+755MW/<S%A0OP9IDD;GK.!]HI);]9;;[W.4DLMU9DS9T[WSTP/Q2<
M     ,!LI?BDT]ZDUBI]_?77G?/..Z^;S%QEC+$J2"2 3M-J*$\\\41GBRVV
MJ.VXK;SRRIU]]MFG<_755W?>>NNMD>.:Q+GS4RD^B6W????M_.<__QEY;,;1
MIOTL>TY,HN\J^YKDF!7UT$,/)6.X\\X[:^]_&L9LTN="F3&8Y/@VV?>DQCL*
M:>/^'M=17?=X -KGWGOOS7Q?B+^':=;T<S;03G?<<4=FD4+\/=-+\0D
M # ;*#[IM#.I-6;VKDHD+V?-JA_;VFNOW3GRR",[-]YX8^>IIY[J?/311]U"
ME9B)/_X;?XZ_CW^/GXN?SVIGM=56ZUQYY97=U[55K"!P[+'')L=\ZZVW[IQ[
M[KG=&7-??_WU[JHNL8I)K)+RQ1=?=-Y[[[WN6%Q__?6=XX\_OK/NNNM6FBS<
M9))PST^I^"2VBR^^>.2Q&4?;]K/,.3&)OJOL:Y)C5E2LP)2*8:^]]JJ]_VD8
MLTF?"V7&8)+CVV3?DQ[WV.)ZF:9B6 "*BQ5/LMX+XC,=3+.FG[.!=HH53[**
M%.+[7::7XA,      & V4'S2Z33^"_THTLA+GEQQQ14[SSWW7.E^OOGFF\[1
M1Q^=3,JYZZZ[NH45XXB?O_ONN[NOSVIWCSWVZ'SRR2>E8Z]:%)',G3LW&?-+
M+[TT=IM1:+-@P8+D6%1U3M79]J#77GNML]%&&\VT'S/*7W;99:7;;6H?AB4F
MK[#""MV5;YHRB?VL6Y-]3V(_FWX_B/MEW/-3^QG7X+OOOMM(+(,F>9[EQ5)5
M.U7N4Y%V7,>C]17/,E%0\OSSSW>NN^ZZSB&''))[S<0*;TW>YP%"6]XO)ZW)
M<5AII94R^XJ_AVGF?@*$)9=<,K-(8:FEEIIT:)2@^ 0      )@-%)]TFDTV
M?O755SLKK[QR;C+FA1=>6+J?6+5CAQUV6*3M7_WJ5YUKK[VV\Y___*=4^_'Z
M:ZZYIMO>8!\Q"U\4,;3)88<=ECG651161!%*K)A25Y)(4TG"CSWV6&>--=:8
M:7N555;IK@)3A:;V(:^?_O,SKH\F3&(_ZS9-2>ME^VQ"W(.&G;/GG7=>([$,
MFN1YEA=+5>U4N4]%VG$=%^_K@P\^Z,R;-R_9;KR7Q?,60%/:\GXY:4V.P^:;
M;Y[9UQ9;;%%+?] 4]Q,@K+/..IE%"O'W3"_%)P      P&R@^*337++Q=]]]
M-W25C)UWWKE;S%#&1Q]]U-ETTTT7:7N]]=;KO/SRRQ7MS?\3*X:LN^ZZB_2U
M]MIK=UY\\<5*^RIJ_OSYC21T7W#!!;4DB321)'S333<M-)-\'--GGGFFLO:;
M2G0>EL3?V_;::Z_2!5CCQE-7NY+6Z^NS"9$@.>Q\W7###1LY7P=-\CS+BZ6J
M=JK<IR+MN([+]W7))9?D7C>QZAE $]KR?CEI38[#'7?<D=E7?/:#:>9^ H2_
M_O6OF44*\?T=TTOQ"0      ,!LH/NDTEVQ\ZJFGYB9AKK;::IVWWWZ[5!]?
M??559YMMMEFD[9@9[ZVWWJIH3Q;VQAMO=-9::ZU%^HP"AG???;>6/D<5A3P;
M;[SQ(K%MMMEFG>^__[[2OB(Y/(J'JDX2J3-Q-V(^ZZRS%FHS9A%^YYUW2K?=
MKZE$Y_YV?_G+7^;V6\4*0^/$4U>[DM;KZ[-N3SWUU$Q?*ZVT4N[^/OSPP[7'
M,VB2YUE>+%6U4^4^%6G'=5Q-7T<>>62R_8LOOKB2/@"&:<O[Y:0U/0YWWGEG
MMY WGJ/B,XS"$V8#]Q.@YY9;;NE^M[KDDDMVO]=5>#+]%)\       "S@>*3
M3C/)QH\__OC09/B;;[ZY5!]12! K.@RVN\(**W3^\8]_5+0GV9YXXHG,_=MJ
MJZTZ7W_]=:U]YUFP8$'F6,=LZ75X_OGG*T\2J2MQ]]___G=GWKQY"[6W^^Z[
M=[[XXHO2,0]J*M&YO]USSCDGM]\X7__^][]7VG]>/'6U*VF]OC[K=NRQQ\[T
M=<())^2N@G+888?5'L^@29YG>;%4U4Z5^U2D'==Q-7U]^.&'R>*M-=988Z+/
M(,!/1UO>+R?-.$!YKB. V4OQ"0      ,!LH/NG4GVS\Y9=?=C;<<,/<!,Q#
M#CFD=#\QPW=6VV>>>6;YG1A!:F67XX\_OI'^LT1"=U9,+[WT4FU];KWUUI6>
M4W4D[G[ZZ:>+K-(2L\=7O1I,3U.)SOWMQJHW>^RQ1V[?<^;,Z7S\\<>5QI"*
MIZYV):W7UV>=(B%^U557G>DK"M<NO_SRY/Y&<OUGGWU6:TR#)GF>Y<5253M5
M[E.1=ES'U?4U6$C9OSWXX(.5]0.0TI;WRTDS#E">ZPA@]E)\ @      S :*
M3SKU)QL??OCAN<F7ZZ^_?N?SSS\OU<<KK[S267'%%3/;_O;;;RO:DWS??/--
M9]UUU\W<QX<??KB1& ;MN...F?&4'>\\@T5 956=N/O&&V]T-MEDDX7:.??<
M<TO'F:>I1.?!=J.P9+WUULOM/PI4HE"E#DWLIZ3U^OJLTTTWW333SS;;;-/]
MNR@*2ZW@$-N55UY9:TR#)GF>Y<5253M5[E.1=ES'U?5UPPTW)/LX\<03*^L'
M(*4M[Y>39AR@/-<1P.RE^ 0      )@-%)_4;/[\^;F)E[_\Y2\[CSSR2.E^
MYLZ=F]G^-==<4\%>C"Z2H[/BV&JKK3K_^<]_&HTEK+WVVIGQU+7"1XCC6662
M2)6)NT\\\41GK;76FGE])+K_]:]_+1WC,$TE.F>U&_N\P@HKY,905_%-$_LI
M:7TZ]:\\=/755\_\_<$''YS<Y[B/-JE-XU]5WW7M4Y%V7,?5]16KF:7ZV&FG
MG2KK!R"E+>^7DV8<H#S7$<#LI?@$      "8#12?U.C]]]_OK+'&&KF)ER>?
M?'+I?AY\\,',ME====7.O_[UKPKV9'1???55YU>_^E5F/+?>>FNCL82LU6!B
MBQ4QZO+))Y]4FB125>+N;;?=MM"J"G%N/O;88Z7C&T53B<ZI=O_\YS_GQE!5
M$=BH\539KJ3UZ?//?_YS9C]67GGESA=??#'S;PL6+,C=[V>??;:Q.&?C^+=I
MGUS'U?7UT4<?)?O8>..-*^L'(*4M[RV39AR@/-<1P.RE^ 0      )@-%)_4
M)%;Y2*U&TMNVW'++SK___>_2?>VVVVZ9[1]]]-$5[,GXCCKJJ,QXMMUVV\9C
M666553)C>?311QN/I:@J$G?/.^^\A5ZWT48;=5Y[[;7Z@A[05*)SJMVX'O?=
M=]_<.-9==]UN G,3\539KJ3UZ7/JJ:?.[,>\>?,6^K<??_RQL\$&&R3W^_CC
MCV\LSMDX_FW:)]=Q=7W%LU2JC]566ZVR?@!2VO+>,FG& <IS'0',7HI/
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M^K=8A:?,Y#4Q_O%>V6LO5A\919N/P9MOOCE3*#:XQ4H]1<7D"(I/      "
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M-2>AS>.5I>I"A5@)*0I-LMJ,"2]&U;^Z2#QOC/,^U^9C$"N@32HV      "
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MYO'*4D>A0A1@9+49JS>/:J>==IIYW;C?>;;Y&,08I%Y;=/6I?K%_BD\
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M$L"JZG>2YT23?5?95]5;%?$J/FGFG*UKG\J:9"Q-]MV6,8^"VW'[RRL^"5&
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M$>\O_>W^^M>_KJ3M4;7UG/W'/_[1+> =-9ZEEEJJ<]AAARU2(-Z&^P(
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M            ,$CQ"0  3!G%)P           #1)\0D  $P9Q2<
M   T2?$)  !,&<4G            -$GQ"0  3!G%)P           #1)\0D
M $P9Q2<            T2?$)  !,&<4G            -$GQ"0  3!G%)P
M         #1)\0D  $P9Q2<            T2?$)  !,&<4G
M-$GQ"0  M%BJT&34#0           ,I2? (  "VF^ 0          (!)4WP"
M   MIO@$          " 25-\ @              0)+B$P
M )(4GP               )"D^ 0              ( DQ2<
M   D*3X!               @2?$)                28I/
M    2%)\ @              0)+B$P               )(4GP
M     )"D^ 0              ( DQ2<                D*3X!
M       @2?$)                28I/                2%)\ @
M        0)+B$P               )(4GP               )"D^ 0
M         ( DQ2<                D*3X!               @2?$)
M            28I/                2%)\ @              0)+B$P
M             )(4GP               )"D^ 0              ( DQ2<
M               D*3X!          " _Z]].T8!$(:B(.C]3VUA8[,!$RR,
M,[!E(/6'!P  ).,3                DO$)                R?@$
M          " 9'P"              ! ,CX!               @&9\
M          "0C$\               !(QB<                DXQ,
M          "2\0D               #)^ 0              (!D? (
M         $ R/@$              " 9GP               )",3P
M         $C&)P               "3C$P               )+Q"0
M         ,GX!               @&1\ @              0#(^ 0
M        (!F?                D(Q/                2,8G
M        ).,3                DO$)                R?@$
M      " 9'P"              ! ,CX!               @&9\
M      "0C$\               !(QB<                DXQ,
M      "2\0D               #)^ 0              (!D? (
M     $ R/@$              " 9GP               )",3P
M     $C&)P               "3C$P               )+Q"0
M     ,GX!               @&1\ @              0#(^ 0
M    (/UJ?'+_BR1)DB1)DB1)DB3I"@    !@9.6>:'PB29(D29(D29(D21L$
M     #"R<D\T/I$D29(D29(D29*D#0(     &%FY)WYN? (
M , SQB<                DXQ,               "2\0D
M  #)^ 0              (!D? (              $ R/@$
M " 9GP               )",3P               $C&)P
M "3C$P               )+Q"0               ,GX!
M@&1\ @              0#(^ 0              (!F?
MD(Q/                2,8G                ).,3
MDO$)                R?@$              " 9'P"              !
M,CX!               @&9\               "0C$\               !(
MQB<                DXQ,               "2\0D               #)
M^ 0              (!D? (              $ R/@$              " 9
MGP               )",3P               $C&)P               "3C
M$P               )+Q"0               ,GX!               @&1\
M @              0#(^ 0              (!F?                D(Q/
M                2,8G                ).,3                DO$)
M                R?@$              " 9'P"              ! ,CX!
M               @&9\               "0C$\               !(QB<
M               DXQ,               "2\0D               #)^ 0
M             (!D? (              $ R/@$              " 9GP
M             )",3P               $C&)P               "3C$P
M             )+Q"0               ,GX!               @&1\ @
M            0#(^ 0              (!F?                D(Q/
M            2,8G                ).,3                DO$)
M            R?@$              " 9'P"              ! ,CX!
M           @&9\               "0C$\               !(QB<
M           DXQ,               "2\0D               #)^ 0
M         (!D? (              $ R/@$              " 9GP
M         )",3P               $C&)P               "3C$P
M         )+Q"0               ,GX!               @&1\ @
M        0#(^ 0              (!F?                D(Q/
M        2,8G                ).,3                DO$)
M        R?@$              " 9'P"              ! ,CX!
M       @&9\               "0C$\               !(QB<
M       DXQ,               "2\0D               #)^ 0
M     (!D? (              $ R/@$              " 9GP
M     )",3P               $C&)P               "3C$P
M     )+Q"0               ,GX!               @&1\ @
M    0#(^ 0              (!F?                D(Q/
M    2,8G                ).,3                DO$)
M    R?@$              " 9'P"              ! ,CX!
M   @&9\               "0C$\               !(QB<
M   DXQ,               "2\0D               #)^ 0
M (!D? (              $ R/@$              " 9GP
M )",3P               $C&)P               "3C$P
M )+Q"0               ,GX!               @&1\ @
M0#(^ 0              (!F?                D(Q/
M2,8G                ).,3                DO$)
MR?@$              " 9'P"              ! ,CX!               @
M&9\               "0C$\               !(QB<               "\
MPO@$              " 9'P"              ! .N[#$DF2)$F2)$F2)$F2
M)$F2)$F2).V9\8DD29(D29(D29(D29(D29(D29(RXQ-)DB1)DB1)DB1)DB1)
MDB1)DB1ET^.3Z9<               !L[P3DA/3TN8 290    !)14Y$KD)@
!@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>image_31.jpg
<TEXT>
begin 644 image_31.jpg
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J!A(-)!I(-)!H(-% HH%$ XD&$@WT ]4PL$@D D*2     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>image_310.jpg
<TEXT>
begin 644 image_310.jpg
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M#@  P*QR!CL   "SRAGL    S"IGL ,  #"KG,$.  # K'(&.P   +/*&>P
M  #,*F>P P  ,*N<P0X  ,"L<@8[    L\H9[    ,PJ9[ #   PJYS!#@
MP*QR!CL   "SRAGL    S"IGL ,  #"KG,$.  # K'(&.P   +/*&>P   #,
M*F>P P  ,*N<P0X  ,"L<@8[    L\H9[    ,PJ9[ #   PJYS!#@  P*QR
M!CL   "SRAGL    S"IGL ,  #"KG,$.  # K'(&.P   +/*&>P   #,*F>P
M P  ,*N<P0X  ,"L<@8[    L\H9[    ,PJ9[ #   PJYS!#@  P*QR!CL
M  "SRAGL    S"IGL ,  #"KG,$.  # K'(&.P   +/*&>P   #,*F>P P
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-J@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>image_32a.jpg
<TEXT>
begin 644 image_32a.jpg
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BC(!@! 0C(!@!P0@(]@..9IQ]N$QS,     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>image_34.jpg
<TEXT>
begin 644 image_34.jpg
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6T#L5 /&\VBCN,P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>image_39a.jpg
<TEXT>
begin 644 image_39a.jpg
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> 1$&1!@084!_ %D015+E=OU0     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>image_3a.jpg
<TEXT>
begin 644 image_3a.jpg
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33O92>I^1<P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>image_40a.jpg
<TEXT>
begin 644 image_40a.jpg
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M(!@!P0@(1D P H(1$(R 8 0$(R!8Y_KZVOH,H>NLKJZFO;V]-)E,K,\2LM^
MW6XW+2\OI]%H9'V><'T YMG?WT_3Z=3Z7&'Z!U!F964E75U=69\M1)\"YCDX
M.$BOKZ_69W3=EX R\N\W-S?6YW3;MX R"PL+:3@<IK>W-^OSNFLFP#S]?C^-
MQV/K,[NJ$6!^&P\/#]/[^[OUV5W4&##/QL9&NKN[LSZ_>3\&E%E<7$Q'1T=S
M_39"@'FVMK;2P\.#];.8U J@3*_72\?'Q];/HUYK@'EV=G;2T].3]7.IU3I@
M?AM/3T^MGTVE(H!Y=G=WT_/SL_4S%JTHH,S2TE(Z/S^W?LYB%0?,4^O25@U0
M1I:V%Q<7UL_<:JJ >6I:VIH RLC2]O+RTOKYX<P \T1?VIH#RL@9HGY>=0$H
M$W5IZP8PCRQM;V]OK5UFSAU@?ANC+&U= N:)L+1U#9C?1L]+6_> >;PN;<,
MRL@G!&]+VU" >3PM;4,"RLC2]N3DQ-HO+F >ZZ5M>$ 96=J>G9T1$!V+I6U5
M@#+:2]OJ /-H+6VK!921I6WI>]]5 ^8IN;2="T"94DO;N0',T_;2=JX 2UR
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M"$9 , *"$1",@& $!",@& '!" A&0# "@A$0C(!@! 0C(-@O*49EV=8'Q^$
+    245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>image_41a.jpg
<TEXT>
begin 644 image_41a.jpg
MB5!.1PT*&@H    -24A$4@    <   !H" 8    ]\.I<    "7!(67,  $SE
M  !,Y0%USO"5    *4E$051XG.W),0T   @$,?Q[?"V@ %:67G)3*TEO%X00
=0@@AA/ +^V@  A$U\99E2>T     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>image_42a.jpg
<TEXT>
begin 644 image_42a.jpg
MB5!.1PT*&@H    -24A$4@   !@   "L" 8   !A+&R;    "7!(67,  $SE
M  !,Y0%USO"5   !;DE$051XG.W9OZ?#8!3&\?YKI63J%$H)I5/)FJEKIU)9
M,W7M5#)URIJI8\D:,I5.I902SO5>PKUN;IH?[QGN]7UYUO,ASK.<C$3YC0
M                         /X;$,>QO%XO/6 ^GXOG>7(^G_6 \7C\F<UF
M([?;30\PF4ZG<CP>I2Q+':#*:K62+,OT )/)9")A&,KC\= !JKBN*TF2Z %5
M@B"0HBCT !/'<62_W[?N3F>@2MON] ;:=F<P\*X[5H"F[E@%ZKIC'?C:'57
M!                     #@SP"[W4X'6"Z7<KE<I'K6 '-//1P./PZ#5H#U
M>BW7ZU7JWB!@-IM)FJ:U@P<!YK(819$\G\_&X;T W_<ES_.W@SL#YKI[.IU:
M#^X$;+=;N=_OG8>_!1:+Q;>=M@;\MM-6@*:='@2TV>E>@/F3T7:G>P$V/T<M
GH#H=                H,O[ #%PZA.)SKC2     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>image_43a.jpg
<TEXT>
begin 644 image_43a.jpg
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7@MX!#PQH'V\JVMX     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>image_44a.jpg
<TEXT>
begin 644 image_44a.jpg
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M\]MX>GIJ_6PJ%0',L[N[FYZ?GZV?L6A% 666EI;2^?FY]7,6JSA@GEJ7MFJ
M,K*TO;BXL'[F5E,%S%/3TM8$4$:6MI>7E];/#V<&F"?ZTM8<4$;.$/7SJ@M
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,     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>image_45a.jpg
<TEXT>
begin 644 image_45a.jpg
MB5!.1PT*&@H    -24A$4@   %$   "@" 8   !T08"*    "7!(67,  $SE
M  !,Y0%USO"5   #3DE$051XG.W<SV9K41B&\=Q:**&C4$*F(83>04>EA,Y#
M*27D#D(HH7<0(?0.2BD=E1#"JEW6.:?GY*SFS[OWM];:S\,WW_D-7FG3M.'H
MY!K6#Y!#( H"41"(@D 4!*(@$ 6!* A$02 * E$0B() % 2B(! %@2@(1$$@
M"@)1$(B"0!0$HB 0!8$H"$1!( H"41"(@D 4!*(@$ 6!* A$02 * E$0B()
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8$ 5] KHDG_*IG9.N     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>57
<FILENAME>image_46.jpg
<TEXT>
begin 644 image_46.jpg
MB5!.1PT*&@H    -24A$4@  !K8   !3" 8   #:S#=V    "7!(67,  $SE
M  !,Y0%USO"5   #04E$051XG.W9P0E"01 %P<T_*V/R[A<]>A%D<.FE'E0&
M,Z=>C_OMFK#6 @      @*]^:5&O+6$+      " ?Q*V        2!"V
M    2!"V        2!"V        2!"V        2!"V        2!"V
M    2!"V        2!"V        2!"V        2!"V        2!"V
M    2!"V        2!"V        2!"V        2!"V        2!"V
M    2!"V        2!"V        2!"V        2!"V        2!"V
M    2!"V        2!"V        2!"V        2!"V        2!"V
M    2!"V        2!"V        2!"V        2!"V        2!"V
M    2!"V        2!"V        2!"V        2!"V        2!"V
M    2!"V        2!"V        2!"V        2!"V        2!"V
M    2!"V        2!"V        2!"V        2!"V        2!"V
M    2!"V        2!"V        2!"V        2!"V        2!"V
M    2!"V        2!"V        2!"V        2!"V        2!"V
M    2!"V        2!"V        2!"V        2!"V        2!"V
M    2!"V        2!"V        2!"V        2!"V        2!"V
M    2!"V        2!"V        2!"V        2!"V        2!"V
M    2!"VX,/4;0,      /L)6QQM]X,!      !SA"V.MOO!      " .<(6
M1]O]8       P!QABZ/M?C       &".L,71=C\8       P1]CB:+L?#
M    F"-L<;3=#P8      ,QYAZW+S,S,S,S,S,S,S,S,++ G2#+BN26$O=<
+    245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>58
<FILENAME>image_4a.jpg
<TEXT>
begin 644 image_4a.jpg
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M@5!(5/VZ*HLQ5[_><9VY.A:A8LGGCB6'D._^4W$=2\UF%54W3(P,-J_<PI.
MTO#6Q:BA1'LJ3D\",-<U,_Z@*-CW(5CQAJ9JR+#D_P:Q#/$L8 /UW1$G,]1P
L?L+PMVHIU;\0\0.()\< '+HL>1"Q#/D?AFG8"=^M)ND     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>59
<FILENAME>image_51.jpg
<TEXT>
begin 644 image_51.jpg
MB5!.1PT*&@H    -24A$4@   \    !3" 8   !0S&[K    "7!(67,  $SE
M  !,Y0%USO"5   "E$E$051XG.W<34[#,!2%T>Y_5ZR).2"0D%IHFL3Y>;'O
MN=*9/P^_B6^?C?MX?P,  (#3;-U-_ (  - + 0P  $",TP*X^J$   !D$\
M  #$.#R JQ\(    WPX-X.K' 0  P#T!#   0(S= [CZ00   /",  8  "#&
M;@%<_1    "8LSF JQ\     2PA@    8C0'</7A    L(8 !@  (,;J *X^
M&    %HM#N#J0P$  & + 0P  $",V0"N/A    #V(( !  "((( !  "((8 !
M  "((( !  "((( !  "(,!G U8<!  # G@0P    ,00P    $00P    $00P
M    $00P    $00P    $00P    ,1X"N/H8    .(H !@  ((( !@  (((
M!@  ((( !@  ((( !@  ((8 !@  (,)/ %<? 0   $<3P    $00P    $00
MP    $3P"18    1!#     1!#     1!#    ##^YT !@  8&@"&   @ @"
M&   @ @"&   @ @/ 2R" 0  &-']!#    ##$L    !$$,    !$$,    !$
M$,    !$$,     ,[^\$,    $.:#& 1#   P$@$,    !$$,    !$$,
M !$$,    ,-[-@$,  # <&8#6 0#  #0NZG]"V 1#   0,\$,    ,-[M:<!
M+((!  #HD0 &  !@>'.;#& 1#   0"^6[&4 BV    !Z(( !   8WM+-!K (
M!@  X,IV#6 1#   P!6MF0 &  "@2VNW.(!%,    %<B@ $  !A>RU8%L @&
M  #@"DX)8!$,  ! I=8)8    +JQ94T!+((!  "H4!+ 9F9F9F9F9CWM"\[)
25+!XY3R-     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>60
<FILENAME>image_5a.jpg
<TEXT>
begin 644 image_5a.jpg
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MV0P_6'_%@QZ?ZW)OB*FVGP^:#SYH#:\\ZNG>P( 2R?#9BH?;0B(N8F B2+5
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D_:O!8<.DUFR6%UJ45SGP7V]@*8;I?6%_     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>61
<FILENAME>image_61.jpg
<TEXT>
begin 644 image_61.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #: 68# 2(  A$! Q$!_\0
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M#D,0IQD @+TYR=#_ ()S>';"'X1W6K-9V_G7#PQ,&,,A<1^8PF^4$AG#9*$
MC;Q5OX@MI^G_ /!0GX,6UM/:1[="U*%K:%521',$I4L@ V@@G&1Z@=371B9\
M]1/LE^*_X)E"-HE3]NO7]$\*?&[]G;6/$-\^F:-IVJ7]Y<7B2O%Y*I]D.2R
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M=3&)(QQ;?LKH]\\)VT]KX?TB&Z;S+E+:-97,93+A "0I/'.:VE&015:S)-O
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M&&W5>!Y8!'O@#^E7$ZTQ8@K+@XQGC_/UJ11@UYUFW=^9TI620^BBBJ&%%%%
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M(4+@8&'SDUXF7^[AZ]:79)?]O-?I<]"OK4C$^F=@+ XY&<4N*6BO/.D****
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MHHKRSL"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M #.W!:4[]R>BBFN2%..M>0]#T!U(W(IFXX'/-1W+2&!A&P63L6&0#[CO0FF
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>62
<FILENAME>image_6a.jpg
<TEXT>
begin 644 image_6a.jpg
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M?5V!]W=^]MU7KW6$0%? M.V+%Y>MU=_60?F&G9]#Q9^6$[PFRV)&,W1-<YL
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-[     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>63
<FILENAME>image_71.jpg
<TEXT>
begin 644 image_71.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #+ 6,# 2(  A$! Q$!_\0
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MV/8$[% 0$LRA=QSZ:.M  .M.HHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUG?!?X?>!8OBU#X8\*Z3%X@T?P!9@ZQXHU417-Y?:H[^9:(ETGW_ +-&;I9
M?E4R1(.5KU;QYHL/PE^"UUX2^'-G'X4U"Y@FLM!$%E+-;6]]*S&)9V6&5(HV
MD<#S)2!E@,@D5V&D747@7X=0W7B*XEMTTS3&N=3NQ<3W90I#NN&61P9I5!5R
MIY8@<#A: .M:$[6C09?<"SE1M)X)./H?SQ7CWQ/_ &F/#'PZ\8:3X+6'4]?\
M>ZRZFR\,:! KW4B."1(TDS1PQ@;22970@ G;MRU>/WW[2GCK]I^[O_#?P#TN
M33_#*3I!J'Q(U+]PMD-\;3K;V\L9;SO+D)&_#<]%^\/8?@9^S!X8^#NLW7B
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M4QEEWX<].H^FK0%96VHX1BQ+,^1P>,#MG)/X4 7**** "BBB@ HHHH ****
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MY;RS<2J%MU>18T5BD<9'EQL4+["6_P!9RQ!Q5C1/!NE:-XIUG7K2T2#5M8$
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MKQ+XE:]/\3?'$GPF7P;JMWH\EO!J.K>)+EE@L+=/,62!()&CD%Q+YD8)B(4
M G<<8K@?'WQT\6>/='O/A[I'PQ\>V7BO4K1[>\N?#FO:86T2?R][1R7BSO'"
MX5EV^;M9P^4!(!JW\*]9^(OPI\ Z7H.B_!'Q7JUO#&9V?5/&6F74JRN[,Z1R
M27!+1Y.5R5&&H ^B/">AV'AG1]*TC2+;['I5C:Q6UK;A3&(X8XPD:A<<;5"K
MM(!&.>U=!7B!^,/Q(:_O!_PHWQ$UDJ.UM/%KVCEK@C!1=GVP; _(SN;&W.#T
MI6^+WQ'$-RR_ 7Q)YL3QK BZ]HVV56 +AC]L^4J<@##;N#D=* /;J*\6L/BS
M\0;DWAN_@?X@L?("FV;^W-'D\\DX*?\ 'U^[P#GWVX[U&_QA^)2S +\!/$#Q
M_P#/7^W='X_\FJ /;:*\5C^,/Q$:6,2? ?Q&$+ $IKFCDCGKC[6.G6F'XQ_$
MA6!3X">*9$WN-G]N:+\PSPW-[0![;17B3_&?XE;3L_9[\4;NV_7=$Q^EX3^E
M(/C)\3E7<?V?O$7']W7]'S_Z54 >W45X@WQK^)V./V??%!/I_;^C#_VZH7XS
M_% #<?V??$X_[F'1C^GVJ@#V^BO$?^%V?$[_ *-^\4?^#[1O_DJG1?&CXFRR
MQHWP"\2PJS!3)+KVD;4!/+';<DX'7@$\4 >V45XM-\5?B/ +]HO@EJ=PL#@Q
MM'K^FJMQD\M&7D4@\Y^<(..M.C^+'Q.DMH)_^%(:G"968?99?$6F>>F 2&;;
M*R8;&!M<]1G'4 'L]%>(V_Q>^*$I<_\ "A]=MRO/^D^(]*^;MM7RYWZ=><5/
M!\6/B;+-A_@=KD "LWF-XATLQ\*3MXGW9.,#Y<9(R5&2 #V>BO&D^)GQ'F19
M/^%(ZO'N&[9)KNF;ESV.+@C/T)HH ]EHHHH 0]*0=:=10 4444 (>E-I]% #
M*4=:=10 AZ4VGT4 ,QGBC9CFGT4 -'6E/2EHH :.M),H>)E.[!&#MZTRZSY#
M89EZ<J0"!GGDUX.?B]XU\=>*Y+#P#X3AE\'^9+:W/C&[U5(Q:,(=^^&R\LR2
M$2,G+##=#P> #T7XC_$WPI\,;&TN?%>K1:3:W]['IT#R*S-/<2_<B"J"6.!T
MQSTKRQ?$?QI^*T6JVFF^&K7X8^&Y-0%G!J>L7?VC59;)2/,FCMT5XT:3:442
M.I"MO!9B,=Y\*_AIJGA;2I6\6:\WBS7;EH'N=2>VCA5?+MXT$:K&%4*'61PP
M&?WK"O2XBIPP/#<+]* .?\->%[30)2]N+J8R222K+J%W->3Q"0 R(LDSNR*6
MC0F,80$#%=+110 445'.2L+$8)QP"<9/8?C0 LA8(2I /J1FO#/CU\6M0L-_
MPY^'^M:?!\8==TR2\T:PU*&1XDMU)\V;>J>6KA5?8)6"EPH;*DYL?'+]I+2O
MA-XBT7PG9Z9-XH\?:\\0TWPW;DP-/&T@C:;SWC,:!<G)9N@(Z\5U_P +_ ^F
M^%AJ-]%I\MMJVK7DVI7[7DXGE2XG(DFC27:,HAV( ORC9@?=H /A?\+M*^&R
M7SZ;+?7-[JMP+W5;_4)WEEU"Z,2H\\B_*D<C"*/=LC1,* JJ#@=_110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!P'Q,^,7@GX0V.F7?
MC3Q#9Z!;ZA,\,$E\2%E=$+N...%4GGVKJ-)UFWU_3+;5-/G2:SO(8Y;>4G]W
M*CHKHX]B&'UKC?V@M'T[6?@IX\CU-K**(:%?,9M05F@A @=O,<*K-A<;LJ"P
MQE><5\(_LU^,?B%^R/8?#.X\6WEGJGPC^((M([)WOMO]C^=&CPRDS!3& &)=
M -OS,PY!H ^Z_&GQO\%_#CQ+I6B^(?$$.G:QJH7[!820S&2Y=Y1&%0QJPD)=
ME!0 LHRQX!([O3IDN CJY8G=\Q7:6(.&&,#[IXY%?,_[8VD:7)J'P$UI+"UN
M-03XEZ):Q:B85,J1222,P$F-RJ[*C';U(4GBO2?'O[0OAOP9X^T+P-!!>^)?
M%^LLZIHNA3VSW=HJP&8RSK+/'Y:%,A7SRQ YR* /8**\2^!W[2OA_P"/.IZ]
M8Z3I.M:1K6A3B#4M)URVC@N(27D0%]DCJ0#&0><@HV,D@'@M*_;W\(>*],U>
MY\-^!OB-XFDTZ^^P3IX>\+R76X*Y =9%)B$>%?EW1@,G:#B@#ZJHKY=MOV[O
M"6L^%],UOPUX4\<^+S=1SO?6/A_1HKJYT;RFV9O$\_%OYG5 2V55CQUKU+X;
M?&OPS\6/A*OQ"TV[DTOPTT4\\DVI&.%[);=Y$E:7YF1=IC)/.!CGC- 'J%%?
M).K?MW6>DS0:M?\ PT\<6GPVN5GC'C$Z2/LSE658Y @D+?9V1GD\PE6XP$.U
MR/1/B1^TWI'PO\&^&/%C>&O$_B71?$*Q36\OARRCG6!941XVFWR1[%?<,9RV
M[=VH ]RJ.?'E')*].0,]_H:H:1<27-K;3/#) TBJQBD WQ@KD(X7@$9]35ZX
M#&%@F=W&,?7^7Z^G- 'EOQ$_:%^'GPDU>TT_Q;XHAT34)N(8;E)V>4]<*%3#
M XQO_#O7+Z=^VQ\#M5EMHK3XDZ3_ *:8X[:2\$L419MP0L[H%4-Y;\L0/EKP
M'_@J?I\USX5\!:E%]E:V@U-TE\T)]I+2B/RO*W?/LP&W;.-VW=7U7\4A\-;;
MPA<Z/XQMM!?1KN 1#3;E8@UX&1PD=M$ 7DD;YE14&\DG;SB@#M-/UG3=8TFW
MU&SN()]/N8EEBO;:426[(REUDCD4[60AC\ZGISGO7"^,_CQX5\'>(M.\.M?W
M&J>(;N\AT\Z=IEL][)822122QO<I$"\*NJ9&[EEY0$!B/AK]DZZOO%GQ7^)O
MP;T;Q/XQ\-_#6Y@N[_17L)WL=2T\PWMNR?9VEC,L.]'='5ATW9YQ7:^!_P!I
M;PA\/(_%/COX7_#'6_%'P_AU.1_%OC"YOF;5&G#.$DB@G=GN(XTE499XV5&V
MMRQ+ 'N&C_ ?Q[\1)=+M_C#XLL-:TK2[A+V/1_#$<^G1W4H(80WB^84N+>+Y
M-BJB$G[V><_0.@Z-8Z%:PV6G6=O8VL(8);V\2Q)""?NJJ_*H]A7AOQ]_:@?X
M!:3X.\4W?@_4=<\ :JQ.H:MI9#7&FEXP8"87"($<L%+F5<,< .3@]1\2OBOJ
MO@?X&7?CNPT6#5M4-K:S0:4EQ^[GDG>&,*)-O)(D& %[$9YS0![#17BGQ$^-
M]W\/O#OANS?P^=9^)>OPQI;>$-*O(9'2Z,1=WE=B"MG$X5'N0IV!E;!SBL?X
M0_M01^)_B8_PS\;:')X3^):PM>'3;>9;RUDAVF1-L\?<1D$B15Z#&2PH ]_G
MQY1!!8' PI(/7VKQ/X??M1>#?B1K,VB:!;:E?>([.5(M1T<6R136"FY:WEDE
M!DVE8V0%MK,55H^/FQ7MLI(0D9S[#-?G?^RSXRT?PA^V3\<WUWQ'H.D17.J:
MC]EM[Z:&.XE/V[/[N9D!\OU3S/F/S;/DW  ^N_C1\?/#7P"\*S:_XH75!ID:
M)_I-M 94<N^/+#<!7VY8!RH('!)P#B^)_C.WB S>'_A9J.D:GX]M_)EN-,UT
M3PMIMK),$:XE@*I(RC(/E;D)&UEX&&^;_P#@HM\5_ 7CKX,6FGZ!K&C^*=4&
MHVMS%?Z;JUE<FW02!7.U)3)\PSPJ%,KS@\C[)^&7@2R\#Z180"]O-=U);2*W
MN-?U7RWO[\JN!)/*BC>^%V\] JB@# ^#/PRO_A]I%Z^J:W?>(M>O+B25[G5=
M1FO!:(3F&WB,I,BHJ;2RDC<S,W&<+C_%']IOPI\'_$>F:%XADU&QU'4[RTM+
M:,VX5#YYQY_FR.D;PQ-CS"&W+D#!S@^V3DB%B.PSZ?KV^M?"?[<_PN7XV_'#
MX;>"5NX;._N]$UNXL;RVVM<R7<:1R+$ZMQ%&50A9#U/F+QB@#[=AN%(<8BC\
ML,0&^ZJ@8S[#OQG@UYO\:?CWX5^ 4&A3^*9Y;2VUF_73H94B,RQ[QDSO_=BC
MS@^S5Y[^PG\88/BO\!-(@E>1-;\+QIHFH"Y9=VZ(!8IB-[M\\07YWQEE? Q7
MQG^W9XJO?BRTWC];R[?X?Z7K!\.^'=T:P6[RK$IO9&^02Q[G@"H&/S")B/E-
M 'ZH>'-7@U_1=)U*VCF%M=P)<(+I DJ!XPPWCLV#S_O&MFO'_B!\8-(^"_PU
MT'4KVQO]8N;XVFF:=H=CL-S?3RE$1$5B"1E@6/90QP<8/DNJ?M:?$;X67FB3
M_%OX/OX8\,ZA<_8SK>CZY%J213L42/SP$1$B;=]]FZ*Q"Y44 ?75%?-7Q4_:
MCU?X5?'?X?\ @.;PE8:CI'C*Y6"SUF'6B)XTWJLK/:FW  !=2I$A# 9S4_C'
M]HG7?"'[27AWX6OX1T^XL-<B2>#6IM86W_=-@3+Y4B;9)4<+B))"2CK0!]'4
M5Y'>_%&_L_CU8_#ZPTR.]A&@SZW>W8NE\^W591'!"(\C.\ECN<X/KQ7S'X8_
MX*+^)/&VDZH?#GP4U'Q'J>E2N;NRLM3N)%BMU&/,9ULV!=G4+Y1+?>^^5S0!
M]\45\L?"_P#:M\4^-/C<OPT\2_#S3/ NL1VQO;D77BB.>=83'N188U@Q-)@Y
M9 RE%W$]*]'T[XR:A=?M,WOPNB\-+_9]CX?BURXUT7NS:9)7BCA%OY7.3'*<
M^8>F<4 >P4444 %%%% !1110 4444 %%%% '"?'I()/@;\1$NE=[9O#NHB18
MU#,R_9I,@ \$^@->7?"?X4^&/BM^Q_\ ##P[XFT:WUG2KGPEI+I'?1 R0$V4
M2K,G(,,BJ2 T9R,]:]L\<^$[+QWX1U7P]J,MS%8:G";6<VD[0R&-N&4.I! 8
M<''."17-_"#X2>&/@EX2C\,^$8KNST>.62Z6WO+Z>Z>-F(! ,K%]O'0\4 ?G
M@L_Q'^$GQ"^%'P.\?7TVO66C>.M#O_#.I/%&J-IT4\D0*E<N6828VN[%%51Z
MU])?%OQ9:>(?VHM)^'WP^L-&\/?%"XM&GU+QW=Z-#-=6%DBI(EO%OCS*9(VD
M7.X>7Y??->^^,O@[X3^)'B3PUKOB728M6U/PQ=?:]'N9'EC6WN/-1M^U'"N1
M)#&WS \J*XSXH?LA?"_XS^+1XB\3^'[JYUPPK#)J%GJ-U9R2H%VB-S%( P #
M#!_O$4 ?/W_!/BVN+;X]?M 6\NHOKCVFKK;S:Q.JI+<NMS=*9&*\%I/+\S'H
M:Z3]@S1M8TCP-\9M.6Y^VBS\8ZC:VE[#\D-PX10\L8W#RRSA7W9X!0UZ[X&_
M8^^$GPW\96GBKPUX2&E:M;@0PC[9<-%'V+!#*5#8)Y8$YQCFM?X2?LW^"?@N
M^O+X7M+VSAU_+ZA;S:A*\<TI&6<1L_[MSN(^7UH \6_8,TZ]T+]EW6K_ %.S
MG/C:2]U)]9U#4YXY9-1O4>1 SSHS>< R%=Q9B3O/\5>7_""UUC5?^"6?C=M,
MU&#[1/::G=1V]H@L5M[56W2POD@*'C69\=XY%7M7UO\ !?\ 9I\$_ 7P[J>@
M^#[.ZLM+U''VBTN+^>?(V!./,<[<@-T]:M?!SX >#/@/X:OO#G@^TN;31[EP
MTMG=7;W"YVA6.)<C&P+D#MF@#YJ^%WA#X"?%7]G+3]8\0:UK>J>'=(TFU&MZ
M5J'B;5H+*UGM[>*2206QN%!( #@1C:0W )-?1W@;Q9\/OAC\&O#6IZ;/'X7\
M#2V4,VEQWF],0RG=$@63Y@29!\O+?-SP#7!ZM^P1\%];\<:EXMU'PQ<ZEJEW
MJ+ZE*LVIW*PF1G,C;(DE";,D?(1CBO2?C#^S[X%^.]AIMAXYT1-2CTYW:TEA
MN9;=X=VTN049?O;%RIS]W\: /1[?RUD"1JVT9QGH!P>/SJ6[+"!@K%&8A0P&
M2N2!D<'IGTQ7&>/?B'H7PJ\%ZCKWB348=.TZT@,LOF1R3/@ <! 2TAY48 Y]
MNH\ZT#3/B)\;],6[\61'P%X0NGEC'AFV3?J-S;LF(FGNUD/EJR.-\2(CHZ8+
MD9! /E[_ (*4_&3PYXT\-Z#X2T"YO-5OK35Y8[Z:RN+B&VMYHEB;R98PODW+
M'S,\,?+ZX^>OL3Q7\+_AEI/C-OBMXA\/Z6VN:3:JR:[J#%OL4,8)0Q"0[8B!
MNY09Z]<US7C']B_X2>/=&\-:3J7A>:'2O#5L]II=GIVIW5NEK&S;G4"*0!F+
M?-O;YLXS6%:_\$]_@@C@W_AS4M<@4$>1K&O7UW W;S#&\I7>.1TXX^M 'BWP
M#UWQ-XH_:!^*WQ_GEO-8\ V6CZC:Z-=/ L"W$$<J.D:+M5QL$+#S'B+'=SSO
MKBO%FEWGQ _8I\4?%"TU72_A7X-O[1KBV\!>#;&&V@>Z$T4(CNIX0CSN[0@8
MVK@2(#D(<_I%:Z+8Z?H]KI,%M"FG00I;0V9 V")5VI'SS@ ?I7@FE?L"_ [2
M1?/'X3+6U]<+<M:RZG=^1&1NV^6GF@1YW,.!SDB@"[J?P9T_XH_LF?\ "O(-
M2D2'5= @MK>\U"<WT\1&)(W=V8LQ#CY2.5VX'(%?/W[*WQ'\5?''4/!WPQNW
METVT^&=SY^NWEHC00ZLML3;V=N\2D.C*Z*^&.T^1E@3Q7VG\-/A=X4^#GA.T
M\,>#]*AT'1K8R3QV<;ERFXY<Y<L>2?6L[P%\&/"'@#Q9XD\3^'M%_L_7/$DY
MN-6NS<2R&Z)=VY#.R+AI'.$Q0!\G_M-:]X5\%?M[> /$7CW4M0\.^&KCPA-8
MQZG97%U &E\^4JC26SK(F#,IW<J.Y')'J7AWPO\ !GP/^T5X0N?#&E6^M^/?
M$JW[2Z]%KEQ?3P+%;*7>8R2ONW A S8Y8=Z]G^+'PB\+_&?PM?:!XLTBWU;2
MYH]@Q(\<D9R""&0AA@@'@]N>,UXCX;D^"_[(.JVOA#P)H%S=>)/%UT(VTG3I
M9=1N9O*WY>5BSJBQB0@[BO#>M 'TOJ^L6.@V;3ZA<QVL3,L9EE("[G8(H)/J
MS ?C7YU?L[^ _"_Q1_;&^/&A^)_#&A^)])EFU*>(:C:1W!@=KS#%9>0A*RD
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M'PA\,_!/PA:^'/"UK%;VR/)-/-G=+=2,S,\CO_$Q9OPZ5W%N%C*QA8\J.D?
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M^_9FL_%ND?$OQ+J?PV\&Z@GP;UW2HT\/7OBV^FMUTIX'/[F.V9WEC@:26:0
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M_P#LDZ3\2OV@O@GJNK:!\<+#P]>ZOJ=]<:[H]SX2LK[9<SR/EVR8W3S!M(#
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>64
<FILENAME>image_7a.jpg
<TEXT>
begin 644 image_7a.jpg
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M@]5%=/5\);VXMY_>/#]*OST\0'>N[*+S9S9115D^31P[D#J%=[!LCZ^_N.R
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MJX0=.[8W3B'[]$J@T2/2J"!_ E5M+?#<JIZ_0"H ) .I ) ,I ) ,I * ,E
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MZ5GIV@<"N =I4G$I8-&$Y>NL0-L4+28P>W8N:G5;O*HH.CWE>Q ?W:K6/A#
M/4B3:L;4#*$ <W)'!=PFU^X6M5F^OO7?(XT:GB9LB[^HUCT(P%VT(?S@!S]2
7?_X%)8KMLWIJ#ND     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>65
<FILENAME>image_8a.jpg
<TEXT>
begin 644 image_8a.jpg
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M0S=?K#4AQ/HIB' )"2 24GA.5L4, MW(&[<FY.4^(J:ABJ+$*X82&.@9B!!
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M?79,&['ZK&4>L#D_L*&N-P180VKB\K8.(#KMK6I?6:65&<!Z'5UC2=W$5NY
MQOMURQS E+V+LT89:@L?&1(!"3,=U9V/T[1Z4@OFW2%+"TC5IAQ.JZPH<9_;
:&H: D'\"[X17'0>TZ*4     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>66
<FILENAME>image_9a.jpg
<TEXT>
begin 644 image_9a.jpg
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MIEU?E;9DEPG#2!:VU"**(^N&S4,*A>2!:YO<BV1A\V1AGAR0(<96U82ASS-
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M",,BGEK]*I?CGJDXY'YIDRC,6M-Y=%G(7(7L?T+U1M/WENZGR'D=QHL.0U]
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M,!01ED6?EF3U0Q-Z6J'H$%@WQZ V7-($=)(WA:YXC*$!88?1@H<$!@S&#Z'
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MV50<>!22HQ"OPN]___OV?QZFH3_//?=<6_T8@A']EZ13M X2?:@C 72C'_(
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M>N@KRNR++[ZPU8@I-@)1B"%R\,$'VU GB$#"C0DUIA(CC7#CN>::RX8@X^E
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M@+'!W!GH;-MHQ2Q\:+GX"A:^Y<==A>@1ELI]0<+G#A:F_U;]<0EP>!\G?0]
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M <*M"2"BFD+6#U8=/43W66?T$? JS(34GYKU].+(7$,.;K%1]E*1)UB81N8
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M >:M.0 @PU&:)):/-8@=F-V DQH<,! 0"/#@P /A ?DBIPQ!:RZ[U@;89]P
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M#[^;!]: ZYL?0$KSW_PSGP-D9WZ9[V&\=\J0:P(Z&?P 7^O0LYHKUJV^Y3
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MZ"??)3<8MB+I0!K&%P!(?P);17S3&,: #7)*4$.J*$#0> 7T V(Q-GN3BH#
MG=88QE+/EV[Y/!'>!F4NW1CA"(#0\[W!EA6+^=RU5@#)*L4JK8N/]_\#Q'>Q
M;3*9 :^OK1<L0>L!F O@Q?QDF-,9YGQ2='P'T&X<VG%P3?K &I2BWX \\! @
M#VQN,#X,W:Q#1K_Y8MV9.]*XS,^LK\_4[M8!U[/[L_5BW5F#/@=^6R?F(\?"
M.TD# TQ['@P/0+-Y=>V:A=$/?J;F7U@+>W5<5^E>UH:^!H+J1_UFW/11=+HQ
MM$;9!,8DS/\4G=_:Y7T%%C9HV#K99]G5<M9I6FU&-8. YW3M)2#A70##O37_
MU,#>*UCXD_>8Z^%M 0NWUML62'A.]\T-(5L7;K'&PX9KGVN2,YS'AV'WD+/T
M)!(&78(YC\V>H!I[BET6H)#<]3\ H, SH#%U9E/?%> G*P+C+1MMI+Q+-]=G
M@[)3 XP)BB8M=FX^E;DS ^JI53B9WKU+]-Z<B[[J5.2,11B8= N]RG;SC, [
M.H>^F9L$=GW#!![9@&P2]CK[D)T)Z,/.I,> AH+4L2WI<V.30&AJ([IG FGL
M3N/ ;E<_F<W-9F!'Z&\@+%N$?N0S>)X J*M^V?/_PL9OVROM(8!"QRM8^)8?
M<P$^=^5ZSO%_*K#PJ-'S4/=[S#%J83YK0K10Z4T3$N7B[,S:A*).% ^J>L"-
M*+*N#Q7V4VH4 @ND<F%,480851P03CSAS1%L!R .)Z47%DS8+W[WC(3VJD;1
MI+FGQ2EIFOO<>:O'_:[C>1]#J@V:<R#C?8]K&O37:-V7$S3LG;VW"O].PP=H
ME%U  5B, L8%D)N!D0U"U#L)( @(!$8P/&9:<-(B@13 $B #XTU*)$#-V@&T
M9=.%[.[+X AH$49?HI;Y/4S !O\ &AA1KI7=8;.Y Y $ &?M<OZE7S \&92
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MW[O3D]E&@F,"T6P=\I1\E<;ZSCOOG'0+7<.V%'QF@V*MLTO9:&2T:P&@^&Z
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M]4P5!LP#':1",CQ$E$4I13&!$(P4K$ &(0.2P0>< 4X  ]]]]]T3LXE! ZP
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ME!(#$.B'_21J:LT"6JPYX!\@#2AOW4G!8)1B34FI%C66BIE=?L,8S$Z^F+X
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MATF/G??:DLFKS[= PNZ;+8"PZ^@%F.H6)H#6SQ_'H\'7N>-K;_8Q&8JI#Q=
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M%)%='SGC' *..3HUP0HH#&T=>,@)%(T!=@!0 (2<"8 CX)$#18%QV,(H#,N
M4Q2F5X,)';V:$9:C8&'/D0E0[#'X)J-P#RC<2J,\(DLR/OVN6ZS'2YB%+PTL
M?.S6<[_72/X7HV<"6AU%;N<=," U'Y#!6&LCC^$@VHM5:_TP4!@+HK9  L8>
MX(!1PD!3PP1CT+H!+D@;X62+%"==.#L%8R])5V&L #Z:G=M 85(])EOW")@]
MY=,*:.\U, V2CMIW3<".J ?4T:^,Z43"&<[D1&KV2*76OX!4,D8Z)Z.9H<<(
M(Y<8PR+A^DS?Y%YM\/>[MX.P%[W>T@,KXVZ5ACS7[RH-N>L;S=3CE0R:<NA<
M'<,I4WH>:(GV=VJYL4BMQV9C=K],?9A4H^Q\;'Z:N\9/Z0K!(VN"KL Z8Z S
MU+,9ECI, 0H!3[YC+=$G'!=&OW679YHRK9]I@GG>!PCGN;+S=3;:\7F#A,W8
M"Z._#_=(ZG:G)_>.RZZ;M/G,88Q8,@"3V/S%)N:@81!+-WOSYLU)GG D])UU
MX#I)ETYJ>-+ ,G>G;3%;!SMFVG_/BUX'O7Y;]VJ<)VO,>]G-V=HSI@F&8&H8
M4_*-3%/':>YLGBR"=@97+-VY\_@6L']?/7,)('8$+#Q:N_ E@X77!@KO QA>
M<MY+\ VOZ0L_!&#X','"ME-:#G;9GQF "S@3P"OV()V7@$ZWML-FT#:[\OI>
MEU=A&V+X\:V >0++_"TL0OHB&V.0O8),J?7./@3NT3M\+<%D+$7L=?:H(!6P
M$'N?[>3Z2KFP08&.]!,][9KJ]*5L1)C\[4_VO&AVX:HDDC%UM"[:J@LY@UG3
MGIKW6)5=F1E ^D(?>3>L0N\+%*2C](E2-OJ!;2X0;3,UH"+?54F>KFD<-J'Q
M8FM*)U8+7/\:(T"AZP)B@81( L;MF[[IFTZ HO%X[_UR*O2@9VV[Y2Y@X190
M^ H67JF]'B_GN);";$,QBFT*SJE4>^'WHIW/W]3VZ=@V+;L%9Q=MG[7!0LN.
M YSG=#W_\SV.!Z><HN&H "JP!SGEG#I..""0LL+@P>3AT(7UD<*Z4LK0KU&L
M14X(1(J*L\])N/F"HT,A<J8X"W&"IO.3%.XV'/8$YUW!PMF?JXAB'/0MH' J
MMRV#YX@L::-E#RR<@.$$$5;U*EX"6.BXQAK6#ZOT?D<#2 T6!@ ),-# COG+
M:9:J 0Q@.'#Z 7^,.4PJ*7@BNP'?&6Z,!@ZV-!/&BS6GYJ!U Q1)(6E H'62
M5):N@9-UGOJ UM#J.ZM4FKN A2M0;+*1<JV>S[Z3.H])[\R&1:[3&Y< $QAG
M %$@*98@9J5(MV %D! @ 6!*V@A&L[1MC$-&+G"*L3R+9T_'O ,FG8Y^Z5R=
M0.I6[<*5?%DQ#+8,XE508@4FG'/LYWG-MIVU)=,O,?9G'[0LS7M['^N"7@%P
M!^@UWS$A $B,9T"AL:17 A9BI#&R.3(8%1BW4I:M#?/!6@A8F.>:<SCCDO=J
M]D?J,6IT43;;Z8UVHC=[C<S#YZZ=>KYQ$N>F/<U P/# &I'>)=@&Y XC7]%S
M[TEF8 Z3 60*AR1!@93L2,VHS.WIP,TUJ[5CVKM5=R!DKH.5W1.]!&SE\%AO
MY)UGYVQEDR8.4I@4G"[V!>>(WK?..Y-@LD:FG3-UVAX+^*[ZY5(P[!Q8N (*
MM\#"(Z#A<P3AG@HHO,OSWN6<Y^X;7M,7OLNX/W>PL/LQ=F'+G148,].4S]4?
M#INP@<+8(][5==A#P"?^$K!.T(5?)1T6.TW=:[8.G<$? R;2(V0JDH> -?_*
M=>@:>H(-)9##_@1D"; "QUSSB[[HBT[^FV 5_2J(+1CGN_0.^XG.(>/I2>_0
MS[T"G:9^Z!VBV\:>>NF(3$U -\!L!U&W E_T&'W,7J!WD&#8WX*5Z@0+0 ((
M];.?RFG)EM.W]!6])F.'#<,^</W4=*9_,>KU%=O4.8+_^E.@TYBQ83 *V3<"
M@NP>-C__(($S8V6.)!![5[#P'%#X"A9>H;T>+^>XEL)LD*DC)O-HY_H(6.B(
M SMW@)KW;39<U\N8]:V:J=>*V-\4&,>=<XY&C0'(V<:"(M@(TQ1GY<!E@P:U
MUE+C(K76./#. 7J@KG/P*2H"E1+T3)XCRM'?V3DU;(ZD5,7YF<S,%<-AJV;A
MN3G2_3G9A9.AN54\=D6-7QD\1V5)/]=*Z4Z0H8'"K3J*+ZEFH>,::[@!P39^
M''->M '2#*4PUO2[OSGPHKD80>J4A94KY<':8GCY/P!0^H'U(8*LMI[UPO"3
M7NO[ !% &9 PJ7KN,^?9%MC3*:LQK%:[I%VZ7B98.&7@E)/SNP$$K7ER)^^E
M^5M*J/?6APP[*:MOWKPY]4]V[@.H ")$Q1F[#&B !(,W!C1##"L+*)$TTJ3;
M3D<F0))^"FAQ%"S<ZJ>5H==K>2M]9,4.7(WU:BU?8K>LGC7,S_3%W"DZX,P\
MIEZ*##7_S%] H3D-Z ,4?O,W?_,)4))^3&\ E$3ULP-X-XZ1*#\&A>"3-869
M;DUT>G '[.81!S#.@SE(SYA[:;V>&UANO;[JWP!P67/M(";HE;[QF7G/03"G
M!>)2@PI@&F8#9T4]4K)!O]&A@FWT**?%&C&OK1?W7#%B5^NPGS5RP;EA5+=\
MF^N@Y::^T4_ZS#.I'<JQ8C,86P PYTA*&P#4.V),*J% ]G4*<M<KG&EEDZ$[
M62H/#1;>!1#; PNW@,*7 !8>!6J>&B1\!0N?#BR\*V#X7,%"1X-=DZW6_D:7
M25GM>AP@JT'$#M@&0(M-GZ :NP>0A-7&IF'CI"G+X3,^F4"3P!L[$T@X@XWT
M#%N3#96-Q.@5A _7$(1S/;H'>S$E,/A_SG$N'<.7[&?MS(QI[SFF[]+96IV]
MLS4VT3&=V1-9&OV4@-\L+1.]'0(,<(]_"3!E@V#_*:$E0PY0J"ZXS4R >*G/
MF-1KS$-ZC2W*-S8^L55=5]^PYP&[]!I=3O?I7\"C>I#(-&&#9A,S93JP0#T+
M^Q10R!XV?LE<> BP< 443MSAH=HK6/C,%,+K<>RXEL(,T# W'5D]SW2RS[%Y
M6F%M 5$S5:>+K(<MP9E([;)F.419$5#^+RJ%MBZ%DD-&8**X$W 8#]@[V![J
M+BC0JL9%G'3_)W"!A!Q!YU-.A"'%1^D 469DBL /B\BS @[]OUD-LY]:$4W
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MTO?I%(9_P'/K(G-YZL65?)OK>99V:+FYQ;AMF3P-[K[FJO1#OJ-?PTKHS4"
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M-0?@B&+H5*K5V&Z!>W<9@[[F=+#V#/R5(3.?;3J/1]?-?)YF.VXIZ-6NJ7L
MT27K][FN]?O*O$Z1V&/X38 B<YC2#U!_#BR<8]KS;*6\5^>VD120/1L8K8#"
M(W/@DOFX>OXV\GJ>=N!BEA;PO]16%0UF](IL8S<#_ !_C#G&%V!0?1E@!+!)
MD *H(L6102V(@>$L;1G0F)IV*<SM^MD1D%$)6$T:4,9L];XM"U:.RT/HP=6<
M6-WCR'725L;E-!PG>-3GG0,UIJ.=YTRTWWI@P-,W&5.UE6Q*HSX2U@0'B#ZA
M8S H/O.9SYQ8#QREU/:A5S#O&-B==NR>#3A/O7$)6#A3D5>[W5]2G_:<?'4=
MCB*]#3C#QN=88-'J%\P'\]K?=*N^XV!Z=\^4^V1]S1(4G3H\9<P66-A [UY-
MJ9ZK[A6PTW-R<CFEG";K$T.4?2"5'.B+!8.U84ZD+ D[H6L5KH*#<T[O 85[
M8.&E^N%2T&G+5GA(L'#E5%^S/1>@\*Z@X7W>]YQ_]!R.:_@\#[6&+AV#:X*%
MK1M6Y8?:[FYB1I=2F'K<][/9!M )*"5H M3B?R%ID)>??3_U&).0;4,?T)D"
MIL G@5#9%\['( 1LL7/H2-EAKJ?.,U:ZH!O@ROD8WL!"C#?ILO0KUB'_#U#H
MFJZ5#:U:)[9L;MO"]\+NZXU=(M/IJ/:)XJM-WVH%?DT_IQF,T?_)8-"?]"D@
MC[[T3FH( E8#Z+$;I5P##=75QR344J<PNTG336P-[Q$[GVT=G0U0!.KJ6R C
M7<=79H^R5=U#8%L C8\-T$7024ISZF9GGDQ=\%!@X1ZK,'KD$ISG2'L%"Y^9
M0IC'?07ZVPH87G->G#-4]P[?M;BS8U9O5M#1F7XOPO/FYN9D?%,.'+*D_<X"
M_F%-N1Y#W?<)1@ZY&@HB*E*("$XI?Q0+IXVB0M-&UU8O@V/'P1.APH(@++_K
MN[[K1(<'/HJ: "V!%U,8M:*(D$_=M9F>N'+XML9V@GMW!6Q7UYR@X5ZT<ZZ%
M>9U+'?]YC97C?VXGK#V0Z))^Z;YYB6O]"%C8Q9?#;EG=(W,X1E)JU6S5USSZ
MO%MR=W5>F,79V*8W9NAZ.0$*5X[U7<9R;VWTFFAYT\^7G4[]W[5\Q^? /  >
MX('1*H A795!*_H+!,R&%WX*5-AU'<!$)@EB"&CXGV '\ *3C6''^&7HA57-
M( 8:DI,I)KUBDCHR-U9&UGU ]]61>VT%(8Y<O^?2C/YW0*$!Y"EC]];0E+'S
M.1W^%P#OYOU=&+'6W[QY<]J%$>#+$3)^F!,8ZL;13S5Q!:*D*'.,@$R 7^<#
MEN9\SDZ'J=F7^747L+#K-&:SD[19\[/UTS3>MX);?7A&\QU;DC-AKG-@.!P
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MOY7QN#6F <_FYAF1%^><]ZWW/#<_[CONY_IXJS6@DJ ',(\L8U@)=$CO #0
MEJ0J @@%+3[WN<^=&%68:0PR( KCCS%-;F&J2=-)@(/<(J\8U(Q)QECZ-X$7
MGZ<0^61QS[I]S1J<D?*9^KIB%6XY-_>U+;;&?!J2YP"..6_WP,)98B(MZ4#T
M L8;H!  S,!FG&.%TB] 0M%]XPL(!I9)6WWSYLVIOH^Z39P>H!- "6",=4>_
M^8XZN8)DQE:?[\F^E0-_Z7P^![RF=>I5ITTYKPO:TY^ ;+64@.+ ;4 A%HCY
M#%SCX %5.79=JQ&S!" ':%0',O4*FUG8#L,J#;[EU0HLW)J#_A\@6,JQ8"&0
MCQ,LI2X%]8VI9^;D>I_4B%*7LM/IS O.&C:(L>Q=-_= Z=4SG@/7>QQ7>O"H
M7KT+4+A:?P\%%NZEE[V"A9>!A?=QMK=DS7.QBZ[A\UQJ5V_98Y< AM< "U>R
M8RN@W.=D<R@ZD9PDKZ4<"Q"I2TM. K. A&P:@2*ZD<P$;I'_?#'ZP?>1-1!#
MZ%=@(8!+T$R:*_"1OB17^7\R+ 11V44 2'I$\$90"D I\ 9<]$QD+[W$CHF?
MVNLANB%]$%]NEF3IS<5FP+M!UEDGN@.Q?;]^CO:)LRF8YVX %J.=3L'\8RM*
MLZ:#V(K8E=CY0%09#/J3C8A5*:C)KV;ON9?G21F5#GC:4=F8N6:8FO0T0!;[
MW_T$\P"%B#OZ-AN/)4LE]9U37BSIQYW"G?<_%\RZ%"R\3RF%^[97L/"9*03'
MGC"^2Z3MJ0V!QSBN,1\B5",4>Z>HK>=I,"(1F C'K@'%N2:("#I H30FP)Y(
M"@>,(T;I$&+9R1A[$(L06(A5^)&/?.04&0$D,N0).PHE].Q$729 2*@FS2J%
M:KWC=$BVA/V*>;-EX$Y%_)AK=:Z7IUKG>^OW2#OGW#PD8-3/^!S7>1^7RL,5
M6-@1Y<S/_E_F>\[+??M>\WH!TCMUL V&2_MT;^[<=>PO75-;WPDK*74*15V!
M'< "AAXP1,0[=52!)PPS "$#+X8P YKAAUW(J+:;+L/:>;Z#G:@&' "#00:$
MB#$<>1I@L--G&C ,X)/-,E8I- T@;LFT%3C_4'9%CW//OVD\KG3WGH'HF&!2
MMYF&E\;@Y<AP8D3K_R][=X\C6Y=4#Y_^@C9[!CT.A($),\!!/ XV4W@L7"P,
M)(P[!"0,#)P:2@WE__:O]*S6>D/[?&5F9=6]5$I'MVY5YLES]MXG(M:*%;'Y
M#WX$T<<OF4O9=_-J'LTWX&17060QA9E>N'['GT59*@#GD\PK@ ,P4;+Q0^9@
MC_@Y$X><G8LC(-NEV-WLW>^MF?CPEY>7-^ 'L%C7UBU @R24W - )/#X< 2K
M-4U5HF37./')QA=03,]"_CAQ1M;AD8*_;<^T9],7>OF[Y\$S!:2E3Y8J [&(
MZ@.J%J#)\PNL4LD@"($UI&'F'D&,&$::NH?LACQWK]XC"_?F>O7JYV05KYXA
M)VXA"L^0];>0A5N \)FDX%;I\_=.%J[Z?&V5>G^1A>=\UEG;>N69?!99V+%:
MQWA;L53BG=A\2G*VFVI>6Q65$DA"-E("+4E/]E)<P_;_[=_^[9M_D("1B+$!
M!]_*3O)]2H^)./@%:O.??OKI+3:"__A:U1;^3^G&!U/;L=%\*(+1-<%TB*SN
M\3O[&K?*NTF_66K=O8M79<.3; S1V'%4V_V>?[^/&B_)2+B4FMW8N"_^E*],
MHDI,2$DIYN"#"&@HVI&)JA80M\YA?I!VV:'9=_!O_O9?__5?;TI%_@H!J7K%
M.8EL8&?GU1-218M$-T)1>Q#X'%9/'&D=] 9HV=@O52\9YU4_P2U?=2M9N!<+
MO@=1Z/@B"S^Y0W@/HO!'( R?L1Z,0Y?<,08>U*-QF$8U98J,&8"M@3B@P-B3
MD,LH<2:,)& A.X7X"XC.3HI1%2()4X(L,Z+<22 ON.=4]"5D2#DV/8AZJ_O>
M37-*R*?Q:=*SB<(C@#W+IAHLO.>SV>-^%&B\YVOO&;Z5.+Q797-TK3\"6;@"
M<EMDX23S^F]SW>9O.><,+ONZIM+KD?/4 <85LO 1SUB^G\T(T8#L03*P,91B
M@BQJ9@%N2A<1)H(Q 9J_R8@+V&2'9<L%V,@5JFGVCOT3B"O1U+\U)(1@K#=_
M2*^8N8E)]XE-)KC_%D(QP?!L5CU)PM4:>N1KSNL,X%=!XNJ:5M<UR:25NG >
MQ@UQE2";'U$^K!\A_P(4:8MA[I!*%')\&=!BKA#'_!K%G4VY^#2*.LH*A"'B
MD<]+'TIKR3SLM< X,X:W^HV5K9YVP)%-38 2]T@52 &A9Q2BD/HCZ]C!7_/-
M"'&['@-Y_+RQX?^!#*#1\X,P!)SXZ1#B<W,7US#OR[][9&'[POS.^WV'^_#\
MFC-S@90W+\K:*&4 78 W1&$ L/GW+)M+"DE@#:@REWWMLR_FUKI?^>N]N>O[
M6OGY6\C"6^+E1Y"%>X#PV43A'H'VO9"%<USW-@8X MV?$?<\ _.<C056QYDX
M]J/)PI6MW'KY3O$#4H]]EDSAUR3 X"Q$(-()/NN#?X3?$%NJ*MA4"32V7A4&
M\LEU."_R4,)%TDU%!1^;<ENM'J@5;0JG!["8B/^@PD-BI=HB/?*2&&P2+W%2
M$E\=TZ[F+^*858_!'LOXQ-G',#VEC6_[*8?OYR.0;:Z?WR"40912\HDSC &%
M/G^:,F$*0*(9A*$-\<21\+**!TFW^)XH^WP_7RJ&X9_$I8A6L67'I?"SI!ZR
M%U'H/0A+8RR^=0YSE6H#1*'Y<^T._MO!EXH-@BEFLF*+,'P467C&+C_B^"(+
M/[E#. N,O\C"QQ_)A@2<=H9FC[C)O/D;P\60,30R0#848>!D+KY]^_;6P)6<
MG*%,8US9% %Z5(5*?SBA/_SA#V\_ R5__.,?WQP5AR)X%^!'O4"E",QP*HQ;
M[T[8@51 \E8F9(+75;/\LXJ<U9Q="0C.O+:"DF>OXS/W>94P7#F;>^]E7M]G
M>\;G:U[O&<7()+];(=MM!?*\KY2%_@UI?@2 )[%[A=0[NO<F(_OZSHS9/?ZO
M"11!D8PJE7(G/$(."6P%R0(P1" [A7B0@4<8(9B\1T HFRMXD^A@TQ KLO""
MN__^[_]^LU\"01G=*)9B?Y*TZ)Z#<Y?;$(4I"\_[>^?JV+^C;/ CGXU>QZND
MS)Y]G:J(K>OJ\Y\A+?*]_!0R"_E+.0?H*'OBE\P/L@AQ1.T@4R_8MQ:HTY!/
MB#1*,^H+BD)S+KA'&/)Q@G%_%V0+QLUM^MM-OW$TWE?LZ]FUWB"HVX9$!6%<
MK'=$F;4,9%COV03$.@9&^&_D&D6MDGH^69E5=O66O'O]I5>5<FS@!'$:E?]J
MON>U^_F(+)SW[^_6?P";N79-@!NU"J+>L^F9[ /XE010&H?\5'H-O%*%2!:(
M,YPWSUJ>JRA,]M;G%;\V/W>5*'P/LG#O'%>)PB^R\#%DX6J3I"^R\#%8>.]S
MMQ"&SR0+LTZVDL&MF!-#L-5(OI>7ES?UO*0/?XBT8O/9^]___O=_+F?5"HK"
M7 ))+,-_\J,^+T'$YB,)V7JJ0HHZY_SIIY_>$JCP''M+O0W7J=+0E@I.3**)
MK24\F8K!D*&Y_B;RFL#KL<C:SUB$<$Q2ML_?8YWO6FT4-@G&?,Y[W;<8066!
MRA&Q'O]HK*@)*2H1A0A3A!Z!#-+06"-G)9J-ES'E>_@NOC,[5//3,/8LZ^:G
MQ:3FBP#'7,'2XL\H"K70$<_X?%K8)$'-MXF-K ??%[+0]X4L##8(8;O5KNL,
M6;BG.E\EL]^;*'1\D86?W"'<0Q9N!0%?9.&Y8QK?5M--8JS!33L?H#0; ' .
M#-S<04M&0P .@'$T#*7L%,.&+*0<Y(2 $$2BH!WXEMU2MBSKI#\4XXB$U,25
M8@ YF2;MLQ=%R)*M8'$O( [A$M"^(@NWU"^K@&(5,-P2#$P#?!6(O-?:/'._
M6_>]"K(>=1_S^C[;,SY?\WK/D(4KLCO!S0R@MLBX#J"L=>?S]]7UK<C",_=T
M-.XY]PQVS]BQLX'WT?<:/]ELMDR0AOQ @@B(E9@*Y 2WR :D0DIIV#6!H+\C
MC[1)$/BQ=0[!H4#.[YU+-IC]\CT"Z_2#R=CW?'8/',%]CNQ.G7E.CYV\MW]_
M-O!ZQ&L^UTT2KGHIKC9=:6)H149O/2=[MCP[=;_^"<P@:<T!52'"3S"-+$+Z
M C'9"5>2*\1?2ED%VC[+MR$(*060A8@U?DJI.J  -,C:-SG6Q]8SMC6.J\![
MQC='\^EWG=RS_JC^^&S !B'NGI5 *4%3JHOP[G7L_]0AG@%KGLI?_T;D-[(1
M^9UR7=\1A2' @3C-&I^D]<J.Q%YE_4RR</5\^[MY%A?X[H K9&%VB02$)2K%
M&\J.@5?WE7Y9E#7(8,"*(A%)G)Y9LW_5'M&YE0@[LD>W$(1'/N)>LO!,#'Z&
M*/PB"]^'+-PB#+_(PMNQ\)5X8^]Y?199..U-;&KCO-[@"GX*9F/_*<D13_JU
M)CF$T-(:BOK-__E)I%\28_ 8?X<@X_.H]OE)=I/:4 ]?_M%GQ$OI>8@H5&[+
M;_I>FWZD2HSM%M^L=B$.4;7JO1P[[-_$LY/<:Y\RGY,>,_\F=ID"$K^+[^XU
MP=?SJ<;#O<.L2#IQGWOG8Y)@AGF)8[3?0NC!NU3\R#^D+8R+..5[^##C2Z7I
MO/QMRIG%HXDU^3/GA*OYM)P7_N;/S)5Y4?TW$]!B4'Y;/(HP]![WDJ0G04[B
M\HZG9H5 C^,J9IEV[!:R\+ULPA=9^,D=PBUDX58V\XLLO':TX8P!CK1[%12W
M(0T09$1D/!AZ3D?V7C8%<&(H9908-.":<D//"YD4QE(&!%F(./1[QHWA0Q(J
MYU/2A2#4\X*18SPY." D69&0G&G:[F^1KK>3V2(,5\Z\G>O<%& %$%;K>2^@
MOV7==3"PM;;[O,]<FUO/\)E@:'[N403&ZCL^VS,^7T=K: 7@6DDX&SD'F.?>
M9S"9L;">4HHP=SN;US?)PKWQO.*'<NXM%=%<9X\BY/T^1*'Q$RPAA@1\W[Y]
M>[-C[!>"!"FHU,/_]31CIY!%-CK)D1T#)3PD/@2(2FT0+P)C)3D(&@%Q^A%&
ML>0:9J!E/-J^I7]A)T42Q(4PG*T7C@*M1[ZFG5KYEMY5.T<4DLGV)_B?]FSK
MF9[KI(GGC(EQ V8T U=>C+A%\)I;/LA\*3\VSXA 8(A*WF>L"3Z.VE1YD.Q_
MYCOEYX@VH =8"EG;0*.?S[/]@;,.5D'V]&DS@;4ZK^]/%8 ^G*[7?4KJN6<*
M_O3B!&SBF_T?X*$D1*@ASWU&KR3^F7H0P'#NJ!5:N9B=+!-'G/&!$[ =$:SY
MC+$6 P2\(N;-&Q &Y"+XQ1WB$  +L/([BF!$(1(YO9![HS3G7!'Q*Q)P92O?
MDRR\115XE2P\$XL?$85?9.'CR,+9^W./,/PB"V_S>7O8Z2QA^ RR,->ZBG7-
M>^([<0=[C'P2ATB&L8LP&X4?8@N9AW!"%.HCKYP55J,D%\O80(,81(PD(2-F
M<E[QB?/RKW @HE [AU19( KY5TIU,1022[FM[W]Y>?E_KZ^OFW@KST.KVK:2
MBKE?_MXU\7G>.\>HSSDWT)HQ1!/T_;[VT[Z+'T3*=2(2KI64"D%H5V)*33_S
M0WP/Y:$$)"6FQ)8Y,J:P=:I<J WU?11W!D]3^)L;<Y4-0@EO0LCRZ39FD_A.
M>Q!^.3&_6*0WS>.G^4USP>]1&)I?8YEY, ;I^SCCMBVR<"9P?QBR<,](?,_'
M9WC=ZS3WRHWV H*K),9'CE^/SY:3FN.T"@".C@GJ6IG2A&%G<))52.\LQD=V
M2O\MX%KY$MDU98*&\8 S8PAL &,I98I46L9*L$ZUD/X5ROV $*7&V3(^/0E=
M1^ZU0;Y GJ'+CH6NO3--<^V<)0M;<;E5>K0W/^]!%L[@_9EDX=8ZNDK<['W^
M$<_<ZOR?R0ZN7GMK: NX]3KM3&$ >_JXS/5S"UDXU]\M-F=K#O*<7B4+FTRY
M)<#PG@0_;,CKGX(DQ% V-!'P(4^T1!#DZFTG 4)!Z!#D(4^01H@4]D["0U L
MVRM@\S=98+91<"X G"1:R)"^U@2TF9ML:I)>A9,4;!O>"M%GKON^[MCG+I%.
MOT6'>PD!FON99.&T)3W?JS68==HDJR!8=AQQQ)\(R 7F5.N">;Y'R0[_9.XH
M'O@@\V\=F"]K KB2W1>T(POY.(0A LIF)WH329CYG@EPFK#,KM>N,=>\%1,U
M4=@M-IH8F''/5,9GW*T?A%Y:A0!TQB&;NU#< 1D(-"0A]5UV4;2.50=( %(U
M " 2>12%_'^4@_'1KLO]FEL$HN\W!KT>5_'?_-T6F-MZ^5S4D^(!<^%^S9NR
M8G,.M )7P)MX1-FYYQ:9#^0IP_[?__W?M\\9+VLG_;,"CB:0G;ZWGX,99^P]
MCU?BB#-$X16R\ QA>$3&G2$*]ZJ!GD44?I&%GR\FNA??WA-_W'I-9TG#(Z)P
M+XXY&]//Z^GX+KO<9^,-ZGJEK'P940:%N#CEK__ZK]]LOIZT^NDAGQ"&2"F^
M47(4P<?NBY6L.;Z;C_7_EU_*F5,>*R9*C_JT>9"08FLEU_A8K2^0C*[/-7=<
MV]5<<]UWRYP>1[^/@C(J1>]?C7EBE-7Y^IGLYZ_G* I&?D^<8 ,T<8"DD^H$
M)*G8 D&8\>P^A8C$]'VD[D04\EG!WP@[,0M%X<\___Q&%(I7D(^(QIR70M'W
M2("I8I&<%IOJE>B\?!D2D _CA]V?^\XXP<R)+_T<PI#_D_!S?UF3DRSL7HY=
M=7?&CNV1A:OGX%.2A6<,Q?=T?(;7GI&]A23L1;85/*\6VY5C#W2NWO^(\<ZY
M9Q8PP6>#@91VK<#FF6,5E.><.0*D8T1D/90; 5#DTH)KTFA9C^QV#'AP/ R7
MC!2P+2C7Q!4Y*/O!N,FP^)OW<T0A"CDC2HXTB4\/KDC XP Y@NSB% EU2I.-
M5=_C-/I[ZZG+.:\H"X\"B+,$VMY</3*HW;KVJ]=U[ST^,C#?NK?/8@?[M34.
M>V"P[6+6ZJJTL_L6[B47.NCIS^P%M+?:U:.UW>??>G^?+]?>*JY5NX MD-V!
MI4#Z]9< B=VQ 09B)!L\*,]!#LG 4Y,)\D(.(A(%AK*][)[?R:@C%BFPV$<9
M9\0*6S6#WXQYWV-L?<C"$&ML<6]NDGGK$M^/)@NGKTH6VW4GB$\F.SM!I^%X
MYJU]TR3 0HBNU 4^:[P$N2FU$L13T5%$Z$=G_JA$S17_DT;@P U"3 F1<F.?
ME1!3#H0L1+(A&Y%E2EJ! B0PT(4(#G$V>_DDP$X6WUCX7>9F"RQ.HK!CG8YQ
M\A[?&X+4=5C'E([ (<6',0!F #5J2.LY2EA$(?^,+#0FQL.Z-B;4) "-=>Q>
M;2Z&4..CC7'NJ<N,8Y>BG$WBHI_;!G^KOL"Y_[8)>R]_CZK1\PR$ F#4C]0S
M"%[W"0PC"]VO9QL(0_B:<P1QJABR4WD3A;-7TU;B9"]^W'M^YF>/"+Q'$86/
M(.2N'"L"\2CY?^8[SQ*3WS-9N"I%WB-ESR31/OIU-1Z^YWCOZUK%35O)5;^+
MGP_Y$@)FKRW,O,;VE1T_^5UB"#:1;>,+4GJ,N),$Y0-@-$06 @H11?U&V!'U
M&V(1<:5-"]_M>F$N9)1$V7_\QW^\^5=^A7]-Z;'DJ?^+A_A,_?/XT:BW83=V
M>Q6/SF-5@MR*PR3E$F>PW5$7MF^9,=A63_I)&K9@II6:[D5"2KQ']"(&-)XP
M+G^#T-.;'TFHS)LXAL+2YB\2;_P4(M<<N5Y^1VL/[3,0A9+3QA-1B!2$H9TK
MNQVKB$AB6D6,&$5"$$974FP\>B/3D)Q)W":V;*6A&"J5>AF'$+G-$<PJQ"O<
MS1Y9N&>G'X$[^KB+++S7B-Q"3MUZLY_M=65<IJ.\DKGL;=3G3HCS@3\B_%9.
MNQ?L*O.]"C+NG8\$TQ,TMU,)LQ^E1BN"SJZ)%5!O-41 '@/#: #145@P0#)3
MLD@<"'5%-_97NB1KSZ!Q-C%J,BD.?^.49*T83OV/-!_7-PE1R('XSI:19TZC
M!G)=');,/Y#/:,ON .,A"W.?$\"VDYCD:#>SG7T9MLC",^L^UW%O\+%G$ZZ\
M5N<_4F2=N8;5[\]>QWO9LL]F(_?F^"Q1V&1AK]N5\Y[G:5O50>96H#0#IM4Y
MMX#7$0";]]XV;VO,\MZVAQUDKX*7%0'C?6Q,E&?L2 @"&5T!EX .J<1&2890
ME2GOD+U%/+!K[)D SK\(P_0_0S8*! 7G;!H"I[.T?6UMYSN!DZ N@5P'=]V_
M,)G>)FV.R)7W7-MM;],O*;UQV';C+##VL]^;MUY[69NMS&N?EY+023!ZO^^@
M2$?\Z#VG@;H VKR91X&ZN1/,(\=DZ<VQLF39^#08-V?\2LA"\XA0 HJH\A!0
M0(_? V$IQ9UDO>OS._/FVJ)VR#BUSYU@?T4.3%5;QMAXI!\A(@^ 0>PINP;0
M !-$*7!H#!""?'4K"8V'WR/'^72D(E"I_)K/!VJR:0F0YYZ2R&OBMLGBGI^H
M$P*XNM]P*_?Z<V=C*^_S^6RPXCK3'H7:!<&/"-6T7X6#1"9"5+F<V .I:KZM
MRY#866='.XMOD0&W^,*9/'G&<8:T.TOD'7W/2B&[17:=(097F& +?/Y(9.%9
M]>8667BT7I_YNB4NOO5XUC5O8;GY'C8E"KU6>:5W7[#,UC6T#VF%E[_Y??PO
MN\8OP%A\F"HPR2!V$%8+40B745^SD1(J["9%H8088E "S;7QP]H\J +3SH)"
MT7OU_96$$0LA"RD*$84$)=F@4FLI"9FTJ'#-?;V= $]<T_'=%+0D-A G12&7
MC3R2L%I5RC6'$"PX-SYI_!B59O>WYF/$#.(]1"ER%<[-!C'(0N(8?A;>32(Y
MNT!+O"5V2.6!6-$\&7?)+$2AZ@>$H^2F6-.\^2ZJ?_A9;T*^GH!'M9\Q1D!&
M'=@D=,8LR><92ZXJE*9?[S8K*R7H+<>>?SF#,[;(Q*-G_\/(PD<2A9_)H)]]
MG1V7+7+N;% P%VLOV!7)=P305]>PRB!O97SS]WO&K8%B$U,AR9(Y81 YE_3P
M8P2ND(5[\Y2 WCDYKM[I6)9>\,WHR\9G-R;9(X$X<I"!=)!=.Q@X&YO$@0#8
M')/FN<A% (:S81R!+O>SNM8VV*X+( #R':[1T;+IK;&=Y7$-6&(P9RGVE=TZ
MKXSU%7OQR.=^ I.5\NQ'LTN?X;4W]V>)PK9-6RK8%6#: PV3L+M'J;)'(%Y9
M5UOCE^MT?]G9;VOSCY4OB>]H!5J((8&3:Q9DZ3%(C2381?X)R) NE%;*DY%,
M[!P[]IO?_.8M&Z_\&"$E$!>0*X%,MKA[K^WYI";9NI0T@3#;EZ.SPKGW9(\_
M@BSL>6I?%K+,>".9DN1IPFF20L8A0"?W'I_7F?(N4[7^@1G$#S6G^5)J2]G
M1PFPD6*"=_/'7PGJS;&R<WZM=ZL6M*?'$U*0_]/33I#OWV3N>Q[,5:OI7)M[
MB#H_Y4 9HQ"B,S&U4A"MB+24%/E^H"/]J  8RD=J#NN8BI /IJJC=  ,?_>[
MW[VM7_\W%I3_B$2@![E(39C-/IH@G#NN'ZV%!K51NH3X3BE4EZ0?;;:T%;<X
MK_5A'+(&4AJFT3YEAGM&[B.,S;N_ 5C63>_0O;*C*T)J10;<^LRT?8L=N*J^
MNY4HO$K<7?$!G:BY4D9[AB2<S\>62O5'( O/*'..R,+/2!C>0OK=>CSK?MJ7
M=Q*L7]X3G,77\(M)HD6Q[?-;WQ$?DL1IQSWY?1*.SB^!1E5(Y"$Y!H\A!W_]
MZU^_Q3!Z%.I_QT=()"'[^$6^CABC$W5\&9\H&1>%(O\"V_D\/,CGZH4H'N);
M$6/4[N[1,]K^/HFOJ"R#R1+;->'5_;D;#^=HTK43JRM<%_^;-EP=/TW?E9B1
M?Z'\$P^($].:A._D0]T_5:'QY%O%'&(/5714FK#SMV_?WL9/;\#XO%R#9*<R
M;0E.R3N86<S"=\'3$IT27=JF4/W#Y/R^L?59<V6,C4'.W;VC>VP;\\ZJC5ZW
M$R,T!ED1L%O'6;)PS]]L890M.W?T['^1A1_T.CLNCU(5WI/Q78'DU35L+="K
MRL(S)$&^>Z6RB.'/@][*PGZH^UR=B>S[Z&Q49V@8VJAM9.>5<7$PRK@X&1D4
MB@-&3P^*O_W;OWUS$@R:K ?G(YN21JX,I[_)JG@?)T+!X/<4#$JZ !O FN%T
M;QFKU3KI)N8 IX,CG#T+Y[C'>5XE"X_*CNYY)NZQ%_?8@0E,,KZWD#K?BUWZ
M#*^]N;^5+)SE&?>2A6<)P[,.^^R:6H'E^=F^OMC#/,.=?6Z"OP.-'KML^,#.
M25(@"]E3YT:,", $REHK"-J0A4HX9865[203GYXQ@FN*0Z7*VBEH+"WSGIU@
MCTI=<G]MLU>9\R@,9T8X]]Z9\6>^&AS-P&^6(J>9=I2%KCWV-=<=>VT]=R8\
MJHM6%F9,_=Y<*B.7:>=;J!V 'IEY?DB&WT$U@3 ":)#!5(5((\W;J>CC3_@7
M 3A5AK]1V"'09._]SONF'^F,O.MR_>[;_9JS* LG6;A5SM/EZ-FY$+EEG2*Z
MH_A'CE&S4@-JZV'=6K_Z#F:3,3X:,<@'IQ27#P?JK&WKG*I6Y0#B%,!$F+K/
M[';<@&+O>9YV;SZWQBIS.LOK6R731-/TW8F%G,.X(/_-GWY8 )=YM=LDH$:1
M(3Y!%@)O?_,W?_-&_@.\+R\O_[^$XQ%1-6WK>Y"%JUCXD43A>Y"%>[YC1;B>
M(;RNXH*S1.$16?@(PO 99.$98/U%%C[WGE;/<:_+_*W[$F?CLVRHU#VD5UBA
M2<GXD2C?THI"#"+9(QZ1.%$JS,XG>219)HD"GR&@*-]45""_Q#\21M1S""@'
MI3U%'3^8TF/O)1IA3_E9?>HE8I3&:NW!GVB#X7-\%D(O_K'GIN^CVZM,16%7
M?[4/B%(N,5(?33BV?TF\U3V?$U<DJ2P.,)YB"SB58A_YR;<8(^H^6-9]BS%@
M7/[%F%+_(5*-D7A$FQ/EQ?P3I3XACN1T=I)&J%+R2];YG,W&D(/.2W3C.\R=
MF(6/3[]D,0K_]5H5,DE<MJA@$H:K_H,M5MJ*S3M.?291^$46_D"@_"I9^ C"
M</8M/"(+^SHG8;AW#;U8KR[(K0=N14S.![6!4Y?*=B8I[PU@2V =@]KE43&.
M?L=@- AAS)&$@F>2\:@(*33T3@"^@&+!-^?2&Y@ S;/IJM\#*=ZCV2V)MI_]
MRYDH$6)\.1+.R#6U$YS&(K)]QE!@[P#Z9S/U.?97R<)9TOB19.&*?%FM[:O/
MZ-;Y?T2[]!E>CR8+N\_H++&8@.D,&;QW#6>.,R3A43#?A-E6HF8&>!U,SK8!
M6X?W9B,$@5IVBW-^=HA-DABA?!;P(E%D<95G4D2S<=W_3*",E*!F0R2EYUWW
MS-F;FWEO>\3(D0+:>9[]''9":P;=36Q'!9>^A9WPBB)BM1;:E[6BL($8GR
MI_P3F)LK*E#9?KY(AI\_,E_*I03X_)F@FY^3&+,6S'^R\OX-"868HRB@LD>B
M26[YSM[U.&17?+*Y\/M5&?(D"ULEV4?4]))XOA/ "'$)A"'%@#J^%%E--0)H
M( 'Y9_?[QU\V&$-R X=^[_X!'9]16JV,"1$*L%B_2$+WG5TOT[\O<]O7.NW
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MK,]5$NW1Q."M29\]6[UZ?9&%'_1Z#[)P+Z"9"^O6P&W+D<=(Y8%:98*.SM=
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MIYS8O20^2C7,5!-NE;0?^8/5O%QY-4?RD43AD1_>\B-?9.$'O6X=EZM!SEE
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MCGGW&4JVN\%#K]UN!Y&$6CZ79$@KX<R1,BF]_2C)J-<H*9"#@OHHT23%$$Q
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MGC$F6V/SC*!M=:]Y.)N0FF6N(:3.;M Q@_V0A@)^ADD&([LH(@B!"62=0!G
M8. %\4 NHT^AX!"PRYCXO4":X1+P<SJR[()LV2J]!P72G(, /0UCHP1DB($6
M@ *0\%Z.AH%U;DX+*<GH4AZX-H2BP)YL?0*Q*#$#&CMCTDK-SF =!4\SP&NR
M<!*&*Z)P3\UT[S-Q=LW&"4:YTTK((Z)PSWYL!9\_HEUZABVZ];A"$AX!F7O
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M(@61;>Z#"@^AZ;G(CN =5R!LW9>_N2?O<W_NTWO%&L8DNV?Z+O=G7JD\Q!"
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M+$H"3H/R3[9=F1V5 7(/N/#=\WX93])VAH^# 2J0D4J.FJB4U4<F,J8R^("
M\ZTV&DF9[>QY-<MP.WCOL9_$V2K(6Y&%^=T>47C%V!X]%U>>D:R)OO:9.=HC
MB[:^<X]T^E'MTC."Q"O'O63A*B"]Q99MC=,CR<(KSCNO#GZZ['XJ?6*7\HQX
M+G+-Z0\DT$+V)$N/+/GV[=N;W1,4RB)3(<G0LUV(0L%=$QU48U1,B :9^6PB
MD?XQ:4 =HB$EQ[%MZ3G:&YO<2A9N]0-ZYM'SY1IZE\?8Z20YD@A"]*01N(,O
M\/X&2L:0?Q%(ZT.G]!N 01 *Z)6&\VL4:P)S1*&Y00()W $A?@8P0@)UJXO9
MMS+DI;D$!E)*#&0 6\ 1'PAT=8DN11I_F9TC^53DVMS(PZ%$# A)FP\D(4!"
MQ0&X4.6G)U](3H#.M6=>^_J[5*W75OH3 E8(0NO=>29)B.!$JBKI1K(!BJX?
M.'1=%"7 #: #2+F7E!<K*W9/?'PV_7%/J5(P!L[A9^H4\8GY\5U(0O/C_LP]
M(K:)NI7RMGV_^7)?P*IY0C(ZI[8K2O(D/Q'*E,">782A>(<J$I 3VQA?2A#?
MVX S8#7 ;&O'\M5SNF4WSQ"&CWSMQ19GR<);B,*K,<.\UK9K':>MDKDS]IFQ
MR*/&:2O9O$46/G(NGXDOMV*ZC_ CSSB>[2.O/.LAN]CPU]?7-[4SU9DX!4:C
M-I>TI*)G6_D:/I%?04SQAY)JB+&T4LCF:L&/$J7\&.*/SX'-V$=J-[$.>XE(
MHTX4]TB":><!"[*WXB>^LG<H7MWCUO.]>F9G#,?>\F5B!=\5'Q&BK/O6-\'(
M;GN?^ *1)PZ@FM?&@FI=LI>RW'W"POQ$R%:)+]@5 6N,$:[&$5%(P9X$4EK.
M9*,4I*PXP#AE<\_>K,R\$,R8+P2OA%Q*FB4;S86YX@NSD_3L9STWQ$G_R_GR
MWI2_7XDQK]B?K?=G+KXWHM#Q119^P.N91GGK>^:"/>K!<I4,F@_&7F"S(I]F
M -(ER[WK4=07##P#S?#)Q"/H!-Z,/*,.X"+ITB1=0(^D2V^>E&<!7  ON3E@
MQ<!Q0IP \E$0#P21:R/U'(PA4,P !PQFAZKL2LG),(9  U A0P-LQWD!"X+Y
M;@SKWIJ@6Y4&]SCVV 1L9UQ[#%N]N94-GM]Y1!3>FKW>>BZNVHL92*_6[Y9J
M8>_[5D'Q%77A]VB7/BI0W)K71Q]S;NX=IZMDX2."];[V21;.C&O(P@2,L1E-
M)K(;[)>@4Z",,&&+J)&0A.PB&X;@D %F1Y$@;"?%&CO+9DIVS%(4P6-Z$LVD
M1S<MG[WYFD@[HS2?/N?(CSWKF'/5*M"VQ5$<&B^!/Q)/@(SPR482O2F(X)S_
MH9Q7JDH9AHQ"4"$+^1?_]WO!-R#%CYF;*"F<-\%WDFY^]CN!><K0^3$^+_WY
M$':^EV_C9RD !/>^P\^2:X $E1J2D&(- $'\46,@R1R29-84\@JA:8T!99)T
M/H>D V"0U5':69NNB<^GG#-F 0#6CO'K=B1\LWL5'R# NKP8*69C,B7,P)+D
M(G6_OIR2C-0IN>Z0A$".P]I'MJ6$%["*4H\2TGVF90F2D0HC]Z6L&/GI_@ H
MXT9!X=E!M/;]I<S;W$=]&V6J&"-EW]8+A:7X 7@S5L;,N7V7[P\ 5%TA]O"O
M:Q8C><:]%\%KC+(+:-9PUG,(ZVQ^U+%&VYNS=O.,G7[D:\_6GB$+;R4*;XT7
M5O'-7D_I*YNY71FKU3A])%FXFLMG8:N/B).>20P\ZYZR=L[Z>"]K.ZHX]HX/
MA/=LEL%FL]?\"=L,<T7)C?3B<_@9,0U?QD<X#U_'WFD_(?G5I<SL(OOO<_Z5
M;%$%YO?L-_]'..(SDF;.D9V/^>KN)=B]<U?/5V*TE3W),S;+L)/$2ZN7* L;
M&[9?3,FV:^7_W*>Q4S&79!(?AKCCY\00$G?\!IS,1XLWJ"@33XCUDM#L1!4?
MR[<ZO\]D;F!>OL=A7B3/^* DG/E[?@B>YPN3=';N^,+$AUDWW2^Y"=KY:N)T
M92/OL8M[-F[:\N^)*'1\D84?\+HR!N]A]-O1GREGV)*)[]U?/Q2M_CL*9G+D
M8>[=DM/(%JAE-++%.V/R\HL*)L$Q(RXX%N!S&+(BE O9$1+0538D4&;X!>_I
M7<%((009*M)GP(H#8!"!IZ@]<@C2&6'7YYK]RX!S%E0? %,:S8>LM*NA+ VC
M"53HS2 SQ?'%,*8OPY82<*HG K)3RM>; [2#F83AG/-)4*Z4>GM$\JW/W+WV
MHM?U'CFT91M6CGL5$%]1*?VH=ND1QR.)OS/?M34OMXY3C]466?BH('UUW_FN
M219V4-KO#Z&R(JH$G6P. @J1(@@4L+&CR!L!7K+ $BU4V;+U;)>@&5$DJ<)N
M4JM1:H7(F=_5-J>?I^[5%_54?_9,(.?OJV#L"L'_7K')O+ZV(_X-4==DH*#>
M>/()49CQ.4@O_@E(4AHKP!=TFQ.*0GV%)*;X/T0NGXCDDZ$W-\Z??G,]UKX?
M@$H),<4&E2ABT#F ++Z2,H-_!1R *"24 YB@NG!0TOM^:P1YYO [[P.ZJ#*4
M(SD7-8AS*X&2H -@*""19ZZ!6D-2SGT;%VLU(,QZ-GXIH5^1G))\U!.3Z*1X
M!$ZL8??CFD(, D<J#=)+">A$L"7!QZ=3<@(Y8@C$8O<8Y/?38Q!80D0BTRDQ
MW!N24LQ".2%^23] 0,NST[LW9T.;Q$'I#1F@ZW/&)XG2['A,#>F>S)%8Q_U0
M.%HGXA'/-&#H/<:!JA# L\9<@^_/^LTZ[4T)0A:NFNH?^9?I7U? :>]\M[[V
M;.X167@/47@5_/4U-5$X*TU6QZJMSZVQVMXX;9&%,W8\2P2]Q_P^"C=]]/&(
M^_I,]]_)RVZ;=+1&O)>/1'K!9V(5MCR;8[%S*AZ(0]AL!PSH]_PDK,7^\Y]I
M/\'>L;_B%XIR]I/]1I[Q:7RKI)"?V7HJ<+Z#KV+')6?XF[3DZ$TVF\2;N_+V
MFET]Z[/*:R9;NR5(?$94=8T+X=$0>,:,SZ':T_>6G^C6('P$OV ,C1NBT-A1
M$HH'?88?Y9,EEL42SI\8PK6(6_Q=3"AIB 04$Z17OZH"[4<0NN(#)*+Y:V5]
M-L>#\_GU3I0%XX8L-':]EKH]U\H^)!Y>B4!NL8EG$EP35[X'.?A(&SB/+[+P
M UY7[O_11G\2A6<(HJN!AM^OB,(H27IWVBZ%Z^O-@Q]9,:.879N &888:%"J
M TPP?.F)Q, S?+(BI.? $Y(00?>7?_F7;_]G"-.<54#/0#%N@!D#GQVLNGRI
MC="6RL^_R$SGD/5B+!EBU_$7?_$7?SZ .80EP,%04A4"91Q6^GOYSE6@U4:G
M _<H#UQ[E#QS8Y15^=(5LO ,47CK,_=H>W'+]:P<P R&O\C"QP6+SR *'[$N
MCL;J*EEXZ[CT<Y?O6I&%L:M]O@ZF.FG@8%O3OD&@)I@6++--;)3R4#;K-[_Y
MS9\/9!1%M*"9"O'EY>7-)G>?'M]_]M6J[)0LG^F%-L?;=WY6LG#OFHT9NY]=
M@_D/\R%H%GPK&<IF)I)*DEI4?,A<V7_D#]_&SYD?R3# QGO,#S))R57O,MT$
MLM_SKX@G)!NB#AA"XB&=K 6D4TJ3@#'J?.6VOM=&7=IZ2(9)R/F=LEQ^+CL<
M!K#QB0A"1!KU*H"&Z +@).;2)X\O3//V[,!LG (J,]?^+T;@=P$8J@F R'UK
M%0+@9$,2*CN $?A1\@0@43BDG#A]A-V/L?SM;W_[-IY^=E_*L  >GT.6&INH
M Y&!8@GW8WZH3:@WS)?G0[P2\C<@:^[8V'8DL53[\#P?48FX7_/E^R0<70MP
MAIBU!MR7^"/]$=V?I*6Y\C=Q$-+6<PP$(F0#;EU3CW-4L2E![MZ09Y[-:3./
MR+8SS\_5UYXM/F-[;R4*]VS/UC5M$86SM+Z/CK//$(9GQVPU3BNR<!4[/I,L
MS/4^&CM]]/&(>_I,]S[QR]F8P7OY,>(-Y!Z;*]$AX9$6%^P;.\V>(PNIP"5U
M)*:H!1%\/N_[V3J^-BHX_E+2AR*<DIRM3V)%<HCO@M>H"?D8OID=9LNS61:"
MD*]FY[O?JVOW3*Z>A7[>9S7=Q*(1AB 'FRQDCT-()O$:OYC*.W[=M5/0(^BH
MWMUGM]/01D-E@K&$H_E)?@7.YI^=S[CYGG[>7#-LSA])B/'OXA.D(!_DG(D7
MG-M\(7@EU^!W:OBNU)M8T_=EO201[6]>^7ML7F+@(SNQ%5>?L2_3%NXEN.;[
M'TT4GL4>MQY?9.$'O,[>_Z.-_LK!KTI.5_U/MDH9YGWUP[=2ODVBJK/1?;UQ
M(@POH\$0IMR8L6*,DAT1( ,T##Q PZ!GAV/!,<#"V#-4C*&,AO=0$@#$^A()
MZA%U4<1$-KZU <LDU[J_4QJE<T"R_$JP&$JE80"WXW>_^]T;@))M<=U4!\ 2
MH):RO;F34\:[QSG@.KTB.(8T> U9V"3!["]TCZIPE4VYYWE[E+VXQP;T=ZV>
ME2ZK^2(+[P\6GTT6/FK\YUAMD>9GU_)58-IVN(G J<+K[V@[T(#2OX)-P?/+
MR\L;T2'(DW1A)Q$I["822!">WG)(H_19I=Y",C09U0FA:3/F?7A%79<-&KH?
M6@=_>W.W%Y#U_#QKC3MB/[9\7@[WF(;ELNGI#9C268$^THF2PI@+]I6T9D=!
M_BY* "H(!)!Y1  !0OP;_YE="AU\JL#?=_%]V1%1H,^O4AV$>,I&'KZ#.BV;
M=/!M@(:?^33^%7GI&J@&*/60ED@U1!VPAKRC\$/F(:>5WBJ?Y3/YSI0<Q9\9
M$W% =F%&E'6IMC%2/I8>FPA(*@4 QQCY;O?A.K(+<-]/^EI9U^*$Q OB!_?7
M*@CCS:>[%]_ANWPGH",F,4>N!>BAXG!?QK6K$XQUU)%S4Z*IP$UIU=REO)6?
MK@& !881F-G(C8(#H>OYS88WP&#(0O>- #9&YMM<(&KSW(7 ;-(JB8DH@+N!
M_UF;>63GWI,L[&O9BI%O)0MO]5>KZYE$89,'31R8ASY6A.%>'']VO%9C=$95
M^$46/N9XQ#U]IGOON&6U&W+_/2VGQ!>2(R^_['K,#VH9P=>)51!;R$$VSK]\
M$*)++ /K40R*;VP8Q1_R?>RS1 M5.]**0AR!QN=);F6W7K;?]_ I["U[3ZG/
M=\*,:>41)5]V 7;-$8!$#9=GH9^'MHWSN5^IB3WCOI-/3,]%XY3DJN]*:QF^
M)ZI)%73N(;LZ(PKYMVS^PI<3TU !\I42:Y)L?!R_QN>^OKZ^W9^#+S,G$F'B
M#/[(.%,A)G:0*#0?X@8)+.I%W\U?25)1M",Q^4S^)_T>9ZNL"(BB,C0>?N_5
M2;6V.9. [1BLX[,K-FK/CVW9U3.QZ3W/_GO8P#Z^R,(/>!W=_WL8_2VB<,J<
M;R4+IZ%K16'OX#M[:LWSY3P!3HQ=]Y20'2'Y!H 8;!)GDG D863.#!*C)_!7
MZBOHEU5G$#D3[^,\ "'GX"B0C\Z?'EL)E'M<MA1VG<5)OZD /9DJSH<!CC*'
M4N'WO__]F]'DE 3Y##$'R @WV-[J]Q)GVCMG&BL.:44VAGR-6B?.^<SQWN7'
M?4_WV(M'//OSF5EES3,67V3A_<'BLTC"1Z[3U5BMP.V9L;P*2%=V. '/JC]4
M'W[?"N,<;(4 4-!,!25Y(N.,1,C.\<@&F7ID SN*9&%S!7JR]-1N@D9VJ!-$
MW9<PST[;U0[07%]VZ9N;.?1&3GMSN#4G6\_C,]9X^X<0GZLYROP8L^Y;R.<A
MTY314LDI:05J!.+9F5'//(< G&_S=PDHO@UAY1PAJAS^C\ 2X ,\_!\@(&&%
MQ .<D&&4]RE!SX[%:1;?94H E>^G4@/.K W]^:@'^6C@P;4C!ZTQQ">R"\F'
M(.1[^;[>-3N*NVSFDE@@OM6: TZ #/X3V074Z%M%_<&WIK2*.M::I8CD=UU[
M=B-&J(D7K/'$#( 3XA.H 1*="[ !3/M>D'7&S1CG7J@B/ OFK@_7#3SZ6P"F
M];WJ09<$98!1-F,Q3NX[,5"J*0 _)"9P:T[<F_N@XJ 2 9[=H_N-N@-9J,3:
MKLZJ*P(&Q5HK@BEVIT%;YNA,^6 _<RNR:2N^>"]_N;(!]Y"%]Y*$J_&9A,$D
M"KLLK\OS)F$X=SB_.K9'6.)') N?'0^=C5V><3SKGAJ+MD_T;U1B[%^4A!3C
M6CMIY:#T.(043,=6L^W\%)O.)[';?!!_QJ]%O>X\B"F^3V*,CY)(0CCR=^RH
M9*B?M:3@1Q"%"$<VE^WED_FA;-X6Q;OG+14"?%J(O-DV(_<ZU^Q\SO;ZE'K>
M?5=ZVZ85EO>[IK3J4C5'N"+!""]38?+5? 4_%U]AW/R.S^3#^1:]?/EL_IKO
M\GWF@Z\S?A)D2,B(=IR?:M^<9",P_E;<R \KY?9W:E"?$3^F#S&_*"$F]DL2
MJFU*)\X<DRQ<]2+,.DJ58L=@TX9U\OK(OF2.]F+SK<]<Q3.WX,A'VX0OLO #
M7D?W_VBCO^?<)R%V2Z/DW-.**.SL9^_^N*>8\SOOZ4;KRMMD+QAX07IZ5# Z
MC#F#)$ 6Y),X"X1ESY7<")(YD311!6(0=$JL  W.@]%GT+L'SU$OQXQ#%#%I
M-AL%I',RHK[/M2$**0J50KL^Q*4@G_/A ($-6:)5\+PR8+Z?X0NP3+D68]Y9
M%^]KN?]4_IPA"L^H"A_Q7-QC+Q[QO$]GO<KP3:+[1[)+SPP4GTT4/FJ-K,;J
MENO; Z+3!LQCDH5SC%;WV&14['%4?+*YB *V54"I=$3PC4!A/QU((N2A(!,Q
M@9!2SO+R\O+G("^;3?2.O7/WU@:\W:?(OR'*LJE#2*,MDNW,&EX]=\]:Z^8C
M07V7T:;<:OJ_?,88I8D[/X*4$K3;K98_R:9=(>FR286=#)%9 G#SF<;C@$L:
MN OP@0?GY/^\U[Q3!/")V1%1>1# Q'=U:3%0 5P@$"7G "R;J""=K!LJ-> +
M$ !0^#9D)(*27W0]40:$V-C:F,?1B4/@JW?J1MHI&TMS=F.0LN)9)NWZW8>6
M)(Z43*=D#8GFOK+FQ12(3ZI$]T/] &RV A)(XW.MV2Z=CZ*KRX:]+XE/AS7N
MO>;</0?0=+S4GWNMG3^-J_O6:Q&I[UK=KWC'O>DI*B$IWG"?^HRZ+R2O,4$@
M>A_R% @63Z6Z0AR1N"9^K^.0)L#S#$<1=-9FKN+19Y.%*SMP*UGX**)PCL^J
M_'CVKK1&^H@B.X3A43GRF;%=C=&**-RJ5/J>R<)GQD2WK)?W.#[RWKSB-U.I
MQ8]%M<:O2&Y(WB #]<)EQZ)NSX8F"#Y^(;N[\WOB'$275A!\(-_'WSD/0HNB
M'&'&MXE_^#9^C<_E>WUWE/K\$#)NJB+]'!6XO_LW/F)%%N[%,9F+5G7WT1N7
M\(_^GV=<_,1'N5<J2'VEW8=Q<6_N,WXQ/D.,A] S'HA"?D9",2K_$*(PK@29
M\9.4E%A$+HI#XHLDJ*)JEZ3BD_DJUR"I9T,O:D?QC3EQ_6EI,>U)[%]BU]BY
M7(]7^ZP^HO9,*[..P69[J;-DX<J'S7/,N=V*U>]Y]I]I ]^-+'RV(=K[OL_V
MVAJ']S#X4WX[ [-9WN!A[+X(JQZ#*W5'9YQ791();/::UO=U^[P'^_5/ 3(E
MA "=<:>N (80A232@(%,B.">H1<$,X .OY,Y9_PH+J@-9#,837V%@!@9)B1D
M>C TH;G*K$_"+&/<@)#AHRZ0*?$]"$$.3/ N<&><!>\<D<P8H,:1 5+.,0.R
ME6+)T4H<SB+JPMY]-',60YM ,D'D:M.9K;6R"N97 >>50&3+</;[]Q0(CP04
M\_I6 ?%59>$]QO[9K_>PS[<0@N]%%CYRS%=KY<IXK(C!K<3$5K*BP7N?<^MY
MC,(X=CZ]8 6";!7RA=*:,DM0QV9IX4!M)0AG2V7:D4@((>4LR"9!<S;+<-[T
ME8DBJC?1B%^(;^A>;3Z7X#=)CTD6SF#L$6MXE4SK('7KV%-=QS;-1%(G<CIA
MEFO/]80L1$8AII!4@(JYH8  D,R' )P/1-91L".0E"E3GP$)/BO19GZIT?P-
MP48]:OX0P\"2X)TJ0-"?33$H%I&10!0B#9  PI0440SPJ8BF[.X+3%&:2GY1
M?E@;?+;OIDC(KLM\3>QZ9_U#7!LG]XW@Y)?Y4HDTB4+E8_PEXI3"TO7RZZX%
M4*%RM&ZMV6PH%G+0$=(3@8@@]#[O!S9#NO++ !7BTWV)%]P/!45*U[J9_"1C
M>D[['LV[=9WR[X"CJ?SOWL/>#_ E40KTF3L*1_,D!G+=UD*:^@-F[@MQ*![R
M#*>DVM_^^$M?*K]'!E." -36A_7BNEJED5@H8-B]Y7I[)^0M&SO]^-XSLQ5;
MK&+$]_#Y6SYK%?^MKO46?S2_>Q*$LSJG24(V8K:@"9">9'ROTY7:K^U/V\$9
M"TZ109=&SI8]4\WXGC'/H_'3F;7QR%CI3/QT]*SLQ9IG[G'U?4>JT;W*HZ,Q
MVL(YG3B$IZC:8#_Q"=O'U_%YL%TVL&3CLOF41)KDD3ZRB$)VFPWE"R7-D'W?
MOGU[:XGA?6PHF\@WL)VJTYR;<E^KE6QFPG_Z+'_$+KN^23+YOV>.KP\F6U5)
MK.S(*E:-[5P]CXFSTM,W!)IG7P+7N"5VD "4_.(C)8WXQK_ZJ[_Z,R;E$_E!
M;2S@9#[6O?)WW7J"?9%T5+6@#0?2EA\2*R!LC1_?XIS&E$]"(%(:FC>)-S&(
MEA=B XFP]+Z-K8C/G!LWM0V<JO;V61VG]75/(<U*%;AEH^;SLL*'$Y?V?,XU
M?\5'O(<]F\_XGN]U/(PL/&MLCXSAK<9X[_L_X^MH0A_Q,GYYR'MSCNEL9E^<
M#D(:K.V5@K6:I'NG3++0O\EXKG8LRGE]AA$!%!B\]">4Q0"8*%L8((&^X!?Y
M)C &$*@#&"VJ!R""@5)R#!PI"V8\J2XXD#2@3?#?9-HLE]X+(%/>E^:[Z:LA
ML >H9*I"$G)JC+5,#.(388DHY%@"I/8,2WX7R7NDZ D8L\%)!XDA!U:!9&>@
M&_!L!0Y;"H#,WU90M46^[2E7_=LD=!\S8_UHX+ %%*;RY1;[]5GMTY7 ^:HM
MWPMXSZHU'N%0'SU.>]>R&IM5 +Y'2AVUAMC*;.8Z5P"P2UB0%VR53*]L,KLD
MV&9')5W^^$N?UV2<)6H$X;+\5-F"YO1)C<WQ<X@?@6S_O8]6E+4:,;YG]BW<
M*J,[,^9;:VPJ>-I>MC]<@?&5>F<F6WK7PAZ+[@GG%6+).4(L(960L1);^OPI
MJ4(6IC28#U36P\?P<8)P!%T4!11]P!)@9,Y\'KF&"$/Z D,._M0!@ GJG1^1
MA!3,X7N0B)0!2#1 BW]S;@IZB@L PO>Y!GZ;'^3;TM.I-\-PKQD;OM[[O-_G
M^.<H'ZD;;+B#' 04K3\^W?4C]5P;TA19AM!,ST$'PLS1JL$0W]GE$= !&,45
MQA P-%:^TW<#J?H04EA(7)H3Q&> 1Y=\=HSD91UF?26Q9QW,'E9-%$8A%K(8
M,#,6$H_&''AUS<JC7;_GTN'_YL^X9",:XV*=A$2,0CA])KT?R9N=LH%IH',2
M0=TSU+U%K9%*C.Q*.8G\/).3&)[D_Y[_W )ICR*?SMJ.%5@_LD5705N>_ZR'
M/7(P?3SGT;'@C/5F:7+FU/7T]\<&KCXW@7LVNNGOZT30517C:EX><3QZ/:Q(
M@7O)P*UC$LAGVD1=N=]5?-_)@B0&LAZWUM0DH_>>C]C&8-06D*1/(3LKT:3D
M%W9#3NGQ3D&N,HLM#SD%_TEF\0=\&EO.?DN<(0CY%C_S32HBE!0CQMA)\0UB
MB\_(ABC\G82,9)ID$1\L3N*/^5=VW/W/,0\6#D&5L9K/WJSD6[4).)J?[EGO
MN<\AIIL[1?/O%(5LO_N4/,N&G_PC?\"?BA'$$7H74W2*0UR;[^#[J#.IT,V%
M-B5\$)(QYY6$,Q^P+K^#B/7=2$5)28DIB6FXU[E2QAT_TEAZQEI9;RL?TNNU
M<>(4+G6"^LC?;-GM%2;>JKX[PH:WVK,].S()YW[6.R9I/[]*\#0W<S-9^!Z
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M?<QCKI?.^K=RR+RFKY-_ RYF;XZ4I0$D5 P4)^Z?0]*7B=,R;AKR4KIDAT[
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M6S2XXH\GOM'][$37Y@A7O=EG3%-U?!@V!9W$E9-8>++)*[N=8MO<=3#M0.S
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MXU8%X6G[Z X($[39BW$R+M8'7B+0(@Z;(X*P^6(+DH1\&DYC[LV[L? R=FQ
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M!!'7]ZQX"KOV$N08 _YL[T:(9.?K$]*\SQ;-J@DEPSR?;>6J2/FX_)87\8Q
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M\@NG"M"]!7%7T9S\^DDLW)4*>[M?599S'':BM"J&.,:LT&)O_$^BJG$7T!*
M!:V$,L$:P81=\.W6DK&R]1;7$<015U0:XD1\ESD46/-EJE^JL.)3V72!4CL?
M)F;L:KJ-7=F "AOSRR;Q#(&>0+*Y[.5^";_LW'QV8G']%=F>]U@+58\2BF"$
M8)586E]I"3XV[[M@OFVL1 ?C1&AH"RL>0(SD^]F]=0*C$I [A7EOP9O!8>+I
M%DY/8N%'!,-70=>32K<K\6IOCSUM/=WKP,_K<;:;T>]U-%]5+QG'+]]Z6,(D
M]MQ)W7Q!<U0_RPY'\.J@(CS.>F?S1 7\CLA@GE6#61_6?U5/1,<.]?'^MI3"
M.)AC+>#[^.-N&7,74%\)AE="87SZ]Q8+3_[[-/=70N%3L6#:?4+,[CU(),2K
MK35C7O4X\4F2B. ?IDD&\ /LP+HO000SX)KJ8'/)#OA [S?GG6Q.D,+7MUCH
M_HJ;V**_A17L0)4?>^&3ZT4.G[3S8#,24;"WUAWB0\D%S\:?^9G$ ULD7!/,
MV)E[Y-<D/E3%\:-L7JPJ<4@TLR;@3KZR'57S,)A3?^3F9_NF4W7HB4].G)K8
MSC?Q/?A+O=[Y:<(L/.=/X##.)@'$-YL?<24_0ZSW;'B'<4XTKA^SI)==?^;-
M6.$R.(8Y=TT8S2=(5G:@C+7NNK]^.TC&^)O?>>_[RS,FP$Z<BO>E0^QMK[/5
MV$YZS)9B=X+A74+]7;'P'>'O>V.$5[[IU3U>8=(K_[2Q:N[TF6(A3,$C\:,*
MAGZ*A0^?Z[-$PX\8WE,"LXWE2BP\E4K/@*/3_V0]$%P9*M4#LI, 'W$ R  ?
MZ8B<<C !6H(98M+I3+8[R58@FX(J0-3VA%EQ<#<_$YA.6=73ZZK9\!;J-K#X
MO_?6I+7J"..'] O,@;'L*E(L(.TDRQI (]L(EH"!4 C,>]Y=T3@=TX\4CV9F
MLIX1V9>Y[Z0RSI6CYZ %)9T2RD$1_@2-]?CJ!$8OPB$RPN$)G&S?0EJ0%UE.
MUQ0TF'\B82<ILS6?B0QP;AP89Z82BB-S314\A('ZXA1P?998^'M^_10+?W^Q
M\*.X_BX1>%6)\BJP?*<* ;;+NL.83B&7E+$V$4Y!.^*/<-8* AX3 *QI0@GQ
MC9\(?^=8S/'9E84[B.T^YQCLWDZSJA Q22Q$>'WG=[S\'S8@O["SZJ].+JY:
M@ABF!R!L@#>>6Q#AV3L5%B$6$!<0$<B(),:D$V-E[U5=&9\.X!(,J\81= BZ
MD&C^RUB[#V*E>YL-T^L)9BNTOU'=X>^):\19 71]X=P;H<E]RNCSD9Y) %"/
MH-T[:;[R3\:PI)[/K!?=["%K/"1QID#$7_O>01S\]C^^'=92#RG8WG8N]T>(
M5EU2_[E7@>\6 JZXRVD[ZK2=MI[/ &(F&.,PLS*KC/GT<W.+'#LS5P(C(CLA
MA%\S7HF$YB=AU7CIQV<]L2-C)J#SM^:5#;;UW+Q;6ZI]V+5UZI[;AC8Q:][_
M3%C.M;BQA<^TW@67[-9]N,]L6S!H/DNVJ22I#Z> L=Z&?H^S^#\_RTX$]'B>
MJIQZE1&?V'1;&8W9/&E=0MC[V74B,[$>%O'I_#;1M$-M:G,R@\?=YR_Q9]I5
M=M9<O\+-7;UQ99M/,?SIZU3Q\JJ2Q.]F'[-L?#Y7SSX;UPOF.FR.Z$W,)>C!
MK@Y38LMXJ;EFN\3A*D_]C(T0_=I^:LT3751GL6OSS+9A&!]#@,+35(=Y/PQQ
M72(ZC!$?P&(VQ,^XMU-_Z9.?_6B%X>^Y#?DD8-YMIS\)V%=V><5;PH'9?@2&
M\3GPF-_@%V&_>2*J29R9!VL:EE<YB%<G$O*#\");Z#!"7)XO)+SQL:[+CUG'
M_).UO,7"X@@<G4WB_,5)8@)VX;/A%)MA@^Z!D"5>XFLEX@A\"BRF3;,_-@UK
MB5^PBD#H)9E%$+>56IPJUN1+^4+7@9<P>/N4+42=A,(Y]LW[3DSX_;2=$Z;T
MV9WB+ YVC\9V]L%5&(&3F ]C8VZL*6O46I: @?U\C#%.8&,+YL5XX47:G9CW
M6F9T,%6'F!2C^TQ"(:$6WKLN@19.&Y=\5&M@)H=]KWAGQ_&3+][U<=V[;N**
M<WYVC^NG@N%<9W><_PG'_][7.S'-CE=.6'251+EJ7W0J8)C]PCNYNIV$%0IY
M_10+WWBV[Q41G]SO1T7#$_F>_8NJPNK0CUU!5Z;%WS(4 9# 3) #I($]QR/(
M3"CD3 "89OGSY#]!AF (4515)E/A_;8=(YBN"[@!VVS./)W\:5X:CPCBJ>Q_
MO^96XR=9OCDW?NZ]E5'7O\\X 5)!(R+$P7'"@!P!0Y*19C]3O2,CSUDA= 4,
MIVW($X!_I'#4& :V98%\9R>"\T[*$QQS9!PT9^9Y.&KSRK$)<'TW!GZ.6'(X
MQ@59X=!DN 2PYKV3M#A*8@ ;,"Y R6?^]MMO7[.7KHNP(#&"-=E#A$<PQY&U
M_;C[_RR\^#V_WL&5/\+7GUTL_"A^OTL$G@2;IYY+5]4QK^S:^K&^$&P!G#58
MI9&U0PR3R+&>B!J=B$K04+W6X0YP*?S=Q*;QGEGYV;/P+F-9Q5!"S^Q3"%/;
M&II "!L(7PB*  AVSGY;Q"I"IP!V;H-K*Y6*0/Z',-+62KY*99@@R8LPB"3S
M8XBR3#W?)@LOT!!H"XP0>8&NSQ9TP!X5#I(:G>;;P5#=/_)>Q:. AY_0>U"2
M1>4 (8HXZ'X$VK8"$UL(>WQMAV[PP:[ONN8G_S,KL)!YP0'<Y%]]AJ">SR7V
MP-%914(\FI64 H=Y:F1;KMD/7"=$"3A4:Q)+C0>_0#3RG'#XJG+J).KL0""[
MN*H>F-O%!,;ST)LM%DY!<G[>[$6<&%-%#K\C8".&G7HO&S-CE+B*ZSCLI0->
M!'5$E7ILS4I"\V=M[1,CW<<)=R9F3+&CYYF!E'%B@^:$[7;ZL2#0O H*JY#%
M0_P-&S.7OIM;0:2YELR5[/0W!')K0,".M[#]>L^U[1 _$, 3# F UB+?7%5A
MU4)PA]\FX ORC;&Q-N9?OE7"F-.2?C-P/%7D[8JNI_CY"D-/&/XTV?-$&'I5
MW;C%PJH$JRJ<U:?=A]\9/_,AB0)K;''OL";BSB_?>L_!&'A7974G&_M.,&#C
MYHZ=L ES:=V7*+'V82)\DOCU,[^#NQ(KQ.<JE!.H86P'2Q MK GSOOM+?R3>
MN2N0V+'-CQ8+KUY7?&9SACNA8'[-9,)LL2">X"/8@/6(:_,!; !?AV5L@)\C
M%IGK$@3FWK^MV5HHE"@@ K,A/-[:Y7==6_S6%F3X7Q)DBX4PVAKGF_@E&"$^
M:$MM%=JUJ?+9Q"KVXO-P&3N(X"F?.+?1LD_^B:\28\(M]TLDQ'^L ?<*MVJ+
M 8OY47BSBTQ..[Q.U8);+)QK?HJ%\^^V3X3;?($B&7[>,[IGF(P'6*MP&W[G
MJWWGHXV1-06?%>YX-AR$'W/_?+'QEDAE P1%8RH6M1YKF^&[G^%)KB>6,]?6
M.,[C_;A7IT0;E\W]K@Z%F=7RC44V>]>_\TK .B603@4_3[#X1PN 3UY/U_]3
MD7"+K-GT5>N+_9K7X8>MY0XC@BG6N@2$UT^Q\).^/B(LWEWCHZ+A%@O+/B'9
M\P2Z"8:1#V #X#N%"1$$2H >B',\R$';& B% -\)>7/[K2 5@",4 A=@[WJ(
M#4.,.,\^/:>MT7-<IK.LW'E7M^S7W*8\!;F339WFQ]].P76^"%_&QC,"W"I%
M@'MBJ<R7K+H B[C(H<XM92>2D\/YT;::0YL.T3UP/.9?4.SY!.0:8'=@20W-
M/9\@FX-#+ 7!G+QGY:B!RVQ,[+JS:>H\T #IY?0(%VR.TQ* (3,(+7OC]#A)
MXJ5JC2HT]GQ> ?&?32S<]_E'^/HSBX5/,?DS1,*K,7A2G?*D"F4',G!5ME^U
MA[4H^">4J1"S?F 2?!8L((9$C:H#O'>VISB1XIEAGWYE9WUGO]B$P)HE7VU5
MK<JP)NU(M""D R80?M5+2&PB&&)-<!,L"((07P1[G@"+;'=( \PBZO!+ F+O
M$Q 1T@J*!,+P;F*7X%9BP_<.P""4J';DQV:?W7P$G/,W,(JH!@]EZHUY0J[Y
M,1=>;?OQV?Z> -3VCTZZ1=I\MK&96[01.[C9J::J_@13 BF! -PT+G"T$VW;
MFLIW\^'&AJ!C/-U;AQ48:Y49[HO_)I8*%#W7%GNV'Y_D=%8<["WH;2WW3#U/
MVU)G157;[>;!-_4\*FBY6AO=P_1SWN-:QM-X6PNVO0E&"2 "4'/#G\=Q5!+V
M4EWH=ZINC)N@S/@;'_[.FNH0C[G-;092&W>FR+EYT$S\NEY5N1($YLK\N4_K
MO9ZDYK5@D A.Y$GH)5QWL(UG]O)O24'/45_%*1"6Z*SZH(0B =VUV7&5,)T6
M3E"UY@B0L(G@0/3OFO7!FMN-3]BY@\BY6^2NPN2JFNN*6S\1"E_UHKOZG%=<
M8]I!\[T/W&LMU9<0)L#([-<<&FO8QC:M?>( V\@'S*IJMJ(:U1P1E/#[1 /S
MQ49<EX@.#^ 76V=/^#U!O9/ 88I$.1LD_K ]:XE-L2?W^:IGX6<$XR>1YZ-<
MYXE8>,59KL2!*U[ZBI=,H7 F3^ G?\E?\976MC$GG*D()/[Q@;6Z:)MQ)[03
MH?A&_%["C0^HLJ\D@6IU\0M[FQ7T7[Z=;-LIOXF%N^B ( 9CV$S;C]F@!"8?
M[1[%&,1-]Z[ H*0@.Q2#\/EMS?6">?71=,]:KDANX I5+Q,RX19?:IPJF-G)
MJ*MUN]?J22P\Q6[QI+!B_MZ<P3[C(HF8B.I9)'9P%^O(/%FO? __+?8RGPHQ
M^&2Q4OZWXI.2QF(D8X;?F-MV4, !,;KD:;V1^7MKVWO@" &3?^=G9S6^>T]0
M:AP]V]00JFZL-4CK:*Z=*TZ_A;#9>N3NX*"GHN$6\%_%'!]Y/8EKWA4)Y]CT
M&2>1</<DW'RL.3SYOJX]A>RYHU11@==/L?"3OSXJ%%Z]_R-!>8MC]F68)P_M
MQ<&P$@H%)[*4LL R@D 8&$<. %I"X=S*)$.$> !R3@>I /;$'\ (L*?!O@I*
MYSC-O]W!Q]RJ<A).6U251C]QS//SVK(T]_-[%F.D^D2PZ9E5L'"^G* *0V2-
M<T/@!%H6X":4<_'?557^2!N= BQ'@ 1P..8?:>!0.*KFW!83\\V!$0P14P03
MH12(R.*YAG':#7WWYS:VQA4X(2=( H=(E/['MT-R9-L03T[-6/I;\S]M9=K)
M3['PQWS]6<7"CPB%'PUFKGYW2N9<$9JKH&<^8T$E;(/9@@2)">( C$8*54 A
MY%61$,K@LDR_@!W>"]8G[OJ:@>E.Y+2-9HJ%^X3BL++M#%]&!?'L23A/<118
MU(,0884%[E/@( D!1_FA#IF09>\PA7KO(-9\$LR 3X)E9-ES&Q?OA=>JHXV5
M  99)Y#4M[%M57"I<<B/SN?=AW7P0\1"SPB?)%L$28F$QKT3AQ%U J<@W3.I
M IB5>J[G,_B,QJ-*QBJ[8*R_YX<ZX$)P8#N6X%!P4"]"-@"WZUUGO(R=P(U(
M %L%%S"<'<%8U07\@/ORV6S,YYJOA+JY)7CZXIG1GMNNIC#,!NJ'DVV44/(W
M!76-?0=O%?3-TW3S+Z<UWUJ.9[@W\]2!;<0K@5+M522I^#M!+-M2,56/PBJG
M5&?Y&P&N*BOS9[Z)(?NT:I_;&.S <:[MG0B=580)I9WXW;9\ZT.RTGIWC^8<
M!\$_W!_?G% H,"4Z&V-SZ7X% (1@WU7P"!8%H=;A%L/GO1MWSTJ@$)Q+%!)8
M.U&3K1%5K4.BD7M(+&17]3KS/)VBZKF-P9Z[.6^SJG+;W#N]7K<?>8+5,_&\
M*Y$VK_N(W]YB8<\[ [YVN9@7:]]<$>*L6YP)MB02&GM5L+;,]Y+4][,.+B+:
ME-16K56/-Z(+00(6L O_QKW8NC5"H*F?6B>I6AOX&AX,;ZT-F"+)(_G"WUCO
M"0P_\O49W.F)6'AE6^_$K4_CD8DC\[1[>& ]&6.VP%=*JO-U>#.<YQ/_^M>_
M_E\;T(_6?$EX2"CAVOPB']()Q*YI;4Y18IZR'5YWLNT\L*(>RO!!(HOHS/=U
M^B[?[/.)8I*:[I6MV.T 2V$5K" <VCG KW6PE'ONH*U\EQB5G<'R,*XYF%N.
M9S*S/NWOK->36'BJ+.QSJX;+'_@YS.-/B3#FJG'ALZT?_KHV%_[-_WA>L21A
MS_C@1OR_N?$L)2E=UWJM/8 U2GPTYS Y_V#-JRQ7,6S<<!_"$)&PZDO7GF/C
M^SRTIO[]<YQ+FE:0-'%\K\NK]3;]X-W!07?]ON^JOU^U"?B1K[OD_T>$PJL#
M86:E_B["VOYFZBK6K76-6^"<52G#?J^?8N$/^/JH4'CU_H\*AK,";V=OI^$!
M&^2/@RC(L=V3T]&XVK9C@4W];C@@1 /  3)D%5G,X7@OL.<H. S$T&><[CUB
M=.H3,>=UDOZR&/O$X[TH9Z9B*_MW0L8<SRE,(NR"7T3-]C+$BJ,#OO6"0MJ1
M=83IEU]^^?HW'$.G<$V;WF*A_W^OO;XCA/ILXU<CXGI=((G 02""&-;<7<6"
M ,I+Y8*@%RGDQ!!,6TTX+ &M^=[;JW=PU#QR/ (W)(4 BY!R= 0.I-?GR#HB
MK>Z/4W/?&P2W6'B''7\$K/@I%OYQQ,)W_-6=[[K[FU-"YZI"X2[H\>])W A&
M2'[]HU1V()F" B(:PFB]6JNP696W]8[H(Q:;4$PA<@>L^91]XN?< F%M"B!@
M'JPD/O MDD8J3&8?/\(4?X.4S H6P0-!#YE6+>/>"3DJ(& #H4OPH+*%7_)O
M.$PLXXO@ED2']ZO<(Y@(1E3+^2P89XME6ZOX*?>*S,.N>M->"07S6?DA[R/F
M(5G(MXH<00QATKSP$P1+@1D\<Y\" )5A[@'Y-Y=M!:__D"";B$DT-(9M#7'/
M/H?0::Q4!56= *=K"5+_*;[:[]B'\>&;5)^X1^-N#NHGZ_/:!ETU"1_.]R4@
M[6W#I]-9YSC-AN55Q[7CH9?_[VJ\1,8.*NFPDD2Y^,Q<&S/HJ!+'M:O69(=L
MSS//OF[$-0E1_JZ38-D7V\)_C*^_,79LDSVY1HW@!=%;7*]*;&ZO/B5&2TPF
M.AMK]L2?FGOVV2$L1 %!WC^_'6S"-^^3JXF%@FP<3M*72,?&C%V^7H ("^"'
M]>C_[*NV!.ZCJI4I7K)U8\C^V Y_S:Y\/MS!#V .H9Z Y3Z)_E6NL"G/UT$O
M>QYWD'D5*.T <F]O>R(6/DWL]+FG;8M78N&[OG7RVVR&W2<4FS\80"0TENWZ
MJ7>TBFE8B'^: V(,D:!#;F9O4L($3" NXO<3*W%6XBY?0>CQ?V+D/!RC7IZS
MG0/1L1C VOCU6[72/-@OX>3*U]_Y^W=>W\OIWA$+/\(SN_X3;K+Q@4W4HY8]
M$,E*3!E[M@#'S U?0"PD/K$!ZQ-&P QS#\]@'PYOSE04PC/S!7=W3\AID^T:
M*.DGAJR=$)^F6 2VL@DV T\E87KYO\^W:\W?P@ABE_?ZMP2A9^D $[%F)P';
MT<2W2O*4[%-1R%>YM^9F)F!F^XLM%MYQK1,678E OOS?YY50RU=YN3_SY9[-
ME2(<?GFV![!>_9\/@JNXCX2,,?%>& JG^3+)/$4:XFUMG\RC^:Q5F/&" ZZ'
M%\)D8^>S^9"XCWDSA_-L@]G_TZMGVI6%7@F7M=JHVG_&FCLI?85_N]!GXOLK
ML? CKY[SW=?WB(5/XY&M8TS^?1(*2^!.?K2+I"8_:EUX#Y^<!B2)B(M+(!&6
MO7Z*A7_@K\\0#+=Q-YZS\A!(" YDIV29.0U"T:XFY'AJR(X@ '$!7'T)!6*"
MO]]^^^VKPRA3 5P8Y':Z.Q []8S8<SE%IGWJXMVVU#D^>UO+JU+FR)M "4 C
M\,:)(Q0 UCB64U9U9XP$%H)<  [@D;V38/998N$[ZS"1MCX7'%C;652I"-8U
M1>:D!+>"<,2#\T(P?5<Q8.XY)ADJ ;B A.BG(H;3N%K+W5]@A7QP6 B/:_E<
M3@VQ)1;*(/HY,=%]"F;,>U4]=V+A%8;\$;#BIUCXQQ +W_573WW6*\'PZKGO
MA$)??LZYPU:" O& 8&1[J[6)& H,B(4"@TXE1\IKB=!6X"E@M):FR'':[G>7
MD0U;"0UP@"B!Q",@\*5*E8)0I)78D!A(R.)7D&0"#<(+?^;+S_Q>0D80(N @
M2MC.PV\AUIU87%L$I)@0YE[@-W]G'/BHVF-,(:PDU*EO6L_I;ZKT,0_Y3T$;
MD:9FY?50- ^"'CX5F5=5*,F"_+>=MZW@B3*"-O?+GPH,$B.-H<H+<TJ\,@X=
MYF+."0/L@*\F' GD$PAW_T'C K?;6M;A$VT5K@IP5O5-W[O%XDCLW!:S&Y2?
M#B';I+=6%?.U6WG,X&,3X=F&I4I"PAB1V//SW[;M$T#X:W.D8I7O\>ID30$K
M?\BN<"-CKZK/M9!K]E,E_5X/<:Q)XF>OW02R[M>S(^UM\47:K1GWK.(&QW(?
MN 7NX7X)<YUT7"-\<XZ766-LLI[)[L>XFDOKLRI%Z]1Z\"SFNH"PK87>5Q4+
MOL#7$\2)2/7%$NC6K\[GUSK$.O0LQ$B?\V5M8;\2?5\)-GL[UJFZ\$HL?)+4
MV5N0KWJ<;=[Y$:%P!LN)0L:_M@;P"J_&K]D??(.=^)?@'Z:P!2*0Y$#;CSNT
M H_J!.RY51V&$IP).M8"?( IYI7PP*_ 5+_W.?#,W,*R*3C!7NNIWN2PD*A9
M97*GYM8VX"Y1=N*+W_/ZR-<[8N%GW.,K/E+BHT2<=6I<^54X+K#O@ Q89GXZ
MF1HNU":*>.1WYAWN\4%$.3Z+4,A'FS/7AT7;WR<NM V:C["62\)T K<D&)OA
M^WR>^)$MNA]VPP_B*W!5C,2N?3:<X),(6; #]R<JUG>8?V/K;)503B13N,$O
M=I 4/]&:[#63-K-W_XQ'-K?</N6.ZTU;,U>)NK5=JJ)1X@>F&W/^V/BT]1B&
MMUV8Z&]\9B]C&-[A:?62*VGD6GR5>,WXX$>N8<RL]ZHQ^0QCSH_@1/6=)/C.
M'2+Y]UD5F?W-MC6-34)BF.YO9ZQ97.U:5V+AU@;V=N]P> O8I]=,)IT.0-V'
M:.T=/C_B=:5I/!$+3WYHBM^3+^U=I-M&9_R?^%O[L8J%V)PUAE>**;Q^BH5_
M\*_O"="G<>YKSF 'T /;RM@Y'00"858QQ\G(=LPJ%0&=  ^QX*B068'8/*5V
M;@^> ?06"F>I\:G"<,YC]QZ9FDV@=SGX_-K M1NH[F!F9ARZ7TX1H19<$<>0
M*(X9('."]>HQ9H)>H(PH(WG >']]EEAXM_Y.ZVT*Q8)DY*#M+,AA@8AGXV"0
MT"IW!.HJ>_R^( JPU.-$QHOS,:X[>-O$JBPZ<&-_LFV=+ V<"!Y(+I):111
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M9-\3]-^1C(\&Y:\^ZR,DX<I(MK/<?W<5Z,S7)#,%AA'_+U^^?'4*G#O@4.&
MF (3F<)*F %TIV?)&",,2#82H9J0HZ)$ W@.#*"=>A=-T>V4$9Y_/X7.*3+.
MYSUM"=EBX1ZOG8W>E1!SJ] N3?;WB*[Q(JQ94 B5S&K]_ IT@;2L'3*M6DZ
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M"3Y/H"8DPC2\@%U7_4^H$(?XN>V/. (;(W:R;[& 9X")$BEPK6IHV#JKH;>
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M,[!IH?@W (A "T:(/K9] GB@@PC(<*B0<VH:X0N(,1Q!"E+!40%V8$TH$O
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M%<S)@M7 'F'C' 5O D2@;?R0>5D\3E&P8)R,T<Q8S6<L<&_+GT4_2XCG^,T
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M.!W#%@KW%L53?[Q-&*;Q?U0HW$;V2C2<AC,7XLR*;7(__W:2/4 #R "&K(2
M1>9"\$@<*?,#K( 8T)%-%&36Y+L3&Q&#Q!D"Y!8KIW'/X/J5RKZK_YYF'ZX$
MPY-0\"H[? <*TXYFELD")B0A88)N0&Y<!=L<'0)G;#E-HA<1RCBJ6I = ]P<
M;*=W[GX+L\??Z43)>4Q]Y'2N#?<9>?,9/@_A-X>"=\1/H-)V.<Y*8,H6",A(
MB7M'%F6390(Y=R+#["7602970NP=3D1*/!^BY-Z,#Z(+D! @8\@F$S\$(((J
M6Q'<1UOLRH[F^!$DP9QG!F;U5B*0(K^J=A PGV'.7-O62J(HATV,-+<<MFM.
MQW*J&'@E@-]5TWP$5]\1"O__)!;N"HXK$6_?SUV <244GLC U;7#Y9D5C*#.
MTS)G2X'ZYK0->;X2P#M<0$ !SZW=MJ<2KJQ?(CAL8OOPW]KG[)$#PH:J*G\G
M>=3VY4XKAF/P3$:<R(*H$@*(@WR$M>2Z_ 0,% 0@QVTK)C"T';;MDM;JK!#L
M-<6\>=*P]>W?M03PM8G7U3Q/@6]6'"<2SGZO8>E5Q;OO\U 3V *'9.Z)/5HU
M" @$ $B\C+]Q@Y^PO]-G"3R=, UG5!VTM5L%V-[>;5[A4]M3S75]@PG%LL(J
MDV#\'*?Y++LY]A0+]W:;J\K^=];XY#)/*JP_(A1NL=!S&5O)+$+A/!7<W! *
MP_Q>_J_:T)K(OTF$25Z58&.S1%X!G."/,,NV^13""7]D#1)Z7*L*?3Z+<,9_
M">;80\*Z-3FW%Q/4^#YK6I5M6Y_9?EL#F[>V(IEK=H3L>Z^ VW6M6P%IO2UQ
M.[Z>#>[33J?O-I;F/D'4WWSY=@@:H<DS"^PE1?%'V$ ,(%C4*XO(Y?G9)S\N
MH/!,@FG7Z1"QCXJ%IX#K:NWOY,^I<&!SU2>\_\2U]E:X_F^-P>N]+1X'-"X$
M%EAI+1/DB '$%F-;)2%1H9YTYM/<&FL8#X_9-@QFPX0BMF2NB(2227@,NR7L
ML17K R=BQ[BK=4)@(#3 *SR0#;'AMH"Z/TD)>,76K),$8,D/\SE%IEF%.[$V
MS)F[=$X5_5?<_5VQ</*RG3#IE2"V3U+/)MZI+)PV<1)=ZB4_>]3";LD-X\J7
MF ^^E#UT. AA'GZT19Q R%?S#?RP^>?3V_GEFO4?](R3NYYV6FV!).ZQA=1Y
M.$2V#8>J;,8G\ 4<1+4<^W6_[A,NX/6>BZ@)^W 06 $+V1I!L?8E?D9,G*V!
MXN*)NG/71C;7:Q[:M->X9VQ^]L$84P^8]N?_B84=UM-Z]OPX&<PVIXH>S(/U
MA1O@6/R!=67N2KZ:P\X#F,D5ZY<]P <8"MLEN_  ?^]:LTV8H@=C3USU?MAB
MK<,9 K1[Z^":1-23R%1A4ESIJL?WJ\KK$S>^2]2?-)PMH%VU,'D23^T8?[YF
M<N=*2WHJ%-[%,%>"X2Q.F-OH\U5SE]S$5';;H3IW7YL'S\2Y&)H0#=_I/=8=
MOD HK'*=S;;[P@Y3.I+=2'Q+??__M&)AP'XZ^6:?&G.73=^D80>@5T+A7?GJ
MW7:XF:&<CFL;U*Z&G)\/P#D(((9T$ODZ6IU#X7P$>P 9@+=E+;$D$CO[T@&>
M,A-(3R7,<]RNRFBW4[T*S)]46E[9VM/K79&-6<VSL\U;>.PZ%AH'H:H0V2<&
M"OB0Y;D%#9A;A+8% '\ #K@[>GZ?2IEM1FAV-F$V-9U.<XY9@._]R#[!B],@
M&G,\]0(TWYV6V@E:[IM-<$BR"#*!;$'UBZ!4ME( XWXBB%<!Y=W<^?NVCK&I
M2J$%- 2-ME363!5Q!5;LV#,0P3O!N9-$B=B<>)D]3A() VP$0':-6'',2#%'
M[=IMN0>(YHK#YN39O;GJA.2]W?LD@N]DQ=VVI.^MJGE'3/NS?&WG^JZ8<$I.
MW F%IT!PS^>=X'@W%_,:VTF7T4X48[MLV+_#UUD)L84+ 1]2R%:)(3!=@*F"
M24!A7;-G@09Q0G!/+"&26UM>?DZ4$HA8 T@!$KL%>@)5/4M5K@@>54DCIH+3
M^JA9OX)()(+P;_TASL2)+U_^WZFK55%OOYC/SO_-<9K$:(I$)U\ZL6C.00'\
MW'X6[N9K3[X]O^"^S &\45% *"36P21$7I!O[ 5(5>88=[Y!Y6%]ENH3)A"
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M?_SCOXX9"7#8?0$?FV\/[$>5G>RJ]442ZK/*)OWGK^$8[!Q;S+8)")MFJ6+
M:_D5P Y!:XW?;$S^OV-U@@=5)I&&-]'S5CG[$]U\(@J?VHZ\55Y_Y_U_0A3N
MWI)#I#LBI=YL9-Y^U$]0$+M#K?9X?L<R^0=$2J0*GYD_DFSRO=?Y.\1< ;V*
M+WO,ER()$>\J'0/:'2&V/O?K)IFJ#KD^)7*BEC-LA21;%0$2EDW)K%K,[^DY
MLK"JDCL%-AU=/^Z^)9+]+?D4_%L7/M3G(2-54:HN4JW KMW]<]_9P#M8YY*%
M;_)RY>XF*I\"N2?9?#I.=JL#[S'2K;*YI.%33REXA/ZRW0V1(R=L ]Q%=IR6
M(#_DD?[#XPUU0.RRS\BD!E#!DF36^K,ICK*3*_O/%KMOGPTGL@%LN003OR$8
M1#K"IF2XB<I(*80$.X5L5LDL,"2W$B(21O"6O;K!O;7@NQ"%9,1G>BT\5T+[
M#EO*)B3/]52KQV*8[JVZ\'?(PHM3(T]*TNW0P)V,O*T<GGQ:L61Z&(;87I$[
MS,=GL.?6U_[QR_;='NCYZ5*M3*_\3/P@3MOCIDX4P*<(8K;=O;N7JS/7KT6>
M7/+F$@I+CM[*V:UB@E5@%+@D8HQ-17BZ=[Z0G+.K5<&JP*<+G@4>(<?L4U7)
M\#<"@WUR8L$^7!\3WN?GR#W9V^$=?)ZX)5G*MFR<W7'LR-T(WFT!<8FK/=)/
MQOWK<\BM^[ >=!$N\!SLK;VSA]:#OM-?58$22-M;EASXO[7D,V #ZRD&XJ\D
M"F #A3]^CR3D1[98Y.[]Y4">DM/U<[S5AA&$?E;,Z:+K'6%>TO I.7R)]'Z_
MU;KWE.)6?^]IGX;;?9IPO?'3Q?G+^>S^?L*$$7 ]WS^3+%Q=O43G^I6-0_?+
MS_R^MG6U*2FVZ80J_6!_&M(&O[+Y?(,$%3TLV>W_G3HEK\C%DA+6,?QXG^/?
M@BR\X/4Z^^O0][K3D)^.GCX9X%NJ?,O3WXX@?T46WI)GF^-U-V ER(P51ZT/
MADP/1X)087AD<H /#@EX[)@:<@AX9KAD$&4/_7W'"S*R2X2L(.^]WFJ,*P/]
MW2KS[Q <;\'#[Q F;\'CK2Q\(PO+B%HG3#T'@6CCU*VU=>8L&7H@3T"N8D\V
M$ F7T;*.;\3S'M,H(Y\Q8+!W&K5G8!@*9GV&_00H$'\, S(3:08P<NI5OG!@
M'+6 2D:,_-PC#7N/]WK2M<U2KEXMP=,^^CTCYCX%U(P7$ %$"\JL8^0VH&&M
M 0)K4&;1,S?$Q#,(M@$KS]3Q>\8/L;*]>0"9[0W6D3\5E<"'-;X ]Y*%&?!K
M"W)X3Q4)3[W!GC+GWR4,_U_\:JUOI=)3%=131=03491^W^K=@&.!PC9]7K_B
M9S6NWV,H.T4Q?[)'[@H4R"R@2;8 2\$<(D$@'CDH&&"[59:12< 1D"3[,M$"
M?K:;G:&_ 5%D(7 N(*7C@G<]2.B]:B)!JV >B>']7?[O9X(7F>JF] *&UN16
MVQ3PEWE^ HI/&>9/Q^[OGEW_>JO?WJK8;W#X5.7V!O#>2*_M3\36J)BJUY2U
MLR=5=_*O[!3;POY7U=FQL?93Y4[!DH! $L->VB]!!ENM(HX]W&$%!>M[73(C
M8)A_V.J>IWY-/\56;_MS$T??:=/PI.^_2Q#>RSK8*SH%Z%I_P+<A ?R 0$P@
M]Q^_!I(@4>K3P^<@![W6:[:7'&*G"C!^"J'3T7VZ1L^:2+L]WCJI$9Z[>]#7
M3<HN8;_5;K6<\9[\M227JI6.$#5@A0P*7/-Q=)W=:1A.=FO]-7GR.P%QU3)(
M5[+KO:KZYY_Y54086^,>^$[RMKJ]N.HM6?]7D(5/!. ]"? 4H+[AKUWO2QJF
M:U7RTE,R)QBCNY*6;*L '_ZCZPVLL'[TGIUFRQU-5&W%MC<9MBGUB%BOMY=L
M.UF$*1$O\*3/; *Z]62[R1M" 1Z"A;PW#.0]X!Z^@HQ[+_<D<>3]$!$JNI U
MY+;^J)XQK+DXSGJ0'_:FH[P19$O"57AP8ROOT_&X!O9EHYZ2JK]#%EZ;WCY6
M:?6)]'BJFKH%()%M.U##6H1-^7NRX>0,O6N2.'NO&AVQ+T"W)\ACN)Q]XD_8
M&+I%+M@6V,!I&3KF/>M9[EY:DQN;7K]V3XA=N7XB1%T=8_5,Y(UMDY 7]R"\
M^$!V!P;9(6DP-L*;?6 _Q)Q>[V=THE[*[!-, G__GU]3?,G#/=[J_IK.OF0A
M.Q5A31\CG]?G;87VGL)Z2FAN_!Y9V/.+C<0L/I>NN5^X0+*5_>=OBK/J/0FK
M^9GD(CP&#ZBR%']8 _KN=R6#Z2O9J-^]][0^3GW CNV]>TL?G_SRY2.JSB3S
M.S#KMBK9*MD2W%ME>%^_58;%?&_'\S_UWWOK/[DM5HK]_OC5Q[_A;OG6>\Q\
M/WLK9M_PH*]-S%W_]%<>0[Y8Y^KJGB2H>.O:P"U(N+VJX;^&D[$_M<101*-0
MC-PUMX _$$^05;B!C2*/,"F?8)UK?1;A>NW-OSQ9N#?=)MZR\ULZ?H\%WB.!
M;V3A$V'X5%WX%6%XB<+;"V,=T3+*$54-=4 , 2>  V</H @Z&)YZ[)0Y)Q"(
M0N! X"F[P7D!%F4/M[QW*P9O4'4#]"<EV8#_J[7]J6+=0/.G[_?T=YN!N\!H
MO_R.L04*!'2" XZ0T;?.G"9G"=QQ!O;"411!H(J'SOJWK]?H[/,MV*V")#!F
MOR*1&7 D!*46^'.Z,L\U9E?QP 'M$ 3.#/A'JCD6P9"HFN%L&1D&:@.:MZ!^
M[S%GM%4#]TCW[JG?N6]9>(&=+"69!314;P2<!'L(0&O(^ ED@(,FDM:XVVL
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MRG^7+'S"E1=#KPQN8%R0\_3^:P>><%_55TU#KV(,=A"$P1(P./S2*9X"?GM
MEA")9%&E&+E4C8H@D=RUUK 8^X)PL)?DT/NP&>P+^P&_"?80D\A"]LDE4%9E
M8X^]5X,-^8R.'B-SVCOO7S47W.COV;Q/"9<-%)]LQA-I=0LQ/MFV6VWT-'SR
M)V1A]N2)++ADX5/EX]/[]FS;5Y[NURN>7;">Y().V%O[C0!&BO'U_#I,*HG=
MQ1Z1EZKP8 1[ S.H)A-K="2\7N7I4KYK*\ B7^[1RVL_U\9L97HGI]@"\H4P
M@+7)EG8&3DMY'GZ0[213G@F93=YJQ8$T9WO)/GSNV<1*DJ1B%&2UA([DBQ-1
M/@O!44_VFR#K9,<.-H'9D4B1ASML)SO7T+I/>'7CJRK!:QE5@J"]AN_LL8K/
MW=^J OD:^DK_K $L4#];B6+Z28_AO&UYP1_!@MZ'':B/*)G:-C'WN.U3T4$Z
MLD32K>Y>PG!;;]TDL>=G'_98O6HS/I#=0=[E"V'D&^-^:OW#9UK;DM>1[?P4
M>:!7L'0GYO@[&!>6EESAE]E1_AX>=W]\<:UTGI*O3VURGI+>5^^O?W@C#'_"
M'2WV6?OC^TZ1;A_"/?VY>YP,;U]/>V/=)(3X#"0@C,/>J"(4%]-9)&&M#Y#:
M. 0D.!Q [II&OJ3P4S'<OPU9^-VL]UL6\B=!^AMA>!WB&VGX%5&X0KUG[BDL
M):) % >! @S6WP108;B;=@QP 'N1(X!-?=DR/(30YZUAN6SZ!6%/U0NWO\A3
M8''!Q7?6^6F-;[#X]GZ?]ND:U:=GWA+J#!P'Q5!2I(X6R 1R$L =," @$;P#
M9-8<86#/(N2V//ZMZNY^N;><>F7&'1- 4C (G%"D<96E];L1/ A<R4.E[0RO
M^V*@ZX.X6:1*S;?Y[Y,CJ@*B+-QM7KY7U9'6@0QRNF33?0'6C!G9]:^? 1><
MK&!=H"8HL9[ MB#(^D<4 N<[C:VI<L +QZWJUGOY.T<I.&&ZP-D!8W_\\<?_
MS41ZEAOPKN.X=J-U:V\J[W\:_G"K"S]E@G^79/L=6_IVO9$'OTL:_I1(W-<M
M0%[;N!G);3Q_CS9L4/(T\7#?HWZ#P(RJ 6 (4.) !8N ?,$!V213]!# (Z^
MH6 :^.^(&?#,5I?,Z0(2(RN:6NPU@@CZX-ID!/D&,)N6", #\WH@"MJW ?K:
M96L7*.Z(:^T,KGRO';]V\<UG?I<(^HJH>JMF6W^Z1,O:]PN*W\C-!=%>0U?K
M+0D( UHJ*50U(V0Z6KC!O," C67W(WA][V*+! #LSP8/ @M!%UE!* /%]BO0
MOBU3%M"_]?MYJ^Q[NIY(O:\(NI_8A"<?_V9KKEQ\YWZ^ N+TN>.Y=!)&0M*P
M_8)Q :Z]HX,-E(@4I*/\HB"$#@M"O(<DE7VB\^2BXY\[0.;V/ZO"WL]W J5K
M*S)VD-S:0M^GJ]N<W>^]K^ ,!D%@"E;AC::A_\>OOH4JRSP[.=N$V$YI]=G^
MS_=).O*O2 [$E?>$(>IGY+U]+Y@5\%LK^J&M@?>&C:KJ^&>1A8OAWF1^R<+\
MQ"><M79@,7MXIJ$ @E@!F!,]B)Q:G\ ?DI -4J/K[#(9D^QD]P5@$LODD9V&
M"R6251O!.)('R2<;8>]\S][L!<N33SX'^6N_^"&V"GG!3I%U/B0R0E6B!"Q_
MTG%(%4Z26!+%L _Y7!)A>TK>?GU/B9M+&*[/>*KJVS8UV_YAI]->LG _YRNL
M<,G"/5:Y)S_V..<G++)56>2![K,#59>R%?97XMJ>\L<((OO*SK Y?(5]H$N(
M?3B5KO+M\*N_J7(9^0%G*#!H>OH> W2?_@VKLPGVL)Z)39B^1\BO7;[)LMZ'
MK/M\>$)5,A^H>F[[:;IO/H]]Z+@\?\<O^KUGDE!@6]DAY"!]0;#!X-9,)2S[
M@;#N*&E$821HL9?G:?#G'^<4QQ^_>M@U&7F/T.^:O?DBLA4QV#3ER!%KXOTK
M$H'YD"GV"NEI33PO#$?OV4B^7CQ#_\6']%;L(=9IG@ ;30X0-]8/GJ/[Y(8<
M^0RQCK5AM_=H];89N7T95T>VF..)4U@[O(F 32S7#]^S\R.>7\&1&$P,B1BW
MC_P1FZ2@@_SL0*\27EMAN(1[%8/B4?;59T2XDSUD%[VRCGP/X@NA2KY@J:HO
M5>#RS63HJ>CGB;?X5!!S?<-7A.%WXZPG7+S[MN1U@UT:OA1FO]6%[BG;Q)?S
M"TZ>TK<&$<&D]12%%Y#[[!),2^[X*=@GW\#&V9\ET)_B*M>_/%GX%,A\ LB?
MLF(_"<XO87D=Y!-1^16@[V^?RN4)"6.*/:=(E(/Q 5)D<1CL^I(P/ )+%0X$
M@(%BF %>AH=!K4'J9:AOYO:)X%Q%>\H^O@5FOTL6WK7]3IG]6V"RQB+C<#]K
M04Z D;)RV)20<V,H<Z"5XW,0UIU"<I2(+,$&0LJZ,XC;D'6/(W<?;U\YM C#
MLFP, Z#8)&$."TAD!!@%,M%D+?( V'HM(\^P^_M[5)C<U9>'XVU*[!YAN^M<
M%BJ9W5+Y[15C';VGM6",.$3.$Y!U[YQNO;S*Q@M*'-TAPT"R  5@!HR]!JCF
MI#E;!K"FT;*VP!CP8C_H"^<# -D3 <[V.-FIH4_DZ)6KM461A4L29MSO!,@[
MA?WM".WO$H9_-2GXJ>KGKR01OWJ>;--6C.Q4PK>K/>D(10&\ #!@F,QNH%]_
MPIK8 T$ $R)"6P$59YRQ+"=BD+XC[&]_'D%WY#T]I),N@0.P#723>\X<>0%@
M<MXJ$02@V95MFDW._<QKD07(24$+$J$V %O=FXW9I,,E(;(QV<<;\#_)Y=VW
M)YO[5.WVEJS[)+.[]WMD_+Z^Y,56)%Z"\SZO]2 3-83F*P5M@"B@Q8_*NMI3
MP1(;58/VINFR-7QO_>_8'X&AO:KW:N"6#5.A4'_";.SV_=KOGZH);EN3[P;R
MFW![PT6_0_A_%[-]2O*^W=-WR4)KU!%=?EI0@YQ)-P4;R$'[*="K:I ?XEM4
MT<!8D@)5#6[P75_2/4)5T):M*8G7I/.J8.QU52\E#3O>N7*<O[>/'2G:UB#^
M3L(28>7>D=CL1[Z^%@;DE*Q9@RI38(];K>7]_8X\(@;X57];+\<FG$I4L&?L
MC:.N7FN-K97*'N_=\[P%7XL3_FJR\*F*;4\!7%_>UP:$6X%&Y_@'0:^]L^:P
M ^R$;+-.Y,B:U*=,\&^=V&PV0E#;T6/X!6[W?\02^8-=V(;_F,$TWHM=YT>0
M*RYRZGT0%# ,W\-&(;+M;_U4V1<VB0QTW-4% S69ECXX%8/X[OA\_6KS?_G$
M>O@N]GRK^KLV(\([<G@'%E396M"[R=:G"MS?(0N?R,HE"_=HWU?)^BH*&R1#
MYA$G)238%J01C W+VDM[VH"D_'9#E/@)K^'[R0^[!)?K?V=?80WQ1N3 5B&W
MSAV!WI89;-9BVB8#>\ZG?6J=_*[>?.R3]D#N0P*4C5&40E;%FG!(23#/V.5G
M<#B2C)\DBYX+AB>;,#OY9S>08##X;>&PF,2];E_+'7+AWX9W=533SSQS"9ED
M.*+TS:8DIWOL<WMH;D4Q&TG_K8FXA4[!=ITRJ%(]LI3^6SO)%V17,0LYR5YT
MB=E@0$DK<H TLSZ>9V4V_Q.6W?U]L[>1.K?B?>UP-GL+9'P&>?H_OR;ID@=$
M+TZ!34(NN>PONV)MD(9>CV"T5[?7W9["HDM\#__$E_#!;!F=\KYLH%@0ANYD
M32?/_!_1)?YV+Y)B[#/=X:_7-ET.XA8<+-EZBXAN(NDG%8;?)0JO;5O9WZ/?
M#>YYP@S>P^^M)]+U'__XQW]Q%)(0DD1\ !ES]+CAH>Q2O3%+5/ IDB 2%?P>
MG=IDZ&+2[+7K7YHL7 +HSQ*$?R8HOUGRKZH;WXC"2U)1Y$I*9?^0.TVT870P
MZS*(E(?S$90$ZF0H_![ D'U&*%$B1L^F9SRO,%\P=H]KK_.]F<A;]K["O\'^
M[Y"%M[IDU^R^WUM0<K,*2WP]$1*!'.L%" /]C)KJ3 :3@9(UYA@YAP+[&G\#
MA PGQTOQ9%NL/P-9H+!3CN[7WG]]TQ@-RLO! BR,@D"'0RJSS2 (5B..!0X
M3).9<T2"8L]V9=\]-1&QLO(WLG#OM0J=:WS7X7L_]\WIRD8A AE[,MM1#)DC
MX(NS8,"L(X!-CCF$'(D@7J560Q_(?LW7]?EA#!E(@0_'#N CVND!?;*?@8YM
MV+M5%\G7)\+-[W=_O-<.N[C5A9^.(G\*V']BDWY"%/Z$)/PK2,.O",,GF]J5
M_;G'I#98KQ]*%3W;''D;8P-_>Y%+)$.-D]E;<@K$T&-@29#%"2,)R2-9!)P
M0<"&S64/!(JJ">@DW:LRL(HS__=[LHF$$O #E$W-16@(& %OP2.0#AR1\RZ
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M[I]!;S /H&3=W#-G26[KZT-V.0]54WL!QIRNM9>) V)D;07HG$E5/8QCP!O
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M='*C_HXP&'L+<\/A$BA\(E]/ACW?Y0D6$ZUMN.U<EE.X=N063EV<]13G?,)
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MM@:;='GR?VM7]TAQ)''5B&LK]_23S^EH-9F61.^$C>>57""?3B=Z;G$MWX(
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MGB25)#Z])H=5_-^JP"4,;L7EVJ:;M/OJ)%8^US-K9\)?[> D_@U&1WY))"!
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M:[ISS[@82?),@L':U"O?W],-.*5A$T_V<67AQA([P&$'=RQI?2OD=ST:<-5
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M-]B"%]A')+XCV))_;+CGIN>P&[M,K_GFIC_#VK"'ZA48(6)O+R23WR,7K+'
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M=Z]VC[.5-_"\9.UW@_]+%N[U1 +?8ZF^-A"]E:XK4Y(([ 6@RM:HCJ"KJZ.
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MTLA=@-7:+-A^(CC>?O>=O7@"_OOU1!8^);IN=<Q6:JP?WHJ$ZS?8%&"WOF^
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MO>YQEAMP=0\^SVO)FCVFR^P\^;??@!Y;3;]E]9#>'#XY 4K9=3).[JH,I!M
M)P*:'9!%]'JR!G Y*@\LD9F.NVW&N[85]4($)NB9]]Y>)NP6V?/W[,G_FAZ;
M[@MQ!A@"<H(?%3:J"-@9H++^AFSBT_"K]=4+ZN^1MJ?*BMW7)]+X$[&V9.YF
M<S=8!)([2LBV /3\+^*TJ9?6C5WJN'=]"ZV5"UA3@2(@H--\,U*5[8E8Z7XV
MV70SRF]$RI/]_2L2IG]&__XJLG#OXRF9]Y:Y?B.6?I<L_,XS_<ZUS_0=''QM
MV-O>TQEZYU0)GR\04V$@.& #.G*6WM-Y]L#_]S@]OT/7$=W_^>N('/O$7M'I
M"(CMY[K'BM>'7++^B=3_BM19_'SWPVNKKM@)D]F/+O=)]^@WOPM?TVV!4L-&
M8 IKP 9V"J1**6OAA(&D@;5MHF<DB+6I"@UFATO8:/@ 5H!GJN9H (  VV<+
MSOEVZ\R_PX2U#_*^>[&S[D-PSR^45(7]JAZ%47PN/Z!:1^"-@(0O8!OO8RW6
MUCQAIM6C2U2O'7^J>HTP?$OVO&&$.ZCH'L5;3+(QR9-\]/JGA/XFABK4Z.0.
M@NOV3^-7&V9"1P3B2Q#ZO@G9UAYF]'H^ !',#_"52!/$._]";M*;)?.>,'7/
MV[-T*JWC_9X#OM[A)DW-7;^RZ[3[&CXF%S"Z&-0:(&7(I],PG@4>(<]D324R
MN49*(Z]+*DJP=\*MZC3/"O^42-SD0GM[G_&>\%@=WS6[";9(CL432Q3U/GOL
M>N72^U:])HE/+\4"9, :B,&1A(BX^OW5_[43(!TUAA?$!NRP> S!1IY@"O&<
M6( =0<IM16A#]9IR72]*W[/!,"-;8X_$4/9(C"#F9%\0U>R ^X =51*Z+_?(
M#I%51+9G88M@23**S';<GITH5A+/DE?W*IG-9B&-X2%_3];9NA(>UDHR19*I
M/JV>W6NM!5M+5F#(K2;T#&R5F EF\F_QT_:()XN(+N]%UZPQNTKWV#SOQP8K
M1&%#K6NRD!SL:<AKSSZ=J%A\^9W"A8O=;IR\F&9[I;^=Z/-ZLDL&V'%Z"G>+
M5ZTY&>6[R269M/?-+X!3K1-=]3KKR1Y9)YB]N-BZ9(,Z&;#^O6?X5+SQ56%'
MUT>R\+M!7E^[J$\9K@U GP#B_]17CC<AR"CZ^:>*$Z00(\M1 28"0(I%T3H&
M6<80,=%T1<)2,%*)]74"2Q;ZE_%).#;+>[^6K-U*L:=,XG>. /VSUOO/D(6;
MJ=NL]R=9"JA:PTA?Q)]]8.201Y2THZF"2UE]/Q?D YWVG*/P>?LYOJ]\VVL<
M@Z#<B"AD(T<$['/8'7<%^@$9LL(8,-H<'8?'L+B_QM2O@4Q..G*Y$PMOR?9;
M]>@UBH&0@#K'4[4L("P0)^,JZ9H8O4=J.#5KUS$@WW/*C*#75!'%:7@?LOTD
MMX'1)B[;'U<](J^LND<D)I)5AH;CY5@;,@&,(RRM/S*&8:YJ, (%\'>LV',"
M @QZC7TE ^R%/:_/D[6R/E[#>'.NGLN:D!?.6 8/P'!O#+LU=;^5HN^PH;>C
M:MF?)8CO5. _0Q9>70SX/54Q7O+YGV$K;@!TJUSOD?L[)?GMV'I@-"!:->?]
M\CKO!: *J &^>G7ZU_<E&(!IP289D3E5!8(P)%L=BT/J(:*:\B;#*[CT=V2'
MS 'WD>^(O:I3@?O;R\JE%R@;4G]-QXG\K.M.7'8/Y+\A/3X#T*3'@*%@EF[S
M9QUAV6%:3WXB8!^8W\F:]>;Y:H_?R)BW1(^O]<_N$9% MZKF!SB!5R#</EC+
M#=#9W'J_V"- #' 52%@7?P?HEJQA6VZ5=@FG)T!VB9&5XZ=L[:=JW;]"C_X[
MR<+[N9<HO5GK[R2.?Y<L_"N)PTM^7OG\:IW><(V_)T,(#^ ?@8^P(K=L!E\I
M>*CWJ2 "44BOR3 ;H6*(KR&[_(^@C$Y[OWQF?8ZK9 PS;"^MM_8#GV0BOW23
M.6&5)VSJ;VK74Y_A<$M)SZIQ^%?/('A$!K%3_*DU8D_I[F(.=E#%%'VV%DA3
MP3T["T>QW>%LP2@,#_<A(.$T02L;R5:R%6RI]V<S805!K[55G0CSPWC9S'J+
MUSJ(;ZCO%WP "]BK[! [SDYWQ%'0C-1@DP7^JD8:Y%9RTGU?>5M=N]<F&'?P
MQA,YDU_\SH"3K93;GIS7!R_.[&OM]U/[B2=LG[PB71!7UKJ$'1N-R(.U83C[
MB$"Q7XX0(X>L.3WJ0KR44",K$2=(&QB<?/''WH_,20C:9_M ;IYZ0^YS[-=6
M T84-L3/50]EN'*'FVP\<S%[E]_#(NY+P0D2BGRZ?SB831!SUB*(GI!I=@/Y
M@/2!F6$2,0=BNLI8>)?O<V_NZR98KT]^VR_WMQ63Q:V7\/9]Q0_;5W];?NWI
MHFM;O8ZMH.OV# :H/WP5I>RI>("-8%/WJ#'[ZO=>BS 6LXGC80&G,N"TV@N(
M[SIIT/.2B^+U>O353HS,NK>F4C>5FWR*2:INS(8UC1F^LV?D59Q%3MDH,8M8
M%)&-X"U>]!G6AXV#+_D V%)\P[9X-N\C$8649(_84?HB[H1=O;<3,C[+O?G\
MCJI+IGH][&AM?+Z8&><!^Y*]+L0AO.N][ $]]!Q5Q<-?[J=!*%44-CW:?F[U
M\QO6OTG&)]+PVL6OR,(GW]W7)>RW G;U8[_\;$^_\3?V!4%/1A&H]H1,X@?X
M]TA]/HYMTNJ*+(HS&G;:2;6-[5>/.HU8RX G'_'=:]?SE2S\"H2].91E7[]S
M_.1?B2Q\JBST?PO/^ $>ZZ@H:]DL8*V&]Y0!>4#).MY4U0+ (<#A]!JK7I"U
M):LY$X8HL%//DD]58S?3NT,P;B;P.UG]?]9Z_QFR<+.C]PC%FRRUOI2I_AX4
MCY/A.!%- NR:BG(BC"9CRSC*U""/&+2.!&^5 .?@]S4ME;7C?"@]$)I#V+Y9
MB$C&(+G@E*HHK/3_-H7?)LE[O/(>,]_!)T^50A=<=@2)<[8^?\P1*2"64Y&-
M D* #F0@HI!A ZRK>O)_#H%SDDF254?2<9!*V!%HY/K*6Q5#NS<<="2>>P'
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M*FLY),Y.)I.3 <20).1Z@:7/]YF1\>MLK0T@ -P AW3.>]$[]^0S@'U."#
M$.TC!\4Q DT(RPA[X#*G6ZL/?4S7/'<GYC80?F>FN%_.&5GD/KPOO1?@D1O
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MC#<0"=QR<(PM$+K9RZL[>SK8RDY./,"R1/)F\)=TWM.TKV'P'@4T7L?Q<3X
M.\)"$!/Q>8$8N;=FG2I*]@5 " @!$8?"H2+</</*L[T#+@ 7F4Z$# /;R;,Y
M7>2)P#Z SZD)_.F;=78_G<C,,;F?3I%"OB#PD([ 0*T%@(#]2T<61"\XW.P1
M.X!$)1N"%02%>["_R(>__O6O_W#"[(1GCBQ< N3JX5X+U#? >B/(?D:0[WUJ
M5;,7M<OLM?-8RHR3K8C%;8F_\S3W^JIE]2DPN3IQU_"I96??;TGQ[[2'+MD
MR-:VMG8?N".+S</Q'5 5N #OR.2R@@),:U=UFG6P=LVG98]JCP,. +*J:M@*
M($/ 7-4 F0/&.B59$$0G&MY-_NDH($(G:F?V,X%#L\_HD*#5?=,3.N;S/&/D
M(1*-;8N( %R 9$ 5B"8;R4'[_]7,HN3[$UE84%O09?VL%9U"9 +W[I5-8'<B
M105*C1] WMH/P2&09I_8J\WBL\<"3_O;2:9D=$G+.V3_)FIV=,G5]4]DX<].
MTOU/D85OG_V=2KZOJO:^@Q>>]/9I%,XFU#;YL)7X)0F6:'FZK[=@?K_6AC4&
MA;X@LI 3[(D@K/;!G:]512S]),=\#6PA>&1/LLE5\T2\"=CH*CU1J89T$=@V
MD/_.-OY$%CX14"4@M[LA7<_&AUV;[]Q[M69>2Y?9$H$F?19 LCDP,Q]*+^DL
MVY:OAZG\WWI($-!_9 F"D?YZ+UBLJFAX0T *@PB^="&P!]8T,B%2I?F!@F95
MU];9>N;7PN5LA#@ CA $=I@A?U!21T7.CFB!#=C@3J-E@SR'>_'WL()[O0G=
M3[;R3>;:JY)XM:,][6,G7WNN$M0W87GE8;'F6_7XO=^+WQ>C^FRR3$;AL=JX
M2QK#A,@2?@@>#0]VN)PU;^[7SAQ7S=0!%HV@X#.;\4F7JOKW.3X7KEF?%2;<
M&>%K^V_5YL[^MJ[Y]]K4$2+T,%+LC@)8&_-&7/@[.MV!/_2%;:B-7KS!U\/I
MC08BX_2)?L'BY+HV]]LQL(GBFUS86/*M<M(S5CVY%8-+9F2+&SO@7G9N\MJF
M]<$^T_N2$_9-_!81@RBLD@[^$0]425C7F#B,7) 5=I;\L"&P!!L$JXD+R )]
MC"0,ZS9OTKVR XTD\W?(/&LK!I1\9$?@0S%!58[VJ)FT'<94FS$2304A6\8>
MB%$:=U"E>'N2#$:T6C]QDW7PF?9[KZIK?;;G;CP.78HL9$_96_=%CV I>J78
M0M<D.^7>R)UGI3-B1/=H/]R?O8==Q5OL6X18-L]GJ&RMHI6M]K>-^PE+UNK]
M5,W[Q&-<&_24V/N*,+SX8=]O8X>G+JIL@/LB[VP9&\;'*W*!+ZTA6V4?LE')
M([TE&[ ]'([X9NO\/>ZAN;5[E7@LOJ^%^Q-!^$84?@?_O9*%7WW0$VC:0.R-
M+/R?K"S\+DFUF3-*6>O8!HP[U)XA:" U09#98K1D%#I*G$(QF)%6!1];96-=
M"$#M(K<\/8?O^\Y.>KHB#;=5]RD3^*](%JZLW2JA_?D%6H$<:\.X8OT99<"#
MD>1<.=I*M1%> GY[SGD(CLM^-/<0(*7,*G  4MD@F2&@GTS4)LAAD0\_!UC)
M!3),-L;[?0(>S<>X<T!V9I:OE=W^+C"X0?P]B;> JM+I!B=S/H"X]@;@'%"O
MK0%IR/'4UL=!,W3(# X8Z< ) 3/(#T2(M>(8^G=$0X>& /5T!<&")/2W50[E
M>'V6SV9@[1>C"QA4X=A)DHC-YI')]'L?Y?(Y*=DLSV@?K5.RTKIOA>964= M
M((4A%^!9%PXUI^CY[3_P06[(AO6_%4J7Y'JSL>W/D_V\!-EOT<&U>9%8 :*N
M2,*]W@C#6X6XI.&2AY].Z]IK*WB?@OLG O7))CR]W]NUP[K=/T CBUKV&K K
M.[@G+-;2BB1G-]@#E<N=JNO]EDBZ!+#G62"\%>P2&EMM2">!#S[(_?A<@2>9
M!T[=$WL#*+)I=*6Y.&;B"%KID& "H":_5<0+IF3;!<" M" ;<0D$"MH 8I4>
M0#6]39<]8U4%R<96%F3CGEJWGA)".RO89_@LGRG!$LE2ZZ9G]4R>QS-WZG%5
M)-9+0HC]Z' 8?P/  \/\N3WF%]8F9 ^>!K!OYGNKM;\B"Y_\[O\FLO K(N\)
MI'\'P'Y%%EZB\*E:<&WZMCK=P?I;:;4D\#YK<OI4A="UOKA1-LTVIMNUPJID
M$\R35WZ.?7'!D8('NBAIQ^\(T-SC?GEF[]\<9KCBDH4%XCL#:O7Q;4V78.H$
MUKTN6;@DXA(BVRX%1[&K["._S,:I=&'/D/^>':&'=!-$E0#HY&<VKT-,8#A^
M'9[CUV%UM@+F5FV#9))TL89TG9UC(Q!);$$=$>P#DI*MA3\0 &S/5H3R=1L$
M(A6]KSWKL#<XH,1SR9F("Q?\PC8A>& (58G6@;U<G[YR=O?COFZ_-C[X1!:6
M@&X?(PLW^?&$O;?B_VE6\!-9N-<2/[6@1G@T)QM1 G_R.?;"R)?FJ\%SFSPK
M_K*VUKT1''P!;,BW\=/\A+^Q7Q*]9 X&IT]TLH/HUI:YW^WX>FOCW^=:6>$/
M\XL1:%L==-MR-]E?U5 5]<W&LT;-I2.K=$%2O/EW=4B1/<]/)N$!LHU88Q?8
M(>^9C;N=2,E%9.':C#!+105\]'?(PCU=/3O0C/0JR_S_$M:N'9%$OV%X. !Y
ME0[27S:#7V\-Z+@8(1UL5!([TN$18C&)@>0 2>B>-@G>K/NJ">%ZA%D=(;">
MCHSVA#WW&>32^B/*Q"=L&%D,F\ OB#K/0,;)HXIE-D9\$@FT+>IK2ZVOU[&E
M[)RJ0OI0<4I$>56,U@<YB9L0J_(G\%V'5E;]6"6[U\*9L!8[Q=;23SB,'%7%
M[AXB_-ESOHJ=W82)^-#/W:>_$0=::S)M[\..2Q8N4?@58?C&8WP'BVSW07AA
MXZRW#HF-S^R1>\\'\Q'D4PLZ.X\KXL_()0P.CTL@D<]B5C(L?NRP4SC!^VWL
M4'5X7%%K1D[<\QM!^IVD[*>O1[+P1YG)?K8@[6U>X9]%%OY6(BIVN-EV@A0;
MSSAOVY. S<92@-J_(D\038(3!D"6 1!@8&SN$@ KC#Z[LNR,[QU\6R56Q&(&
M=Z\E-6[I]Y\]/^E']N9']NA)1C=C>0\S6,?O-=84@ 9(&'E!N""9$J\CL<^"
M9/M'#NRAP'\/_I"5M,>JUF1U*#I PM RTNL@? ;#RWCXF\J+.:,"Z26)=D96
M,WZ:<[*9^RJT]AD7D&V;Z#V\8AT^@UVF7^ LZ]K)HF2]5CX.Q[\9/\ >Z.7X
M.EV.T^D@!>O+^7$BS5CAF'?VAGU@6#DB.L; "@* 0P&!-?-9G13)\2 ][%?$
M@'L28-BW JL&5N]I;_:.DW(_C*QUM Z;0=HV]PAYCHP,> 9[SL%:EP8'-Q-$
MP,>Q @V=\&7/;GOKSB9\D^U-OOPLV_F4M>YS=A9,UU:*% 1>(K! <:N:[X$D
MG]K5/K4M/[7?/Y&/??93*_3;^R]!<(>I<]#V6K )P#6<VIYW:B:Y"X !ZWXG
MRR\(47E*KLE;(-B>+\EPLY/VUGUX/1D5\"/F$.CTR)PM8)]>(BZ[^*3__,__
M_(>N=,(R&\3> " JE';>80>E[($H.]N0//-AG;3*EWE?@=JV\0/*])E_])QL
MJG4# &M5KIU_0>_.Y+RVOW];$VOF?9IC)GB,/&67 '(Z7QNA9V$; '2DH&=@
ME^@DN\ ^V3-!%(#FM>R'[#Y;#YSM$//VIN#MB6#JNO.^"AZ?9GJ^5>/\#+_[
M/TD6WOU\ ^K?R71_YQ[?[.6M*+R)G]W#)_NT;3V;I'TC"]\"C\5SV11!)A*J
MREC$!_D4E/&Q>[HQF>1#!0YDGN[SE_3,,^R7S]V3%V&5Q@8(QMBUDC1W1,!3
M0'3Q0^VJ NA-/E[;&^&POJ)3F",[W!.[*IE66S"\@-2O$H=.(_+9+@&6X)7^
M2HK4<BPX9Q/8G^8(LD."V )Y=A-16+ &V[%QC5#Q.6Q$74#VA!U@N[UGI$ID
MEB!7$L=GVQMXKTI%<0#"AHTM6/=_1,%617;ZL<23 -PZ"+JMU=,X@RW 6'N2
M_[]?X>!D_!8:W)F%75M8<!,<2U*L7[YS]BY9N'H2IMJ@OVI;/H*M+TG6P24J
MX> IY 9<9Y_H"Q(=!N7?(FGYL.:-\W?\V9YR"T?2*9B0+M%!?H6N-!:J>"&[
MLBW%C:0)=S^UY6X74'*?OE015FQRQR+4V;&%".(-<@V[YO_X?SH#XUH/\D2V
M.K1CY]]9GV8T2MZ3;<_;3/3N8_<V(OG3J*-M96^^L_?<4Y[O<U_,%ZD:YNJ>
M2KQM@M?KZ"#_W+BG9L!%%,+@59=63- H%O+0+'5V@'TE5\8=6%/ZSF["^;O/
MBX'%#.RWN$\,8Q\0@_:!_5($PLY([L 48A7XH@*B"&OV'7:!J7 $;/O?_O:W
M?^QOAUC0!>O2VJ_.=5A..)&=\G=(=<2CRF98K]9[M@FIC@AT;^ZU S6+\]@B
MLN1R;^Q3A[W OMZ;/;7V;* XD5Q:#SB5/4?@PJO6U-][WFRW>X#!Z#/]Y@=J
MZZ[8X.E0G*=.@!\=J?84\UR\$$[8N&#MX5,'8Y?7N?=&7I0 8]OI')*^6;MD
M@5R2S^22;X!5R85UVP,1D;+P-%GTE2UU+UO<X?,C"[^3H/U1HM#7_T,6WH5X
M D-OO[]DX=MUJ]I^-D'U!IB_6RU)6  ;1E6V 3D0J D<V/B"L%HR.[W([Q%0
ME!"XHU $:8/%I\^V-I6O;V7&GIC\!HRW.BP"Z&8D;K#R%5GX1Y&&/X,L?+K7
M%*@JO,IRK[&H6H@RVB-&D1&WCXPZ9\+H"L(Y5X:0HV @&40D'V<A$_2?O\X7
M8Q 88DZK$PTY"@ZCUEQE\@)N%7/D L@%0".L-MB,O-E6C:JZ=G#PGA)VGW-)
MZ;V2D>;3,=H,$G*$(><8 "K@6::?D6?(R#70Y3D!+TYR2]@]N[7SG$ 90&^=
M$*OTR7?OS3%Q6,@\9?<(#_IE78!P1"& SYFKI/*9]"KG"X3+S-BO,C+ $&?M
M[YJYAGS<8=4!_W5(EZ1-KFKU+Z-<-0CGZOX\NRH%8-3GNS^@#'"Q=IX;2<JQ
MTN4<_5:MI,]/#NT&")^<XH_JWJU2N 'V4[+G*>"^!-QUY$^M?KL.@<RM4KG5
MB 6;VR9S*Q^_TQ+=M2W\>P]E18$OML'>V6MMZ_:3W2?;@CT J 11K23T YE(
M-LB<H*<6]WL*\YL/L!^;;8^<9G,$"V5T!98 6@?]L$<"'X"SPU)NZ[)@ I!N
MIJ=@MOE9+@"&7LG "S@\6T$NH(?$H/\%7/2,_:-GS34L: =VZ4L5Q!'S6U%Q
M6]"O'R!_UJ $0R>B N?L#6)!$ B0L@'9A49(U*J(" #4[)WG\$Q[<K0J%&O#
M=EB_AMJ3HV1_Y?Z);-[VO?3Y4Y#_W=$9O\>W_D^1A6_W\UM\^UOR\HDL?*LJ
MO';K5A%>@G"OM=%/S[5DX=K0#3S($?D7B,(1=%6@R]\A]P5G$@ULB"M"3)#6
M^ Z!K*K[6B7I4KBF+_?H\^A8E3TWL5CPM?9X@Z%+&NR<T&QN1,"^[U;87OM>
MRQZ"T+W#PC"U-=".!CO!#O24+ZT"I^'_$JT2,WPKW"%)@"1@8YM+Z%E]1@D>
M9"S<)EB#,:HH%+3"=^P%^XT\8!NJLJ'_B( J94IZP&BP'_MF']8GL*\=8G?;
MC>&3VE]WCC/LTWB63J,G(];MDH5+[FTE_:W0WJ_]FSNS\))V3S/A[G4)PLC@
MK4;<MNDG78UTBS1:LHT,D3'XS)[:.[(!)\+5DM'VWQK"6N2$S>:'V7IK3VXB
MRTIZL??V7;*K"OE..J97?"B96>*L^]^$^Q(TS:_.AJ?OBZEW],KM\+I=(8OS
MEQ#CYYO;#8=(/D=.TP.RQ%9(['E6OCUB"B9I+C%BU?/SF?PG7\JOWOF4-VF<
M_M^1!4]Q1(F$Q6AAL!V;M'.MMZBEOPV/;Z5EE;!TG W-=M#MNCP\IS6@?W0N
M_:MS J81.\ #B#!QC;A#O.&]Z#3]9MMN@<UVF> #Z*OX L:R%V233)(U=JHD
M!]N%N';9$_)*AN$6^N_OFY79C%6)#C;'^NVXJ$WBUW9,;IOO#JN*V_@4MHP?
MZ3/]FXUC=Q"9GKTN*W:2#K@'W(;N+3BH]F0R)U'.9\&:<#%,A\O()I)3GR^6
M]IX=^@@KTDWR*0$DAO1S\1]L?(L+U@?OB*VGT2&?9AA^119>(FV3P;?:^A9<
MU0%ZW]/K[1O?9B_)!WR,#*ZU&TYEE_!$L">YY./H*CVFIVP=_X:<A:LK-K#?
M[FUQ1Q7/\47T9SFBM\ZJ-[+P.U__C2S\#E'XED5]"SB_FUG_F83A!:;?>:9U
M<C9?D%/VDU(#=@Q3&0S9*X:I.0B$@')R3@@.QHC3HQB5$]\2]_N\ZSBWW6]/
MQGU:KWU.[Y%AV;D:MWSVMNK=[/Z_ EEX[]$S=1@-A\@)+4%;\&9-!>",&] '
M3#*JE4IS*(PY4,A9I["WW3B@2R;\?7.&@-%.X"(K9((AD 5CT+7R,;+-QVIO
M,T;=ZYW9U>RX2&1RZO>1A9_6=F5D2_H[>;@J)@Y"H )@"%H8>89?!2$2D#-B
MT  7@([#!<* $0;/1?Z!].: >%:?Q?@!R5Z#P"C;J[K"VE2UY#M]X]Q\+J+"
M.G9X0X# _YNIH95+1@NPXL0 +@Z5[EEC:Y4AW8#R:>Y?8+$V2,Z1LPRD<+C6
M!B#;H=D=6L->"&8X<GM,CQ=@5V6UX'2S\66TGV;SK>YN%O^[7TM&7GO]:4[1
M9K2>[/R3?;]5YMOBNVTZM>CL7,2N'0Q.!^V%H$)P17:[_-_/FP]46T-_W[\W
M:[SM/>2$W+#Y "'; %S7XF)_@< =&DX6.XF3OC00GS[5\O<=W5P=;11%&?<"
M[=H(K9_7[7Q;SRW [81EX ]IZ=X!TVQ4L[^ %  Z_P541Z M@1B)Z+7^1J#-
MSM%?^D;' 1OVD)^L2ABI3E^:F]:0<'L3$&Z6V5MEF=][;B0D/[K5A!(OGL5^
M:"<N2+0O;"_ #I@+(ESV)V+1_FTKMLO[V&,5S4OR!DC?#@K;*I)(T*_(PB<]
M_M],%M[[^JW^_A(03\#_.U6%ERB\5=3[_R6 GY[GVL2=,5PU'IFGF_ &_1 $
M"*@$9_PD6:[ZHJ03DI_MH4.7J"-KGN56.V8[P@N;*+[RMVNRY-,2XTN0[+RU
MJD%VQMV^SP9=7L,V"?(+*G401 9)KA1LTULVE3XV#H9>LU>--O%ZOE7P"I^S
MVY[5VOO.7O@<^,KZ\<7AA\:7N! K_#9;%FZHBL-^%3Q:;_Z[PTS<.PS YE41
MBBCLY-UL*;O)OH@)$%FU\[$Q"(ZJ%Q$$S9+,)MX*O4NR/1U2=[^* [)9-XFQ
MV&+)HBO'VS:^U:5;1=;LO3NW]>K]^JO]F^;6V4M["H/J!+%.?*I N_7E;QOI
M4T(+*?(?OYY@W5RV2!*$&GP)2_(?$3/\4J>O^NS%/ILL7M*LSI[TK]??Y/L>
M&+.5EW>OED3M4,$Z>_@\,BSAK)N +^?[R#*\Z[F;R8>,\MW_JY[S[/1*O,K_
M>WZ59(@?,0Q9NAARKXT]+LFYUYWQO2WMM^KXB2B\G2A;,+'QFM]5C6Q=$+Z>
M"1:@VY[9&OR?__-__LNOUWE4V[^X#@Y2K&%-Z3%96XSN62ZWL56E[ #[S79;
M6W:)O/E,G^WZMW_[M__ZMY^[![:-7=\3;IL#[9FJ;*57UN>.&; F?EX2F>Q*
M,) 3Y"^[I*")G-CO*DUA'H?8*?B0X!73>@ULZ^^*D_PMOD)\!].5C.%_^"XV
M?*O^+JGM.8J)Z[JT+V)ALE@U.!VD?_;R*:FWA0A;X?PV1N02AN&J)SRU>&,Q
MPR6$JY[?0XBVRC$]WO=@N^P'[$VVR(<U1]+:=[B9',+;S5)EQ_)M]!KQC*3E
M%R6M["G9L-=DT[->S/1D4W>TTU=<SX]BO;]<T/45J7:)P:?KR;"\5;,]!0J_
M!;A^Q2 _+>!>6Z5#4&P^A>&X&IY*"0$;F[]SC_R_4Q4!FHZ[!C P\)P,@YB@
M):0)>&!TJYEN=FHKH.ZS[;YM__Q;F\FG2M$_@S#\/63A9N-ZOEH'/$M$V#+M
M?F<].J0&2&.L$5<R*3)UE+9,,Y")-&/8&.1.#).!\G? I=?(Q#1<62#*. *'
MP+^? 8DY" 08\M%[<CKN@^%O1L?-D"S)LN7^FZG;C.X&J$]S0A>$>I^ ]:V2
M=*^,>U4Y*J;(->,7 =AL#JT<_@Y9R!EPH/0$D&8P<TS(%VO(T0/:#*.U\YXJ
M]%00JA@":)!Q^WZ<G3WI)$3W)5/5+#+D)0 @..#T./](HX@C^AS(>ZKNN<2[
MGWFM_>$L97BU728O@@1.$,D@\! P6"..VCY7C1H@+1O=,.A.FMN +MNP@/X3
M4;@&_[OZ=HG"=<2;.7OZ^[>_N^,EEA!Y"]B39>NP1*#+WB'_9.KHB#44; (V
M9$CE&L"+U.GR_UK0;E5;<S)=S=8KR(FLC&Q#<I'1!3[DM*H7]GX/T1#$T'\@
ME,P7R+K_'>[_1!Y=G]CO H55.KIGS^]YW"O=S_85Q-4"X1FMCXPQWT6OD?ET
MCCX*.,BHH-4]5S$<F:85HLH-&4_VC&]K*+<+Z.ZP!6N#T+=.?*3/0)C28S82
M.+0F )1[$9!WRJ!G^N77DS_3A6WK]4Q\L/V00.@D.3ZX$Q^K)MGAW>Z[UBOW
MZ6+;2^;0V<9#=(([NV+_@#0VT5I;_Z<Y32OS.^?I5@IOUOI)1_ZHZL)_-;+P
M1PG#^_J+\9X(PZ]:D3>(?6LM?WJ>&]3NG& VADY6Z::%R^@1P0!_10^1(?2/
M_)%/?L3%A_*#<,I63B^I=,G"2RQMJ^.U,TL(K7_9*JD2SG#45F[?F<FW;7&K
MP3T_>\3_\XEL4:=O(NDD(6&D$JQTLFIM:\+&('M@+;X7F2^(8A=* '6QWQ(5
M\(8U9I/@ S9-U0]\1O?9 /B!OX8=5- @#DH2>,YF@?$I\-K.)/,,L(K[K[6,
MC=PYA<U)\TQ^+YD)RU35P\X(+'N.*J[MPY($3V3A/9CF2397)B_V6QU9_-/O
M5C:6.-YD9Z?!-G]OVW+?WB^9JA*&;$1ZP-55\=L[1!!L6%+9WK'3_&[58QVN
M1V:L,W^ <+??'1C!IO-'8K@.C,B^-Y.NBL)KGW<-FAG^)/OK'S8AL0=Y7 )X
M28I.385=X$Q)-W).3R3[R'[5A-;"<_)W)2TCP_@^<4=52M:/O'E^V-C:\KUD
M_))B-ZZ_^"XR]?[-$BW;-;/MR_=$VSO^97WL?E9$B/6&"SO,1&6:9Z*[[(/]
M]MPE0'<<&-O26 =VQ'K"(M['6G<P1QB]YW7_< D,RGYUZCD<(@:*I/2Y]@ Q
MB*"L6Z'69UC1O;#IL)9[5IS"#[")9!%6;4S-5NDNED[_R:O7PH3D18S!M\"<
M[F\+/=A6R2C_%X>)U=@OMDP,BY_P;_="/MA7S\;OL(=5;=<.?4G?G:T-:XH#
M2^:*V23!R*+1/'X.!Y)MV,\S7!Q4$NN2A4_V:'WXD^S\*%F8C=M11'<V^XZ%
MJW/1[\FF9]K#KCK+@M_AV]@H\D!6PJL=IF6]^"KK;__$L&NGED2^75]/7:3%
M<-?._XSD]%^>6G*_(M?6H'RJ(GQC-9]:@)](H>\$PY\JJ"Z(_$1RKI/FR"@A
M@*""RN97ZDSY;3ZR$$@ !@1;-IV3V].U&((V>EN(FR<2">CSN_<EPI;PV:S=
MF]-?(7EJ]_Y$$GY%&/[,K]]+%FYKP%9H;49UV]V\KWU@_"@BQ]D<&XZ$84-&
M<<8":8". 60$(B(XEIWOL.7O':XA^$0>"6:]'T!:1H4Q8=S=@R#Y.H>;/5F0
ML8#KZ4"'S4#Y_:V8",PE9X 24DW5'T<!O'.F#;=%%@!@C%TG&P,>GEW WW!A
MH->S(?<0?JH+D8W>3Z;*ZSDC0$WV"6%0M18'8ATY*,$3/6,PD0S^S[$"^YP>
M1\OI6'/ B7%EE)NEP0EQZ+4:+Z@M0[2G:VU&_8DHM$Y>;Z]DX,B+^[-&2(@.
MC^C$L-J/K0.; 90ANK:=H)+QVLEKY5H9OL325T3ACY"%ERA\<L"!_:>_7[+K
MRNHE4=X"]$!B9+Z]:0!X)*%UDVD5_-$[3E.&DST55-@/X*A+=MC/[#^RCX[5
MJDL>(AC]?]LHJM3UN3ZS@S, *H!., _TL.\ .A J".3T:_6A*\V 0;0#7W3#
M<UT"N'::B(C;MMTZD0=K@LQO'=P_LA1X;8[- JJJB6JGMHY\C^>EYWR9=0(H
M51>X3\ $B$2*+I%(QA&)GAW@ 8J!;L^[09EU =39S YB$!2S(8(U 0O]C5#T
M_FQNK3>"_D[#JTHH0L3Z>59[RL;X.WKOO=T'.QMQZXJX97>[+WOC M0E\CR#
MW[F0B?[OYQ'][ G[Q.;OB<@WR[WX9BLKM@IM$X(W:?.),/P1G?[*M_ZSD86?
M[O73/;_AP^\D@V\%]%-+T]6__?^GZJV]?Y^;'E8E17_I+AGF9^D;76NT!G_&
M=M S/H[N(+&0AOP<O\KF-?2];H*Z$)[(PI+-VU&RY$UK=DG59'!]PP8B52XL
M8;55'55>W<.PV%IXBP[# _PV(I0>T[M((+8UVT*'D0#TG5T2A"( V7JZ67!=
M)9: E0WQ>[:[$X_9'^-@2N:S&]Z[+@\80P4-7%8 F[_V;.R/]_3Y; /_SR^4
M1(+WFUT+\_$+*D8066(#>-#O5'3#3X@K:P"O\#-L7[/C^LQD+=WT?:M%WV8$
M7IF\^_P)_^]G7;+P$L%;5?A&%FZE8EA\22'OZ^_X9>O+%R$HK#'\"$?1#3IA
M?<E)'3OL/LRE@G-G$W:85>V.]A_&Y&O(#NR9[$C U:GU-C?YRO=6D.]8E*?Y
MA9]L>_I:4K"D?8<AT!.Q!U_)#[,/Y)5-V'9C\0;_1\ZL =WADZV5=1.OBD6]
M%^*1_8%)$4QL4]5'3WCNDIQ/_FF3)"7-G@[_VC5<NYM<;97LM=4E#$ODPGAD
MI4(-.M7A@AV")#;?V>62BXU*$BO '=Z'[+$;<.>V/U?!Y^?6BNW6L@XG(=W8
M;;8)AO!9UI\L(@M5$R>7B%S[9+\Z<1FV:D221$'C3MC)IUFRNZ9;9,!.-=(!
MIF5'[&U)#>LC5O/<6[04;B9G?F8]R!E=X9/8-K&9I([79V?7YVS<:=W<AWM@
M0Y';=-?:DUGKQ+<UCJWDB+^I0V;CL)6E9/ 6'7PB"^]A06]DX;6/V^*]584;
ME[ 97<4I;+<]I+OXG@X_[$1NE9WT%#G8">UTEIS25;;-:_T-7X_ A=&+47[Y
M=6365BD_S<J^>I1/N-UCG^+'[W)L_P]9^%VB\#L@^&;./Q&#3_<0"?(=L/D&
M(I](PLO07M)%\((4H5 <&' #R'2J$@--") J?@=\<$X (<?$T!"L!A;OQOA_
M0WUW5L83 _X$ZGV]90Z?UOB-$/SJ^F<E"SWGSO6*C%VBY;:8^J+X@F;D567"
M2%Y*S<E2<$$C)XL<DC%AS!G-!L@RQL"H_?9Z8)<\-,R:40!H. B!,H (")$E
M[[.EPE?>(_H:-NW?$9UW;=[6S/M&2!5X1TJ5N?:%'.%<&"E.!6'*L76<N^P8
MYP>$( L8-8Z.460D@28DJ@P4)X$H ?88/H[9:V6(@?'F$&YF'@#WV< ,@M#?
M6U<.R_\Y,8Z'PT$\ .:<+8"OLM%[65-5GT@4>[NM+=9S">6MR'R;F>9K*W-K
M5>=8W1O@85^;.5$KH_T'4NUUU:CNR6>M+?2]8?>W]389CLQ=8N[-EOZ(;GY%
M%.9PEER_^OI6=?#4GGF!X3UXZ3IEY%U$H8JS2$(Z!P@!&HAZH!?9)0!P(7>
M.7((L !",K9(1;*!.$0TRI(*O+V?]^[$VX;MDVF_Y[!5Q;'Y9(]3IQ.-FK#?
M]!Q0) NJAA%A9#\BW=Y[S@M4-D"X<WRZ^(*(L@:;LT.>PW<VQ#UOU?0;";
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MYUEW'\0AXIMDDV[#D&23O49$DC>?0R;]G\Z36_K?P8XN-IYLXP_(NV=@&^D
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M@IRG5M[-YMXLF-?74F<S?IE93]LJ!B@Q4D@)I 62Q*8B5Q@@U6.<F<"R]BE
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M)VRPNKX58W4^EB3(!I=@S8](E) A\D,^8-L(*'$JF6HF,]LHEO*,OHMC%&3
MN]95K +_P&#6PV<LL7L[UXHGQ)3^#H8BAV076<@N_L>O,QSI<'$1^6,';ER[
M(]ENT<3:KD]D?LGKQ=+]_8Y[JV HF[HSY'=<7J1U/AQ6[03N*E#M/=ON^<AB
M\\SY;[(C5MJ.4S(+HY)?NFQ-[)&X5QQ6?.T^MS/@7XHLO"#M$S#=;/I36><:
MY:WNV>NMY+0;O:7@$9,K9/<U:P3]W.L+IO>40X!'(*T<EW,'8IJ-0!DY+\(
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M 2@2 &D"I-M_AJ&VB4XWXD0Z+3C LD: (Y'58G@[ >P.F/]N\+*RLUFG/2R
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M>PF'[Y)ENW>W9>*IM=-K_9Y\L<GW9#-ZV]!B8-7^ O4J ,BP];+_P #]81\
MI=I R$7C"F1VK7W 7>(!@4\FFF7C_K[C0W\+0?CIO5JW3\#K$G][+>#=ZV;3
M+UFXA'\@R+_I :!:6V!SA 3F@AWK'!G+_Y+A/:B O>OT.#()7",,MW* GK+1
M0&TGV+-;G82\E<,^"UA4B0$8-SZD*IM/LW/>B,)+%A9\?R(+=_V^\_4C<G.Q
MP1-9^",MR4^5L9^(PS^#+%S?M:1(Y,H367A)@25ZW]HY[_TUIY#,L/_L)G_
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MRM#+!E9AQ;$!CK*_#5H&+ $9!K(9%D]M(&0QO=YJP?OU1!;ZV:[=&U'8C S
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M=F1)V?N\2Q8NF;45T'O=RL(E:7<[RU:Q6*<E!-JVQ?X"9()*\FQ> 6#K8%T
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MZMS*M:OS=VTW&WM/,+W [)[."6 !U&2TQOX=)K55IL8/A%LO[VX-59'NJ66
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M-]ZJ0"-_L'@@&^ [OF]N831S!I\95X?Y1;J:;S&+1 \=H=]TLH1N%<3FH$/
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MGY\(I#=2\M,XEYSQ?F5B@2ZVS#RUA8..R?"V+:D>H1TB)#B590?(Z.9??S2
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M?*CY8M<C);R#^R)NW*<3F_GI*C_"A6W%]G,V >[IP$/)48<P((2,T7P8D_O
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MSQOI>9N=;I#V%C@O^/W48^J[Y.%7(/YGJOK^D43AGZDR7+FR#IVRQH"ZVOJ
MZ&&D&3N9/R %4=BI93+(,B@, ? L" !H&0" <IOL+P%PUW3+]<LD9D!7MCM]
MRM@X ( *R1&(1R*14:"5,ZUG'>.D6H'<"B:05XC,&B9[YE;M7?V]@>/.?\X,
M.#=/@FJ.EV/F^.E035P[/*53L#SW5G+LM=5LJZ]O1/G]XV?UV.@^52EZMG<7
MP !296H9<7,)I'HG^@V %' L 6?^.1WOPX&Z#X=8EIFSWBT0YL*< '<(*8&$
MBP/R?[:&0P$L]Z1 F3KVQWH&#( &X,:ZRNP#R4@3(-ZS 5EC$7 ";Y%3;6G9
M0"% &G"^E=I+^"W0_+05\69.WWS#5X375\D,8]S*C#U1LTIR((<>TL<J.]EL
M004;'C%E#>J'9[X%\?[OYW0;H!?P">#IX8*9@JV(U$!WC>MK7K]728';DV7;
M4WQ%%GX%&+[CDZ]N?T7\_2SPZ/?KQ\T1L&H].JQ'-2$=O/T" 5%RSZ8@R.F2
M0(!^=1@3&0?.S7G)E61QJ_3KB1B1PP8:1_,.2)()-HLM$]#0-7I&[^F[[Y G
M<O:TI6CE>0/W)[)P2<(G/?H.6?CW( H_D84_BQG^;,+OTY^?)0LWR(V@BDQ9
MTN!3?]1\T!V;GY$O-A:.Y&-M2>0KR*M F3RQ]U4;5;%0-1L?SI:S3U6RU9C?
M?03<?+R 5V#F^X)&01G[[[/T@%U)7O)_D86W.L;EY_2"GZA_$Y(O?"$(1<C0
MQ5J:5-4E>*6;@BV?$W#?DQV]1]NUMB_<)BJLB]^5<(%S^#%Z+DG'?\(VYFLO
M6(==* #CRP7'GJ=2C9W/M_._Y@YQ([CU'N9/$ >WF$?).[K.OW>P!!]BCMA]
M<PP;(E#9!62#^PC@5:' A^:%GV:K8 "8T%CXX"J?(PL+<G^?'KOU[+L!<]CG
M4R5ONK4[4<(^5> 71&]/K.W#V3TZR*0@VWHJI" 3;+3YK"]A)].3"YBEGGR(
M@]I%(%;)!=V@(^3-.G<8G[5J.V ]*07O'0B"'*X_841A!S?PSP@ :V8.Z[F]
MF#';TOS<?GMONZQ\QKH9+Z(X[ WSDOE.I36>"$+Z::RUK=H^GBJ+$&:U*R*S
M2,+__G&X@;6W7I%Y54&:,VL A[(E9+:3E543>BX[ DNR%>X=WK;NM^?9QJ2[
MLZHMH.GK[1N]E5N^PX<BHV!@!)4U1I C\L@('(7 ].[MDND0/C8%44B'85IR
M1:_H:^0B0H=>^IU83(6@[R"1^6KV@3Y*RG=X"ESWOW[TC::CG<3=05+))&RW
M!!L2FZZRO]9A^[8G1UUQ"^WT,@_L3F1A?;*[1]6MZZ>>B,*(,3@%QO%^$>;F
M$C[E0\A<12!TAMUBM\D2F[N8N(11\<_VQK^]LA=[6&NZU.G>^31^BGVSOGP"
MFTH&\P>2"-:.3:;7[ >Y6I];<4*8S;/S 9M8NG9I,8)_^T[)YZHZV]5E#<V#
MM;&N8CICIQ_FE*XLJ5]EI&(@;20DY-@V=H[LTEDR+IX@\Q4@T#/O20[)JO<O
M@61^*C93%$(WQ&I(5^MDC#<1^3.XYU^:+/R5A&&9H*=>1_>H\@6@"]9W&_*>
M1GI+53DMY "CQ)!1S P^Q20$'!*#C22I^2QE(K!OE1V]1]N1GT[56V>V?RYP
M?PH>O@O^_PPY]X\B"O_>9&'S6[;P]Q^5)B[&&<MO71$#' YG J S&,C"B$*&
M!!CB! 64' Y"C%PP5 OT F.>Z8^Q)].,9>3"S?#L]CG&3E L^]K!.XPUYTE6
M&3..$(CB#,M>(K\81XX4($-LNU>G#>^A'Y\J5EN7G6/W$5QH<"U  )XZV0PP
M1!(RG@RC0!N8Z$ '[W;O7=!0E4%]"]/7MP;!3^O>&F^CY3TAMX.,D WF$QFH
MD@AH 5: 3QDB<]=)PP*A3D3TSD!>Q)P H@,N)!-DH-@1H(C\L"4"$W(DF.A$
M0"2@WUFS0'%]6?P;,*ZR&;@QQDA",E"372"VJC5$Z.^3-6SK5UM; \QK3^[)
MK-<N??KS1"A_]9W[O0503Z#@R:]L-<_-X'9"8?TA!24%PL!D&>]-"K5%J& 2
MD!4(M)V'K " MW_<ZO-;\LIG:ZQ>I<"2C'MM)<33G'W'MG\''+RMVZ_PWV^Z
MW?O3/^LAD*9/]*V^0GMJ>\WPV3G!QW_]V"+$EN5_@5 R;BYWF^D^,[*0[:$?
M !Y[[__9&F#2.@M4C0,XE&SQ?P$:.U9O2O*V+4&:L_O.3V3A$U'X*5!-1W_&
MW_\*LO!G?/&O( G_WF3A/65W2<$]H&E][SU(:<G"76O?(4OD$1E2-2&?P0^P
M(WM(#WO#'[#M[ P?3OX%^$@#& )154];Y 1B M[PO;9[\O=\DR NO%&E1H=2
M;$] /[MSYW=P#WTT;CH@^&R[L8H+ODKU(]]DFZV+;_(^;0>$ER()C;D^Q,CU
MDI);W=CS(RV6>!#P\FTP1;W&^$<)-+998-IIQ_PA7\@N"-KHMV=)!IH7 2OB
MP'L@G%2,N __NMOEX)6V@?(7NXV0;ZD?%1_/OPN4W0,>M.M$-9U@$YG!5L$/
MYH)=8>\ZW*[6,OXN4>PY?$M)ZP+]VQKDJ6C@J=]LNU$Z+&!;=2Q)L&3A)2]\
M+N(;:;$]E;<"'WGA0HB136MC7@7A/L?'MNN&W>ZD8^\IV";O[>*!:Y!)D;#U
M8"YYZGF>6WL(0;\ GMS!8(+OB*[:>50MF#^]>'9CM*V W[91]34F8["#Y](-
MXR2'WIE.P@\=-E$B@(X:<]6O'2K8+ALXE,S#*4O2E0SU,S*-K*$3B,9L28D#
MSX<A^4MD)']%]L@LG?(.WFWUOG==O!192![)3.U[C*E3U3NU^_<?B3=^N"WC
MV\]4$04[5X4I8I_.6%^^E=W(M_L\/3:O8BES5(+>?'=B>8E$E_6GMSX/EXN_
M$#;)*<(F0I*=M0[^C63U77:S]C P-)ME+=I>6L_X)Y^=#D86UF>3S6B+KSFZ
M,>!BW=UUD%_:9[')G;)NSF 1<VJ-PT-L%CL#FZC4S=98RV2]YVV/U.U1N$3A
M)AO\G_R9CWP:'970Y8NL 1FDDV0=7JO]D76$U<16DE_L*;FY;6$6[W960Q70
MQE5O_S?_[[W,/_VP=O62-0_&[&__Y]NV)SF;+V8V]M79^F)7*4FG:D&$_)24
MXYO8Q8H/8$)R)^[S&?:Q1$>]&ZT='TF>)<;%\?@F:VQ>BODOIGS#[?]69.$?
MN9[^1+(5T.ZU 'H-_R77MB%M)RE'0D0>4&S.!N!AT#@ZX*2> (P;@U33:4"(
MHV/@ T)/).""^TOVK</_:JO>OM.O["/XCR0!?S59^-WJA*?+_#&HC#I0R9CY
MV\6! \R<,K #H#,<@60 1L8!Z>/WC+8,,F,JJUV?F3T!:V5A,WJ58U=9&+FS
M)S)W\AS'P5AO9A<I6"5A?7O:.L?A<B0<(:#A'1G5MN+OM8?]//5EN@$9&?Q]
M&ETSQ (=S^.L$3)E3!GM>F5TDA@]N?>.3+\'6[2%N JL;1]PG?B"PB5Q]IZ>
M3V\9>T0?AU8%:95D@CS91L"'8T3Z^7UM"&0T@11KP0'YV__)C+)VI"/'63\D
M()H3\K? BTQQ(M:K"BK!#"<#S&SUH/L"#)RON048S?=FI-DB:PNP1#KO^FYS
M^R=[\A: ?+(QUZ$\ ?!/?Q:T/E5,7++MCL//MY_*$LKU/@'>D#LUUU89(1!&
M:EM38%_FCU,7" M0.FF7'E6U($ DQ_S$E;/5YUN9N==N^;G;OO;DYVLO_MZD
MT*\D"U>?+QF]I)TUD4"H&7SVS'I4'1U0$_RPL9$1OB= 0::4F E<A@NV<FP/
M.=G^8!UBU,F8 *6@1" !"-/%R$HV02#+OJD^8$OK0?MTZ-@;67@/A[F^_!+G
MMY+WXIP_"A3_F7'!=\'IFV]Z(POO825=MZ)ZM\5N=>%6F&1_"K;)D0"B"@/5
M;!)F? ;Y02"Q\62[GK1\C< *@>"S9(\OK;JHREN$.IO%)R %JMY"%K)=_(-@
MO;Y.[9C90_6JTC!>?Q97(PCX<143\(6@O#YT?%-$8<&4Y_)E!?_U)N1'D6F"
MH/Q1_9<[-.&2A?EH\\]WT2M!NX"*7:CZP[S!.&RS>>PT>O[6W/"+?*)Y$#":
M0WB>O3<_YHXO]@[()]B>OV5;$ N^#U_! S!@1"$RQ/NT#O3?N/AFZR@^0(8@
MR\R'.3,FGS.6=IEXMRI\\E'YK4Y0K>?NG;/MJ_[4]_1II]'V!BL1[7K:HM<S
M-L'&-I(_@;YUA840 !T(0R[8YZK9!,:=3E^[)AC)VB#-2_"PV>%</H"\M*VY
MGLV(X3T4A&^V7N;7NL-?\!;,#7.J].NTVGK0/E5.KHW.;JR=B5"I7R8_@2@Q
M9CC+/'1P&7FJ?R)"D'YTV(JX8'O(P1GTJ;95L'$]S6MKX5GM^F@'C/_S;V3(
M\WV/[)DC]S;_,+_G(RS_YX]^=>2=GW3_FTB[MG'M8GV$V_T0L5Q_=(0F._'?
M/UJX6$^8"H'"-Y,/[\EWJBXS)G-A'<D(>P=/P=8^BSR!E?E^_S:O+K[>_\D/
M6U2_;7./=$8^B\>]J[GH0,#:\'B&GY%#I)"_K8'/PM/N27;,D?&7>"2/G49;
M-6#Z]=1;>'NBU\N[JKW:RW0^P?8!?-HU\(2]K9TUM.Y(33)/1\R-:D.VFNRS
M,SZGF(3\>S;;XL_V\ZLH):*WY$5VI03XQDWF@3WDEZYO8$^M:\D"6,FZ(&';
M_>%[Y$4,:SZ6B[F'*2T^WK93EPM9GV_.S!,;C9OA>]D3SR:7[+JUWD/KR"9;
M17?$]??P3_[:Y\@E7?)=]ES59H1L+3*JPB>C[+ZXCU_H<$3V@0R23;KOL_P2
M6]7N0S)S[?Q3@N./X+*?Y=L^X:P_$Q?LGY\F"]]>ZFF@"[QO/ZRW8+9@)4"T
M/3P25(MDL0 ""L$9,%"10QP ,- I.( 'TF9/UZ28G2)VJT6V0N0M0/_4V^MI
ML;XS9]]9]'^FX&"OMRJCGR4-OY(_\\UX 0.<<;V!7()!CHESX9 [G0MPJ>J+
M;) 3H B9  S)/)*EW4;\5#E:QK\MBX'%,G:,']D2?-3[3!:2T6.(VW+,&!D7
M0UTVEZ&+O.1(@#%$W?:FN]LTRR0&XNI5LIG(U:F"<;(/0#": '[7)=,!S_J@
M<#[U4[IK%5FX#J-3<#<[OAFQV\RV[-C:CLV8ET7US@Q^SAB0 T0Y$HZ"8T'0
M :9^#OATB(A_=] 1!^D[@*. )A#'^; A-?TE.[+CULKW!8_ G;\+'B-%/%>P
MV59+SL4Z FCL#T<#M 'SY*U*T9V3@MTJ*ML&\>9\5I>>=.^K8/Z/.*(G>_@&
MG)ZV-E]YW.")[!3L 2OFL2T"9;TW".Z4\[8<</!L/F!K+8!*,DU'+EFX6[Z6
M!'SJLQAY=7O#K(_:[:V_BOQYL_.[YK^*+%R=V[YPZ31Y!.[8)T1[)[>S9W2F
MGIWTB.XA(WP.2:Y2J IE@=22XU7@[/-V>_<>TI//KOK$S]EO@ [!0Q_9=W:5
MG-!S8Q&4D =!-)O*%G6:7^^_<OU&%K[Y_*=U23>V>N@?2=C]:IG[F=]_)6MW
MSCZ1A=L7;]LO+$!_ZF>XQ&*8;@D9]V*#V9D.Q^.G!<T%#'QSP8AD4-O'V'K5
M.$B/#AN+J-J#4?@C,HF0*%F)M.-+)+J064MT;I_.#J_([_JS"0[/X[,1= )2
M1!B_5 5C6[/JD>AG_%L]^1!"OLOWP\7;=_D>3+7DNC7+]AFK[WH/B1F8BIU&
M#-(_MJ#^9OQD 2F"5<)!X"](-/\"N&TC@SAH^W:5(WRNH)==X?_Y5W@+5F%/
MZB5H#=R376CG1 <O16A9DQK7\R\JE9 [WF</#[AM/]8>F:^]+HFW!S;M=0]W
MW'FM5WM$X=/5*<B>Z?]LFGF +P3&YI!,L'M(%^^Y6UYA(G;2?"(0S '"!OZL
MVDF2#2D&"\)OWLG?[+C@F0YT"FDVEU\FW];+<SJ57N4. J#=7; GOPS+51%F
M/G=.]V3?:SO6QM!K<^T[]#E"P#O03S)94@O6JY6 JVW7?@8;D@_CC1Q#)M1'
M[B;N(TSR74M4;I$ ^6,WS 7]:_NQ"_XT]R4=C)F/7 +B[B+9XI8.%:JZ$%XW
M!OIP>Q':=<47LW/((S:@ Q4[S;@#R=I-8WR=SKP'D/B^^4'*(!"1>?32NZCF
M(DL^RR9X+[+2 46(&?&.^7!_M@)VZ[ 4-FQ['&_U(=DIED>PM66XI,H2-ENL
MM,5 UZ?LP7M[>N_M!?I$$#XEQ]MZ;M[)@!B3'$82%MO!N/2V(I6U\\;82=I5
M/_HLFT_VED3.]VX2S&?X-7K*#G3J>3&QRUK[/S*XG6QMZ0ZK>:[YJ'HP.4L_
MFZ<;RRVN>L)'/L?.LK?L+EE!I%[2F(RP+9U,S(<U_C"_\4L4BP7)MIA;8MK\
M\\MDI<N\UR8#F>B]/:<#=(K'V0*R2O84=TA&1>JVW7];0^4?(I>?DM#?V9WQ
M'1SW,YC^[T86_BPQ]"E(N>#[]L\I8'OZSE,5G@6H3PBEZ<A[V079,P:>,+6E
M(%((:VPK9VQPY>+;"^UFZSXUJF]\MV=18_U5"_/5GS\*^/]19.$?)0R_>A]S
MSA!:3YD"#AQQY&(D@#X $QC<J\PA0P L ZW *F-5J74$\9-\NVH,3$:VO'\;
MY#*PQL58 5T,,$<JJ,X@ >^V0R,Y.&6! R<+1#/4"/!Z!=VM< &V3N 3>'=2
MK/'X_1+=3X0>>?<=0-#% /I^F1*&W)_(_ALH7[W?;<-[<A]],J;Z@@3 ]T3S
MG(WON_?5GR4Q?,88(SH%.D 6 HFN1PIP.(@#!A\@U,>BOI6__?;;__>7O_SE
M?U]^UO9TEW]WV?9DFY(*!&"R W& '0X&X/%_8$DI>Q4.YK13M+<1^9*HVPME
M#7JVKHSBG@CXR;8\Z?LG'?LS?[KWS73?DV+?6DU<![8VU?R0%54!@EC!)+ #
M@ HXZ8MU:=VL*WV*<*\2H%XV@D_Z1.877/FSV_U<5?C< Q)N%=-6#Y;-?7K?
M[Y"UG];RTWI><OC/KNNNP1+_"Z3-H0 2\*V7&)O&CEF'@B[97XD1P020CRBD
MK_1V$Q#YX6T(GW[<WSTUM3?G/@=\LYT%@X(Q8R$7;+_@ARV04 2>Z2>;[5F[
MO;-Y?B,+WW83[+HMYKEDX9^IN/]9D/EG__P1?/'W(@OKS94<WBKU*BLBTK8R
M=5L$Y%]*2H0C! ^(/8&I2A9DDCYV=B-TT$.D4M5L@F !>+W]5+9TX%KM4!!:
M@ABRURFS? E\*L@1'-&+<$V)R-6!FS!:WR @-0:!%N*>'V0?Z\_,GSG4#2;N
MM%7OP9:JMJ6;*KLZ6.6NT>*=V[NKH-08$50">8$5_RO :[NU( \AP&?RU25P
M!& "9QA)LI^M9E=@,D0$PA%IL%5.Q@_G(RY\%\Z"NPJPDRMC*H%@S4HF5I5B
MCB0#W9?_]CQVP5K"4[7]J )I;5.[)99<V-ZU:ZOV )Z]-K"^2>GMIP;KU*NP
M.*4JJ [68T_)7NTZX$Z5.6PO&VSN^4;KD1Q4[6=^V4PR2O;I %U@']W7>S6N
MDGMLMX0+7&MNW<.<6FMD>-N/.X74&."QM@'"R)O@;C=.<YD.>8[W#<]>F[2V
MHPIAN,'8VUYX*ZKXJGI+TX_=@FZ.D"E("G+*G\ >?)=D;P?[=4IS9$A__-_O
MR ^B&BD*$XH_85'R9Y[R1QV@@.@0']#A#GDQ-_Z$L;;"/[G:'3K9@P[<*39
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M8\F&B*P-$B_9\'0B]U,U]/4]X:5.0#;''9JRNSW:EOC[CQ.PR1E9$-22M0X
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MY+W@^UYO535/%46?KGO/&_Q?AWN_\R0/-T#>=7,OZVE=K:^*%Z7%G#X0Q)@
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MU24.K\Y?'Y2=S9^O/6N;8:0S6T:6)&RVU0Y?APBUO@AG\]<)NQU@@BRLPD\
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MU""KZYG/-B/BZ#'?$EGN/AMO+0ZX?,E6'9O+DDKDDK^H?R9Y,09R1P_(('_
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MZ";A;DP:KW,/]R3#UC%[14?%8,A(MH+<L5?UDC<./Z,/; 9[1E;\S;?P"?P
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M<[B.;^>SZ6B''(0)2^;2=228M5%4H*K+O C^.E53,E> BK1$#"-9S#%[MX?
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M72.+UL#SR"H=0U0;._U&7)F73AWWSF3=.L#ON^-L\7+KL5C@^@"?^:J0YB:
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M(1S(X_J#YK3"$6M;)9#Q(I4\$X9V3_*/6#,7@GZ$H2HD8R)?9!(I"-.K$.X
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M265Z$128@/# 0-5W0)B4#"9*J+BN[:+N\SY$Q^C5#\;2!=8"< +0$)E[-F+
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MEN&E;?C8O),E@?3F,+^._DTO66OOTH_JB*,IZ\7^-D[\5FT_]+4\X#OST G
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M_^___5OSM_M<XYG>IU]HLY/":];!>M*;UM9\Z&_CW6;,]7MM+?-@G-$^V@W
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M?7_MQ;UNL;:EJYK/GFS*GKFTN4E^OXWVTR70V@4,:S'U)00+@G!SC!&=A2+
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MV+9R;'FY^0CP"3"\X'3.5@[-.L%7ORR]K.Q<&@Y\"0A<6BW*C>[3/>MP1.O
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M_Y _+M&,K":?!64J%4/N"/P)6M"_@CIV Y!W^IO-M[L[UDYO[O?SW5J=S-G
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M:WUG1X.2)VB$#=PVRQW_ MX+DEP^^S2OJPMVNSL>*YM.'V2,R<@ %@)^V$Q
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M#>=)T7OT+"L#\&8W#["L;:-JR\G* 'Z5+<MI^^6O3X>\M9ANN8C-WMV 4R4
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MK;%P0?,WL/,IFV>C;6NPK!!,:4:C:SP_1;!N9D\\=R/QT=EU,MZB[1OY>BL
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M\7UULSD2P!Y F;I\[ F@$F=$_3J $SM5%B%0#3!8;>/FKRU2[-0%'P4J@8.
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M&$:08L8R!)AQW98 Q*!X,$7-@/Z37V]!MJ@$QQIK12$L=LQ)B""$"EBN JH
M-2)Q+<.QE@)R;]F):UP] 6%/!O@%@J[BO,CS-7P79+F R*?LG&ND_.C/)T?M
MZ;HG)_*"I%]1; NB?@4L-&[K:/W0D>T^@&6U5!B!'#2"A('8:90,0V"A+%4
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MGL2OZ,!Z<Z;P\IXJN=NHGK* MYS!VW:4)R#_D^%TP8.[=F_@7;H_F5.VVO?
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MUU RC+,%#:O[PF@E>.XD/3FG:_2D;(KX9S#<C,D? 4'>VE<)X4EA_#:R%I^
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M3Y1QMUF_^0"['?&3C[5KT(%CZ>"58S[/5K:>] O9+GB$3LEZ]@DZ1<?HAEW
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MFB-.Z!;WIOCV ))?_KJ@=J?OO8&%%*GG"I;@D3)OR5U_D\&<2TJ9?"1_ 8?
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M1U^P\=I.Q/ZJ4#EPPGR0,9T:V6F\%3P'HG6@F0 P$)(,PQN>0;9R*&3QT5U
M.M\%^ $(R+WJ7M7ZS/?Z1R;J#[FLW^0CL--XZ#+C-&X93M911C@PF-SO\#X
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M8G?12_A@#]<@)_2U+=UT/KK5+\ D8(\=QYYCU]'_=)= E7>2:?24^03"<C(
MH6U-]#>=YCMCU ]]!\35V(Z^!T#@&^,Q)_YG8Y"5[$UR'S^YUEKBUX!2.M+6
M?QF2Z*$3CO$I9R=Z"*BE5X$@^-8XT(1GH)<.;P#DT*-D 1ZF.P0"\;PY:BW+
MPC3O^E)@'-U9JP!#]%G]T[;*Y41'UP'O=[O:RL8+-BQHL/9QMM,&T],/U8%L
MR^<"=LN3UR[:P%3USGW_I-=7;Q64KA;BGB"\!Y2MT[X^P&;2[;-SLG.D%RAL
M+K\"%F9G9.=MIO33.*IO7"M(P#Y@0PO\\7'0'%M.H *P#H1ADZ U=$:'L-,\
M8_V2I\#/RN,;5$U7N.;M@),-EN%%=A%;$DBN;W@<<,"6*KL(/\N0))?P$-T)
MP">7R"BT+6& ; I\QY?X@&YE@_$_Z46RR;@]BUSL!.9*03R!-E<?W&W!%^Q[
MJH/Y5 OP^FJ[.^WZD 'G>__3-N$?\=\NZ/\I064SS2Y//&WM+TB<[HI?FB]C
M(H> V_0>F48N_]5?'^9$MA?LZ; 3_AZYY_KJ$]ZR30ML)XN6;_W6U\#"M;%W
M7CR;'2S8(\A#YM,%Z*ED";X4/J)+Z.]*/9 C@?WI[?JSP0K\]A8D268LG3R5
M&MG=C,G->\W=Z5B_-G"[68^;;5O;9Y?48_W\;@[O\[;?]#L?'>_F,]%1[1!H
M=P"@GYRB&P6ZV!UTIT"B@&H'I;T=6+2Z;!,(GK8>KV[[*O;Q53#P4_#[_^V
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M@CD226QE)RGOP48;K*=[YDK2@4TV)NN+X[I^?13Q)#^3.8G\JLA\;K>!WZK
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MI^S>Q,RM>+_^S-UQL=7P6_2Q<K6^X:OO_:T(>]G4'<,GCO*J;/I4#;4\^A4
M?_6P6YV\12Z;B-[QF==MS\*_@+_\"G8$#I-9]L1:PD@_MW4\GO+"H^6.<8*X
M]"9<2E*4'-VDR18;>!]LYD?5?YC=%E\0/&2OZ9!QP7UR="L+[\Z,;>-V@X0;
M)[A!Z"VN>066JRR\K69>A^1<CE/,8?GUW0:?_X$?*!0KAM(:MP[N8ZSF@BWC
MS_,_^(3XCC@0'&KG4QR(/64;O6][O,,)_%5PV?,N#EP<+2B[AQ1M8=;EG-^J
MJ7\G./@I*/C?)5CX.TF#/_/UQP636\U3&3\!L%@U]A:0 ,X6E0$2R '*G-6J
M"3MJO-YH2!]B+'*,U%9:&J&HH?O=AAR ;6#19VOR"VB0+V2L_A0<KSV!608:
M:?3^(O_;@R& Z52VLA(O17L)WS6N <X&GUZ9V@6J#1C>_A>W,O$*_AU'[_M6
MHOZI2O!UG5MYM9_O.2[(E0G;RK$:-+<-I#)LQ!T!!@ZJ,9 % -(6)#(DV(7(
M(\>(;^7?KO7C9Z6HZ[^"A?M\-S/Z<AQ[G@B)<6XV_)+'#6AO\+CWW:VU]ZN
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M6.TD:8Z&>6%O5!^6 #;6:V,W\7634*N[!5RKSJ0OYJL>@(*% OF^X[%T=JM
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MKPB?8RADM-K6&=&_S?U? :S(G_%TJI#FMFU#KL254> P(7*,1[UX$J""06N
MJU2X^^)WDJ]#LV6MK[XJZW#O//?:C$$.T/:OV,S>-=87^"_!*!NY_?/V&@'S
M=1 #_YL-?FW5V&!,U[L9ZMW>6+ 0N')T?$<&R(.@+_ @*\BXK(* $V//:4!V
M@8P@-;+;%N8UR.Y1-<\*^R5NOR*6:[SO=H%[F$V!M5?5X;W7=8YOANT%2M?
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MV:]7H/#/C/5US3]V4O9-";#);*\ZP4=RD!)93(37PG.4+6R9<L2.XT,XD"Q
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M0(S(;E:;\\-A)20<%T$$ 1Y.%" MVU+ ,"?X[M6_S4OO-N0<#8KD^HBD#*J
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M<K#.6Q539![><UA5+IA[\^!^GIM-A&'TP7C\S"[Y7]5@/F?.$$\.BXJE=$6
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MXYI[LM#.H1^G.KE"J+"_0^X\OUB*S^.%])D-86=PPEI'="*PH*%QT66<RUK
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M,@-=X :<D-(.3]@^*SWK]L&0?3?F*@\H)4"F!)Z3L@.9&G52\+8T]7X 2,F
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M>$8&X0\_P'7J1^I: H7;2SU\A;_M9$@>_:^**WZ4:UFK;2F!+PC(2<+5^[U
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MK!1,P/,D-02R.LB,_:^JT#S W0YEHJ/F!P>K[4F'_G2X%/F%[04D/@5:7L[
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M;%G5-GO*$8)K'=OB0T$!AFM2\MVNEY+6ZZK3ECA_P : (MSF"X @/1F^*C6
M8.#':'L& "%@"8A?&0XR92X!,*-E+ &IL0&R^@8:N[FN1Z.Y8N3)JSF3?0&:
MG$8 9ER^ R1C9>"-@0,)M,B/N4 ,RVRN<]K: ZY*OSLMG+&VYD"URH1.!/=5
MIHU,;I#P5QF-6V48**R"FQLRP6&AGPA A]*8;[+$*#,>YLS\D1T!%+KNL_4A
MDUUEN%V##G R$2C/Q6 R'G0&P2+OYFJWKIFG#>K]"B"W&F>K"F^P<+/SMQKC
M_N^3T_\Z(?;E$-WJB>:9[I)/<F.]ZUG#:>38T@N8@7!P;.D*9X2,,L[FUHNN
MU%_%>^ 9G.AE':V3]: 7'.!.;;.F]0L-]QALUV.$$4X$M=.07]O:S;&  ./>
MB7BN7[4XAZ@M!,@0>6^>DC\X7\/L/=$4SH3) AIPU?7I*Z=N W]TT;-5&>"9
M.(/F%2;3Q9HXPX*VH_B9O+$[@G(PWSS10W(/DXS!O, 6Y!810H3O2:7FR7/6
M9\M:"<9&0,VK8 1=0<2,_?8,J\]DV>;%8MAC# (S=+'FT6P#&:%#G19NGGMU
MT$8)//>GMQQ?V(W\L0](6]O[Z*5[&M/JGO%Y1K(!]]@%^NVS54S0<;)J'6$:
M,KY5#I[=-;S(#N>CGF#F"^8*%G82)]M@'3DG] $919+-WU9CP@S71[*MN>>R
M?ITH#<?-$WG<$V#C&-GW>(QKDEFVC,PANEL%Q.X(/GA&]I],F.>J_"XN;?_!
MFY1X!0PWX[T$]-4BH<]['QN3'=]*8_84YG(:\"]S2K<D_N" M;<&<0-RS-'$
M)6JQ4>N(#J>K=<M6!M#1DFOX2KR.G:-WG=R\?1=KJ6'L;?':BL_%5_K22>]P
M )^ I<9,Y^B%8*' B^U_L$,PKZH_-E[ U'OI$\>;LPJSX"C9@8_MRFC;:KM/
MMG\?^70/^E/"!5; #_@GF<.NX6:>A>QQAJI:WLK.3F W=P4+ZUGX(N/?R/X&
M"\WM/7ALJ_TV6$CG!2_(B+F"6_54\^R>NZVRMV?A!@O#GJWB6 ?BCKOF\07_
MJX+'+? )F-1V-7;!2S54"80"TIYU>WMZ3O+DN:P%>RCX;8VL*9DGV_6(9!]<
MPV?CY>36_\@R7;>N;!S<JPU!VU_]'PZ'!\G\)H'<P_7@&/ZX?-:V9G,.5SSW
M5L<LA_/EVK"\Y[)FN#3,$_!G@V"7>UF?>K/N 0]LPH^?[0JJ%N]P,KH@8<V^
MT DZ@H^VQ9?MW(J:=98W:/@Z6.YW?#?_VT,%C+%@(=LB\ ]S2@9UZBPL@@'&
MS6:0'7;*.GOA2%YM[12,(0_6D@[#"]>(]^_A6G227!:\]=SUYH9%Y@]WPNM@
MI;4,>PH\PAOVE>Z0;WX-VVC^W8.=9^>L [P@+^Y3Q1I^XIGB)W03;M3;'!;2
M";+8CA[R6@)(8!(VLX797++G.AV^@G]VR. F[\F2]:?[;2&FDZHGX:5[X0;T
M#6\I*9<_OY7OYM&STRN\JMU;!>8*Z(1K81J<X;N9'WI'-LUU":L.I&,7S!DY
MS?:VF\7]JRYE%SM/H=8G>%'K5+_9[?U:@HM<=DA7ATSB;=8-CIKW6FV135C*
M]S'^"HX*.!HG7Y4L5&"UU:/LKC4GDW_[V7>9;8$UM=. Q7YN1Z?W*%HA[S"A
M]C[6J\-[^+N>E>_F_E4@PV ^';FB:_2!/'<0$Q_5?(LSD/D2IL;@.M;>6K85
M&J9U6G(5R^:Z@U>L(8X%]_CYYJ$D8Q6J7K7ZL;[M)N)#D4,VBURR"^3#VEEG
MSU/<I I1LG0#7QLX?!V,&89M'.D;]KVJ"O^O"Q;N9.X$!NR4!K!:=(M&H!!)
M!(E"6E1"SRA1[+8=[E;15W#P5Q/S^ON^?XD[Y[!@8:<J(8 ,!@%DE.H' "2J
M&&CB"Q8:-R6IP7 ]7CC]2#G@0=(!"$$MN]ZD;Y_'LN5(  .%H-=/C (P%I29
MX#>NW:($N"A99=J"-0P!8$#NC049[0 1][M!DAR.MG=U+8#!(#!\'#CS!#!J
M;&N\B!(#B)Q0\ARPY,,SUB."L4:T*'J]R1AMAKU,+\#Q.>,TWOJ2 ?::V'/<
MD 8$'TG?YJ:N4:]!P.5G1(>\ 3'/!DSK]]CV0]?D<#">@,QS6PN@6+8*6,DT
MNA=B!4P[518H K*"A6U!MOX(=+H3(?5\C#QY="_ "<#+CC'2=.H&O+<7WVL[
MR*<2Z 6&!4KK9AQD!.C>K>R,!%TAC\"?8\[8(KW6M$->Z#8B7@/G>I+D2"'6
MR$'$VOJ0:?+QZG7TC6"^G.NM*BR@^@KL;?7?SM->^[4M\):=;Q!R<6N=E@VX
MD0.Z3&X*V'$8!4C(4'V'D$XZC @QU#6ACCCXWBG*\+5#?NAJ)R#",N026?2=
ML;8NY)1\TV5Z!)==S_H@",@#+#)W-QB:#%HO>B"3AW23&1@H>2!8&6DC_UM%
MMR>*F0OKWTG&L)+^P$^R9EZ,#S%&3B0O"D#0*=>!*0A4)^3!)J07%M-;LN99
M.LW8/3LDP;VK;.1X(3;6!8GNE'2Z#:\0<-@!ES98:$W-$UUW#7ILK.:9(T-W
MX!I"Y;-("[E,1M+G B?&MJ?#>D[$AZ, H\@ &:G:%WE'TLO(-\=M1^X4Q9Q4
MN,49J!>8(,!6157%WC.F!Z[G&>F[ !_Y(I-M8^V@(G( OVK% "/<5_(&)@JX
MLK_^YUZ"-AQ3Q-BZ":#\Y2]_^?OKCS_^^/OXX)#WF5]DNX#MZEE!>&O%;GHF
MN.,9K2>9=-_ZSA8LW#Z"9+U3'\GM;D^OFD+@PGC@I/];GVVD?WG'K4K>?K&?
MJI+[S%;L;-N(Q:F^S$?;M=*Y3A8FWQP0:P//"Q;63-_?Z]W&2>!\E/#EP-++
M[6',:8 9;+?U88_-.8RG<P7+<$#KA1=T$C%Y)*/6P#R3S7WY6Y6(-[A*;];9
MLYX2:NPXC"./!9N]!&!*;EHW.B.0X'EAG;'"2)A9,+0=,)M$]IR<+)5UN(%K
MVS;JY?^P MYT$!A;2!;9-^.U?M9 $BCGT>=<RW=S2K[H,EY"STJ870)_"?GN
M>$ENXI55](2Y6^UWJ]]OL%  $S^K07_!0KP/SR+[-UBX"8K=RG7'O'KB_P74
M.J69W))C:VO.8' 5)+@LK*"39+/>;#Z;GE0I4I]KV-M68@X\K,)O8"ILXE"2
MQQ(DNU-J6QW@9)X=3L("]@X_-@ZZ0L[A\/)\U\MFNJ;G8[]P6CR5?V2^R8)G
M9*?;5LHVF<N+#X(M5=>P5^3..M%)@0'RQRY65=@6RKA*OD>54=YG'CR'H* Q
MX1(J]> \_P-OH]/\$]<LT;5]N[XYS7_68=[$.%D0 ,$IZ A[03;)8Z]TB:[#
M?CI%3F"2M6;O>IFO@A8W(.YS!>X+8I'S#7JMC)![>-1!&>P//B00 Q=<#[;@
M<_R%6OAL3UO7(8,%B^!F[0O,,ZR3?&4#=T<6ON-Y!+QPR@Z9@]>U5/&,QE"+
M*':0'L";UZG$UAR/=RW/3@;)+ Y%'_,MS:WWPT#/ZOGX:"4(89]Y2_XV,4$^
MV$Q\".Y41>:]M:'8=AV]S(4YDGAU/_A-/F&69ZK??3O*NF_QB0XE9=_2Z78C
MJ)!DPUR+C)$U,E>[I0V,EX@I2%B2JV"F>("$?DF%^!$L*UBX2<0P 3^"_S"&
MK27'Y-PU*LXID&F]R0G<,4ZVT-Q[?NMDCO!9[^<?LT_91/K"EKDN.?%^<P;K
M/)-YMBY\/$'/;4EE3/B4Q"#.X#[NW?;Q7G26#32752GC'AV\VK7(,CR%.WP
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M<(EM\J/5S[(6] I/\CV;4+^;776!-3]!K,^Q*_8K./)]]% 0RP?5X=.\K:.
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MVOZ42),4J?8>I1( 5_N%\V'DG!IRR@EX/^,I6?A.$#=X7_")^-SNIC=9Z/T
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M+4^ UVX,4ERA<_K23NF.?77]%@._=:[2UVRKDR'MODO"<,S(EK$9 WEW!4M
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MH4,@)5X]P]@9PHZOX\759&!(B!8B7<%]1*N.7-X#]"_IW$">,Y#  ?2UJ0<
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M6*?55LZ=@!;$P!CKAJ35M&?+ \ &[Z'#\-::%NQL;:WM\EK=(/.!W]4 E>1
MQHT-J>AZ# P31"#I[(9NP2BD$XY(C, <NK[D_!(M_HIMP[*N5Y,+_(5]OKM"
MWR6,_-M:UO"#?2#S7=]#F*PI'(%YL*)D8:]-J*P3KF8J/V:>Y@R[K1?9"N %
MS+<14E>U8+\ "K9X'YP1V/H=W2NHB>RQ0?KP=+(P_>YD(3G!UTX@6WO$L897
M\%KP(BF^)\Y:ZSW1TD;?GLBVIM510P@E#B30JVD$4ZQ7#3BL7SYZ7UO7LQ/C
MR#;]A^7P:.L5=W6UZ^-\D!-);*9-H3TUMPF_3A5T6J"$O7_7];EK@6U\WC(&
MJYM;H'SK=3YMG#R1-._QV3I \H'FWTT!P3_RW\F[$F4");\C<VLH8##^>V+,
MF/R\@+9$>J<7=GY[LF>; N1[OEX-'_A4ZP[[Z#-=9ENPQEALN+(S"7W^A*X:
MJQ>]H\_L/BY'K\TO>S0_..<%;[W(0+)!TH[^PPP8# .ZFHZ+^<XV(-ECIUW,
M T:Q"7HOD2$1[S-XI.0A_,(1R*E WAS;F(-;=8?L.E5VA!_CA-:!_I 56WIJ
M5E*RD$QK:-&I]&UJ$??9SJ+X#HZ%CY6TQ,<$XKAL5[N>&E+=KJI[B^%=@+&V
MV<:G\9HCNX?#@GBV:"T%HL;$UW3RI\8.>V(WCMZ)+^.E1VR^$VG=CBG1@HO!
MM>I#WL9BUMO:PW<\K9>$![VH=N4&__&B/>7,1N 6#B]>,,^>2P<E:.$QW@^_
M\73Z1B;75U3#MMKH-0/R'+K'W]BPV5AA^<#Z8+(3,WDF7\+V2\*P$7;AF7Y>
M\P@Z^"DX_6[ ^I1([K5))S* ^^R!S/&7-O3X:C8KF7^3A2NS+5EQRT%D%[?$
MPW+&V^A@:Q:2"=^$/XEKXKDV)-AT3=_PZY*%%[.M1:>U.[T'+\R=W^*_^73/
MHL/%J\N=X7LEF.!^W6!+;C3_G4O)3CACHQ!G@P>=;J6#\(XMX3#\(7Y8]_<Z
M!M<<:'D5F_Z:^L,;F]KLH;-.E]ELW@,H$N42=7R6YY-QM:L]!Q^L'X+/D#%9
M2$[1X1+E.-3.USK#+L^U7G &OL$]?L)XPCP;*#89V(4Q[$G%>PUYXSWR[\0P
MO#$^^ [7\;#P D[##.MC?OQ?"=5.&Y<OP??@E_C+.DO8;HWGFG:6!V'S\(:>
M&;OU(Q-C:T. K,BY9DCWI+?UE4SD:WT_&?%1Y/3W5Y=K.DC/;;A)^.+_^)0Y
MBR/;8/"])2AM1,!/?MCG8+OGFQN\VIND-\=DCG2N.K2^ V?;S6HZ3([TM<TL
M<JY!S\;*>UU_;?LFX&Y"+6RX383^2A:>9.$MJ!F@%NA9"(H/M#N! A@0-XI1
M@7:&COQ9^'8.<K!>.?V*\T;4MV-:672)F#HH(F\</&"+ +33W2X+Y>6,*5AU
MV00\"!*G@Z16BX4!!0Q]-T.DM+['/#GGNF@BW,@F0D.A&2>"8)P @H.YNSWD
MQRD  I\1S-1MU#.!#$?=58N<P 8/QLO @2PCY40DWP"I.3)03I_!"K"!R-/5
MRE[61* MP 2>G!2PL!,@L$)RN[K8;L[329*<AS$C=\@9H >(Y%]'*H!:IZQJ
M$+;[@Y@!IKKS>=GAV"M&/@OH!8$(F/7U762/K)M/X'.-VUJ0)R<"Z#MY5? 1
MT-,+\S0/ 8UY6W^?HX. NA-A=*4=\XK5UT7,YY%8NV<"?L!MCF3!-HQ?,.'[
MO%=@DIWE\+<Y0/5#NI*Z =L"V@:AU;2H*Q>G:*VMZ>Y>LEMK30<X%^!O-\IG
M[@[ZE@BPWFP0T3&7$K!TTEH+4#F7"E0C)^V>T?-L;W%FU^O3]>+=2=R:2'LB
M,SEM\/_I*O(3^+Z[VA$!W2O#;3# #7J-\.Y5.&2'S=.'R@2082=BUU;WBLZ]
M=GZ3J[V\=T^/DGE-@]@U?(!] EPZ34_#OF1N'GX.%P29G+.3,.Q0 I_S1_[8
MI)\+QF C7.NZPSU=5Z!9(QBZ#"MAZR:,8 ;"7!#-?I!TQ)&/069@'5DB*TB[
MW6?$H0V:#1#VJK@U8<N>#[O9O3E).%@G@>D]V</6Z*FY&2,2!"-+@E=?B#^@
MUQ(AG:+IM<VJ;B#7*0/$4,($>867 D+/%#3#27X&J8<E?(<U86=U5A?H2[21
MF80+,@U;)5<ZS5QM77,W%V,UAM5YXS5?]LF'L%>X6+ *(V!FM<U@+YQ [FL,
MM;5S\J?='JC>&]VWIG"X:ZAX@OE5QZ@@N"OAE>+8A/J>].ET"EV@MX(ZMB99
M9.X(I[7R;[*U6=/U&1A6G<EW)ZA*GO$!6Z("MI8(PTMV8VG+!ES=W)L3-]BY
MA.V)S%5V(%MBL_3(^N$C^ 5[@>W\:*]M&%;@[?/W!*?_FZ_?X2,%/IO4W+7(
M9^U-D#IAYP]A"MV2&*2C=-5:67<^QUKX/SRA?VR*OZ(;7CA/1=;I=@U]Z"5L
MZW0M.Z6CN)! ".9)\K$OV )_!2Z"-H&'<536Q#K2Y4YK6,L:+WB^!)< AAV1
M,2RE<_2BFPALP#J8IZ2]!("QXIY\8?6W\",ZV*9G=:[)>0,2?ZQ)ITNZ59/_
MW(WRW?"FFW4+MMXPHP01#(5E,(:,V*+D4TGS-M&SLUL#:GW5/7F1?J[_ZD:0
MH);MNUGBN^$XFZ2;."(YX2'6VOO@]KTV:NY\I^"8W 3\UM5ZX])U&>7[8%BG
M:WRW^=UF<7"CM:J6)IR#Q7Y&-V%<I[G:3-KZJ7L-&<;!,#C'%F$1[@=_ZFA,
M)^N<R[[N%6_C)8,VR'KMJ7.V),Z!1UO6Y29TC+=:YV0A"4F7^4 RY\?9"QWG
M(\WUCR0+OQ.XW@V/-L:M)YG5(*FUM#&X->')3#+.G&\28!.&6\/S<JN+K7N"
M;)L%+E_IQ#T,@0$U?G.BV=_T6(*L6J1P[P;HY@D3K7>XZGWF8D[PN-M(V04[
MA17L%Q;R\=:(;M%_GZ]>=$F36S>97M(GX\<?R-=F(!MD.S6[@]/6P//Q(7_C
M8'[/#OF -B4JE=1A";_S#'CCF9[=1@D?)-'49I78"[9[OCF$F]7A(VMZ8(QP
M5HQ,]^$6&>,ZYE.MP[N98,WX]#:\.U13V86:=XA7/(M?DD<P!\\)=UNWY1M^
MS[YA=GT'^)Y**.!J\**F+95R*B%.OEUGA\5U%-Y#-%U')@=S]#GV4>S9;;-N
M,Q@[+BV69-_D!O>,BX\Q5L_IFG<O?*6F:+@D?U"C&CR[S?2X?V6(S)4]PL:M
M]=]-TV+=DH76GBU;"Z<R*PG18:UN'I$SGP5_V ,=80O&0H?@59LL? /Y=/VZ
MVI#]?^NW/EU!OK'</71R7T\;M^]NCORG_OR4R<(-]DH:;O *C( 'P ) E(:A
M6%#7"20@VB'DQ 5;E ,8M M2G8&<6<6:"RZ 0-ERAL?X*3=CX_1DR_WM9^TP
M]'R3H)0"2;MXNQ-=AS0*OM=IVA7WW24*S0]H,0".JCI0@$>BCE%V_1CA()?M
MY+B*Y/D()?!%?!$(#I'C$;@(\,UG3TNV:"FP.9H7XP=*#)8!E01UBI+3WZM5
M75DJJ;*$Q/P!)>-#:*NOH^8<\H;8 !' 7[+PZ:152FC,2 EY "V.U1@YC';\
M.;]T S!RK@ -4'$(3B\YR2+)!*"ZCGP+FDL4 -P2%?1@DUM/V7_KO)VLJJOA
MF?07 >/HK8'W"5X0*&2;OG1%I]IF>Z)F3X15[\EZUQ'//*VS[P.D.86N4GO>
M/0VW1>8157]O;8J;+&P,V5176"O0SI%WW;%&"L"?K"4/!9&2,G5T8P<W6;C@
M:KW)2B+5/ 0<B*@$!]E*1M8-"U'@I#E_@9JD%D*S)Q9N,XAW0'P3=??*=?/E
M2$LV[#R^ _#OOG\!>L=0W2[CL.X( 8<->^@]^3HE@*1PFO1L3SHDUR6PS:U-
ME(C:/76Y"0URI=^^!P$A][I\(B<PIX[I=#FBF=Q]#UV$N0A+]56LY>XPLDV!
MNN^19(=)L+G.Y)LHZ54 BRQTL@QYA<?T@GW  O]G=["WJZI^UBEELBS0A?$P
MU5IW$N9>DR,OV&7.WE\W\!(I"!^"VU74L-=:DA$L91.":H&+1"&9UO%< H;>
MF_\V(?+YFA%YYB90VY6']>3-UU2[E<_B8\P7=@I:!7=D0#Z=;J\3L[$C5^0@
MV0:K).&\QYK9_)'L,^>]!K^-+;R,4[#K.7 51OEN.%%';<\02$O(D*6UH2=P
MCMYW)2Y[KI:GWR&T<()O,%>)6WX,?^ 3;98)3."A<6Q]4SIZDVP;*';%L>NB
MGBWI0$?KB)B?A'.(/OPU5_JX/*?$Q%Z=AR-TB-SVQ 7N44,#IS'XH3JOTJ5*
M!^RFY!+3IYI95W<C<$MDJ_=9]U5CP9G\G_^E%W2(CO.G-G'Y=?:#,]2IGH]#
MSJN!U2DUZ]:)R8B][]PQ[NG=RQF[Q@SC<#?<QKK0*SZ(/V3C_LUOP$MX@&<(
M!+Q7L$>?S8<_\CO!LL_4*;/DG<"/#DGZ"-8\CV[Z&XZ8I^?A"L;"5ODM_)*N
MF:?Q9J_\=^5%/(/MPV^OFM*Q#\G"ZB>M[I,9FS;?W1C&0^F@-2B8*TE3.8?J
M2ZT/LOZ5>ZEC>%QZ>4[OLY;LA^SH.7N%%[@'OP#'X*?@"T\C-WJPM0_W2O$]
ML;3ZF]W$+5<GC(/N=#(&3[:VOA.',PZ;:/02CN*P>SN&7/>TI/'!>G8&2P3[
MG93Z]=4-F8R=9();<+,Z=^S4&M_3(N24K^.S?09&"'"M'?X'E^@)&^LV0/[8
M'_]O,T%@7NW="O7#(CQ L@0_8I]\)G]-S^Y)4G@J=J(G,-R&#QQGRW4U9PMT
M#.?>ZYAQ@FYHX8OPRAP%]W@SNX&-E8FA'VU>&S\]_E'P^7^;3-S-/+9#7C#
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MSZ!TH1*H=/T+2:)DO7PGDE!BKD[!DG]()X"^Y-S<D$J$@J-$$)!G!@>@@+-
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M]I2D+DX"DJ\I[K\G?2QP9)'C[;F4@N)Z+B/:>AN4A.%$D-KY"2 YVG9M 3*
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M3G@#V]GS;)Z<' .02&6R/>DE<T<?(5QSV8?DTOR1??_/B ,VWM&?WMO?.7'
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MBMISXR#9R.F+9&,07.]OK#8F)>R^%"6E9GX(-B.?7@&,8@0^)7G& ]C,$[(
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M]3S/)C_)H-A.\9[Z;$: VPDWS\GJ(Z>((G/$$)HOZQR@1%X8<^MMK&E2[^]
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MXUF2'-NU'<;4SORL$$G J4_CM*9D]E6U/N$@P!?6DBU@H_W=7.:D>NON^^3
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M1^59Z8_ N9--*"HOHJ&Q*F>. RV#II71?,\9T6F@$>7?V02)H/6:-R#.NV_
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MP!MHZ+78YK;OE^^WDNGYW^1H4UKSWOXO"C29GOEN&^U3&5N#OPF*_=F&*%F
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M/Y3;45 :T7-\$86<-V5CE)*>/IP\C52E/W.29=LHW9+]019FJ6%G]ER5(TX
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MZ)]D83LEDVCO'H8S:)4Q;9F]^7G(D!"&IUYR<_QS#1*@H"N4(<I^TUA:B:S
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M)[]V>X_6M8V7^YK89_IR5QCL]"Y37G*_M!)AYQ!["#[VQZ&Q>A6R36GGYJR
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ML3G&V3+2I'TR5C:'L<%:1^.WOF";3CG)[:8?-]F/O9\9C1/<7#E1$USW.H4
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M2HA A"!B4,KS+_[%O_A&% +93A!4>B>:(9OF7_VK?W4#V4C@]$=HIS>R<'(
MVSF>#EJ<CLY&NB(M-C9_([0>V93]F4[9571BEHR<0,&'BB)N<K4YUB?#>$42
M/@+.'XTD/>-HO_3='P&/+QW3FUR]5][UU0&'9]+K[QG(>\[C)*(WXO!>Q.\J
M4#")P@GVIT/COO07VZ04483V'_[#?WBS.4H\1'=%=.E"685L$J"FER%"T2GP
M2DC8(J3%=-CG^)HL;"+P1!8&@,Y,H7ODZ"-[9.Z#MMO;<QX-GLTYWH);6W;_
MU$6/K&_OSY.M]*R4(B>KL%N2-)"?MFC>[^3LGN;_?>B+1X,S+P6@\UGMV,[_
M:QO9:S:!^E;I<7+<\_/@& X18EXFKT"E@"<< U=J7:,B!6ZT=V40ZK<,SW1F
M,(<,V<_1TG;@]1?]K644YO3(F87:9.$C>^Q]R, F$XVUKC(=KC#1U)\G!_KJ
M>AL$X:/O_!("Z$0@/F,;W^3:2,.7E!I?S?M<ZS<E A^Y3KKR7<C%F^Z[>^\Q
MQW/2>R<[M_D$5[[?A_B\3_WTH=_KWCH_2AQN)/P,8IV"Y&P)+,+_UKI+KT)]
M"O_<G_MSMXK+CS_^^&:W<I@>LI#MDB&OA=L?_^-__/._]M?^VJVZ#UYU*!<;
MR'8%6[5>:,Q](K$VLC"!["LR[9Y]N4?Z;VLPO_/H6L][O90L?%N^T)4N_C(3
MA3YWR<*K3>YE3 *0#4 1^";F\O'O1/-G/RH #+F$25=?+P(LF^UW_L[?^?EW
M?_=WWTJ2<^(D\M"&P:3;($@JF1X.UK"QFCAT/_=%&GK65+X;8=9-M-MA. 'K
M:02;#)R.U33@5XS[/0/^*-CQ?',\>Q-T9D4WB?==T7CE=D"S1JJB[4KN1#&4
M'Z>9JJB\=&@9-3_X@S]X.X#&[U%0:9I*'AI(1YZ: &GETYDEO2$B:Y-<?"32
M>A71ON= G<#_?(=)&)Z4S>;,/^)LO^O/-)PM2_>,XCTGXPJ<GQ3B=KUMX/$2
MH/BAKBM'YFU>SSA]CUSWLDLVT+41AR=#?B^"N1$V#1@:##5)1Q_**)+U+D,0
M /OA'_[A6_DQT$;OR2C4Z\P!3P(J@ES*%Q$-__V___=;5A+;0S^Y?Q-4#=XF
M*=7D7'1GZ\'(:(#;:0XV9_#1/7)EW[9GW-.5V[VVC(L.&$V;-N7DREY>[>W<
M-[8_!^G,PRA.Y,^5KCPYN<_JL#>YYI@>T;4OU9]M_TXVOIVE23!'IH+!4G&1
MTJA@R9,M<5_?@S5@#GL6[D/4:U/SXS_^X[> ,A(?F2^P*8-09H;]R^%*WV5X
M4ZF7K SE7Z]?O_[ZX3>N'#*7+-13R?K5'&XVYGW)1/3%O6R/*YF]LDF/!J0>
M)8(>M?&/O/LS&/JTGUMG?>CK)03AE8YZGQCF?<G%HSKL);(SQ[/M[VGKKHCF
M9X-O[^/S/O32E_7]KG3%,SKOA',C"ZEJ9$_8%R2A #,;!D?^C;_Q-[Z..25*
ML5MZ9,.=;!<;AB-AVWQ71KS680Z090L%N-S[E- QW^&$G3,OC9%/.NF$\Y_=
MUW/N3WONWAK/^UR1A2_1O\\F1LSY>&E@Y$-\+LG">YO<RP'XP#8@!4"9M(#&
M?/R[2<64_0; A%57[N&T2=D9&'4;Q:$:B03+,D1:N3[ZHL<,H"<B#.AI NIW
M9;@!? [9L&F,K96PS^8PY"3BSL+K#3,_ 6'90 &]\_2^1,G;L7H4*)Z4U16)
MF2OE.)Q68)I"\FYQ6KMG4RX1]7_Z3__I[11JF8-(6HU4?\$O^ 6??_6K7[V5
M(#O<A,+Z=;_NUWW^NW_W[[[UFU2RK"DX@C:G*WGG*=S]3DT6AJ#MS)+\7A15
M.ZV)QCP2=3T1AJ=-NLWKMC>R_O<4SQ99V,#:AU("VWMMCOH5R#LI_WO@_%&P
M^;:!QYL Q/=]/4*XOLWK68+Q'EAZ)/JZD4*3.#P9YWM[>LYE]$Z(NNB7V"@!
M+.6+ D]:*XC8RDH2.$$V(!C8(C8( <'VZ&6H_ZY3X $^! ,;$!WH>;%_G974
M8\@X_&PC"UMV^WMODRB<^Z/G[(JHV^Z_.4\=99_99&T#3O+UR'.OWBGST0&S
M5!9T=G_F_>K^FWU^B9/[-J]M/(^,X]E/;%_6,G(\YV4&(9I4:P(=3H&]@D."
M)4_OEF?;3["-/0?O_9?_\E]N+0-41JAV@$W@2+VP'<X6_"@K@[/E9WH]P3L"
MI A&V<1I!A]L&!(S5\M,DX6/R-]<F_<A$TU<W NHG!R3DTU_QEX\XS"^R>?>
M?#QC:Z?>^M#72PC"*WO_/C',(S+Q+N7B;<C/U7A.=O,>CLG:?1F(PGZ/]W%]
MV3Y7NN(1G-RDX,29_C\!,K:%KZR-VNO7KV]]_E7F):M0_VO\A\->84TMP"3L
M^!-9B!.1-*6]!I\=Y_&__M?_NF43LJELJV=O.KMEK#'QAL^W[]TCQ$[VY9&]
MO=G[^3N/KN.F?]Z$+'PI4;CY_M](1*'/D2R\!T8#/B+T7?([%]WWD^5F<P!:
M)C@3$Z?'_W'29'/8+$X__M-_^D]__GM^S^_Y_/N^[_MNI2(8=@!/QJ%>43([
M_)_L#AEN2L4TLE;2+--0OQI,O0T4 )@-G$BA=TBY[JSO/V6C3<4P[[4U7C\Y
ML)M0W%-.]P"GCS%Y)XXKPA!9&++67)@3#<!EP>@SJ(Q;=J<^"2+M%))(!K*0
MDO)GHO'Z2B;]&4FKA^1_^V__[58"E"S3*[*PG8UDF&1=IE*8<M=S?=6 ]%ZT
MXU'"<-N@<TQ7!,=)";^),_^N/E-);T[[IN1.RO\*A#\*--\%\'B)(_&AKW=!
M#+YD/39GZE$B<2.S3LY9DPSWLA,?,;@3P#=QT<0#T(9T^+$?^[&;+=$S1@8U
MNY,#MY"&@B6___?__EN_5F!--A.P)J+; ;'<GUW(J;NG8-0$;B<2PL]FQM;;
MUB]MO[,F&Q%[NO>5XS2S"KO9^P:^-KEYZ?MD[A+=WTYW;I!\=;^WK;_>]'KI
M&)[]M/WN(%_/RPFW1)[]VYSWZ8R(>LY36IC,?>S?"<[Z/=D8L(ML7ED5R'W$
MO4Q@/40%,[_G>[[GAA7U=T(2JE11>FS_(@H_^>236T  9K2'W2]!U00E9T7,
M*4/X:DY/#M#[D(G>?R>=^8BN> D^O6=GWH8\7HWU);9^LTE7V?+O\WHI0?AE
MQR_WY.)]?UZ"-^>>F\&2>]E&]VSJ^_J\3YOU9?P\HBM.<AP^(_ZH=8YMC,WT
M<UB0_=)7\'_^S__Y.?^9#1.PXE-K><-&P9SLEK8WZ;'+?JFP_&-_[(]]_K?^
MUM^ZM=M(1J'[-M\P]?7<7[&I5QFN/K'Y5PD 5WKHF?W=>VC[G6?6<&*1S;>X
M1Q@^&KQY*5GXC"[\4)^O/&M0VYF91%MZ%L[?]WW_%[(P0"R3E 4$RFP>I)6-
M(T*L+%F9L3(OQ.$?_L-_^$8>RB9$5B$*.7)*9OW,!D-@_?D__^=O&P[IJ(<4
M,*E$UOWS_%[H",M&-LV2U_Q_;ZP&$Y,@FAOI479Y@K K [NM7>84\$X932[E
MQIQB)Q?+AI$5J(Q81%Z3;WT**2=1C!S/SDD&NJ5% ^%_XD_\B1O(UL]+GP1E
M>Z]?O_Y9Q/%4."T7,V(['?C>&+WINWSIZF2X>UE(5^MPSRE]%!2<HBPO58#O
M^G-2L%>R>L_I>090OB_@\3;&^G/U>M8FG(#3B3B<>^MTKRO2\<K9[??8QK<1
M%_2DX,G__M__^W9PUD_\Q$]\_K?_]M^^92;I&2-0I6^K:*XR9(=ML3G^7ZDC
MW<G& '[T7Z*Z&0==$%W<MG+JF!-9..4[^O.*-'T;.F;J@D?O>]*/6U;A/+1F
MRQ0_95\\^RZ-20+:9]^HGO-'[_F-=+V-3^3O1!;.?3W)99_&A?8,HA!9G\ N
M>9CKW02C("@, []H!J^J!!Z!_^ 36;^"R1PKY#ZR$(81Z)1IJ#<V#*.$ZT=_
M]$=OCAH\!!ME?TYLV+V(-[EYUAZ^C_6>>_ 1^_V(S-_3_R^Q+^_Z\ZQ=RS7Q
MW8>^7D(0?DB=\Z:XXQOML^V[37Y.F.A#?[[1[-&[^KQ$GCMCWL4^6%^?#G:Q
M7Q)U9+*K8E&9@J^0K,,N"62Q6ZFH1!1J_Z7B3_DQ7.I $SUY859!+K:3;=ST
M^TG?QXZ?JONR1KG'%1:_%[1_=/U/<_R,S$S[M_D4][)^GR4'[^GL>\&T1W3C
MA_I<DH4GHQFB9IZ$DTR)N4C)0$S9:S(KII+T;S_G4(DN*XG5?S!LN\BOJ#%
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M!A0RCH7X\,0+.0;64K#-!P RU99Y^X&[_D_Q]QYAA40 G6*LCA2V45+2-:_
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MIU*PG_T>R&BC^QX%%= &//RF;_JFY?Y"GPD% **-#L #PO&._\(O_,*2)!_
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M?O;0D:-RJ:_)$4A80WYKZZ#AB&4XZ\^:'-FC2]2F'P&7*E!8PX]'<S[3'=:
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MZ2O6QJ'W9^^:K-^?G4-K?5B[WR7V[U'YM1=865.<1_*CG]M5+ZL,P\XLM.8
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M]8]8V'O.S<Q+YG+$%A[E25Q+E[!VWNX!!/> 6+-S><8*WVN(GJ+'W =(>%M
M<<]XGP(8/F2#=H^.O":3N]S;:GM PU/ PZ/ PYYWO:1]<.EVJ;5E'N,\[F=
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M 'I]WYG>L>=,[O-8@?O^SG<-&#XTH/!4L/ A7GOUP"VP\"A@>!N@\ H6/AX
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MZMJ<O=/(25-!O0[RS'2FK;,J<UN=1[W 3EC<_5WVK)FC\F$+\%W3<== PU[
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MON$;EOPPO+S 0@44/O53/W4)#P%<?/_W?_^+__R?__,"&-U\3/ES[YEA6P&
M&)#5&$S>Q%'5T5F.L)E7=ZM5L'4K-^7,L51!DLKRJ4!B9ZGF/5.0QW@!V3H
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M6 !M,7JE #!/G_ )G[#,TRNOO++L3X!N"@UA0EM+6*J]N% /C:YGV6A^:DJ
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M8S+.,7@TQ3TT1KK?8_@(R]7\7XLQ[_,)Z70O]Z0$47X ,H!#>>8PRX2?ZB>
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M<(W6:V5/>1>,004ZY!L$@,DGZ+V_YWN^9YGOY ], [P!!(6+ N0 = J-6"_
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M_;M,C2RJS+6,3U(&8 <;XQ3E(6O)2;(;^,Y1X=W)4F-BKP+S[5][%W"GD5D
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M>0@QD.1STV?@BK7BO83W440II-91PCM3B 0XF!R$C'^AQ<!!(3, ;:PO14B
MD,8!$(VQBD%H'('CUAM0FG*;BL056!HQ=#J0MU=V=*5SQ.@;.1'N4O'=DEUK
M8&$'$,X!%F8MC4*@U_(15] PA88 67Z.831B;68, KA%=PC@EMRA' 7 [N?/
MGR^,0J S$!ISSEJU/A-^"E0"-,498A\"IJT]<B;@4'5\UBB)M%DNYWZ.9"]W
ML&A6&*;F,ZSO7V56C,@JI_0CH=K&-R'(*5 4AF%UOMB'9#[ $%A6#4S[V^\
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M!A2>.L?]N0$#DX^PAY/E[S5LB6%$(<"@8-@Q@AA=PEPI H 9(6- 0J .YAJ
MD($,I)(S#F"5_%S8%8 JS X&'$.M C?=2/-_QACEHH.&,6;3WWP^#!R-0>=>
M"=GK0&'-=U:!H I )LP0* #,#*L0(X7QZAUX2KLA7T,?DVO*_/:YJ7/<97EE
M\P6X3!XP]P_34[\8SC_\PS^\A',+TV.( FFQ5P!M6)[8=X T!KEY9""G(G,U
MAFO^UH2_5; P_:V*4>]O?Z>ZM@(FF'/@,,.:\0\\QA *^&S]R&VI_YB$*CJK
M))J*V=BK6(7"7'BPL5LIJQA(V(G 1\   Q[8FU#VK(L &9'_>7]K)P! #4NN
MX%*7RWF_6KBJGYFG,NONZ\H:G3DXUG2(<[ *9_)X#:RM>?XJ>%C;R/G796W6
M;4#NVNP]^QVXQ/C!B+;WR#> -9";TX3#!%LL%7?M1XP+3+/D.R57K+-44$^X
M;X"Y,-K(X)N;FS?S9M8".UU^5^"GCY_[!^QT7^P0+''O ;2W3^R1ZDS2?(>L
MT1_]#?NP DYQ-,49-8K0B&SU-_?Q3L; V0+ T_0%J,\1$Q SK+Z;-YA]^DGN
M^JZSR3FB_X!7_Y(K?N?[YLGG;UJ%9L]/9>SJB.KY2$?KJJ^I.*O<H^9G]%S/
MUU>-<0U$Q+(1'BTLF9P#&"K.(GP/(QSS5-Y93@[O7O/'5I9/U4FS9L,8U0?O
MEC-SEI-[%CDSLGMF^M&I0.'L.=?K>EVORU[V7]5_^QF2YG=)84&6D&^<O9PS
MU2FB<90 "9V1*=9$[E2Y]58""_?(R3T@X14L?)C7@P<+LT#O&C#LP,9=M]E&
M6ML\:\R^7D6PABJ-<@)US^L:4V2D/*TQ3SI(N <HG#%WWDK7)87^: W>!;NP
MKJ=SS>WL$ M86 N#Y.\Q-E.AEK'*,&.T"8?"Z!#."9 !S@"D&#> 0>&@0$)@
M(0:-?"4 '[FF,-V$@V%*4"C<BQ''J.JLNPJ\5*.Y5]=,&'5/JA]@,09A+V 0
M.5;#M'K^P["'?)?!Q_#$*&3< Z"PU1ARR36&F>)]C%7 M]HZ6#B:I\X,ZIY=
M?4K58"U ULW'#&  )E9.@+8P\H 5"0=GC I_Q&C"=L&J8<@&#$R>L8"L,2P3
MCMC[4PW6#D[T]^M@8=:?\0)T&E=C"4B66TRHM' \K$'L04"+,&H@H29T#Q/'
M^UE_0E^PN>HZHYPF3#S 2@]=CURN?:I,KC!; R94@+HKNN8M"G2M=M^=3(\1
M+)SI$GO2A9S**AS)KYG\W&(Z=E;_R @:/3^&4P<+[0U[!\"E* F9"*3'" -<
M6Y/D($:LW)I8L,!M:YH\M$894>2&M57#2/6+/$K1GP!CC"S_QJG2P<(.;(8M
MV<?1^G1O !29)?P9>XT<>_X&NSO@>E) >)X]X>>;-P#+,)$KRSNI%T;,PAHR
MK1_>M^? U:<4T,K]W=OWZIJHS+J:1S*@?]7C HA5,&QF9-4UMK96Z^=G:RAS
MDG[6M>D\X6P2NE=3=P +Y3/D7",' =#6ES'OS,*NFZ0O?DX>V+#S$UY> <,P
MJ6?LPIFNT\>J.U37#."]!N_UNE[7Z_)7;( XRKN>,]J;_D:><&9Q.B7'*R<Z
M'9/>G/RO=#%RB&QP=3GRU,'"-5+4%2Q\&O+_48"%:]Z]<P"&%2C;L\%OV[8V
MS9:RUP&[4:A2JL+6<.0>@KP'+!SU>V;('#&PUA2NI[3!]EZ7%%BS/36:@[W]
MGAF\(T_^.>:UWRM@88"PSBR,\>7O##8&*O89, <8E0J?#!QAQ0"I-*R95U]]
M=0FSPS849B445-XF0)!P,"P)B@1CE!$3L+(J)-4(#%,C3,&P#A/:F^\FM"[Y
MR!(JYCN56=C#2",7NDSP7<H/A@I@$\")"01H$V8HC%I"9Z%B&"(\J,* C16#
MNA:&B2$=,*"OA^K)K6!6W?LQ !G0-Q\S'#%M*%[&$>"@?_J!-0BP$):+40C
M!5J8'ZQ"11> G,+Q*'8UO"WC5XW)A#HF#+F#-!F[^IF^9OU<@8P:HFVL@!.8
MFEB%QE8^+^'2-3Q/\S[>!7L5.,VX!B8RKH'6\N5@N@(<A6,+C3$?QBN 9XSM
M_AXU]#X,P[[FPN0,Z-'GZ-+,PON0@6OZPYIBW,&'H^\UTPVV=)R1/K,%&*5_
MH_V9]4LV8K"19V2;2K@8A?:=]2C)N[4I'4,:^0BL!RH"LX%S0*-4(,\X^7_
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M"Y%\TQ]G1!B[W8@<.6!JNHFM]7ST3*USN-=1.W.$KZV+T97W[?JQWT?N&7?
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MU3BG$K64(G$I()5H(I^O^_^M"A:> A2^U6S]Q]@>/%B81;IU8.]1O+:,@DL
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M&H"2)!^84^!$2%57$>8<"<&B9@$+0;[ PEF!L14.^C:J%0XJ0 <TOG___N2
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M&SLQJP?O54M_ZOWA.0_*3VVYQE61DQ7,>FSK>7/N<[8>QB\!A3TN"2<-9*/
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M/L2]+LUW3%5IY_KK.=R0I<%00_+.:9?/3.5NL!  LGE *<:N"3UF<Z0L8-\
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M/:'-("0P2)4&$BJDXF="OD SCAHXR-%W7O(:"IEV'C__\S]_<MJ 3N&\H"=
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MY\9;G)/W7M>OY?BH8>%JPMP3%GZ(8P\^36"X>FAY*;"PC\? PJ="UGD#^=
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M7L^<BC.O5\_5'J=VGF>(<CYW%KD(,/(>$$B.+#F9J%DH5CA0U"S"8\$]3A3
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M:]SU+5@(VMG, G'!7)M/5*!"AHUMU*(VKVP\V+12V=@]Z0M?^,()%K(QTF6
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MNRK)J7),30H2^TYCST;;3 .!S<-LRK2-[6(ZK>)>A9JG_Z*:3=&K!H8S-/F
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MX11JS#8"O/_B7_R+4PY!-L!]A4VD:#=FBCY%B2P?H?L2$,QNL*$VO!2K,>X
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M9&L"J,PE]DW.._^VYH2K6E?@$L#(AOD,G\6^)F?J7I_TN623(7_+M;J&%.X
M]6R.F(?>!QHE]-A&P+_\E__R!+U 3*D?J.W 0O-?.+(<L."8$%OV%F3L(QLO
MZ;^I+IZ%D%9S8 4+T_=M$WO,?;;UY_Y@0\G]0KH ^1^!O(P#9:<U#0""A0Z
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M]G[1<W?F:.M<HPU>S!UC+R4"6V5S V!G^X2[LG/4:-:5^11U*AO)7K%%-EW
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ME!D@K\TDJD'P,)LIE/#6O8T"&P;N)?KFC_VQ/W:RI0 K.P%(LJ\V#Z0GT*_
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MY]?YV1SZ&*20EPRX '1!7V/*&36NG%4*(Z^10Y*S:[X8+["P@59#VAG*.R'
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MUYSA@)NG'/75]S18[1#\+L R%6BSLFCZ<Z\%XC@_\U>(NCZ3AX[S+X>=*LB
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M0'-]PJ6I,,]5W&P@V.%K[1SWV%WJ-/O=A(5;H60-1"E&C3'02<$F3Y;Q! C
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MR4%&'03R@&@4.M1!G.=<[VP^-P!WPK19A&0%"V?^P3G_]Q0BO0[B\/E,N;*
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M\=Y'_=KKN-D[:X*B?AX MH<X'OIXD   &\_ 0C$GA60 J2E+/2CR&>/I^/O
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M=W_M\*S"I:JZBCHVQ\N8QZC6_IY(I(+$L[.SJ>_!(+$+J56IOYP?2 @"@+M
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M)=8<XZW&74I<-6VLX]3[I[IV]GW"WSUK9 4A<Y"M'Z,"MR2$B0N8_F%427
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MN:%LY7+EF!O_J=[D=..\ HT>/XU1$VC#$ %8&!8,3H8Q*,8H9: R3!DC$DR
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M;@'H)7MIX$J%A=H,\#!^:S(0ZBKCP4W4W\;+_T @P,7[S=% -<?2IJH87(*
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M7M:M:X:''SYK+1MK</+.G3O3O .)C;F]"[RTC]G// 32?J[RSM%^[[J<AW?
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MX]:D)XSHP+RX83.\&(S4'. -]9X86.)>,2@9CPQ&:K4.XBHLK$:\[XBK73?
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MU6;PE'K2=S):$[=LI-:H\ZVJIGK"D8 (\ $8 DD!+X8G8U.F8R[@8 =#4MN
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M8I$[(7<P@#&J2#&LHO@ X+212B1J+BZ@%$?4(U%U> \HQ_4,P 3EP!M&&JC
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M+\,J<">1BGD!X'$)U(:XM%HC ;7)5!M G_7C.&#$6]_ZUDE99 Z"F@&&5+0
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M3N[@M-8HKN=@8<(#@,>4VM2%UK"]WP,!<\7# 0#1O+-?>WC@FN?AA/TFUSQ
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M H7<EH%<4 ^$HC#TM_> B/[/Y;568^C_WF<LJ40=FV+0<7Q&[$2)."@702Z
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M.@!4];W^JZ[A^A]X!1"!=W$*94KFND^9:3P=M[JH)G:H[ZD)) (3\S"@KY/
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MPZP:MQ7D^!RH)>;:IS[UJ2F3,=?CG_F9GYG@Q\M?_O()(B5I!ECXN9_[N1,
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M^1P0P7U8%E:@4(*&=[[SG9/;J4RNSWG.<R8P*(,K6"CI!0@"B@ ?P!,@!7J
M53V;=#<:.RSLY[G&P%@ZM[DZ B.C8XY<R9<R6X]@(:C386%5-N8\_=V!^)PZ
M-I^)VLRXU>S@QA]PB@LYH">FH,098N)]Y",?.?^-W_B-27TH*<D'/O"!2=D&
M HI#R,58_<F?_,DIDZ_7?OJG?WI2$]ZY<V?Z+%#X'__C?YP4A8"9\]269)I6
M KFBQ$N?S&7S[7-ZY%)\&6-Q'Z-QSI@U)L[#^5(46BO@.*C^=_[.WYF2_U#?
M4F>*2<A5_[&/?>SY4Y[RE$F!*_.QA";6"[=]P%;_4X-2AAHSX]EA7> P0 A
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M12TX:=(DM]566TG*,0X, 82@*#SHH(-$677CC3>ZAQYZR $942XN7+A05(W
MH")CFC3&J@ +:R_J&"5M(&/@6MY-5=6;H3R@,+R/,BR\]_"ZLM2%(30,P6$(
M"Y-@7K]K"Z\I"2HGG2/I^'HL;6;B@W=J"Y*:KZ"0VIRD'M/4!U!(:OX22RPA
MW<%1W5*C\+O?_:ZH<E$4TB!(5;>D,3-'F&]<4];S"N.NJO7/7YNZ @JQ*N=Q
M$^^_2LM:-_/"PJ)U,IOV#*K^'*GR;Z:J[BF,'X.%YEWV+IJ-7WO,GE6<&2RL
MR>I>H,U'V\N(TY@_>OWT8[^)B8(P547Q;\ >@%"5A:1&HGI292$ C9\#"E]Z
MZ24!A$\]]91[_/''!12B%KSJJJL$%I)&.7_^? >T (:@G'KKK;>D.RM-3<X\
M\TRI4TBM-6JOK;CBB@(+^9YF)G1\/?744P4^/O'$$](Y&5#8Z_7DFK@'KCMK
MS/K]\>__+DGYY7=^CDE5*P,:5KT9R@,*P^LO>QT.GT>2FL]/$<^"AC$U*&.N
M+1RK\%K\<R0U_M'S8;R?N (2 N8__/!# >[:%9P.W\R=TT\_75*/ >D[[KBC
M@,$UUUQ3NH(#"DE'ILG)#W_X0^D@?LDEETC]3U2] 'H4A1R?.<+YT\8[:>RK
M6O_"<<VC<"T[!LNTJN9Q4^^_*LM:-XN PK8WUO&MZABL<LVH^O/18*%YU[V+
M9N/7'K-G%6<&"VNRNA=H\]'V,N(TY@]>K9>FM=&TVS%?_:[!? \4U)J%6J^0
M5%]M'H(#_^A"C#J0NH.D/0+_@'K77'.-J*)P%%*D0Z)RH@X;X/#))Y\4]=/,
MF3-%-85ZD'3CM=9:RRV[[+*29HF*"C7544<=)6JI1QYY1" AL!&0Z3=/"4&(
MCE<6X$F#.B$ \E5C88VZ/."P'WRK8P/6;T,4>UUEK\/A=:4!PQAHJ-\7A87^
M-:5=3U;\J,I103/'XN?$+W$,</_SG_\L@(\Y@=)VQHP9HK:=,F6*VV>??02D
MH[JE1N%ZZZTGM3R9'[ONNJMT#J<QT$477220'F /P'_WW7=%K0B0Y!H45-:]
MWN6-P:QY4W8,EFE-_1SIDF5]#@X""KNB,*Q[;@][S3!8:&Y>GG?1;/S:8_:L
MXLQ@84U6]P)M/MI>1IS&_,&KJ<<*"8$(./_6;JR\%I"A34ZT"S*O]U.6^4H=
M0M2!P$#2@P&#%UYXH3OOO/-$X433DFNOO59^CR+PY9=?=L\]]YRD$0,5+[C@
M G?TT4=+/4)4A(#"E5=>V2V]]-*BGJ(.&R $Y2%JJ5=>>46NQV^RDI7JR<]"
M2)BF.O,]K<%)&EPL"@^;  LU=F*O<= 8CHWO,';3-OJQT-!_AGE@8=HX)3UC
M'\IKK/DU.E6]R[&8/RAS__G/?XJ:$!!^PPTWR-Q!(7C((8>X"1,FB&H0=>T6
M6VSA-MED$W%2\U$8CA\_7A2%TZ9-<^>??[Z[^>:;!10R3S@NQ_<[+>M]9JT9
M=:Q_18!U&V AUL3/D:Y8UF=@&:"P"\"PCOE<Y9IAL-#<O#SOHMGXM<?L6<69
MP<*:K.X%VGRTO8PXC?F#%WBAC110":HKR%#5$T"#?ZOJD/=HHPAU?D<J,:I"
M( <IDZBAJ)E&RC @$%"(VI"T9%(K41/.F3-'5(?GG'..._;88]V^^^XK,&3=
M==<5M=0::ZSA5EMM-8$A-',XYIAC1#&%<A%5H=_M. W\^&/BPT*M0>AWH>5X
MFE:=U@PC#1 .&QA6%7]9FZ*Z8&'2=65M^$.U:!KL]9]5&#/]KBD-0B3]3%6\
MQ!9 /H3<J'5]4,A<H<D/*EI2\G?;;3>W]=9;B]H60$@CDPTWW%#4A#OLL(/\
MGAJ%)YYXHH!"8/W<N7,7*0I1+/I-?[BFM UPW; P:6R+S(\F6A,_1[IB:9]_
M80P- @K[-3QI.KRN:SY7L5YT"10:+#1O@G?1;/S:8_:LXLQ@84U6]P)M/MI>
M1IS&_-$+!--.QSBIQ3@P0].0.18;(E5%^;7Z_%J'O(^&)J@$Z;Q*\Y&33CI)
MZJL==]QQ OBT8S%J)UYWSSWW2!U#E(*D'I->B7)JFVVV$;44ZBE2+;?==EL!
MA8<==I@[XXPS)"T3H$+C!TV)]A6/7*-V>?65AOZ])]5K5,67[YIFK??L=\[-
M4Q2_"[ PSS4-8QU.V[3UV_PG=2A. H5%8&':M>AY_7-P;N(,:$<ZL!^[-/<!
M%#(O9L^>+?.';L=[[KFGU":D%B'IQD!T=: AZ?K4\ 0J,C> ]"@*F1_SYLUS
M;[_]MH!"YC?QG95R[P/3NC>J_2!F3!PVT9KX.=(5BUDK#!;6-Z>'O59T"10:
M+#1O@G?1;/S:8_:LXLQ@84U6]P)M/MI>1ISV^\-7&RKXM0@!&$ %?@8@8V.$
M\8>K*J, 'KIAXJNJ"GD_==8 @N>>>ZXHG(![^^^_OX! TI ?>^PQ40-2K_"^
M^^YS5U]]M8#"@P\^6" A0 2EU)9;;BF0<.>==W9[[[VWI!Z3G@P,N?CBB]U-
M-]TDQZ)A0^__NC-_\LDGTGR%ZP#&:.W")!45X^/?DW:!!I*JNM)/N?8['RLH
M],>QJ[ PQ@>-X3SQW6\#%P,!DD!A%B3+NJ:DZPA5JW[,\%6;!9$23+P"\HC=
MUUY[3=2V@,*SSCI+Y@SI^"AJUU]_?5'8DI+_Y2]_6;H?H[I%9<C\F#IUJJ@)
M>2_*76H= AY1^JJB4-./%9+K]65U; ['H,HUL&C<E1V#95L3/T>Z8OWF9LPZ
M$<+T-*ANL+ Y7A?,,UAHWG7OHMGXM<?L6<69P<*:K.X%VGRTO8PXC8&% $&
M&.#BL\\^6P0,@0LHH%19J*_WTWSY&=^KJK#7ZPD$O/[ZZR7U&-BQWW[[2<,%
M@"%IR$ ,ZAH^_?334J.0-$M>]]WO?E?2*FEB0JU"TBV!A[Q/(2$PA)J'@$)
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MY?F]]]X3(()""P=Z*NQ4)94V/?'_\-:QXP]R58%Q7]P/<!#XJ< P%A;V\Z*
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9GE6<_3\NNBX'[T: 3     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>cutr-20210630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:cutr="http://cutera.com/20210331/20210630"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cutr-20210630.xsd" xlink:type="simple"/>
    <context id="ide53b89e851c44e5908a02860291ac35_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0f37c4df46fd44559fdc74b178f893a0_I20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="i85fff53fbac547228677e769db10e805_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic827721b28ff49aca3277a242cc858a0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2fcfd7b210f74dc5976983de27855478_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibcb365aaec5f4975a3f836175dc8e2ce_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibfb65299d11046adb017318fb542b3be_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idb26dda9fd88462aabb4723bea6e2287_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia8b6fed2a51f45858d2dcecd28277fef_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i73f49a322eb84c7383e92e7174381a6c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icd94bfca54cb406f8ffb1fc2d03add57_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i467c84ff364946159dcd87dd18558b41_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8a0c97ff1a1844bfaafd62ddbe64c6ed_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaf7ddfb11c484a379285f7f24ccbb30f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if7d9d29deb264e90befea8186ad2923a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic54b608c69b7450ab0118143a7142782_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idbee004c85ae406b9b109bd61037d4b4_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i71ba6bea3ea04bdf840846d3dc75fca6_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i73640a3ad3ca43178734929432dc6628_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icf4c9f98bfbf40d2a4bbf237cf1e1846_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ieaee018047a74b78859eeb591b6c591f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i485b22c217834e23b0364e76e06a2371_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if3010403a70d436483ab771b941a207d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie8367f0895fb4ca3b02c812b17b329e3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia490656dd3ce42e2bf315a7086535095_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i484a97403f27472ea9481c015d1527fb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie07d79b96d4d4295b68c970c1206cf32_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i44e8ae2855f24ec191abeac87edead4a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9e00e169b2114d2997dc62ba88fc41f2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id1e3e98112d445a2b78ea2ada37f81ed_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib5bc0220b3cd4bbd82245f12526ec90e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2f3e187f8cdd4a27a16464c1e2230fec_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i244e0262c30f4bc59029986047588df0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i570d20ed67764205924e7fee40c9295a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4b3d4dae27cb4fb68ccfb9a3a1a93823_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i33947892bb224113abf96b09e46ffa54_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i85bdd8375cea4bfcbeb0257fbde7b2b9_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i170f952087874acbaa3da79723af4837_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia3b47574caca46b99fb6499883087ed3_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iba9e052e19bc4d9cb3949ba436e89381_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib5cfedb49abf43a58191f2993ef3e540_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie7cb0aefbadc4fae96b37599c7955716_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i341bd948a0694080b463b58e446e0e46_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i03250011c65e4e58a12c712ed93a235f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ieb9afea6585c438abf605e46f4b90bf5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i3c44dc3e39a944f386ee804f3d8d2f1d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iaca8eee5ccbc423ea5d21f84cdc0c483_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ibc6ab3c5a57d4419a7741a81e73e8cba_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iff1d956612db4dee81869096bfed413a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i06df2fa92c07439982ab4b6fddb466f1_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia11ce6b42e50441a8bfd1cd6564d5f99_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if7fdc7a0b6b84196a94bd8e81d4ff9ca_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic074f4f3008d47a7a3965891ed645a3b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8358e3138b90489dafac816f75a0e5f8_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2456eaded80b44f784a0a4a1f81e0150_D20210305-20210305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-05</startDate>
            <endDate>2021-03-05</endDate>
        </period>
    </context>
    <context id="i65e02799f7d2458f8b8251dfac3c7b7b_I20210305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-05</instant>
        </period>
    </context>
    <context id="ie60ebd26bc7440ba9911c6237d5ce6df_D20210305-20210305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-05</startDate>
            <endDate>2021-03-05</endDate>
        </period>
    </context>
    <context id="ibd2a463e83364d2bbb2747aea222f7be_D20181001-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cutr:ProductRemediationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i95ac0510552241b18a45a3559b512564_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cutr:ProductRemediationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa7cefa41ffa4fcca09040bf29e8bd08_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cutr:ProductRemediationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie45277ed62d346cdb9916dbb3ad17292_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cutr:ProductRemediationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia2c95c40b3a643028669a714bdf84fcc_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cutr:ProductRemediationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3522b04102fc4ee69538b27d4416746f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cutr:ProductRemediationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic95c28211b0e434aad49ee7875023aa1_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cutr:ProductRemediationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifc4ad6178c2c49418650716374160150_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2407102de7bf456bba0a70df24f73953_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-07-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i881844cc567943b08e58b8c62bf2cdb7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iebd0fb6eb91a42ec917f088a099d13af_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id5f9a379644248b4bb314bae98be198c_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifc6d773f0c1a4f6b95a87d9eb4d6ac20_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i470d10cc776b41649b8a03cf1ec2f3fc_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if3f410467d4d4330ad372e3a956470ad_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:CustomerMarketingSupportMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i36aa596dff8748588786668800832709_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:LoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6f22dd0f34be4388a01961e660f5caf8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:LoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i274a6e322a504ca69c72bdb069af291a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3c7a53758f744376b8ee593f5591f92b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i35c2ccc976154aaa943236bfb9c494ca_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia3cba542e3a741d4a477c46679b67946_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6676b6bef6f2454fbbc76aea9a2cc1da_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iea529016b4144eb5becac8fb1c31a306_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i39a83be3b8224826a825113043c0f630_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i56e825e587f849159fe52471c86de3c9_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i043c44727e4748838f975923cbe8de27_D20190601-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8051166907c44cc3b4d720878ae84444_I20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:AmendedAndRestated2004EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-31</instant>
        </period>
    </context>
    <context id="ibc771595ca97435b917e76c6379187af_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1c1cc14f1d17439ab6dc582f75bd1a5b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cutr:NonEmployeeDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia86610d6c30943a98b2884869af2e9a8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cutr:ExecutiveOfficersSeniorManagementAndCertainEmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie9988de6b19146808f537a79f2f4003b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cutr:ExecutiveOfficersSeniorManagementAndCertainEmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i13634336729642d784da25921efe552a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cutr:NonEmployeeDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if82f30c5243c44b4ad80cd7520748ea9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cutr:ExecutiveOfficersAndSeniorManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8283a2c2e73d47759779e4f3016de4be_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cutr:ExecutiveOfficersAndSeniorManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5eb930ee997642608de2ef098dda5547_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cutr:ExecutiveOfficersAndSeniorManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:NonqualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8b76898f620849e68db8504b5c340666_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cutr:ExecutiveOfficersAndSeniorManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:NonqualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie7a69c86013f47fd84b88ded0e2796dd_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8d63e931f0e34f97838b48f7c9d93f52_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:NonqualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib2f388401ace46cab8547a66f8274e5c_D20190930-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-30</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0086c16aff3843a88d06e0b9a23ab663_D20190930-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-30</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i260072c69a4b43b297a42091f34d2d34_D20190930-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-30</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1c46e2208d6a4e10972c5f842c7fcf68_D20190930-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-30</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3774f37aef574876bfd257a704d58d18_D20190930-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">cutr:ShareBasedPaymentArrangementTrancheFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-30</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ida744089b3ac429ba5d244a28072197f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i686fa2a5de5542978b650edda0bb93db_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i20bf571b99a94909a5b0526d60ddfc07_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i244333557f0f4c1f9b9e1e26967d871c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if91020effb684eec96e7ae9b7579c211_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i04a939a51cb44bbfab0551c699f24582_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i38c5dcae21c84726b4ba51da80b02ac4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie58ba076e2704369a7e7ca1be3068f0a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6e5db1d27c0d467fa8a06f3edfd4046b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4c3011eb06b8441e960fb49156c2b7bb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie6d4ff6c6be04324bd9520f1387d71dc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i41584b05a4664ba3af97fb224bccbdae_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i19202ea6769b485981af1a269c354a3e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibe19bb61d2c04cc187ecedbd6e6de449_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if15f1055aa4c497db7227c965f673e0b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia1d2e0e7bf114927b546768a3c34a81d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="idb17262b381746f787063be8b5d55b71_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1e15052c9d0d44619f2e3d20485ef206_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9707b7e07a2a420e93afba7c1ea09419_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idee8ae2735f8498b9407c4ced951bf09_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic21ba9ca8ecf493ba645bdbe2ad6c2a1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i26b8cbc3a16e449f9a39f3289247bef9_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i28760ad245b749f6b1743389a6736740_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaaac0feab41147a8a2bc8fd8f7ba33f3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie3e1bb0168eb49be9bc31f592a1a35d1_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i99969d197ffd450f94deac6fd22dac12_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8fcff246ef044996b2ff3e18abe4904e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2385bd8fa768474f8fd3a114312d5e7d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia4ecd89ae62344f7917567fbab93bd54_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i24a4aae559244b6da9a355eef4892d50_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if55087856ea4480f878b84dad9aa0b2f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1c67032870244a09929098911256c828_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic2e0ff6f1deb4186b8284936187d5163_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6d1b842b5a004755b84c230f3296b806_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i134de9f1f57f47888632a9ceef35480a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic53569eddd914356abdacfc8f46a8065_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia12fb8b4c6934135894efcee0133760d_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib073b66268e747c7beb7c3e8cb6725cd_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id1c39d3cd4704eb18a973e3632ebf4c9_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i927cb99cf11849a28b18cccb13b34952_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i248c328a529348aa9cc98c13d080a639_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5fcb4b561a904836a0f0d23aa399f03b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic24aac68960d4d5abac630ee5fc03264_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i422e7e2d5153428685677e8df3cd31cf_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icea00b8fe11140daa1cb985e030d37f8_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1aafabe8c64f4228aed37026513d86ff_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ieedfa579e0344b4d82de2102e49f38e2_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4b551207fffb4cf09782a3a505b3bc0e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i401936e680d64b628acd735705146547_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="idbf8f9287eb3474aaf029523648da76e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5163e2df3c5d4005869929c9e18ad6d6_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id4ce9a67e28441f483cb009b64dade32_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0774db4163af4fd1a5b476fc7f6ec2c8_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia2ec6fabd2ce464c93e692843370b13e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iceba727bc88e4acfafb969683a5040c0_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia7cbfd7fb2004b41977955079c24d470_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5dfc2cdcabad463db38b6603f1116204_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie02f2877a5a94ba1af32fcc4842c447f_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i35e40b62c61640d6ac4a638987ded61b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2704d4d253f94eceac8a62deac8a8b8a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0078d122644a4dddab29d2f40360b3c0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i895c5dc933e94035967c4ca15bcf095a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3039819417a84fd7b2aa536ffb2ed8d4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i41feb9a60cd54b25be885f1459623391_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic0624b58f9374ca4b58497be819f0521_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib7035befba854bb787b41b7a326649e7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaea3ce259c6d4b31887911f5a24f9386_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026FirstConversionTriggerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i07f11bb2c2e748f7a93f2cf71e0ba828_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026SecondConversionTriggerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5ddc6ffd69484d648267e3fa81be0a45_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i489cafda5c3f4762af77cae7f75a401e_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1290f60e05c943b9995db59a6927e23a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia674f145a1a94467899389e49f535d8f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic40cdb4b583b4d60bd81237f32311633_I20210304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2021-03-04</instant>
        </period>
    </context>
    <context id="ib0131d61368a466d8a6ca8117c109ad7_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia1ba13fde0c14860bd56f281fcae9480_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2dceabdb8060472888bc8746205213da_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic0afd02d742a4c50bfc5ec134cc472c9_I20180530">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:WellsFargoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-30</instant>
        </period>
    </context>
    <context id="i6f5872525ec8417bb65b72a9ac49e61b_D20200709-20200709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:SiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-09</startDate>
            <endDate>2020-07-09</endDate>
        </period>
    </context>
    <context id="i73dd1591ec4d4f828e27088ad0d09aeb_I20200709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:SiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-09</instant>
        </period>
    </context>
    <context id="i84e5687763244213b65265c035c8bdcd_D20200709-20200709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:SiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-09</startDate>
            <endDate>2020-07-09</endDate>
        </period>
    </context>
    <context id="id99d22627e1c49f080008eaaceb8a64e_D20200422-20200422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-22</startDate>
            <endDate>2020-04-22</endDate>
        </period>
    </context>
    <context id="i22ce661a87cf458ba03c056354564a8e_I20200422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-22</instant>
        </period>
    </context>
    <context id="id84ea3c345a84c8c820c9be723af5e27_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i54330428060a4653bc4b61cd17bfbb1e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0d2437002d5848e6ba1f2e904bcedb15_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5cd8c122a6db4b479f4cb170d5340e5f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifc32166982764821b862930f62f92b51_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0916cb6cfef149efba3569c230352115_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifc041928fcd442d691a2b8f145bf69f3_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i60cc413c28af471da2fd3a5cb7567dfe_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i001f2e7ffc384283a6262f680531b654_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i45c4fddf3ca04af29dc98fd3b2a1c1b3_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaee1d9be4d174579b2a79cbe1837cf25_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i605c06860c2a4b9ba038414773646e05_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6b993bcbab604605a3f9186a75679bc5_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icac68fb392c34970af1e7c3bbd64b047_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5628efd5ddc746118fb44e8463069210_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iec6fc50f8e8e41c4b1b36ce9c699fe36_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia1e77ae11263421aacb8d6bb8940ff5b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6b6561e7c0bc4c82b78cc302b59ada69_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iedce34eaadb2414ca33df76ede46361d_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i72c021f9acb64626b780975f2f7b37bd_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ieae31fb3cfae4ce588f0407780016251_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i74194697532c48e689caa0d810cf7dee_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic61b8af9d2a44ba89d29a042679de961_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i257d2e51a1bc4c85b8cffc47eabccc0b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ProductsExcludingConsumablesAndSkincareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id006d6e7ce234b7486129ec2b87c40c0_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ProductsExcludingConsumablesAndSkincareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibe8306ccc3f44558b1235fa08edef7ed_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ProductsExcludingConsumablesAndSkincareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id97644f373e8442c982dab972c23de51_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ProductsExcludingConsumablesAndSkincareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ief96e147f922486883c4d8cc587f8f60_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibd1e322af3b8489a8e9d1c2f562b5e8b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if3afbc47a9fd48df8033033413b4338e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0c347ebd3f934ddaaec736c2f53a0eeb_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i612e38fd3e404dcb98febb98ac966dcd_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i532d55314af64158ac48f5d2f1d43acc_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i70f692ff4e534504a06fd1b76829e106_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9a21f86e33ca4228a03854c5f5b0821c_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="country">
        <measure>cutr:country</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="day">
        <measure>cutr:day</measure>
    </unit>
    <unit id="usdPerItem">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>cutr:item</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>cutr:segment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80L2ZyYWc6OGZmMGM1MDBjOGMyNGU3ODlkZjM1YTRiODJiZDg0ZDIvdGFibGU6NjUwZWIxYmQ1NjQ5NDliNzhmNzFhM2VjYWE2ZTFhOTUvdGFibGVyYW5nZTo2NTBlYjFiZDU2NDk0OWI3OGY3MWEzZWNhYTZlMWE5NV8yLTEtMS0xLTA_51935e3e-a23d-453b-9b79-4d1943d47ed4">0001162461</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80L2ZyYWc6OGZmMGM1MDBjOGMyNGU3ODlkZjM1YTRiODJiZDg0ZDIvdGFibGU6NjUwZWIxYmQ1NjQ5NDliNzhmNzFhM2VjYWE2ZTFhOTUvdGFibGVyYW5nZTo2NTBlYjFiZDU2NDk0OWI3OGY3MWEzZWNhYTZlMWE5NV8zLTEtMS0xLTA_ade6a893-1ee1-4e13-933c-f6ac1d887efa">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80L2ZyYWc6OGZmMGM1MDBjOGMyNGU3ODlkZjM1YTRiODJiZDg0ZDIvdGFibGU6NjUwZWIxYmQ1NjQ5NDliNzhmNzFhM2VjYWE2ZTFhOTUvdGFibGVyYW5nZTo2NTBlYjFiZDU2NDk0OWI3OGY3MWEzZWNhYTZlMWE5NV80LTEtMS0xLTA_e0c4e1e6-200e-478b-81d2-cd625a28cb73">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80L2ZyYWc6OGZmMGM1MDBjOGMyNGU3ODlkZjM1YTRiODJiZDg0ZDIvdGFibGU6NjUwZWIxYmQ1NjQ5NDliNzhmNzFhM2VjYWE2ZTFhOTUvdGFibGVyYW5nZTo2NTBlYjFiZDU2NDk0OWI3OGY3MWEzZWNhYTZlMWE5NV81LTEtMS0xLTA_d43283c9-363d-4762-8ab2-bae01cf0972d">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80L2ZyYWc6OGZmMGM1MDBjOGMyNGU3ODlkZjM1YTRiODJiZDg0ZDIvdGFibGU6NjUwZWIxYmQ1NjQ5NDliNzhmNzFhM2VjYWE2ZTFhOTUvdGFibGVyYW5nZTo2NTBlYjFiZDU2NDk0OWI3OGY3MWEzZWNhYTZlMWE5NV82LTEtMS0xLTA_7cb39057-a0b4-4c69-bd9a-3e49352791af">2021</dei:DocumentFiscalYearFocus>
    <cutr:ExtendedServiceContractOptionOneTerm
      contextRef="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfMzg0ODI5MDY5ODIyNg_e653e8fe-f332-4582-857d-3372b1518b74">P1Y</cutr:ExtendedServiceContractOptionOneTerm>
    <cutr:ExtendedServiceContractOptionTwoTerm
      contextRef="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfMzg0ODI5MDY5ODIzOA_506311e3-b01b-41cc-9bc7-3004836d0ad0">P2Y</cutr:ExtendedServiceContractOptionTwoTerm>
    <cutr:ExtendedServiceContractOptionOneTerm
      contextRef="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODg3OA_37d5a87f-934a-4984-8ce6-ca3dbd45b43b">P1Y</cutr:ExtendedServiceContractOptionOneTerm>
    <cutr:ExtendedServiceContractOptionTwoTerm
      contextRef="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODg5MA_759bd265-f34f-4f56-92c1-11dc5f2a0f73">P2Y</cutr:ExtendedServiceContractOptionTwoTerm>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="i274a6e322a504ca69c72bdb069af291a_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcxMDQxMA_6ae4c934-3ce2-494d-a9ef-e60aa0c8aad9">P2Y</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear
      contextRef="ie7a69c86013f47fd84b88ded0e2796dd_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83Ni9mcmFnOjI5NzM2Yjc3MDVhMzRkMDI4MTc5ODQ1MjcyYjNjMTJlL3RhYmxlOjNiNzc1YjM2ZTE1ZDQwNTI4Y2M3NjUwMDBhMGFlNWZhL3RhYmxlcmFuZ2U6M2I3NzViMzZlMTVkNDA1MjhjYzc2NTAwMGEwYWU1ZmFfMi0xLTEtMS0w_04968a77-b6fb-4e41-bcb5-e9307174b6c2"
      unitRef="number">0.0278</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear
      contextRef="i8d63e931f0e34f97838b48f7c9d93f52_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83Ni9mcmFnOjI5NzM2Yjc3MDVhMzRkMDI4MTc5ODQ1MjcyYjNjMTJlL3RhYmxlOjNiNzc1YjM2ZTE1ZDQwNTI4Y2M3NjUwMDBhMGFlNWZhL3RhYmxlcmFuZ2U6M2I3NzViMzZlMTVkNDA1MjhjYzc2NTAwMGEwYWU1ZmFfMi0xLTEtMS0w_8e23faa9-da2c-490c-8f82-d1f6d830180b"
      unitRef="number">0.0278</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i8d63e931f0e34f97838b48f7c9d93f52_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83Ni9mcmFnOjI5NzM2Yjc3MDVhMzRkMDI4MTc5ODQ1MjcyYjNjMTJlL3RhYmxlOjNiNzc1YjM2ZTE1ZDQwNTI4Y2M3NjUwMDBhMGFlNWZhL3RhYmxlcmFuZ2U6M2I3NzViMzZlMTVkNDA1MjhjYzc2NTAwMGEwYWU1ZmFfMy0xLTEtMS0w_739a98a0-2332-4f0a-aa44-1b71811a467d"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ie7a69c86013f47fd84b88ded0e2796dd_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83Ni9mcmFnOjI5NzM2Yjc3MDVhMzRkMDI4MTc5ODQ1MjcyYjNjMTJlL3RhYmxlOjNiNzc1YjM2ZTE1ZDQwNTI4Y2M3NjUwMDBhMGFlNWZhL3RhYmxlcmFuZ2U6M2I3NzViMzZlMTVkNDA1MjhjYzc2NTAwMGEwYWU1ZmFfMy0xLTEtMS0w_fb71f808-fcda-41b6-972d-ddba9b4f9d6a"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:LesseeFinanceLeaseRemainingLeaseTerm
      contextRef="i274a6e322a504ca69c72bdb069af291a_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDkwNw_973afb6b-4acd-4a55-af58-d468b11c7d99">P1Y</us-gaap:LesseeFinanceLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="i274a6e322a504ca69c72bdb069af291a_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDkwNw_c98812fc-de92-4bc9-ae63-a2ea2dcf1178">P1Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_191ff28f-24ee-4553-9783-0b42ebb65ac6">us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_919b7924-791c-4466-b8a7-24aa8118f77b">us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_b5e783e0-1851-4646-b5d7-45c5c8303178">us-gaap:AccruedLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_f32d24a1-2fa6-47cd-9e48-aa722ac2d210">us-gaap:AccruedLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_10ea67d4-7eb5-4177-82e5-7c042f1357e2">us-gaap:OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_88c2e4ea-2944-4622-bbd8-af1b7cb70fc0">us-gaap:OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i0d2437002d5848e6ba1f2e904bcedb15_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDAvZnJhZzo2M2IwM2M2NDc3Mjk0NzZhYWQ0ZmM0MTQ0YjMxODA0NS90YWJsZTo5OGI3Y2Y3MjU5Y2Q0ZTIyODQ2NzIzM2Y0NDExY2JjYy90YWJsZXJhbmdlOjk4YjdjZjcyNTljZDRlMjI4NDY3MjMzZjQ0MTFjYmNjXzEtMy0xLTEtMzAwMw_0ee4a481-56e1-4dd3-a996-8ce260a87a0e"
      unitRef="number">0.0301</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <dei:DocumentType
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDcx_57222b5b-97e1-45c9-8ebb-fb2bafac115c">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6ODEyYWQzZmIyNTEzNGYxZWIxN2RkMWJhMjEzNWY4YmMvdGFibGVyYW5nZTo4MTJhZDNmYjI1MTM0ZjFlYjE3ZGQxYmEyMTM1ZjhiY18wLTAtMS0xLTA_dbd93ee4-5d57-48c9-badb-a09621df70cd">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMTk5MDIzMjU3NjM4_40d9a4ee-66e6-4c50-9be6-6d90f9111b42">2021-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6Y2RmZDY4ZGVmZTIwNDg3YzgyZTVhNWQzNTQxZjAyY2IvdGFibGVyYW5nZTpjZGZkNjhkZWZlMjA0ODdjODJlNWE1ZDM1NDFmMDJjYl8wLTAtMS0xLTA_58e051d2-41e0-4552-b821-27dedb7f0e77">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDcy_7c8669f2-fbac-4629-bacb-8fad7f115d1e">000-50644</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDcz_6a3fb106-e28c-41ac-8c9c-3a080fc54c33">Cutera, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6YWY4YWI2OTI1YTBkNGZkMWFmNTIyOTk3N2ZjZmZkYTQvdGFibGVyYW5nZTphZjhhYjY5MjVhMGQ0ZmQxYWY1MjI5OTc3ZmNmZmRhNF8wLTAtMS0xLTIyNQ_3c4141f4-f48f-46e7-980b-013262cae3d3">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6YWY4YWI2OTI1YTBkNGZkMWFmNTIyOTk3N2ZjZmZkYTQvdGFibGVyYW5nZTphZjhhYjY5MjVhMGQ0ZmQxYWY1MjI5OTc3ZmNmZmRhNF8wLTEtMS0xLTA_3fdbd20e-6bf1-48f9-a8da-75d127ce2298">77-0492262</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDc4_e230b3ec-be09-4d50-a253-ee2aa4102cc0">3240 Bayshore Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDc5_dfea992f-cb46-4c2e-b1ad-ba996ff3dd9b">Brisbane</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8zODQ4MjkwNjk5Mjk3_754f122d-57d6-4d12-90d1-43f0f31f259e">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDgw_e7ed0f0c-8698-4c6b-a28d-5b799724c286">94005</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDc0_07198069-5d07-43c5-bb12-b5153be9ab91">415</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDc1_35f174ed-cf5f-405f-b329-fd6bb318e7fb">657-5500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6NGE5YWE5OWMyZWFiNDJlODg2ZjhjZGJjYzVjY2MwM2EvdGFibGVyYW5nZTo0YTlhYTk5YzJlYWI0MmU4ODZmOGNkYmNjNWNjYzAzYV8xLTAtMS0xLTA_e950e56e-ae31-4d4d-8727-7a34e554825d">Common Stock ($0.001 par value)</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6NGE5YWE5OWMyZWFiNDJlODg2ZjhjZGJjYzVjY2MwM2EvdGFibGVyYW5nZTo0YTlhYTk5YzJlYWI0MmU4ODZmOGNkYmNjNWNjYzAzYV8xLTEtMS0xLTA_06c570b9-3072-4d14-8f56-52bfd4cf9dc0">CUTR</dei:TradingSymbol>
    <dei:TradingSymbol
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6NGE5YWE5OWMyZWFiNDJlODg2ZjhjZGJjYzVjY2MwM2EvdGFibGVyYW5nZTo0YTlhYTk5YzJlYWI0MmU4ODZmOGNkYmNjNWNjYzAzYV8xLTEtMS0xLTA_482fd247-4b8b-41ea-9ae5-ee73ce565429">CUTR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6NGE5YWE5OWMyZWFiNDJlODg2ZjhjZGJjYzVjY2MwM2EvdGFibGVyYW5nZTo0YTlhYTk5YzJlYWI0MmU4ODZmOGNkYmNjNWNjYzAzYV8xLTItMS0xLTIxNQ_56497388-3a83-4e27-800e-6d9756c66521">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDc2_3405accc-6fb7-4c90-bebe-b267fb6591a9">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8yMDY5_f88fbc6e-16fe-4c4b-b141-ed9e0e05b78b">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6ZDEwOGRkZjcwODQ2NGMzZDhjOGNmZmY0YzM4NmIwZTUvdGFibGVyYW5nZTpkMTA4ZGRmNzA4NDY0YzNkOGM4Y2ZmZjRjMzg2YjBlNV8wLTItMS0xLTA_696b959e-2a49-4eab-a3f5-63f4e8bb7384">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6ZDEwOGRkZjcwODQ2NGMzZDhjOGNmZmY0YzM4NmIwZTUvdGFibGVyYW5nZTpkMTA4ZGRmNzA4NDY0YzNkOGM4Y2ZmZjRjMzg2YjBlNV8wLTctMS0xLTA_36235b8c-17ab-45f0-9586-08d320bf3e36">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGFibGU6ZDEwOGRkZjcwODQ2NGMzZDhjOGNmZmY0YzM4NmIwZTUvdGFibGVyYW5nZTpkMTA4ZGRmNzA4NDY0YzNkOGM4Y2ZmZjRjMzg2YjBlNV8wLTktMS0xLTA_73dc4b92-dd9e-428a-9f1c-07ad6f174eac">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8zODQ4MjkwNjk5Mjk4_39f71386-b0cc-44c4-bb5f-56f9b1eb1b2b">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i0f37c4df46fd44559fdc74b178f893a0_I20210730"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xL2ZyYWc6ZTM5YTI2ZTY4YTFjNGI2Mjg2NGJhNDVlMjk0MGRkYmYvdGV4dHJlZ2lvbjplMzlhMjZlNjhhMWM0YjYyODY0YmE0NWUyOTQwZGRiZl8zODQ4MjkwNjk5MzI3_e982dee0-7127-4a66-bc46-12288e4d489f"
      unitRef="shares">17942446</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMy0xLTEtMS0w_a7cc4688-d327-4b5f-9ad9-5581af57d63f"
      unitRef="usd">169200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMy0zLTEtMS0w_e5c69269-817c-444a-b892-f31001432933"
      unitRef="usd">47047000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNC0wLTEtMS0wL3RleHRyZWdpb246ZGQyMzc3ZjVkOTc1NGEwNmEwM2E1MThlMjU4YTY5YzJfMjE5OTAyMzI1NTY1Nw_37f4a90a-8761-44b0-a8cc-dab0fd2587b3"
      unitRef="usd">1639000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNC0wLTEtMS0wL3RleHRyZWdpb246ZGQyMzc3ZjVkOTc1NGEwNmEwM2E1MThlMjU4YTY5YzJfNzA_8b8f6949-00ea-4a37-a702-34d131047791"
      unitRef="usd">1598000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNC0xLTEtMS0w_36385ac0-18b5-41b4-b03b-43406aeb1e55"
      unitRef="usd">25903000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNC0zLTEtMS0w_b678bb3e-3d04-447e-89bf-929aa247d7f1"
      unitRef="usd">21962000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNS0xLTEtMS0w_ff02c849-d89c-4807-ba67-492f6d4a92c0"
      unitRef="usd">34591000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNS0zLTEtMS0w_60233852-9933-4814-8daa-9ade22126561"
      unitRef="usd">28508000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNi0xLTEtMS0w_7947d5ec-1104-48f4-a82b-52cc7697fbb4"
      unitRef="usd">8856000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNi0zLTEtMS0w_782d922e-2546-4ab3-8ea0-e0861cbe6e24"
      unitRef="usd">8779000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNy0xLTEtMS0w_3df37dc4-fd79-4dae-b817-5c1973e69e30"
      unitRef="usd">238550000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNy0zLTEtMS0w_c9235d9f-6718-4507-b9e2-3f40501d2be4"
      unitRef="usd">106296000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfOS0xLTEtMS0w_735c30f0-63e8-433c-af0b-e24b8a8dbebc"
      unitRef="usd">2148000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfOS0zLTEtMS0w_0d287565-9f5a-4e19-8705-d9af98ed10e9"
      unitRef="usd">2299000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTAtMS0xLTEtMA_38b1a870-6cf6-4334-b492-91adc4905d9c"
      unitRef="usd">592000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTAtMy0xLTEtMA_b2ce9e9f-b286-41b2-83f0-f8d40feac659"
      unitRef="usd">643000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTEtMS0xLTEtMA_955c224a-b7c1-47ad-85f7-97b8e9c7f6aa"
      unitRef="usd">15919000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTEtMy0xLTEtMA_ad310d73-4e42-4238-a5a3-54a19fe65368"
      unitRef="usd">17076000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTItMS0xLTEtMA_6ccebe36-823e-4d94-a271-6363876ede33"
      unitRef="usd">1339000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTItMy0xLTEtMA_6c100840-d248-4aee-89a8-33e80ff8cdef"
      unitRef="usd">1339000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTMtMS0xLTEtMA_c2f5c335-4be4-412a-93f7-c92dc1119e4d"
      unitRef="usd">5615000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTMtMy0xLTEtMA_cbda10c1-d769-48f9-9c10-2e05f738dca6"
      unitRef="usd">5080000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTQtMS0xLTEtMA_71754b1a-fafe-40cc-ad8b-6438321b7dc4"
      unitRef="usd">264163000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTQtMy0xLTEtMA_2d2d1aa0-461f-4c1d-91c7-f3815d916182"
      unitRef="usd">132733000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTgtMS0xLTEtMA_63ad8576-9852-43f0-b136-7f4a39f28d30"
      unitRef="usd">6210000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTgtMy0xLTEtMA_8347e233-3fbc-4ce8-8007-5c4c1d29fdaa"
      unitRef="usd">6684000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTktMS0xLTEtMA_606da794-3b0b-44fd-9768-96e35cb82979"
      unitRef="usd">41343000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMTktMy0xLTEtMA_2ef18032-323c-4e28-82d5-b264984f776c"
      unitRef="usd">31079000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjAtMS0xLTEtMA_4a71dfd6-5e08-4c54-9401-fc91702a8f2d"
      unitRef="usd">2422000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjAtMy0xLTEtMA_32357f57-3ee0-41c5-a259-c6d849e6cc63"
      unitRef="usd">2260000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjEtMS0xLTEtMA_4a6c3272-f256-4634-a937-feecbce100e9"
      unitRef="usd">0</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjEtMy0xLTEtMA_a1dabc87-b94f-4ac6-9752-29a5adfd0fa5"
      unitRef="usd">3630000</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:ExtendedProductWarrantyAccrualCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjItMS0xLTEtMA_4d7c9c6d-6a02-4b3c-91eb-4484a2bf471a"
      unitRef="usd">649000</us-gaap:ExtendedProductWarrantyAccrualCurrent>
    <us-gaap:ExtendedProductWarrantyAccrualCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjItMy0xLTEtMA_87d57a67-4ede-486e-8183-9a20fd87f119"
      unitRef="usd">1216000</us-gaap:ExtendedProductWarrantyAccrualCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjMtMS0xLTEtMA_92adb23c-0c93-4716-9aa4-0c56170d9699"
      unitRef="usd">9695000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjMtMy0xLTEtMA_a94bb240-92c6-4d43-9e3f-fd76e5efae6a"
      unitRef="usd">9489000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjQtMS0xLTEtMA_bf845964-9ea1-4c09-87bf-121851d0c0ad"
      unitRef="usd">60319000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjQtMy0xLTEtMA_ff57ebbc-16c9-4128-83ac-ecf35a0ec560"
      unitRef="usd">54358000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjYtMS0xLTEtMA_f8fdc722-97c7-4b64-92fd-1687a19492f0"
      unitRef="usd">1708000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjYtMy0xLTEtMA_92423149-33be-49e8-bf5f-4156253651b8"
      unitRef="usd">1748000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjctMS0xLTEtMA_464359b4-730b-481b-9b6a-2b87cd915a7c"
      unitRef="usd">14705000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjctMy0xLTEtMA_6dd5a79e-185a-4a3a-988a-7bcd1ce40bb1"
      unitRef="usd">15950000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjgtMS0xLTEtMA_aad363ae-aed8-4c28-bc9d-3d928644cbdd"
      unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjgtMy0xLTEtMA_956f6732-de25-45f0-ad60-46be46d89bf1"
      unitRef="usd">3555000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmVmZjJkMGEwMDZjMTRiODNhZDliZWY2OTQyYjQxZTc0XzY1_2f9e0923-c2c5-44ee-9bcc-8aba7e15d421"
      unitRef="usd">4450000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjktMS0xLTEtMA_48e7b645-dce6-4f86-803c-bad5a3022cd8"
      unitRef="usd">133800000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMjktMy0xLTEtMA_690fd541-5e90-4bac-a817-4ccc7b03e641"
      unitRef="usd">0</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzAtMS0xLTEtMA_4ef78c48-2fd5-4b7e-994c-e513cc8a505f"
      unitRef="usd">288000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzAtMy0xLTEtMA_f9282331-5409-4133-a93b-0baf5856fa36"
      unitRef="usd">242000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzEtMS0xLTEtMA_8c992cae-129f-4f7f-99f6-d0d7920b3f37"
      unitRef="usd">210820000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzEtMy0xLTEtMA_b79e8690-eb57-4717-953e-8ad58088fba8"
      unitRef="usd">75853000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzMtMS0xLTEtMA_06301e36-648d-4cb2-ab22-712d7bb8dfdb"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzMtMy0xLTEtMA_c011a998-2745-431d-847f-30f452085df0"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4Mjk0YzcxZGY3MjRiYmQ5ZmUzZGExZTdmZDdjMzdkXzE4_1fc8c1c2-345e-4b28-a56c-9efd1b78cc9e"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4Mjk0YzcxZGY3MjRiYmQ5ZmUzZGExZTdmZDdjMzdkXzE4_467b2080-6518-47da-ab8f-691801cf4525"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4Mjk0YzcxZGY3MjRiYmQ5ZmUzZGExZTdmZDdjMzdkXzQ0_9a096e3f-d389-4073-bea3-22f2199f3d85"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4Mjk0YzcxZGY3MjRiYmQ5ZmUzZGExZTdmZDdjMzdkXzQ0_c3ec2ed5-5957-4267-ab06-0df4deb53f37"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4Mjk0YzcxZGY3MjRiYmQ5ZmUzZGExZTdmZDdjMzdkXzc5_1674434d-8339-4aa4-b84f-dd4bced2ad3d"
      unitRef="shares">17933020</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4Mjk0YzcxZGY3MjRiYmQ5ZmUzZGExZTdmZDdjMzdkXzc5_297cf9b3-0dd1-409b-9663-b7e90ba91e22"
      unitRef="shares">17933020</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4Mjk0YzcxZGY3MjRiYmQ5ZmUzZGExZTdmZDdjMzdkXzg2_961b71bb-1564-4dfc-9cd8-9f3a0cc285bd"
      unitRef="shares">17679232</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4Mjk0YzcxZGY3MjRiYmQ5ZmUzZGExZTdmZDdjMzdkXzg2_c623987f-6942-4b06-97d8-3275d17769a6"
      unitRef="shares">17679232</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMS0xLTEtMA_3fc906dd-43f8-419b-8bc2-dc34220b4590"
      unitRef="usd">18000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzYtMy0xLTEtMA_946db9bf-80ac-42f6-82ff-d61547d52ce2"
      unitRef="usd">18000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzctMS0xLTEtMA_5fbabb29-e839-43f2-82a6-65bb78718ec5"
      unitRef="usd">106173000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzctMy0xLTEtMA_9377087d-a49a-4516-96af-679c1bf65e3c"
      unitRef="usd">117097000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzgtMS0xLTEtMA_152e6887-4a66-4f68-aea0-176208380395"
      unitRef="usd">-52848000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzgtMy0xLTEtMA_8d0f14b4-50bc-4d72-9cb7-c154acbf1129"
      unitRef="usd">-60235000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzktMS0xLTEtMA_72633838-4a65-4c93-8d24-b525850cced8"
      unitRef="usd">53343000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfMzktMy0xLTEtMA_40ca6b01-9fef-445a-b0d3-ea51beb15336"
      unitRef="usd">56880000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNDAtMS0xLTEtMA_61adb58f-6d78-4146-adca-6e2a07706109"
      unitRef="usd">264163000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xOS9mcmFnOjE1OTk2MDc2YTQ5MzRlNjNiM2RmN2FiYmQyNmM0M2Q0L3RhYmxlOjUyMmE4Y2YxZmQyZDQ2NTRiYjIyNzQzOTU0N2FiMjljL3RhYmxlcmFuZ2U6NTIyYThjZjFmZDJkNDY1NGJiMjI3NDM5NTQ3YWIyOWNfNDAtMy0xLTEtMA_4e4001fe-51ba-4693-a3e6-6f4536e13204"
      unitRef="usd">132733000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2fcfd7b210f74dc5976983de27855478_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMy0xLTEtMS0w_22e7cc09-801f-45a1-9a19-eb3ca68d0a39"
      unitRef="usd">51812000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibcb365aaec5f4975a3f836175dc8e2ce_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMy0zLTEtMS0w_4b693800-6083-4e67-bcff-e6d5f1880f6e"
      unitRef="usd">21745000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibfb65299d11046adb017318fb542b3be_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMy01LTEtMS01Mzc_ef3b29b6-f929-4dde-b6a6-10f2cfb3d2ea"
      unitRef="usd">95363000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idb26dda9fd88462aabb4723bea6e2287_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMy03LTEtMS01Mzk_14d83606-1eba-40d1-8a24-83426fb6aa82"
      unitRef="usd">48136000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia8b6fed2a51f45858d2dcecd28277fef_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNC0xLTEtMS0w_68d0bcf0-1bb5-4afa-90a0-fa35a0de1949"
      unitRef="usd">6777000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i73f49a322eb84c7383e92e7174381a6c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNC0zLTEtMS0w_e93a7b9d-1568-4c19-ace2-bed8743a5104"
      unitRef="usd">4624000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNC01LTEtMS01Mzc_0707e399-3f94-4bbd-999e-df63e03a4b02"
      unitRef="usd">12894000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="icd94bfca54cb406f8ffb1fc2d03add57_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNC03LTEtMS01Mzk_ec2e8367-d0fa-45d2-bb7b-92ae8e5ba128"
      unitRef="usd">10472000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNS0xLTEtMS0w_703c591f-e03b-4142-a2d7-a977d67fff2b"
      unitRef="usd">58589000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNS0zLTEtMS0w_a40ad88a-0298-4062-bf49-0ca9ff56c62d"
      unitRef="usd">26369000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNS01LTEtMS01Mzc_2a874e82-3811-45dc-b2ce-d1f18e7a488c"
      unitRef="usd">108257000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNS03LTEtMS01Mzk_b5724f04-1a12-439a-aef3-8042e84c9a4e"
      unitRef="usd">58608000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2fcfd7b210f74dc5976983de27855478_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNy0xLTEtMS0w_688b1c6a-1982-41be-b37f-c1f8ac9b4ec4"
      unitRef="usd">20893000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ibcb365aaec5f4975a3f836175dc8e2ce_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNy0zLTEtMS0w_093510aa-7992-4646-a2fd-0b33be7f4e45"
      unitRef="usd">12206000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ibfb65299d11046adb017318fb542b3be_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNy01LTEtMS01NDE_7d4ac69e-2dfa-46f5-82fc-004877357623"
      unitRef="usd">39224000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="idb26dda9fd88462aabb4723bea6e2287_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfNy03LTEtMS01NDQ_fdac71a3-92f9-4d8e-8ffd-38db7a936467"
      unitRef="usd">26309000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ia8b6fed2a51f45858d2dcecd28277fef_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfOC0xLTEtMS0w_c91232b4-812a-42c6-9493-47956cc7cba1"
      unitRef="usd">3907000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i73f49a322eb84c7383e92e7174381a6c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfOC0zLTEtMS0w_077235d3-5187-400f-9b84-7f136e30a501"
      unitRef="usd">2539000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfOC01LTEtMS01NDE_6a6d3787-f463-4191-b8d9-6939545d65f4"
      unitRef="usd">7534000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="icd94bfca54cb406f8ffb1fc2d03add57_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfOC03LTEtMS01NDQ_98acbd40-0088-410b-a710-3f28c54b25c4"
      unitRef="usd">6339000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfOS0xLTEtMS0w_e6b35956-0dbc-41f2-abd5-fb3954940cac"
      unitRef="usd">24800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfOS0zLTEtMS0w_8b367cc2-7c20-4470-8251-f2fe240600f4"
      unitRef="usd">14745000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfOS01LTEtMS01NDE_b4a4c495-e6fa-47ae-ae71-6df952da8584"
      unitRef="usd">46758000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfOS03LTEtMS01NDQ_28e8d58b-65f3-4878-bd5b-40bde536948a"
      unitRef="usd">32648000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTAtMS0xLTEtMA_664fd142-0b7d-4bfc-a4a6-20315401d800"
      unitRef="usd">33789000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTAtMy0xLTEtMA_b7a2d63e-9e73-45f1-818e-2a7cdc8e2b8b"
      unitRef="usd">11624000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTAtNS0xLTEtNTQx_e7349397-7f7b-42f1-98a7-0b67064127c9"
      unitRef="usd">61499000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTAtNy0xLTEtNTQ0_352e08d2-9be6-4dbe-b06e-97e20a5a0cdc"
      unitRef="usd">25960000</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTMtMS0xLTEtMA_0599b273-1789-4a75-a730-5661a0e5b4ee"
      unitRef="usd">18410000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTMtMy0xLTEtMA_d91e6387-284d-4f7e-af0b-a5f192f2b8ef"
      unitRef="usd">11035000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTMtNS0xLTEtNTQ4_666173d6-25b7-488a-ab36-7315dabd9388"
      unitRef="usd">33478000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTMtNy0xLTEtNTUy_cac279a7-2ac0-4514-b2de-461dc1c446e6"
      unitRef="usd">25823000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTQtMS0xLTEtMA_1ec330fb-f6dd-4ac7-900a-19b32d791855"
      unitRef="usd">4850000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTQtMy0xLTEtMA_9a8fc69a-76e9-4af5-818c-4d7ede9e3987"
      unitRef="usd">2991000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTQtNS0xLTEtNTQ4_63ad1141-fb6b-44fb-bb6e-6a70d5a501c2"
      unitRef="usd">8962000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTQtNy0xLTEtNTUy_136987a5-48ab-4ee4-8cb0-2e65408393f7"
      unitRef="usd">6862000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTUtMS0xLTEtMA_5339b111-1ff3-4af4-aae5-6f2ffa00b278"
      unitRef="usd">8461000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTUtMy0xLTEtMA_9f3e95be-09ea-4444-b5ce-d55be7d7466c"
      unitRef="usd">8529000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTUtNS0xLTEtNTQ4_2caceae0-9423-4250-9f62-6d96f669fcb8"
      unitRef="usd">15826000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTUtNy0xLTEtNTUy_8aae286c-a165-474e-904a-bb4848aa9a1a"
      unitRef="usd">16336000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTYtMS0xLTEtMA_9ee31c37-a67b-414a-bf39-eaa87e199943"
      unitRef="usd">31721000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTYtMy0xLTEtMA_17288473-afd2-4e1c-9016-5006b63e696c"
      unitRef="usd">22555000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTYtNS0xLTEtNTQ4_d1b23965-e318-4dc6-a1a7-43d90b711764"
      unitRef="usd">58266000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTYtNy0xLTEtNTUy_6ead5b8c-ac5d-4ab3-95a5-784e1c10b0c8"
      unitRef="usd">49021000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTctMS0xLTEtMA_80c978ee-13d4-44c3-938d-1de3fc0c5934"
      unitRef="usd">2068000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTctMy0xLTEtMA_43aaac16-b7c8-48ff-ae32-3162a603309d"
      unitRef="usd">-10931000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTctNS0xLTEtNTQ4_a1cf1eb2-e85b-400b-9992-00ade9cf0043"
      unitRef="usd">3233000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTctNy0xLTEtNTUy_acc75a90-c4a8-4730-a760-12c640395af3"
      unitRef="usd">-23061000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTktMS0xLTEtMA_352a9a44-05ff-40e7-aeda-ea9eccc4fd61"
      unitRef="usd">215000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTktMy0xLTEtMA_2d12a209-a354-4189-b3dc-618ffae06c91"
      unitRef="usd">0</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTktNS0xLTEtNTU2_aacb433e-0efd-45ad-ba5d-274f29543858"
      unitRef="usd">267000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMTktNy0xLTEtNTYw_9bfe96bb-c6e7-4cd8-a583-4844675d9d39"
      unitRef="usd">0</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseDebt
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjAtMS0xLTEtMA_5df877f8-87f4-444a-8ff6-00af1f1d9cfd"
      unitRef="usd">778000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjAtMy0xLTEtMA_926b4616-637e-4b11-970f-c8e3aa28811a"
      unitRef="usd">0</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjAtNS0xLTEtNTU2_619f2dd0-a4fc-4eed-9ca3-9a234bc1d327"
      unitRef="usd">969000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjAtNy0xLTEtNTYw_8023aecf-8f8b-4b63-97ad-48c914979d85"
      unitRef="usd">0</us-gaap:InterestExpenseDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjEtMS0xLTEtNTIwNg_40731346-01c6-4379-ae33-44ce61e66a8f"
      unitRef="usd">7185000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjEtMy0xLTEtNTIwNg_3c853585-d326-4ee7-8a62-54a0e19827f4"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjEtNS0xLTEtNTIwNg_2eb68186-9298-47ef-bc21-fc5e636af4ac"
      unitRef="usd">7185000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjEtNy0xLTEtNTIwNg_a2eafb7b-a32f-4bb5-88ca-74b9d3787d27"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjEtMS0xLTEtMA_e1c648e7-9535-4c11-95ab-bd897512d214"
      unitRef="usd">-392000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjEtMy0xLTEtMA_edb151d8-3940-432a-bff8-11adddfdae78"
      unitRef="usd">3000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjEtNS0xLTEtNTU2_5949fe66-ad3d-46f8-8adc-b25cd2e8382c"
      unitRef="usd">-1415000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjEtNy0xLTEtNTYw_d71ca608-7a5e-494f-99eb-a6d063c0d681"
      unitRef="usd">-204000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjItMS0xLTEtMA_42456d98-32f5-44b8-b2fd-90c4a469955b"
      unitRef="usd">5800000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjItMy0xLTEtMA_202dfe93-4a44-48aa-b1d7-b29ae43445dd"
      unitRef="usd">3000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjItNS0xLTEtNTU2_fd1b5403-e0f8-4469-a433-0165385baf28"
      unitRef="usd">4534000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjItNy0xLTEtNTYw_6eef2f4e-1f56-4d1c-9685-03f020863813"
      unitRef="usd">-204000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjMtMS0xLTEtMA_fa3ba32a-9341-4c4d-8b9c-d402d3ee1595"
      unitRef="usd">7868000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjMtMy0xLTEtMA_6cd2f247-09c1-485e-b34f-3d35e4205274"
      unitRef="usd">-10928000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjMtNS0xLTEtNTU2_05bb2961-e899-4b4f-8158-53a8e63d6d70"
      unitRef="usd">7767000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjMtNy0xLTEtNTYw_f07ebc7a-b40c-44f9-9ee7-3f352dfb2755"
      unitRef="usd">-23265000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjQtMS0xLTEtMA_f6ef73ac-7da8-4daa-8b5b-202c6e64122a"
      unitRef="usd">122000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjQtMy0xLTEtMA_75268d70-cb28-445f-bcc0-70a0eafe2c12"
      unitRef="usd">466000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjQtNS0xLTEtNTU2_2d5c630e-9d14-4293-b4f0-8ebed9f983a6"
      unitRef="usd">380000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjQtNy0xLTEtNTYw_1311b2ae-71ec-4cc4-97e8-bf8f92ed7a2c"
      unitRef="usd">543000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjUtMS0xLTEtMA_b2d37b1d-406c-4c40-a663-7c23db0b0f84"
      unitRef="usd">7746000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjUtMy0xLTEtMA_e0169dd0-cb63-4daf-b842-9f2c7abc801a"
      unitRef="usd">-11394000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjUtNS0xLTEtNTU2_ae12db4c-f232-44b2-8714-2da9eeabbd16"
      unitRef="usd">7387000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjUtNy0xLTEtNTYw_905040ef-91f3-4884-b155-9ba55bb70aea"
      unitRef="usd">-23808000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjgtMS0xLTEtMA_1889d49a-b88b-4ef5-92eb-c1c0475e7495"
      unitRef="usdPerShare">0.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjgtMy0xLTEtMA_48910880-2165-4776-b508-54286f887c39"
      unitRef="usdPerShare">-0.67</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjgtNS0xLTEtNTYy_2f557795-803f-4951-afe3-fa0b88551794"
      unitRef="usdPerShare">0.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjgtNy0xLTEtNTY2_4997c172-0bec-4d0b-bed1-0236d01eaeb9"
      unitRef="usdPerShare">-1.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjktMS0xLTEtMzE1NA_8712644e-fd13-4ef4-8d03-0659cf19222c"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjktMS0xLTEtMzE1NA_f0e42c5b-c208-4f14-8d88-dc20fb4105f2"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjktMy0xLTEtMzE1NA_1b06ef4b-5639-43cb-8d96-a0a0bb3af37f"
      unitRef="usdPerShare">-0.67</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjktMy0xLTEtMzE1NA_71afcbb9-141a-4def-bad0-94fb929a3e80"
      unitRef="usdPerShare">-0.67</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjktNS0xLTEtMzE1NA_4917a147-3b4c-4f90-a89e-d24ad41050c1"
      unitRef="usdPerShare">0.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjktNS0xLTEtMzE1NA_a5bebe1f-0c02-47c3-a905-9c8de2cb8c58"
      unitRef="usdPerShare">0.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjktNy0xLTEtMzE1NA_01d0ea8f-0301-4e37-b1eb-8cdc02029734"
      unitRef="usdPerShare">-1.51</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMjktNy0xLTEtMzE1NA_ee9c25a4-a03a-41e5-b9d5-d29a851d3be0"
      unitRef="usdPerShare">-1.51</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMzEtMS0xLTEtMA_e9e8b725-0e48-4318-a2ab-4552617a2efa"
      unitRef="shares">17862000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMzEtMy0xLTEtMA_518bad1c-f035-4b6e-90bf-0d13b796acf3"
      unitRef="shares">17055000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMzEtNS0xLTEtNTY5_a5910721-5646-4753-a5f9-ab7a5fe5e94c"
      unitRef="shares">17815000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMzEtNy0xLTEtNTcy_ab556825-7e0c-46c6-b53d-1aa0db716bc8"
      unitRef="shares">15744000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMzItMS0xLTEtMzE1MA_b4c2a25f-538f-48dc-9bb0-2254cad36e85"
      unitRef="shares">22453000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMzItMy0xLTEtMzE1MA_774534ce-8852-486a-8568-db9c32b741f7"
      unitRef="shares">17055000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMzItNS0xLTEtMzE1MA_2d1d444e-1db0-4af4-847b-d3d30bfbaeee"
      unitRef="shares">20855000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yNS9mcmFnOjc4ZDI1NTQyYTMxMTQ0ZDk5MzAzMDhhMmNkODMzMzdhL3RhYmxlOjY1NzNkM2IxYTczNjQ4OTE4ODU1OTMzYWU5YjBlNzcxL3RhYmxlcmFuZ2U6NjU3M2QzYjFhNzM2NDg5MTg4NTU5MzNhZTliMGU3NzFfMzItNy0xLTEtMzE1MA_9dd5012f-e034-4511-9441-2cc344f6359d"
      unitRef="shares">15744000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfMi0xLTEtMS0w_d4e83669-2b7a-48ea-9ce4-c576c6f5175f"
      unitRef="usd">7746000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfMi0zLTEtMS0w_981874bf-06c1-4052-ad3d-b654eec1708a"
      unitRef="usd">-11394000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfMi01LTEtMS01OTc_1229d83e-689a-4b2a-9e62-60235eea0738"
      unitRef="usd">7387000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfMi03LTEtMS01OTk_93af3c59-8335-4638-b2ff-84cd4baecd2b"
      unitRef="usd">-23808000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNS0xLTEtMS0w_80b1f28b-5fb7-4ef4-a985-f96fed2d26cf"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNS0zLTEtMS0w_70eabf33-7d71-4db0-a859-af0fa62dd549"
      unitRef="usd">-2000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNS01LTEtMS02MDE_55df9bf8-a197-4570-b347-4a94e0d53a68"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNS03LTEtMS02MDM_1db58fdd-9caa-4a3f-825c-801815605539"
      unitRef="usd">-63000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNi0xLTEtMS0w_228faf04-5497-421c-9f57-5a6575f77c3e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNi0zLTEtMS0w_e50307f9-8b03-4f0a-a72e-a41ea287080b"
      unitRef="usd">2000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNi01LTEtMS02MDE_d0077d1d-34a9-4185-8c61-276b402dc5f8"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNi03LTEtMS02MDM_a88dfb31-3dbd-4556-a64d-d8b3549860e4"
      unitRef="usd">63000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNy0xLTEtMS0w_d37c139f-129e-4509-bb99-fe43b326a88c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNy0zLTEtMS0w_427db695-6b5e-4d5d-bcfc-b814f623add6"
      unitRef="usd">2000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNy01LTEtMS02MDE_22fd9079-a80b-463e-ba79-9e1497c59c94"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfNy03LTEtMS02MDM_d59620e5-1c47-4a24-8aea-6bc1a6be80e7"
      unitRef="usd">63000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfOC0xLTEtMS0w_dba1091b-ec9e-488d-84ed-741d19eba074"
      unitRef="usd">7746000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfOC0zLTEtMS0w_2778ae97-3ec8-4fc3-b055-133305f16f11"
      unitRef="usd">-11392000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfOC01LTEtMS02MDE_9ae023a6-8646-478f-a2b7-6853fcd59581"
      unitRef="usd">7387000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8yOC9mcmFnOjYwMDhlNWMwYjM1MDQzMDBiY2Q0NDYyZDM0NzQwYTk2L3RhYmxlOjkzYTFjMDJlODE2YjRmNmRiYWQ5NWJmNDBmZGYzOWJmL3RhYmxlcmFuZ2U6OTNhMWMwMmU4MTZiNGY2ZGJhZDk1YmY0MGZkZjM5YmZfOC03LTEtMS02MDM_31bacd0e-4769-495c-aaed-30f657af0d42"
      unitRef="usd">-23745000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8a0c97ff1a1844bfaafd62ddbe64c6ed_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMi0xLTEtMS0w_bacb4912-9aea-4ed9-a4fb-615a6269a0da"
      unitRef="shares">17679232</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i8a0c97ff1a1844bfaafd62ddbe64c6ed_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMi0zLTEtMS0w_adb49cdc-57aa-4f43-b744-19e9ca760a93"
      unitRef="usd">18000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaf7ddfb11c484a379285f7f24ccbb30f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMi01LTEtMS0w_656f1964-7e09-4f21-87ac-d29f5e804f86"
      unitRef="usd">117097000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if7d9d29deb264e90befea8186ad2923a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMi03LTEtMS0w_7826ce2a-85fd-4738-8816-6e298282f358"
      unitRef="usd">-60235000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic54b608c69b7450ab0118143a7142782_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMi05LTEtMS0w_800677b5-e73b-485d-974a-e95dc8a42957"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMi0xMS0xLTEtMA_500e502d-0226-4118-9864-689bb00e5ac7"
      unitRef="usd">56880000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="idbee004c85ae406b9b109bd61037d4b4_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMy0xLTEtMS0zNDAz_894d556b-954c-442c-b544-06ea28a849b3"
      unitRef="shares">38991</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i71ba6bea3ea04bdf840846d3dc75fca6_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMy01LTEtMS0zNDAz_14990733-37c1-4384-bfca-e83f0082f435"
      unitRef="usd">645000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMy0xMS0xLTEtMzQwMw_d93e288f-ef33-4fb3-96bb-1410dc6d97cb"
      unitRef="usd">645000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="idbee004c85ae406b9b109bd61037d4b4_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMy0xLTEtMS0w_6893b5a6-f716-4717-9025-0326c19bc48f"
      unitRef="shares">53598</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i71ba6bea3ea04bdf840846d3dc75fca6_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMy01LTEtMS0w_bea1f6ef-20aa-4aa3-b2e3-d730a953201f"
      unitRef="usd">1252000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfMy0xMS0xLTEtMA_42f493cf-69e3-4be1-9d5e-8a23d7db11a2"
      unitRef="usd">1252000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cutr:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall
      contextRef="i71ba6bea3ea04bdf840846d3dc75fca6_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfNC01LTEtMS0w_cac112e2-4332-4652-b480-9f1664e3cc84"
      unitRef="usd">-16134000</cutr:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall>
    <cutr:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfNC0xMS0xLTEtMA_deb13a3d-2f08-4998-ad9b-c4176203d3d9"
      unitRef="usd">-16134000</cutr:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="idbee004c85ae406b9b109bd61037d4b4_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfNS0xLTEtMS0w_b67225ac-4ee5-4017-b75a-f6d2f6f7df87"
      unitRef="shares">161199</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i71ba6bea3ea04bdf840846d3dc75fca6_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfNS01LTEtMS0w_26a99b92-fb0d-44ec-9746-7f2515e7bdb4"
      unitRef="usd">-1452000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfNS0xMS0xLTEtMA_8fa6b762-570a-47f4-92ba-ebc0ee599469"
      unitRef="usd">-1452000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i71ba6bea3ea04bdf840846d3dc75fca6_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfNi01LTEtMS0w_e91bb92c-153e-4446-8893-284b3d0eae1a"
      unitRef="usd">4765000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfNi0xMS0xLTEtMA_532774fa-a279-407a-b7d4-f81c72dfca20"
      unitRef="usd">4765000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i73640a3ad3ca43178734929432dc6628_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfNy03LTEtMS0w_bfc4900c-1603-467b-8838-33005a2b7a4a"
      unitRef="usd">7387000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfNy0xMS0xLTEtMA_ada277d9-48de-4633-923c-104f67893fbd"
      unitRef="usd">7387000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="icf4c9f98bfbf40d2a4bbf237cf1e1846_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfOC0xLTEtMS0w_2daa1eb0-7173-421f-a022-da2906e33771"
      unitRef="shares">17933020</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="icf4c9f98bfbf40d2a4bbf237cf1e1846_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfOC0zLTEtMS0w_849d8f41-40e0-49fe-b237-08b371036f5f"
      unitRef="usd">18000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieaee018047a74b78859eeb591b6c591f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfOC01LTEtMS0w_8cde7dcd-1470-42f1-a2fd-5e590532f1d0"
      unitRef="usd">106173000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i485b22c217834e23b0364e76e06a2371_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfOC03LTEtMS0w_27857a2d-69d5-4508-a486-460bf1eadab7"
      unitRef="usd">-52848000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if3010403a70d436483ab771b941a207d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfOC05LTEtMS0w_fce47f74-77c9-4a25-a6c2-9968c198aae3"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjU1NmIwMmNmNDE3ZDRlZDQ5NmVmMjgwOTg2YTFhNjU4L3RhYmxlcmFuZ2U6NTU2YjAyY2Y0MTdkNGVkNDk2ZWYyODA5ODZhMWE2NThfOC0xMS0xLTEtMA_48e117bd-c779-4059-b6b3-a06ca8cda86f"
      unitRef="usd">53343000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie8367f0895fb4ca3b02c812b17b329e3_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMi0xLTEtMS02MTQ_e0caa191-0c5b-42bb-9870-0d2827232e2a"
      unitRef="shares">17801926</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ie8367f0895fb4ca3b02c812b17b329e3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMi0zLTEtMS02MTg_ed0139a7-9d4e-447e-8c79-e08017756518"
      unitRef="usd">18000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia490656dd3ce42e2bf315a7086535095_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMi01LTEtMS02MTY_32a73477-f351-4995-97ec-aec4f98d0de8"
      unitRef="usd">102206000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i484a97403f27472ea9481c015d1527fb_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMi03LTEtMS02MjI_c6147844-82b0-4bf9-857c-6c53600aebf6"
      unitRef="usd">-60594000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie07d79b96d4d4295b68c970c1206cf32_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMi05LTEtMS02MjQ_6f9961cc-fa3b-4c28-8146-d049a9aa4082"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i44e8ae2855f24ec191abeac87edead4a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMi0xMS0xLTEtNjI2_a57c2ff0-978f-4dfa-9778-1e4a31fd66ed"
      unitRef="usd">41630000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i9e00e169b2114d2997dc62ba88fc41f2_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMy0xLTEtMS0zNDA5_77446f21-d708-4ab6-b6f5-fc8990f00f29"
      unitRef="shares">38991</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="id1e3e98112d445a2b78ea2ada37f81ed_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMy01LTEtMS0zNDA5_577d45ca-4450-44cf-85dc-5a0ba18787d7"
      unitRef="usd">645000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMy0xMS0xLTEtMzQwOQ_a5b51a44-0c8a-4c35-9334-ef89fe9dc326"
      unitRef="usd">645000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i9e00e169b2114d2997dc62ba88fc41f2_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMy0xLTEtMS02MTQ_ce03bcdd-0f33-4911-891b-bda78ba7dc46"
      unitRef="shares">29508</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="id1e3e98112d445a2b78ea2ada37f81ed_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMy01LTEtMS02MTY_bf2e2cdc-218d-424c-a39b-9a45597d55f5"
      unitRef="usd">856000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfMy0xMS0xLTEtNjI2_9e4075be-7994-417e-bf1c-2d048d4d2425"
      unitRef="usd">856000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i9e00e169b2114d2997dc62ba88fc41f2_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfNS0xLTEtMS02MjA_13b80465-a839-4707-ac2f-0ff4b850eef2"
      unitRef="shares">62595</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="id1e3e98112d445a2b78ea2ada37f81ed_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfNS01LTEtMS02MTY_f69f1f90-0db6-4d9c-a6fc-1fe841c0da91"
      unitRef="usd">-453000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfNS0xMS0xLTEtNjI2_60b00cac-2798-445d-808a-d12983209e84"
      unitRef="usd">-453000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id1e3e98112d445a2b78ea2ada37f81ed_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfNi01LTEtMS02MTY_b8039c6f-7f2f-41a8-af5b-af88328e5211"
      unitRef="usd">2919000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfNi0xMS0xLTEtNjI2_920d529a-1641-4aea-8daf-a170f4480ca0"
      unitRef="usd">2919000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="ib5bc0220b3cd4bbd82245f12526ec90e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfNy03LTEtMS02Mjg_ff29e06e-68c1-4c94-81e5-5e4ce8265c7b"
      unitRef="usd">7746000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfNy0xMS0xLTEtNjI2_b5f86096-bccf-43b8-8553-6bc003a9709e"
      unitRef="usd">7746000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="icf4c9f98bfbf40d2a4bbf237cf1e1846_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfOC0xLTEtMS02MzA_f6a43328-c689-494a-a730-0e43be976dd1"
      unitRef="shares">17933020</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="icf4c9f98bfbf40d2a4bbf237cf1e1846_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfOC0zLTEtMS02MzA_001669ae-b8b6-40be-ac6b-32fc149b8618"
      unitRef="usd">18000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieaee018047a74b78859eeb591b6c591f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfOC01LTEtMS02MzA_6378a274-3787-4d1f-a84e-4f49af2b5aa7"
      unitRef="usd">106173000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i485b22c217834e23b0364e76e06a2371_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfOC03LTEtMS02MzA_4ca56fb8-f782-42fc-876d-2937c1062abb"
      unitRef="usd">-52848000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if3010403a70d436483ab771b941a207d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfOC05LTEtMS02MzA_3d81771e-b528-416c-9784-8cc15499073d"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmM0ZTMzMmFhOThkMjRkYThiNWZlODg5OWI4ZWJhZTgxL3RhYmxlcmFuZ2U6YzRlMzMyYWE5OGQyNGRhOGI1ZmU4ODk5YjhlYmFlODFfOC0xMS0xLTEtNjI2_5933378d-580f-4494-a873-360fd6185606"
      unitRef="usd">53343000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2f3e187f8cdd4a27a16464c1e2230fec_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMi0xLTEtMS0w_277913e7-c28e-469c-87d1-4bdf61023eea"
      unitRef="shares">14315586</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i2f3e187f8cdd4a27a16464c1e2230fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMi0zLTEtMS0w_e3b2e0a7-feef-4fc2-acd8-494c3bbf2c9d"
      unitRef="usd">14000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i244e0262c30f4bc59029986047588df0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMi01LTEtMS0w_61e7a9b0-dda1-42e8-9759-62f8645f8e5c"
      unitRef="usd">82346000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i570d20ed67764205924e7fee40c9295a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMi03LTEtMS0w_d125c845-597f-4951-b675-5516bb628d62"
      unitRef="usd">-36358000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4b3d4dae27cb4fb68ccfb9a3a1a93823_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMi05LTEtMS0w_a040c595-9f6a-49fa-b5b4-4ccb47ecc9a6"
      unitRef="usd">-60000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i33947892bb224113abf96b09e46ffa54_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMi0xMS0xLTEtMA_05bdb042-bd45-4740-bd03-509f1a3be1c5"
      unitRef="usd">45942000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i85bdd8375cea4bfcbeb0257fbde7b2b9_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMy0xLTEtMS0zMTY5_65a3d2ef-b03f-434b-9ff1-64cac811ca38"
      unitRef="shares">39248</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i170f952087874acbaa3da79723af4837_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMy01LTEtMS0zMTY5_c1449616-b0ac-4404-896e-4bc7250e9f31"
      unitRef="usd">437000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMy0xMS0xLTEtMzE2OQ_afafa3fc-1807-4213-b020-0d3d6a66a617"
      unitRef="usd">437000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i85bdd8375cea4bfcbeb0257fbde7b2b9_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMy0xLTEtMS0w_7cf9595a-cbc5-4b1c-86a6-5bf190ea4d1d"
      unitRef="shares">46128</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i170f952087874acbaa3da79723af4837_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMy01LTEtMS0w_a7ff3e11-06de-4863-a162-5b423dedd713"
      unitRef="usd">411000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfMy0xMS0xLTEtMA_99071cbf-cd4a-452e-9192-e1b92a5ebac5"
      unitRef="usd">411000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i85bdd8375cea4bfcbeb0257fbde7b2b9_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNC0xLTEtMS0w_00e1232e-e547-4403-8711-089d7d533f3f"
      unitRef="shares">423976</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i85bdd8375cea4bfcbeb0257fbde7b2b9_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNC0zLTEtMS0w_be38f55f-6b52-4882-b1c8-97e87a13e351"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i170f952087874acbaa3da79723af4837_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNC01LTEtMS0w_b927335d-8df1-4597-ada1-131a1afd4f1d"
      unitRef="usd">-3118000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNC0xMS0xLTEtMA_54dddea1-de37-4096-bf04-813ce3e5fbb7"
      unitRef="usd">-3117000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i85bdd8375cea4bfcbeb0257fbde7b2b9_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNi0wLTEtMS0zNTU2L3RleHRyZWdpb246NDk1OGYyNzZhZTQ1NDk2Y2E3ZTM3YjRjNzQ0YTgyNTFfMjE5OTAyMzI1NTY1Ng_871b7bc8-236d-4f34-8cf1-882787fa3b66"
      unitRef="usd">2303000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i85bdd8375cea4bfcbeb0257fbde7b2b9_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNS0xLTEtMS03OTc_60bb4076-005a-43e4-86a2-c18b0d22d94e"
      unitRef="shares">2742750</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i85bdd8375cea4bfcbeb0257fbde7b2b9_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNS0zLTEtMS03OTc_ddd22227-9865-4961-abe0-0f8142346c78"
      unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i170f952087874acbaa3da79723af4837_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNS01LTEtMS03OTc_06c52987-977d-4b6e-8a5a-e8509bbc6716"
      unitRef="usd">26493000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNS0xMS0xLTEtNzk3_e6866f49-1c3c-4495-b7e7-05bd931f4818"
      unitRef="usd">26496000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i170f952087874acbaa3da79723af4837_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNS01LTEtMS0w_816948d9-3664-48f2-b4a6-f1d2c8e00773"
      unitRef="usd">6075000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNS0xMS0xLTEtMA_095b6c4a-695d-4561-a08a-d73650f072b9"
      unitRef="usd">6075000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="ia3b47574caca46b99fb6499883087ed3_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNi03LTEtMS0w_b8d2c095-eedb-4cec-bffe-0d11f3c1bbda"
      unitRef="usd">-23808000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNi0xMS0xLTEtMA_04abf387-67a5-4155-9544-30cf2f729b34"
      unitRef="usd">-23808000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="iba9e052e19bc4d9cb3949ba436e89381_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNy05LTEtMS0w_3fd46548-063f-44f8-9bcd-2e5f964e25df"
      unitRef="usd">63000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfNy0xMS0xLTEtMA_45f46a42-b63c-4acf-8b65-27d9a4a5bbe3"
      unitRef="usd">63000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib5cfedb49abf43a58191f2993ef3e540_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfOC0xLTEtMS0w_f489d79e-57d4-4de7-9ce6-74d83e712382"
      unitRef="shares">17567688</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib5cfedb49abf43a58191f2993ef3e540_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfOC0zLTEtMS0w_c8641a07-b4e5-4c07-ba10-8a4dd6393db5"
      unitRef="usd">18000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie7cb0aefbadc4fae96b37599c7955716_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfOC01LTEtMS0w_8e0517d8-7d4d-47f9-8501-d02bb4f3eb1b"
      unitRef="usd">112644000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i341bd948a0694080b463b58e446e0e46_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfOC03LTEtMS0w_4dc43aa5-e1f6-4e64-87fe-735f0ee7342b"
      unitRef="usd">-60166000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i03250011c65e4e58a12c712ed93a235f_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfOC05LTEtMS0w_354dabc5-8365-47a6-88a7-85a0d52c0783"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOjBlZTQzYmJkZTkyMDRhNmU5MzAxMTU4NWY4YmNlM2M5L3RhYmxlcmFuZ2U6MGVlNDNiYmRlOTIwNGE2ZTkzMDExNTg1ZjhiY2UzYzlfOC0xMS0xLTEtMA_555cacb1-e767-42d3-8dcb-a975afa442a4"
      unitRef="usd">52499000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3c44dc3e39a944f386ee804f3d8d2f1d_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMi0xLTEtMS02NDU_d3c2e67a-c549-4049-9050-2172dbae53d4"
      unitRef="shares">14578146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i3c44dc3e39a944f386ee804f3d8d2f1d_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMi0zLTEtMS02NDk_27980ed3-0789-4f0d-8056-510b6fadf212"
      unitRef="usd">15000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaca8eee5ccbc423ea5d21f84cdc0c483_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMi01LTEtMS02NDc_eed6b9b4-bdd4-45c3-b968-6ce4931def81"
      unitRef="usd">82292000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibc6ab3c5a57d4419a7741a81e73e8cba_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMi03LTEtMS02NTM_dbe58c88-7438-4a83-b8f4-d20255c5a8cc"
      unitRef="usd">-48772000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iff1d956612db4dee81869096bfed413a_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMi05LTEtMS02NTM_b7e07c8c-79ae-451b-a818-e42db4794075"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i06df2fa92c07439982ab4b6fddb466f1_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMi0xMS0xLTEtNjUz_295d4ca3-8b6a-4714-a77e-c1f300274957"
      unitRef="usd">33536000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ia11ce6b42e50441a8bfd1cd6564d5f99_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMy0xLTEtMS0zMTc4_ce476a31-3449-4650-9fad-63ae3334b8c4"
      unitRef="shares">39248</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="if7fdc7a0b6b84196a94bd8e81d4ff9ca_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMy01LTEtMS0zMTc4_a651ea63-c97f-4b96-9324-dc22b2a6f746"
      unitRef="usd">437000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMy0xMS0xLTEtMzE3OA_39f5ea75-68ca-4f78-a9af-cdb310f2f526"
      unitRef="usd">437000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ia11ce6b42e50441a8bfd1cd6564d5f99_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMy0xLTEtMS02NDU_790effe7-973f-455a-aa2b-397801cfe76a"
      unitRef="shares">23837</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if7fdc7a0b6b84196a94bd8e81d4ff9ca_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMy01LTEtMS02NDc_7313e7a4-b5a8-4541-8ef0-962fa821188e"
      unitRef="usd">210000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfMy0xMS0xLTEtNjU1_d2ed7893-c5f8-4dd5-b276-1494a84c477d"
      unitRef="usd">210000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ia11ce6b42e50441a8bfd1cd6564d5f99_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNC0xLTEtMS02NDU_b7fce47e-55c5-4735-a986-47f10d3edbf6"
      unitRef="shares">183707</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ia11ce6b42e50441a8bfd1cd6564d5f99_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNC0zLTEtMS02NTE_7669e5e6-1629-44ff-b207-abd52c7dec0c"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="if7fdc7a0b6b84196a94bd8e81d4ff9ca_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNC01LTEtMS02NDc_1b61f0a9-b869-4fee-909c-465a249a9776"
      unitRef="usd">-883000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNC0xMS0xLTEtNjU1_648f074d-2880-4494-ab01-7e17e02b3023"
      unitRef="usd">-883000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="ia11ce6b42e50441a8bfd1cd6564d5f99_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNS0wLTEtMS04NjkvdGV4dHJlZ2lvbjpiN2NlODVkMjVkOGE0OGE2YWM1NDVjMWI2NzZkNjA4NV8zODQ4MjkwNjk3MzIx_94c42847-6119-4818-830d-55134efda329"
      unitRef="usd">2303000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ia11ce6b42e50441a8bfd1cd6564d5f99_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNS0xLTEtMS04MDE_3aa22234-247e-44ad-b5af-cf6d1158ad8b"
      unitRef="shares">2742750</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ia11ce6b42e50441a8bfd1cd6564d5f99_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNS0zLTEtMS04MDE_65d93168-3a49-4156-9673-b5a40b56637a"
      unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="if7fdc7a0b6b84196a94bd8e81d4ff9ca_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNS01LTEtMS04MDE_228f0c18-a279-4e40-b910-4a2c964668d9"
      unitRef="usd">26493000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNS0xMS0xLTEtODAx_a2352d7b-0c46-4640-9dad-0033aaf71a3f"
      unitRef="usd">26496000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if7fdc7a0b6b84196a94bd8e81d4ff9ca_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNS01LTEtMS02NDc_de3eb743-7514-42eb-9d51-b44ff2872a4d"
      unitRef="usd">4095000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNS0xMS0xLTEtNjU1_81efdded-76ee-44fd-a595-4ef13c266349"
      unitRef="usd">4095000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="ic074f4f3008d47a7a3965891ed645a3b_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNi03LTEtMS02NTc_538229eb-69a2-4872-ab63-3ae2d7f9bd3b"
      unitRef="usd">-11394000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNi0xMS0xLTEtNjU1_2c6b8a56-7b4f-4524-bd3e-8a8b6c68255a"
      unitRef="usd">-11394000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i8358e3138b90489dafac816f75a0e5f8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNy05LTEtMS02NTk_99ad1a1f-a7e4-4b11-ac9b-2e4b10ffff5b"
      unitRef="usd">2000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfNy0xMS0xLTEtNjU1_c26d75b6-d41f-4a87-8fef-4f28bfc6ee03"
      unitRef="usd">2000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib5cfedb49abf43a58191f2993ef3e540_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfOC0xLTEtMS02NjE_0cf92b71-481f-482c-b1d4-1c25eca276ab"
      unitRef="shares">17567688</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib5cfedb49abf43a58191f2993ef3e540_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfOC0zLTEtMS02NjE_175b2976-15ac-4e79-bb56-8da252f40e9d"
      unitRef="usd">18000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie7cb0aefbadc4fae96b37599c7955716_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfOC01LTEtMS02NjE_42f79b66-eabe-4ba5-9aa4-58fc093e9a41"
      unitRef="usd">112644000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i341bd948a0694080b463b58e446e0e46_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfOC03LTEtMS02NjE_ebff27ef-d55d-46bd-85d7-95b2c2a5ad9a"
      unitRef="usd">-60166000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i03250011c65e4e58a12c712ed93a235f_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfOC05LTEtMS02NjE_84e6fa09-dee9-4bc3-aecc-dc6f14337296"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zMS9mcmFnOjA4ZTBlNDBiNGYwMzRlY2U4ODBhYzRkMmI0NzQ2ZTE0L3RhYmxlOmQ3NTZiOTlhMTM4YjRhMmM4OWNmZjljMDgwMzAzMTU2L3RhYmxlcmFuZ2U6ZDc1NmI5OWExMzhiNGEyYzg5Y2ZmOWMwODAzMDMxNTZfOC0xMS0xLTEtNjU1_f7badb17-7027-45e7-9b62-e948ca06fa1c"
      unitRef="usd">52499000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMy0xLTEtMS0w_bd2da935-5aef-49f6-bb77-1cfd33127fa5"
      unitRef="usd">7387000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMy0zLTEtMS0w_eaba8e35-32b7-4152-9c43-3cabb25ed7b4"
      unitRef="usd">-23808000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNS0xLTEtMS0w_a42afaea-4889-4908-bcdf-dc57c3a9d702"
      unitRef="usd">4765000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNS0zLTEtMS0w_6fbbe678-cf0d-44a7-a38c-1720f9c20da3"
      unitRef="usd">6075000</us-gaap:ShareBasedCompensation>
    <cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNi0xLTEtMS0w_3ab1ba81-1ab5-44dd-9a0d-530b29123f96"
      unitRef="usd">707000</cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts>
    <cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNi0zLTEtMS0w_1a2fea45-472b-4356-acbb-eaf9d61a849f"
      unitRef="usd">715000</cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts>
    <us-gaap:AmortizationOfAcquisitionCosts
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNy0xLTEtMS0w_7567400e-2cd9-4451-91c3-bd95cdb73363"
      unitRef="usd">1003000</us-gaap:AmortizationOfAcquisitionCosts>
    <us-gaap:AmortizationOfAcquisitionCosts
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNy0zLTEtMS0w_4f32a61e-1a66-4ba5-8cbc-c443d9cf2ce5"
      unitRef="usd">1392000</us-gaap:AmortizationOfAcquisitionCosts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfOC0xLTEtMS0w_40633e82-9801-4c1c-9bc9-0463f46734e1"
      unitRef="usd">267000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfOC0zLTEtMS0w_beb2275d-0857-40e9-9d13-2b4854cd9fcf"
      unitRef="usd">0</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:CapitalizedComputerSoftwareImpairments1
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfOS0xLTEtMS0w_17a6776e-57a6-4abd-bd84-ff1e8c685b6c"
      unitRef="usd">182000</us-gaap:CapitalizedComputerSoftwareImpairments1>
    <us-gaap:CapitalizedComputerSoftwareImpairments1
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfOS0zLTEtMS0w_be753438-b9eb-496d-847b-ddc0cb3f5458"
      unitRef="usd">805000</us-gaap:CapitalizedComputerSoftwareImpairments1>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTAtMS0xLTEtMA_1dd9249d-b5c6-47ed-adfb-4a4a82eabffa"
      unitRef="usd">51000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTAtMy0xLTEtMA_0f8312f1-d916-4698-8c8c-8cb84fcc839a"
      unitRef="usd">4000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTEtMS0xLTEtMA_2d1dd376-81da-42c8-a308-53cd08a7dce7"
      unitRef="usd">492000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTEtMy0xLTEtMA_be26249d-0169-40ed-8290-d04f650c0a6b"
      unitRef="usd">1696000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTItMS0xLTEtMA_afb2a8c5-3aae-4e79-adc6-6898dadd18c6"
      unitRef="usd">82000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTItMy0xLTEtMA_7675f008-5a69-4b97-b1b3-a927159a5ebe"
      unitRef="usd">0</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTMtMS0xLTEtNDEyMA_995369cf-5205-4e27-889e-b3faf6995255"
      unitRef="usd">7185000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTMtMy0xLTEtNDI0Mw_cf17192a-04ad-4b00-a894-3c8be779ac24"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <cutr:ChangeInRightofuseAssetAndLiabilityDueToModification
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTMtMS0xLTEtMA_74170465-700f-467a-b6d0-05932b64ddba"
      unitRef="usd">604000</cutr:ChangeInRightofuseAssetAndLiabilityDueToModification>
    <cutr:ChangeInRightofuseAssetAndLiabilityDueToModification
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTMtMy0xLTEtMA_fcf4440b-56d4-422e-a784-c8e6efc784da"
      unitRef="usd">0</cutr:ChangeInRightofuseAssetAndLiabilityDueToModification>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTQtMS0xLTEtMA_158f8ed5-670c-471e-bd8f-f38f3c06e835"
      unitRef="usd">0</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTQtMy0xLTEtMA_299783f2-0035-40f7-98e0-0c8157a01248"
      unitRef="usd">198000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTYtMS0xLTEtMA_dac8feeb-a645-4689-871a-0be762b671e3"
      unitRef="usd">4433000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTYtMy0xLTEtMA_cca400fb-3286-409d-b14a-d956c9b262b5"
      unitRef="usd">-6034000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTctMS0xLTEtMA_54ef359b-b7d6-45d3-856e-6aec26666cd0"
      unitRef="usd">5958000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTctMy0xLTEtMA_f924b786-e68b-47f0-98ac-6768b6207be1"
      unitRef="usd">-2681000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTgtMS0xLTEtMA_f6124a4f-31ea-4a41-8335-5f5f8f685d51"
      unitRef="usd">77000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTgtMy0xLTEtMA_efaa183d-b537-4863-81c5-17495019252f"
      unitRef="usd">-316000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTktMS0xLTEtMA_0ab3227f-e92c-4c19-8406-076b489420fe"
      unitRef="usd">1720000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMTktMy0xLTEtMA_1333e7f3-6827-4b7a-8bf5-d75df2e0c5fc"
      unitRef="usd">519000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjAtMS0xLTEtMA_9fd47db4-3f5e-4901-aa3f-fb4bf9afd33a"
      unitRef="usd">-474000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjAtMy0xLTEtMA_70a8a483-de82-442a-8696-71fb126362d2"
      unitRef="usd">-1004000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjEtMS0xLTEtMA_55f4b6a7-615a-4133-a76b-628cbf3355b5"
      unitRef="usd">10220000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjEtMy0xLTEtMA_e6478d99-1c55-4be6-884d-37a60a245c00"
      unitRef="usd">-9754000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <cutr:IncreaseDecreaseInExtendedProductWarrantyAccrual
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjItMS0xLTEtMA_ad676e27-f674-47c8-8006-28a6b285d7e8"
      unitRef="usd">-567000</cutr:IncreaseDecreaseInExtendedProductWarrantyAccrual>
    <cutr:IncreaseDecreaseInExtendedProductWarrantyAccrual
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjItMy0xLTEtMA_a08175fd-6b2d-4e85-9409-7eaa3cc24177"
      unitRef="usd">-339000</cutr:IncreaseDecreaseInExtendedProductWarrantyAccrual>
    <cutr:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjMtMS0xLTEtMA_d57c30a3-45e6-471d-af45-30a600585ffd"
      unitRef="usd">-530000</cutr:IncreaseDecreaseInOperatingLeaseLiabilities>
    <cutr:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjMtMy0xLTEtMA_33c9b777-e294-483e-ac06-14896bbe55c6"
      unitRef="usd">0</cutr:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjQtMS0xLTEtMA_f81793a7-b248-4003-b402-4d37e3428a33"
      unitRef="usd">166000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjQtMy0xLTEtMA_92ff0d9b-9ec9-4761-919e-a2f8811db957"
      unitRef="usd">-2443000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjUtMS0xLTEtMA_e011d786-8fa0-4ad9-9bd0-f0b83d8b027f"
      unitRef="usd">4818000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjUtMy0xLTEtMA_277fc7be-9b79-4554-a7e8-8724cdd00a9a"
      unitRef="usd">-17951000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjgtMS0xLTEtMA_a12969a1-6767-4ca5-8257-2bcbd8a31878"
      unitRef="usd">370000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjgtMy0xLTEtMA_9d6c3875-3637-4fc9-a3c1-ccdf1b7db196"
      unitRef="usd">435000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjktMS0xLTEtMA_a6b5002d-a333-46bf-91b8-63007810317b"
      unitRef="usd">71000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMjktMy0xLTEtMA_0008c75f-110b-4c0e-8387-ebab60f5caa8"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzAtMS0xLTEtMA_26f1abdc-cb2a-4752-a697-d3e4ed89473f"
      unitRef="usd">0</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzAtMy0xLTEtMA_3d9638f2-2449-422f-ac39-fbb0b4e049ee"
      unitRef="usd">10900000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzEtMS0xLTEtMA_8ac15573-d863-4f71-bb23-896dc7a6cb56"
      unitRef="usd">0</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzEtMy0xLTEtMA_27f48825-b8ad-4e8b-ae91-0c25ef8fef1a"
      unitRef="usd">16167000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzItMS0xLTEtMA_dc5ff073-7412-4f33-bacc-a3aaae45d7da"
      unitRef="usd">-299000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzItMy0xLTEtMA_db35746b-71d8-4bc0-b544-642227c338e4"
      unitRef="usd">-5702000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzUtMS0xLTEtMA_2f686908-af55-46a2-a827-02fb38d61471"
      unitRef="usd">1897000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzUtMy0xLTEtMA_03fe5a18-e333-4b53-b7eb-4009031f1427"
      unitRef="usd">848000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsForDerivativeInstrumentFinancingActivities
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzYtMS0xLTEtMA_f9f21475-516a-4277-96da-f48ad299817c"
      unitRef="usd">16134000</us-gaap:PaymentsForDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsForDerivativeInstrumentFinancingActivities
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzYtMy0xLTEtMA_c4a43a5c-c9c2-4a56-8227-cd9cde91a1f7"
      unitRef="usd">0</us-gaap:PaymentsForDerivativeInstrumentFinancingActivities>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzctMS0xLTEtMA_bb03e941-0055-4d46-be2c-2722b89736bc"
      unitRef="usd">138250000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzctMy0xLTEtMA_dccf3319-f971-414d-bef4-73d85341799f"
      unitRef="usd">7149000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzgtMS0xLTEtMA_ad53ac72-5cd1-4423-b3b5-c6331ac0e133"
      unitRef="usd">4717000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzgtMy0xLTEtMA_a43192d5-0953-4675-8f02-572519bced69"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDAtMS0xLTEtMzIwNQ_e8def00e-7e99-4ac9-87e8-00cb5cb16d49"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDAtMy0xLTEtMzIwNQ_52bce4e4-1063-40ef-8d55-4d7af83e5a7e"
      unitRef="usd">28799000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDEtMS0xLTEtMzIwNQ_e13219b1-433d-4dd4-a62b-0d0740cfb169"
      unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDEtMy0xLTEtMzIwNQ_68bb43ab-2c6e-4ae5-ac36-8a73abeafd35"
      unitRef="usd">2303000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzktMS0xLTEtMA_52a9c581-0371-42ba-b1fd-4c82718f67e2"
      unitRef="usd">1451000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfMzktMy0xLTEtMA_e2a7cd69-7bbf-4ed8-bfc1-6813124c99e2"
      unitRef="usd">3117000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDAtMS0xLTEtMA_0b079170-26f5-4248-9833-e54350805e66"
      unitRef="usd">211000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDAtMy0xLTEtMA_774de236-7e91-4da7-9077-a357d82b8a85"
      unitRef="usd">380000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDEtMS0xLTEtMA_57d552b8-87d1-4287-8eed-e386625efc28"
      unitRef="usd">117634000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDEtMy0xLTEtMA_cec6114a-c8b1-4b57-bf45-ccb1998fd6ce"
      unitRef="usd">30996000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDMtMS0xLTEtMA_f5c042e8-d051-4289-97b5-35cf5ff5799c"
      unitRef="usd">122153000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDMtMy0xLTEtMA_a3ceb9fd-2066-432b-84d9-670e5fe8bfa3"
      unitRef="usd">7343000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDQtMS0xLTEtMA_abd7062b-1306-452b-87c4-ca4712d45882"
      unitRef="usd">47047000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i33947892bb224113abf96b09e46ffa54_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDQtMy0xLTEtMA_2cab3ab7-3fca-4ab8-8645-2f1c53cb33a7"
      unitRef="usd">26316000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDUtMS0xLTEtMA_74c8ac67-8382-48cb-9371-20247b6dee6b"
      unitRef="usd">169200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDUtMy0xLTEtMA_39676202-970f-4e2a-a324-8602cc9b1c37"
      unitRef="usd">33659000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDgtMS0xLTEtMA_68de1562-fa6c-448b-b570-a83f37044c33"
      unitRef="usd">25000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDgtMy0xLTEtMA_efd0f558-2c2c-4959-8ee4-4452e8b46f32"
      unitRef="usd">27000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDktMS0xLTEtMA_65c35e40-1e49-4d15-9ea0-358cd8739601"
      unitRef="usd">123000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDktMy0xLTEtMA_39bc1753-9d26-47d0-a5e3-11271b122d69"
      unitRef="usd">1169000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:NotesReduction
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDktMS0xLTEtNDI0NQ_477a7e47-c50c-489b-918e-5f21db171e6c"
      unitRef="usd">7185000</us-gaap:NotesReduction>
    <us-gaap:NotesReduction
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNDktMy0xLTEtNDI0NQ_564a9b60-0eaf-452d-ad5f-0dafecd13cb1"
      unitRef="usd">0</us-gaap:NotesReduction>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNTAtMS0xLTEtMA_5f577ad0-954b-4fee-9f34-a52c03fffe20"
      unitRef="usd">452000</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNTAtMy0xLTEtMA_774b62fc-c9cb-49a0-add4-b6ed54d33dbb"
      unitRef="usd">0</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNTItMS0xLTEtMA_54385efe-e4e5-43a1-827b-ff540dcc8711"
      unitRef="usd">458000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8zNC9mcmFnOmIzZTNlNmNjNTA3NzQwYjU4OWIwMmE5ODM0ZmY4OTFkL3RhYmxlOmM3NDAyMmFiZDZhYzRhN2ViY2JjYjdhMDBhZTBlMDQ2L3RhYmxlcmFuZ2U6Yzc0MDIyYWJkNmFjNGE3ZWJjYmNiN2EwMGFlMGUwNDZfNTItMy0xLTEtMA_907416d3-bdb4-47fb-9873-eb42c78a941b"
      unitRef="usd">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMTQ0NDI_f8663c87-214e-4980-9bbb-384272caeaed">Summary of Significant Accounting Policies&#160;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Operations and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cutera, Inc. (&#x201c;Cutera&#x201d; or the &#x201c;Company&#x201d;) provides energy-based aesthetic systems for practitioners worldwide. The Company develops, manufactures, distributes, and markets energy-based product platforms for use by physicians and other qualified practitioners, enabling them to offer safe and effective aesthetic treatments to their customers. The Company currently markets the following system platforms: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;enlighten, excel, Secret PRO, Juliet, Secret RF,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;xeo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Several of the Company&#x2019;s systems offer multiple hand pieces and applications, providing customers the flexibility to upgrade their systems. The sales of (i) systems, system upgrades, and hand pieces (collectively &#x201c;Systems&#x201d; revenue); (ii) replacement hand pieces, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Titan, truSculpt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;D,truSculpt iD&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt flex&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; cycle refills, as well as single use disposable tips applicable to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret PRO, Juliet&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret RF&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;Consumables&#x201d; revenue); (iii) the distribution of third party manufactured skincare products (&#x201c;Skincare&#x201d; revenue); and (iv) the leasing of equipment through a membership program; are collectively classified as &#x201c;Products&#x201d; revenue. In addition to Products revenue, the Company generates revenue from the sale of post-warranty service contracts, parts, detachable hand piece replacements (except for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Titan, truSculpt 3D, truSculpt iD&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt flex)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and service labor for the repair and maintenance of products that are out of warranty, all of which are collectively classified as &#x201c;Service&#x201d; revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s corporate headquarters and U.S. operations are located in Brisbane, California, where the Company conducts manufacturing, warehousing, research and development, regulatory, sales and marketing, service, and administrative activities. The Company also maintains regional distribution centers (&#x201c;RDCs&#x201d;) in select locations across the U.S. These RDCs serve as forward warehousing for systems and service parts in various geographies. The Company markets, sells and services its products through its sales and service employees in North America (including Canada), Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, Spain, Switzerland, and the United Kingdom. Sales and services outside of these direct markets are made through a worldwide distributor network in over 42 countries. The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements included in this report reflect all adjustments necessary for a fair statement of its condensed consolidated statements of financial position as of June&#160;30, 2021 and December&#160;31, 2020, and its condensed consolidated statements of results of operations, comprehensive income (loss), changes in equity, and cash flows for the three and six months ended June&#160;30, 2021, and 2020. The December&#160;31, 2020 condensed consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles in the United States of America (&#x201c;GAAP&#x201d;). The results for interim periods are not necessarily indicative of results for the entire year or any other interim period.&#160;Presentation of certain prior year balances have been updated to conform with current year presentation. All significant intercompany accounts and transactions have been eliminated upon consolidation. The accompanying condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s previously filed audited financial statements and the related notes thereto included in the Company&#x2019;s annual report on Form 10-K for the year ended December&#160;31, 2020 filed with the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on March 23, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's future results of operations involve a number of risks and uncertainties. Factors that could affect the Company's future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company's products, stability of global financial markets, cybersecurity breaches and other disruptions that could compromise the Company&#x2019;s information or results, business disruptions that are caused by natural disasters or pandemic events, management of international activities, competition from substitute products and larger companies, ability to obtain and maintain regulatory approvals, government regulations and oversight, patent and other types of litigation, ability to protect proprietary technology from counterfeit versions of the Company's products, strategic relationships and dependence on key individuals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020,&#160;the World Health Organization declared the COVID-19&#160;outbreak a pandemic. The COVID-19&#160;outbreak has negatively affected the United States and global economies. Though the economy is gradually recovering as of the second quarter of 2021, the timing and extent of a full global economic recovery is still uncertain. The spread of the coronavirus and the Delta variant in particular, has impacted the global economy broadly in 2020, including restrictions on travel, shifting work &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;forces to work remotely and quarantine policies put into place by businesses and governments, had a material economic effect on the Company&#x2019;s business during the year ended December&#160;31, 2020 and in the six months ended June&#160;30, 2021. Healthcare facilities in many countries effectively banned elective procedures and this had a significant impact on the Company. Many of the Company&#x2019;s products are used in aesthetic elective procedures and as such, the bans on elective procedures substantially reduced the Company&#x2019;s sales and marketing efforts in the early months of the pandemic and led the Company to implement cost control measures. Although the Company&#x2019;s revenues and profits have&#160;improved compared to the first half of fiscal 2020 and the overall economic outlook has also improved in 2021, the&#160;COVID-19&#160;outbreak continues to be fluid especially in light of the Delta variant, and the long-term impact on the Company's business due to COVID-19 is still uncertain. The Company&#160;cannot presently predict the scope and severity of any impacts in future periods from business shutdowns or disruptions due to the&#160;COVID-19&#160;pandemic, but the impact on economic activity including the possibility of recession or financial market instability could have a material adverse effect on the Company&#x2019;s business, revenue, operating results, cash flows and financial condition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continues to assess whether any impairment of its goodwill or its long-lived assets has occurred and has determined that no&#160;charges, other than an impairment loss of $0.2 million on capitalized implementation costs of&#160;cloud-based customer relationship management (&#x201c;CRM&#x201d;) software occurred were necessary during the six months&#160;ended June&#160;30, 2021.&#160;The Company will continue to monitor future conditions important to its assessment of potential impairment of its long-lived assets and goodwill, including the impacts of the&#160;COVID&#x2013;19&#160;pandemic and other ongoing impacts which are subject to uncertainty.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has experienced a significant increase in sales of skincare products under the exclusive distribution agreement with ZO Skin Health, Inc. (&#x201c;ZO&#x201d;), which allows&#160;the Company to sell ZO&#x2019;s skincare products in Japan. The reason for the increase in skincare products sales may have been the&#160;result of changes in customers&#x2019; spending habits as customers purchased more aesthetic treatments that were able to be applied at home, due to limitations on&#160;in-person&#160;aesthetic procedures, social distancing and mask wearing requirements due to the&#160;COVID-19&#160;pandemic. Future growth in sales of skincare products depends on customers&#x2019; spending habits, which may revert to original spending habits after the&#160;COVID-19&#160;pandemic. Such changes may have a material adverse effect on the Company&#x2019;s revenue, operating results, and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These unaudited condensed consolidated financial statements are prepared in accordance with the rules and regulations of the SEC applicable to interim financial statements. While these statements reflect all normal recurring adjustments that are, in the opinion of management, necessary for fair presentation of the results of the interim period, they do not include all of the information and footnotes required by GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the financial statement disclosures in its annual report on Form 10-K for the year ended December&#160;31, 2020 filed with the SEC on March 23, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the same accounting policies in preparing quarterly and annual financial statements. Unless otherwise noted, amounts presented within the notes to condensed consolidated financial statements refer to the Company&#x2019;s continuing operations. Note 13 provides information about the Company&#x2019;s adoption of the new accounting standard for debt with conversion and other options, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#x2019;s own equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company issued $138.3 million of convertible senior notes ("Notes" or "Convertible notes") in a private placement offering on March&#160;5, 2021. The Convertible notes bear interest at a rate of 2.25% per year. In accordance with Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2020-6,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contracts in Entity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;s Own Equity (Subtopic 815-40),&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the Company recorded the Convertible&#160;notes as long-term debt with no separation between the Convertible notes and the conversion option. Each reporting period, the Company will determine whether any criteria is met for the note holders to have the option to redeem the Convertible notes early, which will result in a change in the classification of the Convertible notes to current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The circumstances described in the paragraph above were met during the second quarter of 2021 as the Company's stock traded at a price in excess of the conversion price, and as a result, the Notes are convertible at the option of the holder from July 1, 2021 until September 30, 2021. Upon any conversion of the Convertible notes, the Company would be required to pay or deliver, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#x2019;s election. To the extent there are any conversions during the period from July 1, 2021 until September 30, 2021, the Company intends to settle such conversions by issuing shares of common stock; therefore, as of June&#160;30, 2021, the Convertible notes have been included as long term liability on the condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The costs associated with issuance of the Convertible notes, including underwriters&#x2019; fees, are presented in the condensed consolidated balance sheet as a direct deduction from the carrying amount of the Convertible notes. The debt issuance costs are being amortized over the life of the Convertible notes as additional non-cash interest expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with issuance of the Convertible notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally designated to reduce the potential dilution of the Company's&#160;common stock upon any conversion of the Notes. The capped calls were purchased for $16.1 million and recorded as a reduction to additional paid in capital in the condensed consolidated balance sheet as of June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalized cloud computing systems implementation costs of $0.6&#160;million during the three months ending June 30, 2021. These costs relate to an on-going implementation of a new Enterprise Resource Planning system and are included in Other long-term assets and Other current assets and prepaid expenses on the condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commission, allowance for credit losses, sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, implicit and incremental borrowing rates related to the Company&#x2019;s leases, variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, assumptions used in operating and sales-type lease classification, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, residual value of leased equipment, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;No.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2019-12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740)-Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to remove certain exceptions and improve consistency of application, including, among other things, requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. The Company adopted this guidance in the three and six months&#160;ended June&#160;30, 2021. The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the&#160;FASB&#160;issued ASU No. 2020-6, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt &#x2013; Debt with Conversion and Other Options (Topic 470) and Derivatives and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity (Topic 815), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to simplify the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the amendment, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#x2019;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the computation of diluted earnings per share. The Company early adopted the guidance on a prospective basis effective January 1, 2021. See Note 13 &#x2013; Debt.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMTQ0NDM_93742ea2-85a3-41ae-b7f2-66529c348871">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Operations and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cutera, Inc. (&#x201c;Cutera&#x201d; or the &#x201c;Company&#x201d;) provides energy-based aesthetic systems for practitioners worldwide. The Company develops, manufactures, distributes, and markets energy-based product platforms for use by physicians and other qualified practitioners, enabling them to offer safe and effective aesthetic treatments to their customers. The Company currently markets the following system platforms: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;enlighten, excel, Secret PRO, Juliet, Secret RF,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;xeo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Several of the Company&#x2019;s systems offer multiple hand pieces and applications, providing customers the flexibility to upgrade their systems. The sales of (i) systems, system upgrades, and hand pieces (collectively &#x201c;Systems&#x201d; revenue); (ii) replacement hand pieces, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Titan, truSculpt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;D,truSculpt iD&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt flex&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; cycle refills, as well as single use disposable tips applicable to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret PRO, Juliet&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret RF&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;Consumables&#x201d; revenue); (iii) the distribution of third party manufactured skincare products (&#x201c;Skincare&#x201d; revenue); and (iv) the leasing of equipment through a membership program; are collectively classified as &#x201c;Products&#x201d; revenue. In addition to Products revenue, the Company generates revenue from the sale of post-warranty service contracts, parts, detachable hand piece replacements (except for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Titan, truSculpt 3D, truSculpt iD&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt flex)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and service labor for the repair and maintenance of products that are out of warranty, all of which are collectively classified as &#x201c;Service&#x201d; revenue.&lt;/span&gt;&lt;/div&gt;The Company&#x2019;s corporate headquarters and U.S. operations are located in Brisbane, California, where the Company conducts manufacturing, warehousing, research and development, regulatory, sales and marketing, service, and administrative activities. The Company also maintains regional distribution centers (&#x201c;RDCs&#x201d;) in select locations across the U.S. These RDCs serve as forward warehousing for systems and service parts in various geographies. The Company markets, sells and services its products through its sales and service employees in North America (including Canada), Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, Spain, Switzerland, and the United Kingdom. Sales and services outside of these direct markets are made through a worldwide distributor network in over 42 countries. The condensed consolidated financial statements include the accounts of the Company and its subsidiaries.</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <cutr:NumberOfCountriesInWhichEntityUtilizesADistributorNetwork
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMjQwOA_11fe282a-b906-45ed-b194-975c9972e50a"
      unitRef="country">42</cutr:NumberOfCountriesInWhichEntityUtilizesADistributorNetwork>
    <cutr:BasisOfPresentationPolicyTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMzg0ODI5MDcxNjYyNg_7e7e6def-bcfd-4fec-9b89-092b975b2bc4">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements included in this report reflect all adjustments necessary for a fair statement of its condensed consolidated statements of financial position as of June&#160;30, 2021 and December&#160;31, 2020, and its condensed consolidated statements of results of operations, comprehensive income (loss), changes in equity, and cash flows for the three and six months ended June&#160;30, 2021, and 2020. The December&#160;31, 2020 condensed consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles in the United States of America (&#x201c;GAAP&#x201d;). The results for interim periods are not necessarily indicative of results for the entire year or any other interim period.&#160;Presentation of certain prior year balances have been updated to conform with current year presentation. All significant intercompany accounts and transactions have been eliminated upon consolidation. The accompanying condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s previously filed audited financial statements and the related notes thereto included in the Company&#x2019;s annual report on Form 10-K for the year ended December&#160;31, 2020 filed with the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on March 23, 2021.&lt;/span&gt;&lt;/div&gt;</cutr:BasisOfPresentationPolicyTextBlock>
    <cutr:RisksAndUncertaintiesPolicyPolicyTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMTQ0NDQ_a3659068-0030-4937-99a0-82fc02292100">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's future results of operations involve a number of risks and uncertainties. Factors that could affect the Company's future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company's products, stability of global financial markets, cybersecurity breaches and other disruptions that could compromise the Company&#x2019;s information or results, business disruptions that are caused by natural disasters or pandemic events, management of international activities, competition from substitute products and larger companies, ability to obtain and maintain regulatory approvals, government regulations and oversight, patent and other types of litigation, ability to protect proprietary technology from counterfeit versions of the Company's products, strategic relationships and dependence on key individuals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020,&#160;the World Health Organization declared the COVID-19&#160;outbreak a pandemic. The COVID-19&#160;outbreak has negatively affected the United States and global economies. Though the economy is gradually recovering as of the second quarter of 2021, the timing and extent of a full global economic recovery is still uncertain. The spread of the coronavirus and the Delta variant in particular, has impacted the global economy broadly in 2020, including restrictions on travel, shifting work &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;forces to work remotely and quarantine policies put into place by businesses and governments, had a material economic effect on the Company&#x2019;s business during the year ended December&#160;31, 2020 and in the six months ended June&#160;30, 2021. Healthcare facilities in many countries effectively banned elective procedures and this had a significant impact on the Company. Many of the Company&#x2019;s products are used in aesthetic elective procedures and as such, the bans on elective procedures substantially reduced the Company&#x2019;s sales and marketing efforts in the early months of the pandemic and led the Company to implement cost control measures. Although the Company&#x2019;s revenues and profits have&#160;improved compared to the first half of fiscal 2020 and the overall economic outlook has also improved in 2021, the&#160;COVID-19&#160;outbreak continues to be fluid especially in light of the Delta variant, and the long-term impact on the Company's business due to COVID-19 is still uncertain. The Company&#160;cannot presently predict the scope and severity of any impacts in future periods from business shutdowns or disruptions due to the&#160;COVID-19&#160;pandemic, but the impact on economic activity including the possibility of recession or financial market instability could have a material adverse effect on the Company&#x2019;s business, revenue, operating results, cash flows and financial condition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continues to assess whether any impairment of its goodwill or its long-lived assets has occurred and has determined that no&#160;charges, other than an impairment loss of $0.2 million on capitalized implementation costs of&#160;cloud-based customer relationship management (&#x201c;CRM&#x201d;) software occurred were necessary during the six months&#160;ended June&#160;30, 2021.&#160;The Company will continue to monitor future conditions important to its assessment of potential impairment of its long-lived assets and goodwill, including the impacts of the&#160;COVID&#x2013;19&#160;pandemic and other ongoing impacts which are subject to uncertainty.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has experienced a significant increase in sales of skincare products under the exclusive distribution agreement with ZO Skin Health, Inc. (&#x201c;ZO&#x201d;), which allows&#160;the Company to sell ZO&#x2019;s skincare products in Japan. The reason for the increase in skincare products sales may have been the&#160;result of changes in customers&#x2019; spending habits as customers purchased more aesthetic treatments that were able to be applied at home, due to limitations on&#160;in-person&#160;aesthetic procedures, social distancing and mask wearing requirements due to the&#160;COVID-19&#160;pandemic. Future growth in sales of skincare products depends on customers&#x2019; spending habits, which may revert to original spending habits after the&#160;COVID-19&#160;pandemic. Such changes may have a material adverse effect on the Company&#x2019;s revenue, operating results, and cash flows.&lt;/span&gt;&lt;/div&gt;</cutr:RisksAndUncertaintiesPolicyPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfNTUxOA_6b41ad95-c220-404e-a9c5-2186c869dd5b"
      unitRef="usd">200000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMTQ0NDY_93fea48b-a6b1-4085-8fbb-ea4c94da4d7d">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These unaudited condensed consolidated financial statements are prepared in accordance with the rules and regulations of the SEC applicable to interim financial statements. While these statements reflect all normal recurring adjustments that are, in the opinion of management, necessary for fair presentation of the results of the interim period, they do not include all of the information and footnotes required by GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the financial statement disclosures in its annual report on Form 10-K for the year ended December&#160;31, 2020 filed with the SEC on March 23, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the same accounting policies in preparing quarterly and annual financial statements. Unless otherwise noted, amounts presented within the notes to condensed consolidated financial statements refer to the Company&#x2019;s continuing operations. Note 13 provides information about the Company&#x2019;s adoption of the new accounting standard for debt with conversion and other options, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#x2019;s own equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company issued $138.3 million of convertible senior notes ("Notes" or "Convertible notes") in a private placement offering on March&#160;5, 2021. The Convertible notes bear interest at a rate of 2.25% per year. In accordance with Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2020-6,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contracts in Entity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;s Own Equity (Subtopic 815-40),&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the Company recorded the Convertible&#160;notes as long-term debt with no separation between the Convertible notes and the conversion option. Each reporting period, the Company will determine whether any criteria is met for the note holders to have the option to redeem the Convertible notes early, which will result in a change in the classification of the Convertible notes to current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The circumstances described in the paragraph above were met during the second quarter of 2021 as the Company's stock traded at a price in excess of the conversion price, and as a result, the Notes are convertible at the option of the holder from July 1, 2021 until September 30, 2021. Upon any conversion of the Convertible notes, the Company would be required to pay or deliver, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#x2019;s election. To the extent there are any conversions during the period from July 1, 2021 until September 30, 2021, the Company intends to settle such conversions by issuing shares of common stock; therefore, as of June&#160;30, 2021, the Convertible notes have been included as long term liability on the condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The costs associated with issuance of the Convertible notes, including underwriters&#x2019; fees, are presented in the condensed consolidated balance sheet as a direct deduction from the carrying amount of the Convertible notes. The debt issuance costs are being amortized over the life of the Convertible notes as additional non-cash interest expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with issuance of the Convertible notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally designated to reduce the potential dilution of the Company's&#160;common stock upon any conversion of the Notes. The capped calls were purchased for $16.1 million and recorded as a reduction to additional paid in capital in the condensed consolidated balance sheet as of June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalized cloud computing systems implementation costs of $0.6&#160;million during the three months ending June 30, 2021. These costs relate to an on-going implementation of a new Enterprise Resource Planning system and are included in Other long-term assets and Other current assets and prepaid expenses on the condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i2456eaded80b44f784a0a4a1f81e0150_D20210305-20210305"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfOTQ2Mw_74be82f1-9cc8-4d06-a2c3-2114d2d07f87"
      unitRef="usd">138300000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i65e02799f7d2458f8b8251dfac3c7b7b_I20210305"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfOTYxNQ_3cea609e-279e-450a-86ad-38cc075d581a"
      unitRef="number">0.0225</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <cutr:CappedCallTransactionsCosts
      contextRef="ie60ebd26bc7440ba9911c6237d5ce6df_D20210305-20210305"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMTA4NjM_eec9d98e-3f4d-44a1-b974-1c64de7b9b43"
      unitRef="usd">16100000</cutr:CappedCallTransactionsCosts>
    <us-gaap:CapitalizedComputerSoftwareAdditions
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMjE5OTAyMzI3NDk0OA_3405dae1-31c9-4389-a8c3-0919fce9c6a2"
      unitRef="usd">600000</us-gaap:CapitalizedComputerSoftwareAdditions>
    <us-gaap:UseOfEstimates
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMTQ0NDc_6b930124-3682-42ea-8d9e-696b0fa70fcf">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commission, allowance for credit losses, sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, implicit and incremental borrowing rates related to the Company&#x2019;s leases, variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, assumptions used in operating and sales-type lease classification, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, residual value of leased equipment, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80MC9mcmFnOmFhNWQ4NDFkYmI2MDQ5NjI5MjhhZjYxZTA0MGVkOWZkL3RleHRyZWdpb246YWE1ZDg0MWRiYjYwNDk2MjkyOGFmNjFlMDQwZWQ5ZmRfMTQ0NDg_434805a0-7ebc-4f9f-b41a-42129f1e79ca">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;No.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2019-12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740)-Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to remove certain exceptions and improve consistency of application, including, among other things, requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. The Company adopted this guidance in the three and six months&#160;ended June&#160;30, 2021. The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the&#160;FASB&#160;issued ASU No. 2020-6, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt &#x2013; Debt with Conversion and Other Options (Topic 470) and Derivatives and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity (Topic 815), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to simplify the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the amendment, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#x2019;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the computation of diluted earnings per share. The Company early adopted the guidance on a prospective basis effective January 1, 2021. See Note 13 &#x2013; Debt.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80Ni9mcmFnOmJmN2ZlNmM2NDRiMjQ2OGQ5ZjIwNzZjMGUzZDMzN2I4L3RleHRyZWdpb246YmY3ZmU2YzY0NGIyNDY4ZDlmMjA3NmMwZTNkMzM3YjhfMTgx_7e1389f4-97d1-4251-b532-cadd3f1c4484">Cash, Cash Equivalents&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's cash and&#160;cash equivalents (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;169,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;47,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had no marketable securities as of June&#160;30, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80Ni9mcmFnOmJmN2ZlNmM2NDRiMjQ2OGQ5ZjIwNzZjMGUzZDMzN2I4L3RleHRyZWdpb246YmY3ZmU2YzY0NGIyNDY4ZDlmMjA3NmMwZTNkMzM3YjhfMTgy_fd451db5-af42-416c-bf5c-bfb70c3a0014">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's cash and&#160;cash equivalents (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;169,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;47,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80Ni9mcmFnOmJmN2ZlNmM2NDRiMjQ2OGQ5ZjIwNzZjMGUzZDMzN2I4L3RhYmxlOjZhYzU0ZmFkMGVjODRhZGJhNTY4ZTczYTlhN2M2YTU1L3RhYmxlcmFuZ2U6NmFjNTRmYWQwZWM4NGFkYmE1NjhlNzNhOWE3YzZhNTVfMS0xLTEtMS0w_7d9106ae-3d7c-44d5-b7a3-87f81ad749bd"
      unitRef="usd">169200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80Ni9mcmFnOmJmN2ZlNmM2NDRiMjQ2OGQ5ZjIwNzZjMGUzZDMzN2I4L3RhYmxlOjZhYzU0ZmFkMGVjODRhZGJhNTY4ZTczYTlhN2M2YTU1L3RhYmxlcmFuZ2U6NmFjNTRmYWQwZWM4NGFkYmE1NjhlNzNhOWE3YzZhNTVfMS0zLTEtMS0w_31a2eb66-d6e2-469b-95f7-c0fdb38073ab"
      unitRef="usd">47047000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecurities
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80Ni9mcmFnOmJmN2ZlNmM2NDRiMjQ2OGQ5ZjIwNzZjMGUzZDMzN2I4L3RleHRyZWdpb246YmY3ZmU2YzY0NGIyNDY4ZDlmMjA3NmMwZTNkMzM3YjhfMTQx_c8cae86b-990e-41af-971d-a439852672af"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF80Ni9mcmFnOmJmN2ZlNmM2NDRiMjQ2OGQ5ZjIwNzZjMGUzZDMzN2I4L3RleHRyZWdpb246YmY3ZmU2YzY0NGIyNDY4ZDlmMjA3NmMwZTNkMzM3YjhfMTQx_f7df959e-0331-4d3d-a6f6-98a186cbe744"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81Mi9mcmFnOjZlN2UyNjc3ZWY3YjQ3YjJiMGNjODA4ZmJlZjA2NDI4L3RleHRyZWdpb246NmU3ZTI2NzdlZjdiNDdiMmIwY2M4MDhmYmVmMDY0MjhfMjA2Mw_56326039-f169-4530-82a1-48e06ad80538">Fair Value of Financial Instruments&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain financial assets at fair value, including cash and cash equivalents. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value hierarchy contains the following three levels of inputs that may be used to measure fair value, in accordance with ASC 820:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Level 1: inputs, which include quoted prices in active markets for identical assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Level 2: inputs, which include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. When sufficient quoted pricing for identical securities is not available, the Company uses market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Level 3: inputs, which include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques, as well as significant management judgment or estimation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considering counterparty credit risk in its assessment of fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 13 - Debt for the carrying amount and estimated fair value of the Company&#x2019;s Convertible notes due 2026.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMTQzNQ_c200fcec-fe32-4b17-aa7f-ace5cea7ef71">Balance Sheet Details&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021 and December&#160;31, 2020, inventories consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;34,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021 and December&#160;31, 2020, accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued payroll and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales and marketing accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued inventory in transit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product warranty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued sales tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;41,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Product Remediation Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2018, the Company recognized a liability for a product remediation plan related to one of its legacy systems. This was related to a voluntary action initiated by the Company to replace a component in one of the Company&#x2019;s &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;legacy products. The remediation plan consists primarily of replacement of a component in the system. The accrued liability consisted of the estimated cost of materials and labor to replace the component in all units that were under the Company's standard warranty or were covered under the existing extended warranty contracts. The Company recorded a&#160;liability of approximately $5.0 million in 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021 and December&#160;31, 2020, approximately $0.3 million of the total product remediation liability balance was recorded as a component of the Company&#x2019;s product warranty and included in accrued liabilities,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $0.7 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $1.2 million, respectively, was separately recorded as extended warranty liability. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended June&#160;30, 2021, the Company recorded $0.1&#160;million and $0.2&#160;million, respectively, of excess reserve related to extended warranty and product warranty. Total costs incurred (including excess reversals) related to product warranty and extended warranty liability during the three and six months&#160;ended June&#160;30, 2021 were $0.1 million and $0.5 million, respectively. Total costs incurred related to product warranty and extended warranty liability during the three and six months ended June&#160;30, 2020 were Nil and $0.3 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMTQzNg_897d845c-c77b-40ae-8d2a-f0d56ba138a9">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021 and December&#160;31, 2020, inventories consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;34,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjllY2M0MGZlMTY0NzRhZGVhMTkwZmVjNmE3YmY2MzAyL3RhYmxlcmFuZ2U6OWVjYzQwZmUxNjQ3NGFkZWExOTBmZWM2YTdiZjYzMDJfMS0xLTEtMS0w_2ebb7aa6-f5b0-447e-b235-39fe4f8f34a8"
      unitRef="usd">15862000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjllY2M0MGZlMTY0NzRhZGVhMTkwZmVjNmE3YmY2MzAyL3RhYmxlcmFuZ2U6OWVjYzQwZmUxNjQ3NGFkZWExOTBmZWM2YTdiZjYzMDJfMS0zLTEtMS0w_a59fc019-092e-4f83-9039-3ef2ae2e067e"
      unitRef="usd">14874000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjllY2M0MGZlMTY0NzRhZGVhMTkwZmVjNmE3YmY2MzAyL3RhYmxlcmFuZ2U6OWVjYzQwZmUxNjQ3NGFkZWExOTBmZWM2YTdiZjYzMDJfMi0xLTEtMS0w_1c32ed88-2935-4c6b-92c2-e99a8833860e"
      unitRef="usd">1145000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjllY2M0MGZlMTY0NzRhZGVhMTkwZmVjNmE3YmY2MzAyL3RhYmxlcmFuZ2U6OWVjYzQwZmUxNjQ3NGFkZWExOTBmZWM2YTdiZjYzMDJfMi0zLTEtMS0w_d32a1284-4f7f-428d-ae08-be0c2c23ce71"
      unitRef="usd">1030000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjllY2M0MGZlMTY0NzRhZGVhMTkwZmVjNmE3YmY2MzAyL3RhYmxlcmFuZ2U6OWVjYzQwZmUxNjQ3NGFkZWExOTBmZWM2YTdiZjYzMDJfMy0xLTEtMS0w_5fbad377-e03d-4d84-a670-c7d312dc8c88"
      unitRef="usd">17584000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjllY2M0MGZlMTY0NzRhZGVhMTkwZmVjNmE3YmY2MzAyL3RhYmxlcmFuZ2U6OWVjYzQwZmUxNjQ3NGFkZWExOTBmZWM2YTdiZjYzMDJfMy0zLTEtMS0w_378f3ebf-6237-46aa-8ada-36e7dbf512b6"
      unitRef="usd">12604000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjllY2M0MGZlMTY0NzRhZGVhMTkwZmVjNmE3YmY2MzAyL3RhYmxlcmFuZ2U6OWVjYzQwZmUxNjQ3NGFkZWExOTBmZWM2YTdiZjYzMDJfNC0xLTEtMS0w_c748925b-1c84-49bb-b3b8-6f4877ec476d"
      unitRef="usd">34591000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjllY2M0MGZlMTY0NzRhZGVhMTkwZmVjNmE3YmY2MzAyL3RhYmxlcmFuZ2U6OWVjYzQwZmUxNjQ3NGFkZWExOTBmZWM2YTdiZjYzMDJfNC0zLTEtMS0w_ab72c7a9-1997-416f-949d-f6809852cf6d"
      unitRef="usd">28508000</us-gaap:InventoryNet>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMTQzNw_8fff466d-f125-4ade-88ea-5cfeb3f3140a">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021 and December&#160;31, 2020, accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued payroll and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales and marketing accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued inventory in transit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product warranty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued sales tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;41,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfMS0xLTEtMS0w_3b0dae36-8db0-4519-adac-a99560c59e51"
      unitRef="usd">16427000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfMS0zLTEtMS0w_a592d494-c768-451a-b1c5-9d3f5db8f230"
      unitRef="usd">12197000</us-gaap:AccruedSalariesCurrent>
    <cutr:SalesAndMarketingAccrualsCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfMi0xLTEtMS0w_032b0006-b48b-4fac-a2c0-e01c4ca5f5db"
      unitRef="usd">3124000</cutr:SalesAndMarketingAccrualsCurrent>
    <cutr:SalesAndMarketingAccrualsCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfMi0zLTEtMS0w_488033b7-d4d4-41f3-a079-9ff93339ff70"
      unitRef="usd">2352000</cutr:SalesAndMarketingAccrualsCurrent>
    <cutr:AccruedInventoryInTransitCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfMy0xLTEtMS0w_59513754-c699-4ff6-9cbb-88b1654b8cf4"
      unitRef="usd">4469000</cutr:AccruedInventoryInTransitCurrent>
    <cutr:AccruedInventoryInTransitCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfMy0zLTEtMS0w_28b73a2e-9a36-4595-9c46-115daf78df67"
      unitRef="usd">2476000</cutr:AccruedInventoryInTransitCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfNC0xLTEtMS0w_0a00002a-0d36-4b3b-9f7c-ac95038a7006"
      unitRef="usd">3789000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfNC0zLTEtMS0w_e23a8a11-8854-407d-873a-7ee693d2922a"
      unitRef="usd">2908000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfNS0xLTEtMS0w_874b61bc-20c2-41e7-95e1-641afe9d07ec"
      unitRef="usd">5439000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfNS0zLTEtMS0w_51f9a833-c764-4da3-a8b0-a1ccdb0b7504"
      unitRef="usd">5343000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfNi0xLTEtMS0w_48ef0dbd-e681-46a5-a493-b1be2b452a22"
      unitRef="usd">8095000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfNi0zLTEtMS0w_a6663149-9935-4162-b09e-1ab0ece05937"
      unitRef="usd">5803000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfNy0xLTEtMS0w_2a75a6c4-b56b-43a7-8d8b-d7c998f0445f"
      unitRef="usd">41343000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RhYmxlOjE5MzE1ZWMxZTQ2NDRjOWViMjRlYTFlNzJkNWFhZmUxL3RhYmxlcmFuZ2U6MTkzMTVlYzFlNDY0NGM5ZWIyNGVhMWU3MmQ1YWFmZTFfNy0zLTEtMS0w_246dd1d6-c42b-4af2-a487-6747098f4a06"
      unitRef="usd">31079000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="ibd2a463e83364d2bbb2747aea222f7be_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfODc2_0fdccb82-b736-4fc4-ab56-9641c94a8210"
      unitRef="usd">5000000.0</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i95ac0510552241b18a45a3559b512564_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfOTE3_90841af2-b905-43b0-a68e-eb25507dca50"
      unitRef="usd">300000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="ifa7cefa41ffa4fcca09040bf29e8bd08_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfOTE3_c36cfa15-6c6f-47a6-ac10-3d0a8f9c3774"
      unitRef="usd">300000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:ExtendedProductWarrantyAccrual
      contextRef="ifa7cefa41ffa4fcca09040bf29e8bd08_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMTA3NA_14cf27fe-0481-4d22-8f1a-d257851e0e63"
      unitRef="usd">700000</us-gaap:ExtendedProductWarrantyAccrual>
    <us-gaap:ExtendedProductWarrantyAccrual
      contextRef="i95ac0510552241b18a45a3559b512564_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMTA4MQ_05bd9dab-7b88-41ed-91af-2a6fd7e9be18"
      unitRef="usd">1200000</us-gaap:ExtendedProductWarrantyAccrual>
    <cutr:StandardAndExtendedProductWarrantyAccrualExcessReserves
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMzg0ODI5MDY5OTA3NQ_84ac138e-3c47-4e69-b8cf-a3d7d246c97a"
      unitRef="usd">100000</cutr:StandardAndExtendedProductWarrantyAccrualExcessReserves>
    <cutr:StandardAndExtendedProductWarrantyAccrualExcessReserves
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMzg0ODI5MDY5OTA4OQ_bcaa544b-db67-4e55-b0a5-b1cd11c569e5"
      unitRef="usd">200000</cutr:StandardAndExtendedProductWarrantyAccrualExcessReserves>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="ie45277ed62d346cdb9916dbb3ad17292_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMTI3MQ_2c8d139e-0fc5-44b0-a464-ff4272d951b2"
      unitRef="usd">100000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="ia2c95c40b3a643028669a714bdf84fcc_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMTI3OA_7bf18b5e-9586-4a00-80cd-3cf7c25c3f22"
      unitRef="usd">500000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="i3522b04102fc4ee69538b27d4416746f_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMzg0ODI5MDY5OTExNA_ecd1312b-2901-473b-8244-6155183eeced"
      unitRef="usd">0</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="ic95c28211b0e434aad49ee7875023aa1_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF81NS9mcmFnOmRjNjkyYmM0ZTc0NTQ3Njc4NzUxNmMwY2VjNzY2OTNlL3RleHRyZWdpb246ZGM2OTJiYzRlNzQ1NDc2Nzg3NTE2YzBjZWM3NjY5M2VfMjE5OTAyMzI1NzQ1Nw_ed36e10b-f8be-418b-8ce0-aba6b2823959"
      unitRef="usd">300000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyDisclosureTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMTY2Mg_699fe324-e412-4898-a390-4f4b6cbc5032">Warranty and Extended Service Contract&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a direct field service organization in North America (including Canada). Internationally, the Company provides direct service support in Australia, Belgium, France, Germany, Hong Kong, Japan, Spain, Switzerland, and the United Kingdom. In several other countries, where the Company does not have a direct presence, the Company provides service through a network of distributors and third-party service providers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis. The Company provides for the estimated cost to repair or replace products under standard warranty at the time of sale. Costs incurred in connection with extended service contracts are recognized at the time when costs are incurred, except for a one-time extended service contracts charge of $3.2 million recorded in the year ended December&#160;31, 2018 related to the cost to replace a component in one of the Company's legacy products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the changes in the product&#160;warranty accrual for the three and six months ended June&#160;30, 2021 and 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&#160;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&#160;(1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Add: Accruals for warranties issued during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Settlements made during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The ending product warranty accrual balance excludes 0.6&#160;million and 1.7&#160;million as of June&#160;30, 2021 and 2020, respectively, related to one-time extended service contracts costs to replace components in one of the Company&#x2019;s legacy products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The $1.8 million and $2.9 million&#160;of settlements made in the three and six months ended June&#160;30, 2021, and $1.3 million and $3.2 million made in the three and six months ended June&#160;30, 2020, respectively, exclude costs&#160;related to extended service contract cost of $0.1 million and $0.3 million in the respective periods, incurred to replace a component in one of the Company's legacy products.&lt;/span&gt;&lt;/div&gt;</us-gaap:ProductWarrantyDisclosureTextBlock>
    <us-gaap:ExtendedProductWarrantyAccrualPayments
      contextRef="ifc4ad6178c2c49418650716374160150_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfOTY5_bb1e8055-2e3d-4e88-b3dc-8683d34344aa"
      unitRef="usd">3200000</us-gaap:ExtendedProductWarrantyAccrualPayments>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMTY2Mw_984a32a5-b0f5-4817-abdd-a8d1242c81f5">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the changes in the product&#160;warranty accrual for the three and six months ended June&#160;30, 2021 and 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&#160;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&#160;(1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Add: Accruals for warranties issued during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Settlements made during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The ending product warranty accrual balance excludes 0.6&#160;million and 1.7&#160;million as of June&#160;30, 2021 and 2020, respectively, related to one-time extended service contracts costs to replace components in one of the Company&#x2019;s legacy products.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i44e8ae2855f24ec191abeac87edead4a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfMi0xLTEtMS0w_de76bc4d-d547-4716-8853-0d3873635466"
      unitRef="usd">3351000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i06df2fa92c07439982ab4b6fddb466f1_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfMi0zLTEtMS0w_a437cef0-d622-4b47-81cc-c9e564bd22fc"
      unitRef="usd">3398000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfMi01LTEtMS05ODA_8845feee-37f5-4a7d-ae23-b1265c797879"
      unitRef="usd">2908000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i33947892bb224113abf96b09e46ffa54_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfMi03LTEtMS05ODI_0b182626-77a3-4449-9a4f-46df2dcf6e66"
      unitRef="usd">4401000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfMy0xLTEtMS0w_b1547fa6-5267-4bbf-ae89-5abce02e9d08"
      unitRef="usd">2210000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfMy0zLTEtMS0w_90a94f08-3d61-4345-b253-7832bdfbc469"
      unitRef="usd">1100000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfMy01LTEtMS05ODA_088f75ee-924f-4baa-90cf-6df30c7b1059"
      unitRef="usd">3735000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfMy03LTEtMS05ODI_21a89c0a-89e6-436c-9594-455205580c27"
      unitRef="usd">1960000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfNC0xLTEtMS0w_6b3bb415-1c42-4718-bef6-075f517e8808"
      unitRef="usd">1772000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfNC0zLTEtMS0w_90558d7f-3c82-47cf-aba3-cf5285ae69f1"
      unitRef="usd">1343000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfNC01LTEtMS05ODA_7a505bad-389b-4147-b6a8-8a1c897ade5c"
      unitRef="usd">2854000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfNC03LTEtMS05ODI_daa150d2-4540-4f66-b0e0-337685a1bf10"
      unitRef="usd">3206000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfNS0xLTEtMS0w_0112afa5-a96a-42d5-9f56-94e0509b5781"
      unitRef="usd">3789000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfNS0zLTEtMS0w_326d14c5-c5f1-4dcb-b7df-a62e7d675c6e"
      unitRef="usd">3155000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfNS01LTEtMS05ODA_e4b19ed4-e7e7-4caf-9572-62df92581c3a"
      unitRef="usd">3789000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RhYmxlOmNmNWY5MDZkZmEzMTRiNWJhNDc1MjIzMmUxZjY3MWE1L3RhYmxlcmFuZ2U6Y2Y1ZjkwNmRmYTMxNGI1YmE0NzUyMjMyZTFmNjcxYTVfNS03LTEtMS05ODI_e535e73f-0828-4991-a58e-e7ba1f4624e9"
      unitRef="usd">3155000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:ExtendedProductWarrantyAccrual
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMzg0ODI5MDcwMDQyNg_2c480703-18e4-479e-828b-c350c473cb18"
      unitRef="usd">600000</us-gaap:ExtendedProductWarrantyAccrual>
    <us-gaap:ExtendedProductWarrantyAccrual
      contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMzg0ODI5MDcwMDQzOQ_a902d077-5a85-4462-921d-2b5ab521eec2"
      unitRef="usd">1700000</us-gaap:ExtendedProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMTQyNg_91e75474-c452-457b-a664-acecf08a9440"
      unitRef="usd">1800000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMjE5OTAyMzI1NzI0NA_9559314f-a7c3-44c2-8f0e-a5de33a5adda"
      unitRef="usd">2900000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMjE5OTAyMzI1NzI0OA_6e1f25eb-9672-4723-b38e-c9f2c26d94aa"
      unitRef="usd">1300000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMjE5OTAyMzI1NzI1Ng_d358c77b-95b7-4de9-9638-dc0e4c8efe7e"
      unitRef="usd">3200000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:ExtendedProductWarrantyAccrualPayments
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMjE5OTAyMzI1NzYxNg_36b66210-c644-4e8d-bb19-505cab0e1956"
      unitRef="usd">100000</us-gaap:ExtendedProductWarrantyAccrualPayments>
    <us-gaap:ExtendedProductWarrantyAccrualPayments
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMjE5OTAyMzI1NzYxNg_85de7252-164d-45d2-87a9-1f1e8778cfa3"
      unitRef="usd">100000</us-gaap:ExtendedProductWarrantyAccrualPayments>
    <us-gaap:ExtendedProductWarrantyAccrualPayments
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMjE5OTAyMzI1NzY0Mw_778dd540-817f-4357-8b86-0551295acaa6"
      unitRef="usd">300000</us-gaap:ExtendedProductWarrantyAccrualPayments>
    <us-gaap:ExtendedProductWarrantyAccrualPayments
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82MS9mcmFnOmIzYjc5NmI2MDgxMTRjNDdiYjVjZDVmZDhkZTdlYzQ1L3RleHRyZWdpb246YjNiNzk2YjYwODExNGM0N2JiNWNkNWZkOGRlN2VjNDVfMjE5OTAyMzI1NzY0Mw_dd58b85d-1076-49ed-8052-fbf1a783d24b"
      unitRef="usd">300000</us-gaap:ExtendedProductWarrantyAccrualPayments>
    <cutr:ContractWithCustomerLiabilityTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfNzcz_587f6586-7c19-4c08-85ee-b398393b8cdf">Deferred Revenue&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records deferred revenue when revenue is to be recognized subsequent to invoicing. For extended service contracts, the Company generally invoices customers at the beginning of the extended service contract term. The Company&#x2019;s extended service contracts typically have &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfMzg0ODI5MDY5ODIyNg_e653e8fe-f332-4582-857d-3372b1518b74"&gt;one&lt;/span&gt;, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfMzg0ODI5MDY5ODIzOA_506311e3-b01b-41cc-9bc7-3004836d0ad0"&gt;two&lt;/span&gt; or three year terms. Deferred revenue also includes payments for training and extended marketing support service. Approximately 84% of the Company&#x2019;s deferred revenue balance of $11.4 million as of June&#160;30, 2021 will be recognized over the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides changes in the deferred revenue balance for the three and six months ended June&#160;30, 2021 and 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Add: Payments received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,834)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Revenue included in the beginning balance and recognized as revenue in the current quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs for extended service contracts were $2.2 million and $4.2 million for the three and six months ended June&#160;30, 2021, respectively, and were $2.3 million and $3.5 million for the three and six months ended June&#160;30, 2020, respectively.&lt;/span&gt;&lt;/div&gt;</cutr:ContractWithCustomerLiabilityTextBlock>
    <cutr:ExtendedServiceContractOptionThreeTerm
      contextRef="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfMzg0ODI5MDY5ODI1Nw_bc2486a7-e722-4302-bcc6-93bd4e1dca68">P3Y</cutr:ExtendedServiceContractOptionThreeTerm>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i2407102de7bf456bba0a70df24f73953_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfNDQ5_1c3099ba-b31c-4ad6-a3d4-2b5c070a7470"
      unitRef="number">0.84</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfNDk3_1e4178ed-899e-4c00-88dd-a760a7575ca9"
      unitRef="usd">11400000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i2407102de7bf456bba0a70df24f73953_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfNzc0_3c24afab-d75f-4788-9a62-54264d910ae7">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfNzc1_f2c305d0-0499-4600-aca8-46e1a140979d">The following table provides changes in the deferred revenue balance for the three and six months ended June&#160;30, 2021 and 2020 (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Add: Payments received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,834)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Revenue included in the beginning balance and recognized as revenue in the current quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i44e8ae2855f24ec191abeac87edead4a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfMi0xLTEtMS0w_61935443-b3a8-48ba-8841-e578a66c8481"
      unitRef="usd">11737000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i06df2fa92c07439982ab4b6fddb466f1_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfMi0zLTEtMS0w_cbb48c7e-34d2-4de9-95f0-49d82f93f0df"
      unitRef="usd">12969000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfMi01LTEtMS05Nzg_09ec0044-9760-4069-8694-9dbd7084506b"
      unitRef="usd">11237000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i33947892bb224113abf96b09e46ffa54_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfMi03LTEtMS05NzQ_c8650e8d-563c-4043-8a92-37a14d0b11ee"
      unitRef="usd">14222000</us-gaap:ContractWithCustomerLiability>
    <cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfMy0xLTEtMS0w_b33e7c35-188b-4f45-9735-a821cc196e62"
      unitRef="usd">4423000</cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived>
    <cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfMy0zLTEtMS0w_8fdaad67-cef0-492a-b909-3ea6fa5e036c"
      unitRef="usd">2554000</cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived>
    <cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfMy01LTEtMS05Nzg_ea0fc918-c7c0-4b35-930d-02725048b804"
      unitRef="usd">9352000</cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived>
    <cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfMy03LTEtMS05NzQ_665632ed-4ee3-4815-8136-96729f4395c0"
      unitRef="usd">6125000</cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived>
    <cutr:ContractWithCustomerLiabilityPeriodDecrease
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNC0xLTEtMS0w_d2d41bdc-cfa1-461c-862c-2bb302aa5d68"
      unitRef="usd">1834000</cutr:ContractWithCustomerLiabilityPeriodDecrease>
    <cutr:ContractWithCustomerLiabilityPeriodDecrease
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNC0zLTEtMS0w_752701ae-8303-41e9-9915-6ee2c7d4f6f7"
      unitRef="usd">1107000</cutr:ContractWithCustomerLiabilityPeriodDecrease>
    <cutr:ContractWithCustomerLiabilityPeriodDecrease
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNC01LTEtMS05Nzg_93505dd7-810c-4618-9ff5-3d944aaa9dfd"
      unitRef="usd">2279000</cutr:ContractWithCustomerLiabilityPeriodDecrease>
    <cutr:ContractWithCustomerLiabilityPeriodDecrease
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNC03LTEtMS05NzQ_e715cd65-48b3-486d-b3cb-1bda9d4d7fd9"
      unitRef="usd">1699000</cutr:ContractWithCustomerLiabilityPeriodDecrease>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNS0xLTEtMS0w_146a0202-25d8-4efe-b784-5e1330f68a10"
      unitRef="usd">2923000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNS0zLTEtMS0w_e13e1df3-a66f-4817-8138-afbd0eafe735"
      unitRef="usd">2637000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNS01LTEtMS05Nzg_2649c095-7b5f-47fa-9467-94f69af6b5ef"
      unitRef="usd">6907000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNS03LTEtMS0xMDQ1_eb56b055-ae82-47da-a813-be88ebcc1551"
      unitRef="usd">6869000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNi0xLTEtMS0w_44e9ed91-3068-457c-ba6b-fc038f62bd22"
      unitRef="usd">11403000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNi0zLTEtMS0w_29fd6c3b-46fe-4a1c-82bc-33c55b0db8a5"
      unitRef="usd">11779000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNi01LTEtMS05Nzg_6e225301-164b-41a0-8d25-6aa0e9f98b0e"
      unitRef="usd">11403000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ieb9afea6585c438abf605e46f4b90bf5_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RhYmxlOjc2MWNjM2EwOTBlODRhMmZiNWM2NDMxYjE1ZmZmNDVmL3RhYmxlcmFuZ2U6NzYxY2MzYTA5MGU4NGEyZmI1YzY0MzFiMTVmZmY0NWZfNi03LTEtMS05NzQ_378f8039-37c8-4797-a2ef-9770b388a168"
      unitRef="usd">11779000</us-gaap:ContractWithCustomerLiability>
    <cutr:CostsForExtendedServiceContracts
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfNzE2_6b9a14bd-5a0b-4439-8947-de7ac434f8ef"
      unitRef="usd">2200000</cutr:CostsForExtendedServiceContracts>
    <cutr:CostsForExtendedServiceContracts
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfNzIz_f623b7f5-2ca5-4040-93a2-8afa47b817e6"
      unitRef="usd">4200000</cutr:CostsForExtendedServiceContracts>
    <cutr:CostsForExtendedServiceContracts
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfMjE5OTAyMzI1NjM0NA_2e897398-0ef9-4c8b-a2cf-7a95b3cfe835"
      unitRef="usd">2300000</cutr:CostsForExtendedServiceContracts>
    <cutr:CostsForExtendedServiceContracts
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfMjE5OTAyMzI1NjM1Ng_e1f5ac4f-d740-4b3c-b700-153dcd17b477"
      unitRef="usd">3500000</cutr:CostsForExtendedServiceContracts>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMTE1ODM_b3f29a13-3c6b-4316-a783-6d1837369186">Revenue&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company&#x2019;s performance obligations are satisfied either over time or at a point in time. Revenue from performance obligations that are transferred to customers over time accounted for approximately 12% of the Company's total revenue for the three months ended June&#160;30, 2021 and 2020, and 18% of the Company's total revenue for the six months ended June&#160;30, 2021 and 2020. &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has certain system sale arrangements that contain multiple products and services. For these bundled sale arrangements, the Company accounts for individual products and services as separate performance obligations if they are distinct. The Company&#x2019;s products and services are distinct if a customer can benefit from the product or service on its own or with other resources that are readily available to the customer, and if the Company&#x2019;s promise to transfer the products or service to the customer is separately identifiable from other promises in the sale arrangements. The Company&#x2019;s system sale arrangements can include all or a combination of the following performance obligations: the system and software license (considered as one performance obligation), system accessories (hand pieces), training, other accessories, extended service contracts, marketing services, and time and materials services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the Company&#x2019;s system sale arrangements that include an extended service contract, the period of service commences at the expiration of the Company&#x2019;s standard warranty offered at the time of the system sale. The Company considers the extended service contracts terms in the arrangements that are legally enforceable to be performance obligations. Other than extended service contracts and marketing services, which are satisfied over time, the Company generally satisfies all performance obligations at a point in time. Systems, system accessories (hand pieces), service contracts, training, and time and materials services are also sold on a stand-alone basis, and these performance obligations are satisfied at a point in time. For contracts with multiple performance obligations, the Company allocates the transaction price of the contract to each performance obligation on a relative standalone selling price basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The determination of whether two or more contracts entered into at or near the same time with the same customer should be combined and accounted for as one contract may require the use of significant judgment. In making this determination, the Company considers whether the contracts are negotiated as a package with a single commercial objective, have price interdependencies, or promise goods or services that represent a single performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company&#x2019;s purchase agreements do not provide customers with a contractual right of return, the Company maintains a sales allowance to account for potential returns or refunds as a reduction in transaction price at the time of sale. The Company estimates sales returns and other variable consideration based on historical experience.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines the standalone selling price ("SSP") for each performance obligation as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Systems: The SSPs for systems are based on directly observable sales in similar circumstances to similar customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Extended warranty/Service contracts: SSP is based on observable price when sold on a standalone basis (by customer type).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Products and Services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Systems&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Systems revenue is generated from the sale of systems and from the sale of upgrades to existing systems. A system consists of a console that incorporates a universal graphic user interface, a laser or other energy-based module, control system software and high voltage electronics, as well as one or more hand pieces. In certain applications, the laser or other energy-based module is contained in the hand piece, such as with the Company&#x2019;s &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pearl&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pearl Fractional&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; applications, rather than within the console.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers customers the ability to select the system that best fits their practice at the time of purchase and then to cost-effectively add applications to their system as their practice grows. This provides customers the flexibility to upgrade their systems whenever they choose and provides the Company with a source of additional Systems revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The system or upgrade and the right to use the embedded software represent a single performance obligation as the software license is integral to the functionality of the system or upgrade.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For systems sold directly to end-customers that are credit approved, revenue is recognized when the Company transfers control to the end-customer, which occurs when the product is shipped to the customer or when the customer receives the product, depending on the nature of the arrangement. When collectability is not established in advance of receipt of payment from the customer, revenue is recognized upon the later of the receipt of payment or the satisfaction of the performance obligation. For systems sold through credit approved distributors, revenue is recognized upon shipment to the distributor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company typically receives payment for its system consoles and other accessories within 30 days of shipment. Certain international distributor arrangements allow for longer payment terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Skincare products&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sells&#160;third-party manufactured skincare products in Japan. The skincare products are purchased from a&#160;third-party manufacturer and sold to medical offices and licensed physicians. The Company warrants that the skincare products are free of significant defects in workmanship and materials for&#160;90 days from shipment. These are typically sold in a separate contract as the only performance obligations. The Company acts as the principal in this arrangement, as the Company determines the price to charge customers for the skincare products and controls the products before they are transferred to the customer. The Company recognizes revenue for skincare products upon shipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consumables and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other accessories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies its customers' purchases of replacement cycles for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt iD&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt flex,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as well as replacement hand pieces, Titan and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt 3D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; hand pieces, and single use disposable tips applicable to&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret PRO, Juliet,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;and&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret RF,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as Consumable revenue, which provides the Company with a source of recurring revenue from existing customers. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Juliet&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret RF&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; products'&#160;single use disposable tips&#160;must be replaced after every treatment. Sales of these consumable tips further enhance the Company&#x2019;s recurring revenue. The Company&#x2019;s systems offer multiple hand pieces and applications, which allow customers to upgrade their systems.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equipment leasing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases equipment to customers through membership programs and receives a fixed monthly fee over the term of the arrangement. The Company classifies its lease income as product revenue. The Company recognizes lease income over the term of the lease if the lease is classified as an operating lease. For agreements that grant customers the right to purchase the leased system, the Company typically classifies the lease as a sales-type lease as the Company has determined it is reasonably certain that the customer will exercise the purchase option. On the commencement of sales-type leases, the Company recognizes revenue upfront in product revenue and the corresponding receivables recorded in other current assets and prepaid expenses on the condensed consolidated balance sheets (See Note&#160;11 - Leases). There was no revenue recognized for sales-type leases for the three and six months ended June&#160;30, 2021 or 2020. Revenue from equipment leases, which was accounted for as operating leases, was&#160;not&#160;material for&#160;the three and six months&#160;ended&#160; June&#160;30, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Extended contract services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers post-warranty services to its customers through extended service contracts that cover parts and labor for terms of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODg3OA_37d5a87f-934a-4984-8ce6-ca3dbd45b43b"&gt;one&lt;/span&gt;, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODg5MA_759bd265-f34f-4f56-92c1-11dc5f2a0f73"&gt;two&lt;/span&gt;, or three years. Service contract revenue is recognized over time, using a time-based measure of progress, as customers benefit from the service throughout the service period. The Company also offers services on a time-and-materials &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;basis for systems and detachable hand piece replacements. Revenue related to services performed on a time-and-materials basis is recognized when performed. These post-warranty services serve as additional sources of recurring revenue from the Company&#x2019;s installed product base.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Training&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales of systems to customers include training on the use of the system to be provided within 180 days of purchase. The Company considers training a separate performance obligation as customers can immediately benefit from the training together with the customer&#x2019;s system. Training is also sold separately from systems. The Company recognizes revenue for training when the training is provided. Training is not required for customers to use the systems.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Customer Marketing Support&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In North America, the Company offers marketing and consulting phone support to its customers across all system platforms. These customer marketing support services include a practice development model and marketing training, performed remotely with ongoing phone consultations for six months from date of purchase. The Company considers customer marketing support a separate performance obligation, and recognizes revenue over the six-month term of the contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loyalty Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has&#160;a customer loyalty program for qualified customers located in the U.S. and Canada. Under the loyalty program, based on their purchasing levels, customers accumulate points that can be redeemed for such rewards as the right to attend the Company&#x2019;s advanced training event for&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, or a ticket for the Company&#x2019;s annual forum. A customer&#x2019;s account must be in good standing to receive the benefits of the rewards program. Rewards are earned on a quarterly basis and must be used in the following quarter.&#160;All unused rewards are forfeited. The fair value of the reward earned by loyalty program members is included in accrued liabilities and recorded as a reduction of net revenue at the time the reward is earned. As of June&#160;30, 2021 and December&#160;31, 2020,&#160;the liability for the loyalty program included in accrued liabilities was $0.6 million and $0.3 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Sales Commissions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Incremental costs of obtaining a contract, which consist primarily of commissions and related payroll taxes, are capitalized and amortized on a straight-line basis over the expected period of benefit, except for costs that are recognized when product is sold. The Company uses the portfolio method to recognize the amortization expense related to these capitalized costs related to initial contracts and such expense is recognized over a period associated with the revenue of the related portfolio, which is generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcxMDQxMA_6ae4c934-3ce2-494d-a9ef-e60aa0c8aad9"&gt;two&lt;/span&gt; to three years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total capitalized costs as of June&#160;30, 2021 and December&#160;31, 2020 were $3.6 million and $3.4 million, respectively, and are included in Other long-term assets in the Company&#x2019;s condensed consolidated balance sheet. Amortization expense for these assets was $0.5 million and $1.0 million during the three and six months ended June&#160;30, 2021, respectively, and was $0.7 million and $1.4 million during the three and six months ended June&#160;30, 2020, respectively. The amortization related to these capitalized costs is included in sales and marketing expense in the Company&#x2019;s condensed consolidated&#160;statement of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <cutr:RevenuePerformanceObligationSatisfiedOverTimePercent
      contextRef="i881844cc567943b08e58b8c62bf2cdb7_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMjE5OTAyMzI2ODM4Mg_0202dce0-997e-4441-82cd-d24ae690fefb"
      unitRef="number">0.12</cutr:RevenuePerformanceObligationSatisfiedOverTimePercent>
    <cutr:RevenuePerformanceObligationSatisfiedOverTimePercent
      contextRef="iebd0fb6eb91a42ec917f088a099d13af_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMjE5OTAyMzI2ODM4Mg_8c5c4a5e-5eaf-43eb-bd07-738cd468588f"
      unitRef="number">0.12</cutr:RevenuePerformanceObligationSatisfiedOverTimePercent>
    <cutr:RevenuePerformanceObligationSatisfiedOverTimePercent
      contextRef="id5f9a379644248b4bb314bae98be198c_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMjE5OTAyMzI2ODc5NQ_2514ac6e-1ea5-4493-9f8f-0fa45f94cb2f"
      unitRef="number">0.18</cutr:RevenuePerformanceObligationSatisfiedOverTimePercent>
    <cutr:RevenuePerformanceObligationSatisfiedOverTimePercent
      contextRef="ifc6d773f0c1a4f6b95a87d9eb4d6ac20_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMjE5OTAyMzI2ODc5NQ_cc042dcd-61c8-4eb0-976d-42491b97212f"
      unitRef="number">0.18</cutr:RevenuePerformanceObligationSatisfiedOverTimePercent>
    <cutr:RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcxMDY0OA_b4cd1e53-0831-46b0-a912-e9884fec4425">P30D</cutr:RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment>
    <cutr:SaleOfThirdPartyProductWarrantyPeriod
      contextRef="i470d10cc776b41649b8a03cf1ec2f3fc_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcxMDYzMQ_42e24d4f-2c4c-4ce7-a8d9-3546108bd26a">P90D</cutr:SaleOfThirdPartyProductWarrantyPeriod>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODg1OQ_b6a3b92c-7974-41fe-a073-6046ed61ed73"
      unitRef="usd">0</us-gaap:SalesTypeLeaseRevenue>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODg1OQ_b9cb6754-c1c3-43f8-a1cd-fb977f51dafd"
      unitRef="usd">0</us-gaap:SalesTypeLeaseRevenue>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODg1OQ_d96e2322-5997-4ca3-b904-159911ef2868"
      unitRef="usd">0</us-gaap:SalesTypeLeaseRevenue>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODg1OQ_f5dff5fe-88ac-40a1-83ec-c8c8ba53405a"
      unitRef="usd">0</us-gaap:SalesTypeLeaseRevenue>
    <cutr:ExtendedServiceContractOptionThreeTerm
      contextRef="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODkwNA_3f83d961-35e6-4ee7-a8e1-1428e2121547">P3Y</cutr:ExtendedServiceContractOptionThreeTerm>
    <cutr:ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcxMDM5MQ_da012253-9f25-48d5-a858-84e68daaf49f">P180D</cutr:ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod>
    <cutr:RevenueFromContractWithCustomerTermOfContract
      contextRef="if3f410467d4d4330ad372e3a956470ad_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcxMDY3OQ_273c9698-4c48-4db2-9366-0e935adbe0ae">P6M</cutr:RevenueFromContractWithCustomerTermOfContract>
    <cutr:RevenueFromContractWithCustomerTermOfContract
      contextRef="if3f410467d4d4330ad372e3a956470ad_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcxMDY0Mg_630746c7-1cf9-41ab-a092-9f68d67e4fd3">P6M</cutr:RevenueFromContractWithCustomerTermOfContract>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i36aa596dff8748588786668800832709_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMTA2MTg_303af04b-acfb-427e-b189-f0d68b8db277"
      unitRef="usd">600000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i6f22dd0f34be4388a01961e660f5caf8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMTA2MjU_b1c5c459-2814-41a9-af58-8b70cce588e5"
      unitRef="usd">300000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="i3c7a53758f744376b8ee593f5591f92b_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcxMDQyNA_5ba48e76-33a6-4c21-b197-5f4210bf5bfa">P3Y</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:CapitalizedContractCostNet
      contextRef="i35c2ccc976154aaa943236bfb9c494ca_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMTEyNTM_eb2df5d3-8dc2-4d04-a42b-ab2149d20aad"
      unitRef="usd">3600000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostNet
      contextRef="ia3cba542e3a741d4a477c46679b67946_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMjE5OTAyMzI2NzE4NA_b685c3b2-1a68-48bd-8288-a435e61713ff"
      unitRef="usd">3400000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i6676b6bef6f2454fbbc76aea9a2cc1da_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMTE0MTE_e16b783f-33bd-4c9f-becc-5c97cf29e8a3"
      unitRef="usd">500000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="iea529016b4144eb5becac8fb1c31a306_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMjE5OTAyMzI2NzYyMg_ac6aebfd-7a36-4a15-b50d-3f4628e0fe2e"
      unitRef="usd">1000000.0</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i39a83be3b8224826a825113043c0f630_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMjE5OTAyMzI2NzYxOA_61476853-c80d-4d35-86bb-bbded0aee07d"
      unitRef="usd">700000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i56e825e587f849159fe52471c86de3c9_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMjE5OTAyMzI2NzY2NQ_96f67ee6-2d17-4ff9-a00b-610b700a6e31"
      unitRef="usd">1400000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfNDUyMA_899279fc-bf53-4928-a0f4-21fc2bf83afb">Stockholders&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Equity and Stock-based Compensation Expense&lt;/span&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s equity incentive plans are broad-based, long-term programs intended to attract and retain talented employees and align stockholder and employee interests. In June 2019, stockholders approved an amendment and restatement of the Amended and Restated 2004 Equity Incentive Plan as the 2019 Equity Incentive Plan (the &#x201c;2019 Plan&#x201d;) and approved an additional 700,000 shares, available for future grants (in addition to the 9,701,192 shares provided under the Prior Plan). In June 2021, stockholders approved an additional 450,000 shares for future grants. The 2019 Plan provides for the grant of incentive stock options, non-statutory stock options, RSAs restricted stock units (&#x201c;RSUs&#x201d;), stock appreciation rights, performance stock units, performance shares, and other stock or cash awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The Company issued 4,085 PSUs to a non-employee director during the three months ended June 30, 2021. The Company&#x2019;s Board of Directors granted its executive officers, senior management and certain employees 82,549 and 171,137 performance stock units (&#x201c;PSUs&#x201d;) during the three and six months&#160;ended June&#160;30, 2021. The PSUs granted in the three and six months ended June&#160;30, 2021 vest subject to continued service and the Company&#x2019;s achievement of certain operational goals for the 2021 fiscal year related to product milestones, sales and commercial milestones and certain cost reduction targets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The Company issued 29,361 RSUs to its non-employee directors during the three months ended June 30, 2021.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The Company&#x2019;s Board of Directors also granted its executive officers and senior management 73,186 and 129,783 RSUs and 103,466 and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;172,139 non-qualified stock options (&#x201c;NQs&#x201d;) during the three and six months&#160;ended June&#160;30, 2021, respectively. The RSUs and NQs vest over four years with one-fourth&#160;vesting&#160;on the first anniversary of the vesting commencement date of January 1, 2021 and 1/36th of the underlying shares vesting each month thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;On September 30, 2019, the Company's Board awarded its new CEO, David H. Mowry, 67,897 shares, which were scheduled to vest over four years from 2019 through 2022 (the 2019 tranche is 15% of the award, or 10,185 PSUs; the 2020 tranche is 25% of the award, or 16,974 PSUs; the 2021 tranche is 30% of the award, or 20,369 PSUs; the 2022 tranche is 30% of the award, or 20,369 PSUs). These PSUs are subject to certain performance-based vesting criteria related to the achievement of financial metrics included in the Board approved annual budgets for the years 2019 through 2022. As of June 30, 2021, the 2019, 2020 and 2021 tranches met the criteria for measurement and recognition.  8,657 shares of the 2019 tranche vested during the three months ended March 31, 2020.  The 2020 tranche did not vest in accordance with the initial terms, however, during the quarter ending June 30, 2021, the Company&#x2019;s Board of Directors approved the vesting of Mr. Mowry&#x2019;s 2020 PSU tranche. Upon this modification to the vesting terms of the 2020 PSU tranche, the Company recognized $0.5&#160;million of stock-based compensation expense in the quarter ending June 30, 2021.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 2019 Plan, the Company issued 92,103 and 214,797 shares of common stock during the three and six months ended June&#160;30, 2021, in conjunction with stock options exercised and the vesting of RSUs and PSUs, net of shares withheld for employee taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021,&#160;the unrecognized compensation cost, net of expected forfeitures, was $2.0 million for stock options, which will be recognized over an estimated weighted-average remaining amortization period of&#160;3.6 years. The unrecognized compensation cost, net of expected forfeitures, for stock awards, including performance-based awards, was $16.1 million, which will be recognized over an estimated weighted-average remaining amortization period of&#160;2.0 years. The actual expense recorded in the future may vary based on a number of factors, including, actual forfeitures experienced and the degree of achievement of the performance goals related to the PSUs granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity under the 2019 Plans is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shares&lt;br/&gt;Available&lt;br/&gt;for Grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Number of&lt;br/&gt;Stock Options&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted Average Remaining Term&lt;br/&gt;&#160;(in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Aggregate Intrinsic Value &lt;br/&gt;(in Millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,085,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;217,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional shares reserved&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Awards granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(354,735)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(172,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;172,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(53,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock awards canceled / forfeited / expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;212,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options canceled / forfeited / expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16,224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,237,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;319,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Awards Outstanding&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of Awards Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value &lt;br/&gt;(in Millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Awards released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards canceled / forfeited / expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212,571)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense&#160;by department recognized during the three and six months ended June&#160;30, 2021 and 2020 was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i043c44727e4748838f975923cbe8de27_D20190601-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfNDI4_f2657cbc-c08d-4112-84f9-7517c58fe635"
      unitRef="shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i8051166907c44cc3b4d720878ae84444_I20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfNDg3_dcffde80-4e02-44c3-ad1f-0ad7a850c880"
      unitRef="shares">9701192</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="ibc771595ca97435b917e76c6379187af_D20210601-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMjE5OTAyMzI2MDEwMA_5e5a3b61-8e61-4e86-bf0e-17bf7615e6ea"
      unitRef="shares">450000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i1c1cc14f1d17439ab6dc582f75bd1a5b_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwNTA1MA_49293f09-425b-4dd0-9053-f98a34d61242"
      unitRef="shares">4085</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ia86610d6c30943a98b2884869af2e9a8_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcxMDA5OA_bc01aad1-fb97-4021-90d3-0dcaa8f77124"
      unitRef="shares">82549</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie9988de6b19146808f537a79f2f4003b_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcxMDEwNg_1058c175-c646-43af-bfec-3b7be92cb7fd"
      unitRef="shares">171137</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i13634336729642d784da25921efe552a_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMjE5OTAyMzI2MTQyMA_2506971d-5e31-4f69-835d-90f22003fef0"
      unitRef="shares">29361</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if82f30c5243c44b4ad80cd7520748ea9_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMTM3NQ_830327cd-1a8f-4221-bda1-847bcb4edffc"
      unitRef="shares">73186</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8283a2c2e73d47759779e4f3016de4be_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwMzM0OA_1a4848a3-a53d-4da0-bfc0-a43a23a528c0"
      unitRef="shares">129783</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i5eb930ee997642608de2ef098dda5547_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMTM4Nw_5901d18a-118d-4ff7-93a2-b533ea27d2e9"
      unitRef="shares">103466</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i8b76898f620849e68db8504b5c340666_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwMzM1Nw_0b8ae150-91b6-4a56-9b7d-c5246b4aff3e"
      unitRef="shares">172139</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ie7a69c86013f47fd84b88ded0e2796dd_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMTQ4NA_0e0e3f89-d033-4717-a792-1aaf0866dc19">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i8d63e931f0e34f97838b48f7c9d93f52_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMTQ4NA_81d6a57b-1545-4796-ae81-397ceb66dd49">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ib2f388401ace46cab8547a66f8274e5c_D20190930-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODczNA_32c70c15-df19-4caa-a04d-dafc900c66cd"
      unitRef="shares">67897</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib2f388401ace46cab8547a66f8274e5c_D20190930-20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODc0OQ_3ad8a6b4-84ac-42f3-b129-79ce2693a0f4">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i0086c16aff3843a88d06e0b9a23ab663_D20190930-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODc2MQ_7a8aa193-263d-4234-94d4-7134f41e75b8"
      unitRef="number">0.15</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i0086c16aff3843a88d06e0b9a23ab663_D20190930-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODc2Ng_35e46dcf-177f-4dca-8b1c-e7fa059b46ac"
      unitRef="shares">10185</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i260072c69a4b43b297a42091f34d2d34_D20190930-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODc3NA_e6eb62c0-38ee-4d24-918c-34104be8adc4"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i260072c69a4b43b297a42091f34d2d34_D20190930-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODc3OQ_8d2926d9-55b2-4a21-8b95-1f3e09b00eb1"
      unitRef="shares">16974</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i1c46e2208d6a4e10972c5f842c7fcf68_D20190930-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODc4Nw_0949bef9-b9ac-4f87-ad9c-639f01aac094"
      unitRef="number">0.30</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i1c46e2208d6a4e10972c5f842c7fcf68_D20190930-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODc5Mg_29bab53b-6f77-44b8-9ced-6f18614cd547"
      unitRef="shares">20369</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i3774f37aef574876bfd257a704d58d18_D20190930-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODgwMA_6dac46be-75c7-40c6-9f04-97bd3b5a1462"
      unitRef="number">0.30</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i3774f37aef574876bfd257a704d58d18_D20190930-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODgwNQ_06ed2250-4a79-43c1-8bfd-57df360a7a85"
      unitRef="shares">20369</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ida744089b3ac429ba5d244a28072197f_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODgxMw_3dfa864c-32ea-4f99-8b38-0147c15c0ac4"
      unitRef="shares">8657</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i686fa2a5de5542978b650edda0bb93db_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwODgyMA_95c08867-84a5-4a90-8f42-350f96faeb57"
      unitRef="usd">500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i20bf571b99a94909a5b0526d60ddfc07_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzQ4MQ_06794af1-380f-4737-84a9-dbf6348cc042"
      unitRef="shares">92103</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i244333557f0f4c1f9b9e1e26967d871c_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg0ODI5MDcwMzM3Nw_290c22d8-8855-4466-96ba-a1ce0eebab27"
      unitRef="shares">214797</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="if91020effb684eec96e7ae9b7579c211_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzczOA_16167aba-c92c-4b0b-b1f0-3a34eb4fdc1e"
      unitRef="usd">2000000.0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i04a939a51cb44bbfab0551c699f24582_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzg1Mw_9c756810-da09-4622-b2f8-b88d802e036f">P3Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i38c5dcae21c84726b4ba51da80b02ac4_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfMzk4MA_f455324f-5fc2-47ea-9909-2bd78fc5da8e"
      unitRef="usd">16100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ie58ba076e2704369a7e7ca1be3068f0a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfNDA3Nw_d7458c73-9297-43b5-b6e8-0e42aa5986d2">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfNDUyMQ_dd2c454f-9523-40e8-889a-d08241e8ba1e">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity under the 2019 Plans is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shares&lt;br/&gt;Available&lt;br/&gt;for Grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Number of&lt;br/&gt;Stock Options&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted Average Remaining Term&lt;br/&gt;&#160;(in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Aggregate Intrinsic Value &lt;br/&gt;(in Millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,085,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;217,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional shares reserved&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Awards granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(354,735)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(172,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;172,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(53,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock awards canceled / forfeited / expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;212,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options canceled / forfeited / expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16,224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,237,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;319,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Awards Outstanding&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of Awards Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value &lt;br/&gt;(in Millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Awards released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards canceled / forfeited / expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212,571)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfMi0xLTEtMS0w_985d2f64-c635-43c5-a465-61c4873c03f2"
      unitRef="shares">1085170</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfMi0zLTEtMS0w_9e7cb308-e727-4ad7-ac70-88ff8f45c1b8"
      unitRef="shares">217007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfMi01LTEtMS0w_f6bcbab4-546b-48e6-9dfa-d4791a828b7c"
      unitRef="usdPerShare">22.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i6e5db1d27c0d467fa8a06f3edfd4046b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfMi03LTEtMS01NTE1_160ace5a-937b-4d13-8b8e-938cb1b4c6b3">P3Y9M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfMi05LTEtMS01NTE1_c96e6963-17be-4998-ae1f-e98d8216dc8e"
      unitRef="usd">1470000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfMy0xLTEtMS0zMzYx_f3285075-f6e3-4324-9a23-93b4a4d3ac19"
      unitRef="shares">450000</cutr:ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNC0xLTEtMS02MDU0_bb4a3d8a-5199-477a-993b-2ce521d90346"
      unitRef="shares">354735</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfMy0xLTEtMS0w_5839fcd3-273f-473f-9436-e92e2e649555"
      unitRef="shares">172139</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfMy0zLTEtMS0w_ce7dd43b-5dc9-49fd-973b-783295de72fe"
      unitRef="shares">172139</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfMy01LTEtMS0w_67c5aa2d-6fae-4705-a3fa-a6b9e75adb05"
      unitRef="usdPerShare">30.71</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNC0xLTEtMS0w_e3ae217b-bcf7-454b-9ae1-d9df47e39de4"
      unitRef="shares">0</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNC0zLTEtMS0w_7f47b635-a3a5-4bae-abca-82fbb87441bc"
      unitRef="shares">53598</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNC01LTEtMS0w_4133251d-e2b8-4569-99a5-023b519cc007"
      unitRef="usdPerShare">23.34</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNS0xLTEtMS0w_acd9f5a1-15ee-40cb-bf46-d2a0a6df28a8"
      unitRef="shares">212571</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNi0xLTEtMS0w_e88447de-3521-4d3a-9a2a-0fe2396f323a"
      unitRef="shares">16224</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNi0zLTEtMS0w_14c3045d-2acb-4d09-9192-e05d7702c3e1"
      unitRef="shares">16224</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNi01LTEtMS0w_a678b5d7-8f6b-4e60-939f-5ad3dce152df"
      unitRef="usdPerShare">33.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNy0xLTEtMS0w_9c55093d-da5b-4e13-bcd1-6f01a22df6ff"
      unitRef="shares">1237091</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNy0zLTEtMS0w_fc1c22a2-3d1f-4ade-bfa5-8bdb7e34847a"
      unitRef="shares">319324</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfNy01LTEtMS0w_9f51d49f-93e2-4c8b-9449-3ca59f5f6261"
      unitRef="usdPerShare">26.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfOC03LTEtMS01NTE1_5f9db3f9-4f27-4c4b-98e8-935da06be411">P5Y1M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjYyMGE1ZWE1OTlmYTRmNTFiMzU1OWI0MWZjZWE0YTExL3RhYmxlcmFuZ2U6NjIwYTVlYTU5OWZhNGY1MWIzNTU5YjQxZmNlYTRhMTFfOC05LTEtMS01NTE1_6fcb5f20-7253-4e5f-adf1-2303fbe85061"
      unitRef="usd">7340000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i4c3011eb06b8441e960fb49156c2b7bb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfMS0xLTEtMS01NTI4_bdd77153-e239-4990-946f-f024fbb83770"
      unitRef="shares">779757</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i4c3011eb06b8441e960fb49156c2b7bb_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfMS0zLTEtMS01NTI4_597f256b-1ab5-4a7d-9fa7-12b6a67f68b3"
      unitRef="usdPerShare">23.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="i4c3011eb06b8441e960fb49156c2b7bb_I20201231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfMS01LTEtMS01NTI4_0673f32c-f206-436f-ac20-50ef1d39919a"
      unitRef="usd">18800000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie58ba076e2704369a7e7ca1be3068f0a_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfMy0xLTEtMS01NTI4_a4b4bfda-17f5-45c2-b9d8-6de4447939c7"
      unitRef="shares">354735</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie58ba076e2704369a7e7ca1be3068f0a_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfMy0zLTEtMS01NTI4_5be5aa4a-cbfb-4a4a-aed9-ee1775641603"
      unitRef="usdPerShare">31.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ie58ba076e2704369a7e7ca1be3068f0a_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfNC0xLTEtMS01NTI4_a8eeb500-0e78-4a6e-aa51-af654c9f7814"
      unitRef="shares">161199</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie58ba076e2704369a7e7ca1be3068f0a_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfNC0zLTEtMS01NTI4_3ebfdbbe-7750-4eda-9c0a-c8cbccc25f7d"
      unitRef="usdPerShare">22.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ie58ba076e2704369a7e7ca1be3068f0a_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfNS0xLTEtMS01NTI4_41034763-350e-48ed-855d-d52f53da2820"
      unitRef="shares">212571</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ie58ba076e2704369a7e7ca1be3068f0a_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfNS0zLTEtMS01NTI4_17ff1622-bac3-4587-bbdd-a65d70812fcf"
      unitRef="usdPerShare">28.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i38c5dcae21c84726b4ba51da80b02ac4_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfNi0xLTEtMS01NTI4_d4c03690-abb7-4213-84ec-e832bc8efd5f"
      unitRef="shares">760722</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i38c5dcae21c84726b4ba51da80b02ac4_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfNi0zLTEtMS01NTI4_3ed8e88a-5bd8-487d-906d-beb643d50eed"
      unitRef="usdPerShare">26.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="i38c5dcae21c84726b4ba51da80b02ac4_I20210630"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjY3ZmNkNzM5NGY5NTRkYmNhMTk5MzcxMWU3OGQ2MGYyL3RhYmxlcmFuZ2U6NjdmY2Q3Mzk0Zjk1NGRiY2ExOTkzNzExZTc4ZDYwZjJfNi01LTEtMS01NTI4_07104ec7-30aa-4974-9323-effce4102d0e"
      unitRef="usd">7340000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RleHRyZWdpb246OTVlZTVmNDc1NzY0NGYzMWI1Zjk4Nzk2NWUwN2I3YWZfNDUyMg_7c95f463-a3c7-42a6-ad76-bc2c5f44d108">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense&#160;by department recognized during the three and six months ended June&#160;30, 2021 and 2020 was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie6d4ff6c6be04324bd9520f1387d71dc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfMi0xLTEtMS0w_b7f818ef-763d-45ca-908c-019a4010cddb"
      unitRef="usd">434000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i41584b05a4664ba3af97fb224bccbdae_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfMi0zLTEtMS0w_24b4ffca-6745-49c1-b8f8-79c3f0920069"
      unitRef="usd">743000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i19202ea6769b485981af1a269c354a3e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfMi01LTEtMS0xMDQy_51d56dc5-b82d-434c-84ce-8bcd4739eda9"
      unitRef="usd">578000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibe19bb61d2c04cc187ecedbd6e6de449_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfMi03LTEtMS0xMDQy_05520c31-4232-45fb-90cf-cd1e8c7e1214"
      unitRef="usd">1033000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6676b6bef6f2454fbbc76aea9a2cc1da_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfMy0xLTEtMS0w_5a2f6c91-8681-4649-a8b8-f23247fcf738"
      unitRef="usd">522000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i39a83be3b8224826a825113043c0f630_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfMy0zLTEtMS0w_1b4e12ba-00da-40b0-918e-f3f5d17e0c55"
      unitRef="usd">1251000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iea529016b4144eb5becac8fb1c31a306_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfMy01LTEtMS0xMDQy_374e3ad6-b68c-4a01-9384-0e50829da05f"
      unitRef="usd">1243000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i56e825e587f849159fe52471c86de3c9_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfMy03LTEtMS0xMDQy_30c7fd78-5904-4856-ba55-08f9c31d2fd4"
      unitRef="usd">1970000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if15f1055aa4c497db7227c965f673e0b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNC0xLTEtMS0w_f465e3d7-d550-4786-8dc1-9d941fd05bb0"
      unitRef="usd">307000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia1d2e0e7bf114927b546768a3c34a81d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNC0zLTEtMS0w_8e96b762-07d3-4fe0-bba7-fc9c6593be52"
      unitRef="usd">769000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idb17262b381746f787063be8b5d55b71_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNC01LTEtMS0xMDQy_68c0a8f1-0778-4ec4-8b09-0247f5531ae4"
      unitRef="usd">608000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1e15052c9d0d44619f2e3d20485ef206_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNC03LTEtMS0xMDQy_13c19051-fc89-419d-aae5-a75a9793fc8b"
      unitRef="usd">1090000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9707b7e07a2a420e93afba7c1ea09419_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNS0xLTEtMS0w_bd998126-686d-4d5c-baeb-0d7d293582f6"
      unitRef="usd">1656000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idee8ae2735f8498b9407c4ced951bf09_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNS0zLTEtMS0w_6237daab-aecd-410d-b03e-32f7a22f6ccb"
      unitRef="usd">1332000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic21ba9ca8ecf493ba645bdbe2ad6c2a1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNS01LTEtMS0xMDQy_1e0944d5-a4d9-45e9-a6fb-a5913c168994"
      unitRef="usd">2336000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i26b8cbc3a16e449f9a39f3289247bef9_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNS03LTEtMS0xMDQy_69458553-ba37-4279-b3b6-6f961a42f9f8"
      unitRef="usd">1982000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNi0xLTEtMS0w_45799224-dd70-4609-9a7a-991e2c9da784"
      unitRef="usd">2919000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNi0zLTEtMS0w_420b2ee3-a6bd-425a-94e3-ff7a728fb018"
      unitRef="usd">4095000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNi01LTEtMS0xMDQy_bf00bc0d-ea75-4976-b931-54aed0aff27a"
      unitRef="usd">4765000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83My9mcmFnOjk1ZWU1ZjQ3NTc2NDRmMzFiNWY5ODc5NjVlMDdiN2FmL3RhYmxlOjgwYWMwNTU4NjIyMjRlZTU4YjU2ODNhNzExMTRkNTQ5L3RhYmxlcmFuZ2U6ODBhYzA1NTg2MjIyNGVlNThiNTY4M2E3MTExNGQ1NDlfNi03LTEtMS0xMDQy_4d931fb8-46c5-4aa1-8cc0-fc9b8564dcde"
      unitRef="usd">6075000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RleHRyZWdpb246YjA3MWY4NjNhNWQwNDY2NDhiNDhmYjQ2ZGFhZDg1YzlfMTg5OQ_8af6cb4b-1909-490c-9916-03e8b6188215">Net Income (Loss) Per Share&lt;div style="margin-top:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2021, the Company adopted the accounting standard update to simplify the accounting for convertible debt instruments. The Company now uses the if converted method for its Convertible notes in calculating the diluted net income per share, and includes the effect of potential share settlement for the Convertible notes, if the effect is dilutive. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share (&#x201c;EPS&#x201d;) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method or the if-converted method. Dilutive potential common shares include outstanding stock options, stock awards, performance stock awards, and conversion shares under the Convertible notes. The diluted EPS is computed with the assumption that the Company will settle the convertible debt in shares, rather than cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As of June&#160;30, 2021, the Company&#x2019;s Convertible notes were potentially convertible into 4,167,232 shares of common stock. The Company used the if converted stock method to calculate the potential dilutive effect of the conversion spread on diluted net income per share, for the three and six  months ended June&#160;30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The denominator for diluted net income per share does not include any effect from the capped call transactions the Company entered into concurrently with the issuance of the Convertible notes, as this effect would be anti-dilutive. In the event of conversion of a Convertible note, shares delivered to the Company under the capped call will offset the dilutive effect of the shares that the Company would issue under the Convertible notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;For the three and six months ended June&#160;30, 2020, basic loss per common share and diluted loss per common share are the same as inclusion of any potentially issuable&#160;shares would be&#160;anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income (loss) and the weighted average number of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;shares used in computing basic and diluted net income (loss) per share (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss) used in calculating net income (loss) per share,  basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(11,394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense on Convertible notes, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of debt issuance cost, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income used in calculating net income per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(11,394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(23,808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dilutive effect of incremental shares and share equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average shares of common stock outstanding used in computing net income (loss) per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net income (loss) per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss) per share, basic &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss) per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following numbers of shares outstanding, prior to the application of the if converted stock method, were excluded from the computation of diluted net income (loss) per common share for the periods presented because including them would have had an anti-dilutive effect (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capped call (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The Company entered into capped call transactions with certain financial institutions, which are generally designated to reduce common stock dilution upon conversion of the Convertible notes. The capped call transactions are excluded from the computation of diluted net income (loss) per common share as their effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments
      contextRef="i28760ad245b749f6b1743389a6736740_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RleHRyZWdpb246YjA3MWY4NjNhNWQwNDY2NDhiNDhmYjQ2ZGFhZDg1YzlfNjMw_9caaa72b-6c97-4e5f-9cbe-54aad6246c16"
      unitRef="shares">4167232</us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RleHRyZWdpb246YjA3MWY4NjNhNWQwNDY2NDhiNDhmYjQ2ZGFhZDg1YzlfMTkwMA_84c70a24-ffd6-4e61-a706-6104e64c0937">The following table sets forth the computation of basic and diluted net income (loss) and the weighted average number of &lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;shares used in computing basic and diluted net income (loss) per share (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss) used in calculating net income (loss) per share,  basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(11,394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense on Convertible notes, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of debt issuance cost, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income used in calculating net income per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(11,394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(23,808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dilutive effect of incremental shares and share equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average shares of common stock outstanding used in computing net income (loss) per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net income (loss) per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss) per share, basic &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss) per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMi0xLTEtMS0w_6ddd1b22-b32e-4899-a8d5-7e3c5b1ef204"
      unitRef="usd">7746000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMi0zLTEtMS0w_7620cfb6-61d9-4bce-949a-2a1c08fb2d3f"
      unitRef="usd">-11394000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNC01LTEtMS0xMDcw_b8a6c30c-bbae-41bc-af04-882788dc1adc"
      unitRef="usd">7387000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNC03LTEtMS0xMDcw_374cd371-b50e-449d-b04b-f3e2b382a9b2"
      unitRef="usd">-23808000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNC0xLTEtMS01MTUx_4a9ae025-0e9e-4105-b5ca-cb4d02e11275"
      unitRef="usd">758000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNC0zLTEtMS01NDE0_de2a5c20-b6fb-4b7e-bf66-37fbbff49f01"
      unitRef="usd">0</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNC01LTEtMS01MTU4_a218fbfb-ab27-440c-b733-cb1ecab23230"
      unitRef="usd">740000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNC03LTEtMS01NDE4_73860b33-721b-4c82-baf1-fb8819dccdc4"
      unitRef="usd">0</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <cutr:AmortizationOfDebtIssuanceCostsNetOfTax
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNS0xLTEtMS01MTUx_4025416f-a0eb-4613-887e-2523e627f71a"
      unitRef="usd">209000</cutr:AmortizationOfDebtIssuanceCostsNetOfTax>
    <cutr:AmortizationOfDebtIssuanceCostsNetOfTax
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNS0zLTEtMS01NDE0_dac5c019-970b-42f1-b29d-957779eb2f47"
      unitRef="usd">0</cutr:AmortizationOfDebtIssuanceCostsNetOfTax>
    <cutr:AmortizationOfDebtIssuanceCostsNetOfTax
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNS01LTEtMS01MTU4_1a939b9f-881a-4f6d-8f87-e4a40b353339"
      unitRef="usd">204000</cutr:AmortizationOfDebtIssuanceCostsNetOfTax>
    <cutr:AmortizationOfDebtIssuanceCostsNetOfTax
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNS03LTEtMS01NDE4_423b7311-1a97-43a6-a50e-4216db10916b"
      unitRef="usd">0</cutr:AmortizationOfDebtIssuanceCostsNetOfTax>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNi0xLTEtMS01NDEy_a48a6a38-66b9-4bd3-bea9-7cb06ae89ffd"
      unitRef="usd">8713000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNi0zLTEtMS01NDE0_d333efad-64d2-46b2-961f-685be4325f5b"
      unitRef="usd">-11394000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNi01LTEtMS01NDE2_97a32ca2-8568-4148-9fda-31a656691dcc"
      unitRef="usd">8331000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNi03LTEtMS01NDE4_0490f0f2-4e6d-43ef-9e3f-9381067cb47b"
      unitRef="usd">-23808000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNC0xLTEtMS0w_a93bc612-f136-4b1b-b225-3557cdbe0d02"
      unitRef="shares">17862000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNC0zLTEtMS0w_257c0123-6e9d-4768-8a42-e8f769b3488a"
      unitRef="shares">17055000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNi01LTEtMS0xMDcy_1898a42e-89e8-43c1-a1f8-ef4543cd2adc"
      unitRef="shares">17815000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNi03LTEtMS0xMDc0_a180a7cd-6766-42bc-be1a-063886428409"
      unitRef="shares">15744000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTAtMS0xLTEtNTE4NQ_3f7ec208-ff66-41b2-9cd1-88098b6f6ce5"
      unitRef="shares">4167000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTAtMy0xLTEtNTQyMA_17fe8027-9da0-49ab-abbf-682b390625c0"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTAtNS0xLTEtNTE5OQ_e3ef9574-0526-4110-896c-b4e957eeed60"
      unitRef="shares">2625000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTAtNy0xLTEtNTQyMg_886cd43d-1d77-49d5-a43b-525110d14b55"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="iaaac0feab41147a8a2bc8fd8f7ba33f3_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtMS0xLTEtNTE4NQ_1b99f2cd-a538-46c0-aa69-213449937a44"
      unitRef="shares">65000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ie3e1bb0168eb49be9bc31f592a1a35d1_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtMy0xLTEtNTQyMA_c408ac42-5739-45aa-895d-e538e1dc2d6c"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i04a939a51cb44bbfab0551c699f24582_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtNS0xLTEtNTE5OQ_a050b785-fb95-4dab-b621-f46434ff1e4c"
      unitRef="shares">63000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i99969d197ffd450f94deac6fd22dac12_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtNy0xLTEtNTQyMg_310094eb-482c-4178-9ecf-9310300234db"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i8fcff246ef044996b2ff3e18abe4904e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTItMS0xLTEtNTE4NQ_bbfe1e30-1ce1-4d37-a5ed-0201e3fd27a8"
      unitRef="shares">259000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i2385bd8fa768474f8fd3a114312d5e7d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTItMy0xLTEtNTQyMA_ae7d6fa9-e2f8-4fe1-8c10-1fc77471543e"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ie7a69c86013f47fd84b88ded0e2796dd_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTItNS0xLTEtNTE5OQ_2e6a4d2a-b132-421b-bd7a-0713bf64f3ac"
      unitRef="shares">270000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia4ecd89ae62344f7917567fbab93bd54_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTItNy0xLTEtNTQyMg_4c2d0cf5-5a8d-4bf6-be79-b7e7a1a39efe"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i24a4aae559244b6da9a355eef4892d50_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTMtMS0xLTEtNTE4NQ_9d864302-d677-4bde-a038-2f9a9dbe7ea9"
      unitRef="shares">77000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if55087856ea4480f878b84dad9aa0b2f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTMtMy0xLTEtNTQyMA_f88d08a4-b7eb-4bbf-8371-1728fd02dc9e"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i1c67032870244a09929098911256c828_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTMtNS0xLTEtNTE5OQ_61dcbe30-b869-4180-9bf6-b4d0683ba380"
      unitRef="shares">64000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic2e0ff6f1deb4186b8284936187d5163_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTMtNy0xLTEtNTQyMg_e944bec1-271d-4ff5-85dd-99adb4938b61"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6d1b842b5a004755b84c230f3296b806_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTQtMS0xLTEtNTE4NQ_9cb0b3aa-e57a-4a10-9f31-682c301c8a2f"
      unitRef="shares">23000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i134de9f1f57f47888632a9ceef35480a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTQtMy0xLTEtNTQyMA_b4a71b4e-6b4e-4a25-a700-d30ba1503668"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic53569eddd914356abdacfc8f46a8065_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTQtNS0xLTEtNTE5OQ_f1510aa2-8fd6-4c98-b85e-b41f52e304ee"
      unitRef="shares">18000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia12fb8b4c6934135894efcee0133760d_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTQtNy0xLTEtNTQyMg_2cb67cd3-b952-48d3-bdd9-fce80cd3e2fd"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNi0xLTEtMS0w_87f40309-70b1-44e3-a70e-0521ba74a7ed"
      unitRef="shares">22453000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfNi0zLTEtMS0w_c9760113-dc6d-4a4b-a227-2ffb2b660c66"
      unitRef="shares">17055000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfOC01LTEtMS0xMDcy_a69fd038-c197-48ed-a0c9-be0a92af3b11"
      unitRef="shares">20855000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfOC03LTEtMS0xMDc0_41a1c6c7-cbbc-4bf5-8493-b5232ae582d1"
      unitRef="shares">15744000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfOC0xLTEtMS0w_7147bebf-cf2d-445e-9d48-0b19da67805b"
      unitRef="usdPerShare">0.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfOC0zLTEtMS0w_99ee072f-12bf-4c3c-81be-e83e07d7a591"
      unitRef="usdPerShare">-0.67</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTAtNS0xLTEtMTA3Ng_bc54f285-412f-48be-bb6c-5ac540c2e2a5"
      unitRef="usdPerShare">0.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTAtNy0xLTEtMTA3Ng_ab38921f-e736-4c56-9eb1-6c2de846b4e0"
      unitRef="usdPerShare">-1.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtMS0xLTEtNDE3NA_8712644e-fd13-4ef4-8d03-0659cf19222c"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtMS0xLTEtNDE3NA_f0e42c5b-c208-4f14-8d88-dc20fb4105f2"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtMy0xLTEtNDE3NA_1b06ef4b-5639-43cb-8d96-a0a0bb3af37f"
      unitRef="usdPerShare">-0.67</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtMy0xLTEtNDE3NA_71afcbb9-141a-4def-bad0-94fb929a3e80"
      unitRef="usdPerShare">-0.67</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtNS0xLTEtNDE3NA_4917a147-3b4c-4f90-a89e-d24ad41050c1"
      unitRef="usdPerShare">0.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtNS0xLTEtNDE3NA_a5bebe1f-0c02-47c3-a905-9c8de2cb8c58"
      unitRef="usdPerShare">0.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtNy0xLTEtNDE3NA_01d0ea8f-0301-4e37-b1eb-8cdc02029734"
      unitRef="usdPerShare">-1.51</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOmNkNmVkYTdjODI4NjQ1NzVhZTA4MGMzM2QwY2NlZDUxL3RhYmxlcmFuZ2U6Y2Q2ZWRhN2M4Mjg2NDU3NWFlMDgwYzMzZDBjY2VkNTFfMTEtNy0xLTEtNDE3NA_ee9c25a4-a03a-41e5-b9d5-d29a851d3be0"
      unitRef="usdPerShare">-1.51</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RleHRyZWdpb246YjA3MWY4NjNhNWQwNDY2NDhiNDhmYjQ2ZGFhZDg1YzlfMTkwMQ_af1ec447-9c6f-49f2-a5f4-c85e7b35c0d7">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following numbers of shares outstanding, prior to the application of the if converted stock method, were excluded from the computation of diluted net income (loss) per common share for the periods presented because including them would have had an anti-dilutive effect (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capped call (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The Company entered into capped call transactions with certain financial institutions, which are generally designated to reduce common stock dilution upon conversion of the Convertible notes. The capped call transactions are excluded from the computation of diluted net income (loss) per common share as their effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib073b66268e747c7beb7c3e8cb6725cd_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfMi0xLTEtMS0w_27b59669-2b91-4932-8ac4-0293db9f11f5"
      unitRef="shares">4167000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id1c39d3cd4704eb18a973e3632ebf4c9_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfMi0zLTEtMS0w_0a3e04ab-8884-4468-91a2-c194ac889408"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i927cb99cf11849a28b18cccb13b34952_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfMi01LTEtMS0xMDY1_e765cce6-bd4c-4d8d-a755-64f85fce4536"
      unitRef="shares">4167000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i248c328a529348aa9cc98c13d080a639_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfMi03LTEtMS0xMDY3_8e3c768f-5671-4980-b4b7-4ce3daa10503"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5fcb4b561a904836a0f0d23aa399f03b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfMy0xLTEtMS0w_933afc4c-7033-435e-bc0c-e0873346fb60"
      unitRef="shares">189000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic24aac68960d4d5abac630ee5fc03264_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfMy0zLTEtMS0w_de39bca8-e7cb-488c-9721-85f462d97b61"
      unitRef="shares">231000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i422e7e2d5153428685677e8df3cd31cf_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfMy01LTEtMS0xMDY1_f81bdd4c-57bc-4e4f-96e3-d7c48600b196"
      unitRef="shares">143000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icea00b8fe11140daa1cb985e030d37f8_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfMy03LTEtMS0xMDY3_3199d92f-7cd5-4b08-b5fb-470db723d216"
      unitRef="shares">253000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1aafabe8c64f4228aed37026513d86ff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNC0xLTEtMS0w_bfc968f8-2c62-45f0-8d20-0145ed567616"
      unitRef="shares">11000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ieedfa579e0344b4d82de2102e49f38e2_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNC0zLTEtMS0w_91ac837c-8d16-44e6-a36d-8b9510698721"
      unitRef="shares">803000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4b551207fffb4cf09782a3a505b3bc0e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNC01LTEtMS0xMDY1_bb8ab66f-ad47-4f68-ab7b-3f18716dd903"
      unitRef="shares">2000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i401936e680d64b628acd735705146547_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNC03LTEtMS0xMDY3_d604f4a5-f702-4c4d-b065-12257b5c419f"
      unitRef="shares">736000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idbf8f9287eb3474aaf029523648da76e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNS0xLTEtMS0w_d1591f4b-c21c-40be-ad87-153481eb08fd"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5163e2df3c5d4005869929c9e18ad6d6_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNS0zLTEtMS0w_2d71cb44-0675-492c-bfbd-144d7a10a493"
      unitRef="shares">71000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id4ce9a67e28441f483cb009b64dade32_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNS01LTEtMS0xMDY1_d0b9af3c-260b-4289-bf03-c4840f1daf63"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0774db4163af4fd1a5b476fc7f6ec2c8_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNS03LTEtMS0xMDY3_6c8e79aa-b42f-4e53-a1ed-5c3f5be740e0"
      unitRef="shares">145000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia2ec6fabd2ce464c93e692843370b13e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNi0xLTEtMS0w_6e862d6d-4b80-45ed-9e80-ebb0265ad74a"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iceba727bc88e4acfafb969683a5040c0_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNi0zLTEtMS0w_4bfbb452-c241-4c94-b979-ba005018724f"
      unitRef="shares">58000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia7cbfd7fb2004b41977955079c24d470_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNi01LTEtMS0xMDY1_1016df81-d80f-4f4c-a6fa-f7cd88ec53c1"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5dfc2cdcabad463db38b6603f1116204_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNi03LTEtMS0xMDY3_40c82395-547f-423c-b5d9-39ff5a7fed5a"
      unitRef="shares">58000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNy0xLTEtMS0w_7e276a4e-cf8d-4974-a26c-11ab4ce48aec"
      unitRef="shares">4367000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNy0zLTEtMS0w_671699d6-7ed8-41ca-9066-36392f36ffaa"
      unitRef="shares">1163000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNy01LTEtMS0xMDY1_e1e330bc-84dd-4001-b0f2-1a7b4ffbf9ee"
      unitRef="shares">4312000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF83OS9mcmFnOmIwNzFmODYzYTVkMDQ2NjQ4YjQ4ZmI0NmRhYWQ4NWM5L3RhYmxlOjFkODFjOWYwMTExNTQxYjc5ZWZjMjU5MjhmNjQ5MTdjL3RhYmxlcmFuZ2U6MWQ4MWM5ZjAxMTE1NDFiNzllZmMyNTkyOGY2NDkxN2NfNy03LTEtMS0xMDY3_704eb85d-d654-4412-ad5f-e8e221d3a183"
      unitRef="shares">1192000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84NS9mcmFnOjUwNDI4ZjdkYjNhODRlYTM5YmJhNGY5NGFlNmU0NDI1L3RleHRyZWdpb246NTA0MjhmN2RiM2E4NGVhMzliYmE0Zjk0YWU2ZTQ0MjVfMzY5_e51da327-1021-4e67-8409-4603b3976d08">Income Taxes&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and six months ended June&#160;30, 2021, the Company's income tax expense was $0.1 million and $0.4 million, respectively, compared to $0.5 million for both three and six months ended June&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's income tax expense for the three and six months ended June&#160;30, 2021 is due primarily to income taxes in foreign jurisdictions. The PPP loan forgiveness recognized during the three months ended June&#160;30, 2021 is excluded from taxable income under Section 1106(i) of the Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;). The Company continues to maintain a full valuation allowance on its U.S. deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the U.S. federal government enacted the CARES Act, which changed several of the existing U.S. corporate income tax laws by, among other things, increasing the amount of deductible interest, allowing companies to carry back certain &lt;/span&gt;&lt;/div&gt;Net Operating Losses (&#x201c;NOLs&#x201d;) and increasing the amount of NOLs that corporations can use to offset income. The CARES Act did not have a material impact on the Company's income tax provision, deferred tax assets and liabilities, and related taxes payable. The Company is currently assessing the future implications of these provisions within the CARES Act on the Company's consolidated financial statements, but does not expect the impact to be material.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84NS9mcmFnOjUwNDI4ZjdkYjNhODRlYTM5YmJhNGY5NGFlNmU0NDI1L3RleHRyZWdpb246NTA0MjhmN2RiM2E4NGVhMzliYmE0Zjk0YWU2ZTQ0MjVfMjE5OTAyMzI1NzQ3Mg_aebae755-07bb-4dcd-bdfe-a4af8d12c20d"
      unitRef="usd">100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84NS9mcmFnOjUwNDI4ZjdkYjNhODRlYTM5YmJhNGY5NGFlNmU0NDI1L3RleHRyZWdpb246NTA0MjhmN2RiM2E4NGVhMzliYmE0Zjk0YWU2ZTQ0MjVfMjE5OTAyMzI1NzQ3Ng_14765f00-f6b3-40f7-bbb0-82149cb84981"
      unitRef="usd">400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84NS9mcmFnOjUwNDI4ZjdkYjNhODRlYTM5YmJhNGY5NGFlNmU0NDI1L3RleHRyZWdpb246NTA0MjhmN2RiM2E4NGVhMzliYmE0Zjk0YWU2ZTQ0MjVfMjE5OTAyMzI1NzQwMw_05f4105b-3f46-40aa-bde1-d47a0c86e089"
      unitRef="usd">500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84NS9mcmFnOjUwNDI4ZjdkYjNhODRlYTM5YmJhNGY5NGFlNmU0NDI1L3RleHRyZWdpb246NTA0MjhmN2RiM2E4NGVhMzliYmE0Zjk0YWU2ZTQ0MjVfMjE5OTAyMzI1NzQwMw_c76d3a98-5923-47f4-8ca1-ab4360e19e2f"
      unitRef="usd">500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDYyMw_9b195d6f-cf4e-4117-a120-0cfb4ef6a9f3">Leases&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a party to certain operating and finance leases for vehicles, office space and storage facilities. The Company&#x2019;s operating leases consist of office space, as well as storage facilities and finance leases consist of automobiles. The Company&#x2019;s leases generally have remaining terms of&#160;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDkwNw_973afb6b-4acd-4a55-af58-d468b11c7d99"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDkwNw_c98812fc-de92-4bc9-ae63-a2ea2dcf1178"&gt;one&lt;/span&gt;&lt;/span&gt;&#160;to&#160;ten years, some of which include options to renew the leases for up to&#160;five years. The Company leases space for operations in the United States, Japan, Belgium, France and Spain. In addition to the above facility leases, the Company also routinely leases automobiles for certain sales and field service employees under finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if a contract contains a lease at inception. Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments&#160;not&#160;yet paid. Operating lease assets represent the right to use an underlying asset and are based upon the operating lease liabilities adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments&#160;not&#160;yet paid, the Company estimates the incremental secured borrowing rates corresponding to the maturities of the leases. The Company based the rate estimates on prevailing financial market conditions, credit analysis, and management judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce the Company&#x2019;s right-of-use (&#x201c;ROU&#x201d;) asset related to the lease. These are amortized through the ROU asset as reductions of expense over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_191ff28f-24ee-4553-9783-0b42ebb65ac6"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_919b7924-791c-4466-b8a7-24aa8118f77b"&gt;Property and equipment, net (1)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1) Finance lease assets included in Property and equipment, net, in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_b5e783e0-1851-4646-b5d7-45c5c8303178"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_f32d24a1-2fa6-47cd-9e48-aa722ac2d210"&gt;Accrued liabilities (1)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_10ea67d4-7eb5-4177-82e5-7c042f1357e2"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_88c2e4ea-2944-4622-bbd8-af1b7cb70fc0"&gt;Other long-term&#160;liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1) Finance lease liabilities included in Accrued liabilities in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease costs during the&#160;three and six&#160;months ended&#160; June&#160;30, 2021&#160;and&#160;2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest for finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in the measurement of lease liabilities during the&#160;six&#160;months ended June&#160;30, 2021 and 2020&#160;was as follows&#160;(in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of facility leases were as follows as of June&#160;30, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&#160;and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;19,953&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;17,127&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Vehicle Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable&#160;finance leases as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term and discount rate,&#160;as of June&#160;30, 2021, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease Term and Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessor Information related to the Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;s system leasing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal year ended December&#160;31, 2020, the Company entered into leasing transactions, in which the Company is the lessor, offered through the Company's membership program. The Company's leases for equipment rentals were all accounted for as operating leases during the second and third quarters of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter ended December&#160;31, 2020, certain&#160;of the membership program agreements were amended, granting the customers the exclusive right and option to purchase the leased system from the Company, at any time during the period of 12 months from signing the amended agreement. For contracts signed under the amended membership agreement,&#160;the Company classified and accounted for the arrangements as sales-type leases as of December&#160;31, 2020, as the Company determined it is reasonably certain that the customer will exercise the purchase option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the sales-type leases, the net investment of the Company&#x2019;s lease receivable is measured at the commencement date and is included in the condensed consolidated balance sheets as a component of other current assets and prepaid expenses. As of December&#160;31, 2020, the Company recorded $0.7 million of revenue for the sales-type leases in the condensed consolidated statement of operations and the related lease receivable in other current assets of the condensed consolidated balance sheet. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was no revenue recognized from the sales-type lease arrangement for the three and six months ended June&#160;30, 2021 and 2020, respectively. During the three and six months&#160;ended June&#160;30, 2021, the Company received a full payment of $0.1 million and $0.2 million from a customer who exercised its purchase option. As of June&#160;30, 2021, the lease receivable balance included in other current assets of the condensed consolidated balance sheet was $0.5 million &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equipment lease revenue for operating lease agreements is recognized over the life of the lease. The amount of operating lease income included in Product revenue in the accompanying condensed consolidated statements of operations for the three and six months&#160;ended June&#160;30, 2021 was zero and $0.1&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:OperatingLeasesOfLessorDisclosureTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDYyMw_a3ae4b1b-19b3-4ced-85b1-191d4faf32fb">Leases&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a party to certain operating and finance leases for vehicles, office space and storage facilities. The Company&#x2019;s operating leases consist of office space, as well as storage facilities and finance leases consist of automobiles. The Company&#x2019;s leases generally have remaining terms of&#160;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDkwNw_973afb6b-4acd-4a55-af58-d468b11c7d99"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDkwNw_c98812fc-de92-4bc9-ae63-a2ea2dcf1178"&gt;one&lt;/span&gt;&lt;/span&gt;&#160;to&#160;ten years, some of which include options to renew the leases for up to&#160;five years. The Company leases space for operations in the United States, Japan, Belgium, France and Spain. In addition to the above facility leases, the Company also routinely leases automobiles for certain sales and field service employees under finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if a contract contains a lease at inception. Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments&#160;not&#160;yet paid. Operating lease assets represent the right to use an underlying asset and are based upon the operating lease liabilities adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments&#160;not&#160;yet paid, the Company estimates the incremental secured borrowing rates corresponding to the maturities of the leases. The Company based the rate estimates on prevailing financial market conditions, credit analysis, and management judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce the Company&#x2019;s right-of-use (&#x201c;ROU&#x201d;) asset related to the lease. These are amortized through the ROU asset as reductions of expense over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_191ff28f-24ee-4553-9783-0b42ebb65ac6"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_919b7924-791c-4466-b8a7-24aa8118f77b"&gt;Property and equipment, net (1)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1) Finance lease assets included in Property and equipment, net, in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_b5e783e0-1851-4646-b5d7-45c5c8303178"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_f32d24a1-2fa6-47cd-9e48-aa722ac2d210"&gt;Accrued liabilities (1)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_10ea67d4-7eb5-4177-82e5-7c042f1357e2"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_88c2e4ea-2944-4622-bbd8-af1b7cb70fc0"&gt;Other long-term&#160;liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1) Finance lease liabilities included in Accrued liabilities in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease costs during the&#160;three and six&#160;months ended&#160; June&#160;30, 2021&#160;and&#160;2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest for finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in the measurement of lease liabilities during the&#160;six&#160;months ended June&#160;30, 2021 and 2020&#160;was as follows&#160;(in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of facility leases were as follows as of June&#160;30, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&#160;and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;19,953&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;17,127&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Vehicle Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable&#160;finance leases as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term and discount rate,&#160;as of June&#160;30, 2021, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease Term and Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessor Information related to the Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;s system leasing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal year ended December&#160;31, 2020, the Company entered into leasing transactions, in which the Company is the lessor, offered through the Company's membership program. The Company's leases for equipment rentals were all accounted for as operating leases during the second and third quarters of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter ended December&#160;31, 2020, certain&#160;of the membership program agreements were amended, granting the customers the exclusive right and option to purchase the leased system from the Company, at any time during the period of 12 months from signing the amended agreement. For contracts signed under the amended membership agreement,&#160;the Company classified and accounted for the arrangements as sales-type leases as of December&#160;31, 2020, as the Company determined it is reasonably certain that the customer will exercise the purchase option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the sales-type leases, the net investment of the Company&#x2019;s lease receivable is measured at the commencement date and is included in the condensed consolidated balance sheets as a component of other current assets and prepaid expenses. As of December&#160;31, 2020, the Company recorded $0.7 million of revenue for the sales-type leases in the condensed consolidated statement of operations and the related lease receivable in other current assets of the condensed consolidated balance sheet. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was no revenue recognized from the sales-type lease arrangement for the three and six months ended June&#160;30, 2021 and 2020, respectively. During the three and six months&#160;ended June&#160;30, 2021, the Company received a full payment of $0.1 million and $0.2 million from a customer who exercised its purchase option. As of June&#160;30, 2021, the lease receivable balance included in other current assets of the condensed consolidated balance sheet was $0.5 million &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equipment lease revenue for operating lease agreements is recognized over the life of the lease. The amount of operating lease income included in Product revenue in the accompanying condensed consolidated statements of operations for the three and six months&#160;ended June&#160;30, 2021 was zero and $0.1&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:OperatingLeasesOfLessorDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDYyMw_caf38611-c7c6-41d4-8b30-31821b96bd37">Leases&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a party to certain operating and finance leases for vehicles, office space and storage facilities. The Company&#x2019;s operating leases consist of office space, as well as storage facilities and finance leases consist of automobiles. The Company&#x2019;s leases generally have remaining terms of&#160;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDkwNw_973afb6b-4acd-4a55-af58-d468b11c7d99"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDkwNw_c98812fc-de92-4bc9-ae63-a2ea2dcf1178"&gt;one&lt;/span&gt;&lt;/span&gt;&#160;to&#160;ten years, some of which include options to renew the leases for up to&#160;five years. The Company leases space for operations in the United States, Japan, Belgium, France and Spain. In addition to the above facility leases, the Company also routinely leases automobiles for certain sales and field service employees under finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if a contract contains a lease at inception. Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments&#160;not&#160;yet paid. Operating lease assets represent the right to use an underlying asset and are based upon the operating lease liabilities adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments&#160;not&#160;yet paid, the Company estimates the incremental secured borrowing rates corresponding to the maturities of the leases. The Company based the rate estimates on prevailing financial market conditions, credit analysis, and management judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce the Company&#x2019;s right-of-use (&#x201c;ROU&#x201d;) asset related to the lease. These are amortized through the ROU asset as reductions of expense over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_191ff28f-24ee-4553-9783-0b42ebb65ac6"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_919b7924-791c-4466-b8a7-24aa8118f77b"&gt;Property and equipment, net (1)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1) Finance lease assets included in Property and equipment, net, in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_b5e783e0-1851-4646-b5d7-45c5c8303178"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_f32d24a1-2fa6-47cd-9e48-aa722ac2d210"&gt;Accrued liabilities (1)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_10ea67d4-7eb5-4177-82e5-7c042f1357e2"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_88c2e4ea-2944-4622-bbd8-af1b7cb70fc0"&gt;Other long-term&#160;liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1) Finance lease liabilities included in Accrued liabilities in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease costs during the&#160;three and six&#160;months ended&#160; June&#160;30, 2021&#160;and&#160;2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest for finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in the measurement of lease liabilities during the&#160;six&#160;months ended June&#160;30, 2021 and 2020&#160;was as follows&#160;(in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of facility leases were as follows as of June&#160;30, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&#160;and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;19,953&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;17,127&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Vehicle Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable&#160;finance leases as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term and discount rate,&#160;as of June&#160;30, 2021, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease Term and Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessor Information related to the Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;s system leasing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal year ended December&#160;31, 2020, the Company entered into leasing transactions, in which the Company is the lessor, offered through the Company's membership program. The Company's leases for equipment rentals were all accounted for as operating leases during the second and third quarters of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter ended December&#160;31, 2020, certain&#160;of the membership program agreements were amended, granting the customers the exclusive right and option to purchase the leased system from the Company, at any time during the period of 12 months from signing the amended agreement. For contracts signed under the amended membership agreement,&#160;the Company classified and accounted for the arrangements as sales-type leases as of December&#160;31, 2020, as the Company determined it is reasonably certain that the customer will exercise the purchase option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the sales-type leases, the net investment of the Company&#x2019;s lease receivable is measured at the commencement date and is included in the condensed consolidated balance sheets as a component of other current assets and prepaid expenses. As of December&#160;31, 2020, the Company recorded $0.7 million of revenue for the sales-type leases in the condensed consolidated statement of operations and the related lease receivable in other current assets of the condensed consolidated balance sheet. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was no revenue recognized from the sales-type lease arrangement for the three and six months ended June&#160;30, 2021 and 2020, respectively. During the three and six months&#160;ended June&#160;30, 2021, the Company received a full payment of $0.1 million and $0.2 million from a customer who exercised its purchase option. As of June&#160;30, 2021, the lease receivable balance included in other current assets of the condensed consolidated balance sheet was $0.5 million &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equipment lease revenue for operating lease agreements is recognized over the life of the lease. The amount of operating lease income included in Product revenue in the accompanying condensed consolidated statements of operations for the three and six months&#160;ended June&#160;30, 2021 was zero and $0.1&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="i3c7a53758f744376b8ee593f5591f92b_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MjQxMw_c8d93c23-286a-471e-a012-1ac2cafa4fb7">P10Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeFinanceLeaseRenewalTerm1
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMzkw_a96d02be-91e1-40da-80fa-cbec43ded549">P5Y</us-gaap:LesseeFinanceLeaseRenewalTerm1>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDk0NzgwMjMzMDI2OQ_620ae3db-4817-4cd5-836c-fa4dca8dc307">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <cutr:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDYyNA_549e3cfa-87c1-4316-a201-9f12b3be56ea">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_191ff28f-24ee-4553-9783-0b42ebb65ac6"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_919b7924-791c-4466-b8a7-24aa8118f77b"&gt;Property and equipment, net (1)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1) Finance lease assets included in Property and equipment, net, in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_b5e783e0-1851-4646-b5d7-45c5c8303178"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_f32d24a1-2fa6-47cd-9e48-aa722ac2d210"&gt;Accrued liabilities (1)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_10ea67d4-7eb5-4177-82e5-7c042f1357e2"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_88c2e4ea-2944-4622-bbd8-af1b7cb70fc0"&gt;Other long-term&#160;liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1) Finance lease liabilities included in Accrued liabilities in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;Weighted-average remaining lease term and discount rate,&#160;as of June&#160;30, 2021, were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease Term and Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cutr:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMi0zLTEtMS0w_283d556f-3d80-4d9b-aa1e-61de005885fa"
      unitRef="usd">15919000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMi01LTEtMS0w_cc4e1b29-dfc7-429f-a442-7cff036efd0c"
      unitRef="usd">17076000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0zLTEtMS0w_d0578781-717c-4e53-a75a-ec98307f8b25"
      unitRef="usd">602000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy01LTEtMS0w_7028980e-d7e3-4996-b426-f3097c59a660"
      unitRef="usd">467000</us-gaap:FinanceLeaseRightOfUseAsset>
    <cutr:LeaseRightOfUseAsset
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfNC0zLTEtMS0w_e770cb7a-896d-4c99-a5c2-4bfcd6c2a541"
      unitRef="usd">16521000</cutr:LeaseRightOfUseAsset>
    <cutr:LeaseRightOfUseAsset
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfNC01LTEtMS0w_39680be7-e057-4fa1-a67f-4a9d57e87213"
      unitRef="usd">17543000</cutr:LeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfMi0zLTEtMS0w_64b95c1b-ca95-41e1-9249-a21900f0ee2e"
      unitRef="usd">2422000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfMi01LTEtMS0w_7cff7fdc-c2f0-4d46-8803-16309bcd776d"
      unitRef="usd">2260000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfMy0zLTEtMS0w_3fc53bb5-0a8d-40e4-9b05-669e70c88dc8"
      unitRef="usd">14705000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfMy01LTEtMS0w_61fa0207-0e51-4971-9b1d-ee2b0fd5ee09"
      unitRef="usd">15950000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNC0zLTEtMS0w_f59f5921-e247-4ec1-be18-bc7864589a74"
      unitRef="usd">17127000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNC01LTEtMS0w_24994e4d-d647-4341-83a4-388369df8539"
      unitRef="usd">18210000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0zLTEtMS0w_43aa5267-b069-4739-b946-1757d008b2be"
      unitRef="usd">429000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy01LTEtMS0w_3d19d6a0-ffdc-42ae-80d0-35cd045bcfa7"
      unitRef="usd">370000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0zLTEtMS0w_7d982463-240e-47e6-a7c5-6f3dca55d0d9"
      unitRef="usd">288000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC01LTEtMS0w_b6b0f822-a4ef-4267-868e-e3a7e84c6cab"
      unitRef="usd">241000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOS0zLTEtMS0w_faa5c507-99b9-4d2c-8d49-1c1407cba7ef"
      unitRef="usd">717000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ic827721b28ff49aca3277a242cc858a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOS01LTEtMS0w_12e22ec0-82a6-4cb1-b2aa-ad8dccffca9a"
      unitRef="usd">611000</us-gaap:FinanceLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDk0NzgwMjMzMDI2NA_203d3c69-0073-48a6-b1f6-08d874b4d73a">Lease costs during the&#160;three and six&#160;months ended&#160; June&#160;30, 2021&#160;and&#160;2020 (in thousands):&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest for finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in the measurement of lease liabilities during the&#160;six&#160;months ended June&#160;30, 2021 and 2020&#160;was as follows&#160;(in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfMi0zLTEtMS0w_8b3175c8-cece-4391-be07-2c4ad75abe50"
      unitRef="usd">110000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfMi01LTEtMS0w_59f8edb4-7364-4f7f-a196-2192e264df63"
      unitRef="usd">277000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfMi03LTEtMS0xMDU1_6a31d04c-0315-4d4a-9a46-81e20c9bc8b1"
      unitRef="usd">237000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfMi05LTEtMS0xMDU3_f259d62a-c773-4362-93ec-43e269952fde"
      unitRef="usd">425000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfMy0zLTEtMS0w_5f740c98-484b-456b-909b-5bc49c3e0dc0"
      unitRef="usd">14000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfMy01LTEtMS0w_f2d2fa14-6f7c-494d-bf4f-6839cebd7b75"
      unitRef="usd">16000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfMy03LTEtMS0xMDU1_b69da498-2c0c-45c9-8189-4f4214467ece"
      unitRef="usd">28000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfMy05LTEtMS0xMDU3_5ba162ca-389d-4625-b1d9-82f5650537cd"
      unitRef="usd">35000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfNC0zLTEtMS0w_33d3483e-8f11-4f26-9f80-258a91ede249"
      unitRef="usd">881000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfNC01LTEtMS0w_b9b5795c-ada9-4c41-b762-2f5f8fde66a6"
      unitRef="usd">728000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfNC03LTEtMS0xMDU1_fa2b2099-9f18-4e6f-8680-d9fa9044b43b"
      unitRef="usd">1759000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjY2YjU5NjViZjY3ODRiYzE4ZTJjZmQ5MTRlZmJkZjFkL3RhYmxlcmFuZ2U6NjZiNTk2NWJmNjc4NGJjMThlMmNmZDkxNGVmYmRmMWRfNC05LTEtMS0xMDU3_ae5735aa-6874-4cb1-9d37-bb78cf61aaeb"
      unitRef="usd">1456000</us-gaap:OperatingLeaseExpense>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUzN2EyOGJjYTUyNDQ2Y2M5YzY3MDg1YTM2MmQ3MTdjL3RhYmxlcmFuZ2U6ZTM3YTI4YmNhNTI0NDZjYzljNjcwODVhMzYyZDcxN2NfMi0zLTEtMS0w_14ddc269-66ca-49f8-a141-902e83e77c0e"
      unitRef="usd">27000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUzN2EyOGJjYTUyNDQ2Y2M5YzY3MDg1YTM2MmQ3MTdjL3RhYmxlcmFuZ2U6ZTM3YTI4YmNhNTI0NDZjYzljNjcwODVhMzYyZDcxN2NfMi01LTEtMS0w_b65f26a7-61b3-4338-8b25-8c9825675146"
      unitRef="usd">35000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUzN2EyOGJjYTUyNDQ2Y2M5YzY3MDg1YTM2MmQ3MTdjL3RhYmxlcmFuZ2U6ZTM3YTI4YmNhNTI0NDZjYzljNjcwODVhMzYyZDcxN2NfMy0zLTEtMS0w_39528ea8-65b6-4995-bac9-36405604a896"
      unitRef="usd">211000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUzN2EyOGJjYTUyNDQ2Y2M5YzY3MDg1YTM2MmQ3MTdjL3RhYmxlcmFuZ2U6ZTM3YTI4YmNhNTI0NDZjYzljNjcwODVhMzYyZDcxN2NfMy01LTEtMS0w_a45d099a-b346-4689-9024-e1721db576bb"
      unitRef="usd">380000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUzN2EyOGJjYTUyNDQ2Y2M5YzY3MDg1YTM2MmQ3MTdjL3RhYmxlcmFuZ2U6ZTM3YTI4YmNhNTI0NDZjYzljNjcwODVhMzYyZDcxN2NfNC0zLTEtMS0w_b8c7be86-424f-47b7-b12d-1052ce970e9f"
      unitRef="usd">1549000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUzN2EyOGJjYTUyNDQ2Y2M5YzY3MDg1YTM2MmQ3MTdjL3RhYmxlcmFuZ2U6ZTM3YTI4YmNhNTI0NDZjYzljNjcwODVhMzYyZDcxN2NfNC01LTEtMS0w_2a7c1c32-5406-4884-8afa-b186d8a3b7ca"
      unitRef="usd">1454000</us-gaap:OperatingLeasePayments>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDYyNQ_cae37273-5abb-4411-8c54-88a913177316">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of facility leases were as follows as of June&#160;30, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&#160;and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;19,953&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;17,127&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmM4MTAxOTkzNDJiMDQ2NDRhMDM5YjY4NzJiYWY2MDQ2L3RhYmxlcmFuZ2U6YzgxMDE5OTM0MmIwNDY0NGEwMzliNjg3MmJhZjYwNDZfMS0xLTEtMS0w_bc82bb02-7c7e-4443-a050-d4f9656ae076"
      unitRef="usd">1551000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmM4MTAxOTkzNDJiMDQ2NDRhMDM5YjY4NzJiYWY2MDQ2L3RhYmxlcmFuZ2U6YzgxMDE5OTM0MmIwNDY0NGEwMzliNjg3MmJhZjYwNDZfMi0xLTEtMS0w_ee863c98-14f1-49d4-ab0c-28027e913796"
      unitRef="usd">3152000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmM4MTAxOTkzNDJiMDQ2NDRhMDM5YjY4NzJiYWY2MDQ2L3RhYmxlcmFuZ2U6YzgxMDE5OTM0MmIwNDY0NGEwMzliNjg3MmJhZjYwNDZfMy0xLTEtMS0w_5dbe47a8-4715-4329-899e-8c3aac953ce3"
      unitRef="usd">3188000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmM4MTAxOTkzNDJiMDQ2NDRhMDM5YjY4NzJiYWY2MDQ2L3RhYmxlcmFuZ2U6YzgxMDE5OTM0MmIwNDY0NGEwMzliNjg3MmJhZjYwNDZfNC0xLTEtMS0w_4e60fe32-ddf6-42aa-a148-f8eecdeb68e6"
      unitRef="usd">2879000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmM4MTAxOTkzNDJiMDQ2NDRhMDM5YjY4NzJiYWY2MDQ2L3RhYmxlcmFuZ2U6YzgxMDE5OTM0MmIwNDY0NGEwMzliNjg3MmJhZjYwNDZfNS0xLTEtMS0w_86630c0c-90dc-42e2-8a63-121144ee7ea9"
      unitRef="usd">2875000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <cutr:LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmM4MTAxOTkzNDJiMDQ2NDRhMDM5YjY4NzJiYWY2MDQ2L3RhYmxlcmFuZ2U6YzgxMDE5OTM0MmIwNDY0NGEwMzliNjg3MmJhZjYwNDZfNi0xLTEtMS0w_05e7e32d-187a-496b-8f5d-1fa55314f786"
      unitRef="usd">6308000</cutr:LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmM4MTAxOTkzNDJiMDQ2NDRhMDM5YjY4NzJiYWY2MDQ2L3RhYmxlcmFuZ2U6YzgxMDE5OTM0MmIwNDY0NGEwMzliNjg3MmJhZjYwNDZfNy0xLTEtMS0w_ca8a2c30-508c-4dc3-8a9f-7066f3896b6e"
      unitRef="usd">19953000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmM4MTAxOTkzNDJiMDQ2NDRhMDM5YjY4NzJiYWY2MDQ2L3RhYmxlcmFuZ2U6YzgxMDE5OTM0MmIwNDY0NGEwMzliNjg3MmJhZjYwNDZfOC0xLTEtMS0w_4a2ca481-5728-4387-b89f-5791a892980d"
      unitRef="usd">2826000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmM4MTAxOTkzNDJiMDQ2NDRhMDM5YjY4NzJiYWY2MDQ2L3RhYmxlcmFuZ2U6YzgxMDE5OTM0MmIwNDY0NGEwMzliNjg3MmJhZjYwNDZfOS0xLTEtMS0w_04ebc51f-fdaa-4735-9122-9b0f06b88f22"
      unitRef="usd">17127000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDYyMA_7b902f9a-a746-4579-ad0b-362e1aa9f308">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable&#160;finance leases as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUwNjczMDc5YTRkNzQzYWFhZmRlMTJmMzkxN2MyOWZhL3RhYmxlcmFuZ2U6ZTA2NzMwNzlhNGQ3NDNhYWFmZGUxMmYzOTE3YzI5ZmFfMS0xLTEtMS0w_b7c87880-9528-454c-91b9-1ade221464b2"
      unitRef="usd">241000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUwNjczMDc5YTRkNzQzYWFhZmRlMTJmMzkxN2MyOWZhL3RhYmxlcmFuZ2U6ZTA2NzMwNzlhNGQ3NDNhYWFmZGUxMmYzOTE3YzI5ZmFfMi0xLTEtMS0w_48be64e5-5a3b-4eea-93e6-bebddbff319f"
      unitRef="usd">379000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUwNjczMDc5YTRkNzQzYWFhZmRlMTJmMzkxN2MyOWZhL3RhYmxlcmFuZ2U6ZTA2NzMwNzlhNGQ3NDNhYWFmZGUxMmYzOTE3YzI5ZmFfMy0xLTEtMS0w_1831166b-cfdc-4036-a09b-25b024ee1234"
      unitRef="usd">125000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUwNjczMDc5YTRkNzQzYWFhZmRlMTJmMzkxN2MyOWZhL3RhYmxlcmFuZ2U6ZTA2NzMwNzlhNGQ3NDNhYWFmZGUxMmYzOTE3YzI5ZmFfNC0xLTEtMS0yMTU1_95ede536-aa9c-4d41-bd78-b66d0dc48462"
      unitRef="usd">28000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUwNjczMDc5YTRkNzQzYWFhZmRlMTJmMzkxN2MyOWZhL3RhYmxlcmFuZ2U6ZTA2NzMwNzlhNGQ3NDNhYWFmZGUxMmYzOTE3YzI5ZmFfNC0xLTEtMS0w_98067f5b-18b3-4c9f-aad3-ab3dc5b9066b"
      unitRef="usd">773000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUwNjczMDc5YTRkNzQzYWFhZmRlMTJmMzkxN2MyOWZhL3RhYmxlcmFuZ2U6ZTA2NzMwNzlhNGQ3NDNhYWFmZGUxMmYzOTE3YzI5ZmFfNS0xLTEtMS0w_ef8c97d2-fbeb-4b3b-9e01-550f43ed6edb"
      unitRef="usd">56000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOmUwNjczMDc5YTRkNzQzYWFhZmRlMTJmMzkxN2MyOWZhL3RhYmxlcmFuZ2U6ZTA2NzMwNzlhNGQ3NDNhYWFmZGUxMmYzOTE3YzI5ZmFfNi0xLTEtMS0w_48c3b854-cec4-44ca-afb0-c6d33e11a08b"
      unitRef="usd">717000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmOTZjOTdiMGFkZDRkNjQ5MTAwNGNjMWQyY2QwYjBhL3RhYmxlcmFuZ2U6OWY5NmM5N2IwYWRkNGQ2NDkxMDA0Y2MxZDJjZDBiMGFfMi0xLTEtMS0w_c214f37b-a0d7-4185-b220-cf8f6286f764">P6Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmOTZjOTdiMGFkZDRkNjQ5MTAwNGNjMWQyY2QwYjBhL3RhYmxlcmFuZ2U6OWY5NmM5N2IwYWRkNGQ2NDkxMDA0Y2MxZDJjZDBiMGFfMy0xLTEtMS0w_ea7c9c41-b4ec-4330-b896-c13d93cf7745">P1Y8M12D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmOTZjOTdiMGFkZDRkNjQ5MTAwNGNjMWQyY2QwYjBhL3RhYmxlcmFuZ2U6OWY5NmM5N2IwYWRkNGQ2NDkxMDA0Y2MxZDJjZDBiMGFfNS0xLTEtMS0w_3ec06f61-8569-41fe-840d-b9c8a95e7470"
      unitRef="number">0.047</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i85fff53fbac547228677e769db10e805_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmOTZjOTdiMGFkZDRkNjQ5MTAwNGNjMWQyY2QwYjBhL3RhYmxlcmFuZ2U6OWY5NmM5N2IwYWRkNGQ2NDkxMDA0Y2MxZDJjZDBiMGFfNi0xLTEtMS0w_c30020d4-b786-4ae6-87af-c11935cf6db9"
      unitRef="number">0.065</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <cutr:LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm
      contextRef="ie02f2877a5a94ba1af32fcc4842c447f_D20201001-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDk0NzgwMjMzMDI3NA_d1a8ad53-b0f2-4589-8750-25ca77d09658">P12M</cutr:LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="i6e5db1d27c0d467fa8a06f3edfd4046b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMzgwOA_525c8f35-44d7-4dac-ba92-65070858d394"
      unitRef="usd">700000</us-gaap:SalesTypeLeaseRevenue>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable
      contextRef="i35e40b62c61640d6ac4a638987ded61b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMzgwOA_f8ce1588-193f-4e2d-b079-8eb2de5a25c2"
      unitRef="usd">700000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDAxNA_82adf6cd-7b01-43fd-be3f-c31adc17c6d4"
      unitRef="usd">0</us-gaap:SalesTypeLeaseRevenue>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDAxNA_8cbf2b62-8513-4edd-8d10-0ad6a0a8f357"
      unitRef="usd">0</us-gaap:SalesTypeLeaseRevenue>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDAxNA_b2fbfcf2-6257-4246-84eb-6e972d5b1a49"
      unitRef="usd">0</us-gaap:SalesTypeLeaseRevenue>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDAxNA_de0c27e5-c1f4-42b4-8a0f-a7b66ab75684"
      unitRef="usd">0</us-gaap:SalesTypeLeaseRevenue>
    <cutr:ProceedsFromExerciseOfPurchaseOptionSalesTypeLease
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDE3OQ_a6160d01-d0d4-4008-84e6-69ed26bf1a9f"
      unitRef="usd">100000</cutr:ProceedsFromExerciseOfPurchaseOptionSalesTypeLease>
    <cutr:ProceedsFromExerciseOfPurchaseOptionSalesTypeLease
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDMxNg_c9c209c3-94ad-4cef-8df1-bf23259d6201"
      unitRef="usd">200000</cutr:ProceedsFromExerciseOfPurchaseOptionSalesTypeLease>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable
      contextRef="i2704d4d253f94eceac8a62deac8a8b8a_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfNDM1Mw_4ecb2774-0c04-47b8-a379-86710b127fe9"
      unitRef="usd">500000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMzg0ODI5MDcwMjUzMA_94111c95-559b-44ad-b218-998ec8ccd7fd"
      unitRef="usd">0</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMzg0ODI5MDcwMjU0NA_2cad66dd-08aa-4a6d-869d-e4563e4d6011"
      unitRef="usd">100000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85NC9mcmFnOmI5MDlmYmJlZDY2YzRkMzhhYzk2OGY4NzI4M2U0ZjVmL3RleHRyZWdpb246YjkwOWZiYmVkNjZjNGQzOGFjOTY4Zjg3MjgzZTRmNWZfMjA5NQ_9e894d81-a177-4d6b-a5fa-2fec694367da">Contingencies&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named from time to time as a party to other legal proceedings, product liability, commercial disputes, employee disputes, and contractual lawsuits in the normal course of business. A liability and related charge are recorded to earnings in the Company&#x2019;s consolidated financial statements for legal contingencies when the loss is considered probable and the amount can be reasonably estimated. The assessment is re-evaluated each accounting period and is based on all available information, including discussion with outside legal counsel. If a reasonable estimate of a known or probable loss cannot be made, but a range of probable losses can be estimated, the low-end of the range of losses is recognized if no amount within the range is a better estimate than any other. If a material loss is reasonably possible, but not probable and can be reasonably estimated, the estimated loss or range of loss is disclosed in the notes to the consolidated financial statements. The Company expenses legal fees as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;InMode Ltd. filed a complaint with the United States International Trade Commission alleging that Ilooda, Co., Ltd&#x2019;s Secret RF fractional radiofrequency microneedling system, distributed in the United States by the Company, infringes U.S. Patent&#160;No.&#160;10,799,285&#160;("285&#160;patent"). The Company&#160;intends to vigorously defend against this lawsuit and, based on a preliminary investigation, believes that the Company has a&#160;strong defense and that the&#160;patent claim at issue is likely invalid in view of prior art. Based on the current information available to the Company, it&#160;believes that any possible loss will&#160;not&#160;be material.&#160;If, following a successful&#160;third-party action for infringement, the Company cannot obtain a license for the Company&#x2019;s products, it&#160; may&#160;have to stop selling the applicable products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021 and&#160;December&#160;31, 2020, the Company had accrued $0.9 million and $0.4 million, respectively, related to various pending commercial and product liability lawsuits. The Company does not believe that a material loss in excess of accrued amounts is reasonably likely.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LitigationReserve
      contextRef="i0078d122644a4dddab29d2f40360b3c0_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85NC9mcmFnOmI5MDlmYmJlZDY2YzRkMzhhYzk2OGY4NzI4M2U0ZjVmL3RleHRyZWdpb246YjkwOWZiYmVkNjZjNGQzOGFjOTY4Zjg3MjgzZTRmNWZfMTkwMA_a74c58dc-1603-4b01-a4d2-0964dda65fd2"
      unitRef="usd">900000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserve
      contextRef="i895c5dc933e94035967c4ca15bcf095a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85NC9mcmFnOmI5MDlmYmJlZDY2YzRkMzhhYzk2OGY4NzI4M2U0ZjVmL3RleHRyZWdpb246YjkwOWZiYmVkNjZjNGQzOGFjOTY4Zjg3MjgzZTRmNWZfMTkwNw_4796a40a-0174-4ba8-b206-a69c48ca33c3"
      unitRef="usd">400000</us-gaap:LitigationReserve>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTQ0Mjk_04a50855-a65b-4333-a02b-22f83efc43ac">Debt&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible notes, net of unamortized debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2021, the Company issued $138.3 million aggregate principal amount of convertible senior notes&#160;due on March 15, 2026 in a private placement offering. The Convertible notes bear interest at a rate of 2.25% per year payable semiannually in arrears on March 15 and September 15 of each year, beginning on September 15, 2021. Upon conversion, the Convertible notes will be convertible into cash, shares of the Company&#x2019;s common stock or a combination thereof, at the Company&#x2019;s election. The Convertible notes are presented as Convertible notes, net of unamortized debt issuance costs, on the condensed consolidated balance sheet.&#160;Proceeds from the offering were $133.6 million, net of issuance costs, including initial purchasers fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Initially, each $1,000 principal amount of Notes was convertible into 30.1427 shares of the Company&#x2019;s common stock at a conversion price of $33.18 per share. The conversion rate for the Convertible notes is subject to adjustment for certain events as set forth in the Indenture governing the Convertible notes. The Convertible notes will mature on March 15, 2026, unless earlier converted, redeemed, or repurchased in accordance with the terms of the Convertible notes. No sinking fund is provided for the Notes. As of June&#160;30, 2021, the net carrying amount of the Company&#x2019;s Convertible notes was 133.9&#160;million and the unamortized debt issuance costs were&#160;$4.4 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders may convert their Notes at their option prior to the close of business on the business day immediately preceding December 15, 2025, in multiples of $1,000 principal amount, only under the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;During any fiscal quarter commencing after the fiscal quarter ending on June 30, 2021 (and only during such fiscal quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to 130% of the conversion price for the Convertible notes on each applicable trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;During the five-business day period after any five consecutive trading day period (the &#x201c;measurement period&#x201d;) in which the &#x201c;trading price&#x201d;&#160;per $1,000 principal amount of Convertible notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company's&#160;common stock and the conversion rate on each such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Company calls such Convertible notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Upon the occurrence of specified corporate events.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or after December 15, 2025, and until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The circumstances described in the first bullet of the paragraph above were met during the second quarter of 2021 as the Company's stock traded at a price in excess of the conversion price, and as a result, the Notes are convertible at the option of the holder from July 1, 2021 until September 30, 2021.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Upon any conversion of the Convertible notes, the Company would be required to pay or deliver, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#x2019;s election with respect to such conversion. To the extent there are any conversions during the period from July 1, 2021 until September 30, 2021, the Company intends to settle such conversions in shares of common stock, therefore, as of June&#160;30, 2021, the Convertible notes have been included as Long-term debt on its condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may not redeem the Convertible notes prior to March 20, 2024. On or after March 20, 2024, the Company may redeem for cash all or any portion of the Notes, at the Company&#x2019;s option, if the last reported sale price of the Company&#x2019;s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem fewer than all of the outstanding Notes, at least $50.0 million aggregate principal amount of Notes must be outstanding and not subject to redemption as of the relevant redemption notice date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a fundamental change occurs, note holders have the option to require the Company to repurchase any portion or all of their Convertible notes in $1,000 principal increments for cash. The price for such repurchase is calculated as 100% of the principal amounts of Notes, plus accrued and unpaid interest to the day immediately preceding the Fundamental Change repurchase date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, holders of the Notes who convert in connection with a fundamental change are, under certain circumstances, entitled to an increase in conversion rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Convertible notes are general senior unsecured obligations that rank senior to any of the Company&#x2019;s indebtedness that is explicitly subordinated to the Notes. The Notes have equal rank in right of payment with all existing and future unsecured indebtedness that is not subordinated to the Notes. The Notes will be junior to any of the Company&#x2019;s secured indebtedness to the extent of the value of the assets securing such indebtedness. The Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the Convertible notes was approximately $226.4 million as of June&#160;30, 2021, which the Company&#160;determined through consideration of market prices. The fair value measurement is classified as Level 2, as defined in Note 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents outstanding principal amount and carrying value of the Convertible notes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding principal amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;138,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;133,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with issuance of the Convertible notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally intended to reduce the potential dilution of the Company's&#160;common stock upon any conversion or settlement of the Notes or to offset any cash payment the Company is required to make in excess of the principal amount upon conversion of the Notes, as the case may be, with such reduction or offset subject to a cap based on the cap price. If the market price per share of the Company&#x2019;s common stock exceeds the cap price of the capped calls transaction, then the Company&#x2019;s stock would experience some dilution and/or the capped call would not fully offset the potential cash payments, in each case to the extent the then-market price per share of its common stock exceeds the cap price. Under the capped call transactions, the Company purchased from the option counterparties capped call options that in the aggregate relate to the total number of shares of the Company's common stock underlying the Convertible notes, with a strike price equal to the conversion price of the Convertible notes and with an initial cap price equal to $45.5350, which represents a 75% premium over the last reported sale price of the Company's common stock of $26.02 per share on March&#160;4, 2021, with certain adjustments to the settlement terms that reflect standard anti-dilution provisions. The capped call transactions expire over 40 consecutive scheduled trading days ended on March 12, 2026. The capped calls were purchased for $16.1 million. The Company evaluated the capped call transaction under authoritative accounting guidance and determined that it should be accounted for as a separate transaction and classified as a net reduction to Additional paid-in capital within stockholders&#x2019; equity with no recurring fair value measurement recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company early adopted ASU 2020-6, Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40). In accordance with Subtopic 470-20 and 815-40, as revised by ASU 2020-6, the Company records the Convertible notes in long-term debt with no separation between the Notes and the conversion option. Each reporting period, the Company will determine whether any criteria is met for the note holders to have the option to redeem the Notes early, which could&#160;result in a change in the classification of the Notes to current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Debt Issuance Cost&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The issuance costs related to the Convertible notes are presented in the condensed consolidated balance sheet as a direct deduction from the carrying amount of the Convertible notes. During the six months ended June&#160;30, 2021, the Company incurred direct costs associated with the issuance of Convertible notes of $4.7 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The issuance costs are&#160;amortized using&#160;an effective interest method basis over the term of the Convertible notes and accordingly the Company recorded approximately&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.2 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $0.3 million &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of amortization of debt issuance costs during the three and six months ended June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective interest rate on the Convertible notes is 2.97%. Interest expense for the three and six months ended June&#160;30, 2021 totaled approximately $1.0 million and $1.2 million, respectively, of which $0.8 million and $1.0 million, respectively, relate to accruing the semiannual interest payment with the remaining balance relating to the&#160;amortization of debt issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loan and Security Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;30, 2018, the Company and Wells Fargo Bank, N.A. (&#x201c;Wells Fargo&#x201d;) entered into a Loan and Security Agreement (the &#x201c;Wells Fargo Revolving Line of Credit&#x201d;) in the original principal amount of $25.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July&#160;9, 2020, the Company terminated its undrawn revolving line of credit with Wells Fargo and subsequently entered into a Loan and Security Agreement with Silicon Valley Bank for a four-year secured revolving loan facility (&#x201c;SVB Revolving Line of Credit&#x201d;) in an aggregate principal amount of up to $30.0 million. The SVB Revolving Line of Credit matures on July 9, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In order to draw on the full amount of the SVB Revolving Line of Credit, the Company must satisfy certain liquidity ratios. If the Company is unable to meet these liquidity ratios, then availability under the revolving line is calculated as 80% of the Company&#x2019;s qualifying accounts receivable. The proceeds of the revolving loans may be used for general corporate purposes. The Company&#x2019;s obligations under the Loan and Security Agreement with Silicon Valley Bank are secured by substantially all of the assets of the Company. Interest on principal amount outstanding under the revolving line shall accrue at a floating per annum rate equal to the greater of either 1.75% above the Prime Rate or five percent (5.0%). The Company paid a non-refundable revolving line commitment fee of $0.3 million, on the effective date of the Loan and Security Agreement with Silicon Valley Bank of July&#160;9, 2020, and the Company is required to pay an anniversary fee of $0.3 million on each twelve-month anniversary of the effective date of the Loan and Security Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Loan and Security Agreement with Silicon Valley Bank contains customary affirmative covenants, such as financial statement reporting requirements and delivery of borrowing base certificates, as well as customary covenants that restrict the Company&#x2019;s ability to, among other things, incur additional indebtedness, sell certain assets, guarantee obligations of third parties, declare dividends, or make certain distributions, and undergo a merger or consolidation or certain other transactions. The Loan and Security Agreement also contains certain financial covenants, including maintaining a quarterly minimum revenue of $90.0&#160;million, determined in accordance with GAAP on a trailing twelve-month basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;4, 2021, the Loan and Security Agreement dated July&#160;9, 2020 was amended to (i)&#160;permit the Company to issue the Convertible notes and perform its obligations in connection therewith, and (ii)&#160;permit the Capped Call transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, the Company had not drawn on the SVB Revolving Line of Credit and the Company is in compliance with all financial covenants of the SVB Revolving Line of Credit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The Paycheck Protection Program (PPP) Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;22, 2020, the Company received loan proceeds of $7.1 million pursuant to the Paycheck Protection Program (the &#x201c;PPP&#x201d;) under the CARES Act. The loan, which is in the form of a promissory note dated April 21, 2020, between the Company and Silicon Valley Bank as the lender, matures on April 21, 2022 and bears interest at a fixed rate of 1.00% per annum, payable monthly commencing September 2021. There is no prepayment penalty. Under the terms of the PPP, all or a portion of the principal may be forgiven if the loan proceeds are used for qualifying expenses as described in the CARES Act, such as payroll costs, benefits, rent, and utilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The PPP loan and related accrued interest were forgiven under the provisions of the CARES Act, and the $7.2&#160;million gain on forgiveness of PPP loan was recorded as Gain on extinguishment of PPP loan in the condensed consolidated statement of operations for the three and six months ended June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3039819417a84fd7b2aa536ffb2ed8d4_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTAz_7946a4df-aae5-46a8-9ed2-5679a8aae3f6"
      unitRef="usd">138300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3039819417a84fd7b2aa536ffb2ed8d4_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjM4_105adc65-1f31-4e42-8d37-2ac51675c033"
      unitRef="number">0.0225</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i41feb9a60cd54b25be885f1459623391_D20210301-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNjkz_bf2007ad-e8fe-4afb-a8d5-73e019c3b205"
      unitRef="usd">133600000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ic0624b58f9374ca4b58497be819f0521_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfODgx_2dc2d31c-57d4-4613-b254-4d353abf9d54"
      unitRef="usdPerShare">33.18</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:ConvertibleDebt
      contextRef="ib7035befba854bb787b41b7a326649e7_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMzg0ODI5MDcyNzE4OQ_142908a6-795f-4b75-b75c-9f672b30f54a"
      unitRef="usd">133900000</us-gaap:ConvertibleDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ib7035befba854bb787b41b7a326649e7_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTQxMA_0e07b2d7-fa1a-4135-ba91-3bf4826fcb23"
      unitRef="usd">4400000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="iaea3ce259c6d4b31887911f5a24f9386_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTgyMg_ac199006-3770-4801-a8f4-26311d9eb481"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="iaea3ce259c6d4b31887911f5a24f9386_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTg4Ng_23f78162-de1f-459f-8a4a-45d9300fcf20"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="iaea3ce259c6d4b31887911f5a24f9386_D20210301-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjAzMg_c94eb09f-5a89-438b-a2f3-fee4a2d74a8f"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i07f11bb2c2e748f7a93f2cf71e0ba828_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjEyOA_a57c0933-4f96-4713-855d-3e3f76f384f0"
      unitRef="day">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i07f11bb2c2e748f7a93f2cf71e0ba828_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjE2MQ_df5c5f18-e1c5-4fa4-824c-e685573534b7"
      unitRef="day">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i07f11bb2c2e748f7a93f2cf71e0ba828_D20210301-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjM1Nw_74e08e96-0b6d-4df0-989b-370ff71d9591"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <cutr:DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger
      contextRef="i41feb9a60cd54b25be885f1459623391_D20210301-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMzM5Mw_d56990d2-0358-4323-af10-02b44f887da5"
      unitRef="number">1.30</cutr:DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger>
    <cutr:DebtInstrumentRedeemableThresholdTradingDays
      contextRef="i41feb9a60cd54b25be885f1459623391_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMzQ0OA_df058f3d-1062-4743-b4fa-0af0a5467285"
      unitRef="day">20</cutr:DebtInstrumentRedeemableThresholdTradingDays>
    <cutr:DebtInstrumentRedeemableThresholdConsecutiveTradingDays
      contextRef="i41feb9a60cd54b25be885f1459623391_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMzUwMg_4213b52f-34c1-48a4-8a0c-c7f41760d81f"
      unitRef="day">30</cutr:DebtInstrumentRedeemableThresholdConsecutiveTradingDays>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i41feb9a60cd54b25be885f1459623391_D20210301-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMzczOQ_d00e297f-7001-438d-aad2-a248f552c909"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <cutr:DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption
      contextRef="i3039819417a84fd7b2aa536ffb2ed8d4_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMzk1MA_8590d5c1-980f-47f4-99bb-7fea961a12a6"
      unitRef="usd">50000000.0</cutr:DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption>
    <cutr:DebtInstrumentRedemptionIncrementalRepurchaseAmount
      contextRef="i5ddc6ffd69484d648267e3fa81be0a45_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNDIyOQ_ef902ad6-e123-418e-acca-a0d7e89d29c0"
      unitRef="usd">1000</cutr:DebtInstrumentRedemptionIncrementalRepurchaseAmount>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i489cafda5c3f4762af77cae7f75a401e_D20210301-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNDMxMA_51aa7cea-e02d-44fc-b631-add483fac40a"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i1290f60e05c943b9995db59a6927e23a_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNTMzMg_256fb694-83f7-45eb-86aa-57fddb424ad0"
      unitRef="usd">226400000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtTableTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTQ0MzA_ae9bc4ec-b7e5-40d6-be22-ede670362ecf">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents outstanding principal amount and carrying value of the Convertible notes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding principal amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;138,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;133,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib7035befba854bb787b41b7a326649e7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RhYmxlOmM4OWEwNmY5MmVlYzRmOWI5YWQ2MTVmZTE3NWU4OTgwL3RhYmxlcmFuZ2U6Yzg5YTA2ZjkyZWVjNGY5YjlhZDYxNWZlMTc1ZTg5ODBfMS0xLTEtMS0w_a4c285b1-4970-4edd-a7ac-ddd338482374"
      unitRef="usd">138250000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia674f145a1a94467899389e49f535d8f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RhYmxlOmM4OWEwNmY5MmVlYzRmOWI5YWQ2MTVmZTE3NWU4OTgwL3RhYmxlcmFuZ2U6Yzg5YTA2ZjkyZWVjNGY5YjlhZDYxNWZlMTc1ZTg5ODBfMS0zLTEtMS0w_0cf9daae-8985-4480-b4d4-7d1562313ed2"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="ib7035befba854bb787b41b7a326649e7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RhYmxlOmM4OWEwNmY5MmVlYzRmOWI5YWQ2MTVmZTE3NWU4OTgwL3RhYmxlcmFuZ2U6Yzg5YTA2ZjkyZWVjNGY5YjlhZDYxNWZlMTc1ZTg5ODBfMi0xLTEtMS0w_3d0da55c-ddd8-42aa-9766-f1924d475aae"
      unitRef="usd">4450000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="ia674f145a1a94467899389e49f535d8f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RhYmxlOmM4OWEwNmY5MmVlYzRmOWI5YWQ2MTVmZTE3NWU4OTgwL3RhYmxlcmFuZ2U6Yzg5YTA2ZjkyZWVjNGY5YjlhZDYxNWZlMTc1ZTg5ODBfMi0zLTEtMS0w_4444ddfb-714f-4bd4-aa85-1ec54690ab7a"
      unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="ib7035befba854bb787b41b7a326649e7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RhYmxlOmM4OWEwNmY5MmVlYzRmOWI5YWQ2MTVmZTE3NWU4OTgwL3RhYmxlcmFuZ2U6Yzg5YTA2ZjkyZWVjNGY5YjlhZDYxNWZlMTc1ZTg5ODBfMy0xLTEtMS0w_dda80b8f-7b7e-490c-9905-c0cf083d289a"
      unitRef="usd">133800000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia674f145a1a94467899389e49f535d8f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RhYmxlOmM4OWEwNmY5MmVlYzRmOWI5YWQ2MTVmZTE3NWU4OTgwL3RhYmxlcmFuZ2U6Yzg5YTA2ZjkyZWVjNGY5YjlhZDYxNWZlMTc1ZTg5ODBfMy0zLTEtMS0w_7b9c53ae-6650-444b-bd4b-fda5f7e98e1b"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DerivativeCapPrice
      contextRef="i44e8ae2855f24ec191abeac87edead4a_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNjgxMg_d33f0650-b9b7-4033-96fa-a7e8d09d78bc"
      unitRef="usdPerItem">45.5350</us-gaap:DerivativeCapPrice>
    <cutr:DerivativeCapPricePremiumOverStockPricePercent
      contextRef="i44e8ae2855f24ec191abeac87edead4a_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNjgzNQ_ff6be12d-1bf8-4d49-be91-b1449abc7eaa"
      unitRef="number">0.75</cutr:DerivativeCapPricePremiumOverStockPricePercent>
    <us-gaap:SharePrice
      contextRef="ic40cdb4b583b4d60bd81237f32311633_I20210304"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNjkxMw_b58346f2-7f00-407c-bdfe-33e290e8eecb"
      unitRef="usdPerShare">26.02</us-gaap:SharePrice>
    <cutr:DerivativeCappedCallTransactionTermConsecutiveTradingDays
      contextRef="ib0131d61368a466d8a6ca8117c109ad7_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNzA3MA_426198ac-064c-44a7-94b6-b3f2b7193ab6"
      unitRef="day">40</cutr:DerivativeCappedCallTransactionTermConsecutiveTradingDays>
    <us-gaap:PaymentsForDerivativeInstrumentFinancingActivities
      contextRef="ib0131d61368a466d8a6ca8117c109ad7_D20210301-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNzE2OQ_49180bee-cbbd-4131-988b-d135fcf7383b"
      unitRef="usd">16100000</us-gaap:PaymentsForDerivativeInstrumentFinancingActivities>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="ib7035befba854bb787b41b7a326649e7_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfODQ2Nw_b28750bd-98ed-4d6c-91b4-682e525aa13d"
      unitRef="usd">4700000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ia1ba13fde0c14860bd56f281fcae9480_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfODY1Mw_89669b80-7e54-48f7-873f-e6f019e64cfd"
      unitRef="usd">200000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i2dceabdb8060472888bc8746205213da_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjE5OTAyMzI3OTkwOA_b7f26144-71f2-4300-90e7-a4a5250c1d6b"
      unitRef="usd">300000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ia1ba13fde0c14860bd56f281fcae9480_D20210401-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfODc4Mg_2dc62a7e-8bd6-477d-997d-3fa07dcc73bf"
      unitRef="number">0.0297</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i2dceabdb8060472888bc8746205213da_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfODc4Mg_6e8ccc40-1a00-49c9-b027-7ad09153a848"
      unitRef="number">0.0297</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:InterestExpenseDebt
      contextRef="ia1ba13fde0c14860bd56f281fcae9480_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjE5OTAyMzI3MjcwMQ_d10f237c-de91-4451-8c5e-254ccb85cc49"
      unitRef="usd">1000000.0</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i2dceabdb8060472888bc8746205213da_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjE5OTAyMzI3MjcwOQ_86e419ce-f2d2-4a72-bd4c-718fcb3ad917"
      unitRef="usd">1200000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="ia1ba13fde0c14860bd56f281fcae9480_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjE5OTAyMzI3MjcyMA_57281046-498e-42b9-b556-67f2f8f1c204"
      unitRef="usd">800000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i2dceabdb8060472888bc8746205213da_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjE5OTAyMzI3MjcyOA_06bbf92a-f713-4705-bf1b-76e24bdd0d0a"
      unitRef="usd">1000000.0</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic0afd02d742a4c50bfc5ec134cc472c9_I20180530"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfOTMxMA_18317e1a-26ed-4d3a-9268-431459533e0e"
      unitRef="usd">25000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i6f5872525ec8417bb65b72a9ac49e61b_D20200709-20200709"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfNDk0NzgwMjM0MjQ3OA_934e6744-4444-45a2-b53d-7e22c614ef22">P4Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i73dd1591ec4d4f828e27088ad0d09aeb_I20200709"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfOTYwNA_40b07c2c-70f8-4915-a549-a9ace19dd43a"
      unitRef="usd">30000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <cutr:DebtInstrumentPercentageOfQualifyingAccountsReceivable
      contextRef="i73dd1591ec4d4f828e27088ad0d09aeb_I20200709"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfOTkwNw_915705ab-2c8b-45f2-9034-bc81b62d0602"
      unitRef="number">0.80</cutr:DebtInstrumentPercentageOfQualifyingAccountsReceivable>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i84e5687763244213b65265c035c8bdcd_D20200709-20200709"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTAzMzA_96c7c955-b320-486a-b148-95e5d810e38c"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i73dd1591ec4d4f828e27088ad0d09aeb_I20200709"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTAzNzE_c915842c-7ef5-4dce-b7e9-fd572794606c"
      unitRef="number">0.050</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount
      contextRef="i6f5872525ec8417bb65b72a9ac49e61b_D20200709-20200709"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTA0NDM_41df178b-a0fe-4a1e-83be-bc7e35353491"
      unitRef="usd">300000</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <cutr:DebtInstrumentAnniversaryFeeAmount
      contextRef="i73dd1591ec4d4f828e27088ad0d09aeb_I20200709"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTA1OTM_f7fa54a6-5195-4180-9511-ffdf09458596"
      unitRef="usd">300000</cutr:DebtInstrumentAnniversaryFeeAmount>
    <cutr:DebtCovenantQuarterlyMinimumRevenue
      contextRef="i6f5872525ec8417bb65b72a9ac49e61b_D20200709-20200709"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjE5OTAyMzI4NjAwMg_ceb3d2b4-b294-4ca2-a058-9b3b0809ecf7"
      unitRef="usd">90000000.0</cutr:DebtCovenantQuarterlyMinimumRevenue>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="id99d22627e1c49f080008eaaceb8a64e_D20200422-20200422"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTE5NjQ_438a8213-5139-45f6-b66d-2341dd6c7ebc"
      unitRef="usd">7100000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i22ce661a87cf458ba03c056354564a8e_I20200422"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMTIzMDA_4ee300d5-a097-4e46-bdbb-1acd901a44bc"
      unitRef="number">0.0100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="id84ea3c345a84c8c820c9be723af5e27_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjE5OTAyMzI4NTQ1Mw_34881f31-c087-49d0-ad38-c4caa5f973e4"
      unitRef="usd">7200000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i54330428060a4653bc4b61cd17bfbb1e_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF85Ny9mcmFnOmVjZmEzZjQ0ZTk4YjQ0M2RiM2NlNzEyMjAzODQ0ZmRjL3RleHRyZWdpb246ZWNmYTNmNDRlOThiNDQzZGIzY2U3MTIyMDM4NDRmZGNfMjE5OTAyMzI4NTQ1Mw_aedf76dc-fb8e-426a-9103-026258795cf4"
      unitRef="usd">7200000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90ZXh0cmVnaW9uOjZhZGVlMTYwODAzODQ2NmJhMmRjNzJhYzVmYWY3YTBiXzEzNTg_f17c8369-7b78-40ca-8143-4dad0ba4e13d">Segment reportingSegment reporting is based on the &#x201c;management approach,&#x201d; following the method that management organizes the Company&#x2019;s reportable segments for which separate financial information is made available to, and evaluated regularly by, the chief operating decision maker in allocating resources and in assessing performance. The Company&#x2019;s chief operating decision makers ("CODM") are its Chief Executive Officer ("CEO") and Chief Financial Officer (&#x201c;CFO&#x201d;), who make decisions on allocating resources and in assessing performance. The CEO and CFO review the Company's consolidated results as&#160;one&#160;operating segment. In making operating decisions, the CODM primarily considers consolidated financial information, accompanied by disaggregated information about revenues by geography and product. All of the Company&#x2019;s principal operations and decision-making functions are located in the U.S. The Company&#x2019;s CODM view its operations, manages its business, and uses&#160;one&#160;measurement of profitability for the&#160;one&#160;operating segment - which sells aesthetic medical equipment and services, and distributes skincare products, to qualified medical practitioners. Substantially all of the Company&#x2019;s long-lived assets are located in the U.S.&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of revenue by geography for the three and six months June&#160;30, 2021 and 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue mix by geography:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Asia, excluding Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rest of the  World, other than United States, Asia and Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total consolidated revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue mix by product category:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;35,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Skincare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;51,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total consolidated revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90ZXh0cmVnaW9uOjZhZGVlMTYwODAzODQ2NmJhMmRjNzJhYzVmYWY3YTBiXzYxNg_b6991588-1d0d-44bf-976f-24e8fd67682a"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90ZXh0cmVnaW9uOjZhZGVlMTYwODAzODQ2NmJhMmRjNzJhYzVmYWY3YTBiXzEzNTk_02a918e9-b27d-4d3b-a299-2e77158c1283">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of revenue by geography for the three and six months June&#160;30, 2021 and 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue mix by geography:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Asia, excluding Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rest of the  World, other than United States, Asia and Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total consolidated revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue mix by product category:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;35,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Skincare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;51,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total consolidated revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5cd8c122a6db4b479f4cb170d5340e5f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzMtMS0xLTEtMA_b8973b14-b671-4eb4-922f-0ddf62688fa0"
      unitRef="usd">22972000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ifc32166982764821b862930f62f92b51_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzMtMy0xLTEtMA_cc92308b-a87e-4b45-a6ad-a064bfcd4b32"
      unitRef="usd">10915000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0916cb6cfef149efba3569c230352115_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzMtNS0xLTEtMTA4Mw_c3238c4f-6fae-4235-82e9-1427a872c44f"
      unitRef="usd">41816000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ifc041928fcd442d691a2b8f145bf69f3_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzMtNy0xLTEtMTA4NQ_6fcc80fa-ffac-41c6-afb9-2c8902812af5"
      unitRef="usd">24699000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i60cc413c28af471da2fd3a5cb7567dfe_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzQtMS0xLTEtMA_89ba583a-e1c7-480f-9122-3a586f37a857"
      unitRef="usd">17421000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i001f2e7ffc384283a6262f680531b654_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzQtMy0xLTEtMA_62e008ef-33a4-43fb-b8ee-5cc2c3f1d8e0"
      unitRef="usd">8517000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i45c4fddf3ca04af29dc98fd3b2a1c1b3_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzQtNS0xLTEtMTA4Mw_adb7b51d-b85a-4e6e-be27-d2b4563cb8f2"
      unitRef="usd">33976000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iaee1d9be4d174579b2a79cbe1837cf25_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzQtNy0xLTEtMTA4NQ_cab9e2bf-8fd2-4fba-8c1c-f8809d1c8232"
      unitRef="usd">15679000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i605c06860c2a4b9ba038414773646e05_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzUtMS0xLTEtNTIzOQ_7fdbd75e-115e-470a-b3e0-79e43fee1492"
      unitRef="usd">3676000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6b993bcbab604605a3f9186a75679bc5_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzUtMy0xLTEtNTIzOQ_6eb4b40f-7825-47ca-85f6-92c36a80a6ee"
      unitRef="usd">1846000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="icac68fb392c34970af1e7c3bbd64b047_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzUtNS0xLTEtNTIzOQ_9ba3d2a5-ffc0-4711-87a8-ab77ce04612b"
      unitRef="usd">6079000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5628efd5ddc746118fb44e8463069210_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzUtNy0xLTEtNTIzOQ_da2598f5-8ea5-4c25-8bf7-319c729bc07d"
      unitRef="usd">5075000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iec6fc50f8e8e41c4b1b36ce9c699fe36_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzYtMS0xLTEtNTIzOQ_a258dbf0-3abc-4546-87fc-17096f19191b"
      unitRef="usd">4628000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia1e77ae11263421aacb8d6bb8940ff5b_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzYtMy0xLTEtNTIzOQ_c81a5302-a9c5-4504-867b-3e998917426d"
      unitRef="usd">1325000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6b6561e7c0bc4c82b78cc302b59ada69_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzYtNS0xLTEtNTIzOQ_90310cc5-2d0c-4765-8f5d-b67e440e6e06"
      unitRef="usd">9052000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iedce34eaadb2414ca33df76ede46361d_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzYtNy0xLTEtNTIzOQ_4449fb52-5902-45fc-bc2f-7259987d4a50"
      unitRef="usd">4141000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i72c021f9acb64626b780975f2f7b37bd_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzctMS0xLTEtMA_6b45488e-819b-46f7-9d71-c879ce19ef4d"
      unitRef="usd">9892000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ieae31fb3cfae4ce588f0407780016251_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzctMy0xLTEtMA_7d416f04-007d-46b4-9bcd-10d15360771c"
      unitRef="usd">3766000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i74194697532c48e689caa0d810cf7dee_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzctNS0xLTEtMTA4Mw_b4f225db-8b4e-4203-ad05-c24dee9e91ec"
      unitRef="usd">17334000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic61b8af9d2a44ba89d29a042679de961_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzctNy0xLTEtMTA4NQ_ea0256e4-e90d-4ba4-80a8-e2af1a0362ad"
      unitRef="usd">9014000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzgtMS0xLTEtMA_0e645ffd-4435-42ab-b438-02cac756b040"
      unitRef="usd">58589000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzgtMy0xLTEtMA_53e5acf2-8cd4-4188-a20c-cbea80301645"
      unitRef="usd">26369000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzgtNS0xLTEtMTA4Mw_c4e6cd78-1995-41f7-bea4-1aa077f65841"
      unitRef="usd">108257000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzgtNy0xLTEtMTA4NQ_7fc9033d-dd4a-4fb4-b837-5b5838b65262"
      unitRef="usd">58608000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i257d2e51a1bc4c85b8cffc47eabccc0b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEwLTEtMS0xLTA_08980c74-c838-4f66-a188-444e30633f23"
      unitRef="usd">35567000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id006d6e7ce234b7486129ec2b87c40c0_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEwLTMtMS0xLTA_351bea16-b4df-40dd-b8c7-d81a317b97d0"
      unitRef="usd">15541000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibe8306ccc3f44558b1235fa08edef7ed_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEwLTUtMS0xLTEwODc_e0965439-c0bc-4f7f-8d7c-a1a9bafff219"
      unitRef="usd">63887000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id97644f373e8442c982dab972c23de51_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEwLTctMS0xLTEwODk_1e88aa5c-6c96-4ad3-8937-71bcab26bb1b"
      unitRef="usd">36500000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ief96e147f922486883c4d8cc587f8f60_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzExLTEtMS0xLTA_9c9d0e51-852f-4318-966d-7da65f428271"
      unitRef="usd">4433000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibd1e322af3b8489a8e9d1c2f562b5e8b_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzExLTMtMS0xLTA_e4eb7ad6-2f6b-4116-890e-b4ca0abfc8a5"
      unitRef="usd">1426000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if3afbc47a9fd48df8033033413b4338e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzExLTUtMS0xLTEwODc_14591a7c-2a70-44d8-ae87-1a9d4243b6b3"
      unitRef="usd">7358000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0c347ebd3f934ddaaec736c2f53a0eeb_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzExLTctMS0xLTEwODk_12f6f47d-90ec-4cde-8883-0447564cd652"
      unitRef="usd">3959000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i612e38fd3e404dcb98febb98ac966dcd_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEyLTEtMS0xLTA_a1bdfb1b-ae08-44a8-bff1-e1fcbdd83fed"
      unitRef="usd">11812000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i532d55314af64158ac48f5d2f1d43acc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEyLTMtMS0xLTA_a2429402-0a53-4de3-8746-8be24ce8a714"
      unitRef="usd">4778000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i70f692ff4e534504a06fd1b76829e106_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEyLTUtMS0xLTEwODc_1ebe2374-0641-4235-97f6-3d30f38871b8"
      unitRef="usd">24118000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9a21f86e33ca4228a03854c5f5b0821c_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEyLTctMS0xLTEwODk_4ba13e77-61b7-4445-a805-160d08c8d830"
      unitRef="usd">7677000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2fcfd7b210f74dc5976983de27855478_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEzLTEtMS0xLTA_e4f05bf2-0af6-4165-9bdc-075a6945db67"
      unitRef="usd">51812000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibcb365aaec5f4975a3f836175dc8e2ce_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEzLTMtMS0xLTA_46cfac36-48cc-470d-a5b7-91b3fd6db688"
      unitRef="usd">21745000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibfb65299d11046adb017318fb542b3be_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEzLTUtMS0xLTEwODc_72c87d86-60f4-43b2-99f7-6cb5dfa596b4"
      unitRef="usd">95363000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idb26dda9fd88462aabb4723bea6e2287_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzEzLTctMS0xLTEwODk_0811da9c-0044-4b4f-b976-80f5d4890c93"
      unitRef="usd">48136000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia8b6fed2a51f45858d2dcecd28277fef_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzE0LTEtMS0xLTA_1c4828d3-1281-4292-914e-2c933927bcf7"
      unitRef="usd">6777000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i73f49a322eb84c7383e92e7174381a6c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzE0LTMtMS0xLTA_a09d2961-d414-4d0d-88c0-a527c318e4d5"
      unitRef="usd">4624000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8d6280ba43fc4a6d8e572d51843bc28a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzE0LTUtMS0xLTEwODc_6cffc70e-3fdb-4e09-b8cb-b51fe5d7c849"
      unitRef="usd">12894000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="icd94bfca54cb406f8ffb1fc2d03add57_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzE0LTctMS0xLTEwODk_4129b02d-843b-41cb-9b6c-d3e2fd94b10d"
      unitRef="usd">10472000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i467c84ff364946159dcd87dd18558b41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzE1LTEtMS0xLTA_95741eaa-c52d-41bf-a5ba-b9eef86c07b3"
      unitRef="usd">58589000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3f2e30ba2bea423aaec8fd8a3256582d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzE1LTMtMS0xLTA_84151908-6c4d-47f4-8568-0f9f96ae82de"
      unitRef="usd">26369000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ide53b89e851c44e5908a02860291ac35_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzE1LTUtMS0xLTEwODc_98aaafe8-4f23-4178-8b5e-bf3eac125936"
      unitRef="usd">108257000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4de55e4b1e914536a0715a93bcad7ece_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF8xMDMvZnJhZzo2YWRlZTE2MDgwMzg0NjZiYTJkYzcyYWM1ZmFmN2EwYi90YWJsZTphNDg1NDE2MjgxMmE0NTU4YWVkMDQwYWU5YTI1OGZhYi90YWJsZXJhbmdlOmE0ODU0MTYyODEyYTQ1NThhZWQwNDBhZTlhMjU4ZmFiXzE1LTctMS0xLTEwODk_a903bc89-1f56-4fb2-8d3d-0edaf2c2e3f6"
      unitRef="usd">58608000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736665131656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jul. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-50644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cutera, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0492262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3240 Bayshore Blvd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Brisbane<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">657-5500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock ($0.001 par value)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CUTR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,942,446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001162461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736739836808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 169,200<span></span>
</td>
<td class="nump">$ 47,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses of $1,639 and $1,598, respectively</a></td>
<td class="nump">25,903<span></span>
</td>
<td class="nump">21,962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">34,591<span></span>
</td>
<td class="nump">28,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other current assets and prepaid expenses</a></td>
<td class="nump">8,856<span></span>
</td>
<td class="nump">8,779<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">238,550<span></span>
</td>
<td class="nump">106,296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">2,148<span></span>
</td>
<td class="nump">2,299<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax asset</a></td>
<td class="nump">592<span></span>
</td>
<td class="nump">643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">15,919<span></span>
</td>
<td class="nump">17,076<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,339<span></span>
</td>
<td class="nump">1,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">5,615<span></span>
</td>
<td class="nump">5,080<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">264,163<span></span>
</td>
<td class="nump">132,733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">6,210<span></span>
</td>
<td class="nump">6,684<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">41,343<span></span>
</td>
<td class="nump">31,079<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">2,422<span></span>
</td>
<td class="nump">2,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">PPP loan payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,630<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtendedProductWarrantyAccrualCurrent', window );">Extended warranty liability</a></td>
<td class="nump">649<span></span>
</td>
<td class="nump">1,216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">9,695<span></span>
</td>
<td class="nump">9,489<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">60,319<span></span>
</td>
<td class="nump">54,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">1,708<span></span>
</td>
<td class="nump">1,748<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">14,705<span></span>
</td>
<td class="nump">15,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">PPP loan payable, net of current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible notes, net of unamortized debt issuance costs of $4,450</a></td>
<td class="nump">133,800<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">288<span></span>
</td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">210,820<span></span>
</td>
<td class="nump">75,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Notes 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; authorized: 50,000,000 shares; issued and outstanding: 17,933,020 and 17,679,232 shares at June&#160;30, 2021 and December&#160;31, 2020, respectively</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">106,173<span></span>
</td>
<td class="nump">117,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(52,848)<span></span>
</td>
<td class="num">(60,235)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">53,343<span></span>
</td>
<td class="nump">56,880<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 264,163<span></span>
</td>
<td class="nump">$ 132,733<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtendedProductWarrantyAccrualCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount at end of the reporting period of the aggregate extended product warranty liability that is expected to be paid within one year of the balance sheet date or normal operating cycle, if longer. Does not include the balance for the standard product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtendedProductWarrantyAccrualCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, uncollateralized debt obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of uncollateralized debt obligation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736665679816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit loss, current</a></td>
<td class="nump">$ 1,639<span></span>
</td>
<td class="nump">$ 1,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized debt issuance costs</a></td>
<td class="nump">$ 4,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (in shares)</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (in shares)</a></td>
<td class="nump">17,933,020<span></span>
</td>
<td class="nump">17,679,232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (in shares)</a></td>
<td class="nump">17,933,020<span></span>
</td>
<td class="nump">17,679,232<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736740330696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">$ 58,589<span></span>
</td>
<td class="nump">$ 26,369<span></span>
</td>
<td class="nump">$ 108,257<span></span>
</td>
<td class="nump">$ 58,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of revenue</a></td>
<td class="nump">24,800<span></span>
</td>
<td class="nump">14,745<span></span>
</td>
<td class="nump">46,758<span></span>
</td>
<td class="nump">32,648<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">33,789<span></span>
</td>
<td class="nump">11,624<span></span>
</td>
<td class="nump">61,499<span></span>
</td>
<td class="nump">25,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">18,410<span></span>
</td>
<td class="nump">11,035<span></span>
</td>
<td class="nump">33,478<span></span>
</td>
<td class="nump">25,823<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">4,850<span></span>
</td>
<td class="nump">2,991<span></span>
</td>
<td class="nump">8,962<span></span>
</td>
<td class="nump">6,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">8,461<span></span>
</td>
<td class="nump">8,529<span></span>
</td>
<td class="nump">15,826<span></span>
</td>
<td class="nump">16,336<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">31,721<span></span>
</td>
<td class="nump">22,555<span></span>
</td>
<td class="nump">58,266<span></span>
</td>
<td class="nump">49,021<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">2,068<span></span>
</td>
<td class="num">(10,931)<span></span>
</td>
<td class="nump">3,233<span></span>
</td>
<td class="num">(23,061)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseAbstract', window );"><strong>Interest and other income (expense), net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt issuance costs</a></td>
<td class="num">(215)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(267)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest on convertible notes</a></td>
<td class="num">(778)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(969)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of PPP loan</a></td>
<td class="nump">7,185<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,185<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(392)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(1,415)<span></span>
</td>
<td class="num">(204)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total interest and other income (expense), net</a></td>
<td class="nump">5,800<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">4,534<span></span>
</td>
<td class="num">(204)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes</a></td>
<td class="nump">7,868<span></span>
</td>
<td class="num">(10,928)<span></span>
</td>
<td class="nump">7,767<span></span>
</td>
<td class="num">(23,265)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">466<span></span>
</td>
<td class="nump">380<span></span>
</td>
<td class="nump">543<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 7,746<span></span>
</td>
<td class="num">$ (11,394)<span></span>
</td>
<td class="nump">$ 7,387<span></span>
</td>
<td class="num">$ (23,808)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income (loss) per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (USD per share)</a></td>
<td class="nump">$ 0.43<span></span>
</td>
<td class="num">$ (0.67)<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="num">$ (1.51)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (USD per share)</a></td>
<td class="nump">$ 0.39<span></span>
</td>
<td class="num">$ (0.67)<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="num">$ (1.51)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted-average number of shares used in per share calculations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">17,862<span></span>
</td>
<td class="nump">17,055<span></span>
</td>
<td class="nump">17,815<span></span>
</td>
<td class="nump">15,744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">22,453<span></span>
</td>
<td class="nump">17,055<span></span>
</td>
<td class="nump">20,855<span></span>
</td>
<td class="nump">15,744<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Total product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">$ 51,812<span></span>
</td>
<td class="nump">$ 21,745<span></span>
</td>
<td class="nump">$ 95,363<span></span>
</td>
<td class="nump">$ 48,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of revenue</a></td>
<td class="nump">20,893<span></span>
</td>
<td class="nump">12,206<span></span>
</td>
<td class="nump">39,224<span></span>
</td>
<td class="nump">26,309<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">6,777<span></span>
</td>
<td class="nump">4,624<span></span>
</td>
<td class="nump">12,894<span></span>
</td>
<td class="nump">10,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of revenue</a></td>
<td class="nump">$ 3,907<span></span>
</td>
<td class="nump">$ 2,539<span></span>
</td>
<td class="nump">$ 7,534<span></span>
</td>
<td class="nump">$ 6,339<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736745557416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 7,746<span></span>
</td>
<td class="num">$ (11,394)<span></span>
</td>
<td class="nump">$ 7,387<span></span>
</td>
<td class="num">$ (23,808)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Available-for-sale investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Reclassification adjustment for losses on investments recognized during the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net change in unrealized gain on available-for-sale investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive gain, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">$ 7,746<span></span>
</td>
<td class="num">$ (11,392)<span></span>
</td>
<td class="nump">$ 7,387<span></span>
</td>
<td class="num">$ (23,745)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736660681416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes In Stockholders' Equity (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings (Accumulated Deficit)</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (loss)</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,315,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 45,942<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 82,346<span></span>
</td>
<td class="num">$ (36,358)<span></span>
</td>
<td class="num">$ (60)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for employee purchase plan</a></td>
<td class="nump">437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock unites, net of shares withheld for employee taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">423,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(3,117)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(3,118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with public offering, net of offering cost of $2,303 (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,742,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering, net of offering cost of $2,303</a></td>
<td class="nump">26,496<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">26,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">6,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(23,808)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,808)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net change in unrealized loss on available-for-sale investments</a></td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,567,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2020</a></td>
<td class="nump">52,499<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">112,644<span></span>
</td>
<td class="num">(60,166)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,578,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2020</a></td>
<td class="nump">33,536<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">82,292<span></span>
</td>
<td class="num">(48,772)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for employee purchase plan</a></td>
<td class="nump">437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock unites, net of shares withheld for employee taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(883)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(883)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with public offering, net of offering cost of $2,303 (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,742,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering, net of offering cost of $2,303</a></td>
<td class="nump">26,496<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">26,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">4,095<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,095<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(11,394)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,394)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net change in unrealized loss on available-for-sale investments</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,567,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2020</a></td>
<td class="nump">$ 52,499<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">112,644<span></span>
</td>
<td class="num">(60,166)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">17,679,232<span></span>
</td>
<td class="nump">17,679,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 56,880<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">117,097<span></span>
</td>
<td class="num">(60,235)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for employee purchase plan</a></td>
<td class="nump">$ 645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">53,598<span></span>
</td>
<td class="nump">53,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 1,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall', window );">Purchase of capped call</a></td>
<td class="num">(16,134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock unites, net of shares withheld for employee taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(1,452)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,452)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">4,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">7,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net change in unrealized loss on available-for-sale investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Jun. 30, 2021</a></td>
<td class="nump">17,933,020<span></span>
</td>
<td class="nump">17,933,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2021</a></td>
<td class="nump">$ 53,343<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">106,173<span></span>
</td>
<td class="num">(52,848)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,801,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2021</a></td>
<td class="nump">41,630<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">102,206<span></span>
</td>
<td class="num">(60,594)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for employee purchase plan</a></td>
<td class="nump">645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock unites, net of shares withheld for employee taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(453)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(453)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">2,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">7,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net change in unrealized loss on available-for-sale investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Jun. 30, 2021</a></td>
<td class="nump">17,933,020<span></span>
</td>
<td class="nump">17,933,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2021</a></td>
<td class="nump">$ 53,343<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 106,173<span></span>
</td>
<td class="num">$ (52,848)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of adjustments to additional paid in capital purchase of capped call.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736740372328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 7,387<span></span>
</td>
<td class="num">$ (23,808)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">4,765<span></span>
</td>
<td class="nump">6,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts', window );">Depreciation and amortization</a></td>
<td class="nump">707<span></span>
</td>
<td class="nump">715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfAcquisitionCosts', window );">Amortization of contract acquisition costs</a></td>
<td class="nump">1,003<span></span>
</td>
<td class="nump">1,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">267<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareImpairments1', window );">Impairment of capitalized cloud computing costs</a></td>
<td class="nump">182<span></span>
</td>
<td class="nump">805<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Change in deferred tax asset</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Allowance for credit losses</a></td>
<td class="nump">492<span></span>
</td>
<td class="nump">1,696<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Gain on sale of property and equipment</a></td>
<td class="num">(82)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of PPP loan</a></td>
<td class="num">(7,185)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification', window );">Change in right-of-use assets</a></td>
<td class="nump">604<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">198<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(4,433)<span></span>
</td>
<td class="nump">6,034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(5,958)<span></span>
</td>
<td class="nump">2,681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Other current assets and prepaid expenses</a></td>
<td class="num">(77)<span></span>
</td>
<td class="nump">316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="num">(1,720)<span></span>
</td>
<td class="num">(519)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Accounts payable</a></td>
<td class="num">(474)<span></span>
</td>
<td class="num">(1,004)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">10,220<span></span>
</td>
<td class="num">(9,754)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual', window );">Extended warranty liabilities</a></td>
<td class="num">(567)<span></span>
</td>
<td class="num">(339)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(530)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">166<span></span>
</td>
<td class="num">(2,443)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="nump">4,818<span></span>
</td>
<td class="num">(17,951)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Acquisition of property, equipment, and software</a></td>
<td class="num">(370)<span></span>
</td>
<td class="num">(435)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from disposal of property and equipment</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from maturities of marketable investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(16,167)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(299)<span></span>
</td>
<td class="num">(5,702)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from exercise of stock options and employee stock purchase plan</a></td>
<td class="nump">1,897<span></span>
</td>
<td class="nump">848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities', window );">Purchase&#160;of capped call</a></td>
<td class="num">(16,134)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of Convertible notes</a></td>
<td class="nump">138,250<span></span>
</td>
<td class="nump">7,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of issuance costs of Convertible notes</a></td>
<td class="num">(4,717)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from equity offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Cost of equity offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,303)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(1,451)<span></span>
</td>
<td class="num">(3,117)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Payments on finance lease obligations</a></td>
<td class="num">(211)<span></span>
</td>
<td class="num">(380)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">117,634<span></span>
</td>
<td class="nump">30,996<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">122,153<span></span>
</td>
<td class="nump">7,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">47,047<span></span>
</td>
<td class="nump">26,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">169,200<span></span>
</td>
<td class="nump">33,659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Assets acquired under finance lease</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Assets acquired under operating lease</a></td>
<td class="nump">123<span></span>
</td>
<td class="nump">1,169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReduction', window );">Gain on extinguishment of PPP loan</a></td>
<td class="nump">7,185<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction', window );">Debt issuance costs accrued</a></td>
<td class="nump">452<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income tax paid</a></td>
<td class="nump">$ 458<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the change in right-of-use asset and liability due to modification during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ChangeInRightofuseAssetAndLiabilityDueToModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets, excluding contract acquisition costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in extended product warranty accrual.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of capitalized costs associated with acquisition of business. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareImpairments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss from capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareImpairments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of notes retired (or transferred to another entity) in noncash investing or financing transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3505-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736740700264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Changes In Stockholders' Equity (Unaudited) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issued, offering cost</a></td>
<td class="nump">$ 2,303<span></span>
</td>
<td class="nump">$ 2,303<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736665428616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies&#160;<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Operations and Principles of Consolidation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cutera, Inc. (&#8220;Cutera&#8221; or the &#8220;Company&#8221;) provides energy-based aesthetic systems for practitioners worldwide. The Company develops, manufactures, distributes, and markets energy-based product platforms for use by physicians and other qualified practitioners, enabling them to offer safe and effective aesthetic treatments to their customers. The Company currently markets the following system platforms: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten, excel, Secret PRO, Juliet, Secret RF,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Several of the Company&#8217;s systems offer multiple hand pieces and applications, providing customers the flexibility to upgrade their systems. The sales of (i) systems, system upgrades, and hand pieces (collectively &#8220;Systems&#8221; revenue); (ii) replacement hand pieces, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan, truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">D,truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cycle refills, as well as single use disposable tips applicable to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO, Juliet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;Consumables&#8221; revenue); (iii) the distribution of third party manufactured skincare products (&#8220;Skincare&#8221; revenue); and (iv) the leasing of equipment through a membership program; are collectively classified as &#8220;Products&#8221; revenue. In addition to Products revenue, the Company generates revenue from the sale of post-warranty service contracts, parts, detachable hand piece replacements (except for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan, truSculpt 3D, truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and service labor for the repair and maintenance of products that are out of warranty, all of which are collectively classified as &#8220;Service&#8221; revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s corporate headquarters and U.S. operations are located in Brisbane, California, where the Company conducts manufacturing, warehousing, research and development, regulatory, sales and marketing, service, and administrative activities. The Company also maintains regional distribution centers (&#8220;RDCs&#8221;) in select locations across the U.S. These RDCs serve as forward warehousing for systems and service parts in various geographies. The Company markets, sells and services its products through its sales and service employees in North America (including Canada), Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, Spain, Switzerland, and the United Kingdom. Sales and services outside of these direct markets are made through a worldwide distributor network in over 42 countries. The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements included in this report reflect all adjustments necessary for a fair statement of its condensed consolidated statements of financial position as of June&#160;30, 2021 and December&#160;31, 2020, and its condensed consolidated statements of results of operations, comprehensive income (loss), changes in equity, and cash flows for the three and six months ended June&#160;30, 2021, and 2020. The December&#160;31, 2020 condensed consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;). The results for interim periods are not necessarily indicative of results for the entire year or any other interim period.&#160;Presentation of certain prior year balances have been updated to conform with current year presentation. All significant intercompany accounts and transactions have been eliminated upon consolidation. The accompanying condensed consolidated financial statements should be read in conjunction with the Company&#8217;s previously filed audited financial statements and the related notes thereto included in the Company&#8217;s annual report on Form 10-K for the year ended December&#160;31, 2020 filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 23, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's future results of operations involve a number of risks and uncertainties. Factors that could affect the Company's future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company's products, stability of global financial markets, cybersecurity breaches and other disruptions that could compromise the Company&#8217;s information or results, business disruptions that are caused by natural disasters or pandemic events, management of international activities, competition from substitute products and larger companies, ability to obtain and maintain regulatory approvals, government regulations and oversight, patent and other types of litigation, ability to protect proprietary technology from counterfeit versions of the Company's products, strategic relationships and dependence on key individuals.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020,&#160;the World Health Organization declared the COVID-19&#160;outbreak a pandemic. The COVID-19&#160;outbreak has negatively affected the United States and global economies. Though the economy is gradually recovering as of the second quarter of 2021, the timing and extent of a full global economic recovery is still uncertain. The spread of the coronavirus and the Delta variant in particular, has impacted the global economy broadly in 2020, including restrictions on travel, shifting work </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">forces to work remotely and quarantine policies put into place by businesses and governments, had a material economic effect on the Company&#8217;s business during the year ended December&#160;31, 2020 and in the six months ended June&#160;30, 2021. Healthcare facilities in many countries effectively banned elective procedures and this had a significant impact on the Company. Many of the Company&#8217;s products are used in aesthetic elective procedures and as such, the bans on elective procedures substantially reduced the Company&#8217;s sales and marketing efforts in the early months of the pandemic and led the Company to implement cost control measures. Although the Company&#8217;s revenues and profits have&#160;improved compared to the first half of fiscal 2020 and the overall economic outlook has also improved in 2021, the&#160;COVID-19&#160;outbreak continues to be fluid especially in light of the Delta variant, and the long-term impact on the Company's business due to COVID-19 is still uncertain. The Company&#160;cannot presently predict the scope and severity of any impacts in future periods from business shutdowns or disruptions due to the&#160;COVID-19&#160;pandemic, but the impact on economic activity including the possibility of recession or financial market instability could have a material adverse effect on the Company&#8217;s business, revenue, operating results, cash flows and financial condition. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to assess whether any impairment of its goodwill or its long-lived assets has occurred and has determined that no&#160;charges, other than an impairment loss of $0.2 million on capitalized implementation costs of&#160;cloud-based customer relationship management (&#8220;CRM&#8221;) software occurred were necessary during the six months&#160;ended June&#160;30, 2021.&#160;The Company will continue to monitor future conditions important to its assessment of potential impairment of its long-lived assets and goodwill, including the impacts of the&#160;COVID&#8211;19&#160;pandemic and other ongoing impacts which are subject to uncertainty.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has experienced a significant increase in sales of skincare products under the exclusive distribution agreement with ZO Skin Health, Inc. (&#8220;ZO&#8221;), which allows&#160;the Company to sell ZO&#8217;s skincare products in Japan. The reason for the increase in skincare products sales may have been the&#160;result of changes in customers&#8217; spending habits as customers purchased more aesthetic treatments that were able to be applied at home, due to limitations on&#160;in-person&#160;aesthetic procedures, social distancing and mask wearing requirements due to the&#160;COVID-19&#160;pandemic. Future growth in sales of skincare products depends on customers&#8217; spending habits, which may revert to original spending habits after the&#160;COVID-19&#160;pandemic. Such changes may have a material adverse effect on the Company&#8217;s revenue, operating results, and cash flows.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Policies</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements are prepared in accordance with the rules and regulations of the SEC applicable to interim financial statements. While these statements reflect all normal recurring adjustments that are, in the opinion of management, necessary for fair presentation of the results of the interim period, they do not include all of the information and footnotes required by GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the financial statement disclosures in its annual report on Form 10-K for the year ended December&#160;31, 2020 filed with the SEC on March 23, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the same accounting policies in preparing quarterly and annual financial statements. Unless otherwise noted, amounts presented within the notes to condensed consolidated financial statements refer to the Company&#8217;s continuing operations. Note 13 provides information about the Company&#8217;s adoption of the new accounting standard for debt with conversion and other options, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued $138.3 million of convertible senior notes ("Notes" or "Convertible notes") in a private placement offering on March&#160;5, 2021. The Convertible notes bear interest at a rate of 2.25% per year. In accordance with Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020-6,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contracts in Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">s Own Equity (Subtopic 815-40),</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company recorded the Convertible&#160;notes as long-term debt with no separation between the Convertible notes and the conversion option. Each reporting period, the Company will determine whether any criteria is met for the note holders to have the option to redeem the Convertible notes early, which will result in a change in the classification of the Convertible notes to current liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The circumstances described in the paragraph above were met during the second quarter of 2021 as the Company's stock traded at a price in excess of the conversion price, and as a result, the Notes are convertible at the option of the holder from July 1, 2021 until September 30, 2021. Upon any conversion of the Convertible notes, the Company would be required to pay or deliver, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#8217;s election. To the extent there are any conversions during the period from July 1, 2021 until September 30, 2021, the Company intends to settle such conversions by issuing shares of common stock; therefore, as of June&#160;30, 2021, the Convertible notes have been included as long term liability on the condensed consolidated balance sheet.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs associated with issuance of the Convertible notes, including underwriters&#8217; fees, are presented in the condensed consolidated balance sheet as a direct deduction from the carrying amount of the Convertible notes. The debt issuance costs are being amortized over the life of the Convertible notes as additional non-cash interest expense.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with issuance of the Convertible notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally designated to reduce the potential dilution of the Company's&#160;common stock upon any conversion of the Notes. The capped calls were purchased for $16.1 million and recorded as a reduction to additional paid in capital in the condensed consolidated balance sheet as of June&#160;30, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalized cloud computing systems implementation costs of $0.6&#160;million during the three months ending June 30, 2021. These costs relate to an on-going implementation of a new Enterprise Resource Planning system and are included in Other long-term assets and Other current assets and prepaid expenses on the condensed consolidated balance sheet.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commission, allowance for credit losses, sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, implicit and incremental borrowing rates related to the Company&#8217;s leases, variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, assumptions used in operating and sales-type lease classification, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, residual value of leased equipment, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">No.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)-Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to remove certain exceptions and improve consistency of application, including, among other things, requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. The Company adopted this guidance in the three and six months&#160;ended June&#160;30, 2021. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated financial position and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the&#160;FASB&#160;issued ASU No. 2020-6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt &#8211; Debt with Conversion and Other Options (Topic 470) and Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Topic 815), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to simplify the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the amendment, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#8217;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the computation of diluted earnings per share. The Company early adopted the guidance on a prospective basis effective January 1, 2021. See Note 13 &#8211; Debt.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736740821320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash, Cash Equivalents<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Cash, Cash Equivalents</a></td>
<td class="text">Cash, Cash Equivalents<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's cash and&#160;cash equivalents (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">169,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no marketable securities as of June&#160;30, 2021 and December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736740566760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text">Fair Value of Financial Instruments<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain financial assets at fair value, including cash and cash equivalents. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy contains the following three levels of inputs that may be used to measure fair value, in accordance with ASC 820:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level 1: inputs, which include quoted prices in active markets for identical assets or liabilities;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level 2: inputs, which include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. When sufficient quoted pricing for identical securities is not available, the Company uses market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level 3: inputs, which include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques, as well as significant management judgment or estimation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considering counterparty credit risk in its assessment of fair value.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 13 - Debt for the carrying amount and estimated fair value of the Company&#8217;s Convertible notes due 2026.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736746244344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Details</a></td>
<td class="text">Balance Sheet Details<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021 and December&#160;31, 2020, inventories consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,862&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,591&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28,508&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Liabilities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021 and December&#160;31, 2020, accrued liabilities consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued payroll and related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,427&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,197&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued inventory in transit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued sales tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,343&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31,079&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Remediation Liability</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2018, the Company recognized a liability for a product remediation plan related to one of its legacy systems. This was related to a voluntary action initiated by the Company to replace a component in one of the Company&#8217;s </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">legacy products. The remediation plan consists primarily of replacement of a component in the system. The accrued liability consisted of the estimated cost of materials and labor to replace the component in all units that were under the Company's standard warranty or were covered under the existing extended warranty contracts. The Company recorded a&#160;liability of approximately $5.0 million in 2018.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021 and December&#160;31, 2020, approximately $0.3 million of the total product remediation liability balance was recorded as a component of the Company&#8217;s product warranty and included in accrued liabilities,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $0.7 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $1.2 million, respectively, was separately recorded as extended warranty liability. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2021, the Company recorded $0.1&#160;million and $0.2&#160;million, respectively, of excess reserve related to extended warranty and product warranty. Total costs incurred (including excess reversals) related to product warranty and extended warranty liability during the three and six months&#160;ended June&#160;30, 2021 were $0.1 million and $0.5 million, respectively. Total costs incurred related to product warranty and extended warranty liability during the three and six months ended June&#160;30, 2020 were Nil and $0.3 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736658590088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warranty and Extended Service Contract<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantiesDisclosuresAbstract', window );"><strong>Product Warranties Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyDisclosureTextBlock', window );">Warranty and Extended Service Contract</a></td>
<td class="text">Warranty and Extended Service Contract<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a direct field service organization in North America (including Canada). Internationally, the Company provides direct service support in Australia, Belgium, France, Germany, Hong Kong, Japan, Spain, Switzerland, and the United Kingdom. In several other countries, where the Company does not have a direct presence, the Company provides service through a network of distributors and third-party service providers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis. The Company provides for the estimated cost to repair or replace products under standard warranty at the time of sale. Costs incurred in connection with extended service contracts are recognized at the time when costs are incurred, except for a one-time extended service contracts charge of $3.2 million recorded in the year ended December&#160;31, 2018 related to the cost to replace a component in one of the Company's legacy products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the changes in the product&#160;warranty accrual for the three and six months ended June&#160;30, 2021 and 2020 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020&#160;(1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020&#160;(1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,908&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,401&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Add: Accruals for warranties issued during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,772)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,343)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,854)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,206)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,789&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,155&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,789&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,155&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">The ending product warranty accrual balance excludes 0.6&#160;million and 1.7&#160;million as of June&#160;30, 2021 and 2020, respectively, related to one-time extended service contracts costs to replace components in one of the Company&#8217;s legacy products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $1.8 million and $2.9 million&#160;of settlements made in the three and six months ended June&#160;30, 2021, and $1.3 million and $3.2 million made in the three and six months ended June&#160;30, 2020, respectively, exclude costs&#160;related to extended service contract cost of $0.1 million and $0.3 million in the respective periods, incurred to replace a component in one of the Company's legacy products.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantiesDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantiesDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -URI http://asc.fasb.org/topic&amp;trid=2155896<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736659891720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ContractWithCustomerLiabilityTextBlock', window );">Deferred Revenue</a></td>
<td class="text">Deferred Revenue<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records deferred revenue when revenue is to be recognized subsequent to invoicing. For extended service contracts, the Company generally invoices customers at the beginning of the extended service contract term. The Company&#8217;s extended service contracts typically have <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfMzg0ODI5MDY5ODIyNg_e653e8fe-f332-4582-857d-3372b1518b74">one</span>, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82NC9mcmFnOjJiNTgzYmVlMTdhMDRhZDdhZDI1ZTU5NzNiMDJkNDM2L3RleHRyZWdpb246MmI1ODNiZWUxN2EwNGFkN2FkMjVlNTk3M2IwMmQ0MzZfMzg0ODI5MDY5ODIzOA_506311e3-b01b-41cc-9bc7-3004836d0ad0">two</span> or three year terms. Deferred revenue also includes payments for training and extended marketing support service. Approximately 84% of the Company&#8217;s deferred revenue balance of $11.4 million as of June&#160;30, 2021 will be recognized over the next 12 months.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in the deferred revenue balance for the three and six months ended June&#160;30, 2021 and 2020 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,737&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,969&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Add: Payments received</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,834)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,699)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Revenue included in the beginning balance and recognized as revenue in the current quarter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,923)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,637)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,907)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,869)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,403&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,779&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,403&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,779&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs for extended service contracts were $2.2 million and $4.2 million for the three and six months ended June&#160;30, 2021, respectively, and were $2.3 million and $3.5 million for the three and six months ended June&#160;30, 2020, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ContractWithCustomerLiabilityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of contract with customer liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ContractWithCustomerLiabilityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736658493048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company&#8217;s performance obligations are satisfied either over time or at a point in time. Revenue from performance obligations that are transferred to customers over time accounted for approximately 12% of the Company's total revenue for the three months ended June&#160;30, 2021 and 2020, and 18% of the Company's total revenue for the six months ended June&#160;30, 2021 and 2020. &#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain system sale arrangements that contain multiple products and services. For these bundled sale arrangements, the Company accounts for individual products and services as separate performance obligations if they are distinct. The Company&#8217;s products and services are distinct if a customer can benefit from the product or service on its own or with other resources that are readily available to the customer, and if the Company&#8217;s promise to transfer the products or service to the customer is separately identifiable from other promises in the sale arrangements. The Company&#8217;s system sale arrangements can include all or a combination of the following performance obligations: the system and software license (considered as one performance obligation), system accessories (hand pieces), training, other accessories, extended service contracts, marketing services, and time and materials services.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s system sale arrangements that include an extended service contract, the period of service commences at the expiration of the Company&#8217;s standard warranty offered at the time of the system sale. The Company considers the extended service contracts terms in the arrangements that are legally enforceable to be performance obligations. Other than extended service contracts and marketing services, which are satisfied over time, the Company generally satisfies all performance obligations at a point in time. Systems, system accessories (hand pieces), service contracts, training, and time and materials services are also sold on a stand-alone basis, and these performance obligations are satisfied at a point in time. For contracts with multiple performance obligations, the Company allocates the transaction price of the contract to each performance obligation on a relative standalone selling price basis. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Judgments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of whether two or more contracts entered into at or near the same time with the same customer should be combined and accounted for as one contract may require the use of significant judgment. In making this determination, the Company considers whether the contracts are negotiated as a package with a single commercial objective, have price interdependencies, or promise goods or services that represent a single performance obligation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company&#8217;s purchase agreements do not provide customers with a contractual right of return, the Company maintains a sales allowance to account for potential returns or refunds as a reduction in transaction price at the time of sale. The Company estimates sales returns and other variable consideration based on historical experience.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the standalone selling price ("SSP") for each performance obligation as follows:</span></div><div style="margin-top:10pt;padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Systems: The SSPs for systems are based on directly observable sales in similar circumstances to similar customers.</span></div><div style="margin-top:10pt;padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Extended warranty/Service contracts: SSP is based on observable price when sold on a standalone basis (by customer type).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Products and Services</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Systems</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systems revenue is generated from the sale of systems and from the sale of upgrades to existing systems. A system consists of a console that incorporates a universal graphic user interface, a laser or other energy-based module, control system software and high voltage electronics, as well as one or more hand pieces. In certain applications, the laser or other energy-based module is contained in the hand piece, such as with the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl Fractional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> applications, rather than within the console.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers customers the ability to select the system that best fits their practice at the time of purchase and then to cost-effectively add applications to their system as their practice grows. This provides customers the flexibility to upgrade their systems whenever they choose and provides the Company with a source of additional Systems revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The system or upgrade and the right to use the embedded software represent a single performance obligation as the software license is integral to the functionality of the system or upgrade.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For systems sold directly to end-customers that are credit approved, revenue is recognized when the Company transfers control to the end-customer, which occurs when the product is shipped to the customer or when the customer receives the product, depending on the nature of the arrangement. When collectability is not established in advance of receipt of payment from the customer, revenue is recognized upon the later of the receipt of payment or the satisfaction of the performance obligation. For systems sold through credit approved distributors, revenue is recognized upon shipment to the distributor.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company typically receives payment for its system consoles and other accessories within 30 days of shipment. Certain international distributor arrangements allow for longer payment terms.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skincare products</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells&#160;third-party manufactured skincare products in Japan. The skincare products are purchased from a&#160;third-party manufacturer and sold to medical offices and licensed physicians. The Company warrants that the skincare products are free of significant defects in workmanship and materials for&#160;90 days from shipment. These are typically sold in a separate contract as the only performance obligations. The Company acts as the principal in this arrangement, as the Company determines the price to charge customers for the skincare products and controls the products before they are transferred to the customer. The Company recognizes revenue for skincare products upon shipment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consumables and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accessories</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its customers' purchases of replacement cycles for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as well as replacement hand pieces, Titan and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt 3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces, and single use disposable tips applicable to&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO, Juliet,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as Consumable revenue, which provides the Company with a source of recurring revenue from existing customers. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Juliet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products'&#160;single use disposable tips&#160;must be replaced after every treatment. Sales of these consumable tips further enhance the Company&#8217;s recurring revenue. The Company&#8217;s systems offer multiple hand pieces and applications, which allow customers to upgrade their systems.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equipment leasing</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases equipment to customers through membership programs and receives a fixed monthly fee over the term of the arrangement. The Company classifies its lease income as product revenue. The Company recognizes lease income over the term of the lease if the lease is classified as an operating lease. For agreements that grant customers the right to purchase the leased system, the Company typically classifies the lease as a sales-type lease as the Company has determined it is reasonably certain that the customer will exercise the purchase option. On the commencement of sales-type leases, the Company recognizes revenue upfront in product revenue and the corresponding receivables recorded in other current assets and prepaid expenses on the condensed consolidated balance sheets (See Note&#160;11 - Leases). There was no revenue recognized for sales-type leases for the three and six months ended June&#160;30, 2021 or 2020. Revenue from equipment leases, which was accounted for as operating leases, was&#160;not&#160;material for&#160;the three and six months&#160;ended&#160; June&#160;30, 2021 or 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Extended contract services</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers post-warranty services to its customers through extended service contracts that cover parts and labor for terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODg3OA_37d5a87f-934a-4984-8ce6-ca3dbd45b43b">one</span>, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcwODg5MA_759bd265-f34f-4f56-92c1-11dc5f2a0f73">two</span>, or three years. Service contract revenue is recognized over time, using a time-based measure of progress, as customers benefit from the service throughout the service period. The Company also offers services on a time-and-materials </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">basis for systems and detachable hand piece replacements. Revenue related to services performed on a time-and-materials basis is recognized when performed. These post-warranty services serve as additional sources of recurring revenue from the Company&#8217;s installed product base.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Training</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of systems to customers include training on the use of the system to be provided within 180 days of purchase. The Company considers training a separate performance obligation as customers can immediately benefit from the training together with the customer&#8217;s system. Training is also sold separately from systems. The Company recognizes revenue for training when the training is provided. Training is not required for customers to use the systems.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer Marketing Support</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In North America, the Company offers marketing and consulting phone support to its customers across all system platforms. These customer marketing support services include a practice development model and marketing training, performed remotely with ongoing phone consultations for six months from date of purchase. The Company considers customer marketing support a separate performance obligation, and recognizes revenue over the six-month term of the contracts.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loyalty Program</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has&#160;a customer loyalty program for qualified customers located in the U.S. and Canada. Under the loyalty program, based on their purchasing levels, customers accumulate points that can be redeemed for such rewards as the right to attend the Company&#8217;s advanced training event for&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or a ticket for the Company&#8217;s annual forum. A customer&#8217;s account must be in good standing to receive the benefits of the rewards program. Rewards are earned on a quarterly basis and must be used in the following quarter.&#160;All unused rewards are forfeited. The fair value of the reward earned by loyalty program members is included in accrued liabilities and recorded as a reduction of net revenue at the time the reward is earned. As of June&#160;30, 2021 and December&#160;31, 2020,&#160;the liability for the loyalty program included in accrued liabilities was $0.6 million and $0.3 million, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Sales Commissions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract, which consist primarily of commissions and related payroll taxes, are capitalized and amortized on a straight-line basis over the expected period of benefit, except for costs that are recognized when product is sold. The Company uses the portfolio method to recognize the amortization expense related to these capitalized costs related to initial contracts and such expense is recognized over a period associated with the revenue of the related portfolio, which is generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF82Ny9mcmFnOjY2ZjVlZmM5NDY4YzQ5ZWE5YTEzNzI4Mjg0MjI4ZWNkL3RleHRyZWdpb246NjZmNWVmYzk0NjhjNDllYTlhMTM3MjgyODQyMjhlY2RfMzg0ODI5MDcxMDQxMA_6ae4c934-3ce2-494d-a9ef-e60aa0c8aad9">two</span> to three years.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total capitalized costs as of June&#160;30, 2021 and December&#160;31, 2020 were $3.6 million and $3.4 million, respectively, and are included in Other long-term assets in the Company&#8217;s condensed consolidated balance sheet. Amortization expense for these assets was $0.5 million and $1.0 million during the three and six months ended June&#160;30, 2021, respectively, and was $0.7 million and $1.4 million during the three and six months ended June&#160;30, 2020, respectively. The amortization related to these capitalized costs is included in sales and marketing expense in the Company&#8217;s condensed consolidated&#160;statement of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736659840712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-based Compensation Expense<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stockholders' Equity and Stock-based Compensation Expense</a></td>
<td class="text">Stockholders<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity and Stock-based Compensation Expense</span><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s equity incentive plans are broad-based, long-term programs intended to attract and retain talented employees and align stockholder and employee interests. In June 2019, stockholders approved an amendment and restatement of the Amended and Restated 2004 Equity Incentive Plan as the 2019 Equity Incentive Plan (the &#8220;2019 Plan&#8221;) and approved an additional 700,000 shares, available for future grants (in addition to the 9,701,192 shares provided under the Prior Plan). In June 2021, stockholders approved an additional 450,000 shares for future grants. The 2019 Plan provides for the grant of incentive stock options, non-statutory stock options, RSAs restricted stock units (&#8220;RSUs&#8221;), stock appreciation rights, performance stock units, performance shares, and other stock or cash awards.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company issued 4,085 PSUs to a non-employee director during the three months ended June 30, 2021. The Company&#8217;s Board of Directors granted its executive officers, senior management and certain employees 82,549 and 171,137 performance stock units (&#8220;PSUs&#8221;) during the three and six months&#160;ended June&#160;30, 2021. The PSUs granted in the three and six months ended June&#160;30, 2021 vest subject to continued service and the Company&#8217;s achievement of certain operational goals for the 2021 fiscal year related to product milestones, sales and commercial milestones and certain cost reduction targets.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company issued 29,361 RSUs to its non-employee directors during the three months ended June 30, 2021.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company&#8217;s Board of Directors also granted its executive officers and senior management 73,186 and 129,783 RSUs and 103,466 and </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">172,139 non-qualified stock options (&#8220;NQs&#8221;) during the three and six months&#160;ended June&#160;30, 2021, respectively. The RSUs and NQs vest over four years with one-fourth&#160;vesting&#160;on the first anniversary of the vesting commencement date of January 1, 2021 and 1/36th of the underlying shares vesting each month thereafter.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On September 30, 2019, the Company's Board awarded its new CEO, David H. Mowry, 67,897 shares, which were scheduled to vest over four years from 2019 through 2022 (the 2019 tranche is 15% of the award, or 10,185 PSUs; the 2020 tranche is 25% of the award, or 16,974 PSUs; the 2021 tranche is 30% of the award, or 20,369 PSUs; the 2022 tranche is 30% of the award, or 20,369 PSUs). These PSUs are subject to certain performance-based vesting criteria related to the achievement of financial metrics included in the Board approved annual budgets for the years 2019 through 2022. As of June 30, 2021, the 2019, 2020 and 2021 tranches met the criteria for measurement and recognition.  8,657 shares of the 2019 tranche vested during the three months ended March 31, 2020.  The 2020 tranche did not vest in accordance with the initial terms, however, during the quarter ending June 30, 2021, the Company&#8217;s Board of Directors approved the vesting of Mr. Mowry&#8217;s 2020 PSU tranche. Upon this modification to the vesting terms of the 2020 PSU tranche, the Company recognized $0.5&#160;million of stock-based compensation expense in the quarter ending June 30, 2021.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2019 Plan, the Company issued 92,103 and 214,797 shares of common stock during the three and six months ended June&#160;30, 2021, in conjunction with stock options exercised and the vesting of RSUs and PSUs, net of shares withheld for employee taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021,&#160;the unrecognized compensation cost, net of expected forfeitures, was $2.0 million for stock options, which will be recognized over an estimated weighted-average remaining amortization period of&#160;3.6 years. The unrecognized compensation cost, net of expected forfeitures, for stock awards, including performance-based awards, was $16.1 million, which will be recognized over an estimated weighted-average remaining amortization period of&#160;2.0 years. The actual expense recorded in the future may vary based on a number of factors, including, actual forfeitures experienced and the degree of achievement of the performance goals related to the PSUs granted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the 2019 Plans is summarized as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.456%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Options Outstanding</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shares<br/>Available<br/>for Grant</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of<br/>Stock Options<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average Remaining Term<br/>&#160;(in Years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aggregate Intrinsic Value <br/>(in Millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,085,170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">217,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional shares reserved</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(354,735)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(172,139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">172,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(53,598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock awards canceled / forfeited / expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">212,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options canceled / forfeited / expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16,224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance, June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,237,091&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">319,324&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.14&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.34&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Awards Outstanding</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Awards Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value per Share</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value <br/>(in Millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.96&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awards released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161,199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards canceled / forfeited / expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212,571)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760,722&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.68&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.34&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation Expense</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense&#160;by department recognized during the three and six months ended June&#160;30, 2021 and 2020 was as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,090&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,919&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,095&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,765&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,075&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736659887352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income (Loss) Per Share</a></td>
<td class="text">Net Income (Loss) Per Share<div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021, the Company adopted the accounting standard update to simplify the accounting for convertible debt instruments. The Company now uses the if converted method for its Convertible notes in calculating the diluted net income per share, and includes the effect of potential share settlement for the Convertible notes, if the effect is dilutive. </span></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share (&#8220;EPS&#8221;) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method or the if-converted method. Dilutive potential common shares include outstanding stock options, stock awards, performance stock awards, and conversion shares under the Convertible notes. The diluted EPS is computed with the assumption that the Company will settle the convertible debt in shares, rather than cash.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of June&#160;30, 2021, the Company&#8217;s Convertible notes were potentially convertible into 4,167,232 shares of common stock. The Company used the if converted stock method to calculate the potential dilutive effect of the conversion spread on diluted net income per share, for the three and six  months ended June&#160;30, 2021. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The denominator for diluted net income per share does not include any effect from the capped call transactions the Company entered into concurrently with the issuance of the Convertible notes, as this effect would be anti-dilutive. In the event of conversion of a Convertible note, shares delivered to the Company under the capped call will offset the dilutive effect of the shares that the Company would issue under the Convertible notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the three and six months ended June&#160;30, 2020, basic loss per common share and diluted loss per common share are the same as inclusion of any potentially issuable&#160;shares would be&#160;anti-dilutive.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income (loss) and the weighted average number of </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares used in computing basic and diluted net income (loss) per share (in thousands, except per share data):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) used in calculating net income (loss) per share,  basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11,394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,808)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense on Convertible notes, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of debt issuance cost, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income used in calculating net income per share, diluted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11,394)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23,808)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,055&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dilutive effect of incremental shares and share equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares of common stock outstanding used in computing net income (loss) per share, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,453&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,055&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,855&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,744&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss) per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) per share, basic </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.67)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.51)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following numbers of shares outstanding, prior to the application of the if converted stock method, were excluded from the computation of diluted net income (loss) per common share for the periods presented because including them would have had an anti-dilutive effect (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capped call (1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,367&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,312&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,192&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">The Company entered into capped call transactions with certain financial institutions, which are generally designated to reduce common stock dilution upon conversion of the Convertible notes. The capped call transactions are excluded from the computation of diluted net income (loss) per common share as their effect would be anti-dilutive.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736659865160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended June&#160;30, 2021, the Company's income tax expense was $0.1 million and $0.4 million, respectively, compared to $0.5 million for both three and six months ended June&#160;30, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's income tax expense for the three and six months ended June&#160;30, 2021 is due primarily to income taxes in foreign jurisdictions. The PPP loan forgiveness recognized during the three months ended June&#160;30, 2021 is excluded from taxable income under Section 1106(i) of the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;). The Company continues to maintain a full valuation allowance on its U.S. deferred tax assets.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the U.S. federal government enacted the CARES Act, which changed several of the existing U.S. corporate income tax laws by, among other things, increasing the amount of deductible interest, allowing companies to carry back certain </span></div>Net Operating Losses (&#8220;NOLs&#8221;) and increasing the amount of NOLs that corporations can use to offset income. The CARES Act did not have a material impact on the Company's income tax provision, deferred tax assets and liabilities, and related taxes payable. The Company is currently assessing the future implications of these provisions within the CARES Act on the Company's consolidated financial statements, but does not expect the impact to be material.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736665784376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to certain operating and finance leases for vehicles, office space and storage facilities. The Company&#8217;s operating leases consist of office space, as well as storage facilities and finance leases consist of automobiles. The Company&#8217;s leases generally have remaining terms of&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDkwNw_973afb6b-4acd-4a55-af58-d468b11c7d99"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDkwNw_c98812fc-de92-4bc9-ae63-a2ea2dcf1178">one</span></span>&#160;to&#160;ten years, some of which include options to renew the leases for up to&#160;five years. The Company leases space for operations in the United States, Japan, Belgium, France and Spain. In addition to the above facility leases, the Company also routinely leases automobiles for certain sales and field service employees under finance leases.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract contains a lease at inception. Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments&#160;not&#160;yet paid. Operating lease assets represent the right to use an underlying asset and are based upon the operating lease liabilities adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments&#160;not&#160;yet paid, the Company estimates the incremental secured borrowing rates corresponding to the maturities of the leases. The Company based the rate estimates on prevailing financial market conditions, credit analysis, and management judgment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce the Company&#8217;s right-of-use (&#8220;ROU&#8221;) asset related to the lease. These are amortized through the ROU asset as reductions of expense over the lease term.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.658%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_191ff28f-24ee-4553-9783-0b42ebb65ac6"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_919b7924-791c-4466-b8a7-24aa8118f77b">Property and equipment, net (1)</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total leased assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,521&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,543&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1) Finance lease assets included in Property and equipment, net, in the condensed consolidated balance sheets.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,127&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,210&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_b5e783e0-1851-4646-b5d7-45c5c8303178"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_f32d24a1-2fa6-47cd-9e48-aa722ac2d210">Accrued liabilities (1)</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_10ea67d4-7eb5-4177-82e5-7c042f1357e2"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_88c2e4ea-2944-4622-bbd8-af1b7cb70fc0">Other long-term&#160;liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">611&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1) Finance lease liabilities included in Accrued liabilities in the condensed consolidated balance sheets.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease costs during the&#160;three and six&#160;months ended&#160; June&#160;30, 2021&#160;and&#160;2020 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest for finance lease</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,759&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities during the&#160;six&#160;months ended June&#160;30, 2021 and 2020&#160;was as follows&#160;(in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">leases</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of facility leases were as follows as of June&#160;30, 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026&#160;and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19,953</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17,127</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vehicle Leases</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable&#160;finance leases as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term and discount rate,&#160;as of June&#160;30, 2021, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Term and Discount Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average discount rate</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessor Information related to the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s system leasing</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year ended December&#160;31, 2020, the Company entered into leasing transactions, in which the Company is the lessor, offered through the Company's membership program. The Company's leases for equipment rentals were all accounted for as operating leases during the second and third quarters of 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter ended December&#160;31, 2020, certain&#160;of the membership program agreements were amended, granting the customers the exclusive right and option to purchase the leased system from the Company, at any time during the period of 12 months from signing the amended agreement. For contracts signed under the amended membership agreement,&#160;the Company classified and accounted for the arrangements as sales-type leases as of December&#160;31, 2020, as the Company determined it is reasonably certain that the customer will exercise the purchase option.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the sales-type leases, the net investment of the Company&#8217;s lease receivable is measured at the commencement date and is included in the condensed consolidated balance sheets as a component of other current assets and prepaid expenses. As of December&#160;31, 2020, the Company recorded $0.7 million of revenue for the sales-type leases in the condensed consolidated statement of operations and the related lease receivable in other current assets of the condensed consolidated balance sheet. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no revenue recognized from the sales-type lease arrangement for the three and six months ended June&#160;30, 2021 and 2020, respectively. During the three and six months&#160;ended June&#160;30, 2021, the Company received a full payment of $0.1 million and $0.2 million from a customer who exercised its purchase option. As of June&#160;30, 2021, the lease receivable balance included in other current assets of the condensed consolidated balance sheet was $0.5 million </span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment lease revenue for operating lease agreements is recognized over the life of the lease. The amount of operating lease income included in Product revenue in the accompanying condensed consolidated statements of operations for the three and six months&#160;ended June&#160;30, 2021 was zero and $0.1&#160;million, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to certain operating and finance leases for vehicles, office space and storage facilities. The Company&#8217;s operating leases consist of office space, as well as storage facilities and finance leases consist of automobiles. The Company&#8217;s leases generally have remaining terms of&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDkwNw_973afb6b-4acd-4a55-af58-d468b11c7d99"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDkwNw_c98812fc-de92-4bc9-ae63-a2ea2dcf1178">one</span></span>&#160;to&#160;ten years, some of which include options to renew the leases for up to&#160;five years. The Company leases space for operations in the United States, Japan, Belgium, France and Spain. In addition to the above facility leases, the Company also routinely leases automobiles for certain sales and field service employees under finance leases.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract contains a lease at inception. Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments&#160;not&#160;yet paid. Operating lease assets represent the right to use an underlying asset and are based upon the operating lease liabilities adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments&#160;not&#160;yet paid, the Company estimates the incremental secured borrowing rates corresponding to the maturities of the leases. The Company based the rate estimates on prevailing financial market conditions, credit analysis, and management judgment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce the Company&#8217;s right-of-use (&#8220;ROU&#8221;) asset related to the lease. These are amortized through the ROU asset as reductions of expense over the lease term.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.658%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_191ff28f-24ee-4553-9783-0b42ebb65ac6"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_919b7924-791c-4466-b8a7-24aa8118f77b">Property and equipment, net (1)</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total leased assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,521&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,543&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1) Finance lease assets included in Property and equipment, net, in the condensed consolidated balance sheets.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,127&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,210&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_b5e783e0-1851-4646-b5d7-45c5c8303178"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_f32d24a1-2fa6-47cd-9e48-aa722ac2d210">Accrued liabilities (1)</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_10ea67d4-7eb5-4177-82e5-7c042f1357e2"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_88c2e4ea-2944-4622-bbd8-af1b7cb70fc0">Other long-term&#160;liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">611&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1) Finance lease liabilities included in Accrued liabilities in the condensed consolidated balance sheets.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease costs during the&#160;three and six&#160;months ended&#160; June&#160;30, 2021&#160;and&#160;2020 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest for finance lease</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,759&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities during the&#160;six&#160;months ended June&#160;30, 2021 and 2020&#160;was as follows&#160;(in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">leases</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of facility leases were as follows as of June&#160;30, 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026&#160;and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19,953</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17,127</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vehicle Leases</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable&#160;finance leases as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term and discount rate,&#160;as of June&#160;30, 2021, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Term and Discount Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average discount rate</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessor Information related to the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s system leasing</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year ended December&#160;31, 2020, the Company entered into leasing transactions, in which the Company is the lessor, offered through the Company's membership program. The Company's leases for equipment rentals were all accounted for as operating leases during the second and third quarters of 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter ended December&#160;31, 2020, certain&#160;of the membership program agreements were amended, granting the customers the exclusive right and option to purchase the leased system from the Company, at any time during the period of 12 months from signing the amended agreement. For contracts signed under the amended membership agreement,&#160;the Company classified and accounted for the arrangements as sales-type leases as of December&#160;31, 2020, as the Company determined it is reasonably certain that the customer will exercise the purchase option.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the sales-type leases, the net investment of the Company&#8217;s lease receivable is measured at the commencement date and is included in the condensed consolidated balance sheets as a component of other current assets and prepaid expenses. As of December&#160;31, 2020, the Company recorded $0.7 million of revenue for the sales-type leases in the condensed consolidated statement of operations and the related lease receivable in other current assets of the condensed consolidated balance sheet. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no revenue recognized from the sales-type lease arrangement for the three and six months ended June&#160;30, 2021 and 2020, respectively. During the three and six months&#160;ended June&#160;30, 2021, the Company received a full payment of $0.1 million and $0.2 million from a customer who exercised its purchase option. As of June&#160;30, 2021, the lease receivable balance included in other current assets of the condensed consolidated balance sheet was $0.5 million </span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment lease revenue for operating lease agreements is recognized over the life of the lease. The amount of operating lease income included in Product revenue in the accompanying condensed consolidated statements of operations for the three and six months&#160;ended June&#160;30, 2021 was zero and $0.1&#160;million, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to certain operating and finance leases for vehicles, office space and storage facilities. The Company&#8217;s operating leases consist of office space, as well as storage facilities and finance leases consist of automobiles. The Company&#8217;s leases generally have remaining terms of&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDkwNw_973afb6b-4acd-4a55-af58-d468b11c7d99"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RleHRyZWdpb246Y2M2N2FjYjQ3ZTBjNGIxMThhYTNiYjEwNGU3YTAyNTJfMjE5OTAyMzI2MDkwNw_c98812fc-de92-4bc9-ae63-a2ea2dcf1178">one</span></span>&#160;to&#160;ten years, some of which include options to renew the leases for up to&#160;five years. The Company leases space for operations in the United States, Japan, Belgium, France and Spain. In addition to the above facility leases, the Company also routinely leases automobiles for certain sales and field service employees under finance leases.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract contains a lease at inception. Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments&#160;not&#160;yet paid. Operating lease assets represent the right to use an underlying asset and are based upon the operating lease liabilities adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments&#160;not&#160;yet paid, the Company estimates the incremental secured borrowing rates corresponding to the maturities of the leases. The Company based the rate estimates on prevailing financial market conditions, credit analysis, and management judgment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce the Company&#8217;s right-of-use (&#8220;ROU&#8221;) asset related to the lease. These are amortized through the ROU asset as reductions of expense over the lease term.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.658%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_191ff28f-24ee-4553-9783-0b42ebb65ac6"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_919b7924-791c-4466-b8a7-24aa8118f77b">Property and equipment, net (1)</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total leased assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,521&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,543&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1) Finance lease assets included in Property and equipment, net, in the condensed consolidated balance sheets.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,127&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,210&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_b5e783e0-1851-4646-b5d7-45c5c8303178"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_f32d24a1-2fa6-47cd-9e48-aa722ac2d210">Accrued liabilities (1)</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_10ea67d4-7eb5-4177-82e5-7c042f1357e2"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_88c2e4ea-2944-4622-bbd8-af1b7cb70fc0">Other long-term&#160;liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">611&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1) Finance lease liabilities included in Accrued liabilities in the condensed consolidated balance sheets.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease costs during the&#160;three and six&#160;months ended&#160; June&#160;30, 2021&#160;and&#160;2020 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest for finance lease</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,759&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities during the&#160;six&#160;months ended June&#160;30, 2021 and 2020&#160;was as follows&#160;(in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">leases</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of facility leases were as follows as of June&#160;30, 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026&#160;and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19,953</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17,127</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vehicle Leases</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable&#160;finance leases as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term and discount rate,&#160;as of June&#160;30, 2021, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Term and Discount Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average discount rate</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessor Information related to the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s system leasing</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year ended December&#160;31, 2020, the Company entered into leasing transactions, in which the Company is the lessor, offered through the Company's membership program. The Company's leases for equipment rentals were all accounted for as operating leases during the second and third quarters of 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter ended December&#160;31, 2020, certain&#160;of the membership program agreements were amended, granting the customers the exclusive right and option to purchase the leased system from the Company, at any time during the period of 12 months from signing the amended agreement. For contracts signed under the amended membership agreement,&#160;the Company classified and accounted for the arrangements as sales-type leases as of December&#160;31, 2020, as the Company determined it is reasonably certain that the customer will exercise the purchase option.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the sales-type leases, the net investment of the Company&#8217;s lease receivable is measured at the commencement date and is included in the condensed consolidated balance sheets as a component of other current assets and prepaid expenses. As of December&#160;31, 2020, the Company recorded $0.7 million of revenue for the sales-type leases in the condensed consolidated statement of operations and the related lease receivable in other current assets of the condensed consolidated balance sheet. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no revenue recognized from the sales-type lease arrangement for the three and six months ended June&#160;30, 2021 and 2020, respectively. During the three and six months&#160;ended June&#160;30, 2021, the Company received a full payment of $0.1 million and $0.2 million from a customer who exercised its purchase option. As of June&#160;30, 2021, the lease receivable balance included in other current assets of the condensed consolidated balance sheet was $0.5 million </span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment lease revenue for operating lease agreements is recognized over the life of the lease. The amount of operating lease income included in Product revenue in the accompanying condensed consolidated statements of operations for the three and six months&#160;ended June&#160;30, 2021 was zero and $0.1&#160;million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessor's operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph Note 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph Note 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLessorDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736659846824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies</a></td>
<td class="text">Contingencies<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named from time to time as a party to other legal proceedings, product liability, commercial disputes, employee disputes, and contractual lawsuits in the normal course of business. A liability and related charge are recorded to earnings in the Company&#8217;s consolidated financial statements for legal contingencies when the loss is considered probable and the amount can be reasonably estimated. The assessment is re-evaluated each accounting period and is based on all available information, including discussion with outside legal counsel. If a reasonable estimate of a known or probable loss cannot be made, but a range of probable losses can be estimated, the low-end of the range of losses is recognized if no amount within the range is a better estimate than any other. If a material loss is reasonably possible, but not probable and can be reasonably estimated, the estimated loss or range of loss is disclosed in the notes to the consolidated financial statements. The Company expenses legal fees as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">InMode Ltd. filed a complaint with the United States International Trade Commission alleging that Ilooda, Co., Ltd&#8217;s Secret RF fractional radiofrequency microneedling system, distributed in the United States by the Company, infringes U.S. Patent&#160;No.&#160;10,799,285&#160;("285&#160;patent"). The Company&#160;intends to vigorously defend against this lawsuit and, based on a preliminary investigation, believes that the Company has a&#160;strong defense and that the&#160;patent claim at issue is likely invalid in view of prior art. Based on the current information available to the Company, it&#160;believes that any possible loss will&#160;not&#160;be material.&#160;If, following a successful&#160;third-party action for infringement, the Company cannot obtain a license for the Company&#8217;s products, it&#160; may&#160;have to stop selling the applicable products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021 and&#160;December&#160;31, 2020, the Company had accrued $0.9 million and $0.4 million, respectively, related to various pending commercial and product liability lawsuits. The Company does not believe that a material loss in excess of accrued amounts is reasonably likely.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736659798504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible notes, net of unamortized debt issuance costs</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Company issued $138.3 million aggregate principal amount of convertible senior notes&#160;due on March 15, 2026 in a private placement offering. The Convertible notes bear interest at a rate of 2.25% per year payable semiannually in arrears on March 15 and September 15 of each year, beginning on September 15, 2021. Upon conversion, the Convertible notes will be convertible into cash, shares of the Company&#8217;s common stock or a combination thereof, at the Company&#8217;s election. The Convertible notes are presented as Convertible notes, net of unamortized debt issuance costs, on the condensed consolidated balance sheet.&#160;Proceeds from the offering were $133.6 million, net of issuance costs, including initial purchasers fees.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Initially, each $1,000 principal amount of Notes was convertible into 30.1427 shares of the Company&#8217;s common stock at a conversion price of $33.18 per share. The conversion rate for the Convertible notes is subject to adjustment for certain events as set forth in the Indenture governing the Convertible notes. The Convertible notes will mature on March 15, 2026, unless earlier converted, redeemed, or repurchased in accordance with the terms of the Convertible notes. No sinking fund is provided for the Notes. As of June&#160;30, 2021, the net carrying amount of the Company&#8217;s Convertible notes was 133.9&#160;million and the unamortized debt issuance costs were&#160;$4.4 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their Notes at their option prior to the close of business on the business day immediately preceding December 15, 2025, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-top:10pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During any fiscal quarter commencing after the fiscal quarter ending on June 30, 2021 (and only during such fiscal quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to 130% of the conversion price for the Convertible notes on each applicable trading day;</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the five-business day period after any five consecutive trading day period (the &#8220;measurement period&#8221;) in which the &#8220;trading price&#8221;&#160;per $1,000 principal amount of Convertible notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company's&#160;common stock and the conversion rate on each such trading day;</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company calls such Convertible notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Upon the occurrence of specified corporate events.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after December 15, 2025, and until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The circumstances described in the first bullet of the paragraph above were met during the second quarter of 2021 as the Company's stock traded at a price in excess of the conversion price, and as a result, the Notes are convertible at the option of the holder from July 1, 2021 until September 30, 2021.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Upon any conversion of the Convertible notes, the Company would be required to pay or deliver, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#8217;s election with respect to such conversion. To the extent there are any conversions during the period from July 1, 2021 until September 30, 2021, the Company intends to settle such conversions in shares of common stock, therefore, as of June&#160;30, 2021, the Convertible notes have been included as Long-term debt on its condensed consolidated balance sheet.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may not redeem the Convertible notes prior to March 20, 2024. On or after March 20, 2024, the Company may redeem for cash all or any portion of the Notes, at the Company&#8217;s option, if the last reported sale price of the Company&#8217;s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem fewer than all of the outstanding Notes, at least $50.0 million aggregate principal amount of Notes must be outstanding and not subject to redemption as of the relevant redemption notice date.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a fundamental change occurs, note holders have the option to require the Company to repurchase any portion or all of their Convertible notes in $1,000 principal increments for cash. The price for such repurchase is calculated as 100% of the principal amounts of Notes, plus accrued and unpaid interest to the day immediately preceding the Fundamental Change repurchase date. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, holders of the Notes who convert in connection with a fundamental change are, under certain circumstances, entitled to an increase in conversion rate.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Convertible notes are general senior unsecured obligations that rank senior to any of the Company&#8217;s indebtedness that is explicitly subordinated to the Notes. The Notes have equal rank in right of payment with all existing and future unsecured indebtedness that is not subordinated to the Notes. The Notes will be junior to any of the Company&#8217;s secured indebtedness to the extent of the value of the assets securing such indebtedness. The Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Convertible notes was approximately $226.4 million as of June&#160;30, 2021, which the Company&#160;determined through consideration of market prices. The fair value measurement is classified as Level 2, as defined in Note 3.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents outstanding principal amount and carrying value of the Convertible notes (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding principal amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Carrying Value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133,800&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with issuance of the Convertible notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally intended to reduce the potential dilution of the Company's&#160;common stock upon any conversion or settlement of the Notes or to offset any cash payment the Company is required to make in excess of the principal amount upon conversion of the Notes, as the case may be, with such reduction or offset subject to a cap based on the cap price. If the market price per share of the Company&#8217;s common stock exceeds the cap price of the capped calls transaction, then the Company&#8217;s stock would experience some dilution and/or the capped call would not fully offset the potential cash payments, in each case to the extent the then-market price per share of its common stock exceeds the cap price. Under the capped call transactions, the Company purchased from the option counterparties capped call options that in the aggregate relate to the total number of shares of the Company's common stock underlying the Convertible notes, with a strike price equal to the conversion price of the Convertible notes and with an initial cap price equal to $45.5350, which represents a 75% premium over the last reported sale price of the Company's common stock of $26.02 per share on March&#160;4, 2021, with certain adjustments to the settlement terms that reflect standard anti-dilution provisions. The capped call transactions expire over 40 consecutive scheduled trading days ended on March 12, 2026. The capped calls were purchased for $16.1 million. The Company evaluated the capped call transaction under authoritative accounting guidance and determined that it should be accounted for as a separate transaction and classified as a net reduction to Additional paid-in capital within stockholders&#8217; equity with no recurring fair value measurement recorded.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company early adopted ASU 2020-6, Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40). In accordance with Subtopic 470-20 and 815-40, as revised by ASU 2020-6, the Company records the Convertible notes in long-term debt with no separation between the Notes and the conversion option. Each reporting period, the Company will determine whether any criteria is met for the note holders to have the option to redeem the Notes early, which could&#160;result in a change in the classification of the Notes to current liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Debt Issuance Cost</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance costs related to the Convertible notes are presented in the condensed consolidated balance sheet as a direct deduction from the carrying amount of the Convertible notes. During the six months ended June&#160;30, 2021, the Company incurred direct costs associated with the issuance of Convertible notes of $4.7 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance costs are&#160;amortized using&#160;an effective interest method basis over the term of the Convertible notes and accordingly the Company recorded approximately&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.2 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $0.3 million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of amortization of debt issuance costs during the three and six months ended June&#160;30, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective interest rate on the Convertible notes is 2.97%. Interest expense for the three and six months ended June&#160;30, 2021 totaled approximately $1.0 million and $1.2 million, respectively, of which $0.8 million and $1.0 million, respectively, relate to accruing the semiannual interest payment with the remaining balance relating to the&#160;amortization of debt issuance costs.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loan and Security Agreement</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;30, 2018, the Company and Wells Fargo Bank, N.A. (&#8220;Wells Fargo&#8221;) entered into a Loan and Security Agreement (the &#8220;Wells Fargo Revolving Line of Credit&#8221;) in the original principal amount of $25.0 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;9, 2020, the Company terminated its undrawn revolving line of credit with Wells Fargo and subsequently entered into a Loan and Security Agreement with Silicon Valley Bank for a four-year secured revolving loan facility (&#8220;SVB Revolving Line of Credit&#8221;) in an aggregate principal amount of up to $30.0 million. The SVB Revolving Line of Credit matures on July 9, 2024.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to draw on the full amount of the SVB Revolving Line of Credit, the Company must satisfy certain liquidity ratios. If the Company is unable to meet these liquidity ratios, then availability under the revolving line is calculated as 80% of the Company&#8217;s qualifying accounts receivable. The proceeds of the revolving loans may be used for general corporate purposes. The Company&#8217;s obligations under the Loan and Security Agreement with Silicon Valley Bank are secured by substantially all of the assets of the Company. Interest on principal amount outstanding under the revolving line shall accrue at a floating per annum rate equal to the greater of either 1.75% above the Prime Rate or five percent (5.0%). The Company paid a non-refundable revolving line commitment fee of $0.3 million, on the effective date of the Loan and Security Agreement with Silicon Valley Bank of July&#160;9, 2020, and the Company is required to pay an anniversary fee of $0.3 million on each twelve-month anniversary of the effective date of the Loan and Security Agreement.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan and Security Agreement with Silicon Valley Bank contains customary affirmative covenants, such as financial statement reporting requirements and delivery of borrowing base certificates, as well as customary covenants that restrict the Company&#8217;s ability to, among other things, incur additional indebtedness, sell certain assets, guarantee obligations of third parties, declare dividends, or make certain distributions, and undergo a merger or consolidation or certain other transactions. The Loan and Security Agreement also contains certain financial covenants, including maintaining a quarterly minimum revenue of $90.0&#160;million, determined in accordance with GAAP on a trailing twelve-month basis. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;4, 2021, the Loan and Security Agreement dated July&#160;9, 2020 was amended to (i)&#160;permit the Company to issue the Convertible notes and perform its obligations in connection therewith, and (ii)&#160;permit the Capped Call transactions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company had not drawn on the SVB Revolving Line of Credit and the Company is in compliance with all financial covenants of the SVB Revolving Line of Credit.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Paycheck Protection Program (PPP) Loan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;22, 2020, the Company received loan proceeds of $7.1 million pursuant to the Paycheck Protection Program (the &#8220;PPP&#8221;) under the CARES Act. The loan, which is in the form of a promissory note dated April 21, 2020, between the Company and Silicon Valley Bank as the lender, matures on April 21, 2022 and bears interest at a fixed rate of 1.00% per annum, payable monthly commencing September 2021. There is no prepayment penalty. Under the terms of the PPP, all or a portion of the principal may be forgiven if the loan proceeds are used for qualifying expenses as described in the CARES Act, such as payroll costs, benefits, rent, and utilities. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PPP loan and related accrued interest were forgiven under the provisions of the CARES Act, and the $7.2&#160;million gain on forgiveness of PPP loan was recorded as Gain on extinguishment of PPP loan in the condensed consolidated statement of operations for the three and six months ended June&#160;30, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736748063960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment reportingSegment reporting is based on the &#8220;management approach,&#8221; following the method that management organizes the Company&#8217;s reportable segments for which separate financial information is made available to, and evaluated regularly by, the chief operating decision maker in allocating resources and in assessing performance. The Company&#8217;s chief operating decision makers ("CODM") are its Chief Executive Officer ("CEO") and Chief Financial Officer (&#8220;CFO&#8221;), who make decisions on allocating resources and in assessing performance. The CEO and CFO review the Company's consolidated results as&#160;one&#160;operating segment. In making operating decisions, the CODM primarily considers consolidated financial information, accompanied by disaggregated information about revenues by geography and product. All of the Company&#8217;s principal operations and decision-making functions are located in the U.S. The Company&#8217;s CODM view its operations, manages its business, and uses&#160;one&#160;measurement of profitability for the&#160;one&#160;operating segment - which sells aesthetic medical equipment and services, and distributes skincare products, to qualified medical practitioners. Substantially all of the Company&#8217;s long-lived assets are located in the U.S.<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of revenue by geography for the three and six months June&#160;30, 2021 and 2020 (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.185%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue mix by geography:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asia, excluding Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rest of the  World, other than United States, Asia and Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total consolidated revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue mix by product category:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skincare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total product revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,745&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,363&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,136&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,624&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total consolidated revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58,589&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,369&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,257&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,608&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736658263992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Description of Operations and Principles of Consolidation</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Operations and Principles of Consolidation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cutera, Inc. (&#8220;Cutera&#8221; or the &#8220;Company&#8221;) provides energy-based aesthetic systems for practitioners worldwide. The Company develops, manufactures, distributes, and markets energy-based product platforms for use by physicians and other qualified practitioners, enabling them to offer safe and effective aesthetic treatments to their customers. The Company currently markets the following system platforms: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten, excel, Secret PRO, Juliet, Secret RF,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Several of the Company&#8217;s systems offer multiple hand pieces and applications, providing customers the flexibility to upgrade their systems. The sales of (i) systems, system upgrades, and hand pieces (collectively &#8220;Systems&#8221; revenue); (ii) replacement hand pieces, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan, truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">D,truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cycle refills, as well as single use disposable tips applicable to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO, Juliet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;Consumables&#8221; revenue); (iii) the distribution of third party manufactured skincare products (&#8220;Skincare&#8221; revenue); and (iv) the leasing of equipment through a membership program; are collectively classified as &#8220;Products&#8221; revenue. In addition to Products revenue, the Company generates revenue from the sale of post-warranty service contracts, parts, detachable hand piece replacements (except for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan, truSculpt 3D, truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and service labor for the repair and maintenance of products that are out of warranty, all of which are collectively classified as &#8220;Service&#8221; revenue.</span></div>The Company&#8217;s corporate headquarters and U.S. operations are located in Brisbane, California, where the Company conducts manufacturing, warehousing, research and development, regulatory, sales and marketing, service, and administrative activities. The Company also maintains regional distribution centers (&#8220;RDCs&#8221;) in select locations across the U.S. These RDCs serve as forward warehousing for systems and service parts in various geographies. The Company markets, sells and services its products through its sales and service employees in North America (including Canada), Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, Spain, Switzerland, and the United Kingdom. Sales and services outside of these direct markets are made through a worldwide distributor network in over 42 countries. The condensed consolidated financial statements include the accounts of the Company and its subsidiaries.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_BasisOfPresentationPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements included in this report reflect all adjustments necessary for a fair statement of its condensed consolidated statements of financial position as of June&#160;30, 2021 and December&#160;31, 2020, and its condensed consolidated statements of results of operations, comprehensive income (loss), changes in equity, and cash flows for the three and six months ended June&#160;30, 2021, and 2020. The December&#160;31, 2020 condensed consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;). The results for interim periods are not necessarily indicative of results for the entire year or any other interim period.&#160;Presentation of certain prior year balances have been updated to conform with current year presentation. All significant intercompany accounts and transactions have been eliminated upon consolidation. The accompanying condensed consolidated financial statements should be read in conjunction with the Company&#8217;s previously filed audited financial statements and the related notes thereto included in the Company&#8217;s annual report on Form 10-K for the year ended December&#160;31, 2020 filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 23, 2021.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock', window );">Risks and Uncertainties</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's future results of operations involve a number of risks and uncertainties. Factors that could affect the Company's future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company's products, stability of global financial markets, cybersecurity breaches and other disruptions that could compromise the Company&#8217;s information or results, business disruptions that are caused by natural disasters or pandemic events, management of international activities, competition from substitute products and larger companies, ability to obtain and maintain regulatory approvals, government regulations and oversight, patent and other types of litigation, ability to protect proprietary technology from counterfeit versions of the Company's products, strategic relationships and dependence on key individuals.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020,&#160;the World Health Organization declared the COVID-19&#160;outbreak a pandemic. The COVID-19&#160;outbreak has negatively affected the United States and global economies. Though the economy is gradually recovering as of the second quarter of 2021, the timing and extent of a full global economic recovery is still uncertain. The spread of the coronavirus and the Delta variant in particular, has impacted the global economy broadly in 2020, including restrictions on travel, shifting work </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">forces to work remotely and quarantine policies put into place by businesses and governments, had a material economic effect on the Company&#8217;s business during the year ended December&#160;31, 2020 and in the six months ended June&#160;30, 2021. Healthcare facilities in many countries effectively banned elective procedures and this had a significant impact on the Company. Many of the Company&#8217;s products are used in aesthetic elective procedures and as such, the bans on elective procedures substantially reduced the Company&#8217;s sales and marketing efforts in the early months of the pandemic and led the Company to implement cost control measures. Although the Company&#8217;s revenues and profits have&#160;improved compared to the first half of fiscal 2020 and the overall economic outlook has also improved in 2021, the&#160;COVID-19&#160;outbreak continues to be fluid especially in light of the Delta variant, and the long-term impact on the Company's business due to COVID-19 is still uncertain. The Company&#160;cannot presently predict the scope and severity of any impacts in future periods from business shutdowns or disruptions due to the&#160;COVID-19&#160;pandemic, but the impact on economic activity including the possibility of recession or financial market instability could have a material adverse effect on the Company&#8217;s business, revenue, operating results, cash flows and financial condition. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to assess whether any impairment of its goodwill or its long-lived assets has occurred and has determined that no&#160;charges, other than an impairment loss of $0.2 million on capitalized implementation costs of&#160;cloud-based customer relationship management (&#8220;CRM&#8221;) software occurred were necessary during the six months&#160;ended June&#160;30, 2021.&#160;The Company will continue to monitor future conditions important to its assessment of potential impairment of its long-lived assets and goodwill, including the impacts of the&#160;COVID&#8211;19&#160;pandemic and other ongoing impacts which are subject to uncertainty.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has experienced a significant increase in sales of skincare products under the exclusive distribution agreement with ZO Skin Health, Inc. (&#8220;ZO&#8221;), which allows&#160;the Company to sell ZO&#8217;s skincare products in Japan. The reason for the increase in skincare products sales may have been the&#160;result of changes in customers&#8217; spending habits as customers purchased more aesthetic treatments that were able to be applied at home, due to limitations on&#160;in-person&#160;aesthetic procedures, social distancing and mask wearing requirements due to the&#160;COVID-19&#160;pandemic. Future growth in sales of skincare products depends on customers&#8217; spending habits, which may revert to original spending habits after the&#160;COVID-19&#160;pandemic. Such changes may have a material adverse effect on the Company&#8217;s revenue, operating results, and cash flows.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Accounting Policies</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Policies</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements are prepared in accordance with the rules and regulations of the SEC applicable to interim financial statements. While these statements reflect all normal recurring adjustments that are, in the opinion of management, necessary for fair presentation of the results of the interim period, they do not include all of the information and footnotes required by GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the financial statement disclosures in its annual report on Form 10-K for the year ended December&#160;31, 2020 filed with the SEC on March 23, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the same accounting policies in preparing quarterly and annual financial statements. Unless otherwise noted, amounts presented within the notes to condensed consolidated financial statements refer to the Company&#8217;s continuing operations. Note 13 provides information about the Company&#8217;s adoption of the new accounting standard for debt with conversion and other options, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued $138.3 million of convertible senior notes ("Notes" or "Convertible notes") in a private placement offering on March&#160;5, 2021. The Convertible notes bear interest at a rate of 2.25% per year. In accordance with Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020-6,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contracts in Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">s Own Equity (Subtopic 815-40),</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company recorded the Convertible&#160;notes as long-term debt with no separation between the Convertible notes and the conversion option. Each reporting period, the Company will determine whether any criteria is met for the note holders to have the option to redeem the Convertible notes early, which will result in a change in the classification of the Convertible notes to current liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The circumstances described in the paragraph above were met during the second quarter of 2021 as the Company's stock traded at a price in excess of the conversion price, and as a result, the Notes are convertible at the option of the holder from July 1, 2021 until September 30, 2021. Upon any conversion of the Convertible notes, the Company would be required to pay or deliver, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#8217;s election. To the extent there are any conversions during the period from July 1, 2021 until September 30, 2021, the Company intends to settle such conversions by issuing shares of common stock; therefore, as of June&#160;30, 2021, the Convertible notes have been included as long term liability on the condensed consolidated balance sheet.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs associated with issuance of the Convertible notes, including underwriters&#8217; fees, are presented in the condensed consolidated balance sheet as a direct deduction from the carrying amount of the Convertible notes. The debt issuance costs are being amortized over the life of the Convertible notes as additional non-cash interest expense.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with issuance of the Convertible notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally designated to reduce the potential dilution of the Company's&#160;common stock upon any conversion of the Notes. The capped calls were purchased for $16.1 million and recorded as a reduction to additional paid in capital in the condensed consolidated balance sheet as of June&#160;30, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalized cloud computing systems implementation costs of $0.6&#160;million during the three months ending June 30, 2021. These costs relate to an on-going implementation of a new Enterprise Resource Planning system and are included in Other long-term assets and Other current assets and prepaid expenses on the condensed consolidated balance sheet.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commission, allowance for credit losses, sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, implicit and incremental borrowing rates related to the Company&#8217;s leases, variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, assumptions used in operating and sales-type lease classification, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, residual value of leased equipment, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronoucements</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">No.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)-Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to remove certain exceptions and improve consistency of application, including, among other things, requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. The Company adopted this guidance in the three and six months&#160;ended June&#160;30, 2021. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated financial position and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the&#160;FASB&#160;issued ASU No. 2020-6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt &#8211; Debt with Conversion and Other Options (Topic 470) and Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Topic 815), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to simplify the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the amendment, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#8217;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the computation of diluted earnings per share. The Company early adopted the guidance on a prospective basis effective January 1, 2021. See Note 13 &#8211; Debt.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_BasisOfPresentationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basis of Presentation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_BasisOfPresentationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for risks and uncertainties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_RisksAndUncertaintiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736658441016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash, Cash Equivalents (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Summary of Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's cash and&#160;cash equivalents (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">169,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736740615560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021 and December&#160;31, 2020, inventories consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,862&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,591&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28,508&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021 and December&#160;31, 2020, accrued liabilities consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued payroll and related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,427&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,197&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued inventory in transit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued sales tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,343&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31,079&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736665399080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warranty and Extended Service Contract (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantiesDisclosuresAbstract', window );"><strong>Product Warranties Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Product Warranty Liability Accrual</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the changes in the product&#160;warranty accrual for the three and six months ended June&#160;30, 2021 and 2020 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020&#160;(1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020&#160;(1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,908&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,401&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Add: Accruals for warranties issued during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,772)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,343)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,854)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,206)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,789&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,155&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,789&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,155&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">The ending product warranty accrual balance excludes 0.6&#160;million and 1.7&#160;million as of June&#160;30, 2021 and 2020, respectively, related to one-time extended service contracts costs to replace components in one of the Company&#8217;s legacy products.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantiesDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantiesDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736659847656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Summary of Deferred Service Contract Revenue</a></td>
<td class="text">The following table provides changes in the deferred revenue balance for the three and six months ended June&#160;30, 2021 and 2020 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,737&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,969&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Add: Payments received</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,834)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,699)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Revenue included in the beginning balance and recognized as revenue in the current quarter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,923)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,637)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,907)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,869)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,403&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,779&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,403&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,779&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736740536568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-based Compensation Expense (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Activity under the 2019 Plan</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the 2019 Plans is summarized as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.456%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Options Outstanding</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shares<br/>Available<br/>for Grant</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of<br/>Stock Options<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average Remaining Term<br/>&#160;(in Years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aggregate Intrinsic Value <br/>(in Millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,085,170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">217,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional shares reserved</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(354,735)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(172,139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">172,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(53,598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock awards canceled / forfeited / expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">212,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options canceled / forfeited / expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16,224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance, June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,237,091&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">319,324&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.14&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.34&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Awards Outstanding</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Awards Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value per Share</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value <br/>(in Millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.96&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awards released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161,199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards canceled / forfeited / expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212,571)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760,722&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.68&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.34&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Stock-based Compensation Expense</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense&#160;by department recognized during the three and six months ended June&#160;30, 2021 and 2020 was as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,090&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,919&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,095&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,765&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,075&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736740257992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Basic and Diluted Net Income (Loss)</a></td>
<td class="text">The following table sets forth the computation of basic and diluted net income (loss) and the weighted average number of <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares used in computing basic and diluted net income (loss) per share (in thousands, except per share data):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) used in calculating net income (loss) per share,  basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11,394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,808)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense on Convertible notes, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of debt issuance cost, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income used in calculating net income per share, diluted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11,394)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23,808)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,055&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dilutive effect of incremental shares and share equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares of common stock outstanding used in computing net income (loss) per share, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,453&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,055&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,855&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,744&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss) per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) per share, basic </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.67)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.51)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following numbers of shares outstanding, prior to the application of the if converted stock method, were excluded from the computation of diluted net income (loss) per common share for the periods presented because including them would have had an anti-dilutive effect (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capped call (1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,367&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,312&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,192&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">The Company entered into capped call transactions with certain financial institutions, which are generally designated to reduce common stock dilution upon conversion of the Convertible notes. The capped call transactions are excluded from the computation of diluted net income (loss) per common share as their effect would be anti-dilutive.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736660364008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Supplemental Balance Sheet Information</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.658%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_191ff28f-24ee-4553-9783-0b42ebb65ac6"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjA5MzZhY2NhMmUyNjRhZWE4ZjE5MzZmOTgwZTFiYTk0L3RhYmxlcmFuZ2U6MDkzNmFjY2EyZTI2NGFlYThmMTkzNmY5ODBlMWJhOTRfMy0xLTEtMS0yOTA5_919b7924-791c-4466-b8a7-24aa8118f77b">Property and equipment, net (1)</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total leased assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,521&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,543&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1) Finance lease assets included in Property and equipment, net, in the condensed consolidated balance sheets.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,127&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,210&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_b5e783e0-1851-4646-b5d7-45c5c8303178"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfNy0xLTEtMS0yOTIw_f32d24a1-2fa6-47cd-9e48-aa722ac2d210">Accrued liabilities (1)</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_10ea67d4-7eb5-4177-82e5-7c042f1357e2"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ODk2MjY4NTk4MDQ1ZjBiYzU1YzlkMDU2Mzc3NDIwL3NlYzpiNDg5NjI2ODU5ODA0NWYwYmM1NWM5ZDA1NjM3NzQyMF84OC9mcmFnOmNjNjdhY2I0N2UwYzRiMTE4YWEzYmIxMDRlN2EwMjUyL3RhYmxlOjlmYmM1OGNiY2RhNDRhNzg5NDc5Y2YyNTQ0Njg1MmIyL3RhYmxlcmFuZ2U6OWZiYzU4Y2JjZGE0NGE3ODk0NzljZjI1NDQ2ODUyYjJfOC0xLTEtMS0yOTI1_88c2e4ea-2944-4622-bbd8-af1b7cb70fc0">Other long-term&#160;liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">611&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1) Finance lease liabilities included in Accrued liabilities in the condensed consolidated balance sheets.</span></div>Weighted-average remaining lease term and discount rate,&#160;as of June&#160;30, 2021, were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Term and Discount Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average discount rate</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Summary of Lease Costs</a></td>
<td class="text">Lease costs during the&#160;three and six&#160;months ended&#160; June&#160;30, 2021&#160;and&#160;2020 (in thousands):<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest for finance lease</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,759&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities during the&#160;six&#160;months ended June&#160;30, 2021 and 2020&#160;was as follows&#160;(in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flow</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Summary of Maturities of Facility Leases</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of facility leases were as follows as of June&#160;30, 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026&#160;and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19,953</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17,127</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Summary of Minimum Finance Lease Payments</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable&#160;finance leases as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736659682120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Summary of Convertible Notes</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents outstanding principal amount and carrying value of the Convertible notes (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding principal amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Carrying Value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133,800&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of borrowings which can be exchanged for a specified number of another security at the option of the issuer or the holder. Disclosures include, but are not limited to, principal amount, amortized premium or discount, and amount of liability and equity components.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736658382168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock', window );">Summary of Revenue by Geography</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of revenue by geography for the three and six months June&#160;30, 2021 and 2020 (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.185%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue mix by geography:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asia, excluding Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rest of the  World, other than United States, Asia and Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total consolidated revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue mix by product category:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skincare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total product revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,745&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,363&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,136&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,624&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total consolidated revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58,589&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,369&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,257&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,608&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736740515544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 05, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>country</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>country</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork', window );">Number of countries in which entity utilizes a distributor network | country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of Convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 138,250<span></span>
</td>
<td class="nump">$ 7,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAdditions', window );">Capitalized cloud computing systems implementation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member', window );">Convertible Senior Notes Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_CappedCallTransactionsCosts', window );">Capped call transactions costs</a></td>
<td class="nump">$ 16,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes | Convertible Senior Notes Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of Convertible notes</a></td>
<td class="nump">$ 138,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_CappedCallTransactionsCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of costs associated with capped call transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_CappedCallTransactionsCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Countries In Which Entity Utilizes A Distributor Network</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additions made to capitalized computer software costs during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736665338408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash, Cash Equivalents - Summary of Cash and Cash Equivalents (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 169,200<span></span>
</td>
<td class="nump">$ 47,047<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736740550968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash, Cash Equivalents - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736660345176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 15,862<span></span>
</td>
<td class="nump">$ 14,874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">1,145<span></span>
</td>
<td class="nump">1,030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">17,584<span></span>
</td>
<td class="nump">12,604<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 34,591<span></span>
</td>
<td class="nump">$ 28,508<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736665985144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued payroll and related expenses</a></td>
<td class="nump">$ 16,427<span></span>
</td>
<td class="nump">$ 12,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_SalesAndMarketingAccrualsCurrent', window );">Sales and marketing accruals</a></td>
<td class="nump">3,124<span></span>
</td>
<td class="nump">2,352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_AccruedInventoryInTransitCurrent', window );">Accrued inventory in transit</a></td>
<td class="nump">4,469<span></span>
</td>
<td class="nump">2,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent', window );">Product warranty</a></td>
<td class="nump">3,789<span></span>
</td>
<td class="nump">2,908<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Accrued sales tax</a></td>
<td class="nump">5,439<span></span>
</td>
<td class="nump">5,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">8,095<span></span>
</td>
<td class="nump">5,803<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 41,343<span></span>
</td>
<td class="nump">$ 31,079<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_AccruedInventoryInTransitCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents current accrued inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_AccruedInventoryInTransitCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_SalesAndMarketingAccrualsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for sales and marketing costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_SalesAndMarketingAccrualsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12524-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68070138&amp;loc=d3e11281-110244<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736740489368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyLiabilityLineItems', window );"><strong>Product Warranty Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Standard product warranty accrual</a></td>
<td class="nump">$ 3,789<span></span>
</td>
<td class="nump">$ 3,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,789<span></span>
</td>
<td class="nump">$ 3,155<span></span>
</td>
<td class="nump">$ 3,351<span></span>
</td>
<td class="nump">$ 2,908<span></span>
</td>
<td class="nump">$ 3,398<span></span>
</td>
<td class="nump">$ 4,401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtendedProductWarrantyAccrual', window );">Extended product warranty accrual</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves', window );">Standard and extended product warranty, excess reserves</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=cutr_ProductRemediationLiabilityMember', window );">Product Remediation Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyLiabilityLineItems', window );"><strong>Product Warranty Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued', window );">Product warranty accrual, Increase for warranties issued, total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Standard product warranty accrual</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtendedProductWarrantyAccrual', window );">Extended product warranty accrual</a></td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualPayments', window );">Costs incurred related to product warranty and extended warranty liability</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Standard And Extended Product Warranty Accrual, Excess Reserves</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtendedProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate extended product warranty liability. Does not include the ending balance for the standard product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1),(c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtendedProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard and extended product warranty accrual from warranties issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyLiabilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyLiabilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1),(c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=cutr_ProductRemediationLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=cutr_ProductRemediationLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736659587432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warranty and Extended Service Contract - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantiesDisclosuresAbstract', window );"><strong>Product Warranties Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtendedProductWarrantyAccrualPayments', window );">Extended service contracts charge</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 3,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualPayments', window );">Settlements</a></td>
<td class="nump">$ 1,772<span></span>
</td>
<td class="nump">$ 1,343<span></span>
</td>
<td class="nump">$ 2,854<span></span>
</td>
<td class="nump">$ 3,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtendedProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the extended product warranty. Excludes standard product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtendedProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantiesDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantiesDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736665914520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warranty and Extended Service Contract - Summary of Warranties (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward', window );"><strong>Movement in Standard Product Warranty Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Beginning Balance</a></td>
<td class="nump">$ 3,351<span></span>
</td>
<td class="nump">$ 3,398<span></span>
</td>
<td class="nump">$ 2,908<span></span>
</td>
<td class="nump">$ 4,401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued', window );">Add: Accruals for warranties issued during the period</a></td>
<td class="nump">2,210<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">3,735<span></span>
</td>
<td class="nump">1,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualPayments', window );">Less: Settlements made during the period</a></td>
<td class="num">(1,772)<span></span>
</td>
<td class="num">(1,343)<span></span>
</td>
<td class="num">(2,854)<span></span>
</td>
<td class="num">(3,206)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Ending Balance</a></td>
<td class="nump">3,789<span></span>
</td>
<td class="nump">3,155<span></span>
</td>
<td class="nump">3,789<span></span>
</td>
<td class="nump">3,155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtendedProductWarrantyAccrual', window );">Extended product warranty accrual</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtendedProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate extended product warranty liability. Does not include the ending balance for the standard product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1),(c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtendedProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardProductWarrantyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1),(c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736740562024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Deferred revenue balance, amount</a></td>
<td class="nump">$ 11.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_CostsForExtendedServiceContracts', window );">Costs for Extended Service Contracts</a></td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="nump">$ 4.2<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ExtendedServiceContractOptionOneTerm', window );">Extended service contract, option one, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ExtendedServiceContractOptionTwoTerm', window );">Extended service contract, option two, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ExtendedServiceContractOptionThreeTerm', window );">Extended service contract, option three, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-07-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-07-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Deferred revenue balance, percentage</a></td>
<td class="nump">84.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Expected timing of satisfaction, period</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_CostsForExtendedServiceContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs for extended service contracts during period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_CostsForExtendedServiceContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ExtendedServiceContractOptionOneTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extended Service Contract, Option One, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ExtendedServiceContractOptionOneTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ExtendedServiceContractOptionThreeTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extended Service Contract, Option Three, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ExtendedServiceContractOptionThreeTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ExtendedServiceContractOptionTwoTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extended Service Contract, Option Two, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ExtendedServiceContractOptionTwoTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-07-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-07-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736666344008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue - Summary of Deferred Service Contract Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ChangeInContractWithCustomerLiabilityRollForward', window );"><strong>Change in Contract with Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Beginning balance</a></td>
<td class="nump">$ 11,737<span></span>
</td>
<td class="nump">$ 12,969<span></span>
</td>
<td class="nump">$ 11,237<span></span>
</td>
<td class="nump">$ 14,222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived', window );">Add: Payments received</a></td>
<td class="nump">4,423<span></span>
</td>
<td class="nump">2,554<span></span>
</td>
<td class="nump">9,352<span></span>
</td>
<td class="nump">6,125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ContractWithCustomerLiabilityPeriodDecrease', window );">Less: Revenue</a></td>
<td class="num">(1,834)<span></span>
</td>
<td class="num">(1,107)<span></span>
</td>
<td class="num">(2,279)<span></span>
</td>
<td class="num">(1,699)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Less: Revenue included in the beginning balance and recognized as revenue in the current quarter</a></td>
<td class="num">(2,923)<span></span>
</td>
<td class="num">(2,637)<span></span>
</td>
<td class="num">(6,907)<span></span>
</td>
<td class="num">(6,869)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Ending balance</a></td>
<td class="nump">$ 11,403<span></span>
</td>
<td class="nump">$ 11,779<span></span>
</td>
<td class="nump">$ 11,403<span></span>
</td>
<td class="nump">$ 11,779<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ChangeInContractWithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in Contract with Customer, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ChangeInContractWithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from advance payments received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ContractWithCustomerLiabilityPeriodDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from revenue deferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ContractWithCustomerLiabilityPeriodDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736664934152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment', window );">Typical payment receipt, period post shipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseRevenue', window );">Sales-type lease, revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod', window );">Training provided with sale of system, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="nump">$ 11,403,000<span></span>
</td>
<td class="nump">11,779,000<span></span>
</td>
<td class="nump">$ 11,403,000<span></span>
</td>
<td class="nump">11,779,000<span></span>
</td>
<td class="nump">11,237,000<span></span>
</td>
<td class="nump">$ 11,737,000<span></span>
</td>
<td class="nump">$ 12,969,000<span></span>
</td>
<td class="nump">$ 14,222,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Capitalized Contract Cost, Amortization Period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Capitalized Contract Cost, Amortization Period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization expense</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Capitalized contract costs</a></td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ExtendedServiceContractOptionOneTerm', window );">Extended service contract, option one, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ExtendedServiceContractOptionTwoTerm', window );">Extended service contract, option two, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ExtendedServiceContractOptionThreeTerm', window );">Extended service contract, option three, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_CustomerMarketingSupportMember', window );">Customer Marketing Support</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_RevenueFromContractWithCustomerTermOfContract', window );">Term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_LoyaltyMember', window );">Loyalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_SkincareMember', window );">Skincare | Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_SaleOfThirdPartyProductWarrantyPeriod', window );">Sale of third-party product, warranty period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Transferred over Time | Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_RevenuePerformanceObligationSatisfiedOverTimePercent', window );">Revenue from performance obligations transferred to customers, percent</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Training Provided With Sale Of System, Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ExtendedServiceContractOptionOneTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extended Service Contract, Option One, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ExtendedServiceContractOptionOneTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ExtendedServiceContractOptionThreeTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extended Service Contract, Option Three, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ExtendedServiceContractOptionThreeTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ExtendedServiceContractOptionTwoTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extended Service Contract, Option Two, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ExtendedServiceContractOptionTwoTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_RevenueFromContractWithCustomerTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Term Of Contract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_RevenueFromContractWithCustomerTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Typical Payment Receipt, Period Post Shipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_RevenuePerformanceObligationSatisfiedOverTimePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of revenue from performance obligations that are transferred to customers over time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_RevenuePerformanceObligationSatisfiedOverTimePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_SaleOfThirdPartyProductWarrantyPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Third-Party Product, Warranty Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_SaleOfThirdPartyProductWarrantyPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68051541&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68051541&amp;loc=SL49131251-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68051541&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sales-type lease revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121576215&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=121640914&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_CustomerMarketingSupportMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_CustomerMarketingSupportMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_LoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_LoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_SkincareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_SkincareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736654875448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-based Compensation Expense - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>May 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Grants in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">354,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,095<span></span>
</td>
<td class="nump">$ 4,765<span></span>
</td>
<td class="nump">$ 6,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember', window );">Stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Grants in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">354,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Estimated weighted-average remaining amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs | Non-Employee Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Grants in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs | Executive Officers, Senior Management, and Certain Employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Grants in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs | CEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Grants in period (in shares)</a></td>
<td class="nump">67,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs | 2019 Tranche | CEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Grants in period (in shares)</a></td>
<td class="nump">10,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (percentage)</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs | 2020 Tranche | CEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Grants in period (in shares)</a></td>
<td class="nump">16,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (percentage)</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs | 2021 Tranche | CEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Grants in period (in shares)</a></td>
<td class="nump">20,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (percentage)</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs | 2022 Tranche | CEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Grants in period (in shares)</a></td>
<td class="nump">20,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (percentage)</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear', window );">Award vesting rights, monthly after first year (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Non-Employee Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Grants in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Executive Officers And Senior Management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Grants in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cutr_NonqualifiedStockOptionsMember', window );">Non-qualified Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear', window );">Award vesting rights, monthly after first year (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cutr_NonqualifiedStockOptionsMember', window );">Non-qualified Stock Options | Executive Officers And Senior Management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Estimated weighted-average remaining amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cutr_TwoThousandNineteenEquityIncentivePlanMember', window );">2019 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cutr_AmendedAndRestated2004EquityIncentivePlanMember', window );">Prior Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,701,192<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The monthly percentage of award vesting rights after the first year under a share-based compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=cutr_NonEmployeeDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=cutr_NonEmployeeDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=cutr_ShareBasedPaymentArrangementTrancheFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=cutr_ShareBasedPaymentArrangementTrancheFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=cutr_ExecutiveOfficersAndSeniorManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=cutr_ExecutiveOfficersAndSeniorManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cutr_NonqualifiedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cutr_NonqualifiedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cutr_TwoThousandNineteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cutr_TwoThousandNineteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cutr_AmendedAndRestated2004EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cutr_AmendedAndRestated2004EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736666352520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-based Compensation Expense - Activity Of Options Outstanding Under the 2019 Plans (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward', window );"><strong>Shares Available for Grant</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Beginning balance (in shares)</a></td>
<td class="nump">1,085,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved', window );">Additional shares reserved (in shares)</a></td>
<td class="nump">450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="num">(354,735)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="num">(172,139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod', window );">Options exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Stock awards canceled (in shares)</a></td>
<td class="nump">212,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options canceled (in shares)</a></td>
<td class="nump">16,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Ending balance (in shares)</a></td>
<td class="nump">1,237,091<span></span>
</td>
<td class="nump">1,085,170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Stock Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">217,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">172,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="num">(53,598)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options canceled (in shares)</a></td>
<td class="num">(16,224)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">319,324<span></span>
</td>
<td class="nump">217,007<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 22.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">30.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (in dollars per share)</a></td>
<td class="nump">23.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Options canceled (in dollars per share)</a></td>
<td class="nump">33.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">$ 26.14<span></span>
</td>
<td class="nump">$ 22.35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Term (in Years)</a></td>
<td class="text">5 years 1 month 17 days<span></span>
</td>
<td class="text">3 years 9 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, beginning balance</a></td>
<td class="nump">$ 1,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, ending balance</a></td>
<td class="nump">$ 7,340<span></span>
</td>
<td class="nump">$ 1,470<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Exercises In Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Available For Grant</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment, Shares Available For Grant, Additional Shares Reserved</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736740326248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-based Compensation Expense - Activity of Stock Awards Outstanding Under the 2019 Plans (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Number of Awards Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Stock awards granted (in shares)</a></td>
<td class="nump">354,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Stock awards canceled / forfeited / expired (in shares)</a></td>
<td class="num">(212,571)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember', window );">Stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Number of Awards Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">779,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Stock awards granted (in shares)</a></td>
<td class="nump">354,735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Awards released (in shares)</a></td>
<td class="num">(161,199)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Stock awards canceled / forfeited / expired (in shares)</a></td>
<td class="num">(212,571)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">760,722<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 23.96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Stock awards granted (in dollars per share) | $ / shares</a></td>
<td class="nump">31.48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Awards released (in dollars per share) | $ / shares</a></td>
<td class="nump">22.33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Stock awards canceled / forfeited / expired (in dollars per share) | $ / shares</a></td>
<td class="nump">28.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 26.68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value (in Millions)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Beginning balance | $</a></td>
<td class="nump">$ 18,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Ending balance | $</a></td>
<td class="nump">$ 7,340<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736739842584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-based Compensation Expense - Stock-based Compensation Expense By Department (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 2,919<span></span>
</td>
<td class="nump">$ 4,095<span></span>
</td>
<td class="nump">$ 4,765<span></span>
</td>
<td class="nump">$ 6,075<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">434<span></span>
</td>
<td class="nump">743<span></span>
</td>
<td class="nump">578<span></span>
</td>
<td class="nump">1,033<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">522<span></span>
</td>
<td class="nump">1,251<span></span>
</td>
<td class="nump">1,243<span></span>
</td>
<td class="nump">1,970<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">769<span></span>
</td>
<td class="nump">608<span></span>
</td>
<td class="nump">1,090<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 1,656<span></span>
</td>
<td class="nump">$ 1,332<span></span>
</td>
<td class="nump">$ 2,336<span></span>
</td>
<td class="nump">$ 1,982<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736665318440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member', window );">Convertible Senior Notes Due 2026 | Convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments', window );">Debt convertible to common shares (in shares)</a></td>
<td class="nump">4,167,232<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736740420696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share - Net Income (Loss) Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) used in calculating net income (loss) per share, basic</a></td>
<td class="nump">$ 7,746<span></span>
</td>
<td class="num">$ (11,394)<span></span>
</td>
<td class="nump">$ 7,387<span></span>
</td>
<td class="num">$ (23,808)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestOnConvertibleDebtNetOfTax', window );">Interest expense on Convertible notes, net of tax</a></td>
<td class="nump">758<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">740<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_AmortizationOfDebtIssuanceCostsNetOfTax', window );">Amortization of debt issuance cost, net of tax</a></td>
<td class="nump">209<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">204<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income used in calculating net income per share, diluted</a></td>
<td class="nump">$ 8,713<span></span>
</td>
<td class="num">$ (11,394)<span></span>
</td>
<td class="nump">$ 8,331<span></span>
</td>
<td class="num">$ (23,808)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic (in shares)</a></td>
<td class="nump">17,862<span></span>
</td>
<td class="nump">17,055<span></span>
</td>
<td class="nump">17,815<span></span>
</td>
<td class="nump">15,744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Dilutive effect of incremental shares and share equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Convertible notes (in shares)</a></td>
<td class="nump">4,167<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,625<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares of common stock outstanding used in computing net income (loss) per share, diluted (in shares)</a></td>
<td class="nump">22,453<span></span>
</td>
<td class="nump">17,055<span></span>
</td>
<td class="nump">20,855<span></span>
</td>
<td class="nump">15,744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net income (loss) per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) per share, basic (USD per share)</a></td>
<td class="nump">$ 0.43<span></span>
</td>
<td class="num">$ (0.67)<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="num">$ (1.51)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) per share, diluted (USD per share)</a></td>
<td class="nump">$ 0.39<span></span>
</td>
<td class="num">$ (0.67)<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="num">$ (1.51)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Dilutive effect of incremental shares and share equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based payment arrangements (in shares)</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Dilutive effect of incremental shares and share equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based payment arrangements (in shares)</a></td>
<td class="nump">259<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Dilutive effect of incremental shares and share equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based payment arrangements (in shares)</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Dilutive effect of incremental shares and share equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based payment arrangements (in shares)</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_AmortizationOfDebtIssuanceCostsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Debt Issuance Costs, Net Of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_AmortizationOfDebtIssuanceCostsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestOnConvertibleDebtNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The after-tax amount of interest recognized in the period associated with any convertible debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestOnConvertibleDebtNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736739726296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share - Antidilutive Securities Excluded From Computation of Earnings Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">4,367<span></span>
</td>
<td class="nump">1,163<span></span>
</td>
<td class="nump">4,312<span></span>
</td>
<td class="nump">1,192<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">4,167<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,167<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">189<span></span>
</td>
<td class="nump">231<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">803<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">736<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember', window );">Performance stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember', window );">Employee stock purchase plan shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736656684904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 122<span></span>
</td>
<td class="nump">$ 466<span></span>
</td>
<td class="nump">$ 380<span></span>
</td>
<td class="nump">$ 543<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736665894424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating leases renewal terms (up to)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseRenewalTerm1', window );">Finance leases renewal terms (up to)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorLeaseDescriptionLineItems', window );"><strong>Lessor, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm', window );">Customers' right to purchase leased system, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseRevenue', window );">Sales-type lease, revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease', window );">Proceeds from customer's exercise of purchase option</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Revenue from equipment leases</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease terms of operating leases</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm', window );">Remaining lease terms of finance leases</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease terms of operating leases</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember', window );">Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorLeaseDescriptionLineItems', window );"><strong>Lessor, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable', window );">Sales-type lease receivable</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessor, Sales-type Lease, Lessee Option to Purchase Underlying Asset, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash inflow from proceeds from the exercise of purchase option sales type lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseRenewalTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's finance lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseRenewalTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121576215&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121561866&amp;loc=SL77919311-209978<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=121640914&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term guaranteed by lessee or other third party unrelated to lessor, from sales-type and direct financing leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121576215&amp;loc=SL77919391-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121576215&amp;loc=SL77919379-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sales-type lease revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121576215&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=121640914&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736739725880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">$ 15,919<span></span>
</td>
<td class="nump">$ 17,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease</a></td>
<td class="nump">602<span></span>
</td>
<td class="nump">467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_LeaseRightOfUseAsset', window );">Total leased assets</a></td>
<td class="nump">$ 16,521<span></span>
</td>
<td class="nump">$ 17,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Property and equipment, net<span></span>
</td>
<td class="text">Property and equipment, net<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OperatingLeaseLiabilitiesLesseeAbstract', window );"><strong>Operating lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">$ 2,422<span></span>
</td>
<td class="nump">$ 2,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">14,705<span></span>
</td>
<td class="nump">15,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total Operating lease liabilities</a></td>
<td class="nump">17,127<span></span>
</td>
<td class="nump">18,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_FinanceLeaseLiabilitiesLesseeAbstract', window );"><strong>Finance lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities, current</a></td>
<td class="nump">429<span></span>
</td>
<td class="nump">370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities, non-current</a></td>
<td class="nump">288<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total Finance lease liabilities</a></td>
<td class="nump">$ 717<span></span>
</td>
<td class="nump">$ 611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Accrued liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Accrued liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Other long-term liabilities<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_FinanceLeaseLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liabilities, Lessee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_FinanceLeaseLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_LeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under finance and operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_LeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_OperatingLeaseLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Liabilities, Lessee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_OperatingLeaseLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736665366856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Finance lease cost, Amortization expense</a></td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">$ 277<span></span>
</td>
<td class="nump">$ 237<span></span>
</td>
<td class="nump">$ 425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Finance lease cost, Interest for finance lease</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease cost</a></td>
<td class="nump">$ 881<span></span>
</td>
<td class="nump">$ 728<span></span>
</td>
<td class="nump">$ 1,759<span></span>
</td>
<td class="nump">$ 1,456<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736658273352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Cash Paid for Amounts Included in the Measurement of Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flow, Finance lease</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flow, Finance lease</a></td>
<td class="nump">211<span></span>
</td>
<td class="nump">380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flow, Operating lease</a></td>
<td class="nump">$ 1,549<span></span>
</td>
<td class="nump">$ 1,454<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736665427400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Operating Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2021</a></td>
<td class="nump">$ 1,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">3,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">3,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">2,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">2,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour', window );">2026</a></td>
<td class="nump">6,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">19,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="nump">2,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 17,127<span></span>
</td>
<td class="nump">$ 18,210<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736743884104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Finance Leases Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2021</a></td>
<td class="nump">$ 241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 717<span></span>
</td>
<td class="nump">$ 611<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736659551720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Lease Information (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_WeightedAverageRemainingLeaseTermAbstract', window );"><strong>Weighted-average remaining lease term (years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases</a></td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases</a></td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_LeasesWeightedAverageDiscountRateAbstract', window );"><strong>Weighted-average discount rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">4.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases</a></td>
<td class="nump">6.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_LeasesWeightedAverageDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases, Weighted Average Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_LeasesWeightedAverageDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_WeightedAverageRemainingLeaseTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Lease Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_WeightedAverageRemainingLeaseTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736665428088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated Litigation Liability</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736652000808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 09, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 22, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>day </div>
<div>$ / shares </div>
<div>$ / item</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Mar. 05, 2021</div></th>
<th class="th">
<div>Mar. 04, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 30, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeCapPrice', window );">Cap price (in USD per per share) | $ / item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.5350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DerivativeCapPricePremiumOverStockPricePercent', window );">Premium over stock price (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays', window );">Capped-call transaction term, consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities', window );">Purchase of capped call</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,134,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest on Convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 778,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">969,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,185,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">7,185,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member', window );">Convertible Senior Notes Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Convertible debt, conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member', window );">Convertible Senior Notes Due 2026 | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement | Wells Fargo | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement | Silicon Valley Bank | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable', window );">Qualifying accounts receivable</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount', window );">Commitment fee amount</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DebtInstrumentAnniversaryFeeAmount', window );">Anniversary fee amount</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DebtCovenantQuarterlyMinimumRevenue', window );">Quarterly minimum revenue</a></td>
<td class="nump">$ 90,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement | Silicon Valley Bank | Revolving Credit Facility | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_PaycheckProtectionProgramCARESActMember', window );">PPP Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Loan proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes | Convertible Senior Notes Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Notes issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 138,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from Debt, Net of Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 133,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Carrying amount of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger', window );">Redemption threshold percentage of stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DebtInstrumentRedeemableThresholdTradingDays', window );">Redemption threshold trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays', window );">Redemption threshold consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption', window );">Required outstanding amount not subject to redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance cost, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Effective interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.97%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.97%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest on Convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Interest expense, excluding amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes | Convertible Senior Notes Due 2026 | Occurrence of Fundamental Change</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount', window );">Incremental repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes | Convertible Senior Notes Due 2026 | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Convertible debt at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 226,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 226,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes | Convertible Senior Notes Due 2026, First Conversion Trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Conversion threshold trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold Consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Conversion threshold percentage of stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes | Convertible Senior Notes Due 2026, Second Conversion Trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Conversion threshold trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold Consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Conversion threshold percentage of stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtCovenantQuarterlyMinimumRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents quarterly minimum revenue under debt covenant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtCovenantQuarterlyMinimumRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtInstrumentAnniversaryFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents anniversary fee amount for debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtInstrumentAnniversaryFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of required outstanding amount not subject to redemption of a convertible debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents percentage of qualifying accounts receivable for debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redeemable, Threshold Consecutive Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redeemable, Threshold Percentage of Stock Price Trigger</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtInstrumentRedeemableThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redeemable, Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtInstrumentRedeemableThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redemption, Incremental Repurchase Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DerivativeCapPricePremiumOverStockPricePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percent premium over the stock price for derivative caps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DerivativeCapPricePremiumOverStockPricePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative, Capped Call Transaction Term, Consecutive Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCapPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cap rate on a price risk derivative such as a cap or collar. A payment or receipt is triggered if the market rate exceeds the cap rate on the contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCapPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:perUnitItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3505-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_LoanAndSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_LoanAndSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=cutr_WellsFargoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=cutr_WellsFargoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=cutr_SiliconValleyBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=cutr_SiliconValleyBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_PaycheckProtectionProgramCARESActMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_PaycheckProtectionProgramCARESActMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736666229672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Outstanding Debt and Carrying Value (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized debt issuance costs</a></td>
<td class="num">$ (4,450)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member', window );">Convertible Senior Notes Due 2026 | Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding principal amount</a></td>
<td class="nump">138,250<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized debt issuance costs</a></td>
<td class="num">(4,450)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">$ 133,800<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736659578856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139736661269080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Summary of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">$ 58,589<span></span>
</td>
<td class="nump">$ 26,369<span></span>
</td>
<td class="nump">$ 108,257<span></span>
</td>
<td class="nump">$ 58,608<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Total product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">51,812<span></span>
</td>
<td class="nump">21,745<span></span>
</td>
<td class="nump">95,363<span></span>
</td>
<td class="nump">48,136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_ProductsExcludingConsumablesAndSkincareMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">35,567<span></span>
</td>
<td class="nump">15,541<span></span>
</td>
<td class="nump">63,887<span></span>
</td>
<td class="nump">36,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_ConsumablesMember', window );">Consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">4,433<span></span>
</td>
<td class="nump">1,426<span></span>
</td>
<td class="nump">7,358<span></span>
</td>
<td class="nump">3,959<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_SkincareMember', window );">Skincare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">11,812<span></span>
</td>
<td class="nump">4,778<span></span>
</td>
<td class="nump">24,118<span></span>
</td>
<td class="nump">7,677<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">6,777<span></span>
</td>
<td class="nump">4,624<span></span>
</td>
<td class="nump">12,894<span></span>
</td>
<td class="nump">10,472<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">22,972<span></span>
</td>
<td class="nump">10,915<span></span>
</td>
<td class="nump">41,816<span></span>
</td>
<td class="nump">24,699<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_JP', window );">Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">17,421<span></span>
</td>
<td class="nump">8,517<span></span>
</td>
<td class="nump">33,976<span></span>
</td>
<td class="nump">15,679<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cutr_AsiaExcludingJapanMember', window );">Asia, excluding Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">3,676<span></span>
</td>
<td class="nump">1,846<span></span>
</td>
<td class="nump">6,079<span></span>
</td>
<td class="nump">5,075<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">4,628<span></span>
</td>
<td class="nump">1,325<span></span>
</td>
<td class="nump">9,052<span></span>
</td>
<td class="nump">4,141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cutr_RestOfWorldMember', window );">Rest of the World, other than United States, Asia and Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">$ 9,892<span></span>
</td>
<td class="nump">$ 3,766<span></span>
</td>
<td class="nump">$ 17,334<span></span>
</td>
<td class="nump">$ 9,014<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_ProductsExcludingConsumablesAndSkincareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_ProductsExcludingConsumablesAndSkincareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_ConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_ConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_SkincareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_SkincareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cutr_AsiaExcludingJapanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cutr_AsiaExcludingJapanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cutr_RestOfWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cutr_RestOfWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>131
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M7&R.6=7CNSW&K\SXER()7T"H?3F 3TWNMNUV)UJLBIVON=!:I,5AQ%G(I7D
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MX8S5SE34FC()MUF0*($,O)QM#F-BBP5S',P[J2.@00<T\ +]D*:R 5R0C*D
MD/>%F*(*"H=<(EY >K<;  H%2I7(<HT*"4&JS>L3,HU8TGH)PS")IV"D7HLV
M)8LGEZ<[+.&!"S1,,!LXZI B243=CH:=HZ'7T4_5!N(O52Z<:Q!:<[(@3,@
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M', ; 7B_E%!R]P_F/K_[_6;Q'U!+ P04    "  *B 93@H44R.("  #Y!P
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MI5X:WZ%-(ZK7*&BW!JIGKBP<);9X%W5&<,J<;'=QC#)FBP?8*,/1E/K10)#
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M8'987=09/K<?AB5,1NRH F3D/)RP870T1M1OC)9%N3==PU-4A\"%,GN/#J!
MU1"9O4Y"7![1HR>BD3>3OK4]:)Z?9=H.98_:#.VK!ZU=&X2^-;HW;55M(H:(
MH'56KO=E9\Z]Z3:Z%.IW*7VZZ5FZ2>&@ SV/.+$WI0L0AIT=#\SFU&D(%L;!
M5($:[0GUVY,AV7Z@V;4)E.HR:FMV8:!F@ TG-FP%L7DTC^:$GF).=HW(]^N)
M;NEQ0W<L]PS_C)8N&ZLG\U?/DYJZ/<=1BY4DQ$Y( $:)VY($8&G((GL7"L""
MA$SU'MA81!G]69U==M!I]^_K3^[M,F@_GZ1VG@,P;5>P[44 F/;R=G=T!4T:
M,9Q.A'(LGLQ?/.]Y\U2LO9D]%B7F;[B?FMGC@L].:;?_*+/=G6@4Q[%]-Z N
MNM.#!E"$)K:C6D$P',03S40VEA86_[2\'E=OYE^]3\_KQ'E:68J=0+HH&MIV
M8@F@8G=#!: BQNR<GA^\:ZUX\]B^Y)9:T;Y6W9NTX>SP(OU#^_K8.G]#+A8$
M.+\D%ZON-?E(W[VU_Y@UCT4M4<DW>BI\'NM;WG0OPKL#)7;MF]X'H92HVJ];
MGN6\,0#]^T8(]7I@)AC^'>'Z7U!+ P04    "  *B 93ECH+_V<#   M"P
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MP)<[ _]@MDR;J'5RS=M-\@/,>)M,D]_N;I)WW[U/ODMDD_RZ4;N6-ZOV8F9
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MK[!M: *B\0YT7VGMMH9_8)RI^1M02P,$%     @ "H@&4^_FN62U%P  HT,
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MK%ECQ69J4X+LR"7)+!!N#DWI9?WJJ"D]Y/<2"9U>8)]E#+TX2,-C).C9'A$
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M<6$R3WHW]M*Q=XSD'I?EA[ZC,H<3V0TA3:06NN':".H;;2'2&TTIPJ/NLW0
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MN W_2M]P-)X>P.=T49I>T 'Y[W)\]R]02P,$%     @ "H@&4Q?C0<E= @
M; 4  !D   !X;"]W;W)K<VAE971S+W-H965T,3 N>&ULI53;;MI $/V5D56I
MJ82P,012!$A 4K61(D5)+P]5'Q9[C%?9B[.[#DF_OK-KXQ UX:%]\<[US)E=
MS\QVVMS9$M'!HQ3*SJ/2N6H:QS8K43+;UQ4J\A3:2.9(-=O85@99'I*DB-,D
M&<>2<14M9L%V;18S73O!%5X;L+64S#RM4.C=/!I$>\,-WY;.&^+%K&);O$7W
MK;HVI,4=2LXE*LNU H/%/%H.IJN1CP\!WSGN[($,OI.-UG=>^9+/H\030H&9
M\PB,C@=<HQ >B&C<MYA15](G'LI[]$^A=^IEPRRNM?C!<U?.H[,(<BQ8+=R-
MWGW&MI]3CY=I8<,7=DWL<!)!5ENG99M,#"17S<D>VWLX2#A+WDA(VX0T\&X*
M!9;GS+'%S.@=&!]-:%X(K89L(L>5?Y1;9\C+*<\MULR6/?!?N+BO^0,3J)R=
MQ8ZP?42<M3BK!B=] V<,5UJYTL*%RC%_F1\3IXY8NB>V2H\"7M:J#\.D!VF2
M#H[@#;M&AP%O>*118"K_JU?XN=Q89^CW^'6DS*@K,PIE1O]]G_^" U]+A$(+
M&B6NMN#81F [3_PW6G#D7FM9,?7TWD*V;SD(> !SPA7%ZMJ2UWZ8PLDY83)C
MX84=Z TPO,$Y9B@W:& X:$F]"OL.!N.//=H')(TFO60T"81;1E"R')2FO]?<
M84L=L]IPQXDZLZ"+YXK^U4.1%Z7)FO1?>Z7X8 (DFFV8<[H!72O7#$-G[5;)
MLIF@Y_!F#UTQL^7*@L""4I/^Y#0"T\QVHSA=A7G::$?3&<22UB$:'T#^0FNW
M5WR!;L$N_@!02P,$%     @ "H@&4P*34_K.!   Y L  !D   !X;"]W;W)K
M<VAE971S+W-H965T,3$N>&ULK599;]M&$/XK Q7HDR+)DN,8/@3XJ-$426'$
M;?)0]&%)#L6ME[OT'I*57]^979*F;-EY:%\D+CG']\VU<[8Q]MY5B!X>:Z7=
M^:CROCF93EU>82W<Q#2HZ4MI;"T\'>UJZAJ+HHA*M9K.9[.C:2VD'BW/XKM;
MNSPSP2NI\=:""W4M[/82E=F<CPY&W8LO<E5Y?C%=GC5BA7?H_VQN+9VFO95"
MUJB=-!HLEN>CBX.3RT.6CP)?)6[<X!F826;,/1\^%N>C&0-"A;EG"X+^UGB%
M2K$A@O'0VASU+EEQ^-Q9OXG<B4LF'%X9]4T6OCH?'8^@P%($Y;^8S:_8\GG/
M]G*C7/R%39)='(T@#\Z;NE4F!+74Z5\\MG$8*!S/7E&8MPKSB#LYBBBOA1?+
M,VLV8%F:K/%#I!JU"9S4G)0[;^FK)#V_O!'2PE>A H(IX49JH7,I%'S4SMM
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MKDLRRIJW=2;NJ&S:>N,1FC+OFW(0P23VO0):NK;8L8>G,,DC#"\$N@'4SD9
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M^2[:U@"EQHV.1\)*_7UG&W.\[**(@SPA1[8@=.+TVJG.1=H>%,9,6&32*IN
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M7T\1BI?.AVB2 K2A-Z3XI<=Q1;&M4)5>[STB0$7]F3M]&CCKWF(SYB'<2+:
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M W[?.-"W](4V*/\<X\W_ U!+ P04    "  *B 93Q1?FZ>0)  "M&@  &0
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MK68C]PJM^]#H+?\@<:F;1E?\N%$21P9-P/A*ZZ;[0!OTOU"]_!-02P,$%
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M?T96P6J^A/^#* J2H_FA6TK6*UR*DV =K@\A6S UC063X-W',&2>)W(/[T-
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M/S&.BD;;COA6&*H*:(M5'VM!2B&<31/1=,AE4R@*P 3\ #;DN&*TB3#BW?]
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M<VAE970Q."YX;6R=56UOVS80_BL';=A:P+!DV4F#U#;@I!G6 <6,N-T^#/M
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M,KUP>V']8-6&?I]NJ2RX( TSP6$?P@GP?:64K1]P@>8'"V_^"U!+ P04
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MDC7R4EGL1_O<\WZ%S@P<DS::&VR^&*O?F)XMYM3,Z!IK&U,;URB-_U1-.X"
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M[^H!W[*,S6%A)FEG/*YV7;@J4;'?J=-@HMYNK$\XJO%82H=+2_ &Y'R[HKA
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M(]?'D]/P\"QA>V_PIY)W=N^9.).5UI_YY6UY/)DQ(5G+PC&"P+];>2[KFH%
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MG9 9;L##B].=OW6NM,,=UC]6^-$@#1M@?ZVUV[YP@-W/D)-_ 5!+ P04
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M8Q'2XN65]56_8MAI" W2(;K9L,=&:EYXO5Y24L-*&/_2>LON[B!=2]8;$R-
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M#^ ^[22G+S1!_A,5K_X?4$L#!!0    (  J(!E-10%";5@(  "X%   9
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M4FIR,CF-P+33V2I.UV$B5MK1? 6QHH6&Q@>0O]3:;15?H%^1V7]02P,$%
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M5++1J^F)^%F.'GG^KU*E_[&PJ7$ 7+>"K'6[9H=R';V4@,:]!SM>*5O_66(
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M\"5KAQO.T#NT ==74IK=!QW0_3'B^C]02P,$%     @ "H@&4X]VI3&- @
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M;W)K<VAE971S+W-H965T,S(N>&ULI57;;MLX$/V5@9"'%B"B^\VP#239[J5
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MVB"-65A6]", ZQ/H?&,,'@(_:^.O)?\#4$L#!!0    (  J(!E/I_0#9D0(
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M@+(.^'TII7G;V)G3_6+R?U!+ P04    "  *B 93C-E6]Q #  "'"   &0
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M:&5E=#,X+GAM;+576X_:.A#^*U;4AU;:L[F1 "M *@L45NW1:NGEH>J#-QG
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MH[TQ>3B:Q%'$,YPT564A&>:2^I_S:>+W!RKNIVJJ-X#<(#@%S;LH+;HHO6L
M^8%["EK60=[0&9R"5DU*PS/071W4ZSDOYD[V(BCW(FC=B_FS!'T0_=)>%))!
MQ9'0<<ZVHHYQ^^>@>0>AQ4^$3J(.RZC#;AFH/@@N+<&5FHI "'69$L"?H/'?
M(JR[5PNSCO$N1= O(^BW1G"LU@=((28XO["5!=M2HX-2?_"73X-A:6G8*9+S
MQ+M"*QJI>[, I.[2QVD" A$A,HBOD&2R,3]GPUJA!,ZE!7>=E^N&\^>/+:-9
MW7N_EA]=0,N?@$Z#JMRAW#]?_T:SZDJ]MKN E@94W2KW8FVXWDM47FM4MTQ(
ME2<TRCA7L7%(L%1?R1K"K)X Y6C27$HF?*_N=.W\:P#55J@."6K'7P.HONUV
MY1:= M_FKS:!(I916=P RM'R9?@V?P^=C4_=FYG;,#YW;Q;%N^]%OGB&JEO,
MEE"!$M@H4\ZU?K?QXF57="3;YW?X1R;5FR!O[M1K&+@&J/D-8_+8T0;*]_7D
M?U!+ P04    "  *B 93!!]BX\L"  !V"   &0   'AL+W=O<FMS:&5E=',O
M<VAE970S.2YX;6RE5M]OVC 0_E>L: ^MM#4_H14"I$) VZ1.J*SKP[0'DQPD
M:F(SVX'VO]_9"1D+(4/J2V)?[OON_/GLRW#/Q8M, !1YS3,F1U:BU'9@VS)*
M(*?RAF^!X9<U%SE5.!4;6VX%T-B \LSV'*=OYS1EUGAH; LQ'O)"92F#A2"R
MR',JWB:0\?W(<JV#X3'=)$H;[/%P2S>P!/6T70B<V35+G.; 9,H9$; >6??N
M8-[3_L;A1PI[>30F>B4KSE_TY$L\LAR=$&00*<U \;6#*629)L(T?E><5AU2
M X_'!_:Y63NN944E3'GVG,8J&5EW%HEA38M,/?+]9ZC68Q*,>";-D^PK7\<B
M42$5SRLP9I"GK'S3UTJ'(P#RM .\"N U <$9@%\!_$LC!!4@N#1"KP+TFH#^
M&4"_ O2-]J581NF0*CH>"KXG0GLCFQZ8[3)H%#AENK"62N#7%'%J_$R%H$R]
M$<IB,GM5P&*(R1+$+HV 3#E3 C>??"+?M*.N G(5@J)I)J_1^K0,R=6':_*!
MI(Q\3W@AD4<.;86IZ0!V5*4Q*=/PSJ3ADP<,E4@RT_%;\&$WOO\__+P;[WH=
M!#9J6@OK'82=>)V,7PMV0WSG(_$<SVU):'HYW&G3XWW19^^+/N^&AQ AW-5P
M]ZY#2[\N4M_P^6?X%H+'!59A5:PI2!*F,LJX+ 2.?]ZOI"G37QVQ@CI68&(%
M9V+59T!69R"JSH D44+%!MJ*NZ3L&TI]E>_&KH.Z[8[W^]3';_J$%_#,+N"9
MM_AX1T[_"-.KA>EU"H,]1F6 /46UGN_>:>JWMUY#@Q8G/_ ;(IPZ>7>]H*'"
MJ1.NL-]8H7UT+^: >Z<[&.XC+Y@JJZ^VUDWRWO2&AGWB#J9NBSUT![.R!_ZE
M+SOR Y9*RB3)8(VAG)M;3%B47:Z<*+XUM_***[SCS3#!'P,0V@&_KSE7AXD.
M4/]JC/\ 4$L#!!0    (  J(!E/:JG7Z8@,  +L*   9    >&PO=V]R:W-H
M965T<R]S:&5E=#0P+GAM;*56VV[C-A#]%4+8AUV@&]UEQ[ -Q)>B+1H@B+N[
M#XL^,-+8(I8B79*RLG_?H20KCJPX1OMBB]29,W,.+YII)=4/G0,8\EQPH6=.
M;LQ^XKHZS:&@^D;N0>";K50%-3A4.U?O%="L#BJX&WA>XA:4"6<^K><>U'PJ
M2\.9@ =%=%D45/U< )?5S/&=X\0CV^7&3KCSZ9[N8 /FR_Y!X<CM6#)6@-!,
M"J)@.W/N_,EZ;/$UX"N#2I\\$ZOD2<H?=O![-G,\6Q!P2(UEH/AW@"5P;HFP
MC']:3J=+:0-/GX_LO];:4<L3U;"4_!O+3#YSQ@[)8$M+;AYE]1NT>F++ETJN
MZU]2M5C/(6FIC2S:8*R@8*+YI\^M#R<!R#,<$+0!03\@>B,@; /":S-$;4!T
M;8:X#:BENXWVVK@5-70^5;(BRJ*1S3[4[M?1Z!<3=I]LC,*W#./,_!M5B@KS
MDU"1D?6S 9%!1C:@#BP%LI3"*%Q+\IELFHU$Y):T,0PT^;@"0QG7GQ#Q9;,B
M'S]\(A\($^2O7)8:.?74-5BF3>:F;4F+IJ3@C9)"<H]I<TW6MI:!^-7E^.1"
MO(OV=!X%1X\6P47"/TIQ0T+O%Q)X@3]0S_+Z<&](SO_+OO[/V5^9$78;)JSY
MPC?X[N4!\)XP=I$W!E>8JHP\*)F5N$VZW727IJJDG'Q_E)P3/-(5POZ^D#[J
MTD=U^NB-] O8,2&8V)$%Y52D,+2_&HJDIK 7Y6$>AC%Z=SA=M"'0[?@U:'4.
M"FZ]'FA]#HHB[R7=*YUQIS.^J/,NRR9'%S7![P&I7DX=T[K$4YJ5RAIA<B![
M4$P.G95%DR8^51#X7L^+<Y#O>SW0ZAP4CL*XY\4 TVWB#7N1=%XD%[WX$[2>
MX)UD#*^WGL8+,(/KY"=G]7SV1Z.@IW\(%49ASX !5#".HYX# Z@P\))A"T:=
M!:.+%N!5]LZ>'PVLSOBVIW, Y,>])5Q=P[1^A^F5R'$G<GQ9Y/'SLV^ODZK[
M.#4'84CW^.SP)?V=NSS'^*.S[7T%T?H=HD:U>_(U+D#MZC9(DU26PC3W;#?;
M=5IW=8/1FU_XDZ4_,+_"SJQII%[HF[;NGBJ\'C7AL,54WLT(%T@UK5(S,')?
M]P)/TF!G43_FV%V"L@!\OY72' <V0=>OSO\%4$L#!!0    (  J(!E,< ETO
MC@,  &P-   9    >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;,U7VV[;.!#]
ME8'0 BW@6%?G!MM ?"FVB\TVB+?;AZ(/M#VVB4JDEJ3M].]W2"FRG2ARFO2A
M+[9X.6?.#(?DL+N5ZKM>(1JXRU*A>][*F/S2]_5LA1G3;9FCH)&%5!DSU%1+
M7^<*V=R!LM2/@N#4SQ@77K_K^FY4ORO7)N4";Q3H=98Q]6. J=SVO-"[[[CE
MRY6Q'7Z_F[,E3M!\SF\4M?R*9<XS%)I+ 0H7/>\JO!R'B06X&?]RW.J];["N
M3*7\;AL?YSTOL(HPQ9FQ%(S^-CC$-+5,I.._DM2K;%K@_O<]^P?G/#DS91J'
M,OW"YV;5\\X]F.."K5-S*[=_8.E0Q_+-9*K=+VS+N8$'L[4V,BO!I"#CHOAG
M=V4@]@#$4P^(2D#T$) \ 8A+0/Q<"TD)2)YKH5,"G.M^X;L+W(@9UN\JN05E
M9Q.;_7#1=VB*%Q<V429&T2@GG.F/<(%*X1QN<8-BC7 "?S.EF%T^>#="PWBJ
MWU/OY\D(WKUY#V^ "[CF:4K+K+N^(0V6R9^5]@:%O>@)>S%<2V%6&L9BCO,:
M_*@9?]J ]\GW*@#1?0 &42/AGVO1ACAH011$88V>X?/A09T[K[,^?K'U@V#$
M53;$CB]^@J],@A9E@SUDN%C"#2IW'(D9PJ=IRI?,;O 6C.]RVNN4./_PS,Z3
M"YC0D%ZPX@3X^A=QPT>#F?[6H"RIE"5.67(L3U69IU.66DTM8)E<"U.7B07C
MA6.T!^:F'X;MI.MO]M?GR*0#L9U*;*=1[%!JHX'"1E$R:!,5)J@VG$(XI.Q5
M%*+:K=-YI"5J1X=ZAW5SX@<^/9Z3/.09/YX3MSOU;I]6;I\VNEWZV+#:9Q73
MV6^6A^>5LO-&'ZL%U>6"SLH%;8',G4$I2+=!E=6=!LWD(?Q IAI47E0J+UZI
MTFSETRJ;R2.G4C?(#(/=[1.\5NA*84- C_#'Q[7NW91A(]>O2\H63 Q3!NC&
M1OAZ=<?UMTMW YP$9R=!V*0VVJF-?K,M%.YNF3!^X6&>HYJA,%2BUI86S;3G
M23L(WM9FR<\##UW;75-A\SU5Q=)4L=0'*T\><EE7^ R.,(<19*[TJ77P1=C"
M1W^O>LQ0+5W9KFDGTK5:E Y5;_4TN'(%\8/^07@Y#&OZ1_8IX:K5'7WQ#KEF
M:LF%AA079"IHG]&MI(K2OF@8F;O:=2H-5<+N<T7/(51V HTOI#3W#6N@>F#U
M_P=02P,$%     @ "H@&4WDI)!YK P  S0H  !D   !X;"]W;W)K<VAE971S
M+W-H965T-#(N>&ULI59-C]LV$/TKA)!# B0KB9+E#]@&UI:+MDB Q3I)#T4/
MM#2VB$BD0U)VMK^^)"6K7IEVC/:REJCWWO -A[,S/7+Q318 "OVH2B9G7J'4
M?N+[,BN@(O*![X'I+ULN*J+TJ]CY<B^ Y)94E3X.@L2O"&7>?&K7GL1\RFM5
M4@9/ LFZJHAX64#)CS,O]$X+SW17*+/@SZ=[LH,UJ"_[)Z'?_$XEIQ4P23E#
M K8S[S&<K$8&;P%?*1SEV3,R3C:<?S,OO^4S+S ;@A(R912(_CG $LK2".EM
M?&\UO2ZD(9X_G]1_L=ZUEPV1L.3E'S17Q<P;>2B'+:E+]<R/OT+K9V#T,EY*
M^Q<=6VS@H:R6BE<M6>^@HJSY)3_:/)P1M(Z;@%L"[A/B*X2H)43W1HA;0GQO
MA$%+L-;]QKM-7$H4F4\%/R)AT%K-/-CL6[;.%V6F3M9*Z*]4\]0\A2T( 3EZ
MA@.P&M 'M&Y*!O$MZKZN01QH!FC)F1+Z<#OXVQ04H:5\IXE?UBEZ^^8=>H,H
M0Y\+7DO"<CGUE=ZGB>9G[9X6S9[PE3U%Z),.4TBT8CGD#GYZFY_<X/LZ/UV2
M\"E)"WQ3\/>:/: H>(]P@$/'?I;WTP.7G?\7??6?H[]*1M153&3UHBMZRX*P
M'9@C[HKA2%6!EK980;Q''RG9T)*J%_3G,R]+I&_TD8C\KQO!XRYX;(/'5X(O
M8$<9HVRGNT-)6 :NZFHD$BMA^N1A'H;#:#CU#^=GYD#A<3)^C4I=6KBOM7*@
M8HQQAWKE==!Y'=ST^ICG$_1$7G175E+WY QT2W5=AT6C,S@+'\<XZOF]!.'!
M(.[9O02-HP'NN;T$)2$>N,TFG=GDIMF/(.7DU%5<'I.+H!_"4=3;_]*%"H/>
M<:4.%,;#WM&O7%K)>.SV.>Q\#N_WJ2]15M:Z1YG;I I FWYY(]U!S='S':-_
M:QPQA7#B6DI6ZP;-%/I>$Z% N%(W=-@=7]2'"Y7T*SUUH))Q/\$K%VJ47$G=
MJ$O=Z&;J=#?_R<4?.2YK'/2-NE##_NFG=VFM?J;5&/7/_C_K#KFS@Y%$&:^9
M:AIOM]K-7H]VY.BM+\+),G2LIWI6:T:K?^6;0>\3$;JD)"IAJT,%#T-]**(9
MGIH7Q?=V.MAPI=NW?2STO G" /3W+>?J]&("=!/L_!]02P,$%     @ "H@&
M4S]T/3*I!0  ?QL  !D   !X;"]W;W)K<VAE971S+W-H965T-#,N>&ULM5E=
M;^(X%/TK%MJ59J1.B6U(H&J1RM=,1]/=:IC9?5CM@QL,6$WBK&V@C.;'KYV$
M!%KC1!W1AT+"/>?>W&N?:\?76RZ>Y(I2!9[C*)$WK952Z56[+<,5C8F\Y"E-
M]"\++F*B]*58MF4J*)EGH#AJ(\_SVS%A26MPG=U[$(-KOE812^B# '(=QT3L
MAC3BVYL6;.UO?&7+E3(WVH/KE"SIC*KOZ8/05^V29<YBFDC&$R#HXJ9U"Z_N
ML&\ F<5?C&[EP7=@'N61\R=S<3>_:7DF(AK14!D*HC\V=$2CR##I./XK2%NE
M3P,\_+YGGV8/KQ_FD4@ZXM'?;*Y6-ZU>"\SI@JPC]95O/]'B@;J&+^21S/Z#
M;6X;:(_A6BH>%V!]';,D_R3/12(. )K'#D % +T$=$X < ' 33UT"D"GJ8=N
M >B^!/@G 'X!\)MZ" I T!30*P"]IH!^ >AGPR&O7U;\,5%D<"WX%@ACK=G,
MEVP$96A=<Y:8P3Y30O_*-$X-OM(-3=84? !_$"&(&7G@W9@JPB+Y7M_]/AN#
M=[^]OVXK[<Q VF%!/,R)T0EB#.YYHE823)(YG5OP8S?>K\-/W7B(' 1MG:4R
M56B?JB%R,GY>)Y< >Q< >0A: AHUAWNV?/R:]\FO>9^ZX6,::C@\"?_HAM\3
M4<)MP7]J#K=YOVL</.P[!@(NYPS.^/ I/B;)<BGHDF1ZS1=@/XO^^:)-P9VB
ML?S7X:A3.NIDCCHG''W;I2PD$4C)3O<7I9M+2%FJ+D!*!>-SD'*I@%RQU/QJ
M&U)N>NR!.=E)1Z#=,M"NDVE&(BH_J%U*041UZ[G0H689L>E&3N5G5*87;P:Z
MIIO#B51K,:ZUF-1:3%];!)[Y*\V.4N&7J?#=-1-ZA<&2)4@%WS"M/%K0U0I(
MG2$S4N1.ZM&QKZ"M9FYZV*LM6E!&&CBI1EH>A5YLY 'FO8:*"Q Q\L@BIG:V
MX@6OD@9AQ\.':<MKF!MVCPR#H/_*<-R4<=*4<6HS1#AX9?C1YCJP&'ZR&**^
M_]KUG<6P@Q Z.:IZ9:UZSEK=ZS$5KV-'U?LE4_^\X@6]:FGAN0<829DB$?NA
M)T$YV$9:LR[ ;<R%8C_R&!Y.S85AC0,$=I0(:5U<O %Y_)@'*RCHK@UYKJD-
M1!47.G-UJB8&\;FKXW: '=5Y _+X,:L6"MU-+FM-@"1SO6H63U1I:7;Q5AT/
M=L]<J:JC0+?F'Y6#/NM]KK0VUH+F4'VZQQTMEV:+76"Q&UOLH&<QG-@,.XY>
M"JL6!=T]ZD^UH@+<2DF5<SA4.@I[9RY;);2PWWB"A?L)%NH)9IL2PX+LL&MA
MWUJ5_JMD6PVG-D9755 E[,BMGC,J-BRDKCU5I9X(GK<@J!)7A)QA3YX5-7M!
M(//XRZI< )[FWA.]=%54Q-;]F9L=9J+E"K229N36O_I U98[ G6SU_<^5*DK
M<JMK@TA7@KJ26K-%J8^U4FSDWJ2,BA4NN-\W C!;IZG65A=]I=+(/_- KE01
MN57QFTZF<;!/MC6Q;@H?Q-G;$5<\E:@B]^KT"]^1Z.5^X9BK4DUTYO4IKF0,
MUZQ/W[(!*C@/Y=<JTPWMIA8[[!!I7 DK=B]+9T\L"8F@X"?X3%*2N%)622@^
M\_H4'[QD<<O4K-@QJQ43\P\I$6IG]M3SM1&7K7E9F9@[)_?1-?3]VGTTKE00
MU[RGT;'(!15""R'?:(7YQF*3]_H^B2OUPF=>;^)*R;![O;DG7@@>FP1G1RJ)
M%G?^&+'<OP3JX)D5+V>/S%YMA/;W4<,:QQ!=>M[OME>K;P6.ZX"]$\#)&X!Y
MNML'+^-U0I;928[46KU.5/Z.L;Q;GA;=9F<D+^X/X=4(6NZ/X=4D/PNJZ/.C
M*=W8EDS7)J(+[<J[#/20$OEI3WZA>)H=!3QRI:N5?5U1,J?"&.C?%YRK_85Q
M4)ZY#?X'4$L#!!0    (  J(!E,YC+>V,0<  %LL   9    >&PO=V]R:W-H
M965T<R]S:&5E=#0T+GAM;,V:84_;.!C'OXI5W>F8!#2V$Z>9 &E -T"W#<'8
MO3C="].Z-%H:=XY+Z70?_NPDU*%)G!1Z4MY DOIY_-C^^^<G=HZ67/Q(IHQ)
M\#2+XN2X-Y5R_K[?3T93-J/)(9^S6/TRX6)&I;H5#_UD+A@=IT:SJ(\<A_1G
M-(Q[)T?ILVMQ<L07,@IC=BU LIC-J%B=LH@OCWNP]_S@)GR82OV@?W(TIP_L
MELF[^;50=_VUEW$X8W$2\A@(-CGN?8#OKTB@#=(2WT.V3 K70#?EGO,?^N9R
M?-QS=$0L8B.I75#U[Y&=L2C2GE0</W.GO76=VK!X_>S]8]IXU9A[FK S'OT5
MCN7TN#?H@3&;T$4D;_CR@N4-\K2_$8^2]"]8YF6='A@M$LEGN;&*8!;&V7_Z
ME'=$P0"Z-08H-T!M#7!N@-L:N+F!V]; RPV\M@8D-R!M#?S<P-\P0'4&@]Q@
MT+:&(#<(-@UPW< YSR/GI K*ACS5RSF5].1(\"40NKSRIR]2T:7V2B9AK.?'
MK13JUU#9R9-;R4<_ICP:,Y'\ 88_%Z%< 1J/0?K#@9;>&)SQF9J/"4T5/7S2
MUPP<@"]4"*KE#?;.F:1AE+Q33^]NS\'>;^_ ;R",P;<I7R3*77+4ERI:76=_
ME$=VFD6&ZB)C\T. G7V '!A4F)_9S:\6\;,Y@A7FYZW-*VL?OJWVCW;SSU0H
M<UAK_JE][4Z%^<7;@K]\6^U736U?Y4W?[/B^TO9:X&@M<)2ZPW4RFE+!JG3\
M08DW?F"*]1+<KT"QW#5=I8\_+*D8@[__5"[!I62SY!]+0'@=$$X#<FL"^J2J
ME8F>'',F0CX&>^HRT;4G[ZK&*O/FI=[T:O=X@CW7Q]Y1_[$B"G<=A6N-XNM<
M=T("'G0TJLFMPW%+X4 ?01Q4A^.MP_&LX7SCDD8@*3!G5!PKEC&G:AYF?DDA
M'A1 $TTV7<J%7"?P7A:ZJ"CDDXU"E^5"Q/%KQH*L&T^LC4]1"Z@66V(1F+]V
MYW=#\8-U0(.=*GZPE>*#=12!-8KO+-E*Z$%9Z 3"H$;HT#$+KF.-XRX6;,0?
MXO#7ILI'/)&5"YU3$IT*Q7%>2G/8KMA%8[&7[2HD$M#:KF$B0Y6OJD8MTZ24
MC0_H(Q,JR59YM,[4P_@!T!D7,OR5M3<;A\KUR5X5 BM&A6VN0+,\0&3U=7U[
MEX!_P1<>'PQG\XBO& /GH1HBR>TU&-Y#W(WY" W\H9W^6\[((2Q3WW4&-1,2
M&NA#._7SOA\^L=$BS2._3B;A2&6B^^"6Q2$7X#.-:=9#^VE6>L:$2C15$IH/
ME76$#'\AZ<@(&89#?[<CY)=&:( \-]B<_.5BT(<0^S5#:1 /[8S/A_)L^-76
M?,-J&'1C1)#A-K)S>\L1.<W=%;N:^(.@IJ>1X2RRPT^O8QJEM?0\;7#@-M(3
M%9+K5O34N3KXICIH-&6-*D"&G*@CY$2&G&BGY#Q%%?FR ^O0B0PZD1V=6?,>
M<RT(O> F8$_%-%*-5\BL#L;N$WJ'CO.[K9L,49$]I=TRV?J8NWN!+^+5S15#
M462GZ%J>R&DO3\,\-.B(/ TWD3W)W5J>55ENX+O5'8\-++$=EJ^29X-/U"1/
M;!B*[0A\_>MF[KB8/7MUN3,V&,4M,8I@:YWBPH9#1S"*#4;Q;C&*RQA%#B8U
M+V/88!3_#QAM\(F=)IT:C&([1HTN4'M=&#KBCFP48(-4O-.M@E-<WBNPZ<)P
M%-LY^CI=V'TVZL(U>'7M*+Q1NK Y,B!T83<DX!H6NG86-N:W%PT.FO-;UZ#3
MM6_6OD8'%PT^&]<QM["):\=H57C[8,9C.8U6@$XD$V 2BD2F7=(<N+TV=.@/
MK'$;[+IV1-Z\<M/%->1T._)*[QK<NKM]I7?+[^HHP 36;/P;QKIVQM[4[;J
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M)&E.*$\9!059W0[NX,T,14JADO@K)3N^]PR4*4^,/:O!E^1VX*H=D8PLA8+
M\N>%3$B6*22YCQ\-Z*!=4RGN/[^A_U(9+XUYPIQ,6/8]3<3F=A /0$)6N,S$
M ]O]2AJ# H6W9!FO_H)=(^L.P++D@N6-LMQ!GM+Z%[\V1.PI2!RS FH4D*[@
MOZ/@-0K>J2OXC8)_Z@I!HU"9[M2V5\1-L<#C4<%VH%#2$DT]5.Q7VI*OE*I
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M[EL;3,V(LW>1FI-B7=U@<]GYEE34MU_M;'M+?E?=#6OS]_!F @WS4W@SJ^_
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MIL]Z85)U;>8V5:T[YMI /5\Q]4%6#_0"S9\!\_\!4$L#!!0    (  J(!E/
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MKP<[7.,-#M)LP/6E$/IM8NZ([C_!^ ]02P,$%     @ "H@&4_^ "Y.; @
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M;)1]@78^%6 >:.?_78 ?J[U%X]KEYP7ZQ42_"/2+,_2/O=R#(;HF;HY\55V
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M1KWS=^I=Q\]#J=>>KS4^_SNI'L_WENOC+\NODY-7Y8)SNJVHSW\!4$L#!!0
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M<' N>&UL4$L! A0#%     @ "H@&4S#;QC_N    *P(  !$
M ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ "H@&4YE<G",0
M!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    "  *B 931$%0OB8%  !(%0  &               @($-"
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ "H@&4U>Q<6M^
M!@  RQD  !@              ("!:0T  'AL+W=O<FMS:&5E=',O<VAE970R
M+GAM;%!+ 0(4 Q0    (  J(!E."A13(X@(  /D'   8              "
M@1T4  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    "  *B 93
ML^Y(51$'  ":(   &               @($U%P  >&PO=V]R:W-H965T<R]S
M:&5E=#0N>&UL4$L! A0#%     @ "H@&4Y8Z"_]G P  +0L  !@
M     ("!?!X  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    (
M  J(!E,JB7^?W0@  *8T   8              " @1DB  !X;"]W;W)K<VAE
M971S+W-H965T-BYX;6Q02P$"% ,4    "  *B 93\\S7Y;,(  "_)0  &
M            @($L*P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#
M%     @ "H@&4_4>"<U' @  7P4  !@              ("!%30  'AL+W=O
M<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    (  J(!E/OYKEDM1<  *-#
M   8              " @9(V  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q0
M2P$"% ,4    "  *B 93%^-!R5T"  !L!0  &0              @(%]3@
M>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    (  J(!E,"DU/Z
MS@0  .0+   9              " @1%1  !X;"]W;W)K<VAE971S+W-H965T
M,3$N>&UL4$L! A0#%     @ "H@&4VZ$#%X2!0  3@T  !D
M ("!%E8  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    "  *
MB 93#L*C"3D%  #:#   &0              @(%?6P  >&PO=V]R:W-H965T
M<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    (  J(!E.6@V19E ,  (((   9
M          " @<]@  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#
M%     @ "H@&4[]UVP-^$   FC$  !D              ("!FF0  'AL+W=O
M<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    "  *B 93Q1?FZ>0)  "M
M&@  &0              @(%/=0  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM
M;%!+ 0(4 Q0    (  J(!E,#Y)4W,P<  !05   9              " @6I_
M  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ "H@&4S:&
M_5*: P  [ <  !D              ("!U(8  'AL+W=O<FMS:&5E=',O<VAE
M970Q."YX;6Q02P$"% ,4    "  *B 93\8:I^X8*  "\4   &0
M    @(&EB@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    (
M  J(!E-BXQ'WJ@4  *\,   9              " @6*5  !X;"]W;W)K<VAE
M971S+W-H965T,C N>&UL4$L! A0#%     @ "H@&4ZX\CRL^$P  K3L  !D
M             ("!0YL  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"
M% ,4    "  *B 93FAOR"I %  "2#   &0              @(&XK@  >&PO
M=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    (  J(!E/@;E9DNA8
M *Y"   9              " @7^T  !X;"]W;W)K<VAE971S+W-H965T,C,N
M>&UL4$L! A0#%     @ "H@&4U% 4)M6 @  +@4  !D              ("!
M<,L  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    "  *B 93
MV0$P[%<#  "J!P  &0              @(']S0  >&PO=V]R:W-H965T<R]S
M:&5E=#(U+GAM;%!+ 0(4 Q0    (  J(!E/]]"H#4P,  $ '   9
M      " @8O1  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%
M  @ "H@&4S#>).L+ P  EP8  !D              ("!%=4  'AL+W=O<FMS
M:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    "  *B 93!;"W][ $  #E"@
M&0              @(%7V   >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+
M 0(4 Q0    (  J(!E, "%TC8P4  !L.   9              " @3[=  !X
M;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ "H@&4S,][$&7
M!0  F!   !D              ("!V.(  'AL+W=O<FMS:&5E=',O<VAE970S
M,"YX;6Q02P$"% ,4    "  *B 93CW:E,8T"  !I!0  &0
M@(&FZ   >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (  J(
M!E/5H$AWF ,  )\'   9              " @6KK  !X;"]W;W)K<VAE971S
M+W-H965T,S(N>&UL4$L! A0#%     @ "H@&4XW8,C=_ P  A0L  !D
M         ("!.>\  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
M    "  *B 93B('Q(P\"  "=!   &0              @('O\@  >&PO=V]R
M:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    (  J(!E-,*\4C_P$  &8$
M   9              " @37U  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL
M4$L! A0#%     @ "H@&4^G] -F1 @  ;@8  !D              ("!:_<
M 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    "  *B 93C-E6
M]Q #  "'"   &0              @($S^@  >&PO=V]R:W-H965T<R]S:&5E
M=#,W+GAM;%!+ 0(4 Q0    (  J(!E,[J&J<U0,  &L/   9
M  " @7K]  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @
M"H@&4P0?8N/+ @  =@@  !D              ("!A@$! 'AL+W=O<FMS:&5E
M=',O<VAE970S.2YX;6Q02P$"% ,4    "  *B 93VJIU^F(#  "["@  &0
M            @(&(! $ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4
M Q0    (  J(!E,< ETOC@,  &P-   9              " @2$( 0!X;"]W
M;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ "H@&4WDI)!YK P
MS0H  !D              ("!Y@L! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX
M;6Q02P$"% ,4    "  *B 93/W0],JD%  !_&P  &0              @(&(
M#P$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    (  J(!E,Y
MC+>V,0<  %LL   9              " @6@5 0!X;"]W;W)K<VAE971S+W-H
M965T-#0N>&UL4$L! A0#%     @ "H@&4[1:U\WO!   "1,  !D
M     ("!T!P! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  J(!E,D_K,KN@,  !@0   9              "
M@10R 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ "H@&
M4\!6CJUG @  C 8  !D              ("!!38! 'AL+W=O<FMS:&5E=',O
M<VAE970U,2YX;6Q02P$"% ,4    "  *B 93!R$I$AX$  #;$0  &0
M        @(&C. $ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0
M   (  J(!E,HKPW"P ,  (\.   9              " @?@\ 0!X;"]W;W)K
M<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ "H@&4QH?<-G& @  =0@
M !D              ("![T ! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q0
M2P$"% ,4    "  *B 93R0\PAI("  "@!@  &0              @('L0P$
M>&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    (  J(!E-1?1YB
MP@(  !\(   9              " @;5& 0!X;"]W;W)K<VAE971S+W-H965T
M-38N>&UL4$L! A0#%     @ "H@&4_^ "Y.; @  ,0<  !D
M ("!KDD! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    "  *
MB 93&LQVSRL"  #[!0  &0              @(& 3 $ >&PO=V]R:W-H965T
M<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    (  J(!E,\>;!&'P(  ,@$   9
M          " @>). 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#
M%     @ "H@&4["(;F'G"   _BT  !D              ("!.%$! 'AL+W=O
M<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    "  *B 93NPWV%)L"   D
M!P  &0              @(%66@$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM
M;%!+ 0(4 Q0    (  J(!E,G[.01 P(  %<$   9              " @2A=
M 0!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ "H@&4W%_
M<&/E!   >Q<  !D              ("!8E\! 'AL+W=O<FMS:&5E=',O<VAE
M970V,RYX;6Q02P$"% ,4    "  *B 93Y]T._RL#   2$P  #0
M    @ %^9 $ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    (  J(!E.7BKL<P
M !,"   +              "  =1G 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M  J(!E,"";R?X@0  *8I   /              "  ;UH 0!X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    "  *B 93)V75I0P"  "$)0  &@
M@ ',;0$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  *
MB 93[M7M&.8!  #U)   $P              @ $0< $ 6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     1P!' &@3   G<@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>220</ContextCount>
  <ElementCount>400</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>62</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Consolidated Statements of Changes In Stockholders' Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited</Role>
      <ShortName>Consolidated Statements of Changes In Stockholders' Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1007007 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1406401 - Statement - Consolidated Statements of Changes In Stockholders' Equity (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnauditedParenthetical</Role>
      <ShortName>Consolidated Statements of Changes In Stockholders' Equity (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2104102 - Disclosure - Cash, Cash Equivalents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/CashCashEquivalents</Role>
      <ShortName>Cash, Cash Equivalents</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/FairValueofFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2109104 - Disclosure - Balance Sheet Details</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/BalanceSheetDetails</Role>
      <ShortName>Balance Sheet Details</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2114105 - Disclosure - Warranty and Extended Service Contract</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/WarrantyandExtendedServiceContract</Role>
      <ShortName>Warranty and Extended Service Contract</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2118106 - Disclosure - Deferred Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/DeferredRevenue</Role>
      <ShortName>Deferred Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2122107 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2124108 - Disclosure - Stockholders' Equity and Stock-based Compensation Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpense</Role>
      <ShortName>Stockholders' Equity and Stock-based Compensation Expense</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2130109 - Disclosure - Net Income (Loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/NetIncomeLossPerShare</Role>
      <ShortName>Net Income (Loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2135110 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2137111 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2146112 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2148113 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2152114 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://cutera.com/20210331/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Cash, Cash Equivalents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/CashCashEquivalentsTables</Role>
      <ShortName>Cash, Cash Equivalents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/20210331/role/CashCashEquivalents</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2310302 - Disclosure - Balance Sheet Details (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/BalanceSheetDetailsTables</Role>
      <ShortName>Balance Sheet Details (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/20210331/role/BalanceSheetDetails</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2315303 - Disclosure - Warranty and Extended Service Contract (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/WarrantyandExtendedServiceContractTables</Role>
      <ShortName>Warranty and Extended Service Contract (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/20210331/role/WarrantyandExtendedServiceContract</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2319304 - Disclosure - Deferred Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/DeferredRevenueTables</Role>
      <ShortName>Deferred Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/20210331/role/DeferredRevenue</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2325305 - Disclosure - Stockholders' Equity and Stock-based Compensation Expense (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseTables</Role>
      <ShortName>Stockholders' Equity and Stock-based Compensation Expense (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpense</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2331306 - Disclosure - Net Income (Loss) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/NetIncomeLossPerShareTables</Role>
      <ShortName>Net Income (Loss) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/20210331/role/NetIncomeLossPerShare</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2338307 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/20210331/role/Leases</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2349308 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/20210331/role/Debt</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2353309 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/20210331/role/SegmentReporting</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2403402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Cash, Cash Equivalents - Summary of Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/CashCashEquivalentsSummaryofCashandCashEquivalentsDetails</Role>
      <ShortName>Cash, Cash Equivalents - Summary of Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - Cash, Cash Equivalents - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/CashCashEquivalentsNarrativeDetails</Role>
      <ShortName>Cash, Cash Equivalents - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Balance Sheet Details - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/BalanceSheetDetailsInventoriesDetails</Role>
      <ShortName>Balance Sheet Details - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Balance Sheet Details - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Details - Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - Balance Sheet Details - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/BalanceSheetDetailsNarrativeDetails</Role>
      <ShortName>Balance Sheet Details - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - Warranty and Extended Service Contract - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/WarrantyandExtendedServiceContractNarrativeDetails</Role>
      <ShortName>Warranty and Extended Service Contract - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2417409 - Disclosure - Warranty and Extended Service Contract - Summary of Warranties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/WarrantyandExtendedServiceContractSummaryofWarrantiesDetails</Role>
      <ShortName>Warranty and Extended Service Contract - Summary of Warranties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2420410 - Disclosure - Deferred Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails</Role>
      <ShortName>Deferred Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2421411 - Disclosure - Deferred Revenue - Summary of Deferred Service Contract Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails</Role>
      <ShortName>Deferred Revenue - Summary of Deferred Service Contract Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2423412 - Disclosure - Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/RevenueNarrativeDetails</Role>
      <ShortName>Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2426413 - Disclosure - Stockholders' Equity and Stock-based Compensation Expense - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails</Role>
      <ShortName>Stockholders' Equity and Stock-based Compensation Expense - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2427414 - Disclosure - Stockholders' Equity and Stock-based Compensation Expense - Activity Of Options Outstanding Under the 2019 Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails</Role>
      <ShortName>Stockholders' Equity and Stock-based Compensation Expense - Activity Of Options Outstanding Under the 2019 Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2428415 - Disclosure - Stockholders' Equity and Stock-based Compensation Expense - Activity of Stock Awards Outstanding Under the 2019 Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails</Role>
      <ShortName>Stockholders' Equity and Stock-based Compensation Expense - Activity of Stock Awards Outstanding Under the 2019 Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2429416 - Disclosure - Stockholders' Equity and Stock-based Compensation Expense - Stock-based Compensation Expense By Department (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails</Role>
      <ShortName>Stockholders' Equity and Stock-based Compensation Expense - Stock-based Compensation Expense By Department (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2432417 - Disclosure - Net Income (Loss) Per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/NetIncomeLossPerShareNarrativeDetails</Role>
      <ShortName>Net Income (Loss) Per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cutera.com/20210331/role/NetIncomeLossPerShareTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2433418 - Disclosure - Net Income (Loss) Per Share - Net Income (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails</Role>
      <ShortName>Net Income (Loss) Per Share - Net Income (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cutera.com/20210331/role/NetIncomeLossPerShareTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2434419 - Disclosure - Net Income (Loss) Per Share - Antidilutive Securities Excluded From Computation of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails</Role>
      <ShortName>Net Income (Loss) Per Share - Antidilutive Securities Excluded From Computation of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cutera.com/20210331/role/NetIncomeLossPerShareTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2436420 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2439421 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2440422 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2441423 - Disclosure - Leases - Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/LeasesLeaseCostsDetails</Role>
      <ShortName>Leases - Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2442424 - Disclosure - Leases - Cash Paid for Amounts Included in the Measurement of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/LeasesCashPaidforAmountsIncludedintheMeasurementofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Cash Paid for Amounts Included in the Measurement of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2443425 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2444426 - Disclosure - Leases - Maturities of Finance Leases Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Finance Leases Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2445427 - Disclosure - Leases - Lease Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/LeasesLeaseInformationDetails</Role>
      <ShortName>Leases - Lease Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2447428 - Disclosure - Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/ContingenciesNarrativeDetails</Role>
      <ShortName>Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2450429 - Disclosure - Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/DebtNarrativeDetails</Role>
      <ShortName>Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2451430 - Disclosure - Debt - Outstanding Debt and Carrying Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails</Role>
      <ShortName>Debt - Outstanding Debt and Carrying Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2454431 - Disclosure - Segment Reporting - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/SegmentReportingNarrativeDetails</Role>
      <ShortName>Segment Reporting - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="cutr-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2455432 - Disclosure - Segment Reporting - Summary of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails</Role>
      <ShortName>Segment Reporting - Summary of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="cutr-20210630.htm">cutr-20210630.htm</File>
    <File>a1zomedicalandcuteraagreem.htm</File>
    <File>a2zoskinhealthamendment21a.htm</File>
    <File>a3zoskinhealthamendment25j.htm</File>
    <File>a4zoskinhealthamendment14j.htm</File>
    <File>cutr-20210630.xsd</File>
    <File>cutr-20210630_cal.xml</File>
    <File>cutr-20210630_def.xml</File>
    <File>cutr-20210630_lab.xml</File>
    <File>cutr-20210630_pre.xml</File>
    <File>cutr-20210630x10qexx311.htm</File>
    <File>cutr-20210630x10qexx312.htm</File>
    <File>cutr-20210630x10qexx321.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>137
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cutr-20210630.htm": {
   "axisCustom": 0,
   "axisStandard": 23,
   "contextCount": 220,
   "dts": {
    "calculationLink": {
     "local": [
      "cutr-20210630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cutr-20210630_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "cutr-20210630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cutr-20210630_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cutr-20210630_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cutr-20210630.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 513,
   "entityCount": 1,
   "hidden": {
    "http://cutera.com/20210331/20210630": 6,
    "http://fasb.org/us-gaap/2020-01-31": 12,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 23
   },
   "keyCustom": 43,
   "keyStandard": 357,
   "memberCustom": 23,
   "memberStandard": 34,
   "nsprefix": "cutr",
   "nsuri": "http://cutera.com/20210331/20210630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://cutera.com/20210331/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104102 - Disclosure - Cash, Cash Equivalents",
     "role": "http://cutera.com/20210331/role/CashCashEquivalents",
     "shortName": "Cash, Cash Equivalents",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - Fair Value of Financial Instruments",
     "role": "http://cutera.com/20210331/role/FairValueofFinancialInstruments",
     "shortName": "Fair Value of Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109104 - Disclosure - Balance Sheet Details",
     "role": "http://cutera.com/20210331/role/BalanceSheetDetails",
     "shortName": "Balance Sheet Details",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114105 - Disclosure - Warranty and Extended Service Contract",
     "role": "http://cutera.com/20210331/role/WarrantyandExtendedServiceContract",
     "shortName": "Warranty and Extended Service Contract",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cutr:ContractWithCustomerLiabilityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118106 - Disclosure - Deferred Revenue",
     "role": "http://cutera.com/20210331/role/DeferredRevenue",
     "shortName": "Deferred Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cutr:ContractWithCustomerLiabilityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122107 - Disclosure - Revenue",
     "role": "http://cutera.com/20210331/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124108 - Disclosure - Stockholders' Equity and Stock-based Compensation Expense",
     "role": "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpense",
     "shortName": "Stockholders' Equity and Stock-based Compensation Expense",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130109 - Disclosure - Net Income (Loss) Per Share",
     "role": "http://cutera.com/20210331/role/NetIncomeLossPerShare",
     "shortName": "Net Income (Loss) Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135110 - Disclosure - Income Taxes",
     "role": "http://cutera.com/20210331/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock",
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137111 - Disclosure - Leases",
     "role": "http://cutera.com/20210331/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock",
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146112 - Disclosure - Contingencies",
     "role": "http://cutera.com/20210331/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148113 - Disclosure - Debt",
     "role": "http://cutera.com/20210331/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152114 - Disclosure - Segment Reporting",
     "role": "http://cutera.com/20210331/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Cash, Cash Equivalents (Tables)",
     "role": "http://cutera.com/20210331/role/CashCashEquivalentsTables",
     "shortName": "Cash, Cash Equivalents (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2310302 - Disclosure - Balance Sheet Details (Tables)",
     "role": "http://cutera.com/20210331/role/BalanceSheetDetailsTables",
     "shortName": "Balance Sheet Details (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315303 - Disclosure - Warranty and Extended Service Contract (Tables)",
     "role": "http://cutera.com/20210331/role/WarrantyandExtendedServiceContractTables",
     "shortName": "Warranty and Extended Service Contract (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319304 - Disclosure - Deferred Revenue (Tables)",
     "role": "http://cutera.com/20210331/role/DeferredRevenueTables",
     "shortName": "Deferred Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325305 - Disclosure - Stockholders' Equity and Stock-based Compensation Expense (Tables)",
     "role": "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseTables",
     "shortName": "Stockholders' Equity and Stock-based Compensation Expense (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331306 - Disclosure - Net Income (Loss) Per Share (Tables)",
     "role": "http://cutera.com/20210331/role/NetIncomeLossPerShareTables",
     "shortName": "Net Income (Loss) Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cutr:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338307 - Disclosure - Leases (Tables)",
     "role": "http://cutera.com/20210331/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cutr:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2349308 - Disclosure - Debt (Tables)",
     "role": "http://cutera.com/20210331/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353309 - Disclosure - Segment Reporting (Tables)",
     "role": "http://cutera.com/20210331/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cutr:NumberOfCountriesInWhichEntityUtilizesADistributorNetwork",
      "reportCount": 1,
      "unitRef": "country",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - Cash, Cash Equivalents - Summary of Cash and Cash Equivalents (Details)",
     "role": "http://cutera.com/20210331/role/CashCashEquivalentsSummaryofCashandCashEquivalentsDetails",
     "shortName": "Cash, Cash Equivalents - Summary of Cash and Cash Equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - Cash, Cash Equivalents - Narrative (Details)",
     "role": "http://cutera.com/20210331/role/CashCashEquivalentsNarrativeDetails",
     "shortName": "Cash, Cash Equivalents - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Balance Sheet Details - Inventories (Details)",
     "role": "http://cutera.com/20210331/role/BalanceSheetDetailsInventoriesDetails",
     "shortName": "Balance Sheet Details - Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Balance Sheet Details - Accrued Liabilities (Details)",
     "role": "http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails",
     "shortName": "Balance Sheet Details - Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StandardProductWarrantyAccrual",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - Balance Sheet Details - Narrative (Details)",
     "role": "http://cutera.com/20210331/role/BalanceSheetDetailsNarrativeDetails",
     "shortName": "Balance Sheet Details - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i467c84ff364946159dcd87dd18558b41_D20210401-20210630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "cutr:StandardAndExtendedProductWarrantyAccrualExcessReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i467c84ff364946159dcd87dd18558b41_D20210401-20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ExtendedProductWarrantyAccrualPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - Warranty and Extended Service Contract - Narrative (Details)",
     "role": "http://cutera.com/20210331/role/WarrantyandExtendedServiceContractNarrativeDetails",
     "shortName": "Warranty and Extended Service Contract - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i467c84ff364946159dcd87dd18558b41_D20210401-20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ExtendedProductWarrantyAccrualPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i467c84ff364946159dcd87dd18558b41_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations",
     "role": "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i467c84ff364946159dcd87dd18558b41_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i44e8ae2855f24ec191abeac87edead4a_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StandardProductWarrantyAccrual",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417409 - Disclosure - Warranty and Extended Service Contract - Summary of Warranties (Details)",
     "role": "http://cutera.com/20210331/role/WarrantyandExtendedServiceContractSummaryofWarrantiesDetails",
     "shortName": "Warranty and Extended Service Contract - Summary of Warranties (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i467c84ff364946159dcd87dd18558b41_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StandardProductWarrantyAccrualWarrantiesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420410 - Disclosure - Deferred Revenue - Narrative (Details)",
     "role": "http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails",
     "shortName": "Deferred Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i467c84ff364946159dcd87dd18558b41_D20210401-20210630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "cutr:CostsForExtendedServiceContracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i44e8ae2855f24ec191abeac87edead4a_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421411 - Disclosure - Deferred Revenue - Summary of Deferred Service Contract Revenue (Details)",
     "role": "http://cutera.com/20210331/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails",
     "shortName": "Deferred Revenue - Summary of Deferred Service Contract Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i467c84ff364946159dcd87dd18558b41_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cutr:RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423412 - Disclosure - Revenue - Narrative (Details)",
     "role": "http://cutera.com/20210331/role/RevenueNarrativeDetails",
     "shortName": "Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cutr:RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426413 - Disclosure - Stockholders' Equity and Stock-based Compensation Expense - Narrative (Details)",
     "role": "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails",
     "shortName": "Stockholders' Equity and Stock-based Compensation Expense - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ie58ba076e2704369a7e7ca1be3068f0a_D20210101-20210630",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ic827721b28ff49aca3277a242cc858a0_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427414 - Disclosure - Stockholders' Equity and Stock-based Compensation Expense - Activity Of Options Outstanding Under the 2019 Plans (Details)",
     "role": "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails",
     "shortName": "Stockholders' Equity and Stock-based Compensation Expense - Activity Of Options Outstanding Under the 2019 Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "cutr:ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428415 - Disclosure - Stockholders' Equity and Stock-based Compensation Expense - Activity of Stock Awards Outstanding Under the 2019 Plans (Details)",
     "role": "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails",
     "shortName": "Stockholders' Equity and Stock-based Compensation Expense - Activity of Stock Awards Outstanding Under the 2019 Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i4c3011eb06b8441e960fb49156c2b7bb_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i467c84ff364946159dcd87dd18558b41_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429416 - Disclosure - Stockholders' Equity and Stock-based Compensation Expense - Stock-based Compensation Expense By Department (Details)",
     "role": "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails",
     "shortName": "Stockholders' Equity and Stock-based Compensation Expense - Stock-based Compensation Expense By Department (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ie6d4ff6c6be04324bd9520f1387d71dc_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i28760ad245b749f6b1743389a6736740_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432417 - Disclosure - Net Income (Loss) Per Share - Narrative (Details)",
     "role": "http://cutera.com/20210331/role/NetIncomeLossPerShareNarrativeDetails",
     "shortName": "Net Income (Loss) Per Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i28760ad245b749f6b1743389a6736740_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i467c84ff364946159dcd87dd18558b41_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433418 - Disclosure - Net Income (Loss) Per Share - Net Income (Loss) Per Share (Details)",
     "role": "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails",
     "shortName": "Net Income (Loss) Per Share - Net Income (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i467c84ff364946159dcd87dd18558b41_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i467c84ff364946159dcd87dd18558b41_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)",
     "role": "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i467c84ff364946159dcd87dd18558b41_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i467c84ff364946159dcd87dd18558b41_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434419 - Disclosure - Net Income (Loss) Per Share - Antidilutive Securities Excluded From Computation of Earnings Per Share (Details)",
     "role": "http://cutera.com/20210331/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
     "shortName": "Net Income (Loss) Per Share - Antidilutive Securities Excluded From Computation of Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i467c84ff364946159dcd87dd18558b41_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i467c84ff364946159dcd87dd18558b41_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436420 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://cutera.com/20210331/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeaseRenewalTerm1",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439421 - Disclosure - Leases - Narrative (Details)",
     "role": "http://cutera.com/20210331/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ie02f2877a5a94ba1af32fcc4842c447f_D20201001-20201231",
      "decimals": null,
      "lang": "en-US",
      "name": "cutr:LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cutr:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440422 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)",
     "role": "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cutr:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i467c84ff364946159dcd87dd18558b41_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441423 - Disclosure - Leases - Lease Costs (Details)",
     "role": "http://cutera.com/20210331/role/LeasesLeaseCostsDetails",
     "shortName": "Leases - Lease Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i467c84ff364946159dcd87dd18558b41_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseInterestPaymentOnLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442424 - Disclosure - Leases - Cash Paid for Amounts Included in the Measurement of Lease Liabilities (Details)",
     "role": "http://cutera.com/20210331/role/LeasesCashPaidforAmountsIncludedintheMeasurementofLeaseLiabilitiesDetails",
     "shortName": "Leases - Cash Paid for Amounts Included in the Measurement of Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseInterestPaymentOnLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443425 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)",
     "role": "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturities of Operating Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444426 - Disclosure - Leases - Maturities of Finance Leases Liabilities (Details)",
     "role": "http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails",
     "shortName": "Leases - Maturities of Finance Leases Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445427 - Disclosure - Leases - Lease Information (Details)",
     "role": "http://cutera.com/20210331/role/LeasesLeaseInformationDetails",
     "shortName": "Leases - Lease Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i0078d122644a4dddab29d2f40360b3c0_I20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447428 - Disclosure - Contingencies - Narrative (Details)",
     "role": "http://cutera.com/20210331/role/ContingenciesNarrativeDetails",
     "shortName": "Contingencies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i0078d122644a4dddab29d2f40360b3c0_I20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i2f3e187f8cdd4a27a16464c1e2230fec_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Consolidated Statements of Changes In Stockholders' Equity (Unaudited)",
     "role": "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited",
     "shortName": "Consolidated Statements of Changes In Stockholders' Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i2f3e187f8cdd4a27a16464c1e2230fec_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i44e8ae2855f24ec191abeac87edead4a_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeCapPrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerItem",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450429 - Disclosure - Debt - Narrative (Details)",
     "role": "http://cutera.com/20210331/role/DebtNarrativeDetails",
     "shortName": "Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i44e8ae2855f24ec191abeac87edead4a_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeCapPrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerItem",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i85fff53fbac547228677e769db10e805_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451430 - Disclosure - Debt - Outstanding Debt and Carrying Value (Details)",
     "role": "http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails",
     "shortName": "Debt - Outstanding Debt and Carrying Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ib7035befba854bb787b41b7a326649e7_I20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454431 - Disclosure - Segment Reporting - Narrative (Details)",
     "role": "http://cutera.com/20210331/role/SegmentReportingNarrativeDetails",
     "shortName": "Segment Reporting - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i467c84ff364946159dcd87dd18558b41_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455432 - Disclosure - Segment Reporting - Summary of Revenue (Details)",
     "role": "http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails",
     "shortName": "Segment Reporting - Summary of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "i257d2e51a1bc4c85b8cffc47eabccc0b_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007007 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ia11ce6b42e50441a8bfd1cd6564d5f99_D20200401-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1406401 - Statement - Consolidated Statements of Changes In Stockholders' Equity (Unaudited) (Parenthetical)",
     "role": "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnauditedParenthetical",
     "shortName": "Consolidated Statements of Changes In Stockholders' Equity (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ia11ce6b42e50441a8bfd1cd6564d5f99_D20200401-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://cutera.com/20210331/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20210630.htm",
      "contextRef": "ide53b89e851c44e5908a02860291ac35_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 62,
   "tag": {
    "country_JP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "JAPAN",
        "terseLabel": "Japan"
       }
      }
     },
     "localname": "JP",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails",
      "http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_AccruedInventoryInTransitCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents current accrued inventory.",
        "label": "Accrued Inventory In Transit, Current",
        "terseLabel": "Accrued inventory in transit"
       }
      }
     },
     "localname": "AccruedInventoryInTransitCurrent",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of adjustments to additional paid in capital purchase of capped call.",
        "label": "Purchase of capped call",
        "terseLabel": "Purchase of capped call"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_AmendedAndRestated2004EquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended And Restated 2004 Equity Incentive Plan",
        "label": "Amended And Restated 2004 Equity Incentive Plan [Member]",
        "terseLabel": "Prior Plan"
       }
      }
     },
     "localname": "AmendedAndRestated2004EquityIncentivePlanMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_AmortizationOfDebtIssuanceCostsNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization Of Debt Issuance Costs, Net Of Tax",
        "label": "Amortization Of Debt Issuance Costs, Net Of Tax",
        "terseLabel": "Amortization of debt issuance cost, net of tax"
       }
      }
     },
     "localname": "AmortizationOfDebtIssuanceCostsNetOfTax",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_AsiaExcludingJapanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia, Excluding Japan [Member]",
        "terseLabel": "Asia, excluding Japan"
       }
      }
     },
     "localname": "AsiaExcludingJapanMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cutr_BasisOfPresentationPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of Presentation",
        "label": "Basis of Presentation [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfPresentationPolicyTextBlock",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cutr_CappedCallTransactionsCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of costs associated with capped call transactions.",
        "label": "Capped Call Transactions Costs",
        "terseLabel": "Capped call transactions costs"
       }
      }
     },
     "localname": "CappedCallTransactionsCosts",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_ChangeInContractWithCustomerLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Contract with Customer, Liability",
        "label": "Change in Contract with Customer, Liability [Roll Forward]",
        "terseLabel": "Change in Contract with Customer, Liability [Roll Forward]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityRollForward",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cutr_ChangeInRightofuseAssetAndLiabilityDueToModification": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the change in right-of-use asset and liability due to modification during the period.",
        "label": "Change in right-of-use asset",
        "terseLabel": "Change in right-of-use assets"
       }
      }
     },
     "localname": "ChangeInRightofuseAssetAndLiabilityDueToModification",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_ConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to consumables.",
        "label": "Consumables [Member]",
        "terseLabel": "Consumables"
       }
      }
     },
     "localname": "ConsumablesMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from advance payments received.",
        "label": "Contract With Customer, Liability, Increase, Advance Payments Received",
        "terseLabel": "Add: Payments received"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_ContractWithCustomerLiabilityPeriodDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from revenue deferred.",
        "label": "Contract With Customer, Liability, Period Decrease",
        "negatedLabel": "Less: Revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityPeriodDecrease",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_ContractWithCustomerLiabilityTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of contract with customer liability.",
        "label": "Contract with Customer Liability [Text Block]",
        "terseLabel": "Deferred Revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityTextBlock",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DeferredRevenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Training Provided With Sale Of System, Period",
        "label": "Contract With Customer, Liability, Training Provided With Sale Of System, Period",
        "terseLabel": "Training provided with sale of system, period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to the first conversion trigger of debt.",
        "label": "Convertible Senior Notes Due 2026, First Conversion Trigger [Member]",
        "terseLabel": "Convertible Senior Notes Due 2026, First Conversion Trigger"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2026FirstConversionTriggerMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ConvertibleSeniorNotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to convertible senior notes due 2026.",
        "label": "Convertible Senior Notes Due 2026 [Member]",
        "terseLabel": "Convertible Senior Notes Due 2026"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2026Member",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails",
      "http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails",
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNarrativeDetails",
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to the second conversion trigger feature of debt.",
        "label": "Convertible Senior Notes Due 2026, Second Conversion Trigger [Member]",
        "terseLabel": "Convertible Senior Notes Due 2026, Second Conversion Trigger"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2026SecondConversionTriggerMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_CostsForExtendedServiceContracts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs for extended service contracts during period.",
        "label": "Costs For Extended Service Contracts",
        "terseLabel": "Costs for Extended Service Contracts"
       }
      }
     },
     "localname": "CostsForExtendedServiceContracts",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_CustomerMarketingSupportMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Marketing Support",
        "label": "Customer Marketing Support [Member]",
        "terseLabel": "Customer Marketing Support"
       }
      }
     },
     "localname": "CustomerMarketingSupportMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_DebtCovenantQuarterlyMinimumRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents quarterly minimum revenue under debt covenant.",
        "label": "Debt Covenant, Quarterly Minimum Revenue",
        "terseLabel": "Quarterly minimum revenue"
       }
      }
     },
     "localname": "DebtCovenantQuarterlyMinimumRevenue",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DebtInstrumentAnniversaryFeeAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents anniversary fee amount for debt instrument.",
        "label": "Debt Instrument, Anniversary Fee Amount",
        "terseLabel": "Anniversary fee amount"
       }
      }
     },
     "localname": "DebtInstrumentAnniversaryFeeAmount",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of required outstanding amount not subject to redemption of a convertible debt instrument.",
        "label": "Debt Instrument, Convertible Required, Outstanding Amount Not Subject To Redemption",
        "terseLabel": "Required outstanding amount not subject to redemption"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents percentage of qualifying accounts receivable for debt instrument.",
        "label": "Debt Instrument, Percentage Of Qualifying Accounts Receivable",
        "terseLabel": "Qualifying accounts receivable"
       }
      }
     },
     "localname": "DebtInstrumentPercentageOfQualifyingAccountsReceivable",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Redeemable, Threshold Consecutive Trading Days",
        "label": "Debt Instrument, Redeemable, Threshold Consecutive Trading Days",
        "terseLabel": "Redemption threshold consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentRedeemableThresholdConsecutiveTradingDays",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Redeemable, Threshold Percentage of Stock Price Trigger",
        "label": "Debt Instrument, Redeemable, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Redemption threshold percentage of stock price trigger"
       }
      }
     },
     "localname": "DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_DebtInstrumentRedeemableThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Redeemable, Threshold Trading Days",
        "label": "Debt Instrument, Redeemable, Threshold Trading Days",
        "terseLabel": "Redemption threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentRedeemableThresholdTradingDays",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Redemption, Incremental Repurchase Amount",
        "label": "Debt Instrument, Redemption, Incremental Repurchase Amount",
        "terseLabel": "Incremental repurchase amount"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionIncrementalRepurchaseAmount",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets, excluding contract acquisition costs.",
        "label": "Depreciation and amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortizationExcludingContractAcquisitionCosts",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DerivativeCapPricePremiumOverStockPricePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percent premium over the stock price for derivative caps.",
        "label": "Derivative, Cap Price, Premium Over Stock Price, Percent",
        "terseLabel": "Premium over stock price (percent)"
       }
      }
     },
     "localname": "DerivativeCapPricePremiumOverStockPricePercent",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Capped Call Transaction Term, Consecutive Trading Days",
        "label": "Derivative, Capped Call Transaction Term, Consecutive Trading Days",
        "terseLabel": "Capped-call transaction term, consecutive trading days"
       }
      }
     },
     "localname": "DerivativeCappedCallTransactionTermConsecutiveTradingDays",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cutr_ExecutiveOfficersAndSeniorManagementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Executive Officers And Senior Management",
        "label": "Executive Officers And Senior Management [Member]",
        "terseLabel": "Executive Officers And Senior Management"
       }
      }
     },
     "localname": "ExecutiveOfficersAndSeniorManagementMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExecutiveOfficersSeniorManagementAndCertainEmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Executive Officers, Senior Management, And Certain Employees",
        "label": "Executive Officers, Senior Management, And Certain Employees [Member]",
        "terseLabel": "Executive Officers, Senior Management, and Certain Employees"
       }
      }
     },
     "localname": "ExecutiveOfficersSeniorManagementAndCertainEmployeesMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExtendedServiceContractOptionOneTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extended Service Contract, Option One, Term",
        "label": "Extended Service Contract, Option One, Term",
        "terseLabel": "Extended service contract, option one, term"
       }
      }
     },
     "localname": "ExtendedServiceContractOptionOneTerm",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_ExtendedServiceContractOptionThreeTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extended Service Contract, Option Three, Term",
        "label": "Extended Service Contract, Option Three, Term",
        "terseLabel": "Extended service contract, option three, term"
       }
      }
     },
     "localname": "ExtendedServiceContractOptionThreeTerm",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_ExtendedServiceContractOptionTwoTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extended Service Contract, Option Two, Term",
        "label": "Extended Service Contract, Option Two, Term",
        "terseLabel": "Extended service contract, option two, term"
       }
      }
     },
     "localname": "ExtendedServiceContractOptionTwoTerm",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_FinanceLeaseLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liabilities, Lessee",
        "label": "Finance Lease, Liabilities, Lessee [Abstract]",
        "terseLabel": "Finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesLesseeAbstract",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of increase (decrease) in extended product warranty accrual.",
        "label": "cutr_IncreaseDecreaseInExtendedProductWarrantyAccrual",
        "verboseLabel": "Extended warranty liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInExtendedProductWarrantyAccrual",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of increase (decrease) in operating lease liabilities.",
        "label": "cutr_IncreaseDecreaseInOperatingLeaseLiabilities",
        "verboseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_LeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under finance and operating lease.",
        "label": "Lease Right-Of-Use Asset",
        "totalLabel": "Total leased assets"
       }
      }
     },
     "localname": "LeaseRightOfUseAsset",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_LeasesWeightedAverageDiscountRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases, Weighted Average Discount Rate",
        "label": "Leases, Weighted Average Discount Rate [Abstract]",
        "terseLabel": "Weighted-average discount rate"
       }
      }
     },
     "localname": "LeasesWeightedAverageDiscountRateAbstract",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesLeaseInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cutr_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessor, Sales-type Lease, Lessee Option to Purchase Underlying Asset, Term",
        "label": "Lessor, Sales-type Lease, Lessee Option to Purchase Underlying Asset, Term",
        "terseLabel": "Customers' right to purchase leased system, term"
       }
      }
     },
     "localname": "LessorSalesTypeLeaseLesseeOptionToPurchaseUnderlyingAssetTerm",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_LoanAndSecurityAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the Loan and Security Agreement.",
        "label": "Loan and Security Agreement [Member]",
        "terseLabel": "Loan and Security Agreement"
       }
      }
     },
     "localname": "LoanAndSecurityAgreementMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_LoyaltyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to loyalty",
        "label": "Loyalty [Member]",
        "terseLabel": "Loyalty"
       }
      }
     },
     "localname": "LoyaltyMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_NonEmployeeDirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Employee Directors",
        "label": "Non-Employee Directors [Member]",
        "terseLabel": "Non-Employee Directors"
       }
      }
     },
     "localname": "NonEmployeeDirectorsMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_NonqualifiedStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to non-qualified stock options.",
        "label": "Non-qualified Stock Options [Member]",
        "terseLabel": "Non-qualified Stock Options"
       }
      }
     },
     "localname": "NonqualifiedStockOptionsMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_NumberOfCountriesInWhichEntityUtilizesADistributorNetwork": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Countries In Which Entity Utilizes A Distributor Network",
        "label": "Number Of Countries In Which Entity Utilizes A Distributor Network",
        "terseLabel": "Number of countries in which entity utilizes a distributor network"
       }
      }
     },
     "localname": "NumberOfCountriesInWhichEntityUtilizesADistributorNetwork",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cutr_OperatingLeaseLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Liabilities, Lessee",
        "label": "Operating Lease, Liabilities, Lessee [Abstract]",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesLesseeAbstract",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cutr_PaycheckProtectionProgramCARESActMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents loan designed to provide funds for small businesses to keep their employees on the payroll.",
        "label": "Paycheck Protection Program CARES Act [Member]",
        "terseLabel": "PPP Loan"
       }
      }
     },
     "localname": "PaycheckProtectionProgramCARESActMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash inflow from proceeds from the exercise of purchase option sales type lease.",
        "label": "Proceeds From Exercise Of Purchase Option, Sales-Type Lease",
        "terseLabel": "Proceeds from customer's exercise of purchase option"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfPurchaseOptionSalesTypeLease",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_ProductRemediationLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to product remediation liability.",
        "label": "Product Remediation Liability [Member]",
        "terseLabel": "Product Remediation Liability"
       }
      }
     },
     "localname": "ProductRemediationLiabilityMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ProductsExcludingConsumablesAndSkincareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to products excluding consumables and skincare.",
        "label": "Products Excluding Consumables and Skincare [Member]",
        "terseLabel": "Products"
       }
      }
     },
     "localname": "ProductsExcludingConsumablesAndSkincareMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_RestOfWorldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rest of World [Member]",
        "terseLabel": "Rest of the World, other than United States, Asia and Europe"
       }
      }
     },
     "localname": "RestOfWorldMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents restricted stock units and performance share units.",
        "label": "Restricted Stock Units and Performance Share Units [Member]",
        "terseLabel": "Stock awards"
       }
      }
     },
     "localname": "RestrictedStockUnitsAndPerformanceShareUnitsMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_RevenueFromContractWithCustomerTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer, Term Of Contract",
        "label": "Revenue From Contract With Customer, Term Of Contract",
        "terseLabel": "Term of contract"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTermOfContract",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer, Typical Payment Receipt, Period Post Shipment",
        "label": "Revenue From Contract With Customer, Typical Payment Receipt, Period Post Shipment",
        "terseLabel": "Typical payment receipt, period post shipment"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTypicalPaymentReceiptPeriodPostShipment",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_RevenuePerformanceObligationSatisfiedOverTimePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of revenue from performance obligations that are transferred to customers over time.",
        "label": "Revenue, Performance Obligation, Satisfied Over Time, Percent",
        "terseLabel": "Revenue from performance obligations transferred to customers, percent"
       }
      }
     },
     "localname": "RevenuePerformanceObligationSatisfiedOverTimePercent",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_RisksAndUncertaintiesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for risks and uncertainties.",
        "label": "Risks and Uncertainties, Policy [Policy Text Block]",
        "terseLabel": "Risks and Uncertainties"
       }
      }
     },
     "localname": "RisksAndUncertaintiesPolicyPolicyTextBlock",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cutr_SaleOfThirdPartyProductWarrantyPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Third-Party Product, Warranty Period",
        "label": "Sale Of Third-Party Product, Warranty Period",
        "terseLabel": "Sale of third-party product, warranty period"
       }
      }
     },
     "localname": "SaleOfThirdPartyProductWarrantyPeriod",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_SalesAndMarketingAccrualsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for sales and marketing costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Sales And Marketing Accruals, Current",
        "terseLabel": "Sales and marketing accruals"
       }
      }
     },
     "localname": "SalesAndMarketingAccrualsCurrent",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The monthly percentage of award vesting rights after the first year under a share-based compensation arrangement.",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Award Vesting Rights, Monthly Percentage After First Year",
        "terseLabel": "Award vesting rights, monthly after first year (percentage)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMonthlyPercentageAfterFirstYear",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Exercises In Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Exercises In Period",
        "terseLabel": "Options exercised (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExercisesInPeriod",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Available For Grant",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Available For Grant [Roll Forward]",
        "terseLabel": "Shares Available for Grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment, Shares Available For Grant, Additional Shares Reserved",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment, Shares Available For Grant, Additional Shares Reserved",
        "verboseLabel": "Additional shares reserved (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cutr_ShareBasedPaymentArrangementTrancheFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Payment Arrangement, Tranche Four",
        "label": "Share-based Payment Arrangement, Tranche Four [Member]",
        "terseLabel": "2022 Tranche"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementTrancheFourMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_SiliconValleyBankMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to Silicon Valley Bank.",
        "label": "Silicon Valley Bank [Member]",
        "terseLabel": "Silicon Valley Bank"
       }
      }
     },
     "localname": "SiliconValleyBankMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_SkincareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Skincare [Member]",
        "terseLabel": "Skincare"
       }
      }
     },
     "localname": "SkincareMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails",
      "http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_StandardAndExtendedProductWarrantyAccrualExcessReserves": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Standard And Extended Product Warranty Accrual, Excess Reserves",
        "label": "Standard And Extended Product Warranty Accrual, Excess Reserves",
        "terseLabel": "Standard and extended product warranty, excess reserves"
       }
      }
     },
     "localname": "StandardAndExtendedProductWarrantyAccrualExcessReserves",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_TwoThousandNineteenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to the 2019 equity incentive plan.",
        "label": "Two Thousand Nineteen Equity Incentive Plan [Member]",
        "terseLabel": "2019 Plan"
       }
      }
     },
     "localname": "TwoThousandNineteenEquityIncentivePlanMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_WeightedAverageRemainingLeaseTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Lease Term",
        "label": "Weighted Average Remaining Lease Term [Abstract]",
        "terseLabel": "Weighted-average remaining lease term (years)"
       }
      }
     },
     "localname": "WeightedAverageRemainingLeaseTermAbstract",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesLeaseInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cutr_WellsFargoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to the lender, Wells Fargo.",
        "label": "Wells Fargo [Member]",
        "terseLabel": "Wells Fargo"
       }
      }
     },
     "localname": "WellsFargoMember",
     "nsuri": "http://cutera.com/20210331/20210630",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "CEO"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r281",
      "r282",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r431",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails",
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r281",
      "r282",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r431",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails",
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r177",
      "r260",
      "r264",
      "r406",
      "r430",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations",
      "http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/20210331/role/RevenueNarrativeDetails",
      "http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r177",
      "r260",
      "r264",
      "r406",
      "r430",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations",
      "http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/20210331/role/RevenueNarrativeDetails",
      "http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r272",
      "r281",
      "r282",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r431",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails",
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r272",
      "r281",
      "r282",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r431",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails",
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r178",
      "r179",
      "r260",
      "r265",
      "r433",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails",
      "http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r178",
      "r179",
      "r260",
      "r265",
      "r433",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails",
      "http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r183",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r3",
      "r16",
      "r184",
      "r185"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for credit losses of $1,639 and $1,598, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails",
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r37"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Salaries, Current",
        "terseLabel": "Accrued payroll and related expenses"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r51",
      "r53",
      "r56",
      "r106",
      "r107",
      "r108",
      "r343",
      "r435",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r106",
      "r107",
      "r108",
      "r309",
      "r310",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r283",
      "r285",
      "r314",
      "r315"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r240",
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "terseLabel": "Stock issued, offering cost"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r285",
      "r305",
      "r313"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r22",
      "r186",
      "r193"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for credit loss, current"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfAcquisitionCosts": {
     "auth_ref": [
      "r91",
      "r201"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of capitalized costs associated with acquisition of business. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Acquisition Costs",
        "terseLabel": "Amortization of contract acquisition costs"
       }
      }
     },
     "localname": "AmortizationOfAcquisitionCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r68",
      "r91",
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance cost, net of tax"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r91",
      "r364"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "negatedLabel": "Amortization of debt issuance costs",
        "terseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows",
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r101",
      "r163",
      "r167",
      "r173",
      "r191",
      "r339",
      "r344",
      "r354",
      "r408",
      "r420"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets",
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r46",
      "r101",
      "r191",
      "r339",
      "r344",
      "r354"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r286",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails",
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails",
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Accounting Policies"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAdditions": {
     "auth_ref": [
      "r202"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions made to capitalized computer software costs during the period.",
        "label": "Capitalized Computer Software, Additions",
        "terseLabel": "Capitalized cloud computing systems implementation costs"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAdditions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareImpairments1": {
     "auth_ref": [
      "r450",
      "r452"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss from capitalized computer software costs.",
        "label": "Capitalized Computer Software, Impairments",
        "terseLabel": "Impairment of capitalized cloud computing costs"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareImpairments1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAmortization": {
     "auth_ref": [
      "r198"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Amortization",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAmortizationPeriod": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Capitalized Contract Cost, Amortization Period",
        "terseLabel": "Capitalized Contract Cost, Amortization Period"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortizationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_CapitalizedContractCostNet": {
     "auth_ref": [
      "r197"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Net",
        "terseLabel": "Capitalized contract costs"
       }
      }
     },
     "localname": "CapitalizedContractCostNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r1",
      "r32",
      "r93"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CashCashEquivalentsSummaryofCashandCashEquivalentsDetails",
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).",
        "label": "Cash, Cash Equivalents, and Marketable Securities [Text Block]",
        "terseLabel": "Cash, Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CashCashEquivalents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r88",
      "r93",
      "r98"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r88",
      "r355"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash items:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r100",
      "r101",
      "r123",
      "r127",
      "r131",
      "r134",
      "r136",
      "r145",
      "r146",
      "r147",
      "r191",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r43",
      "r212",
      "r412",
      "r425"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies (Notes 12)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r106",
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited",
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnauditedParenthetical",
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r15",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)",
        "terseLabel": "Common stock outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value; authorized: 50,000,000 shares; issued and outstanding: 17,933,020 and 17,679,232 shares at June\u00a030, 2021 and December\u00a031, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r59",
      "r61",
      "r62",
      "r64",
      "r415",
      "r427"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "auth_ref": [
      "r99",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "terseLabel": "Description of Operations and Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Summary of Deferred Service Contract Revenue"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DeferredRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r247",
      "r248",
      "r261"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Contract with customer, liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails",
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "negatedLabel": "Less: Revenue included in the beginning balance and recognized as revenue in the current quarter"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebt": {
     "auth_ref": [
      "r12",
      "r410",
      "r422"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.",
        "label": "Convertible Debt",
        "terseLabel": "Carrying amount of convertible debt"
       }
      }
     },
     "localname": "ConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "terseLabel": "Convertible debt at fair value"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails",
      "http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails",
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "Convertible notes, net of unamortized debt issuance costs of $4,450"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.",
        "label": "Convertible Debt Securities [Member]",
        "terseLabel": "Convertible notes"
       }
      }
     },
     "localname": "ConvertibleDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of borrowings which can be exchanged for a specified number of another security at the option of the issuer or the holder. Disclosures include, but are not limited to, principal amount, amortized premium or discount, and amount of liability and equity components.",
        "label": "Convertible Debt [Table Text Block]",
        "terseLabel": "Summary of Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r71",
      "r406"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Total cost of revenue"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Cost of revenue:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r10",
      "r11",
      "r12",
      "r409",
      "r410",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails",
      "http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails",
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNarrativeDetails",
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r12",
      "r232",
      "r410",
      "r419"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Outstanding principal amount"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Conversion price (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r40",
      "r241",
      "r242",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Convertible debt, conversion ratio"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments": {
     "auth_ref": [
      "r40",
      "r241",
      "r242",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.",
        "label": "Debt Instrument, Convertible, Number of Equity Instruments",
        "terseLabel": "Debt convertible to common shares (in shares)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleNumberOfEquityInstruments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Threshold Consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Conversion threshold percentage of stock price trigger"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Conversion threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r363",
      "r365"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Notes issued"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r39",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Effective interest rate during period"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails",
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails",
      "http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails",
      "http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails",
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNarrativeDetails",
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Occurrence of Fundamental Change"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price, percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r41",
      "r103",
      "r241",
      "r243",
      "r244",
      "r245",
      "r362",
      "r363",
      "r365",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails",
      "http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r362",
      "r365"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Unamortized debt issuance costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r233",
      "r364"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedLabel": "Unamortized debt issuance costs",
        "terseLabel": "Unamortized debt issuance costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction": {
     "auth_ref": [
      "r95",
      "r96",
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction.",
        "label": "Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction",
        "terseLabel": "Debt issuance costs accrued"
       }
      }
     },
     "localname": "DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r318",
      "r319"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax asset"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r91",
      "r102",
      "r324",
      "r329",
      "r330",
      "r331"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Change in deferred tax asset"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "terseLabel": "Deferred revenue, net of current portion"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeCapPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cap rate on a price risk derivative such as a cap or collar. A payment or receipt is triggered if the market rate exceeds the cap rate on the contract.",
        "label": "Derivative, Cap Price",
        "terseLabel": "Cap price (in USD per per share)"
       }
      }
     },
     "localname": "DerivativeCapPrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "perUnitItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails",
      "http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r260",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails",
      "http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stockholders' Equity and Stock-based Compensation Expense"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpense"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income (loss) per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r65",
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r120",
      "r123",
      "r134",
      "r135",
      "r136",
      "r140",
      "r141",
      "r416",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (USD per share)",
        "verboseLabel": "Net income (loss) per share, basic (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations",
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Net income (loss) per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r65",
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r123",
      "r134",
      "r135",
      "r136",
      "r140",
      "r141",
      "r416",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (USD per share)",
        "verboseLabel": "Net income (loss) per share, diluted (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations",
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Dilutive effect of incremental shares and share equivalents:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDilutedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareDilutedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r306"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Estimated weighted-average remaining amortization period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee stock purchase plan shares",
        "verboseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Options",
        "verboseLabel": "Options to purchase common stock"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r106",
      "r107",
      "r108",
      "r110",
      "r116",
      "r118",
      "r144",
      "r192",
      "r240",
      "r246",
      "r309",
      "r310",
      "r311",
      "r325",
      "r326",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r435",
      "r436",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited",
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnauditedParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtendedProductWarrantyAccrual": {
     "auth_ref": [
      "r226"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the aggregate extended product warranty liability. Does not include the ending balance for the standard product warranty liability.",
        "label": "Extended Product Warranty Accrual",
        "terseLabel": "Extended product warranty accrual"
       }
      }
     },
     "localname": "ExtendedProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsNarrativeDetails",
      "http://cutera.com/20210331/role/WarrantyandExtendedServiceContractSummaryofWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExtendedProductWarrantyAccrualCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount at end of the reporting period of the aggregate extended product warranty liability that is expected to be paid within one year of the balance sheet date or normal operating cycle, if longer. Does not include the balance for the standard product warranty liability.",
        "label": "Extended Product Warranty Accrual, Current",
        "terseLabel": "Extended warranty liability"
       }
      }
     },
     "localname": "ExtendedProductWarrantyAccrualCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExtendedProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the extended product warranty. Excludes standard product warranties.",
        "label": "Extended Product Warranty Accrual, Decrease for Payments",
        "terseLabel": "Extended service contracts charge"
       }
      }
     },
     "localname": "ExtendedProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/WarrantyandExtendedServiceContractNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r350",
      "r396",
      "r397",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/FairValueofFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r273",
      "r274",
      "r279",
      "r280",
      "r350",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r396",
      "r397",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r371",
      "r379",
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Finance lease cost, Interest for finance lease"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r374",
      "r380"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flow, Finance lease"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesCashPaidforAmountsIncludedintheMeasurementofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r369",
      "r385"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Present value of lease liabilities",
        "totalLabel": "Total Finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails",
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r369"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease liabilities, current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]",
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Summary of Minimum Finance Lease Payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r369"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease liabilities, non-current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]",
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesMaturitiesofFinanceLeasesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r373",
      "r380"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedLabel": "Payments on finance lease obligations",
        "terseLabel": "Financing cash flow, Finance lease"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows",
      "http://cutera.com/20210331/role/LeasesCashPaidforAmountsIncludedintheMeasurementofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "cutr_LeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance lease"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r371",
      "r379",
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Finance lease cost, Amortization expense"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r383",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesLeaseInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r382",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesLeaseInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r91",
      "r204",
      "r207"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "negatedLabel": "Gain on sale of property and equipment"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r91",
      "r237",
      "r238"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Gain on extinguishment of PPP loan",
        "verboseLabel": "Gain on extinguishment of PPP loan"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows",
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations",
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r199",
      "r200",
      "r407"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r70",
      "r101",
      "r163",
      "r166",
      "r169",
      "r172",
      "r175",
      "r191",
      "r354"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r91",
      "r203",
      "r206"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment of Long-Lived Assets Held-for-use",
        "terseLabel": "Impairment loss"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r104",
      "r163",
      "r166",
      "r169",
      "r172",
      "r175"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r321",
      "r322",
      "r323",
      "r327",
      "r332",
      "r334",
      "r335",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r102",
      "r117",
      "r118",
      "r162",
      "r320",
      "r328",
      "r333",
      "r429"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations",
      "http://cutera.com/20210331/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income tax paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other long-term assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Other current assets and prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "auth_ref": [
      "r129",
      "r130",
      "r136"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "terseLabel": "Convertible notes (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r136"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive effect of share-based payment arrangements (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InterestExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expense [Abstract]",
        "terseLabel": "Interest and other income (expense), net:"
       }
      }
     },
     "localname": "InterestExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r74",
      "r236"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "negatedLabel": "Interest on convertible notes",
        "terseLabel": "Interest on Convertible notes"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations",
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Interest expense, excluding amortization"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestOnConvertibleDebtNetOfTax": {
     "auth_ref": [
      "r122",
      "r128",
      "r136"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The after-tax amount of interest recognized in the period associated with any convertible debt.",
        "label": "Interest on Convertible Debt, Net of Tax",
        "terseLabel": "Interest expense on Convertible notes, net of tax"
       }
      }
     },
     "localname": "InterestOnConvertibleDebtNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r24",
      "r195"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/BalanceSheetDetailsInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r2",
      "r45"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/BalanceSheetDetailsInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsInventoriesDetails",
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r26",
      "r195"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/BalanceSheetDetailsInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r25",
      "r195"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/BalanceSheetDetailsInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Summary of Lease Costs"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Finance Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease terms of finance leases"
       }
      }
     },
     "localname": "LesseeFinanceLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeFinanceLeaseRenewalTerm1": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's finance lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Finance Lease, Renewal Term",
        "terseLabel": "Finance leases renewal terms (up to)"
       }
      }
     },
     "localname": "LesseeFinanceLeaseRenewalTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Summary of Maturities of Facility Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease terms of operating leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Operating leases renewal terms (up to)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessor, Lease, Description [Line Items]",
        "terseLabel": "Lessor, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LessorLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LessorLeaseDescriptionTable": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessor's leases.",
        "label": "Lessor, Lease, Description [Table]",
        "terseLabel": "Lessor, Lease, Description [Table]"
       }
      }
     },
     "localname": "LessorLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r36",
      "r101",
      "r168",
      "r191",
      "r340",
      "r344",
      "r345",
      "r354"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r21",
      "r101",
      "r191",
      "r354",
      "r411",
      "r424"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r38",
      "r101",
      "r191",
      "r340",
      "r344",
      "r345",
      "r354"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r35",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": {
     "auth_ref": [
      "r35"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Commitment Fee Amount",
        "terseLabel": "Commitment fee amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r35"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r43",
      "r212"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Estimated Litigation Liability"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r12",
      "r234",
      "r410",
      "r422"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Carrying Value"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails",
      "http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails",
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r41",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails",
      "http://cutera.com/20210331/role/DebtOutstandingDebtandCarryingValueDetails",
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r221",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r413"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CashCashEquivalentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard Product Warranty Accrual [Roll Forward]",
        "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]"
       }
      }
     },
     "localname": "MovementInStandardProductWarrantyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/WarrantyandExtendedServiceContractSummaryofWarrantiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r88",
      "r89",
      "r92"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r0",
      "r57",
      "r60",
      "r63",
      "r92",
      "r101",
      "r109",
      "r111",
      "r112",
      "r113",
      "r114",
      "r117",
      "r118",
      "r132",
      "r163",
      "r166",
      "r169",
      "r172",
      "r175",
      "r191",
      "r354",
      "r414",
      "r426"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows",
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations",
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r111",
      "r112",
      "r113",
      "r114",
      "r120",
      "r121",
      "r133",
      "r136",
      "r163",
      "r166",
      "r169",
      "r172",
      "r175"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net income (loss) used in calculating net income (loss) per share, basic"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r122",
      "r133",
      "r136"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Net income used in calculating net income per share, diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronoucements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total interest and other income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReduction": {
     "auth_ref": [
      "r95",
      "r96",
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of notes retired (or transferred to another entity) in noncash investing or financing transactions.",
        "label": "Notes Reduction",
        "terseLabel": "Gain on extinguishment of PPP loan"
       }
      }
     },
     "localname": "NotesReduction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r163",
      "r166",
      "r169",
      "r172",
      "r175"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r372"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncome": {
     "auth_ref": [
      "r143",
      "r388",
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.",
        "label": "Operating Lease, Lease Income",
        "terseLabel": "Revenue from equipment leases"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r369"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities",
        "totalLabel": "Total Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails",
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r369"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities",
        "verboseLabel": "Operating lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets",
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r369"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, non-current",
        "verboseLabel": "Operating lease liabilities, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets",
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r375",
      "r380"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flow, Operating lease"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesCashPaidforAmountsIncludedintheMeasurementofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "cutr_LeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets",
        "verboseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets",
      "http://cutera.com/20210331/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r383",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesLeaseInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r382",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesLeaseInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesOfLessorDisclosureTextBlock": {
     "auth_ref": [
      "r366",
      "r367",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for lessor's operating leases.",
        "label": "Lessor, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "OperatingLeasesOfLessorDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r105",
      "r119",
      "r155",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r37"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r347",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Available-for-sale investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r49",
      "r50",
      "r52"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Net change in unrealized loss on available-for-sale investments",
        "totalLabel": "Net change in unrealized gain on available-for-sale investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive gain:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r58",
      "r61",
      "r337",
      "r338",
      "r342"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive gain, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "auth_ref": [
      "r52",
      "r54",
      "r55",
      "r189"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
        "negatedLabel": "Reclassification adjustment for losses on investments recognized during the period"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r347",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other Current Assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForDerivativeInstrumentFinancingActivities": {
     "auth_ref": [
      "r84",
      "r87"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.",
        "label": "Payments for Derivative Instrument, Financing Activities",
        "negatedLabel": "Purchase\u00a0of capped call",
        "terseLabel": "Purchase of capped call"
       }
      }
     },
     "localname": "PaymentsForDerivativeInstrumentFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows",
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Payment of issuance costs of Convertible notes"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedTerseLabel": "Cost of equity offering"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r188"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchase of marketable investments"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Acquisition of property, equipment, and software"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "PSUs",
        "verboseLabel": "Performance stock units"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r286",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r4",
      "r30",
      "r31"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Other current assets and prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate"
       }
      }
     },
     "localname": "PrimeRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from issuance of Convertible notes"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows",
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from Debt, Net of Issuance Costs"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from equity offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Loan proceeds"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r81",
      "r308"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from exercise of stock options and employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r77",
      "r78",
      "r188"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from maturities of marketable investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from disposal of property and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]",
        "terseLabel": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Total product revenue"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations",
      "http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductWarrantiesDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Warranties Disclosures [Abstract]"
       }
      }
     },
     "localname": "ProductWarrantiesDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductWarrantyAccrualClassifiedCurrent": {
     "auth_ref": [
      "r37",
      "r220",
      "r223"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Product Warranty Accrual, Current",
        "terseLabel": "Product warranty"
       }
      }
     },
     "localname": "ProductWarrantyAccrualClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.",
        "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments",
        "terseLabel": "Costs incurred related to product warranty and extended warranty liability"
       }
      }
     },
     "localname": "ProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r225"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.",
        "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued",
        "terseLabel": "Product warranty accrual, Increase for warranties issued, total"
       }
      }
     },
     "localname": "ProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyDisclosureTextBlock": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.",
        "label": "Product Warranty Disclosure [Text Block]",
        "terseLabel": "Warranty and Extended Service Contract"
       }
      }
     },
     "localname": "ProductWarrantyDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/WarrantyandExtendedServiceContract"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProductWarrantyLiabilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Warranty Liability [Line Items]",
        "terseLabel": "Product Warranty Liability [Line Items]"
       }
      }
     },
     "localname": "ProductWarrantyLiabilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductWarrantyLiabilityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about product warranty liability, including, but not limited to, reductions in the liability for payments made under the warranty, changes in the liability for accruals related to product warranties issued, and changes in the liability for accruals related to preexisting warranties.",
        "label": "Product Warranty Liability [Table]",
        "terseLabel": "Product Warranty Liability [Table]"
       }
      }
     },
     "localname": "ProductWarrantyLiabilityTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r47",
      "r205",
      "r379"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r67",
      "r194"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r317",
      "r451"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSUs",
        "verboseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r18",
      "r246",
      "r312",
      "r423",
      "r438",
      "r439"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r106",
      "r107",
      "r108",
      "r110",
      "r116",
      "r118",
      "r192",
      "r309",
      "r310",
      "r311",
      "r325",
      "r326",
      "r435",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings (Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r160",
      "r161",
      "r165",
      "r170",
      "r171",
      "r177",
      "r178",
      "r181",
      "r259",
      "r260",
      "r406"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Total net revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations",
      "http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r257",
      "r258",
      "r263",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Deferred revenue balance, amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Expected timing of satisfaction, period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Deferred revenue balance, percentage"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Net revenue:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r381",
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Assets acquired under finance lease"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r381",
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Assets acquired under operating lease"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "auth_ref": [
      "r7",
      "r34"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Sales and Excise Tax Payable, Current",
        "terseLabel": "Accrued sales tax"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable": {
     "auth_ref": [
      "r389",
      "r393"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term guaranteed by lessee or other third party unrelated to lessor, from sales-type and direct financing leases.",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable",
        "terseLabel": "Sales-type lease receivable"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseRevenue": {
     "auth_ref": [
      "r143",
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sales-type lease revenue.",
        "label": "Sales-type Lease, Revenue",
        "terseLabel": "Sales-type lease, revenue"
       }
      }
     },
     "localname": "SalesTypeLeaseRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/LeasesNarrativeDetails",
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Summary of Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CashCashEquivalentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Computation of Basic and Diluted Net Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": {
     "auth_ref": [
      "r123",
      "r127",
      "r134",
      "r136",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r285",
      "r304",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Summary of Stock-based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r9",
      "r27",
      "r28",
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]",
        "terseLabel": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "terseLabel": "Product Warranty Liability Accrual"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/WarrantyandExtendedServiceContractTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": {
     "auth_ref": [
      "r69",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]",
        "terseLabel": "Summary of Revenue by Geography"
       }
      }
     },
     "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r286",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r290",
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Activity under the 2019 Plan"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r156",
      "r158",
      "r159",
      "r163",
      "r164",
      "r169",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r180",
      "r181",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations",
      "http://cutera.com/20210331/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/20210331/role/RevenueNarrativeDetails",
      "http://cutera.com/20210331/role/SegmentReportingSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Stock awards canceled / forfeited / expired (in shares)",
        "terseLabel": "Stock awards canceled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Stock awards canceled / forfeited / expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "negatedTerseLabel": "Awards granted (in shares)",
        "terseLabel": "Grants in period (in shares)",
        "verboseLabel": "Stock awards granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Stock awards granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Awards released (in shares)",
        "terseLabel": "Vested in period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Awards released (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseStockbasedCompensationExpenseByDepartmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "terseLabel": "Number of Awards Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Additional shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Options canceled (in shares)",
        "terseLabel": "Options canceled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Options canceled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "negatedLabel": "Options granted (in shares)",
        "terseLabel": "Options granted in period (in shares)",
        "verboseLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r307"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Aggregate Intrinsic Value, ending balance",
        "periodStartLabel": "Aggregate Intrinsic Value, beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r292",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Stock Options Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted- Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r284",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Options exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "2019 Tranche"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Three [Member]",
        "terseLabel": "2021 Tranche"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "2020 Tranche"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Stock price (in USD per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Award vesting rights (percentage)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value (in Millions)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityofStockAwardsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Term (in Years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_StandardProductWarrantyAccrual": {
     "auth_ref": [
      "r226"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.",
        "label": "Standard Product Warranty Accrual",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "terseLabel": "Standard product warranty accrual"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetailsNarrativeDetails",
      "http://cutera.com/20210331/role/WarrantyandExtendedServiceContractSummaryofWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Decrease for Payments",
        "negatedLabel": "Less: Settlements made during the period",
        "terseLabel": "Settlements"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/WarrantyandExtendedServiceContractNarrativeDetails",
      "http://cutera.com/20210331/role/WarrantyandExtendedServiceContractSummaryofWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r225"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Increase for Warranties Issued",
        "terseLabel": "Add: Accruals for warranties issued during the period"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/WarrantyandExtendedServiceContractSummaryofWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r100",
      "r101",
      "r123",
      "r127",
      "r131",
      "r134",
      "r136",
      "r145",
      "r146",
      "r147",
      "r191",
      "r240",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r44",
      "r106",
      "r107",
      "r108",
      "r110",
      "r116",
      "r118",
      "r144",
      "r192",
      "r240",
      "r246",
      "r309",
      "r310",
      "r311",
      "r325",
      "r326",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r435",
      "r436",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited",
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnauditedParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations",
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited",
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnauditedParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r106",
      "r107",
      "r108",
      "r144",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations",
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited",
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnauditedParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r14",
      "r15",
      "r240",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock for employee purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r14",
      "r15",
      "r240",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock in connection with public offering, net of offering cost of $2,303 (in shares)",
        "verboseLabel": "Issuance of common stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r14",
      "r15",
      "r240",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of common stock in settlement of restricted and performance stock unites, net of shares withheld for employee taxes (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r14",
      "r15",
      "r240",
      "r246",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised (in shares)",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited",
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseActivityOfOptionsOutstandingUnderthe2019PlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r14",
      "r15",
      "r240",
      "r246"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock for employee purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r14",
      "r15",
      "r240",
      "r246"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock in connection with public offering, net of offering cost of $2,303"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r240",
      "r246"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r44",
      "r240",
      "r246"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r15",
      "r19",
      "r20",
      "r101",
      "r187",
      "r191",
      "r354"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets",
      "http://cutera.com/20210331/role/ConsolidatedStatementsofChangesInStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Balance Sheet Details"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/BalanceSheetDetails"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r260",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r260",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]",
        "terseLabel": "Transferred over Time"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnsecuredDebtCurrent": {
     "auth_ref": [
      "r10",
      "r409",
      "r421"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term, uncollateralized debt obligations due within one year or the normal operating cycle, if longer.",
        "label": "Unsecured Debt, Current",
        "terseLabel": "PPP loan payable"
       }
      }
     },
     "localname": "UnsecuredDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredLongTermDebt": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of uncollateralized debt obligation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Unsecured Long-term Debt, Noncurrent",
        "terseLabel": "PPP loan payable, net of current portion"
       }
      }
     },
     "localname": "UnsecuredLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/StockholdersEquityandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r122",
      "r136"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average shares of common stock outstanding used in computing net income (loss) per share, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations",
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r120",
      "r136"
     ],
     "calculation": {
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations",
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Weighted-average number of shares used in per share calculations:",
        "verboseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cutera.com/20210331/role/CondensedConsolidatedStatementsofOperations",
      "http://cutera.com/20210331/role/NetIncomeLossPerShareNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1930-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1930-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2029-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=121640914&loc=SL77927221-108306"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131251-203054"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68070138&loc=d3e11281-110244"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12524-110249"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1),(c)(5)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "460",
   "URI": "http://asc.fasb.org/topic&trid=2155896"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "Note 1",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "Note 3",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918631-209977"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121561866&loc=SL77919311-209978"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919391-209981"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919359-209981"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919372-209981"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919372-209981"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919379-209981"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888252"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756"
  },
  "r453": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r454": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r455": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r456": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r457": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r458": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3505-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>138
<FILENAME>0001628280-21-016106-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-21-016106-xbrl.zip
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M1A';EM1YS*?<]M<4!]$54=,E\\(:4\&^G1D^88"L'!%*3@0A;4G15 !4#$#
MNO,R\'6Q,G83QB%:EODI?)ID@+CIIO(&XC%3H[/TU4OG)U-FRY2A#6]<WL'
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MF01E?PA*3,J%6,Q$'!,:U'J_-#S_P]Y@)X+R27WROW__N%VKSS?Z%F>#UH0
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MV!^4_( BA:B$JN"TPHX8-']2VW790BS$;)C9%W!-8B'6Y10=RH<^E3X I7C
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MK[Y<4*7@]&$PC:FQKZ&)BP@/V323/F[$:4RM(?@MCT4@S."9K>C)&^YG0CF
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M<;0Y$^K>F4X>O/;96>.'23U0E!<FN=>'ESU"RI%[ZL2_$1YPD\'4-\<\0GK
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MJ5U+[.OA/-E'VSK5F6IFVF9"R@/P3!(+JB*C&YHC'8_ JBINOX7>D/_B\1A
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MG?/@&EHK65SB<^*9>" [OBAAWWTS&IO*N:USI@:FU;9(B&*84N4*<V[=-A-
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M46"?1Z'[*%E+"H:!%-BTAIKKBV=_@4&D;0_R\[]01" AE%RIK9W$S,AUM:"
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M1%A5R>TV#O S-W!2\&8T, J/J2O =8$HA)RQ*\2,\5 IMS"2RL]8JUZ.1C4
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M4;9&POJQ &X8)?O)8KP-XT7O787<5@=^:8FRPL(]ZX=1+%&.Y\JB*??.Q_"
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M%V*<($[0G#Q-I3.M09PPIN7'.(A\LZ&WSP%ZE+EL%SRE7B!%,0OB!>9?#?"
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MTXJ1@V(U(' IP2 []*;N RJ"&5%I3"#%!)]DG0\9Z!FC1:Q.8\% 96*T@G_
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MI60066D#9=3D@%A-][9_(@7S@L>K7Y!.H#\A DE(<>0^$2 ?CX*N2Z%-VJ6
M*EV$090<L3 EO1BD1E;&4]0.9$ XY!P(8G45')[&6 \8B[QY0+@(]*''JBFY
M0U8F:&/A$:;+_'B2E8:++ADKY!K9PCDI^B8P2^T;\^;?M_\^E2;?R+Y/0JI>
M0Q !O$-I(LD*27B#_A^I<\;B%"+:_.:01C%4%35X.*TB(-NX"@\O*$H C@*E
MJ-P.[,UE[&G*DSA0SABI9)#J"FTT7K"AX#Y4WI?(+"J>3<3,U#K^?7MEV(L
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MRR7+Y*Q36 +.8_/BX=,A7[Z(FTLRYUED")@4D(4D<_&0<$F6OL''%U9^9I$
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M41CT,D')@"5P<2#O1=!:>7**WI^GO5%(<S&+V^QH_U,G*8\Q@0W;$ "( 'B
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M2\!)?2]&\%!@!KC=M^PR3'.+(&"_1O&,F49-\C&\,.DV5G7BLZU]TF2GY_*
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M:"X\?^R7E1K2&D96A8[RVTKP=7N-YG898R_/ 3VDCA&YTJRMZQB[AU?'V*[
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MJQPY?<0L] \ZPRHBN>BL,H(EEZU^%OL\>-B:I+)1G.2$&0$.T#<>*F9#A;E
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MR13!HE L;I,H;C"( *V>(U05^P@*MH:3S$=2NQ8COB@=1W(%^_=B1/#9BH1
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M"_79G,VS8>![<OO&\CNA7FW,$N%)9[IJ7/+3#[>;P6EJ*%Q7IXF6!_E9-I<
MU7N4:0T%5$5B2<,K[[6JQJ:]>N(1L>\>:Q.64D=!+:U''!R'(*C4VEXTFXNJ
M8%L-)W4U$'L(AT6JKE<C=5YB\=_,!Z&1!BQPB]ARHV7+76X 2 $NBOT"P290
MO1Y"F9L9K/2^GL7 -B@I/9^L8L; ,RAXC<4D@V8!VK"DZ7ZI(URQ5@PC]^3
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MA:=^$::^N<7U$8_[?8E;.'9ZN/T9U$K 7Q/48?</)/I*W(B8#_W 3ZD&A!U
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MOT/MM]NMVN_\_94_X<'\T5]?^%RTV[WQH#7HMIWVL.4,QX.!YXZ=@3MJBN:
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M/U^&J?K/WEL3-_#%A%8F8) :NVDPTT O?![@&&R/,M +_^%/63Y-2XVT.MV
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M3XRR&/(%,8N%RBF$DQ/]@R2!40-0PCJ5?P3P%Z^0K 2&9_!XI-],9L($:/>
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M-"O<6I:>2P5(JSX(@S2M9?&Y@IVCE0B5!*#E!:1\1Y;C3&K@"#31DQ\3^BQ
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MW[BHTJ\FN5.>&$^V\]+X5;>?<(#Z>(F&WI/A_GH9@(*4 ^S;D^B-@?TWAG%
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M\LMI'2_;$V"9]P)T8I?5D;NE4[+*Y4WQU&I6M;#2J(_'LG5%&RZ<"B8.%^6
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M&^SBM'9<>70J <WPA (:>RVBJ5KVB00T!UO'U^"A;)6.'>,,UAQB['K05['
M7?J]]5R"2=[&'4'B0<1TG*,[$?!HW#>LN9@WK#D#C3[>U>M$\9Q+DV7G@:8)
M$.C(B*:U+]H-2IUGWW+8^SW;8?6HI9WUJ*NE@8=IKF+5-LYQH7*\<^R>S#FV
MJR8S<7CD/-L7.0-+P+X!;#(=&=N$>-!6/&5 B9E;G<%:I%061^(F8DZ*2:X-
MFHK]H!7VL8'=A)9E#,O;N21>"+U@K8Q^+6A?'HB,WK4;"0&O"4'DD*'80CA2
MYM84:*AXA$4VB-XW2!_;AUQ*Y:WB2:6/BW^C]+$VF0")I1'%LB5S^WK+(20
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M7'H="H<_KG\$ ORHKEL/.3RQ%;H5#9N=40/=>M"B;I6K'1PB*6.NC7F9(.N
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M@,*> .'@@AQ449B3!Q<<Y7V'D_32OS?KA4EM53Q5V@+\7-/;2:?H<(.E$8]
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M*,F.D^2,6\J L06X**U2WU,=1_" ;BC93U'G* LH)\Y':-F16:_3=8.&:BO
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M?"@0;160K:\N]NY*[WB!Q>=N6-S<NRO><H2I*:H]1E@.F19*Y(QL NP ^4(
M8<N9>'7J^[ A EY;68%!;_D<DW&<)\X\#G!/=D1WTB4HKDR.C)%$@UWM=P_^
M*GL)\$M-6U7G<@C?[U+;J!M%8)TR/"W5ETT9_5O%?_B^^@8\O5U''62U]A=D
MN:L,9%7F_!.6&$G4WY/]/6 ,1GGU,7"=.&$,M,%#PS?V>!X#-5K#3@";%R.
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M-.U!>'1$)V8;GCX;OO# ,#I08M.;<>A>1OOUJ-]/6.<#9]J-8/K;75^&N]?
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MK>H;N+_>;#;JU;S12@,'![11WQI7ZV]CI;7-:_"Y<KY+*N7CT^KI9RVIB58
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M2X-R!AO-F)!*0WRCTQ(B3KE7<0E&U%=&0.<XFG\11H\&Z3SOW6'H7.#M\R^
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M_9X?N6&MOQ_Z7W(7+B?&32X-+F+\U[WN8-1)N>6#E+-_G'>=Z:]DT.A!Z[R
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M]%TH-*T(4#W].+;EWI=W9.]+@U9&OK7]Y?"-;M4ZNZA6/B:55H-5Z\>L4OZ
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MQ@^N).6.HHA T)#$ J4.3$06DDEJE5'>!NN2"MC&K$E^\')NM7!J7"&!II'
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M%4TB-&<-K6T0P=I8U'4BW)C,H+]QO!1&*XSV,DE0A=&F9;0;19)XXK$Q")C
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M# (L!4&**D1UTC(X::M[2N3?"?0O#HD%!//3%8P"YB: >:RYND<1,\N (^N
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MAT0CL3"%NTOU_IFQ_\M\?1>#],#I56&!^;+ C1N#I64S#@NPB<B!J1C!!$J
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M]+FADS<&E.4V+X@303!,B$E&$[F;@E(27)<&J+7'DA2@U@34&^^&Y$2H9&^
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MO1<EZ&.AP+R SHH"\=HA/N&C("1ZC:0&HY#-N4P!K$F_ZH"9EHYKIUD1W"N
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M97@2I_WJ>H@7=DKKDOM.TH>[E<@FLG2MV^1F;I/3 V'!!%-<(VLL!]:.+9*
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M&6QCD:B70F/J*8]G[[;:_,2T>9$BH3OP^-VP#+)5^0=3^9F3$"P?02EW2+J
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M3ME K.=1DZEZAGTVGRCI<-Z,.KVR'*<VG#=G&R_!++HS]\;E0%37;T5C"*0
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M)@32E LGB9%:<F ,\C:'C2VIE^/)]+UKGOY]66N8MO?=$D1=;M+WJJV]N\-
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M0IWSEWY5378385+=G2\B\XX/!C].%ZGGN^P<:;BC\1YXUTDEBM$PBB8&*#M
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M!GMN*V_KY(WOO3G"P@43K$/*:9U#G0,RL LC:F4**AH726[FM;M<!Z*1MQV
MU]%9]-EMU+O<*8 [BF=V6#&P6>Q=MFXF>+W;>7S\=,;?.#X9QEBD?]3]W#F%
MKY[ <,M8E_GKLANR3- F>L.E\IJG!%::X9(($WS0*@2BA=".D[IZ.9^K7KZA
M E4U6&J&4V*4KU.DEY]SD\^EKEP_G%I='<-X7HF]%X?B=8;T-T>: ^]AP&29
MYPKQ* W*90V094$%N+TWRF9(7]>JI2$_FV+KG2K<MS+RS66$OWYSY+RU@G.'
M@I-91H1 #EN1R_\%0KR0)HHL(^O*\:S!8B"XL<QY_GN>]-GSB&4TSA*V2'YW
M.R6TJKC+1ID%YR/4D O49SY<^:SJ)WR*PQ&(SC]G'[*22U^S#W3"]:!:#7<=
MLE;^M4V4)')!E8I!TL! %8,SALC@'+.!*&KH?0#I]0ZO/^QE=F_^P.IP\(H!
M$Z%>!\(,,-_DP?[GV?[GDJ.4.%4T&$$<70V3G;LBI*7>" _V#;.2LXR-TEA%
MN M)9^OG/A"R7?P;%__U\R/E$M%.1&2$EHA;C)'&/L"6F92GPK-$R^(O!\FO
MIJ%K4.LK M,ZMH<K3-I *AG80@YS@FGR/*<\"Z8=58%S(A67J4@E;B )WR"5
M0&Y]ELP+()FCV+^C6.(?32SGMNB7G\$RC[ 3,T(=H@9FGBOFD*:<(V#?@F@6
MHX_AR;/];F]91#?%I8Q*5%-"'(Z<<6L#-S$JK02FS%I22P"YG02TN'07 ?CP
M,G.SR[VK5Z1<>W$4 Y.18(>2=A%,90T"X"/L4LY*!\O%C#"K'9IK,.HV\1IE
MTF\\89;DR0V&LWX8PWEUW-'^8!P[8K?SE?MS+8CVB^[(]P:C\^&V].6B>Q.A
M?G5U^,&+_=-7=._%\>>] Q#R%Z%[^.'O#^]?_'WZ_L7)Q_<' >[_ABP*]>&'
M_>[^U4=Z^.'PXO4+0*K?]_ ^_5=W_]W^Q_UW[S^^_AV$/2O%B[S9'M*]XR-I
M3(J,<A0YH0AD2X,M:C#BB3OI0;@PHQ4B@2S&\#S#B" **\$I@!WG/A+G*"6P
M.#Q(8EVDBWV\WLUNJXU5V'D+-DC79]]'=:B]%$>WV+UM.2CBQA=Y'+ZCV;/\
MDW(L$;I#0(9.ZL8>\(IZH@;#8]OO7M7C[W?V!SFL[7F9+3MKA/UJ^S;8?^YV
M7N4(JW[Y@NUE&W#6UP2DYQ-HUJAY6/.8T?G9&=PY/^$Y3,L09LCN='Z)O>/N
M^>E.!X"L[^-.Y_<(FTH?[OE_!O#(_PO_['3^9>'..YVW9[:;_^^B.[Z*PQZL
M^DY9^OSTOV"G@\7_O_">87":7Q$>#,8B\+-!20;V@W.0AWR*TKDXR6QI]IW#
M -ZW/QC#-'V*TWDZRQ9M>:N5 VQ&!E1M<'Y\ M_KQS%PH(_9)@Y=&&/7G8\'
MPU']EMUA0&=V" +;?+.^U7#T&$_.<^1:F9C!L NO"#,]8;1G<,L!K,XI+!BH
M93DD*U2VE@$[S-%6J42H%)MJRHJ;J6EB4CK.CKJC'->2+^R,80AU%?PFI*9<
M,!^Y,EFB'&BY(B2GBKVQW6&^;Q.%TP0/U3$SR[$U=EPQ\_P*L,*Y0,TN/'*.
M_7=+E%$_5OP+)/5D_=!&91YF0T1G'@!"VJ]-BWQ5\X"=X@HY&]<AI(/<62]?
M?LU#_ F(4'GCC4[I/+< =TI[ZKD!)B(%5@3( %@(F A<1>G4>^,71NE<[]';
M-I[XS;?4UP>'XL@YDC._!**1!<2CULBQX)&6F@4&#!XH_)-G[)I#E.DI0!W6
M=AGML#8I5T6Z$#UKRU8Q:A/=N5W8\']/HI8GD7D/TSQU0;(F >C;U$+U8:C:
MQ9'1W#*:'<$X":!J1(&Y$0*R.I"<*Z-)$H^RA>K!7+O3JFOI9&<H\GQB^\=Q
MU.A#+:.5#DQ1OT*AR5:RT3%<N:YX:!Y)MU6"\2ZNXLLW;;?*Y2ZA7Z>#*;E=
M!]--VZVN?^C6O2S3O'U9RKY)(UOS2'NW'A1DVJL0Z65&I-+!==+?]A[:VC[6
MJ7D+4'V[B;F_+LB;Y QN^?3=LBORK4;\P\T<KBC!/\@_[[>Q]/<U2ZU\W;-\
M_0BU@G^)P&_[F=W_4H5BMTVYVYZU-X4U\JAMI%J(1'GTQ&27OO5:Q1!MX+8.
M/V=?4G'U=BD;#UP9XJ[^AJHRQ.G^*=Q;[+UX__']Z<LK^$YW_]V_3O9?>++W
MX=75WNE?G]]_@-&\>TD6*T,<TD,8Q\>+_=,_3P\/]C[O__Z*')Z^Q/M7?UWN
M?=B[?'_PV^G^!__Y\.#O^9Z0(2KI/ \HB!SEJ(C,Y=M9;L>@%9-,<%GZ+S"Q
M+LYQZUK7MKVY6YS[.CB'94@T64,]5IP9HZEUW,D4@@,U2:1*>VAQ;FMP;J8<
M)&<Y10JC("E%W '8:>(]\B8*R5V@-/F"<^:+FU.T.+>E.(=_5)S#VU?DJ\6Y
M^\0Y4N-<'L^1UERD&"-B*A\^6140D/-<NYI*X9516IE[ZL/30ET+=8\;ZA@S
M7&E#<SP:)X19EXS,A:*Y3,F*DLD*]FP+==L"=6P*=:^.L".:2BH1;$\,<9[+
M?5N>$,]$/?@D8[9>^0['C\9ZO:=>(A5 F>U%J"K@+82GG5H1JLBRBTD=H4ZW
M%!*:3>"H8N#:AB-?*[WX_E!M;3FH%N5N@7*S%; =$5PE*Y&@.<74N01L3ALD
MK/,1T]S63&<V!\NY17T,VDXD]ZS:+-'(L+/41<MS-E'T.@4-EIF00M-P4W99
MJ]K;HMI3GY3!UO"$-6)!$L09%\A1P9#2C+J0G.<2##6R Z2V5>W'H]J;FB!?
M6O"A5>UM4>TY-PS6.BD1(S(T6R3.6F2P3PA,$X:]<@3GO$.VHUC;0NP[UFX.
MZBTB=R0:P@63%BLBK&'.VZ"BCS<E!;?:O2W:/>=YH,1JX[%% -P2]F[ID1&&
M(RX$Q6!M84]5WKN-W*:]^S[;BVV]<^'?<31ZVGD;Q^->J40]ZIS:$._)G_!X
M.RG_XU$Z%)8RUEK0NAFT]G^=<21(QQPLF4# ,FF.]-'(Q2015B()HJ+6V9%
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M7NYC5-?$;1H@Q\^E<?%HDQ9$=^1UWU];UF]?]WG2>,A?P%@N]X^/J.<:*\Q
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MRC655E-!",.<>9Q C&Y(<&XEZ^M(UN?78*@1KF K9,AKD"<>F$!:.H>< W'
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MEH/9:QFR@N68+HN!U7J<8YLM9590[6'+(+!G*+TB_[#L&9N+E8C.,!S!9E+
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M@(T$9%:#\4*,2HNG?.Q!"A3<J( 9Y6-H%7!> 3_O71RQD*R6'$Q>&BW036-
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M3T)6>]?"I\]?2HC#;7"EDT] .61,.!N=TM&4P"#1UD5N,(_%KU!W8/HP[5<
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M&_K0M]B/A_G++GI[W(^Y 7A:'A9\[J!QTCWNA,:>_1'A1VC 5%L0"70N$PV
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M)5X0R2+-AY B0'M"2V.H\282;8,,LO@0%D&V+WT(-"CB'><(2R40-]0CEUQ
MA/.@+,&6&[ S5 DV6&ZQ#MQ'8Z6*5',.6*^9=Q@;)WFP(;+[7I,HBKQ&PC[I
M6 C8&0OPC:C$#G&J#0@\9LASS7$BP28YO\CG(O6UEGJL% ^.@TJWB:= K'!<
MR>15DM%37\(0%D*^)]T+TNNHC+7(\5Q^,@J&+(D!"<^2<%%Q7*4EY*)&LOT2
MPA#>'AQUNJ?QW+=P<7_AJ&-'J=]*3,)M6&5I]#)9%ZB/7')O6)0&V IC"CO"
MBJMA81%L/#>$C%I2L",1=QJC')V 3(3?HG,Y_L0&Q>V\[V65PX]Z2KR/SBJJ
MG-<Z<NN33<Y((W4^V>38X^)J6 39OG0U<)><XX(B3SE!@. <.:/ _+ 8"TRT
MHCRMK M=Q'JIQ=HJ[U)0R679!>/#*&6$P,K MLCI7(JK87&%?=+5 $LH0]($
M!8W!%$G<(PL4#B7E V"Z%RR7E2G*_"5(O0C)4Q^\=39PR8)CVDF)62*$2(IY
M<34L@GQ/NAJ A&G*C$""*Y!ORCQR(AC$3$K"JA2#L#53Z',*9*A]@?EA\N7N
MP'9FB5^XM<H$GBPT\0*3T,U80[ODEJHWW(TG6U"1*FEY1#[I@+A1'%DJ/2+$
M.NXCUS;ZG%>*S9Y7:NZRMT G+@5P;@6<&<L/%\"I.^!<.DND(M*8()&*02-.
MO$4&2XF89(:"QDG) K<BJT3.ZSYI 9S;ZFB]M%1X,U9N+5!3=ZB9RIM)(@/-
MXI'F ?@-&.+(X401L<H!PW7)Q%CQ&S+SE9,Y2EX!FL4'FAF+71:@J3O03/J,
MJG3M6@04I,@IO0E%-HB$HHZ4DL LT:SB-689@.::2IECI?9&3T#9<?2*D;7K
MZ^T-7VH?AG@X>(6(KB#HD>2Z:O%5>P =\'<HLCA6\:0.'?IS8D+E&N-YKG(E
MR"S6]O"T457-B:'1/AQT&WZL=LN@!_T8;K-^XZ0]V&MX6%?;/FRD]J$]]&W;
M@2_!>@R.J\^L-D[VVGZOD2LV?HN'L0>-G (LY<*[-J<:@?;A0<=^,D'IL!!D
M!8I'\&-85+(_5FGRS;#,9#OOS\/N(/;7&KG_-W;5SKGZI.WG!MJ]\ZJ1P^*2
M+D[6E%R;K![YQT2MU^N*P>9-7V&EX]KD(B_":)SS4#@OA#<!"\F4XA3O:K%R
M>U'*+ #/46;T^B)N+5BC!L%KC4>N=_NA6K8M^W.CW?>P=L>UJ5S+6^=J:/_+
M";3!=_;#]^W]UM[FQJ?.]E93;!_\O==ZORU:[]]U6@=?,'R&3%>N;6V]QI7*
MH9_:3?J6M][_N]<\Z[2W#][BG?WO>/OK%[JS]1$^\V]JGFV+W2A(L(PJ1&#"
M$(]2 7/%!G&)F6-&R8#UD&C )HSA=68'P'&M"#8&:@(/5N1+\@(3ACFW LLK
M=6Z'<]Z 2<^A>=-[?%P IO;[<#U^_;C)[G')H@Q,P7N&$Q.<D?DX/)^024WB
MHA3>?3>J7SNH*C_:0U#0[9\-0)A<Z##F0H>-7.1PJ,L97FWD+;\Z K\*I?^_
M_CE*#>Q/0+>C>-B/C1. IO]S6S'U.3OGQ8TB^';8H[\ ]E/[D@[*ER:'^V_%
MYM;KT^;9!P)]8,UONS8Z&W.Y!:R<0QQF'+F0(K+<)AT(]12'E76\=O4V40-V
M8B>O:-XP]UGF6?T499GON<RM;[N$*PFZ&Z,D'4,<)X6<<QAI2KCQ3G.C25YF
M?N,RKP(YZA\!P0 RT3E=K0B+[0UIT[V$?$;CL:S^_5;_I'FRBT7B!(N<BH1+
M6/U\U2!$@D!96>RUC%B;6YP 5Q=QUE.-LHCW7T0/#(E9HY$P%$18)8ZTMP19
MQYG$D9A(4Q;AJ[=$;H;N7+D>S-^]>ZE^/&5++ +%V?H55TD/X4"-=K\1CF/C
MJ <;NP>]SF!XV7C,3\HM0T\.&_O'O78_M(=6X-!&_.>??QJ=KJT^\PUP]3#V
M^P"SOOOM$,86H.T>V,9C_;I#?Z9,2_LS>S+..W4,7^PU/L>A@!/0K;^U?[\T
M9'O=0_NCW3ON-UZWPVKC4^RT8UJM9N,MR'_W ,RDD1/NM/$:;,W?<B0@Q7^^
M>?WI[>?\2O4W^?/WX?C.;?ASUER5 3D $[TRTVTC'8-Q_,-V1AP<3.7N297,
M(Q/R0;_Q9>WS&L!&BKU*T<!RV7X_#OH+N $W#QM-V_-[#:J&0O0X7AAZI\ZL
M/K(+Z-:'5WNM6MD40_;"-+YU?\3>X4$\',#.ME7:UVH_GF^J<\^-W[.'WW).
MV/BC^MYHW\:?;5A9D).J4=_M'75[=A#'I;QC3_H-!ZS%@@1]:P#BQ2SNV5.\
MFC_7B[9_+FFV<AE73ICL#1HZ=MJ5%ZH/7:DV:?YL18 .V\--[6VO=]K(#LT+
M+]15A\M5!\MHZD?SP^F:R@[%HVZ_G3_SJA<[-O.M/T_:8;!W[JL?^^+(0XHO
MOV)=OYM=1S=^Y4I%ZF<2B+'*T\,)&ONYU[OTMWZ+R,'R?$<V06=?V<Z)/>VO
M_#$I]2#R4W,X/?P;!YG2HPURB#Y >_)^S(M3P6_^%/3)UJ8O#5 M0.K^Y]>>
M/@6*M%(G(!S_^<,N["#>9"Y[F!-%V?7K=N$B*)3K/5B_]DBUXJ"Q>13S! *(
M_;<+"K5_H<=;F__MGZOP2NW?B(WYD_"2'5P ;N7<]C 1QT"G !*[*?4OO-<C
M/G".Z(W0#ME9WMBS/Z!5X 0@VY7#'C 5WH;AW.A=.NIU?[3[E45Z#36H>MUI
M6]?N5">%0_92 >GP<S#:(WN:=_$D1P'J!,2F!]L":%QNJW\QZG0\..[%W+=.
MVX\&.M0]^3+P>7>&AQ#MPTG==74HL&C5D575H<NCBOX 7L@Z$+KLCO.)%_0T
M3U%FJ-!.;F0T.S"Y+E[,V=HUNN4*/;JC)U\OH">?/+HG_[^P%V)\5RU5_"^(
M0^S7Q9._^>;\0+FUW]H/>]OT V[1+R?;9V!C;KWEVU_?GFT??/C9!#NU1=^>
M-/>_G$[;I=NT25OTW?[V_D>VL_77?NL]?'YK;V][J]7>WG][TGK_A6V#+=K:
M^CNU-K9/P18UCA@19$(^\8@X(0I9DK.3^^1X3-*:Q*:=Y<91)Y(GQ%'%C8C&
M*6-L+I(#RZ"CGO;E/_*B7F#@<$$W4U[E;J]^AS7/M,26V>RE<XB8[#'T,2 M
M'($_2>#))D:3FU[B )I'8>>4HH[;Q%VN;F:4QY(Z0PQ_XB4>RNW40K_P9?6P
M<EH2@KSR$B0W<*0=PX@130FP!0=+>$5R)35)PFI8RGB2P5A/O 6J0;B&GWYZ
M68<3?>T9\ZU___)\[M<0,K4?!?,Q:1N4=]G-[8+TP<"NAB_!-^E-+.K7^WCR
M.5)PRZ)WP1O%B;3:.98+. A.H(^!W_2<7T_LY',LI2 )/%*+>2Z4;2W70GE#
M/4@'\7I!SANG:)<%0M8;5+ZS<]NY>T%0,WL;DJ38Z%3[JG+5_8A[;=_)] YH
M9CNG?P5F-/+;#8"-?@/69OV( TX0O>KNJOJS/_:,4;N9F+7[%;L=;W0U1UB<
MQ$XG_WNU\>MZ.-:2/08#O0ML]*9NC+YR&9%24>)>S&ZRBH#&WD&FFZ-(JO'U
M@OGWJ/T3[<&&C8>O7@R4C3G':7/C^TD+"(EB-CGI$+<^P \AD$U"H\"E=H1X
M%8R9VNUE]BYFSQNM"4T>3&M#$7?>(!LE0Y9&2X,'XU$!MG0/XP5&5_\,M^2@
M.]J:MRASYI458)7JI#AG2CH=0:.S)'*66D/=[H=+'3X6&IJ7Z%4X[IUT>Z$?
M#^^BWS^="T[UUQ8(SPO3\Q/+N__Q9];Y.ACF*4- GRSBBD1D,<F1XIX"'[ \
M.;6R/HB'C=-H>U<4]VJCGVUO +.A&Q9L\7S"  !Z4=H;S&90#=E$'</HXZ/&
M7?:&%BDEP9*S7G!%H8]*125-< 1'C<4L>V/<9ON4^V@[>4N0E[8GSKX#H3<R
M8.HB,B02E$L8(HV31=Y%SUF(07!S.R5_S)6:EN*+M7IA2]7:^(Y;9]^@G>99
M<P/Z^'%74FPC"[FP,-C9/)<JU$QZX&8\>*N#9QC$-[6!-EPKO]-_3_J]1@([
MY$]9;$>\*$OVR)GUY;"=?56?LX<*&-??%KZXVO@K=KZUCP]6&^]Z%??)/.CS
M$8#O6N/#82.']59$%]"A\ARZ[H\+VG3^U(D8LH;M] %)NL>P"V+GHF-C!*KJ
MWCE%[-O.!?F*G7PHU/N1.5L<)>WKCPX[)ZG9 IX<CB]6B)D.PD=@;8!;5N*9
M#_6K7V!6,IFN!MJPE><U5A"]-N;P';U[K:^T"DT>.WZV@TM(KV*.([18'=-E
MY^755L>;ZL6C7NSGS^8FSG_/9[V5)AE^X<B>5A[/H9(X[ Z&OYS& ;S5#C?V
M>[+Q*J@_[[/L>,[^Y^I0X+2R'O+GJV'FH3EH(@S#N//WNK=TWX:\Z-E!"UL.
M'G;>TP;\:;T',S=,C2&?(\)W;:<1VKU8+4D_OSK\5%Z+PWR4-W)(9T]NNU?-
M938WKATFR&GW<L5GF,=),8NPF;/ON#]T*6<'?_YR=D'GHWT8F.OV>L,SSE[U
M.0]_QSY,6Z@,DJ% 0Q.CRSCGY[ C"9M E^&45ZN4CV0OGPUK (/Y86'"H<U+
M-SB(X?=8[><A?L!\00?A=Y@VVSD%LVHX@2!68(=5$[A_'+[E7Q9<MB\$KS\=
ME-*_H%4Y2 +ZV+.Y#93;RS,,-G0^01\3UKQGUAJO1QB<S4K8 Q'F>#"V$[.\
M5.%[Z?APM)OWNIUJ;_:@O>%^GX*$DSU@B:!D#C,\5 <KU86)P36&;266J)M0
M%LOS Z9/FU\NSY<JX;PXFNE>]K_:0UD.>M614V]0/7NP!\KAVU[U,6CG7+C[
MPTY<',N<3]YU4W+%Q_0(WD=_/.B]>EU)\.O#\-]+4!D2G>H ]24[(5NO=X%I
M1N:!>VKE@8HR(L'4A*DTB5#'7!0RVFG?ES:8"<Z]L19SJXV17E$'9C^W1%$K
MK_B6%T'^/Q\?'77.X=?9SK"2T5ZLSDV'%#ISJ#$9&0%!#JVWF1#E:)1^X[>*
MJ76/H2^A__NKNP"AJ"ZE5??<+J-)JHMU,/B./>K'5^>__!G:_:../7W5/JR&
M4'WISU%;HQ"4'',Q=:^NFN7AVZ-P#&/6%%;Y\'J4SVGTX%&PQEIUKCUU27#X
M'A-KG-S\-EXC-[[W2,W>_IY@;.Z=)61-"KE(G=5W:O87";[JF3'\^A/I\Y./
M&_)W+>:@WG1 T[;3*/3A'H.[\?+]G>9A&)U6JYG($;<-AE?_XWI_K&>]_Y(G
M8R.",>B 8S%R,2%X8D(>6B/@/EEK:BTY0Q9XATTRVU3<86L]/!/JR^WDDE?0
MK';HIW$CS3Y\NR[@T*_W+<UC]-/;=.:B1;6;N_\S2\F9>V3D>*[ VCM>@[O/
M@<@#\]],G8OD?FZF+_U8J9:ZY+5YJ!]AE-?FM6B>[<!W6GO-@R^GK?U/>SM?
MW_*=_;?Y]8/-K6\G.UOOVMM;W_&5O#8;W\]:!^_VM^G;TYVM#S1?O]O>VCMH
M;N77MZ'??W6:7__>V]SZE)KCA0VH9D$(F1 +N6A), Y92R*2),1<(A-6-N?J
M$ZN&F!I572J 5 #I-D#RFBI%B:,Z)6ZLS_DVE*6<>J^%MK@")$PH(P60Z@!(
MY *0O.<1ULV@D+Q"G)J$+.<4*9\29C*F@#T DEK%:N8J\Z4,W/W2HXR?(,]B
MS"W2H)<I5.YII?HR!_GIYM9KL4L,20D &5$>(^)",&249@@[3J-S4E@ORWS/
M;[Z!L3EE*$?*$(\XEQ(Y;15,O[6:$)V4<BOK__3RH?O@M#K%C/_WN'V43V%6
MJX1K8SGRIOXII69J945-,I.)8+_"2V:1J$M#*6"AM-($*:+\J#:M$A9%;S3#
M*FE'Q<JZQ#.G_BS%H.HKH0\W*XJ$/I*$7EH."E-M-(XHJ,@0-T;F.M(2)8:-
M\L)8*?'*.I^]RLECUW22R^5?KDHY#8V&\(S.Y4>NSU*[:;^W)VB.$[0T@/^(
MCNTJ/*YH@!DU0.O-&$>+2F'OE$7:Y#+<WAADA<\7N9(/TE,K.%E9)W)5T*MI
M/%]XY9D"GP4^:\27"WP^%7Q>$FAFI,8N*A3!UD4\Y9R:,E='M28(%36L)*M<
M[X(O3^&NV\M<7(D3KD.MB*IX16/"&W]^(6AT)37GJVK<XME;/;_1EJ^7Y$L"
M83(;TT0$]MWNBCU'&#7!> T/,]L]((Y:&/$8<=0,/RR(^%>AR?,/^LZAR<0L
M4&?IW6;V%T9U/6WG&^*H+V_-O.00VQ)O7.*-9PEI[-Q+C%Y:?.]"=').0<@5
M1U3#U+@+NH-7S_-SOM0 Y5FEN00%OLR@P">/4CYG;Z=OA@*[)*Z)SD%N=_-]
MJ[U-/^VU-N#_9_#L#2^VZ?9I:^LC;NU_(\V##Z?3KHG-KSMY#'R;_KV_\_XM
M;KU_RS:K1"^=_9W]#Z2U\3'W_W1[_^_),&7)G1&>..2M$8CGQ#V&<H,L)0;C
MA&.D<66=KG(ZK]*;"^2:+8!4I['5PSU: .DQ &DLV,"GI%+PR-.4[TUPB;3&
M#!'0'L;YH)0,&9"HQ#4"I#E%*2\%B8850;,0Z06,9;Y]/F*5@FDT)8VCG&WF
M3K?<2SS9 C+25O?0%QUP?QTP'A+*DA?,.8&PU0%Q'#DR#@LDI8D*>ZU#SD1-
M^*K"5VO1E:C0I9'BYZ-Q18H?*L673$Z29&%Y%,)1$,2- M/2D8# I'0X!1$C
M-L,;L&)F*O?8D:-+YO@;1HX^L?OO"8.I7GJLU$L*A7H^JE=4PSU4PT0\:1(&
M_J,$1<H5XM$3Y"+1R'FE)1?:6,6K@"A"9[Y4<%_)J+E/LB#<BT.XYZ/!!>'N
MAW"7Y)=R8WCD 069$8YQ@C2S'#&M&>BFI 7+Y%>O@FI:%(0;,>/SCIQO9SX,
M4'SZ6(>ZM#$V\=<$VBYP+U^"*309[;L )M#2M/'"SDQNW&BSA1TMX&G)$F8B
M>2*&,9&)Y,/)KA-1:18Q(CJ[V"27R(D ?$-XX37#K"JK5N9[7O.=& V46X)H
MLA)QY0,RD6MDK:+4>GB3X)7UU^?E6\;*O3Q)QI>93PMJ!Q5W-P^O&^+26("/
MD<"FA*S,A@R7WBS.K!54*N2P-( *S"!G (J)$BI@K!UU<66=TYGS?-;OK+(@
MSI(BSF,DY"F(,QOBC%TH#L0$:3%*.5*.4QN1Q@$C)GS 7#B?K%I99VH)SU67
MP-R;-4!N ;TLQ01YH-AOOIDP0<@N$#XK5>!(19<#]I5"FD:!E,><)L*$BK3,
M]_SF6VM/(X\64<,YF-B4(N<"F'R)..6=PLF#R;<YV(N]1J=[^ WE,H!#E+W.
MF?APV^^N[KC;HL;N>J]AH:G+HQI+)3#LH6)U:2^I8#3EDB'*<01[*4IDE1=(
M)A:\%2+@8%;6J=8U"O O4KI(!D:1TH=*Z:6-X:3#28.ZLSPFL#$D$ VI(XK,
MJJBYE]XZD%(^KX1OSY+U<P%/3X:QF_,]MIS1RU-2V#W=!"V- GA4FE9@_SZP
M_WD\---:X056R!AG$ _4(QVX0<03CL'@ ?!/*^N*S"O9\_,GJBL@64"RKB#Y
MJ"RY@.3]0/*2&Q,:*8T>(TUS'(!W!#EJ+;)!!^]3\M;8E75)9N;&M0'))<GF
M.1Z2,9[2\[J0C1DR>8Y6O75\ $/Q-TU5-:ZQ9=@_[@_:Z?1Y46G4YTD8"E$P
MITW4@GC.HS 8L <8&Z:&6,_$[D;%U>!_Z)*T32)0!3UONOW!5MY#6]#T7YVN
M_[Z8R-.)__OI=.=K.'*4RVW:I"WZ;G][_R/;V?IKO_4>/K^UM[>]!8BT__:D
M]?X+V]YZ#4CT=VI5Z/(-VFF>-3<^T-;K78I98%X:A+%BB&L %$>21%@'K;CC
M03$[U KM0]BBKW,XOW L)"N<%(J"6F"&PN(X:Y-G'E[1*XT(T'X$TS^ ;;VR
M7DT^M-$?]!OAN)>O_,'6'F+18*\78Y7*MM_^.7SI !ZVUV]$V/AA^$HC)XH<
M_LKP:B,O\O O^-[PEZR'&K]5,M,]AGT8^K^_NB('5X1D-"Q;8>.=7AD3I='V
MY71X&GC4[;?S9U[U8@<^_"->)K/-VWOLBR,<Q9=?L0XD^WAP\U>N9*Y\)BD=
MR] YG,2QGWL7H?E']EM$KA?M=V03=/:5[9S8T_[*'Y-0!#@T-8?3P[]QD"D]
MVB"'D ALIMNKUOP5Z,/8RY^"/MG:]*4!<@/8^#]MQ[615&IA-.8B8>>%\"9@
M(9E2G.)=M;)>@5[. O*?/^S"#N)-5@F'N<B,G1;EZN>4K(Z073 ?D[8!;$=N
MO'-!^F"X(\9J90R=AC:>%#,B)<"VQ)VA%AMNN0/>:ZFFB:[<\!PIN&71N^"-
MXD1:[1QSR1O!230N\.GG8&X#IH*8"+WAV!J%A29<Z<2#8SC=]!Q+*2A 'J%C
MG /=LY9KH;RA'I0B\7KZ.4H[H;&*)G+.I8 9#E(QH(:.)^VCONDYOX3X)<D7
M3B1\<_[YPJE>H_IAS99\X<_36:9YZ2R]VY[]13#5 U)TS^.C9O$2?U>@M551
MX.:0];[-K+=*_WV1''T..=$7<&HJOOFY_?..$W/'+5DOU^4-Q0$NS:7'R8=_
ME[MT#TP97\,]=,>Z G/+K[Y4,X?GNP.78W)PV58SSERI:W%+M'9&_D<O9[$(
MT_+Z("<K/1N:I?'G4?:#/V. R4L_&GU))Y]<*J]Y2DQRPR41)OB@50A$"Z$=
M)Z,C!SYQY/# TN#CVWQ)#D6WZ?;^%WC6O^V=_6VVN?$)^O66[VS]O;]S\%$T
MMSYU=@[^_KZS_^[[]*%H:W^G#>.AK:]_PY,];[W_>[^YM==I'K0.=C:^_VR]
M__=@^^#30?/KI\E2 MHQHH37R$<?$6<F)_7""E'/;5#"NBCPRCJ9/=_- U!V
M 0)#"KB]''!CB4:&G:4N6DZ9M='K%+1E5$BA::C #9^#&R[@]DS@=AGQ(4S2
M,3B.%"@DQ)-*R!(C$26&1BIY2)(!L59S#HM;7G![T<BVI+#VH#"1 FM/#FML
M!&O0CR]D5UI& N8>849$KKABD;&Y[ J)%'OCO'8$H(T].K0]!Z[]NC,%\0KB
MW6RE N2)R!V)AG#!I,6*"&N8\V#R@!DT(G*D$+GG13PQAGAL-U%A@J06>95#
M[IBDR+#HX3>@<L8(FD*5L&=>Q44>%_$6\N!MCF[811K@AWP6$/N#G)FYD<9'
M.\,QSS7SL-CJ94EUQ6-Z-,\WUMNAD[[HA_OHA_%D;B(I#JQ7(ZZY0UQ(APPV
M#@GGN?$LXI#S?1!^/]7P>,RV@,)"@\*C>@(+*,P$"I?>OT0#399P)),"FFAX
M0"[QA*1FQD<7E%,"0$$64"B@4'<_6@&%F4!ATG?FI F6 UN@'ON<=ML@3;1!
M/'%*.#"^Z'/Y]'MF,BK 4(#AZ=U-!1AF H9)%Y-PEDCJ+6+:A)PV4"!' J #
M34#LL&#*AY5U=D\/4XU*E=<:%:8K6\X:T+?(8W_&L+WE42<O+/OWW%U5D_7E
MBH:YOX:9J)_)6&!<LXAT(@3()I7()(T1%=H:$D.DW*RL:SVO_",+%'!2,*=.
M8WM.3UC!G#E@SE@^4..$,L(C&RP8N)X3Y)2D" AM@H6*4EJYLJ[N:^L6S"F8
ML\B.M@>6V"UP]" XFO2^)5 6%!L#Y(=HQ*-,.44Q1L$D:S#GCC.WLDY6E2BE
MEPHH+0HHS<')5T#I*4%ITO-GHU!,6(ND5GR8&]($II!S2OLD"1#;"I2XN.=Q
MX>-79[I+?L=Z)2U\8_M[C2/;#E5 E3V V1E,9G;,*1P/8',?]^)!/!SD'%Q7
M4T%.Y\2[-A/>-3GPJK1Y60B'+Y_8?@/^2]U.IWO2'[YV)27>>-ZLI<C@Q-2:
MY'3NV7 879/JH>EYEB8ITD)UENF[M5JR%\TSF\-TBI[&K'F+?E%%HYZ'(=?/
MS7STPQ.E8%F\+"(SY5^92_*5Q9NS!R?T><E)6O#DR:;/8IV 9+WT+"WXRJV)
MDIYEYOE\B1D,<!U#%/^QIUDG;QXN6<F*@R]G\-KIYON_][>WOISF,A/;M"FV
MSV $&]_(]E:3-@\^LN96V)]V3>QL-=GVU@>^?=#::VW!,S=V]F$\T =_LKGQ
M[U[S;/MT9\/_;-'69'86PD/P5!HDI;>(FZ21)9P@@VG4+"KE<8Y4+/D+"K2]
M<&A[DB#+ FVS0MMXI4J1J+0*2>+R=5ZFD794(.V-ID(J0;B\?ZSE8D/;O8V%
MQ2HJ/\9[9[<'%G;HLU#^7Q0JOL]D+9OJNVZ(2Z/='I6X_]-K@T >V<Y(O?6+
M4KN/4AN_A\R,H#I:C:1P$OBZ$0AVJD%,<BPDYE8;F<L!U:G\<L&>@CW/QJP+
M]LR(/9>$VG(1L#$6.<8!>Z0VV4W 422*DN"$DLX!H=8S9W*M&?8L^=6HQW"B
M+^;0G\U3OLRJ:Z&"\IZ!-C\P**^HLP>HLXG;4DY[Y:(&349Y0EPYA1RA 1$L
MJ(]&X6A2CL@3O(0)%T1:%$1ZOC#A@D@/0Z1+@DVM\L0SB@3' $M:<Z1M KY-
MM,Q7WISR=A@C?,\\8[5'I&OBC&^M\?R<D<=5B]=5F[^^6-<[ZZN#G/.E>8YX
MZ,G-48]YJ<AV?S+P^;%KS??[,4Z"UL4Y6],.CGOP[PNO0[]]VOJXZVUDBBJ&
MA'4.<4X(TEX &.5KY(PHQ8B<KB5?%^F\50Y&BYQC^[NID4:2.;3[^HV3V(MC
M@?KY5_C4->']"Q*\;\R:%NPAL?M:KA$Y_]C]'&'.]#QCP>M%3*\'NM<7VZAQ
MOH-F2U]<KP#6\XIPQX>3N726W&M6#?M3/+#M0Y#BO,+7+>S+B2,J19[N:*!I
MD5(2+,&<"*XH4!BEHI(F.(*CQF+WP\R>HEN)SKF9=K%W-].[=K;8MJ/M+8GM
MUN3-K=<_-[>^G[4V_FY#WVAKX]-><P/LM]S?L[_;VU^!%\'KT[;;]MDW:/.M
MV-QJXN;!AQ-@1+CU'MH_Z[1;^]]8\^#O/;#FX/6=E.]V7GJ3O*;.88J45Q$X
M$V?(8H%1X,E((6W$2E;>)#&O[#N/'G#T$H*%0-;HC=J8WF^LUV)TP:HY8-7&
M<6Q!I[9.8N=''%YJ*TAU'Z1JCR%5C%JRG,J>\$00-X$CZ[!'5&.J(AAX*H>0
ML%4B:(T.<E\"G01A8@\"H[LZ[0L8S0>,,E7:.ND6#+H/!IV.89 (+G)E->(J
M%Y=CU"!M3$3:,VN]$<Q'5F&0KE/>L"4G1.<8Q LA6A0,VNO%)<G+\T0HU'HS
MAD(\2IPBHRB$E,, K,V7WS1*.D8?HI,ZYF#:5:UFC@ H3.B^*"0*$UH0%'K7
M/2Z.HWN!T+CC2$M8IUPFQ.#@ 80B1=I*A@@EA/,85;1F"$+SNJE6J-"=04@.
M9SCG\QKLQ5ZT:1![A1X] S#YXT'O=E3:ZOX5_['M *CT.B]3@::'0-.XIP@+
M0!^60R*URLD!I$,Z"?@S62$8X4EIX$=RE>&9K;3"C^YUWKK5'=C.*"/5T4@;
MS\*79CN'?$[,NGY^ZH%9]R53!:GN@U3C_B1OM:6>822P!A(5/ ,291)26,K$
M-""7C"OKQ*P:P:Y 57TB\\K1WQ-.?9;*5XWVP='QH,KY-\S 4<A=78'RRV%H
M]WV.,XKA[4\/'QU&'174O =J;D[XOP S+=<$"44UXDPKY#2@IE"&6&VHT3A4
MIB>=.2=UX7?WXB__ !3EM*,_;.<XWBGYZ!U5QBA^E,'<A^YQCD8]'\S"AJ)=
M/X,/#46;QP35!?(7@1O? /8%U.\#ZN/^1,RC\X(DE((%HUTQ@0RA%!F'$Y9.
MZT0I4&&U2J[)ZK>P5'@.8CO'&@E_3%QDJ<W=B'O>T/DW[K4]S.1_G_RFSG@"
MCW)#9_J&3O/UKG(&TV0LLBJGX@#"AFS #C%)([%@^3*L%_*&SNL;[MRL5AG9
MWW0/H$^GC5Q1PW</#MJ#;+H-NHV#]F'[X/A@RB-697?_,=S%_>%[ =1=CM?O
M= ^_(;#X#AJPC9'/NZV3]]7PJ6D\C]IX\8X'7OVY?G[+;:"7=1L(OX#;0/AE
MW@;"CWL;J-;VUV.G%*ZG;35SHH:'VU9WX$HOX9+/EY/6OC]K;GBQO?7I.[1Y
MMOWUW=[.P:=.<^OO@^;9]Y\MVCS=_+JS=S5!PVO:.FN>M,XZ>ZWW'Z'_K3WX
M[L'.^R\_FP?;9YM;;]GVV0>Q<_!NZI*/\EIIC5'.P@BTBWNPK9Q!Q(9(*>&2
M.["M*'_T*S[%R5_N]RP*!BWOY9TG0J#QD RN791@5"-AF4,\1HL,BQ*YZ$)P
M*3&2DU:Q$K#Z]#CS@J[NU!5GENM>SA/!RW@<!=&,$"D=\BD'HV(FD<7&H?^?
MO3=O;MO8TH>_"DHS\YND7K8NNM$ &LDM5RE>,LY<2;&M)&/_H^I5@LWM@J1E
M^=._YW0#)+A)HBU'I,6[6!*)I9=SGK/T65BJ8@9H0UG"#YY0M@]%_=OAY1%E
MY6PUO'Q'*3=_#\"T4FZNC\_^H.=%:O&, *!%%ABLQ2E1)A=$99F)C>:"9VA%
M[6-*_UZOW=\64[I'HWM!HST(?1D(79T7(LYRERI"!7:&TH4#*#()D2HQ.E5%
M#!K0P9,\7PX5W;MQ'H;]'GNLYE9AT'<>B/DW 5+;KVR=T$5N&''**L)5HDAA
M8TK2-'8\L2:S!@ IW4=A_KT:T=\<A;D___OJI=D#^%T ? _4FP#UO/M=)TJD
MG&BK.>%<2R*=BHG.3))82F4L4'.D]]PO^:N8XON/:[PUPZ5=1SY0O"CB)(7]
M*Z3T3?.*3.=,Y8GDDN9,9H$=X1YKCC",.56"21XG4G#+XRP5QAJC-.?<N<PF
MZ<&3O_Q+K2$25E5>V*CR9^_3OD*1CS;#3/)&>XHJ.;:=.L-\;=S;0E7JGU84
MQI\+0EOQ]1T^:>UDO7J<'>886#8<C$J\YJ?*=N'BC[:.)ZLAK75C3:7Q[!:I
M@"9!95][RU(<TT.E^K.%16S]>UG-HK N+%&5E1^(+P3PD^Q>R>O1P3_F.0'8
M8&$-%Z>_=I+.?;-)!HX$63&H_)[_Y ,A\2H8D]R:L427%0K _R@5%T7&,I&"
MM<Y3%RN=IKHP<9HE><Y9?)X?//&AP,@X__R'W-E)/$6Y[WUM<I&5FU#K9?SB
M+D\*T!&PR357!9-QP248#BR73##'UN$>@)V)64H+:PK.8UGD<2HHSX7C1B6Q
M6W=?+E0JXMP6%B O2V%&)LN3C%+%P7:Q8FUX<2A\O_*9MV/J/D3VD87(UHFY
M*"[/&G'YK!&7KT%<?D^QLGZRZR.!OR\+>[7<O9O2],.UE=7HQZ_IS'BG+*!-
MNGZNTK#S(.VW><$7FEVN/^"Y$S]ME8G=3FY<F9BTB4W=RE^$H>B?S*2Z]J&S
M-V4O-M1\%(CY=4/+_DO$,[K+]O;[;N_T[-W[TS-3'O_ZXL.[9V!SOW^5'I\=
M79W\"F_YZ]7U6_;JZNW[7Y;L[=._WJ8GO>/TA+V\>OL7W/<K)D)^@/<<Q6_9
M\:=WSWY[_^[9+_C<^7 WS2AW2:Z(C$U..!4I48R!O>V$RV #79[Q@R?98;)D
MFGX#)-T5'G\QE[WTC=KX/GK6;WO6]HQ_'XS?#D2S,M>%QL@0;C7A21)C:8J,
M:)J8(M$.K">P#^AA_C6,O].:TIP7:0,Q_BU:F^\*,MY9^_GN(G9OKOS0G_24
MK>[E"&+I!.)&%:FQ[="T^]U6:)]-#R<(VX/FK: Y=XR<6!UG+J-$I%D!VI*S
M1/#8$%5H(8O4YCR/#Y[PP_LZG?C*4X:'8('_^@KYL"LH=T?]CZV<YQ[*UD/9
M#2K?'LB^%LCFS+XDCEEL.%&YR B7-B,BEPZT/UHDJ7:9406:?1NF(7P?>#4]
MDET^UKNA"L6V%YO!"+]!%;WL!_,+>=H?.(;Z'JWB'P];HD@PFF]9(^U1-+H>
MC6TH?@+D?9>:)-MU1/]L4J%.[GR&>H3&=F3[!G;^F=46X;P^$Z?>2Q[/UX+Q
M+OT0%#IHEB :5S"<  FC#GP575V6^G+NOG+D_^QZNNM$ ^?\8\:7H.E<S%WZ
MWZ.HYX<QNBR'T; :7%2R=QB=S5U1EXK!BC/VWY-RB%':0,%]V,6FLW2W&TE=
MQTWZ"_'0?\$BB4Q8"WS]R )[FR@4GR\K$_U[(BN8[*BN+Q$?[NQ6X_3<8%*-
M+YM)W;+C&C!9EOWP,4P?'["\*9&\J*P-M7_"FO?\8SL1?-L?-V_6L 2#'BXD
M_F4_Z>YD5'ZTD8=_O]Z#H4<@H*CAI-*7_B3BTC8EA&I^<]6@UZ:33B3Q[NMH
M#"O6WDC8XW)@_#GU#3XJ&S/'1)[+5!9<22I=PIS&=!BF.<^=KYL5TSC4S8HI
M2^A*9U4/'GJY5#9_4+T!961T=CVL@\'J4JLXS[/![_4L__!'V-<P\"/X>HRN
MJ]W47;ZBP-:'^.3S!3SG^//QLY?)R=&YH5)(DR9$Q8X1GHH"M)$T)BS5,L]-
M7&2IP*3(15=4Y'=B%.AD!+S7T$--E3-J/8Q> !P@-: >,_(73TM5M>]HD?ST
MYCJ"J(UMNBM'H]*5-J#'/.KXYU7 #Q<UIP ,C9 VR!B(HU7S"NAU'3O*T1R6
M&HOG="6.N1PCLE;PD$$?])3KAG/A>N".-O=%5R4@HOT$VG)9\]>4V0+_[2"^
MO:@7>&E!@]#J6UB>_D<[&GOY4 -9O8RU=E'+$EA#;<N//@"B1 DD1Q,44,TJ
M#GKP".VW,#*@)_F=A@O+/L"9\0*QOA HIX^P!;_Y<T^O5"G9]4;BZ-+:0 ,2
MGSD<].N!#;#A"6Q6A4(,OA_YR^ =P\H.96E@YX;XW-%A='0CK;0)I<)H&1S<
M?VX0"YO9% PUPW(-)D&6.^#&.'.)-<[PF&<J &-34+ &QE90;+I!.=)YD'QM
M/]I^*],J>V1@> Q >'ITG@+2"9>DA',\A3-2$R4+1K(TSF.1"I,4?*/HYB2U
M/%89TQG->&PRJ;G,$E&('&@CH\K;X_>TD4=]\ZP$NAL'Z[UQ1([J#6YX[+'O
M,49QT50( A:V(]PR ^(N!TEG%3,VE4 "[.!)O,)WN/1!!+C:10H 4*@"!TT%
MS[*@N1FF1F/XT6!EK2S#][52;*<VXC)D]E<C6 VY=T'%PVB5H;<VJ^;O$C%G
MV(C*E\#<@..^J"CKC/5>GKQ8UC6!_ZX S4>VOQF*[FC6P5>HE$>?0(T43!J7
M:4-R!:O,$P<<9H'7=$*ET337F=D011VS2:PD4U9REDAI :6-D E+02-EII:+
MO):+^SW]!GNJE6,@R CP50*H:0P1AL8DEB#48HE",]]H3SDP*@A'16U!>9K
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MS'=?' ZQZ V&[8XK&)>LPU']DYO@[#K)SQNCMAK*"J-(ZZY9ZQ[0"F?N-D6
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MN^?PK>7P32T-GH+U;(Q+M(RY=*PPNA @QQ635%.5[/TCN\7A"_X1:52N4FJ
MMU-)N,TL49;E!.L9IEFBP:AD!T^2I%/D7^T?V;/Y]K*YM)::0EEN:,[3O #V
MS@NM+!5)KAU+]PZ%'6/S>8>"EJJP3#D"T,T(=TH2H:DF3HBX,%0+Y@]OTDZ6
M?[5#X1[9_+&%^1R-2MF);-/0.?IR!\-=';P[#5I9G.HX$UFLF>2JP!IU@E.>
MYTG&,QNG>P?#+H'6'U,'P\G9R\^GK\YS9Y3)4TLHA7]X'DNB$AN3O+!@CH#
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M">^O[RF][RA4;\8!S>3V8(CHBI%-WETT!L%HX"<HR=VN]9:W/T?QEDH;9MT
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MSSXS($3[),'+,>E&>3O!IKA+H@"9- ,\5[@%M&-ISR)1/GN&^;725%!SQ&L
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MH2]R)*K!ZN4GP\UB7>D3B]"WK1,-HN@8F[[ T>RAM8=FCPKYF,?"'ON,T-?
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MW!<DL1<$/PT'EBXF)/Y^^?6?UQ_/+&G!P^CP1M<VW"F,?<>C1LJU5=K^I8?
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M*$&VB\H$'E39##-=04F$Z&B&0@W09!SP4&$#*28G6 D?PS1;P\9]!3>2D<3
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M2R>2OS9?73%;V(L3=L<+T2FR =$V1RDDPX9%,/.1A^U9?J)9&P>+7S!%G*
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MEIW,'D#7"(O))U3V5SU?2Z>H,OY/:[G_\WX4.(_PSR2>>K_^?U!+ P04
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MHC>D-%"ENCR7F0$/6^/1!A!ZT)MT"DC,TTHSM6*N5L1V#UBJCQ^)A.8-:<!
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M^J*OBW7?B/1V1B5+"V56RR^.O4%/F%)+W.2.Q:U(TKUN;D8WC3^>3R[IF,@
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MQ)T )HQW-6EIF#?:,8Y<@)8>D7=Q)*Y%T_).J;.'GN903?#6ERP9+X&65);
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M- (;S=3H OZA[OY/96/;7N>/)9M@[Z6_G\)X^A*F\^)9Y0I@,IX5T*2%0/J
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M .(B&V<3D"V'+6V$\C@#DSK7\78<VD-!1V-3\ ZU48X504>NUB@9N!@8%FW
MF$Q?;)+2^)18], (HL=!HFWTTH(\"W#C;QDSRQ0^\NRDXYYQ;2W3HBCFM3/,
MR *>^QCE[4R!C@BS#M'A3>0&&KS-D4[$WV&^TMH\8(59"K+KF 91Z$W@C@&:
MQ'+U^HVPG&_D.SVYLHG.[91.)'RPOGB;@/K>BB&V4M1&*?&[2/EP]3#*E9"X
M8LYP9)J7P$(*G"F,DAB?DMPH>^@QJG[;8HCN-;^-<)L70W#KLK/>LEQSE73F
MM?:^YB\!R)2SQ\2;Q$\?93'$5IJYMQAB&[%VG7J\O +Z#<9_XI2LF?>7GSZ-
MQM,%-#(PI$/(C-A+T%SB-9(S3U8SII9JQ%L:7W?)?^]S#F^Z[:&!41OQ=9WO
M^WKT%097PR6-RUK%6&N")5;W1+ 8?:#33>3:/\.*5#92Y(V/?;)ZVUTX'5I6
M\[3A/_O#!./EBA*H:% XEEQ23,=Z@E@0C >=="C E9$;Z>GFYS[E37-?,34X
M%G^&02TK>7^..'U=?[N*LAH 1GK(E4D2/.'R7C 02C)K<U$B<"&-;7%"K@-T
M,EY1IY)OT'UJ%:X%YS=!UC).NQ[:<8*SW:AP U[L(?\#[1D+A%%$3Z]!HNW+
MU5B.4RP(D+0K"JU,$K3)-:F_.#0S'@BX'IH8VXB] 2'>3,]Q?#:9X'2R.-6
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M/&K:5;0UGFF>'0-)_D3)/A@Z-$#8SD[1YEJ\Y]SL5HG;2*UCY?U&DKJXO%@
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MCZ6P\&;K\<11&J17#'R]I=12,T OF 3:+$OPVL/W,/.BD<KOG6ZQC>B?RF"
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MN&5:DG$=:E_GDE((1CD$U:0X;#-XIQ*1:*",!B,:KJ#]AE#[JLP+8N_@7;Q
MFX!M&;K8"NUQXADMU+Z.6<UTUB#PL25H$-Y%"(Q;S$S78NL8#+UX&;FIK5&S
M;9*>^0@(]D"(Y/'Q:PM5M>35J^&GR^ED)@&Y.(Z]"U$E*QA(7XLKG68^&LM
MYX(ZVP"N27_)>S =WAIJJ,UUO-E3%0WN8%ZOR$2>AQ<]#T4K8,J17:B!1Q9C
M(@->10-%TRLDXZ'RP$_)^NE$X T&"ZW"];I.+!TO[PDVP-=V-/?] (\UI+L+
M=6[ D;UUT2)]XR&<45@C/.UK7A7:W,!'%E2(#&4$7[0-2AUL$VG/E0?'>!^#
M*MNHH.O(RS]Q,* 3=?QQM#CL' 0G;-)TB-:F#B (5G*&OLPV21U ^\T":K<_
M^1A#N;L4_*@KJ75]0?.>%I9&0[)>!OCU9QC^N< $&#3IQ#+N96': F?@Z1QT
M5A4,M0Z2BXTTN>8!IZ30+F38(O=JQ4Z4LLR<P-@$<1:<92'%P"2J@"D2S[#)
M?GVZYMZ>0FXP5? FHJ5!L0&FEL;=*E#',>CV5=B]^M]#VLTW@ 4V(64RH226
M4">F>4P,"CF[B6NTWF:=2I,>1X=CP -FVB$(L(V0&RC^'7X>#3[7QB<WVZ+,
MCR6MO#"1$RZL?SC#6?3@F+417-!:8FPR)O)>5(>W!_97W*B5U!O$@:XW*YAQ
MWID J O4L;>&:7)-6+2VL&RRRCY#C&T"S;>!G(HAL)> &XR.O8YG0>Y-$+4T
M NY".HX)L)^J[M'['G)N< JL0*:(S;J$7%O:U/8#-K!01XYH6Z)T27F.3=+O
M#Z7Y!X[^UHK?1KP-%/YV3)*H<);^9RH:3-2UG(B6:(-AA, P)X3C],]SQ";3
M5&_A./S1OJ]J[E3O[R[7!D?Y^RE!F0VD&L!DLIBB.:-S4((;$RP#@85IJ0H+
MSBHF-=FU"D2(V.3:;RVB4SG<NQ'Y72[LW5#P.IZK7*^'$35U]>] .LXIWY'.
M;KM[W0B\A;=_%UG1G@=C/>.9:SKC<F&Q%'(\ OHLP-D8[%.FP /'_<$8L(V<
MFQ397ER,AC- 2V<3N"RN2.; UV%1N7:A2)H%-!9 (_VOR3RN.TB.X-;OJ9X[
MA;7[R+9Y4>VUJ::SMNHS=JN@72(:,Q$-,EI\9H"ELEMX;8KG$@_0Y7X5M%.Q
M!SI6PEV:[#V9ZWZ$2Z-X XR'*\A=#?(Q%.?NK^"M^+.'=IH7[J[!FG/015O!
MDHGU0!5(FV(VS"25:7<57O$FEL;Q&+150>]Q"+2-4@Y.G#?#I3O-55&!#E/&
M=76G*^"8-5ED/JMHA36^32;BAOB.7<;3A7*W8L]NFEEKZOS'3[<$]YJ^G/U@
M]OTJF'=8?JC__>/=JRLAILLICN%O:73QTRRI1"GQTTR(%?RUN=OU2_K;"QB/
M:T?O^;1<G$)_,+D);=*_^#1XL'A\BT__Z=LB;BYN\8@;G.A\.?AE6I-7\H\_
M]//??^QS6H+CJ+VU48N0?48$M.AHBTDER-X6S^GRM7]]U1XO$IN(,<"<"[FV
M00W,0Y0L9)(%USKE> "K] I/M[O;4HZ+-K\Z25.45BP;4S-_N"5G(Y''(;T+
MTB?->9-"L_M '7L?VXT)]V]=>XB]N6OVQQ#FXVLPU^G=%>!BEN_9,,]^==$(
M=C9![7><]A"#<"8D)GUT3(=H&*A2&X!(5>ND339-PK=[XCY%8K557J-.>U>]
MA(NN-2><Y)!T)#G,0A1*,_#6H$_6V#:SF!]GX^9]6+&S6)OWU9H',< 8\"8K
M)IRKK..%15$*4_]_>=?2&[<-A._]+VSY?EP*!$%0U!<;<8L<C>'+6:2V#&DW
M2/Y]A_N($WO7D5:4O'8NANV#./IF1,['(;_AVDD6DV!NAMSY).1WZWW\PZ$]
M%?G=/3)2UF2(U  1-B,L43 "3#M"J>8,8@(7)SGO=]J*>X.<^W/%O2$@SZFM
MUL>N7UIQ;Y#C^HJL'8/ZG%$1C(V1YD"H+QWB024".1G"<;I4D/';D#-,":>G
MN#=), P!^SD4]X1T0"4F-=E$360&27P1BI509L$4<K(/M)A?A>+>(+<,5=P;
M@ND4=[[W:4OCND8=CY1DYUFYW;2^@AY(Y@%\L#GYB>Y[G[@(_YA,8#30$["$
M ^+2?:SZI47X![FMG_;Z,9C/)\(/3 5MF2(T"9R:F$;K=&($R:Q4SE(NY"0E
MNU,7X9\@$(9 /9L(/TTR:T\CX2KYLF&EB74*/>:B%CD:'?0D>]2G+<(_R%6]
M1/B'X#Q;$>URL]_P/MV57<[;Z\O5S0VT7YN\;5HWHH+6]]%URF='O<B#VIEW
M.D<J,.4+3B;A?3":J9RSA:RH-E=]!QG)UQ8=7%^WZ7K=[_Y\]_#[':Y$L](2
M&#&V2%NMR[%)!?S-ZXBA&B6=Y#S_SPRK<%VQ/*\TQ\-/:-E"6'Y8+#^^777+
MYB:U?]^&_U:E9OFF]$;K4OP'OEQE1[4.F+4K'7&6=AP())RJ,:6W$)V(@9LI
ML#C"UF=@/34C:<\UQTF]-45A;C\>&P(@:,I*(%FS43DBA8W$TG(Q,R--LU0I
MSR:Y#ON44;/MI4\9*-50?^[=]:Y=WI\E_RL5_=N[CXL &\%!JV44-MA2[L.,
M =D]QK9!%@DZ,\EX2*Q/!T0<Y+O8P;\>QLV35CP;HZ[FXZ8VUA43Z;51FQCZ
MWJ3==F\/HP90ZWZ!<,B:>1EU16\U4T$]6QPPZ:U/@1*WODS*D#\ :$&"T)A;
M)@ F^Z0DI^C_ SQZ;O</0;CF7GHY_M%^O?KW\BI$(Y.+E&@I$D%BAY.;,8E
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M1\W'!AKY</F,KH?'R><NOK[VN&&1A<B>V;PMDC5C0E"=IA(2(97MX&)SLJ6
M2!$9(QXA)..VKZ#;]W]V/*<7?;>=X,!,T$IF6^#IID)VW0)\R>?90TW.W4N/
M'R*>)+$0*,4P(N:%Q3R0D%&L(4H"$@F64*J]'+#7XSUZ\S,;F5P50[*ED&[
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MZZPEZOJL\0Q-3^UV[$C?>_VX7:IL]G919N7WST]L/G^U*K*%*HJ9D %.@U!
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M;YO IL(&3"102&.50J:Q\,H7[&QM:E_]UMC(6@N*1=38ZUEFK1-B-Q((!MS
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M;5_!&&G%[/'^A!NRCA$#'.4$*)GK5*20$RK\]@?'Z*U1-PHGU5]N(\2(7\S
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MK1G)$XBYERAL1V-3&U[V;;4?6&-M]%MEK^>\NQ-GMPEV*/2&'C-Z ^<OZ>F
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MK?SOEUK[V:I"W]Z]^V13?9F5.FB2A@I5_J*,H0_L^RQ.XCSF5 *44&W+\0I
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MT SJ!,N4QT#"E *(!0%4)@S@1%-.=*I@[#0I/-? U!BE.1*P-;*J7.5[<.(
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MT79WG\WCJDPDN[LK.L"O-D4VLJN1?%%V3_AIQS_S;RL[W;1/>J["8,%V@Z]
MNWLCN,^#1]P#OL+O_>W?:Q[48ZAI]6^^JM5K(52K(ELKX=TMZ@69U(+EL<9
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MARGYT0!A#RN_U-M-=_H#6UFY[O)>K2H1B:KRZRPUK,M2*H!"=EV $ ),ZA3
M/!48H4P([97?$=:\R3'Q3LWD7?^BK8-1ZV%D7\5HQT=[4^NE/5,757XV%98]
MXYZ!WP(W;G^[OAV8[=^B6Z^HEAT2_6&J:0>Q\(VJ;8=$]WPU[J"M],CG^5*4
MOY>W"_FK06>U9L7"-G^_G!?B1_WGIB;XC.<L@UID@)*, 9BF"!#$,I!#%+-$
M9TK'[@KK[NU.C?LKRZN@[)[M'IDI'IAW$_* 2 [,M&= M-HZUN3HM^:_UO:H
M,MXG]<<#8(\<H&& 'BD9Z'U1BOFR?%E5@QL3PN8+V]7C<PVT#0>M-IWRLNMB
MJ/P@?_PZ$X4\'C=>QI"_CWNI0SUN[[=Z>,?*QX_SY1^_&)_,C_;$6[U+NI G
M D+;EV=3$T\(GO D3@$F2IO! *6 4ZB 2$5,$<69EKG/>N%:@Z8V2GQ]>7Z>
M5VI\;![)O8]OL5P ZV-4K-53^1>_"?_5'><VQ1^S.P8>:JPKD?7E)FJ\B3;N
M5&1W*MP=[?"E0V5)[TE\*'Q#3MNOMFG4B7HH! ^GYL&>VS.LL]'UM/-^M2BK
M><&.N&?Y\X]C[<\_V$K6 NOE7\V5Z_)3H_[R=V4+:2AY^ZI6[)OZ\%VM1%&J
M^U4AU Q)G*%8)T D&!L.YQ00G@N0D"SE*$V4@)E7S&<\VZ=&]Y7E2D8_%8M(
M+N=SMBIM:9FHM.[^R3.F,^(KX!CPF6;'#AT-VI% WO5[5P>YC/B/Z*16LO6^
M+3IAUC4U G;#H,;@)FI1B!H8HA:'J (B8,!H_-X+&DT:T?QQ0TWC]\M1'.H-
M3.BY8%DI6=BCKG4-J*IL_2S)F91(4*")0 "2U-88R!F(&8(0(1H3Z734K*N1
MJ8TTM8U1:V3T6VVFY[[!23@=EP97@C3T=-\7'_^Y>P< 0>?CI]H9=X[=X>G1
MO+GKVA#:%.^69BJ^6A=\KNH?2ZMQ:*DEF7&(,*?<0$CRW! !$X"3W J629ID
M.4HUC?N+572T/#EVV-@7/5L#@TQ(W?O!C4$&07=@6CF2OM@QN_U+!7O@R9LW
M5L.I8W0U_H9R&0Z8=.MGN#R@'X$=S(=^>;$YWW?ZO=WO4[*:6)5W+^MRS1:R
M6'R;9;D@%&D.I(@Y@)(10#F)0:X53P2*48Z)#XUYMC\U,FOLK#BLXJW2D[A\
M\9=4&^2I!@(2 B WG<"1F4]B&*L\,>#GD/H4*AD2_Q$*DVQ6J*Q9H=:=4&5E
M+Y^>#-F55<[;<NM"]%)6ZH15.9.7*L1JBY@433&-N2VFL1V';B(Y=A>[C5 #
M=MS X]115*&VW?99;7:T8_=-U'@4;KSJB5S(4<O7A%''KI[X'(Y@?1_3;QP[
MS#KYF96%F"F>)PEF.<CBU(Q66.2 "XW-'R16*),IRKQ2M4^V,K4QJ3(J^NG7
MK^][3Z=/HTE4%@M&4Y#$2@*H(36KEYP CK,8:ZY53).9Z6V^' W/W=:&0_27
MKO&!#P6WVSAP-80#L_UQON%-5-D8CM [(0A)VZ<;&I6<.WT]I.#NB_L1;<OC
M=^9E9W;V]%5]J\*P,XABS0P) $F%H8<T,<R0(0923%&>"19GU.M4^=F6ID:X
MV_G+LC4U*AM;_8C@/+AN9! $LH$)88O6QLKHZR6TO#GA(A(A>>%\8Z-RPT6?
M#_GA\@W^\D\?%NMB_>-C,6]F?#.1,LDQ%T FB9F#Y5)8O5X-$I&Q5+-4J-3I
M[/"IAT^-"6K[(FM@LZIQ5WHZ J[[D[\6CJ&'?7<DO$2=SKE\A9K3T2-'DW$Z
MY\RN?M/9:_IO6/1.N3M]\X3>NBH$/G!>7#<(H6/;;YW#UNWMJ:CU^/EFYQ(
M/OS/B_ETME'TLBJ+^O#(%DUJP,?E2JMB;<MIU-D!,YI++AE3(.-Q; ^0:$ P
M-+-9C+(D%F8(PUY"%R/:/K6QL#YLS*PS923LF=+Y-5'4,=\"+A#F:<I!@K@"
MD.844&;K5B*SD"%"Y!BS5H'FX9_W9=C7KWEXLW?BW^S1CMI^\[/Z_ERL_EG>
M%+=Q<VH=/YWDQ NYB;7_.YO:95070E\;"+:9BQL4MLF+(^8FAN^\47,3 YH_
MK=S$\/WBG9LX@ G]YE";%?YG96PYV)KYHFPF5/M+,PX\)3.&!4Y42D .TP1
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MSJ%+&959*C* TL1,Y72F#+H&9YUCB5.9L(1XQ=A#H#M*VHX9+1?K6L;3\L]
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M-B"8)C*EG$DI@LB&4:ZT-S=.J<TK?@@@E*>LCMHLUFJZTM8=;6(&:TFF^J]
M_'.GAN:5CN6PK.=ZK2/,^,8AO)X9I[-4+]::8,%]-7HOA5L-D7').]>:G)1Y
M#/U_S3VFMWF(0:]_V<3!5Q_^%"4K*L&744XPE2R$"<T%1&'.($FPFN=D0@HB
M*5&_=Q:/?M:$N7%49UB]DU5'Y&X:BSV%-9_OEUP0RF1&(8MSH@>*2/5+FL$H
MDQ3S(,(\#I=K\4UOGKYIS^1-S_1-\=<WK85 ="9.VB=F8X;?+\#S,-*O%7%4
MW:-7, +0%W"VIL0?I.2+-J%*%_=J_:MT5H?K/<3Q*$\6OW[>BOG$L@^B9!77
M/ORDL8K.U7?]_Q\.4\ O0HV2A=YBU+^X6_/C'_2N;(S[I*>6]<%X\U_U[]6.
M*]L__,F^Z[=9GS]]J&>BRX 2%(B PY2F4F\A9I"D,8(B"E# \I"C@"^W&S5+
M-6/;:<VW&D/W3OBCD<]BVTSL=3JESNG2RBAZ6E__I3>KMU66GO2=,./[^?:T
MY[%"N[( ^D_0\TB?.'7.-K_4_?[Z9T<W-"" #@7P4X?#S_KHOX4"=%C400"@
M0<.E@/9;]*);'>Y)/9A8SOLM>N=4%?Q-K!@W?G[>K#>-RO7ZFVIE\R3: XTE
MD5S(*$*0AJ%:6J0!KC>T89#+@.& ,$:MAKJ++<UM5'K4;:CAJ TFTKRTJ56E
MB]IJ\)-H[/ZYSC&V&YHNPVTVBC@!T3/A]VT$GUK,6C,='HY=A<(E:UYN;%*"
MN^KS:RZZ?L/MJK5?M,3,O?Q')6J1A&6<\R )40R3)$,0!0F'A&<Q%$D:)^H7
M.$RMCL,&VIK;IM"1'NUX.=K7B)IQ@R.</+/#:QDP;2C<2*A,[614B-2E4.X8
MVSWM5G4,Y]W3IMP6_QHNM7"3YNP%P'P)S+YN[LW49"_X/20=>^F66V0)[SN2
M:L18NK.VOY/MKNS.W Y%6Z,D2WD84B@YPFIJD@N(@R" L2[AEF8"Q;'5;O0(
M&^;&/+W2NZW!15.FY"-AS8GRKZ-5"^TZQXRL/$/NF<0Z3<.]_7NUJ$.*7^>$
MU[*X-\#H7O;0SHPW4$$<A=-Y4<1QCQJEXW$DU'TJP+@_J^8H)$DDB9IWI1%$
M>2#4O"N/8,YYD@=)C+B,+00^#)N=&Q%VAD/2*M>79^1<P4\O@I2F9T&6_3!,
M@/[0]<QY)R4!SBFXF@01W/2.VTB0>,!XH@QR(ZR=Z8]8XG1%F,3T:5,JEEAZ
M^$K*Q/;ND3%A7<GSPRE9J[L3R(Q*F@G((I'JPB\8$J0HGH0BSSG&-*96.487
M6YH;E[=GA98A71=Q))%(<IPG:O;"$$0$!Y#0.(5IQ$(9AT',,VDGR><$R6E4
M^+J8B+X4<%^-SQ7(9M-_)\!Y'O#.!B\<XANZ$ 8/!;BNHN,T7NYB8]-&REWS
M^21&[NH-XWCX%U(5U;UL,P=T"$-=W*_Y\[#,Y:G$ 4D5*>>)(F6&,HBSB$.!
M21P*G*(\%S:D;-;LW!CZ8&Y33[.PW6$P1-N,5=QCZ)EB:H/U+LW!Y&D*D]HA
MY9)N#%N>E'OLT'A-1)9WCV.E5[/0SSO-=/>R":RZWVVK+5GK V)M#%NB5#TD
MRPB,::*U/C&!>4 HY%D>\(0)$C KE0VKUN?&4;51XR- [9"/,44BP D,,%/#
M0B(QQ%02&/*(Q P120)L-\?TAOTT\\[]4K;;CVFS-UZ+06\.GH"=GG+5&M^Z
MJ+K^R;J)%*N/DG7"ZL]:+Z!YU +0*3O8;"3RUFE3;_(TEM?)_DV_]8Q?@-I\
M=Z/2*-1<#DYV!DPZ1HW"YO50->XA+D2AZD'RZW,I"+]?_P<I"[U!KJ.8PB6/
MHTB@&.MDDEA7N(X@B?1@%851P%"*&3+:M[9M>([C5 6JVE2@>/%':^S- E$#
MV)NQF0]$/1/9B3A4@^[7/;J=X76<J"]EJ.M0^=.%&FC[#56AKB,RK EE</_(
M. 0UJ]":G8K]Q%JO8YN$\SS&,D]TW0ZBE_E2I_734,(XIYS3A& 6,:M0@[/-
MS(V*:F6+(S/')?-? -6,=6Z'RC/'C$#)_H!_$ 2G9_CG6YKVF'[0VY.3^.&K
M1TI]J"[^K#K]_4:?\RQ91%BJ_@=E%#.(A%I)DTB1 )%9P *:HCQ*K;0]CAX_
MM^]>6P>T>>#WQD!;\8YC\,R^\_&0>/Z^+="PE^,XZ[13_8WC%J85W#CKW8G"
MQOFK;E)T_*AL.2>]?=A*1DD8$,0(#-(\A B'$:288!@B0F6:\BCG5AOWI@W/
M[5MO[1ZEN'@=9;-/WP=VGDFA-1GHEQ[LE?[_Z"O]JUF CSU[6[ \Z!U>;_LM
M] R-$;F@5VA^_XCXO>/ERQ?!A7BJ@P-5]U3?-ZN>INV]K,\R'\J"B<>R^/9-
ME$O%54DBLQA&:L&AYA_J#YKF&51$)60<X#C@1NL/![;,C\"X>&K+LG8.Z&WA
MUH.#,,>S=@)L&R\LPM)N[+IA"IRX0Z;>;CGXL@![;WI:W/6.<MT[M4?@<>K>
ML8@DG*Z7)@HO]-Y;=A&(;O =#$N\L8GI8A7=8'$4P.CHD2.GY<?)0O=4%]83
M_-.ZRV3^N"DOQ-(ON<0LBG35XY3HLU020IJG"92)9&$J<9B'5@<#-]@RM[&O
M=J "A/US5Y2"@YTN3P@.:;<C$A!OZ2G#V?XT^/M> )QD+(+.$WUFO=>?T!++
MK_*##NE!#E<%MX/J=*%P@SG3KAUNQ^UD.>'@D;>G8^^?V<:L5DW$.M<'O1^+
MBI'5?PI2+F-$\B!(4IC2@.M"/+DBUQRK?F41QX+',4-CL[3-3)@;I^Z-U+,=
M/848G\!MV =FM.D76<]L^2K=NY<?N=T *L #*7A7?:*%OO$#:$?\Y'K;@>@K
M!=S0BC?+#+=#:2AAW/))8T5-R;:.RW^W(E753F3O_BRJ91PRDF520)$P A%+
M),1QG*I_9EBD48XQL]*CN-C2W BMMN^P=/M=VVAYH',953/N<H*59XJR@VF$
M!.45"-PJ35YJ;&)!R2L^G^I&7KMA'"LTFC>/Y,]6]N87L1:RV"XIPAPG.8-!
MQ!4G2))!&C,.<9#*"-$H#9#5(="%=N;&"*T:TY;\"5H1*SLZN 2G&1DX ,DS
M%;3X*!,/=5U:*QTJ5UW!P24?7&IJ4C:XXN]K+KAV^8U,("H]Y_PLMDO)<,2P
M#LX/ T4"'*>0HDA &68)95D0X]QJ"73:Q(R__V=EX<B/_X"@Y7<_"I?)/GE1
MM:N1SP.J?N,_]A/GO7SGAU;>YA,_\?+BUWUZY<B K791\;BY:W9#_T[*_Q);
MO</]5;!6"6F94!((B11PC&%=[#R!&/,$1E)(1D*>YZ&T$\HW:M?H19]4&_^A
M2_Y6$]ZGO<6@6/\0U?;)7FS9#'XSHG 'Z40!8JV]>B^CM1@<3 8'FQW&C=E
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M1:_.5PK@DH8TD2%,U301HE@&,.<\5E-'G&8Q93B,K*:.5]J;&S.^:VK#%6O
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M3Y\WR6=\T8WN [U\P;AU^JO#\\\[_3FWFP?]0_;WQ6JG+CM$LG[:BJ=#A+M
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M8VO W/CIB]!1"*L7<,<WSW4D]MX;T+C#QIQ]6_>+&9OY1-LSK2G33['MC%^
MMN2W3>GO$25RQJ'GME".I0T3E\L9A]!IT9R1SQF5R?]#K'>BE^1Y3U==@*OZ
MLY*%X/<_1/E8/(E63&P9<A31F,0P0VD.41P+2 AB,,4QRT04I#@U*J$]VH+Y
M\6#M0Q,CVL]PWNQ=J8!:[JXK*=3JE^O)"-M5V\V3,F[1J1!:I:./Z+9AEIRD
M,SS39&O^XBCS_^#! NQ] -H)H+U8=$J?ON&WT@/PVPT3*0(\'*EKED8?R7>R
M!?K0_]+7 C:ZX[;*;W>2 >/!OB(:,.+!4\H&C/?[E7# #0\:'8-ZL6;P(9B
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M>7Y^Z0UJ+43)*8&0.H+BUH%/TD(4C#,CDBQW->H<[I;L.CGC)B8;P6D R7>
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MW_+ZPX+^YA-]9/-^:F(#+TZ%0 )G%E1]7!=L)O? VU1XD2RD)F];3\CCN+V
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M*X@;-* #-YI$;7+8;UCY-Y?J!'%]X&+13$D=F.7[3J]?+[M?*J6"5.BA%&=
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MN(__GE_.Z-7":9LIUS5)@"H)ZT+0#)FS*+2QRJHVC:+;TSAN!G!,Q.VGEM-
M7)VX<\E<8<IY9T"[:D1"6' N,2BU*=8']-8UN>/:B<IQ8[&CHFY/U8Q=G[@?
M@5X'J!O6?IN?+S:<%>%XB%Y!R$R3Y^:A+GZ40/Q:8[U4H6PW5FNGKQUW#.3A
M*&HLZ)%G_G^<KFJZ\_LL3[]-\_EF]U&VB>G:!F5#W60NK8'@,()QQO/@A9=^
ML-4O#U(P+FC&30.'44MON*H3<]:=P[5:]WGZ]>/\U]EJNOIQN6!)&A=J!28:
M4RW3%PC)D7EF4;RAW_NM2@_[(>YIVL;;1C( "I["U( J&?L@?#.?75;D7DT7
MF.BO7I:$<Q8A<4,N>+UL.SL-P7,D7GR6P@F9O-CJU'O\.SI"R) ZG0\OX+%Q
M\NMWI/^??B.9E6FBS_R L^E\\4>8A0M__F*67^)B1;*Z9/>239311RL1BJ20
M4!7!(4CF0 CM''>*J[Q=!^/^-(RW&>=H.#N2@KK#(;%UE],-6SIX;R)WH$UM
M#8[<0L3$(1:7M$-;O,O[X>[1[QPG\1L79\,H8.2HZ^7G*9:[K%W>NQM-\29/
M9!1(YI$<HU T,R!_[4+16$P:+,)Z@HYQ(OMC86M()?1;U+I.?Q[+?EY?C0P+
M,O',R T'D;!NO4O@BRB0+;-6%\<:C0LZG/1Q%Q+T<15Y9 "<,N3?G%<+?UM>
MY#RM_R2<7338O3A??9XOZ@@"RMP\H34RX(5Y4$PKB,'9>IUBA+71Y-"DJ:,A
M3YVW\PX,SZ&L8V"L_ QF<T\ 1EN3O*:CDLDZ3)G7AW!6@&;>ZL E'9FR2V/9
MRT3&:]_KW$0.PL4I&\;EZ[[E:G&^/N7?KC[CXN/G,-NT//ZSKB];_GXY_#GE
M1"&DL<!-J;-970:2#8(/A2++(&VZVXPZLKWLR&#G#8B=FE%+%)VR=3W(_3\7
M\^5RXKCCE.D;"-RE6E_GM4%=@111,JG)]8@F8S<:\#+R-=J)VLQ V#AE\UC_
MV-R=7_#/)UQQ0W%H!+29XM"@V45C,V*.L60;I3QFS\I>3(R<TY^H01R*AEXL
MX=XPN/N\QZ=X?S_]]'FUW"S$#I]P0L+.7B)Y E09E"#'X)Q(P%2V&'UVZNZ"
MW@%-8FANQMVBV(-MC(J/L:^D!O$.%Q+X8SY;?3[[<2V(%X6(_&VZ6*[^%X;%
M1,;"/$6:8!7W%&3Z6@4/"GAPB8Y3:[!LMX'O>#2/NR-R)./H&1>]G"E-DK(J
M-<Q729DTW$G'-!C%"RBE,[BZ[-5%Z172G_K.(J\=&1QW"V8/)T]O*.K NC9C
MG#$_+*#-'-])3)I.5)9J#V_=$JH1(I<6O-0Q14;"MTVFW&]'WK@[-T=&=@,-
M=H#+]8O?WY?+<\ROSA=7&=%%G?H-_GO]1\N)0<NM$0I$IJQ(.:7 H7* RA.'
M4CG39GCK=N2-O*-S;)<[O KW!N8W7,3YT.,$GAJ/_V8^^[8^&-8"77Z<K\+9
MS3]?;_Z;4T"VNAZ>/U$>=8G* H94ASG3 >*PU$<Q484L0W!W=V8//(Y@:(Y&
M7A@ZL@'T 90.G'DS05QXE-_FB\U_JG^/3[05WF2>P$@2D5(Y@K/:UEM,X\BA
M<*Z:W&D?E\V15Z7^K+9U.*1^JA4FE_N/WI9-NO/V?+5<T;^B\_S/&7T.94."
M<5^'OBR/NN9D+\K&6X5RN"#[6)?"N,9 L1FP=6\M=P:B30YL1*NT2<'I)L-9
MQUF7<EAM[G*'V#=29FT2):^RONY\/S\[HU_7OS*A6%<+A@@Y>0;*UC%:)C*P
MWF6F!694]CGC:4[E2:](V06QP]1DA]9[!R'<4!UF=T4RR48I:Y,"SC0% 5Y:
M.EE1@';),HZ*)Z:;9/"-&!IQR&D_>&W4GG@0>/8VHJ\798M56*S&N?][A/N[
M;<WO"6J+;Y0=!BV*2%J"ES4[1,4@:(G@BF=!:J,3D\V.E!V)'7%>:W?FTB5
MNBBY':TQLR3A8I8!=#0*%,N!8@6!(+Q2C@E3O.SK[<A)M/?V:6Y=@VMWL_,7
M9C?#3S4H_CA^Y/=$@V?.(8N2"ZFK.J",!6)4&DI4@8F89$A]=='WUOS[DUK4
M0) YU'A&;/.Z'?'^^AT7:;K$:Q^B)7?2QP2&D2-14CL(TFD0(7 9+<]!;3<,
MO16%X_3^]FD/_4#AE"L(SQZSI**"TYM-."5)H7RJLK"EOJ^AV-:7.B+<2.^\
M$8+W]:IQ=Q['Z2/NT\YZA]@I6]]M 9S7/'.6?_W^=;JXF.AQ+1#'-<_1@'=6
M@_+T(QIA(#E!7@IYSKI)\T)SSL9I2OY)+:T)G$[9OIXK<:I28M!.DF,)) >&
M!H*N6]X#TSDJ1KST-=EEB/KXX%W(/ZDU#0F> ^OCO\X.2YN&\BPWKM5OJD<'
M.I0#CZ"=5A0L9T]"* R22C$:7NKVRZ[,Z$EVQAUV,<)];$?H..7#YKX4+CS(
MA'/-%-9H-ME:79$D *XB*)U#=,:PI/MZ^_(8)R<Z*6E >+:SF#VP,OJE:\N2
M9.%6FI 1DK?UR)=U.&_FH%7,*)36QK9[ESQ"%;N_7M)^S>90O/1Q[?K4"XZ;
M>R$OBY-Y8G.2P08.7I4$*M"O(F,6O/#D'(KG3K1IY]F9U!.==-00\FVU/>JE
MS/'J%LE%SDUF@%E2RF4IY8I<*L HDY2Q"!W[RM<'+8/U-^6HWR-B6"S]/ T#
M]R/.% MGV3@P/O$ZI5.#8W7*1S%.1R59T5VV"^R7G?0W&*E?&SH,*S]?R>M?
M6$> 8'Y!86#XA)<G];O%-&'56=GH+%B9F&(*6*D;O&OWK$MU,S.&DDF$A7<V
MZV)O5L<-\WZ.4ED+5/U<9;2G)#2Q/AO+DP3RCR064Q3XR!(4D>D/I(_>\Q,V
MMI^FY-8$YN-8Y4Z8.YTBW:,[&!ZLNCPI(.]4\778A"RNU!FC&0+J.FA4<?H-
M!31EG NAX7C\:8IZ71CF2-@[A7/R.='<ZUU\4CJZ!(_1"U!*UH$P%,L'+1+$
M(-"$9)AVX[S!&)3-GZ;\>!+&V0Z!IV"?AQ:BGA06CX;EA!)$B Z4=R0G)PS%
M'!:UB+IDV65GQ4%<_S3%T"ZLMQM\_@3&O&V"P%GTRGH#Z+,'E9 2!*$#6*U2
M,DX6[&SQ3X.D]!0JK:=@H"TP]Y/49J_?8%^7 J_K>S%H+)%SR,XK4+:NO%#(
MP001$;G10G1Y6?@D5^.>C2=<<1T.*[V<8_%Y8<2=?<I[K(MCZ;^_G,_6HCD/
M9Q]Q\45,$KF](%.F4SYS"MX3!R=(C7410$*GG,1VF>-Q>3WMHNN 2!]JP\21
M8->+90YSVO].DIC.EM/TG^'L'"=,!L<8BQ!8K.U Q4*0B@*1D(U*44>9MUE^
M/69,>9NCTZZ@-K:RT2%T.O<6>XLCIGI3DT@_:,F_I)+ ,V,A:JN*%L6@CC^?
M175;]CQ%B]H%0H,F73V-KYV7]5^[F /<W0C;G:D;?XSM80+M8Y2MJ;N.F(H@
MHB?+T$E Y+XF?$&)Y!GR-N/VQQEE>^5ITF?,YV>X>36ZUZW*Q_K*=))9U#H4
M";$41NZ%9PA9! B1E3K/RFMOFQQ.0W%PTF-M=T'OO=-F% QTD/M<4$Y_^<7W
MZ7+"2LXI,P2#&$$5+L"G.L@C,/HOU@IFFG1!WJ)BY$Q^'"3<W6&TMUHZP-3^
M@KMF>Y;K8?DF?,%7\UIFF&@FG,E%0;#!U:;J BYY 3R9:-&C<R.-1=Z#F7$1
M?@"V!NM"&$C18R\O?8]T]DQ3W356@[\_9]-5O9%]AXLR7WP)L\T>CO5__P/7
M[?C"BB!2RE#JK"3E903OM0$MDLH^(&=\N_'VNW]WYR72YF"9'T]SI^"%G]]'
MXU'*[*R!7"0GZ?( ,5#.G#,/,I1ZI/75R7)%^LAURBYBB",#X)0A_V:^F6MW
M?^[=PT^\ZKPM5W@!J>N&[3J&-40IH2X[Q11-%*5T91F[<MCY63$P= <;/]42
M1Z=L8,_.D[S:3+9YM8CDX(PT=,1J6:=)9CKB"U/@2K(Z)<=BZ.OHV97#$S6P
MM@@_VOC20^!V^K=LN\[IETY9D]&!R)&B$!4=1"_HMP6]4(915-S7<_,62R#Z
MN]7^26SQ +#U,12HF63^<^VBKB23F2^,,Y('K^.2G"'U^9(I-W Q4[(;5>YK
M,]B.#)[H5?A/8H8'@.VT)QGM,>O<)Q6E818RTR2<2#]<H-]J3>[*,&]8P-.R
MQ/W&Z??WH.<G,<;#(/<3C#[:.8)7RHA@2H24W;K7*(.O,]*S2(;)2.)3?X.$
ML;\'/#^)01X"MU-_N;.]<.YTB*\C^U?D47X+T\6Z^>[6F"RF W-<@\)0IW]F
M"8&'"%DGKKGDA:>^FJ/;R.%$D\^1*ZT=8/+O48]]5GP3BAYR" Z!24H25*KC
MK[-+(-!F(T,T$D_UY'V6^1.MXO9@/1UZ@IV@_+<K S\OOA046DE:CRG5FH$/
MX 3I7Z4DT >#+/5U*SJT!$[T+/];N8.6H/ZI0X+;!<+G!8>,\K:(I'1CZCN;
M:"!(01E3U)3C,>5D9W-PAI; B=:S_U;>H"6H?VIO<&,&T?-2\RE(SGR"B&@J
M "(X;07D5)27 F4ZT?6S6[%_HJ7TOY4?: ;GG]H)[)!:!1>5YA;!1D^I5157
MW0H,-D3N=6%U0?!IN8"!JP3]E>[_5@Z@$91[JOW?>\*\Q1289^7VXM.GQ?K6
M\/8K^ZM7F5E+HS6GI(GB)E#>K'>O6O#,)D7Y$V>FW4ZX,3@^T:A_P'I^]SCK
MY4P^IJ!NW+9.A$U!:?2@7: D)F16YS-)\-8%6ZSQ(:N?PB9O,-U!I;Y_NQC;
MFO<%:5^U^+$DQHLTJE0Y^=HBY*RCP(H[,$8Y$V)$&=NU:?=LUFTK[O_'K%N!
M]*>;OO3D'_[RXQ42[%95LD>=NK0S5>--6SI,@)U,6?)<Y<P\\)SJT&<?Z$RS
MY%6ELF04/C#>)"/Z6:8L^:1ESK% P3IBU*D"+BL&PL8DN3398YM;YO\S96E'
M]+:;LK0+!CK(]GZ?D?,CYT4"KHR\KO^@\EL'L/#H!8LZ L6ZQ(H2E&YSHZ P
M'QPG*$;7Y&[D"9I^E@E,.Z%DWD9E_:)O,T(E.E6W(6@H@M5R3Q04FL4,A0<C
MHF263/J(^.MA0M)@NM\.4WLHH@-4U8."3#2<X>6 '%9BRJ1M$,FX.EBU=LHD
M#E$%EX600O,F9:5[E'2)GGVT/!]2Y!U@Y@.>T1]]>C'+?X3%7[BB7V]B]PT_
MOFB6"KEHER3Q(\AM^Z IQ. 1N8K*<='F3< SA(U;9FB'J$$5T@' WI-BB(#/
MQ- K_(9G\Z]58+=90B$8,IM!,X&@F+#@!6I(7*B 65H?FSS>W(*V<>^.VL%L
M:+5T@+1_X@P7X8PX>I&_3&?3FAZMIM_P-E,VI(A"FOIJLV[/B8:B!4J>3+'<
M.)UR:;/I>BOJQNU+:H>VX573 =X&N-A5B4GA-8G32 DJUL?]JDY,]*Y$D13:
MV%<7WNN?;9S?(0GID0'0 >1?G*W_#N:'6=^8\T3I[(/A]66\,: R-^!=*!!-
MR9B<MR4W@?5VY'5P[WQ$T-P=8SV\!@?#Y?#W06]P=7&HO9XOE^]PL69ZGRN<
MAS]HJ%N7+<@<Z*+DU["H^\&NON2JB)RBR75Z*2116P!31HBB" K]/.:4C$7;
M) 1_C*!#/=7=S_U( OR%_L)?$UE2*K[N2[1U?79Q B+2#UT*-QDC4Z')OJ)'
M*1K7'PV"B+M>9ACIGYIC64<4>]T0/_5Q39W,0R2W=C7(9,1D&#CF:P'#: @!
M$X5<2F,1T<K0)#IHY6JN@]&[WT#'ZS35#'MZ=EZ'^%1A7YM"TMPD%QPX.E$I
M])0<O%(>K/>2!1EMQ#:+T_:CMU,WM0N:'K_];*>Y#J+V:S9?S%;37%FBW/L#
MIO/%=#7%Y:_?T]DY&?QO)/4:#)Y?J/6^5*XED%'%XDH]'$2 6MJ&&'0$R7R,
MJ'R.;2IVP[,R;B+;&-:CZ/O4CNTW87%1C3J@Q6N[#VYZE#_-1NM#W:>D91VW
M%4*IU4$I('"LI>.@N"NIZ'*4J'KX0_U0&UJ7F;1WVF**8%!0RJZ8!J>4A,0-
M4XZA++I-?_^@;'0: NR"O7:^<F<]=Q 9O,*XNFX>7G=3:(<ZZV(!'=HZ<">"
MY\: BUB,%TE$UL20[Y/22\_3\8$Q'U1+W>'LQK8HYIQAR",D4Y#$H@+$&!1H
M;VS.(@4,ICW:>MD#=ZBBG\3-GE(?>Z';R_H*>+&:DA%]P-ETOG@S7^'RU3F2
M9LWFXC#J^D;99C#1U(MJ%."C+!"0D^_/&&32ST5PVWY93PC95Z7SAO+MP-L<
MZ+!_^?'P!US8(PD5G7# ;1TTP3@'QVV@U#][750H9*Y-KK;:\=3+5>[HYVPO
MN.G6A&[X&U%J1X:I=Y!U)TB6#'R6!K1!X[+T).8F+QN?(VSD1:Z](&@K9.^I
MS@[@>>/0JB?B-4N; RL0%XH%#86X(IX"0JSQ4V5'1RL179.FU6?HZA&<^X+@
M7B/T<!KI & '&O+KJUX-.G"L2;RN"ZU\6RG U48*'PPK&%BT>$0_N3L#(\].
M^6F"@_T0T8$EW,XX;ICYQ=H%XO3N$_1)%@&-L A8V]25%9[$3#^R=L4KJ456
MK@7F=R>U1X?<&E)/%@D&U^_)708]]!\'OQAZZDO:7A)MS5[K"R,>*=Q0M50?
M8P8E5*I+!06%!IYGXX-7L4F(=OPND$T/P2\_R)J_S&<OS\)R>7$>N<R5#U:!
M\CZ2#+PE0XIDQLX(+,2 ;[0A:7=:.[WZV05%VW=_#*.Q#@[OBT9W^LOK##(Q
M%!H]A^"XJ@]E%01T'$3(DCRW4RXT.9=O4='+K4XCG=^-&O=60 ?HV?]MQ37;
ML_SN+,QN))F%"\FERL"TT* B4B(898!H4M3>%R5CNTEW S,S<OBX/[9V?<C2
M6M$=@/U7BN;F/_!BGM'%\*S+%]V.EZQ#W2E7GZ5A2> YN8-LDT\N252QR9SD
M1RGJ_ %+<[#<;38?1',=0/ ]4E0S3?5Q3F7ES]ETM7S_X<\-,P)S?>)-YXZA
M'PK)P+U4$H22Q22M<F%-VJ:?I*J#87\]07$X#78 1XJ,RGSQ)<P2KH5X5<HM
M41FN$)*N5\U8&=*R0&8^%2=(?-&W .(C]'0^W?G8$!Q":QV [Y93OYQ'4-!J
M-!Y*\0E4" SJ5,VZ=3D%AR9PT:19Z %:.E\@,NH1O(>V]@;<-US$^5"0>S@C
MO"ZS:FG(6J0#$0TE@DI:\(EK*%IJF8WQIDWOQW.$]=+ <9R4>E U=>#I;I5D
M7WP+T[/U8Z/YA=!N#F3=<'H]^#&E&(HSD(TE1JTR$(AQ0.5TR4Y9[YLD)GM3
MW%<1\3#@S,?0XDG!=?V&;L*\\39*#CFS0G&'I6- HP,= U<4$0?+F_23[TCG
MN- \$GKVQNSNJNP J;_/Z+,H(7L[N].<0GR_+1_#]XE+E(]%23&QKS6S7 ($
MJ3C$( (W.0NE=0ML/DO9N"?Z.&@<5EUCMZV_^#(G#OYK<W6_OF1?+L]K5K8>
MYWS%DS99222>BA2.HF[NP*5$C'E?WUSF(O*=_J!'6M>W_,)QL^7C(JN9(CIP
M;CM+<A*Y#-R5#%S5D3[)&H@%&4ARZBQ8B\4TN7#?F=)Q<^O>C^)]U+D_7N>K
M<#8(7N_L\+ML+KHH4=W81K)A[WHD_CHTOQY*4_N.*-RHZ_T\66FH4Z\2UM8C
M2B>%=TPW::<<AOR^9@T,FO^,H-\NBD;;\KV)H*,A[E2L)?\:P:0$/E@/4GC!
MI5))FR:7WSM1.6XJ- :0]L3R[CKM K*/^($KT44A PJ?(!6*L)5)&D+,&IQ-
MSGJFLN5-[G>>H6O<R+6I\QQ2(QW$IA3)+-;7$.%L$[^L+>?%:K68QO/59613
MD[SE551^W0 ]D2X(%WT %I"#"O6YLZ",+WG!@F*,8JPFZY@.I+O+ZN9^&+J_
M)>-H"CT5_-Z_7[MQ_39Q):A07SI1E"Y <=07SYV0#B7T 1D/30[ZPTGO,D8]
M'HJ'4VL'0'XDD-D(]5X\,PF%4;0B(V!*Q!Y9*PF60.9,=-RRF&4Z9G;U&)U=
M1@*#0+2EPCHH CPS9?%&5[\)Q6@*WG7=H6,\KXU2ED+J9%$;8TJ;!6Q;TC=N
M@>JHD>@0&NK $3[(UD1%AC%Y!=&;]1A/"T$S!45EZ82,DJNCS+SN(.MNHO=M
ML+63$GI.GR=!Z90E\2 E8V1V68'/-4K(6AG#G+.QR1+41^CI*XX[!I[V4<2
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M63MFHFP(L>?(ZS$ZW1,16Q3C#E1/-Z"[6>UY@">NI21O7H#7C4$D*$K_7)"
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MGXLY<+5[T#AO#8\E>\:W.O>V_,*1T[%#M3IO+.(./,PC\U$V;143(IE.=AU
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M#+I3Q^ @NNK ]3WV\)!;QE1A$0JK_0\I9G"Q6-#,D3OWHDAVC'&9.UV7^A,
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M'JR)OLG@@ONDC.MJ!M+QW<SI,('W )GYER]UM!0Q<!FI!THC;1%@@U.U?:V
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M\&:^^G >_S],JX_S:QE,T 5K;4Z0<EVX%T2$Z"GY#U%%&;32,NX3LNU/T78
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M22YD+W,235;#[4%KE[?V>X)E?ES-M6]3V_Q!_1'#$O^?__;_ U!+ P04
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MMVY'>P?\W[=UXV-+-5\S]25S$9&NXG9)8@2]+RA*UDK<A6H2R]Q@G5_4 ?P
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M/ 2=P-I'0,M@,%.UET/D "-2AO4AG_ENJ+K&KYCX>ZJ+_P!02P,$%     @
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M9A #:J2!8BL @3K2RD^H.W7+D42)2.DY53[1UI<XCNC561W!4SB;0(JOO3A
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M;F1C=71E<F%A9W)E96TN:'1M4$L! A0#%     @ "H@&4W269"N""P  MF4
M !X              ( !2U ! &$R>F]S:VEN:&5A;'1H86UE;F1M96YT,C%A
M+FAT;5!+ 0(4 Q0    (  J(!E.WN0H>:0X  'Q2   >              "
M 0E< 0!A,WIO<VMI;FAE86QT:&%M96YD;65N=#(U:BYH=&U02P$"% ,4
M"  *B 93=*O@/"Q"  #LIP$ '@              @ &N:@$ 831Z;W-K:6YH
M96%L=&AA;65N9&UE;G0Q-&HN:'1M4$L! A0#%     @ "H@&4U3EA2L0+@(
M4U 9 !$              ( !%JT! &-U='(M,C R,3 V,S N:'1M4$L! A0#
M%     @ "H@&4]6VM_UJ$@  8<<  !$              ( !5=L# &-U='(M
M,C R,3 V,S N>'-D4$L! A0#%     @ "H@&4]0T';OH(   >$(! !4
M         ( ![NT# &-U='(M,C R,3 V,S!?8V%L+GAM;%!+ 0(4 Q0    (
M  J(!E,8?3;=8U,  '&H P 5              "  0D/! !C=71R+3(P,C$P
M-C,P7V1E9BYX;6Q02P$"% ,4    "  *B 938DWPYC#V  !E' H %0
M        @ &?8@0 8W5T<BTR,#(Q,#8S,%]L86(N>&UL4$L! A0#%     @
M"H@&4VI_,+G_D0  :[8& !4              ( ! ED% &-U='(M,C R,3 V
M,S!?<')E+GAM;%!+ 0(4 Q0    (  J(!E.8RJM " @  *HE   ;
M      "  33K!0!C=71R+3(P,C$P-C,P>#$P<65X>#,Q,2YH=&U02P$"% ,4
M    "  *B 93"MYFG0D(  "W)0  &P              @ %U\P4 8W5T<BTR
M,#(Q,#8S,'@Q,'%E>'@S,3(N:'1M4$L! A0#%     @ "H@&4]+54T=E!0
MQ!X  !L              ( !M_L% &-U='(M,C R,3 V,S!X,3!Q97AX,S(Q
:+FAT;5!+!08     #0 - )4#  !5 08    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
